Citrus Sinensis ID: 003855
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 791 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.988 | 0.774 | 0.383 | 1e-145 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.988 | 0.762 | 0.380 | 1e-134 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.972 | 0.745 | 0.365 | 1e-132 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.955 | 0.644 | 0.358 | 1e-121 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.975 | 0.787 | 0.343 | 1e-119 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.962 | 0.609 | 0.332 | 1e-114 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.962 | 0.607 | 0.337 | 1e-113 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.972 | 0.673 | 0.307 | 1e-100 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.954 | 0.685 | 0.329 | 1e-97 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.930 | 0.738 | 0.319 | 4e-97 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 516 bits (1328), Expect = e-145, Method: Compositional matrix adjust.
Identities = 314/819 (38%), Positives = 476/819 (58%), Gaps = 37/819 (4%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G+IP+++ L + L NN SG+ PP ++N+S++++L + N SGRL +G L
Sbjct: 198 LEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGIL 257
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LPN+ S + N TG IP +++N + L L + N+ G I TFGN+ +L LL N
Sbjct: 258 LPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSI-PTFGNVPNLKLLFLHTN 316
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+L ++SS FL+SLTNC L L G N LGG LP I N SA L +
Sbjct: 317 SLGSDSSR--DLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLIS 374
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G+IP +IGNL L L L N L+G + ++G+L L+ LSL +N L G IP + ++ +
Sbjct: 375 GSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTM 434
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + L+ N G +P L + + L EL +G NKL +IP + ++ +L +++S NSL
Sbjct: 435 LETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLI 494
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
SLP ++ L+ L L L N+LSG +P T+G +E+L L N F G IP+ G L+
Sbjct: 495 GSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVG 553
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
++ +DLS N+LSG IP+ + S+L+ N+S N LEG++PVKG F+N + S GN LC
Sbjct: 554 VKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLC 613
Query: 421 G--------PPKLRVPPCKPDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKRCRNR 472
G P + P +S K V + V I ++ + V I + KR +N+
Sbjct: 614 GGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNK 673
Query: 473 STKHLDHEDFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKG-TISDGTDVAIK 531
T + L + Y D++ AT+ F+ N++G+GSFG+VYK +++ VA+K
Sbjct: 674 ETNNPTPSTLEVLH--EKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVK 731
Query: 532 IFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD-----FKALVLEFMPNGSLEK 586
+ N+Q A +SF +ECE L+++RHRNL+K+L++CS+ D F+AL+ EFMPNGSL+
Sbjct: 732 VLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDM 791
Query: 587 WLYSH--------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN 638
WL+ + L +LERLNI IDV S L+YLH H PI HCDLKP+N+LLD++
Sbjct: 792 WLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHV-HCHEPIAHCDLKPSNVLLDDD 850
Query: 639 MAAHVSDFGISKLLGE-GEDSVTQTMTMA----TIGYMAPEYGSEGIVSAKCDVYSYGVL 693
+ AHVSDFG+++LL + E+S ++ A TIGY APEYG G S DVYS+G+L
Sbjct: 851 LTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGIL 910
Query: 694 LMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL--VREEQAFSAKMDCILSI 751
L+E FT KRPT+E+F G +L + K +LP + ++VD ++ + F ++C+ +
Sbjct: 911 LLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPV-VECLTMV 969
Query: 752 MDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDDASAT 790
++ L CC ESP R+ + +L I+ +F + T
Sbjct: 970 FEVGLRCCEESPMNRLATSIVVKELISIRERFFKASRTT 1008
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1231), Expect = e-134, Method: Compositional matrix adjust.
Identities = 310/814 (38%), Positives = 459/814 (56%), Gaps = 32/814 (3%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G+IP +I L+ + + A N +G+ PP I+N+S++ L++ GN SG L G L
Sbjct: 213 IEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSL 272
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LPN++ L + N+ TG IP +++N + L LD+ N G I +FG R +LL +N
Sbjct: 273 LPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFG--RLQNLLLLGLN 330
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
N + + S+ FL +LTNC L L+ G N LGG LP I N S L + +
Sbjct: 331 NNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLIS 390
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G+IP IGNL L L L N L G + P++G L L+ + L +N L G IP L ++
Sbjct: 391 GSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISG 450
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + L N G IP L S + L +L+LG+NKL SIP L L ++ +N+S N L
Sbjct: 451 LTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLV 510
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
L ++ KLK L LD+S N+LSG IP T+ LE L L N F GPIP+ G L
Sbjct: 511 GPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTG 569
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
L LDLS NNLSG IP+ + S+L+ N+S N +G +P +G F+N S S FGN LC
Sbjct: 570 LRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLC 629
Query: 421 GP-PKLRVPPCK---PDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYK-RCRN-RST 474
G P L++ PC P S + + + ++ ++ L V+ + YK R ++ R+
Sbjct: 630 GGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRAN 689
Query: 475 KHLDHEDFLPLAT-WRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKI 532
+ + F P+ + + + Y ++ + T F+ NL+G+G+FG+V+KG + S VAIK+
Sbjct: 690 NNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKV 749
Query: 533 FNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNP-----DFKALVLEFMPNGSLEKW 587
NL A +SF +ECE L +RHRNL+K+++ CS+ DF+ALV EFMPNG+L+ W
Sbjct: 750 LNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMW 809
Query: 588 LYSH--------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM 639
L+ + L + RLNI IDV SAL YLH + PI HCD+KP+NILLD+++
Sbjct: 810 LHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHT-YCHNPIAHCDIKPSNILLDKDL 868
Query: 640 AAHVSDFGISKLLGEGED-----SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 694
AHVSDFG+++LL + + + TIGY APEYG G S DVYS+G++L
Sbjct: 869 TAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVL 928
Query: 695 METFTRKRPTDEMFTGEMSLRRWVKESL-PHGLTEVVDANLVREEQAFSAKM-DCILSIM 752
+E FT KRPT+++F ++L + K +L ++ D ++R A M +C+ +
Sbjct: 929 LEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLVF 988
Query: 753 DLALDCCIESPDMRINVTDAAAKLKKIKVKFLDD 786
+ + C ESP RI++ +A +KL I+ F D
Sbjct: 989 RVGVSCSEESPVNRISMAEAISKLVSIRESFFRD 1022
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1213), Expect = e-132, Method: Compositional matrix adjust.
Identities = 297/812 (36%), Positives = 448/812 (55%), Gaps = 43/812 (5%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
M G+IP E+ L + + A N+ SG PP ++NIS++ L+L N SG L + G+L
Sbjct: 205 MRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYL 264
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LPN+ LLL N TG IP ++ N + L D+ N +G I +FG LR+L L +
Sbjct: 265 LPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLG--IR 322
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
N + ++S+ F+ ++ NC L L G N LGG LP I N S +L + + +
Sbjct: 323 NNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLIS 382
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G IP +IGNL L LSL +N L+G + + G+L LQ + L +N + G IP ++
Sbjct: 383 GTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTR 442
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + L N G IP L L +L + +N+L +IP + + + I+LS+N L
Sbjct: 443 LQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLT 502
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
P V KL++L L S N+LSG +P IG +E L + N F G IP+ + L+S
Sbjct: 503 GHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVS 561
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
L+++D S NNLSG+IP+ L +L L+ N+S N+ EG +P G F+N + S FGN +C
Sbjct: 562 LKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNIC 621
Query: 421 GPPK-LRVPPCKPDNSKSTKNVALTVLKYILPPI---VCSVLLVITII----MYKRCRNR 472
G + +++ PC S K L+V K ++ I + S+LL+I + KR +
Sbjct: 622 GGVREMQLKPCIVQASP-RKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKN 680
Query: 473 STKHLDHEDFLPLATW-RRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAI 530
+ + D L + + Y ++ AT F+ NL+G+G+FG+V+KG + + VA+
Sbjct: 681 NASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAV 740
Query: 531 KIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN-----PDFKALVLEFMPNGSLE 585
K+ NL A +SF +ECE + +RHRNL+K+++ CS+ DF+ALV EFMP GSL+
Sbjct: 741 KVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLD 800
Query: 586 KWLY--------SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE 637
WL H+ L E+LNI IDV SALEYLH H P+ HCD+KP+NILLD+
Sbjct: 801 MWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHV-HCHDPVAHCDIKPSNILLDD 859
Query: 638 NMAAHVSDFGISKLLGEGE-----DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGV 692
++ AHVSDFG+++LL + + + + TIGY APEYG G S + DVYS+G+
Sbjct: 860 DLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGI 919
Query: 693 LLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIM 752
LL+E F+ K+PTDE F G+ +L + K S+ G T +N + E ++
Sbjct: 920 LLLEMFSGKKPTDESFAGDYNLHSYTK-SILSGCTSSGGSNAIDEGLRL---------VL 969
Query: 753 DLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784
+ + C E P R+ +A +L I+ KF
Sbjct: 970 QVGIKCSEEYPRDRMRTDEAVRELISIRSKFF 1001
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 435 bits (1119), Expect = e-121, Method: Compositional matrix adjust.
Identities = 309/862 (35%), Positives = 456/862 (52%), Gaps = 106/862 (12%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G I EIG L++L+ L NN +G P +I N+ + +LT+ N +SG LP+ +G L
Sbjct: 324 LVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLG-L 382
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
L N+ +L N LTG IP SI+N T L LDL N G I FG + +L+ +S N
Sbjct: 383 LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRN 441
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECK-- 178
+ T E + NC NL LS N L G L P+IG LQK +
Sbjct: 442 HFTGE--------IPDDIFNCSNLETLSVADNNLTGTLKPLIG----KLQKLRILQVSYN 489
Query: 179 -LKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCH 237
L G IP+EIGNL L +L LHSN G I M L LQGL + +N+LEG IP ++
Sbjct: 490 SLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFD 549
Query: 238 LKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYI-------- 289
+KL+ + L+ NK SG IP L SL L L NK SIP+SL SL +
Sbjct: 550 MKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDN 609
Query: 290 ------------------LDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTI 331
L +N S+N L ++P + KL+++ +DLS N SG IP ++
Sbjct: 610 LLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSL 669
Query: 332 GALKDLETL-------------------------SLARNQFQGPIPESVGSLISLESLDL 366
A K++ TL +L+RN F G IP+S G++ L SLDL
Sbjct: 670 QACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDL 729
Query: 367 SGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPPKLR 426
S NNL+G+IP+SL LS LK ++ N L+G +P G FKN + GN LCG K
Sbjct: 730 SSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-P 788
Query: 427 VPPCKPDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKRC-------RNRSTKHL-D 478
+ PC S + V+ IL +L+++ +++ C N S L D
Sbjct: 789 LKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPD 848
Query: 479 HEDFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE 538
+ L L +R ++++ATD FN N++G+ S +VYKG + DGT +A+K+ NL+
Sbjct: 849 LDSALKL---KRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEF 905
Query: 539 RAF--RSFDSECEVLRNVRHRNLIKILS-SCSNPDFKALVLEFMPNGSLEKWLY-SHNYF 594
A + F +E + L ++HRNL+KIL + + KALVL FM NG+LE ++ S
Sbjct: 906 SAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPI 965
Query: 595 LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654
+LE++++ + + S ++YLH G+ PI+HCDLKP NILLD + AHVSDFG +++LG
Sbjct: 966 GSLLEKIDLCVHIASGIDYLHSGY-GFPIVHCDLKPANILLDSDRVAHVSDFGTARILGF 1024
Query: 655 GEDSVTQTMTMA---TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPT--DEMFT 709
ED T T A TIGY+APE+ V+ K DV+S+G+++ME T++RPT ++ +
Sbjct: 1025 REDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDS 1084
Query: 710 GEMSLRRWVKESLPH---GLTEVVDANL------VREEQAFSAKMDCILSIMDLALDCCI 760
+M+LR+ V++S+ + G+ V+D L +++E+A I + L L C
Sbjct: 1085 QDMTLRQLVEKSIGNGRKGMVRVLDMELGDSIVSLKQEEA-------IEDFLKLCLFCTS 1137
Query: 761 ESPDMRINVTDAAAKLKKIKVK 782
P+ R ++ + L K++ K
Sbjct: 1138 SRPEDRPDMNEILTHLMKLRGK 1159
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 429 bits (1103), Expect = e-119, Method: Compositional matrix adjust.
Identities = 288/839 (34%), Positives = 434/839 (51%), Gaps = 67/839 (7%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIF---NISTMRILTLEGNQLSGRLPSTV 57
+ G IP E+G L L YL N L+G +P +F + S+++ + L N L+G +P
Sbjct: 127 LHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNY 186
Query: 58 GHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHI-LNTFGNLRHLSLLS 116
L + LLL +N LTG +P S++N+T L +DL N +G + + L L
Sbjct: 187 HCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLY 246
Query: 117 QVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYE 176
N+ + +++ + F +SL N +L L N LGG + + + S +L + + +
Sbjct: 247 LSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQ 306
Query: 177 CKLKGNIPQEIG------------------------NLSGLTLLSLHSNDLNGTISPTMG 212
++ G+IP EI LS L + L +N L G I +G
Sbjct: 307 NRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELG 366
Query: 213 RLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGS 272
+ RL L + NNL GSIP +L + + L GN LSG +P L +L L L
Sbjct: 367 DIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSH 426
Query: 273 NKLTSSIP----SSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP 328
N LT +IP S+L +L+ L +NLSSN L+ +P + K+ ++ +DLS N+LSG IP
Sbjct: 427 NNLTGTIPVEVVSNLRNLK--LYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIP 484
Query: 329 STIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQF 388
+G+ LE L+L+RN F +P S+G L L+ LD+S N L+G IP S + S LK
Sbjct: 485 PQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHL 544
Query: 389 NVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPPKLRVPPCKPDNS-------KSTKNV 441
N S N L G + KGSF ++ESF G+ LCG K + CK + +
Sbjct: 545 NFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACKKKHKYPSVLLPVLLSLI 603
Query: 442 ALTVLKYILPPIVCSVLLVITIIMYKRCRNRSTKHLDHEDFLPLATWRRTPYLDIQRATD 501
A VL P+V + +Y + + + D + R Y + AT
Sbjct: 604 ATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQND----PKYPRISYQQLIAATG 659
Query: 502 EFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFR-SFDSECEVLRNVRHRNLI 560
FN +L+G+G FG VYKG + + T VA+K+ + + F SF EC++L+ RHRNLI
Sbjct: 660 GFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLI 719
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF---LDILERLNIMIDVGSALEYLHHG 617
+I+++CS P F ALVL MPNGSLE+ LY Y LD+++ +NI DV + YLHH
Sbjct: 720 RIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHH- 778
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV----------TQTMTMAT 667
+S ++HCDLKP+NILLD+ M A V+DFGIS+L+ E++V T + +
Sbjct: 779 YSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGS 838
Query: 668 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727
+GY+APEYG S DVYS+GVLL+E + +RPTD + SL ++K P L
Sbjct: 839 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLE 898
Query: 728 EVVDANLVR------EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780
+++ L R E+ + IL +++L L C +P R ++ D A ++ ++K
Sbjct: 899 GIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLK 957
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 413 bits (1062), Expect = e-114, Method: Compositional matrix adjust.
Identities = 276/831 (33%), Positives = 418/831 (50%), Gaps = 70/831 (8%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G++P EI L+ L+ L EN SG +P I N ++++++ + GN G +P ++G L
Sbjct: 420 LEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRL 479
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
+ L L N L G +P S+ N +L LDL N +G I ++FG L+ L L N
Sbjct: 480 -KELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNN 538
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+L Q + SL + RNLT ++ N L G + P+ G S+S F +
Sbjct: 539 SL--------QGNLPDSLISLRNLTRINLSHNRLNGTIHPLCG--SSSYLSFDVTNNGFE 588
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
IP E+GN L L L N L G I T+G+++ L L + +N L G+IP L K
Sbjct: 589 DEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKK 648
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ I L N LSG IPP L L+ L EL L SN+ S+P+ L++ +L ++L NSLN
Sbjct: 649 LTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLN 708
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
S+P + L L VL+L +NQ SG +P +G L L L L+RN G IP +G L
Sbjct: 709 GSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQD 768
Query: 361 LES-LDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP------------------- 400
L+S LDLS NN +G IP ++ TLS+L+ ++SHN+L GE+P
Sbjct: 769 LQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNL 828
Query: 401 ---VKGSFKNFSVESFFGNYALCGPPKLRVPPCKPDNSKSTKNVALTVLKYILPPIVCSV 457
+K F + +SF GN LCG P R + +N + + V+ + +
Sbjct: 829 GGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIG 888
Query: 458 LLVITIIMYKRCRNRSTKHLDHED-----------------FLPLATWRRTPYLDIQRAT 500
L+++ I ++ + R+ K + H F A+ + DI AT
Sbjct: 889 LMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEAT 948
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNL 559
+E ++G+G G VYK + +G VA+K + + + +SF E + L +RHR+L
Sbjct: 949 HNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHL 1008
Query: 560 IKILSSCSNPD--FKALVLEFMPNGSLEKWLYS-------HNYFLDILERLNIMIDVGSA 610
+K++ CS+ L+ E+M NGS+ WL+ LD RL I + +
Sbjct: 1009 VKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQG 1068
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM--ATI 668
+EYLHH PI+H D+K +N+LLD NM AH+ DFG++K+L E D+ T + T +
Sbjct: 1069 VEYLHH-DCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSY 1127
Query: 669 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP---HG 725
GY+APEY + K DVYS G++LME T K PTD +F EM + RWV+ L
Sbjct: 1128 GYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSA 1187
Query: 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776
+++D L + + D ++++AL C SP R + A L
Sbjct: 1188 RDKLIDPKL---KPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 408 bits (1048), Expect = e-113, Method: Compositional matrix adjust.
Identities = 279/827 (33%), Positives = 422/827 (51%), Gaps = 66/827 (7%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G++P EIG L L+ + EN SG +P I N + ++ + GN+LSG +PS++G L
Sbjct: 421 LEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRL 480
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
++ L L N L G IP S+ N ++ +DL N +G I ++FG L L L N
Sbjct: 481 -KDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNN 539
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+L Q + SL N +NLT ++F SN G + P+ G S+S F E +
Sbjct: 540 SL--------QGNLPDSLINLKNLTRINFSSNKFNGSISPLCG--SSSYLSFDVTENGFE 589
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G+IP E+G + L L L N G I T G++ L L + N+L G IP +L K
Sbjct: 590 GDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKK 649
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ I L N LSG IP L L L EL L SNK S+P+ ++SL IL + L NSLN
Sbjct: 650 LTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLN 709
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
S+P + L+ L L+L NQLSG +PSTIG L L L L+RN G IP +G L
Sbjct: 710 GSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQD 769
Query: 361 LES-LDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP------------------- 400
L+S LDLS NN +G+IP ++ TL +L+ ++SHN+L GE+P
Sbjct: 770 LQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNL 829
Query: 401 ---VKGSFKNFSVESFFGNYALCGPPKLRVPPCKPDNSKSTKNVALTVLKYI--LPPIVC 455
+K F + ++F GN LCG P N +S + ++ I L I
Sbjct: 830 EGKLKKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIAL 889
Query: 456 SVLLVITII-----MYKRCRNRSTKHLDHED------FLPLATWRRTPYLDIQRATDEFN 504
VL++I ++K+ R ++ + F + DI AT N
Sbjct: 890 MVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLN 949
Query: 505 ECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNLIKIL 563
E ++G+G G VYK + +G +A+K + + + +SF+ E + L +RHR+L+K++
Sbjct: 950 EEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLM 1009
Query: 564 SSCSNP--DFKALVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGSALEYLHH 616
CS+ L+ E+M NGS+ WL+++ L RL I + + +EYLH+
Sbjct: 1010 GYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHY 1069
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM--ATIGYMAPE 674
PI+H D+K +N+LLD N+ AH+ DFG++K+L D+ T++ TM + GY+APE
Sbjct: 1070 -DCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPE 1128
Query: 675 YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL--PHG---LTEV 729
Y + K DVYS G++LME T K PT+ MF E + RWV+ L P G ++
Sbjct: 1129 YAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKL 1188
Query: 730 VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776
+D+ L + + + ++++AL C P R + A+ L
Sbjct: 1189 IDSEL---KSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 368 bits (944), Expect = e-100, Method: Compositional matrix adjust.
Identities = 266/865 (30%), Positives = 424/865 (49%), Gaps = 96/865 (11%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
++GQIP+EIG+ NL L AE ++SG +P ++ + + L++ +SG +PS +G+
Sbjct: 214 ISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNC 273
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
+ L L N+L+G IP I TKL L L NS G I GN +L ++ +N
Sbjct: 274 -SELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLN 332
Query: 121 NLTTE-SSSADQWSFL---------------SSLTNCRNLTILSFGSNPLGGILPPVIGN 164
L+ SS + SFL ++++NC +L L N + G++P +G
Sbjct: 333 LLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGT 392
Query: 165 FSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRN 224
+ L F+A+ +L+G+IP + + + L L L N L GTI + L+ L L L +
Sbjct: 393 LTK-LTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLIS 451
Query: 225 NNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLW 284
N+L G IP ++ + + +RL N+++G IP + SL + L SN+L +P +
Sbjct: 452 NSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIG 511
Query: 285 SLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLAR 344
S + I+LS+NSL SLP+ V L L VLD+S NQ SG IP+++G L L L L++
Sbjct: 512 SCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSK 571
Query: 345 NQFQGPIPESVGSLISLESLDL-------------------------SGNNLSGKIPKSL 379
N F G IP S+G L+ LDL S N L+GKIP +
Sbjct: 572 NLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKI 631
Query: 380 ETLSQLKQFNVSHNRLEGEI-----------------------PVKGSFKNFSVESFFGN 416
+L++L ++SHN LEG++ P F+ S + GN
Sbjct: 632 ASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGN 691
Query: 417 YALCGPPKLRVPPC----KPDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKRCRNR 472
LC + C + N A K L + L V+ +I+ R
Sbjct: 692 KKLCSSTQ---DSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIR 748
Query: 473 STKHLDHEDFLPLA---TWRRTPYLDIQRATDEFNEC----NLLGTGSFGSVYKGTISDG 525
+ +++D+E L W+ TP+ + + D+ C N++G G G VY+ + +G
Sbjct: 749 ARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNG 808
Query: 526 TDVAIKIF---------NLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576
+A+K + + + SF +E + L +RH+N+++ L C N + + L+
Sbjct: 809 EVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMY 868
Query: 577 EFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL 635
++MPNGSL L+ LD R I++ L YLHH PI+H D+K NIL+
Sbjct: 869 DYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHH-DCLPPIVHRDIKANNILI 927
Query: 636 DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 695
+ +++DFG++KL+ EG+ + GY+APEYG ++ K DVYSYGV+++
Sbjct: 928 GLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVL 987
Query: 696 ETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLA 755
E T K+P D + L WV+++ G EV+D+ L + A+ D ++ ++ A
Sbjct: 988 EVLTGKQPIDPTVPEGIHLVDWVRQN--RGSLEVLDSTLRSRTE---AEADEMMQVLGTA 1042
Query: 756 LDCCIESPDMRINVTDAAAKLKKIK 780
L C SPD R + D AA LK+IK
Sbjct: 1043 LLCVNSSPDERPTMKDVAAMLKEIK 1067
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 358 bits (919), Expect = 1e-97, Method: Compositional matrix adjust.
Identities = 266/807 (32%), Positives = 400/807 (49%), Gaps = 52/807 (6%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G+IP EIGNL + + F+EN L+G +P +I +++L L N L G +P +G L
Sbjct: 295 LTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGEL 354
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
+E L L+ N L G IP + LV L L N G I G + S+L N
Sbjct: 355 TL-LEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSAN 413
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+L+ + + L +LS GSN L G +P + SL K + +L
Sbjct: 414 SLSG--------PIPAHFCRFQTLILLSLGSNKLSGNIPRDLKT-CKSLTKLMLGDNQLT 464
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G++P E+ NL LT L LH N L+G IS +G+LK L+ L L NNN G IP ++ +L
Sbjct: 465 GSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTK 524
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ G ++ N+L+GHIP L S +++ L L NK + I L L Y+ + LS N L
Sbjct: 525 IVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLT 584
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLE-TLSLARNQFQGPIPESVGSLI 359
+P + L L L L N LS +IP +G L L+ +L+++ N G IP+S+G+L
Sbjct: 585 GEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQ 644
Query: 360 SLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYAL 419
LE L L+ N LSG+IP S+ L L N+S+N L G +P F+ +F GN+ L
Sbjct: 645 MLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGL 704
Query: 420 CGPPKLRVPPCKP----------DNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKRC 469
C + P P + S+ K + +T + ++ SV L+ + +
Sbjct: 705 CNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCI------VIGSVFLITFLGLCWTI 758
Query: 470 RNRSTKHLDHED----------FLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYK 519
+ R + ED + P + +D AT F+E +LG G+ G+VYK
Sbjct: 759 KRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVD---ATRNFSEDVVLGRGACGTVYK 815
Query: 520 GTISDGTDVAIKIFNLQLERAF--RSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577
+S G +A+K N + E A SF +E L +RHRN++K+ C + + L+ E
Sbjct: 816 AEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYE 875
Query: 578 FMPNGSLEKWLY--SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL 635
+M GSL + L N LD R I + L YLHH I+H D+K NILL
Sbjct: 876 YMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHH-DCRPQIVHRDIKSNNILL 934
Query: 636 DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 695
DE AHV DFG++KL+ + S + + + GY+APEY V+ KCD+YS+GV+L+
Sbjct: 935 DERFQAHVGDFGLAKLI-DLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLL 993
Query: 696 ETFTRKRPTDEMFTGEMSLRRWVKESLPHGL--TEVVDANLVREEQAFSAKMDCILSIMD 753
E T K P + G L WV+ S+ + + E+ DA L ++ +M +L I
Sbjct: 994 ELITGKPPVQPLEQGG-DLVNWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKI-- 1050
Query: 754 LALDCCIESPDMRINVTDAAAKLKKIK 780
AL C SP R + + A + + +
Sbjct: 1051 -ALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 356 bits (914), Expect = 4e-97, Method: Compositional matrix adjust.
Identities = 268/840 (31%), Positives = 400/840 (47%), Gaps = 104/840 (12%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLS-GRLPSTVGH 59
+G IP G +NL+ L N L G +PP + NIST+++L L N S R+P G+
Sbjct: 144 FSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSPSRIPPEFGN 203
Query: 60 LLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVM 119
L N+E + L +L G IP S+ +KLV LDL N GHI + G L ++ +
Sbjct: 204 LT-NLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNVVQIELYN 262
Query: 120 NNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKL 179
N+LT E L N ++L +L N L G +P + L+ YE L
Sbjct: 263 NSLTGE--------IPPELGNLKSLRLLDASMNQLTGKIPDEL--CRVPLESLNLYENNL 312
Query: 180 KGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
+G +P I L + + N L G + +G L+ L + N G +P DLC
Sbjct: 313 EGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKG 372
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYI---------- 289
+ + + N SG IP L SL + L N+ + S+P+ W L ++
Sbjct: 373 ELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSF 432
Query: 290 ----------------------------------LD----INLSSNSLNDSLPSNVQKLK 311
LD ++ S N + SLP ++ L
Sbjct: 433 SGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLG 492
Query: 312 VLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNL 371
L LDL NQ SG++ S I + K L L+LA N+F G IP+ +GSL L LDLSGN
Sbjct: 493 ELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMF 552
Query: 372 SGKIPKSLETLSQLKQFNVSHNRLEGEIP---VKGSFKNFSVESFFGNYALCGPPKLRVP 428
SGKIP SL++L +L Q N+S+NRL G++P K +KN SF GN LCG K
Sbjct: 553 SGKIPVSLQSL-KLNQLNLSYNRLSGDLPPSLAKDMYKN----SFIGNPGLCGDIKGL-- 605
Query: 429 PCKPDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKRCRNRSTKHLDHEDFLPLATW 488
C +N ++ K + +L+ I + VLL Y + R L ++
Sbjct: 606 -CGSEN-EAKKRGYVWLLRSIF-VLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSF 662
Query: 489 RRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIF---------NLQLER 539
+ + + + +E N++G G+ G VYK +++G VA+K + E+
Sbjct: 663 HKLGFSE-HEILESLDEDNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKETGDCDPEK 721
Query: 540 AFR------SFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLY-SHN 592
++ +F++E E L +RH+N++K+ CS D K LV E+MPNGSL L+ S
Sbjct: 722 GYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKG 781
Query: 593 YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652
L R I++D L YLHH S PI+H D+K NIL+D + A V+DFG++K +
Sbjct: 782 GMLGWQTRFKIILDAAEGLSYLHH-DSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAV 840
Query: 653 G-EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
G+ + ++ + GY+APEY V+ K D+YS+GV+++E TRKRP D GE
Sbjct: 841 DLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPEL-GE 899
Query: 712 MSLRRWVKESLPH-GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCC----IESPDMR 766
L +WV +L G+ V+D L + F + I I+++ L C I P MR
Sbjct: 900 KDLVKWVCSTLDQKGIEHVIDPKL---DSCFKEE---ISKILNVGLLCTSPLPINRPSMR 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 791 | ||||||
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.989 | 0.719 | 0.564 | 0.0 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.987 | 0.736 | 0.574 | 0.0 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.981 | 0.713 | 0.574 | 0.0 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.989 | 0.768 | 0.544 | 0.0 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.974 | 0.641 | 0.543 | 0.0 | |
| 359483677 | 1229 | PREDICTED: LRR receptor-like serine/thre | 0.984 | 0.633 | 0.529 | 0.0 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.984 | 0.535 | 0.528 | 0.0 | |
| 359497186 | 1140 | PREDICTED: LRR receptor-like serine/thre | 0.984 | 0.683 | 0.531 | 0.0 | |
| 255585401 | 843 | serine-threonine protein kinase, plant-t | 0.981 | 0.920 | 0.525 | 0.0 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.984 | 0.746 | 0.550 | 0.0 |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 868 bits (2243), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/788 (56%), Positives = 580/788 (73%), Gaps = 5/788 (0%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G+IP EIGNLQNLQ + + NNL+G +P +FNISTM+ + + N L G LP+++G
Sbjct: 300 LTGRIPLEIGNLQNLQIVHLSFNNLNGSIPHALFNISTMKWIAMTSNNLLGNLPTSLGLH 359
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LPN+ L L N L+G IP I+NA+KL L+L NSF G I ++ G+LR+L L ++
Sbjct: 360 LPNLIWLYLGINKLSGPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTL-KLGA 418
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
NL + ++ + + SSL NC+NL L NPL G LP +GN S SL+ F A + +K
Sbjct: 419 NLLSSKKTSQELTIFSSLKNCQNLKYLWLSYNPLDGYLPHSVGNLSNSLESFLASDGLIK 478
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G++ + IGNLS LT L+L +NDL G I T+G LK LQGL L N+L+GSIP +LC L+
Sbjct: 479 GSVHESIGNLSSLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRT 538
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
++ + LTGNKLSG IP C +LTSLR L L SN+ S+I S+LW+L+ IL +NL+SN L
Sbjct: 539 LYNLELTGNKLSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLT 598
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
SLPS ++ L+ + ++++S+NQLSG+IP +IG L+DL L L+ N+ QGPIP+SVG + S
Sbjct: 599 GSLPSEIENLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKS 658
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
LE LDLS NNLSG IPKSL+ L LK FNVS N L+GEIP GSF NFS +SF GN ALC
Sbjct: 659 LEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALC 718
Query: 421 GPPKLRVPPCKPDNSKSTKNV-ALTVLKYILPPIVCSVLLVITIIMYKRCRNRSTKHLDH 479
G +L+V PCK DNS++T+ + VL+Y+LP IV +V ++ +IM KR R K
Sbjct: 719 GSARLQVSPCKDDNSRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIE 778
Query: 480 EDFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLER 539
+DFL L T RR Y ++Q AT+ F E N LG GSFGSVYKGT+SDGT +A K+FNLQLER
Sbjct: 779 DDFLALTTIRRISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLER 838
Query: 540 AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE 599
AF+SFD+ECEVLRN+RHRNL+KI++SCS P+FKALVLEFMPN SLEKWLYS +YFL+ L+
Sbjct: 839 AFKSFDTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQ 898
Query: 600 RLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659
RLNIM+DV S LEYLHHG+ + P+ HCD+KP+N+LL+E+M A ++DFGISKLLGE E SV
Sbjct: 899 RLNIMLDVASVLEYLHHGY-TIPMAHCDIKPSNVLLNEDMVAFLADFGISKLLGE-EGSV 956
Query: 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 719
QTMT+ATIGYMAPEYGSEGIVS + DVYSYGVLLMETFT+K+PTD+MFT ++SL+ WV+
Sbjct: 957 MQTMTLATIGYMAPEYGSEGIVSVRGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVE 1016
Query: 720 ESLPHGLTEVVDANLVR-EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778
+SL +T+V+DANL+ EE +AK DCI+SI+ LAL C + P RI++ L+K
Sbjct: 1017 QSLSCEVTQVIDANLLGIEEDHLAAKKDCIVSILKLALQCSADLPHDRIDMKHVVTTLQK 1076
Query: 779 IKVKFLDD 786
IK KFL D
Sbjct: 1077 IKTKFLRD 1084
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 867 bits (2241), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/789 (57%), Positives = 576/789 (73%), Gaps = 8/789 (1%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G IP E+GNL LQ L NN++G +P T FN S +R + + N LSG LPS G
Sbjct: 271 LTGVIPNEMGNLHTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLG 330
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LPN+E L L N L+G IP SI NA+KL+ LDL +NSF+G I + GNLR+L L+ N
Sbjct: 331 LPNLEELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAEN 390
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
LT++S ++ LSSL+NCR+L L F NPL G LP IGN SASL++ YA++C++
Sbjct: 391 ILTSKSLRSELSF-LSSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAFDCRII 449
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
GNIP+ IGNLS L L L N+L G I +GRLK LQ SL +N L+G IP ++CHL+
Sbjct: 450 GNIPRGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLER 509
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + L N SG +P CL ++TSLREL+LGSN+ TS IP++ WSL+ +L INLS NSL
Sbjct: 510 LSYLYLLENGFSGSLPACLSNITSLRELYLGSNRFTS-IPTTFWSLKDLLQINLSFNSLT 568
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
+LP + LKV+TV+D S NQLSGDIP++I L++L SL+ N+ QGPIP S G L+S
Sbjct: 569 GTLPLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVS 628
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
LE LDLS N+LSG IPKSLE L LK FNVS NRL+GEI G F NFS SF N ALC
Sbjct: 629 LEFLDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALC 688
Query: 421 GPPKLRVPPCKPDNS-KSTKNVALTVLKYILPPIVCSVL-LVITIIMYKRCRNRSTKHLD 478
GP +++VPPCK ++ + +K V++YI+P I +L L + +I+++R R K
Sbjct: 689 GPIRMQVPPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKR--KLST 746
Query: 479 HEDFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE 538
ED LP ATWR+ Y ++ RAT+ FNE NLLGTGS GSVYKGT+SDG +A+K+F+LQLE
Sbjct: 747 QEDPLPPATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLE 806
Query: 539 RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL 598
FDSECEVLR +RHRNL+KI+SSC N DFKAL+LEF+P+GSLEKWLYSHNY+LDIL
Sbjct: 807 GELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDIL 866
Query: 599 ERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658
+RLNIMIDV SALEYLHHG + P++HCDLKP+N+L++E+M AHVSDFGIS+LLGEG D+
Sbjct: 867 QRLNIMIDVASALEYLHHG-CTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLLGEG-DA 924
Query: 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV 718
VTQT+T+ATIGYMAPEYG EGIVS K DVYSYG+ LMETFTRK+PTD+MF GEMSL+ WV
Sbjct: 925 VTQTLTLATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWV 984
Query: 719 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778
K+SLP +TEV+DANL+ EE+ F AK DCI SI++LAL+C + P RI + D L+K
Sbjct: 985 KQSLPKAITEVIDANLLIEEEHFVAKKDCITSILNLALECSADLPGERICMRDVLPALEK 1044
Query: 779 IKVKFLDDA 787
IK+K+ D
Sbjct: 1045 IKLKYKKDV 1053
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 838 bits (2164), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/783 (57%), Positives = 572/783 (73%), Gaps = 7/783 (0%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
++G++P EIG+L L L +N+L+G +P IFNIS+M +L N LSG LP G
Sbjct: 304 LSGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSY 363
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LPN+E+L+L N L+GIIP SI NA+KL +LD G+N G I + G+LR L L+ +N
Sbjct: 364 LPNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVN 423
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
NL ES + SFL+SLTNC+ L IL NPL GILP IGN S SLQ+F A CKLK
Sbjct: 424 NLKGESY-IQELSFLTSLTNCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLK 482
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
GNIP EIGNLS L LLSL++NDL GTI P++G+L++LQGL L +N L+GSIP D+C L+
Sbjct: 483 GNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRN 542
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + LT N+LSG IP CL LT LR L+LGSNKL S+IPS+LWSL +IL +++SSN L
Sbjct: 543 LGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLV 602
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
LPS++ LKVL +DLSRNQLSG+IPS IG L+DL +LSLA N+F+GPI S +L S
Sbjct: 603 GYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKS 662
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
LE +DLS N L G+IPKSLE L LK +VS N L GEIP +G F NFS ESF N ALC
Sbjct: 663 LEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALC 722
Query: 421 GPPKLRVPPCKPDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKRCRNRSTKHLDHE 480
G P+L++PPC+ ST ++ +LKYILP I+ ++L + I ++ RCR R+
Sbjct: 723 GSPRLKLPPCRTGTRWST-TISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPTQS 781
Query: 481 DFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERA 540
+ L ATWRR Y +I +AT+ F+ NLLG GS GSVY+GT+SDG + AIK+FNLQ E A
Sbjct: 782 ESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAA 841
Query: 541 FRSFDSECEVLRNVRHRNLIKILSSCSNP--DFKALVLEFMPNGSLEKWLYSHNYFLDIL 598
F+SFD+ECEV+ ++RHRNLIKI+SSCSN DFKALVLE++PNGSLE+WLYSHNY LDIL
Sbjct: 842 FKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDIL 901
Query: 599 ERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658
+RLNIMIDV A+EYLHHG S P++HCDLKP+NILLDE+ HV DFGI+KLL E E+S
Sbjct: 902 QRLNIMIDVALAMEYLHHG-CSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLRE-EES 959
Query: 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV 718
+ +T T+ATIGYMAP+Y S GIV+ DVYSYG++LMETFTR+RPTDE+F+ EMS++ WV
Sbjct: 960 IRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWV 1019
Query: 719 KESLPHGLTEVVDANLVR-EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777
+ L +TEVVDANL+R E++ F AK CI I+ LA+DC +SP+ RI + D LK
Sbjct: 1020 WDWLCGSITEVVDANLLRGEDEQFMAKKQCISLILGLAMDCVADSPEERIKMKDVVTTLK 1079
Query: 778 KIK 780
KIK
Sbjct: 1080 KIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2118), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/788 (54%), Positives = 553/788 (70%), Gaps = 5/788 (0%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
G IP E+G L L+ L N LSG +P +IFN++++R + + N LSG +P
Sbjct: 231 FTGVIPEELGFLPMLEVLNLGVNMLSGDLPRSIFNMTSLRTMQICCNNLSGSIPQENSID 290
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LPN+E L L N +TG +P + N ++L LDL +N G++L FGNLR L +LS N
Sbjct: 291 LPNLEELQLNLNGITGSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSN 350
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+ T SS +F++SLTN R L L G NPL G+LP +GN S+ L KFY Y KLK
Sbjct: 351 SFTNHPSS-QTLNFITSLTNSRQLKELHIGDNPLDGMLPNSVGNLSSFLTKFYVYASKLK 409
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
GNIP EIGNLS L +LSL N L G I T+G L+++Q L L NNL GSIP D+C +
Sbjct: 410 GNIPGEIGNLSNLIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARR 469
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ I L N LSG IP C+ +LTSLR L+L N L+S+IP +LWSL+ +L +NL SN L
Sbjct: 470 LVDITLNNNVLSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLY 529
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
SLPS V +++ + LS NQLSG+IPSTIG+L++L SL++N FQG IPE+ G L+S
Sbjct: 530 GSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVS 589
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
LE LDLS NNLSG+IPKSLE L L+ F+VS N L+GEIP G F NF+ SF N LC
Sbjct: 590 LELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLC 649
Query: 421 GPPKLRVPPCKPDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKRCRNRSTKHLDHE 480
GP +L+VPPC ++ K +K + +L++ LP + +L+V I + CR R K E
Sbjct: 650 GPSRLQVPPCSIESRKDSKTKS-RLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPE 708
Query: 481 DFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERA 540
A RR YL++ AT+EF+E NLLG GSFGSVY+G + DG +VA+KIFNLQL+RA
Sbjct: 709 ALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRA 768
Query: 541 FRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER 600
FRSFD+ECE++RN+RHRNL+KI+ SCSN DFKALVLE+MP GSLEKWLYSHNY LDI++R
Sbjct: 769 FRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQR 828
Query: 601 LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660
+NIMIDV SALEYLHHG+ S P++HCDLKP+N+LLDE+M AHV DFGI+KLLGE E S
Sbjct: 829 VNIMIDVASALEYLHHGYPS-PVVHCDLKPSNVLLDEDMVAHVCDFGIAKLLGENE-SFA 886
Query: 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 720
QT T+ATIGYMAPEYG +G+VS K DVYS+G++LME TRKRPTDEMF GEMSL+R VKE
Sbjct: 887 QTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKE 946
Query: 721 SLPHGLTEVVDANLVREEQAFSAKMD-CILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
SLP + ++VD+N++ +S K + C+ SIM+LAL C ESP R+ + + A+LK I
Sbjct: 947 SLPDSVIDIVDSNMLNRGDGYSVKKEHCVTSIMELALQCVNESPGERMAMVEILARLKNI 1006
Query: 780 KVKFLDDA 787
K +FL D+
Sbjct: 1007 KAEFLRDS 1014
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 806 bits (2081), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/782 (54%), Positives = 552/782 (70%), Gaps = 11/782 (1%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
G IP E+GNL NLQ+L NNL+G+VP IFNIS +++L+L GN LSG LPS++G
Sbjct: 419 FTGNIPKELGNLVNLQFLSLNVNNLTGIVPEAIFNISKLQVLSLAGNHLSGSLPSSIGSW 478
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LPN+E LL+ N +GIIP SI+N + L++LD+ N F G++ GNLR L LL N
Sbjct: 479 LPNLEQLLIGGNEFSGIIPMSISNMSNLISLDISDNFFIGNVPKDLGNLRQLQLLGLSHN 538
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
LT E S A + +FL+SLTNC L LS NPL G++P +GN S SL+ YA +C+L+
Sbjct: 539 QLTNEHS-ASELAFLTSLTNCIFLRTLSISDNPLKGMIPNSLGNLSISLEIIYASDCQLR 597
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G IP I NL+ L L L NDL G I GRL++LQ LS+ N + GSIP LCHL
Sbjct: 598 GTIPTGISNLTNLIGLRLDDNDLTGLIPTPFGRLQKLQMLSISQNRIHGSIPSGLCHLTN 657
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + L+ NKLSG IP C +LT LR ++L SN L S IPSSL +L +L +NLSSN LN
Sbjct: 658 LAFLDLSSNKLSGTIPSCSGNLTGLRNVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLN 717
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
LP V +K L LDLS+NQ SG+IPSTI L++L L L+ N+ QG IP + G L+S
Sbjct: 718 SQLPLQVGNMKSLVALDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVS 777
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
LESLDLSGNNLSG IPKSLE L L+ NVS N+L+GEIP G F NF+ ESF N ALC
Sbjct: 778 LESLDLSGNNLSGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFANFTAESFISNLALC 837
Query: 421 GPPKLRVPPCKPDNSKSTKNVALTVLKYILPPIV--CSVLLVITIIMYKRCRNRSTKHLD 478
G P+ +V C+ D+ K+TK++ +LK I+P V +++LV+ + +KR + +S +
Sbjct: 838 GAPRFQVMACEKDSRKNTKSL---LLKCIVPLSVSLSTIILVVLFVQWKRRQTKSETPIQ 894
Query: 479 HEDFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE 538
+ LP R P+ ++ AT+ F E NL+G GS G VYKG +SDG VA+K+FNL+L+
Sbjct: 895 VDLSLP-RMHRMIPHQELLYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQ 953
Query: 539 RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL 598
AF+SF+ ECEV+RN+RHRNL KI+SSCSN DFKALVLE+MPNGSLEKWLYSHNY+LD +
Sbjct: 954 GAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFV 1013
Query: 599 ERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658
+RL IMIDV S LEYLHH +S+ P++HCDLKP+N+LLD++M AH+SDFGI+KLL G +
Sbjct: 1014 QRLKIMIDVASGLEYLHHYYSN-PVVHCDLKPSNVLLDDDMVAHISDFGIAKLL-MGSEF 1071
Query: 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV 718
+ +T T+ T+GYMAPEYGSEGIVS K D+YSYG+LLMETF RK+PTDEMF E++L+ WV
Sbjct: 1072 MKRTKTLGTVGYMAPEYGSEGIVSTKGDIYSYGILLMETFVRKKPTDEMFVEELTLKSWV 1131
Query: 719 KESLPHGLTEVVDANLVREE-QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777
ES + + EV+DANL+ EE ++F+ K C SIM LALDC +E P+ RIN D +LK
Sbjct: 1132 -ESSTNNIMEVIDANLLTEEDESFALKRACFSSIMTLALDCTVEPPEKRINTKDVVVRLK 1190
Query: 778 KI 779
K+
Sbjct: 1191 KL 1192
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2052), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/785 (52%), Positives = 543/785 (69%), Gaps = 6/785 (0%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G IPT GNL+ L++L NNL+G VP IFNIS ++ L + N LSG LPS++G
Sbjct: 449 LIGSIPTSFGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTW 508
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
L ++E L +A N +GIIP SI+N +KL L L NSF G++ GNL L +L N
Sbjct: 509 LSDLEGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGN 568
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
LT E A + FL+SLTNC+ L L G+NP G LP +GN +L+ F A C+ +
Sbjct: 569 QLTDEHV-ASEVGFLTSLTNCKFLKNLWIGNNPFKGTLPNSLGNLPIALESFIASACQFR 627
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G IP IGNL+ L L L +NDL G+I T+GRLK+LQ L + N L GSIP DLCHLK
Sbjct: 628 GTIPTRIGNLTNLIWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKN 687
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + L+ NKLSG IP C L +L+EL L SN L +IP+SLWSL +L +NLSSN L
Sbjct: 688 LGYLHLSSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLT 747
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
+LP V +K +T LDLS+N +SG IP +G ++L LSL++N+ QGPIP G L+S
Sbjct: 748 GNLPPEVGNMKSITTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVS 807
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
LESLDLS NNLSG IPKSLE L LK NVS N+L+GEIP G F NF+ ESF N ALC
Sbjct: 808 LESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALC 867
Query: 421 GPPKLRVPPCKPDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKRCRNRSTKHLDHE 480
G P +V C +N + +LKYIL P+ V LV+ I+++ R R+ +
Sbjct: 868 GAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPID 927
Query: 481 DFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERA 540
+LP T + + + AT++F E NL+G GS G VYKG +S+G VAIK+FNL+ + A
Sbjct: 928 SWLP-GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGA 986
Query: 541 FRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER 600
RSFDSECEV++ +RHRNL++I++ CSN DFKALVLE+MPNGSLEKWLYSHNYFLD+++R
Sbjct: 987 LRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQR 1046
Query: 601 LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660
LNIMIDV SALEYLHH SS ++HCDLKP N+LLD++M AHV+DFGI+KLL + E S+
Sbjct: 1047 LNIMIDVASALEYLHHDCSSL-VVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTE-SMQ 1104
Query: 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 720
QT T+ TIGYMAPE+GS+GIVS K DVYSYG+LLME F+RK+P DEMFTG+++L+ WV E
Sbjct: 1105 QTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWV-E 1163
Query: 721 SLPHGLTEVVDANLV-REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
SL + + +VVDANL+ RE++ + K+ C+ SIM LAL C +SP+ R+N+ DA +LKK
Sbjct: 1164 SLSNSVIQVVDANLLRREDEDLATKLSCLSSIMALALACTTDSPEERLNMKDAVVELKKS 1223
Query: 780 KVKFL 784
++K L
Sbjct: 1224 RMKLL 1228
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2052), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/785 (52%), Positives = 541/785 (68%), Gaps = 6/785 (0%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G IP E+GNL NLQ L +ENNL+G++P IFNIS ++ L+L N SG LPS++G
Sbjct: 674 IQGNIPNELGNLINLQNLKLSENNLTGIIPEAIFNISKLQSLSLAQNHFSGSLPSSLGTQ 733
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LP++E L + N +GIIP SI+N ++L LD+ N F G + GNLR L L+ N
Sbjct: 734 LPDLEGLAIGRNEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLEFLNLGSN 793
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
LT E S A + FL+SLTNC L L NPL GILP +GN S SL+ F A C+ +
Sbjct: 794 QLTDEHS-ASEVGFLTSLTNCNFLRTLWIEDNPLKGILPNSLGNLSISLESFDASACQFR 852
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G IP IGNL+ L L L NDL G I T+G+LK+LQ L + N L GSIP DLC LK
Sbjct: 853 GTIPTGIGNLTSLISLELGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPNDLCRLKN 912
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + L+ N+L+G IP CL L LREL+L SN L S+IP SLW+L +L +NLSSN L
Sbjct: 913 LGYLFLSSNQLTGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSNFLT 972
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
LP V +K + LDLS+NQ+SG IP T+G L++LE LSL++N+ QGPIP G L+S
Sbjct: 973 GHLPPEVGNIKSIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGDLLS 1032
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
L+ LDLS NNLSG IPKSL+ L+ LK NVS N+L+GEIP G F NF+ ESF N ALC
Sbjct: 1033 LKFLDLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALC 1092
Query: 421 GPPKLRVPPCKPDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKRCRNRSTKHLDHE 480
G P +V C + L +LKYILPP++ + LV+ ++++ R R +
Sbjct: 1093 GAPHFQVIACDKSTRSRSWRTKLFILKYILPPVISIITLVVFLVLWIRRRKNLEVPTPID 1152
Query: 481 DFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERA 540
+LP + + + + AT+ F E NL+G GS VYKG +S+G VA+K+FNL+ + A
Sbjct: 1153 SWLP-GSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGA 1211
Query: 541 FRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER 600
FRSFDSECEV++++RHRNL+KI++ CSN DFKALVLE+MP GSL+KWLYSHNYFLD+++R
Sbjct: 1212 FRSFDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQR 1271
Query: 601 LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660
LNIMIDV SALEYLHH S ++HCDLKP NILLD++M AHV DFGI++LL E E S+
Sbjct: 1272 LNIMIDVASALEYLHHDCPSL-VVHCDLKPNNILLDDDMVAHVGDFGIARLLTETE-SMQ 1329
Query: 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 720
QT T+ TIGYMAPEYGS+GIVS K DV+SYG++LME F RK+P DEMF G+++L+ WV E
Sbjct: 1330 QTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWV-E 1388
Query: 721 SLPHGLTEVVDANLV-REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
SL + EVVDANL+ RE++ F+ K+ C+ SIM LAL C +SP+ RI++ D LKKI
Sbjct: 1389 SLADSMIEVVDANLLRREDEDFATKLSCLSSIMALALACTTDSPEERIDMKDVVVGLKKI 1448
Query: 780 KVKFL 784
K++ L
Sbjct: 1449 KIELL 1453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 793 bits (2047), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/785 (53%), Positives = 543/785 (69%), Gaps = 6/785 (0%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G IPT GNL+ L++L NNL+G VP IFNIS ++ L + N LSG LPS++G
Sbjct: 360 LIGSIPTSFGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTW 419
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LP++E L +A N +GIIP SI+N +KL L L NSF G++ GNL L +L N
Sbjct: 420 LPDLEGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGN 479
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
LT E A + FL+SLTNC+ L L G+ P G LP +GN +L+ F A C+ +
Sbjct: 480 QLTDEHV-ASEVGFLTSLTNCKFLKNLWIGNIPFKGTLPNSLGNLPIALESFIASACQFR 538
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G IP IGNL+ L L L +NDL G+I T+G+L++LQ L + N + GSIP DLCHLK
Sbjct: 539 GTIPTGIGNLTNLIRLDLGANDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKD 598
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + L+ NKLSG IP C L +L+EL L SN L +IP+SLWSL +L +NLSSN L
Sbjct: 599 LGYLFLSSNKLSGSIPSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLT 658
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
+LP V +K +T LDLS+N +SG IPS +G L+ L TLSL++N+ QGPIP G L+S
Sbjct: 659 GNLPPEVGNMKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVS 718
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
LESLDLS NNLSG IPKSLE L LK NVS N+L+GEIP G F NF+ ESF N ALC
Sbjct: 719 LESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALC 778
Query: 421 GPPKLRVPPCKPDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKRCRNRSTKHLDHE 480
G P +V C +N + +LKYIL P+ V LV+ I+++ R R+ +
Sbjct: 779 GAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPID 838
Query: 481 DFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERA 540
+LP T + + + AT++F E NL+G GS G VYKG +S+G VAIK+FNL+ + A
Sbjct: 839 SWLP-GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGA 897
Query: 541 FRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER 600
RSFDSECEV++ +RHRNL++I++ CSN DFKALVLE+MPNGSLEKWLYSHNYFLD+++R
Sbjct: 898 LRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQR 957
Query: 601 LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660
LNIMIDV SALEYLHH SS ++HCDLKP N+LLD++M AHV+DFGI+KLL + E S+
Sbjct: 958 LNIMIDVASALEYLHHDCSSL-VVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTE-SMQ 1015
Query: 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 720
QT T+ TIGYMAPE+GS+GIVS K DVYSYG+LLME F+RK+P DEMFTG ++L+ WV E
Sbjct: 1016 QTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGGLTLKTWV-E 1074
Query: 721 SLPHGLTEVVDANLV-REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
SL + + +VVDANL+ RE++ + K+ C+ SIM LAL C SP+ R+N+ DA +LKK
Sbjct: 1075 SLSNSVIQVVDANLLRREDEDLATKLSCLSSIMALALACTTNSPEKRLNMKDAVVELKKS 1134
Query: 780 KVKFL 784
K+K L
Sbjct: 1135 KMKLL 1139
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 792 bits (2046), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/793 (52%), Positives = 554/793 (69%), Gaps = 17/793 (2%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G IPTEIG L NL +L+ N L+G +P T+ NIS ++ +++ NQLSG LPST+G+
Sbjct: 63 LTGPIPTEIGKLSNLVHLLLRYNFLTGSIPSTLLNISAIKTISINVNQLSGHLPSTLGYG 122
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LPN+E L + N G +P SI+NA+KL L+ NS +G I +T NL++L L+ N
Sbjct: 123 LPNLEELYITRNQFIGTLPPSISNASKLTILESSSNSLSGPIPDTLCNLKNLKRLNLADN 182
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+ T D+ FL+SL C+ L L NPL LP IGN S S++ F C +K
Sbjct: 183 SFT------DELGFLASLARCKELRRLVLIGNPLNSTLPTSIGNLS-SIEYFNVQSCNIK 235
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
GNIP EIG LS L L L +N+L G+I T+G L++LQ L L N L GSIP D+CHL
Sbjct: 236 GNIPSEIGVLSNLITLHLQNNELVGSIPVTIGGLQKLQRLYLHGNLLYGSIPTDICHLSN 295
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + L+ N L G +P C L SLR LHL SN TS IP SLWSL+ +L++NLSSNSL+
Sbjct: 296 LGELFLSNNSLFGPLPACFGDLISLRILHLHSNNFTSGIPFSLWSLKDVLELNLSSNSLS 355
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
+P ++ LKVLT +D S N LSG IP+ IG+L++L +LSL N+F+GPIPE G LIS
Sbjct: 356 GHIPLSIGNLKVLTQVDFSYNSLSGIIPNAIGSLRNLMSLSLTHNRFEGPIPEPFGELIS 415
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
LESLDLS NNLSGKIPKSLE L LK NVS N L+GE+P KG+F NFS SF GN ALC
Sbjct: 416 LESLDLSSNNLSGKIPKSLEQLKYLKYLNVSFNNLDGEVPNKGAFANFSASSFLGNLALC 475
Query: 421 GPPKLRVPPCKPDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKRCRNRSTKHLDHE 480
G L + PCK + +K +L Y+LP S+L + I+++ RC+ + +
Sbjct: 476 GSRLLPLMPCKNNTHGGSKTSTKLLLIYVLP---ASILTIAFILVFLRCQKVKLELENVM 532
Query: 481 DFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERA 540
D + + TWRR + ++++ATD F NLLG G +GSVYKG + DGT+VAIK+FNL +E A
Sbjct: 533 DIITVGTWRRISFQELEQATDGFCASNLLGAGGYGSVYKGRLEDGTNVAIKVFNLGVEGA 592
Query: 541 FRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER 600
F+ FD+ECEV+ ++RHRNL+KI+S CSN DFKA+VLE+MPNGSLEKWLYSHNY L+I +R
Sbjct: 593 FKIFDTECEVMSSIRHRNLVKIISCCSNQDFKAIVLEYMPNGSLEKWLYSHNYCLNIQQR 652
Query: 601 LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660
L +MIDV SALEYLHHG SAPI+HCDLKP+N+LLD++M HV+DFG++KLLGEG D +T
Sbjct: 653 LEVMIDVASALEYLHHGF-SAPIVHCDLKPSNVLLDQDMVGHVADFGMAKLLGEG-DLIT 710
Query: 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE--MSLRRWV 718
QT T+ATIGYMAPEYGS+GIVS DVYS+G+LLMETFTR +PTD+MF GE +SL++++
Sbjct: 711 QTKTLATIGYMAPEYGSKGIVSISGDVYSFGILLMETFTRMKPTDDMF-GERVLSLKQYI 769
Query: 719 KESLPH-GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777
+++L H ++E+ DAN + +E+ S K DC+ SI+ LALDC +E P RI+++ A L+
Sbjct: 770 EDALLHNAVSEIADANFLIDEKNLSTK-DCVSSILGLALDCSVELPHGRIDMSQVLAALR 828
Query: 778 KIKVKFLDDASAT 790
IK + L ++ T
Sbjct: 829 SIKAQLLASSART 841
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2042), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/790 (55%), Positives = 565/790 (71%), Gaps = 11/790 (1%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+G IP EIG+L +L+ ++ N LSGLVP I+N S M + L NQLSG LPS+
Sbjct: 259 FSGTIPDEIGDLAHLEEIILNVNGLSGLVPSGIYNASKMTAIGLALNQLSGYLPSSSN-- 316
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LPN+E ++ NN TG IP S+ NA+KL +DLG+NSF G I + GNL+ L + S +N
Sbjct: 317 LPNLEFFIIEDNNFTGPIPVSLFNASKLGNIDLGWNSFYGPIPDELGNLKSLEVFSFWVN 376
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+LT +SSS+ S SSLT C++L +NPL G LP +GN S+SL+ ++C +
Sbjct: 377 HLTVKSSSSGL-SLFSSLTKCKHLRRFDLSNNPLNGNLPISVGNLSSSLEVVEIFDCGIT 435
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G IP+EIGNLS L+ L L +NDL GTI T+ +L +LQ L L N LEGS PY+LC L+
Sbjct: 436 GTIPKEIGNLSSLSWLDLGANDLRGTIPTTIRKLGKLQELKLHYNRLEGSFPYELCDLQS 495
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + L N LSG IP CL ++ SLR L +G NK +S+IPS+LW L IL++NLSSNSL+
Sbjct: 496 LAYLYLEVNALSGQIPSCLGNVNSLRTLSMGMNKFSSTIPSTLWRLADILELNLSSNSLS 555
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
SL ++ LK +T++DLS NQLSG IPS+IG LK L LSLA N+ +G IP+ G IS
Sbjct: 556 GSLAVDIGNLKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGSIPQLFGDAIS 615
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
L+ LDLS NNLSG+IPKSLE L L FNVS N L+GEIP +F N S +SF GN LC
Sbjct: 616 LQLLDLSNNNLSGEIPKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSAKSFMGNKGLC 675
Query: 421 GPPKLRVPPCKPDNSKSTKNVALTVLKYILPPIVCSVLLVITI-IMYKRCRNRSTKHLDH 479
G KL+V PC+ + +K + L+Y L ++L V + I++ R R R+ +
Sbjct: 676 GAAKLQVQPCETSTHQGSKAASKLALRYGLMATGLTILAVAAVAIIFIRSRKRNMR--IT 733
Query: 480 EDFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLER 539
E LPLAT +R Y ++++ATD+FNE NLLG GSFGSVYKGT SDG+ VA+K+FNLQ+E
Sbjct: 734 EGLLPLATLKRISYRELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEG 793
Query: 540 AFRSFDSECEVLRNVRHRNLIKILSSCS--NPDFKALVLEFMPNGSLEKWLYSHNYFLDI 597
AF+SFD ECEVLR +RHRNL+KI++SCS N DFKALVLEFMPN SLEKWL S +FL++
Sbjct: 794 AFKSFDVECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLEL 853
Query: 598 LERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657
LERLNIM+DV SA+EYLHHG+ + PI+HCDLKP+NILLDENM AHV+DFGI+KLLG+ E
Sbjct: 854 LERLNIMLDVASAVEYLHHGY-AMPIVHCDLKPSNILLDENMVAHVTDFGIAKLLGD-EH 911
Query: 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRW 717
S QT+T+AT+GYMAPEYGSEG+VS D+YS+G+LLMETFTRK+PTD+MF E+S+++W
Sbjct: 912 SFIQTITLATVGYMAPEYGSEGVVSTGGDIYSFGILLMETFTRKKPTDDMFNEEISMKQW 971
Query: 718 VKESLPHGLTEVVDANLVR-EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776
V+ES+P G+T++ D +L+R EEQ FSAK DCILS+M +AL C + P+ R N+ D L
Sbjct: 972 VQESVPGGVTQITDPDLLRIEEQHFSAKKDCILSVMQVALQCSADLPEERPNIRDVLNTL 1031
Query: 777 KKIKVKFLDD 786
KVKFL D
Sbjct: 1032 NHTKVKFLKD 1041
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 791 | ||||||
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.738 | 0.569 | 0.376 | 4.4e-141 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.737 | 0.577 | 0.363 | 1.5e-140 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.749 | 0.575 | 0.354 | 1.2e-134 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.738 | 0.577 | 0.347 | 3.7e-133 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.917 | 0.708 | 0.398 | 6.2e-133 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.965 | 0.651 | 0.344 | 2.9e-112 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.817 | 0.641 | 0.360 | 2.3e-103 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.912 | 0.736 | 0.358 | 7.7e-103 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.729 | 0.709 | 0.369 | 5.2e-97 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.978 | 0.702 | 0.329 | 1e-93 |
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 4.4e-141, Sum P(2) = 4.4e-141
Identities = 226/600 (37%), Positives = 331/600 (55%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
G+IP +I L+ + + A N +G+ PP I+N+S++ L++ GN SG L G LLP
Sbjct: 215 GEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLP 274
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
N++ L + N+ TG IP +++N + L LD+ N G I +FG L++L LL +NN
Sbjct: 275 NLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLG--LNNN 332
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN 182
+ + S+ FL +LTNC L L+ G N LGG LP I N S L + + G+
Sbjct: 333 SLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGS 392
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
IP IGNL L L L N L G + P++G L L+ + L +N L G IP L ++ +
Sbjct: 393 IPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLT 452
Query: 243 GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYXXXXXXXXXXXXXX 302
+ L N G IP L S + L +L+LG+NKL SIP L L
Sbjct: 453 YLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGP 512
Query: 303 XXXXVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLE 362
+ KLK L LD+S N+LSG IP T+ LE L L N F GPIP+ G L L
Sbjct: 513 LRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLR 571
Query: 363 SLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGP 422
LDLS NNLSG IP+ + S+L+ N+S N +G +P +G F+N S S FGN LCG
Sbjct: 572 FLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGG 631
Query: 423 -PKLRVPPCK---PDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYK-RCRN-RSTKH 476
P L++ PC P S + + + ++ ++ L V+ + YK R ++ R+ +
Sbjct: 632 IPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNN 691
Query: 477 LDHEDFLPLAT-WRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFN 534
+ F P+ + + + Y ++ + T F+ NL+G+G+FG+V+KG + S VAIK+ N
Sbjct: 692 ENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLN 751
Query: 535 LQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF-----KALVLEFMPNGSLEKWLY 589
L A +SF +ECE L +RHRNL+K+++ CS+ DF +ALV EFMPNG+L+ WL+
Sbjct: 752 LCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLH 811
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 932 (333.1 bits), Expect = 1.5e-140, Sum P(2) = 1.5e-140
Identities = 219/603 (36%), Positives = 338/603 (56%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G+IP+++ L + L NN SG+ PP ++N+S++++L + N SGRL +G L
Sbjct: 198 LEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGIL 257
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LPN+ S + N TG IP +++N + L L + N+ G I TFGN+ +L LL N
Sbjct: 258 LPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSI-PTFGNVPNLKLLFLHTN 316
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+L ++SS FL+SLTNC L L G N LGG LP I N SA L +
Sbjct: 317 SLGSDSSR--DLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLIS 374
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G+IP +IGNL L L L N L+G + ++G+L L+ LSL +N L G IP + ++ +
Sbjct: 375 GSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTM 434
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYXXXXXXXXXXXX 300
+ + L+ N G +P L + + L EL +G NKL +IP + ++
Sbjct: 435 LETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLI 494
Query: 301 XXXXXXVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
+ L+ L L L N+LSG +P T+G +E+L L N F G IP+ G L+
Sbjct: 495 GSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVG 553
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
++ +DLS N+LSG IP+ + S+L+ N+S N LEG++PVKG F+N + S GN LC
Sbjct: 554 VKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLC 613
Query: 421 GPPK-LRVPPCKPDNSKSTKNVALTVLKYILPPIVCSVLLV------ITII-MYKRCRNR 472
G ++ PC K + + K ++ V LL+ +T+I + KR +N+
Sbjct: 614 GGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNK 673
Query: 473 STKHLDHEDFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIK 531
T + L + Y D++ AT+ F+ N++G+GSFG+VYK + ++ VA+K
Sbjct: 674 ETNNPTPSTLEVLH--EKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVK 731
Query: 532 IFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF-----KALVLEFMPNGSLEK 586
+ N+Q A +SF +ECE L+++RHRNL+K+L++CS+ DF +AL+ EFMPNGSL+
Sbjct: 732 VLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDM 791
Query: 587 WLY 589
WL+
Sbjct: 792 WLH 794
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 930 (332.4 bits), Expect = 1.2e-134, Sum P(2) = 1.2e-134
Identities = 219/617 (35%), Positives = 331/617 (53%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
M G+IP E+ L + + A N+ SG PP ++NIS++ L+L N SG L + G+L
Sbjct: 205 MRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYL 264
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LPN+ LLL N TG IP ++ N + L D+ N +G I +FG LR+L L N
Sbjct: 265 LPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNN 324
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+L SSS + F+ ++ NC L L G N LGG LP I N S +L + + +
Sbjct: 325 SLGNNSSSGLE--FIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLIS 382
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G IP +IGNL L LSL +N L+G + + G+L LQ + L +N + G IP ++
Sbjct: 383 GTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTR 442
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYXXXXXXXXXXXX 300
+ + L N G IP L L +L + +N+L +IP + +
Sbjct: 443 LQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLT 502
Query: 301 XXXXXXVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
V KL++L L S N+LSG +P IG +E L + N F G IP+ + L+S
Sbjct: 503 GHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVS 561
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
L+++D S NNLSG+IP+ L +L L+ N+S N+ EG +P G F+N + S FGN +C
Sbjct: 562 LKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNIC 621
Query: 421 GPPK-LRVPPCKPDNSKSTKNVALTVLKYILPPI---VCSVLLVITII----MYKRCRNR 472
G + +++ PC S K L+V K ++ I + S+LL+I + KR +
Sbjct: 622 GGVREMQLKPCIVQASPR-KRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKN 680
Query: 473 STKHLDHEDFLPLATWR-RTPYLDIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAI 530
+ + D L + + Y ++ AT F+ NL+G+G+FG+V+KG + + VA+
Sbjct: 681 NASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAV 740
Query: 531 KIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN-----PDFKALVLEFMPNGSLE 585
K+ NL A +SF +ECE + +RHRNL+K+++ CS+ DF+ALV EFMP GSL+
Sbjct: 741 KVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLD 800
Query: 586 KWLYSHNYFLDILERLN 602
WL L+ LER+N
Sbjct: 801 MWLQ-----LEDLERVN 812
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 874 (312.7 bits), Expect = 3.7e-133, Sum P(2) = 3.7e-133
Identities = 208/599 (34%), Positives = 318/599 (53%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
G++P E+ L + L + N G+ PP I+N+S + L L G+ SG L G+LLP
Sbjct: 200 GEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLP 259
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
NI L L N+L G IP +++N + L + N G I FG + L L N L
Sbjct: 260 NIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPL 319
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN 182
S + F+ SLTNC +L +LS G LGG LP I N S L G+
Sbjct: 320 G--SYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGS 377
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
IPQ+IGNL GL L L N L G + ++G+L RL LSL +N + G IP + +L +
Sbjct: 378 IPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLE 437
Query: 243 GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYXXXXXXXXXXXXXX 302
+ L+ N G +PP L + + +L +G NKL +IP + +
Sbjct: 438 ILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGS 497
Query: 303 XXXXVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLE 362
+ L+ L L L N+ SG +P T+G +E L L N F G IP ++ L+ +
Sbjct: 498 LPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIP-NIRGLMGVR 556
Query: 363 SLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGP 422
+DLS N+LSG IP+ S+L+ N+S N G++P KG+F+N ++ FGN LCG
Sbjct: 557 RVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGG 616
Query: 423 PK-LRVPPCKPDNSK-STKNVALTVLKYILPPIVCSVLLVITIIMYKRCRNRST-KHLDH 479
K L++ PC TK+ + IL I ++LL++ I C R K+
Sbjct: 617 IKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQT 676
Query: 480 EDFLP--LATWR-RTPYLDIQRATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNL 535
+ +P L + + Y D++ AT+ F+ N++G+GSFG+V+K + ++ VA+K+ N+
Sbjct: 677 NNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNM 736
Query: 536 QLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF-----KALVLEFMPNGSLEKWLY 589
Q A +SF +ECE L++ RHRNL+K+L++C++ DF +AL+ E++PNGS++ WL+
Sbjct: 737 QRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLH 795
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1303 (463.7 bits), Expect = 6.2e-133, P = 6.2e-133
Identities = 303/760 (39%), Positives = 442/760 (58%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
++G IP+ +G L +L + +NNLSG++P +I+N+S++R ++ N+L G +P+
Sbjct: 212 LSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKT 271
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
L +E + + N G IP S+ NA+ L + + N F+G I + FG LR+L+ L +
Sbjct: 272 LHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTEL-YLWR 330
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYEC-KL 179
NL ++ D W F+S LTNC L L+ G N LGG+LP N S SL F A E K+
Sbjct: 331 NLF-QTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLS-FLALELNKI 388
Query: 180 KGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
G+IP++IGNL GL L L +N+ G++ ++GRLK L L NNL GSIP + +L
Sbjct: 389 TGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLT 448
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYXXXXXXXXXXX 299
+ + L NK SG IP L +LT+L L L +N L+ IPS L++++
Sbjct: 449 ELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNN 508
Query: 300 XXXXX-XXVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSL 358
+ LK L N+LSG IP+T+G + L L L N G IP ++G L
Sbjct: 509 LEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQL 568
Query: 359 ISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYA 418
LE+LDLS NNLSG+IP SL ++ L N+S N GE+P G+F S S GN
Sbjct: 569 KGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAK 628
Query: 419 LCGP-PKLRVPPCKP--DNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKRCRNRSTK 475
LCG P L +P C P +N K + ++V I+ S+ L+IT +KR + +
Sbjct: 629 LCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAALAILSSLYLLIT--WHKRTKKGAPS 686
Query: 476 HLDHEDFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNL 535
+ PL + Y + +ATD F NLLG+GSFGSVYKG ++ VA+K+ L
Sbjct: 687 RTSMKGH-PLVS-----YSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKL 740
Query: 536 QLERAFRSFDSECEVLRNVRHRNLIKILSSCSN-----PDFKALVLEFMPNGSLEKWLY- 589
+ +A +SF +ECE LRN+RHRNL+KI++ CS+ DFKA+V +FMPNGSLE W++
Sbjct: 741 ENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHP 800
Query: 590 -----SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVS 644
+ L++ R+ I++DV AL+YLH H P++HCD+K +N+LLD +M AHV
Sbjct: 801 ETNDQADQRHLNLHRRVTILLDVACALDYLHR-HGPEPVVHCDIKSSNVLLDSDMVAHVG 859
Query: 645 DFGISKLLGEGEDSVTQ-TMTMA---TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 700
DFG++++L +G + Q T +M TIGY APEYG I S D+YSYG+L++E T
Sbjct: 860 DFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTG 919
Query: 701 KRPTDEMFTGEMSLRRWVKESLPHG-LTEVVDANLVREEQ 739
KRPTD F ++ LR++V+ L HG +T+VVD L+ + +
Sbjct: 920 KRPTDSTFRPDLGLRQYVELGL-HGRVTDVVDTKLILDSE 958
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
Identities = 278/806 (34%), Positives = 439/806 (54%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
++G++P ++G L NL+ L +N L+G +P +I N + +++L L NQ++G +P G +
Sbjct: 372 ISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM 431
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
N+ + + N+ TG IP I N + L L + N+ G + G L+ L +L N
Sbjct: 432 --NLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYN 489
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+LT + N ++L IL SN G +P + N + LQ Y L+
Sbjct: 490 SLTGPIPR--------EIGNLKDLNILYLHSNGFTGRIPREMSNLTL-LQGLRMYSNDLE 540
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G IP+E+ ++ L++L L +N +G I +L+ L LSL+ N GSIP L L L
Sbjct: 541 GPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSL 600
Query: 241 MFGIRLTGNKLSGHIP-PCLVSLTSLR-ELHLGSNKLTSSIPSSLWSLEYXXXXXXXXXX 298
+ ++ N L+G IP L SL +++ L+ +N LT +IP L LE
Sbjct: 601 LNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNL 660
Query: 299 XXXXXXXXVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLE-TLSLARNQFQGPIPESVGS 357
+Q K + LD S+N LSG IP + D+ +L+L+RN F G IP+S G+
Sbjct: 661 FSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGN 720
Query: 358 LISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNY 417
+ L SLDLS NNL+G+IP+SL LS LK ++ N L+G +P G FKN + GN
Sbjct: 721 MTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNT 780
Query: 418 ALCGPPKLRVPPCKPDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKRCRNRSTKHL 477
LCG K + PC S + V+ IL ++LLV+ +++ C + K +
Sbjct: 781 DLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILGS-AAALLLVLLLVLILTCCKKKEKKI 838
Query: 478 DH--EDFLP-----LATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAI 530
++ E LP L R P ++++ATD FN N++G+ S +VYKG + DGT +A+
Sbjct: 839 ENSSESSLPDLDSALKLKRFEPK-ELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAV 897
Query: 531 KIFNLQLERAFRS---FDSECEVLRNVRHRNLIKILS-SCSNPDFKALVLEFMPNGSLEK 586
K+ NL+ E + S F +E + L ++HRNL+KIL + + KALVL FM NG+LE
Sbjct: 898 KVLNLK-EFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLED 956
Query: 587 WLYSHNYFL-DILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSD 645
++ + +LE++++ + + S ++YLH G+ PI+HCDLKP NILLD + AHVSD
Sbjct: 957 TIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGF-PIVHCDLKPANILLDSDRVAHVSD 1015
Query: 646 FGISKLLGEGEDSVTQTMTMA---TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR 702
FG +++LG ED T T A TIGY+APE+ V+ K DV+S+G+++ME T++R
Sbjct: 1016 FGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQR 1075
Query: 703 PT--DEMFTGEMSLRRWVKESLPHG---LTEVVDANLVREEQAFSAKMD-CILSIMDLAL 756
PT ++ + +M+LR+ V++S+ +G + V+D L + S K + I + L L
Sbjct: 1076 PTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVSLKQEEAIEDFLKLCL 1133
Query: 757 DCCIESPDMRINVTDAAAKLKKIKVK 782
C P+ R ++ + L K++ K
Sbjct: 1134 FCTSSRPEDRPDMNEILTHLMKLRGK 1159
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1024 (365.5 bits), Expect = 2.3e-103, P = 2.3e-103
Identities = 242/671 (36%), Positives = 366/671 (54%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G+IP +I L + L NN SG+ PP +N+S++ L L GN SG L G+L
Sbjct: 198 LEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNL 257
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LPNI L L N LTG IP ++ N + L +G N G I FG L +L L N
Sbjct: 258 LPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANN 317
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+L S S +FL +LTNC +L LS N LGG LP I N S L +
Sbjct: 318 SLG--SYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIY 375
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G+IP +IGNL GL L L N L G + ++G L L L L +N G IP + +L
Sbjct: 376 GSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQ 435
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYXXXXXXXXXXXX 300
+ + L+ N G +PP L + + +L +G NKL +IP + +
Sbjct: 436 LVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLS 495
Query: 301 XXXXXXVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
+ +L+ L L L N LSG +P T+G +E + L N F G IP+ G L+
Sbjct: 496 GSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMG 554
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
++++DLS NNLSG I + E S+L+ N+S N EG +P +G F+N ++ S FGN LC
Sbjct: 555 VKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLC 614
Query: 421 GPPK-LRVPPCKPDNSK-STKNVALTVLKYILPPIVCSVLLVITIIMYKRCRNR-STKHL 477
G K L++ PC T++ +L I + ++LL++ I+ + R + + +
Sbjct: 615 GSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKI 674
Query: 478 DHEDFLPLATWR-RTPYLDIQRATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNL 535
++ L + + Y D++ ATD F+ N++G+GSFG+V+K + ++ VA+K+ N+
Sbjct: 675 NNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNM 734
Query: 536 QLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF-----KALVLEFMPNGSLEKWLYS 590
Q A +SF +ECE L+++RHRNL+K+L++C++ DF +AL+ EFMPNGSL+KWL+
Sbjct: 735 QRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHP 794
Query: 591 HNYFLDILER----LNIMIDVGSALEYLH-----HGHSSAPIIHCDLKPTNILLDENMAA 641
++ + R L ++ + A++ H H PI HCDLKP+NILLD+++ A
Sbjct: 795 EE--VEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTA 852
Query: 642 HVSDFGISKLL 652
HVSDFG+++LL
Sbjct: 853 HVSDFGLARLL 863
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1019 (363.8 bits), Expect = 7.7e-103, P = 7.7e-103
Identities = 275/767 (35%), Positives = 405/767 (52%)
Query: 3 GQIPTEI---GNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVG 58
G IP ++ G+ +LQY+ + N+L+G +P ++ +R L L N+L+G +PS++
Sbjct: 153 GSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLS 212
Query: 59 HLLPNIESLLLAANNLTGIIPHS-ITNATKLVALDLGFNSFAGHILNT-----FGNLRHL 112
+ N++ + L +N L+G +P I+ +L L L +N F H NT F +L +
Sbjct: 213 NST-NLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANS 271
Query: 113 SLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKF 172
S L ++ L S + S + L+ NL + N + G +PP I N +L
Sbjct: 272 SDLQEL--ELAGNSLGGEITSSVRHLSV--NLVQIHLDQNRIHGSIPPEISNL-LNLTLL 326
Query: 173 YAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIP 232
L G IP+E+ LS L + L +N L G I +G + RL L + NNL GSIP
Sbjct: 327 NLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIP 386
Query: 233 YDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIP----SSLWSLEY 288
+L + + L GN LSG +P L +L L L N LT +IP S+L +L+
Sbjct: 387 DSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKL 446
Query: 289 XXXXXXXXXXXXXXXXXXVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQ 348
+ K+ ++ +DLS N+LSG IP +G+ LE L+L+RN F
Sbjct: 447 YLNLSSNHLSGPIPLE--LSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFS 504
Query: 349 GPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNF 408
+P S+G L L+ LD+S N L+G IP S + S LK N S N L G + KGSF
Sbjct: 505 STLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKL 564
Query: 409 SVESFFGNYALCGPPKLRVPPCKPDNSKSTKNVALTVL-KYILPPIVC--SVLLVITIIM 465
++ESF G+ LCG K + CK + + V L VL I P++C LV
Sbjct: 565 TIESFLGDSLLCGSIK-GMQACKKKHKYPS--VLLPVLLSLIATPVLCVFGYPLVQRSRF 621
Query: 466 YKRCRNRSTKHLDHEDFLPL--ATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTIS 523
K + + ++ E+ + R Y + AT FN +L+G+G FG VYKG +
Sbjct: 622 GKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLR 681
Query: 524 DGTDVAIKIFNLQLERAFR-SFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNG 582
+ T VA+K+ + + F SF EC++L+ RHRNLI+I+++CS P F ALVL MPNG
Sbjct: 682 NNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNG 741
Query: 583 SLEKWLYSHNYF---LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM 639
SLE+ LY Y LD+++ +NI DV + YLHH +S ++HCDLKP+NILLD+ M
Sbjct: 742 SLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHH-YSPVKVVHCDLKPSNILLDDEM 800
Query: 640 AAHVSDFGISKLL-GEGE-----DSV----TQTMTMATIGYMAPEYGSEGIVSAKCDVYS 689
A V+DFGIS+L+ G E DSV T + ++GY+APEYG S DVYS
Sbjct: 801 TALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYS 860
Query: 690 YGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736
+GVLL+E + +RPTD + SL ++K P L +++ L R
Sbjct: 861 FGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSR 907
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 964 (344.4 bits), Expect = 5.2e-97, P = 5.2e-97
Identities = 224/607 (36%), Positives = 336/607 (55%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
++G IP+ G L+ L +L A NNLSG +P I+NIS++ I + N+LSG LP+
Sbjct: 186 LSGSIPSSFGQLRRLSFLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSN 245
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
LP+++ + + N G IP SI NA+ + +G NSF+G + G +R+L L +
Sbjct: 246 LPSLQEVYMYYNQFHGRIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLE--LP 303
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+E+ + W F+++LTNC NL + G GG+LP + N S+SL + K+
Sbjct: 304 ETLSEAEETNDWKFMTALTNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKIS 363
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G++P++IGNL L LSL +N L G++ + +LK L+ L++ NN L GS+P + +L
Sbjct: 364 GSLPRDIGNLVNLQYLSLANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQ 423
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYXXXXXXXXXXXX 300
+ + + N G IP L +LT L +++LG N IP ++S+
Sbjct: 424 LTNMEVQFNAFGGTIPSTLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNL 483
Query: 301 XXXX-XXVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLI 359
+ KLK + N+LSG+ PSTIG + L+ L L N G IP ++ L
Sbjct: 484 EGSIPKEIGKLKNIVEFHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLK 543
Query: 360 SLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYAL 419
L++LDLSGNNLSG+IP SL + L N+S N GE+P G F N S GN +
Sbjct: 544 GLDTLDLSGNNLSGQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHI 603
Query: 420 CGP-PKLRVPPCKPDNSKSTKNVALTVLKYILPPIVC--SVLLVITII-MYKRCRNRSTK 475
CG P+L +P C + K K+ L +L ++C S L V +++ M C R K
Sbjct: 604 CGGIPELHLPTCSLKSRKKKKHQIL-----LLVVVICLVSTLAVFSLLYMLLTCHKRRKK 658
Query: 476 HLDHEDFL---PLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTIS--DG--TD- 527
+ + P+ T+++ + +ATD F+ +LLG+GSFGSVYKG DG T
Sbjct: 659 EVPATTSMQGHPMITYKQ-----LVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSL 713
Query: 528 VAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN-----PDFKALVLEFMPNG 582
VA+++ L+ +A +SF +ECE LRN RHRNL+KI++ CS+ DFKA+V +FMPNG
Sbjct: 714 VAVRVLKLETPKALKSFTAECETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNG 773
Query: 583 SLEKWLY 589
SLE WL+
Sbjct: 774 SLEDWLH 780
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 933 (333.5 bits), Expect = 1.0e-93, P = 1.0e-93
Identities = 267/811 (32%), Positives = 399/811 (49%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ G+IP EIGNL + + F+EN L+G +P +I +++L L N L G +P +G L
Sbjct: 295 LTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGEL 354
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
+E L L+ N L G IP + LV L L N G I G + S+L N
Sbjct: 355 TL-LEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSAN 413
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+L+ + + L +LS GSN L G +P + SL K + +L
Sbjct: 414 SLSGPIPA--------HFCRFQTLILLSLGSNKLSGNIPRDLKTCK-SLTKLMLGDNQLT 464
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G++P E+ NL LT L LH N L+G IS +G+LK L+ L L NNN G IP ++ +L
Sbjct: 465 GSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTK 524
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYXXXXXXXXXXXX 300
+ G ++ N+L+GHIP L S +++ L L NK + I L L Y
Sbjct: 525 IVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLT 584
Query: 301 XXXXXXVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLE-TLSLARNQFQGPIPESVGSLI 359
L L L L N LS +IP +G L L+ +L+++ N G IP+S+G+L
Sbjct: 585 GEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQ 644
Query: 360 SLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYAL 419
LE L L+ N LSG+IP S+ L L N+S+N L G +P F+ +F GN+ L
Sbjct: 645 MLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGL 704
Query: 420 CGPPKLRVPPCKP-DNSKSTKNVALTVLKYILPPIVCSVLLVITIIMYKR-C---RNRST 474
C + P P +SK + + + IL I C V+ + +I + C + R
Sbjct: 705 CNSQRSHCQPLVPHSDSKLNWLINGSQRQKILT-ITCIVIGSVFLITFLGLCWTIKRREP 763
Query: 475 KHLDHEDFL-P--LATW----RRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTD 527
+ ED P + ++ + Y + AT F+E +LG G+ G+VYK +S G
Sbjct: 764 AFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEV 823
Query: 528 VAIKIFNLQLERAF--RSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLE 585
+A+K N + E A SF +E L +RHRN++K+ C + + L+ E+M GSL
Sbjct: 824 IAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLG 883
Query: 586 KWLY--SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV 643
+ L N LD R I + L YLHH I+H D+K NILLDE AHV
Sbjct: 884 EQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHD-CRPQIVHRDIKSNNILLDERFQAHV 942
Query: 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
DFG++KL+ + S + + + GY+APEY V+ KCD+YS+GV+L+E T K P
Sbjct: 943 GDFGLAKLI-DLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPP 1001
Query: 704 TDEMFTGEMSLRRWVKESLPHGLT--EVVDANLVREEQAFSAKMDCILSIMDLALDCCIE 761
+ G L WV+ S+ + + E+ DA L ++ +M +L I AL C
Sbjct: 1002 VQPLEQGG-DLVNWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKI---ALFCTSN 1057
Query: 762 SPDMRINVTDAAAKLKKIK-VKFLDDASATN 791
SP R + + A + + + L +S T+
Sbjct: 1058 SPASRPTMREVVAMITEARGSSSLSSSSITS 1088
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 791 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-85 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-56 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-55 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-23 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-22 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.002 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 291 bits (747), Expect = 1e-85
Identities = 226/778 (29%), Positives = 372/778 (47%), Gaps = 51/778 (6%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL 60
+ GQIP E+G +++L+++ NNLSG +P I ++++ L L N L+G +PS++G+L
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNL 259
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
N++ L L N L+G IP SI + KL++LDL NS +G I L++L +L N
Sbjct: 260 -KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN 318
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
N T + A L+SL L +L SN G +P +G + +L L
Sbjct: 319 NFTGKIPVA-----LTSLPR---LQVLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLT 369
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
G IP+ + + L L L SN L G I ++G + L+ + L++N+ G +P + L L
Sbjct: 370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
++ + ++ N L G I + SL+ L L NK +P S S + + +++LS N +
Sbjct: 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFS 488
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
++P + L L L LS N+LSG+IP + + K L +L L+ NQ G IP S +
Sbjct: 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPV 548
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
L LDLS N LSG+IPK+L + L Q N+SHN L G +P G+F + + GN LC
Sbjct: 549 LSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLC 608
Query: 421 GPPKLR-VPPCKPDNSKSTK--NVALTVLKYILPPIVCSVLLVITIIMYKRCRNRSTKHL 477
G +PPCK + + T+ +++ +V + I + N K +
Sbjct: 609 GGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFI-----RGRNNLELKRV 663
Query: 478 DHEDFLPLATW-------RRTPYLDIQRATDEFNECNLLGTGSFGSVYKG-TISDGTDVA 529
++ED TW + + + I E N++ G G+ YKG +I +G
Sbjct: 664 ENED----GTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFV 719
Query: 530 IKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLY 589
+K N + S ++ + ++H N++K++ C + L+ E++ +L + L
Sbjct: 720 VKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775
Query: 590 SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649
+ L R I I + AL +L H S ++ +L P I++D H+
Sbjct: 776 N----LSWERRRKIAIGIAKALRFL-HCRCSPAVVVGNLSPEKIIIDGKDEPHL------ 824
Query: 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFT 709
L T T + Y+APE ++ K D+Y +G++L+E T K P D F
Sbjct: 825 -RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG 883
Query: 710 GEMSLRRWVKESLPH-GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMR 766
S+ W + L +D ++ + S + I+ +M+LAL C P R
Sbjct: 884 VHGSIVEWARYCYSDCHLDMWIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTAR 938
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 2e-56
Identities = 154/426 (36%), Positives = 213/426 (50%), Gaps = 40/426 (9%)
Query: 1 MAGQIPTEIGNL-QNLQYLVFAENNLSGLVPP-TIFNISTMRILTLEGNQLSGRLPSTVG 58
++G IP +I +L+YL + NN +G +P +I N+ T L L N LSG +P+ +G
Sbjct: 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLET---LDLSNNMLSGEIPNDIG 161
Query: 59 HLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQV 118
+++ L L N L G IP+S+TN T L L L N G I G ++ L +
Sbjct: 162 -SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG 220
Query: 119 MNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECK 178
NNL+ E + L+SL + L N L G +P +GN +LQ + Y+ K
Sbjct: 221 YNNLSGEIPY--EIGGLTSLNH------LDLVYNNLTGPIPSSLGNLK-NLQYLFLYQNK 271
Query: 179 LKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHL 238
L G IP I +L L L L N L+G I + +L+ L+ L L +NN G IP L L
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 239 KLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNS 298
+ ++L NK SG IP L +L L L +N LT IP L S + + L SNS
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391
Query: 299 LNDS------------------------LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGAL 334
L LPS KL ++ LD+S N L G I S +
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM 451
Query: 335 KDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNR 394
L+ LSLARN+F G +P+S GS LE+LDLS N SG +P+ L +LS+L Q +S N+
Sbjct: 452 PSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK 510
Query: 395 LEGEIP 400
L GEIP
Sbjct: 511 LSGEIP 516
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 2e-55
Identities = 145/423 (34%), Positives = 209/423 (49%), Gaps = 43/423 (10%)
Query: 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNIS-TMRILTLEGNQLSGRLPSTVGH 59
++G+I + I L +Q + + N LSG +P IF S ++R L L N +G +P
Sbjct: 81 ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP---RG 137
Query: 60 LLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVM 119
+PN+E+L L+ N L+G IP+ I + + L LDLG N G I N
Sbjct: 138 SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN--------------- 182
Query: 120 NNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKL 179
SLTN +L L+ SN L G +P +G SL+ Y L
Sbjct: 183 -----------------SLTNLTSLEFLTLASNQLVGQIPRELGQMK-SLKWIYLGYNNL 224
Query: 180 KGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
G IP EIG L+ L L L N+L G I ++G LK LQ L L N L G IP + L+
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQ 284
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL 299
+ + L+ N LSG IP ++ L +L LHL SN T IP +L SL + + L SN
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 300 NDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLI 359
+ +P N+ K LTVLDLS N L+G+IP + + +L L L N +G IP+S+G+
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404
Query: 360 SLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKG------SFKNFSVESF 413
SL + L N+ SG++P L + ++S+N L+G I + + + F
Sbjct: 405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464
Query: 414 FGN 416
FG
Sbjct: 465 FGG 467
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 2e-48
Identities = 129/368 (35%), Positives = 192/368 (52%), Gaps = 39/368 (10%)
Query: 35 NISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSI-TNATKLVALDL 93
N S + + L G +SG++ S + L P I+++ L+ N L+G IP I T ++ L L+L
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRL-PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 94 GFNSFAGHILNTF-GNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSN 152
N+F G I NL L L NN+ + D SF +L +L G
Sbjct: 126 SNNNFTGSIPRGSIPNLETLDL----SNNMLSGEIPNDIGSF-------SSLKVLDLG-- 172
Query: 153 PLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMG 212
GN L G IP + NL+ L L+L SN L G I +G
Sbjct: 173 ----------GNV-------------LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG 209
Query: 213 RLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGS 272
++K L+ + L NNL G IPY++ L + + L N L+G IP L +L +L+ L L
Sbjct: 210 QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ 269
Query: 273 NKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIG 332
NKL+ IP S++SL+ ++ ++LS NSL+ +P V +L+ L +L L N +G IP +
Sbjct: 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT 329
Query: 333 ALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSH 392
+L L+ L L N+F G IP+++G +L LDLS NNL+G+IP+ L + L + +
Sbjct: 330 SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS 389
Query: 393 NRLEGEIP 400
N LEGEIP
Sbjct: 390 NSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 70/192 (36%), Positives = 98/192 (51%), Gaps = 10/192 (5%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSC 566
LG G FG+VY G VAIKI + E E+L+ + H N++K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
+ + LV+E+ GSL+ L + L E L I++ + LEYLH S IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH----SNGIIHR 116
Query: 627 DLKPTNILLDENMA-AHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE-YGSEGIVSAK 684
DLKP NILLD + ++DFG+SKLL + + + T YMAPE +G S K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEK 174
Query: 685 CDVYSYGVLLME 696
D++S GV+L E
Sbjct: 175 SDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 4e-46
Identities = 75/200 (37%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLER--AFRSFDSECEVLRNVRHRNLIKILSS 565
LG+GSFG+VYK G VA+KI + E+ ++ E +LR + H N+++++ +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 566 CSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIH 625
+ D LV+E+ G L +L E I + + LEYLH S IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLH----SNGIIH 121
Query: 626 CDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--YGSEGIVSA 683
DLKP NILLDEN ++DFG++K L S T T YMAPE G G
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGY-GP 178
Query: 684 KCDVYSYGVLLMETFTRKRP 703
K DV+S GV+L E T K P
Sbjct: 179 KVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 7e-45
Identities = 68/199 (34%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 507 NLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFR-SFDSECEVLRNVRHRNLIKILS 564
LG GSFG VY G VAIK+ + + R E ++L+ ++H N++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPII 624
+ D LV+E+ G L L E + + SALEYLH S I+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFYLRQILSALEYLH----SKGIV 119
Query: 625 HCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAK 684
H DLKP NILLDE+ ++DFG+++ L GE T + T YMAPE
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF---VGTPEYMAPEVLLGKGYGKA 176
Query: 685 CDVYSYGVLLMETFTRKRP 703
D++S GV+L E T K P
Sbjct: 177 VDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 8e-41
Identities = 76/265 (28%), Positives = 122/265 (46%), Gaps = 30/265 (11%)
Query: 509 LGTGSFGSVYKGTI-----SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKI 562
LG G+FG VYKGT+ T VA+K E F E +++ + H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
L C+ + +V E+MP G L +L H L + + L + + + +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE----SKN 122
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVS 682
+H DL N L+ EN+ +SDFG+S+ + E + + I +MAPE +G +
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 683 AKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741
+K DV+S+GVLL E FT ++P M EV+ L+ +
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQPYPGM-----------------SNEEVL--ELLEDGYRL 223
Query: 742 SAKMDCILSIMDLALDCCIESPDMR 766
+C + +L L C P+ R
Sbjct: 224 PRPENCPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 8e-41
Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 12/206 (5%)
Query: 509 LGTGSFGSVYKGTISD-----GTDVAIKIFNL-QLERAFRSFDSECEVLRNVRHRNLIKI 562
LG G+FG VYKG + +VA+K E+ F E ++R + H N++K+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
L C+ + +V+E+M G L +L + L + + L+ + + +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE----SKN 122
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVS 682
IH DL N L+ EN+ +SDFG+S+ L + D + I +MAPE EG +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 683 AKCDVYSYGVLLMETFTR-KRPTDEM 707
+K DV+S+GVLL E FT ++P M
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPYPGM 207
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 9e-41
Identities = 79/266 (29%), Positives = 122/266 (45%), Gaps = 32/266 (12%)
Query: 509 LGTGSFGSVYKGTISDG-----TDVAIKIFNL-QLERAFRSFDSECEVLRNVRHRNLIKI 562
LG G+FG VYKGT+ +VA+K E+ F E ++R + H N++K+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWL-YSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
L C+ + +V+E+MP G L +L + L + + L+ + + +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SK 122
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV 681
IH DL N L+ EN+ +SDFG+S+ L + D I +MAPE EG
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYKVKGGKLPIRWMAPESLKEGKF 181
Query: 682 SAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740
++K DV+S+GVLL E FT + P M EV+ +++
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGM-----------------SNAEVL--EYLKKGYR 222
Query: 741 FSAKMDCILSIMDLALDCCIESPDMR 766
+C + L L C E P+ R
Sbjct: 223 LPKPPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 507 NLLGTGSFGSVYKGTISDG----TDVAIKIFNLQLERAFRS-FDSECEVLRNVRHRNLIK 561
LG G+FG VYKG + T+VA+K R F E V++ + H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSH--------NYFLDILERLNIMIDVGSALEY 613
+L C+ + LVLE+M G L +L L + + L+ I + +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAP 673
L S +H DL N L+ E++ +SDFG+S+ + + + +T I +MAP
Sbjct: 121 LA----SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 674 EYGSEGIVSAKCDVYSYGVLLMETFTR 700
E +GI ++K DV+S+GVLL E FT
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 507 NLLGTGSFGSVYKGTISD-GTDVAIK--IFNLQLERAFRSFDSECEVLRNVRHRNLIKIL 563
LLG GSFGSVY D G +A+K + E + + E +L +++H N+++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 564 SSCSNPDFKAL--VLEFMPNGSLEKWLYS---------HNYFLDILERLNIMIDVGSALE 612
S + + L LE++ GSL L Y ILE L
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE----------GLA 115
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA-TIGYM 671
YLH S I+H D+K NIL+D + ++DFG +K LG+ E T ++ T +M
Sbjct: 116 YLH----SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-EGTGSVRGTPYWM 170
Query: 672 APEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
APE D++S G ++E T K P
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 8/217 (3%)
Query: 497 QRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRH 556
+R +EF LG+G FG V++G + VAIKI + F E + L+ +RH
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLH 615
++LI + + CS + ++ E M GSL +L S L + +++ V + YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675
+ IH DL NIL+ E++ V+DFG+++L+ ED + + APE
Sbjct: 122 EQN----SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEA 175
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGE 711
S G S K DV+S+G+LL E FT + P M E
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 64/196 (32%), Positives = 96/196 (48%), Gaps = 8/196 (4%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
+G G FG VYK G +VAIK+ L+ + +E ++L+ +H N++K S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCD 627
D +V+EF GSL+ L S N L + + ++ LEYLH S IIH D
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH----SNGIIHRD 123
Query: 628 LKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDV 687
+K NILL + + DFG+S L + + TM + T +MAPE + K D+
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM-VGTPYWMAPEVINGKPYDYKADI 180
Query: 688 YSYGVLLMETFTRKRP 703
+S G+ +E K P
Sbjct: 181 WSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 5/193 (2%)
Query: 508 LLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFR-SFDSECEVLRNVRHRNLIKILSSC 566
+G G+FG VYKG + T+VA+K L + F E E+L+ H N++K++ C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
+V+E +P GSL +L L + + L + +D + +EYL S IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE----SKNCIHR 117
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
DL N L+ EN +SDFG+S+ G +V+ + I + APE + G +++ D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 687 VYSYGVLLMETFT 699
V+SYG+LL ETF+
Sbjct: 178 VWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 508 LLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
+G G FG V G G VA+K A ++F +E V+ +RH NL+++L
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 568 NPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
+ +V E+M GSL +L S + + ++L +DV +EYL +H
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE----EKNFVHR 126
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
DL N+L+ E++ A VSDFG++K E S Q + + APE E S K D
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSD 181
Query: 687 VYSYGVLLMETFTRKR 702
V+S+G+LL E ++ R
Sbjct: 182 VWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 1e-26
Identities = 71/216 (32%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 502 EFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLER---AFRSFDSECEVLRNVRH-R 557
+ LG GSFG VY D VA+K+ +LE F E ++L ++ H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVGSALEYLH 615
N++K+ + LV+E++ GSLE L + E I+ + SALEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 616 HGHSSAPIIHCDLKPTNILLDEN-MAAHVSDFGISKLLGEGEDSVTQTMTMA----TIGY 670
S IIH D+KP NILLD + + DFG++KLL + + + + T GY
Sbjct: 119 ----SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 671 MAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRP 703
MAPE S S+ D++S G+ L E T P
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 32/209 (15%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRS-FDSECEVLRNVRHRNLIKILSSC 566
LG GS G VYK G A+K ++ + FR E + LR+ ++K C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 567 SNPDFK----ALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHHGHSSA 621
+K ++VLE+M GSL L + +L + I G L+YLH
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKG--LDYLHTKRH-- 120
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT-MATIGYMAPE------ 674
IIH D+KP+N+L++ ++DFGISK+L E+++ Q T + T+ YM+PE
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPERIQGES 176
Query: 675 YGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
Y S D++S G+ L+E K P
Sbjct: 177 Y------SYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 507 NLLGTGSFGSVYKGT-ISDGTDVAIKIFNL------QLERAFRSFDSECEVLRNVRHRNL 559
+G GSFG VY SDG +K +L + E A E ++L+ + H N+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL---ERLNIMIDVGSALEYLHH 616
IK S +V+E+ G L + + + L+ + + AL+YLH
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE-- 674
S I+H D+KP NI L N + DFGISK+L + +T+ T Y++PE
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVV-GTPYYLSPELC 175
Query: 675 ----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
Y + K D++S G +L E T K P F GE
Sbjct: 176 QNKPY------NYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 3e-26
Identities = 66/209 (31%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 509 LGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFD---SECEVLRNVRHRNLIKILS 564
LG GSFG V G A+K+ + + + +E +L + H ++K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-HGHSSAPI 623
+ + LVLE+ P G L L F + R ++ ALEYLH G I
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLHSLG-----I 114
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA-TIGYMAPEYGSEGIVS 682
I+ DLKP NILLD + ++DFG++K E ++T T T Y+APE
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAK---ELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171
Query: 683 AKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
D +S GVLL E T K P F E
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPP----FYAE 196
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 507 NLLGTGSFGSVYKGT---ISDGT--DVAIKIFNLQLERAFRS-FDSECEVLRNVRHRNLI 560
LG G FG V + D T VA+K N E RS F+ E E+LR + H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 561 KILSSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
K C P ++ L++E++P+GSL +L H +++ L + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT-QTMTMATIGYMAPEYGS 677
IH DL NIL++ +SDFG++K+L E +D + + I + APE
Sbjct: 130 ----YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 678 EGIVSAKCDVYSYGVLLMETFTRKRPT 704
S+ DV+S+GV L E FT P+
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 65/193 (33%), Positives = 101/193 (52%), Gaps = 6/193 (3%)
Query: 508 LLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFR-SFDSECEVLRNVRHRNLIKILSSC 566
LLG G+FG V+KGT+ D T VA+K L + + F SE +L+ H N++K++ C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
+ +V+E +P G +L L + + +D + + YL S IH
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE----SKNCIHR 117
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
DL N L+ EN +SDFG+S+ +G S + + I + APE + G S++ D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 687 VYSYGVLLMETFT 699
V+SYG+LL ETF+
Sbjct: 177 VWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIF---NLQLERAFRSFDSECEVLRNVRHRNLIKILSS 565
LG G FG V+ GT + T VA+K + E +F E ++++ +RH L+++ +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE----AFLQEAQIMKKLRHDKLVQLYAV 69
Query: 566 CSNPDFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLHHGHSSAPII 624
CS + +V E+M GSL +L S L + + +++ + + YL S I
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE----SRNYI 125
Query: 625 HCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAK 684
H DL NIL+ EN+ ++DFG+++L+ + E + + I + APE + G + K
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP-IKWTAPEAANYGRFTIK 184
Query: 685 CDVYSYGVLLMETFTRKR 702
DV+S+G+LL E T R
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 81/291 (27%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 509 LGTGSFGSVYKGTIS------DGTDVAIKIF-NLQLERAFRSFDSECEVLRNVRHRNLIK 561
LG G+FG V+ G D VA+K A + F+ E E+L N +H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL-------------ERLNIMIDVG 608
C+ D +V E+M +G L K+L SH L + L I + +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
S + YL +S +H DL N L+ ++ + DFG+S+ + + TM I
Sbjct: 133 SGMVYL----ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 669 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLT 727
+M PE + + DV+S+GV+L E FT K+P + E V E + G
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VIECITQGRL 242
Query: 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778
L R C + D+ L C P RIN+ D +L+K
Sbjct: 243 ------LQRPR-------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 12/219 (5%)
Query: 502 EFNECNLLGTGSFGSVYKGT-ISDG----TDVAIKIFNLQLER-AFRSFDSECEVLRNVR 555
E + +LG+G+FG+VYKG I +G VAIK+ + A + E V+ +V
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 556 HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 615
H +++++L C + L+ + MP G L ++ +H + LN + + + YL
Sbjct: 68 HPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675
++H DL N+L+ ++DFG++KLL E I +MA E
Sbjct: 127 EKR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 676 GSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMS 713
I + K DV+SYGV + E T +P + + E+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 507 NLLGTGSFGSVYKG-TISDGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKIL 563
+L+G G+FG VYKG + G VAIK +L+ E A +S E ++L+N++H N++K +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI--MIDVGSALEYLHHGHSSA 621
S D ++LE+ NGSL + + F E L + V L YLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPF---PESLVAVYVYQVLQGLAYLH----EQ 118
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV 681
+IH D+K NIL ++ ++DFG++ L + S + T +MAPE
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 682 SAKCDVYSYGVLLMETFTRKRP 703
S D++S G ++E T P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFN---LQLERAFRSFDSECEVL-RNVR 555
D+F ++G GSF +V + AIKI + L E+ + E EVL R
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 556 HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 615
H +IK+ + + + VLE+ PNG L +++ LD ++ ALEYLH
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG------ 669
S IIH DLKP NILLD++M ++DFG +K+L + I
Sbjct: 120 ----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 670 ------------YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
Y++PE +E D+++ G ++ + T K P
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 70/219 (31%), Positives = 114/219 (52%), Gaps = 21/219 (9%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568
+G G FG+V +G + G VA+K N++ + ++F E V+ + H+NL+++L +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 569 PDFKALVLEFMPNGSLEKWLYSHNYFL-DILERLNIMIDVGSALEYLHHGHSSAPIIHCD 627
+V+E M G+L +L + L +++ L +DV +EYL S ++H D
Sbjct: 71 NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE----SKKLVHRD 125
Query: 628 LKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDV 687
L NIL+ E+ A VSDFG++++ G D+ + + + APE S+K DV
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAPEALKHKKFSSKSDV 180
Query: 688 YSYGVLLMETFTRKR-PTDEMFTGEMSLRRWVKESLPHG 725
+SYGVLL E F+ R P +M E VKE + G
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKE------VKECVEKG 213
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 73/291 (25%), Positives = 129/291 (44%), Gaps = 44/291 (15%)
Query: 509 LGTGSFGSVYKGTI------SDGTDVAIKIFNLQLERAFRS-FDSECEVLRNVRHRNLIK 561
LG G+FG VYKG + T VAIK E + F E E++ +++H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMID 606
+L C+ ++ E++ +G L ++L ++ LD + L+I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
+ + +EYL SS +H DL N L+ E + +SDFG+S+ + + Q+ ++
Sbjct: 133 IAAGMEYL----SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL 726
+ +M PE G + + D++S+GV+L E F+ F+ +
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--------------- 233
Query: 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777
EV+ ++R Q DC + L ++C E P R D +L+
Sbjct: 234 -EVI--EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-23
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 13/216 (6%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRS---FDSECEVLRNVRHR 557
E +G+G FG V+ G + VAIK + S F E +V+ + H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIK----TIREGAMSEEDFIEEAQVMMKLSHP 59
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG 617
L+++ C+ LV EFM +G L +L + L + +DV + YL
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE-- 117
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS 677
S+ +IH DL N L+ EN VSDFG+++ + + + + T T + + +PE S
Sbjct: 118 --SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFS 174
Query: 678 EGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEM 712
S+K DV+S+GVL+ E F+ K P + E+
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-22
Identities = 62/191 (32%), Positives = 93/191 (48%), Gaps = 11/191 (5%)
Query: 312 VLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNL 371
+ L L L G IP+ I L+ L++++L+ N +G IP S+GS+ SLE LDLS N+
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 372 SGKIPKSLETLSQLKQFNVSHNRLEGEIP--VKGSFKNFSVESFFGNYALCGPPKLRVPP 429
+G IP+SL L+ L+ N++ N L G +P + G + + +F N LCG P LR
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLR--A 536
Query: 430 CKPDNSKSTK-NVALTVLKYILPPIVCSVLLVITIIMYKRCRNRSTKHLDHEDFLPLATW 488
C P S K +A V L ++C+ + +KR +N P A
Sbjct: 537 CGPHLSVGAKIGIAFGVSVAFLFLVICA------MCWWKRRQNILRAQRIAAREAPYAKA 590
Query: 489 RRTPYLDIQRA 499
R D+Q
Sbjct: 591 RTHFSRDVQMT 601
|
Length = 623 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 508 LLGTGSFGSVYKGTIS--DGT--DVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIK 561
+LG G FGSV +G +S DG+ VA+K L + F SE +++ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 562 IL------SSCSNPDFKALVLEFMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGSA 610
++ SS ++L FM +G L +L L + L M+D+
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT-MTMATIG 669
+EYL S+ IH DL N +L E+M V+DFG+SK + G D Q + +
Sbjct: 126 MEYL----SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPVK 180
Query: 670 YMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 700
++A E ++ + ++K DV+++GV + E TR
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 56/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 509 LGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRS-FDSECEVLRNVRHRNLIKILSSC 566
+G G+FG V+ G + +D T VA+K L ++ F E +L+ H N+++++ C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
+ +V+E + G +L + L + E + ++ + + +EYL H IH
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC----IHR 118
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
DL N L+ E +SDFG+S+ +G + T M + + APE + G S++ D
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 687 VYSYGVLLMETFT 699
V+S+G+LL E F+
Sbjct: 179 VWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 75/284 (26%), Positives = 128/284 (45%), Gaps = 21/284 (7%)
Query: 508 LLGTGSFGSVYK---GTISDGTD--VAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKI 562
LG G+FGSV + D T VA+K R F+ E E+L++++H N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 563 LSSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
C + + LV+E++P GSL +L H LD + L + +EYL S
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL----GS 126
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS-VTQTMTMATIGYMAPEYGSEG 679
+H DL NIL++ + DFG++K+L + ++ + + I + APE +E
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 680 IVSAKCDVYSYGVLLMETFT---RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736
S DV+S+GV+L E FT + F M + + + H + L++
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI------ELLK 240
Query: 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780
A C I + +C P R + ++ A +++ I+
Sbjct: 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 74/262 (28%), Positives = 115/262 (43%), Gaps = 32/262 (12%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRS--FDSECEVLRNVRHRNLIKILSSC 566
LG+G FG V+ G DVAIK+ E A F E +V+ + H NL+++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
+ +V E+M NG L +L L L++ DV A+EYL S IH
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE----SNGFIHR 124
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
DL N L+ E+ VSDFG+++ + + + + T + + PE S+K D
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 687 VYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL--VREEQAFSAK 744
V+S+GVL+ E F+ G+M R+ +EVV++ R + A
Sbjct: 184 VWSFGVLMWEVFS---------EGKMPYERFSN-------SEVVESVSAGYRLYRPKLAP 227
Query: 745 MDCILSIMDLALDCCIESPDMR 766
+ + C E P+ R
Sbjct: 228 T----EVYTIMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 507 NLLGTGSFGSVYKG-TISDGTDVAIKIFNLQLER--AFRSFDSECEVLRNVRHRNLIKIL 563
N +G G+FG VY + G +A+K +Q + E +VL ++H NL+K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERLNIMIDVGSALEYLHHGHSSA 621
+ + + +E+ G+LE+ L H LD ++ + + G L YLH S
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEG--LAYLH----SH 118
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM--TMATIGYMAPEYGSEG 679
I+H D+KP NI LD N + DFG + L ++ + + T YMAPE + G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 680 IVSAK---CDVYSYGVLLMETFTRKRPTDEM 707
D++S G +++E T KRP E+
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 68/217 (31%), Positives = 112/217 (51%), Gaps = 22/217 (10%)
Query: 508 LLGTGSFGSVYKG-TISDGTDVAIKIFNLQLERAFR----------SFDSECEVLRNVRH 556
L+G G++G VY ++ G +A+K L A R + SE E L+++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
N+++ L + ++ ++ LE++P GS+ L ++ F + L R V L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLH- 125
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM-ATIGYMAPE- 674
S I+H DLK N+L+D + +SDFGISK + D+ Q M+M ++ +MAPE
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND-QNMSMQGSVFWMAPEV 181
Query: 675 -YGSEGIVSAKCDVYSYGVLLMETFTRKRP--TDEMF 708
+ SAK D++S G +++E F +RP +E
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 9e-22
Identities = 66/258 (25%), Positives = 121/258 (46%), Gaps = 29/258 (11%)
Query: 507 NLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 561
++G G FG V +G + DVAIK ++ F +E ++ H N+I+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
+ + ++ E+M NGSL+K+L ++ + + + ++ + S ++YL S
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL----SEM 125
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV 681
+H DL NIL++ N+ VSDFG+S+ L + E + T I + APE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 682 SAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740
++ DV+S+G+++ E + +RP +M + + +V+ A V +
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPYWDM-SNQ----------------DVIKA--VEDGYR 226
Query: 741 FSAKMDCILSIMDLALDC 758
MDC ++ L LDC
Sbjct: 227 LPPPMDCPSALYQLMLDC 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 71/213 (33%), Positives = 107/213 (50%), Gaps = 25/213 (11%)
Query: 508 LLGTGSFGSVYKG-TISDGTDVAIKIFNL-----QLERAFRS----FDSECEVLRNVRHR 557
L+G+GSFGSVY G S G +A+K L + RS E +L+ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG 617
N+++ L S + D + LE++P GS+ L ++ F + L R N + + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT-------MATIGY 670
+ IIH D+K NIL+D +SDFGISK L E + T T ++ +
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGARPSLQGSVFW 178
Query: 671 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
MAPE + + K D++S G L++E T K P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 30/279 (10%)
Query: 508 LLGTGSFGSVYKGTI--SDGTDVAIKIFNLQ---LERAFRSFDSECEVLRNVRHRNLIKI 562
++G G FG V++G + +VA+ I L+ E+ + F SE ++ H N+I++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
+ ++ E+M NG+L+K+L H+ + + ++ + + ++YL S
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL----SDMN 127
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEG-EDSVTQTMTMATIGYMAPEYGSEGIV 681
+H DL NIL++ N+ VSDFG+S++L + E + T + I + APE +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 682 SAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740
++ DV+S+G+++ E + +RP +M EV+ A + +
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERPYWDMSN-----------------HEVMKA--INDGFR 228
Query: 741 FSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
A MDC ++ L L C + R D L K+
Sbjct: 229 LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 30/261 (11%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568
LG G FG V+ GT + T VAIK + +F E +V++ +RH L+++ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 569 -PDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
P + +V E+M GSL +L +L + + +++ + S + Y+ + +H
Sbjct: 73 EPIY--IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN----YVHR 126
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
DL+ NIL+ EN+ V+DFG+++L+ + E + Q I + APE G + K D
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSD 185
Query: 687 VYSYGVLLMETFTRKR-PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKM 745
V+S+G+LL E T+ R P M EV+D V
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVN-----------------REVLDQ--VERGYRMPCPP 226
Query: 746 DCILSIMDLALDCCIESPDMR 766
+C S+ DL C + P+ R
Sbjct: 227 ECPESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 30/279 (10%)
Query: 508 LLGTGSFGSVYKGTIS--DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKI 562
++G G FG V G + ++ + I L+ E+ R F SE ++ H N+I +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
+ +V E+M NGSL+ +L H+ +++ + ++ + S ++YL S
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL----SDMG 126
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV-TQTMTMATIGYMAPEYGSEGIV 681
+H DL NIL++ N+ VSDFG+S++L + ++ T I + APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 682 SAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740
++ DV+SYG+++ E + +RP EM +V+ A + E
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMSN-----------------QDVIKA--IEEGYR 227
Query: 741 FSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
A MDC ++ L LDC + + R + L K+
Sbjct: 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568
LGTG FG V G DVAIK+ + + F E +V+ + H L+++ C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 569 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDL 628
+V E+M NG L +L H + L + DV + YL S IH DL
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE----SKQFIHRDL 126
Query: 629 KPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM-TMATIGYMAPEYGSEGIVSAKCDV 687
N L+D+ VSDFG+S+ + +D T ++ + + + PE S+K DV
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 688 YSYGVLLMETFTRKRPTDEMFT 709
+++GVL+ E ++ + E F
Sbjct: 185 WAFGVLMWEVYSLGKMPYERFN 206
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 65/196 (33%), Positives = 97/196 (49%), Gaps = 14/196 (7%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568
+G G FG V G G VA+K ++ + ++F +E V+ +RH NL+++L
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 569 PDFKA-LVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
+V E+M GSL +L S L L +DV A+EYL + +H
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----ANNFVHR 126
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
DL N+L+ E+ A VSDFG++K E S TQ + + APE E S K D
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 687 VYSYGVLLMETFTRKR 702
V+S+G+LL E ++ R
Sbjct: 182 VWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 509 LGTGSFGSVYKGT--ISDGT--DVAIKIF-NLQLERAFRSFDSECEVLRNVRHRNLIKIL 563
LG G+FGSV KG + G +VA+K + + F E V+ + H +++++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPI 623
C LV+E P G L K+L + + V + YL H
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVS-DLKELAHQVAMGMAYLESKH----F 116
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT-QTMTMATIGYMAPEYGSEGIVS 682
+H DL N+LL A +SDFG+S+ LG G D T + + APE + G S
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 683 AKCDVYSYGVLLMETFTR-KRPTDEM 707
+K DV+SYGV L E F+ +P EM
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 507 NLLGTGSFGSVYKGTISD-GTDVAIKIF---NLQLERAFRSFDSECEVLRNVRHRNLIKI 562
+ LG G +G VY+G VA+K +++E F E V++ ++H NL+++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKEIKHPNLVQL 67
Query: 563 LSSCS-NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSS 620
L C+ P F ++ EFM G+L +L N ++ + L + + SA+EYL +
Sbjct: 68 LGVCTREPPF-YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGI 680
IH DL N L+ EN V+DFG+S+L+ G+ I + APE +
Sbjct: 125 --FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 681 VSAKCDVYSYGVLLMETFT 699
S K DV+++GVLL E T
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 69/281 (24%), Positives = 128/281 (45%), Gaps = 32/281 (11%)
Query: 508 LLGTGSFGSVYKGTIS----DGTDVAIKIFNL-QLERAFRSFDSECEVLRNVRHRNLIKI 562
++G G FG V +G + VAIK E+ R F SE ++ H N+I +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
+ ++ EFM NG+L+ +L ++ +++ + ++ + + ++YL S
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL----SEMN 126
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA---TIGYMAPEYGSEG 679
+H DL NIL++ N+ VSDFG+S+ L + T T ++ I + APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 680 IVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738
++ DV+SYG+++ E + +RP +M +V++A + ++
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----------------QDVINA--IEQD 227
Query: 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
MDC ++ L LDC + + R + L K+
Sbjct: 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 9e-21
Identities = 71/225 (31%), Positives = 102/225 (45%), Gaps = 56/225 (24%)
Query: 507 NLLGTGSFGSVYKGT-ISDGTDVAIK-IFN-----LQLERAFRSFDSECEVLRNVRHRNL 559
+G+G++G V G VAIK I N + +R R E ++LR++RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 560 IKILS---SCSNPDFKAL--VLEFMPNGSLEKWLYS--------HNYFL-DILERLNIMI 605
I +L S DF + V E M L K + S YFL IL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQIL------- 113
Query: 606 DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT- 664
L+YLH SA +IH DLKP+NIL++ N + DFG+++ + ED +T
Sbjct: 114 ---RGLKYLH----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF-LTE 165
Query: 665 -MATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 701
+ T Y APE Y ++ I D++S G + E TRK
Sbjct: 166 YVVTRWYRAPELLLSSSRY-TKAI-----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 72/260 (27%), Positives = 117/260 (45%), Gaps = 27/260 (10%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568
LG G FG V++G ++ T VA+K + F +E ++++ +RH LI++ + C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 569 PDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCD 627
+ +V E M GSL ++L L + + +++ V S + YL + IH D
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN----YIHRD 128
Query: 628 LKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDV 687
L N+L+ EN V+DFG+++++ E + + I + APE S K DV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 688 YSYGVLLMETFTRKR-PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMD 746
+S+G+LL E T R P M E V + + G
Sbjct: 188 WSFGILLTEIVTYGRMPYPGMTNAE------VLQQVDQGYRMPCPPG------------- 228
Query: 747 CILSIMDLALDCCIESPDMR 766
C + D+ LDC E PD R
Sbjct: 229 CPKELYDIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 507 NLLGTGSFGSVYKGTISDGTDV-AIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKI 562
++G G+FG V D + A+K N Q + + R+ +E +L+ + H L+ +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN------IMIDVGSALEYLHH 616
S + + LV++ + G L Y L + + + ++ ALEYLH
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEIVLALEYLH- 117
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYG 676
S IIH D+KP NILLDE H++DF I+ + + + T T GYMAPE
Sbjct: 118 ---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS---TSGTPGYMAPEVL 171
Query: 677 SEGIVSAKCDVYSYGVLLMETFTRKRP 703
S D +S GV E KRP
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 45/285 (15%)
Query: 509 LGTGSFGSVYKGT------ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKI 562
LG G+FG V+ D VA+K A + F E E+L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDV 607
C + D +V E+M +G L K+L +H L + + L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT 667
S + YL H +H DL N L+ N+ + DFG+S+ + + TM
Sbjct: 133 ASGMVYLASQH----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 668 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGL 726
I +M PE + + DV+S+GV+L E FT K+P W +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-------------WFQ----LSN 231
Query: 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTD 771
TEV++ + + + C + D+ L C P R+N+ +
Sbjct: 232 TEVIEC--ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKE 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 502 EFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFD--------SECEVLR 552
++ +G GSFG+V K SDG + K E + + SE +LR
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWK------EIDYGNMTEKEKQQLVSEVNILR 54
Query: 553 NVRHRNLIKILSSCSNPDFKAL--VLEFMPNGSLEKWL---YSHNYFLDILERLNIMIDV 607
++H N+++ + + L V+E+ G L + + +++ I+ +
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 608 GSALEYLHHG-HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
AL H+ ++H DLKP NI LD N + DFG++K+LG S +T +
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTY-VG 172
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
T YM+PE + K D++S G L+ E P
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 13/225 (5%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568
LG G FG V+ GT + T VAIK +F E ++++ +RH L+ + + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 569 -PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
P + +V EFM GSL +L + +L + + +++ + + Y+ + IH
Sbjct: 73 EPIY--IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN----YIHR 126
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
DL+ NIL+ +N+ ++DFG+++L+ + E + Q I + APE G + K D
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSD 185
Query: 687 VYSYGVLLMETFTRKR-PTDEMFTGEM--SLRRWVKESLPHGLTE 728
V+S+G+LL E T+ R P M E+ + R + P G E
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE 230
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERA-FRSFDSECEVLRNVRHRNLIKILSSC 566
LG G+ G V K G +A+K L++ A + E ++L ++ +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 567 SNPDFKALVLEFMPNGSLEKWL--YSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPII 624
N ++ +E+M GSL+K L IL + I + V L YLH H II
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEKHK---II 123
Query: 625 HCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAK 684
H D+KP+NIL++ + DFG+S G+ +S+ +T T YMAPE S K
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVS---GQLVNSLAKTFV-GTSSYMAPERIQGNDYSVK 179
Query: 685 CDVYSYGVLLMETFTRKRP 703
D++S G+ L+E T + P
Sbjct: 180 SDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 508 LLGTGSFGSVYKG-TISDGTDVAIKIFNL-----QLERAFRSFDSECEVLRNVRHRNLIK 561
LLG+GSFGSVY+G + DG A+K +L + A + + E +L ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL---NIMIDVGSALEYLHHGH 618
L + D + LE +P GSL K L + F + + RL I+ LEYLH +
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----LGLEYLHDRN 122
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG---YMAPEY 675
+H D+K NIL+D N ++DFG++K V + + G +MAPE
Sbjct: 123 ----TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAPEV 172
Query: 676 -GSEGIVSAKCDVYSYGVLLMETFTRKRP 703
+G D++S G ++E T K P
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 27/210 (12%)
Query: 507 NLLGTGSFGSVYKGTIS-DGT--DVAIKIFN-LQLERAFRSFDSECEVLRNV-RHRNLIK 561
+++G G+FG V + I DG + AIK+ E R F E EVL + H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILERLNIMID 606
+L +C N + + +E+ P G+L +L L + L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
V + ++YL S IH DL N+L+ EN+A+ ++DFG+S+ GE E V +TM
Sbjct: 128 VATGMQYL----SEKQFIHRDLAARNVLVGENLASKIADFGLSR--GE-EVYVKKTMGRL 180
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLME 696
+ +MA E + + + K DV+S+GVLL E
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 72/261 (27%), Positives = 121/261 (46%), Gaps = 30/261 (11%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568
LG G FG V+ GT + T VA+K + SF E ++++ +RH L+++ + S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 569 -PDFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
P + +V E+M GSL +L L + +++ V + + Y+ + IH
Sbjct: 73 EPIY--IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN----YIHR 126
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
DL+ NIL+ + + ++DFG+++L+ + E + Q I + APE G + K D
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSD 185
Query: 687 VYSYGVLLMETFTRKR-PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKM 745
V+S+G+LL E T+ R P M R V E + G
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGYR-------------MPCPQ 226
Query: 746 DCILSIMDLALDCCIESPDMR 766
DC +S+ +L L C + P+ R
Sbjct: 227 DCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 72/230 (31%), Positives = 108/230 (46%), Gaps = 32/230 (13%)
Query: 494 LDIQRATDEFNECNLLGTGSFGSVYKG-TISDGTDVAIKIFNLQLERAFRSFDSECEVLR 552
L+ + DE E +LG G++G VY +S +AIK + R + E +
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 553 NVRHRNLIKILSSCSNPDFKALVLEFMPNGSLE-----KW--LYSHN-----YFLDILER 600
++HRN+++ L S S F + +E +P GSL KW L + Y ILE
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE- 119
Query: 601 LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-NMAAHVSDFGISKLLGEGEDSV 659
L+YLH I+H D+K N+L++ + +SDFG SK L G +
Sbjct: 120 ---------GLKYLHDNQ----IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPC 165
Query: 660 TQTMTMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKRPTDEM 707
T+T T T+ YMAPE +G A D++S G ++E T K P E+
Sbjct: 166 TETFT-GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 69/291 (23%), Positives = 119/291 (40%), Gaps = 44/291 (15%)
Query: 509 LGTGSFGSVYKGTIS------DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKI 562
LG G+FG V+ D VA+K E A + F E E+L ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------------LNIMIDVG 608
C+ +V E+M +G L ++L SH IL L I +
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
S + YL H +H DL N L+ + + + DFG+S+ + + TM I
Sbjct: 133 SGMVYLASLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 669 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLT 727
+M PE + + D++S+GV+L E FT K+P W + S T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-------------WYQLS----NT 231
Query: 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778
E ++ + + + C + + C P R+ + D ++L+
Sbjct: 232 EAIEC--ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 509 LGTGSFGSVYKG---TISDG---TDVAIKIFNLQLERA----FRSFDSECEVLRNVRHRN 558
LG GSFG VY+G + G T VAIK N E A F +E V++ +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH------NYFLDILERLNIM---IDVGS 609
++++L S +V+E M G L+ +L S N L + ++
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG 669
+ YL +H DL N ++ E++ + DFG+++ + E + + +
Sbjct: 131 GMAYLAAKK----FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 670 YMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+MAPE +G+ + K DV+S+GV+L E T
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 40/217 (18%)
Query: 508 LLGTGSFGSVYKGTISD-GTDVAIKIFNL-----QLERAFRSFDSECEVLRNVRHRNLIK 561
LLG G+FG VY D G ++A+K + ++ + + E ++L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSALE 612
+ + ++ +E+MP GS++ L ++ Y ILE +E
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE----------GVE 118
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL------GEGEDSVTQTMTMA 666
YLH I+H D+K NIL D + DFG SK L G G SVT
Sbjct: 119 YLHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-----G 169
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
T +M+PE S K DV+S G ++E T K P
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 14/210 (6%)
Query: 502 EFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQ-LERAFRSFD-SECEVLRNVRHRN 558
+F N +G GSFG V+K +D A+K +L + R R E VL +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGSALEYLH 615
+I+ S + +V+E+ NG L K L D + R I I +G L +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG--LAHLH 118
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675
S I+H D+K N+ LD + D G++KLL + + T+ + T Y++PE
Sbjct: 119 ----SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTI-VGTPYYLSPEL 172
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRPTD 705
+ + K DV++ GV+L E T K P D
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 69/272 (25%), Positives = 103/272 (37%), Gaps = 41/272 (15%)
Query: 508 LLGTGSFGSVYKGTISDGT----DVAIKIF-NLQLERAFRSFDSECEVLRNVRHRNLIKI 562
LG GSFG V +G S VA+K + +L F E ++ ++ H NLI++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 563 LSSCSNPDFKALVLEFMPNGSL-EKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
+V E P GSL ++ I + + + + + YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT-IGYMAPEYGSEGI 680
IH DL NILL + + DFG+ + L + ED + + APE
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 681 VSAKCDVYSYGVLLMETFTRKRPTDEMFT-GEMSLRRWVKESLPHGLT-----EVVDANL 734
S DV+ +GV L EMFT GE W GL+ + +D
Sbjct: 177 FSHASDVWMFGVTLW----------EMFTYGEEP---WA------GLSGSQILKKIDKEG 217
Query: 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMR 766
R E+ C I ++ L C +P R
Sbjct: 218 ERLERP----EACPQDIYNVMLQCWAHNPADR 245
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 507 NLLGTGSFGSVYKGTIS-DG--TDVAIKIFN-LQLERAFRSFDSECEVLRNV-RHRNLIK 561
+++G G+FG V K I DG D AIK + R F E EVL + H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILERLNIMID 606
+L +C + + L +E+ P+G+L +L L + L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
V ++YL S IH DL NIL+ EN A ++DFG+S+ G+ E V +TM
Sbjct: 121 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRL 173
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLME 696
+ +MA E + + + DV+SYGVLL E
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 34/210 (16%)
Query: 509 LGTGSFGSVYKG-TISDGTDVAIKIFNLQLER------AFRSFDSECEVLRNVRHRNLIK 561
+G G++G VYK G VA+K ++ E+ A R E ++L+ +RH N+++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 562 ---ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
I++S +V E+M + L L S + M + L+YLH
Sbjct: 63 LKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE---- 674
I+H D+K +NIL++ + ++DFG+++ +S T + T+ Y PE
Sbjct: 121 ----ILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELLLG 175
Query: 675 ---YGSEGIVSAKCDVYSYGVLLMETFTRK 701
YG E D++S G +L E F K
Sbjct: 176 ATRYGPE------VDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 9e-19
Identities = 66/205 (32%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 508 LLGTGSFGSVYK-GTISDGTDVAIKIFNLQLERAFRSFDS--ECEVLRNVRHRNLIKILS 564
LG GS+GSVYK +SD A+K +L D+ E +L +V H N+I
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER---LNIMIDVGSALEYLHHGHSSA 621
+ + + +V+E+ P G L K + ++ I I + L+ LH
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH----EQ 122
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG---YMAPEYGSE 678
I+H DLK NILL N + D GISK+L + M IG YMAPE
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVL-------KKNMAKTQIGTPHYMAPEVWKG 175
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRP 703
S K D++S G LL E T P
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 84/281 (29%), Positives = 124/281 (44%), Gaps = 47/281 (16%)
Query: 507 NLLGTGSFGSVYKGTI-SDG--TDVAIK-IFNLQLERAFRSFDSECEVL-RNVRHRNLIK 561
+++G G+FG V K I DG D AIK + + R F E EVL + H N+I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILERLNIMID 606
+L +C + + L +E+ P+G+L +L L + L+ D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
V ++YL S IH DL NIL+ EN A ++DFG+S+ G+ E V +TM
Sbjct: 133 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ-EVYVKKTMGRL 185
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHG 725
+ +MA E + + + DV+SYGVLL E + P M E+ E LP G
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQG 239
Query: 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMR 766
R E+ ++C + DL C E P R
Sbjct: 240 Y---------RLEKP----LNCDDEVYDLMRQCWREKPYER 267
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 75/280 (26%), Positives = 117/280 (41%), Gaps = 42/280 (15%)
Query: 509 LGTGSFGSVYKGTI------SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKI 562
LG G+FG V+ D VA+K + A + F E E+L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHN------------YFLDILERLNIMIDVGSA 610
C D +V E+M +G L K+L +H L + L+I + +
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGY 670
+ YL H +H DL N L+ EN+ + DFG+S+ + + TM I +
Sbjct: 133 MVYLASQH----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 671 MAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEV 729
M PE + + DV+S GV+L E FT K+P ++ E V E + G
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIECITQG---- 238
Query: 730 VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINV 769
+ C + DL L C P MR+N+
Sbjct: 239 ---------RVLQRPRTCPKEVYDLMLGCWQREPHMRLNI 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 507 NLLGTGSFGSVYKGT-ISDGTDVAIK-IFNLQLER--------AFRSFDSECEVLRNVRH 556
LG G++ VYK G VAIK I + + A R E ++L+ ++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR----EIKLLQELKH 61
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
N+I +L + LV EFM LEK + + L + + M+ LEYLH
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH- 119
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE-- 674
S I+H DLKP N+L+ + ++DFG+++ G + T + T Y APE
Sbjct: 120 ---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF--GSPNRKMTHQVVTRWYRAPELL 174
Query: 675 YGSEGIVSAKCDVYSYGVLLMETFTRK 701
+G+ D++S G + E R
Sbjct: 175 FGARHYGVG-VDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 66/226 (29%)
Query: 501 DEFNECNLLGTGSFGSV----YKGTISDGTDVAIKIFNL-------QLERAFRSFDSECE 549
D+F LGTGSFG V +KG+ G A+KI + Q+E +E
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVL----NEKR 53
Query: 550 VLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWL-------------YSHNYFLD 596
+L+++RH L+ + S + LV+E++P G L L Y+ L
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL- 112
Query: 597 ILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656
ALEYLH I++ DLKP N+LLD + ++DFG +K +
Sbjct: 113 -------------ALEYLHSLD----IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154
Query: 657 DSVTQTMTM-ATIGYMAPEYGSEGIVSAK-----CDVYSYGVLLME 696
T T+ T Y+APE I+ +K D ++ G+L+ E
Sbjct: 155 -----TYTLCGTPEYLAPE-----IILSKGYGKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 502 EFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
+ E LG GS+GSVYK G VAIK+ + E + E +L+ ++
Sbjct: 6 DILEK--LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIV 61
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVGSA 610
K S +V+E+ GS DI++ N I+
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG- 669
LEYLH S IH D+K NILL+E A ++DFG+S G+ D++ + T+ IG
Sbjct: 112 LEYLH----SNKKIHRDIKAGNILLNEEGQAKLADFGVS---GQLTDTMAKRNTV--IGT 162
Query: 670 --YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
+MAPE E + K D++S G+ +E K P
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 26/198 (13%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILS 564
+G G+ G VYK T + G +VAIK L+ E E ++++ +H N++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPNIVDYYD 82
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPII 624
S D +V+E+M GSL + + ++ + + +V LEYLH S +I
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH----SQNVI 138
Query: 625 HCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE------YGSE 678
H D+K NILL ++ + ++DFG + L + + ++ + T +MAPE YG
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN-SV-VGTPYWMAPEVIKRKDYG-- 194
Query: 679 GIVSAKCDVYSYGVLLME 696
K D++S G++ +E
Sbjct: 195 ----PKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 6e-18
Identities = 68/241 (28%), Positives = 113/241 (46%), Gaps = 12/241 (4%)
Query: 502 EFNECNLLGTGSFGSVYKGT-ISDGTDV----AIKIFNLQL-ERAFRSFDSECEVLRNVR 555
E +LG+G+FG+VYKG + +G V AIKI N +A F E ++ ++
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 556 HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 615
H +L+++L C +P + LV + MP+G L +++ H + LN + + + YL
Sbjct: 68 HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675
++H DL N+L+ ++DFG+++LL E I +MA E
Sbjct: 127 ERR----LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 676 GSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734
+ + DV+SYGV + E T +P D + T E+ E LP +D +
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM 242
Query: 735 V 735
V
Sbjct: 243 V 243
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 509 LGTGSFGSVYKGTISDGT---DVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKIL 563
LG G FGSV +G ++ VA+K + + F SE ++ H N+++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 564 SSC----SNPDFKA--LVLEFMPNGSLEKWL-YSH----NYFLDILERLNIMIDVGSALE 612
C + + + ++L FM +G L +L YS +L + M D+ S +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
YL SS IH DL N +L+ENM V+DFG+SK + G+ + + ++A
Sbjct: 127 YL----SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 673 PEYGSEGIVSAKCDVYSYGVLLMETFTR 700
E ++ + + K DV+S+GV + E TR
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 509 LGTGSFGSVYKG-TISDGTDVAIKIFNLQLE------RAFRSFDSECEVLRNVRHRNLIK 561
+G G++G VYK G VAIK L+ E A R E ++L+ + H N+IK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
+L + LV EFM + L K + L + + + L + H S
Sbjct: 63 LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH----SH 117
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--YGSEG 679
I+H DLKP N+L++ ++DFG+++ G T + T Y APE G +G
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 680 IVSAKCDVYSYGVLLMETFTRK 701
S D++S G + E +R+
Sbjct: 176 -YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 63/218 (28%), Positives = 92/218 (42%), Gaps = 38/218 (17%)
Query: 509 LGTGSFGSVYK-GTISDGTDVAIK------IFNLQLERAFRSFDSECEVLRNVRHRNLIK 561
LG G FG V S A+K I + S E E+L H ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI--MIDVGSALEYLHHGHS 619
+ + + + +++E+ G L L F + R I ++ A EYLH+
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV---LAFEYLHNRG- 113
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM-ATIGYMAPEYGSE 678
II+ DLKP N+LLD N + DFG +K L G+ +T T T Y+APE
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPE---- 162
Query: 679 GIVSAK-----CDVYSYGVLLMETFTRKRPTDEMFTGE 711
I+ K D +S G+LL E T + P F +
Sbjct: 163 -IILNKGYDFSVDYWSLGILLYELLTGRPP----FGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 63/233 (27%), Positives = 99/233 (42%), Gaps = 60/233 (25%)
Query: 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNL 559
+ F +G GSFG VYK VAIK+ +L+ ++E E+ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE--------EAEDEIEDIQQE--- 49
Query: 560 IKILSSCSNP-----------DFK-ALVLEFMPNGSLEKWLYSHNYFLDILE--RLN--- 602
I+ LS C +P K +++E+ GS LD+L+ +L+
Sbjct: 50 IQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC----------LDLLKPGKLDETY 99
Query: 603 ---IMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659
I+ +V LEYLH IH D+K NILL E ++DFG+S G+ ++
Sbjct: 100 IAFILREVLLGLEYLH----EEGKIHRDIKAANILLSEEGDVKLADFGVS---GQLTSTM 152
Query: 660 TQTMTMA-TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
++ T T +MAPE + K D++S G+ E+ GE
Sbjct: 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGI----------TAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 9e-18
Identities = 64/203 (31%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 509 LGTGSFGSV----YKGTISDGTD--VAIKIFNLQLERAFRS-FDSECEVLRNVRHRNLIK 561
LG G FG V Y +DGT VA+K + + S + E +L+ + H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 562 ILSSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
CS K L++E++P GSL +L H L++ + L + + YLH H
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQH- 127
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED--SVTQTMTMATIGYMAPEYGS 677
IH DL N+LLD + + DFG++K + EG + V + Y A E
Sbjct: 128 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLK 183
Query: 678 EGIVSAKCDVYSYGVLLMETFTR 700
E S DV+S+GV L E T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 75/305 (24%), Positives = 124/305 (40%), Gaps = 54/305 (17%)
Query: 509 LGTGSFGSVYKGT------ISDGTDVAIKIFNLQLERA-FRSFDSECEVLRNVRHRNLIK 561
LG G FG V K T + T VA+K+ + R SE +L+ V H ++IK
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWL-----------------YSHNYFLDILERLNIM 604
+ +CS L++E+ GSL +L S L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 605 I------DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658
+ ++YL + ++H DL N+L+ E +SDFG+S+ + E +
Sbjct: 128 DLISFAWQISRGMQYL----AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRW 717
V ++ + +MA E + I + + DV+S+GVLL E T P + G R +
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP----YPGIAPERLF 239
Query: 718 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777
NL++ +C + +L L C + PD R D + +L+
Sbjct: 240 ---------------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
Query: 778 KIKVK 782
K+ VK
Sbjct: 285 KMMVK 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 13/206 (6%)
Query: 509 LGTGSFGSVYKGTI---SDGTDVAIKIFNLQLERAFR-SFDSECEVLRNVRHRNLIKILS 564
LG+G+FG V KG DVAIK+ + E++ R E E++ + + +++++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPII 624
C LV+E G L K+L + + + +M V ++YL + +
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN----FV 117
Query: 625 HCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT--IGYMAPEYGSEGIVS 682
H DL N+LL A +SDFG+SK LG +DS + + + + APE + S
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALG-ADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 683 AKCDVYSYGVLLMETFTR-KRPTDEM 707
++ DV+SYG+ + E F+ ++P +M
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 17/217 (7%)
Query: 502 EFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQ------LERAFRSFDSECEVLRNVR 555
E+ + +LG G++G+VY G + G +A+K L E+ + E ++L++++
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 556 HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDI-LERLNIMIDVGSALEYL 614
H N+++ L +C + + ++ +EF+P GS+ L + + I G A YL
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA--YL 118
Query: 615 HHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG----Y 670
H+ ++H D+K N++L N + DFG ++ L T + + ++ +
Sbjct: 119 HNNC----VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 671 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
MAPE +E K D++S G + E T K P M
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 44/291 (15%)
Query: 509 LGTGSFGSVYKGTIS-DGTD----VAIKIF-NLQLERAFRSFDSECEVLRNVRHRNLIKI 562
LG +FG +YKG + G D VAIK ++ + + F E ++ + H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHN----------------YFLDILERLNIMID 606
L + ++ E++ G L ++L + LD + L+I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
+ + +EYL SS +H DL NIL+ E + +SD G+S+ + + Q ++
Sbjct: 133 IAAGMEYL----SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL 726
I +M PE G S+ D++S+GV+L E F+ F+ +
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--------------- 233
Query: 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777
EV++ +VR+ Q DC + L +C E P R D +L+
Sbjct: 234 -EVIE--MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 507 NLLGTGSFGSVYKGTISD----GTD---VAIKIFNL-QLERAFRSFDSECEVLRNVRHRN 558
N LG+G+FG VY+GT +D G+ VA+K ++ + F E ++ N H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYS------HNYFLDILERLNIMIDVGSALE 612
++K+L C + + +++E M G L +L L + E L+I +DV
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAA-----HVSDFGISKLLGEGEDSVTQTMTMAT 667
YL H IH DL N L+ E + DFG+++ + + + + +
Sbjct: 121 YLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 668 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MAPE +G + + DV+S+GVL+ E T
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 501 DEFNECNLLGTGSFGSVYKG-TISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNL 559
+++ +G+G++G VYK I+ G VAIK+ L+ F E +L+ RH N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI---DVGSALEYLHH 616
+ S D +V+E+ GSL+ +Y L L I + L YLH
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IY--QVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT----IG--- 669
IH D+K NILL E+ ++DFG+S L T T+A IG
Sbjct: 120 TG----KIHRDIKGANILLTEDGDVKLADFGVSAQL---------TATIAKRKSFIGTPY 166
Query: 670 YMAPEYGSE---GIVSAKCDVYSYGVLLME 696
+MAPE + G KCD+++ G+ +E
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 27/204 (13%)
Query: 512 GSFGSVYKG-TISDGTDVAIKIFN---LQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
G++G V+ S G AIK+ + + +E ++L + ++K+ S
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-HGHSSAPIIHC 626
LV+E++P G L L + + + R + ++ ALEYLH +G IIH
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYLHSNG-----IIHR 117
Query: 627 DLKPTNILLDENMAAHVSDFGISKL------LGEGEDSVTQTMTMATIGYMAPEYGSEGI 680
DLKP NIL+D N ++DFG+SK+ + +D + T Y+APE +
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE-----V 172
Query: 681 V-----SAKCDVYSYGVLLMETFT 699
+ S D +S G +L E
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568
LG G FG V+ G + T VAIK Q + +F +E +++ ++H L+++ + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 569 -PDFKALVLEFMPNGSLEKWL-YSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
P + ++ E+M NGSL +L L I + +++ + + ++ + IH
Sbjct: 73 EPIY--IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY----IHR 126
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
DL+ NIL+ E + ++DFG+++L+ E + + I + APE + G + K D
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 687 VYSYGVLLMETFTRKR 702
V+S+G+LL E T R
Sbjct: 186 VWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 496 IQRATDEFNECNLLGTGSFGSVYKGT----ISDGTDVAIKIFNLQLERAFRS-FDSECEV 550
IQR C +G G FG VY+G ++ VA+K + R F E +
Sbjct: 3 IQREDITLGRC--IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60
Query: 551 LRNVRHRNLIKILSSCS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 609
+R H +++K++ + NP + +V+E P G L +L + Y LD+ + + +
Sbjct: 61 MRQFDHPHIVKLIGVITENPVW--IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG 669
AL YL S +H D+ N+L+ + DFG+S+ L E E + I
Sbjct: 119 ALAYLE----SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIK 173
Query: 670 YMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRP 703
+MAPE + ++ DV+ +GV + E +P
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 12/230 (5%)
Query: 502 EFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLE-----RAFRSFDSECEVLRNVR 555
EF + +LG+G+FG+VYKG I +G V I + +L +A + E V+ +V
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 556 HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 615
+ ++ ++L C + L+ + MP G L ++ H + LN + + + YL
Sbjct: 68 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675
++H DL N+L+ ++DFG++KLLG E I +MA E
Sbjct: 127 ERR----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 676 GSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPH 724
I + + DV+SYGV + E T +P D + E+S E LP
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 502 EFNECNLLGTGSFGSVYKGT-ISDGTDVAIK-IFNLQLERAFRSFDSECEVLRNVRHRNL 559
E N +G+G+ G+VYK G A+K I+ + R E E+LR+V H N+
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
+K + ++LEFM GSLE + FL + R + S + YLH H
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-----QILSGIAYLHRRH- 188
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM-----TMATIGYMAPE 674
I+H D+KP+N+L++ ++DFG+S++L QTM ++ TI YM+PE
Sbjct: 189 ---IVHRDIKPSNLLINSAKNVKIADFGVSRILA-------QTMDPCNSSVGTIAYMSPE 238
Query: 675 YGSEGIVSAKC-----DVYSYGVLLMETFTRKRP 703
+ + D++S GV ++E + + P
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 509 LGTGSFGSVYKG-TISDGTDVAIKIFNLQLERAFRSFDS---ECEVLRNVRHRNLIKILS 564
+G G+ VY + + VAIK +L E+ S D E + + H N++K +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDL--EKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGSALEYLH-HGHSS 620
S D LV+ ++ GSL + +Y L+ I + +V LEYLH +G
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MATIGYMAPEYGSE 678
IH D+K NILL E+ + ++DFG+S L +G D + + T +MAPE +
Sbjct: 124 ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 679 GI-VSAKCDVYSYGVLLMETFTRKRP 703
K D++S+G+ +E T P
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 14/204 (6%)
Query: 508 LLGTGSFGSVY--KGTISDGTDVAIKIFNL-QLERAFR-SFDSECEVLRNVRHRNLIKIL 563
++G G+FG V+ + +D V IK + Q+ + R + +EC+VL+ + H N+I+
Sbjct: 7 VVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
+ +V+E+ P G+L +++ N LD L+ + + L LHH H+
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI---LLALHHVHTKL- 121
Query: 623 IIHCDLKPTNILLDEN-MAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV 681
I+H DLK NILLD++ M + DFGISK+L + T + T Y++PE
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGKPY 178
Query: 682 SAKCDVYSYGVLLMETFTRKRPTD 705
+ K D+++ G +L E + KR +
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 50/192 (26%), Positives = 100/192 (52%), Gaps = 7/192 (3%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568
LG G FG V+ G ++ T VA+K + ++F E +++ ++H L+++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 569 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERL-NIMIDVGSALEYLHHGHSSAPIIHCD 627
+ ++ E+M GSL +L S +L +L + + + Y+ + IH D
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRD 128
Query: 628 LKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDV 687
L+ N+L+ E++ ++DFG+++++ + E + + I + APE + G + K DV
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSDV 187
Query: 688 YSYGVLLMETFT 699
+S+G+LL E T
Sbjct: 188 WSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNL--------QLERAFRSFDSECEVL 551
++ E + LG G+ GSV K + + G A+K Q+ R E E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-------ELEIN 53
Query: 552 RNVRHRNLIKILSSCSNPDFK--ALVLEFMPNGSLEKWLYSHNYFLDILER--------- 600
++ + ++K + + + +E+ GSL+ +Y + +R
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYK-----KVKKRGGRIGEKVL 107
Query: 601 LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660
I V L YLH S IIH D+KP+NILL + DFG+S GE +S+
Sbjct: 108 GKIAESVLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLA 160
Query: 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 696
T T T YMAPE S DV+S G+ L+E
Sbjct: 161 GTFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTD----VAIK-IFNLQLERAFRSFDSECEVLRN 553
E + LLG+G FG+V+KG I +G VAIK I + + F+ + +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 554 VRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 613
+ H ++++L C + LV + P GSL + H LD LN + + + Y
Sbjct: 66 LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 614 LH-HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
L H ++H +L NILL + ++DFG++ LL + + I +MA
Sbjct: 125 LEEHR-----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 673 PEYGSEGIVSAKCDVYSYGVLLMETFT 699
E G + + DV+SYGV + E +
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 501 DEFNECNLLGTGSFGSVY--KGTISDGTDVAIKIFNL-------QLERAFRSFDSECEVL 551
D+ +GTG+FG V+ + IS A+K+ + Q + +E VL
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRIS-EHYYALKVMAIPEVIRLKQEQHV----HNEKRVL 55
Query: 552 RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 611
+ V H +I++ + + F +++E++P G L +L + F + ++ AL
Sbjct: 56 KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCAL 114
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM-ATIGY 670
EYLH S I++ DLKP NILLD+ ++DFG +K L +T T+ T Y
Sbjct: 115 EYLH----SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEY 164
Query: 671 MAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
+APE S+G A D ++ G+L+ E P
Sbjct: 165 LAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAF--RSFDSECEVLRNVRHRNLIKILSSC 566
LG+G FG V+ G VAIK N E A F E +V+ + H L+++ C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFL--DILERLNIMIDVGSALEYLHHGHSSAPII 624
+ +V EFM NG L +L L D+L L++ DV +EYL I
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERNS----FI 122
Query: 625 HCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAK 684
H DL N L+ VSDFG+++ + + E + + + + PE + S+K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 685 CDVYSYGVLLMETFTRKR 702
DV+S+GVL+ E FT +
Sbjct: 182 SDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 44/218 (20%)
Query: 507 NLLGTGSFGSVYKGT-ISDGTDVAIKI---FNLQL--ERAFRSFDSECEVLRNVRHRNLI 560
+ +G G++G V T G VAIK F Q +R R E ++LR +H N+I
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66
Query: 561 KILSSCSNPDFKA-----LVLEFMPNGSLEKWLYSHN-------YFL-DILERLNIMIDV 607
IL P F++ +V E M L K + + + YFL IL
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR-------- 117
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--M 665
L+Y+H SA ++H DLKP+N+LL+ N + DFG++++ D T +T +
Sbjct: 118 --GLKYIH----SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH-TGFLTEYV 170
Query: 666 ATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
AT Y APE S+G A D++S G +L E + +
Sbjct: 171 ATRWYRAPEIMLNSKGYTKA-IDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 507 NLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNL 559
LG G+FG VY+G D ++ + + L E+ F E ++ H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 560 IKILSSC--SNPDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSAL 611
++++ P F ++LE M G L+ +L L + + L DV
Sbjct: 72 VRLIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLD---ENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
+YL H IH D+ N LL A ++DFG+++ + M I
Sbjct: 130 KYLEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 669 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+M PE +GI ++K DV+S+GVLL E F+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 62/239 (25%), Positives = 107/239 (44%), Gaps = 28/239 (11%)
Query: 508 LLGTGSFGSVYK--GTISDGTDVAIKIFNL----------QLERAFRSFDSECEVLR-NV 554
LG+G+FG VYK + +A+K N+ + +++ SE +++ +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 555 RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYS----HNYFLDILERL-NIMIDVGS 609
RH N+++ + D +V++ + L + S F + ER+ NI + +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVL 124
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG 669
AL YLH I+H DL P NI+L E+ ++DFG++K T + TI
Sbjct: 125 ALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTIL 178
Query: 670 YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP--TDEMFTGEMSLRRWVKESLPHGL 726
Y PE K DV+++G +L + T + P + M + + V E LP G+
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 508 LLGTGSFGSVYKGTI--SDGT--DVAIKIFNLQLERA--FRSFDSECEVLRNVRHRNLIK 561
+LG G FGSV + + DG+ VA+K+ + + F E ++ H N+IK
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 562 ILSSCSNPDFKA------LVLEFMPNGSLEKWLYSHN-----YFLDILERLNIMIDVGSA 610
++ K ++L FM +G L +L + L + + MID+ S
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGY 670
+EYL SS IH DL N +L+ENM V+DFG+SK + G+ + + +
Sbjct: 126 MEYL----SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 671 MAPEYGSEGIVSAKCDVYSYGVLLMETFTR 700
+A E ++ + + DV+++GV + E TR
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 503 FNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFD-----SECEVLRNVRH 556
+ L+G G++G+VY+G + G VA+KI NL D E +L +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQ 58
Query: 557 ---RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVGSAL 611
N+ K S +++E+ GS+ + + I E+ I+ +V AL
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP----IAEKYISVIIREVLVAL 114
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYM 671
+Y+H +IH D+K NIL+ + DFG++ LL + S T T +M
Sbjct: 115 KYIHK----VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTFV-GTPYWM 168
Query: 672 APEYGSEGIV-SAKCDVYSYGVLLMETFTRKRP 703
APE +EG K D++S G+ + E T P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 73/232 (31%), Positives = 111/232 (47%), Gaps = 24/232 (10%)
Query: 508 LLGTGSFGSVY---KGTISD-GTDVAIKIF---NLQLERAFRSFDSECEVLRNVRHRNLI 560
+LG GSFG V+ K T D G A+K+ L++ R+ E ++L V H ++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI-MIDVGSALEYLHHGHS 619
K+ + L+L+F+ G L L F + E + + ++ AL++LH
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAELALALDHLH---- 115
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM-ATIGYMAPEYGSE 678
S II+ DLKP NILLDE ++DFG+SK E D + + T+ YMAPE +
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRP---TDEMFTGEMSLRRWVKESLPHGLT 727
+ D +S+GVL+ E T P D T M L+ K +P L+
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK--AKLGMPQFLS 222
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 63/230 (27%), Positives = 111/230 (48%), Gaps = 15/230 (6%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568
LG G FG V+ T + T VA+K + +F +E V++ ++H L+K L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVK-LHAVVT 71
Query: 569 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERL-NIMIDVGSALEYLHHGHSSAPIIHCD 627
+ ++ EFM GSL +L S L +L + + + ++ + IH D
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRD 127
Query: 628 LKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDV 687
L+ NIL+ ++ ++DFG+++++ E + + I + APE + G + K DV
Sbjct: 128 LRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 688 YSYGVLLMETFTRKR-PTDEMFTGEM--SLRRWVK----ESLPHGLTEVV 730
+S+G+LLME T R P M E+ +L R + E+ P L ++
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 508 LLGTGSFGSVYKGTISD-GTDVAIK--IFNLQLERAFRSFDS-ECEV--LRNVRHRNLIK 561
LLG G+FG VY +D G ++A+K F+ + + ++ ECE+ L+N+RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 562 ILSSCSNPDFKALVL--EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
+P+ K L + E+MP GS++ L ++ + + R + + YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---- 123
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISK------LLGEGEDSVTQTMTMATIGYMAP 673
S I+H D+K NIL D + DFG SK + G G SVT T +M+P
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-----GTPYWMSP 178
Query: 674 EYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDE 706
E S K DV+S ++E T K P E
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 71/229 (31%), Positives = 113/229 (49%), Gaps = 40/229 (17%)
Query: 497 QRATDEFNECNLLGTGSFGSVYKGTISD-GTDVAIKIFNLQLER------AFRSFDSECE 549
+R D+F+ +G G++G VYK D G VA+K L E+ A R E +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR----EIK 58
Query: 550 VLRNVRHRNLIK---ILSSCSNP-DFKA------LVLEFMPN---GSLEKWL--YSHNYF 594
+LR + HRN++ I++ + DFK LV E+M + G LE L +S ++
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 595 LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654
+++L ++ L Y H + +H D+K +NILL+ ++DFG+++L
Sbjct: 119 KSFMKQL---LE---GLNYCHKKN----FLHRDIKCSNILLNNKGQIKLADFGLARLY-N 167
Query: 655 GEDSVTQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
E+S T + T+ Y PE G E A DV+S G +L E FT+K
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEERYGPA-IDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-15
Identities = 57/190 (30%), Positives = 89/190 (46%), Gaps = 17/190 (8%)
Query: 525 GTDVAIKIF---NLQLERAFRSFDSECEVLRNVRHRNLIKILSS-CSNPDFKALVLEFMP 580
G +VAIK+ + E F E + + H N++ +L S + P V E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL---DE 637
+L + L + L E +M+ V L+ L H+ I+H DLKP NI++
Sbjct: 63 GRTLREVLAADGA-LPAGETGRLMLQV---LDALACAHNQG-IVHRDLKPQNIMVSQTGV 117
Query: 638 NMAAHVSDFGISKLLGEGEDSVTQTMTMAT--IG---YMAPEYGSEGIVSAKCDVYSYGV 692
A V DFGI LL D+ T+T T +G Y APE V+ D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 693 LLMETFTRKR 702
+ +E T +R
Sbjct: 178 IFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 65/208 (31%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 509 LGTGSFGSVY----KGTISDGTDVAIKIFN----LQLERAFRSFDSECEVLRNVRHRNLI 560
LGTG++G V+ G G A+K+ +Q + +E +VL VR +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 561 KILSSCSNPDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGSALEYLHHGH 618
L D K L+L+++ G L LY +F + + I ++ AL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHF--TESEVRVYIAEIVLALDHLHQ-- 123
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY--- 675
II+ D+K NILLD ++DFG+SK E+ + TI YMAPE
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVIRG 180
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRP 703
GS G A D +S GVL E T P
Sbjct: 181 GSGGHDKA-VDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 46/225 (20%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAF-------RSFDSECEVLRNVRHRNLI 560
+G+G++G V G VAIK ++ AF R+ E ++LR+ +H N+I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTL-RELKILRHFKHDNII 67
Query: 561 KILS--SCSNPDFKA--LVLEFMPNGSLEKWLYSH--------NYFLDILERLNIMIDVG 608
I DFK +V++ M + L ++S YFL L R
Sbjct: 68 AIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR-------- 118
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MA 666
L+Y+H SA +IH DLKP+N+L++E+ + DFG+++ L MT +A
Sbjct: 119 -GLKYIH----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 667 TIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG 710
T Y APE S + D++S G + E R+ ++F G
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 9/189 (4%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
+G G+ G+VY ++ G +VAIK NLQ + +E V+R +H N++ L S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCD 627
D +V+E++ GSL + +D + + + ALE+LH +IH D
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ----VIHRD 140
Query: 628 LKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDV 687
+K NILL + + ++DFG + E S TM + T +MAPE + K D+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 198
Query: 688 YSYGVLLME 696
+S G++ +E
Sbjct: 199 WSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 508 LLGTGSFGSVYKGTISD-GTDVAIKIFNLQLE-----RAFRSFDSECEVLRNVRHRNLIK 561
LLG G+FG VY +D G ++A+K E + + + E ++L+N+ H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 562 ILSSCSNPDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
+P + L +E MP GS++ L S+ + + R LE + + HS
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR----QILEGVSYLHS 124
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLL------GEGEDSVTQTMTMATIGYMAP 673
+ I+H D+K NIL D + DFG SK L G G SVT T +M+P
Sbjct: 125 NM-IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-----GTPYWMSP 178
Query: 674 EYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDE 706
E S K D++S G ++E T K P E
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 20/233 (8%)
Query: 499 ATDEFNECNLLGTGSFGSVY----KGTISDG--TDVAIKIFNLQLERAFR-SFDSECEVL 551
A ++ LG GSFG VY KG + D T VAIK N R F +E V+
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 552 RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYS-----HNYFLDILERLNIMI- 605
+ +++++L S +++E M G L+ +L S N + L MI
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 606 ---DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT 662
++ + YL ++ +H DL N ++ E+ + DFG+++ + E +
Sbjct: 124 MAGEIADGMAYL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 663 MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 715
+ + +M+PE +G+ + DV+S+GV+L E T + + E LR
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 508 LLGTGSFGSVYKGTISDGTD-------VAIKIFNLQ-LERAFRSFDSECEVLRNV-RHRN 558
LG G+FG V K + G D VA+K+ E+ SE E+++ + +H+N
Sbjct: 19 PLGEGAFGQVVKAE-AVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH-------NYFLDILERLNIMI------ 605
+I +L C+ +V+E+ +G+L +L + + +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 606 --DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM 663
V +E+L +S IH DL N+L+ E+ ++DFG+++ + + T
Sbjct: 138 AYQVARGMEFL----ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 664 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MAPE + + + + DV+S+GVLL E FT
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 46/177 (25%), Positives = 79/177 (44%), Gaps = 16/177 (9%)
Query: 543 SFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER-- 600
F E ++L + N+ ++L C+ +++E+M NG L ++L H L
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 601 --------LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652
L + + S + YL S +H DL N L+ +N ++DFG+S+ L
Sbjct: 125 KSLSFSTLLYMATQIASGMRYL----ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 653 GEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKRPTDEM 707
+ Q I +MA E G + K DV+++GV L E T R++P + +
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 507 NLLGTGSFGSVYKGTISDG----TDVAIKIFN--LQLERAFRSFDSECEVLRNVRHRNLI 560
++G G FG VY GT+ D A+K N LE F E ++++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV-EQFLKEGIIMKDFSHPNVL 59
Query: 561 KILSSCSNPDFKALV-LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
+L C + LV L +M +G L ++ S + + + + + V +EYL +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL----A 115
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT--IGYMAPEYGS 677
S +H DL N +LDE+ V+DFG+++ + + E T A + +MA E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 678 EGIVSAKCDVYSYGVLLMETFTRKRP 703
+ K DV+S+GVLL E TR P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 509 LGTGSFGSVYKGTISDGTDV--AIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC 566
LG G+FG VYK T + A KI ++ E F E ++L +H N++ + +
Sbjct: 13 LGDGAFGKVYK-AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
+ +++EF G+L+ + L + + + AL +LH S +IH
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH----SHKVIHR 127
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY-----GSEGIV 681
DLK NILL + ++DFG+S + T + T +MAPE +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSA-KNKSTLQKRDTF-IGTPYWMAPEVVACETFKDNPY 185
Query: 682 SAKCDVYSYGVLLMETFTRKRPTDEM 707
K D++S G+ L+E + P E+
Sbjct: 186 DYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 54/157 (34%), Positives = 82/157 (52%), Gaps = 18/157 (11%)
Query: 576 LEFMPNGSLEKW---LYSHNYFL--DILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKP 630
+E M + SL+K+ +Y + DIL + I + + ALEYLH S +IH D+KP
Sbjct: 79 MEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLH---SKLSVIHRDVKP 132
Query: 631 TNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY----GSEGIVSAKCD 686
+N+L++ N + DFGIS G DSV +T+ YMAPE ++ K D
Sbjct: 133 SNVLINRNGQVKLCDFGIS---GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSD 189
Query: 687 VYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP 723
V+S G+ ++E T + P D T L++ V+E P
Sbjct: 190 VWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP 226
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 509 LGTGSFGSVY--------KGTISDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRN 558
LG G FG V K + T VA+K+ E+ SE E+++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWL---------YSHN------YFLDILERLNI 603
+I +L +C+ +++E+ G+L ++L Y +N L + ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 604 MIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM 663
V +EYL +S IH DL N+L+ E+ ++DFG+++ + + T
Sbjct: 146 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 664 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MAPE + I + + DV+S+GVLL E FT
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 508 LLGTGSFGSVYKG-TISDGTDVAIKIFNLQLE-----RAFRSFDSECEVLRNVRHRNLIK 561
LLG G+FG VY + G ++A K E + + + E ++L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 562 ILSSCSNPDFKALV--LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
+ K L +E+MP GS++ L ++ + + R + + YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---- 123
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLL------GEGEDSVTQTMTMATIGYMAP 673
S I+H D+K NIL D + DFG SK L G G SVT T +M+P
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-----GTPYWMSP 178
Query: 674 EYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDE 706
E S K DV+S G ++E T K P E
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 502 EFNECNL-----LGTGSFGSVYKGT---ISDGTDVAIKIFNLQLERAFRSFD-----SEC 548
EF NL LG G+FG V + T +S +D +K+ L+ S + SE
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSK-SDAVMKVAVKMLKPTAHSSEREALMSEL 89
Query: 549 EVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMID 606
+++ ++ H N++ +L +C+ ++ E+ G L +L FL + + L+
Sbjct: 90 KIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
V + +L +S IH DL N+LL + DFG+++ + + V +
Sbjct: 150 VAKGMAFL----ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MAPE + + + DV+SYG+LL E F+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 5e-14
Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 24/197 (12%)
Query: 503 FNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSEC--EV--LRNVRHR 557
+ + LG G++G VYK G VA+K ++L+ S E+ L+ ++H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKK--IRLDNEEEGIPSTALREISLLKELKHP 58
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG 617
N++K+L LV E+ L+K+L L +IM + L Y H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH-- 115
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MATIGYMAPEY 675
S I+H DLKP NIL++ + ++DFG+++ G +T T + T+ Y APE
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFGLARAFG----IPLRTYTHEVVTLWYRAPE- 168
Query: 676 GSEGIVSAKCDVYSYGV 692
+ YS V
Sbjct: 169 -----ILLGSKHYSTAV 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQ------LERAFRSFDSECEVLRNVRHRNLI 560
LGTG+F S Y+ + GT +A+K E + E ++ + H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 561 KIL-SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
++L ++C + F L +E+M GS+ L + F + + +N + L YLH
Sbjct: 67 RMLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGAFKEAVI-INYTEQLLRGLSYLHENQ- 123
Query: 620 SAPIIHCDLKPTNILLDEN-MAAHVSDFGI-----SKLLGEGEDSVTQTMTMATIGYMAP 673
IIH D+K N+L+D ++DFG +K G GE Q + TI +MAP
Sbjct: 124 ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE---FQGQLLGTIAFMAP 177
Query: 674 E------YGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
E YG CDV+S G +++E T K P
Sbjct: 178 EVLRGEQYGRS------CDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 9e-14
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 39/209 (18%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-------HRNLI 560
LG G+FGSVY G VAIK ++++ F S++ EC LR V+ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREVKSLRKLNEHPNIV 61
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSALEYLH-HG 617
K+ D V E+M G+L + L E + +I+ + L ++H HG
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--- 674
H DLKP N+L+ ++DFG+++ E T ++T Y APE
Sbjct: 120 F-----FHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRWYRAPEILL 171
Query: 675 ----YGSEGIVSAKCDVYSYGVLLMETFT 699
Y S+ D+++ G ++ E +T
Sbjct: 172 RSTSY------SSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 68/305 (22%), Positives = 127/305 (41%), Gaps = 46/305 (15%)
Query: 495 DIQRATDEFNECNLLGTGSFGSVYKGTISDGTD------VAIKIFNLQLERAFRS-FDSE 547
+I +T F E LG FG VYKG + VAIK + E R F E
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 548 CEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDI---------- 597
+ ++H N++ +L + +++ + + L ++L + D+
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 598 --LER---LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652
LE ++I+ + + +E+L SS ++H DL N+L+ + + +SD G+ + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL----SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 653 GEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM 712
+ ++ I +M+PE G S D++SYGV+L E F+
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYG----------- 223
Query: 713 SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772
++ + +V++ ++R Q DC + L L+C E P R D
Sbjct: 224 -----LQPYCGYSNQDVIE--MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
Query: 773 AAKLK 777
++L+
Sbjct: 277 HSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 37/209 (17%)
Query: 508 LLGTGSFGSVYKGTISD-GTDVAIKIFNLQLER---------AFRSFDSECEVLRNVRHR 557
L+G GS+G V K + G VAIK F LE A R E +L+ +RH
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMR----EIRMLKQLRHE 60
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG 617
NL+ ++ LV EF+ + L+ L + LD + + +E+ H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCH-- 117
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--- 674
S IIH D+KP NIL+ ++ + DFG ++ L + T +AT Y APE
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD--YVATRWYRAPELLV 173
Query: 675 ----YGSEGIVSAKCDVYSYGVLLMETFT 699
YG D+++ G L+ E T
Sbjct: 174 GDTKYGR------AVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 59/231 (25%), Positives = 107/231 (46%), Gaps = 35/231 (15%)
Query: 509 LGTGSFGSVY--------KGTISDGTDVAIKIF-NLQLERAFRSFDSECEVLRNV-RHRN 558
LG G FG V K + VA+K+ + E+ SE E+++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDIL----------ERLNI 603
+I +L +C+ +++E+ G+L ++L + Y DI + ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 604 MIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM 663
V +EYL +S IH DL N+L+ EN ++DFG+++ + + T
Sbjct: 143 TYQVARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 664 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR------PTDEMF 708
+ +MAPE + + + + DV+S+GVL+ E FT P +E+F
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 509 LGTGSFGS--VYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILS 564
LG G+FG +Y+ T D + V K NL E+ R +E +L ++H N+I +
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 565 SCSNPDFKALVLEFMPNGSL-------EKWLYSHNYFLDILERLNIMIDVGSALEYLHHG 617
+ + + +E+ G+L + L+ L L + + SA+ Y+H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ------IVSAVSYIH-- 118
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS 677
A I+H D+K NI L + + DFGISK+LG E S+ +T+ + T YM+PE
Sbjct: 119 --KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETV-VGTPYYMSPELCQ 174
Query: 678 EGIVSAKCDVYSYGVLLMETFTRKR 702
+ K D+++ G +L E T KR
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 509 LGTGSFGSVYK-GTISDGTDVAIKIFNLQLERAFR-SFDSECEVLRNVRHRNLIKILSSC 566
LG G+ GSV K I GT +A K+ ++ + + R E +++ R ++ +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHHGHSSAPIIH 625
N + + +EFM GSL++ ++IL + I + V L YL++ H I+H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR---IMH 127
Query: 626 CDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKC 685
D+KP+NIL++ + DFG+S GE +S+ T + T YM+PE G + K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTF-VGTSTYMSPERIQGGKYTVKS 183
Query: 686 DVYSYGVLLMETFTRKRPTDE 706
DV+S G+ ++E K P
Sbjct: 184 DVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 58/253 (22%), Positives = 102/253 (40%), Gaps = 38/253 (15%)
Query: 505 ECNLLGTGSFGSVY----KGTISDGTD--VAIKIFN-LQLERAFRSFDSECEVLRNVRHR 557
E LG G FG V+ KG +G + V +K + E F E ++ R + H+
Sbjct: 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWL--------YSHNYFLDILERLNIMIDVGS 609
N++++L C + ++LE+ G L+++L L +++ + +
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM-----T 664
+++L + +H DL N L+ VS +SK D
Sbjct: 129 GMDHLSNAR----FVHRDLAARNCLVSSQREVKVSLLSLSK------DVYNSEYYKLRNA 178
Query: 665 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR------KRPTDEMFTG--EMSLRR 716
+ + ++APE E S K DV+S+GVL+ E FT+ +E+ L
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238
Query: 717 WVKESLPHGLTEV 729
V E P L ++
Sbjct: 239 PVPEGCPSRLYKL 251
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIK---IFNLQLERAFRSFDSECEVLRNVRHRNLIKILS 564
+G G F VY+ T + DG VA+K IF+L +A E ++L+ + H N+IK +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGSALEYLHHGHSSA 621
S + +VLE G L + + ++ + + + SALE++H S
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH----SR 125
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG---YMAPEYGSE 678
++H D+KP N+ + + D G+ + S T + +G YM+PE E
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPERIHE 180
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRP 703
+ K D++S G LL E + P
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 6/201 (2%)
Query: 199 HSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPC 258
S++ + ++ RL L LS + L L L + L N+L +I
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPS-LDLNLNRLRSNISEL 112
Query: 259 LVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDL 318
L LT+L L L +N +T P + +++LS N + LPS ++ L L LDL
Sbjct: 113 L-ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDL 170
Query: 319 SRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKS 378
S N LS D+P + L +L L L+ N+ +P + L +LE LDLS N++ ++ S
Sbjct: 171 SFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSS 227
Query: 379 LETLSQLKQFNVSHNRLEGEI 399
L L L +S+N+LE
Sbjct: 228 LSNLKNLSGLELSNNKLEDLP 248
|
Length = 394 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 32/216 (14%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQL------ERAFRSFDSECEVLRNVRHRNLIK 561
+G G+ G V+K G VA+K L+ +A R E + L+ +H ++K
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR----EIKALQACQHPYVVK 63
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
+L + LV+E+MP L + L L + + M + + Y+H +
Sbjct: 64 LLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH----AN 118
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--YGS-- 677
I+H DLKP N+L+ + ++DFG+++L E E + + +AT Y APE YG+
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL-YSHQVATRWYRAPELLYGARK 177
Query: 678 --EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
G+ D+++ G + E P +F GE
Sbjct: 178 YDPGV-----DLWAVGCIFAELL-NGSP---LFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 65/291 (22%), Positives = 119/291 (40%), Gaps = 39/291 (13%)
Query: 509 LGTGSFGSVY------KGTISDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 561
LG G FG V +G + G VA+K + E E+LRN+ H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 562 ILSSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
C+ L++EF+P+GSL+++L + +++ ++L + + ++YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL----G 126
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM-ATIGYMAPEYGSE 678
S +H DL N+L++ + DFG++K + ++ T + + + + APE +
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 679 GIVSAKCDVYSYGVLLMETFT----RKRPTDEMFT------GEMSLRRWVKESLPHGLTE 728
DV+S+GV L E T P G+M++ R V+
Sbjct: 187 SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR--------- 237
Query: 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
++ E + +C + L C P R + + I
Sbjct: 238 -----VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVA---IKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILS 564
+G G F VYK + DG VA ++IF + +A + E ++L+ + H N+IK L+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLD----ILERL--NIMIDVGSALEYLHHGH 618
S + +VLE G L + + +F I ER + + SALE++H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTIWKYFVQLCSALEHMH--- 123
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT----MATIGYMAPE 674
S I+H D+KP N+ + + D G+ + +T + T YM+PE
Sbjct: 124 -SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS------KTTAAHSLVGTPYYMSPE 176
Query: 675 YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE-MSL 714
E + K D++S G LL E + P F G+ M+L
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 59/206 (28%), Positives = 88/206 (42%), Gaps = 30/206 (14%)
Query: 508 LLGTGSFGSVYKGTISD-GTDVAIKIF------NLQLERAFRSFDSECEVLRNVRHRNLI 560
++G G++G V K G VAIK F + A R E +VLR +RH N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR----EVKVLRQLRHENIV 63
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
+ + LV E++ LE L + L + + + A+ Y H S
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH----S 118
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE------ 674
IIH D+KP NIL+ E+ + DFG ++ L S T +AT Y APE
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPELLVGDT 177
Query: 675 -YGSEGIVSAKCDVYSYGVLLMETFT 699
YG DV++ G ++ E
Sbjct: 178 NYGKP------VDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 503 FNECNLLGTGSFGSVYKG-TISDGTDVAIKIFNLQLER------AFRSFDSECEVLRNVR 555
F + +G G++G VYK G VA+K L E A R E +L+ +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELN 57
Query: 556 HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID-VGSALEYL 614
H N++K+L + LV EF+ + L+K F+D I + + S L L
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLPLIKSYLFQL 109
Query: 615 HHGHS---SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYM 671
G + S ++H DLKP N+L++ A ++DFG+++ G T T + T+ Y
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYR 167
Query: 672 APE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
APE G + S D++S G + E TR+
Sbjct: 168 APEILLGCK-YYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 489 RRTPYLDIQRATDEFNECNLLGTGSFGSVYKG-TISDGTDVAIKIFNLQLERAFRSFDSE 547
RR P ++F +G+G++G VYK ++ G AIK+ L+ F E
Sbjct: 4 RRNP-------QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQE 56
Query: 548 CEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 607
++++ +H N++ S D + +EF GSL+ +Y + L I
Sbjct: 57 IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IY---HVTGPLSESQIAYVS 112
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT 667
L+ L++ HS + H D+K NILL +N ++DFG+S + + T +
Sbjct: 113 RETLQGLYYLHSKGKM-HRDIKGANILLTDNGHVKLADFGVS-----AQITATIAKRKSF 166
Query: 668 IG---YMAPEYGS---EGIVSAKCDVYSYGVLLME 696
IG +MAPE + +G + CD+++ G+ +E
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 54/205 (26%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 528 VAIKIFNLQLERAFRS-FDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEK 586
VA+K+ + + R+ F E +++ +++ N+I++L C + D ++ E+M NG L +
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 587 WL--------YSHNYFLDILERLNIM---IDVGSALEYLHHGHSSAPIIHCDLKPTNILL 635
+L ++H + + N++ + + S ++YL +S +H DL N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL----ASLNFVHRDLATRNCLV 162
Query: 636 DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 695
+ ++DFG+S+ L G+ Q + I +MA E G + DV+++GV L
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 696 ETFT--RKRP----TDEMF---TGE 711
E FT +++P +DE TGE
Sbjct: 223 EMFTLCKEQPYSLLSDEQVIENTGE 247
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 528 VAIKIFNLQLERAFRS-FDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEK 586
VA+K+ + R+ F E +++ ++ N+I++L+ C D ++ E+M NG L +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 587 WLYSHNY----------FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD 636
+L H + + + + S ++YL SS +H DL N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL----SSLNFVHRDLATRNCLVG 164
Query: 637 ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 696
+N ++DFG+S+ L G+ Q + I +M+ E G + DV+++GV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 697 TFT--RKRP----TDEMF---TGE 711
T +++P +DE TGE
Sbjct: 225 ILTLCKEQPYSQLSDEQVIENTGE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 503 FNECNLLGTGSFGSVYKGTISDGTD--VAIKIFNLQ-LERAFRSFDSECEVLRNVRHRNL 559
F + +G GSFG V+KG I + T VAIKI +L+ E E VL +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
K S +++E++ GS L + + D + ++ ++ L+YLH
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---- 118
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG 679
S IH D+K N+LL E ++DFG++ L + + + + + T +MAPE +
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQS 176
Query: 680 IVSAKCDVYSYGVLLMETFTRKRPTDEM 707
+K D++S G+ +E + P +M
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 70/234 (29%), Positives = 106/234 (45%), Gaps = 44/234 (18%)
Query: 508 LLGTGSFGSVYKGTISDGTDVAIKIFNLQ-LERA--FRS------FDSECEVLRNVRHRN 558
+LG G +G V++ G D KIF ++ L++A R+ +E +L V+H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTG-KIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI-MIDVGS-------- 609
++ ++ + L+LE++ G L + H LER I M D
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGEL----FMH------LEREGIFMEDTACFYLSEISL 111
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG 669
ALE+LH II+ DLKP NILLD ++DFG+ K E +VT T TI
Sbjct: 112 ALEHLHQ----QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFC-GTIE 165
Query: 670 YMAPEYGSEGIVSAKCDVYSYGVLLMETFT---------RKRPTDEMFTGEMSL 714
YMAPE D +S G L+ + T RK+ D++ G+++L
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 67/228 (29%), Positives = 102/228 (44%), Gaps = 41/228 (17%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISD-GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNL 559
++ + +G G+FG+V K GT +A+K RS E E R + ++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVK--------RIRSTVDEKEQKRLLMDLDV 55
Query: 560 IKILSSCSN------PDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERL---NIMID 606
+ S C F+ + +E M + SL+K Y + Y ++L+ + I+
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDK-FYKYVY--EVLKSVIPEEILGK 111
Query: 607 VG----SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT 662
+ AL YL IIH D+KP+NILLD N + DFGIS G+ DS+ +T
Sbjct: 112 IAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKT 165
Query: 663 MTMATIGYMAPE----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDE 706
YMAPE +G + DV+S G+ L E T K P +
Sbjct: 166 RDAGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 54/231 (23%), Positives = 94/231 (40%), Gaps = 60/231 (25%)
Query: 503 FNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERA------FRSFDSECEVLRNVR 555
+ E +G G++G+VYK ++ G VA+K + L R E +L+ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR----EIALLKQLE 56
Query: 556 ---HRNLIKILSSCSNPDFK-----ALVLEFM-----------PNGSLEKWLYSHNYFLD 596
H N++++L C P LV E + P L
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETI------- 109
Query: 597 ILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656
++M + +++LH S I+H DLKP NIL+ + ++DFG++++
Sbjct: 110 ----KDLMRQLLRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-- 159
Query: 657 DSVTQTMTMATIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRK 701
+ T + T+ Y APE Y + D++S G + E F R+
Sbjct: 160 -EMALTSVVVTLWYRAPEVLLQSSYAT------PVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 11/204 (5%)
Query: 502 EFNECNLLGTGSFGSVYKGT-ISDGTD----VAIKIFNLQLE-RAFRSFDSECEVLRNVR 555
E + +LG+G+FG+VYKG I DG + VAIK+ +A + E V+ V
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 556 HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 615
+ ++L C + LV + MP G L ++ + + + LN + + + YL
Sbjct: 68 SPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE 126
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675
++H DL N+L+ ++DFG+++LL E I +MA E
Sbjct: 127 ----EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 676 GSEGIVSAKCDVYSYGVLLMETFT 699
+ + DV+SYGV + E T
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 66/207 (31%), Positives = 88/207 (42%), Gaps = 20/207 (9%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNL---QLERAFRSFDSECEVLRNVRHRNLIKILS 564
+G GSFG+VY + VAIK + Q ++ E L+ +RH N I+
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81
Query: 565 SCSNPDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPI 623
C + A LV+E+ GS L H L +E I L YLH S
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH----SHER 136
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY---GSEGI 680
IH D+K NILL E ++DFG + L+ V T +MAPE EG
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEGQ 190
Query: 681 VSAKCDVYSYGVLLMETFTRKRPTDEM 707
K DV+S G+ +E RK P M
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 17/214 (7%)
Query: 509 LGTGSFGSVYKG---TISDGTDVAIKIF-NLQLERAFR-SFDSECEVLRNVRHRNLIKIL 563
LG+G+FG+V KG VA+KI N + A + E V++ + + +++++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERLNIMIDVGSALEYLHHGHSSA 621
C + LV+E G L K+L + + + I E ++ V ++YL +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELVH---QVSMGMKYLEETN--- 115
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV-TQTMTMATIGYMAPEYGSEGI 680
+H DL N+LL A +SDFG+SK LG E+ +T + + APE +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 681 VSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMS 713
S+K DV+S+GVL+ E F+ ++P M E++
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 58/229 (25%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISD-GTDVAIKIFNLQLE------RAFRSFDSECEVLRN 553
D + + +G+G++G V + G VAIK + + R +R E +L++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKH 70
Query: 554 VRHRNLIKILS----SCSNPDFKA--LVLEFMPNGSLEKWLYS------HNYFL--DILE 599
+ H N+I +L + S DF+ LV M L + H FL IL
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 600 RLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659
L+Y+H SA IIH DLKP+NI ++E+ + DFG+++ +D +
Sbjct: 130 ----------GLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEM 172
Query: 660 TQTMTMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 701
T +AT Y APE Y + D++S G ++ E T K
Sbjct: 173 TG--YVATRWYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 86/249 (34%), Positives = 131/249 (52%), Gaps = 12/249 (4%)
Query: 134 FLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGL 193
SSL+ +L +LS L +L+ NI E+ L+ L
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSLDGSE--NLLNLLPLPSLDLNLNRLRSNIS-ELLELTNL 118
Query: 194 TLLSLHSNDLNGTISPTMGRLK-RLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLS 252
T L L +N++ I P +G LK L+ L L +N +E S+P L +L + + L+ N LS
Sbjct: 119 TSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS 176
Query: 253 GHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKV 312
+P L +L++L L L NK+ S +P + L + +++LS+NS+ L S++ LK
Sbjct: 177 -DLPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKN 233
Query: 313 LTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS 372
L+ L+LS N+L D+P +IG L +LETL L+ NQ S+GSL +L LDLSGN+LS
Sbjct: 234 LSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLS 290
Query: 373 GKIPKSLET 381
+P
Sbjct: 291 NALPLIALL 299
|
Length = 394 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 34/219 (15%)
Query: 503 FNECNLLGTGSFGSVYKGTISDGTD--VAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
F + +G GSFG V+KG I + T VAIKI +L+ ++E E+ +++ I
Sbjct: 6 FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLE--------EAEDEI-EDIQQE--I 53
Query: 561 KILSSCSNP-----------DFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 608
+LS C +P D K +++E++ GS L LD + I+ ++
Sbjct: 54 TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREIL 111
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
L+YLH S IH D+K N+LL E+ ++DFG++ L + + + + + T
Sbjct: 112 KGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTP 165
Query: 669 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
+MAPE + +K D++S G+ +E + P E+
Sbjct: 166 FWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 48/241 (19%)
Query: 509 LGTGSFGSVYKGTISDGTD-----------------VAIKIFNLQLERAFRS-FDSECEV 550
LG G FG V+ + + D VA+KI + R+ F E ++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 551 LRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER---------- 600
L ++ N+I++L C + D ++ E+M NG L ++L S ++ D E
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL-SSHHLDDKEENGNDAVPPAHC 131
Query: 601 ---------LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651
L++ + + S ++YL SS +H DL N L+ EN+ ++DFG+S+
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL----SSLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 652 LGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKRP----TD 705
L G+ Q + I +MA E G + DV+++GV L E +++P TD
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247
Query: 706 E 706
E
Sbjct: 248 E 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 64/238 (26%), Positives = 104/238 (43%), Gaps = 58/238 (24%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDV-AIKIFN--LQLERAFRSFD-SECEVLRNVRH 556
D+F ++G G+FG V+ D V A+K+ ++R + +E ++L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI--MIDVGSALEYL 614
++K+ S + + LV+E+MP G L L + F + R I ++ AL+ +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV---LALDSV 117
Query: 615 HH-GHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSV------------ 659
H G IH D+KP NIL+D + H+ +DFG+ K + + +D
Sbjct: 118 HKLGF-----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 660 ----------TQTMTMA--TIG---YMAPE------YGSEGIVSAKCDVYSYGVLLME 696
Q A T+G Y+APE YG E CD +S GV+L E
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE------CDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 12/200 (6%)
Query: 509 LGTGSFGSVYKGTISD-GTDVAIKIFN---LQLERAFRSFDSECEVLRNVRHRNLIKILS 564
LG G FG V + G A K + L+ + + +E ++L V R ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHHGHSSAPI 623
+ D LV+ M G L+ +Y+ + + LE+LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR----I 116
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSA 683
++ DLKP N+LLD++ +SD G++ L G+ T GYMAPE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 684 KCDVYSYGVLLMETFTRKRP 703
D ++ G L E + P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 38/222 (17%)
Query: 509 LGTGSFGSVYKGTI------SDGTDVAIKIF----NLQLERAFRSFDSECEVLRNVRHRN 558
+G G+FG V++ T VA+K+ + ++ F E ++ H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA---DFQREAALMAEFDHPN 69
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWL--------------------YSHNYF-LDI 597
++K+L C+ L+ E+M G L ++L N L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 598 LERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657
E+L I V + + YL +H DL N L+ ENM ++DFG+S+ + +
Sbjct: 130 TEQLCIAKQVAAGMAYLSERK----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
I +M PE + + DV++YGV+L E F+
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 509 LGTGSFGSVYKGTISD------GTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNLIK 561
LG GSFG VY+G D T VA+K N R F +E V++ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYS-----HNYFLDILERLNIMI----DVGSALE 612
+L S +V+E M +G L+ +L S N L MI ++ +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
YL ++ +H DL N ++ + + DFG+++ + E + + + +MA
Sbjct: 134 YL----NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 673 PEYGSEGIVSAKCDVYSYGVLLMETFT 699
PE +G+ + D++S+GV+L E +
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 509 LGTGSFGSV----YKGTISDGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKI 562
+G GS+G V ++ +DG IK NL+ R ++ + E ++L ++H N++
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 563 LSSCSNPD-FKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGSALEYLHHGHS 619
S D +V+ F G L L L + E + + + AL+YLH H
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKH- 122
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG 679
I+H DLK N+ L V D GI+++L E + + T+ + T YM+PE S
Sbjct: 123 ---ILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTL-IGTPYYMSPELFSNK 177
Query: 680 IVSAKCDVYSYGVLLMETFTRK 701
+ K DV++ G + E T K
Sbjct: 178 PYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 70/215 (32%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 508 LLGTGSFGSV-YKGTISDGTDVAIKIFNLQ------LERAFRSFDS--ECEVLRNVR-HR 557
+LG+G+ G+V +SDG A+K+ +++ RA C+ V+ H
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 558 NLIKILSSCSNPD---FKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSAL 611
+ K NP+ ALVL++ G L + + S N E + I V L
Sbjct: 99 DFAK--KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV---L 153
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG-EDSVTQTMTMATIGY 670
+HH HS +IH D+K NILL N + DFG SK+ D V +T T Y
Sbjct: 154 LAVHHVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTPYY 211
Query: 671 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTD 705
+APE S K D++S GVLL E T KRP D
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIK---IFNLQLERAFRSFDSECEVLRNVRHRNLIKILS 564
+G G F VY+ T + D VA+K IF + +A + E ++L+ + H N+IK L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLD----ILERL--NIMIDVGSALEYLHHGH 618
S + +VLE G L + + YF I ER + + SA+E++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMI---KYFKKQKRLIPERTVWKYFVQLCSAVEHMH--- 123
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG---YMAPEY 675
S ++H D+KP N+ + + D G+ + S T + +G YM+PE
Sbjct: 124 -SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLVGTPYYMSPER 177
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRP--TDEM 707
E + K D++S G LL E + P D+M
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 509 LGTGSFGSVYKG-TISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
+G G+ G+VY I+ G +VAIK NLQ + +E V+R ++ N++ L S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCD 627
D +V+E++ GSL + +D + + + AL++LH S +IH D
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH----SNQVIHRD 140
Query: 628 LKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDV 687
+K NILL + + ++DFG + E S TM + T +MAPE + K D+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 198
Query: 688 YSYGVLLMETFTRKRP 703
+S G++ +E + P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 16/212 (7%)
Query: 502 EFNECNLLGTGSFGSVYKGTISDGTDV----AIKIFN----LQLERAFRSFDSECEVLRN 553
F +LGTG++G V+ G D A+K+ +Q + +E VL +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 554 VRHRNLIKILSSCSNPDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 612
VR + L + K L+L+++ G + LY + F + R ++ ALE
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALE 119
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
+LH I++ D+K NILLD ++DFG+SK E T + TI YMA
Sbjct: 120 HLH----KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYMA 174
Query: 673 PE-YGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
PE +G D +S G+L+ E T P
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 57/175 (32%), Positives = 81/175 (46%), Gaps = 20/175 (11%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEV-------LRNVRHRNLI 560
+G GSFG V +DG A+K+ ++A + + L+NV+H L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQ---KKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
+ S D VL+++ G L L F + R ++ SAL YLH S
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH----S 114
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG-EDSVTQTMTMATIGYMAPE 674
II+ DLKP NILLD ++DFG+ K EG E S T + T Y+APE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
+G G+ G+V+ ++ G +VAIK NLQ + +E V++ +++ N++ L S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCD 627
D +V+E++ GSL + +D + + + ALE+LH +IH D
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ----VIHRD 140
Query: 628 LKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDV 687
+K N+LL + + ++DFG + E S TM + T +MAPE + K D+
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 198
Query: 688 YSYGVLLMETFTRKRP 703
+S G++ +E + P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 57/231 (24%), Positives = 107/231 (46%), Gaps = 35/231 (15%)
Query: 509 LGTGSFGSVY--------KGTISDGTDVAIKIF-NLQLERAFRSFDSECEVLRNV-RHRN 558
LG G FG V K + VA+K+ + ++ SE E+++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDIL----------ERLNI 603
+I +L +C+ +++E+ G+L ++L + +Y D + ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 604 MIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM 663
V +EYL +S IH DL N+L+ E+ ++DFG+++ + + T
Sbjct: 140 AYQVARGMEYL----ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 664 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR------PTDEMF 708
+ +MAPE + + + + DV+S+GVLL E FT P +E+F
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 36/207 (17%)
Query: 512 GSFGSVYKG-TISDGTDVAIKIF------------NLQLERAFRSFDSECEVLRNVRHRN 558
G+FGSVY S G AIK+ N++ ERA E
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP--------Y 58
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
+ K+ S + D+ LV+E++ G + + + + + +V +E LH
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLHQRG 117
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--YG 676
IIH D+KP N+L+D+ ++DFG+S+ E + V T Y+APE G
Sbjct: 118 ----IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETILG 167
Query: 677 SEGIVSAKCDVYSYGVLLMETFTRKRP 703
D +S G ++ E P
Sbjct: 168 VGDD--KMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 509 LGTGSFGSVYKGTISD-GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
LG G+FG VYK + G A K+ + E + E E+L H ++K+L +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCD 627
+++EF P G+++ + + L + I + AL+YLH S IIH D
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH----SMKIIHRD 135
Query: 628 LKPTNILLDENMAAHVSDFGIS----KLLGEGEDSVTQTMTMATIGYMAPEY-----GSE 678
LK N+LL + ++DFG+S K L + DS + T +MAPE +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSF-----IGTPYWMAPEVVMCETMKD 189
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
K D++S G+ L+E + P E+
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 38/89 (42%), Positives = 52/89 (58%)
Query: 219 GLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSS 278
GL L N L G IP D+ L+ + I L+GN + G+IPP L S+TSL L L N S
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 279 IPSSLWSLEYILDINLSSNSLNDSLPSNV 307
IP SL L + +NL+ NSL+ +P+ +
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 67/232 (28%), Positives = 101/232 (43%), Gaps = 33/232 (14%)
Query: 507 NLLGTGSFGSV----YKGTISDGTDVAIKIFNLQLERAFRSFD---SECEVLRNVRHRNL 559
LGTGSFG V +KGT G AIK + + E +L + H +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
+ ++ S + + +LEF+ G L L F + + + ++ A EYLH
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHAELVLAFEYLH---- 135
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM-ATIGYMAPEY-GS 677
S II+ DLKP N+LLD V+DFG +K + + +T T+ T Y+APE S
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPEVIQS 189
Query: 678 EGIVSAKCDVYSYGVLLMETF---------TRKRPTDEMFTGEMSLRRWVKE 720
+G A D ++ GVLL E T R +++ G + W
Sbjct: 190 KGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240
|
Length = 329 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 9/196 (4%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
+G G+ G+VY ++ G +VAI+ NLQ + +E V+R ++ N++ L S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCD 627
D +V+E++ GSL + +D + + + ALE+LH S +IH D
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH----SNQVIHRD 141
Query: 628 LKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDV 687
+K NILL + + ++DFG + + + + T +MAPE + K D+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 688 YSYGVLLMETFTRKRP 703
+S G++ +E + P
Sbjct: 200 WSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 70/238 (29%), Positives = 108/238 (45%), Gaps = 24/238 (10%)
Query: 503 FNECNLLGTGSFGSVYKGTISDGTDV----AIKIFN----LQLERAFRSFDSECEVLRNV 554
F +LGTG++G V+ G D A+K+ +Q + +E +VL ++
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 555 RHRNLIKILSSCSNPDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGSALE 612
R + L D K L+L+++ G L L F + + + I ++ ALE
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALE 119
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
+LH II+ D+K NILLD N ++DFG+SK E E + TI YMA
Sbjct: 120 HLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEYMA 174
Query: 673 PEY--GSEGIVSAKCDVYSYGVLLMETFTRKRP----TDEMFTGEMSLRRWVKESLPH 724
P+ G +G D +S GVL+ E T P ++ E+S RR +K P+
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS-RRILKSEPPY 231
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 509 LGTGSFGSVYKGTISDG---TDVAIKIFNLQLERAF---RSFDSECEVLRNVRHRNLIKI 562
+G G FG V G ++ G V +K L++ + F E + R+++H NL++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVK--ELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYS----HNYFLDILERLNIMIDVGSALEYLHHGH 618
L C+ LV+EF P G L+ +L S D + ++ L +LH +
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE---- 674
IH DL N LL ++ + D+G+S + + VT + ++APE
Sbjct: 121 ----FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 675 -YGSEGIV--SAKCDVYSYGVLLMETF 698
+G+ +V + + +V+S GV + E F
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 53/224 (23%)
Query: 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERA-FRSFDSECEVLRNVRHRN 558
DE + LG G++GSVYK G +A+K L+L+ + F E ++L H+
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HK- 55
Query: 559 LIKILSSCSNP---DFKA---------LVLEFMPNGSLEKWLYSHNYFL-----DILERL 601
+P DF + +E+M GSL+K LY+ D+L R+
Sbjct: 56 -------AVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRI 107
Query: 602 NIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661
+ G L++L H+ IIH D+KPTN+L++ N + DFG+S G S+ +
Sbjct: 108 TYAVVKG--LKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAK 159
Query: 662 TMTMATIG---YMAPEYGSEGIVSA------KCDVYSYGVLLME 696
T IG YMAPE G + + DV+S G+ ++E
Sbjct: 160 T----NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 503 FNECNLLGTGSFGSVYKGTISDGTDV-AIKIFNLQ-LERAFRSFDSECEVLRNVRHRNLI 560
F + +G GSFG VYKG + +V AIKI +L+ E E VL +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 561 KILSSCSNPDFKALVLEFMPNGS----LEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
+ S +++E++ GS L+ Y IL ++ L+YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGLDYLH- 118
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYG 676
S IH D+K N+LL E ++DFG++ L + + + + + T +MAPE
Sbjct: 119 ---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVI 173
Query: 677 SEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
+ K D++S G+ +E + P ++
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 508 LLGTGSFGSV-YKGTISDGTDVAIKIFNLQLERAFRSFD---SECEVLRNVRHRNLIKIL 563
LLG G+FG V + G A+KI ++ A +E VL+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPI 623
S D V+E++ G L L F + R ++ SAL+YLH G I
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSGK----I 116
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEG-EDSVTQTMTMATIGYMAPEYGSEGIVS 682
++ DLK N++LD++ ++DFG+ K EG D+ T T Y+APE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 683 AKCDVYSYGVLLMETFTRKRP 703
D + GV++ E + P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 70/236 (29%), Positives = 96/236 (40%), Gaps = 45/236 (19%)
Query: 499 ATDEFNECNLLGTGSFGSVYKGTISD-GTDVAIKIFNLQLERAFRSFDSECEVLRNV-RH 556
T F ++G G++G VYK G VAIKI ++ + E +LR H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNH 62
Query: 557 RNLIK-----ILSSCSNPDFKA-LVLEFMPNGS---LEKWLYSHNYFLDILERLN----- 602
N+ I + D + LV+E GS L K L +RL
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG------KRLKEEWIA 116
Query: 603 -IMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVS--DFGISKLLGEGEDSV 659
I+ + L YLH +IH D+K NILL +N A V DFG+S L DS
Sbjct: 117 YILRETLRGLAYLHENK----VIHRDIKGQNILLTKN--AEVKLVDFGVSAQL----DS- 165
Query: 660 TQTMTMATIG---YMAPE-----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
T IG +MAPE + A+ DV+S G+ +E K P +M
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 65/207 (31%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 509 LGTGSFGSVYKGTISDGTD-VAIKIFNL---QLERAFRSFDSECEVLRNVRHRNLIKILS 564
+G GSFG+VY T S + VA+K + Q ++ E + L+ ++H N I+
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE-YK 87
Query: 565 SCSNPDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPI 623
C + A LV+E+ GS L H L +E I L YLH S +
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNM 142
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY---GSEGI 680
IH D+K NILL E ++DFG + V T +MAPE EG
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEGQ 196
Query: 681 VSAKCDVYSYGVLLMETFTRKRPTDEM 707
K DV+S G+ +E RK P M
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 5e-11
Identities = 72/230 (31%), Positives = 111/230 (48%), Gaps = 57/230 (24%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIK-IF----NLQ-LERAFRSFDSECEVLRNVR-HRNLI 560
LG G++G V+K VA+K IF N +R FR E L+ + H N++
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR----EIMFLQELGDHPNIV 70
Query: 561 KILSSCSNPDFKA-------LVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSA 610
K+L+ KA LV E+M E L++ N D+ +R IM + A
Sbjct: 71 KLLNV-----IKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKA 119
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT-QTMT--MAT 667
L+Y+H S +IH DLKP+NILL+ + ++DFG+++ L E E++ +T +AT
Sbjct: 120 LKYIH----SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 668 IGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG 710
Y APE Y ++G+ D++S G +L E K +F G
Sbjct: 176 RWYRAPEILLGSTRY-TKGV-----DMWSVGCILGEMLLGK----PLFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 57/240 (23%), Positives = 99/240 (41%), Gaps = 42/240 (17%)
Query: 507 NLLGTGSFGSVYKG--TISDGTDVAIKIFNLQLERAFRSFDS--------------ECEV 550
LG G++G V K T+ G VAIK + + D E ++
Sbjct: 15 AHLGEGTYGKVEKAYDTL-TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 551 LRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 610
+ ++H N++ ++ DF LV++ M L+K + L + I++ + +
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNG 131
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG----------EGEDSVT 660
L LH +H DL P NI ++ ++DFG+++ G +
Sbjct: 132 LNVLH----KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 661 QTMT--MATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRR 716
+ MT + T+ Y APE G+E A D++S G + E T K +F GE + +
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFA-VDMWSVGCIFAELLTGK----PLFPGENEIDQ 242
|
Length = 335 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 37/203 (18%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
+G GS G V T S G VA+K +L+ ++ +E ++R+ +H N++++ SS
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGSALEYLHHGHS 619
D +V+EF+ G+L DI+ R+N + + V AL +LH
Sbjct: 87 VGDELWVVMEFLEGGALT----------DIVTHTRMNEEQIATVCLAVLKALSFLH---- 132
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE----- 674
+ +IH D+K +ILL + +SDFG + ++ + + T +MAPE
Sbjct: 133 AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 675 -YGSEGIVSAKCDVYSYGVLLME 696
YG+E D++S G++++E
Sbjct: 191 PYGTE------VDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 498 RATDEFNECNLLGTGSFGSVYKGTISD-GTDVAIKIFNLQLERAFRSFDS--ECEVLRNV 554
R+ EF + N +G G++G VY+ + G VA+K + ER S E +L N+
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 555 RHRNLIKILSSC--SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 612
RH N++++ + D LV+E+ L L + + +M+ + L+
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
YLH IIH DLK +N+LL + ++DFG+++ G +T + T+ Y A
Sbjct: 123 YLHENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRA 176
Query: 673 PE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
PE G +A D+++ G +L E K
Sbjct: 177 PELLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 64/253 (25%), Positives = 109/253 (43%), Gaps = 37/253 (14%)
Query: 509 LGTGSFGSVYKGTISDGTD-VAIKIFNLQL-----ERAFRSFDSECEVLRNVRHRNLIKI 562
+G G +G V+ D + VA+K L E R +E ++L + L+K+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV--RHVLTERDILTTTKSEWLVKL 66
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
L + + ++ L +E++P G L ++ L M ++ A++ LH
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHE----LG 121
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVS 682
IH DLKP N L+D + ++DFG+SK + +SV + + YMAPE ++
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPE-----VLR 171
Query: 683 AK-----CDVYSYGVLLMETFTRKRP-----TDEMFTGEMSLRRWVKESLPHGLTEVVDA 732
K D +S G +L E P +E + +L+ W KE+L + +
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW-KETLQRPVYDDPRF 227
Query: 733 NLVREEQAFSAKM 745
NL E K+
Sbjct: 228 NLSDEAWDLITKL 240
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 53/216 (24%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 509 LGTGSFGSVYK----GTISDGTD----VAIKIF-NLQLERAFRSFDSECEVLRNV-RHRN 558
LG G FG V + G D VA+K+ + ++ SE E+++ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDILER----------LNI 603
+I +L C+ +++E+ G+L ++L + +Y DI + ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 604 MIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM 663
V +EYL S IH DL N+L+ E+ ++DFG+++ + + + +
Sbjct: 140 AYQVARGMEYL----ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 664 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MAPE + + + + DV+S+G+L+ E FT
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 59/194 (30%), Positives = 89/194 (45%), Gaps = 12/194 (6%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFN----LQLERAFRSFDSECEVLRNVRHRNLIKI 562
++G GSFG V SDG+ A+K+ L+ + +L+N++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
S + VL+++ G L L FL+ R +V SA+ YLH S
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH----SLN 116
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVS 682
II+ DLKP NILLD ++DFG+ K E E+ T + T Y+APE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYD 174
Query: 683 AKCDVYSYGVLLME 696
D + G +L E
Sbjct: 175 RTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAF-RSFDSECEVLRNVRHRNLIKILSSC 566
LG G+ G+VYK + +A+K+ L + + SE E+L +I +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
+ ++ EFM GSL+ + + L I + V L YL S I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLW----SLKILHR 119
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
D+KP+N+L++ + DFG+S L +S+ +T + T YMAPE S D
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTY-VGTNAYMAPERISGEQYGIHSD 175
Query: 687 VYSYGVLLMETFTRKRPTDEMFTGEMSL 714
V+S G+ ME + P ++ + SL
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSL 203
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 489 RRTPYLD---IQRATDEFNECNLLGTGSFGSVYKG-TISDGTDVAIKIFNLQLERAFRSF 544
RR P D IQR +G+G++G VYK + G A+KI L+ F
Sbjct: 4 RRNPQHDYELIQR----------VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLI 53
Query: 545 DSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 604
E +++ +H N++ S + + + +E+ GSL+ +Y L L+ +
Sbjct: 54 QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVC 112
Query: 605 IDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT 664
+ L YLH S +H D+K NILL +N ++DFG++ +T T+
Sbjct: 113 RETLQGLAYLH----SKGKMHRDIKGANILLTDNGDVKLADFGVAA-------KITATIA 161
Query: 665 -----MATIGYMAPEYGS---EGIVSAKCDVYSYGVLLME 696
+ T +MAPE + G + CD+++ G+ +E
Sbjct: 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 63/242 (26%), Positives = 117/242 (48%), Gaps = 25/242 (10%)
Query: 509 LGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
+G GS G V T G VA+K +L+ ++ +E ++R+ H N++ + +S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCD 627
D +V+EF+ G+L + +H ++ + + + V AL YLH + +IH D
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHTR-MNEEQIATVCLSVLRALSYLH----NQGVIHRD 143
Query: 628 LKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDV 687
+K +ILL + +SDFG + ++ + + T +MAPE S + D+
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 688 YSYGVLLMETFTRKRPTDEMFTGEMSLR--RWVKESLP------HGLTEV----VDANLV 735
+S G++++E + P + E L+ R ++++LP H ++ V +D LV
Sbjct: 202 WSLGIMVIEMIDGEPP----YFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV 257
Query: 736 RE 737
RE
Sbjct: 258 RE 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 31/88 (35%), Positives = 50/88 (56%)
Query: 196 LSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHI 255
L L + L G I + +L+ LQ ++L N++ G+IP L + + + L+ N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 256 PPCLVSLTSLRELHLGSNKLTSSIPSSL 283
P L LTSLR L+L N L+ +P++L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 41/119 (34%), Positives = 56/119 (47%), Gaps = 10/119 (8%)
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
AL YL H +IH D+KP+NILLD + + DFGIS G DS +T +
Sbjct: 125 KALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAKTRSAGCA 178
Query: 669 GYMAPEY----GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP 723
YMAPE + DV+S G+ L+E T + P T L + ++E P
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 509 LGTGSFGSVYKGTISDGTDVA-IKIFNLQLERAFR---SFDSECEVLRNVRHRNLIKILS 564
+G G FG V G G A + + L+ F E + R + H N+++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFL------DILERLNIMIDVGSALEYLHHGH 618
C LVLEF P G L+ +L S+ + D+L+R+ +V S L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQAD 120
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE---- 674
IH DL N L +++ + D+G++ + +T+ + ++APE
Sbjct: 121 ----FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 675 YGSEGIV---SAKCDVYSYGVLLMETFT 699
G + + + K +++S GV + E FT
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/192 (30%), Positives = 88/192 (45%), Gaps = 41/192 (21%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGT--DVAIKIF-------NLQLERAFRSFDSECEVL 551
++FN LGTGSFG V T + VAIK F Q++ F SE ++L
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF----SERKIL 85
Query: 552 RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS-- 609
+ H + + S + + LVLEF+ G +L + F + DVG
Sbjct: 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN---------DVGCFY 136
Query: 610 ------ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM 663
EYL S I++ DLKP N+LLD++ ++DFG +K++ T+T
Sbjct: 137 AAQIVLIFEYLQ----SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTY 186
Query: 664 TM-ATIGYMAPE 674
T+ T Y+APE
Sbjct: 187 TLCGTPEYIAPE 198
|
Length = 340 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 63/217 (29%), Positives = 92/217 (42%), Gaps = 29/217 (13%)
Query: 508 LLGTGSFGSVYKGTISDGTD--VAIKIFNLQLERAFRSFDSECEVLRN------VRHRNL 559
+LG GSFG V + GTD AIK+ L+ + + D +C + +H L
Sbjct: 2 VLGKGSFGKVMLAELK-GTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-HGH 618
+ D V+E++ G L + F + R +V AL +LH HG
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRHG- 116
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG--EDSVTQTMTMATIGYMAPEYG 676
+I+ DLK NILLD ++DFG+ K EG T T T Y+APE
Sbjct: 117 ----VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFC-GTPDYIAPEIL 168
Query: 677 SEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 708
E D ++ GVL+ E + P D++F
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 49/207 (23%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 508 LLGTGSFGSVYKGTISDGTD----VAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKI 562
+LGTG FG + +G + + VAI ++ R F +E L H N++++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
+ + +V E+M NG+L+ +L H L + + ++ + S ++YL S
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL----SEMG 127
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG-YMAPEYGSEGIV 681
+H L +L++ ++ +S F +L + +++ TM+ + + APE
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 682 SAKCDVYSYGVLLMETFTR-KRPTDEM 707
S+ DV+S+G+++ E + +RP +M
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 61/195 (31%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 508 LLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVL-RNVRHRNLIKI 562
++G GSFG V DG A+K+ ++ + + +E VL +NV+H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
S + VL+F+ G L L F + R ++ SAL YLH S
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH----SIN 116
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEG-EDSVTQTMTMATIGYMAPEYGSEGIV 681
I++ DLKP NILLD ++DFG+ K EG S T T T Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 682 SAKCDVYSYGVLLME 696
D + G +L E
Sbjct: 174 DNTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 509 LGTGSFGSVY--KGTISDGTDVAIKIFNLQLERAFRSFDSECEV--LRNVRHRNLIKILS 564
+G GSFG +Y K SD IK +L S+ EV L ++H N++ +
Sbjct: 8 IGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 565 SCSNPDFKALVLEFMPNGSLEKWL-YSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPI 623
S +V+E+ G L K + + L+ + + L+++H I
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH----DRKI 122
Query: 624 IHCDLKPTNILLDEN-MAAHVSDFGISKLLGEGEDSVTQTMTMA-TIGYMAPEYGSEGIV 681
+H D+K NI L +N M A + DFGI++ L DS+ T T Y++PE
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEICQNRPY 179
Query: 682 SAKCDVYSYGVLLMETFTRKRP 703
+ K D++S G +L E T K P
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 66/220 (30%), Positives = 98/220 (44%), Gaps = 53/220 (24%)
Query: 509 LGTGSFGSVYKGTISD-GTDVAIK-IFN-----LQLERAFRSFDSECEVLRNVRHRNLIK 561
+G G++G V S+ VAIK I N + +R R E ++LR++ H N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68
Query: 562 ILSSCSNPDFKA-----LVLEFMPNGSLEKWLYS-------H-NYFLDILERLNIMIDVG 608
I P +A +V E M + L + + S H YFL L R
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------- 119
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
L+Y+H SA ++H DLKP+N+LL+ N + DFG+++ E D +T+ + T
Sbjct: 120 -GLKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE--YVVTR 172
Query: 669 GYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 701
Y APE Y DV+S G + E RK
Sbjct: 173 WYRAPELLLNCSEYT------TAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 63/212 (29%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 503 FNECNLLGTGSFGSVYKG-TISDGTDVAIKIFNL---QLERAFRSFDSECEVLRNVRHRN 558
F++ +G GSFG+VY + + VAIK + Q ++ E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
I+ LV+E+ GS L H L +E + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 132
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY--- 675
S +IH D+K NILL E + DFG + ++ V T +MAPE
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILA 185
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
EG K DV+S G+ +E RK P M
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 69/249 (27%), Positives = 110/249 (44%), Gaps = 30/249 (12%)
Query: 503 FNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLER-AFRSFDS----ECEVLRNVRH 556
F + +LG G FG V + + G A K L+ +R R +S E ++L V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--RLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLH 615
+ ++ + + D LVL M G L+ +Y+ N + L ++ LE LH
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675
+ ++ DLKP NILLD+ +SD G++ + EGE + + T+GYMAPE
Sbjct: 120 REN----TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAPEV 172
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735
+ + D + G L+ E + P F G KE + E VD ++
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSP----FRGR-------KEKVKR---EEVDRRVL 218
Query: 736 REEQAFSAK 744
E+ +SAK
Sbjct: 219 ETEEVYSAK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 23/223 (10%)
Query: 498 RATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFD----SECEVLR 552
R+ DE+ + N + G++G VY+ G VA+K L++E+ F E +L
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILL 59
Query: 553 NVRHRNLIKI--LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 610
++H N++ + + SN D +V+E++ + L+ + + E +M+ + S
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSG 118
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGY 670
+ +LH I+H DLK +N+LL+ + DFG+++ G TQ + T+ Y
Sbjct: 119 VAHLHDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWY 172
Query: 671 MAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
APE G S D++S G + E K+P +F G+
Sbjct: 173 RAPELLLG-AKEYSTAIDMWSVGCIFAE-LLTKKP---LFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 51/230 (22%)
Query: 509 LGTGSFGSV----YKGTISDGTDVAIK----IFN--LQLERAFRSFDSECEVLRNVR-HR 557
LG G++G V T S+ VAIK +F+ + +RA R E ++LR+ R H+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHK 62
Query: 558 NLIKILS-SCSNPD-FKALVL--EFMPNGSLEKWLYS-------H-NYFL-DILERLNIM 604
N+ + P F L L E M L + + S H F+ IL
Sbjct: 63 NITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQIL------ 115
Query: 605 IDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT 664
L+Y+H SA ++H DLKP N+L++ + + DFG+++ E MT
Sbjct: 116 ----CGLKYIH----SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 665 --MATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
+AT Y APE S + DV+S G +L E RK +F G+
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK----PVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRS-FDSECEVLRNVRHRN 558
D+F + + LG G+ G V+K + G +A K+ +L+++ A R+ E +VL
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLD-ILERLNIMIDVGSALEYLHHG 617
++ + + ++ +E M GSL++ L + IL +++I + G L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG--LTYLREK 122
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS 677
H I+H D+KP+NIL++ + DFG+S G+ DS+ + + T YM+PE
Sbjct: 123 HK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQ 175
Query: 678 EGIVSAKCDVYSYGVLLMETFTRKRP 703
S + D++S G+ L+E + P
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 39/216 (18%)
Query: 509 LGTGSFGSVYKG-TISDGTDVAIKIFNLQLER------AFRSFDSECEVLRNVRHRNLIK 561
+G G+FG V+K VA+K ++ E+ A R E ++L+ ++H N++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 75
Query: 562 ILSSCSNP-----DFKA---LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 613
++ C +K LV EF + L L + N + E +M + + L Y
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MATIGYM 671
+H I+H D+K NIL+ ++ ++DFG+++ ++S T + T+ Y
Sbjct: 135 IH----RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 672 APE-------YGSEGIVSAKCDVYSYGVLLMETFTR 700
PE YG D++ G ++ E +TR
Sbjct: 191 PPELLLGERDYGP------PIDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 509 LGTGSFGSVYKGTISD-GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
LG G+FG VYK + G A K+ + + E + E ++L + H N++K+L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL----NIMIDVGSALEYLHHGHSSAPI 623
+ +++EF G+++ + LER I + LE L++ H + I
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLE-------LERPLTEPQIRVVCKQTLEALNYLHENK-I 124
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG---YMAPEY----- 675
IH DLK NIL + ++DFG+S +++ T + IG +MAPE
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
+ K DV+S G+ L+E + P E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 63/214 (29%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 508 LLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSEC-----EVLRNVRHRNLIK 561
+LG GSFG V + G A+K+ L+ + + D EC +L R+ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 562 ILSSC-SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
L C PD V+EF+ G L + F + R ++ SAL +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH----D 114
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG-EDSVTQTMTMATIGYMAPEYGSEG 679
II+ DLK N+LLD ++DFG+ K EG + T + T Y+APE E
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 680 IVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 708
+ D ++ GVLL E P D++F
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 57/224 (25%), Positives = 110/224 (49%), Gaps = 27/224 (12%)
Query: 509 LGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
+G GS G V T+ S G VA+K +L+ ++ +E ++R+ +H N++++ +S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN------IMIDVGSALEYLHHGHSSA 621
D +V+EF+ G+L + +H R+N + + V AL LH +
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHT-------RMNEEQIAAVCLAVLKALSVLH----AQ 135
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV 681
+IH D+K +ILL + +SDFG + ++ + + T +MAPE S
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKSLVGTPYWMAPELISRLPY 193
Query: 682 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR--RWVKESLP 723
+ D++S G++++E + P + E L+ + ++++LP
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPP----YFNEPPLKAMKMIRDNLP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 4/93 (4%)
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
V +E+L +S IH DL NILL EN + DFG+++ + + D V +
Sbjct: 182 VARGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MAPE + + + + DV+S+GVLL E F+
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 16/196 (8%)
Query: 509 LGTGSFGSVYKGTIS--DGTDVAIKIFNLQLERA--FRSFDSECEVLRNVRHRNLIKILS 564
LG GS+ +VYKG IS +G VA+K+ +++ E F + E +L+ ++H N++ +
Sbjct: 13 LGEGSYATVYKG-ISRINGQLVALKVISMKTEEGVPFTAI-REASLLKGLKHANIVLLHD 70
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPII 624
+ V E+M + L +++ H L M + L Y+H H I+
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH----IL 125
Query: 625 HCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--YGSEGIVS 682
H DLKP N+L+ ++DFG+++ + S T + + T+ Y P+ G+ S
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATD-YS 182
Query: 683 AKCDVYSYGVLLMETF 698
+ D++ G + +E
Sbjct: 183 SALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 63/212 (29%), Positives = 88/212 (41%), Gaps = 18/212 (8%)
Query: 503 FNECNLLGTGSFGSVYKGTISDGTDV-AIKIFNL---QLERAFRSFDSECEVLRNVRHRN 558
F + +G GSFG+VY +V AIK + Q ++ E + L+ ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
I+ LV+E+ GS L H L +E I L YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--- 142
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY--- 675
S +IH D+K NILL E ++DFG + + V T +MAPE
Sbjct: 143 -SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILA 195
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
EG K DV+S G+ +E RK P M
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 508 LLGTGSFGSVY----KGTISDGTDVAIKIFNLQLERAFRSFD---SECEVLRNVRHRNLI 560
LLG G+FG V K T G A+KI ++ A +E VL+N RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
+ + D V+E+ G L L F + R ++ SALEYLH S
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH----S 113
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG-EDSVTQTMTMATIGYMAPEYGSEG 679
+++ D+K N++LD++ ++DFG+ K EG D T T Y+APE +
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 680 IVSAKCDVYSYGVLLMETFTRKRP 703
D + GV++ E + P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 503 FNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLER-AFRSFDS----ECEVLRNVRH 556
F + +LG G FG V + + G A K L+ +R R +S E ++L V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGESMALNEKQILEKVNS 59
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM--IDVGSALEYL 614
R ++ + + D LVL M G L+ +Y H E + ++ LE L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 615 HHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE 674
H I++ DLKP NILLD++ +SD G++ + EG+ T + T+GYMAPE
Sbjct: 119 HQER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPE 171
Query: 675 YGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
+ D ++ G LL E + P
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 508 LLGTGSFGSVY----KGTISDGTDVAIKIFNLQLERAFRSFD---SECEVLRNVRHRNLI 560
LLG G+FG V K T G A+KI ++ A +E VL+N RH L
Sbjct: 2 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
+ S D V+E+ G L L F + R ++ SAL+YLH S
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH---SE 114
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG-EDSVTQTMTMATIGYMAPEYGSEG 679
+++ DLK N++LD++ ++DFG+ K EG +D T T Y+APE +
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDN 171
Query: 680 IVSAKCDVYSYGVLLMETFTRKRP 703
D + GV++ E + P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 25/80 (31%), Positives = 51/80 (63%), Gaps = 1/80 (1%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
G IP +I L++LQ + + N++ G +PP++ +I+++ +L L N +G +P ++G L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG-QLT 490
Query: 63 NIESLLLAANNLTGIIPHSI 82
++ L L N+L+G +P ++
Sbjct: 491 SLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 62/261 (23%), Positives = 106/261 (40%), Gaps = 72/261 (27%)
Query: 508 LLGTGSFGSVYKGTI------SDGTDVAIKIFNLQLERA----FRSFDSECEVLRNV-RH 556
+LG G+FG V + + S VA+K+ E A ++ SE ++L ++ H
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLK---EGATASEHKALMSELKILIHIGNH 70
Query: 557 RNLIKILSSCSNPDFKALVL-EFMPNGSLEKWLYS-HNYFLDILE--------------- 599
N++ +L +C+ P+ +V+ EF G+L +L + +F E
Sbjct: 71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130
Query: 600 -RLNIMIDVGSALEYL-----HHGHSSAPI------------------------------ 623
R++ I+ G A S+ P
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190
Query: 624 -----IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE 678
IH DL NILL EN + DFG+++ + + D V + + +MAPE +
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD 250
Query: 679 GIVSAKCDVYSYGVLLMETFT 699
+ + + DV+S+GVLL E F+
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 501 DEFNECNLLGTGSFGSVYK-GTISDGTDVAIKIFNLQLERAFRS-FDSECEVLRNVRHRN 558
D+F + LG G+ G V K G +A K+ +L+++ A R+ E +VL
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHHG 617
++ + + ++ +E M GSL++ L +IL +++I + G L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG--LAYLREK 122
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS 677
H I+H D+KP+NIL++ + DFG+S G+ DS+ + + T YM+PE
Sbjct: 123 HQ---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VGTRSYMSPERLQ 175
Query: 678 EGIVSAKCDVYSYGVLLMETFTRKRP 703
S + D++S G+ L+E + P
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 66/229 (28%), Positives = 97/229 (42%), Gaps = 34/229 (14%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNV---- 554
TD + +G G++G VYK T DG+ A+KI + D E E N+
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNILQSL 75
Query: 555 -RHRNLIKILSSCSNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLN---IMI 605
H N++K D LVLE GS+ + + L +RL+ I
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISY 132
Query: 606 DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM 665
+ AL L H H++ IIH D+K NILL + DFG+S L + + ++
Sbjct: 133 ILYGALLGLQHLHNNR-IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSV 189
Query: 666 ATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
T +MAPE Y A+CDV+S G+ +E P +M
Sbjct: 190 GTPFWMAPEVIACEQQYDYS--YDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 42/219 (19%)
Query: 507 NLLGTGSFGSVYKGTISDGT-----DVAIKIFN-----LQLERAFRSFDSECEVLRNVRH 556
+LL G+FG ++ G + D +V +K +Q+ E +L + H
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL----LLQESCLLYGLSH 67
Query: 557 RNLIKILSSCS-NPDFKALVLEFMPNGSLEKWLYSHNYF-------LDILERLNIMIDVG 608
+N++ IL C + + ++ +M G+L+ +L L + +++ I +
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK--------LLGEGEDSVT 660
+ YLH +IH D+ N ++DE + ++D +S+ LG+ E+
Sbjct: 128 CGMSYLH----KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-- 181
Query: 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MA E S+ DV+S+GVLL E T
Sbjct: 182 ------PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 55/226 (24%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIK-IFN-----LQLERAFRSFDSECEVLR 552
T+ + + +G G+FG V G +VAIK I + +R +R E ++L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR----ELKLLK 64
Query: 553 NVRHRNLIKILSSCSNP--DFKALVLEFM--------PNGSLEKWLYSHNYFLDILERLN 602
++RH N+I + +P D V E + + LEK YFL + R
Sbjct: 65 HLRHENIISLSDIFISPLEDI-YFVTELLGTDLHRLLTSRPLEKQFI--QYFLYQILR-- 119
Query: 603 IMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT 662
L+Y+H SA ++H DLKP+NIL++EN + DFG++++ +D T
Sbjct: 120 -------GLKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDP-QMT 163
Query: 663 MTMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 701
++T Y APE Y E D++S G + E K
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 68/249 (27%), Positives = 107/249 (42%), Gaps = 30/249 (12%)
Query: 503 FNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLER-AFRSFDS----ECEVLRNVRH 556
F +LG G FG V + + G A K L+ +R R ++ E +L V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKRILEKVNS 59
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLH 615
R ++ + + D LVL M G L+ +Y+ N D + ++ LE L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675
I++ DLKP NILLD+ +SD G++ + EGE T + T+GYMAPE
Sbjct: 120 RER----IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEV 172
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735
+ + D + G L+ EM G+ R+ KE + E VD +
Sbjct: 173 INNEKYTFSPDWWGLGCLIY----------EMIQGQSPFRKR-KERVKR---EEVDRRVK 218
Query: 736 REEQAFSAK 744
+++ +S K
Sbjct: 219 EDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 12/210 (5%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL---ERAFRSFDSECEVL-RNVRHRNLIKI 562
++G GSFG V ++ A+K+ + ++ + SE VL +NV+H L+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
S D VL+++ G L L FL+ R ++ SAL YLH S
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH----SLN 116
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVS 682
I++ DLKP NILLD ++DFG+ K E + T + T Y+APE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 683 AKCDVYSYGVLLMETFTRKRPTDEMFTGEM 712
D + G +L E P T EM
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 509 LGTGSFGSVYKG-TISDGTDVAIKIFNLQLER------AFRSFDSECEVLRNVRHRNLIK 561
+G G++G VYKG G VA+K L+ E A R E +L+ ++H N++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVC 63
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIMIDVGSALEYLHHGHS 619
+ L+ EF+ + L+K+L S ++D + + + + + H
Sbjct: 64 LQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---- 118
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--YGS 677
S ++H DLKP N+L+D ++DFG+++ G T + T+ Y APE GS
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGS 176
Query: 678 EGIVSAKCDVYSYGVLLMETFTRK 701
S D++S G + E T+K
Sbjct: 177 P-RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 31/169 (18%)
Query: 501 DEFNECNLLGTGSFGSVY----KGTISDGTDVAIKIFNLQ-------LERAFRSFDSECE 549
F + LLG G G V+ KGT G A+K+ + + ++R +E E
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVL----TEQE 53
Query: 550 VLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWL--YSHNYFLDILERLNIMIDV 607
+L + H L + +S + LV+++ P G L + L + + R +V
Sbjct: 54 ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EV 112
Query: 608 GSALEYLH-HGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLG 653
ALEYLH G I++ DLKP NILL E+ H+ SDF +SK
Sbjct: 113 LLALEYLHLLG-----IVYRDLKPENILLHES--GHIMLSDFDLSKQSD 154
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-09
Identities = 31/81 (38%), Positives = 44/81 (54%)
Query: 179 LKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHL 238
L+G IP +I L L ++L N + G I P++G + L+ L L N+ GSIP L L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 239 KLMFGIRLTGNKLSGHIPPCL 259
+ + L GN LSG +P L
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 21/219 (9%)
Query: 496 IQRATDEFNECNLLGTGSFGSVYKGTISDGTDV-AIKIFNLQLERAFRS----FDSECEV 550
+Q ++++ ++G G+FG V V A+K+ + + E RS F E ++
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS-KFEMIKRSDSAFFWEERDI 96
Query: 551 LRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDVG 608
+ ++++ + + + +V+E+MP G L + NY D+ E+ +V
Sbjct: 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTAEVV 152
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
AL+ +H S +IH D+KP N+LLD++ ++DFG + E V + T
Sbjct: 153 LALDAIH----SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE-TGMVRCDTAVGTP 207
Query: 669 GYMAPEY----GSEGIVSAKCDVYSYGVLLMETFTRKRP 703
Y++PE G +G +CD +S GV L E P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 22/170 (12%)
Query: 542 RSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF--LDILE 599
++ E ++L+ + HR +I ++ + K+ V MP Y + F +D
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPK-------YKCDLFTYVDRSG 180
Query: 600 RLN----IMIDVG--SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653
L I I AL YLH IIH D+K NI LDE A + DFG + L
Sbjct: 181 PLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
D+ T+ +PE + AK D++S G++L E +
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 38/212 (17%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNL 559
D+F + LG G+ G V K G +A K+ +L+++ A R+ +++R
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN-----QIIRE------ 49
Query: 560 IKILSSCSNPD----FKALV--------LEFMPNGSLEKWLYSHNYF-LDILERLNIMID 606
+K+L C++P + A +E M GSL++ L +IL +++I +
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVL 109
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
G L YL H I+H D+KP+NIL++ + DFG+S G+ DS+ + +
Sbjct: 110 RG--LTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF-VG 160
Query: 667 TIGYMAPE--YGSEGIVSAKCDVYSYGVLLME 696
T YM+PE G+ V + D++S G+ L+E
Sbjct: 161 TRSYMSPERLQGTHYTVQS--DIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 509 LGTGSFGSV-YKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
+G GS G V G VA+K+ +L+ ++ +E ++R+ +H+N++++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGSALEYLHHGHS 619
+ +++EF+ G+L DI+ RLN + V AL YLH
Sbjct: 89 VGEELWVLMEFLQGGALT----------DIVSQTRLNEEQIATVCESVLQALCYLH---- 134
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG 679
S +IH D+K +ILL + +SDFG + +D + + T +MAPE S
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKSLVGTPYWMAPEVISRT 192
Query: 680 IVSAKCDVYSYGVLLMETFTRKRP 703
+ D++S G++++E + P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-09
Identities = 22/59 (37%), Positives = 40/59 (67%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLL 61
G IP +G++ +L+ L + N+ +G +P ++ ++++RIL L GN LSGR+P+ +G L
Sbjct: 456 GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 495 DIQRATDEFNECNLLGTGSFGSVYKGTISDGTDV-AIKIFNLQLERAFRS----FDSECE 549
++ ++F+ ++G G+FG V V A+K+ + + E RS F E +
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERD 95
Query: 550 VLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM--IDV 607
++ + ++++ + + + +V+E+MP G L + NY DI E+ +V
Sbjct: 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DIPEKWARFYTAEV 151
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT 667
AL+ +H S IH D+KP N+LLD++ ++DFG + V + T
Sbjct: 152 VLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-NGMVRCDTAVGT 206
Query: 668 IGYMAPEY----GSEGIVSAKCDVYSYGVLLME 696
Y++PE G +G +CD +S GV L E
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 1e-08
Identities = 59/241 (24%), Positives = 94/241 (39%), Gaps = 44/241 (18%)
Query: 496 IQRATDEFNECNLLGT-----GSFG--SVYKGTISDGTDV----AIKIFNLQLERAFRSF 544
+ C ++ G FG SV K + V K FN +E
Sbjct: 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQ- 63
Query: 545 DSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIM 604
++++ + N IK+ S + L+++++ +G L L L E I+
Sbjct: 64 -----LMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKII 115
Query: 605 IDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA-AHVSDFGISKLLGEGEDSVTQTM 663
+ AL LH + IIH D+K N+L D ++ D+G+ K++G T +
Sbjct: 116 RQLVEALNDLHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG------TPSC 165
Query: 664 TMATIGYMAPEYGSEGIVSAKCDV----YSYGVLLMETFTRKRP----TDEMFTGEMSLR 715
T+ Y +P E I DV ++ GVL E T K P DE E L+
Sbjct: 166 YDGTLDYFSP----EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221
Query: 716 R 716
R
Sbjct: 222 R 222
|
Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 62/244 (25%), Positives = 97/244 (39%), Gaps = 66/244 (27%)
Query: 499 ATDEFNECNLLGTGSFGSVYKG-TISDGTDVAIKIFNLQLER------AFRSFDSECEVL 551
++ LG G+FG VYK I G VA+K + E+ A R E ++L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKIL 61
Query: 552 RNVRHRNLIKIL---------SSCSNPDFKALVLEFMP---NGSLE----KWLYSH--NY 593
+ ++H N++ ++ S +V +M +G LE K S Y
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSV-YMVTPYMDHDLSGLLENPSVKLTESQIKCY 120
Query: 594 FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL- 652
L +LE +N YLH H I+H D+K NIL+D ++DFG+++
Sbjct: 121 MLQLLEGIN----------YLHENH----ILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 653 --------GEGEDSVTQTMTMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMET 697
G G + T + T Y PE Y + D++ G + E
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA------VDIWGIGCVFAEM 220
Query: 698 FTRK 701
FTR+
Sbjct: 221 FTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 501 DEFNECNLLGTGSFGSVYKG-TISDGTDVAIKIFNLQLERA--FRSFDSECEVLRNVRHR 557
D + + LG GS+ +VYKG + +G VA+K+ LQ E F + E +L+ ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHA 63
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG 617
N++ + + LV E++ + L +++ H L + + L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS 677
+ I+H DLKP N+L+ + ++DFG+++ + S T + + T+ Y P+
Sbjct: 123 Y----ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 678 EGIVSAKC-DVYSYGVLLME 696
+ C D++ G + +E
Sbjct: 177 GSTEYSTCLDMWGVGCIFVE 196
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 31/205 (15%)
Query: 509 LGTGSFGSVYKGTISD-GTDVAIKIF-----NLQLER-AFRSFDSECEVLRNVRHRNLIK 561
+G GS+G V+K + G VAIK F + +++ A R E +L+ ++H NL+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
++ LV E+ + L + L + + I+ A+ + H
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCH----KH 119
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE------- 674
IH D+KP NIL+ + + DFG +++L D T +AT Y APE
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD--YVATRWYRAPELLVGDTQ 177
Query: 675 YGSEGIVSAKCDVYSYGVLLMETFT 699
YG DV++ G + E T
Sbjct: 178 YGP------PVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 68/233 (29%), Positives = 95/233 (40%), Gaps = 41/233 (17%)
Query: 502 EFNECNLLGTGSFGSVYKGTISDGTD--VAIKIFNLQLERAFRSFDSEC-----EVLRNV 554
+FN +LG GSFG V GTD AIKI L+ + + D EC VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALP 57
Query: 555 RHRNLIKILSSC-SNPDFKALVLEFMPNGSLE-------KWLYSHNYFLDILERLNIMID 606
+ L SC D V+E++ G L K+ H F +
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--------AAE 109
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG--EDSVTQTMT 664
+ L +LH S II+ DLK N++LD ++DFG+ K E T+T
Sbjct: 110 IAIGLFFLH----SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFC 162
Query: 665 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMFTGEM 712
T Y+APE + D +++GVLL E + P DE+F M
Sbjct: 163 -GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 495 DIQRATDEFNECNLLGTGSFGSVYKGTISDGTDV-AIKIFNLQLERAFRS----FDSECE 549
D++ +++ ++G G+FG V V A+K+ + + E RS F E +
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERD 95
Query: 550 VLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--IMIDV 607
++ ++++ + + + +V+E+MP G L + NY D+ E+ +V
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY--DVPEKWARFYTAEV 151
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT 667
AL+ +H S IH D+KP N+LLD++ ++DFG + + E V + T
Sbjct: 152 VLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGT 206
Query: 668 IGYMAPEY----GSEGIVSAKCDVYSYGVLLMETFTRKRP 703
Y++PE G +G +CD +S GV L E P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 26/237 (10%)
Query: 501 DEFNECNLLGTGSFGSVY----KGTISDGTDVAIKIFN---LQLERAFRSFDSECEVLRN 553
+F+ +L+G G FG V K T G A+K+ L + F+ E ++L
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 554 VRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 613
+ ++ + + D LV+E+ P G L L N + D + + +
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLA 114
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAP 673
+H H +H D+KP N+L+D ++DFG + L V + + T Y+AP
Sbjct: 115 IHSVHQMG-YVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAP 172
Query: 674 EY------GSEGIVSAKCDVYSYGVLLMETFTRKRPTDE-----MFTGEMSLRRWVK 719
E +G +CD +S GV+ E + P E + M+ +R++K
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 42/221 (19%)
Query: 501 DEFNECNLLGTGSFGSV-YKGTISDGTDVAIKIF------NLQLERAFRSFDSECEVLRN 553
D + + +G+G++G+V G VAIK L +RA+R E +L++
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKH 70
Query: 554 VRHRNLIKILSSCSNPDFKA-------LVLEFMPNGSLEKWLYSHNYFLDILERLNIMI- 605
++H N+I +L + PD LV+ FM G+ L H + +R+ ++
Sbjct: 71 MKHENVIGLLDVFT-PDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSE--DRIQFLVY 125
Query: 606 DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM 665
+ L+Y+H +A IIH DLKP N+ ++E+ + DFG+++ DS T +
Sbjct: 126 QMLKGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDS-EMTGYV 176
Query: 666 ATIGYMAPEYGSEGIVS-----AKCDVYSYGVLLMETFTRK 701
T Y APE I++ D++S G ++ E T K
Sbjct: 177 VTRWYRAPEV----ILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 34/209 (16%)
Query: 509 LGTGSFGSVYKG-TISDGTDVAIKIFNLQLER------AFRSFDSECEVLRNVRHRNLIK 561
+G G++G VYK G VA+K L+ E A R E +L+ + H N+++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF-LD---ILERLNIMIDVGSALEYLHHG 617
+L + + LV EF+ + L+K++ S LD I L ++ + Y H
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL---QGIAYCH-- 116
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV---TQTMTMATIGYMAPE 674
S ++H DLKP N+L+D A ++DFG+++ G V T T + T+ Y APE
Sbjct: 117 --SHRVLHRDLKPQNLLIDREGALKLADFGLARAFG-----VPVRTYTHEVVTLWYRAPE 169
Query: 675 --YGSEGIVSAKCDVYSYGVLLMETFTRK 701
GS S D++S G + E R+
Sbjct: 170 ILLGSR-QYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 36/140 (25%), Positives = 59/140 (42%), Gaps = 12/140 (8%)
Query: 512 GSFGSVYKGTISDGTDVAIKIFNL--QLERAFRSFDSECEVLRNVRHRNLIKILSSCSNP 569
+ K + T VA+K NL + + E R ++H N++ ++S
Sbjct: 13 LMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 570 DFKALVLEFMPNGSLEKWLYSHNYFLDILERL---NIMIDVGSALEYLHHGHSSAPIIHC 626
+V M GS E L +H F + L L I+ DV +AL+Y+H IH
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKG----FIHR 125
Query: 627 DLKPTNILLDENMAAHVSDF 646
+K ++ILL + +S
Sbjct: 126 SVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 508 LLGTGSFGSV----YKGTISDGTDVAIKIFNLQLERAFRSFDSEC-----EVLRNV-RHR 557
+LG GSFG V KGT A+K+ L+ + + D EC VL +H
Sbjct: 2 VLGKGSFGKVLLAELKGT---DELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHP 56
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-H 616
L ++ S D V+E++ G L + F + R ++ L++LH
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAAEIVLGLQFLHER 115
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG-EDSVTQTMTMATIGYMAPEY 675
G II+ DLK N+LLD ++DFG+ K EG VT + T Y+APE
Sbjct: 116 G-----IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEI 167
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 708
S D ++ GVLL E + P DE+F
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 4/93 (4%)
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
V +E+L +S IH DL NILL EN + DFG+++ + + D V +
Sbjct: 188 VAKGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MAPE + + + + DV+S+GVLL E F+
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 508 LLGTGSFGSVY----KGTISDGTDVAIKIFN----LQLERAFRSFDSECEVLRNVRHRNL 559
LLG G+FG V K T G A+KI + + + +E VL+N RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFL 57
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
+ S D V+E+ G L L F + R ++ SAL YLH
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH---- 112
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG-EDSVTQTMTMATIGYMAPEYGSE 678
S +++ DLK N++LD++ ++DFG+ K EG D T T Y+APE +
Sbjct: 113 SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRP 703
D + GV++ E + P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 60/208 (28%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 503 FNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFD-----SECEVLRNVRH 556
F +LG G FG V + + G A K L+ +R + +E ++L V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKQILEKVNS 59
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLH 615
R ++ + + D LVL M G L+ +Y+ N D + ++ LE LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675
I++ DLKP NILLD+ +SD G++ + EGE T + T+GYMAPE
Sbjct: 120 ----RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEV 172
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRP 703
+ D + G L+ E K P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 509 LGTGSFGSVYKG-TISDGTDVAIKIFNLQLER-----AFRSFDSECEVLRNVRHRNLIKI 562
LG G++ +VYKG + G VA+K +L E A R E +++ ++H N++++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELKHENIVRL 63
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF--LDILERLNIMIDVGSALEYLHHGHSS 620
+ LV E+M + L+K++ +H LD + + + + H
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--YGSE 678
++H DLKP N+L+++ ++DFG+++ G + T + + T+ Y AP+ GS
Sbjct: 121 --VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSR 176
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG 710
S D++S G ++ E T RP +F G
Sbjct: 177 -TYSTSIDIWSVGCIMAEMIT-GRP---LFPG 203
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 19/205 (9%)
Query: 509 LGTGSFGSVYKGTI-SDGTDVAIKIFN---LQLERAFRSFDSECEVLRNVRHRNLIKILS 564
LG G FG V + + G A K N L+ + + E +L V R ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
+ LV+ M G L +Y+ N + S LE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA-TIGYMAPEY--GSE 678
II+ DLKP N+LLD + +SD G++ L +G+ ++T A T G+MAPE G E
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYAGTPGFMAPELLQGEE 173
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRP 703
S D ++ GV L E + P
Sbjct: 174 YDFSV--DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIK----IFN--LQLERAFRSFDSECEVLRNVRHRNLIK 561
+G G+FG V+ T DG VA+K +F + +R FR E ++L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNVLS 63
Query: 562 ILSSCSNPD---FKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
L P F+ + V E M L K + S ++ + + L+YLH
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH- 120
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE-- 674
SA I+H D+KP N+L++ N + DFG+++ + E ++S T + T Y APE
Sbjct: 121 ---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 675 YGSEGIVSAKCDVYSYGVLLMETFTRK 701
GS SA D++S G + E R+
Sbjct: 177 MGSRHYTSA-VDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 43/218 (19%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLE------RAFRSFDSECEVLRNVRHRNLI 560
++G GS+G V G VAIK N E R R E ++LR +RH +++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDIV 62
Query: 561 KILSSCSNP---DFKAL--VLEFM---------PNGSLEKWLYSHNYFLDILERLNIMID 606
+I P +FK + V E M N L H +FL L R
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTP--EHHQFFLYQLLR------ 114
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL-LGEGEDSVTQTMTM 665
AL+Y+H +A + H DLKP NIL + + + DFG++++ + ++ T +
Sbjct: 115 ---ALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 666 ATIGYMAPEY-GS-EGIVSAKCDVYSYGVLLMETFTRK 701
AT Y APE GS + D++S G + E T K
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 46/221 (20%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSF------DSECEVLRNV 554
+ + + +G+G++GSV + T +++ +L R F+S E +L+++
Sbjct: 17 ERYQNLSPVGSGAYGSVCA---AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73
Query: 555 RHRNLIKILSSCSNPDFKALVLEFMPNGSLEK----WLYSHNYFLDI-----LERLN--- 602
+H N+I +L F P SLE+ +L +H D+ ++L
Sbjct: 74 KHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 121
Query: 603 ---IMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659
++ + L+Y+H SA IIH DLKP+N+ ++E+ + DFG+++ +
Sbjct: 122 VQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----- 172
Query: 660 TQTMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFT 699
T +AT Y APE + + D++S G ++ E T
Sbjct: 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 39/136 (28%), Positives = 63/136 (46%), Gaps = 10/136 (7%)
Query: 569 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDL 628
PD +L+ M G L L H F + R ++ LE++H+ +++ DL
Sbjct: 69 PDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF----VVYRDL 123
Query: 629 KPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV-SAKCDV 687
KP NILLDE+ +SD G++ + + ++ T GYMAPE +G + D
Sbjct: 124 KPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGTAYDSSADW 179
Query: 688 YSYGVLLMETFTRKRP 703
+S G +L + P
Sbjct: 180 FSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 503 FNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLI 560
F L+G G++G VYKG + G AIK+ ++ + E +L+ HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 561 KILSSC--SNP----DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 614
+ NP D LV+EF GS+ + N + L+ I L L
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGL 124
Query: 615 HHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT-MATIGYMAP 673
H H +IH D+K N+LL EN + DFG+S L + +V + T + T +MAP
Sbjct: 125 SHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAP 180
Query: 674 EY-----GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
E + K D++S G+ +E P +M
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 43/214 (20%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFN--LQLE----RAFRSFDSECEVLRNVRHRNLI 560
+G+G++GSV G VAIK + Q E RA+R E +L++++H N+I
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQHENVI 77
Query: 561 KIL----SSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 614
+L S+ S +F+ LV+ +M L+K + H D ++ L + G L+Y+
Sbjct: 78 GLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQK-IMGHPLSEDKVQYLVYQMLCG--LKYI 133
Query: 615 HHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MATIGYMA 672
H SA IIH DLKP N+ ++E+ + DFG+++ MT + T Y A
Sbjct: 134 H----SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRA 182
Query: 673 PEYGSEGIVS-----AKCDVYSYGVLLMETFTRK 701
PE I++ D++S G ++ E T K
Sbjct: 183 PEV----ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 10/127 (7%)
Query: 569 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDL 628
PD + +L+ M G L L H F + R ++ LE++H+ +++ DL
Sbjct: 69 PDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMHNRF----VVYRDL 123
Query: 629 KPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV-SAKCDV 687
KP NILLDE+ +SD G++ + + ++ T GYMAPE +G+ + D
Sbjct: 124 KPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADW 179
Query: 688 YSYGVLL 694
+S G +L
Sbjct: 180 FSLGCML 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 31/105 (29%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 595 LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654
L L+ L+ V +E+L +S +H DL N+LL + + DFG+++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFL----ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH 289
Query: 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ V++ T + +MAPE + + + DV+SYG+LL E F+
Sbjct: 290 DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 500 TDEFNECNLLGTGSFGSVYK-GTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNV---- 554
+D + +G G++G V+K +G+ A+KI + D E E N+
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKAL 71
Query: 555 -RHRNLIKILSSCSNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLN---IMI 605
H N++K D K LVLE GS+ + FL ER+ I
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAY 128
Query: 606 DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM 665
+ AL L H H + IH D+K NILL + DFG+S L + + ++
Sbjct: 129 ILHEALMGLQHLHVNK-TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSV 185
Query: 666 ATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLME 696
T +MAPE + + A+CDV+S G+ +E
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 56/214 (26%), Positives = 104/214 (48%), Gaps = 18/214 (8%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDV-AIKIFNL--QLERAFRS-FDSECEVLRNVRH 556
++F ++G G+FG V + + V A+KI N L+RA + F E +VL N +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLH 615
+ + + + + + LV+++ G L L + + + R + ++ A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-YLAEMVIAIDSVH 119
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS-KLLGEGEDSVTQTMTMATIGYMAPE 674
H +H D+KP NIL+D N ++DFG KL+ +G +V ++ + T Y++PE
Sbjct: 120 QLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPE 173
Query: 675 Y-----GSEGIVSAKCDVYSYGVLLMETFTRKRP 703
+G +CD +S GV + E + P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 64/267 (23%), Positives = 115/267 (43%), Gaps = 52/267 (19%)
Query: 509 LGTGSFGSVYKGTISD-GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKIL---- 563
LG GS G V+ SD VA+K L ++ + E +++R + H N++K+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 564 --SSCSNPDFKAL--------VLEFMPNG---SLEKWLYSHNYFLDILERLNIMIDVGSA 610
S D +L V E+M LE+ S + RL M +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-----RL-FMYQLLRG 126
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLD-ENMAAHVSDFGISKLLG-EGEDSVTQTMTMATI 668
L+Y+H SA ++H DLKP N+ ++ E++ + DFG+++++ + + T
Sbjct: 127 LKYIH----SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 669 GYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG--EMSLRRWVKESLPHG 725
Y +P S + D+++ G + E T K +F G E+ + + ES+P
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----PLFAGAHELEQMQLILESVP-- 236
Query: 726 LTEVVDANLVREEQAFSAKMDCILSIM 752
+VREE + +L+++
Sbjct: 237 --------VVREED-----RNELLNVI 250
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 508 LLGTGSFGSVYKGTISDGTDV-AIKIFNLQLERAFRSFDSECE-VLRNV-----RHRNLI 560
+LG GSFG V + + AIK L+ + D EC V R V H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
+ + + V+E++ G L + S F + R ++ L++LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-YAAEIICGLQFLH----K 114
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISK--LLGEGEDSVTQTMTMATIGYMAPEYGSE 678
II+ DLK N+LLD++ ++DFG+ K + GEG+ S T Y+APE
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST----FCGTPDYIAPEILKG 170
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 708
+ D +S+GVLL E + P DE+F
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 4/105 (3%)
Query: 595 LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654
LD + L+ V + +L +S IH DL NILL + DFG+++ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ V + + +MAPE + + + DV+SYG+LL E F+
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 501 DEFNECNLLGTGSFGSVYKGT--ISDGTDVAIKIFNLQLE------RAFRSFDSECEVLR 552
D++ + +G G++G VYK +++ T +A+K L+ E A R E +L+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNET-IALKKIRLEQEDEGVPSTAIR----EISLLK 56
Query: 553 NVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI-MIDVGSAL 611
++H N++++ + LV E++ + L+K + S F + + + +
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLDE-NMAAHVSDFGISKLLGEGEDSVTQTMTMATIGY 670
Y H S ++H DLKP N+L+D A ++DFG+++ G T T + T+ Y
Sbjct: 116 AYCH----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWY 169
Query: 671 MAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
APE GS S D++S G + E +K
Sbjct: 170 RAPEILLGSRH-YSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 509 LGTGSFGSVYKGT--ISDGTDVAIKIFNLQLERAFRSFDS--ECEVLRNVR---HRNLIK 561
+G G++G V+K + G VA+K +Q + E VLR++ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 562 ILSSC--SNPDFKA---LVLEFMPNGSLEKWLYSHNYFLDILERL-NIMIDVGSALEYLH 615
+ C S D + LV E + + L +L E + ++M + L++LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675
S ++H DLKP NIL+ + ++DFG++++ + T + T+ Y APE
Sbjct: 128 ----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEV 180
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRP 703
+ + D++S G + E F R++P
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMF-RRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 33/206 (16%)
Query: 509 LGTGSFGSVYKG-TISDGTDVAIKIFNLQLERAFRSFD-----SECEVLRNVR-HRNLIK 561
+G G+F V K + G AIK +++ F+S + E + LR + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 562 ILSSCSNPDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-HGH 618
++ + ALV E M + +L + + L + M + +L+++H +G
Sbjct: 63 LIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG- 120
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ----TMTMATIGYMAPE 674
I H D+KP NIL+ +++ ++DFG + + T ++T Y APE
Sbjct: 121 ----IFHRDIKPENILIKDDI-LKLADFGSCR-------GIYSKPPYTEYISTRWYRAPE 168
Query: 675 -YGSEGIVSAKCDVYSYGVLLMETFT 699
++G K D+++ G + E +
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 63/233 (27%), Positives = 89/233 (38%), Gaps = 53/233 (22%)
Query: 503 FNECNLLGTGSFGSV----YKGTISDGTDVAIKIFNLQ--LER-AFRSFDSE---CEVLR 552
F +LG G FG V YK T G AIK + R S E E
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 553 NVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS--- 609
+ RH L+ + + D V+E+ G L ++I DV S
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDL---------------MMHIHTDVFSEPR 102
Query: 610 ----------ALEYLH-HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658
L+YLH + I++ DLK N+LLD ++DFG+ K G G
Sbjct: 103 AVFYAACVVLGLQYLHENK-----IVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGD 156
Query: 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
T T T ++APE +E + D + GVL+ E + P F G+
Sbjct: 157 RTSTFC-GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 67/229 (29%), Positives = 99/229 (43%), Gaps = 33/229 (14%)
Query: 502 EFNECNLLGTGSFGSVYKGTISD--GTD--VAIKIFNLQLERAFRSFDSECEVLRNVRHR 557
+FN +LG GSFG V +++ GTD AIKI L+ + + D EC + V R
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKI--LKKDVVIQDDDVECTM---VEKR 52
Query: 558 NL--------IKILSSC-SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 608
L + L SC D V+E++ G L + F + + ++
Sbjct: 53 VLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP-HAVFYAAEIA 111
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
L +LH S II+ DLK N++LD ++DFG+ K D VT T
Sbjct: 112 IGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTP 165
Query: 669 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMFTGEM 712
Y+APE + D +++GVLL E + P DE+F M
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 50/216 (23%), Positives = 88/216 (40%), Gaps = 42/216 (19%)
Query: 509 LGTGSFGSVYKGTISD-GTDVAIKIFNLQLERAFRSFDSECEV-----LRNVRHRNLIKI 562
+G G++G+VYK G VA+K +Q + EV L H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 563 LSSCS-----------------NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 605
+ C+ + D + + + P G L ++M
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG------------LPAETIKDLMR 115
Query: 606 DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM 665
L++LH + I+H DLKP NIL+ ++DFG++++ + T +
Sbjct: 116 QFLRGLDFLH----ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALTPVV 168
Query: 666 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 701
T+ Y APE + + D++S G + E F RK
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 508 LLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECE-VLRNV-----RHRNLIK 561
+LG GSFG V+ + GT+ I L+ + D EC V + V H L
Sbjct: 2 MLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
+ + + V+E++ G L + S + F D+ ++ L++LH S
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF-DLPRATFYAAEIICGLQFLH----SK 115
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISK--LLGEGEDSVTQTMTMATIGYMAPEYGSEG 679
I++ DLK NILLD + ++DFG+ K +LG+ + T T T Y+APE
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFC-GTPDYIAPEILLGQ 171
Query: 680 IVSAKCDVYSYGVLLMETFTRKRP 703
+ D +S+GVLL E + P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 71/231 (30%), Positives = 98/231 (42%), Gaps = 24/231 (10%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQ-LERAFRSFDSECE-------VLRNVRHRNLI 560
+G GSFG V + D +I+ L+ + +A SE VL V ++
Sbjct: 1 IGKGSFGKVMQVRKRD----TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIV 56
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
+ S +P+ LVL F+ G L L F R ++ ALE LH
Sbjct: 57 PLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLH----K 111
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGI 680
+I+ DLKP NILLD + DFG+ K L +D T T T Y+APE G
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFC-GTPEYLAPELLL-GH 168
Query: 681 VSAKC-DVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL--PHGLTE 728
K D ++ GVLL E T P + EM R+ ++E L P G
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-YRKILQEPLRFPDGFDR 218
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTD-VAIKIF--NLQLERAFRSFDSECEVLRNVRHR 557
++F ++G G++G V K + + VAIK F + + E + E ++LR ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 558 NLIKILSSCSNPDFKALVLEF-----------MPNGSLEKWLYSHNYFLDILERLNIMID 606
N++++ + LV E+ MPNG + + S+ Y L
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL----------- 109
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
++ +H H + I+H D+KP N+L+ N + DFG ++ L EG ++ T +A
Sbjct: 110 ----IKAIHWCHKND-IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVA 163
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLME------TFTRKRPTDEMFT 709
T Y +PE D++S G +L E F + D++FT
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 67/241 (27%), Positives = 122/241 (50%), Gaps = 33/241 (13%)
Query: 495 DIQRATDE-FNECNLLGTGSFGSVYKGTISDGTD-VAIKIFNLQLERAFRSFDSECEVLR 552
DI R+ ++ + N++G GSFG VY+ D ++ VAIK ++ + + + E +++
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK----KVLQDPQYKNRELLIMK 114
Query: 553 NVRHRNLIKI----LSSCSNPD----FKALVLEFMPNGSLEKWL--YS-HNYFLDILERL 601
N+ H N+I + + C + F +V+EF+P ++ K++ Y+ +N+ L +
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVK 173
Query: 602 NIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-AAHVSDFGISKLLGEGEDSVT 660
+ AL Y+H S I H DLKP N+L+D N + DFG +K L G+ SV+
Sbjct: 174 LYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229
Query: 661 QTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV 718
+ + Y APE G+ + D++S G ++ E +F+G+ S+ + V
Sbjct: 230 Y---ICSRFYRAPELMLGATN-YTTHIDLWSLGCIIAEMILGY----PIFSGQSSVDQLV 281
Query: 719 K 719
+
Sbjct: 282 R 282
|
Length = 440 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 27/222 (12%)
Query: 503 FNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLI 560
F ++G G++G VYKG + G AIK+ ++ E E +L+ HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76
Query: 561 KIL------SSCSNPDFKALVLEFMPNGS---LEKWLYSHNYFLDILERLNIMIDVGSAL 611
S + D LV+EF GS L K + D + + I G A
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT-MATIGY 670
+ H +IH D+K N+LL EN + DFG+S L + +V + T + T +
Sbjct: 137 LHAHK------VIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYW 187
Query: 671 MAPEY-----GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
MAPE + + D++S G+ +E P +M
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 509 LGTGSFG-SVYKGTISDGTDVAIKIFNL------QLERAFRSFDSECEVLRNVRHRNLIK 561
+G GSFG ++ + DG IK N+ + E + + E VL N++H N+++
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK----EVAVLSNMKHPNIVQ 63
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER-LNIMIDVGSALEYLHHGHSS 620
S +V+++ G L K + + L ++ L+ + + AL+++H
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH----D 119
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG---YMAPEYGS 677
I+H D+K NI L ++ + DFGI+++L T + IG Y++PE
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELARTCIGTPYYLSPEICE 174
Query: 678 EGIVSAKCDVYSYGVLLMETFTRK 701
+ K D+++ G +L E T K
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 38/131 (29%), Positives = 63/131 (48%), Gaps = 8/131 (6%)
Query: 574 LVLEFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTN 632
LV+ M G L+ +Y+ L++ ++ + + +LH S I++ D+KP N
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH----SMDIVYRDMKPEN 125
Query: 633 ILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGV 692
+LLD+ +SD G++ L +G+ T T T GYMAPE E S D ++ G
Sbjct: 126 VLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGC 182
Query: 693 LLMETFTRKRP 703
+ E + P
Sbjct: 183 SIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 27/202 (13%)
Query: 509 LGTGSFGSVYKGTISDGTDV-AIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
+G G+FG VY+ D + A+K+ + + A + EV + RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54
Query: 568 NP-------DFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 615
+P F+ LV ++M G L L F + + I ++ ALE+LH
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH 113
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE- 674
I++ DLKP NILLD + DFG+SK ++ T T T Y+APE
Sbjct: 114 KYD----IVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFC-GTTEYLAPEV 167
Query: 675 YGSEGIVSAKCDVYSYGVLLME 696
E + D +S GVL+ E
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 509 LGTGSFGSVYKGTIS-DGTDVAIKIFNLQLER-----AFRSFDSECEVLRNVRHRNLIKI 562
LG G++ +V+KG VA+K L+ E A R E +L+N++H N++ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
LV E++ + L+++L + + + M + L Y H
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK----RK 123
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--YGSEGI 680
I+H DLKP N+L++E ++DFG+++ + + T + + T+ Y P+ GS
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTE- 180
Query: 681 VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL 722
S D++ G +L E T RP MF G VKE L
Sbjct: 181 YSTPIDMWGVGCILYEMAT-GRP---MFPGST-----VKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 60/258 (23%), Positives = 106/258 (41%), Gaps = 54/258 (20%)
Query: 501 DEFNECNLLGTGSFGSVYKG-TISDGTDVAIKIFNLQLER------AFRSFDSECEVLRN 553
D + + +G G++G VYK + G VA+K L+++ A R E +L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQM 56
Query: 554 VRHRNLIKILSSCSNPDFKA------LVLEFMPNGSLEKWLYSH----NYFLDILERLNI 603
+ I L + + K LV E++ + L+K++ S+ L +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 604 MIDVGSALEYLH-HGHSSAPIIHCDLKPTNILLD-ENMAAHVSDFGISKLLGEGEDSVTQ 661
M + + + H HG ++H DLKP N+L+D + ++D G+ + S T
Sbjct: 116 MYQLLKGVAHCHKHG-----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 662 TMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK------------------ 701
+ T+ Y APE GS S D++S G + E ++
Sbjct: 171 EIV--TLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL 227
Query: 702 --RPTDEMFTGEMSLRRW 717
PT++++ G LR W
Sbjct: 228 LGTPTEQVWPGVSKLRDW 245
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 54/244 (22%), Positives = 104/244 (42%), Gaps = 36/244 (14%)
Query: 516 SVYKGTISDGTDVAIKIF---NLQLERAFRSFDSECEVLRNVRHRNLIKI----LSSCSN 568
S+YKG I + +V I+ F + + ++E + LR + N++KI + +
Sbjct: 35 SIYKG-IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 569 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDL 628
+L+LE+ G L + L L +L++ ID L L+ +++ P + +L
Sbjct: 94 LPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYK-YTNKP--YKNL 149
Query: 629 KPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVS------ 682
+ L+ EN K++ G + + + + +M Y S +++
Sbjct: 150 TSVSFLVTEN--------YKLKIICHGLEKILSSPPFKNVNFMV--YFSYKMLNDIFSEY 199
Query: 683 -AKCDVYSYGVLLMETFTRKRPTDEMFTGE---MSLRRWVKESL----PHGLTEVVDANL 734
K D+YS GV+L E FT K P + + T E + + + L P + +V+A
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259
Query: 735 VREE 738
+
Sbjct: 260 SHDS 263
|
Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 66/224 (29%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 502 EFNECNLLGTGSFGSVYKGTISDGTD--VAIKIFNLQLERAFRSFDSEC-----EVLRNV 554
+FN +LG GSFG V GTD AIKI L+ + + D EC VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQ 57
Query: 555 RHRNLIKILSSC-SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 613
+ L SC D V+E++ G L + F + + + ++ L +
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEISVGLFF 116
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAP 673
LH II+ DLK N++LD ++DFG+ K D VT T Y+AP
Sbjct: 117 LHR----RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAP 170
Query: 674 EYGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMFTGEM 712
E + D ++YGVLL E + P DE+F M
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 17/149 (11%)
Query: 509 LGTGSFGSVYKGTISDGTD--VAIKIFNLQLER-----AFRSFDSECEVLRNVRHRNLIK 561
LG GS+ +VYKG S T VA+K L+ E A R E +L++++H N++
Sbjct: 13 LGEGSYATVYKG-RSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVT 67
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
+ LV E++ + L++++ L + + + L Y H
Sbjct: 68 LHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--- 123
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISK 650
++H DLKP N+L+ E ++DFG+++
Sbjct: 124 -VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 37/159 (23%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM 639
P + L + + L ++ + V + +E+L +S +H DL N+L+ E
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFL----ASKNCVHRDLAARNVLICEGK 276
Query: 640 AAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ DFG+++ + + +++ T + +MAPE + + DV+S+G+LL E FT
Sbjct: 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
Query: 700 ------RKRPTDEMFTGEMSLRRWVKESLP-HGLTEVVD 731
+ P +E F +++R + + P H E+ +
Sbjct: 337 LGGTPYPELPMNEQFYN--AIKRGYRMAKPAHASDEIYE 373
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDV-AIKIFNL--QLERAFRS-FDSECEVLRNVRH 556
D+F ++G G+FG V + + A+KI N L+RA + F E VL N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
+ + + + + ++ LV+++ G L L + F D L + + +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE-- 674
H +H D+KP N+LLD N ++DFG S L + +V ++ + T Y++PE
Sbjct: 118 IHQLH-YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 675 ---------YGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
YG E CD +S GV + E + P
Sbjct: 176 QAMEDGMGKYGPE------CDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 55/183 (30%), Positives = 77/183 (42%), Gaps = 15/183 (8%)
Query: 528 VAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKW 587
V K L ER SE L H ++K + D L++E+ G L K
Sbjct: 96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155
Query: 588 ----LYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV 643
L H F + L + + AL+ +H S ++H DLK NI L +
Sbjct: 156 IKQRLKEHLPFQEYEVGL-LFYQIVLALDEVH----SRKMMHRDLKSANIFLMPTGIIKL 210
Query: 644 SDFGISKLLGEGEDSVTQTMTMATIG---YMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 700
DFG SK + DSV+ + + G Y+APE S K D++S GV+L E T
Sbjct: 211 GDFGFSK---QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267
Query: 701 KRP 703
RP
Sbjct: 268 HRP 270
|
Length = 478 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-07
Identities = 30/88 (34%), Positives = 50/88 (56%), Gaps = 1/88 (1%)
Query: 42 LTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGH 101
L L+ L G +P+ + L +++S+ L+ N++ G IP S+ + T L LDL +NSF G
Sbjct: 423 LGLDNQGLRGFIPNDISKL-RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 102 ILNTFGNLRHLSLLSQVMNNLTTESSSA 129
I + G L L +L+ N+L+ +A
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 30/233 (12%)
Query: 508 LLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRN------VRHRNLIK 561
+LG GSFG V + G + L+ + D EC ++ + L
Sbjct: 2 VLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
+ + + V+EF+ G L + F D+ ++ L++LH S
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-DLYRATFYAAEIVCGLQFLH----SK 115
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV 681
II+ DLK N++LD + ++DFG+ K G++ + T Y+APE
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKY 173
Query: 682 SAKCDVYSYGVLLMETFTRKRP-----TDEMFTGEMSLR-------RWV-KES 721
+ D +S+GVLL E + P DE+F S+R RW+ KES
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE---SIRVDTPHYPRWITKES 223
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-07
Identities = 58/229 (25%), Positives = 89/229 (38%), Gaps = 40/229 (17%)
Query: 508 LLGTGSFGSVYKG-TISDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKIL 563
L+G G G VY VA+K L + F E ++ ++ H ++ +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 564 SSCSNPDFKALVLEFMP--NGSLEKWLYSHNYFLDILER-----------LNIMIDVGSA 610
S CS+ D V MP G K L + + L + L+I + +
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED-----------SV 659
+EY+H S ++H DLKP NILL + D+G + E+
Sbjct: 126 IEYVH----SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 660 TQTMT-----MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
+MT + T YMAPE S D+Y+ GV+L + T P
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 22/200 (11%)
Query: 509 LGTGSFGSVYKGTISDGTDVA---------IKIFNLQLERAFRSFDSECEVLRNVRHRNL 559
LG GSFG+VY + D VA I + L ++ + E ++L + H +
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAI 64
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGSALEYLHH 616
+K +S D ++ E+ L+ L + L + I + + Y+H
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYG 676
I+H DLK NI L N+ + DFG+S+LL D T T T T YM+PE
Sbjct: 125 RR----ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLAT-TFT-GTPYYMSPEAL 177
Query: 677 SEGIVSAKCDVYSYGVLLME 696
+K D++S G +L E
Sbjct: 178 KHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 73/318 (22%), Positives = 116/318 (36%), Gaps = 46/318 (14%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLV--PPTIFNISTMRILTLEGNQLSGRLPSTVGHLL 61
NL NL L + NL+ L + ++ + L L+ N ++ +P +G L
Sbjct: 81 SSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLK 139
Query: 62 PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNN 121
N++ L L+ N + +P + N L LDL FN +L L L ++N
Sbjct: 140 SNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN-----------DLSDLPKLLSNLSN 187
Query: 122 LTTESSSADQWSFLSSLTN-CRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
L S ++ S L L L +N +
Sbjct: 188 LNNLDLSGNKISDLPPEIELLSALEELDLSNNSI-------------------------- 221
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
+ + NL L+ L L +N L +G L L+ L L NN + SI L
Sbjct: 222 IELLSSLSNLKNLSGLELSNNKLEDLPES-IGNLSNLETLDLSNNQIS-SISSLGSLTNL 279
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
L+GN LS + P + L L EL L ++ L S+ +I + + +
Sbjct: 280 RELD-LSGNSLS-NALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSS 337
Query: 301 DSLPSNVQKLKVLTVLDL 318
S ++ L L LD
Sbjct: 338 PEALSILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 43/192 (22%)
Query: 525 GTDVAIKI----FNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP-----DFKA 573
G +VAIK F +RA+R +++ V H+N+I +L+ P +F+
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYREL----VLMKLVNHKNIIGLLN-VFTPQKSLEEFQD 95
Query: 574 --LVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGSALEYLHHGHSSAPIIHCDLKP 630
LV+E M + +L + + LD ER++ ++ + +++LH SA IIH DLKP
Sbjct: 96 VYLVMELM-DANLCQVI---QMDLD-HERMSYLLYQMLCGIKHLH----SAGIIHRDLKP 146
Query: 631 TNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE------YGSEGIVSAK 684
+NI++ + + DFG+++ G S T + T Y APE Y
Sbjct: 147 SNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGY------KEN 197
Query: 685 CDVYSYGVLLME 696
D++S G ++ E
Sbjct: 198 VDIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 47/206 (22%), Positives = 89/206 (43%), Gaps = 22/206 (10%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRN------VRHRNLIKI 562
+G G FG V I T VA + ++ +A S + E L+ ++H N+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVV--VKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFL---DILERLNIMIDVGSALEYLHHGHS 619
L C LV E+ G L+ +L + +L + ++ + + ++H +
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN- 119
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE- 678
+H DL N L ++ V D+GI + + T+ + ++APE E
Sbjct: 120 ---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 679 --GIVSAK----CDVYSYGVLLMETF 698
G+++A+ +V++ GV L E F
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 40/212 (18%)
Query: 509 LGTGSFGSVYKG-TISDGTDVAIKIFNLQLERAFRSF------DSECEVLRNVRHRNLIK 561
+G+G++GSV VA+K +L R F+S E +L++++H N+I
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENVIG 78
Query: 562 ILS----SCSNPDFKALVLEFMPNGS-------LEKWLYSHNYFLDILERLNIMIDVGSA 610
+L + S +F + L G+ +K H FL I + L
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL-IYQLLR-------G 130
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGY 670
L+Y+H SA IIH DLKP+N+ ++E+ + DFG+++ + +D +T +AT Y
Sbjct: 131 LKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTG--YVATRWY 181
Query: 671 MAPEYGSEGI-VSAKCDVYSYGVLLMETFTRK 701
APE + + D++S G ++ E K
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 28/219 (12%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDV-AIKIFNL--QLERAFRS-FDSECEVLRNVRH 556
D+F ++G G+FG V + + V A+KI N L+RA + F E +VL N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER------LNIMIDVGSA 610
R + + + + + LV+++ G L L + F D L L M+ +
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDS 117
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS-KLLGEGEDSVTQTMTMATIG 669
+ L + +H D+KP N+LLD+N ++DFG +LL +G +V + + T
Sbjct: 118 VHQLGY-------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGTPD 168
Query: 670 YMAPEY-----GSEGIVSAKCDVYSYGVLLMETFTRKRP 703
Y++PE +G +CD +S GV + E + P
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 30/79 (37%), Positives = 47/79 (59%), Gaps = 7/79 (8%)
Query: 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-HGHSSAPIIHCDLKPTN 632
LV+E++ G ++ L+ + YF + + I +V AL+YLH HG IIH DLKP N
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHRHG-----IIHRDLKPDN 134
Query: 633 ILLDENMAAHVSDFGISKL 651
+L+ ++DFG+SK+
Sbjct: 135 MLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 40/182 (21%), Positives = 74/182 (40%), Gaps = 23/182 (12%)
Query: 547 ECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 606
E +L+NV H ++I++ + + +VL + L +L + L I + L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM- 665
+ L YLH IIH D+K NI +++ + D G ++ V +
Sbjct: 166 ILEGLRYLH-AQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF------PVVAPAFLG 215
Query: 666 --ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR---------PTDEMFTGEMSL 714
T+ APE + ++K D++S G++L E P + + + L
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275
Query: 715 RR 716
+
Sbjct: 276 LK 277
|
Length = 357 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 30/105 (28%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 595 LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654
LD+ + L V +++L +S IH D+ N+LL + A + DFG+++ +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL----ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ V + + +MAPE + + + + DV+SYG+LL E F+
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 47/191 (24%), Positives = 82/191 (42%), Gaps = 40/191 (20%)
Query: 510 GTGSFGSVYKG---TISDGTDVAIKIFNLQLER-------AFRSFDSECEVLRNVRHRNL 559
G G++G VYK DG + AIK F E+ A R E +LR ++H N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR----EIALLRELKHENV 64
Query: 560 IKILSSCSNPDFKA--LVLEFMPNGSLE--KWLYSHNYFLDILERL--NIMIDVGSALEY 613
+ ++ K+ L+ ++ + + K+ + + I + +++ + + + Y
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKF-HRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 614 LHHGHSSAPIIHCDLKPTNILL----DENMAAHVSDFGISKLLGE------GEDSVTQTM 663
LH ++H DLKP NIL+ E + D G+++L D V
Sbjct: 124 LHSNW----VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV---- 175
Query: 664 TMATIGYMAPE 674
+ TI Y APE
Sbjct: 176 -VVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 49/204 (24%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 509 LGTGSFGSVYKGTISD-GTDVAIKIFNLQLE------RAFRSFDSECEVLRNVRHRNLIK 561
+G G++G+V+K + VA+K L + A R E +L+ ++H+N+++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 63
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
+ + LV E+ + L+K+ S N +D + M + L + H +
Sbjct: 64 LYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--- 119
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--YGSEG 679
++H DLKP N+L+++N ++DFG+++ G + + T+ Y P+ +G++
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKL 176
Query: 680 IVSAKCDVYSYGVLLMETFTRKRP 703
S D++S G + E RP
Sbjct: 177 -YSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 509 LGTGSFGSVYKGTISDGTD--VAIKIFNLQLER-----AFRSFDSECEVLRNVRHRNLIK 561
LG G++ +VYKG S TD VA+K L+ E A R E +L++++H N++
Sbjct: 14 LGEGTYATVYKGR-SKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVT 68
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
+ LV E++ + L+++L + + N+ + + L L++ H
Sbjct: 69 LHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--YGSEG 679
++H DLKP N+L++E ++DFG+++ + + T + + T+ Y P+ GS
Sbjct: 125 -VLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTD 181
Query: 680 IVSAKCDVYSYGVLLMETFTRKRP 703
S + D++ G + E T RP
Sbjct: 182 -YSTQIDMWGVGCIFYEMST-GRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 64/253 (25%), Positives = 103/253 (40%), Gaps = 70/253 (27%)
Query: 501 DEFNECNLLGTGSFGSV-YKGTISDGTDVAIKIFNLQLERAFRS-----FDSECEVLRNV 554
++F+ ++G G+FG V G A+K L F+ +E +VL
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAES 58
Query: 555 RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 614
++ + S + + L++EF+P G L L ++ F + + R M + A+E +
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAV 117
Query: 615 HHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS------------KLLGEGE------ 656
H IH D+KP NIL+D +SDFG+S + L +G+
Sbjct: 118 H----KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 657 --------DSVTQTMT--------------MA--TIG---YMAPE------YGSEGIVSA 683
DS+ TM+ MA T+G Y+APE YG E
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE----- 228
Query: 684 KCDVYSYGVLLME 696
CD +S G ++ E
Sbjct: 229 -CDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 11/224 (4%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+P+ + NL NL+ L + N+LS L P + N+S + L L GN++S LP + L +
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPPEIE--LLS 209
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
L +NN + S++N L L+L N + + GNL +L L + NN
Sbjct: 210 ALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETL-DLSNNQI 267
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNI 183
+ SS + L L N + L +L ++ N +L+ +LK N
Sbjct: 268 SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKAL-----ELKLNS 322
Query: 184 PQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNL 227
N+ S + L S N +
Sbjct: 323 ILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYI 366
|
Length = 394 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 1e-05
Identities = 62/245 (25%), Positives = 104/245 (42%), Gaps = 41/245 (16%)
Query: 493 YLDIQRATDEFNECNLLGTGSFGSVY----KGTISDGTDVAIKIFNLQLERAFRSFDSEC 548
Y D + +E+ +G G FG V+ K T AI L+ ER E
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEV 63
Query: 549 EVLRNVRHRNLIKILSSCSNPDFKAL--VLEFMPNGSLEKWLYS-HNYFLDILER--LNI 603
V+R ++H+N+++ + N + L ++EF G L + + + F I E ++I
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123
Query: 604 MIDVGSALEYLHH---GHSSAPIIHCDLKPTNILLDENM-----------------AAHV 643
+ AL Y H+ G + ++H DLKP NI L + A +
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 644 SDFGISKLLGEGEDSVTQTMTMATIG---YMAPEYGSEGIVS--AKCDVYSYGVLLMETF 698
DFG+SK +G ++M + +G Y +PE S K D+++ G ++ E
Sbjct: 184 GDFGLSKNIG------IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 699 TRKRP 703
+ K P
Sbjct: 238 SGKTP 242
|
Length = 1021 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 41/196 (20%)
Query: 538 ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKW--LYSHNYFL 595
+RA+R E +++ V H+N+I +L+ F P SLE++ +Y +
Sbjct: 68 KRAYR----ELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELM 111
Query: 596 DI-----------LERLNIMI-DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV 643
D ER++ ++ + +++LH SA IIH DLKP+NI++ + +
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
DFG+++ G S T + T Y APE D++S G ++ E
Sbjct: 168 LDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV- 223
Query: 704 TDEMFTGEMSLRRWVK 719
+F G + +W K
Sbjct: 224 ---LFPGTDHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 1e-05
Identities = 20/59 (33%), Positives = 33/59 (55%)
Query: 337 LETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRL 395
L++L L+ N+ + L +L+ LDLSGNNL+ P++ L L+ ++S N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 1e-05
Identities = 26/59 (44%), Positives = 32/59 (54%)
Query: 313 LTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNL 371
L LDLS N+L+ L +L+ L L+ N PE+ L SL SLDLSGNNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 49/193 (25%), Positives = 97/193 (50%), Gaps = 14/193 (7%)
Query: 509 LGTGSFGSVYKGTISDGTD--VAIKIFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSS 565
LG G++ +V+KG S T+ VA+K L+ E A + E +L++++H N++ +
Sbjct: 14 LGEGTYATVFKGR-SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 566 CSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIH 625
LV E++ + L++++ +I+ N+ I + L L + H ++H
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRRK-VLH 127
Query: 626 CDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--YGSEGIVSA 683
DLKP N+L++E ++DFG+++ + + T + + T+ Y P+ GS S
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSE-YST 184
Query: 684 KCDVYSYGVLLME 696
+ D++ G + E
Sbjct: 185 QIDMWGVGCIFFE 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 44/202 (21%), Positives = 82/202 (40%), Gaps = 15/202 (7%)
Query: 509 LGTGSFGSVYKGT---ISDG-----TDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
LG G+F ++KG + D T+V +K+ + SF ++ + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
C D +V E++ GSL+ +L + ++I +L + + AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE----D 118
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT--IGYMAPEYGSE 678
+ H ++ N+LL + KL G + I ++ PE
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIEN 178
Query: 679 G-IVSAKCDVYSYGVLLMETFT 699
+S D +S+G L E F+
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 41/196 (20%)
Query: 538 ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKW--LYSHNYFL 595
+RA+R E +++ V H+N+I +L+ F P SLE++ +Y +
Sbjct: 61 KRAYR----ELVLMKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELM 104
Query: 596 DI-----------LERLNIMI-DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV 643
D ER++ ++ + +++LH SA IIH DLKP+NI++ + +
Sbjct: 105 DANLCQVIQMELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKI 160
Query: 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
DFG+++ G S T + T Y APE D++S G ++ E K
Sbjct: 161 LDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI- 216
Query: 704 TDEMFTGEMSLRRWVK 719
+F G + +W K
Sbjct: 217 ---LFPGRDYIDQWNK 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 46/166 (27%), Positives = 69/166 (41%), Gaps = 37/166 (22%)
Query: 508 LLGTGSFGSVY----KGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKIL 563
L+G G FG VY KI NL+ E + E V N+ + I +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDIDKIALW 74
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--------------------NI 603
+ N D + + GS ++ + + L LE+L NI
Sbjct: 75 KNIHNIDHLGIPK-YYGCGSFKRCRMYYRFIL--LEKLVENTKEIFKRIKCKNKKLIKNI 131
Query: 604 MIDVGSALEYLH-HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGI 648
M D+ + LEY+H HG I H D+KP NI++D N ++ D+GI
Sbjct: 132 MKDMLTTLEYIHEHG-----ISHGDIKPENIMVDGNNRGYIIDYGI 172
|
Length = 294 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 76/324 (23%), Positives = 107/324 (33%), Gaps = 84/324 (25%)
Query: 97 SFAGHILNTFGNLRHLSLLSQVM------NNLTTESSSADQWSFLSSLTNCRNLTILSFG 150
S G +L T L L + N L E++ A S+L +L L
Sbjct: 4 SLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKA----LASALRPQPSLKELCLS 59
Query: 151 SNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPT 210
N G I + ++ Q + GL L L N L
Sbjct: 60 LNETGRIPRGL-------------------QSLLQGLTKGCGLQELDLSDNALGPDGCGV 100
Query: 211 MGRLKR---LQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRE 267
+ L R LQ L L NN L G+RL L P L +
Sbjct: 101 LESLLRSSSLQELKLNNNGLGDR------------GLRLLAKGLKDLPPA-------LEK 141
Query: 268 LHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGD- 326
L LG N+L S +L +L +N + LK L +L+ N +
Sbjct: 142 LVLGRNRLE----------------GASCEALAKALRAN-RDLKEL---NLANNGIGDAG 181
Query: 327 IPSTIGALKD---LETLSLARNQFQ----GPIPESVGSLISLESLDLSGNNLSGKI---- 375
I + LK LE L L N + E++ SL SLE L+L NNL+
Sbjct: 182 IRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241
Query: 376 -PKSLETLSQLKQFNVSHNRLEGE 398
L L ++S N + +
Sbjct: 242 ASALLSPNISLLTLSLSCNDITDD 265
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 44/234 (18%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISD-GTDVAIKIFN----LQLERAFRSFDSECEVLRNVR 555
D+F ++G G+FG V D G A+KI L+ E+ +E ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQV-AHIRAERDILVEAD 59
Query: 556 HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 615
++K+ S + L++EF+P G + L + + + I V A++ +H
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV-LAIDAIH 118
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE--------------DSVTQ 661
IH D+KP N+LLD +SDFG+ L + D Q
Sbjct: 119 Q----LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 662 TM-------------------TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 696
M T+ T Y+APE + + CD +S GV++ E
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 45/194 (23%), Positives = 79/194 (40%), Gaps = 55/194 (28%)
Query: 546 SECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 605
+E ++L + ++K+ S + ++ L++E++P G + L + F + R I
Sbjct: 50 AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 606 DVGSALEYLH-HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK-------------- 650
+ A++ +H G+ IH D+KP N+LLD +SDFG+
Sbjct: 110 TI-LAIDSIHKLGY-----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163
Query: 651 ---LLGEGEDSVTQTM-------------------TMATIGYMAPE------YGSEGIVS 682
L D +++ M T+ T Y+APE Y E
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE---- 219
Query: 683 AKCDVYSYGVLLME 696
CD +S GV++ E
Sbjct: 220 --CDWWSLGVIMYE 231
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 54/233 (23%), Positives = 92/233 (39%), Gaps = 42/233 (18%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDV-AIKIF---NLQLERAFRSFDSECEVLRNVRH 556
++F ++G G+FG V D V A+KI ++ + +E ++L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
++K+ S + L++EF+P G + L + + + I V A++ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV-LAIDSIHQ 119
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE--------------DSVTQT 662
IH D+KP N+LLD +SDFG+ L + D Q
Sbjct: 120 ----LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 663 M-------------------TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 696
M T+ T Y+APE + + CD +S GV++ E
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 33/145 (22%), Positives = 62/145 (42%), Gaps = 14/145 (9%)
Query: 505 ECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI--KI 562
LL G VY + D +KI + + A R + E +L+ + + L K+
Sbjct: 2 SIKLLKGGLTNRVYLLG-TKDEDYVLKINPSREKGADR--EREVAILQLLARKGLPVPKV 58
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
L+S + + L++E++ +L++ + E+ +I + L LH
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQ-LPLLV 109
Query: 623 IIHCDLKPTNILLDENMAAHVSDFG 647
+ H DL P NIL+D+ + D+
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 39/158 (24%), Positives = 68/158 (43%), Gaps = 15/158 (9%)
Query: 546 SECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIM 604
+E +LR + H ++I++ + + F L+L P + + Y + + I + L I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 605 IDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT 664
V A++YLH IIH D+K NI ++ + DFG + + +
Sbjct: 189 RSVLRAIQYLHENR----IIHRDIKAENIFINHPGDVCLGDFGAACFPVD----INANKY 240
Query: 665 ---MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
TI APE + D++S G++L E T
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 58/266 (21%), Positives = 99/266 (37%), Gaps = 56/266 (21%)
Query: 503 FNECNLLGTGSFGSVYKGTISD-GTDVAIKIF---NLQLERAFRSFDSECEVLRNVRHRN 558
F + LG G+FG V D A+K ++ L +E ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
++++ S + D V++++P G + L F + L R I ++ A+E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVH--- 118
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGI---------SKLLGEG----EDSVTQTMT- 664
IH D+KP NIL+D + ++DFG+ SK G +DS+ +
Sbjct: 119 -KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 665 -------------------------------MATIGYMAPEYGSEGIVSAKCDVYSYGVL 693
+ T Y+APE + CD +S GV+
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237
Query: 694 LMETFTRKRP--TDEMFTGEMSLRRW 717
L E + P +M + W
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 68/319 (21%), Positives = 110/319 (34%), Gaps = 66/319 (20%)
Query: 42 LTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGI----IPHSITNATKLVALDLGFNS 97
L+L+G L + + L ++ L L N L + ++ L L L N
Sbjct: 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNE 62
Query: 98 F---------AGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILS 148
L L+ L L +N + D L SL +L L
Sbjct: 63 TGRIPRGLQSLLQGLTKGCGLQELDL----SDN----ALGPDGCGVLESLLRSSSLQELK 114
Query: 149 FGSNPLGG----ILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNL----SGLTLLSLHS 200
+N LG +L + + +L+K +L+G + + L L+L +
Sbjct: 115 LNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLAN 174
Query: 201 NDLNG----TISPTMGRLKRLQGLSLRNNNL--EGSIPYDLCHLKLMFGIRLTGNKLSGH 254
N + ++ + L+ L L NN L EG+ L
Sbjct: 175 NGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--ALAE----------------- 215
Query: 255 IPPCLVSLTSLRELHLGSNKLTSSI-----PSSLWSLEYILDINLSSNSLND----SLPS 305
L SL SL L+LG N LT + + L +L ++LS N + D L
Sbjct: 216 ---TLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAE 272
Query: 306 NVQKLKVLTVLDLSRNQLS 324
+ + + L LDL N+
Sbjct: 273 VLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 1/83 (1%)
Query: 25 LSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITN 84
L G +P I + ++ + L GN + G +P ++G + ++E L L+ N+ G IP S+
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS-ITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 85 ATKLVALDLGFNSFAGHILNTFG 107
T L L+L NS +G + G
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 39/163 (23%), Positives = 63/163 (38%), Gaps = 46/163 (28%)
Query: 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNIL 634
V++++P G + L F + L R I ++ A+E +H IH D+KP NIL
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH----KMGFIHRDIKPDNIL 133
Query: 635 LDENMAAHVSDFGI---------SKLLGEGEDSVTQTMT--------------------- 664
+D + ++DFG+ SK +G+ +M
Sbjct: 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRK 193
Query: 665 -----------MATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 696
+ T Y+APE + CD +S GV+L E
Sbjct: 194 RQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 37/173 (21%)
Query: 538 ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKW--LYSHNYFL 595
+RA+R E +L+ V H+N+I +L+ F P SLE++ +Y +
Sbjct: 65 KRAYR----ELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELM 108
Query: 596 DI-----------LERLNIMI-DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV 643
D ER++ ++ + +++LH SA IIH DLKP+NI++ + +
Sbjct: 109 DANLCQVIHMELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKI 164
Query: 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 696
DFG+++ + T + T Y APE D++S G ++ E
Sbjct: 165 LDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 54/236 (22%), Positives = 100/236 (42%), Gaps = 33/236 (13%)
Query: 509 LGTGSFGSVYKGTI---SDG--------TDVAIKIFNLQLERAFRSFDSECEVLRNVRHR 557
LG G+F ++YKG + SD V +K+ R +F ++ + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG 617
+L+K+ C + +V E++ G L+ +L+ + + +L++ + SAL YL
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118
Query: 618 HSSAPIIHCDLKPTNILL---DENMA----AHVSDFGISKLLGEGEDSVTQTMTMATIGY 670
++H ++ NIL+ N +SD GI + E+ V + I +
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPW 170
Query: 671 MAPEYGSEGIVSAK--CDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLP 723
+APE G S D +S+G L+E + + P + + E + LP
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP 226
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 58/250 (23%), Positives = 98/250 (39%), Gaps = 54/250 (21%)
Query: 503 FNECNLLGTGSFGSV-YKGTISDGTDVAIKIFNLQ--LER-AFRSFDSECEVLRNVRHRN 558
F + LG G+FG V + A+K + L R +E ++L +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
++K+ S + D V++++P G + L F ++L R I ++ A+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH--- 118
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGI---------SKLLGEG----EDSVTQT--- 662
IH D+KP NIL+D + ++DFG+ SK +G +DS+ +
Sbjct: 119 -KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 663 ------------MTM-----------------ATIGYMAPEYGSEGIVSAKCDVYSYGVL 693
T+ T Y+APE + CD +S GV+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 694 LMETFTRKRP 703
L E + P
Sbjct: 238 LFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 29/106 (27%)
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL--------LGEG--EDSV 659
ALEYLH + I+H DLKP N+L+ ++DFG+SK+ L EG E
Sbjct: 113 ALEYLH----NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 660 TQTMTMATIG---YMAPE------YGSEGIVSAKCDVYSYGVLLME 696
+ + G Y+APE YG D ++ G++L E
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGK------PVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 7e-04
Identities = 20/60 (33%), Positives = 29/60 (48%)
Query: 264 SLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQL 323
+L+ L L +N+LT + L + ++LS N+L P L L LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 8/97 (8%)
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL-LGEGEDSVTQTMTMATI 668
AL +LH II+ DLK N+LLD + ++D+G+ K LG G+ T + T
Sbjct: 108 ALNFLHE----RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTP 160
Query: 669 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTD 705
Y+APE D ++ GVL+ E + P D
Sbjct: 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 49/230 (21%)
Query: 502 EFNECNLLGTGSFGSVYKGTISDGTD---VAIKIFNLQLERAFRSFDS--ECEVLRNVRH 556
E+ C + G G++G VYK DG D A+K Q+E S + E +LR ++H
Sbjct: 3 EYEGCKV-GRGTYGHVYKAKRKDGKDEKEYALK----QIEGTGISMSACREIALLRELKH 57
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWL---YSHNYFLDI---------------L 598
N+I AL F+ + + WL Y+ + I L
Sbjct: 58 PNVI------------ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQL 105
Query: 599 ERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL----DENMAAHVSDFGISKLLGE 654
R + + L+ +H+ H++ ++H DLKP NIL+ E ++D G ++L
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 655 GEDSVTQ-TMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
+ + T Y APE G+ A D+++ G + E T +
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKA-IDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 502 EFNECNLLGTGSFG-SVYKGTISDGTDVAIKIFNLQLERAFRSFDS---ECEVLRNVRHR 557
++N ++G GSFG ++ ++ A+K ++L ++ + + E +L ++H
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMK--EIRLPKSSSAVEDSRKEAVLLAKMKHP 58
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFL---DILERLNIMIDVGSALEYL 614
N++ S +V+E+ G L + + L D + L + + ++++
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQWFVQMCLGVQHI 116
Query: 615 HHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT-MATIGYMAP 673
H ++H D+K NI L +N + DFG ++LL T + T Y+ P
Sbjct: 117 HEKR----VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT---SPGAYACTYVGTPYYVPP 169
Query: 674 EYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
E + K D++S G +L E T K P
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 502 EFNECNLLGTGSFGSVYKGTISDGTD---VAIKIFNLQLERAFRSFDS--ECEVLRNVRH 556
E+ C + G G++G VYK DG D A+K Q+E S + E +LR ++H
Sbjct: 3 EYEGCKV-GRGTYGHVYKAKRKDGKDDRDYALK----QIEGTGISMSACREIALLRELKH 57
Query: 557 RNLIKILSS-CSNPDFKALVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGSA 610
N+I + S+ D K +L L + H N L R + +
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILL----DENMAAHVSDFGISKLLGEGEDSVTQ-TMTM 665
L+ +H+ H++ ++H DLKP NIL+ E ++D G ++L + +
Sbjct: 118 LDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 666 ATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
T Y APE G+ A D+++ G + E T +
Sbjct: 177 VTFWYRAPELLLGARHYTKA-IDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 33/99 (33%), Positives = 47/99 (47%), Gaps = 12/99 (12%)
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG-EDSVTQTMTMATI 668
AL +LH II+ DLK N+LLD ++D+G+ K EG T + T
Sbjct: 108 ALNFLHERG----IIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTP 160
Query: 669 GYMAPEY--GSEGIVSAKCDVYSYGVLLMETFTRKRPTD 705
Y+APE G + S D ++ GVL+ E + P D
Sbjct: 161 NYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 32/101 (31%), Positives = 46/101 (45%), Gaps = 8/101 (7%)
Query: 606 DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG-EDSVTQTMT 664
++ AL YLH II+ DLK N+LLD ++D+G+ K EG T +
Sbjct: 104 EISLALNYLHE----RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTF 156
Query: 665 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTD 705
T Y+APE D ++ GVL+ E + P D
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 42/151 (27%), Positives = 64/151 (42%), Gaps = 16/151 (10%)
Query: 495 DIQRATDEFNECNLLGTGSFGSVYKGTISDGTD-VAIKIFNLQLERAFRSFDSECEVLRN 553
DI +T F +LLG G+FG V + + A+KI + + R E + +
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR-NVPKYTRDAKIEIQFMEK 181
Query: 554 VRHRN------LIKILSSCSNPDFKALVLEFMPN--GSLEKWLYSHNYFLDILERLNIMI 605
VR + L+KI N ++ MP L W+ H F I+
Sbjct: 182 VRQADPADRFPLMKIQRYFQNETGHMCIV--MPKYGPCLLDWIMKHGPF-SHRHLAQIIF 238
Query: 606 DVGSALEYLHHGHSSAPIIHCDLKPTNILLD 636
G AL+Y H + ++H DLKP NIL++
Sbjct: 239 QTGVALDYFH---TELHLMHTDLKPENILME 266
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 791 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.32 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.28 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.24 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.24 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.24 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.24 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.21 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.03 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.95 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.94 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.93 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.76 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.74 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.66 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.54 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.54 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.53 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.49 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-92 Score=864.24 Aligned_cols=759 Identities=29% Similarity=0.466 Sum_probs=557.8
Q ss_pred CccCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCcc
Q 003855 2 AGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHS 81 (791)
Q Consensus 2 ~g~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~ 81 (791)
.|.+|..|+++++|++|+|++|++.+.+|..|.++++|++|+|++|.+++.+|..+.. +++|++|+|++|.+++..|..
T Consensus 177 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~L~~n~l~~~~p~~ 255 (968)
T PLN00113 177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG-LTSLNHLDLVYNNLTGPIPSS 255 (968)
T ss_pred cccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhc-CCCCCEEECcCceeccccChh
Confidence 5678888888888888888888888888888888888888888888888778877766 788888888888888778888
Q ss_pred CcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCc-c---------------ccccccccCCCCCCc
Q 003855 82 ITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSA-D---------------QWSFLSSLTNCRNLT 145 (791)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~---------------~~~~~~~l~~l~~L~ 145 (791)
|+++++|++|+|++|++.+..+..+.++++|+.|++++|.+....... . ....+..+..+++|+
T Consensus 256 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~ 335 (968)
T PLN00113 256 LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQ 335 (968)
T ss_pred HhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCC
Confidence 888888888888888887777777888888888888888776432111 0 001122344455555
Q ss_pred EEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccc
Q 003855 146 ILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNN 225 (791)
Q Consensus 146 ~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 225 (791)
.|++++|.+.+.+|..++.+ .+|+.|++++|++.+.+|..+..+++|+.|++++|.+.+..|..+..+++|+.|+|++|
T Consensus 336 ~L~L~~n~l~~~~p~~l~~~-~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n 414 (968)
T PLN00113 336 VLQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414 (968)
T ss_pred EEECcCCCCcCcCChHHhCC-CCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCC
Confidence 55555555555555444443 34555555555555555555555555555566666655556666666666777777777
Q ss_pred cCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCc
Q 003855 226 NLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPS 305 (791)
Q Consensus 226 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~ 305 (791)
++++..|..|..+++|+.|++++|.+++.+|..+..+++|+.|+|++|++.+..|..+ ..++|+.|++++|++++..|.
T Consensus 415 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~ 493 (968)
T PLN00113 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPR 493 (968)
T ss_pred EeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccCh
Confidence 7766666667777777777777777776666666777777777777777776666544 457788889999999888999
Q ss_pred ccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccC
Q 003855 306 NVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQL 385 (791)
Q Consensus 306 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 385 (791)
.+..+++|+.|+|++|++.+.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|||++|++++.+|..+..+++|
T Consensus 494 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 573 (968)
T PLN00113 494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESL 573 (968)
T ss_pred hhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceEEccCCCCcccCCCCCCCcCCccccccCCccccCCCC-CCCCCCCCCCCCCcccccceeeeeecchhhHH-H-HHHHH
Q 003855 386 KQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPPK-LRVPPCKPDNSKSTKNVALTVLKYILPPIVCS-V-LLVIT 462 (791)
Q Consensus 386 ~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~~-~~~~~c~~~~~~s~~~~~~~v~~~~~~~~~~~-~-~l~i~ 462 (791)
+.|++++|+++|.+|..+.+..+...++.||+.+|+++. ...++|..... ...++.+++++++++ + ++++.
T Consensus 574 ~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 647 (968)
T PLN00113 574 VQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK------TPSWWFYITCTLGAFLVLALVAF 647 (968)
T ss_pred CEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc------cceeeeehhHHHHHHHHHHHHHH
Confidence 999999999999999988888888889999999998652 23456743211 111122222111111 1 11111
Q ss_pred Hhhhhhcccc-ccccCCccCc-cccccCC--CCChhHHHHHhhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh
Q 003855 463 IIMYKRCRNR-STKHLDHEDF-LPLATWR--RTPYLDIQRATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL 537 (791)
Q Consensus 463 ~~~~~~~r~~-~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~ 537 (791)
++++.+++++ ..+..+.+.. ....... .............|...+.||+|+||.||+|+. .++..||||++....
T Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~ 727 (968)
T PLN00113 648 GFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN 727 (968)
T ss_pred HHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc
Confidence 2222222211 1111111110 0000000 001122333446678888999999999999997 478999999886432
Q ss_pred hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc
Q 003855 538 ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG 617 (791)
Q Consensus 538 ~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~ 617 (791)
. ....|++.+++++|||||+++|+|.+++..++||||+++|+|.++++. ++|.++.+++.|+|+|++|||+.
T Consensus 728 ~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~ 799 (968)
T PLN00113 728 S----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCR 799 (968)
T ss_pred c----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccC
Confidence 2 123468889999999999999999999999999999999999999963 78999999999999999999965
Q ss_pred CCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHH
Q 003855 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 697 (791)
Q Consensus 618 ~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~el 697 (791)
+ +.+|+||||||+||+++.++.+++. ||.+..... .....++.+|+|||+..+..++.++|||||||++|||
T Consensus 800 ~-~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el 871 (968)
T PLN00113 800 C-SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIEL 871 (968)
T ss_pred C-CCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHH
Confidence 5 5689999999999999999998876 666544321 1123578999999999999999999999999999999
Q ss_pred HhCCCCCCccccCcchHHHHHHHhcCCC-hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 698 FTRKRPTDEMFTGEMSLRRWVKESLPHG-LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 698 ltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
+||+.||+..........+|++...... ...++|+.+.... ....+...++.+++.+||+.||++||+|.||+++|
T Consensus 872 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 872 LTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV---SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred HhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC---CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence 9999999765555666777776554432 4445555443221 11223456788999999999999999999999999
Q ss_pred HHHHHHhccccc
Q 003855 777 KKIKVKFLDDAS 788 (791)
Q Consensus 777 ~~~~~~~~~~~~ 788 (791)
+++.+...+..+
T Consensus 949 ~~~~~~~~~~~~ 960 (968)
T PLN00113 949 ESASRSSSSCVT 960 (968)
T ss_pred HHhhcccccccc
Confidence 999776655443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-52 Score=439.78 Aligned_cols=288 Identities=42% Similarity=0.684 Sum_probs=247.6
Q ss_pred cCCCCChhHHHHHhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeee
Q 003855 487 TWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC 566 (791)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 566 (791)
....+++.+++.+|++|...+.||+|+||.||+|..++|+.||||++........++|..|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45678999999999999999999999999999999999999999988765432145699999999999999999999999
Q ss_pred ccCC-eeeEEEecCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEe
Q 003855 567 SNPD-FKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVS 644 (791)
Q Consensus 567 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~ 644 (791)
.+.+ +.++|||||++|+|.++++.... .++|.+|.+||.++|+||+|||+.+ ..+|+||||||+|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~-~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC-PPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC-CCCEecCCCCHHHeeECCCCCEEcc
Confidence 9988 59999999999999999997765 7999999999999999999999876 4479999999999999999999999
Q ss_pred eeccccccCCCCCcceeecc-cccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccc-cCcchHHHHHHHhc
Q 003855 645 DFGISKLLGEGEDSVTQTMT-MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMF-TGEMSLRRWVKESL 722 (791)
Q Consensus 645 Dfgla~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~-~~~~~~~~~~~~~~ 722 (791)
|||+|+....... ..... .||.+|+|||+...+..+.|+|||||||+++|++||+.|.+... ..+..+..|+....
T Consensus 220 DFGLa~~~~~~~~--~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEGDT--SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcccc--ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 9999966543111 11112 79999999999999999999999999999999999999888644 34556899988777
Q ss_pred CC-Chhhhcchhhhh-hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 723 PH-GLTEVVDANLVR-EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 723 ~~-~~~~~~d~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
.. .+.+++|+.+.. +... ......+..++.+|++.+|++||+|.||+++|+.+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~----~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPD----EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCCh----HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 66 488999999863 2111 1455678999999999999999999999999976644
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=483.87 Aligned_cols=412 Identities=34% Similarity=0.570 Sum_probs=320.3
Q ss_pred CCccCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCc
Q 003855 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPH 80 (791)
Q Consensus 1 ~~g~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~ 80 (791)
++|.+|..++++++|++|+|++|.+.+.+|..|.++++|++|+|++|.+.+.+|..+.. +++|++|+|++|.+++.+|.
T Consensus 152 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~L~~n~l~~~~p~ 230 (968)
T PLN00113 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ-MKSLKWIYLGYNNLSGEIPY 230 (968)
T ss_pred ccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcC-cCCccEEECcCCccCCcCCh
Confidence 35789999999999999999999999999999999999999999999999889988877 89999999999999999999
Q ss_pred cCcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCCh
Q 003855 81 SITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPP 160 (791)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 160 (791)
.|+++++|++|+|++|.+.+..+..|.++++|+.|++++|++.... +..+.++++|+.|++++|.+.+.+|.
T Consensus 231 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~--------p~~l~~l~~L~~L~Ls~n~l~~~~p~ 302 (968)
T PLN00113 231 EIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI--------PPSIFSLQKLISLDLSDNSLSGEIPE 302 (968)
T ss_pred hHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccC--------chhHhhccCcCEEECcCCeeccCCCh
Confidence 9999999999999999999999999999999999999999987532 33456666677777777766666666
Q ss_pred hhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccc---
Q 003855 161 VIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCH--- 237 (791)
Q Consensus 161 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--- 237 (791)
.+..+ .+|+.|++++|.+.+..|..+..+++|+.|+|++|.+++..|..++.+++|+.|+|++|++++.+|..++.
T Consensus 303 ~~~~l-~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~ 381 (968)
T PLN00113 303 LVIQL-QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGN 381 (968)
T ss_pred hHcCC-CCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCC
Confidence 55544 34666666666666666666666666666666666666555666666666666666666655555555544
Q ss_pred ---------------------cCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccC
Q 003855 238 ---------------------LKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSS 296 (791)
Q Consensus 238 ---------------------l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 296 (791)
+++|+.|++++|++++..|..+.++++|+.|++++|++.+..+..+..+++|+.|++++
T Consensus 382 L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 461 (968)
T PLN00113 382 LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR 461 (968)
T ss_pred CCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcC
Confidence 44555555555555544555555555555555555555555555555555666666666
Q ss_pred CcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCc
Q 003855 297 NSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 376 (791)
Q Consensus 297 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 376 (791)
|.+.+..|..+ ..++|+.|++++|++++..|..+..+++|+.|+|++|++.+.+|..+..+++|+.|+|++|.+++.+|
T Consensus 462 n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 540 (968)
T PLN00113 462 NKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540 (968)
T ss_pred ceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCC
Confidence 66655555544 34678888888888888888889999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCceEEccCCCCcccCCCC-CCCcCCccccccCCccccCCC
Q 003855 377 KSLETLSQLKQFNVSHNRLEGEIPVK-GSFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 377 ~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~~ 423 (791)
..|..+++|+.|+|++|++++.+|.. ..+..++.+.+.+|+..+.-|
T Consensus 541 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 541 ASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred hhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 99999999999999999999988863 557788889999998876544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=401.94 Aligned_cols=260 Identities=31% Similarity=0.475 Sum_probs=214.8
Q ss_pred ccccccccCCCcceEEEEEEecCCcEEEEEEeehhhh--HHHHHHHHHHHHHHhccCCccceeeeeeccCC-eeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSCSNPD-FKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 578 (791)
++...+.+|+|+||+||+|.++....||||++..... ...+.|.+|+.+|.+++|||||+++|+|.++. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 3445566999999999999996544499999976542 22568999999999999999999999999887 78999999
Q ss_pred CCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCC-eEecCCCCCCeEeCCCC-cEEEeeeccccccCCC
Q 003855 579 MPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLHHGHSSAP-IIHCDLKPTNILLDENM-AAHVSDFGISKLLGEG 655 (791)
Q Consensus 579 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~-i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~ 655 (791)
+++|+|.++++. ....+++..+.++|.|||+||.||| +.+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH----~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH----SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh----cCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999998 4667999999999999999999999 556 99999999999999998 9999999999876543
Q ss_pred CCcceeecccccccccCCCccC--CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGS--EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
. ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||...... ......+....+
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~~~~v~~~~~R---------- 264 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QVASAVVVGGLR---------- 264 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhcCCC----------
Confidence 2 2333367999999999999 669999999999999999999999999876542 111111111111
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
.+-+..|+..+..++.+||+.||+.||++.+++..|+.+......
T Consensus 265 -------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 265 -------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 111223677888999999999999999999999999999876654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=404.16 Aligned_cols=256 Identities=30% Similarity=0.507 Sum_probs=219.5
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
+.+..++.||+|.||+||.|.++...+||+|.++... -..++|.+|+.+|++++|++||+++|+|..++.++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 3455678999999999999999888899999987642 234678899999999999999999999999889999999999
Q ss_pred CCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 581 NGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 581 ~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
.|+|.+||+. .+..+...+...++.|||+||+||+ ++++|||||.++||||+++..|||+|||+|+...+.. +.
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe----s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~ 359 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE----SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YT 359 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH----hCCccchhhhhhheeeccCceEEEcccccccccCCCc-ee
Confidence 9999999997 5667899999999999999999999 7889999999999999999999999999999554433 32
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......-+..|.|||.+..+.++.|||||||||+||||+| |+.||+.+...+. + ...+.+
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-----~--------------~~le~G 420 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-----L--------------ELLERG 420 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-----H--------------HHHhcc
Confidence 3333345678999999999999999999999999999999 8889877533221 1 123345
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
.+.+.+..||..+.++|..||+.+|++||||..+...++.+..
T Consensus 421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 5667788999999999999999999999999999988888754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=375.60 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=210.5
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCC-eeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD-FKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 576 (791)
.++.+..+.||+|..|+|||++++ +++.+|+|++.... ....+++.+|+++++..+||+||.++|+|.... ...++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 345667789999999999999986 78889999995443 445678999999999999999999999999888 599999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
|||.+|||.+++...+. +++....+|+.+|++||.|||+ .+.||||||||+|||++..|+|||||||.++.+-+.
T Consensus 158 EYMDgGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~---~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHE---ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhh---ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999999986644 8999999999999999999995 468999999999999999999999999999887543
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
.....+||..|||||.+.+..|+.++||||||++++|+.+|+.||....+..... .+.++.-+.+
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~------------~~Ll~~Iv~~ 297 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI------------FELLCAIVDE 297 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH------------HHHHHHHhcC
Confidence 2344689999999999999999999999999999999999999987642211111 1222222221
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....+.. .+++++.+++..|+++||.+||++.|+++
T Consensus 298 ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 298 PPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22222221 47888999999999999999999999876
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=368.70 Aligned_cols=200 Identities=33% Similarity=0.533 Sum_probs=181.8
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehh--hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
..+|...+.||+|+||+||+|+++ ++..||||.+... ..+..+.+..|+.+++.++|||||++++++.+++..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888899999999999999975 7899999999776 4566778899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC------CcEEEeeecccc
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN------MAAHVSDFGISK 650 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~------~~~kl~Dfgla~ 650 (791)
|||.||||.+|++.++. +++.....++.|+|.||++|| +++||||||||.|||++.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~----~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLH----ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999998765 899999999999999999999 7889999999999999864 568999999999
Q ss_pred ccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCcc
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~ 707 (791)
.+.++.. ....+|++-|||||++..++|+.|+|+||.|+|+|+|++|+.||+..
T Consensus 164 ~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 164 FLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9875432 33468999999999999999999999999999999999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=403.42 Aligned_cols=263 Identities=28% Similarity=0.463 Sum_probs=225.4
Q ss_pred hccccccccCCCcceEEEEEEec------CCcEEEEEEeehhhhH-HHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
.+.+..+.||+|+||.||+|+.. +.+.||||.++...+. ..++|++|+++++.++|||||+++|.|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 45566789999999999999842 4567999999887765 7789999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc
Q 003855 574 LVLEFMPNGSLEKWLYSH-------------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA 640 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~ 640 (791)
+|+|||..|||.+||+.+ ..+++..+.+.||.|||.||+||- ++.+|||||.++|+||.++..
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs----~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS----SHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCcccccchhhhhceeccceE
Confidence 999999999999999842 123788999999999999999998 677999999999999999999
Q ss_pred EEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHH
Q 003855 641 AHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVK 719 (791)
Q Consensus 641 ~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 719 (791)
|||+|||+++.....+++.......-+++|||||.+..++||+++||||||||+||+++ |+.||.+....+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV------- 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV------- 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------
Confidence 99999999998877776665555566889999999999999999999999999999999 9999987543321
Q ss_pred HhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhccc
Q 003855 720 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDD 786 (791)
Q Consensus 720 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~ 786 (791)
++ ...++...+.++.||.++++||.+||+..|++||+|+||-..|..........
T Consensus 715 ----------Ie--~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~ 769 (774)
T KOG1026|consen 715 ----------IE--CIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKY 769 (774)
T ss_pred ----------HH--HHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccc
Confidence 11 11122235667789999999999999999999999999999999886655443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=381.51 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=210.3
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
..|...+.||+|||+.||.++. .+|+.||+|++.+.. ..+.+...+|+++.++++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999997 799999999998653 455678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
|+|++|+|..+++ ....+++.++..+++||+.||.||| +.+|+|||||..|+|++++.+|||+|||+|+.+...+
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH----~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH----SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH----hcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999888 4456999999999999999999999 7889999999999999999999999999999886442
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
. .....+||+.|+|||++.....+..+||||+|||||-|++|++||+...- ...+.+. ..
T Consensus 173 E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-kety~~I-----------------k~ 232 (592)
T KOG0575|consen 173 E--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-KETYNKI-----------------KL 232 (592)
T ss_pred c--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-HHHHHHH-----------------Hh
Confidence 2 22335799999999999999999999999999999999999999976211 1111111 11
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. ..-+...+.+..++|.++|+.||++|||+.+|+.
T Consensus 233 ~~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 233 NE--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cC--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11 1112245566789999999999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=350.34 Aligned_cols=257 Identities=23% Similarity=0.359 Sum_probs=206.0
Q ss_pred hhccccccccCCCcceEEEEEE-ecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeee-eccC-CeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSS-CSNP-DFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~-~~~~l 574 (791)
..+|++.++||+|.||+||++. ..+|..||.|.+.-.. .+..+....|+.++++++|||||+++++ +.+. ...++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3578899999999999999997 4689999999886432 4556788999999999999999999984 3333 44899
Q ss_pred EEecCCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 575 VLEFMPNGSLEKWLY---SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 575 v~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
|||||.+|||.+.++ +.+..+++..+|++..|++.||.++|..-+..-|+||||||.||+++.+|.||++|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999987 45667999999999999999999999522223399999999999999999999999999998
Q ss_pred cCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
+.... ......+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.+. .+....+. +.++
T Consensus 178 l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~K-I~qg------ 243 (375)
T KOG0591|consen 178 LSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKK-IEQG------ 243 (375)
T ss_pred hcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHH-HHcC------
Confidence 86543 2344568999999999999999999999999999999999999999763 22221111 1111
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
+... -....++.++.++|..|+.+||+.||+...+++.+
T Consensus 244 -----d~~~-~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 244 -----DYPP-LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred -----CCCC-CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 0000 11246778899999999999999999854444433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=362.31 Aligned_cols=253 Identities=28% Similarity=0.379 Sum_probs=205.5
Q ss_pred HhhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhh-------HHHHHHHHHHHHHHhccCCccceeeeeeccCC
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLE-------RAFRSFDSECEVLRNVRHRNLIKILSSCSNPD 570 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 570 (791)
..+.|.+.+.+|+|+||.|-+|.. ++|+.||||++.+... .......+|+++|++++|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346788899999999999999985 5899999999975431 12234679999999999999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC---CcEEEeeec
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN---MAAHVSDFG 647 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg 647 (791)
..|+||||++||+|.+++-.++. +.+..-.-+++|++.|+.||| +.||+||||||+|||+..+ -.+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH----~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH----SQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH----HcCcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999987765 677777889999999999999 7899999999999999755 779999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCCCC---CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH 724 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (791)
+|+..+.+ ..+...+||+.|.|||++.++. +..++|+||+|||+|-+++|.+||.+.........+..+..+..
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 99987643 2345578999999999987654 33478999999999999999999987433221111111111100
Q ss_pred ChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 725 GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 725 ~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+.+.+++++..++|.+||..||++||++.|+++
T Consensus 402 ---------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 402 ---------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ---------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11344567788999999999999999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=343.76 Aligned_cols=264 Identities=22% Similarity=0.270 Sum_probs=206.3
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++.|+...++|+|+||+|||++.+ +|+.||||++.... ....+-..+|++++++++|||+|.++++|......++||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 357888999999999999999976 79999999996543 234456789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
|||+. ++.+-+.......+...+.++++|+++|+.|+| +.+++||||||+|||++.+|.+|+||||+|+.+....
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH----k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH----KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh----hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99987 666667766666999999999999999999999 7789999999999999999999999999999987433
Q ss_pred CcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHH--HHHhcCCC---hhhhc
Q 003855 657 DSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRW--VKESLPHG---LTEVV 730 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~---~~~~~ 730 (791)
+ ..+-.+.|++|+|||.+.+ ..|...+||||.||++.||++|.+-|++ +.++.+. +......- -..++
T Consensus 156 d--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG----~SDiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 156 D--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG----RSDIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred c--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC----cchHHHHHHHHHHHcccCHHHHHHh
Confidence 2 2344578999999998765 7899999999999999999999988765 3333332 22221111 11111
Q ss_pred chh----------hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 731 DAN----------LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 731 d~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+ ..........-.....-+.+++..|++.||++|++.+|++.
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111 00000000111133456889999999999999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=393.65 Aligned_cols=258 Identities=26% Similarity=0.472 Sum_probs=224.1
Q ss_pred cccccccCCCcceEEEEEEec----CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 503 FNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
..+.++||.|.||+||+|+++ ....||||.++... +++.++|..|+.+|.+++||||+++-|+.......++|.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 456789999999999999975 24569999998654 6678899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
||++|+|..||+.+..++.+.+...+.++||.|+.||. .+++|||||.++||||+.+..+|++|||++|.+.++..
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs----dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh----hcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999999999888999999999999999999999 78999999999999999999999999999998865542
Q ss_pred c-ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 658 S-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 658 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
. .....-.-+.+|.|||.+..+++|.++|||||||||||.++ |.+||.++.+.+. ++ -.
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV-----Ik--------------aI 847 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-----IK--------------AI 847 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH-----HH--------------HH
Confidence 1 11111223578999999999999999999999999999887 9999987644321 11 13
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
+++.+.+.+++||..+.+||..||++|-.+||.|.|++..|.++.++-
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 345567889999999999999999999999999999999999986653
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=381.67 Aligned_cols=372 Identities=23% Similarity=0.263 Sum_probs=199.8
Q ss_pred CeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccC
Q 003855 16 QYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGF 95 (791)
Q Consensus 16 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 95 (791)
+.||+|+|+|..+.+..|.++++|+++++.+|.++ .||..... ..+|+.|+|.+|.|+.+....+..++.|+.||||.
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~-sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHE-SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccccc-ccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 44555555555555555555555555555555555 55554332 44555555555555555555555555555555555
Q ss_pred ccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcc
Q 003855 96 NSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAY 175 (791)
Q Consensus 96 N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~ 175 (791)
|.|+.+....|..-.++++|+|+.|+|+++..+. |.++.+|..|.|+.|+|+.. |...++..+.|+.|+|.
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~--------F~~lnsL~tlkLsrNrittL-p~r~Fk~L~~L~~LdLn 229 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGH--------FDSLNSLLTLKLSRNRITTL-PQRSFKRLPKLESLDLN 229 (873)
T ss_pred chhhcccCCCCCCCCCceEEeecccccccccccc--------ccccchheeeecccCccccc-CHHHhhhcchhhhhhcc
Confidence 5555555555555555555555555555555443 55555555555555555533 33333323445555555
Q ss_pred cccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCC
Q 003855 176 ECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHI 255 (791)
Q Consensus 176 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~ 255 (791)
.|+|..+---.|.+|++|+.|.|..|+|.....++|..+.++++|+|+.|+++..-..++.+++.|+.|+||+|.|..+.
T Consensus 230 rN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih 309 (873)
T KOG4194|consen 230 RNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIH 309 (873)
T ss_pred ccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheee
Confidence 55555443444555555555555555555555555555555555555555555444555555555555555555555555
Q ss_pred CccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCC---cchh
Q 003855 256 PPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP---STIG 332 (791)
Q Consensus 256 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~ 332 (791)
++.+...++|++|+|++|+|+...+.+|..+..|+.|+|++|.|.......|..+++|+.|||++|.|+..+. ..|.
T Consensus 310 ~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~ 389 (873)
T KOG4194|consen 310 IDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFN 389 (873)
T ss_pred cchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhc
Confidence 5555555555555555555555555555555555555555555554444455555555555555555543322 2344
Q ss_pred ccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccC
Q 003855 333 ALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEI 399 (791)
Q Consensus 333 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 399 (791)
++++|+.|.|.+|+|+.....+|.+++.|+.|||.+|.|..+-|.+|..+ .|++|-++.-.+-|.+
T Consensus 390 gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDC 455 (873)
T KOG4194|consen 390 GLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDC 455 (873)
T ss_pred cchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEec
Confidence 55555555555555553333455555555555555555555555555555 5555555444444433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=369.76 Aligned_cols=262 Identities=26% Similarity=0.449 Sum_probs=213.3
Q ss_pred HhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
-.+++.+...||+|.||+||+|+|. .+||||+++... .++.+.|+.|+.++++-+|.||+-++|||..+.. .+|+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 3455667889999999999999985 369999997653 4578899999999999999999999999998887 9999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
.+|+|-+|..+++.....++..+...||+|||+|+.||| .++|||||||..|||+.+++.|||+|||++..-....
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH----AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH----AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh----hhhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 999999999999977777999999999999999999999 7899999999999999999999999999997654432
Q ss_pred CcceeecccccccccCCCccCC---CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
........-|...|||||++.. ..|++.+||||||+|+|||+||..||.. ...+..+. .+.++ ++.+.
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIif-----mVGrG---~l~pd 613 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIF-----MVGRG---YLMPD 613 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEE-----Eeccc---ccCcc
Confidence 2223333457888999998754 5699999999999999999999999984 22221110 01111 00000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
. ......|+.++.+|+..||..+|++||.+.+++.+|+.+...
T Consensus 614 ~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 614 L------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred c------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 0 111236888999999999999999999999999999888664
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=373.65 Aligned_cols=401 Identities=22% Similarity=0.222 Sum_probs=360.2
Q ss_pred CCeeecCCCcccccCCccccCC--CCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEe
Q 003855 15 LQYLVFAENNLSGLVPPTIFNI--STMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALD 92 (791)
Q Consensus 15 L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 92 (791)
-..||+++++|..+.-..+.++ +.-+.|++++|+|+ .+...+|..+++|+++++..|.++ .+|.......+|+.|+
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~ 131 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD 131 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccc-cCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence 4678999999976544444443 35567999999999 666666667999999999999999 6788777788899999
Q ss_pred ccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhh
Q 003855 93 LGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKF 172 (791)
Q Consensus 93 L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L 172 (791)
|.+|.|+++....++-++.|+.|+|+.|.|+.++... |..-.++++|+|++|.|+......|..+. +|.+|
T Consensus 132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~s--------fp~~~ni~~L~La~N~It~l~~~~F~~ln-sL~tl 202 (873)
T KOG4194|consen 132 LRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPS--------FPAKVNIKKLNLASNRITTLETGHFDSLN-SLLTL 202 (873)
T ss_pred eeccccccccHHHHHhHhhhhhhhhhhchhhcccCCC--------CCCCCCceEEeeccccccccccccccccc-hheee
Confidence 9999999999999999999999999999999988654 77888999999999999998888888886 89999
Q ss_pred hcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccC
Q 003855 173 YAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLS 252 (791)
Q Consensus 173 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 252 (791)
.|++|+++...+..|.+|++|+.|+|..|+|.-...-.|.++++|+.|.|..|.|...-...|..+.++++|+|+.|+++
T Consensus 203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~ 282 (873)
T KOG4194|consen 203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ 282 (873)
T ss_pred ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh
Confidence 99999999888889999999999999999998555778999999999999999999888899999999999999999999
Q ss_pred CCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchh
Q 003855 253 GHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIG 332 (791)
Q Consensus 253 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 332 (791)
..-..++-+++.|+.|+||+|.|..+.++++.-.++|++|+|++|+|+...+..|..+..|+.|+|++|.++..-...|.
T Consensus 283 ~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~ 362 (873)
T KOG4194|consen 283 AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFV 362 (873)
T ss_pred hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHH
Confidence 88889999999999999999999999999999999999999999999999999999999999999999999977777899
Q ss_pred ccccccccccccccCCCCCC---cccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCc
Q 003855 333 ALKDLETLSLARNQFQGPIP---ESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409 (791)
Q Consensus 333 ~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~ 409 (791)
++++|++|||++|.|+..+. ..|..|++|+.|+|.+|+|..+.-.+|.++++|+.|||.+|.+...-|.+..-..|+
T Consensus 363 ~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk 442 (873)
T KOG4194|consen 363 GLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELK 442 (873)
T ss_pred HhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhh
Confidence 99999999999999986554 357789999999999999997777899999999999999999998887765545788
Q ss_pred cccccCCccccCCCCCC
Q 003855 410 VESFFGNYALCGPPKLR 426 (791)
Q Consensus 410 ~~~~~~n~~~c~~~~~~ 426 (791)
.+.+....++|+.+..+
T Consensus 443 ~Lv~nSssflCDCql~W 459 (873)
T KOG4194|consen 443 ELVMNSSSFLCDCQLKW 459 (873)
T ss_pred hhhhcccceEEeccHHH
Confidence 88888889999977543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=347.70 Aligned_cols=244 Identities=27% Similarity=0.329 Sum_probs=202.8
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
..++|++.++||+|+||.||.++.+ +++.+|+|++++.. ....+...+|..++.+++||+||+++..|++++..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999999864 78999999997664 3456778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
|+||+.||.|..+|++++. +++..+.-++..|+.||.||| +++||||||||+|||+|++|+++|+|||+++..-.
T Consensus 103 Vld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH----~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH----SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999997765 788888889999999999999 78999999999999999999999999999986433
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
.. ......+||+.|||||++.+..|+..+|+||+||++|||++|.+||..... .+++....... +
T Consensus 178 ~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~~I~~~k--------~ 242 (357)
T KOG0598|consen 178 DG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYDKILKGK--------L 242 (357)
T ss_pred CC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHHHHhcCc--------C
Confidence 22 223346899999999999999999999999999999999999999976322 22222211111 0
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRIN 768 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt 768 (791)
...+...+.+..+++.+.++.||++|..
T Consensus 243 ------~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 243 ------PLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ------CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 0011123455679999999999999963
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=397.53 Aligned_cols=260 Identities=27% Similarity=0.450 Sum_probs=219.9
Q ss_pred hccccccccCCCcceEEEEEEec--CCc----EEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS--DGT----DVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
+.....+.||+|+||+||.|.+. +|. .||||.+.... .+...+|.+|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 44556788999999999999865 233 48999887654 556788999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeec
Q 003855 574 LVLEFMPNGSLEKWLYSH------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFG 647 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 647 (791)
+++|||++|||..||++. ...+...+...++.|||+|+.||+ ++.+|||||.++|+|+++...|||+|||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe----~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE----SKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH----hCCCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999976 667899999999999999999999 7789999999999999999999999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCCh
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGL 726 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 726 (791)
+|+++...+.+.......-+..|||||.+.++.++.|+|||||||++||++| |..||......+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-------------- 913 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-------------- 913 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--------------
Confidence 9997666555443333234578999999999999999999999999999999 8899987433221
Q ss_pred hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 727 ~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
+.. ..++.+.+.+..|+..++++|..||+.+|++||+|.++++.+..+....
T Consensus 914 ---~~~--~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 914 ---LLD--VLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ---HHH--HHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 110 1122355667789999999999999999999999999999888876544
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=350.41 Aligned_cols=279 Identities=25% Similarity=0.369 Sum_probs=214.9
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHh--ccCCccceeeeeeccCC----eeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRN--VRHRNLIKILSSCSNPD----FKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~l 574 (791)
+..+..+.||+|.||.||||++. ++.||||++... ..+.|..|.++++. ++|+||++++++-.... .+++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 45566779999999999999994 599999999754 44677788888875 58999999999876555 7899
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG-----HSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
|+||.+.|+|.+||..+. ++|....+|+..+++||+|||+. +.+++|+|||||++||||.+|+++.|+|||+|
T Consensus 286 Vt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999999876 89999999999999999999963 44678999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCCCCC------ccccHHhHHHHHHHHHhCCCCCC--ccccCcchHHHHHHHh
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVS------AKCDVYSYGVLLMETFTRKRPTD--EMFTGEMSLRRWVKES 721 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~------~~~Dv~s~G~vl~elltg~~p~~--~~~~~~~~~~~~~~~~ 721 (791)
..+.++.........+||.+|||||++.+...- .+.||||+|.|+|||+++...++ ...+-...+..-+..+
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 998876655555558999999999988764422 26899999999999999775442 1112222333333322
Q ss_pred cCCC-hhh-hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 722 LPHG-LTE-VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 722 ~~~~-~~~-~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
..-+ +.+ ++.++.+......+........+.+.+..||++||+-|.|+.=|-+++.++...+.+
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 2211 111 222222222222333334567788999999999999999999999999998776654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=356.88 Aligned_cols=268 Identities=25% Similarity=0.295 Sum_probs=210.9
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC--CeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP--DFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 574 (791)
.+.|+.+++||+|+||.||+|+. .+|+.||+|.+..+. .+......+|+.+|++++||||+++.+...+. ...|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 46788889999999999999985 589999999887654 44556678899999999999999999998766 78999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
|||||++ ||.-++......++..++..++.|++.||+||| +++|+|||||.+|||+|.+|.+||+|||+|+++..
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH----~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH----SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh----hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999988 999999988777999999999999999999999 78999999999999999999999999999998865
Q ss_pred CCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC---CChh---
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP---HGLT--- 727 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~--- 727 (791)
... ...+..+.|.+|+|||.+.+ ..|+.++|+||.|||+.||++|++.|.+..+-+. +...++-.-. ..+.
T Consensus 271 ~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ-l~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 271 SGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ-LHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH-HHHHHHHhCCCChhcccccc
Confidence 443 34677789999999997655 6799999999999999999999999876433211 1111111110 0011
Q ss_pred ----hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 ----EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ----~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+.+.-.....-.......+...++|+..+|..||++|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 01111000000001112345567789999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=325.30 Aligned_cols=264 Identities=26% Similarity=0.373 Sum_probs=209.3
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++|...+.+|+|.||+||+|+. ++|+.||||.++... ........+|++.++.++||||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4678889999999999999985 589999999987543 2234567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
||+. +|...++.....+...++..++.++.+|++||| .+.|+|||+||.|+|++++|.+||+|||+|+.+.....
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H----~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH----SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH----hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9976 999999988888999999999999999999999 77899999999999999999999999999999876554
Q ss_pred cceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHH--Hhc----CCCh---h
Q 003855 658 SVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK--ESL----PHGL---T 727 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~--~~~----~~~~---~ 727 (791)
.... .+.|.+|+|||.+.+ ..|+..+||||.|||+.||+-|.+-|.+ +.++.+... ... ++.+ .
T Consensus 157 ~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG----~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 157 IQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG----DSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred cccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC----CchHHHHHHHHHHcCCCCcccCcccc
Confidence 4333 378999999998766 5699999999999999999998876554 333333321 111 1111 1
Q ss_pred hhcchhhhhhHHh---hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 728 EVVDANLVREEQA---FSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 728 ~~~d~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..-|......... ......++..+.+++..++..||.+|+++.|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111111110000 00112355677999999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=354.77 Aligned_cols=266 Identities=24% Similarity=0.294 Sum_probs=209.5
Q ss_pred HHhhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHH-HHHHHHHHHHHhcc-CCccceeeeeeccCC-eee
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAF-RSFDSECEVLRNVR-HRNLIKILSSCSNPD-FKA 573 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~ 573 (791)
...++|.+.++||.|+||.||+|+- .+|..||||.++....... ..=.+|+..++++. ||||+++.+.+.+.+ ..+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3568899999999999999999985 4789999999876543321 23467999999998 999999999998887 999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+|||||+. +|.+.++.+++.+++..+..|++||++||+|+| .+|+.|||+||+|||+.....+||+|||+||.+.
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH----k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH----KHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH----hcCcccccCChhheEecccceeEecccccccccc
Confidence 99999965 999999998889999999999999999999999 7899999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccCCCcc-CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHH--hcCC----Ch
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE--SLPH----GL 726 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~--~~~~----~~ 726 (791)
... ..+..+.|++|+|||++ +.+.|+.+.||||+|||++|+.+-++-|.+. ....+.++- .+.. .+
T Consensus 162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~----sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA----SEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC----cHHHHHHHHHHHhCCCccccc
Confidence 544 34456789999999965 6788999999999999999999999887653 222222221 1111 01
Q ss_pred hh------hcchhhhhhHH-h-hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 727 TE------VVDANLVREEQ-A-FSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 727 ~~------~~d~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.+ .+.-.+..-.. . ......++.+..+++.+|+.+||.+||||.|+++.
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 10 00000000000 0 00112367888999999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=341.15 Aligned_cols=261 Identities=25% Similarity=0.322 Sum_probs=214.0
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|+..+.||.|..++||+|+. ..++.||||++..+. ....+.+.+|+..|+.++||||++.+..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 36799999999999999999984 578999999998665 3446889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 578 FMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 578 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||.+||+.+.+... ...+++..+..|.+++++||.||| .+|.+|||||+.|||++++|.|||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH----~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH----QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH----hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999853 344899999999999999999999 6899999999999999999999999999987765544
Q ss_pred Ccc-ee-ecccccccccCCCccCC--CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 657 DSV-TQ-TMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 657 ~~~-~~-~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
... .. ...+||+.|||||++.. ..|+.|+|||||||+..|+.+|..||....+..+.+... +...+.-.....+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLTSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCcccccCCh
Confidence 221 12 44589999999998543 569999999999999999999999998876655444332 22222111112221
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+........+.+++..|+..||++|||++++++
T Consensus 260 ---------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 260 ---------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ---------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 122234567889999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=346.14 Aligned_cols=256 Identities=28% Similarity=0.391 Sum_probs=204.0
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCC--eeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD--FKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 577 (791)
.+|...+.||+|+||.||.+... +|+..|||..........+.+.+|+.+|++++|||||+.+|...... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45778889999999999999975 58999999987664444677899999999999999999999855444 5889999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-CCcEEEeeeccccccCC-C
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-NMAAHVSDFGISKLLGE-G 655 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla~~~~~-~ 655 (791)
|+++|+|.+++...+..+++..+..+++||++||+||| +++||||||||+|||++. ++.+||+|||++..... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH----s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH----SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999977656999999999999999999999 789999999999999999 79999999999987653 1
Q ss_pred CCcceeecccccccccCCCccCCCC-CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
..........||+.|||||++..+. ...++||||+||++.||+||++||...... ..++-...... ..+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~----~~~~~~ig~~~----~~P-- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE----AEALLLIGRED----SLP-- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch----HHHHHHHhccC----CCC--
Confidence 1122233457999999999998543 445999999999999999999999864111 11111110000 000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
.-+...+.+..+++.+|+..+|++||||.++++.--
T Consensus 243 -------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 -------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred -------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111235567789999999999999999999987643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=365.04 Aligned_cols=261 Identities=27% Similarity=0.423 Sum_probs=214.5
Q ss_pred hhccccccccCCCcceEEEEEEecC--C---cEEEEEEeehh---hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISD--G---TDVAIKIFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 571 (791)
.++....++||+|+||.||+|++.. + ..||||..+.+ .+.+..++.+|+++|++++|||||+++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455566899999999999998652 2 23899998753 36778899999999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++|||+|.||+|.++|++.+..++..++..++.+.|.||+||| +++++||||.++|+|++.++.+||+|||+++.
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh----~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH----SKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH----HCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999999988777999999999999999999999 78899999999999999999999999999875
Q ss_pred cCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
-. ..........-+..|+|||.+..+.|++++|||||||++||+++ |..||.+.... ....++.
T Consensus 312 ~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~----------- 376 (474)
T KOG0194|consen 312 GS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIV----------- 376 (474)
T ss_pred Cc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHH-----------
Confidence 42 11111112235689999999999999999999999999999999 88899875332 2233321
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhc
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~ 784 (791)
......+.+...+.++..++.+||..+|++||+|.++.+.++.+.....
T Consensus 377 -----~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 377 -----KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -----hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1111112222456778899999999999999999999999999877654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=350.84 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=210.8
Q ss_pred HHHhhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCe
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDF 571 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 571 (791)
.....+|...+.||+|+|++|++|+. .+++.||||++.+.- +...+-+..|..+|.+| .||.|++++..|.|...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34557899999999999999999985 479999999987542 33345677899999999 89999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.|+|+||+++|+|.++|++-+. +++.....++.+|+.||+||| +.|||||||||+|||+|+||+++|+|||.|+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH----~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH----SNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999999998765 889999999999999999999 88999999999999999999999999999998
Q ss_pred cCCCCCc---------ce--eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHH
Q 003855 652 LGEGEDS---------VT--QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 720 (791)
Q Consensus 652 ~~~~~~~---------~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 720 (791)
+.+.... .. ....+||..|.+||++.++..++.+|+|+||||+|.|+.|++||.+..+ -...+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--yliFq---- 297 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--YLIFQ---- 297 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--HHHHH----
Confidence 8653222 11 1447899999999999999999999999999999999999999976321 11111
Q ss_pred hcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 721 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 721 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.+..-.. .-+...++.+.+|+.+.|..||.+|+|..||.+.
T Consensus 298 ------------kI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 ------------KIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ------------HHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111111 1122455778899999999999999999888763
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=335.09 Aligned_cols=280 Identities=25% Similarity=0.385 Sum_probs=222.4
Q ss_pred CCCCChhHHHHHhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHh--ccCCccceeeee
Q 003855 488 WRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRN--VRHRNLIKILSS 565 (791)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~ 565 (791)
....|+...+....+....+.||+|.||+||+|+| .|+.||||+|....+ +.+.+|.++++. ++|+||+.++++
T Consensus 198 GSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaa 273 (513)
T KOG2052|consen 198 GSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAA 273 (513)
T ss_pred CCCchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhc
Confidence 34566777888889999999999999999999999 589999999975543 456667777776 499999999987
Q ss_pred eccC----CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHc----cCCCCCeEecCCCCCCeEeCC
Q 003855 566 CSNP----DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH----GHSSAPIIHCDLKPTNILLDE 637 (791)
Q Consensus 566 ~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~----~~~~~~i~H~dlk~~Nill~~ 637 (791)
-..+ ...++|.+|.+.|||.|||.... ++.....+++..+|.||+|||. ...++.|+|||||+.||||..
T Consensus 274 D~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 274 DNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred cccCCCceEEEEEeeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 6433 35789999999999999998744 8999999999999999999993 123667999999999999999
Q ss_pred CCcEEEeeeccccccCCCCC--cceeecccccccccCCCccCCCCCC------ccccHHhHHHHHHHHHhCC--------
Q 003855 638 NMAAHVSDFGISKLLGEGED--SVTQTMTMATIGYMAPEYGSEGIVS------AKCDVYSYGVLLMETFTRK-------- 701 (791)
Q Consensus 638 ~~~~kl~Dfgla~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~------~~~Dv~s~G~vl~elltg~-------- 701 (791)
++.+.|+|+|+|........ .......+||.+|||||++...... ..+||||||.|+||+..+.
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 99999999999987655422 2344557899999999987664321 2599999999999998743
Q ss_pred --CCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 702 --RPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 702 --~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
.||.+..+.+.++.+.. +-+..+.+.....+.+....+...+.++|+.||..+|+-|.|+-.+.++|.++
T Consensus 432 y~~Pyyd~Vp~DPs~eeMr--------kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPSFEEMR--------KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred hcCCcccCCCCCCCHHHHh--------cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 57776666555544421 22333333333334455556778899999999999999999999999999998
Q ss_pred HH
Q 003855 780 KV 781 (791)
Q Consensus 780 ~~ 781 (791)
..
T Consensus 504 ~~ 505 (513)
T KOG2052|consen 504 SN 505 (513)
T ss_pred hc
Confidence 64
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.88 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=210.6
Q ss_pred hccccccccCCCcceEEEEEE-ecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
..|....+||+|+.|.||.|+ ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+..|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 457777899999999999997 4578999999998776666678899999999999999999999999899999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
+||+|.+.+.... +++.++..|++++++||+||| ..+|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH----~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH----ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH----hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 9999999987654 899999999999999999999 78999999999999999999999999999988765443
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
....-+||+.|||||+.....|++|+||||+|++++||+.|++||-. |..++..+.- ...+. +
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLI-a~ng~-----P------- 487 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLI-ATNGT-----P------- 487 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHH-hhcCC-----C-------
Confidence 34456899999999999999999999999999999999999999864 2222222110 00010 0
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
....+...+..+.+++.+||+.||++||+++|+++
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 11122345677899999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=361.52 Aligned_cols=261 Identities=26% Similarity=0.438 Sum_probs=206.4
Q ss_pred HhhccccccccCCCcceEEEEEEe------cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccC-
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTI------SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNP- 569 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 569 (791)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346899999999999999999974 235689999986543 33456788999999999 899999999988764
Q ss_pred CeeeEEEecCCCCCHHHHHhhCC---------------------------------------------------------
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHN--------------------------------------------------------- 592 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 592 (791)
...++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 45789999999999999997431
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccc
Q 003855 593 ----YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668 (791)
Q Consensus 593 ----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~ 668 (791)
..+++.++..++.||++||+||| +.+|+||||||+||++++++.+||+|||+++...............++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 23678888999999999999999 6789999999999999999999999999998764433322233344678
Q ss_pred cccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHH
Q 003855 669 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDC 747 (791)
Q Consensus 669 ~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 747 (791)
.|+|||++.+..++.++|||||||++|||++ |..||......+ .+...+.. .. ....+..+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~----~~-------------~~~~~~~~ 302 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKD----GT-------------RMRAPENA 302 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhc----CC-------------CCCCCCCC
Confidence 8999999988899999999999999999997 999987632221 11111110 00 00011234
Q ss_pred HHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 748 ILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 748 ~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=349.81 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=209.4
Q ss_pred CCChhHHHHHhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccC
Q 003855 490 RTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNP 569 (791)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 569 (791)
..||+++. ..+-+|.|+.|.||.|+++ ++.||||+++. .-+.+++-|++++||||+.|.|+|...
T Consensus 120 eiPFe~Is-------ELeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 120 EIPFEEIS-------ELEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred cCCHHHhh-------hhhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCC
Confidence 45665543 3568999999999999994 68899997642 224578899999999999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
..++||||||..|-|...|+.... +.......+..+||.|+.||| .+.|||||||.-||||+.+..|||+|||.+
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~~-itp~llv~Wsk~IA~GM~YLH----~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLH----LHKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred ceeEEeeeccccccHHHHHhccCc-cCHHHHHHHHHHhhhhhHHHH----HhhHhhhccCCCceEeeccceEEeccccch
Confidence 999999999999999999987654 777788899999999999999 667999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV 729 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
+...+. .+.-..+||..|||||++.....++|+||||||||||||+||..||.+...... +-.
T Consensus 260 ~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----IwG--------- 322 (904)
T KOG4721|consen 260 KELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IWG--------- 322 (904)
T ss_pred Hhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----EEe---------
Confidence 877543 223346799999999999999999999999999999999999999976322110 000
Q ss_pred cchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhc
Q 003855 730 VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784 (791)
Q Consensus 730 ~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~ 784 (791)
+ -......+-+..|++.+.-|+++||+..|..||+|.+++..|.-.....+
T Consensus 323 V----GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 323 V----GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred c----cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 0 00111234566899999999999999999999999999999877655443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=344.05 Aligned_cols=246 Identities=29% Similarity=0.427 Sum_probs=209.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++|.+.+.||+|.||+||||+.+ +.+.||+|.+.+.. ++..+.+.+|+++++.++||||+.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 67888999999999999999865 78899999987654 4556789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+.| +|..++...+. ++++.+..++.++..||.||| +.+|+|||+||+|||++..|.+|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh----s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH----SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-- 153 (808)
T ss_pred hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH----hcCcccccCCcceeeecCCCceeechhhhhhhcccC--
Confidence 9976 99999987665 999999999999999999999 788999999999999999999999999999987553
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
....+...||+-|||||...++.|+..+|.||+|||+||+++|++||-. .++.+.++....+..
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~~d~v----------- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSILKDPV----------- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHhcCCC-----------
Confidence 2334456799999999999999999999999999999999999999854 123333333222211
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+...+..+..++...+..||..|.+..+++.
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 111245567889999999999999999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=323.94 Aligned_cols=266 Identities=24% Similarity=0.321 Sum_probs=205.7
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhH--HHHHHHHHHHHHHhccCCccceeeeeec--cCCeee
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLER--AFRSFDSECEVLRNVRHRNLIKILSSCS--NPDFKA 573 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~ 573 (791)
..++|+..+.|++|+||.||+|+.+ +++.||+|+++.+.+. ..-...+|+.++.+.+|||||.+-.+.. +-+..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 4578999999999999999999975 7899999999866532 2234578999999999999999988764 346799
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+|||||+. ||...+..-+..+...++..++.|+++|++||| ...|+|||||++|+|+...|.+||+|||+||.++
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH----~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH----DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh----hceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 99999988 999999988777999999999999999999999 6789999999999999999999999999999987
Q ss_pred CCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc--C-C----C
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL--P-H----G 725 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--~-~----~ 725 (791)
... ...+..+.|.+|+|||.+.+ ..|++..|+||+|||+.|++++++-|.+. ++.+..+-+-... + + +
T Consensus 229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~--sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK--SEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC--chHHHHHHHHHHhCCCccccCCC
Confidence 653 34556678999999997765 56999999999999999999999888763 2222222221111 0 0 1
Q ss_pred hhhh--cc-hhhhhhH-----HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 726 LTEV--VD-ANLVREE-----QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 726 ~~~~--~d-~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+. +. ..+.... ..+... .....-++++...+..||++|.|+.|.++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~-~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGAL-SLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccccchhhccccCCCCchhhhhhcccc-ccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1100 00 0000000 011111 13356779999999999999999999875
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.30 Aligned_cols=248 Identities=27% Similarity=0.372 Sum_probs=208.4
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
..|...+.||+|.||.||+|... +++.||+|++.... +...+++++|+.++.+++++||.+.+|.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666789999999999999964 78999999997654 55678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
|.||++.+.++.... +++..+.-|++++..|+.|+| ..+.+|||||+.||++..+|.||++|||.+..+.....
T Consensus 93 ~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH----~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~- 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH----SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK- 166 (467)
T ss_pred hcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh----hcceecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence 999999999986543 478888889999999999999 67899999999999999999999999999987755432
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
.....+||+.|||||++....|+.|+||||+|++.+||++|.+|+....+.... . .+++.....+
T Consensus 167 -rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl--f----lIpk~~PP~L-------- 231 (467)
T KOG0201|consen 167 -RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL--F----LIPKSAPPRL-------- 231 (467)
T ss_pred -ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE--E----eccCCCCCcc--------
Confidence 225578999999999999889999999999999999999999999876553211 0 0111111111
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+++.+.+++..|++.||++||+|+++++
T Consensus 232 -----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 -----DGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred -----ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1146677889999999999999999999876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=340.99 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=205.2
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
..++|+.++.||+|+||.||.|+-+ +|..+|+|++++.. ..+.+.+..|-.+|...++|+||+++..|.+.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4689999999999999999999854 79999999998764 5667888999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||++|||+..+|...+. +++.....++.+++-|++-+| ..|++||||||+|+|||..|++||+|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH----~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH----QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH----HcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999987665 888888899999999999999 78999999999999999999999999999953211
Q ss_pred ----------------------CCCc----ce-------------------eecccccccccCCCccCCCCCCccccHHh
Q 003855 655 ----------------------GEDS----VT-------------------QTMTMATIGYMAPEYGSEGIVSAKCDVYS 689 (791)
Q Consensus 655 ----------------------~~~~----~~-------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s 689 (791)
.+.. .. ....+|||.|||||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 00 01247999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCccccCcc--hHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC
Q 003855 690 YGVLLMETFTRKRPTDEMFTGEM--SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRI 767 (791)
Q Consensus 690 ~G~vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 767 (791)
+|||+|||+.|.+||....+.+. .+..|... -.++....+..+..++|.+|+. ||++|.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~------------------l~fP~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRET------------------LKFPEEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh------------------ccCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence 99999999999999976433221 12222111 1122223445778899999999 999998
Q ss_pred C---HHHHH
Q 003855 768 N---VTDAA 773 (791)
Q Consensus 768 t---~~ev~ 773 (791)
. +.||.
T Consensus 435 G~~G~~EIK 443 (550)
T KOG0605|consen 435 GSKGAEEIK 443 (550)
T ss_pred CcccHHHHh
Confidence 6 55554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=315.57 Aligned_cols=237 Identities=27% Similarity=0.325 Sum_probs=199.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|+..+.+|.|+||.|..++.+ +|..+|+|++++.. -++.+....|..+++.+.||+++++++.+.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 467889999999999999999976 68899999998764 35567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||++||.|.+++++.++ +++....-+|.+|+.|++||| +..|++||+||+|||+|.+|.+||+|||+|+.....
T Consensus 123 meyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH----~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH----SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH----hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999998765 788889999999999999999 788999999999999999999999999999876432
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
....+||+.|+|||++....|..++|+|||||++|||+.|.+||....+ ...+.+.+..
T Consensus 198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~--------------- 256 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEG--------------- 256 (355)
T ss_pred -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhC---------------
Confidence 3346899999999999999999999999999999999999999976432 1111111111
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCC
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMR 766 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 766 (791)
...+ +...+..+.+++...++.|-.+|
T Consensus 257 --~v~f--P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 --KVKF--PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cccC--CcccCHHHHHHHHHHHhhhhHhh
Confidence 0011 11234566788888888888887
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=347.85 Aligned_cols=256 Identities=27% Similarity=0.348 Sum_probs=207.7
Q ss_pred HHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehh----hh-HHHHHHHHHHHHHHhcc-CCccceeeeeeccCC
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ----LE-RAFRSFDSECEVLRNVR-HRNLIKILSSCSNPD 570 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 570 (791)
.....|...+.||+|+||.|+.|... +++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++..+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999999999999854 7899999987654 12 23456678999999998 999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC-CcEEEeeeccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN-MAAHVSDFGIS 649 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfgla 649 (791)
..++||||+.||+|.+++.+ ...+.+.+..++++|++.|++||| +++|+||||||+||+++.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H----~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH----SRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999998 445888999999999999999999 7899999999999999999 99999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCCC-CC-ccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGI-VS-AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++... .........
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~l~~ki~~---- 237 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PNLYRKIRK---- 237 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HHHHHHHhc----
Confidence 9873 1122334568999999999998877 75 789999999999999999999987211 111111000
Q ss_pred hhcchhhhhhHHhhHHHHHH-HHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 728 EVVDANLVREEQAFSAKMDC-ILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 728 ~~~d~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
.. ..-+..+ +.++..++.+|+..+|.+|+++.+++ .-.-++.
T Consensus 238 ---------~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 238 ---------GE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred ---------CC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 00 0111122 56678999999999999999999998 5444443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=341.93 Aligned_cols=247 Identities=23% Similarity=0.300 Sum_probs=200.5
Q ss_pred cccCCCcceEEEEEEecCCcEEEEEEeehhhh---HHHHHHHHHHHHHHhccCCccceeeeeecc----CCeeeEEEecC
Q 003855 507 NLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSCSN----PDFKALVLEFM 579 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 579 (791)
..||+|++|.||+|.+ +|+.||||++..... ...+.+.+|+.++++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 689999999875432 235678899999999999999999999866 34678999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++|+|.+++.+.. .+++....+++.+++.|+.|||. ..+++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~---~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYK---YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHh---cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 9999999998654 48899999999999999999993 2368899999999999999999999999998654321
Q ss_pred eeecccccccccCCCccCC--CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 660 TQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+.........
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-----~~~~~i~~~~~----------- 239 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-----EIYDLIINKNN----------- 239 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhcCC-----------
Confidence 22457889999999876 67999999999999999999999999763211 11111110000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
....+..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 240 --~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 --SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred --CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 001112456778899999999999999999999999998854
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.42 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=216.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.+..+.++||-|.||.||.|.|+ -.-.||||.++.+.. ..++|.+|+.+|+.++|||+|+++|+|..+...|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 35567789999999999999986 456799999876543 3578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
..|+|.+||+... ..++..-.+.+|.||+.|++||. .+.+|||||.++|+||.++..||++|||+++.+..+. +
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE----kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-Y 420 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-Y 420 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH----HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-e
Confidence 9999999999543 34666778899999999999999 6789999999999999999999999999999986443 3
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
..+....-++.|.|||-+....++.|+|||+|||++||+.| |..||.+.. +.+. ..+.+.
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lSqV--------------Y~LLEk 481 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQV--------------YGLLEK 481 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HHHH--------------HHHHhc
Confidence 33333344678999999999999999999999999999999 788987632 2221 123444
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
+.+...++.|+++++++|+.||+++|++||+|.|+-+.++.+-.
T Consensus 482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 45566777999999999999999999999999999999988743
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=341.33 Aligned_cols=263 Identities=25% Similarity=0.395 Sum_probs=219.0
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhh-HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
+...+.++||+|.||+|..+....+..||||+++.... ....+|.+|+++|.+++||||++++|+|..++..++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 44567889999999999999998889999999987764 34588999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++|+|.+|+.++..+ .....-.+|+.|||.|++||. +.++||||+.++|+|+|.++++||+|||++|.+..++.+
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe----s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE----SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH----hhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999987443 355667789999999999999 788999999999999999999999999999988888877
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh--CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
......+-+.+|||||.+.-+++|.++|||+||+++||+++ ...||....+.. ..+-.....+..-
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~---------- 761 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQG---------- 761 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCC----------
Confidence 77777778899999999999999999999999999999886 778987643221 1111111111110
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
.....+.+.-|+.+++++|.+||+.+-++||+|+++...|.+.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 0011233456889999999999999999999999998887653
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=342.98 Aligned_cols=258 Identities=24% Similarity=0.408 Sum_probs=219.1
Q ss_pred hccccccccCCCcceEEEEEEec---CC--cEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS---DG--TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~---~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
+.....+.||.|.||.||+|.+. .| -.||||..+.+. .+..+.|.+|..+|++++||||++++|.|.+ ...++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 44455678999999999999863 23 358899887643 4457789999999999999999999999975 45789
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
|||.++.|.|..|++.++..++......++.||+.||+||| +.+.|||||.++||||.+...||++|||++|.+..
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe----SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE----SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH----hhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999999998888999999999999999999999 78899999999999999999999999999999876
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
...+... ...-++.|||||.+....++.++|||-|||.+||++. |..||.+....+. +-
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------------I~-- 603 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------------IG-- 603 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------------EE--
Confidence 6554433 3445788999999999999999999999999999997 9999987543321 11
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
..+.+.+.+.+..||+.++.++.+||..+|.+||++.|++..|..+....
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 12233456777789999999999999999999999999999999887643
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.59 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=203.2
Q ss_pred hccccccccCCCcceEEEEEEecC-----------------CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCcccee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISD-----------------GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKI 562 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l 562 (791)
++|+..+.||+|+||.||+|.+++ +..||+|++.... ......+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999997532 3469999987543 3345678999999999999999999
Q ss_pred eeeeccCCeeeEEEecCCCCCHHHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeE
Q 003855 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHN------------------YFLDILERLNIMIDVGSALEYLHHGHSSAPII 624 (791)
Q Consensus 563 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~ 624 (791)
++++.+.+..++||||+++|+|.+++.... ..+++..+.+++.||+.||+||| +.+|+
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~iv 160 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS----SLNFV 160 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH----HCCcc
Confidence 999999899999999999999999986431 23678889999999999999999 67899
Q ss_pred ecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh--CCC
Q 003855 625 HCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKR 702 (791)
Q Consensus 625 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~ 702 (791)
||||||+||++++++.+||+|||+++...............++..|+|||+...+.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999987654433222333456788999999888889999999999999999997 456
Q ss_pred CCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 703 PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 703 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
||...... .....+........... ....+..++..+.+++.+||+.||++|||+.||.+.|+
T Consensus 241 p~~~~~~~--~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE--QVIENAGEFFRDQGRQV----------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH--HHHHHHHHHhhhccccc----------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76643211 11111111111000000 00011235677899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=352.93 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=205.3
Q ss_pred hhccccccccCCCcceEEEEEEe------cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI------SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 571 (791)
.++|+..+.||+|+||.||+|++ .++..||||+++... ....+.+.+|+.+++.+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35788999999999999999973 246689999986443 33446788999999999 89999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCC-----------------------------------------------------------
Q 003855 572 KALVLEFMPNGSLEKWLYSHN----------------------------------------------------------- 592 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 592 (791)
.++||||+++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999997432
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 593 ---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 593 ---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
..+++..+.+++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA----SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 14688899999999999999999 67899999999999999999999999999987654332
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
........++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....+++......
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~------------ 336 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYRM------------ 336 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCccC------------
Confidence 222222345678999999999999999999999999999998 88888653221 1222222211100
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
..+...+.++.+++.+||+.||++||++.|+++.|++.
T Consensus 337 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 -----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00112345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.35 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=205.7
Q ss_pred hhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 571 (791)
.++|++.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+.+++.+ +||||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457999999999999999998742 34579999987543 33456788999999999 89999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCC-----------------------------------------------------------
Q 003855 572 KALVLEFMPNGSLEKWLYSHN----------------------------------------------------------- 592 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 592 (791)
.++||||+++|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999986421
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceee
Q 003855 593 ----------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT 662 (791)
Q Consensus 593 ----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 662 (791)
..+++.++.+++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++.+..........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA----SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 23678889999999999999999 6799999999999999999999999999998764432222222
Q ss_pred cccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 663 MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 663 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
...++..|+|||++.+..++.++|||||||++|||++ |+.||....... .....+......
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~----------------- 334 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQM----------------- 334 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCc-----------------
Confidence 2335678999999988899999999999999999997 999987643221 111111110000
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
..+...+.++.+++.+||+.||++||++.++++.|+++.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 001123466889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=333.48 Aligned_cols=256 Identities=22% Similarity=0.361 Sum_probs=206.6
Q ss_pred hhccccccccCCCcceEEEEEEec----CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|.++ .+..||+|+++... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357889999999999999999853 46689999987653 3345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++......+++.++..++.|++.||+||| +.+++||||||+||+++.++.++++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS----EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999999876666899999999999999999999 67899999999999999999999999998765422
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
... .......++..|+|||+..+..++.++|||||||++||+++ |+.||...... ...+.+.. ..
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~----~~------- 225 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVED----GF------- 225 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHC----CC-------
Confidence 111 11112235678999999988999999999999999999875 99999753221 11111110 00
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
..+.+..++..+.+++.+||+.+|++||++.|+.+.|+++
T Consensus 226 ------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0111234567788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=345.64 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=203.2
Q ss_pred HHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCee
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 572 (791)
...++|...++||+|.||.|+.+..+ +++.+|||++++.. .+..+....|.+++... +||+++.++.+|..+++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999976 78899999998764 55677888899998887 599999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||+.||++..+ .+...+++..+.-++..|+.||.||| .++|||||||.+|||+|.+|.+||+|||+++.-
T Consensus 445 ~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH----~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLH----ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHH----hcCceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999994333 33344899999999999999999999 789999999999999999999999999999863
Q ss_pred CCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
-- .....+..+||+.|||||++.+..|+.++|+|||||+||||+.|..||.+. .|..+ +|.
T Consensus 519 m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEee~---------------Fds 579 (694)
T KOG0694|consen 519 MG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--DEEEV---------------FDS 579 (694)
T ss_pred CC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--CHHHH---------------HHH
Confidence 21 122445578999999999999999999999999999999999999999863 22222 222
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINV 769 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 769 (791)
-+..+. ..+..++.+..+++.+++..+|++|..+
T Consensus 580 I~~d~~---~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDEV---RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCCC---CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 222111 1233566788899999999999999977
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=317.43 Aligned_cols=268 Identities=25% Similarity=0.279 Sum_probs=205.0
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehh--hhHHHHHHHHHHHHHHhccCCccceeeeeecc-----CC
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSN-----PD 570 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 570 (791)
....|...+.||+|+||.|+.|..+ +|+.||||.+... ..-..+...+|+.+++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999865 7899999988733 23345667889999999999999999998854 46
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..|+|+|+| ..+|.+.++++.. ++......+++|+++||.|+| +.+|+|||+||+|++++.+...||+|||+|+
T Consensus 100 DvYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH----SAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH----SANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh----cccccccccchhheeeccCCCEEecccccee
Confidence 789999999 5599999886654 888899999999999999999 7899999999999999999999999999999
Q ss_pred ccCCCCCcceeecccccccccCCCcc-CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC----
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---- 725 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 725 (791)
...........+..+.|.+|+|||.+ ....|+...||||.|||+.||++|++-|.+.. ....-+.+....+..
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d--~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD--YVHQLQLILELLGTPSEED 251 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc--hHHHHHHHHHhcCCCCHHH
Confidence 88654333344566889999999975 55789999999999999999999999887632 112222222222221
Q ss_pred hhhhcchhhhh----hH----Hh-hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 726 LTEVVDANLVR----EE----QA-FSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 726 ~~~~~d~~~~~----~~----~~-~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+..+-...... .+ .. ......+.+...+++.+|+..||.+|+|++|+++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111000000 00 00 0111245577889999999999999999999986
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=336.77 Aligned_cols=249 Identities=34% Similarity=0.543 Sum_probs=196.6
Q ss_pred cccccCCCcceEEEEEEec-----CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 505 ECNLLGTGSFGSVYKGTIS-----DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 505 ~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
..+.||.|.||.||+|.+. .+..|+||++.... .+..+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999986 36789999996543 34478899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.+++... ...+++..+.+|+.||++||.||| +.+++|+||+++||++++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh----~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH----SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH----HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999987 556899999999999999999999 56899999999999999999999999999988743333
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
............|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--~~~~~~~~---------------- 220 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--EIIEKLKQ---------------- 220 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--HHHHHHHT----------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccc----------------
Confidence 333334457789999999988889999999999999999999 67888654111 11111110
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
......+..++..+.+++.+||+.+|++||+|.+++++|
T Consensus 221 -~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 -GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 001111224567788999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=347.04 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=206.7
Q ss_pred hhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhcc-CCccceeeeeeccCCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 571 (791)
.++|++.+.||+|+||.||+|+.. .+..||||++.... ....+.+..|+.+++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467889999999999999999852 23469999986543 334567899999999996 9999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCC-----------------------------------------------------------
Q 003855 572 KALVLEFMPNGSLEKWLYSHN----------------------------------------------------------- 592 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 592 (791)
.++||||+++|+|.++++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999987421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC
Q 003855 593 ------------------------------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD 636 (791)
Q Consensus 593 ------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~ 636 (791)
..+++..+..++.|+++||+||| +.+|+||||||+||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dikp~Nill~ 271 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA----SKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHhEEEe
Confidence 23678888999999999999999 67899999999999999
Q ss_pred CCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHH
Q 003855 637 ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLR 715 (791)
Q Consensus 637 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~ 715 (791)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........ ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HH
Confidence 999999999999987644332222233456788999999988899999999999999999997 8999875322111 11
Q ss_pred HHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 716 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
..+.. .. ....+..++..+.+++.+||+.+|++||++.++.++|+++.
T Consensus 351 ~~~~~----~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 NKIKS----GY-------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHhc----CC-------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11110 00 00111245677889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.15 Aligned_cols=249 Identities=24% Similarity=0.307 Sum_probs=200.5
Q ss_pred cccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 503 FNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++|++|+++.+++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999986 479999999987543 22334678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||+++......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ----RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999999888643 335899999999999999999999 7789999999999999999999999999998754322
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ... +.......
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~-~~~~~~~~------------ 220 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REE-VDRRVKED------------ 220 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHH-HHHHhhcc------------
Confidence 12334689999999999999999999999999999999999999976332111 011 11000000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRIN-----VTDAAA 774 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~ev~~ 774 (791)
........+..+.+++.+||+.||++||+ +.++++
T Consensus 221 --~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 --QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00111234567789999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.85 Aligned_cols=255 Identities=25% Similarity=0.439 Sum_probs=219.0
Q ss_pred cccccccCCCcceEEEEEEe-cCC----cEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 503 FNECNLLGTGSFGSVYKGTI-SDG----TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.+..++||+|+||+||+|.| ..| .+||+|++.... .+...++..|+.+|.+++|||+++++|+|.... +.+|+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 44567999999999999986 333 468999886553 445678999999999999999999999998766 88999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
+||+.|+|.+|++.++..+.....+.+..|||+||.||| .+++|||||.++||||.+...+||.|||+|+.+..++
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe----~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE----EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999999988888999999999999999999999 7789999999999999999999999999999988776
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.......-.-.+.|||-|.+....|+.++|||||||++||++| |..||++....+. +.+.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-------------------~dll 913 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-------------------PDLL 913 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------------------hHHH
Confidence 6555544455788999999999999999999999999999999 9999987433221 1223
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
+.+.+.+.+..|+..+..++.+||..|+..||+|+++..++.++.+
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 3333456677899999999999999999999999999999988754
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=339.35 Aligned_cols=258 Identities=25% Similarity=0.436 Sum_probs=207.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCc----EEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGT----DVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.+|+..+.||+|+||.||+|++. +++ .||+|++.... ....+.+..|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56899999999999999999864 333 48999986443 34456788999999999999999999999765 5679
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
|+||+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999999987666899999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
...........++..|+|||++.+..++.++|||||||++|||++ |+.||++.... .....+....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~----------- 228 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE----------- 228 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCCC-----------
Confidence 433222222334678999999999999999999999999999998 99998753211 1111111100
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+.+..++..+.+++.+||..+|++||++.++++.+..+.+.
T Consensus 229 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 229 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0011123445678999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.36 Aligned_cols=255 Identities=26% Similarity=0.498 Sum_probs=207.6
Q ss_pred hccccccccCCCcceEEEEEEecC------CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISD------GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 578889999999999999998642 2579999886543 334567889999999999999999999999888999
Q ss_pred EEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC
Q 003855 574 LVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN 638 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~ 638 (791)
++|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS----SHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccccceEEEcCC
Confidence 9999999999999997531 34788899999999999999999 6789999999999999999
Q ss_pred CcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHH
Q 003855 639 MAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRW 717 (791)
Q Consensus 639 ~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 717 (791)
+.++|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.+.... .....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~ 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEM 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence 9999999999986644333223334456788999999988899999999999999999998 99998753221 11111
Q ss_pred HHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 718 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 718 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
+.... ....+..++.++.+++.+||+.||.+||++.||++.|++
T Consensus 239 i~~~~-----------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IRSRQ-----------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCC-----------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11100 001123567889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=334.88 Aligned_cols=245 Identities=25% Similarity=0.319 Sum_probs=200.7
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+|+.. +++.||+|++.... .+..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999975 78999999987543 234567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH----SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999999998654 3888999999999999999999 6789999999999999999999999999998654321
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..+........
T Consensus 156 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~---------- 215 (291)
T cd05612 156 -----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEKILAGKL---------- 215 (291)
T ss_pred -----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCc----------
Confidence 2246899999999998888999999999999999999999999753211 11111100000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRIN-----VTDAAAK 775 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~ev~~~ 775 (791)
..+..++..+.+++.+|++.||.+||+ +.|+++.
T Consensus 216 -----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 001123456789999999999999995 7777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=299.42 Aligned_cols=248 Identities=25% Similarity=0.312 Sum_probs=208.8
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
+.++|++.+.||+|.||.||.|+.+ ++..||+|++.+.. .+...++.+|+++-+.++||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3478999999999999999999965 67889999987653 3445678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 575 VLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
++||..+|++...++.. ...+++.....++.|+|.|+.|+| .++|+||||||+|+|++.++..||+|||.+....
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h----~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH----LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc----cCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999944 335888889999999999999999 7889999999999999999999999999987543
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.......+||..|.|||...+..++.++|+|++|++.||++.|.+||+... ....+.+..+. +..+
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~-------~~~~-- 241 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKV-------DLKF-- 241 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHc-------cccC--
Confidence 223344679999999999999999999999999999999999999998744 22222222111 1111
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+..++.+..++|.+|+..+|.+|.+..|+++
T Consensus 242 ----------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 242 ----------PSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ----------CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1245566789999999999999999999876
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.79 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=206.4
Q ss_pred hccccccccCCCcceEEEEEEec-CCc----EEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGT----DVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
++|+..+.||+|+||.||+|.+. +++ .|++|.+.... ......+..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 57888999999999999999864 444 47788775432 3345677888889999999999999999864 45678
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
++||+++|+|.+++......+++..+..++.||+.||+||| +.+++||||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE----EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999999876667899999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
...........++..|+|||+..++.++.++|||||||++||+++ |+.||.+.... ...+++.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~---------- 229 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEKGER---------- 229 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCc----------
Confidence 433223333456788999999988899999999999999999998 99998754221 12222211000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
.+.+..++..+.+++.+||..+|++||++.|+++.|..+.+..
T Consensus 230 -------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 230 -------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 0011123455678999999999999999999999999986644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=337.12 Aligned_cols=265 Identities=23% Similarity=0.299 Sum_probs=205.8
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+++.. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368999999999999999999975 68899999987653 3345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++|+|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE---KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhh---cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999998654 38899999999999999999993 2369999999999999999999999999997653321
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC------------
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG------------ 725 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 725 (791)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...... .+...+.......
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCccc
Confidence 22346899999999999889999999999999999999999999653221 1111111100000
Q ss_pred -------------------hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 726 -------------------LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 726 -------------------~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..+..+. +............++.++.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDY-IVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccchhHHHHHHH-HHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 000000000011355778999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=327.28 Aligned_cols=257 Identities=26% Similarity=0.454 Sum_probs=208.9
Q ss_pred hhccccccccCCCcceEEEEEEec----CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.++|+..+.||+|+||.||+|+++ +...||||++.... ......+..|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 367889999999999999999874 24579999886543 3445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++......+++..+.+++.|++.|++||| +.+|+||||||+||++++++.++++|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999999876667899999999999999999999 67899999999999999999999999999988752
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
...........++..|+|||...+..++.++||||||+++|||++ |..||...... ...+.+....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~----------- 225 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGY----------- 225 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC-----------
Confidence 222222222335678999999988899999999999999999998 99998653211 1111111100
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
..+.+..++..+.+++.+|++.+|++||++.|+++.|.++
T Consensus 226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=337.92 Aligned_cols=247 Identities=26% Similarity=0.357 Sum_probs=207.0
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.-|+.++.||+|+-|.|..|++ .+|+.+|||++.+.. ......+++|+-+|+-+.|||++++++.+++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577889999999999999996 489999999997653 233456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|-|++++-.++. +++.+..+++.||..|+.|+| ..+|+|||+||+|+|+|..+++||+|||+|..-.++
T Consensus 92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH----~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH----AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh----hhcceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 99999999999987765 788888999999999999999 678999999999999999999999999999764332
Q ss_pred CcceeecccccccccCCCccCCCCCC-ccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVS-AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
......+|++.|.|||++.+..|. .++||||.|||+|.|+||+.||++. .++..... +..
T Consensus 166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LLlK-V~~----------- 226 (786)
T KOG0588|consen 166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLLLK-VQR----------- 226 (786)
T ss_pred --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHHHH-HHc-----------
Confidence 233446899999999999988764 5899999999999999999999852 22222111 111
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
+.+.-+..++.+..+|+++|+..||++|.|+.||.+.
T Consensus 227 ---G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 227 ---GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1222234567788899999999999999999999874
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=298.71 Aligned_cols=263 Identities=22% Similarity=0.286 Sum_probs=210.2
Q ss_pred HhhccccccccCCCcceEEEEEE-ecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccC-----Cee
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNP-----DFK 572 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 572 (791)
..++|++.+.+|+|||+.||.++ ..+++.||+|++.....+..+...+|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34689999999999999999998 568899999999888777788899999999999999999999988543 348
Q ss_pred eEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 573 ALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
|++++|...|+|.+.+.. .+..+++.+++.|+.+|++||.+||.. ..+++||||||.||++.+++.+++.|||.+
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~--~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK--EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc--CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 999999999999999983 345799999999999999999999953 235999999999999999999999999999
Q ss_pred cccCCCCCcc-------eeecccccccccCCCcc---CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHH
Q 003855 650 KLLGEGEDSV-------TQTMTMATIGYMAPEYG---SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 719 (791)
Q Consensus 650 ~~~~~~~~~~-------~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 719 (791)
+...-..... .+....-|.-|+|||.+ .+...++++|||||||++|+|+.|..||+.......++.-
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL--- 253 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL--- 253 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE---
Confidence 7654221111 12223458889999964 3566889999999999999999999999864332222111
Q ss_pred HhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 720 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 720 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
.+....+ ..+....+++.+.+++..|++.||.+||++.+++..+..+
T Consensus 254 --------Av~n~q~-----s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 --------AVQNAQI-----SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --------eeecccc-----ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111111 1122223678889999999999999999999999988765
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=308.07 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=204.7
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.++|++.+.||+|.|+.||++.. .+|+.+|+|++.... ....+.+.+|+++.+.++|||||++.+........|+||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46788889999999999999875 489999999886543 346788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC---CCCcEEEeeeccccccC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD---ENMAAHVSDFGISKLLG 653 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfgla~~~~ 653 (791)
|+|+||+|..-+-++ ..+++..+...++||++||.|+| .++|||||+||+|+++- ...-+|++|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH----~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH----SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997666544 33677888889999999999999 77899999999999995 34469999999999887
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.+. .....+||++|||||+.+..+|+..+|||+.|||+|-++.|..||.+... ...+.+..+. ..+
T Consensus 165 ~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye~I~~g-----~yd----- 230 (355)
T KOG0033|consen 165 DGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYEQIKAG-----AYD----- 230 (355)
T ss_pred Ccc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhcc-----ccC-----
Confidence 332 34457899999999999999999999999999999999999999976211 1111111111 000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+++..++++..+++++|+..||++|.|+.|+++
T Consensus 231 -----~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 -----YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -----CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 011233456678889999999999999999999874
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.66 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=214.8
Q ss_pred ccccccccCCCcceEEEEEEec--CC--cEEEEEEeehhhhH-HHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS--DG--TDVAIKIFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
+....++||+|.||+|++|.|. .| ..||||.+...... ...+|.+|+.+|-+++|||+++++|...+ ...++||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3455678999999999999985 34 35899999876543 67899999999999999999999999987 6678999
Q ss_pred ecCCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 577 EFMPNGSLEKWLYS-HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 577 e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|.++.|+|.+.|++ ....+.......++.|||.||.||. +++.|||||.++|+++-..-.|||+|||+.+-++..
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe----skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE----SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999997 4556788888999999999999999 788999999999999999999999999999998877
Q ss_pred CCcceeec-ccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 656 EDSVTQTM-TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 656 ~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
+..+.+.. ..-.+.|.|||.+....++.++|||+|||++|||+| |+.||-+.... . +-+.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-q-------------IL~~iD-- 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-Q-------------ILKNID-- 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-H-------------HHHhcc--
Confidence 66554332 345678999999999999999999999999999999 78898763211 0 111122
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
+....+.+..|++.+++++.+||...|++||||..+.+.+-...++.
T Consensus 330 ---~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp 376 (1039)
T KOG0199|consen 330 ---AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQP 376 (1039)
T ss_pred ---ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCC
Confidence 22344566789999999999999999999999999987665554443
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.60 Aligned_cols=259 Identities=28% Similarity=0.447 Sum_probs=209.9
Q ss_pred hccccccccCCCcceEEEEEEec------CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+..|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57889999999999999999742 356689999876655566788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEE
Q 003855 575 VLEFMPNGSLEKWLYSHN------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAH 642 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~k 642 (791)
||||+++++|.+++.... ..+++..+..++.|++.||+||| ..+++||||||+||++++++.++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH----~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCCcEE
Confidence 999999999999997442 24899999999999999999999 67899999999999999999999
Q ss_pred EeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHh
Q 003855 643 VSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKES 721 (791)
Q Consensus 643 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 721 (791)
|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+ ....+..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~~- 237 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQ- 237 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc-
Confidence 999999986643332222233345778999999988889999999999999999998 888986532211 1111111
Q ss_pred cCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 722 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 722 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
.... .....++.++.+++.+||+.+|.+|||+.|+.+.|+.+.+.
T Consensus 238 --~~~~--------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 --GRVL--------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred --CCcC--------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 0000 00112445688999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.17 Aligned_cols=244 Identities=26% Similarity=0.288 Sum_probs=200.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 67899999999999999999975 68999999987543 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGR-FPNDVAKFYHAELVLAFEYLH----SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 99999999999986543 788889999999999999999 6789999999999999999999999999998764322
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... . +..........
T Consensus 173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~-~~~~~i~~~~~---------- 232 (329)
T PTZ00263 173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----F-RIYEKILAGRL---------- 232 (329)
T ss_pred -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----H-HHHHHHhcCCc----------
Confidence 124689999999999998899999999999999999999999865211 1 11111110000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRIN-----VTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~ev~~ 774 (791)
..+..++..+.+++.+||+.||++||+ +.|+++
T Consensus 233 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 -----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 001113355779999999999999997 677763
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.79 Aligned_cols=260 Identities=26% Similarity=0.423 Sum_probs=205.8
Q ss_pred hhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeecc-CC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSN-PD 570 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~~ 570 (791)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++.++ +||||++++++|.. ..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357999999999999999999642 35789999987543 23346678899999999 89999999998864 45
Q ss_pred eeeEEEecCCCCCHHHHHhhCC----------------------------------------------------------
Q 003855 571 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 592 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 592 (791)
..++||||+++|+|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6789999999999999986421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccc
Q 003855 593 --YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGY 670 (791)
Q Consensus 593 --~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y 670 (791)
..+++..+.+++.||+.||+||| +.+|+||||||+||++++++.++|+|||+++.+.............++..|
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH----~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 25789999999999999999999 678999999999999999999999999999876443333333334567789
Q ss_pred cCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHH
Q 003855 671 MAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCIL 749 (791)
Q Consensus 671 ~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 749 (791)
+|||++.+..++.++|||||||++|||++ |..||.+....+ .+...+...... ..+..++.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~-----------------~~~~~~~~ 303 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTRM-----------------RAPEYATP 303 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCCC-----------------CCCccCCH
Confidence 99999999999999999999999999998 999987532221 111111110000 00113346
Q ss_pred HHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 750 SIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 750 ~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 68899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=322.35 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=203.2
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
++|+..+.||+|+||.||+|.++++..+|+|.+.... ...+.+..|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 5688899999999999999999888899999876432 223578889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+|+|.++++.....+++..+..++.|++.||+||| ..+++||||||+||++++++.+|++|||.++....... ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE----RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 99999999865556899999999999999999999 67899999999999999999999999999986543221 11
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....++..|+|||+.....++.++||||||+++|||++ |+.||..... ......+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~~--------------- 220 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFRL--------------- 220 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCCC---------------
Confidence 122235668999999988889999999999999999999 8999865321 1111111110000
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
..+...+..+.+++.+||+.+|++||++.|+++.|
T Consensus 221 --~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 --YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00111235678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.10 Aligned_cols=268 Identities=22% Similarity=0.283 Sum_probs=202.1
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 78999999986543 2223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|++ +++.+++......+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH----QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 6899988876666899999999999999999999 6789999999999999999999999999997543221
Q ss_pred cceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC---hhh-----
Q 003855 658 SVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---LTE----- 728 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~----- 728 (791)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.......+........... ...
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 12233467899999998754 55889999999999999999999999764332222222111100000 000
Q ss_pred hcchh-h----hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 VVDAN-L----VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 ~~d~~-~----~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..++. . .............+..+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 0 0000000011123356789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=338.62 Aligned_cols=252 Identities=23% Similarity=0.294 Sum_probs=203.8
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|+.++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999976 68999999997653 234567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH----ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999997654 4788999999999999999999 67899999999999999999999999999986543
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC-Chhhhcchhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH-GLTEVVDANLV 735 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~ 735 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .... +...... ......++
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~-i~~~~~~~~~~~~~~~--- 225 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWEN-LKYWKETLQRPVYDDP--- 225 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHH-HHhccccccCCCCCcc---
Confidence 2223468999999999998899999999999999999999999997532211 1111 1110000 00000000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
...++.++.+++.+|+..+|++||++.|+++.
T Consensus 226 --------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 --------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.32 Aligned_cols=241 Identities=24% Similarity=0.271 Sum_probs=195.8
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNG 582 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 582 (791)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 78999999997643 234456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceee
Q 003855 583 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT 662 (791)
Q Consensus 583 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 662 (791)
+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~ 153 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH----SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 153 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cccc
Confidence 9999998654 4889999999999999999999 6789999999999999999999999999997542221 1223
Q ss_pred cccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhH
Q 003855 663 MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFS 742 (791)
Q Consensus 663 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 742 (791)
..+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+. .... .
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~~~---~~~~---------------~ 213 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELIL---MEEI---------------R 213 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--HHHHHHHH---cCCC---------------C
Confidence 34689999999999999999999999999999999999999965211 11111111 0000 0
Q ss_pred HHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 743 AKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 743 ~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
.+...+.++.+++.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0113456678999999999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=333.75 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=212.9
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCe-eeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF-KALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv 575 (791)
.++|..++++|+|+||.++..+.+ ++..|++|.+.... ....+...+|+.++++++|||||.+.+.|.+.+. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 467899999999999999998865 67899999886543 3445578899999999999999999999988888 9999
Q ss_pred EecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 576 LEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
|+|++||++.+.+.+.+ ..+++..+.+++.|++.|+.||| +..|+|||||+.|||++.++.|||+|||+|+.+.+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH----~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH----ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998654 67899999999999999999999 67899999999999999999999999999999876
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
.. ......+||+.||.||.+.+..|..|+||||+||++|||++-+++|.... ....+....+..
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-----m~~Li~ki~~~~--------- 222 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-----MSELILKINRGL--------- 222 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-----hHHHHHHHhhcc---------
Confidence 54 23344689999999999999999999999999999999999999997632 222222111111
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..+.+..++.++..++..|+..+|+.||++.+++..
T Consensus 223 -----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 123344567888999999999999999999999987
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=323.28 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=198.9
Q ss_pred HHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh--------------HHHHHHHHHHHHHHhccCCcccee
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE--------------RAFRSFDSECEVLRNVRHRNLIKI 562 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l 562 (791)
+..++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999964 799999999965421 113578899999999999999999
Q ss_pred eeeeccC--CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc
Q 003855 563 LSSCSNP--DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA 640 (791)
Q Consensus 563 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~ 640 (791)
+++..++ +..|||+|||..|.+.. .......+...+.++++.++..||+||| ..+|+||||||+|+|++++|+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH----~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLH----YQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEEcCCCc
Confidence 9999765 67899999999988754 2222223889999999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCC---cceeecccccccccCCCccCCCC----CCccccHHhHHHHHHHHHhCCCCCCccccCcch
Q 003855 641 AHVSDFGISKLLGEGED---SVTQTMTMATIGYMAPEYGSEGI----VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS 713 (791)
Q Consensus 641 ~kl~Dfgla~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 713 (791)
|||+|||.+.....+.. .......+||+.|+|||...++. .+.+.||||+||++|.|+.|+.||-+.+ +..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--~~~ 326 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--ELE 326 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--HHH
Confidence 99999999987633211 12223368999999999776632 4568999999999999999999996522 111
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
+.+- ++. +.-.++...+..+.+.++|.++|.+||+.|.+..+|...
T Consensus 327 l~~K-----------Ivn-----~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 327 LFDK-----------IVN-----DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred HHHH-----------Hhc-----CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 1111 111 111122222455778899999999999999999998754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=329.55 Aligned_cols=265 Identities=21% Similarity=0.282 Sum_probs=201.4
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|+..+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57899999999999999999865 78999999986443 22345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++ |+|.+++......+++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH----KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 97 4999999876666889999999999999999999 67899999999999999999999999999976533221
Q ss_pred ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc---CCChhhh-----
Q 003855 659 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL---PHGLTEV----- 729 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~----- 729 (791)
......+++.|+|||++.+ ..++.++||||+||++|||+||+.||......+ .+........ ......+
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhccccchh
Confidence 2233467899999998765 568999999999999999999999997532211 1111111100 0001110
Q ss_pred ----cchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 ----VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 ----~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+...... ........+.++.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~-~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQP-LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCc-hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000 00011123466789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=322.71 Aligned_cols=248 Identities=26% Similarity=0.441 Sum_probs=199.2
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCH
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSL 584 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 584 (791)
+.||+|+||.||+|+.. +++.||+|.+.... .+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 78999999876433 34456788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecc
Q 003855 585 EKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT 664 (791)
Q Consensus 585 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 664 (791)
.+++......+++..+..++.|++.||+||| +.+++||||||+||+++.++.+|++|||++...............
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE----SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9999876666899999999999999999999 678999999999999999999999999999765432211111112
Q ss_pred cccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHH
Q 003855 665 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSA 743 (791)
Q Consensus 665 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 743 (791)
..+..|+|||.+.++.++.++|||||||++|||++ |..||...... .....+....+ .+.
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~~~-----------------~~~ 217 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQGVR-----------------LPC 217 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCC-----------------CCC
Confidence 23567999999988889999999999999999998 88888653221 11111111000 011
Q ss_pred HHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 744 KMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 744 ~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
+..++..+.+++.+|++.+|++||++.|+.++|.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1234567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=329.78 Aligned_cols=259 Identities=28% Similarity=0.435 Sum_probs=210.2
Q ss_pred hccccccccCCCcceEEEEEEec------CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.+|...+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999742 356699999876655556778999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC
Q 003855 575 VLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM 639 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~ 639 (791)
||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA----SQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCC
Confidence 999999999999997532 23789999999999999999999 77899999999999999999
Q ss_pred cEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHH
Q 003855 640 AAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWV 718 (791)
Q Consensus 640 ~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 718 (791)
.++|+|||+++...............++..|+|||+..+..++.++|||||||++|||+| |+.||......+ ..+.+
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~ 238 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECI 238 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence 999999999986644332222333456788999999988899999999999999999999 999986532211 11111
Q ss_pred HHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 719 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 719 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
.. ..... ....++..+.+++.+||+.+|++||++.+|+++|+++.+.
T Consensus 239 ~~---~~~~~--------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 TQ---GRVLE--------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred hC---CCCCC--------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11 00000 0112456688999999999999999999999999999664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=329.05 Aligned_cols=254 Identities=30% Similarity=0.481 Sum_probs=205.9
Q ss_pred hccccccccCCCcceEEEEEEec------CCcEEEEEEeehhhhH-HHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
++|.+.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 56888899999999999999863 3478999998765433 4578999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc
Q 003855 574 LVLEFMPNGSLEKWLYSHN-------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA 640 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~ 640 (791)
+||||+++|+|.+++...+ ..+++..+..++.|++.|+.||| ..+++||||||+||+++.++.
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA----SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeeccccccceEEEcCCCe
Confidence 9999999999999997542 34788899999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHH
Q 003855 641 AHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVK 719 (791)
Q Consensus 641 ~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 719 (791)
+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |+.||...... ...+.+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~~ 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECIT 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH
Confidence 99999999986543332222233446788999999999999999999999999999998 99998653221 1111111
Q ss_pred HhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 720 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 720 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
. .... ..+..++..+.+++.+||+.||++||++.||++.|+
T Consensus 239 ~---~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 Q---GRLL--------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred c---CCcC--------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 0000 001134567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=313.30 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=207.5
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.+.|+..+.||+|.-|+||.++.+ ++..+|+|++.+.. ++.....+.|.++|+.++||.++.+++.++.+...|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 457888899999999999999986 45889999998764 44456778899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 576 LEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+||+|....+++ +..+++..+.-++..|+-||+||| ..|||+|||||+||||-++|++-|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH----mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH----MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH----hhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999865 456899999999999999999999 78999999999999999999999999999853210
Q ss_pred ---------------------------------CCC---------------------cceeecccccccccCCCccCCCC
Q 003855 655 ---------------------------------GED---------------------SVTQTMTMATIGYMAPEYGSEGI 680 (791)
Q Consensus 655 ---------------------------------~~~---------------------~~~~~~~~g~~~y~aPE~~~~~~ 680 (791)
... .......+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 01122347999999999999999
Q ss_pred CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccc
Q 003855 681 VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCI 760 (791)
Q Consensus 681 ~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 760 (791)
.+.++|+|+|||++|||+.|..||.+.... ..+...+ .+.+ .++.....+..+.+||++.|.
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv------------~~~l-----~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIV------------GQPL-----KFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHh------------cCCC-----cCCCCCcchhHHHHHHHHHhc
Confidence 999999999999999999999999885433 2333222 2111 222222455678899999999
Q ss_pred cCCCCCCC----HHHHHH
Q 003855 761 ESPDMRIN----VTDAAA 774 (791)
Q Consensus 761 ~~P~~RPt----~~ev~~ 774 (791)
+||++|.. +.||.+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999998 777654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=330.45 Aligned_cols=267 Identities=21% Similarity=0.220 Sum_probs=201.5
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++|++.+.||+|+||.||+|+.+ +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999975 68899999987542 2335677889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|++++.+..+. .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH----KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99987666544 33445899999999999999999999 67899999999999999999999999999987643221
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHH--hcCCC-h--------
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE--SLPHG-L-------- 726 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~-~-------- 726 (791)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||......+. ....... ..+.. .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccch
Confidence 122234689999999999888899999999999999999999999975322111 1110000 00000 0
Q ss_pred -hhhcchhhhh-hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 727 -TEVVDANLVR-EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 727 -~~~~d~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....+.... ..........++..+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 00000011135667999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=324.59 Aligned_cols=255 Identities=22% Similarity=0.415 Sum_probs=207.5
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+..|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46899999999999999999998888899999876543 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++|+|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||++++++.++|+|||+++........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE----RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999999754 345888999999999999999999 678999999999999999999999999999876432211
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
......++..|+|||+...+.++.++|||||||++|||+| |+.||...... .....+.....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~-------------- 222 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR-------------- 222 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC--------------
Confidence 1122335678999999988889999999999999999998 99998653211 11121111100
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
.+....++.++.+++.+|++.+|++||++.++.+.|+.+
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 ---MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 011113456678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=312.91 Aligned_cols=267 Identities=25% Similarity=0.307 Sum_probs=204.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh--HHHHHHHHHHHHHHhccCCc-cceeeeeeccCC-----
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE--RAFRSFDSECEVLRNVRHRN-LIKILSSCSNPD----- 570 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~----- 570 (791)
...|..+++||+|+||+||+|+.+ +|+.||+|.+....+ .......+|+.++++++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 566778889999999999999964 789999999876643 34456688999999999999 999999998776
Q ss_pred -eeeEEEecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeee
Q 003855 571 -FKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDF 646 (791)
Q Consensus 571 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 646 (791)
..++||||++. +|.+++.... ..++...+..+++||++||+||| +++|+||||||.||+++++|.+||+||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H----~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH----SHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCcceEEECCCCcEeeecc
Confidence 78899999965 9999999655 35777899999999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCCcceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc--C
Q 003855 647 GISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL--P 723 (791)
Q Consensus 647 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--~ 723 (791)
|+|+.+.-.. ...+..++|.+|+|||++.+. .|+...||||+|||++||++++.-|.+..+. ..+.+ +-... +
T Consensus 165 GlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~-If~~lGtP 240 (323)
T KOG0594|consen 165 GLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFR-IFRLLGTP 240 (323)
T ss_pred chHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHH-HHHHcCCC
Confidence 9999765222 235567899999999987765 7999999999999999999999887764331 11111 11111 0
Q ss_pred --CChhh---hcchh--hhhhHHhhHHHH---HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 724 --HGLTE---VVDAN--LVREEQAFSAKM---DCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 724 --~~~~~---~~d~~--~~~~~~~~~~~~---~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
+.+.. ..+.. +.......+... .......+++.+|++.+|.+|.+++.+++.
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111 11111 100000000000 111367799999999999999999999885
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.28 Aligned_cols=256 Identities=29% Similarity=0.483 Sum_probs=211.2
Q ss_pred HhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
...+|+..+.||+|+||.||+|...+++.+|+|++..........+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678999999999999999999888999999998876655567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.+++... ...+++..+..++.|++.|+.||| ..+++||||+|+||++++++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE----EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999864 345899999999999999999999 67899999999999999999999999999987643221
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
. .....++..|+|||......++.++||||||+++|+|++ |+.||...... ...+.+.....
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~------------- 222 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQITAGYR------------- 222 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHhCCc-------------
Confidence 1 112345678999999988889999999999999999998 89998653211 11111111000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
.+.+..++..+.+++.+||+.+|++|||+.++.+.|+.+
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011124456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=328.36 Aligned_cols=256 Identities=25% Similarity=0.431 Sum_probs=203.7
Q ss_pred HhhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF 571 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 571 (791)
..++|+..+.||+|+||.||+|... ++..||||++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999753 35679999886432 2344568899999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEE
Q 003855 572 KALVLEFMPNGSLEKWLYSHN---------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAH 642 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~k 642 (791)
.++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCcchheEEEcCCCCEE
Confidence 999999999999999997532 23578889999999999999999 67899999999999999999999
Q ss_pred EeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHh
Q 003855 643 VSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKES 721 (791)
Q Consensus 643 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 721 (791)
++|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||.+... ....+++..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~~~~~~~~- 236 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVLRFVME- 236 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHc-
Confidence 999999986544332222222345788999999988899999999999999999999 6888865321 111111111
Q ss_pred cCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 722 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 722 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
.... ..+..++..+.+++.+|++.+|++||++.|+++.|+
T Consensus 237 --~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 237 --GGLL--------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --CCcC--------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0000 001134567889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.94 Aligned_cols=199 Identities=26% Similarity=0.357 Sum_probs=174.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+|... ++..+|+|++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999976 68899999887543 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++|+|.+++.... .+++..+..++.+++.|+.|||+ ..+|+||||||+||++++++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 999999999998654 37889999999999999999993 2469999999999999999999999999997653321
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCc
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDE 706 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~ 706 (791)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1234688999999999888899999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=333.60 Aligned_cols=238 Identities=26% Similarity=0.282 Sum_probs=192.7
Q ss_pred cCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCH
Q 003855 509 LGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSL 584 (791)
Q Consensus 509 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 584 (791)
||+|+||.||+|+.. +++.||+|++.... ......+..|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 68899999987542 33456678899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecc
Q 003855 585 EKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT 664 (791)
Q Consensus 585 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 664 (791)
.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~ 153 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLH----KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTF 153 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccc
Confidence 99998654 3889999999999999999999 67899999999999999999999999999976432221 22334
Q ss_pred cccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHH
Q 003855 665 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAK 744 (791)
Q Consensus 665 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 744 (791)
.||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............ ..+
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~~---------------~~~ 213 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEPL---------------RFP 213 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCC---------------CCC
Confidence 689999999999999999999999999999999999999975211 111111111100 011
Q ss_pred HHHHHHHHHHHhhccccCCCCCCC---HHHHH
Q 003855 745 MDCILSIMDLALDCCIESPDMRIN---VTDAA 773 (791)
Q Consensus 745 ~~~~~~l~~li~~cl~~~P~~RPt---~~ev~ 773 (791)
..++..+.+++.+||+.||++||+ +.|++
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 134466789999999999999986 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=322.89 Aligned_cols=255 Identities=28% Similarity=0.444 Sum_probs=206.4
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|++.+.||+|+||.||+|..++++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46788999999999999999998888899999986543 23456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++++|.+++.... ..+++..+..++.|++.|+.||| +.+++||||||+||++++++.++|+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE----AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 9999999997643 45899999999999999999999 67899999999999999999999999999987653221
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
........+..|+|||+..+..++.++||||||+++|||+| |+.||...... .....+.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~-------------- 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQGYR-------------- 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC--------------
Confidence 11111223457999999988899999999999999999999 99998653211 11111111000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
.+....++..+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 ---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 011123456788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=349.89 Aligned_cols=250 Identities=23% Similarity=0.254 Sum_probs=203.2
Q ss_pred ccccccccCCCcceEEEEEEec-C-CcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-D-GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+..|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999854 3 6788999776555555567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 580 PNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 580 ~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
++|+|.+++.. ....+++.++..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH----SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 99999998864 2345889999999999999999999 6789999999999999999999999999998765433
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
........+||++|+|||++.+..++.++|||||||++|||++|+.||..... ...+.........
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~~~--------- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGKYD--------- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC---------
Confidence 22223345689999999999999999999999999999999999999965221 1111111000000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.+..++.++.+++.+||+.||++||++.+++.
T Consensus 290 -----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011134566889999999999999999999864
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=326.67 Aligned_cols=269 Identities=26% Similarity=0.414 Sum_probs=206.3
Q ss_pred hccccccccCCCcceEEEEEEec-----CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeecc--CCeee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-----DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN--PDFKA 573 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 573 (791)
.+|+..+.||+|+||.||+|..+ +++.||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999742 578999999876666667788999999999999999999998743 35678
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+||||+++|+|.+++......+++..+..++.|++.||+||| ..+++||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG----SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999999999876556899999999999999999999 6789999999999999999999999999998765
Q ss_pred CCCCccee-ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 654 EGEDSVTQ-TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 654 ~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
........ ....++..|+|||+..+..++.++|||||||++|||++|..|+..... .+...............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA------EFMRMMGNDKQGQMIVY 233 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch------hhhhhcccccccccchH
Confidence 43322111 112234569999999888899999999999999999998876543211 11111000000000000
Q ss_pred hh---hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 733 NL---VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 733 ~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
.+ .......+....++.++.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 000111112234567789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=336.53 Aligned_cols=246 Identities=23% Similarity=0.254 Sum_probs=200.0
Q ss_pred hhccccccccCCCcceEEEEEEecC--CcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISD--GTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|+.+. +..||+|++.... ....+.+..|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4679999999999999999998643 3689999986543 2345678889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++..... +++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYLQ----SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999986653 889999999999999999999 77899999999999999999999999999987543
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ......
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~----i~~~~~-------- 245 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQK----ILEGII-------- 245 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHH----HhcCCC--------
Confidence 2 12346899999999998888999999999999999999999999753211 00111 000000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAAK 775 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~~ 775 (791)
. .+...+..+.+++.+|++.||++|+ +++|+++.
T Consensus 246 -----~--~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -----Y--FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----C--CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 0112335567999999999999995 78887653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=315.73 Aligned_cols=262 Identities=26% Similarity=0.330 Sum_probs=196.2
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccC---C--eee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNP---D--FKA 573 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~--~~~ 573 (791)
+-.|...+.+|.|+||.||+|... +++.||||....+.+ ---.|..+|+.++|||||++..+|... + ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 346778899999999999999965 679999998764432 223589999999999999999888432 2 234
Q ss_pred EEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC-CcEEEeeeccc
Q 003855 574 LVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN-MAAHVSDFGIS 649 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfgla 649 (791)
+|||||+. +|.++++. .+..++...+.-++.||.+||.||| +.+|+||||||.|+|+|.+ |.+||||||.|
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh----~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH----SHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH----hcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 89999976 99999983 2445888889999999999999999 6899999999999999965 99999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh-
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT- 727 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 727 (791)
+.+..++.... ..-|+.|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+. .+...+...++-.......
T Consensus 174 K~L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 174 KVLVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred eeeccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCCCCHHH
Confidence 99877665433 235889999997765 67999999999999999999999988762 2222333333221111111
Q ss_pred ---------hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 ---------EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ---------~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.-.+.+.......-.....++++.+++.+++..+|.+|.++.|+++
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111111111000012245678899999999999999999999874
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=322.45 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=203.7
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
++|...+.||+|+||.||.|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 5688889999999999999998777789999886443 223578899999999999999999999998888999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+|+|.+++......+++..++.++.||+.|++||| +.+++|+||||+||++++++.+||+|||.++....... ..
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE----SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 99999999876556899999999999999999999 67899999999999999999999999999986543321 11
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....++..|+|||...+..++.++|||||||++|||++ |+.||...... .....+......
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~--------------- 220 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLRL--------------- 220 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCCC---------------
Confidence 222335678999999988889999999999999999999 99998653221 111111110000
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
..+...+..+.+++.+||+.+|++||++.++++.++
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001123466789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=332.90 Aligned_cols=241 Identities=23% Similarity=0.270 Sum_probs=195.4
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNG 582 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 582 (791)
+.||+|+||.||+++.. +|+.||+|++.... ......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 78999999997653 234556778999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceee
Q 003855 583 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT 662 (791)
Q Consensus 583 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 662 (791)
+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 153 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMK 153 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccc
Confidence 9999887654 4889999999999999999999 67899999999999999999999999999875422211 222
Q ss_pred cccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhH
Q 003855 663 MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFS 742 (791)
Q Consensus 663 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 742 (791)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...... ........ ... .
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~~~----~~~---------------~ 213 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILM----EEI---------------R 213 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHhc----CCC---------------C
Confidence 346899999999999999999999999999999999999998653211 11111100 000 0
Q ss_pred HHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 743 AKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 743 ~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
.+..++.++.+++.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 0113456678999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=326.51 Aligned_cols=255 Identities=25% Similarity=0.439 Sum_probs=204.3
Q ss_pred hccccccccCCCcceEEEEEEe-----cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-----SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
++|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5678889999999999999984 256789999986433 3445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC
Q 003855 575 VLEFMPNGSLEKWLYSHN----------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN 638 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~ 638 (791)
||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS----SHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hcCeehhccccceEEEcCC
Confidence 999999999999986321 24788899999999999999999 6789999999999999999
Q ss_pred CcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHH
Q 003855 639 MAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRW 717 (791)
Q Consensus 639 ~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 717 (791)
+.+||+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||.+... ......
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~ 238 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEM 238 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH
Confidence 9999999999987644332222333445778999999988889999999999999999998 8889865321 111111
Q ss_pred HHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 718 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 718 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
+..... .+.+..++..+.+++.+|++.||++||++.++.+.|+.
T Consensus 239 ~~~~~~-----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRKRQL-----------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCc-----------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111000 01112345678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.99 Aligned_cols=260 Identities=23% Similarity=0.401 Sum_probs=207.3
Q ss_pred hhccccccccCCCcceEEEEEEec-CCc----EEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGT----DVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
.++|+..+.||+|+||+||+|++. +++ .||+|++.... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 357888999999999999999853 444 48999886443 33456788999999999999999999999754 467
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+++||+++|+|.+++......+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+++.+.
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE----EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999999876666899999999999999999999 6789999999999999999999999999998765
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
............++..|+|||...+..++.++|||||||++|||++ |..||+.... .....++......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~-------- 230 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGERL-------- 230 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCcC--------
Confidence 3322222222335678999999988889999999999999999998 8899865321 1222222211100
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
+.+..++..+.+++.+||+.||++||++.++++.++.+.+..
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 ---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111234567889999999999999999999999998885543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.39 Aligned_cols=260 Identities=22% Similarity=0.392 Sum_probs=205.8
Q ss_pred HhhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhcc-CCccceeeeeeccCC
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVR-HRNLIKILSSCSNPD 570 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 570 (791)
..++|.+.+.||+|+||.||+|++. .+..||+|++.... ....+.+..|+.++.++. ||||+++++++....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3467888999999999999999863 34679999997543 333457889999999997 999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhCC----------------------------------------------------------
Q 003855 571 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 592 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 592 (791)
..++||||+++|+|.++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999997431
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCe
Q 003855 593 ---------------------------------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNI 633 (791)
Q Consensus 593 ---------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Ni 633 (791)
..+++..+.+++.|++.||+||| +.+++||||||+||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrdlkp~Ni 270 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA----SKNCVHRDLAARNV 270 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCcCcccCCcceE
Confidence 13567788899999999999999 67899999999999
Q ss_pred EeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcc
Q 003855 634 LLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEM 712 (791)
Q Consensus 634 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~ 712 (791)
++++++.+||+|||+++.+.............++..|+|||.+....++.++|||||||++|||++ |+.||......+.
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999987543322222223356788999999988889999999999999999998 8889865322111
Q ss_pred hHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 713 SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
....+.. +. ..+.+..++.++.+++.+||..+|++||++.|+++.|+++.
T Consensus 351 -~~~~~~~----~~-------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 -FYNAIKR----GY-------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHHHHHc----CC-------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111110 00 00111234567889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.16 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=205.1
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.+|+..+.||+|+||.||+|..+ +++.||+|++.... ...+.+.+|++++++++||||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 46888899999999999999865 58899999987543 23467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++++|.+++... ...+++..+..++.|+++||+||| ..+++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999999754 345899999999999999999999 678999999999999999999999999999876433211
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
......++..|+|||+..+..++.++|||||||++|||++ |..||..... ....+.+.....
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~-------------- 223 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKGYR-------------- 223 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCC--------------
Confidence 1111224568999999988899999999999999999998 8889865211 111111111000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
...+..++.++.+++.+||+.+|++||++.|+.++|+.+
T Consensus 224 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 ---MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 011123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=319.51 Aligned_cols=258 Identities=23% Similarity=0.327 Sum_probs=207.7
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehh---hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999865 7899999987542 2344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 577 EFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 577 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
||+++|+|.+++.. ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..+.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999998863 2345788999999999999999999 6789999999999999999999999999998764
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+......... +.
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~-----~~ 227 (267)
T cd08228 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSLCQKIEQCDY-----PP 227 (267)
T ss_pred chhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHHHHHHhcCCC-----CC
Confidence 3221 112245788999999998888999999999999999999999998542221 1111111110000 00
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
. ....++..+.+++.+||+.+|++||++.+|++.+++++
T Consensus 228 ~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 L--------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred C--------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0 01134566889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.63 Aligned_cols=266 Identities=23% Similarity=0.289 Sum_probs=197.1
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC-----Ceee
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP-----DFKA 573 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 573 (791)
+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999965 78999999986432 23345688899999999999999999987533 3479
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+||||+. ++|.+++.... .+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 69999987654 3899999999999999999999 6789999999999999999999999999998653
Q ss_pred CCCC-cceeecccccccccCCCccCC--CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCCh----
Q 003855 654 EGED-SVTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL---- 726 (791)
Q Consensus 654 ~~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 726 (791)
.... ........|+..|+|||++.+ ..++.++|||||||++|||+||+.||.+... ......+........
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHH
Confidence 3221 112233568999999998765 6789999999999999999999999965321 111111111111000
Q ss_pred hhhcchh-------hhh-hHHhh-HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 727 TEVVDAN-------LVR-EEQAF-SAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 727 ~~~~d~~-------~~~-~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..+.... +.. ..... .....++..+.+++.+||+.||++||++.|+++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 000 00000 0001234667899999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=343.00 Aligned_cols=260 Identities=24% Similarity=0.307 Sum_probs=210.9
Q ss_pred hhccccccccCCCcceEEEEEEecCC-cEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CCccceeeeee-c-----c-CC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDG-TDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSC-S-----N-PD 570 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~-~-----~-~~ 570 (791)
..++++.+.|.+|||+.||.|+...+ ..||+|++....+...+.+.+|+++|++|. |||||.+++.. . . ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 35677889999999999999997655 999999988888888899999999999996 99999999933 1 1 24
Q ss_pred eeeEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
+.++.||||+||.|-+++..+ ...+.+.++++|++++++|+++||.. ..+|||||||.+|||++.++..||||||.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 678999999999999999844 22399999999999999999999953 567999999999999999999999999999
Q ss_pred cccCCCCCcc-e------eecccccccccCCCc---cCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHH
Q 003855 650 KLLGEGEDSV-T------QTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 719 (791)
Q Consensus 650 ~~~~~~~~~~-~------~~~~~g~~~y~aPE~---~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 719 (791)
.......... . .-....|+-|+|||. ..+...++|+||||+||+||-|+....||++...-
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--------- 264 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--------- 264 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence 7543322110 0 111246899999995 46678999999999999999999999999873211
Q ss_pred HhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 720 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 720 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
.+++.. ..++....++..+.+||+.||++||.+||++.||+..+.++....
T Consensus 265 --------aIlng~-----Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 --------AILNGN-----YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred --------eEEecc-----ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 111111 122333467788999999999999999999999999999886543
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.74 Aligned_cols=251 Identities=28% Similarity=0.397 Sum_probs=202.6
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
.+|+..+.||+|+||.||+|.++++..+|+|++..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 45788899999999999999988778899998864322 23467789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+++|.+++......+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||+++........ .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~ 157 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE----SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S 157 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence 99999999876556899999999999999999999 678999999999999999999999999999865432211 1
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....++..|+|||...+..++.++||||||+++|||++ |+.||......+ ....+....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~----------------- 218 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSAGY----------------- 218 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHcCC-----------------
Confidence 111223457999999988899999999999999999999 788986532211 111111000
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
....+..++.++.+++.+||+.+|++|||+.|+++.|
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0011113566788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.73 Aligned_cols=268 Identities=24% Similarity=0.388 Sum_probs=204.5
Q ss_pred cc-ccccccCCCcceEEEEEEe-----cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeecc--CCee
Q 003855 502 EF-NECNLLGTGSFGSVYKGTI-----SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSN--PDFK 572 (791)
Q Consensus 502 ~~-~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 572 (791)
+| +..+.||+|+||+||.+.+ .+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 7889999999999988653 367889999987543 2345678889999999999999999998765 3457
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||+++|+|.+++.... +++.++..++.|++.|+.||| +.+|+||||||+||++++++.++|+|||+++.+
T Consensus 84 ~lv~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH----SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH----HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 89999999999999997654 899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCcce-eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc-CCChhhhc
Q 003855 653 GEGEDSVT-QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL-PHGLTEVV 730 (791)
Q Consensus 653 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 730 (791)
........ .....++..|+|||...+..++.++||||||+++|||+||+.|+............+..... .....+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 54332111 11223566799999998888999999999999999999999998653221111111000000 00011111
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
+... ..+.+..++.++.+++.+||+.+|++||+++++++.|+++.
T Consensus 238 ~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGM-----RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCC-----CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111 11112345678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.45 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=194.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677889999999999999865 78999999986543 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++|+|.+.. ..++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH----RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 9999986532 2567778899999999999999 67899999999999999999999999999987643221
Q ss_pred ceeecccccccccCCCccCC-----CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 659 VTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.....+|+..|+|||++.. ...+.++|||||||++|||++|+.||...... .+...........
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~-------- 292 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMCAICMSQ-------- 292 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhccC--------
Confidence 1223468999999998643 33456899999999999999999999732211 1111111100000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.......++.++.+++.+||+.||++||++.|+++.
T Consensus 293 ------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000112345678899999999999999999999874
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.88 Aligned_cols=242 Identities=24% Similarity=0.302 Sum_probs=196.1
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNG 582 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 582 (791)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 78999999997543 334567788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceee
Q 003855 583 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT 662 (791)
Q Consensus 583 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 662 (791)
+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 153 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH----SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMK 153 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccc
Confidence 9999887654 4889999999999999999999 6789999999999999999999999999987543221 1223
Q ss_pred cccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhH
Q 003855 663 MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFS 742 (791)
Q Consensus 663 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 742 (791)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............ .
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~---------------~ 213 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEDI---------------K 213 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccCCc---------------c
Confidence 34689999999999988999999999999999999999999965211 111111110000 0
Q ss_pred HHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 003855 743 AKMDCILSIMDLALDCCIESPDMRI-----NVTDAAAK 775 (791)
Q Consensus 743 ~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~~ 775 (791)
.+..++.++.+++.+|++.||++|| ++.|+++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0112345678999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=311.15 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=211.7
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
-|.+++++|+|+||.||+|.++ .|+.||||.+... ...+++.+|+.+|++.+.|++|+++|.+......++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4677889999999999999875 7999999987644 446788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
.|++.+.++.+...+.+.++..+++..++||+||| ...-+|||||+.|||++.+|.+|++|||.|..+.+.. ..
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH----~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AK 185 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH----DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AK 185 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH----HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--Hh
Confidence 99999999988888999999999999999999999 5678999999999999999999999999997664432 23
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHh
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 740 (791)
.....||+.|||||++..-.|..++||||+|++..||..|++||.+..+...-+ .++.. .+..
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------MIPT~-----------PPPT 248 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------MIPTK-----------PPPT 248 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------eccCC-----------CCCC
Confidence 445679999999999999899999999999999999999999998755432210 01111 0112
Q ss_pred hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 741 FSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 741 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
+-.++..+.++.++++.|+-..|++|-|+.++++.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 23455677889999999999999999999988763
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.72 Aligned_cols=257 Identities=28% Similarity=0.436 Sum_probs=205.6
Q ss_pred ccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
+|++.+.||+|+||.||+|... ....+|+|.+.... ....+.+..|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 23578999876543 3345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCC
Q 003855 575 VLEFMPNGSLEKWLYSHN-----------------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPT 631 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~ 631 (791)
|+||+.+|+|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~ivH~dikp~ 156 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA----EMKLVHRDLAAR 156 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH----HCCeehhhhhhh
Confidence 999999999999986421 24788999999999999999999 678999999999
Q ss_pred CeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccC
Q 003855 632 NILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTG 710 (791)
Q Consensus 632 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~ 710 (791)
||++++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||.+..+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999986544333222233345678999999888889999999999999999999 99998653211
Q ss_pred cchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 711 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
.+..++..... .+.+..++..+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 237 --~~~~~~~~~~~-----------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 --RLFNLLKTGYR-----------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred --HHHHHHhCCCC-----------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11222111000 01112345678899999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=310.64 Aligned_cols=246 Identities=25% Similarity=0.344 Sum_probs=205.0
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
..+|++.+.+|+|+||.|-+|.. ..|+.||||.+++.. ++..-.+.+|+++|+.++||||++++++|++.+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35788899999999999999985 689999999887654 44556788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||..+|.|.+|+...+. +++.+...+++||..|+.|+| .++++|||||.+|||+|.++++||+|||++-.+...
T Consensus 132 MEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH----knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH----KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh----hccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999987765 899999999999999999999 678999999999999999999999999999887543
Q ss_pred CCcceeecccccccccCCCccCCCCC-CccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
...+..+|++-|.+||+..+..| .+.+|-||+||++|-++.|..||++.. ....+++.-.
T Consensus 207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQIs~----------- 267 (668)
T KOG0611|consen 207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQISR----------- 267 (668)
T ss_pred ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHHhhc-----------
Confidence 23455789999999999988776 457999999999999999999998732 2222222111
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.+...+ -+....-+|+.|+..+|++|.|..||..
T Consensus 268 -GaYrEP~----~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 268 -GAYREPE----TPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -ccccCCC----CCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 1111111 1223447999999999999999999875
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.77 Aligned_cols=261 Identities=22% Similarity=0.365 Sum_probs=210.2
Q ss_pred HhhccccccccCCCcceEEEEEEecC-----CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeecc-CCe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTISD-----GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSN-PDF 571 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 571 (791)
..++|+..+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35788999999999999999999765 6889999886442 3445678899999999999999999998765 567
Q ss_pred eeEEEecCCCCCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEe
Q 003855 572 KALVLEFMPNGSLEKWLYSHN-------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVS 644 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~ 644 (791)
.++++||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH----KRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCHhhEEEcCCCcEEEC
Confidence 899999999999999997532 34889999999999999999999 6789999999999999999999999
Q ss_pred eeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcC
Q 003855 645 DFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLP 723 (791)
Q Consensus 645 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 723 (791)
|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+..++.....
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~ 237 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYR 237 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCC
Confidence 9999987654332222222345778999999988889999999999999999999 9999875321 122222221100
Q ss_pred CChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 724 HGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 724 ~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
......++..+.+++.+||+.||++|||+.|+++.|+.+..+
T Consensus 238 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 -----------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -----------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 011123456788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.94 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=204.8
Q ss_pred hccccccccCCCcceEEEEEEec------CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.+|+..+.||+|+||.||++... ++..+|+|.+........+.+..|+++++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56778899999999999999642 466899998876666666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc
Q 003855 575 VLEFMPNGSLEKWLYSHN--------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA 640 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~ 640 (791)
||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA----SLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH----HCCeecccccHhhEEEcCCCC
Confidence 999999999999997543 24789999999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHH
Q 003855 641 AHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVK 719 (791)
Q Consensus 641 ~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 719 (791)
+||+|||+++...............+++.|+|||+..+..++.++|||||||++|||++ |..||......+ ....+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~ 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECIT 238 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHH
Confidence 99999999976543322222223345678999999988899999999999999999998 888986432211 111110
Q ss_pred HhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 720 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 720 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
... ....+..++..+.+++.+||+.||++||++.|+.+.|+
T Consensus 239 ~~~-----------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 QGR-----------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCc-----------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000 00111234566789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.11 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=203.8
Q ss_pred hccccccccCCCcceEEEEEEec------CCcEEEEEEeehhhh-HHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
.+|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45778889999999999999863 257899999875543 33467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC
Q 003855 574 LVLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN 638 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~ 638 (791)
+++||+++++|.+++... ...+++..+..++.|++.||.|+| +.+|+||||||+||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH----~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS----SHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HcCccccccchhheEecCC
Confidence 999999999999998632 124788889999999999999999 6789999999999999999
Q ss_pred CcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHH
Q 003855 639 MAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRW 717 (791)
Q Consensus 639 ~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 717 (791)
+.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||.+... .++
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~ 235 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDV 235 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----HHH
Confidence 9999999999987644332222233446788999999988889999999999999999998 7788765321 111
Q ss_pred HHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 718 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 718 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
+........ .+.+..++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 236 ~~~i~~~~~--------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQV--------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCc--------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111100 01122456778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.64 Aligned_cols=256 Identities=26% Similarity=0.477 Sum_probs=206.7
Q ss_pred hccccccccCCCcceEEEEEEec-CC---cEEEEEEeehh-hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DG---TDVAIKIFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.+|++.+.||+|+||.||+|... ++ ..||||++... .....+.+..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45788999999999999999865 33 36999998754 244567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++......+++.++..++.|++.|+.||| +.+++||||||+||+++.++.+|++|||++..+...
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH----~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS----EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999876666899999999999999999999 678999999999999999999999999999866443
Q ss_pred CCcceeeccc---ccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 656 EDSVTQTMTM---ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 656 ~~~~~~~~~~---g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
.......... .+..|+|||+..+..++.++|||||||++||+++ |..||..... .....++....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~~~--------- 228 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQDY--------- 228 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCC---------
Confidence 2221111111 2457999999998999999999999999999887 9999865322 12222221110
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
..+.+.+++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 --------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111224556788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=325.97 Aligned_cols=262 Identities=24% Similarity=0.403 Sum_probs=209.2
Q ss_pred HhhccccccccCCCcceEEEEEEec--------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeecc
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS--------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSN 568 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 568 (791)
..++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3578889999999999999999741 34579999886543 34456788999999999 89999999999999
Q ss_pred CCeeeEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCe
Q 003855 569 PDFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNI 633 (791)
Q Consensus 569 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Ni 633 (791)
....++||||+++|+|.+++.... ..+++.++..++.||++||.||| +.+++||||||+||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Ni 168 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA----SQKCIHRDLAARNV 168 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH----HCCeeecccccceE
Confidence 999999999999999999997532 24788899999999999999999 67899999999999
Q ss_pred EeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcc
Q 003855 634 LLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEM 712 (791)
Q Consensus 634 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~ 712 (791)
++++++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 999999999999999987654333222223345678999999988889999999999999999998 778876431
Q ss_pred hHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 713 SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
...+........ ....+..++..+.+++.+||+.+|++||++.|+++.|+++..-.
T Consensus 245 -~~~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 245 -VEELFKLLKEGH--------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred -HHHHHHHHHcCC--------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 111111110000 00111245577889999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=338.61 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=204.7
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+..|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999975 78999999997653 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH----~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH----KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999876 44899999999999999999999 6899999999999999999999999999998765432
Q ss_pred ---------------------------CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCcccc
Q 003855 657 ---------------------------DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFT 709 (791)
Q Consensus 657 ---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~ 709 (791)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00112334689999999999999999999999999999999999999976321
Q ss_pred CcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC-HHHHHHH
Q 003855 710 GEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRIN-VTDAAAK 775 (791)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~ev~~~ 775 (791)
.+ ...+. ... .... ..+....++.++.+++.+|+. ||++||+ +.|+++.
T Consensus 236 ~~-~~~~i-~~~-~~~~-------------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QE-TYNKI-INW-KESL-------------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH-HHHHH-hcc-CCcc-------------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 11110 000 0000 001111245678899999997 9999999 9999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.33 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=206.8
Q ss_pred HhhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCC
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPD 570 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 570 (791)
..++|+..+.||+|+||.||+|... ....||+|++.... .+....+.+|+.+++++ +||||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3467899999999999999999864 23679999887542 34456788999999999 8999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe
Q 003855 571 FKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL 635 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill 635 (791)
..++||||+++|+|.++++.. ...+++..+.+++.|++.|++||| +.+|+||||||+||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA----SKKCIHRDLAARNVLV 165 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCccccccceeeEEE
Confidence 999999999999999999642 245889999999999999999999 6789999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchH
Q 003855 636 DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSL 714 (791)
Q Consensus 636 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 714 (791)
++++.+|++|||+++.+.............++..|+|||+..+..++.++|||||||++||+++ |..||...... ..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~ 243 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--EL 243 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--HH
Confidence 9999999999999987654332222222335678999999988899999999999999999998 88888653211 11
Q ss_pred HHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 715 RRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
.+...... ....+..++..+.+++.+|++.+|++|||+.|+++.|+.+.
T Consensus 244 ~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKLLKEGY-----------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHcCC-----------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111100 00011234567889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.27 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=197.8
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.|+.++.||+|+||.||+|+.. +++.||+|++.... ....+.+..|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999864 78899999997543 3445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++|+|.+++..... +++..+..++.||+.||+||| ..+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~~LH----~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVH----KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999999986543 788889999999999999999 67899999999999999999999999999864321100
Q ss_pred c---------------------------------------------ceeecccccccccCCCccCCCCCCccccHHhHHH
Q 003855 658 S---------------------------------------------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGV 692 (791)
Q Consensus 658 ~---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~ 692 (791)
. ......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0 0011246999999999998888999999999999
Q ss_pred HHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhh--ccccCCCCCCCHH
Q 003855 693 LLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALD--CCIESPDMRINVT 770 (791)
Q Consensus 693 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~P~~RPt~~ 770 (791)
++|||+||+.||......+. ... +... .... ..+....++.++.+++.+ |+..+|..||++.
T Consensus 237 il~elltG~~Pf~~~~~~~~-~~~-i~~~-~~~~-------------~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET-QLK-VINW-ENTL-------------HIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH-HHH-HHcc-cccc-------------CCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999975322111 111 0000 0000 001111234567788887 5566777799999
Q ss_pred HHHHH
Q 003855 771 DAAAK 775 (791)
Q Consensus 771 ev~~~ 775 (791)
|+++.
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=344.81 Aligned_cols=256 Identities=26% Similarity=0.311 Sum_probs=204.0
Q ss_pred HHHhhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCC---
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD--- 570 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 570 (791)
+...++|++.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.++..++|+||+++.+.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 33457899999999999999999985 478999999986542 344567888999999999999999987764322
Q ss_pred -----eeeEEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEE
Q 003855 571 -----FKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAH 642 (791)
Q Consensus 571 -----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~k 642 (791)
..++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.+|
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH----~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH----SKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEeCCCCEE
Confidence 367999999999999999743 345889999999999999999999 67899999999999999999999
Q ss_pred EeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc
Q 003855 643 VSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL 722 (791)
Q Consensus 643 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (791)
|+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+....
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~ 258 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTL 258 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHh
Confidence 999999987654322222334568999999999999999999999999999999999999997521 112222111
Q ss_pred CCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 723 PHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 723 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..... +.+..++.++.+++.+||+.||++||++.++++.
T Consensus 259 ~~~~~--------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRYD--------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCCC--------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11000 0112345678899999999999999999999763
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=335.44 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=202.8
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+|+.. +++.||+|++.... .+..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999865 78999999997653 234567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH----QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999877566899999999999999999999 6789999999999999999999999999998765433
Q ss_pred CcceeecccccccccCCCccC------CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 657 DSVTQTMTMATIGYMAPEYGS------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..+....... ..
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~--~~- 227 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYNNIMNFQ--RF- 227 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHHHHHcCC--Cc-
Confidence 22 223346899999999876 456889999999999999999999999653211 1111110000 00
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+....++..+.+++..|++ +|++||++.++++
T Consensus 228 --------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 --------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0001111244667899999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.20 Aligned_cols=266 Identities=23% Similarity=0.401 Sum_probs=209.9
Q ss_pred hhccccccccCCCcceEEEEEEec--------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS--------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNP 569 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 569 (791)
.++|.+.+.||+|+||.||+|+.. ....||+|.+.... ......+..|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 367889999999999999999742 34579999887543 34456788999999999 699999999999988
Q ss_pred CeeeEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeE
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNIL 634 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nil 634 (791)
...++||||+++|+|.+++.... ..+++.++.+++.|++.||.||| +.+++||||||+||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nil 166 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE----SRRCIHRDLAARNVL 166 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeeccccceeEE
Confidence 89999999999999999997532 34788999999999999999999 679999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcch
Q 003855 635 LDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMS 713 (791)
Q Consensus 635 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 713 (791)
+++++.+||+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||..... ..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~ 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--EE 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--HH
Confidence 99999999999999987643322211122234567999999988899999999999999999999 8888865321 11
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhccccc
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDDAS 788 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~~ 788 (791)
....+... .. ...+..++.++.+++.+|++.+|++||++.|+++.|.++.....+++.
T Consensus 245 ~~~~~~~~---~~--------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 302 (314)
T cd05099 245 LFKLLREG---HR--------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYL 302 (314)
T ss_pred HHHHHHcC---CC--------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCce
Confidence 11111110 00 001123456788999999999999999999999999999876655543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.28 Aligned_cols=241 Identities=23% Similarity=0.307 Sum_probs=193.7
Q ss_pred cccCCCcceEEEEEEe----cCCcEEEEEEeehhh----hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 507 NLLGTGSFGSVYKGTI----SDGTDVAIKIFNLQL----ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+.||+|+||.||+++. .+++.||||++.... ......+..|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357899999987542 22345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++|+|.+++...+. +.+..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLH----QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 999999999976543 778888899999999999999 67899999999999999999999999999975432221
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.......
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~~~------------- 216 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILKGK------------- 216 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCC-------------
Confidence 122346899999999998888999999999999999999999999753211 1111111000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
...+..++..+.+++.+|++.+|++|| ++.++++
T Consensus 217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 001112345678999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.68 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=202.7
Q ss_pred HhhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF 571 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 571 (791)
..++|.+.+.||+|+||.||+|.+. .+..||+|.+.... ......+..|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3577999999999999999999875 35678999876443 3334578889999999999999999999998888
Q ss_pred eeEEEecCCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC---cEE
Q 003855 572 KALVLEFMPNGSLEKWLYSHN------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM---AAH 642 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~---~~k 642 (791)
.++||||+++|+|.+++.... ..+++..+.+++.||+.|++||| +.+++||||||+||+++.++ .+|
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE----ENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchheEEEeccCCCcceE
Confidence 999999999999999997543 24889999999999999999999 67899999999999998754 599
Q ss_pred EeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHh
Q 003855 643 VSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKES 721 (791)
Q Consensus 643 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 721 (791)
++|||+++................+..|+|||++.++.++.++|||||||++|||++ |..||+..... .....+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~ 237 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEFVTGG 237 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC
Confidence 999999987643222111222234568999999988899999999999999999997 99998753221 111111110
Q ss_pred cCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 722 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 722 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
.. ...+..++..+.+++.+|++.+|++||++.+|++.|.
T Consensus 238 ~~-----------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GR-----------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred Cc-----------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 0011234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=322.95 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=195.1
Q ss_pred hccccccccCCCcceEEEEEEec--CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhc---cCCccceeeeeec-----c
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS--DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNV---RHRNLIKILSSCS-----N 568 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~ 568 (791)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 46889999886543 22234455677777665 6999999999874 3
Q ss_pred CCeeeEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeec
Q 003855 569 PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFG 647 (791)
Q Consensus 569 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 647 (791)
....++||||+. ++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456889999996 6999999754 345899999999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc---CC
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL---PH 724 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~ 724 (791)
+++..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.+.... ..+...+.... +.
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 231 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChh
Confidence 99876433 1223346899999999998888999999999999999999999999763221 11111111110 00
Q ss_pred Chhhhc---chhhhhhHH--hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 725 GLTEVV---DANLVREEQ--AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 725 ~~~~~~---d~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...... ...+..... .......++..+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 000000000 00001134567789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.65 Aligned_cols=244 Identities=21% Similarity=0.258 Sum_probs=193.2
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHH---HhccCCccceeeeeeccCCeeeEE
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVL---RNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
|++.+.||+|+||.||+|... +++.||||++.... ....+.+..|++++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999865 78999999997543 23345566666655 456899999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|..+++.. .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH----~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH----ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999988653 4899999999999999999999 678999999999999999999999999998754322
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 155 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~i~~~~---------- 217 (324)
T cd05589 155 G--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDSIVNDE---------- 217 (324)
T ss_pred C--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCC----------
Confidence 1 1223356899999999999889999999999999999999999999753211 1111100000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
...+..++..+.+++.+|++.||++|| ++.++++
T Consensus 218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 001112456678999999999999999 4556554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=317.53 Aligned_cols=258 Identities=24% Similarity=0.329 Sum_probs=208.2
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+|+. .+++.||||.+.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999996 488999999876432 334467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 577 EFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 577 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
||+++++|.+++.. ....+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++++|||++..+.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999999873 2345899999999999999999999 6789999999999999999999999999998764
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.... ......++..|+|||+..+..++.++||||||+++|||++|..||...... ...+........ .+.
T Consensus 158 ~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-----~~~ 227 (267)
T cd08229 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEQCD-----YPP 227 (267)
T ss_pred cCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhhcCC-----CCC
Confidence 3322 112345888999999998888999999999999999999999998643221 111111110000 000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
. ....++..+.+++.+||+.+|++||||.+|+++++++.
T Consensus 228 ~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 L--------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C--------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0 01135567889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.71 Aligned_cols=391 Identities=29% Similarity=0.460 Sum_probs=296.1
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCc
Q 003855 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSIT 83 (791)
Q Consensus 4 ~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 83 (791)
++|++++++..++.|+.|+|+++ .+|+++..+.+|+.|++++|.+. ++|+.+++ +-.|+.|+..+|+|+ ..|..+.
T Consensus 82 ~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~-~~~l~dl~~~~N~i~-slp~~~~ 157 (565)
T KOG0472|consen 82 QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGR-LLDLEDLDATNNQIS-SLPEDMV 157 (565)
T ss_pred hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHH-Hhhhhhhhccccccc-cCchHHH
Confidence 57889999999999999999997 67888999999999999999998 88888888 458899999999998 6788888
Q ss_pred CCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhh
Q 003855 84 NATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIG 163 (791)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 163 (791)
++.+|..|++.+|+++..+++.+. ++.|++|+...|-++++| +.++++.+|..|+|..|+|. .+| .|.
T Consensus 158 ~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tlP---------~~lg~l~~L~~LyL~~Nki~-~lP-ef~ 225 (565)
T KOG0472|consen 158 NLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETLP---------PELGGLESLELLYLRRNKIR-FLP-EFP 225 (565)
T ss_pred HHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcCC---------hhhcchhhhHHHHhhhcccc-cCC-CCC
Confidence 888888899999988877776666 888888888888888765 44566666666666666666 334 343
Q ss_pred hhhhhhhhhhcccccccccCCcc-ccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCc
Q 003855 164 NFSASLQKFYAYECKLKGNIPQE-IGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242 (791)
Q Consensus 164 ~~~~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 242 (791)
.+ ..|.+|++..|.+. .+|.+ ..++.+|..|||++|+++ ..|+.+.-+.+|++||+|+|.|+ ..|..++++ .|+
T Consensus 226 gc-s~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~ 300 (565)
T KOG0472|consen 226 GC-SLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLK 300 (565)
T ss_pred cc-HHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eee
Confidence 33 34666666666666 33333 346666666666666666 55666666666666666666666 455666666 666
Q ss_pred eEEecCCccCC----------------------------------------------------------------CCCcc
Q 003855 243 GIRLTGNKLSG----------------------------------------------------------------HIPPC 258 (791)
Q Consensus 243 ~L~L~~N~i~~----------------------------------------------------------------~~~~~ 258 (791)
.|-+.+|.+.. .+|+.
T Consensus 301 ~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdE 380 (565)
T KOG0472|consen 301 FLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDE 380 (565)
T ss_pred ehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHH
Confidence 66666665430 12221
Q ss_pred ccCCCC---CcEEEcCCCcCCCCCCccccCCCCCCe-EEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhcc
Q 003855 259 LVSLTS---LRELHLGSNKLTSSIPSSLWSLEYILD-INLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGAL 334 (791)
Q Consensus 259 ~~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 334 (791)
...... .+..+++.|++. .+|..+..+..+.+ +.+++|.+ +.+|..++.+++|+.|+|++|.+. .+|..++.+
T Consensus 381 Vfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~l 457 (565)
T KOG0472|consen 381 VFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSL 457 (565)
T ss_pred HHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhh
Confidence 111111 445666666665 45555555544433 45555555 477888899999999999999998 789999999
Q ss_pred ccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCcccccc
Q 003855 335 KDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFF 414 (791)
Q Consensus 335 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~ 414 (791)
..|+.|+++.|+|. .+|..+..+..|+.+-.++|++....|+.+.+|.+|..|||.+|.+...+|..|.+.+++.+.+.
T Consensus 458 v~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~ 536 (565)
T KOG0472|consen 458 VRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELD 536 (565)
T ss_pred hhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEec
Confidence 99999999999999 88998888888888888899999777888999999999999999999999999999999999999
Q ss_pred CCccc
Q 003855 415 GNYAL 419 (791)
Q Consensus 415 ~n~~~ 419 (791)
|||+.
T Consensus 537 gNpfr 541 (565)
T KOG0472|consen 537 GNPFR 541 (565)
T ss_pred CCccC
Confidence 99986
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=321.57 Aligned_cols=259 Identities=23% Similarity=0.375 Sum_probs=206.9
Q ss_pred HhhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCC
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPD 570 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 570 (791)
..++|+..+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3468999999999999999999741 35579999887543 34456788999999999 7999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
..++||||+++|+|.++++... ..+++.++..++.|++.|+.||| +.+++|+||||+||+++.++.++++|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999998543 34899999999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
+...............++..|+|||.+.++.++.++|||||||++|||++ |..||......+ ...+.+......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~---- 263 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGYRM---- 263 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCCcC----
Confidence 87644332222222345678999999988899999999999999999998 999986532211 111111110000
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
..+...+.++.+++.+|++.+|++||++.|+++.|+++
T Consensus 264 -------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 -------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00112345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=326.80 Aligned_cols=261 Identities=26% Similarity=0.413 Sum_probs=207.1
Q ss_pred hhccccccccCCCcceEEEEEEec--------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS--------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNP 569 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 569 (791)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 367999999999999999999752 23569999987543 34456788899999999 799999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeE
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNIL 634 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nil 634 (791)
+..++||||+++|+|.+++.... ..+++.++.+++.|++.||+||| +.+++||||||+||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nil 172 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVL 172 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHHheE
Confidence 99999999999999999998532 24788999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcch
Q 003855 635 LDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMS 713 (791)
Q Consensus 635 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 713 (791)
+++++.+||+|||.++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~ 250 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 250 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HH
Confidence 99999999999999976543222111122234568999999988889999999999999999998 8888864211 11
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
..+.+.... ....+..++.++.+++.+|++.+|++||++.++++.|.++.+..
T Consensus 251 ~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 251 LFKLLKEGH-----------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHcCC-----------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 111111100 00111234567889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=331.19 Aligned_cols=261 Identities=20% Similarity=0.213 Sum_probs=197.8
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.+|++.+.||+|+||.||+|... +++.||+|... ...+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 57999999999999999999864 78899999643 234678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
. ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+....... .
T Consensus 166 ~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH----~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~ 238 (391)
T PHA03212 166 K-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH----ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-N 238 (391)
T ss_pred C-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-c
Confidence 4 79999887654 4889999999999999999999 67899999999999999999999999999975432211 1
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCcccc------CcchHHHHHHHhc------CCChh
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFT------GEMSLRRWVKESL------PHGLT 727 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~------~~~~~~~~~~~~~------~~~~~ 727 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ....+...+.... +....
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 22234689999999999988999999999999999999999987643211 0111111111110 00000
Q ss_pred hhcchhhhhh----------HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVRE----------EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..++...... ..........+.++.+++.+|++.||++|||+.|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0000111235667899999999999999999999985
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=319.84 Aligned_cols=253 Identities=26% Similarity=0.467 Sum_probs=197.7
Q ss_pred ccccccCCCcceEEEEEEecC-Cc--EEEEEEeehh--hhHHHHHHHHHHHHHHhccCCccceeeeeeccC------Cee
Q 003855 504 NECNLLGTGSFGSVYKGTISD-GT--DVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSNP------DFK 572 (791)
Q Consensus 504 ~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 572 (791)
.+.+.||+|+||.||+|++.+ ++ .||+|.++.. .....+.+..|+.+++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999753 33 5899987654 234467788999999999999999999987432 246
Q ss_pred eEEEecCCCCCHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeec
Q 003855 573 ALVLEFMPNGSLEKWLYS-----HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFG 647 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 647 (791)
++||||+++|+|.+++.. ....+++..+..++.|++.||+||| .++|+||||||+||++++++.+||+|||
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS----SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhheEEcCCCCEEECCCC
Confidence 899999999999998852 2234789999999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCCh
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGL 726 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 726 (791)
+++.+.............+++.|+|||+..+..++.++||||||+++|||++ |+.||...... .....+.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~--~- 232 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQGN--R- 232 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCC--C-
Confidence 9987654332222223346778999999998899999999999999999999 78888653211 1111111100 0
Q ss_pred hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 727 ~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
......++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 233 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 --------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001113456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=295.69 Aligned_cols=252 Identities=29% Similarity=0.392 Sum_probs=206.7
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--------hHHHHHHHHHHHHHHhc-cCCccceeeeeecc
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--------ERAFRSFDSECEVLRNV-RHRNLIKILSSCSN 568 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 568 (791)
.-..|...+.+|.|..++|.++..+ +|..+|+|++.... .+..++-.+|+.+++++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456788889999999999998765 78899999885432 33455677899999998 69999999999999
Q ss_pred CCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecc
Q 003855 569 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGI 648 (791)
Q Consensus 569 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl 648 (791)
+...++|+|.|+.|.|.|++.+.-. +++.+..+|++|+..|++||| ...|||||+||+|||+|++.++||+|||+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylH----a~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLH----ARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHH----HhhhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999987644 888999999999999999999 77899999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCCCccC------CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc
Q 003855 649 SKLLGEGEDSVTQTMTMATIGYMAPEYGS------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL 722 (791)
Q Consensus 649 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (791)
|+.+.+++. ....+||++|+|||.+. ...|+..+|+||.|||||.++.|.+||.. .....+.+.+..
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH--RkQmlMLR~Ime-- 242 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH--RKQMLMLRMIME-- 242 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--HHHHHHHHHHHh--
Confidence 998876653 33468999999999654 24588899999999999999999999964 222222221111
Q ss_pred CCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 723 PHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 723 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+-.+ -..+++.+++....++|.+|++.||++|.|++|+++
T Consensus 243 --Gkyq----------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 243 --GKYQ----------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred --cccc----------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1000 122455677788899999999999999999999986
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=316.85 Aligned_cols=248 Identities=25% Similarity=0.455 Sum_probs=197.7
Q ss_pred ccCCCcceEEEEEEec---CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCC
Q 003855 508 LLGTGSFGSVYKGTIS---DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGS 583 (791)
Q Consensus 508 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 583 (791)
.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ...++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999764 45679999986553 3345678999999999999999999998864 56789999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc-eee
Q 003855 584 LEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV-TQT 662 (791)
Q Consensus 584 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~~ 662 (791)
|.+++......+++..+.+++.|++.|++||| +.+++||||||+||+++.++.+||+|||+++......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE----GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999876667899999999999999999999 6789999999999999999999999999998654432211 111
Q ss_pred cccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 663 MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 663 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
...++..|+|||+.....++.++|||||||++||+++ |..||...... .....+....+ .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~-----------------~ 217 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGKR-----------------L 217 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCCC-----------------C
Confidence 1223578999999888889999999999999999996 99998764221 11111111000 0
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
..+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11123567788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.83 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=200.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999975 68999999997543 334566788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||+++.+....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH----KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999998654 4899999999999999999999 6789999999999999999999999999997653221
Q ss_pred Ccc------------------------------------eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhC
Q 003855 657 DSV------------------------------------TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 700 (791)
Q Consensus 657 ~~~------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg 700 (791)
... .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 100 01123689999999999988999999999999999999999
Q ss_pred CCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC---HHHHHH
Q 003855 701 KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRIN---VTDAAA 774 (791)
Q Consensus 701 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~ev~~ 774 (791)
..||......+ ....+... .... ..+....+++.+.+++.+|+. +|.+|++ +.|+++
T Consensus 236 ~~Pf~~~~~~~--~~~~i~~~-~~~~-------------~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQE--TYRKIINW-KETL-------------QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHHH--HHHHHHcC-CCcc-------------CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99997532211 11111100 0000 000111234567789999996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=333.48 Aligned_cols=201 Identities=25% Similarity=0.376 Sum_probs=175.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|+..+.||+|+||+||+|+.. +++.||+|++.... ......+..|+.++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999865 68999999997543 234456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH----~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH----QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999998654 4899999999999999999999 7899999999999999999999999999997653211
Q ss_pred Cc---------------------------------ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCC
Q 003855 657 DS---------------------------------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703 (791)
Q Consensus 657 ~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p 703 (791)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 00 001234799999999999988999999999999999999999999
Q ss_pred CCc
Q 003855 704 TDE 706 (791)
Q Consensus 704 ~~~ 706 (791)
|..
T Consensus 236 f~~ 238 (363)
T cd05628 236 FCS 238 (363)
T ss_pred CCC
Confidence 975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=316.23 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=197.2
Q ss_pred ccCCCcceEEEEEEec---CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCC
Q 003855 508 LLGTGSFGSVYKGTIS---DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNG 582 (791)
Q Consensus 508 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 582 (791)
.||+|+||.||+|.++ ++..||+|++.... ....+.+..|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999753 67889999986443 3345678899999999999999999999864 5678999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc-ee
Q 003855 583 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV-TQ 661 (791)
Q Consensus 583 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~ 661 (791)
+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+|||+++.+....... ..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE----ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999997654 4889999999999999999999 6789999999999999999999999999998765433221 11
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 740 (791)
....++..|+|||......++.++|||||||++|||++ |+.||..... ......+... . .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~---~--------------~ 216 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESG---E--------------R 216 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCC---C--------------C
Confidence 22234578999999888889999999999999999998 9999875322 1122221110 0 0
Q ss_pred hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 741 FSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 741 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
.+.+..++.++.+++.+||+.||++||++.+|.+.|++.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 011123556788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=319.81 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=200.6
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999864 78999999986543 2223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 578 FMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 578 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
|+++|+|.+++... ...+++..+..++.|++.|+.||| +.+++||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH----RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999988754 345899999999999999999999 6789999999999999999999999999998764322
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
. .....|+..|+|||++.+..++.++||||+||++|||++|+.||.+.... ..... +........
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~-~~~~~~~~~---------- 221 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREE-VERRVKEDQ---------- 221 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHH-HHHHhhhcc----------
Confidence 2 22346899999999998888999999999999999999999999753211 11111 111000000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAAK 775 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~~ 775 (791)
...+..++..+.+++.+|++.||++|| ++.++++.
T Consensus 222 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 ----EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ----cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 001123456678999999999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=318.39 Aligned_cols=257 Identities=25% Similarity=0.472 Sum_probs=206.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CC---cEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DG---TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.+.... ....+.+..|++++++++||||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999875 33 379999886542 3445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||++++++.+|++|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS----DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999876666899999999999999999999 67899999999999999999999999999987643
Q ss_pred CCCcce-eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 655 GEDSVT-QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 655 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
...... ......+..|+|||+...+.++.++|||||||++|||++ |+.||..... ......+.. ..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~~---~~------- 227 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAIND---GF------- 227 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhc---CC-------
Confidence 322111 111223457999999988889999999999999999998 9999865321 111111110 00
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
..+....++.++.+++.+|++.+|++||++.+|++.|+++
T Consensus 228 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111223556788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=327.06 Aligned_cols=240 Identities=24% Similarity=0.292 Sum_probs=189.9
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 68889999997643 22334455666777654 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH----KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 99999997654 4889999999999999999999 6789999999999999999999999999997643322 122
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... +.+....... +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~~~~------~--------- 213 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELFDSILNDR------P--------- 213 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHcCC------C---------
Confidence 3356899999999999888999999999999999999999999753211 1111110000 0
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINVT-DAA 773 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~-ev~ 773 (791)
..+..++.++.+++.+||+.||++||++. +++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00112345677999999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=315.27 Aligned_cols=254 Identities=27% Similarity=0.466 Sum_probs=201.3
Q ss_pred cccccccCCCcceEEEEEEecC----CcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCe-----
Q 003855 503 FNECNLLGTGSFGSVYKGTISD----GTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF----- 571 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 571 (791)
|.+.+.||+|+||.||+|.... +..||+|++.... ......+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 3679999987542 3345678999999999999999999998865443
Q ss_pred -eeEEEecCCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEee
Q 003855 572 -KALVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSD 645 (791)
Q Consensus 572 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~D 645 (791)
.++|+||+++|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS----NRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchheEEECCCCeEEECC
Confidence 78999999999999998632 235889999999999999999999 67899999999999999999999999
Q ss_pred eccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCC
Q 003855 646 FGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPH 724 (791)
Q Consensus 646 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 724 (791)
||+++...............++..|+|||++....++.++|||||||++|||++ |..||.+.... ...+++......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~ 234 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGNRL 234 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCC
Confidence 999987654433222222335678999999988899999999999999999999 88888653221 111221110000
Q ss_pred ChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 725 GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 725 ~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
..+..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus 235 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 235 -----------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -----------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=329.47 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=202.8
Q ss_pred hhccccccccCCCcceEEEEEEe------cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccC-C
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI------SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNP-D 570 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 570 (791)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36799999999999999999973 357889999987543 33456788899999999 689999999988654 4
Q ss_pred eeeEEEecCCCCCHHHHHhhCC----------------------------------------------------------
Q 003855 571 FKALVLEFMPNGSLEKWLYSHN---------------------------------------------------------- 592 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------- 592 (791)
..++||||+++|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 5789999999999999987421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecc
Q 003855 593 --------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT 664 (791)
Q Consensus 593 --------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 664 (791)
..+++..+.+++.|+++||+||| +.+|+||||||+||++++++.+||+|||+++..............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 13677888999999999999999 779999999999999999999999999999875433322222223
Q ss_pred cccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHH
Q 003855 665 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSA 743 (791)
Q Consensus 665 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 743 (791)
.++..|+|||...+..++.++||||||+++|||++ |..||......+. ....+..... ...
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~-----------------~~~ 303 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTR-----------------MRA 303 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhccCC-----------------CCC
Confidence 45678999999888889999999999999999997 8899865322111 1111100000 000
Q ss_pred HHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 744 KMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 744 ~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
+..++.++.+++.+||+.+|++||++.|+++.|+.+.+
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11133567899999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=317.69 Aligned_cols=256 Identities=27% Similarity=0.473 Sum_probs=206.7
Q ss_pred hccccccccCCCcceEEEEEEec----CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.+|++.+.||+|+||.||+|... .+..||+|.+.... ....+.+..|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999863 23479999886543 34456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++......+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||++..+...
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999877666899999999999999999999 678999999999999999999999999999876543
Q ss_pred CCcce-eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 656 EDSVT-QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 656 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
..... .....++..|+|||+..+..++.++||||||+++||+++ |..||...... .....+....
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~----------- 226 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGY----------- 226 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCC-----------
Confidence 32111 111223568999999988889999999999999999887 99998653221 1111111100
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
..+....++..+.+++.+|++.+|++||++.++++.|.++
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=349.29 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=205.4
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999865 68999999986532 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeee
Q 003855 577 EFMPNGSLEKWLYSH----------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDF 646 (791)
Q Consensus 577 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 646 (791)
||++||+|.+++... ....++..+.+++.||++||+||| +.+|+||||||+||+++.++.++|+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH----s~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH----SKGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH----HCCccccCCchheEEEcCCCCEEEEec
Confidence 999999999998631 123567788899999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCCc----------------ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccC
Q 003855 647 GISKLLGEGEDS----------------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG 710 (791)
Q Consensus 647 gla~~~~~~~~~----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~ 710 (791)
|+|+........ ......+||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 999876211100 0111246899999999999999999999999999999999999999752211
Q ss_pred cchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHHHH
Q 003855 711 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRI-NVTDAAAKLKKIKVK 782 (791)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~ev~~~L~~~~~~ 782 (791)
...... .. .+ ........+++..+.+++.+|++.||++|| ++.++.+.|+.....
T Consensus 238 ki~~~~----~i-------~~------P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KISYRD----VI-------LS------PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhhh----hc-------cC------hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 111000 00 00 000011124566788999999999999996 667777888777554
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=321.86 Aligned_cols=261 Identities=24% Similarity=0.364 Sum_probs=201.1
Q ss_pred hccccccccCCCcceEEEEEEecC---------------CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISD---------------GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILS 564 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~ 564 (791)
++|++.+.||+|+||.||++.... ...||+|.+.... ......+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987532 2358999987543 334567899999999999999999999
Q ss_pred eeccCCeeeEEEecCCCCCHHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCe
Q 003855 565 SCSNPDFKALVLEFMPNGSLEKWLYSHN-----------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNI 633 (791)
Q Consensus 565 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Ni 633 (791)
++......++||||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Ni 160 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA----SLNFVHRDLATRNC 160 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH----hcCeeccccChhhE
Confidence 9999999999999999999999996432 23688899999999999999999 67899999999999
Q ss_pred EeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh--CCCCCCccccCc
Q 003855 634 LLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKRPTDEMFTGE 711 (791)
Q Consensus 634 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~~~~ 711 (791)
++++++.+||+|||+++...............++..|+|||+...+.++.++|||||||++|||++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 999999999999999986544332222233345778999999888889999999999999999998 55677642211
Q ss_pred chHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 712 MSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
.................. ......++..+.+++.+|++.+|++||++.+|++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGRQIY-----------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhcccccc-----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111000000000000 0001124567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=322.90 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=204.2
Q ss_pred HhhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF 571 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 571 (791)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999753 24579999876443 2234467889999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEE
Q 003855 572 KALVLEFMPNGSLEKWLYSHN---------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAH 642 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~k 642 (791)
.++||||+++|+|.+++.... ...++..+..++.|++.||.||| +++|+||||||+||++++++.++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN----AKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999997421 23466788899999999999999 67899999999999999999999
Q ss_pred EeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHh
Q 003855 643 VSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKES 721 (791)
Q Consensus 643 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 721 (791)
++|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||...... ...+++.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~-- 235 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLKFVM-- 235 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH--
Confidence 999999986544332222222345678999999988899999999999999999999 78888653211 1111111
Q ss_pred cCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 722 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 722 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
..... ..+..++..+.+++.+|++.+|++||++.|+++.++...
T Consensus 236 -~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 -DGGYL--------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -cCCCC--------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00000 001133467889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=316.38 Aligned_cols=253 Identities=28% Similarity=0.454 Sum_probs=203.1
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
++|++.++||+|+||.||+|+..++..||+|++..... ..+.+..|+.++++++||||+++++++.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 56899999999999999999987777899999875332 23568889999999999999999998754 55789999999
Q ss_pred CCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 581 NGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 581 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
+|+|.+++... ...+++..+..++.|+++||+|+| +.+++||||||+||++++++.++|+|||.++.+......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 99999999864 345789999999999999999999 678999999999999999999999999999876443221
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......++..|+|||+..++.++.++||||||+++|||+| |..||......+. ........
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-----~~~~~~~~------------- 220 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQVERGY------------- 220 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-----HHHHhcCC-------------
Confidence 1122346678999999988889999999999999999999 7888865322110 11000000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
..+....++..+.+++.+|++.+|++||++.++.+.|+..
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0011124567788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=321.30 Aligned_cols=262 Identities=24% Similarity=0.375 Sum_probs=205.5
Q ss_pred hhccccccccCCCcceEEEEEEecC-----------------CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccce
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISD-----------------GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 561 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 561 (791)
.++|++.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999997542 2458999987553 345667889999999999999999
Q ss_pred eeeeeccCCeeeEEEecCCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCC
Q 003855 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHN----------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPT 631 (791)
Q Consensus 562 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~ 631 (791)
+++++...+..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH----~~~i~H~dlkp~ 159 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE----SLNFVHRDLATR 159 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH----HcCccccccchh
Confidence 9999999899999999999999999997543 25899999999999999999999 678999999999
Q ss_pred CeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh--CCCCCCcccc
Q 003855 632 NILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKRPTDEMFT 709 (791)
Q Consensus 632 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~~ 709 (791)
||+++.++.++|+|||+++...............++..|+|||+...+.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999987644433233334456788999999888889999999999999999998 6677754321
Q ss_pred CcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 710 GEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
....+............. ..+.+..++.++.+++.+|++.||++|||+.|+++.|+
T Consensus 240 --~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQI----------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhccccccccc----------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111100000000 00011234567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=330.45 Aligned_cols=242 Identities=23% Similarity=0.266 Sum_probs=194.5
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNG 582 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 582 (791)
+.||+|+||.||+++.. +++.||+|++.... ......+..|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 78999999997643 234456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceee
Q 003855 583 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT 662 (791)
Q Consensus 583 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 662 (791)
+|.+++.... .+++..+..++.||+.||+|||+ ..+|+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~---~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS---EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 154 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence 9999887654 48999999999999999999993 26899999999999999999999999999875432211 122
Q ss_pred cccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhH
Q 003855 663 MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFS 742 (791)
Q Consensus 663 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 742 (791)
...||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+. .... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--~~~~~~i~---~~~~---------------~ 214 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELIL---MEEI---------------R 214 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--HHHHHHHh---cCCC---------------C
Confidence 34689999999999888999999999999999999999999965221 11111110 0000 0
Q ss_pred HHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 743 AKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 743 ~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
.+..++.++.+++.+|++.||++|+ ++.++++
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 0112345678999999999999997 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=327.39 Aligned_cols=236 Identities=25% Similarity=0.322 Sum_probs=190.6
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.+ +++.||||++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 68899999987543 23455677888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++....... ..
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH----~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TT 153 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cc
Confidence 99999998654 3889999999999999999999 67899999999999999999999999999875432211 22
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+........
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~~--------------- 213 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILNDEV--------------- 213 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhcCCC---------------
Confidence 3346899999999999889999999999999999999999999753211 11111111000
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINV 769 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~ 769 (791)
..+..++.++.+++.+|++.||++||++
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0011234567899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=326.71 Aligned_cols=247 Identities=21% Similarity=0.265 Sum_probs=195.0
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999865 78899999997643 23345678899999988 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++....... ..
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TT 153 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--cc
Confidence 99999987654 4899999999999999999999 77999999999999999999999999999875322111 22
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccC---cchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG---EMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
....||..|+|||++.+..++.++|||||||++|||++|+.||+..... .....++........ .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------------~ 221 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK------------Q 221 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC------------C
Confidence 2346899999999999999999999999999999999999999742211 111112211111110 0
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCC------HHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRIN------VTDAAA 774 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt------~~ev~~ 774 (791)
.. .+..++.++.+++.+|++.||++||+ +.|+++
T Consensus 222 ~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 222 IR--IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CC--CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 00 11124456789999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=326.46 Aligned_cols=242 Identities=21% Similarity=0.268 Sum_probs=191.0
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999997643 23445677888888877 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TT 153 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--cc
Confidence 99999887654 4899999999999999999999 67899999999999999999999999999975422211 22
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccC---cchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG---EMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
....||..|+|||++.+..++.++|||||||++|||++|+.||...... ......++....... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------------~ 221 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------------Q 221 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC------------C
Confidence 2346899999999999999999999999999999999999999642211 111112211111000 0
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINV 769 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 769 (791)
. ..+..++.++.+++.+||+.||++||++
T Consensus 222 ~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 I--RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred C--CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 0 0111344567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.87 Aligned_cols=244 Identities=23% Similarity=0.292 Sum_probs=194.1
Q ss_pred cCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCH
Q 003855 509 LGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSL 584 (791)
Q Consensus 509 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 584 (791)
||+|+||+||++... +++.||+|.+.... ....+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 78899999987543 22345677899999999999999999999999999999999999999
Q ss_pred HHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 585 EKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 585 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
.+++.. ....+++..+..++.||+.||.||| +.+|+||||||+||++++++.++|+|||++..+...... .
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~ 154 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH----QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--T 154 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--c
Confidence 988853 2345899999999999999999999 678999999999999999999999999999876443221 2
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
....|++.|+|||++.+..++.++|||||||++|||++|+.||....... ............. .
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~---------------~ 218 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILNDS---------------V 218 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcccC---------------C
Confidence 23468999999999999999999999999999999999999997532211 1111111100000 0
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
..+..++..+.+++.+|++.||++|| ++.++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 01123456788999999999999999 6667665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=328.30 Aligned_cols=251 Identities=24% Similarity=0.274 Sum_probs=197.6
Q ss_pred ccccccccCCCcceEEEEEEe----cCCcEEEEEEeehhh----hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCee
Q 003855 502 EFNECNLLGTGSFGSVYKGTI----SDGTDVAIKIFNLQL----ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 572 (791)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+..|+.+++.+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999875 368899999987542 23345678899999999 599999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||+++|+|.+++..... +++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN-FSEDEVRFYSGEIILALEHLH----KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 999999999999999986543 889999999999999999999 678999999999999999999999999999865
Q ss_pred CCCCCcceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
...... ......||..|+|||++.+. .++.++|||||||++|||+||+.||........ ........... +
T Consensus 156 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~------~ 227 (332)
T cd05614 156 LSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKC------D 227 (332)
T ss_pred cccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcC------C
Confidence 433222 12234689999999988764 478899999999999999999999965322111 11111110000 0
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
+ ..+..++..+.+++.+|++.||++|| ++.++++
T Consensus 228 ~---------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 P---------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0 00112345678999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=331.73 Aligned_cols=254 Identities=20% Similarity=0.287 Sum_probs=201.1
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3578999999999999999999875 68899999987542 2334557789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++.... ++...+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999987643 788888899999999999999 67899999999999999999999999999987643
Q ss_pred CCCcceeecccccccccCCCccCCC----CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEG----IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+........ .
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~--~----- 265 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMDHKN--S----- 265 (370)
T ss_pred CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHcCCC--c-----
Confidence 221 122335689999999987543 4889999999999999999999999752211 11111100000 0
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDM--RINVTDAAAK 775 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~ev~~~ 775 (791)
...+....++.++.+++.+|++.+|++ ||++.|+++.
T Consensus 266 --------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 --------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 001111134567789999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.54 Aligned_cols=269 Identities=23% Similarity=0.393 Sum_probs=204.6
Q ss_pred ccccccccCCCcceEEEEEEe-----cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccC--Ceee
Q 003855 502 EFNECNLLGTGSFGSVYKGTI-----SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP--DFKA 573 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 573 (791)
-|++.+.||+|+||.||.+++ .++..||+|.+.... ....+.+.+|+.++++++||||+++.+++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999974 357889999986543 34456789999999999999999999998764 5688
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+||||+++++|.+++.+....+++.++..++.|++.||+||| +.+++||||||+||+++.++.++|+|||+++.+.
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH----~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 999999999999999876556899999999999999999999 6789999999999999999999999999998765
Q ss_pred CCCCcc-eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC-Chhhhcc
Q 003855 654 EGEDSV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH-GLTEVVD 731 (791)
Q Consensus 654 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~d 731 (791)
...... ......++..|+|||+..+..++.++|||||||++|||+|++.|....... ..........+ .....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhcccccccccHHHHHH
Confidence 433221 112234667899999988888999999999999999999987764321110 00000000000 0000000
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
.+ ......+....++..+.+++.+|++.+|++||++.|+++.++.+
T Consensus 238 -~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 -VL-EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HH-HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 00001111224567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=327.20 Aligned_cols=241 Identities=25% Similarity=0.281 Sum_probs=193.4
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccC-CccceeeeeeccCCeeeEEE
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRH-RNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 576 (791)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|.+++..+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999865 67899999987543 2345667889999999976 46888999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 99999999999976543 789999999999999999999 6789999999999999999999999999987532211
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
. ......||+.|+|||++.+..++.++||||+||++|||+||+.||...... .....+.. ..
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~---~~----------- 217 (324)
T cd05587 156 K--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIME---HN----------- 217 (324)
T ss_pred C--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHc---CC-----------
Confidence 1 223346899999999999999999999999999999999999999753211 11111111 00
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINV 769 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 769 (791)
...+..++.++.+++.+|++.||++||+.
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 ----VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00011234567899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=322.04 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=202.9
Q ss_pred hccccccccCCCcceEEEEEEec-CCc--EEEEEEeehh-hhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGT--DVAIKIFNLQ-LERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 575 (791)
++|++.+.||+|+||.||+|..+ ++. .+++|.++.. .....+.+..|+.+++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57889999999999999999875 333 4788887643 234456788999999999 799999999999998999999
Q ss_pred EecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc
Q 003855 576 LEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA 640 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~ 640 (791)
+||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS----EKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCcCCcceEEECCCCe
Confidence 99999999999997532 24788999999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHH
Q 003855 641 AHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVK 719 (791)
Q Consensus 641 ~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 719 (791)
+||+|||++...... ........+..|+|||+.....++.++|||||||++|||++ |..||...... .+..
T Consensus 158 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-----~~~~ 229 (297)
T cd05089 158 SKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-----ELYE 229 (297)
T ss_pred EEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH
Confidence 999999998643211 11111223567999999988889999999999999999998 99998653221 1111
Q ss_pred HhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 720 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 720 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
.... .. ....+..++..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 230 ~~~~-~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 KLPQ-GY-------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHhc-CC-------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1100 00 00011234567889999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.66 Aligned_cols=246 Identities=22% Similarity=0.305 Sum_probs=194.4
Q ss_pred cCCCcceEEEEEEec-CCcEEEEEEeehhhh---HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCH
Q 003855 509 LGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSL 584 (791)
Q Consensus 509 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 584 (791)
||+|+||.||+++.+ +|+.||+|.+..... ...+.+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 689999999865321 2234456799999999999999999999999999999999999999
Q ss_pred HHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeec
Q 003855 585 EKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM 663 (791)
Q Consensus 585 ~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 663 (791)
.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH----SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 9988643 335889999999999999999999 6789999999999999999999999999998764322 2233
Q ss_pred ccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHH
Q 003855 664 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSA 743 (791)
Q Consensus 664 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 743 (791)
..|+..|+|||++.+..++.++||||+||++|||++|+.||....... ............... ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~--------------~~ 218 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDEVK--------------FE 218 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhccccc--------------cc
Confidence 468899999999988889999999999999999999999987532211 111111111110000 00
Q ss_pred HHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 744 KMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 744 ~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
...++.++.+++.+||+.||++||+++|+++..
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 012456678999999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=314.85 Aligned_cols=239 Identities=21% Similarity=0.320 Sum_probs=190.9
Q ss_pred cccCCCcceEEEEEEecC-------------CcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 507 NLLGTGSFGSVYKGTISD-------------GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
+.||+|+||.||+|+..+ ...||+|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999887665556667888999999999999999999999888999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc-------EEEeee
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA-------AHVSDF 646 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~-------~kl~Df 646 (791)
+||||+++|+|..++......+++..+.+++.||++|++||| +.+|+||||||+||+++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE----DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh----hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999998876666899999999999999999999 778999999999999987664 899999
Q ss_pred ccccccCCCCCcceeecccccccccCCCccC-CCCCCccccHHhHHHHHHHHH-hCCCCCCccccCcchHHHHHHHhcCC
Q 003855 647 GISKLLGEGEDSVTQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETF-TRKRPTDEMFTGEMSLRRWVKESLPH 724 (791)
Q Consensus 647 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (791)
|++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..|+......+ .......
T Consensus 157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~---- 224 (262)
T cd05077 157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYEG---- 224 (262)
T ss_pred CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHhc----
Confidence 998754321 2235788899999876 467899999999999999998 5888876422111 1111000
Q ss_pred ChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 725 GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 725 ~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
.. .. ....+.++.+++.+||+.||++||++.++++.+
T Consensus 225 ~~-~~--------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QC-ML--------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Cc-cC--------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 00 001235678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=336.02 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=197.7
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999864 78999999986542 334567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+.+....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH----~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH----KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999998654 4788899999999999999999 7899999999999999999999999999996432210
Q ss_pred Cc---------------------------------------------ceeecccccccccCCCccCCCCCCccccHHhHH
Q 003855 657 DS---------------------------------------------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYG 691 (791)
Q Consensus 657 ~~---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G 691 (791)
.. ......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 000124689999999999888999999999999
Q ss_pred HHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCC---CC
Q 003855 692 VLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMR---IN 768 (791)
Q Consensus 692 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---Pt 768 (791)
|++|||++|+.||...... ..+..... . .... ..+....++.++.+++.+|+. +|.+| ++
T Consensus 236 vil~elltG~~Pf~~~~~~-~~~~~i~~-~-~~~~-------------~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 236 AIMFECLIGWPPFCSENSH-ETYRKIIN-W-RETL-------------YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhhcCCCCCCCCCHH-HHHHHHHc-c-CCcc-------------CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 9999999999999653211 11111100 0 0000 001111234567799999997 77765 59
Q ss_pred HHHHHHH
Q 003855 769 VTDAAAK 775 (791)
Q Consensus 769 ~~ev~~~ 775 (791)
+.|+++.
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9988764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.80 Aligned_cols=247 Identities=30% Similarity=0.487 Sum_probs=199.6
Q ss_pred cccCCCcceEEEEEEecCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCHH
Q 003855 507 NLLGTGSFGSVYKGTISDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLE 585 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 585 (791)
+.||+|+||.||+|...+++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998888999999886543 333456889999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeeccc
Q 003855 586 KWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM 665 (791)
Q Consensus 586 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 665 (791)
+++......+++..+..++.|++.||.|+| ..+++||||||+||++++++.+|++|||++......... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~ 155 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQ 155 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCC
Confidence 999876666899999999999999999999 678999999999999999999999999999754332211 111223
Q ss_pred ccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHH
Q 003855 666 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAK 744 (791)
Q Consensus 666 g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 744 (791)
++..|+|||+..++.++.++||||||+++||+++ |..||...... .....+..... ...+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~~~~-----------------~~~~ 216 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEKGYR-----------------MSCP 216 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCC-----------------CCCC
Confidence 4678999999988899999999999999999998 99998653221 11111111000 0001
Q ss_pred HHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 745 MDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 745 ~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
..++..+.+++.+|++.+|++||++.|++++|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 134567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=327.17 Aligned_cols=241 Identities=23% Similarity=0.252 Sum_probs=193.1
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 67899999987643 23345677788888876 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH----RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TT 153 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cc
Confidence 99999987654 3889999999999999999999 67899999999999999999999999999976432221 22
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+. ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~i~---~~~~--------------- 213 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFESIL---HDDV--------------- 213 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHHHHH---cCCC---------------
Confidence 3346899999999999889999999999999999999999999753211 1111111 0000
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCC-------CHHHHHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRI-------NVTDAAA 774 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RP-------t~~ev~~ 774 (791)
..+..++.++.+++.+|++.||++|| ++.++++
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 00112345678999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=325.01 Aligned_cols=245 Identities=27% Similarity=0.324 Sum_probs=203.1
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehh---hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
-|...+.||.|+||.||-|+.. +.+.||||.+... ..+.+.++.+|+.++++++|||++.+-|||......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3555678999999999999864 7889999988644 34557889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|| -|+-.|.+.-++.++.+.++..|+.+.++||+||| +.+.||||||+.|||+++.|.||++|||.|....+.
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH----S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH----HhhHHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 99 56999999887778999999999999999999999 788999999999999999999999999999876543
Q ss_pred cceeecccccccccCCCcc---CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 658 SVTQTMTMATIGYMAPEYG---SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
...+||+.|||||++ ..+.|+-|+||||+||+..|+..+++|+-.+... +...-+....+.
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--SALYHIAQNesP---------- 243 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNESP---------- 243 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--HHHHHHHhcCCC----------
Confidence 336799999999974 4688999999999999999999999997553211 111111111110
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.....+++..+..++..|++.-|++|||..++++.
T Consensus 244 ------tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 244 ------TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ------CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 01123567788899999999999999999988764
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=310.40 Aligned_cols=249 Identities=25% Similarity=0.321 Sum_probs=203.7
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehh--hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+|...+.||+|+||.||+|..+ +++.|++|.+... .....+.+..|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999875 7899999988643 234456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++++|.+++... ...+++..+..++.|++.|+.||| ..+++||||+|+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH----SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999864 456899999999999999999999 67899999999999999999999999999987654322
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
. .....|+..|+|||+..+..++.++||||||+++|||++|+.||..... ....+.+.. ....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~---~~~~---------- 219 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKIIR---GVFP---------- 219 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHc---CCCC----------
Confidence 1 2234578899999999988999999999999999999999999975321 111111110 0000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.....++..+.+++.+||+.+|++||++.++++.
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 ----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0011345668899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=316.05 Aligned_cols=253 Identities=26% Similarity=0.467 Sum_probs=203.2
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|++.+.||+|+||.||+|..+++..||+|.+..... ..+.+.+|+.++++++|||++++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 467889999999999999999988888999999875432 23568899999999999999999998854 5678999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++++|.+++... ...+++.++..++.+++.|++||| +.+++||||||+||++++++.++|+|||++..+......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE----RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999999864 345899999999999999999999 678999999999999999999999999999876443221
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
......++..|+|||+..+..++.++||||||+++|||++ |..||...... ...+.+....+
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~-------------- 221 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGYR-------------- 221 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC--------------
Confidence 1122235678999999888889999999999999999999 88898653211 11111111000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
.+.+..++..+.+++.+|++.+|++|||+.++.+.|++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 ---MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112345678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=324.11 Aligned_cols=240 Identities=25% Similarity=0.328 Sum_probs=191.2
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 67899999997653 23345566777888764 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH----~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH----SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KT 153 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ce
Confidence 99999998653 3789999999999999999999 67899999999999999999999999999975322211 12
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+....+ .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~~----------------~- 214 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMDNP----------------C- 214 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCC----------------C-
Confidence 2346899999999999889999999999999999999999999753211 11111110000 0
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINVT-DAA 773 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~-ev~ 773 (791)
.+..++.++.+++.+|++.||++||++. ++.
T Consensus 215 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 -YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 0012345677999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=320.00 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=205.1
Q ss_pred hhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
.++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 468899999999999999999864 24689999986443 33456788899999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003855 573 ALVLEFMPNGSLEKWLYSHN---------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV 643 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl 643 (791)
++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||++++++.+||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA----AKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccChheEEEcCCCCEEE
Confidence 99999999999999997432 23678899999999999999999 678999999999999999999999
Q ss_pred eeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhc
Q 003855 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL 722 (791)
Q Consensus 644 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 722 (791)
+|||+++...............++..|+|||...++.++.++|||||||++||++| |..||..... ....+++..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~-- 236 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVID-- 236 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHHhc--
Confidence 99999987654432222233456789999999988889999999999999999998 8999865321 112222110
Q ss_pred CCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 723 PHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 723 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
... ...+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 237 -~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 -GGH--------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -CCC--------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000 0011123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=312.60 Aligned_cols=258 Identities=25% Similarity=0.349 Sum_probs=208.8
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|+..+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999976 89999999886422 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 577 EFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 577 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
||+++|+|.+++.. ....+++.++..++.++++|+.||| +.+++||||+|+||++++++.++++|||+++...
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH----SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999999864 2345889999999999999999999 6799999999999999999999999999987654
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.... ......++..|+|||...+..++.++|||||||++|||++|+.||.... ....++...........
T Consensus 158 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~----- 227 (267)
T cd08224 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEKCDYPP----- 227 (267)
T ss_pred CCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhcCCCCC-----
Confidence 3221 1222457889999999988889999999999999999999999985422 22222211111000000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
. ....++..+.+++.+||+.+|++||++.++++++++++
T Consensus 228 ~--------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 L--------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C--------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 01134566889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=318.39 Aligned_cols=258 Identities=24% Similarity=0.440 Sum_probs=208.0
Q ss_pred hccccccccCCCcceEEEEEEec-CCc----EEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGT----DVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.+|++.+.||+|+||.||+|..+ +|+ .||+|...... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 57888999999999999999864 333 58999876553 3445678899999999999999999999987 77899
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++......+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE----EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 99999999999999877666899999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
...........++..|+|||......++.++||||||+++||+++ |+.||+.... ....+.+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~----------- 228 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEKGE----------- 228 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhCCC-----------
Confidence 333222222234568999999888889999999999999999998 9999875321 11222221100
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+.+..++..+.+++.+||..+|.+||++.+++++|+++.+.
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0011112345677999999999999999999999999998553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=321.30 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=203.9
Q ss_pred hhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
.++|+..+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999863 46789999986543 33456788999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCC
Q 003855 573 ALVLEFMPNGSLEKWLYSHN---------------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPT 631 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~ 631 (791)
++||||+++|+|.+++.... ..+++..++.++.|++.||+||| ..+++||||||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH----~~~i~H~dl~p~ 159 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS----ERKFVHRDLATR 159 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCeecccccHh
Confidence 99999999999999997431 23678889999999999999999 678999999999
Q ss_pred CeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccC
Q 003855 632 NILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTG 710 (791)
Q Consensus 632 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~ 710 (791)
||++++++.++|+|||+++.+..............+..|+|||...+..++.++|||||||++|||++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999976543322222222345678999999888899999999999999999998 88888543211
Q ss_pred cchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 711 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
++......... .+.+..++.++.+++.+|++.+|++||++.|+++.|++
T Consensus 240 -----~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -----EVIYYVRDGNV--------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHHHhcCCC--------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111110000 00111345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=335.21 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=195.6
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.|+.++.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 78899999987543 3445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH----~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999997654 4788889999999999999999 67899999999999999999999999999864321000
Q ss_pred ---------------------------------------------cceeecccccccccCCCccCCCCCCccccHHhHHH
Q 003855 658 ---------------------------------------------SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGV 692 (791)
Q Consensus 658 ---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~ 692 (791)
.......+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011236899999999999889999999999999
Q ss_pred HHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC---H
Q 003855 693 LLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRIN---V 769 (791)
Q Consensus 693 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~ 769 (791)
++|||++|+.||....+.+ ....... . .... ..+.....++++.+++.+++ .+|++|++ +
T Consensus 237 il~elltG~~Pf~~~~~~~-~~~~i~~-~-~~~~-------------~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLE-TQMKVIN-W-QTSL-------------HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHHhCCCCCCCCCHHH-HHHHHHc-c-CCCc-------------CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 9999999999997532211 1111100 0 0000 00111123455677887776 49999997 7
Q ss_pred HHHHH
Q 003855 770 TDAAA 774 (791)
Q Consensus 770 ~ev~~ 774 (791)
.|+++
T Consensus 300 ~ei~~ 304 (382)
T cd05625 300 DEIKA 304 (382)
T ss_pred HHHhc
Confidence 77764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=336.72 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=197.5
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999864 68999999986542 233466888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999998654 3788888999999999999999 6789999999999999999999999999985332100
Q ss_pred C-----------------------------------------cceeecccccccccCCCccCCCCCCccccHHhHHHHHH
Q 003855 657 D-----------------------------------------SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLM 695 (791)
Q Consensus 657 ~-----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ 695 (791)
. .......+||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0 00011246899999999999999999999999999999
Q ss_pred HHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC---CHHHH
Q 003855 696 ETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRI---NVTDA 772 (791)
Q Consensus 696 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP---t~~ev 772 (791)
||++|+.||......+. ... +... .... ..+....++.++.+++.+|+ .+|++|+ ++.|+
T Consensus 236 ell~G~~Pf~~~~~~~~-~~~-i~~~-~~~~-------------~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 236 EMLVGQPPFLADTPAET-QLK-VINW-ETTL-------------HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred ehhhCCCCCCCCCHHHH-HHH-Hhcc-Cccc-------------cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 99999999976322111 000 0000 0000 00111123455678888876 5999999 88888
Q ss_pred HHH
Q 003855 773 AAK 775 (791)
Q Consensus 773 ~~~ 775 (791)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=325.88 Aligned_cols=241 Identities=24% Similarity=0.275 Sum_probs=193.6
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEE
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 576 (791)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|..++..+ +||+|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999875 67899999987643 22334566788888777 5899999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 99999999999976543 889999999999999999999 6789999999999999999999999999997543221
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+.. ...
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~---~~~---------- 218 (323)
T cd05616 156 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIME---HNV---------- 218 (323)
T ss_pred --CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HHHHHHHHh---CCC----------
Confidence 122334689999999999999999999999999999999999999975321 111111111 000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINV 769 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 769 (791)
..+...+.++.+++.+|++.||++|++.
T Consensus 219 -----~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -----AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0011234567899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=314.87 Aligned_cols=253 Identities=24% Similarity=0.426 Sum_probs=204.5
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|++.++||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 467899999999999999999988899999999875433 2457888999999999999999999874 45689999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++|+|.+++... +..+++.++..++.|++.||+||| +.+++||||||+||++++++.++++|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE----RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 999999998754 345899999999999999999999 67899999999999999999999999999987643221
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
.......++..|+|||+.....++.++||||||+++||+++ |+.||.+.... ...+.+.....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~-------------- 221 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGYR-------------- 221 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCCC--------------
Confidence 12222345678999999988889999999999999999999 99999753221 11111111000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
.+.+..++.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 ---MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01112344678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=316.82 Aligned_cols=254 Identities=22% Similarity=0.331 Sum_probs=201.6
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999996 47889999998765545556788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++++|.++++... .+++..+..++.|++.|+.||| +.+|+|||++|+||++++++.++|+|||+++.......
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH----SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 99999999987554 4789999999999999999999 67899999999999999999999999999986643221
Q ss_pred ceeecccccccccCCCccC---CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 659 VTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
......++..|+|||.+. ...++.++|||||||++|||++|+.||......+. ...+.. .... .+..
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~----~~~~---~~~~- 231 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSK----SNFQ---PPKL- 231 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeec----CCCC---CCCC-
Confidence 122345788999999863 45578899999999999999999999864321111 000000 0000 0000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.....++..+.+++.+||+.+|++||++.++++.
T Consensus 232 ------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 ------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred ------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0011244678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=324.57 Aligned_cols=241 Identities=24% Similarity=0.272 Sum_probs=194.1
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.. +++.||||++.... ......+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 68899999997653 23445677888898888 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH----ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TT 153 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cc
Confidence 99999987654 4899999999999999999999 67899999999999999999999999999875322211 12
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.. ...
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~i~~---~~~--------------- 213 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQSILE---DEV--------------- 213 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHHHHc---CCC---------------
Confidence 234689999999999999999999999999999999999999975321 111111110 000
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINV-----TDAAA 774 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~-----~ev~~ 774 (791)
..+..++..+.+++.+||+.||++||++ .++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0011244667899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.18 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=203.6
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.+|+..+.||+|+||.||+|... +++.||+|.+........+.+..|+.+++.++||||+++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888999999999999999864 78999999987665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++++|.+++... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH----~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-- 171 (296)
T cd06654 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (296)
T ss_pred CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence 999999998754 3788999999999999999999 67899999999999999999999999999886543221
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
......+++.|+|||...+..++.++|||||||++|||++|+.||...... ..+... ........
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~~~~~~-~~~~~~~~---------- 236 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYLI-ATNGTPEL---------- 236 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----HhHHHH-hcCCCCCC----------
Confidence 122346888999999998888999999999999999999999999653221 111110 00000000
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..+...+..+.+++.+||..+|++||++.|+++.
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0011344567899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.81 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=206.1
Q ss_pred hccccccccCCCcceEEEEEEecC----CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISD----GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
++|...+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 568888999999999999998643 3468999887554 4456788999999999999999999999875 456899
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++......+++..+..++.+++.|++||| +.+++||||||+||+++.++.++++|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE----SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999999999876656899999999999999999999 678999999999999999999999999999866443
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
.. .......++..|+|||......++.++||||||+++||+++ |..||......+ ...++... .
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~--~---------- 225 (270)
T cd05056 161 SY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENG--E---------- 225 (270)
T ss_pred cc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcC--C----------
Confidence 21 11222234568999999888889999999999999999996 999987543221 11111100 0
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+.+..++..+.+++.+|+..+|++|||+.++++.|..++..
T Consensus 226 -----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 -----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011124556788999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=329.66 Aligned_cols=254 Identities=20% Similarity=0.287 Sum_probs=199.4
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4578999999999999999999975 68899999986532 2334567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++.... +++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+|+....
T Consensus 121 v~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~LH----~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIH----SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999997653 788899999999999999999 67899999999999999999999999999987643
Q ss_pred CCCcceeecccccccccCCCccCCC----CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEG----IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+.+...... .
T Consensus 195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-~~~~~~i~~~~~--~----- 265 (370)
T cd05621 195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-VGTYSKIMDHKN--S----- 265 (370)
T ss_pred CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCc--c-----
Confidence 222 122345699999999987653 378899999999999999999999975321 111111111000 0
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDM--RINVTDAAAK 775 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~ev~~~ 775 (791)
...+.....+..+.+++..|+..+|.+ ||++.|+++.
T Consensus 266 --------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 --------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 001111234566778999999865543 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.63 Aligned_cols=271 Identities=27% Similarity=0.390 Sum_probs=208.7
Q ss_pred hccccccccCCCcceEEEEEEec-----CCcEEEEEEeehhhhH-HHHHHHHHHHHHHhccCCccceeeeeecc--CCee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-----DGTDVAIKIFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSCSN--PDFK 572 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 572 (791)
+.|+..+.||+|+||.||+|++. ++..||||++...... ..+.+.+|+++++.+.||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777889999999999999853 3688999998765443 56789999999999999999999999877 5678
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||+++++|.+++......+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG----SQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 9999999999999999877666999999999999999999999 678999999999999999999999999999877
Q ss_pred CCCCCcce-eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 653 GEGEDSVT-QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 653 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
........ .....++..|+|||...+..++.++||||||+++|||+||+.|+......... +............+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~ 236 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLL 236 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHH
Confidence 53322211 11223456799999998889999999999999999999999987653221110 000000000000000
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
..+. .....+.+..++.++.+++.+||+.+|++||++.||+++|+.+
T Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLK-EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHH-cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000 0011112234567789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.72 Aligned_cols=249 Identities=27% Similarity=0.369 Sum_probs=205.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
++|+..+.||+|+||.||+|... +++.||+|.+..... .+.+.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57889999999999999999976 488999999875533 578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++++|.+++......+++..+..++.|++.|+.||| ..+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH----SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999876667899999999999999999999 67899999999999999999999999999987654321
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
......++..|+|||++.+..++.++||||||+++|||++|+.||......+... .+......
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~--------------- 217 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--MIPNKPPP--------------- 217 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--hhccCCCC---------------
Confidence 2223457889999999988899999999999999999999999987532221100 00000000
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
....+..++..+.+++.+|++.+|++||++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00111234466889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=312.04 Aligned_cols=255 Identities=27% Similarity=0.344 Sum_probs=201.3
Q ss_pred HHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
+.+++++.....||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 344566666779999999999999864 6788999998766656667889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-CCcEEEeeecccccc
Q 003855 576 LEFMPNGSLEKWLYSHNYFL--DILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-NMAAHVSDFGISKLL 652 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla~~~ 652 (791)
+||+++++|.+++......+ ++..+..++.|++.|++||| +.+|+||||||+||+++. ++.++|+|||++...
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH----DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999998654435 78888999999999999999 678999999999999986 679999999999765
Q ss_pred CCCCCcceeecccccccccCCCccCCCC--CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
..... ......++..|+|||+..... ++.++||||||+++|||++|+.||........ ..+.......
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~~~------ 229 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMFKI------ 229 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhhcc------
Confidence 43221 122235788999999876543 78899999999999999999999865322111 1110000000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+ ..+..++.++.+++.+||+.+|++|||+.|+++
T Consensus 230 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 HP---------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CC---------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00 011134466789999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.07 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=201.6
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-----hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-----ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56889999999999999999864 68999999876432 2234578889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
|+||+++++|.+++.... .+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999998654 3788899999999999999999 67899999999999999999999999999986543
Q ss_pred CCCcce-eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVT-QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
...... .....++..|+|||...+..++.++||||+|+++|||++|+.||...... ....+ .. .....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~-~~--~~~~~------- 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-AAIFK-IA--TQPTN------- 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-HHHHH-Hh--ccCCC-------
Confidence 221111 12345778999999999888999999999999999999999998653111 11111 00 00000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
...+..++..+.+++.+||..+|++|||+.|+++.
T Consensus 226 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00111345667899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.79 Aligned_cols=265 Identities=18% Similarity=0.281 Sum_probs=201.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|...+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999865 68889999986543 22334577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++ ++.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 975 899998876666899999999999999999999 67899999999999999999999999999976433221
Q ss_pred ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC----hhhhcc--
Q 003855 659 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG----LTEVVD-- 731 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~d-- 731 (791)
......++..|+|||.+.+ ..++.++||||+||++|||+||+.||...... ..+..... ..... +.....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFR-LLGTPTEETWPGISSND 236 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH-HhCCCCHHHHhhhcchh
Confidence 1223457889999998754 56899999999999999999999999753221 11111111 11000 000000
Q ss_pred ----hhhhhh--HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ----ANLVRE--EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ----~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...... .........++.++.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000 0000111234567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=308.84 Aligned_cols=250 Identities=29% Similarity=0.470 Sum_probs=205.6
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|+..+.||+|+||.||+|... |+.||+|.+..... ..+.+..|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888999999999999999874 78999999876644 4577889999999999999999999999899999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++++|.+++.... ..+++..+..++.|++.|+.||| ..+++||||||+||+++.++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE----EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999998654 35899999999999999999999 67899999999999999999999999999987632211
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
....+..|+|||+...+.++.++||||||+++||+++ |..||..... ......+......
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~------------- 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHVEKGYRM------------- 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhcCCCC-------------
Confidence 2234668999999988889999999999999999997 9999865321 1111111110000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
..+..++..+.+++.+|+..+|++||++.|++++|.++
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 ----EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00113456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.75 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=200.3
Q ss_pred cccCCCcceEEEEEEecC--C--cEEEEEEeehhhh-HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTISD--G--TDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.+..|+.++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 3 3699999876655 567789999999999999999999999988 888999999999
Q ss_pred CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc-
Q 003855 582 GSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV- 659 (791)
Q Consensus 582 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~- 659 (791)
|+|.+++.... ..+++..+..++.|++.||.||| ..+++||||+|+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE----SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH----hCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 99999998765 56899999999999999999999 6789999999999999999999999999998775432221
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......++..|+|||+..+..++.++|||||||++|||++ |+.||...... .....+.... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~-~-------------- 218 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKEG-E-------------- 218 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhcC-C--------------
Confidence 1122356788999999988889999999999999999999 99998653211 1111111100 0
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
....+..++..+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 -RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00011134567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.53 Aligned_cols=250 Identities=25% Similarity=0.332 Sum_probs=200.6
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
.|++.+.||+|+||.||+|... ++..+++|.+........+.+..|+++++.++|||++++++++......++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3677889999999999999975 578889999876555566788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+|+|..++......+++..+..++.|+++||.||| +.+++||||||+||+++.++.+|++|||++........ .
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH----~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~ 159 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH----ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 159 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence 99999988765566899999999999999999999 67899999999999999999999999999976533211 1
Q ss_pred eecccccccccCCCccC-----CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 661 QTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.....++..|+|||++. +..++.++|||||||++|||++|+.||......+ ..........+ ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~----~~------ 228 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPP----TL------ 228 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcCCC----CC------
Confidence 22345888999999873 4557889999999999999999999986532111 11111110000 00
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..++.++.+++.+||+.+|++||++.++++
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 ------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011124456789999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.27 Aligned_cols=257 Identities=30% Similarity=0.490 Sum_probs=201.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCc--EEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGT--DVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|..+ ++. .+|+|.+.... ....+.+.+|+.++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888999999999999999864 454 45777765432 34456788899999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC
Q 003855 575 VLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM 639 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~ 639 (791)
||||+++|+|.++++... ..+++.++..++.|++.|++||| +.+++||||||+||++++++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEecCCC
Confidence 999999999999997432 24789999999999999999999 67999999999999999999
Q ss_pred cEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHH
Q 003855 640 AAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWV 718 (791)
Q Consensus 640 ~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 718 (791)
.+||+|||+++.... ........++..|+|||+..+..++.++|||||||++|||+| |..||...... ...+.+
T Consensus 162 ~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~ 236 (303)
T cd05088 162 VAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL 236 (303)
T ss_pred cEEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHHH
Confidence 999999999864321 111112234667999999888889999999999999999998 99998643211 111111
Q ss_pred HHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 719 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 719 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
+... ....+..++..+.+++.+|++.+|++||++.++++.++++...
T Consensus 237 ----~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 237 ----PQGY-------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred ----hcCC-------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1100 0001112345678999999999999999999999999887443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=312.86 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=190.7
Q ss_pred cccCCCcceEEEEEEecC---CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCC
Q 003855 507 NLLGTGSFGSVYKGTISD---GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNG 582 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 582 (791)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 4578999876543 233457888999999999999999999999989999999999999
Q ss_pred CHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 583 SLEKWLYSHN----YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 583 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+|.++++... ...++..+..++.|++.|++||| +.+++||||||+||++++++++|++|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH----KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999997532 24567788899999999999999 678999999999999999999999999999765433222
Q ss_pred ceeecccccccccCCCccCCC-------CCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 659 VTQTMTMATIGYMAPEYGSEG-------IVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
.......++..|+|||++... .++.++||||||+++|||++ |+.||......+. ..+. .........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~---~~~~~~~~~ 231 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT---VREQQLKLP 231 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH---hhcccCCCC
Confidence 222334577889999987532 35789999999999999996 9999975332211 1110 000000111
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
++.+. ...+..+.+++..|+ .+|++|||+.||++.|.
T Consensus 232 ~~~~~---------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLK---------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccC---------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11110 012345678999998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.04 Aligned_cols=259 Identities=26% Similarity=0.455 Sum_probs=205.4
Q ss_pred hhccccccccCCCcceEEEEEEec-CCc----EEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGT----DVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+.... ......+.+|+.+++.++||||+++++++..+ ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356888899999999999999864 444 57888876543 23345688899999999999999999998754 467
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+|+||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.+.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE----ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh----hcCeeccccccceeeecCCCceEEcccccccccc
Confidence 899999999999999877666899999999999999999999 6789999999999999999999999999998765
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
............++..|+|||++.+..++.++|||||||++||+++ |+.||.+.. .....+++.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~--------- 229 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLEKGER--------- 229 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHCCCC---------
Confidence 4332222223345678999999988889999999999999999997 889986532 1222222221100
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
.+....++..+.+++.+||..+|++||++.++++.++++...
T Consensus 230 --------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 --------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 001112345678999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.05 Aligned_cols=248 Identities=30% Similarity=0.530 Sum_probs=204.2
Q ss_pred cccCCCcceEEEEEEecC----CcEEEEEEeehhhhH-HHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTISD----GTDVAIKIFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|.... +..||+|++...... ..+.+.+|+++++.++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 788999998765433 367889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 582 GSLEKWLYSH--------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 582 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
++|.+++... ...+++..+..++.|+++|++||| +.+++||||+|+||++++++.++|+|||.++...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA----SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH----cCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999876 466899999999999999999999 6789999999999999999999999999998776
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
............++..|+|||......++.++||||+|+++|||++ |..||..... ....+.+.. .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~----~------- 223 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRK----G------- 223 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc----C-------
Confidence 5433223334457889999999888889999999999999999999 6899876421 111111111 0
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
.....+..++.++.+++.+|++.+|++||++.|+++.|+
T Consensus 224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000112234577889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.32 Aligned_cols=248 Identities=31% Similarity=0.513 Sum_probs=200.5
Q ss_pred cccCCCcceEEEEEEecCCcEEEEEEeehhhh-HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCHH
Q 003855 507 NLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLE 585 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 585 (791)
++||+|+||.||+|...+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999998875543 35568899999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeeccc
Q 003855 586 KWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM 665 (791)
Q Consensus 586 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 665 (791)
+++......+++..+..++.+++.|++||| +.+++||||+|+||+++.++.+||+|||++................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE----SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 999876556889999999999999999999 6789999999999999999999999999998654322111112223
Q ss_pred ccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHH
Q 003855 666 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAK 744 (791)
Q Consensus 666 g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 744 (791)
.+..|+|||...++.++.++|||||||++|||+| |..||...... .....+..... .+.+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~~-----------------~~~~ 217 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGYR-----------------MPAP 217 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCCC-----------------CCCC
Confidence 4567999999888899999999999999999999 78888653221 11111111000 0111
Q ss_pred HHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 745 MDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 745 ~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
..++.++.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.79 Aligned_cols=240 Identities=23% Similarity=0.297 Sum_probs=191.0
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.+ +|+.||+|++.... ....+....|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 68899999997653 23345566777887765 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH----SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRA 153 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cce
Confidence 99999997654 3789999999999999999999 6789999999999999999999999999987532211 122
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+....+ .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~~~----------------~- 214 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVDTP----------------H- 214 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCC----------------C-
Confidence 335689999999999999999999999999999999999999975321 111111111000 0
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINVT-DAA 773 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~-ev~ 773 (791)
.+..++.++.+++.+|++.||++||++. ++.
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 -YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0012345677999999999999999985 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.71 Aligned_cols=264 Identities=22% Similarity=0.286 Sum_probs=203.8
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|++.+.||+|+||.||++... ++..||+|.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999865 68889999886543 33445688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++++|.+++.... .+++..+..++.|+++||.|||+ ..+++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999998654 47899999999999999999993 2479999999999999999999999999987653321
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCCh------------
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL------------ 726 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 726 (791)
.....++..|+|||...+..++.++|||||||++|||++|+.||.... ......+.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCC
Confidence 123467899999999888889999999999999999999999986432 1122222211110000
Q ss_pred ---------hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 727 ---------TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 727 ---------~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.+..+.......... ....++.++.+++.+|++.+|++||++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000000 011245678899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=327.19 Aligned_cols=238 Identities=27% Similarity=0.308 Sum_probs=192.2
Q ss_pred cccCCCcceEEEEEEe----cCCcEEEEEEeehhhh--HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 507 NLLGTGSFGSVYKGTI----SDGTDVAIKIFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
+.||+|+||.||+++. .+|+.||+|++..... .....+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3688999999976532 234456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++....... .
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~ 154 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--K 154 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--c
Confidence 999999997654 4899999999999999999999 67899999999999999999999999999986543221 2
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHh
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 740 (791)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~i~~~~~-------------- 215 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETMTMILKAKL-------------- 215 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHHHHHHcCCC--------------
Confidence 22346899999999998888999999999999999999999999753211 11111100000
Q ss_pred hHHHHHHHHHHHHHHhhccccCCCCCCCHHH
Q 003855 741 FSAKMDCILSIMDLALDCCIESPDMRINVTD 771 (791)
Q Consensus 741 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e 771 (791)
..+..++..+.+++.+||+.||++||++.+
T Consensus 216 -~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 -GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 001123456789999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=326.02 Aligned_cols=237 Identities=27% Similarity=0.308 Sum_probs=187.7
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHH-HHHhccCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECE-VLRNVRHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999975 78999999987543 122234444444 56788999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTT 153 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccc
Confidence 99999998654 4888999999999999999999 6789999999999999999999999999987542221 122
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..........
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~--------------- 213 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILNKPL--------------- 213 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCCC---------------
Confidence 334689999999999999999999999999999999999999975321 111111111100
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINVT 770 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 770 (791)
......+..+.+++.+|++.||++||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 00112345678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.42 Aligned_cols=251 Identities=25% Similarity=0.439 Sum_probs=194.8
Q ss_pred cccCCCcceEEEEEEec----CCcEEEEEEeehh-hhHHHHHHHHHHHHHHhccCCccceeeeeec-cCCeeeEEEecCC
Q 003855 507 NLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSCS-NPDFKALVLEFMP 580 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 580 (791)
+.||+|+||.||+|... ++..||+|.+... .....+.+..|+.+++.++||||+++++++. .++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999987543 2344567888999999999999999999775 4556789999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc--
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS-- 658 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-- 658 (791)
+|+|.+++.......++..+..++.|++.|++||| ..+++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA----SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 99999999876555788888999999999999999 678999999999999999999999999999765432211
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhC-CCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
.......++..|+|||+..+..++.++|||||||++|||++| ..||..... .....++.. ..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~---~~------------ 219 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQ---GR------------ 219 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhc---CC------------
Confidence 111123456789999999888899999999999999999995 555653211 111111110 00
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
....+..++..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 220 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 --RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00011123466889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=323.53 Aligned_cols=244 Identities=26% Similarity=0.361 Sum_probs=201.2
Q ss_pred ccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCHHH
Q 003855 508 LLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEK 586 (791)
Q Consensus 508 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 586 (791)
++|+|+||+||.|+.. +...+|||-+.....+..+.+.+|+.+-++++|.|||+.+|.+.+.+..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999965 566799999987777777889999999999999999999999999999999999999999999
Q ss_pred HHhhCCCCC--CHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC-CCCcEEEeeeccccccCCCCCcceeec
Q 003855 587 WLYSHNYFL--DILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD-ENMAAHVSDFGISKLLGEGEDSVTQTM 663 (791)
Q Consensus 587 ~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~ 663 (791)
.+++.=.++ .+.++-.+.+||++||.||| ...|||||||-+|||++ -.|.+||+|||.++.+..- ......
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH----en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TET 735 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH----ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTET 735 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhh----hcceeeccccCCcEEEeeccceEEecccccchhhccC--Cccccc
Confidence 999764445 67788888999999999999 56799999999999996 6899999999999876321 222333
Q ss_pred ccccccccCCCccCCC--CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 664 TMATIGYMAPEYGSEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 664 ~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
..||..|||||++..+ .|..++|||||||++.||.||++||-+.......+.+. ++.. ...
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-------GmyK----------vHP 798 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-------GMYK----------VHP 798 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-------ccee----------cCC
Confidence 5699999999998765 48889999999999999999999998765543322221 1111 011
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+-+.+.+.+...+|.+|+.+||.+||+++++++
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 223456677889999999999999999999875
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=327.82 Aligned_cols=265 Identities=25% Similarity=0.316 Sum_probs=198.4
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCC-----eee
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD-----FKA 573 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 573 (791)
+|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++..++ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999964 78999999886432 234467888999999999999999999998776 789
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+|+||+. ++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+|+...
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 58888886544 4899999999999999999999 6789999999999999999999999999998654
Q ss_pred CCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC-hhhhc-
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG-LTEVV- 730 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~- 730 (791)
.... .......++..|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+....... ..+..
T Consensus 155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 155 PDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHHH
Confidence 3221 22233467899999998766 45899999999999999999999999753221 1111111111110 00000
Q ss_pred -----chhhhhhH-------HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 731 -----DANLVREE-------QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 731 -----d~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
...+.... .........+.++.+++.+|++.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 0000011235678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.56 Aligned_cols=261 Identities=24% Similarity=0.366 Sum_probs=201.6
Q ss_pred hccccccccCCCcceEEEEEEec-----------------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCcccee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-----------------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKI 562 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l 562 (791)
++|++.+.||+|+||.||++... ++..||+|++.... ......+..|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999998532 23468999987543 3345678899999999999999999
Q ss_pred eeeeccCCeeeEEEecCCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCC
Q 003855 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHN----------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTN 632 (791)
Q Consensus 563 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~N 632 (791)
++++...+..++||||+++|+|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dlkp~N 160 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS----SLNFVHRDLATRN 160 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCeecccCChhe
Confidence 999999999999999999999999997532 23677889999999999999999 6789999999999
Q ss_pred eEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh--CCCCCCccccC
Q 003855 633 ILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT--RKRPTDEMFTG 710 (791)
Q Consensus 633 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~~~ 710 (791)
|++++++.++++|||+++.+.............++..|+|||....+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999986644332222222345678999998888889999999999999999998 66787543221
Q ss_pred cchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 711 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
+ ............... ...+.+..++..+.+++.+||+.||++||++.||++.|+
T Consensus 241 ~--~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 Q--VIENTGEFFRDQGRQ----------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H--HHHHHHHHHhhcccc----------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 100000000000000 000111235577889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.43 Aligned_cols=251 Identities=25% Similarity=0.324 Sum_probs=202.5
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
+.|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999975 58999999987766666778899999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++++|..++.+....+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||++....... .
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~ 165 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH----SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--Q 165 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh----cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--c
Confidence 999999988766666899999999999999999999 6789999999999999999999999999987543221 1
Q ss_pred eeecccccccccCCCccC-----CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 660 TQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
......++..|+|||++. ...++.++|||||||++|||++|+.||..... ......+... ....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~----~~~~------ 234 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKS----EPPT------ 234 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-HHHHHHHhcC----CCcc------
Confidence 122345788999999874 45578899999999999999999999865321 1111111100 0000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+..++.++.+++.+||+.+|++||++.|+++
T Consensus 235 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 ------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0011134456789999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=331.27 Aligned_cols=259 Identities=20% Similarity=0.275 Sum_probs=201.4
Q ss_pred hHHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccC
Q 003855 494 LDIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP 569 (791)
Q Consensus 494 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 569 (791)
.+++...++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344555689999999999999999999975 68899999986532 23345678899999999999999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
...++||||+++|+|.+++.... ++...+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999999997643 788888999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCC----CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEG----IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG 725 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (791)
+....... ......+||+.|+|||++... .++.++|||||||++|||++|+.||..... ...+...... ..
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~---~~ 264 (371)
T cd05622 190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNH---KN 264 (371)
T ss_pred eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHcC---CC
Confidence 87643322 122345699999999987643 378999999999999999999999975211 1111111100 00
Q ss_pred hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 003855 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDM--RINVTDAAAK 775 (791)
Q Consensus 726 ~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~ev~~~ 775 (791)
. ...+....++..+.+++..|+...|.+ ||++.|+++.
T Consensus 265 ~------------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 265 S------------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred c------------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0 001111234566789999999844433 7789888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.32 Aligned_cols=238 Identities=21% Similarity=0.309 Sum_probs=189.2
Q ss_pred ccCCCcceEEEEEEecC-------------------------CcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCcccee
Q 003855 508 LLGTGSFGSVYKGTISD-------------------------GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKI 562 (791)
Q Consensus 508 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 562 (791)
.||+|+||.||+|.... ...||+|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 23589999876655556678889999999999999999
Q ss_pred eeeeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC---
Q 003855 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM--- 639 (791)
Q Consensus 563 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~--- 639 (791)
++++.+....++||||+++|+|..++......+++..+.+++.|+++||+||| +.+|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE----DKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----cCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999876666899999999999999999999 67899999999999997644
Q ss_pred ----cEEEeeeccccccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHH-hCCCCCCccccCcch
Q 003855 640 ----AAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETF-TRKRPTDEMFTGEMS 713 (791)
Q Consensus 640 ----~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~ell-tg~~p~~~~~~~~~~ 713 (791)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||......+
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 4899999998654221 12346788999998765 56899999999999999995 6898987532211
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
...+..... ..+ ......+.+++.+||+.+|++||+|.++++.|
T Consensus 230 ~~~~~~~~~-----------------~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFYEKKH-----------------RLP--EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHhcc-----------------CCC--CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111111100 000 01124578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.89 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=201.9
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
++|++.+.||+|+||.||+|....+..||+|.+.... ...+.+.+|++++++++|||++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999998777789999876432 23456888999999999999999999885 456789999999
Q ss_pred CCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 581 NGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 581 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
+|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||+++........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE----RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999999854 345789999999999999999999 678999999999999999999999999999876433211
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......++..|+|||+..+..++.++||||||+++|||+| |+.||.+....+ ...++......
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~-------------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYRM-------------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC--------------
Confidence 1122345678999999988889999999999999999999 899987532211 11111110000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
+.+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 ---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=309.09 Aligned_cols=249 Identities=28% Similarity=0.422 Sum_probs=200.3
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeee-ccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC-SNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~ 578 (791)
.++|++.+.||+|+||.||+|.. .|..||+|.+.... ..+.+..|+.++++++|+|++++++++ .+.+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 35788999999999999999987 47889999886443 245788999999999999999999975 455678999999
Q ss_pred CCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.+++.+... .+++..+..++.|++.||+||| ..+++||||||+||++++++.+|++|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999999986543 4889999999999999999999 6789999999999999999999999999987643322
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
....++..|+|||+..+..++.++|||||||++|||++ |+.||..... ......+......
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~------------ 218 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKM------------ 218 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCC------------
Confidence 12234568999999988889999999999999999998 9999864211 1111111110000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
.....++..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 219 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 -----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 01123456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=310.62 Aligned_cols=248 Identities=28% Similarity=0.463 Sum_probs=198.5
Q ss_pred cccCCCcceEEEEEEec-C---CcEEEEEEeehhhh-HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-D---GTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|++. . +..||+|.+..... ...+.+..|+.++++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999853 2 36899999875543 34567889999999999999999999876 4567999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce-
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT- 660 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~- 660 (791)
|+|.+++.... .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE----SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh----hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999998665 5899999999999999999999 67899999999999999999999999999987654332211
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....++..|+|||...+..++.++|||||||++|||++ |..||..... .....++....+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~---------------- 216 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER---------------- 216 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc----------------
Confidence 111223567999999988899999999999999999998 9999875322 222222221110
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
.+.+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 011123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=322.97 Aligned_cols=260 Identities=23% Similarity=0.386 Sum_probs=206.1
Q ss_pred hccccccccCCCcceEEEEEEec--------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS--------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPD 570 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 570 (791)
.+|.+.+.||+|+||.||+|+.. .+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999742 12368999887543 34457888999999999 8999999999999989
Q ss_pred eeeEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe
Q 003855 571 FKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL 635 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill 635 (791)
..++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Nill 167 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA----SQKCIHRDLAARNVLV 167 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEE
Confidence 9999999999999999997532 24788899999999999999999 6799999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchH
Q 003855 636 DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSL 714 (791)
Q Consensus 636 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 714 (791)
++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~ 242 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----V 242 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----H
Confidence 9999999999999987654322222222234567999999998999999999999999999998 888886532 1
Q ss_pred HHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 715 RRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
..+......... .+.+..++.++.+++.+|++.+|++||++.|+++.|.++....
T Consensus 243 ~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 EELFKLLKEGHR--------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHHcCCC--------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 122111110000 0011134567889999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.15 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=204.7
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
++|++.+.||+|+||.||+|... ++..||+|++........+.+..|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 57889999999999999999975 68999999987666666678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++++|.+++.+....+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH----SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 999999999876666899999999999999999999 67899999999999999999999999999876533221
Q ss_pred eeecccccccccCCCccC-----CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 660 TQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
......++..|+|||.+. ...++.++||||||+++|||++|+.||...... .....+... ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~----~~~------- 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKS----EPP------- 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcC----CCC-------
Confidence 222345888999999864 345788999999999999999999998753211 111111100 000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
....+..++.++.+++.+||+.+|++||++.++++.
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 -----TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000112345667899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=312.14 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=201.3
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|+..+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999864 6899999998766555556788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++++|.+++...+ .+++.++..++.|++.|+.||| ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH----SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 99999999987654 4899999999999999999999 6789999999999999999999999999997654321
Q ss_pred ceeecccccccccCCCccC---CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 659 VTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.......|+..|+|||++. .+.++.++|||||||++|||++|+.||....+... .......... .. ..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~---~~----~~- 231 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNFQ---PP----KL- 231 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCCC---CC----cc-
Confidence 1223346889999999864 45688999999999999999999999864322111 1010000000 00 00
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....++..+.+++.+|++.+|++||++.++++
T Consensus 232 ------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 ------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 001123456779999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.36 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=210.3
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh---HHHHHHHHHHHHHHhcc-CCccceeeeeeccCCeee
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE---RAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 573 (791)
..+.|+..+.||+|.||.||+++.+ +|+.+|+|++.+... ...+.+.+|+.+|+++. |||||.+.+++++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3467888899999999999999976 599999999976643 24468899999999998 999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC----CcEEEeeeccc
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN----MAAHVSDFGIS 649 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfgla 649 (791)
+|||++.||.|.+.+... . +++.....++.|++.|+.||| +.+|+|||+||+|+|+... +.+|++|||+|
T Consensus 113 lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH----~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH----SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH----hCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999877 3 899999999999999999999 7899999999999999643 57999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV 729 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
..... .......+||+.|+|||++....|+..+||||.||++|.|++|.+||.+....+.. ........ +
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-~~i~~~~~-----~- 256 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-LAILRGDF-----D- 256 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-HHHHcCCC-----C-
Confidence 98765 22344578999999999999999999999999999999999999999874322211 11111100 0
Q ss_pred cchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 ~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+.+..++..+.+++..|+..||..|+|+.++++
T Consensus 257 ---------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 257 ---------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ---------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 011233456677889999999999999999999998
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.48 Aligned_cols=242 Identities=26% Similarity=0.288 Sum_probs=189.0
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHH-HHHHHhccCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSE-CEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e-~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.. +++.||+|++.... ......+..| ..+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999975 67889999987543 1222333444 3456788999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.+++..... +.+..+..++.||++||.||| +.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH----~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~ 153 (325)
T cd05602 81 GELFYHLQRERC-FLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TT 153 (325)
T ss_pred CcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Cc
Confidence 999999986543 778888889999999999999 77999999999999999999999999999975432211 22
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.. .. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~---~~--------~------- 213 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILN---KP--------L------- 213 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHHHh---CC--------c-------
Confidence 3346899999999999999999999999999999999999999753211 11111110 00 0
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.....++..+.+++.+|++.||.+||++.+.+..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 0011344567899999999999999998754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.58 Aligned_cols=242 Identities=21% Similarity=0.264 Sum_probs=191.6
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999865 67899999997653 23455678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH----ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TT 153 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ce
Confidence 99999887654 3899999999999999999999 67899999999999999999999999999975322111 22
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccC-cchHHHHHHHhcCCChhhhcchhhhhhHHh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG-EMSLRRWVKESLPHGLTEVVDANLVREEQA 740 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 740 (791)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||+..... ......++....... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------~~- 220 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK------------PI- 220 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC------------CC-
Confidence 3356899999999999999999999999999999999999999643221 111111111111000 00
Q ss_pred hHHHHHHHHHHHHHHhhccccCCCCCCCH
Q 003855 741 FSAKMDCILSIMDLALDCCIESPDMRINV 769 (791)
Q Consensus 741 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 769 (791)
..+...+..+.+++.+|++.||++||++
T Consensus 221 -~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 -RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 0111234567799999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.62 Aligned_cols=262 Identities=23% Similarity=0.287 Sum_probs=191.8
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccC--------C
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNP--------D 570 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~ 570 (791)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999864 68899999875432 2334699999999999999998876321 2
Q ss_pred eeeEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC-cEEEeee
Q 003855 571 FKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-AAHVSDF 646 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~-~~kl~Df 646 (791)
..++||||+++ ++.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH----~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 46689999974 78777752 3456899999999999999999999 67899999999999999664 7999999
Q ss_pred ccccccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC
Q 003855 647 GISKLLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG 725 (791)
Q Consensus 647 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (791)
|+|+.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.... ..+.+.+.......
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCC
Confidence 99987643322 123467999999998765 46899999999999999999999999753221 11222111110000
Q ss_pred hh--hhcch--------hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 726 LT--EVVDA--------NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 726 ~~--~~~d~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. ....+ ...........+...+.++.+++.+||+.||++|||+.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00 00000 000000000111234567889999999999999999999984
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.28 Aligned_cols=254 Identities=28% Similarity=0.464 Sum_probs=205.6
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|++.+.||+|+||.||+|..++++.||||.+..... ..+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 468999999999999999999988888999999875432 3457888999999999999999999999888999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++++|.+++.... ..+++..+..++.+++.|++||| +.+++|+||||+||++++++.+|++|||+++.......
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh----~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE----SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 9999999998653 45899999999999999999999 67899999999999999999999999999987643221
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
.......++..|+|||...+..++.++||||+|+++||+++ |+.||...... . ..+.+.....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~-~~~~~~~~~~-------------- 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-E-VLEQVERGYR-------------- 222 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-H-HHHHHHcCCC--------------
Confidence 11112234568999999988889999999999999999999 99998653211 1 1111111000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
.+.+..++..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 ---MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01111234668899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=329.58 Aligned_cols=265 Identities=18% Similarity=0.214 Sum_probs=199.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
...|.+.+.||+|+||.||+|... +++.||||... ...+.+|++++++++||||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 347999999999999999999975 57889999632 23456799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+ .++|.+++......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 242 ~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 Y-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH----GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9 47999999876666999999999999999999999 678999999999999999999999999999876433222
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccC------cchHHHHHHHhcC--CChhhhc
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG------EMSLRRWVKESLP--HGLTEVV 730 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~------~~~~~~~~~~~~~--~~~~~~~ 730 (791)
.......||..|+|||++.+..++.++|||||||++|||++|..|+-..... ...+.+.+..... .......
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2223356899999999999999999999999999999999988654321110 1112222221100 0000000
Q ss_pred chhhhhhHH-----------h---hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 731 DANLVREEQ-----------A---FSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 731 d~~~~~~~~-----------~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
...+..... . ..........+.+++.+||+.||++|||+.|+++.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 0 00001223467899999999999999999999863
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.18 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=209.0
Q ss_pred hccccccccCCCcceEEEEEEecC-CcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISD-GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
+-|.++..+|.|+||.||+|..++ +-..|.|++.....+..++|.-|+++++.++||+||++++.|.-.+..++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 346677889999999999999764 4446778988888888999999999999999999999999999899999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
.||-+...+-.-+..+.+.++.-+++|++.||.||| +..|+|||||+.|||++-+|.++++|||.+..... ...
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH----s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH----SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQ 185 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh----hcchhhhhccccceEEEecCcEeeecccccccchh--HHh
Confidence 999999999888888999999999999999999999 77899999999999999999999999999864321 122
Q ss_pred eeecccccccccCCCc-----cCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 660 TQTMTMATIGYMAPEY-----GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~-----~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
......||+.|||||+ ..+.+|+.++||||||+++.||..+.+|.....+....+ . -.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll-K----------------ia 248 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-K----------------IA 248 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH-H----------------Hh
Confidence 3445689999999995 567889999999999999999999999976533221110 1 11
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..++.....+..++..+.+++.+|+..||..||+++++++
T Consensus 249 KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 249 KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1122222334567788999999999999999999999875
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=322.61 Aligned_cols=264 Identities=22% Similarity=0.240 Sum_probs=196.6
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC------
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP------ 569 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 569 (791)
..++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999864 68999999986432 23445677899999999999999999988543
Q ss_pred CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH----~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 347899999965 67776643 2788899999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV 729 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
+...... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.+.... ..+...... ......+.
T Consensus 171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~-~~~~~~~~ 245 (359)
T cd07876 171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQ-LGTPSAEF 245 (359)
T ss_pred cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh-cCCCcHHH
Confidence 7643221 122346899999999999999999999999999999999999999753211 111111110 00000000
Q ss_pred cchh---hh---hhH------------------HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 730 VDAN---LV---REE------------------QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 730 ~d~~---~~---~~~------------------~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.+.. .. ... .........+..+.+++.+|++.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 00 000 0000001124567899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=313.34 Aligned_cols=249 Identities=23% Similarity=0.295 Sum_probs=198.1
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+..|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999986 478999999986542 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++|+|..+. .+++..+..++.|++.|+.||| +.+|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW----SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 9999997653 2678889999999999999999 6789999999999999999999999999997654321
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcch--HHHHHHHhcCCChhhhcchhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS--LRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||......... ...+........ .+..
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-- 220 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL-- 220 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC--
Confidence 22346889999999999889999999999999999999999999753322111 011111000000 0000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.....+.++.+++.+|++.+|++||++.|+++.
T Consensus 221 ------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 ------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011234567899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=319.67 Aligned_cols=254 Identities=22% Similarity=0.265 Sum_probs=197.4
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999965 68999999987532 233456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH----QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999875556899999999999999999999 7789999999999999999999999999997654332
Q ss_pred CcceeecccccccccCCCccCC-----CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC-CChhhhc
Q 003855 657 DSVTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP-HGLTEVV 730 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 730 (791)
. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+....... .....
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~-- 228 (331)
T cd05597 157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKEHFQ-- 228 (331)
T ss_pred C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCccc--
Confidence 2 12223468999999998753 4578899999999999999999999965211 111111110 00000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCC--CCCCCHHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESP--DMRINVTDAAAK 775 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P--~~RPt~~ev~~~ 775 (791)
+. +....++..+.+++.+|+..++ ..||++.++++.
T Consensus 229 ---~~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ---FP------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ---CC------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 0011245667788888775533 337899888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=306.79 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=202.4
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
.+|+..+.||+|+||.||+|.+.+++.+|+|.+..... ....+..|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46888899999999999999987788999998864432 23568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+|+|.+++......+++..+..++.+++.|++||| +.+++||||||+||+++.++.++|+|||+++....... ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE----SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 99999999876666899999999999999999999 67899999999999999999999999999986543221 11
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....++.+|+|||...++.++.++||||||+++|||++ |+.||...... ....... ... ....
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~-~~~-~~~~-------- 222 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETIN-AGF-RLYK-------- 222 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHHh-CCC-CCCC--------
Confidence 122235678999999988889999999999999999998 89998653211 1111110 000 0000
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
+...+..+.+++.+||+.+|++||++.|+++.|
T Consensus 223 ----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 ----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 011345688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=307.66 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=205.6
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
++|+..+.||+|+||.||+|... +++.+|+|++........+.+.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57889999999999999999874 67889999998765556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++++|.+++......++...+..++.|++.|+.||| ..+++||||+|+||++++++.++|+|||.+........
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH----ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 999999999876556899999999999999999999 67899999999999999999999999999976543221
Q ss_pred eeecccccccccCCCccCCC---CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 660 TQTMTMATIGYMAPEYGSEG---IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
......++..|+|||..... .++.++||||||+++|||+||+.||......+.. ..... .... ....
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-~~~~~----~~~~---~~~~-- 226 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-FLISK----SNFP---PPKL-- 226 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHh----ccCC---Cccc--
Confidence 12234578899999998776 8899999999999999999999998753321111 00000 0000 0000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......+.++.+++.+||..+|++||++.+++.
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -----KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -----cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011234567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.35 Aligned_cols=241 Identities=24% Similarity=0.277 Sum_probs=192.7
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhcc-CCccceeeeeeccCCeeeEEE
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 576 (791)
+|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+..|..+++.+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999865 78999999987543 233456777888888885 577888999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++..... +++.++..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH----~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLH----RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999999976543 899999999999999999999 6789999999999999999999999999997543221
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.. ...
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~i~~---~~~---------- 218 (323)
T cd05615 156 V--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELFQSIME---HNV---------- 218 (323)
T ss_pred c--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHh---CCC----------
Confidence 1 12234589999999999888899999999999999999999999975321 111111111 000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINV 769 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 769 (791)
..+..++.++.+++.+|++.+|++|++.
T Consensus 219 -----~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -----SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -----CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0011234567799999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.39 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=203.5
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999985 478999999987665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++++|.+++... .+++.++..++.+++.|++||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH----~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 170 (296)
T cd06655 99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH----ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-- 170 (296)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence 999999998754 3899999999999999999999 67899999999999999999999999999886544322
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
......++..|+|||.+.+..++.++|||||||++|||++|+.||......+. .. .+...... .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~-~~~~~~~~---~----------- 234 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY-LIATNGTP---E----------- 234 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHhcCCc---c-----------
Confidence 12234578899999999888899999999999999999999999975322111 11 11100000 0
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+..++..+.+++.+||..||++||++.++++
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0011234566789999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.46 Aligned_cols=242 Identities=26% Similarity=0.315 Sum_probs=189.6
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHH-HHHhccCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECE-VLRNVRHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 78999999987542 223344455544 56778999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|..++.... .+++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH----SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TT 153 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Cc
Confidence 99999887654 4889999999999999999999 67899999999999999999999999999875422211 22
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... +.+....... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~~~~~--------~~------ 214 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNILHKP--------LV------ 214 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHHHcCC--------cc------
Confidence 3346899999999999999999999999999999999999999653211 1111111100 00
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.....+..+.+++.+|++.+|++||++.+.++.
T Consensus 215 -~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 215 -LRPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 001234567799999999999999988644333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=310.72 Aligned_cols=248 Identities=30% Similarity=0.476 Sum_probs=194.9
Q ss_pred cccCCCcceEEEEEEec-CCc--EEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGT--DVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.. ++. .+|+|.+.... ....+.+..|+.+++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999975 343 46888876432 34456788999999999 899999999999998899999999999
Q ss_pred CCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeee
Q 003855 582 GSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDF 646 (791)
Q Consensus 582 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 646 (791)
|+|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||++++++.+|++||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccccceEEEcCCCeEEECCC
Confidence 99999997532 24788999999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCC
Q 003855 647 GISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHG 725 (791)
Q Consensus 647 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (791)
|++..... .........+..|+|||+.....++.++|||||||++|||++ |..||...... ..........
T Consensus 157 gl~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~~~~~ 228 (270)
T cd05047 157 GLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKLPQGY 228 (270)
T ss_pred CCccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHHHhCCC
Confidence 99863221 111112234567999999988889999999999999999997 99998653211 1111111000
Q ss_pred hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 726 ~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
. ...+..++.++.+++.+|++.+|.+||++.|+++.|+++.
T Consensus 229 ~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 R--------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C--------------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 0011124456789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.82 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=188.7
Q ss_pred ccCCCcceEEEEEEecC---CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCC
Q 003855 508 LLGTGSFGSVYKGTISD---GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGS 583 (791)
Q Consensus 508 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 583 (791)
.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 69999999999997543 4568888775443 3345678889999999999999999999999999999999999999
Q ss_pred HHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 584 LEKWLYSHN----YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 584 L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
|.+++.... ...++.....++.||+.|++||| +.+|+||||||+||++++++.+||+|||+++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH----QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH----hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999998643 22467788899999999999999 6789999999999999999999999999997643332222
Q ss_pred eeecccccccccCCCccC-------CCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 660 TQTMTMATIGYMAPEYGS-------EGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
......++..|+|||+.. ...++.++|||||||++|||++ |..||....+.+ .+...+. .......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~----~~~~~~~~ 232 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVR----EQDIKLPK 232 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhh----ccCccCCC
Confidence 223334677899999753 3457889999999999999999 778886532211 1111111 11001111
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
+.. ...++..+.+++..|+ .||++||+++||++.|
T Consensus 233 ~~~---------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 233 PQL---------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred Ccc---------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 100 1134455678888998 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.43 Aligned_cols=248 Identities=27% Similarity=0.481 Sum_probs=197.6
Q ss_pred cccCCCcceEEEEEEecC-------CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 507 NLLGTGSFGSVYKGTISD-------GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+.||+|+||.||+|+..+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2579999875443 24456788999999999999999999999998999999999
Q ss_pred CCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC-----cEEEeeec
Q 003855 579 MPNGSLEKWLYSH------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-----AAHVSDFG 647 (791)
Q Consensus 579 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~-----~~kl~Dfg 647 (791)
+++|+|.+++... ...+++.++..++.|++.|++||| +.+++|+||||+||+++.++ .++++|||
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE----QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH----hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999742 234788999999999999999999 67899999999999999887 89999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCCh
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGL 726 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 726 (791)
+++...............++..|+|||++.++.++.++|||||||++|||+| |+.||..... ......+.. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~---~~- 230 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVTA---GG- 230 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHhc---CC-
Confidence 9986644332222223345778999999999999999999999999999998 9999864321 111111110 00
Q ss_pred hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 727 ~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
....+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 231 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 -------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00111234567889999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.64 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=200.7
Q ss_pred ccccccccCCCcceEEEEEEecCCcEEEEEEeehhh------hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 502 EFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL------ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
+|...+.||+|+||.||+|...+++.+|+|.+.... .+..+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999886432 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++++|.+++.+.. .+++..+..++.|++.|++||| ..+++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH----NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999997654 3789999999999999999999 678999999999999999999999999999765321
Q ss_pred CC----cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 656 ED----SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 656 ~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
.. ........++..|+|||+..+..++.++|||||||++|||++|+.||....... .... +.. .... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~-~~~--~~~~----~ 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFY-IGA--HRGL----M 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHH-hhh--ccCC----C
Confidence 11 111122457889999999988889999999999999999999999997532111 1100 000 0000 0
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+. .+..++.++.+++.+||+.+|++||++.|+++
T Consensus 228 ~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 PR---------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC---------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 01124466789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=309.32 Aligned_cols=249 Identities=20% Similarity=0.277 Sum_probs=201.6
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehh-hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
+|++.+.||+|+||.||+++.. +++.||+|.+... .....+.+..|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999865 7899999988643 2344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++|+|.+++... ...++...+..++.|++.|+.||| +.+++|+||||+||++++++.++++|||.++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH----EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999998753 345789999999999999999999 67899999999999999999999999999976643221
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......++..|+|||+..+..++.++||||||+++|+|++|+.||..... ...+.........
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~----------- 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKVCQGSYK----------- 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHHhcCCCC-----------
Confidence 12234588899999999888899999999999999999999999975211 1111111110000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
+.+..++..+.+++.+||+.||++||++.+++..
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=328.20 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=196.6
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+..|+.++.+++||+|+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 68999999997543 334567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~~L~~lH----~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIH----QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 99999999999986543 889999999999999999999 7899999999999999999999999999987543211
Q ss_pred Cc---------------------------------ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCC
Q 003855 657 DS---------------------------------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703 (791)
Q Consensus 657 ~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p 703 (791)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 00 001134689999999999999999999999999999999999999
Q ss_pred CCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC---HHHHHH
Q 003855 704 TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRIN---VTDAAA 774 (791)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~ev~~ 774 (791)
|......+ .... +... .... ..+.....+.++.+++.+++ .||++|++ +.|+++
T Consensus 236 f~~~~~~~-~~~~-i~~~-~~~~-------------~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 236 FCSETPQE-TYRK-VMNW-KETL-------------VFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCHHH-HHHH-HHcC-CCce-------------ecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 97532211 1111 0000 0000 00111113455678888876 49999995 556554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=314.99 Aligned_cols=256 Identities=23% Similarity=0.298 Sum_probs=205.2
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 367888999999999999999865 68899999876543 3445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++|+|.+++...+ .+++..+..++.+++.|+.|||+ ..+++||||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 84 FMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN---VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred cCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH---hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999999987654 48999999999999999999994 3479999999999999999999999999987543221
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcc------hHHHHHHHhcCCChhhhcc
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM------SLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~d 731 (791)
.....|+..|+|||++.++.++.++|||||||++||++||+.||......+. ....++......
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 228 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------- 228 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-------
Confidence 1234688999999998888999999999999999999999999975432210 011111111100
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
.... .....++.++.+++.+|++.||++||++.|+++..
T Consensus 229 -----~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 229 -----PPPR-LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -----cCCC-CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000 01113556788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=310.87 Aligned_cols=252 Identities=31% Similarity=0.444 Sum_probs=198.9
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHH--HHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERA--FRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
|++.+.||+|+||+||+++.. +++.||+|++....... ......|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999976 56789999998765332 223456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++++|.+++.... .+++..+..++.|+++||+||| +.+++|+||||+||++++++.++|+|||.+..... ...
T Consensus 81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh----~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLH----SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE 153 (260)
T ss_dssp TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHH----HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred ccccccccccccc-cccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccc--ccc
Confidence 9999999998333 3899999999999999999999 67899999999999999999999999999986521 222
Q ss_pred eeecccccccccCCCccC-CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 660 TQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......++..|+|||+.. +..++.++||||+|+++|+|++|..||..... ......+.... ......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~--------~~~~~~-- 221 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKIL--------KRPLPS-- 221 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHH--------HTHHHH--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcc--------cccccc--
Confidence 334456899999999988 88899999999999999999999999986410 01111110000 000000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..........++.+++.+||+.||++||++.++++
T Consensus 222 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 -SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000111367899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=327.72 Aligned_cols=265 Identities=21% Similarity=0.224 Sum_probs=200.7
Q ss_pred hhccccccccCCCcceEEEEEEec---CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS---DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
..+|++.+.||+|+||.||+|... .+..||+|.+... +...+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 4678999987643 23457999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
|++. ++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++......
T Consensus 166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH----~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 6999998543 45899999999999999999999 6789999999999999999999999999998765443
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCc--chHHHHHHHhc------CCChhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE--MSLRRWVKESL------PHGLTE 728 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~------~~~~~~ 728 (791)
.........||+.|+|||++....++.++|||||||++|||++|+.||.+..... ..+...+.... +.....
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 3333334578999999999998999999999999999999999999986543221 11222111110 000000
Q ss_pred hcchhhhhhH---------HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 729 VVDANLVREE---------QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 729 ~~d~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.+...+.... .........+.++.+++.+|+..||++||++.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 0000011234567899999999999999999999864
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=315.55 Aligned_cols=264 Identities=19% Similarity=0.265 Sum_probs=201.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|+..+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999875 68899999986443 23334677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++ ++|.+++......+++..+..++.|+++||+||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH----RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 96 5999999876666899999999999999999999 77899999999999999999999999999976432221
Q ss_pred ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC----Chhhhcchh
Q 003855 659 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH----GLTEVVDAN 733 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~d~~ 733 (791)
......++..|+|||.+.+ ..++.++|||||||++|||+||+.||...... .....+...... .+....+..
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhccc
Confidence 1222356889999998754 45788999999999999999999999753221 111111111110 011111000
Q ss_pred ---------hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 734 ---------LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 734 ---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..... .......++..+.+++.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADC-LHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCcccccc-HHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00111234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=311.64 Aligned_cols=249 Identities=23% Similarity=0.310 Sum_probs=199.3
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
|+..+.||+|+||.||+|... +++.||||.+.... ....+.+..|+.++++++|++|+.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999865 78999999886543 22334577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH----QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999998643 335889999999999999999999 67899999999999999999999999999976543221
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........ .... .. ..+ ...
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~-~~--------~~~-~~~-- 221 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEV-ER--------LVK-EVQ-- 221 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHH-Hh--------hhh-hhh--
Confidence 1234689999999999988999999999999999999999999975322110 0000 00 000 000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRIN-----VTDAAA 774 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~ev~~ 774 (791)
......++..+.+++.+||+.||++||| +.|+++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 ---EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0011234566789999999999999999 888877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.45 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=198.2
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
|+..+.||+|+||+||+|... +++.||+|.+.... ......+..|++++++++|+||+.+.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999875 78899999986543 22334577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH----RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999988754 335899999999999999999999 67899999999999999999999999999976543221
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
.....|+..|+|||++.+..++.++|+|||||++|||++|+.||........ ...+ .........
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~-~~~~~~~~~---------- 222 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEV-DRRVLETEE---------- 222 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-HHhhhcccc----------
Confidence 1234689999999999888999999999999999999999999975322111 1111 110000000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRIN-----VTDAAA 774 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~ev~~ 774 (791)
.....++..+.+++..|++.||++||+ +.++++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 001124456789999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=315.03 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=203.8
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+..|+.+++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36799999999999999999986 47999999998765555556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++++|.+++.+.. +++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.........
T Consensus 98 ~~~~~L~~~~~~~~--~~~~~~~~~~~~l~~~L~~LH----~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 98 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cCCCCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999997543 788999999999999999999 678999999999999999999999999999865433221
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
.....+++.|+|||...+..++.++|||||||++|++++|+.||............ ........
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-----~~~~~~~~--------- 235 (297)
T cd06656 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----ATNGTPEL--------- 235 (297)
T ss_pred --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-----ccCCCCCC---------
Confidence 22345788999999998888999999999999999999999999653221110000 00000000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+...+..+.+++.+||+.+|++||++.++++
T Consensus 236 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 ---QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011133456779999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.99 Aligned_cols=240 Identities=22% Similarity=0.358 Sum_probs=190.6
Q ss_pred cccCCCcceEEEEEEecC--------CcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 507 NLLGTGSFGSVYKGTISD--------GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998632 234888888665555567888899999999999999999999998899999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc--------EEEeeecccc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA--------AHVSDFGISK 650 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~--------~kl~Dfgla~ 650 (791)
+++|+|.++++.....+++..+..++.||+.|++||| +.+|+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE----DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999999876666899999999999999999999 678999999999999987765 6999999987
Q ss_pred ccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCC-CCCCccccCcchHHHHHHHhcCCChhh
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRK-RPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
..... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+...... ........
T Consensus 157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~-------- 220 (258)
T cd05078 157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKLQFYED-------- 220 (258)
T ss_pred ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHHHHHHc--------
Confidence 55322 22357888999999876 45799999999999999999985 555432111 00110000
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
... .+.....++.+++.+||+.+|++|||+.++++.|+
T Consensus 221 ---------~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ---------RHQ--LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------ccc--CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 01112355789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.08 Aligned_cols=253 Identities=23% Similarity=0.418 Sum_probs=204.4
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++|+||+++.+++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46789999999999999999998788889999876542 334678889999999999999999999887 7789999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++|+|.+++.+. ....++.++..++.|++.||.||| ..+++||||+|+||+++.++.+||+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 999999999864 345788999999999999999999 67899999999999999999999999999976543221
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
.......++..|+|||++..+.++.++|||||||++||++| |+.||..... .....++......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~------------- 222 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRM------------- 222 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCCC-------------
Confidence 11222345678999999988889999999999999999999 8999875321 1122222111000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
+.....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111344668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=320.56 Aligned_cols=255 Identities=22% Similarity=0.259 Sum_probs=198.0
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|..++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999975 68889999987532 233456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH----~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH----QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999875556899999999999999999999 7899999999999999999999999999998764432
Q ss_pred CcceeecccccccccCCCccCC-----CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 657 DSVTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
. .......|+++|+|||++.+ +.++.++|||||||++|||++|+.||...... ............-.+.
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~i~~~~~~~~~p 230 (331)
T cd05624 157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHEERFQFP 230 (331)
T ss_pred c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-----HHHHHHHcCCCcccCC
Confidence 2 12233468999999998765 56888999999999999999999999652211 1111110000000000
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDM--RINVTDAAAK 775 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~ev~~~ 775 (791)
.....++.++.+++.+|+...+++ |+++.++++.
T Consensus 231 ----------~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 ----------SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----------CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 001123566788999998866544 4678877653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=320.01 Aligned_cols=255 Identities=22% Similarity=0.267 Sum_probs=197.9
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+++.+ +++.||+|++.... ......+..|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999975 57889999986432 233445788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH----~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999875556899999999999999999999 6789999999999999999999999999997653322
Q ss_pred CcceeecccccccccCCCccC-----CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 657 DSVTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...+........ ..
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~-~~-- 227 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKE-RF-- 227 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-----HHHHHHHhCCCc-cc--
Confidence 1 1223356899999999875 35688999999999999999999999975211 111111110000 00
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDM--RINVTDAAAK 775 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~ev~~~ 775 (791)
.+ ......++..+.+++.+|+..+|.+ |+++.|+++.
T Consensus 228 -~~------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 -QF------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -cC------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 0001134566788999988654444 6889988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.39 Aligned_cols=237 Identities=26% Similarity=0.300 Sum_probs=186.4
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHH-HHHHhccCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSEC-EVLRNVRHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 68899999987543 22233444454 467889999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETT 153 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccc
Confidence 99999887644 3788889999999999999999 6789999999999999999999999999987532221 122
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ........... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~--------~------- 213 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILHKP--------L------- 213 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhcCC--------C-------
Confidence 334689999999999888999999999999999999999999965311 11111111100 0
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINVT 770 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 770 (791)
..+...+..+.+++.+|++.||++||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 00112335577999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=313.20 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=197.9
Q ss_pred HHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeecc------C
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSN------P 569 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~ 569 (791)
.+.+.|+..+.||+|+||.||+|... +++.||+|++..... ....+..|+.++.++ +||||+++++++.. .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 34577888999999999999999865 688999999865432 335678899999998 79999999999864 2
Q ss_pred CeeeEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecc
Q 003855 570 DFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGI 648 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl 648 (791)
...++||||+++|+|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH----~~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4678999999999999999864 345889999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCCCccC-----CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC
Q 003855 649 SKLLGEGEDSVTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP 723 (791)
Q Consensus 649 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (791)
++...... .......|+..|+|||++. +..++.++|||||||++|||++|+.||....... ...... .
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~~~~~-~ 230 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----ALFLIP-R 230 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HHHHHh-c
Confidence 98654322 1223346889999999875 3468889999999999999999999986532211 111000 0
Q ss_pred CChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 724 HGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 724 ~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
... ... ....++..+.+++.+||..+|.+|||+.|+++
T Consensus 231 ~~~-----~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPA-----PRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCC-----CCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 000 01123456789999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.53 Aligned_cols=373 Identities=27% Similarity=0.374 Sum_probs=329.1
Q ss_pred CCCCCCeeecCCCccc-ccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCC
Q 003855 11 NLQNLQYLVFAENNLS-GLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLV 89 (791)
Q Consensus 11 ~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 89 (791)
=|+-.+-.|+++|.++ +..|.....++++++|.|...++. .+|+.+.+ +.+|++|.+++|++. .+.+.+..++.|+
T Consensus 5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~-lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSR-LQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHH-HhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 3556778899999998 678999999999999999999998 99999998 789999999999999 6778899999999
Q ss_pred EEeccCccccc-cccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhh
Q 003855 90 ALDLGFNSFAG-HILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSAS 168 (791)
Q Consensus 90 ~L~L~~N~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~ 168 (791)
.+++..|++.. -+|..+-.|..|+.|+|++|++...| ..+..-+++-.|+||+|+|..+ |..++-...-
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP---------~~LE~AKn~iVLNLS~N~IetI-Pn~lfinLtD 151 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVP---------TNLEYAKNSIVLNLSYNNIETI-PNSLFINLTD 151 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhhhcc---------hhhhhhcCcEEEEcccCccccC-CchHHHhhHh
Confidence 99999999864 34666778999999999999999765 4577889999999999999955 5555544456
Q ss_pred hhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCc-ccCCccccccCCCceEEec
Q 003855 169 LQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLE-GSIPYDLCHLKLMFGIRLT 247 (791)
Q Consensus 169 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~ 247 (791)
|-.|+|++|++. .+|+.+..+.+|++|+|++|.+...--..+..+++|++|.+++.+-+ .-+|..+..+.+|..+|+|
T Consensus 152 LLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS 230 (1255)
T KOG0444|consen 152 LLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLS 230 (1255)
T ss_pred Hhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhcccc
Confidence 889999999998 67888999999999999999997555556677889999999987654 3578899999999999999
Q ss_pred CCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCC-C
Q 003855 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSG-D 326 (791)
Q Consensus 248 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~-~ 326 (791)
.|.+. .+|+++-++++|+.|+||+|+|+ .+........+|++|+||.|+++ .+|.++++++.|+.|++.+|+++- -
T Consensus 231 ~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeG 307 (1255)
T KOG0444|consen 231 ENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEG 307 (1255)
T ss_pred ccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccC
Confidence 99999 89999999999999999999998 55666777889999999999998 899999999999999999999873 3
Q ss_pred CCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCC
Q 003855 327 IPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVK 402 (791)
Q Consensus 327 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 402 (791)
+|+.++.+.+|+.+..++|.+. .+|+.++.+.+|+.|.|++|++- .+|+.+.-++.|+.||+..|+=--.+|..
T Consensus 308 iPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP 381 (1255)
T KOG0444|consen 308 IPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKP 381 (1255)
T ss_pred CccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCc
Confidence 7889999999999999999999 99999999999999999999998 89999999999999999999865555543
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.91 Aligned_cols=238 Identities=21% Similarity=0.377 Sum_probs=189.7
Q ss_pred cccCCCcceEEEEEEecCCc-----------EEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 507 NLLGTGSFGSVYKGTISDGT-----------DVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
+.||+|+||.||+|...+.. .|++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976432 5788877654333 5788899999999999999999999987 778999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC-------cEEEeeecc
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-------AAHVSDFGI 648 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~-------~~kl~Dfgl 648 (791)
|||+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+|++|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE----DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh----hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 9999999999999876656899999999999999999999 67899999999999999888 799999999
Q ss_pred ccccCCCCCcceeecccccccccCCCccCCC--CCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCC
Q 003855 649 SKLLGEGEDSVTQTMTMATIGYMAPEYGSEG--IVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHG 725 (791)
Q Consensus 649 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (791)
++.... .....++..|+|||++... .++.++|||||||++|||++ |..|+..... .....++.. ..
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~~~~---~~ 223 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQD---QH 223 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHHHhc---CC
Confidence 986543 1223467789999998776 78999999999999999999 5677755321 111111110 00
Q ss_pred hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 726 ~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
.. +. .....+.+++.+||..+|++||++.|+++.|+
T Consensus 224 ~~--------------~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 RL--------------PM--PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC--------------CC--CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00 00145779999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.16 Aligned_cols=266 Identities=23% Similarity=0.279 Sum_probs=198.3
Q ss_pred HHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC---
Q 003855 496 IQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP--- 569 (791)
Q Consensus 496 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--- 569 (791)
.....++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3455688999999999999999999864 78899999986542 22345677899999999999999999987532
Q ss_pred ---CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeee
Q 003855 570 ---DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDF 646 (791)
Q Consensus 570 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 646 (791)
...++++|++ +++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecccCChhhEEECCCCCEEEcCC
Confidence 4568999988 78999888643 3899999999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC
Q 003855 647 GISKLLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG 725 (791)
Q Consensus 647 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (791)
|+++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+.++..... ..
T Consensus 163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~-~~ 235 (343)
T cd07878 163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIMEVVG-TP 235 (343)
T ss_pred ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhC-CC
Confidence 999865432 123468999999998866 5689999999999999999999999965321 111122111110 00
Q ss_pred hhhhc---chhhhhhH----Hhh------HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 726 LTEVV---DANLVREE----QAF------SAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 726 ~~~~~---d~~~~~~~----~~~------~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..+.. ........ ... .......+.+.+++.+|++.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000000 000 0001233457899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=308.20 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=207.2
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.+.|+.-++||+|+||+||-++.+ +|+.+|.|.+.+.. +........|..+++++..|+||.+-.+|+.++..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 456888899999999999999865 79999999886553 33344567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 576 LEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
+..|.||||.-+|...+ ..+++..+.-++.+|+.||++|| ..+||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH----~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH----RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH----hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999998654 35899999999999999999999 67899999999999999999999999999998876
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
+.. ....+||.||||||++..+.|+...|+||+||++|||+.|+.||....+.. -.+.+|++.
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------------k~eEvdrr~ 402 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------------KREEVDRRT 402 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--------------hHHHHHHHH
Confidence 543 334589999999999999999999999999999999999999996532211 112344444
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVT 770 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 770 (791)
.......+ ...++++.++....++.||++|....
T Consensus 403 ~~~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 403 LEDPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hcchhhcc--cccCHHHHHHHHHHHccCHHHhccCC
Confidence 44333322 45677888999999999999997543
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.50 Aligned_cols=248 Identities=26% Similarity=0.329 Sum_probs=202.8
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|+..+.||.|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999965 68899999987553 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++++|.+++... .+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++++|||+++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH----EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 9999999999865 5899999999999999999999 6789999999999999999999999999998775432
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
.......++..|+|||++.+..++.++||||||+++|||+||+.||....... ....+..... +.+.
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~--------~~~~--- 219 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKNNP--------PSLE--- 219 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhcCC--------CCCc---
Confidence 12223457889999999988889999999999999999999999996532111 0000000000 0000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. ..++.++.+++.+||..+|++||+++++++
T Consensus 220 ----~-~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 ----G-NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ----c-cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 014556789999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.70 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=203.0
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
..|+..+.||+|+||.||+|... +++.||+|++.... ......+..|+.++++++||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999975 68899999987543 34567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++|+|.+++... .+++.++..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh----~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH----SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 9999999999754 3788999999999999999999 67899999999999999999999999999976643321
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......++..|+|||++.+..++.++|||||||++|||+||+.||........ .... ..... +
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~~-~~~~~----~------ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LFLI-PKNNP----P------ 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----hhhh-hcCCC----C------
Confidence 22234578899999999888899999999999999999999999875432211 0000 00000 0
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.....++..+.+++.+||+.+|++||++.|+++.
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 ---TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1112356678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=340.19 Aligned_cols=258 Identities=25% Similarity=0.431 Sum_probs=212.8
Q ss_pred hccccccccCCCcceEEEEEEec----C----CcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS----D----GTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPD 570 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 570 (791)
++....+.+|+|.||.||+|... . ...||||.++... ..+.+.+..|+++|+.+ +||||+.++|+|..++
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 44456669999999999999743 1 4579999987554 35567899999999999 6999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe
Q 003855 571 FKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL 635 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill 635 (791)
..++|+||++.|+|.++++..+ ..+.......++.|||.|++||+ +.+++|||+.++|||+
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~----~~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA----SVPCVHRDLAARNVLI 451 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh----hCCccchhhhhhhEEe
Confidence 9999999999999999999766 34888999999999999999999 7789999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCccee-ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcch
Q 003855 636 DENMAAHVSDFGISKLLGEGEDSVTQ-TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMS 713 (791)
Q Consensus 636 ~~~~~~kl~Dfgla~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 713 (791)
+++..+||+|||+|+...+...+... +...-+..|||||.+....|+.|+|||||||++||++| |..||.+.... ..
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-~~ 530 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-EE 530 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH-HH
Confidence 99999999999999976555443322 11113557999999999999999999999999999999 88999762211 11
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
+.+ ...++.+...+..|+.+++++|..||+.+|++||++.++++.++...
T Consensus 531 l~~-----------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 531 LLE-----------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHH-----------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 111 22233344556678899999999999999999999999999999853
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.13 Aligned_cols=253 Identities=25% Similarity=0.295 Sum_probs=204.8
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|+..+.||+|+||.||+|..+ +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778889999999999999976 68999999887653 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS-APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++++|.+++......++...+..++.|++.|++||| + .+++||||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH----EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc----CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999999876566899999999999999999999 5 7899999999999999999999999999876532211
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
. ...++..|+|||+..+..++.++||||||+++|+|++|+.||...........+.+.........
T Consensus 157 ~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 222 (265)
T cd06605 157 K----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP---------- 222 (265)
T ss_pred h----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC----------
Confidence 1 15578899999999888999999999999999999999999875432222222222211111000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+ ...++.++.++|.+||..+|++|||+.|+++
T Consensus 223 --~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 --RLP-SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --CCC-hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 000 0114567889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=298.41 Aligned_cols=266 Identities=20% Similarity=0.307 Sum_probs=223.2
Q ss_pred HHHHHhhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeec
Q 003855 495 DIQRATDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCS 567 (791)
Q Consensus 495 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 567 (791)
+++....+++....+.+|.||.||.|.|. +.+.|-||.++... .-+...+.+|...+..+.|||+.++.+.+.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 44555567888889999999999999664 34567777776544 334567888999999999999999999884
Q ss_pred -cCCeeeEEEecCCCCCHHHHHh-----h--CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC
Q 003855 568 -NPDFKALVLEFMPNGSLEKWLY-----S--HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM 639 (791)
Q Consensus 568 -~~~~~~lv~e~~~~g~L~~~l~-----~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~ 639 (791)
+.+.++..|.++.-|+|..|+. + ....+...+...++.|++.|++||| +.+|||.||.++|+++|+..
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh----~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH----NHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH----hcCcccchhhhhcceehhhe
Confidence 5577889999999999999998 2 2334777888999999999999999 78999999999999999999
Q ss_pred cEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHH
Q 003855 640 AAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWV 718 (791)
Q Consensus 640 ~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 718 (791)
+|||+|-.++|.+.+++...-......+..||+||.+....|+..+|||||||++|||+| |+.||.+..+.|+.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~----- 508 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME----- 508 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-----
Confidence 999999999999999888777777778899999999999999999999999999999999 99999875443321
Q ss_pred HHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 719 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 719 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
....++.+...+.+||.+++.+|.-||..+|++||+++|++.-|.++..+.
T Consensus 509 --------------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 509 --------------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred --------------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 112223344556689999999999999999999999999999999987765
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.67 Aligned_cols=265 Identities=25% Similarity=0.313 Sum_probs=198.2
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999875 78999999886442 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 579 MPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 579 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
++ ++|.+++.... ..+++..+..++.|+++||.||| +.+++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH----SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 68999987432 45899999999999999999999 6789999999999999999999999999997654322
Q ss_pred CcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC---h---hhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---L---TEV 729 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~---~~~ 729 (791)
.......++..|+|||++.+ ..++.++|||||||++|||+||+.||....... ............. . ...
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhh
Confidence 12223457889999998765 457889999999999999999999987532111 1111111100000 0 000
Q ss_pred cchh--hhh--hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 VDAN--LVR--EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 ~d~~--~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+.. ... ..........++.++.+++.+|++.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 000 00000011135577889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=302.32 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=203.6
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+|+..+.||+|+||.||.++.. +++.|++|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999854 68899999876542 44556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH----KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999865 445899999999999999999999 67899999999999999999999999999987644331
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
......++..|+|||...+..++.++||||||+++|||++|+.||+.... ...+..........
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~--------- 220 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIVQGNYTP--------- 220 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCCCCC---------
Confidence 22334688999999999888899999999999999999999999865221 11111111111000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
....++.++.+++.+||+.+|++||++.|+++.
T Consensus 221 -----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 -----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -----CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 012345668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=310.93 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=200.8
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+..|+.++++++||||+++++++......++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34667788999999999999865 67899999886443 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++++|.+++... .+++..+..++.|+++|+.||| ..+++|+||+|+||++++++.++++|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH----~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 84 LGGGSALDLLKPG--PLEETYIATILREILKGLDYLH----SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred cCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh----cCCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999999998754 3789999999999999999999 67899999999999999999999999999976543221
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......++..|+|||++.+..++.++|||||||++|||++|+.|+......+. ..++.. .. .+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~----~~----~~~----- 220 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLIPK----NS----PPT----- 220 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhhhhc----CC----CCC-----
Confidence 12223578899999999888899999999999999999999999865322211 111100 00 000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
....++..+.+++.+|++.+|++||++.|+++
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 221 ----LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ----CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01134466789999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.55 Aligned_cols=262 Identities=21% Similarity=0.236 Sum_probs=195.0
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
...+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999975 5788999975432 23458999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+ .|+|.+++......+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 138 ~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 138 HY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH----AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred cc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 99 56999999877667999999999999999999999 6789999999999999999999999999997533221
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCC-CccccCc--------chHHHHHHHhc--CCCh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPT-DEMFTGE--------MSLRRWVKESL--PHGL 726 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~-~~~~~~~--------~~~~~~~~~~~--~~~~ 726 (791)
......||..|+|||++.+..++.++|||||||++|||+++..|+ ....... ..+.+.+.... +...
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 122346899999999999999999999999999999999965554 3211110 01111111100 0000
Q ss_pred hhhcchhhhhhH-------------HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 727 TEVVDANLVREE-------------QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 727 ~~~~d~~~~~~~-------------~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.......+.... ........++..+.++|.+||+.||++|||+.|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 000000000000 000011134456678999999999999999999975
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.88 Aligned_cols=265 Identities=22% Similarity=0.235 Sum_probs=196.8
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC------
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP------ 569 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 569 (791)
..++|+..+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 68899999986532 33446677899999999999999999987543
Q ss_pred CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
...++||||+++ ++.+++.. .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH----~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357899999965 77777753 3788899999999999999999 679999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC----
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---- 725 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 725 (791)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+...+.......
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 8654321 2223468999999999988899999999999999999999999997532111 1111111100000
Q ss_pred ------hhhhcch----------hh-hhhH--HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 726 ------LTEVVDA----------NL-VREE--QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 726 ------~~~~~d~----------~~-~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
....++. .. .... ...........++.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 00 0000 0000011124567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.25 Aligned_cols=195 Identities=23% Similarity=0.300 Sum_probs=159.8
Q ss_pred ccccCCCcceEEEEEEec---CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeecc--CCeeeEEEecCC
Q 003855 506 CNLLGTGSFGSVYKGTIS---DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN--PDFKALVLEFMP 580 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 580 (791)
.++||+|+||+||+|+.. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 56789999886442 22456789999999999999999998854 456789999995
Q ss_pred CCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe----CCCCcEEEeeecc
Q 003855 581 NGSLEKWLYSH--------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL----DENMAAHVSDFGI 648 (791)
Q Consensus 581 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfgl 648 (791)
++|.+++... ...+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5898887632 224888999999999999999999 6789999999999999 4668899999999
Q ss_pred ccccCCCCCc-ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCcc
Q 003855 649 SKLLGEGEDS-VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEM 707 (791)
Q Consensus 649 a~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~ 707 (791)
|+.+...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9876433221 12233568999999998866 45899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.40 Aligned_cols=266 Identities=22% Similarity=0.295 Sum_probs=198.9
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+|+..+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999975 78999999986542 22235677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++ ++|.+++......+++..+..++.||++||.||| ..+++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH----SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 96 5899988765556899999999999999999999 67899999999999999999999999999986543221
Q ss_pred ceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC------hhhhcc
Q 003855 659 VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG------LTEVVD 731 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~d 731 (791)
......++..|+|||++.+. .++.++|||||||++|||+||+.|+......+..+........... .....+
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 12234578899999987654 4789999999999999999999886432222222211111100000 000000
Q ss_pred hh----hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 AN----LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. ......-......++.++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 00000000111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.59 Aligned_cols=249 Identities=27% Similarity=0.403 Sum_probs=199.2
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---------hHHHHHHHHHHHHHHhccCCccceeeeeeccCCe
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---------ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF 571 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 571 (791)
+|.+.+.||+|+||.||+|... +++.||+|.+.... .+..+.+..|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999864 68899999885432 1234678899999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++||||+++++|.+++.... .+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH----~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH----NRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH----hcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999998654 4788899999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCc----ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh
Q 003855 652 LGEGEDS----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727 (791)
Q Consensus 652 ~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
....... .......|+..|+|||.+.+..++.++||||+||++|||++|+.||....... ...+ +.. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~-~~~----~-- 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFK-IGE----N-- 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHH-Hhc----c--
Confidence 6532111 11122347889999999988889999999999999999999999997532111 1100 000 0
Q ss_pred hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+. .+..++..+.+++.+||+.||++||++.|+++
T Consensus 228 --~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 --ASPE---------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --CCCc---------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0000 11134566789999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=303.68 Aligned_cols=251 Identities=20% Similarity=0.320 Sum_probs=186.6
Q ss_pred ccCCCcceEEEEEEecCC---cEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCC
Q 003855 508 LLGTGSFGSVYKGTISDG---TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGS 583 (791)
Q Consensus 508 ~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 583 (791)
.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975433 345677665432 3445688999999999999999999999999999999999999999
Q ss_pred HHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 584 LEKWLYSHN---YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 584 L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
|.++++... ...++..+..++.||++||+||| +.+++||||||+||+++.++.++|+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH----KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999998542 23567778899999999999999 67899999999999999999999999999864322211112
Q ss_pred eecccccccccCCCccCC-------CCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 661 QTMTMATIGYMAPEYGSE-------GIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
.....++..|+|||+... ..++.++|||||||++|||++ |..||...... ..+..... .......++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~----~~~~~~~~~ 232 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIK----DQQVKLFKP 232 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHh----hcccccCCC
Confidence 233457889999998643 345789999999999999997 56677543211 11111111 111111111
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
.+. ......+.+++..|| .+|++||++.||++.|.
T Consensus 233 ~~~---------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QLE---------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccC---------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 113355778999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=307.41 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=199.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|++.+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999976 78999999886542 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 579 MPNGSLEKWLYSH--NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 579 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
+++++|.+++... ...+++..+..++.+++.|+.|||+ ..+++||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE---EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999998764 2358999999999999999999994 3589999999999999999999999999997653221
Q ss_pred CcceeecccccccccCCCccCCC------CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEG------IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... .... +.. ..
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~-~~~--------~~ 223 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQ-LSA--------IV 223 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHH-HHH--------Hh
Confidence 1223578899999987543 35889999999999999999999986422111 0000 000 00
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.. ....+..++.++.+++.+|++.+|++||++.++++
T Consensus 224 ~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 224 DGD------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hcC------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 000 00011135567789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.63 Aligned_cols=265 Identities=19% Similarity=0.250 Sum_probs=195.6
Q ss_pred cccccCCC--cceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 505 ECNLLGTG--SFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 505 ~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
+.++||+| +|++||+++.+ +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 67899999864 78999999987543 334456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999754 334899999999999999999999 678999999999999999999999999876443221110
Q ss_pred c-----eeecccccccccCCCccCC--CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh----
Q 003855 659 V-----TQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT---- 727 (791)
Q Consensus 659 ~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 727 (791)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .........+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhcCCccccccccch
Confidence 0 1112346778999999865 4589999999999999999999999975322111 11111111110000
Q ss_pred --hh---------cchhhhh----------h--HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 --EV---------VDANLVR----------E--EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 --~~---------~d~~~~~----------~--~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+. .+..... . ....+....+++.+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 0000000 0 0000111234567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=320.38 Aligned_cols=265 Identities=20% Similarity=0.206 Sum_probs=197.4
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC------
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP------ 569 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 569 (791)
..++|+..+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999864 68899999986532 33445678899999999999999999987543
Q ss_pred CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
...++||||+++ ++.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999964 78887753 2788899999999999999999 679999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC--hh
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG--LT 727 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 727 (791)
+...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...... ..+...+....... ..
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence 8654321 122346899999999999999999999999999999999999999753221 11111111100000 00
Q ss_pred hhcchhhhhhHH---------------------hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 728 EVVDANLVREEQ---------------------AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 728 ~~~d~~~~~~~~---------------------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..+.+....... ..........++.+++.+|++.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000 000001123567899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=330.19 Aligned_cols=266 Identities=23% Similarity=0.264 Sum_probs=192.9
Q ss_pred HHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccC------Cccceeeeeecc
Q 003855 496 IQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRH------RNLIKILSSCSN 568 (791)
Q Consensus 496 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~ 568 (791)
+....++|++.+.||+|+||.||+|... +++.||||+++... ...+.+..|+.+++.++| ++++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3345688999999999999999999864 68889999986432 223445667777777754 458888888865
Q ss_pred C-CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC--------
Q 003855 569 P-DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-------- 639 (791)
Q Consensus 569 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~-------- 639 (791)
. .+.++|||++ +++|.+++...+ .+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~---~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHT---ELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEecCCcccccccc
Confidence 4 5788999988 789999987654 48999999999999999999993 25899999999999998765
Q ss_pred --------cEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCc
Q 003855 640 --------AAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711 (791)
Q Consensus 640 --------~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 711 (791)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||+.....
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~- 351 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL- 351 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-
Confidence 499999998864322 223457899999999999999999999999999999999999999763221
Q ss_pred chHHHHHHHhc---CCCh---------hhhc----------chhhhhhHH--hhHHHHHHHHHHHHHHhhccccCCCCCC
Q 003855 712 MSLRRWVKESL---PHGL---------TEVV----------DANLVREEQ--AFSAKMDCILSIMDLALDCCIESPDMRI 767 (791)
Q Consensus 712 ~~~~~~~~~~~---~~~~---------~~~~----------d~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~RP 767 (791)
.....+.... +..+ .++. ++....... ...........+.+|+.+||+.||++||
T Consensus 352 -~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 352 -EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred -HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 1111111110 0000 0000 000000000 0000001235578999999999999999
Q ss_pred CHHHHHH
Q 003855 768 NVTDAAA 774 (791)
Q Consensus 768 t~~ev~~ 774 (791)
|+.|+++
T Consensus 431 ta~e~L~ 437 (467)
T PTZ00284 431 NARQMTT 437 (467)
T ss_pred CHHHHhc
Confidence 9999986
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=341.56 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=198.0
Q ss_pred HHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehh--hhHHHHHHHHHHHHHHhccCCccceeeeeecc--CCe
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSN--PDF 571 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 571 (791)
....++|++.+.||+|+||.||+|+.. ++..||+|++... .......+..|+.++++++||||+++++++.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 334578999999999999999999975 6778999988643 23445678899999999999999999998854 456
Q ss_pred eeEEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccC---CCCCeEecCCCCCCeEeCC--------
Q 003855 572 KALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHHGH---SSAPIIHCDLKPTNILLDE-------- 637 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~---~~~~i~H~dlk~~Nill~~-------- 637 (791)
.++||||+++|+|.++|... ...+++..++.|+.||+.||+|||... ...+|+||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999742 245899999999999999999999422 1146999999999999964
Q ss_pred ---------CCcEEEeeeccccccCCCCCcceeecccccccccCCCccCC--CCCCccccHHhHHHHHHHHHhCCCCCCc
Q 003855 638 ---------NMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDE 706 (791)
Q Consensus 638 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~ 706 (791)
.+.+||+|||+++.+..... .....||+.|+|||++.+ ..++.++||||||||+|||+||+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 34589999999987643221 223468999999998753 4588999999999999999999999964
Q ss_pred cccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 707 MFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. ....++.... ... . .....++..+.++|..||+.+|++||++.|+++
T Consensus 246 ~~----~~~qli~~lk-~~p------~--------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 AN----NFSQLISELK-RGP------D--------LPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CC----cHHHHHHHHh-cCC------C--------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 22 1112111110 000 0 000123466889999999999999999999984
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.41 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=198.9
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh----------hHHHHHHHHHHHHHHhccCCccceeeeeeccCC
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL----------ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD 570 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 570 (791)
+|...+.||+|+||.||+|... +++.||+|.+.... ....+.+..|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999864 68999999875321 112356788999999999999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..++||||+++|+|.+++.... .+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++++|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH----SKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh----hCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999998764 4889999999999999999999 6789999999999999999999999999997
Q ss_pred ccCCCCCcceeecccccccccCCCccCCCC--CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
...............++..|+|||...... ++.++||||||+++||+++|..||...... ..+... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~ 231 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----AAMFKL-GNKRSAP 231 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----HHHHHh-hccccCC
Confidence 654322222223345788999999876654 889999999999999999999998642211 111110 0000000
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+... ....++..+.+++.+|++.+|++||++.|+++
T Consensus 232 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PIPPD---------VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcc---------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00000 01134577889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.99 Aligned_cols=254 Identities=23% Similarity=0.385 Sum_probs=203.0
Q ss_pred hccccccccCCCcceEEEEEEec------CCcEEEEEEeehhhhH-HHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
++|+..+.||+|+||.||+|+.+ +.+.|++|.+.....+ ..+.+..|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999864 3467999988655433 5577899999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEee
Q 003855 574 LVLEFMPNGSLEKWLYSHN--------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSD 645 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~D 645 (791)
+||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.++++|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS----NARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh----hcCcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999998543 14899999999999999999999 67899999999999999999999999
Q ss_pred eccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCC
Q 003855 646 FGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPH 724 (791)
Q Consensus 646 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 724 (791)
||++....... ........++..|+|||...+..++.++||||||+++|||++ |..||..... ......... .
T Consensus 161 ~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~~~~~---~ 234 (275)
T cd05046 161 LSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLNRLQA---G 234 (275)
T ss_pred cccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHHHHHc---C
Confidence 99987543222 112223356778999999888889999999999999999999 7788854321 111111110 0
Q ss_pred ChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 725 GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 725 ~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
... .+....++..+.+++.+||+.+|++||++.|+++.|.
T Consensus 235 ~~~-------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLE-------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcC-------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 0011134567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.05 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=195.1
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehh-----hhHHHHHHHHHHHHHHhccCCccceeeeeecc--CCee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ-----LERAFRSFDSECEVLRNVRHRNLIKILSSCSN--PDFK 572 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 572 (791)
.+|+..+.||+|+||.||+|... +++.||+|++... ..+..+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 6899999987533 12345678889999999999999999998865 3567
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++++||+++++|.+++..... +++..+..++.|++.||+||| +.+++||||+|+||++++++.++|+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~LH----~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 899999999999999986543 788999999999999999999 678999999999999999999999999999865
Q ss_pred CCCCCc-ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 653 GEGEDS-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 653 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
...... .......++..|+|||++.+..++.++|||||||++|||++|+.||......+ . +........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----~-~~~~~~~~~----~ 227 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----A-IFKIATQPT----N 227 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----H-HHHHhcCCC----C
Confidence 432111 11122357889999999988889999999999999999999999987532111 1 111000000 0
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.+ +..+...+.+++ +||..+|++||+++|+++
T Consensus 228 ~~~---------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 PQL---------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC---------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000 112334556677 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.79 Aligned_cols=262 Identities=24% Similarity=0.294 Sum_probs=193.2
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhc---cCCccceeeeeecc-----CC
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNV---RHRNLIKILSSCSN-----PD 570 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~ 570 (791)
+|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999865 78999999886532 11223455667666655 79999999998754 34
Q ss_pred eeeEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
..++||||++ ++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999997 58999887543 34899999999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC---CCh
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP---HGL 726 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~ 726 (791)
+....... .....++..|+|||++.+..++.++||||+||++|||++|++||...... ..+.+....... ..+
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhC
Confidence 87643221 22345789999999998888999999999999999999999998653221 112221111100 000
Q ss_pred h-------hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 727 T-------EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 727 ~-------~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. ....+...... ......++.++.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPV--QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCch--HHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000000 0011134567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.78 Aligned_cols=269 Identities=22% Similarity=0.288 Sum_probs=198.7
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh-HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|+||+++.+++.+++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999864 788999999865432 22345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+. +++.+++......+++..+..++.|++.||.||| ..+|+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH----GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 7888888765555788889999999999999999 6789999999999999999999999999997643322
Q ss_pred CcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHh-cC-----------
Q 003855 657 DSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES-LP----------- 723 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~-~~----------- 723 (791)
. ......++..|+|||...+ ..++.++|||||||++|||++|+.||+........+...+... .+
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 1 1223356889999998765 4578899999999999999999999975432211111111000 00
Q ss_pred -CChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 724 -HGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 724 -~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
........................+..+.+++.+|+..||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000000000112456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=304.16 Aligned_cols=250 Identities=30% Similarity=0.534 Sum_probs=201.7
Q ss_pred cccccccCCCcceEEEEEEecC-----CcEEEEEEeehhhhH-HHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 503 FNECNLLGTGSFGSVYKGTISD-----GTDVAIKIFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
+++.+.||+|+||.||+|+..+ +..||+|++...... ..+.+..|+.++++++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999753 488999998755433 5678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 577 EFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
||+++++|.+++...... +++..+..++.|++.|++||| +.+++||||+|+||++++++.++++|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh----~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh----cCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999865544 899999999999999999999 678999999999999999999999999999876544
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
...... ...++..|+|||...+..++.++||||+|+++|||++ |..||.... .....+.+.....
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~~~~~~----------- 222 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--NEEVLEYLKKGYR----------- 222 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCCC-----------
Confidence 222211 2236789999999988889999999999999999998 778876521 1111111111000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
......++.++.+++.+|++.+|++|||+.|+++.|
T Consensus 223 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 001112456788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.88 Aligned_cols=266 Identities=21% Similarity=0.232 Sum_probs=200.7
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++|+..+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.++++++|||++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 68999999886442 2233567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|++++++..++.... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH----KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999988888766443 4899999999999999999999 67899999999999999999999999999987654332
Q ss_pred cceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC--Chhhhcc---
Q 003855 658 SVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH--GLTEVVD--- 731 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~d--- 731 (791)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+. ........... ......+
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhccccc
Confidence 1122347788999998765 5688999999999999999999999975432211 11111100000 0000000
Q ss_pred -------hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 -------ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 -------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+...............+..+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000011234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.52 Aligned_cols=256 Identities=20% Similarity=0.245 Sum_probs=200.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999875 67899999987553 233457888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++++|.+++...+ .+++..+..++.|++.|+.||| +.+++||||||+||++++++.++++|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH----NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999997654 4889999999999999999999 6789999999999999999999999999987421110
Q ss_pred C-------------cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC
Q 003855 657 D-------------SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP 723 (791)
Q Consensus 657 ~-------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (791)
. ........++..|+|||.+....++.++|||||||++|||++|+.||.+.... ++......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~~~~~~~ 230 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFGQVIS 230 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh
Confidence 0 00111235688899999998888999999999999999999999998643211 11111110
Q ss_pred CChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 724 HGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 724 ~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
.... .+ .....++..+.+++.+||+.+|++||++.++.+.++.
T Consensus 231 ~~~~---~~---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDIE---WP---------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cccC---CC---------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0000 00 0001245667899999999999999997666665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=306.83 Aligned_cols=254 Identities=26% Similarity=0.466 Sum_probs=199.0
Q ss_pred cccccccCCCcceEEEEEEec----CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCC------
Q 003855 503 FNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD------ 570 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 570 (791)
|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999853 46889999986542 344567889999999999999999999875432
Q ss_pred eeeEEEecCCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEee
Q 003855 571 FKALVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSD 645 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~D 645 (791)
..++++||+++|+|.+++... ...+++..+.+++.|++.|++||| +.+|+||||||+||++++++.+|++|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS----SKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccchhhEEEcCCCCEEECc
Confidence 347899999999999887532 224788999999999999999999 67899999999999999999999999
Q ss_pred eccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCC
Q 003855 646 FGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPH 724 (791)
Q Consensus 646 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 724 (791)
||+++...............++..|++||......++.++|||||||++|||++ |+.||..... .....++.....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~- 233 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGNR- 233 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCCc-
Confidence 999987644332222223345678999999988889999999999999999999 8888865322 112222111000
Q ss_pred ChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 725 GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 725 ~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
. .....++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 234 -~---------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 -L---------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -C---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00112446788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=304.66 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=200.1
Q ss_pred ccccccccCCCcceEEEEEEecC--CcEEEEEEeehh----------hhHHHHHHHHHHHHHHh-ccCCccceeeeeecc
Q 003855 502 EFNECNLLGTGSFGSVYKGTISD--GTDVAIKIFNLQ----------LERAFRSFDSECEVLRN-VRHRNLIKILSSCSN 568 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 568 (791)
+|++.+.||+|+||.||+|.... ++.+|+|.+... .......+..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999764 688999987532 12334567778888875 699999999999999
Q ss_pred CCeeeEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEee
Q 003855 569 PDFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSD 645 (791)
Q Consensus 569 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~D 645 (791)
.+..++||||+++++|.+++.. ....+++..+++++.|++.|+.|||+ ..+++||||+|+||++++++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK---EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc---CCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998853 34568999999999999999999993 35799999999999999999999999
Q ss_pred eccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC
Q 003855 646 FGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG 725 (791)
Q Consensus 646 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (791)
||.+....... ......++..|+|||+..++.++.++||||||+++|||++|+.||..... ......+.. ..
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~~---~~ 229 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--LSLATKIVE---AV 229 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--HHHHHHHhh---cc
Confidence 99998765432 22344688899999999888899999999999999999999999864211 111111100 00
Q ss_pred hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 726 ~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
... .....++.++.+++.+||+.||++||++.|+.++++
T Consensus 230 ~~~-------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEP-------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCc-------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000 001123466889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.27 Aligned_cols=258 Identities=23% Similarity=0.310 Sum_probs=199.5
Q ss_pred hHHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeec----
Q 003855 494 LDIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCS---- 567 (791)
Q Consensus 494 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~---- 567 (791)
..+....++|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 344456789999999999999999999864 68899999876432 2235677899999999 7999999999873
Q ss_pred -cCCeeeEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003855 568 -NPDFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV 643 (791)
Q Consensus 568 -~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl 643 (791)
.++..++||||+++|+|.+++.. ....+++..+..++.|+++|+.||| +.+++||||||+||++++++.+++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH----VNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH----hCCccccCCCHHhEEECCCCCEEE
Confidence 44678999999999999998863 2345788999999999999999999 678999999999999999999999
Q ss_pred eeeccccccCCCCCcceeecccccccccCCCccC-----CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHH
Q 003855 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV 718 (791)
Q Consensus 644 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 718 (791)
+|||+++....... ......|+..|+|||++. +..++.++||||+||++|||++|+.||...... ..+.
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----~~~~ 239 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----RALF 239 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----HHHh
Confidence 99999986643221 222346889999999874 345788999999999999999999998653221 1111
Q ss_pred HHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 719 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 719 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
. ..........+ +..++..+.+++.+||+.||++||++.|+++.
T Consensus 240 ~-~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 K-IPRNPPPTLHQ------------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred h-ccccCCCcccC------------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 00000000000 11234567899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.45 Aligned_cols=249 Identities=22% Similarity=0.325 Sum_probs=199.2
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
.|.....||+|+||.||++... ++..||||.+........+.+..|+.+++.++||||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999864 688999999876555556778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+++|.+++... .+++.++..++.||+.|++||| +.+|+||||||+||++++++.++|+|||++........ .
T Consensus 103 ~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 174 (292)
T cd06658 103 GGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH----NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K 174 (292)
T ss_pred CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence 99999988654 3789999999999999999999 67899999999999999999999999999976533221 1
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHh
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 740 (791)
.....|+..|+|||+..+..++.++||||||+++|||++|+.||...... ..+.. +....+. ...
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~-~~~~~~~--------~~~----- 239 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-QAMRR-IRDNLPP--------RVK----- 239 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHhcCCC--------ccc-----
Confidence 22345789999999998888999999999999999999999998652211 11111 1110000 000
Q ss_pred hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 741 FSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 741 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.....+..+.+++.+|+..||++|||+.|+++.
T Consensus 240 --~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 --DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011234567789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.92 Aligned_cols=243 Identities=25% Similarity=0.413 Sum_probs=198.6
Q ss_pred ccccCCCcceEEEEEEec-CCcEEEEEEeeh----hhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCe--eeEEEec
Q 003855 506 CNLLGTGSFGSVYKGTIS-DGTDVAIKIFNL----QLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF--KALVLEF 578 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 578 (791)
...||+|+|-+||+|.+. +|..||=-.++. ...+..+.|..|+.+++.|+||||++++.++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 458999999999999874 566665322221 123445789999999999999999999999977655 6789999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC-CCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD-ENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+..|+|..|..+.+. .+...+..|++||++||.|||.. .++|+|||||-+||||+ .-|.|||+|+|+|+......
T Consensus 125 ~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~--~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ--DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred ccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC--CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 999999999998765 88899999999999999999975 45899999999999997 57999999999999875432
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
....+|||.|||||... ..|++.+||||||+.++||+|+..||.+......-+.+......|..+..+-|
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d------ 270 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD------ 270 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC------
Confidence 22368999999999876 68999999999999999999999999887655544444444444444444444
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+++.++|.+|+.. .++|||+.|+++
T Consensus 271 -----------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 -----------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 4456899999999 999999999975
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=299.48 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=199.3
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc-CCeeeEEEe
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN-PDFKALVLE 577 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 577 (791)
+|++.+.||+|++|.||+++.+ +++.||+|.+.... ....+.+.+|++++++++|||++++.+.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999865 67899999986543 3445678899999999999999999988764 446789999
Q ss_pred cCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 578 FMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 578 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
|+++++|.+++... ...+++.++..++.+++.|++||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH----~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH----EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999864 345899999999999999999999 6789999999999999999999999999998764322
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
. ......+++.|+|||+..+..++.++||||||+++|||++|+.||+.... .............
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~--------- 220 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGKLP--------- 220 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcCCC---------
Confidence 1 12234578899999999999999999999999999999999999864221 1111111110000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.+..++..+.+++.+|++.+|++||++.++++
T Consensus 221 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 -----PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -----CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 001134466889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=284.52 Aligned_cols=251 Identities=24% Similarity=0.279 Sum_probs=198.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++.+.+..+|.|+.|.||++++. +|...|||.+.... .+..+.+...+.++..- ++|+||+-+|||......++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 44556678999999999999975 68999999987553 44456666777777665 48999999999998888999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
.|. ..+..++..-..++++.-.-++...+.+||.||.+ +++|+|||+||+|||+|+.|++|+||||++..+-+
T Consensus 172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe---KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--- 244 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--- 244 (391)
T ss_pred HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH---hcceeecccCccceEEccCCCEEeecccccceeec---
Confidence 983 36666676666668888888999999999999986 56899999999999999999999999999977643
Q ss_pred cceeecccccccccCCCccCC---CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
+...+..+|-+.|||||.+.. ..|+.++|||||||+++|+.||+.||.+.......+.. +.
T Consensus 245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk-vl--------------- 308 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK-VL--------------- 308 (391)
T ss_pred ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH-HH---------------
Confidence 444555678899999998754 46888999999999999999999999874333222222 11
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..++...+..+..++.+.+++..|++.|+.+||...++++
T Consensus 309 n~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 309 NEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred hcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1112222223346677889999999999999999998875
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=303.59 Aligned_cols=246 Identities=29% Similarity=0.506 Sum_probs=198.0
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
++|++.+.||+|+||.||+|.. +++.||+|.+.... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688999999999999999986 67889999986543 235788899999999999999999998654 4789999999
Q ss_pred CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 581 NGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 581 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
+|+|.+++.... ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE----SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999998653 35789999999999999999999 6789999999999999999999999999997643221
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
.....+..|+|||++.++.++.++|||||||++|||++ |+.||...... .....+.. ..
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~----~~------------ 214 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECVEK----GY------------ 214 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhC----CC------------
Confidence 11234567999999988899999999999999999998 89998653221 11111110 00
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
.......++..+.+++.+||+.+|++||+++++++.|++
T Consensus 215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 000112345678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.02 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=203.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
++|.+.+.||+|+||.||+|... +++.||+|.+........+.+..|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 68899999999999999999854 78899999987555455577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++++|.+++.+.. +++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH----~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 99 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH----hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 9999999997643 788999999999999999999 67899999999999999999999999999876544322
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
......+++.|+|||+...+.++.++||||||+++||+++|+.||......+.. ... . .... .
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~~~-~---~~~~------------~ 233 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLI-A---TNGT------------P 233 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-eeh-h---cCCC------------C
Confidence 122345788999999988888999999999999999999999999753221110 000 0 0000 0
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
........+..+.+++.+||..+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111234567899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=305.68 Aligned_cols=265 Identities=22% Similarity=0.266 Sum_probs=202.6
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999974 78999999987553 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+ +++|.+++......+++.++..++.||++||+||| +.+++|+||||+||++++++.++++|||++........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH----ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 99999999876666899999999999999999999 67899999999999999999999999999987654322
Q ss_pred ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC----hhhhcc--
Q 003855 659 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG----LTEVVD-- 731 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~d-- 731 (791)
.......++..|+|||.+.+ ..++.++||||+|+++|||++|.+||...... ..+. ++....... ..+..+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLA-IVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHH-HHHHHcCCCChHHHhhccCcc
Confidence 12233468899999998754 44689999999999999999998877643221 1111 111111100 000000
Q ss_pred -hh---hhhhH--HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 -AN---LVREE--QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 -~~---~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. ..... .-.....+.+..+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 00000 000011134577889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=300.73 Aligned_cols=247 Identities=27% Similarity=0.360 Sum_probs=200.0
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-----hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-----ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999976 78999999886533 33557789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
+||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH----DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999998654 4789999999999999999999 678999999999999999999999999999875433
Q ss_pred CCcceeecccccccccCCCccCCCC-CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
. ......++..|+|||...... ++.++|+||||+++|+|++|+.||....... ....+... ....
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~---~~~~------- 221 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGRS---KELP------- 221 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHhc---ccCC-------
Confidence 2 123345788999999887666 8999999999999999999999987533111 01110000 0000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..++..+.+++.+||+.+|++||++.++++
T Consensus 222 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 -------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 001123466789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=299.61 Aligned_cols=248 Identities=21% Similarity=0.329 Sum_probs=201.8
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+|+..+.||+|+||.||+++.. +|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999864 78999999987542 33456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++++|.+++... ...+++.++..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999999764 335789999999999999999999 67899999999999999999999999999986643321
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
. .....|+..|+|||+..+..++.++|||||||+++||++|+.||..... ...+.........
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~---------- 219 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGSYP---------- 219 (256)
T ss_pred h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCCCC----------
Confidence 1 1223578899999999888899999999999999999999999864211 1111111111100
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..++.++.+++.+||+.+|++||++.||++
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 ----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 011234566889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.77 Aligned_cols=240 Identities=23% Similarity=0.228 Sum_probs=185.2
Q ss_pred cCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc---cCCccceeeeeeccCCeeeEEEecCCC
Q 003855 509 LGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV---RHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 509 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
||+|+||.||+|+.. +++.||||++.... .........|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 68999999986543 22233445566666655 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.+++.... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH----~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~ 153 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH----KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TT 153 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Cc
Confidence 99999987654 4889999999999999999999 67899999999999999999999999999975432221 12
Q ss_pred ecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHh
Q 003855 662 TMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 740 (791)
....||..|+|||.+.+. .++.++||||+||++|||++|+.||..... ...+........ .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~------~~------ 216 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFGKV------RF------ 216 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcCCC------CC------
Confidence 234689999999987654 489999999999999999999999865221 111111100000 00
Q ss_pred hHHHHHHHHHHHHHHhhccccCCCCCCC----HHHHHH
Q 003855 741 FSAKMDCILSIMDLALDCCIESPDMRIN----VTDAAA 774 (791)
Q Consensus 741 ~~~~~~~~~~l~~li~~cl~~~P~~RPt----~~ev~~ 774 (791)
+ ...++..+.+++.+||+.||++||+ +.++++
T Consensus 217 -~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 -P-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -C-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 0123456679999999999999994 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=302.66 Aligned_cols=256 Identities=26% Similarity=0.349 Sum_probs=205.0
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+.+++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999864 68899999986443 33567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 579 MPNGSLEKWLYSH--NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 579 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
+++++|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh----~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH----SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999999854 245899999999999999999999 6789999999999999999999999999998765443
Q ss_pred Ccc--eeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 657 DSV--TQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 657 ~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
... ......|+..|+|||++... .++.++|||||||++|||++|+.||...... ....+......+. ... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~----~ 230 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQNDPPS-LET----G 230 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCCCCC-cCC----c
Confidence 221 12334688999999988776 7899999999999999999999999753222 1122221110000 000 0
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....++..+.+++.+|++.||++||++.|+++
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 --------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 001134567889999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.31 Aligned_cols=266 Identities=25% Similarity=0.292 Sum_probs=200.4
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 68999999876432 2234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|++++++.++..... .+++..+..++.|+++|++||| +.+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH----~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999999888776543 3899999999999999999999 67899999999999999999999999999986543322
Q ss_pred cceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHH--HhcCCChhhhcch--
Q 003855 658 SVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK--ESLPHGLTEVVDA-- 732 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~d~-- 732 (791)
......++..|+|||+..+ ..++.++||||||+++|||++|++||...... ....+... ...........+.
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccch
Confidence 1223457889999998765 45788999999999999999999988642211 11111110 0000000011000
Q ss_pred --------hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 733 --------NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 733 --------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..............++..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000111245677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=305.59 Aligned_cols=249 Identities=26% Similarity=0.334 Sum_probs=192.8
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHH-HHhccCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEV-LRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ......+..|... ++..+||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999975 69999999987543 2222344445554 566789999999999999999999999
Q ss_pred cCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-CeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 578 FMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSA-PIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 578 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
|++ |+|.+++.. ....+++..+..++.|++.||+||| +. +++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH----SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 996 688888764 2345899999999999999999999 44 89999999999999999999999999998653
Q ss_pred CCCCcceeecccccccccCCCccCC----CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSE----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV 729 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
... ......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||.........+........
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 225 (283)
T cd06617 156 DSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS------- 225 (283)
T ss_pred ccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC-------
Confidence 321 1223457889999998754 45688999999999999999999998653222111111111000
Q ss_pred cchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 ~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.+ ....++.++.+++.+||..+|++||++.|+++
T Consensus 226 --~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 --PQL--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 01124567889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=312.77 Aligned_cols=194 Identities=29% Similarity=0.374 Sum_probs=169.4
Q ss_pred ccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-C-----CccceeeeeeccCCeeeE
Q 003855 502 EFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-H-----RNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 574 (791)
+|.+.+.||+|+||.|-+|.. ++++.||||+++.... ...+...|+.+|..++ | -|+|+++++|.-.++.|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 789999999999999999985 4799999999986643 3456677999999996 4 389999999999999999
Q ss_pred EEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC--CCcEEEeeeccccc
Q 003855 575 VLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE--NMAAHVSDFGISKL 651 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfgla~~ 651 (791)
|+|.++ -+|.++++.+. ..++...+..|+.||++||.+|| +.+|||+||||+|||+.+ ...+||+|||.|+.
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~----~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH----ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999995 49999999653 45899999999999999999999 778999999999999974 34799999999987
Q ss_pred cCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCc
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDE 706 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~ 706 (791)
...... ..+.++.|+|||++.+.+|+.+.||||||||++||++|.+-|.+
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 654332 34568899999999999999999999999999999999877765
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=307.08 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=201.2
Q ss_pred ChhHHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeecc-
Q 003855 492 PYLDIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSN- 568 (791)
Q Consensus 492 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~- 568 (791)
+..++....+.|++.+.||+|+||.||+|+.. +++.||+|++..... ....+..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34445556688999999999999999999974 688999999865533 335678899999998 79999999999853
Q ss_pred -----CCeeeEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEE
Q 003855 569 -----PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAH 642 (791)
Q Consensus 569 -----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~k 642 (791)
.+..++||||+++|+|.+++... ...+++..+..++.|++.|++||| +.+++||||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH----AHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEE
Confidence 45789999999999999999754 344788889999999999999999 67899999999999999999999
Q ss_pred EeeeccccccCCCCCcceeecccccccccCCCccC-----CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHH
Q 003855 643 VSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRW 717 (791)
Q Consensus 643 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 717 (791)
|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.+... .
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~- 237 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-L- 237 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-h-
Confidence 999999876532211 122346888999999865 3568889999999999999999999986532211100 0
Q ss_pred HHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 718 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 718 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.. ...... ....++..+.+++.+||+.||++||++.|+++
T Consensus 238 ~~~--------~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 IPR--------NPPPKL--------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred Hhh--------CCCCCC--------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 000000 11135567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=299.00 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=200.3
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+|+..+.||+|+||.||+|... +++.+|+|.+.... ....+.+..|+.++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 78899999986542 33456788999999999999999999999989999999999
Q ss_pred CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC-CcEEEeeeccccccCCCC
Q 003855 579 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN-MAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 579 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfgla~~~~~~~ 656 (791)
+++++|.+++... ...+++..+..++.++++|+.||| +.+++||||+|+||+++++ +.+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH----TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999864 345899999999999999999999 6789999999999999854 468999999998764432
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
. .....++..|+|||...+..++.++||||||+++|+|++|+.||+..... ..+.........
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~--------- 219 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIMSGTFA--------- 219 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHHHhcCCC---------
Confidence 2 12245788999999998888999999999999999999999998653211 111111100000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.+..++..+.+++.+||+.+|++|||+.|+++
T Consensus 220 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 -----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 001124566889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=301.64 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=195.9
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-----hHHHHHHHHHHHHHHhccCCccceeeeeeccC--Cee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-----ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP--DFK 572 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 572 (791)
.+|++.+.||+|+||.||.|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999865 68999999875321 23456788899999999999999999988663 467
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||+++|+|.+++..... +++..+.+++.|++.||+||| +.+++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLH----SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 899999999999999986543 788889999999999999999 678999999999999999999999999999865
Q ss_pred CCCCCc-ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 653 GEGEDS-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 653 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
...... .......++..|+|||...+..++.++|||||||++|||++|+.||...... ....+ ...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~----~~~~~~----~ 227 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-AAIFK----IATQPT----N 227 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-HHHHH----HhcCCC----C
Confidence 432111 1122235788999999988888999999999999999999999998653111 11111 000000 0
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+ ..+......+.+++.+|+. +|++||+++|+++
T Consensus 228 ~---------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 228 P---------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred C---------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0 0111234557789999985 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=302.28 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=202.4
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh--HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+..|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 789999999876543 3677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++++|.+++.... .+++..+..++.++++|+.||| +.+++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH----SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999998654 3788999999999999999999 678999999999999999999999999999876543322
Q ss_pred ce--eecccccccccCCCccCCCC---CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 659 VT--QTMTMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 659 ~~--~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.. .....++..|+|||++.+.. ++.++||||||+++||+++|+.||...... ......+......
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~--------- 225 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGAGHKP--------- 225 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhcCCCC---------
Confidence 11 11245788999999987766 889999999999999999999999753211 1111111110000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+....++..+.+++.+||+.+|++||++.|++.
T Consensus 226 ------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 ------PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ------CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01111233566789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.50 Aligned_cols=248 Identities=22% Similarity=0.315 Sum_probs=198.6
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCC
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
|+....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334557999999999999865 7899999998755444456788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
++|.+++... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++........ ..
T Consensus 103 ~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 174 (297)
T cd06659 103 GALTDIVSQT--RLNEEQIATVCESVLQALCYLH----SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR 174 (297)
T ss_pred CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence 9999987653 3789999999999999999999 67899999999999999999999999999976543221 12
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+ ..+........
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~-~~~~~~~~~~~--------------- 237 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAM-KRLRDSPPPKL--------------- 237 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH-HHHhccCCCCc---------------
Confidence 2346889999999998888999999999999999999999998642211 111 11111000000
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
......+..+.+++.+|++.+|++||++.++++.
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0001234567799999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.29 Aligned_cols=255 Identities=24% Similarity=0.279 Sum_probs=199.9
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeecc--CCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSN--PDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 576 (791)
++|+..+.||.|++|.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+ ....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999974 68899999987543 2345678899999999999999999998854 44689999
Q ss_pred ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 577 EFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 577 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
||+++++|.+++.. ....++...+..++.|++.||+||| ..+++|+||+|+||++++++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999988763 3445788999999999999999999 6789999999999999999999999999987653
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCcccc---CcchHHHHHHHhcCCChhhhc
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFT---GEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 730 (791)
.... ....++..|+|||...+..++.++||||+||++|||++|+.||+.... .......++............
T Consensus 157 ~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 157 NSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred cccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence 2211 123467889999999888999999999999999999999999976422 111222222211100000000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......+..+.+++.+||+.+|++|||+.|+++
T Consensus 233 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 -----------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -----------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000123466889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=307.34 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=198.4
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh-HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|+..+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67889999999999999999975 789999999865432 2234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++ ++|.+++......+++..+..++.|+++||.||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH----QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 97 4999999876667899999999999999999999 67899999999999999999999999999875432211
Q ss_pred ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC---CChhhhcc---
Q 003855 659 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP---HGLTEVVD--- 731 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~d--- 731 (791)
......++..|+|||+..+ ..++.++||||+|+++|||++|+.||.........+......... .......+
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1122346788999998765 558899999999999999999999996543211111111111000 00000000
Q ss_pred ---hhh--hhhHHhhHHHHHH--HHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ---ANL--VREEQAFSAKMDC--ILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ---~~~--~~~~~~~~~~~~~--~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
... ............. ...+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000000000011 256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.19 Aligned_cols=246 Identities=27% Similarity=0.320 Sum_probs=197.6
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
+.|+..+.||+|+||.||+|+.. +++.||+|.+.... .+..+.+.+|+++++.++||||+++.+++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999865 68999999886432 334467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||++ |++.+++......+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||++.......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH----~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH----SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 9996 6888888765556899999999999999999999 6789999999999999999999999999997654321
Q ss_pred CcceeecccccccccCCCccC---CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 657 DSVTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
...++..|+|||++. .+.++.++||||||+++|||+||+.||........ ...+.. ... +.
T Consensus 170 ------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~~~~~~---~~~-----~~ 233 (307)
T cd06607 170 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQ---NDS-----PT 233 (307)
T ss_pred ------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--HHHHhc---CCC-----CC
Confidence 235788999999863 46688999999999999999999999865321110 000000 000 00
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.....++..+.+++.+||+.+|++||++.++++.
T Consensus 234 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 --------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0011345678899999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.01 Aligned_cols=194 Identities=23% Similarity=0.304 Sum_probs=158.9
Q ss_pred ccccCCCcceEEEEEEec---CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeec--cCCeeeEEEecCC
Q 003855 506 CNLLGTGSFGSVYKGTIS---DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS--NPDFKALVLEFMP 580 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~ 580 (791)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|+.++++++||||+++++++. .....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999864 45789999886442 2245678999999999999999999884 3567789999986
Q ss_pred CCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe----CCCCcEEEeeecc
Q 003855 581 NGSLEKWLYSH--------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL----DENMAAHVSDFGI 648 (791)
Q Consensus 581 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfgl 648 (791)
++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 5888887521 234788999999999999999999 6789999999999999 5678999999999
Q ss_pred ccccCCCCCc-ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCc
Q 003855 649 SKLLGEGEDS-VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDE 706 (791)
Q Consensus 649 a~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~ 706 (791)
++........ .......+|..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9876543221 12233468999999998866 4589999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=305.37 Aligned_cols=243 Identities=26% Similarity=0.289 Sum_probs=198.8
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|+..+.||+|+||.||++... +++.||+|++.... .+..+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999875 68999999987543 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH----SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999998764 4889999999999999999999 678999999999999999999999999999876433
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
.....+++.|+|||...+..++.++||||||+++|||++|+.||..... ........ ...
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~----~~~----------- 214 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-IQIYEKIL----EGK----------- 214 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHh----cCC-----------
Confidence 2234578999999998888899999999999999999999999865321 11111100 000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAA 773 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~ 773 (791)
...+...+..+.+++.+||..+|.+|| +++|++
T Consensus 215 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 ----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 000112245677999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.79 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=200.4
Q ss_pred ccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh------hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 502 EFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL------ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
+|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+..|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999985 478999999986432 2245678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC-cEEEeeeccccccC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-AAHVSDFGISKLLG 653 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~ 653 (791)
||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||.+..+.
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH----~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH----ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999997654 4789999999999999999999 67899999999999998776 59999999998765
Q ss_pred CCCCc--ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 654 EGEDS--VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 654 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
..... .......++..|+|||...+..++.++||||+|+++|||++|+.||....... .. ..+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~-~~~~~~~~~~~~---- 229 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HL-ALIFKIASATTA---- 229 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hH-HHHHHHhccCCC----
Confidence 43211 11122357889999999888889999999999999999999999986422111 11 111110000000
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+...+.++.+++.+|+..+|++||++.|+++
T Consensus 230 ---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 ---------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0011134566889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=298.65 Aligned_cols=248 Identities=22% Similarity=0.329 Sum_probs=208.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
..-|...+.||+|.|++|-.|++- +|..||||++.+.. .-....+.+|++.|+-++|||||+++++.......|+|.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 345778889999999999999843 89999999997654 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC-CCCcEEEeeeccccccCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD-ENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~ 655 (791)
|.-.+|+|.+||-++...+.+.-..+++.||+.|+.|+|+ ..+|||||||+||.+. .-|-||++|||++-.+.++
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq----LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ----LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh----hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999999888889999999999999999999995 4599999999999875 5789999999999877665
Q ss_pred CCcceeecccccccccCCCccCCCCCCc-cccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSA-KCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
.. .+..+|+..|-|||++.+..|+. ++||||+|||+|-+++|+.||....+.|. +..++|-..
T Consensus 173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------------LTmImDCKY 236 (864)
T KOG4717|consen 173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------------LTMIMDCKY 236 (864)
T ss_pred ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------hhhhhcccc
Confidence 43 34568999999999998877765 78999999999999999999987544432 122222211
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+...+.+..++|..|+.-||.+|.+.+||+.
T Consensus 237 -------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 -------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 122345667789999999999999999999864
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.31 Aligned_cols=265 Identities=25% Similarity=0.282 Sum_probs=199.7
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh-----HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE-----RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
+|+..+.||+|+||.||+|... +++.||||.+..... .....+..|++++++++||||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999965 689999999875432 2345667899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+ +|+|.+++......+++..+..++.||++||.||| +.+++||||+|+||+++.++.++|+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH----SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 89999999866546899999999999999999999 678999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC---Ch-----
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH---GL----- 726 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~----- 726 (791)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... ..+.+........ ..
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhccc
Confidence 22 1222346788999998754 56789999999999999999998777643211 1111111100000 00
Q ss_pred -hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 727 -TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 727 -~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....................+.++.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000000011234567889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=307.28 Aligned_cols=257 Identities=26% Similarity=0.325 Sum_probs=199.7
Q ss_pred hHHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccC--
Q 003855 494 LDIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNP-- 569 (791)
Q Consensus 494 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-- 569 (791)
.++..++++|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 344456788999999999999999999874 78899999886432 2235677899999998 899999999998643
Q ss_pred ---CeeeEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003855 570 ---DFKALVLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV 643 (791)
Q Consensus 570 ---~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl 643 (791)
+..++||||+++|+|.++++. ....+++..+..++.|++.||.||| ..+++||||||+||++++++.+||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH----NNRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEE
Confidence 358999999999999998863 3445899999999999999999999 678999999999999999999999
Q ss_pred eeeccccccCCCCCcceeecccccccccCCCccCCC-----CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHH
Q 003855 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG-----IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV 718 (791)
Q Consensus 644 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 718 (791)
+|||+++....... ......|+..|+|||.+... .++.++|||||||++|||++|+.||...... ..+.++.
T Consensus 170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~~ 246 (291)
T cd06639 170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKIP 246 (291)
T ss_pred eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHh
Confidence 99999986543221 12234578899999987543 3688999999999999999999998753221 1111111
Q ss_pred HHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 719 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 719 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. ......+ +......+.+++.+|++.+|++||++.|+++
T Consensus 247 ~~----~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 RN----PPPTLLH------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cC----CCCCCCc------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10 0000000 1123356789999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.18 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=199.3
Q ss_pred ccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 502 EFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
.|...+.||+|++|.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355567999999999999986 4788999998875554455678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+++|.+++... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||.+........ .
T Consensus 100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFLH----AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 99999999873 4889999999999999999999 67899999999999999999999999999876533221 1
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHh
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 740 (791)
.....|+..|+|||...+..++.++|||||||++|||++|+.||...... ..... +....+. ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~~-~~~~~~~--------~~------ 235 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKR-IRDNLPP--------KL------ 235 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHHH-HHhcCCC--------CC------
Confidence 22345889999999998888999999999999999999999998642111 01110 1100000 00
Q ss_pred hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 741 FSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 741 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....++..+.+++.+||+.+|++||++.++++
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 -KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 001124467889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=297.66 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=206.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh-HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|+..+.||+|++|.||+|+.. +++.||||++..... ...+.+..|+..+++++|||++++++++..+...++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999976 599999999876543 4467889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS-APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++++|.+++... ..+++..+..++.|+++|++||| + .+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh----~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH----TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh----ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999865 44899999999999999999999 6 8999999999999999999999999999987644332
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCcccc-CcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFT-GEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
. .....++..|+|||...+..++.++||||||+++|||+||+.||..... ......+++. .....
T Consensus 156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~~--------- 221 (264)
T cd06623 156 Q--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DGPPP--------- 221 (264)
T ss_pred c--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cCCCC---------
Confidence 2 1233578899999999888999999999999999999999999976432 1111111111 11000
Q ss_pred hHHhhHHHHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 737 EEQAFSAKMD-CILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 737 ~~~~~~~~~~-~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..... ++..+.+++.+|++.+|++||++.|+++.
T Consensus 222 -----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 -----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00112 55678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.21 Aligned_cols=264 Identities=25% Similarity=0.296 Sum_probs=197.6
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+|+..+.||+|+||.||+|+.. +++.||||.+.... ......+..|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 78999999886543 22345788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+. ++|.+++... ...+++..+..++.|++.|++||| ..+++||||+|+||++++++.+|++|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh----~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 6899998753 345899999999999999999999 67899999999999999999999999999976543221
Q ss_pred cceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC--hhhhcchhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG--LTEVVDANL 734 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~~ 734 (791)
......++..|+|||+..+. .++.++|||||||++|||+||+.||..... .....+.+....... ...... .+
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~ 231 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVT-SL 231 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCChhhhhhhh-HH
Confidence 12223468899999987654 468899999999999999999999865321 111222221111000 000000 00
Q ss_pred hhhHH---------hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQ---------AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..... ........+.++.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000 00001123466789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.37 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=205.6
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
..+.|+..+.||+|+||.||+|..+ ++..||+|++..... ..+.+..|++++++++|+|++++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999976 688999999876544 45678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++++|.+++......+++..+..++.+++.||+||| ..+++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH----SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 99999999999977546899999999999999999999 68899999999999999999999999999876543221
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
......++..|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.. .....
T Consensus 172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~----~~~~~--------- 235 (286)
T cd06614 172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITT----KGIPP--------- 235 (286)
T ss_pred --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh----cCCCC---------
Confidence 112234778999999988888999999999999999999999998653211 11111100 00000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......++..+.+++.+|++.+|.+||++.++++
T Consensus 236 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 ---LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0111224567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.82 Aligned_cols=249 Identities=28% Similarity=0.382 Sum_probs=205.0
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
+|+..+.||+|++|.||++... +++.|++|++........+.+.+|++++++++||+++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778889999999999999975 789999999977655566788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+++|.+++......+++..+..++.+++.|+.||| ..+++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH----SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh----cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 99999999876556899999999999999999999 67899999999999999999999999999987654432
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHh
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 740 (791)
.....++..|+|||+.....++.++||||||+++|+|++|+.||........ ...... ......
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~---~~~~~~----------- 217 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFKIAT---NGPPGL----------- 217 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHh---cCCCCc-----------
Confidence 2234578899999998888899999999999999999999999865321110 000000 000000
Q ss_pred hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 741 FSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 741 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....++..+.+++.+|++.||++|||+.|+++
T Consensus 218 -~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 -RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111123566889999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=304.52 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=199.5
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCC------
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPD------ 570 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------ 570 (791)
.+++|++.+.||+|+||.||+|..+ +++.|++|++..... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4688999999999999999999975 678999999875543 346788999999999 7999999999986543
Q ss_pred eeeEEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeec
Q 003855 571 FKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFG 647 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 647 (791)
..++||||+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++++|||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH----ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999998743 356899999999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCC-----CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL 722 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (791)
++....... .......++..|+|||++.. ..++.++|||||||++|||++|+.||....... ...+...
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~--- 232 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPR--- 232 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhc---
Confidence 997654322 12233458889999997643 457889999999999999999999996432211 1111110
Q ss_pred CCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 723 PHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 723 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.... . ......++..+.+++.+||..||++|||+.|+++
T Consensus 233 -~~~~-----~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 -NPPP-----T-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -cCCC-----C-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000 0 0111234567889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.59 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=201.0
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999975 68899999886542 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|++++.+..+.... ..+++..+..++.||+.|+.||| ..+++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCH----SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99887666655443 44899999999999999999999 67899999999999999999999999999987654332
Q ss_pred cceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc---CCChh------
Q 003855 658 SVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL---PHGLT------ 727 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~------ 727 (791)
.......++..|+|||+..+. .++.++||||||+++|||++|+.||......+ .+.. ..... .....
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYL-IQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHhCCCCHHHhhhcccC
Confidence 122234578899999998887 88999999999999999999999987532211 1111 11100 00000
Q ss_pred ------hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 ------EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ------~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.......... .....+..++.++.+++.+||..+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPES-LERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHH-HHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000000 000011124678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.63 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=201.1
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+-|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34777889999999999999864 78899999876433 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++|+|.+++... .+++..+..++.+++.|+.||| ..+++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc----cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999998754 3789999999999999999999 67899999999999999999999999999976543221
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......++..|+|||...+..++.++|||||||++|||++|..||...... .+.......... .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~-~--------- 220 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFLIPKNNPP-T--------- 220 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHHHhcCCCC-C---------
Confidence 122345788999999998888999999999999999999999998653211 111111000000 0
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
....++.++.+++.+|++.+|++||++.++++.
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 ----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011345667899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.47 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=204.1
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeeh--hhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNL--QLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 576 (791)
...|++.++||+||.+.||++...+.+.||+|.+.. ........|..|+..|.++ .|.+||++++|-..++..|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 357899999999999999999988888899886643 3356678899999999999 5999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||= ..||..+|++.....+...+..++.|++.|+.++| ..||||.||||.|+|+. .|.+||+|||+|..+..+.
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH----~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH----QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH----HhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 976 45999999987665554488889999999999999 67899999999999986 5799999999999988877
Q ss_pred CcceeecccccccccCCCccCCCC-----------CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGI-----------VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG 725 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~-----------~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (791)
........+||+.||+||.+.... .++++||||+|||+|+|+.|+.||...... |.+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~aK------ 581 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------IAK------ 581 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------HHH------
Confidence 777777789999999999654432 567899999999999999999999753211 111
Q ss_pred hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 726 ~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+..+.|+.-.-+....+.. .++.++|..||..||.+||+..++++
T Consensus 582 l~aI~~P~~~Iefp~~~~~----~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPEN----DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHhhcCCCccccccCCCCc----hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2223333222122111111 22789999999999999999999986
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.90 Aligned_cols=368 Identities=25% Similarity=0.409 Sum_probs=274.6
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCccee-cCCcc
Q 003855 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTG-IIPHS 81 (791)
Q Consensus 3 g~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~-~~~~~ 81 (791)
|..|.++..|+.+++|.|...++. .+|+.++.+.+|++|.+++|++. ++-..+.. +|.|+.+++.+|++.. -+|..
T Consensus 22 ~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~-Lp~LRsv~~R~N~LKnsGiP~d 98 (1255)
T KOG0444|consen 22 DRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSD-LPRLRSVIVRDNNLKNSGIPTD 98 (1255)
T ss_pred CcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhcc-chhhHHHhhhccccccCCCCch
Confidence 456666666777777777766665 55666777777777777777665 44444444 5666666666666652 24455
Q ss_pred CcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChh
Q 003855 82 ITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPV 161 (791)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 161 (791)
+-.+..|+.||||+|++. ..|..+..-+++-.|+|++|+|.++|... |.+|+.|-.||||+|++. .+|+.
T Consensus 99 iF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~l--------finLtDLLfLDLS~NrLe-~LPPQ 168 (1255)
T KOG0444|consen 99 IFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSL--------FINLTDLLFLDLSNNRLE-MLPPQ 168 (1255)
T ss_pred hcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchH--------HHhhHhHhhhccccchhh-hcCHH
Confidence 556666666777777666 45555666666666677777776666554 666666667777777766 34555
Q ss_pred hhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccc-cccCccccCCCCCCEEEcccccCcccCCccccccCC
Q 003855 162 IGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLN-GTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240 (791)
Q Consensus 162 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 240 (791)
+..+ ..|++|.|++|.+....-..+-.+++|+.|.+++.+-+ ..+|.++..+.+|..+|||.|.+. .+|+.+.++++
T Consensus 169 ~RRL-~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~ 246 (1255)
T KOG0444|consen 169 IRRL-SMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRN 246 (1255)
T ss_pred HHHH-hhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhh
Confidence 5444 34667777777665444444556788888889886543 467888999999999999999998 88999999999
Q ss_pred CceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCc-ccCCcccccCCCCCEEecC
Q 003855 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN-DSLPSNVQKLKVLTVLDLS 319 (791)
Q Consensus 241 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~-~~~~~~~~~l~~L~~L~l~ 319 (791)
|+.|+||+|+|+ .+....+.-.+|++|+||+|+++ .+|..++.++.|+.|++.+|+++ .-+|..++++.+|+.+..+
T Consensus 247 LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aa 324 (1255)
T KOG0444|consen 247 LRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAA 324 (1255)
T ss_pred hheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhh
Confidence 999999999998 45555666778999999999998 78999999999999999999886 3478899999999999999
Q ss_pred CcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEE
Q 003855 320 RNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFN 389 (791)
Q Consensus 320 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~ 389 (791)
+|.+. ..|..++.+.+|+.|.|++|++- .+|+.+.-++.|+.|||..|+-.-..|..-..-++|..-+
T Consensus 325 nN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYN 392 (1255)
T KOG0444|consen 325 NNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYN 392 (1255)
T ss_pred ccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeee
Confidence 99998 89999999999999999999998 7999999999999999999976534554332224454433
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.06 Aligned_cols=247 Identities=27% Similarity=0.334 Sum_probs=201.7
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999975 68999999987543 2446788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++++|.+++... ..+++..+..++.|+++||.||| ..+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH----SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999876 35889999999999999999999 6789999999999999999999999999998765432
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
......|+..|+|||+..+..++.++|+||+|+++|+|++|+.||...... ...++.......
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~------------ 217 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQETA------------ 217 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhccc------------
Confidence 122345788999999998888999999999999999999999998753221 111111111100
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCH--HHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINV--TDAA 773 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~--~ev~ 773 (791)
....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 218 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 --DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 001111344678899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=285.43 Aligned_cols=202 Identities=25% Similarity=0.339 Sum_probs=169.4
Q ss_pred hhccccccccCCCcceEEEEEEec---C--CcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc-CCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS---D--GTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN-PDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~---~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 571 (791)
...|+.+..||+|+||.||+|.-+ + ...+|+|.++.+. ........+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 357899999999999999999632 2 2378999987653 2334566789999999999999999999876 778
Q ss_pred eeEEEecCCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC----CcEEE
Q 003855 572 KALVLEFMPNGSLEKWLYSH----NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN----MAAHV 643 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~----~~~kl 643 (791)
.++++||.+. ||.+.++.+ ...++...+..|+.||+.|+.||| +.=|+||||||.|||+..+ |.|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH----~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH----SNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh----hhheeeccCCcceEEEeccCCccCeeEe
Confidence 8999999988 999999732 356899999999999999999999 5569999999999999866 99999
Q ss_pred eeeccccccCCCCCcc-eeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCc
Q 003855 644 SDFGISKLLGEGEDSV-TQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDE 706 (791)
Q Consensus 644 ~Dfgla~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~ 706 (791)
+|||+||.+...-... .....+.|++|+|||.+.+ ..||.+.||||.|||+.||+|-++-|.+
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999986543322 3444678999999997765 6699999999999999999998877654
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.33 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=198.7
Q ss_pred ccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhcc---CCccceeeeeeccCCeeeEEE
Q 003855 502 EFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVR---HRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 576 (791)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 478999999986542 344567888999999996 999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++++|.+++... .+++..+..++.|++.|+.||| ..+++||||+|+||++++++.++++|||++..+....
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH----KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998764 4889999999999999999999 6789999999999999999999999999998765433
Q ss_pred CcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
. ......|+..|+|||...+ ..++.++|||||||++|+|++|+.||...... .++....... .+.+.
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~~~~-----~~~~~ 223 (277)
T cd06917 156 S--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLIPKSK-----PPRLE 223 (277)
T ss_pred c--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhccccCC-----CCCCC
Confidence 1 2233468889999998765 44789999999999999999999999753211 1111100000 00010
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. ..++.++.+++.+||+.||++||++.|+++
T Consensus 224 ~--------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 D--------NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred c--------ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0 014466889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=282.08 Aligned_cols=270 Identities=21% Similarity=0.334 Sum_probs=210.6
Q ss_pred ChhHHHHHhhccccccccCCCcceEEEEEE-ecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccC
Q 003855 492 PYLDIQRATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNP 569 (791)
Q Consensus 492 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 569 (791)
.|.|.-+.++ +.+|+|+|+.|..++ +.+|..||||++.+..........+|++++.+. .|+||++++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4566655555 489999999999887 678999999999888767777888999999998 599999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC---cEEEeee
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM---AAHVSDF 646 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~---~~kl~Df 646 (791)
...|+|||.|.||+|.++|+++.. +++.+..++.++|+.||.||| .++|+|||+||+|||-.+.. -+|||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH----~kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH----TKGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh----hcCcccccCCccceeecCCCCcCceeeecc
Confidence 999999999999999999998765 889999999999999999999 78999999999999986544 3899999
Q ss_pred ccccccCCCC-----CcceeecccccccccCCCcc-----CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHH
Q 003855 647 GISKLLGEGE-----DSVTQTMTMATIGYMAPEYG-----SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRR 716 (791)
Q Consensus 647 gla~~~~~~~-----~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 716 (791)
.+..-+.... .......++|+..|||||+. ....|+.++|.||+|||+|-|+.|.+||.++-...- .
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---G 300 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---G 300 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---C
Confidence 9875432211 12223456899999999952 235689999999999999999999999987533211 1
Q ss_pred HHHHhcCCChhhhcchhhhhhHHhhH--HHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 717 WVKESLPHGLTEVVDANLVREEQAFS--AKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 717 ~~~~~~~~~~~~~~d~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
|-+...-+...+.+-..+++....++ .+..++.+..+++...+..|+.+|.++.+++.
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 21111111122222223333332222 34577888999999999999999999998876
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.24 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=200.7
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+..|+++++.++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999875 58999999987543 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 577 EFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 577 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
||+.+++|.+++... ...+++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH----LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999999754 345899999999999999999999 678999999999999999999999999998765322
Q ss_pred CCcc---------------------------eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccc
Q 003855 656 EDSV---------------------------TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMF 708 (791)
Q Consensus 656 ~~~~---------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~ 708 (791)
.... ......|+..|+|||+..+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1100 0112357889999999988889999999999999999999999997532
Q ss_pred cCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC----HHHHHH
Q 003855 709 TGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRIN----VTDAAA 774 (791)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt----~~ev~~ 774 (791)
.. ..+.... ... . ..+.....+..+.+++.+|+..+|++||+ +.|+++
T Consensus 237 ~~-~~~~~~~----~~~--------~-----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD-ETFSNIL----KKE--------V-----TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH-HHHHHHh----cCC--------c-----cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 21 1111110 000 0 00111124567889999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=328.13 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=193.7
Q ss_pred HHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehh-hhHHHHHHHHHHHHHHhccCCccceeeeeec--------
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSCS-------- 567 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-------- 567 (791)
+-..+|++.+.||+||||.||+++.+ ||+.||||++... .......+.+|+.++++++|||||+++..+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45578999999999999999999977 9999999998655 3445667889999999999999999872110
Q ss_pred --------------------------------------------------------------------------------
Q 003855 568 -------------------------------------------------------------------------------- 567 (791)
Q Consensus 568 -------------------------------------------------------------------------------- 567 (791)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------cC-------CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 003855 568 ------------------------NP-------DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616 (791)
Q Consensus 568 ------------------------~~-------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~ 616 (791)
++ ...|+-||||+...+.++++.+...-.....++++++|+.||+|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH- 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH- 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH-
Confidence 00 1346889999997888877765533357788999999999999999
Q ss_pred cCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC----------------CCCCcceeecccccccccCCCccCCC-
Q 003855 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG----------------EGEDSVTQTMTMATIGYMAPEYGSEG- 679 (791)
Q Consensus 617 ~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~----------------~~~~~~~~~~~~g~~~y~aPE~~~~~- 679 (791)
+.+||||||||.||++|++..|||+|||+|+... .+......+..+||.-|+|||.+.+.
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 7889999999999999999999999999998721 01112245567899999999987664
Q ss_pred --CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhh
Q 003855 680 --IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALD 757 (791)
Q Consensus 680 --~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~ 757 (791)
.|+.|+|+||+|||++||+. ||....++...+...-+...+.. .+..+++. +.-..+|..
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~~--------------~~e~slI~~ 853 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPEH--------------PEEASLIRW 853 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccccc--------------hHHHHHHHH
Confidence 49999999999999999994 56654333332222222222222 12222221 223489999
Q ss_pred ccccCCCCCCCHHHHHH
Q 003855 758 CCIESPDMRINVTDAAA 774 (791)
Q Consensus 758 cl~~~P~~RPt~~ev~~ 774 (791)
+++.||.+|||+.|+++
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999875
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.67 Aligned_cols=260 Identities=22% Similarity=0.235 Sum_probs=195.2
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhcc-CCccceeeeeeccC--CeeeEEEe
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVR-HRNLIKILSSCSNP--DFKALVLE 577 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 577 (791)
|++.+.||+|+||.||+|... +++.||+|++.... .........|+.++.++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999864 78999999886542 222233456888888885 99999999999877 88999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|++ |++.+++......+++.++..++.|++.||.||| ..+++||||+|+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH----RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 5899988876566899999999999999999999 678999999999999999 9999999999987643322
Q ss_pred cceeecccccccccCCCcc-CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh-------
Q 003855 658 SVTQTMTMATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV------- 729 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 729 (791)
. ....++..|+|||+. .++.++.++||||+||++|||++|..||..... .....+...........+
T Consensus 155 ~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 Y---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred c---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhccc
Confidence 1 223578899999965 445678999999999999999999999965322 111222222111110000
Q ss_pred -----cchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 -----VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 -----~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..... .-......++.++.+++.+||+.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGT-GLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccc-cHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 000111245688999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=295.31 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=200.7
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc--CCeeeEEE
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN--PDFKALVL 576 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 576 (791)
+|++.+.||.|+||.||+|... +++.||+|++.... ....+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 78899999886432 3445678889999999999999999997753 45678999
Q ss_pred ecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccC-CCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 577 EFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHHGH-SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 577 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
||+++++|.+++... ...+++..+..++.|++.|++|||..+ .+.+++|+||+|+||++++++.+|++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999753 456899999999999999999999321 1357999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
..... ......++..|+|||...+..++.++||||||+++|+|++|+.||.... .....+.+.... . .
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~---~-~---- 228 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGK---F-R---- 228 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCC---C-C----
Confidence 54332 1223458899999999988889999999999999999999999997532 111111111100 0 0
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..+..++..+.+++.+|++.+|++||++.+|++.
T Consensus 229 ---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0111345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.44 Aligned_cols=267 Identities=24% Similarity=0.301 Sum_probs=198.2
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccC-----Cee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP-----DFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 572 (791)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+..|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 78999999986432 33445678899999999999999999886543 357
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++|+||++ +++.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH----~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 5888887654 3899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCcc-eeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC----h
Q 003855 653 GEGEDSV-TQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG----L 726 (791)
Q Consensus 653 ~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~ 726 (791)
....... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.+... ......+....... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHHH
Confidence 4332211 1123467899999997644 5689999999999999999999999965321 11111111111111 1
Q ss_pred hhhcchhhhhhHH------h---hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 727 TEVVDANLVREEQ------A---FSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 727 ~~~~d~~~~~~~~------~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..+.+........ . .......+.++.+++.+||+.+|++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111000000 0 00011235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.25 Aligned_cols=254 Identities=25% Similarity=0.309 Sum_probs=194.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhcc-CCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 577 (791)
++|...+.||+|+||.||++... +++.||+|.+.... ......+..|+.++.++. ||||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666789999999999999865 68999999986543 234567888999999996 9999999999998889999999
Q ss_pred cCCCCCHHHHH---hh-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 578 FMPNGSLEKWL---YS-HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 578 ~~~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
|+.. ++.++. .. ....+++..+..++.+++.||+|||+ ..+++||||||+||++++++.++|+|||+++.+.
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE---ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---cCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9854 655543 22 23458999999999999999999994 3489999999999999999999999999997654
Q ss_pred CCCCcceeecccccccccCCCccCCC---CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEG---IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
.... .....|+..|+|||.+.+. .++.++|||||||++|||++|+.||..... ....+........
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~---- 228 (288)
T cd06616 160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKGDP---- 228 (288)
T ss_pred cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCCCC----
Confidence 3221 1223578899999988766 689999999999999999999999865321 1111111111000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
+.+.. .....++.++.+++.+|++.+|++|||+.||++.
T Consensus 229 -~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 -PILSN-----SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CcCCC-----cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0112356678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=303.02 Aligned_cols=246 Identities=27% Similarity=0.336 Sum_probs=197.6
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehh---hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.|...+.||+|+||.||+|+.. ++..||+|++... ..+....+..|++++++++|||++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677889999999999999864 6889999998643 23445678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|++ |++.+.+......+++.++..++.+++.|+.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 996 5888888766666899999999999999999999 678999999999999999999999999998765332
Q ss_pred cceeecccccccccCCCcc---CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 658 SVTQTMTMATIGYMAPEYG---SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
....++..|+|||++ ..+.++.++|||||||++|||++|+.||...... .....+.....+.
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~~---------- 243 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPT---------- 243 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCCC----------
Confidence 123578899999986 3467899999999999999999999998653111 1111111110000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
.....++..+.+++.+|++.+|++||++.|+++..
T Consensus 244 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 244 -------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred -------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 01113446688999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.26 Aligned_cols=263 Identities=24% Similarity=0.285 Sum_probs=199.3
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh--HHHHHHHHHHHHHHhccCCccceeeeeeccC--CeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSCSNP--DFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 574 (791)
.++|+..+.||+|+||.||+|..+ +++.||+|.++.... .....+.+|+.++++++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357889999999999999999976 688999999865432 2234567899999999999999999998776 88999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||++ ++|.+++......+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||+++....
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH----DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999997 5999999876666899999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC---------
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH--------- 724 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 724 (791)
... ......++..|+|||...+. .++.++|+||+|+++|||++|+.||..... .....+........
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-IDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchHHHHHhh
Confidence 321 12234578899999987654 468999999999999999999999875321 11111111110000
Q ss_pred --------ChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 725 --------GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 725 --------~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.........+.. ..+. ...+..+.+++.+|++.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRK---KFPA-LSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhc---cccc-cCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000 0000 013567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=294.87 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=200.0
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+|...+.||+|+||.||+|..+ +|..||+|.+.... ....+.+.+|+.+++.++||||+++++++......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999975 68899999986542 23345778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC-cEEEeeeccccccCCCC
Q 003855 579 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-AAHVSDFGISKLLGEGE 656 (791)
Q Consensus 579 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~ 656 (791)
+++++|.+++.... ..+++..+..++.|+++|+.||| +.+++|+||+|+||++++++ .+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH----DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999997543 35799999999999999999999 67899999999999999886 46999999998765432
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
. ......|++.|+|||+..+..++.++||||||+++|||++|+.||.... ..+++...........
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~------- 222 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGYFAPI------- 222 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccCCCC-------
Confidence 2 1222458889999999888889999999999999999999999986432 1222222111111100
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
....+..+.+++.+|+..+|++|||+.|+++
T Consensus 223 -------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 -------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0123456789999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.69 Aligned_cols=249 Identities=22% Similarity=0.254 Sum_probs=194.4
Q ss_pred hHHHHHhhcccccccc--CCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccC
Q 003855 494 LDIQRATDEFNECNLL--GTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNP 569 (791)
Q Consensus 494 ~~~~~~~~~~~~~~~i--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 569 (791)
.+.....++|++.+.+ |+|+||.||++..+ ++..+|+|++........ |+.....+ +||||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444455677887777 99999999999864 788899999865422111 22222222 799999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC-cEEEeeecc
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-AAHVSDFGI 648 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgl 648 (791)
+..++||||+++|+|.+++.... .+++..+..++.|+++|+.||| +.+++||||||+||+++.++ .++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH----KHNIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999999998764 5899999999999999999999 67899999999999999988 999999999
Q ss_pred ccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 649 SKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 649 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
++...... ...++..|+|||++.+..++.++||||||+++|||++|+.||......+.....+.... ...
T Consensus 157 ~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~--- 226 (267)
T PHA03390 157 CKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK--- 226 (267)
T ss_pred ceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc---
Confidence 97654221 23578899999999888899999999999999999999999975433332233332211 000
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC-HHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRIN-VTDAAA 774 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~ev~~ 774 (791)
.+....++..+.+++.+|++.+|++||+ ++|+++
T Consensus 227 ------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 ------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0011134567889999999999999996 588874
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=303.77 Aligned_cols=268 Identities=21% Similarity=0.296 Sum_probs=195.6
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCC------
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD------ 570 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 570 (791)
.++|+..+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 467999999999999999999975 78999999886442 222345667999999999999999999886543
Q ss_pred --eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecc
Q 003855 571 --FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGI 648 (791)
Q Consensus 571 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl 648 (791)
..++||||+. +++.+++......+++.++..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH----RNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4499999996 5899888876656899999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCCc--ceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHH---hc
Q 003855 649 SKLLGEGEDS--VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE---SL 722 (791)
Q Consensus 649 a~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~---~~ 722 (791)
+..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... .....+.. ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~~~ 243 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCGSI 243 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCC
Confidence 9866433221 112234578899999987654 4788999999999999999999998653221 11111111 01
Q ss_pred CCCh-hhh-----cch-hhhhhH-HhhH---HHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 723 PHGL-TEV-----VDA-NLVREE-QAFS---AKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 723 ~~~~-~~~-----~d~-~~~~~~-~~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+... ... .+. ...... .... ........+.+++.+|++.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 1000 000 000 000000 0000 00012345679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=303.67 Aligned_cols=268 Identities=20% Similarity=0.247 Sum_probs=197.2
Q ss_pred ccccccccCCCcceEEEEEEec---CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccC--Ceee
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS---DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP--DFKA 573 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 573 (791)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999974 47899999987633 33346678899999999999999999999887 8899
Q ss_pred EEEecCCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC----CCcEEEee
Q 003855 574 LVLEFMPNGSLEKWLYSH----NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE----NMAAHVSD 645 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~----~~~~kl~D 645 (791)
+||||+++ ++.+++... ...++...+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH----SNWVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 99999965 777777532 225789999999999999999999 678999999999999999 99999999
Q ss_pred eccccccCCCCC-cceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCc--------chHH
Q 003855 646 FGISKLLGEGED-SVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE--------MSLR 715 (791)
Q Consensus 646 fgla~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~--------~~~~ 715 (791)
||+++....... ........++..|+|||+..+ ..++.++|||||||++|||++|+.||....... ..+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999987643322 112233457889999997765 458899999999999999999999997543322 0111
Q ss_pred HHHHHhcCCC------------hhhh----cchhhhhh--HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 716 RWVKESLPHG------------LTEV----VDANLVRE--EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 716 ~~~~~~~~~~------------~~~~----~d~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.++....... .... ........ .............+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111100000 0000 00000000 0000000134467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=298.41 Aligned_cols=263 Identities=24% Similarity=0.306 Sum_probs=197.5
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
|++.+.||.|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999865 79999999987543 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+ ++|.+++.... ..+++..+..++.|+++||+||| +.+++||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH----~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH----SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 69999998654 35899999999999999999999 67899999999999999999999999999976533221
Q ss_pred ceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc-----ch
Q 003855 659 VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV-----DA 732 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----d~ 732 (791)
......++..|+|||++.+. .++.++||||||+++|||++|+.||...... ....+......... .... .+
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPD-EDVWPGVTSLP 231 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCC-hHHhhhhhhch
Confidence 12223568899999987654 5789999999999999999999998653211 11111111100000 0000 00
Q ss_pred hhhhh----H--HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 733 NLVRE----E--QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 733 ~~~~~----~--~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..... . .........+..+.+++.+|++.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 0 000111234467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=300.75 Aligned_cols=270 Identities=24% Similarity=0.274 Sum_probs=201.0
Q ss_pred HHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCC----
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD---- 570 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 570 (791)
...++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 68899999987543 223356778999999999999999999987654
Q ss_pred ------eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEe
Q 003855 571 ------FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVS 644 (791)
Q Consensus 571 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~ 644 (791)
..++|+||+++ ++.+++......+++..+..++.|++.||+||| ..+|+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH----KKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 888888766556899999999999999999999 6789999999999999999999999
Q ss_pred eeccccccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC
Q 003855 645 DFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP 723 (791)
Q Consensus 645 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (791)
|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+.........
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~ 236 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGS 236 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCC
Confidence 9999987654332 11222346778999997754 4578999999999999999999999875221 1112221111100
Q ss_pred C---Chhhh--------cchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 724 H---GLTEV--------VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 724 ~---~~~~~--------~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. ...++ .+...............++..+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00000 000000000000111134677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.37 Aligned_cols=242 Identities=21% Similarity=0.284 Sum_probs=186.0
Q ss_pred ccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHH---hccCCccceeeeeeccCCeeeEEEecCC
Q 003855 508 LLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLR---NVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 508 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
.||+|+||.||++... +++.||+|.+.... ......+..|..+++ ..+||+|+.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 68999999886432 111223344444333 3479999999999998899999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+|+|.+++...+. +++..+..++.|++.||.||| +.+|+||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH----~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 9999999876543 899999999999999999999 6789999999999999999999999999997653322
Q ss_pred eecccccccccCCCccC-CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 661 QTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....|+..|+|||... +..++.++||||+||++|||++|..||.......... +...... ...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~-----~~~------- 216 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLT-----VNV------- 216 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHHhhc-----CCc-------
Confidence 12245899999999876 4568899999999999999999999997543221111 1100000 000
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAAK 775 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~~ 775 (791)
..+..++.++.+++.+|++.||++|| +++|+++.
T Consensus 217 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 --ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 01123456788999999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=335.13 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=202.5
Q ss_pred HHHhhccccccccCCCcceEEEEEE-ecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
+..+-+|+....||.|.||.||.|. .++|.-.|+|-+.... ....+.+.+|+.++..++|||+|+.+|+-...+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 4445678888999999999999998 4578889999776554 445567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+.||||++|+|.+.+...+ ..++.....+..|++.|++||| +.+||||||||.||+++.+|.+|++|||.|..+.
T Consensus 1311 IFMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH----~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH----EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH----hcCceecCCCccceeeecCCcEEeecccceeEec
Confidence 9999999999999887544 2566666678889999999999 6799999999999999999999999999998876
Q ss_pred CCCCcc--eeecccccccccCCCccCCC---CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 654 EGEDSV--TQTMTMATIGYMAPEYGSEG---IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 654 ~~~~~~--~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
...... .....+||+-|||||++.+. ....+.||||+|||+.||+||++||......-.-+......+.|+
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq---- 1461 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ---- 1461 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC----
Confidence 543221 22334799999999987653 355689999999999999999999987543322222211122221
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.++..+.+-.+++.+|+..||++|.++.|+++
T Consensus 1462 --------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1462 --------------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred --------------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 11224455679999999999999999987765
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=291.86 Aligned_cols=251 Identities=26% Similarity=0.345 Sum_probs=204.5
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC--CeeeEEE
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP--DFKALVL 576 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 576 (791)
+|+..+.||+|++|.||+|... +++.|++|++.... ....+.+.+|+.++++++||||+++++++.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 78999999987654 24567889999999999999999999999888 8899999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++++|.+++.... .+++..+..++.+++.|++||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh----~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH----SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999998765 5899999999999999999999 6789999999999999999999999999998775543
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
.........++..|+|||...+..++.++||||||+++|+|++|..||..... ...............
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~--------- 223 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYKIGSSGEPP--------- 223 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHhccccCCCc---------
Confidence 21112334678899999999888899999999999999999999999876431 111100000000000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+...+..+.+++.+|++.+|++||++.|+++
T Consensus 224 -----~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 -----EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -----CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 011123567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.72 Aligned_cols=274 Identities=27% Similarity=0.342 Sum_probs=203.9
Q ss_pred ccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccC------Ceee
Q 003855 502 EFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP------DFKA 573 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 573 (791)
.|...+.||+|+||.||+|+. .+|+.||||.+.... ....+..-+|++++++++|||||++++.-++. +...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 355667899999999999995 489999999987643 33456678899999999999999999986543 4668
Q ss_pred EEEecCCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC--CCC--cEEEeeec
Q 003855 574 LVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD--ENM--AAHVSDFG 647 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~--~~~--~~kl~Dfg 647 (791)
+|||||.+|||...+.+. ...+++.+...++.+++.||.||| ..+|+||||||.||++- ++| .-||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr----En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR----ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH----HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 999999999999999854 456999999999999999999999 67899999999999984 334 37999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccC-CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchH-HHHHHHh-cCC
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL-RRWVKES-LPH 724 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~-~~~~~~~-~~~ 724 (791)
.|+.+.++. .....+||..|.+||... .+.|+..+|.|||||++||++||..||.......... ..|..-. .+.
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 999886544 456678999999999888 5889999999999999999999999997643332111 1111111 111
Q ss_pred ChhhhcchhhhhhH---HhhHHH----HHHHHHHHHHHhhccccCCCCCC--CHHHHHHHHHHHHHH
Q 003855 725 GLTEVVDANLVREE---QAFSAK----MDCILSIMDLALDCCIESPDMRI--NVTDAAAKLKKIKVK 782 (791)
Q Consensus 725 ~~~~~~d~~~~~~~---~~~~~~----~~~~~~l~~li~~cl~~~P~~RP--t~~ev~~~L~~~~~~ 782 (791)
+..-...+...+.. ..++.+ ......+..++..++..+|++|. .+.+....+..|...
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 11111111111000 011111 12234466788889999999999 777777777666443
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.88 Aligned_cols=264 Identities=22% Similarity=0.244 Sum_probs=197.5
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehh--hhHHHHHHHHHHHHHHhccCCccceeeeeeccC------
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSNP------ 569 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 569 (791)
..++|+..+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999864 7899999998643 223345677899999999999999999987543
Q ss_pred CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
...++||||+. ++|.+.+... ++...+..++.|++.||+||| ..+|+||||||+||++++++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 5898888643 788899999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC---h
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---L 726 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 726 (791)
+....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+...+. ..... .
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~-~~~~~~~~~ 240 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIE-QLGTPSDEF 240 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH-hcCCCCHHH
Confidence 87643221 22235788999999999889999999999999999999999998653211 11111111 00000 0
Q ss_pred hhhcchhhhhh--------H--------------HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 727 TEVVDANLVRE--------E--------------QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 727 ~~~~d~~~~~~--------~--------------~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.+.++...... . .........+..+.+++.+|++.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000 0 0000011235668899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=302.01 Aligned_cols=266 Identities=23% Similarity=0.258 Sum_probs=197.9
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh--HHHHHHHHHHHHHHhccCCccceeeeeeccC--CeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSCSNP--DFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 574 (791)
.++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++++++||||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999975 689999999864432 2233456799999999999999999998654 56899
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||++ ++|.+++......+++.++..++.|+++|++||| +.+++||||||+||++++++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH----ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 5899998866566899999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh----h
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE----V 729 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~ 729 (791)
... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+.......... .
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChhhchhh
Confidence 321 1222345788999998765 55889999999999999999999999753221 1111111111100000 0
Q ss_pred cc------hhhhhhHH-h-hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 VD------ANLVREEQ-A-FSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 ~d------~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+ ..+..... . .......++.+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00000000 0 0001123567789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=299.19 Aligned_cols=253 Identities=22% Similarity=0.275 Sum_probs=196.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.++|++.+.||+|+||.||+|..+ +++.||||++.... ......+..|+.++.+. .||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 367888999999999999999986 48999999987543 23345566677777666 4999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||++ +++.+++......+++..+..++.|+++|++|||+ ..+|+||||+|+||++++++.+||+|||++..+....
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE---KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9985 58888777655568999999999999999999993 2489999999999999999999999999997654322
Q ss_pred CcceeecccccccccCCCccCCCC----CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGI----VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||.........+........+ .
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~------- 238 (296)
T cd06618 170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP-S------- 238 (296)
T ss_pred c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC-C-------
Confidence 2 12235778999999886543 8889999999999999999999986532211111111111000 0
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.+....++.++.+++.+||+.||++||++.++++.
T Consensus 239 --------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 --------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00111245678899999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=304.73 Aligned_cols=267 Identities=23% Similarity=0.278 Sum_probs=199.2
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc----CCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN----PDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 572 (791)
.++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+..|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999865 79999999986542 2334567789999999999999999998753 3567
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||+. |+|.+++..... +++..+..++.||+.||.||| ..+|+||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIH----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 699999876544 899999999999999999999 678999999999999999999999999999765
Q ss_pred CCCCCc--ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh
Q 003855 653 GEGEDS--VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV 729 (791)
Q Consensus 653 ~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... .....+.........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSVLGSPSEEV 235 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHHhCCChhHh
Confidence 433221 11123468889999998755 56889999999999999999999999753221 11111111111100000
Q ss_pred c----chhhhhh----H----Hh-hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 V----DANLVRE----E----QA-FSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 ~----d~~~~~~----~----~~-~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. +...... . .. .......+.++.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 0000000 0 00 0001234677899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.46 Aligned_cols=263 Identities=24% Similarity=0.295 Sum_probs=201.3
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh--HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
|+..+.||+|++|.||+|... +++.+|+|.+..... .....+..|+.++++++||||+++++++.+++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999875 788999998865432 24567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++ ++.+++......+++..+..++.|++.|+.||| ..+|+|+||+|+||++++++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH----SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH----HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 75 999998876566899999999999999999999 6789999999999999999999999999998775443 1
Q ss_pred eeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC----hhhhcc---
Q 003855 660 TQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG----LTEVVD--- 731 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~d--- 731 (791)
......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||...... ..+.... ...... .....+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIF-RTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HHcCCCchHhcccchhhhh
Confidence 12224578889999988766 7899999999999999999999998653221 1111111 111000 000000
Q ss_pred ---hhhhhh--HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ---ANLVRE--EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ---~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+... .........++.++.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 0000112245678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=299.39 Aligned_cols=259 Identities=20% Similarity=0.210 Sum_probs=185.8
Q ss_pred hhccccccccCCCcceEEEEEEecC----CcEEEEEEeehhhhHH-----------HHHHHHHHHHHHhccCCccceeee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISD----GTDVAIKIFNLQLERA-----------FRSFDSECEVLRNVRHRNLIKILS 564 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~ 564 (791)
.++|++.+.||+|+||.||+|...+ +..+|+|+........ ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999999753 4566777543221110 011223334455678999999998
Q ss_pred eeccCC----eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc
Q 003855 565 SCSNPD----FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA 640 (791)
Q Consensus 565 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~ 640 (791)
++.... ..++++|++. .++.+.+.... ..++..+..++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH----EHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCc
Confidence 765433 3467888774 46776665432 3578888999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCCc-----ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHH
Q 003855 641 AHVSDFGISKLLGEGEDS-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 715 (791)
Q Consensus 641 ~kl~Dfgla~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 715 (791)
++|+|||+|+.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999876432211 111234689999999999999999999999999999999999999976422211111
Q ss_pred HHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 716 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
. ... +.+. .+.... .....+++.+.+++..|++.+|++||++.++++.+
T Consensus 245 ~-~~~-------~~~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 A-AKC-------DFIK-RLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred H-hHH-------HHHH-Hhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 000 0000 000000 01124567789999999999999999999999876
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=296.42 Aligned_cols=245 Identities=25% Similarity=0.324 Sum_probs=195.3
Q ss_pred cCCCcceEEEEEEec-CCcEEEEEEeehhhh---HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCH
Q 003855 509 LGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSL 584 (791)
Q Consensus 509 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 584 (791)
||+|+||.||+++.. +|+.||+|++..... ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 589999999865432 4556788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC------c
Q 003855 585 EKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED------S 658 (791)
Q Consensus 585 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~------~ 658 (791)
.+++.... .+++..+..++.|+++||+||| ..+++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH----SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99998755 5899999999999999999999 67899999999999999999999999999876533211 1
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
.......++..|+|||......++.++||||||+++||+++|+.||...... ...........
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~------------ 218 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILNGKI------------ 218 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCc------------
Confidence 1223345788999999988888999999999999999999999998653211 11111100000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
..+.....+..+.+++.+|++.+|++|||+.++.+.|
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0001111256778999999999999999996555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=281.67 Aligned_cols=242 Identities=26% Similarity=0.290 Sum_probs=197.9
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.+++|+..+++|+|.||.|-.++-+ +++.+|+|++++.. ++....-..|-++++..+||.+..+-..|+..+..|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4678999999999999999999865 79999999998775 4455667789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+.||.|.-++..... +++....-+-..|..||.||| +.+||+||+|.+|.++|.+|++||+|||+++.--.
T Consensus 246 VMeyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLH----s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLH----SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhh----hCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999988876544 677777778889999999999 78899999999999999999999999999975221
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
........+||+.|+|||++.+..|...+|+|.+|||+|||++|+.||...... .+...+.
T Consensus 321 --~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--kLFeLIl--------------- 381 (516)
T KOG0690|consen 321 --YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--KLFELIL--------------- 381 (516)
T ss_pred --ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh--HHHHHHH---------------
Confidence 222345578999999999999999999999999999999999999998652111 1111111
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRI 767 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 767 (791)
.+...++ ...+++...++...+..||.+|.
T Consensus 382 -~ed~kFP--r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 382 -MEDLKFP--RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -hhhccCC--ccCCHHHHHHHHHHhhcChHhhc
Confidence 1111111 13445677899999999999997
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=308.10 Aligned_cols=374 Identities=29% Similarity=0.428 Sum_probs=313.7
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCc
Q 003855 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSIT 83 (791)
Q Consensus 4 ~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 83 (791)
++|+.++.+.+|..|++++|.+. ..|+.++.+..|..|+..+|+++ ++|++++. +.+|..|++.+|+++...|..+
T Consensus 105 ~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~-~~~l~~l~~~~n~l~~l~~~~i- 180 (565)
T KOG0472|consen 105 ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVN-LSKLSKLDLEGNKLKALPENHI- 180 (565)
T ss_pred hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHH-HHHHHHhhccccchhhCCHHHH-
Confidence 68999999999999999999998 66888999999999999999998 99998887 5689999999999995544444
Q ss_pred CCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhh
Q 003855 84 NATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIG 163 (791)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 163 (791)
+++.|++||...|.++ ..|..++++.+|.-|++..|+|..+| +|.++..|++|+++.|+|. .+|...+
T Consensus 181 ~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP----------ef~gcs~L~Elh~g~N~i~-~lpae~~ 248 (565)
T KOG0472|consen 181 AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP----------EFPGCSLLKELHVGENQIE-MLPAEHL 248 (565)
T ss_pred HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC----------CCCccHHHHHHHhcccHHH-hhHHHHh
Confidence 4999999999999988 45667899999999999999998654 4888888888999888887 6677777
Q ss_pred hhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcc--------------
Q 003855 164 NFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEG-------------- 229 (791)
Q Consensus 164 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-------------- 229 (791)
.-..++..|+|++|++. ..|+.++-+.+|++||+++|.|+ ..|..++++ +|+.|-+.+|.+++
T Consensus 249 ~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vL 325 (565)
T KOG0472|consen 249 KHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVL 325 (565)
T ss_pred cccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHH
Confidence 66677888888888888 67888888888888999988888 556788888 88888888888754
Q ss_pred --------------------------------------------------cCCccccccC---CCceEEecCCccCCCCC
Q 003855 230 --------------------------------------------------SIPYDLCHLK---LMFGIRLTGNKLSGHIP 256 (791)
Q Consensus 230 --------------------------------------------------~~~~~~~~l~---~L~~L~L~~N~i~~~~~ 256 (791)
.+|......- -....+++.|++. .+|
T Consensus 326 KyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elP 404 (565)
T KOG0472|consen 326 KYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELP 404 (565)
T ss_pred HHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhh
Confidence 1111111111 2567889999999 788
Q ss_pred ccccCCCCCcE-EEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccc
Q 003855 257 PCLVSLTSLRE-LHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALK 335 (791)
Q Consensus 257 ~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 335 (791)
..+..+..+.+ +.+++|.+ +.+|..++.+++|..|+|++|.+. .+|..++.+..|+.|++|+|++. ..|..+..+.
T Consensus 405 k~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq 481 (565)
T KOG0472|consen 405 KRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQ 481 (565)
T ss_pred hhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHH
Confidence 87877777654 55555655 488999999999999999999997 68899999999999999999998 8999999999
Q ss_pred cccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCC
Q 003855 336 DLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVK 402 (791)
Q Consensus 336 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 402 (791)
.|+.+-.++|+++...|..+.+|.+|..|||.+|.+. .+|..+++|.+|++|++++|++. .++..
T Consensus 482 ~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~ 546 (565)
T KOG0472|consen 482 TLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQ 546 (565)
T ss_pred HHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHHH
Confidence 9999999999999666666999999999999999998 88999999999999999999999 44443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=293.28 Aligned_cols=242 Identities=26% Similarity=0.312 Sum_probs=194.5
Q ss_pred cCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCH
Q 003855 509 LGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSL 584 (791)
Q Consensus 509 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 584 (791)
||.|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 58999999987543 23456788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecc
Q 003855 585 EKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT 664 (791)
Q Consensus 585 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 664 (791)
.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+++...... .....
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH----~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH----NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 99998654 3789999999999999999999 6789999999999999999999999999998765432 12234
Q ss_pred cccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHH
Q 003855 665 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAK 744 (791)
Q Consensus 665 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 744 (791)
.++..|+|||...+..++.++|+||+|+++|||++|..||....... .+......... .....+
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-------------~~~~~~ 216 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDILKGN-------------GKLEFP 216 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHhccC-------------CCCCCC
Confidence 57889999999888889999999999999999999999997643211 11111111000 000011
Q ss_pred HHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003855 745 MDCILSIMDLALDCCIESPDMRIN-----VTDAAA 774 (791)
Q Consensus 745 ~~~~~~l~~li~~cl~~~P~~RPt-----~~ev~~ 774 (791)
..++..+.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 122467889999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=298.59 Aligned_cols=244 Identities=23% Similarity=0.320 Sum_probs=196.7
Q ss_pred ccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCH
Q 003855 506 CNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSL 584 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 584 (791)
...||+|+||.||+|..+ +++.||||.+..........+..|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999874 7899999988655445556788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecc
Q 003855 585 EKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT 664 (791)
Q Consensus 585 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 664 (791)
.+++... .+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||++........ .....
T Consensus 105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH----~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 9987644 3789999999999999999999 67899999999999999999999999999876543221 12234
Q ss_pred cccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHH
Q 003855 665 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAK 744 (791)
Q Consensus 665 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 744 (791)
.++..|+|||...+..++.++||||+|+++|||++|..||..... ......+....+.... ..
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~---------------~~ 239 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKLK---------------NL 239 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcccC---------------Cc
Confidence 578899999998888899999999999999999999999864211 1111111111111100 01
Q ss_pred HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 745 MDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 745 ~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..++..+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 123456779999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.31 Aligned_cols=264 Identities=22% Similarity=0.316 Sum_probs=199.1
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh-HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
+|+..+.||+|++|.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788999999999999999975 689999999875532 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 580 PNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 580 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
++ +|.+++.... ..+++..+..++.|++.||.||| +.+++||||+|+||++++++.++++|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH----ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 8999887543 45899999999999999999999 67899999999999999999999999999976533211
Q ss_pred cceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC---Chhhhcc--
Q 003855 658 SVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH---GLTEVVD-- 731 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d-- 731 (791)
......++..|+|||+..+ ..++.++|||||||++|||++|+.||.+.... ....+........ ....+.+
T Consensus 156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhcCc
Confidence 1223456889999998755 45788999999999999999999998753221 1111111110000 0000000
Q ss_pred ---h---hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ---A---NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ---~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. ...... .......++..+.+++.+|++.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQD-LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHH-HHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 000000 00011234577889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=295.09 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=199.4
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC--CeeeEEEe
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP--DFKALVLE 577 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 577 (791)
|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999976 58899999997653 33446788899999999999999999999887 88999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++ +|.+++......+++..+..++.|+++|++||| ..+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH----SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9974 999998866556899999999999999999999 67899999999999999999999999999987654331
Q ss_pred cceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC---Chhhhcc--
Q 003855 658 SVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH---GLTEVVD-- 731 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d-- 731 (791)
.......++..|+|||...+ ..++.++||||||+++|||++|+.||..... ...+.......... ......+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccch
Confidence 11223456788999997654 4678999999999999999999999875321 11111111110000 0000000
Q ss_pred ------hhhhhhHHhhHHHHH-HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ------ANLVREEQAFSAKMD-CILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ------~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.............. ++..+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000000111 3677899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.49 Aligned_cols=264 Identities=21% Similarity=0.218 Sum_probs=194.9
Q ss_pred cccccCCCcceEEEEEEecCCcEEEEEEeehh--hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCC
Q 003855 505 ECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNG 582 (791)
Q Consensus 505 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 582 (791)
+.+.+|.|+++.||++.. +++.||||++... .....+.+..|+.++++++||||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344555566666666655 7899999998754 3445678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc---
Q 003855 583 SLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS--- 658 (791)
Q Consensus 583 ~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--- 658 (791)
++.+++... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+|++|||.+..+......
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH----~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH----SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999999854 345889999999999999999999 678999999999999999999999999998755332211
Q ss_pred --ceeecccccccccCCCccCC--CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC---------
Q 003855 659 --VTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG--------- 725 (791)
Q Consensus 659 --~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 725 (791)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||............ +....+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchhhh
Confidence 11122346778999998765 35889999999999999999999999764322221111 11111100
Q ss_pred ---hh----hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 726 ---LT----EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 726 ---~~----~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.. ...+.... .............++.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNR-DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchh-hhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 00011100 011111222445678899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=318.78 Aligned_cols=270 Identities=17% Similarity=0.210 Sum_probs=189.9
Q ss_pred HhhccccccccCCCcceEEEEEEec--CCcEEEEEE--------------eeh---hhhHHHHHHHHHHHHHHhccCCcc
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS--DGTDVAIKI--------------FNL---QLERAFRSFDSECEVLRNVRHRNL 559 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~--------------~~~---~~~~~~~~~~~e~~~l~~l~h~ni 559 (791)
..++|++.+.||+|+||.||+|..+ ++..+++|. +.. ........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998753 222222221 111 112234568899999999999999
Q ss_pred ceeeeeeccCCeeeEEEecCCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe
Q 003855 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHN----YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL 635 (791)
Q Consensus 560 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill 635 (791)
+++++++...+..++|+|++ .+++.+++.... .......+..++.|++.||.||| +.+|+||||||+|||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH----~~gIiHrDLKP~NILl 300 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH----DKKLIHRDIKLENIFL 300 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE
Confidence 99999999999999999998 458888876432 12335567789999999999999 7789999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCC-CCCccccC-cch
Q 003855 636 DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR-PTDEMFTG-EMS 713 (791)
Q Consensus 636 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~-p~~~~~~~-~~~ 713 (791)
+.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|.. |+...... ...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999876543221 2223568999999999999999999999999999999999875 44332111 112
Q ss_pred HHHHHHHh------cCCC---hhhhcchh-hhh---hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 714 LRRWVKES------LPHG---LTEVVDAN-LVR---EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 714 ~~~~~~~~------~~~~---~~~~~d~~-~~~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.+.+... .+.. ..+.++.. ... ...........+..+.+++.+|++.||++|||+.|+++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 22222111 0110 00111000 000 00000011123456778899999999999999999986
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.46 Aligned_cols=272 Identities=24% Similarity=0.299 Sum_probs=200.7
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehh--hhHHHHHHHHHHHHHHhc-cCCccceeeeeecc--CCee
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ--LERAFRSFDSECEVLRNV-RHRNLIKILSSCSN--PDFK 572 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--~~~~ 572 (791)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+..|+.+++++ +||||+++++++.. ....
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999975 6889999987542 123345677899999999 99999999998854 3468
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||++ ++|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH----SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999996 5999998765 5789999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCc---ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh-
Q 003855 653 GEGEDS---VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT- 727 (791)
Q Consensus 653 ~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 727 (791)
...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ...+.... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~-~~~~~~~ 235 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEV-IGPPSAE 235 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH-hCCCCHH
Confidence 443221 12223457889999997654 568889999999999999999999986532211 11111111 000000
Q ss_pred -----------hhcchhhhhhHHh-hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHH
Q 003855 728 -----------EVVDANLVREEQA-FSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK--LKKI 779 (791)
Q Consensus 728 -----------~~~d~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~--L~~~ 779 (791)
+.++......... ......++.++.+++.+|++.+|++|||+.++++. +.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000000000000 00011246778999999999999999999999975 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=289.20 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=203.9
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+|+..+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999975 68999999987553 24566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 579 MPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 579 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
+++++|.+++... ...+++..+..++.+++.|+.||| +.+++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH----SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 9999999999865 356899999999999999999999 678999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
. .......|++.|+|||...+..++.++||||+|+++|+|++|+.||..... .+............
T Consensus 157 ~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~------- 222 (258)
T cd08215 157 V--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILKGQYPP------- 222 (258)
T ss_pred c--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhcCCCCC-------
Confidence 2 122234678899999998888899999999999999999999999865321 11111111111000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+..++..+.+++.+||..+|++||++.|+++
T Consensus 223 -------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 -------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 01134466889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.52 Aligned_cols=265 Identities=22% Similarity=0.263 Sum_probs=195.1
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh--HHHHHHHHHHHHHHhcc-CCccceeeeeeccCCe-----
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE--RAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDF----- 571 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 571 (791)
++|+..+.||+|+||.||+|... +++.||+|....... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 789999998765432 23456788999999995 6999999999876555
Q ss_pred eeEEEecCCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-CCcEEEeee
Q 003855 572 KALVLEFMPNGSLEKWLYSH----NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-NMAAHVSDF 646 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-~~~~kl~Df 646 (791)
.++||||+++ ++.+++... ...+++..+..++.||++||.||| +.+|+||||+|+||+++. ++.+||+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH----KHGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999975 899988743 234799999999999999999999 678999999999999998 899999999
Q ss_pred ccccccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc-CC
Q 003855 647 GISKLLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL-PH 724 (791)
Q Consensus 647 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~ 724 (791)
|+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||......+ .+........ +.
T Consensus 156 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~ 232 (295)
T cd07837 156 GLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPT 232 (295)
T ss_pred ccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 99986533211 1122356888999997754 557899999999999999999999986532211 1111111000 00
Q ss_pred C--hhhhcc-------hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 725 G--LTEVVD-------ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 725 ~--~~~~~d-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. ...... +........ .....++.++.+++.+|++.||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000000 000000000 011235677889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=288.71 Aligned_cols=246 Identities=29% Similarity=0.349 Sum_probs=201.5
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+|++.+.||+|+||.||+++.. +++.+|+|.+.... ......+..|++++++++||||+++.+++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999864 78899999987543 33456778899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 579 MPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 579 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
+++++|.+++... ...+++..++.++.|++.|++||| +.+++||||+|+||++++++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh----~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH----EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999998752 345899999999999999999999 778999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
. .....++..|+|||...+..++.++|+||+|+++|||++|+.||...... .+...+.. ....
T Consensus 157 ~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~---~~~~-------- 219 (256)
T cd08530 157 M----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR---GKYP-------- 219 (256)
T ss_pred C----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc---CCCC--------
Confidence 1 12245788999999998888999999999999999999999999753211 11111110 0000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....++.++.+++.+|++.+|++||++.|+++
T Consensus 220 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 ------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011134566889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=293.06 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=191.7
Q ss_pred cCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCH
Q 003855 509 LGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSL 584 (791)
Q Consensus 509 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 584 (791)
||+|+||.||+|..+ +|+.||+|.+.... ....+.+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 68999999986542 22344567899999999999999999999999999999999999999
Q ss_pred HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeec
Q 003855 585 EKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM 663 (791)
Q Consensus 585 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 663 (791)
.+++.... ..+++..+..++.|++.|+.||| ..+++||||+|+||++++++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH----QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 99998654 35899999999999999999999 6789999999999999999999999999997654321 1223
Q ss_pred ccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHH
Q 003855 664 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSA 743 (791)
Q Consensus 664 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 743 (791)
..++..|+|||+..++.++.++||||+||++|+|++|+.||...... ............. ....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~---------------~~~~ 217 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEM---------------AVEY 217 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhccccc---------------cccC
Confidence 45788999999988888999999999999999999999998653221 1111111100000 0001
Q ss_pred HHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 744 KMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 744 ~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
+..++..+.+++.+||+.+|++|| ++.++++
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 112356678999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.24 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=202.1
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh--HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+|+..+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|||++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 678999999876543 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++++|.+++... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH----EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999999865 34899999999999999999999 678999999999999999999999999999876543321
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ........ .....
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~----------- 217 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIV-QDDHP----------- 217 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHh-ccCCC-----------
Confidence 2234578899999998887889999999999999999999999865321 11111110 00000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..++..+.+++.+|+..+|++||++.|++.
T Consensus 218 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 ---PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 001123456789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=300.60 Aligned_cols=263 Identities=20% Similarity=0.280 Sum_probs=193.4
Q ss_pred cccCCC--cceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTG--SFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
..||+| +||+||+|+.. +|+.||+|++.... .+..+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 89999999874 79999999986432 33457788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc-
Q 003855 582 GSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV- 659 (791)
Q Consensus 582 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~- 659 (791)
|++.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH----QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999999854 234889999999999999999999 6789999999999999999999999998664332211110
Q ss_pred ----eeecccccccccCCCccCC--CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc---------CC
Q 003855 660 ----TQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL---------PH 724 (791)
Q Consensus 660 ----~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~---------~~ 724 (791)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+. ......... +.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccch
Confidence 0111234567999999865 3478999999999999999999999976432211 111111000 00
Q ss_pred Chhhhcc-----------h--------hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 725 GLTEVVD-----------A--------NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 725 ~~~~~~d-----------~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......+ . .........+....++..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000000 0 000000011223356778999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=296.27 Aligned_cols=247 Identities=27% Similarity=0.317 Sum_probs=196.5
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehh---hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
+.|...+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+++++.++|||++++.+++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777789999999999999965 6788999988642 2344567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+. |++.+++......+++.++..++.|++.|+.||| +.+++||||+|+||+++.++.++++|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9996 6888888766566899999999999999999999 678999999999999999999999999999765432
Q ss_pred CcceeecccccccccCCCccC---CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 657 DSVTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
....++..|+|||.+. .+.++.++|||||||++|||++|+.||...... .....+.....+
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~---------- 232 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP---------- 232 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhcCCC----------
Confidence 1235788999999863 456888999999999999999999998653111 111111110000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
......++..+.+++.+||+.+|++||++.++++.-
T Consensus 233 -------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 233 -------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 001113456678999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=289.02 Aligned_cols=243 Identities=22% Similarity=0.260 Sum_probs=187.8
Q ss_pred cccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHH-HhccCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVL-RNVRHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|... +++.||+|++.... ......+..|..++ ...+|||++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 68999999986542 22223344454444 445899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||+++.... .
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH----QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 99999997654 3789999999999999999999 67899999999999999999999999999875432 1
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
....++..|+|||...+..++.++||||||+++|||++|..||...... ........... ... .
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~~-------------~ 214 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFDNILSRRI--NWP-------------E 214 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhccc--CCC-------------C
Confidence 2235788999999988888999999999999999999999999653221 11111100000 000 0
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
.....++..+.+++.+||+.+|++||++.++.+.+
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 01113556788999999999999999876665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.39 Aligned_cols=271 Identities=25% Similarity=0.296 Sum_probs=201.4
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehh--hhHHHHHHHHHHHHHHhccCCccceeeeeeccC-----Ce
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSNP-----DF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 571 (791)
.++|.+.+.||+|+||+||+|+.. +++.||||.+... .......+..|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999864 7899999988643 223345677899999999999999999987543 35
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++|+||+. ++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH----SANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 69999887654 4899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC----Ch
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH----GL 726 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~ 726 (791)
...... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||..... ...... +...... ..
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~-~~~~~~~~~~~~~ 233 (337)
T cd07858 158 TSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKL-ITELLGSPSEEDL 233 (337)
T ss_pred cCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHH-HHHHhCCCChHHh
Confidence 643321 1223457889999997654 5688999999999999999999999965321 111111 1110000 00
Q ss_pred hhhcchhhhhh---------HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHH
Q 003855 727 TEVVDANLVRE---------EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK--LKKIK 780 (791)
Q Consensus 727 ~~~~d~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~--L~~~~ 780 (791)
..+.+...... .........++.++.+++.+|++.+|++|||+.|+++. ++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00011000000 00001112456778999999999999999999999876 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=295.51 Aligned_cols=265 Identities=23% Similarity=0.294 Sum_probs=195.7
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++|++.+.||+|++|.||+|+.. +++.||+|.+.... ....+.+..|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999975 78999999886432 2334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-CCcEEEeeeccccccCCC
Q 003855 578 FMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-NMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~ 655 (791)
|++ +++.+++.... ...++..+..++.||+.||+||| +.+++||||+|+||++++ ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 58888886543 33678888899999999999999 678999999999999985 567999999999765432
Q ss_pred CCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh-----
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV----- 729 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 729 (791)
.. ......++..|+|||++.+ ..++.++||||+||++|+|+||+.||...... ..+.+... .........
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFR-ILGTPNEETWPGVT 232 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-HhCCCChhhccccc
Confidence 11 1223356889999998765 45789999999999999999999998653221 11111111 000000000
Q ss_pred --cchh--hhh--hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 --VDAN--LVR--EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 --~d~~--~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+.. ... ...........+.++.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000 00000011124566889999999999999999999986
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=295.72 Aligned_cols=244 Identities=27% Similarity=0.317 Sum_probs=194.3
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|+.+++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999864 68899999986432 33456788899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+. |++.+++......+++.++..++.|++.|+.||| +.+++||||+|+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--- 174 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--- 174 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence 95 6888888766666899999999999999999999 678999999999999999999999999998653221
Q ss_pred ceeecccccccccCCCccC---CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 659 VTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
....|+..|+|||++. .+.++.++|||||||++|||++|..||....... ....... ......
T Consensus 175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~---~~~~~~------ 240 (313)
T cd06633 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQ---NDSPTL------ 240 (313)
T ss_pred ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHh---cCCCCC------
Confidence 2245788999999873 4668889999999999999999999986532111 1111110 000000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
....++..+.+++.+|++.+|.+||++.++++.
T Consensus 241 -------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 -------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011233557899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=286.73 Aligned_cols=250 Identities=23% Similarity=0.284 Sum_probs=196.6
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehh-----hhHHHHHHHHHHHHHHhccCCccceeeeeeccC--Cee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ-----LERAFRSFDSECEVLRNVRHRNLIKILSSCSNP--DFK 572 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 572 (791)
.+|++.+.||+|+||.||+|... ++..||+|++... ..+....+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999864 6899999987532 133456788999999999999999999998654 457
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++|+||+++++|.+++..... +++..+.+++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 899999999999999986543 788899999999999999999 678999999999999999999999999999865
Q ss_pred CCCCC-cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 653 GEGED-SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 653 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
..... ........++..|+|||+..+..++.++|||||||++|||++|+.||......+ ...+. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~----~~~~~~~--- 228 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFKI----ATQPTKP--- 228 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHHH----HcCCCCC---
Confidence 32111 111123457889999999988889999999999999999999999987531111 11111 0000000
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+.....++.+++.+|++ +|..||++.+++.
T Consensus 229 ----------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 229 ----------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0112344668899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=274.22 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=196.6
Q ss_pred Hhhccccc-cccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeecc----CCe
Q 003855 499 ATDEFNEC-NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSN----PDF 571 (791)
Q Consensus 499 ~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 571 (791)
.+++|.+. ++||-|-.|.|-.+..+ +|+.+|+|++.... ...+|++.--.. .|||||+++++|.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666654 57999999999998865 89999999886432 234466655444 69999999999854 355
Q ss_pred eeEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC---CCCcEEEeeec
Q 003855 572 KALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD---ENMAAHVSDFG 647 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg 647 (791)
..+|||.|+||.|.+.++.++ ..+++.++..|+.||+.|+.||| +..|+||||||+|+|.+ .+..+|++|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH----~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH----SMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH----hcchhhccCChhheeeecCCCCcceEecccc
Confidence 678999999999999999764 46899999999999999999999 78999999999999996 46679999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
+|+.-.. .......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||....... +.
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--------------is 272 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--------------IS 272 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--------------CC
Confidence 9986543 223344567999999999999999999999999999999999999997543211 11
Q ss_pred hhcchhhhhhHH--hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVREEQ--AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.-...++..... ..+++.+.+++..++|+.+|..+|++|.|+.|++.
T Consensus 273 pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 273 PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 111111111111 12456678899999999999999999999999875
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=288.16 Aligned_cols=241 Identities=21% Similarity=0.294 Sum_probs=185.4
Q ss_pred ccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHH---HHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 508 LLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSEC---EVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 508 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
.||+|+||.||+|... +++.||+|.+.... ......+..|. ..++...||+|+++.+++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 68899999886532 11112233343 34444579999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+|+|.+++.... .+++..+..++.|++.|+.||| +.+|+||||||+||++++++.++|+|||+++......
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 999999887654 4899999999999999999999 6789999999999999999999999999997653321
Q ss_pred eecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 661 QTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....|+..|+|||+..++ .++.++||||+||++|||++|+.||................. ...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~------- 216 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------MAV------- 216 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--------cCC-------
Confidence 1234689999999998654 689999999999999999999999976422111110000000 000
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
..+..++..+.+++.+|+..+|++|| ++.++++
T Consensus 217 --~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 01112346678999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=318.54 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=208.1
Q ss_pred hHHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehh---hhHHHHHHHHHHHHHHhccCCccceeeeeeccC
Q 003855 494 LDIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSCSNP 569 (791)
Q Consensus 494 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 569 (791)
.+++-..++|.++++||+|+||.|..++.+ +++.||.|++.+- .+....-|..|-.+|..-+.+.|++++.+|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 345566789999999999999999999975 7889999998763 244456788899999999999999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
.+.|+|||||+||||-..+.+.. .+++..+..++..|+-||.-+| +.|+|||||||+|||+|..|++|++|||.+
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH----~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH----SMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH----hccceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999999887 6888888889999999999999 889999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccC----C-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGS----E-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH 724 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (791)
-.+..++ .......+|||.|++||++. + +.|++.+|+||+||++|||+.|..||..- ++..-+..
T Consensus 223 lkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~K---- 292 (1317)
T KOG0612|consen 223 LKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGK---- 292 (1317)
T ss_pred HhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHH----
Confidence 8876543 34556678999999999753 3 67999999999999999999999998641 11111111
Q ss_pred ChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC---HHHHHH
Q 003855 725 GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRIN---VTDAAA 774 (791)
Q Consensus 725 ~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~ev~~ 774 (791)
+.+. .+.-.+|...+++.+..++|.+.+. +|+.|.. +.|+..
T Consensus 293 ----Im~h---k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 293 ----IMNH---KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ----Hhch---hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1111 0001122223466777889988775 7888887 777654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=273.56 Aligned_cols=269 Identities=20% Similarity=0.291 Sum_probs=199.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehh--hhHHHHHHHHHHHHHHhccCCccceeeeeecc--------C
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSN--------P 569 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 569 (791)
..|+...+||+|.||+||+|+.+ +|+.||+|++-.+ .+.......+|++++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45667789999999999999864 6888999865432 23334456789999999999999999998843 3
Q ss_pred CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
...|+||++|+. +|.-.+......++..++.+++.++..||.|+| ...|+|||+||.|+|++.+|.+||+|||+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH----r~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH----RNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH----HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 457899999987 999999887677999999999999999999999 678999999999999999999999999999
Q ss_pred cccCCCC--CcceeecccccccccCCCcc-CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcc--hHHHHHHHhcCC
Q 003855 650 KLLGEGE--DSVTQTMTMATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM--SLRRWVKESLPH 724 (791)
Q Consensus 650 ~~~~~~~--~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~ 724 (791)
+.+.... .....+..+.|.+|++||.+ ....|+++.|||+.|||+.||+||.+-+.+..+... .++......-++
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 7664332 22345667889999999965 557899999999999999999999988765322211 112222222222
Q ss_pred ChhhhcchhhhhhH-------HhhHHHHHH------HHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 725 GLTEVVDANLVREE-------QAFSAKMDC------ILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 725 ~~~~~~d~~~~~~~-------~~~~~~~~~------~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
-+.++..-.+...- .......+. ..+..+++..++..||.+||++.+++.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 12111111110000 000011111 236779999999999999999998875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=290.76 Aligned_cols=261 Identities=25% Similarity=0.310 Sum_probs=195.9
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhc---cCCccceeeeeeccCCe-----
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNV---RHRNLIKILSSCSNPDF----- 571 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 571 (791)
|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999986 58999999986432 22234566677777666 59999999999987766
Q ss_pred eeEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
.+++|||+. ++|.+++.... ..+++..+..++.|+++||.||| +.+++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH----~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999996 58999887543 35899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC-h---
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG-L--- 726 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~--- 726 (791)
.+..... .....++..|+|||+..+..++.++|||||||++|||++|+.||..... ...+.++........ .
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcC
Confidence 7643322 1223468889999999888999999999999999999999999875322 222222222111100 0
Q ss_pred ------hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 727 ------TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 727 ------~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
............ .......+..+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSF--KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccch--hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000000 0111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=293.48 Aligned_cols=255 Identities=25% Similarity=0.290 Sum_probs=199.1
Q ss_pred ccccccccCCCcceEEEEEEe----cCCcEEEEEEeehhh----hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCee
Q 003855 502 EFNECNLLGTGSFGSVYKGTI----SDGTDVAIKIFNLQL----ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 572 (791)
+|++.+.||+|+||.||+++. .+++.||||++.... ....+.+..|+.++.++ +||||+++++++......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999974 357889999987432 23345678899999999 599999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||+++|+|.+++.... .+++..+..++.|+++||.||| ..+++||||+|+||+++.++.++++|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH----~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH----QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999997654 4788999999999999999999 678999999999999999999999999999875
Q ss_pred CCCCCcceeecccccccccCCCccCCCC--CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
...... ......|+..|+|||...+.. .+.++||||||+++|||++|..||..... ......+.......
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~------ 227 (288)
T cd05583 156 LAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKS------ 227 (288)
T ss_pred cccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHcc------
Confidence 443221 122345788999999876654 78899999999999999999999853211 11111111111000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
..+.+..++..+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 228 ---------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ---------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 001112244667899999999999999999988776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=290.88 Aligned_cols=249 Identities=28% Similarity=0.396 Sum_probs=201.4
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhcc-CCccceeeeeeccCCeeeEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 575 (791)
++|...+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++++++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999875 79999999987532 233467888999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++++|.+++.+.. .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh----~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH----SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999998764 4899999999999999999999 678999999999999999999999999999876443
Q ss_pred CCc------------------ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHH
Q 003855 656 EDS------------------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRW 717 (791)
Q Consensus 656 ~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 717 (791)
... .......++..|+|||......++.++||||+|++++++++|+.||..... ....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--YLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHH
Confidence 211 122233578899999998888899999999999999999999999875321 111010
Q ss_pred HHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCH----HHHHH
Q 003855 718 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINV----TDAAA 774 (791)
Q Consensus 718 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~----~ev~~ 774 (791)
+. .. ....+...+..+.+++.+|++.+|++||++ .|+++
T Consensus 234 ~~---~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 IL---KL---------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH---hc---------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 00 000111234667899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=296.45 Aligned_cols=266 Identities=24% Similarity=0.309 Sum_probs=198.3
Q ss_pred HHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc-CCe
Q 003855 496 IQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN-PDF 571 (791)
Q Consensus 496 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 571 (791)
+..++++|+..+.||+|+||.||+|... +++.||||++.... ....+.+..|++++++++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456789999999999999999999865 78999999875432 2334667789999999999999999998865 567
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++|+||+ +++|.+++.... +++..+..++.|+++||.||| ..+|+||||+|+||++++++.++|+|||.++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~ql~~aL~~LH----~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVH----SAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 88999998 669998887543 788888899999999999999 67899999999999999999999999999975
Q ss_pred cCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh--
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE-- 728 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 728 (791)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+. ........+
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~-~~~~~~~~~~~ 230 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIIT-DLLGTPPDDVI 230 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH-HHhCCCCHHHH
Confidence 4321 122356788999998765 5689999999999999999999999865322 11111111 111000000
Q ss_pred --hcchh-------hhhhH--HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 729 --VVDAN-------LVREE--QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 729 --~~d~~-------~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..+.. +.... ........++..+.+++.+|++.+|++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000 0000111245778899999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=296.84 Aligned_cols=267 Identities=22% Similarity=0.242 Sum_probs=196.1
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh--HHHHHHHHHHHHHHhccCCccceeeeeeccC-------
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE--RAFRSFDSECEVLRNVRHRNLIKILSSCSNP------- 569 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 569 (791)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999965 689999998864432 2234567899999999999999999887443
Q ss_pred -CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecc
Q 003855 570 -DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGI 648 (791)
Q Consensus 570 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl 648 (791)
...++|+||+.+ ++.+.+......+++..+..++.|+++||+||| +.+++||||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH----ENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 346899999964 788888766556999999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCCcc---------eeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHH
Q 003855 649 SKLLGEGEDSV---------TQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV 718 (791)
Q Consensus 649 a~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 718 (791)
++......... ......+++.|+|||...+ ..++.++|||||||++|||++|+.||.+.... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 98654332211 1122356888999997654 45889999999999999999999998653221 1111111
Q ss_pred HHhcCCC---------hhh----hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 719 KESLPHG---------LTE----VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 719 ~~~~~~~---------~~~----~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
....... ... ......... ...........+.+++.+|++.+|++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT--LEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCcc--HHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1100000 000 000000000 00011123366889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=289.50 Aligned_cols=262 Identities=22% Similarity=0.266 Sum_probs=194.9
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh-HHHHHHHHHHHHHHhcc-CCccceeeeeeccCCeeeEEEecC
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE-RAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
|++.+.||+|+||.||+|+.. +++.||||.+..... .......+|+..+++++ |||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 578899998865432 22234456899999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+|+|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH----KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889999988654 45899999999999999999999 67899999999999999999999999999986643322
Q ss_pred ceeecccccccccCCCccC-CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC----------hh
Q 003855 659 VTQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG----------LT 727 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~ 727 (791)
.....++..|+|||+.. ...++.++||||||+++|||++|+.||......+ .+.. +....... ..
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYK-ICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHH-HHHhcCCCChhhhhhHhhhh
Confidence 12245788999999764 4568899999999999999999999986532111 1110 00000000 00
Q ss_pred hhcchhhhhhH--HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVREE--QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+..+.... .........+..+.+++.+|++.+|++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000 000000112466889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=296.97 Aligned_cols=271 Identities=23% Similarity=0.284 Sum_probs=200.6
Q ss_pred ChhHHHHHhhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc
Q 003855 492 PYLDIQRATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568 (791)
Q Consensus 492 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 568 (791)
...++..++++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999985 478999999986532 2234567789999999999999999998753
Q ss_pred C------CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEE
Q 003855 569 P------DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAH 642 (791)
Q Consensus 569 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~k 642 (791)
. ...+++++++ +++|.+++.... +++..+..++.|+++|++||| +.+|+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEcCCCCEE
Confidence 2 3467888877 789998886543 899999999999999999999 67899999999999999999999
Q ss_pred EeeeccccccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHh
Q 003855 643 VSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES 721 (791)
Q Consensus 643 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 721 (791)
|+|||+++..... .....++..|+|||...+ ..++.++|||||||++|||++|+.||..... ...+.......
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~ 234 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLV 234 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHh
Confidence 9999999764321 122357889999998765 5688899999999999999999999865321 11111111111
Q ss_pred c--CCChhhhcchhhhhhH----Hh-----h-HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 722 L--PHGLTEVVDANLVREE----QA-----F-SAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 722 ~--~~~~~~~~d~~~~~~~----~~-----~-~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
. +......+........ .. . .....++.++.+++.+|++.||++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 0001000000000000 00 0 0001235668899999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=297.53 Aligned_cols=272 Identities=26% Similarity=0.299 Sum_probs=205.1
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCC-----eee
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD-----FKA 573 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 573 (791)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999975 58999999887543 344567889999999999999999999987765 789
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+||||++ ++|.+++.... .+++..+..++.+++.||+||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH----~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58999887654 5899999999999999999999 6789999999999999999999999999998765
Q ss_pred CCCCc-ceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh--
Q 003855 654 EGEDS-VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV-- 729 (791)
Q Consensus 654 ~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 729 (791)
..... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .....+.........+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhHhh
Confidence 43211 112234578899999998877 8999999999999999999999999764321 11111111111000000
Q ss_pred -cchhhhhhH----------HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHH
Q 003855 730 -VDANLVREE----------QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK--LKKIKV 781 (791)
Q Consensus 730 -~d~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~--L~~~~~ 781 (791)
......... .........+..+.+++.+||+.+|++||++.++++. +++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000 0000011245678899999999999999999999984 665543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=276.11 Aligned_cols=253 Identities=25% Similarity=0.285 Sum_probs=193.3
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHH-hccCCccceeeeeeccCCeeeEEEecC
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLR-NVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.+....||.|+||+|+|-.++ .|+..|||++.... +...+++..|.+... .-++||||+++|++..++..|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 344568999999999999875 79999999997654 344556666776554 447999999999999999999999999
Q ss_pred CCCCHHHHHh----hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 580 PNGSLEKWLY----SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 580 ~~g~L~~~l~----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
. .|+..+-. .....+++.-.-.|......||.||.+ ...|+|||+||+|||++..|.+|+||||.+..+.
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~---~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv-- 219 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE---ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV-- 219 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH---HhhhhhccCChhheEEecCCCEeeecccchHhHH--
Confidence 4 36654332 223447888888899999999999986 4579999999999999999999999999997653
Q ss_pred CCcceeecccccccccCCCccCC--CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.+...+..+|-..|||||.+.. ..|+-++||||+|++++|+.||..||.....--..+.+.+..+.+.-..+
T Consensus 220 -~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~----- 293 (361)
T KOG1006|consen 220 -DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD----- 293 (361)
T ss_pred -HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc-----
Confidence 3445556678889999997754 34899999999999999999999999764332222333333222221111
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
....+++..+..++..|+.+|-.+||.+.+++++
T Consensus 294 --------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 --------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --------ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1122456778899999999999999999998764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=300.58 Aligned_cols=266 Identities=20% Similarity=0.260 Sum_probs=195.6
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccC----------
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNP---------- 569 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------- 569 (791)
.+|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67899999999999999999864 6899999998766556667788999999999999999999876543
Q ss_pred ----CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC-CCCcEEEe
Q 003855 570 ----DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD-ENMAAHVS 644 (791)
Q Consensus 570 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~-~~~~~kl~ 644 (791)
...++||||++ ++|.+++... .+++..+..++.||+.||.||| ..+++||||||+||+++ +++.+|++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH----~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 5999888654 3789999999999999999999 67899999999999998 55678999
Q ss_pred eeccccccCCCCCcc-eeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc
Q 003855 645 DFGISKLLGEGEDSV-TQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL 722 (791)
Q Consensus 645 Dfgla~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (791)
|||+++......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+.+ ..........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~ 236 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILESVP 236 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence 999998654322111 1122357889999997543 568889999999999999999999997532211 1111111100
Q ss_pred CCC------hhhhcchhhhh--hHH---hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 723 PHG------LTEVVDANLVR--EEQ---AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 723 ~~~------~~~~~d~~~~~--~~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
... ........... ... ........+.++.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 00000000000 000 00001124567889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=290.41 Aligned_cols=251 Identities=25% Similarity=0.289 Sum_probs=195.3
Q ss_pred ccccccccCCCcceEEEEEEe----cCCcEEEEEEeehhh----hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCee
Q 003855 502 EFNECNLLGTGSFGSVYKGTI----SDGTDVAIKIFNLQL----ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 572 (791)
+|++.+.||+|+||.||.|+. .+|+.||+|++.... ....+.+..|+.+++++ +||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 368999999987542 22346678899999999 599999999999988899
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999998654 4788899999999999999999 678999999999999999999999999999875
Q ss_pred CCCCCcceeecccccccccCCCccCC--CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
...... ......|+..|+|||.... ..++.++||||||+++|+|++|+.||..... ......+........
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~----- 228 (290)
T cd05613 156 HEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE----- 228 (290)
T ss_pred cccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC-----
Confidence 433221 1223457889999998765 3467899999999999999999999864211 111112111111000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
.+.+..++..+.+++.+|++.+|++|| ++.++++
T Consensus 229 ----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 001112445678999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=295.56 Aligned_cols=249 Identities=27% Similarity=0.365 Sum_probs=203.0
Q ss_pred HHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.....|.+...||+|.|+.|..|+.. ++..||+|++++.. ....+.+.+|+++|..++|||||+++.+...+..+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567899999999999999999865 79999999997654 2233458889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+.+|.+.+|+.+++.- .......+..|+.+|++||| .+.|||||||++|||++.+.++||+|||++..+..
T Consensus 133 V~eya~~ge~~~yl~~~gr~-~e~~ar~~F~q~vsaveYcH----~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRM-KEKEARAKFRQIVSAVEYCH----SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEEeccCchhHHHHHhcccc-hhhhhhhhhHHHHHHHHHHh----hcceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999999988764 44788889999999999999 77899999999999999999999999999998864
Q ss_pred CCCcceeecccccccccCCCccCCCC-CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.. .....+|++.|.|||+..+.. .++.+|+||+|+++|-|+.|..||++..-.+.. ++
T Consensus 208 ~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr------------------~r 266 (596)
T KOG0586|consen 208 GL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR------------------PR 266 (596)
T ss_pred cc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc------------------ch
Confidence 33 334467999999999887765 467899999999999999999999974322211 11
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......+.+..+ ..+..+++++++-.+|.+|++..++.+
T Consensus 267 vl~gk~rIp~~m--s~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGKYRIPFYM--SCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeeeeccccee--echhHHHHHHhhccCccccCCHHHhhh
Confidence 111111111111 123448999999999999999999875
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=295.41 Aligned_cols=266 Identities=23% Similarity=0.260 Sum_probs=197.6
Q ss_pred HHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCC--
Q 003855 496 IQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD-- 570 (791)
Q Consensus 496 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 570 (791)
+....++|++.+.||+|+||.||+|... +++.||||++.... ....+.+..|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445688999999999999999999854 78999999885432 233456788999999999999999999886543
Q ss_pred ----eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeee
Q 003855 571 ----FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDF 646 (791)
Q Consensus 571 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 646 (791)
..++||||+ +++|.+++... .+++..+..++.|+++|+.||| ..+|+||||||+||+++.++.++++||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH----~~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 77999888753 3899999999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC--
Q 003855 647 GISKLLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP-- 723 (791)
Q Consensus 647 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-- 723 (791)
|++....... ....++..|+|||.+.+ ..++.++||||+||++|++++|+.||...... ..+.........
T Consensus 163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~ 236 (343)
T cd07880 163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPS 236 (343)
T ss_pred ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCC
Confidence 9998653321 22356889999998765 45889999999999999999999999753211 111111110000
Q ss_pred CChhhhcchh-hhhhH---------HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 724 HGLTEVVDAN-LVREE---------QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 724 ~~~~~~~d~~-~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
....+.+... ..... ........++..+.+++.+|++.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 00000 000011234567889999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=295.94 Aligned_cols=264 Identities=22% Similarity=0.272 Sum_probs=195.0
Q ss_pred hcccc-ccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHH--------------HHHHHHHHHHHHhccCCccceeee
Q 003855 501 DEFNE-CNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERA--------------FRSFDSECEVLRNVRHRNLIKILS 564 (791)
Q Consensus 501 ~~~~~-~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~ 564 (791)
++|.. .+.||+|+||+||+|... +++.||||++....... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 467999999999999865 78999999886432111 124678999999999999999999
Q ss_pred eeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEe
Q 003855 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVS 644 (791)
Q Consensus 565 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~ 644 (791)
++...+..++||||++ |+|.+++.... .+++.....++.|++.||.||| +.+++||||+|+||+++.++.++++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH----~~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH----KWYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 69999987544 3889999999999999999999 6789999999999999999999999
Q ss_pred eeccccccCCCC------------CcceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCc
Q 003855 645 DFGISKLLGEGE------------DSVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711 (791)
Q Consensus 645 Dfgla~~~~~~~------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 711 (791)
|||+++...... .........++..|+|||++.+. .++.++||||+||++|||++|+.||......+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999998664111 01111223467889999988654 47899999999999999999999987532211
Q ss_pred chHHHHHHHhcCCC----hhhhc--------chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 712 MSLRRWVKESLPHG----LTEVV--------DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 712 ~~~~~~~~~~~~~~----~~~~~--------d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+.. +....... +.... ....... .......++.++.+++.+|++.+|++||++.|++.
T Consensus 242 -~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 -QLGR-IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKD--LKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred -HHHH-HHHHhCCCchhhCcchhhcccccccCcCCccc--HHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111 11111000 00000 0000000 00011134567889999999999999999999985
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.17 Aligned_cols=262 Identities=26% Similarity=0.294 Sum_probs=198.8
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|+.++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999975 58999999987653 333466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
+ ++|.+++......+++..+..++.+++.||.||| ..+|+||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH----SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 7 5999999876456899999999999999999999 67899999999999999999999999999987643321
Q ss_pred eeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC----hhhh-----
Q 003855 660 TQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG----LTEV----- 729 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~----- 729 (791)
......++..|+|||.+.+. .++.++|||||||++||+++|+.||...... ..+.+ +....... ....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFK-IFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHH-HHHHhCCCcHHHHHhhccccc
Confidence 12223457789999988766 8899999999999999999999998653211 11111 11100000 0000
Q ss_pred cchhhh---hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 VDANLV---REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 ~d~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+.... .... .......+..+.+++.+|++.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 0000 0001122567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=298.33 Aligned_cols=263 Identities=24% Similarity=0.298 Sum_probs=197.4
Q ss_pred HHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCe---
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF--- 571 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 571 (791)
...++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|||++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999975 68899999886432 2334567789999999999999999998865554
Q ss_pred ---eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecc
Q 003855 572 ---KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGI 648 (791)
Q Consensus 572 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl 648 (791)
.++|+||+ +++|.+++... .+++..+..++.|+++|+.||| +.+|+||||+|+||++++++.++|+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 67999998764 3899999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCCh-
Q 003855 649 SKLLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL- 726 (791)
Q Consensus 649 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 726 (791)
+...... .....++..|+|||...+ ..++.++|||||||++||+++|+.||...... ..+..... ......
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~-~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMN-LVGTPDE 237 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH-hcCCCCH
Confidence 9865432 122357888999998754 46789999999999999999999999653211 11111111 111000
Q ss_pred -----------hhhcchhhhhhHHhh-HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 727 -----------TEVVDANLVREEQAF-SAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 727 -----------~~~~d~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+........... .....++.++.+++.+|++.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000000000 001123577899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=246.13 Aligned_cols=266 Identities=23% Similarity=0.291 Sum_probs=198.7
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.+|...++||+|+||+||+|+. ++++.||+|.+.-.. +.......+|+.+++.++|.|||++++....+...-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 3566778999999999999995 478899999886543 4445677899999999999999999999988889999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
||.. +|..|..+-...++......++.|+.+|+.++| ++.+.|||+||.|.+++.+|+.|++|||+|+-++-.
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch----shnvlhrdlkpqnllin~ngelkladfglarafgip-- 154 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH----SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-- 154 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh----hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--
Confidence 9954 999999887777999999999999999999999 778999999999999999999999999999976532
Q ss_pred cceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHh--cCC-C---hhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKES--LPH-G---LTEV 729 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~--~~~-~---~~~~ 729 (791)
....+..+.|.+|++|.++.+. -|+...|+||.||++.|+.. |++-|.+... ...+.+.++.. ..+ . +...
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCCCccccCCccccC
Confidence 3345566789999999988764 58999999999999999998 4444554221 22222222211 111 1 1111
Q ss_pred cchhhhhhHHhhHHHHHHHH----HHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 VDANLVREEQAFSAKMDCIL----SIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 ~d~~~~~~~~~~~~~~~~~~----~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
-|............+.++.+ .=.+++...+.-+|..|.++.++++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11111111111111111111 1246777788889999999998875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=294.28 Aligned_cols=269 Identities=22% Similarity=0.262 Sum_probs=196.2
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC------
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP------ 569 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 569 (791)
..++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3578999999999999999999864 78999999886432 22345678899999999999999999988644
Q ss_pred CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
...++|+||+. +++.++.. ..+++..+..++.|++.||+||| ..+++||||||+||+++.++.+|++|||++
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH----SAGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred ceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 34689999996 47777653 24789999999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC--Ch
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH--GL 726 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~ 726 (791)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+...+...... ..
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGPEF 238 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHH
Confidence 764321 122356888999998766 46889999999999999999999999753211 1111111100000 00
Q ss_pred hhhcch-hhhh---------hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHH
Q 003855 727 TEVVDA-NLVR---------EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK--LKKIKV 781 (791)
Q Consensus 727 ~~~~d~-~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~--L~~~~~ 781 (791)
.+..+. .... ...........+.++.+++.+||+.||++||++.|+++. ++.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000 0000 000000011234668899999999999999999999844 666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=277.29 Aligned_cols=263 Identities=23% Similarity=0.273 Sum_probs=200.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-C-C----ccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-H-R----NLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~l~~~~~~~~~~ 572 (791)
+.+|.+...+|+|+||.|-++... .+..||||+++.- ....++..-|+++++++. + | -+|++.+|+.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678999999999999999999764 5789999988643 444566777999999993 3 3 378888999999999
Q ss_pred eEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC--------------
Q 003855 573 ALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-------------- 637 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-------------- 637 (791)
++|+|.+ |-|+.+++.++. .+++...+..|+.|++++++||| +.+++|-||||+||++.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh----~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH----DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH----hcceeecCCChheEEEeccceEEEeccCCccc
Confidence 9999988 679999999754 46899999999999999999999 788999999999999942
Q ss_pred ------CCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCc
Q 003855 638 ------NMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711 (791)
Q Consensus 638 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 711 (791)
+..+|++|||.|+.-.+.. +..+.|..|+|||++.+-.++.++||||+|||++|+.||..-|....+.|
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3458999999998754332 44578999999999999999999999999999999999998887654333
Q ss_pred c-hHHHHHHHhcCCCh--------------------------hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCC
Q 003855 712 M-SLRRWVKESLPHGL--------------------------TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPD 764 (791)
Q Consensus 712 ~-~~~~~~~~~~~~~~--------------------------~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~ 764 (791)
. .+.+-+-...+..+ ..+.+. ................++++++.+|+..||.
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~-ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEP-CKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcC-CccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 1 11111111111110 000000 0000111112234456799999999999999
Q ss_pred CCCCHHHHHH
Q 003855 765 MRINVTDAAA 774 (791)
Q Consensus 765 ~RPt~~ev~~ 774 (791)
+|+|+.|++.
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999975
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=316.46 Aligned_cols=146 Identities=27% Similarity=0.442 Sum_probs=131.6
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|.+.+.||+|+||.||+|... +++.||||++.... ......+..|+.+++.++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999976 78999999987542 33346788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
|||+.+++|.+++.... .+++..+..++.||+.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH----~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH----RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997654 3788999999999999999999 6789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=283.42 Aligned_cols=247 Identities=21% Similarity=0.251 Sum_probs=192.2
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-----hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-----ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
+|.+.+.||+|+||.||+++.. .+..+++|+.+... ......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999865 34556666554311 12234566789999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 576 LEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
|||+++++|.+++.. ....+++..+..++.|+++|+.||| +.+++|+||+|+||++++ +.++++|||+++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH----QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH----HcCccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999999874 3445899999999999999999999 678999999999999975 56999999999876
Q ss_pred CCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
..... ......|+..|+|||...+..++.++||||||+++|+|++|..||..... ........... .+
T Consensus 156 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~-----~~ 223 (260)
T cd08222 156 MGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIVEGP-----TP 223 (260)
T ss_pred CCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHcCC-----CC
Confidence 43322 11223578899999998888889999999999999999999999864211 11111110000 00
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..++.++.+++.+||+.+|++||++.|+++
T Consensus 224 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ---------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 011244567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=290.32 Aligned_cols=265 Identities=24% Similarity=0.264 Sum_probs=191.6
Q ss_pred ccccccccCCCcceEEEEEEec-C--CcEEEEEEeehhh--hHHHHHHHHHHHHHHhc-cCCccceeeeeecc----CCe
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-D--GTDVAIKIFNLQL--ERAFRSFDSECEVLRNV-RHRNLIKILSSCSN----PDF 571 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 571 (791)
+|++.+.||+|+||.||+++.. + +..||+|++.... ....+.+.+|+++++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999965 4 7889999886432 22345678899999999 59999999987532 245
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++++||+. ++|.+++.... .+++..+..++.||+.||.||| ..+++||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH----SANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788899885 69999987544 4899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCc--ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC---
Q 003855 652 LGEGEDS--VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG--- 725 (791)
Q Consensus 652 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 725 (791)
+...... .......|+..|+|||+..+ ..++.++||||+||++|+|++|+.||..... ...+...+. .....
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~~~~-~~~~~~~~ 232 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQLNQILQ-VLGTPDEE 232 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHHHHH-HhCCCCHH
Confidence 6433221 11223468899999997655 5689999999999999999999999865221 111111111 00000
Q ss_pred -hhhhcchhhh-------h-hHHhh-HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 726 -LTEVVDANLV-------R-EEQAF-SAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 726 -~~~~~d~~~~-------~-~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....++... . ..... .....++..+.+++.+|++.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 0 00000 000123467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=278.77 Aligned_cols=236 Identities=28% Similarity=0.310 Sum_probs=192.1
Q ss_pred cCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCH
Q 003855 509 LGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSL 584 (791)
Q Consensus 509 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 584 (791)
||+|+||.||++... +++.||+|++.... ....+.+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 58999999987553 23456788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecc
Q 003855 585 EKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT 664 (791)
Q Consensus 585 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 664 (791)
.+++.... .+++..+..++.|+++|+.||| ..+++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh----~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH----SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTF 153 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCC
Confidence 99998664 3899999999999999999999 67899999999999999999999999999987644321 22334
Q ss_pred cccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHH
Q 003855 665 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAK 744 (791)
Q Consensus 665 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 744 (791)
.++..|+|||...+..++.++|+||||+++||+++|+.||..... ... ........ ...+
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~---~~~~~~~~---------------~~~~ 213 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEI---YEKILKDP---------------LRFP 213 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHH---HHHHhcCC---------------CCCC
Confidence 578899999998888889999999999999999999999965321 111 11111100 0011
Q ss_pred HHHHHHHHHHHhhccccCCCCCCCHHH
Q 003855 745 MDCILSIMDLALDCCIESPDMRINVTD 771 (791)
Q Consensus 745 ~~~~~~l~~li~~cl~~~P~~RPt~~e 771 (791)
...+..+.+++.+|+..||++||++++
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 122456789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=276.40 Aligned_cols=242 Identities=25% Similarity=0.287 Sum_probs=195.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 574 (791)
..+|..+.+||+|+||.|-.|..+ +.+.+|||++++.. .+..+--..|.++++-- +-|.+++++.+++.-+..|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457888899999999999999865 56789999998764 22333345677777766 57899999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+.||+|--.+++-+. +.+..+.-+|..||-||-+|| +++|++||||..||++|.+|++||+|||+++.---
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh----~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh----cCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999999987665 667778889999999999999 88999999999999999999999999999975211
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
...+....+||+.|+|||++...+|+.++|+|||||++|||+.|++||++. .|..+.+.+..+
T Consensus 503 --~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe--DE~elF~aI~eh------------- 565 (683)
T KOG0696|consen 503 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDELFQAIMEH------------- 565 (683)
T ss_pred --CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHc-------------
Confidence 122334468999999999999999999999999999999999999999873 233333322221
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRIN 768 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt 768 (791)
....+...+.+..++....+...|.+|..
T Consensus 566 -----nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 -----NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -----cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 11222344567788999999999999964
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=280.88 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=200.1
Q ss_pred HHHhhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh-------hHHHHHHHHHHHHHHhccCCccceeeeeec-
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL-------ERAFRSFDSECEVLRNVRHRNLIKILSSCS- 567 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~- 567 (791)
....++|-+.+.+|+|+|++||+|.. ...+.||||+-.... ....+...+|.++-+.++||-||++++++.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 34457888899999999999999984 467889999864321 223455678999999999999999999995
Q ss_pred cCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC---CCCcEEEe
Q 003855 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD---ENMAAHVS 644 (791)
Q Consensus 568 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~---~~~~~kl~ 644 (791)
+.+..|-|.|||+|.+|.-|+..+.. +++.+...|+.||+.||.||.+- +.+|+|-||||.|||+. ..|.+||+
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccceeEee
Confidence 45677899999999999999987654 88899999999999999999853 56899999999999995 46789999
Q ss_pred eeccccccCCCCCcce-----eecccccccccCCCccCC----CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHH
Q 003855 645 DFGISKLLGEGEDSVT-----QTMTMATIGYMAPEYGSE----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 715 (791)
Q Consensus 645 Dfgla~~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 715 (791)
|||+++++....+... .+...||.+|++||++.- ...+.|+||||.|||+|.++.|+.||....... ++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dI- 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DI- 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HH-
Confidence 9999999865443321 233479999999997543 357889999999999999999999997632211 11
Q ss_pred HHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003855 716 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAA 773 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~ 773 (791)
.... .+ +......++.....+.+..++|++|+++.-++|....++.
T Consensus 694 --LqeN------TI----lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 --LQEN------TI----LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred --Hhhh------ch----hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1100 00 1111122333345567788999999999999998887764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=290.11 Aligned_cols=239 Identities=25% Similarity=0.289 Sum_probs=192.5
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++.|.....+|.|+|+.|-.+.. .+++..+||++.... ..-.+|+.++... .||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 45677777899999999988875 478899999987652 2234466555555 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe-CCCCcEEEeeeccccccCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL-DENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill-~~~~~~kl~Dfgla~~~~~~~ 656 (791)
.+.||-+.+.+..... ...++..|+.+|+.|+.||| +.+|||||+||+|||+ ++.++++|+|||.++...+.
T Consensus 397 ~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH----~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH----EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH----hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999999888876653 22677789999999999999 7899999999999999 69999999999999877554
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
....+-|..|.|||++....|++++|+||+|+++|+|++|+.||.....+.. +.. .+. .+
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-i~~----~i~-------~~---- 529 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-IHT----RIQ-------MP---- 529 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-HHH----hhc-------CC----
Confidence 1223457889999999999999999999999999999999999976433311 111 000 00
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....++..+.+++..||+.||.+||+|.++..
T Consensus 530 -----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 530 -----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -----ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 011355677889999999999999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=251.92 Aligned_cols=277 Identities=21% Similarity=0.333 Sum_probs=205.3
Q ss_pred ccccCCCCChhHHHHHhhccccccccCCCcceEEEEEE-ecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CCccce
Q 003855 484 PLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIK 561 (791)
Q Consensus 484 ~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~ 561 (791)
|...|............++|++++++|+|.|++||.|. ..+.+.++||+++.-.. +.+.+|+.+++.++ ||||++
T Consensus 21 p~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~ 97 (338)
T KOG0668|consen 21 PREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIK 97 (338)
T ss_pred chhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeee
Confidence 33444444444444456899999999999999999998 45788999999975533 46778999999997 999999
Q ss_pred eeeeeccC--CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-C
Q 003855 562 ILSSCSNP--DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-N 638 (791)
Q Consensus 562 l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-~ 638 (791)
+++...++ ..+.+||||+.+.+....-.. +....+...+.++++||.|+| ++||+|||+||.|+++|. .
T Consensus 98 L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCH----S~GImHRDVKPhNvmIdh~~ 169 (338)
T KOG0668|consen 98 LLDIVKDPESKTPSLIFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCH----SMGIMHRDVKPHNVMIDHEL 169 (338)
T ss_pred hhhhhcCccccCchhHhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHH----hcCcccccCCcceeeechhh
Confidence 99999775 456899999999877665433 566778889999999999999 899999999999999994 5
Q ss_pred CcEEEeeeccccccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHH
Q 003855 639 MAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRW 717 (791)
Q Consensus 639 ~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 717 (791)
-..+++|+|+|.++.++... ...+.+..|.-||.+.+ ..|+.+-|+|||||++.+|+..+.||-........+.+.
T Consensus 170 rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI 246 (338)
T KOG0668|consen 170 RKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI 246 (338)
T ss_pred ceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH
Confidence 67999999999999876543 34567888999998755 568999999999999999999999985432222222222
Q ss_pred HHHhcCCChhh-------hcchhhhh--------hHHhhH---HHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 718 VKESLPHGLTE-------VVDANLVR--------EEQAFS---AKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 718 ~~~~~~~~~~~-------~~d~~~~~--------~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+-.....+.. .+|+.+.. .-..+. ...-..+++.+++.+.+..|-++|||++|++.
T Consensus 247 akVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 247 AKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 21111111111 12222211 000110 01113477889999999999999999999875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-33 Score=282.47 Aligned_cols=243 Identities=25% Similarity=0.378 Sum_probs=194.3
Q ss_pred ccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCC
Q 003855 506 CNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNG 582 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 582 (791)
.+.+|.|.||+||-|+.+ +|+.||||++.+-. .+....+.+|+.++++++||.||.+--.|+.++..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 368999999999999864 89999999997643 344577889999999999999999999999999999999999554
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC---CCcEEEeeeccccccCCCCCcc
Q 003855 583 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE---NMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 583 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
=|.-.+.+....+++....-++.||+.||.||| .++|+|+||||+|||+.+ -.++||||||+||++++..
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH----~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--- 721 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH----FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--- 721 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh----hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence 444445556667888888889999999999999 678999999999999964 3579999999999987543
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....+||+.|+|||++..+.|...-|+||.|||+|--+.|.-||.+. .++.+-++. ..+..
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIndQIQN-----------AaFMy--- 783 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDINDQIQN-----------AAFMY--- 783 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhHHhhc-----------ccccc---
Confidence 334578999999999999999999999999999999999999998652 222221111 11110
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAA 773 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~ 773 (791)
....+.++.....++|...++..-.+|-+..+.+
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1123446667778888888888888887776543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=273.22 Aligned_cols=221 Identities=19% Similarity=0.142 Sum_probs=176.0
Q ss_pred CcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCHHHHHhh
Q 003855 512 GSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYS 590 (791)
Q Consensus 512 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 590 (791)
|.||.||+++.. +++.||+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999965 78999999986543 223344555556799999999999999999999999999999999976
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccc
Q 003855 591 HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGY 670 (791)
Q Consensus 591 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y 670 (791)
.. .+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y 148 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALH----REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY 148 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence 54 3899999999999999999999 6789999999999999999999999999886654321 123456789
Q ss_pred cCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHH
Q 003855 671 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILS 750 (791)
Q Consensus 671 ~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 750 (791)
+|||......++.++||||+|+++|||++|+.|+........ ...... .+..++..
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------~~~~~~---------~~~~~~~~ 204 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------THTTLN---------IPEWVSEE 204 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------cccccC---------CcccCCHH
Confidence 999999888899999999999999999999988653211000 000000 01123456
Q ss_pred HHHHHhhccccCCCCCCCHHH
Q 003855 751 IMDLALDCCIESPDMRINVTD 771 (791)
Q Consensus 751 l~~li~~cl~~~P~~RPt~~e 771 (791)
+.+++.+|++.||++||++.+
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCc
Confidence 789999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=291.37 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=204.6
Q ss_pred HhhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeec-----cCCe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCS-----NPDF 571 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-----~~~~ 571 (791)
-++.|++.+.||+|.+|.||+++. ++++.+|+|+....... .++++.|.++++.. +|||++.++|++. .++.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 356789999999999999999984 58899999998766433 36677899999888 7999999999984 4688
Q ss_pred eeEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 572 KALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
.|+|||||.+||..|.++.- +..+.|..+..|++.++.|+.||| ...++|||||-.|||++.++.||++|||.+.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH----~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH----NNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh----hcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 99999999999999999843 556899999999999999999999 5679999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCC-----CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG 725 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (791)
.+... .......+||+.|||||++.- ..|+..+|+||+|++..||.-|.+|+-++.+....+. ++..
T Consensus 172 QldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~------IpRN 243 (953)
T KOG0587|consen 172 QLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------IPRN 243 (953)
T ss_pred eeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc------CCCC
Confidence 76432 223445689999999997643 3477799999999999999999999987765432110 1111
Q ss_pred hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 726 ~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. +...-.+.....++.++|..|+..|-+.||++.++++
T Consensus 244 P-----------PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 244 P-----------PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred C-----------CccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0 0111223456788999999999999999999998764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=281.86 Aligned_cols=207 Identities=23% Similarity=0.375 Sum_probs=176.5
Q ss_pred hccccccccCCCcceEEEEEE-ecCCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.-|..++.||-|+||+|+.++ .++...||.|.+.+.. +.+....+.|-.+|...+.+.||+++..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 347888999999999999997 4466779999987664 566778899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC---
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG--- 653 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~--- 653 (791)
+|++||++-.+|...+. +++.-...++..++.|+++.| ..|+|||||||+|||||.+|++||+|||+++-+.
T Consensus 709 dYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVH----kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHH----hccceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999999999987765 566666667889999999999 8999999999999999999999999999996332
Q ss_pred ------CCCCc-------------------------------ceeecccccccccCCCccCCCCCCccccHHhHHHHHHH
Q 003855 654 ------EGEDS-------------------------------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLME 696 (791)
Q Consensus 654 ------~~~~~-------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~e 696 (791)
.+... ......+||..|+|||++....|+..+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 11000 00123479999999999999999999999999999999
Q ss_pred HHhCCCCCCccccCcc
Q 003855 697 TFTRKRPTDEMFTGEM 712 (791)
Q Consensus 697 lltg~~p~~~~~~~~~ 712 (791)
|+.|+.||....+++.
T Consensus 864 m~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGET 879 (1034)
T ss_pred HhhCCCCccCCCCCcc
Confidence 9999999987666654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=245.18 Aligned_cols=214 Identities=27% Similarity=0.345 Sum_probs=172.5
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.++...+..||+|++|.|-+-++ .+|+..|||.+.... .+..+....|+.+..+. .+|.+|.++|...+....++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 34555667899999999988875 489999999987554 23345566677766554 7999999999999999999999
Q ss_pred ecCCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 577 EFMPNGSLEKWLY---SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 577 e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
|.|.. ||..+-. ..+...++.-+-+||..+.+||.|||+ ...++|||+||+|||++.+|+||+||||.+..+.
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~---kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS---KLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH---HhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99954 8776654 456668999999999999999999995 5679999999999999999999999999998764
Q ss_pred CCCCcceeecccccccccCCCccCC----CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHH
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSE----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 720 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 720 (791)
+ +...+...|-..|||||.+.. ..|+-|+||||+|+++.||.+++.||+........+.+.+..
T Consensus 201 d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 201 D---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred h---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 3 333444567778999997543 468999999999999999999999998765555555554443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=278.97 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=198.5
Q ss_pred hccccccccCCCcceEEEEEEecCCc-EEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGT-DVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.+++.+..+|-|+||.|-.++.+... .+|+|++++.. .++.+.+..|-.+|.+.+.|.||+++-.|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45667788999999999998876433 48888886542 455677888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
|-|-||.++..++.++. ++..+..-++..+.+|++||| +++||+|||||+|.++|.+|-+||.|||+|+.+..+.
T Consensus 500 EaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH----~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH----RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH----hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999998776 677777778889999999999 7899999999999999999999999999999887654
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
. .-..+||+.|.|||++..+..+.++|.||+|+++|||++|.+||.+..+. ..+....+ ++..
T Consensus 575 K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-ktYn~ILk-----Gid~-------- 637 (732)
T KOG0614|consen 575 K---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-KTYNLILK-----GIDK-------- 637 (732)
T ss_pred c---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHh-----hhhh--------
Confidence 3 22367999999999999999999999999999999999999999874322 11111111 1110
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCC
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRIN 768 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt 768 (791)
..-+..+++...++|++.+..+|.+|..
T Consensus 638 ----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 ----IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ----hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1112345567789999999999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=258.60 Aligned_cols=247 Identities=20% Similarity=0.267 Sum_probs=198.6
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 574 (791)
.++|+..++||+|+|+.|-.++++ +.+.+|+|+++++. .+.....+.|..+..+. +||.+|.+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999864 78889999998764 44566778888888887 79999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
|.||++||+|--+++.++. ++++...-+...|.-||.||| +++|++||+|..|||+|..|++|++|||+++.--.
T Consensus 329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh----~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh----hcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999999888876655 888888889999999999999 78999999999999999999999999999975322
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCcc--ccCcchHHHHHHHhcCCChhhhcch
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM--FTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
.. ...+..+||+.|.|||++.+..|...+|+|++||+++||+.|+.||+.. ...++...++.-+.+
T Consensus 404 ~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi---------- 471 (593)
T KOG0695|consen 404 PG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI---------- 471 (593)
T ss_pred CC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH----------
Confidence 22 2334568999999999999999999999999999999999999999853 333443333332221
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRI 767 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 767 (791)
.+..-+.+. ..+-....++..-+++||.+|.
T Consensus 472 --lekqiripr--slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 472 --LEKQIRIPR--SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --hhhcccccc--eeehhhHHHHHHhhcCCcHHhc
Confidence 111111111 1123345788888999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=264.05 Aligned_cols=238 Identities=31% Similarity=0.372 Sum_probs=192.8
Q ss_pred cceEEEEEEec-CCcEEEEEEeehhhhHH-HHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCHHHHHhh
Q 003855 513 SFGSVYKGTIS-DGTDVAIKIFNLQLERA-FRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYS 590 (791)
Q Consensus 513 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 590 (791)
+||.||+|... +++.||+|++....... .+.+.+|++.+++++|+|++++++++......++|+||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 58999999987655433 67889999999999999999999999998999999999999999999986
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccc
Q 003855 591 HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGY 670 (791)
Q Consensus 591 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y 670 (791)
... +++..+..++.++++++.||| ..+++|+||+|+||++++++.++++|||.+....... ......++..|
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH----SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH----HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 554 889999999999999999999 6789999999999999999999999999998765432 22234578899
Q ss_pred cCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHH
Q 003855 671 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILS 750 (791)
Q Consensus 671 ~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 750 (791)
+|||......++.++||||||+++|++++|..||......+ ...++........ ......++.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~~---------------~~~~~~~~~~ 216 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIGKPKPPF---------------PPPEWKISPE 216 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCCCC---------------ccccccCCHH
Confidence 99999888889999999999999999999999986531111 1111111100000 0000004467
Q ss_pred HHHHHhhccccCCCCCCCHHHHHH
Q 003855 751 IMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 751 l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=296.56 Aligned_cols=258 Identities=22% Similarity=0.241 Sum_probs=168.9
Q ss_pred HhhccccccccCCCcceEEEEEEec-C----CcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeee------ec
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-D----GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSS------CS 567 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~ 567 (791)
..++|+..+.||+|+||.||+|+.. + +..||||++...... +....+ .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999975 4 689999987543211 111111 1222223333322222 24
Q ss_pred cCCeeeEEEecCCCCCHHHHHhhCCCCC-------------------CHHHHHHHHHHHHHHHHHHHccCCCCCeEecCC
Q 003855 568 NPDFKALVLEFMPNGSLEKWLYSHNYFL-------------------DILERLNIMIDVGSALEYLHHGHSSAPIIHCDL 628 (791)
Q Consensus 568 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dl 628 (791)
.....++||||+++++|.+++....... ....+..++.|++.||+||| +.+|+||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH----~~gIiHRDL 281 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH----STGIVHRDV 281 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH----HCCEEeCcC
Confidence 5667899999999999999997543211 12345679999999999999 678999999
Q ss_pred CCCCeEeCC-CCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCC----------------------CCCccc
Q 003855 629 KPTNILLDE-NMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG----------------------IVSAKC 685 (791)
Q Consensus 629 k~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~ 685 (791)
||+|||+++ ++.+||+|||+|+.+...... ......++++|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999985 689999999999866433222 22334688999999954321 234567
Q ss_pred cHHhHHHHHHHHHhCCCCCCcccc--------CcchHHHHHHHhcCCChhhhcchhhhhh-HHhhHHHHHHHHHHHHHHh
Q 003855 686 DVYSYGVLLMETFTRKRPTDEMFT--------GEMSLRRWVKESLPHGLTEVVDANLVRE-EQAFSAKMDCILSIMDLAL 756 (791)
Q Consensus 686 Dv~s~G~vl~elltg~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~~~l~~li~ 756 (791)
|||||||++|||+++..|++.... .......|... +.+....+ ...+...........+++.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL---------VEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh---------hccccchhhhhhhhhccccchHHHHHHH
Confidence 999999999999997766543100 00111122111 11110000 0000000011233558999
Q ss_pred hccccCCCCCCCHHHHHH
Q 003855 757 DCCIESPDMRINVTDAAA 774 (791)
Q Consensus 757 ~cl~~~P~~RPt~~ev~~ 774 (791)
+|++.||++|||+.|+++
T Consensus 432 ~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 432 SMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHccCCcccCCCHHHHhC
Confidence 999999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=283.21 Aligned_cols=257 Identities=23% Similarity=0.252 Sum_probs=180.0
Q ss_pred HhhccccccccCCCcceEEEEEEe-----------------cCCcEEEEEEeehhhhHHHH--------------HHHHH
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTI-----------------SDGTDVAIKIFNLQLERAFR--------------SFDSE 547 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~e 547 (791)
..++|++.++||+|+||+||+|.. ..++.||||.+........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467999999999999999999964 23568999998654322222 23447
Q ss_pred HHHHHhccCCcc-----ceeeeeecc--------CCeeeEEEecCCCCCHHHHHhhCC----------------------
Q 003855 548 CEVLRNVRHRNL-----IKILSSCSN--------PDFKALVLEFMPNGSLEKWLYSHN---------------------- 592 (791)
Q Consensus 548 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------- 592 (791)
+.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677777643 356799999999999999987421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeeccccccccc
Q 003855 593 -YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYM 671 (791)
Q Consensus 593 -~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~ 671 (791)
..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++........ ......+++.|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH----~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH----RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 12456778899999999999999 678999999999999999999999999999765433221 111223478999
Q ss_pred CCCccCCCC----------------------CCccccHHhHHHHHHHHHhCCC-CCCccccCc-------chHHHHHHHh
Q 003855 672 APEYGSEGI----------------------VSAKCDVYSYGVLLMETFTRKR-PTDEMFTGE-------MSLRRWVKES 721 (791)
Q Consensus 672 aPE~~~~~~----------------------~~~~~Dv~s~G~vl~elltg~~-p~~~~~~~~-------~~~~~~~~~~ 721 (791)
|||.+.... ...+.||||+||+++||++|.. |+....... .....|....
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 999765322 1134799999999999999875 664321111 1111221100
Q ss_pred cCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCC---CCCCCHHHHHH
Q 003855 722 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESP---DMRINVTDAAA 774 (791)
Q Consensus 722 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P---~~RPt~~ev~~ 774 (791)
.. ...++..........+++.+++..+| .+|+|++|+++
T Consensus 458 ~~--------------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQ--------------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cc--------------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00 00111112344667799999999766 68999999985
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-33 Score=305.71 Aligned_cols=387 Identities=29% Similarity=0.392 Sum_probs=241.3
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccC
Q 003855 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSI 82 (791)
Q Consensus 3 g~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 82 (791)
|+.|..+..+.+|+.|+++.|-|. ..|.+..++.+|++|.|.+|++. .+|..+.. +.+|+.|+++.|++. ..|..+
T Consensus 58 ~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~-lknl~~LdlS~N~f~-~~Pl~i 133 (1081)
T KOG0618|consen 58 SSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISE-LKNLQYLDLSFNHFG-PIPLVI 133 (1081)
T ss_pred ccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHh-hhcccccccchhccC-CCchhH
Confidence 344555555555555555555554 33455555555555555555554 55555544 455555555555555 334333
Q ss_pred cCCCC-------------------CCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCC
Q 003855 83 TNATK-------------------LVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRN 143 (791)
Q Consensus 83 ~~l~~-------------------L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~ 143 (791)
..++. .+.++|..|.+.+.....+..+.+ .|+|++|.+..+. +..+++
T Consensus 134 ~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~d-----------ls~~~~ 200 (1081)
T KOG0618|consen 134 EVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVLD-----------LSNLAN 200 (1081)
T ss_pred HhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhhhh-----------hhhccc
Confidence 33333 334444444444444445555544 5777777776332 555666
Q ss_pred CcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcc
Q 003855 144 LTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLR 223 (791)
Q Consensus 144 L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 223 (791)
|+.|....|++..... .-++|+.|+.++|.+....+.. .-.+|+++++++|++++ .|+++..+.+|+.|+..
T Consensus 201 l~~l~c~rn~ls~l~~-----~g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n 272 (1081)
T KOG0618|consen 201 LEVLHCERNQLSELEI-----SGPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLSN-LPEWIGACANLEALNAN 272 (1081)
T ss_pred hhhhhhhhcccceEEe-----cCcchheeeeccCcceeecccc--ccccceeeecchhhhhc-chHHHHhcccceEeccc
Confidence 6666666666653211 1134566666666665322221 12456666666666663 33666666666666666
Q ss_pred cccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCc----------------------
Q 003855 224 NNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPS---------------------- 281 (791)
Q Consensus 224 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~---------------------- 281 (791)
+|+|+ .+|..+...++|+.|++.+|.+. -+|.....+++|++|+|..|+|....+.
T Consensus 273 ~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~l 350 (1081)
T KOG0618|consen 273 HNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTL 350 (1081)
T ss_pred chhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccc
Confidence 66664 55555555566666666666665 4444455556666666666665422111
Q ss_pred ---cccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCC
Q 003855 282 ---SLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSL 358 (791)
Q Consensus 282 ---~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 358 (791)
.=..+..|+.|++.+|.+++..-..+.+.++|+.|+|++|+|.......+.++..|++|+||+|+++ .+|..+..+
T Consensus 351 p~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~ 429 (1081)
T KOG0618|consen 351 PSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANL 429 (1081)
T ss_pred ccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhh
Confidence 1112345677888888888877777888889999999999998555556788889999999999998 788888889
Q ss_pred CCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccC-CCCCCCcCCccccccCCccc
Q 003855 359 ISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEI-PVKGSFKNFSVESFFGNYAL 419 (791)
Q Consensus 359 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~-~~~~~~~~l~~~~~~~n~~~ 419 (791)
+.|++|...+|++. ..| .+..++.|+.+|++.|+|+... |....+++|+.+.+.||.+.
T Consensus 430 ~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 430 GRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 99999999889888 666 7888899999999999987643 44445578888888898863
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=286.85 Aligned_cols=244 Identities=29% Similarity=0.449 Sum_probs=188.8
Q ss_pred cccccccCCCcce-EEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEecCC
Q 003855 503 FNECNLLGTGSFG-SVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 503 ~~~~~~ig~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
|...+.+|.|+-| .||+|.+ +|+.||||++-.. ......+|+..++.- +|||||++++.-.++...|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 3344678999987 5799999 6889999987533 334567899999988 69999999999999999999999995
Q ss_pred CCCHHHHHhhCCC--C-CCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC---C--CcEEEeeecccccc
Q 003855 581 NGSLEKWLYSHNY--F-LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE---N--MAAHVSDFGISKLL 652 (791)
Q Consensus 581 ~g~L~~~l~~~~~--~-~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~---~--~~~kl~Dfgla~~~ 652 (791)
.+|.+++..... . ........+..|+++||+||| +.+||||||||.||||+. + ..++|+|||+++.+
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH----sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH----SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH----hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 599999987411 1 111445678899999999999 678999999999999975 3 46899999999998
Q ss_pred CCCCCcc-eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhC-CCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 653 GEGEDSV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 653 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
..+..+. ......||.||+|||.+....-+.++||||+|||+|+.++| ..||......+..+.. +.....
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------GNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--------Ccccee
Confidence 7665443 34456799999999999998888999999999999999995 8899875443322111 000000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+ ....++ +..++|.+|++++|..||++.+|+.
T Consensus 734 --~L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 --HL-------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --ee-------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 001122 6779999999999999999999973
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=246.16 Aligned_cols=265 Identities=24% Similarity=0.288 Sum_probs=191.0
Q ss_pred cccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC-----CeeeE
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP-----DFKAL 574 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~l 574 (791)
.+-.+.||-|+||+||..... +|+.||.|++..-. -...+.+.+|..++..++|.|++..++...-+ .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344568999999999999864 89999999875432 22346778899999999999999999876543 24567
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
|+|.|. .+|...+-+.. .++...+.-+++||++||.||| +.+|.||||||.|.|++++-..||||||+|+....
T Consensus 135 ~TELmQ-SDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH----sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH----TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHH-hhhhheeccCC-CCCcchhhhhHHHHHhhhHHHh----hcchhhccCCCccEEeccCceEEecccccccccch
Confidence 888884 37777665443 4788888899999999999999 78999999999999999999999999999997644
Q ss_pred CCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
. ....++..+.|..|+|||++++ ..|+.+.||||.|||+.|++.++.-|....+- ...+.+.........+.....
T Consensus 209 d-~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 209 R-DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred h-hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHhCCCcHHHHHHH
Confidence 3 3445666788999999998877 56999999999999999999988776542221 111222221111100000000
Q ss_pred hh-------hhH---------HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 734 LV-------REE---------QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 734 ~~-------~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
.. +.. ...........+...+...++..||++|.+..+++..+
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 00 000 00111112224456788899999999999999887654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-32 Score=294.40 Aligned_cols=384 Identities=26% Similarity=0.289 Sum_probs=304.0
Q ss_pred CCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEE
Q 003855 12 LQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVAL 91 (791)
Q Consensus 12 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 91 (791)
.-+|+.||+|+|++. ..|..+..+.+|+.|+++.|.|+ ++|..... +.+|++|.|.+|.+. ..|..+..+++|++|
T Consensus 44 ~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~-~~~l~~lnL~~n~l~-~lP~~~~~lknl~~L 119 (1081)
T KOG0618|consen 44 RVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSN-MRNLQYLNLKNNRLQ-SLPASISELKNLQYL 119 (1081)
T ss_pred eeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhh-hhcchhheeccchhh-cCchhHHhhhccccc
Confidence 344999999999997 77999999999999999999999 99988887 899999999999999 799999999999999
Q ss_pred eccCccccccccccccccccccccccccc-cccccCCCc----------cccccccccCCCCCCcEEEccCCCCcccCCh
Q 003855 92 DLGFNSFAGHILNTFGNLRHLSLLSQVMN-NLTTESSSA----------DQWSFLSSLTNCRNLTILSFGSNPLGGILPP 160 (791)
Q Consensus 92 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~----------~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 160 (791)
|+|+|++. ..|..+..+..++.+..++| ++..++... -...++.++..+.+ .|+|++|.+. ..
T Consensus 120 dlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~-- 193 (1081)
T KOG0618|consen 120 DLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VL-- 193 (1081)
T ss_pred ccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh-hh--
Confidence 99999998 55667777778888888877 222221111 00122333444444 5999999987 22
Q ss_pred hhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCC
Q 003855 161 VIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240 (791)
Q Consensus 161 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 240 (791)
.......|+.+....|++.... -..++|+.|+.++|.++...+ . ..-.+|+++|+++|+++ .+|++++.+.+
T Consensus 194 -dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~-~-p~p~nl~~~dis~n~l~-~lp~wi~~~~n 265 (1081)
T KOG0618|consen 194 -DLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDV-H-PVPLNLQYLDISHNNLS-NLPEWIGACAN 265 (1081)
T ss_pred -hhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecc-c-cccccceeeecchhhhh-cchHHHHhccc
Confidence 1223356899999999988433 234789999999999984332 2 23468999999999999 67799999999
Q ss_pred CceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCccc-cc----------
Q 003855 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QK---------- 309 (791)
Q Consensus 241 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~-~~---------- 309 (791)
|+.++..+|+++ .+|..+..+++|+.|.+.+|.+. -+|....+++.|++|+|..|+|.. .|+.+ ..
T Consensus 266 le~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~ 342 (1081)
T KOG0618|consen 266 LEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNV 342 (1081)
T ss_pred ceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccc-cchHHHhhhhHHHHHHhh
Confidence 999999999997 78899999999999999999998 677788889999999999999974 44322 11
Q ss_pred ---------------CCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCC
Q 003855 310 ---------------LKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGK 374 (791)
Q Consensus 310 ---------------l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 374 (791)
++.|+.|++.+|.+++..-..+.+.++|+.|+|++|++.......+.++..|+.|+||+|+++ .
T Consensus 343 s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~ 421 (1081)
T KOG0618|consen 343 SSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-T 421 (1081)
T ss_pred hhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-h
Confidence 224677888888888766667788888888888888888444445678888888888888888 7
Q ss_pred CchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCcc
Q 003855 375 IPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYA 418 (791)
Q Consensus 375 ~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~ 418 (791)
+|..+..++.|++|...+|++.+.| ....++.++++++.-|..
T Consensus 422 Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L 464 (1081)
T KOG0618|consen 422 LPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNL 464 (1081)
T ss_pred hhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchh
Confidence 7788888888888888888888766 666777777777776654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=245.32 Aligned_cols=130 Identities=27% Similarity=0.366 Sum_probs=111.6
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-----C---Cccceeeeeec----
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-----H---RNLIKILSSCS---- 567 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~---- 567 (791)
.+|.+.++||.|.|++||.|.. .+.+.||+|+.+.. ....+....|++++++++ | ..||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6899999999999999999985 46788999998755 334466788999999983 3 36999999984
Q ss_pred cCCeeeEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe
Q 003855 568 NPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL 635 (791)
Q Consensus 568 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill 635 (791)
.+.+++||+|++ |.+|..+|... -+.++...+.+|++||+.||.|||..| +|+|-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeee
Confidence 567999999999 77999999854 345999999999999999999999754 79999999999999
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=236.18 Aligned_cols=210 Identities=35% Similarity=0.513 Sum_probs=182.7
Q ss_pred cCCCcceEEEEEEec-CCcEEEEEEeehhhhH-HHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCHHH
Q 003855 509 LGTGSFGSVYKGTIS-DGTDVAIKIFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEK 586 (791)
Q Consensus 509 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 586 (791)
||+|.+|.||++... +++.+++|++...... ..+.+.+|+..++.+.|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999975 4899999998766432 35678899999999999999999999999899999999999999999
Q ss_pred HHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-CCcEEEeeeccccccCCCCCcceeeccc
Q 003855 587 WLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-NMAAHVSDFGISKLLGEGEDSVTQTMTM 665 (791)
Q Consensus 587 ~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 665 (791)
++......+++..+..++.++++++.||| ..+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH----SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 99876445899999999999999999999 678999999999999999 89999999999987654321 122244
Q ss_pred ccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHH
Q 003855 666 ATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAK 744 (791)
Q Consensus 666 g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 744 (791)
+...|++||..... .++.++|+|++|++++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 67889999988776 888999999999999999
Q ss_pred HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 745 MDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 745 ~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 235689999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-29 Score=255.58 Aligned_cols=196 Identities=23% Similarity=0.357 Sum_probs=168.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHH-----HHHHHHHHHHHHhcc---CCccceeeeeecc
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERA-----FRSFDSECEVLRNVR---HRNLIKILSSCSN 568 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~-----~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 568 (791)
.+|...+.+|.|+||.|+.|.++ +...|+||.+.++. ..+ ....-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46888999999999999999986 56779999887653 111 123556999999997 9999999999999
Q ss_pred CCeeeEEEecC-CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeec
Q 003855 569 PDFKALVLEFM-PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFG 647 (791)
Q Consensus 569 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 647 (791)
.+..|++||-. ++-+|.+++..+.. +++.+...|.+||+.|+++|| +.+|||||||-+||.++.+|.+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh----~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH----DQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc----ccCceecccccccEEEecCCeEEEeecc
Confidence 99999999985 45699999986554 899999999999999999999 7899999999999999999999999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCCCCCC-ccccHHhHHHHHHHHHhCCCCCC
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVS-AKCDVYSYGVLLMETFTRKRPTD 705 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~G~vl~elltg~~p~~ 705 (791)
.|.....+. ....+||.+|.|||++.+..|- ..-|||++|+++|.++....||.
T Consensus 716 saa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998765443 3345799999999999887764 45899999999999999999974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=235.96 Aligned_cols=259 Identities=24% Similarity=0.280 Sum_probs=193.4
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc------CC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN------PD 570 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 570 (791)
..+|.....+|.|.- .|..|... .++.||+|...... ....+...+|..++..+.|+||++++.++.- -.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788999988 66666543 68899999764432 3345666789999999999999999998842 34
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..|+|||+| .++|.+.+.-. ++-.++..|.+|++.|+.||| +.+|+||||||+||++..+..+||.|||+|+
T Consensus 95 e~y~v~e~m-~~nl~~vi~~e---lDH~tis~i~yq~~~~ik~lh----s~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILME---LDHETISYILYQMLCGIKHLH----SAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHHh---cchHHHHHHHHHHHHHHHHHH----hcceeecccCcccceecchhheeeccchhhc
Confidence 678999999 55999988832 677889999999999999999 7899999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC-hhhh
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG-LTEV 729 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 729 (791)
.-... ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|. ++..+.+|.+....-+ ..+-
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHH
Confidence 64332 34455678999999999888889999999999999999999998765 4556666654321111 0000
Q ss_pred cchhhh----------hhHH------h-----hH----HHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 VDANLV----------REEQ------A-----FS----AKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 ~d~~~~----------~~~~------~-----~~----~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+...+. .++. . ++ ...--...+.+++.+||-.+|++|.++.++++
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000000 0000 0 00 00011245778999999999999999999975
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=250.75 Aligned_cols=364 Identities=24% Similarity=0.243 Sum_probs=257.7
Q ss_pred CCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccC-CcceecCCccCcCCCCCCEEe
Q 003855 14 NLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAA-NNLTGIIPHSITNATKLVALD 92 (791)
Q Consensus 14 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ 92 (791)
.-.+++|..|+|+.++|.+|..+.+||.||||+|.|+ .|-+..|.++++|..|-+.+ |+|+.+..+.|++|..|+.|.
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 5678999999999999999999999999999999998 77777778899988877766 999988888999999999999
Q ss_pred ccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcc------------cCC-
Q 003855 93 LGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGG------------ILP- 159 (791)
Q Consensus 93 L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~------------~~~- 159 (791)
+.-|++..+..++|..|++|..|.+.+|.+..+.... |..+..++.+.+..|.+.. ..|
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~t--------f~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~i 218 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGT--------FQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPI 218 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhhhhcccc--------ccchhccchHhhhcCccccccccchhhhHHhhchh
Confidence 9999999999999999999999999999999887655 7788888888888777221 111
Q ss_pred -----------------------hhhhhhhhhhhhhhcccccccccCCc-cccCCCCCCEEEccCCccccccCccccCCC
Q 003855 160 -----------------------PVIGNFSASLQKFYAYECKLKGNIPQ-EIGNLSGLTLLSLHSNDLNGTISPTMGRLK 215 (791)
Q Consensus 160 -----------------------~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 215 (791)
..+.....++..-....+....+-|. .|..+++|+.|+|++|.|+.+.+.+|.++.
T Consensus 219 etsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a 298 (498)
T KOG4237|consen 219 ETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAA 298 (498)
T ss_pred hcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchh
Confidence 11111111222223344444444443 578888888888888888888888888888
Q ss_pred CCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCC-----CCCccc-------
Q 003855 216 RLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS-----SIPSSL------- 283 (791)
Q Consensus 216 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-----~~~~~~------- 283 (791)
.+++|.|..|+|..+....|.++..|+.|+|++|+|+...|.+|..+.+|.+|+|-.|.+.- .+.+++
T Consensus 299 ~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~ 378 (498)
T KOG4237|consen 299 ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVG 378 (498)
T ss_pred hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCC
Confidence 88888888888887667778888888888888888887778888888888888888777641 001111
Q ss_pred ----cCCCCCCeEEccCCcCcc---cCCccccc---------CCCCC-EEecCCcccCCCCCcchhcccccccccccccc
Q 003855 284 ----WSLEYILDINLSSNSLND---SLPSNVQK---------LKVLT-VLDLSRNQLSGDIPSTIGALKDLETLSLARNQ 346 (791)
Q Consensus 284 ----~~l~~L~~L~l~~N~i~~---~~~~~~~~---------l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 346 (791)
.....++.+.++.+.+.+ ..|++.+. ++-+. ....|++.++ .+|..+ -....+|++.+|.
T Consensus 379 ~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~i--P~d~telyl~gn~ 455 (498)
T KOG4237|consen 379 NPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGI--PVDVTELYLDGNA 455 (498)
T ss_pred CCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCC--CchhHHHhcccch
Confidence 112244555555554422 12221111 11122 2223333333 444322 2345677777887
Q ss_pred CCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCC
Q 003855 347 FQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHN 393 (791)
Q Consensus 347 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 393 (791)
++ .+|.. .+.+| .+|+++|+|+..-...|.++.+|.+|-+++|
T Consensus 456 ~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 456 IT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 77 66665 55666 7788888877666667777777777777765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-29 Score=263.03 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=203.9
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
++|+....+|.|+||.|||++.. .++..|||+++-.....+....+|+-+++..+||||+.++|.+...+..++.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 67888999999999999999964 78999999999888888888999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
.+|+|++.-+- ...+++.++..+++...+|++||| +.+-+|||||-.||++++.|.+|++|||.+..+.... .
T Consensus 95 gggslQdiy~~-TgplselqiayvcRetl~gl~ylh----s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~ 167 (829)
T KOG0576|consen 95 GGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLH----SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--A 167 (829)
T ss_pred CCCcccceeee-cccchhHHHHHHHhhhhccchhhh----cCCcccccccccceeecccCceeecccCchhhhhhhh--h
Confidence 99999985443 345889999999999999999999 7889999999999999999999999999997765432 2
Q ss_pred eeecccccccccCCCc---cCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 660 TQTMTMATIGYMAPEY---GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~---~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
......||+.|||||+ ...+.|..++|||+.|+...|+-.-++|.....+... ..... . ...++.-..
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~----l~LmT-k----S~~qpp~lk 238 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA----LFLMT-K----SGFQPPTLK 238 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH----HHHhh-c----cCCCCCccc
Confidence 3344679999999995 4567899999999999999999998888544322211 11100 0 001111111
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
........+.++++.|+..+|++||++...++
T Consensus 239 ------Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 ------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ------CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11234566889999999999999999987765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=233.74 Aligned_cols=199 Identities=29% Similarity=0.431 Sum_probs=172.7
Q ss_pred cccccccCCCcceEEEEEEecC-CcEEEEEEeehhhhH-HHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 503 FNECNLLGTGSFGSVYKGTISD-GTDVAIKIFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
|...+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999764 899999998766544 56788999999999999999999999998899999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+++|.+++......+++..+..++.+++.++.||| ..+++|+|++|+||+++.++.++|+|||.+......... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH----SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L 155 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence 99999999865543789999999999999999999 668999999999999999999999999999877543210 1
Q ss_pred eecccccccccCCCcc-CCCCCCccccHHhHHHHHHHHHhCCCCCCc
Q 003855 661 QTMTMATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTDE 706 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg~~p~~~ 706 (791)
.....++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1223567889999988 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=243.42 Aligned_cols=266 Identities=23% Similarity=0.261 Sum_probs=201.8
Q ss_pred HHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc------CCccceeeeeeccC
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVR------HRNLIKILSSCSNP 569 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~ 569 (791)
+....+|.+....|+|-|++|..|... .|..||||++.... -..+.=..|+++|+++. .-+.++++-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 344578999999999999999999864 57899999997653 33455577999999994 35899999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC-CcEEEeee
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN-MAAHVSDF 646 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~-~~~kl~Df 646 (791)
.++|||||-+ .-+|.+.|.+-+ ..+....+..++.|+.-||.+|. ..+|+|.||||.||||++. ...|||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK----~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK----KCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH----hcCeeecccCccceEeccCcceeeeccC
Confidence 9999999988 459999998543 35788899999999999999998 5689999999999999964 56899999
Q ss_pred ccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHH---------
Q 003855 647 GISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRW--------- 717 (791)
Q Consensus 647 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~--------- 717 (791)
|.|......+.. ....+..|.|||++.+-.|+...|+||.||++||+.||+.-|++.....+ .++
T Consensus 582 GSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M--Lrl~me~KGk~p 655 (752)
T KOG0670|consen 582 GSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM--LRLFMELKGKFP 655 (752)
T ss_pred cccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH--HHHHHHhcCCCc
Confidence 999877654432 22356789999999999999999999999999999999988876433221 111
Q ss_pred ---------HHHhcCCCh---h---------------hhcch------hhhhhHHhhHHHHHHHHHHHHHHhhccccCCC
Q 003855 718 ---------VKESLPHGL---T---------------EVVDA------NLVREEQAFSAKMDCILSIMDLALDCCIESPD 764 (791)
Q Consensus 718 ---------~~~~~~~~~---~---------------~~~d~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~ 764 (791)
...++-..+ . ..+.+ .+................+.+|+..|+..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 111111110 0 00000 11111011122234567789999999999999
Q ss_pred CCCCHHHHHH
Q 003855 765 MRINVTDAAA 774 (791)
Q Consensus 765 ~RPt~~ev~~ 774 (791)
+|.|..++++
T Consensus 736 KRit~nqAL~ 745 (752)
T KOG0670|consen 736 KRITVNQALK 745 (752)
T ss_pred hcCCHHHHhc
Confidence 9999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=223.36 Aligned_cols=256 Identities=20% Similarity=0.267 Sum_probs=190.2
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeee-eccCCeeeEE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSS-CSNPDFKALV 575 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv 575 (791)
..+.|.+.+.+|+|.||.+-.++++ ..+.+++|.+..... ..++|.+|...--.+ .|.||+.-++. |+..+...++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3477999999999999999999976 678899998865533 246777776655455 59999988764 5677788899
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC--CCCcEEEeeeccccccC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD--ENMAAHVSDFGISKLLG 653 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfgla~~~~ 653 (791)
+||++.|+|.+-+...+ +.+....+++.|++.|+.||| ++.+||||||.+|||+- +...+|+||||+.+..+
T Consensus 101 qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH----sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH----SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh----ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999999887654 777888899999999999999 78999999999999994 44579999999998654
Q ss_pred CCCCcceeecccccccccCCCccCCC-----CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEG-----IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
..... ..-+..|.|||..... ...+.+|||.||++++.++||+.||.........+.+|.+=......
T Consensus 175 ~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 175 TTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred ceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--
Confidence 32221 1235569999964332 25668999999999999999999998655555555555331111110
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
...... ...++.++.+.++-+..+|++|--..++.++...
T Consensus 248 ----~~P~~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 248 ----ALPKKF------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred ----cCchhh------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 111111 1233556788889999999999777777666544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=235.56 Aligned_cols=268 Identities=25% Similarity=0.309 Sum_probs=197.1
Q ss_pred HHHhhccccccccCCCcceEEEEEEec----CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCe
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDF 571 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 571 (791)
....+.|..+++||+|.|++||+|... .++.||+|.+...... ..+..|++++..+ -+.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 344577999999999999999999853 4678999988765433 4578899999999 59999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-CCcEEEeeecccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-NMAAHVSDFGISK 650 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla~ 650 (791)
..+|+||++..+..++... ++...+..+++.+..||.|+| ..|||||||||+|++.+. -+.-.|.|||+|.
T Consensus 110 v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h----~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH----KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh----ccCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999988875 567888999999999999999 789999999999999984 5678999999997
Q ss_pred ccCCC---------------C---------------------------CcceeecccccccccCCCccCC-CCCCccccH
Q 003855 651 LLGEG---------------E---------------------------DSVTQTMTMATIGYMAPEYGSE-GIVSAKCDV 687 (791)
Q Consensus 651 ~~~~~---------------~---------------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv 687 (791)
.+... . ........+||+||+|||++.. ...++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 21100 0 0001223479999999998755 567889999
Q ss_pred HhHHHHHHHHHhCCCCCCccccCcchHHHHHHHh----------cCCC--hh---------------hhcc-hhhhhhHH
Q 003855 688 YSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES----------LPHG--LT---------------EVVD-ANLVREEQ 739 (791)
Q Consensus 688 ~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~~--~~---------------~~~d-~~~~~~~~ 739 (791)
||.|||++.+++++.||-.....-..+...+.-. .+.. +. +-++ ..+.....
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999854333322222221100 0000 00 0010 00110000
Q ss_pred ----hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 740 ----AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 740 ----~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
........+..+++++.+|+..||.+|.|++|+++
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00111223447899999999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=215.13 Aligned_cols=170 Identities=21% Similarity=0.167 Sum_probs=131.7
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|+|.++++..+..+++.++..++.|+++||.||| +.+ ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH----RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----hcC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 7999999876667999999999999999999999 444 999999999999999 99998754321
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
..|++.|+|||++.+..++.++|||||||++|||+||+.||.........+..+............
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------ 129 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR------------ 129 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccc------------
Confidence 257899999999999999999999999999999999999997543333333333322211110000
Q ss_pred HHHHHHH--HHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 742 SAKMDCI--LSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 742 ~~~~~~~--~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
....... .++.+++.+||+.+|++||++.|+++.+..+...
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 0011122 2588999999999999999999999998877544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-28 Score=241.37 Aligned_cols=329 Identities=21% Similarity=0.240 Sum_probs=250.3
Q ss_pred cEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccccccccccccccccccccc
Q 003855 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVM 119 (791)
Q Consensus 40 ~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~ 119 (791)
-..+.++-.++ ++|..+ .+.-..++|..|+|+.++|++|+.+++|++||||+|.|+.+.+++|.+|++|..|-+.+
T Consensus 49 ~~VdCr~~GL~-eVP~~L---P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg 124 (498)
T KOG4237|consen 49 GIVDCRGKGLT-EVPANL---PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYG 124 (498)
T ss_pred ceEEccCCCcc-cCcccC---CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhc
Confidence 45778888888 999875 46889999999999999999999999999999999999999999999999988886666
Q ss_pred -ccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEc
Q 003855 120 -NNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSL 198 (791)
Q Consensus 120 -n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 198 (791)
|+|+.++.++ |.+|..|+.|.+.-|++.. +..+.|..+++|..|.+
T Consensus 125 ~NkI~~l~k~~--------F~gL~slqrLllNan~i~C-------------------------ir~~al~dL~~l~lLsl 171 (498)
T KOG4237|consen 125 NNKITDLPKGA--------FGGLSSLQRLLLNANHINC-------------------------IRQDALRDLPSLSLLSL 171 (498)
T ss_pred CCchhhhhhhH--------hhhHHHHHHHhcChhhhcc-------------------------hhHHHHHHhhhcchhcc
Confidence 8888877665 6666666666666666653 34456777888888888
Q ss_pred cCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCC
Q 003855 199 HSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSS 278 (791)
Q Consensus 199 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 278 (791)
.+|.+..+.-..|..+..++.+.+..|.+- ..++++.+... +. ..|..+++.+......+.++++..+
T Consensus 172 yDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~~-~a------~~~ietsgarc~~p~rl~~~Ri~q~ 239 (498)
T KOG4237|consen 172 YDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLADD-LA------MNPIETSGARCVSPYRLYYKRINQE 239 (498)
T ss_pred cchhhhhhccccccchhccchHhhhcCccc-----cccccchhhhH-Hh------hchhhcccceecchHHHHHHHhccc
Confidence 888888555558888888888888888743 13334333211 11 2334455666666667777777765
Q ss_pred CCccccCC-CCCCeEEccCCcCcccCC-cccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccC
Q 003855 279 IPSSLWSL-EYILDINLSSNSLNDSLP-SNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVG 356 (791)
Q Consensus 279 ~~~~~~~l-~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 356 (791)
.+..|... ..+..-..+.+...++.| ..|..+++|+.|+|++|+|+++-+.+|.++..+++|+|..|+|...-...|.
T Consensus 240 ~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~ 319 (498)
T KOG4237|consen 240 DARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQ 319 (498)
T ss_pred chhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhh
Confidence 55544432 222222222332333333 4688999999999999999988889999999999999999999876677889
Q ss_pred CCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCc
Q 003855 357 SLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNY 417 (791)
Q Consensus 357 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~ 417 (791)
++..|+.|+|.+|+|+..-|.+|..+.+|.+|+|-.|++.|.+...+.-++++..+..||+
T Consensus 320 ~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~ 380 (498)
T KOG4237|consen 320 GLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNP 380 (498)
T ss_pred ccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCC
Confidence 9999999999999999999999999999999999999999888766555566655544443
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=266.57 Aligned_cols=339 Identities=20% Similarity=0.269 Sum_probs=186.4
Q ss_pred CccccCCCCCcEEeCCCCc------CcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccccc
Q 003855 30 PPTIFNISTMRILTLEGNQ------LSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHIL 103 (791)
Q Consensus 30 ~~~~~~l~~L~~L~L~~n~------l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 103 (791)
+.+|.++.+|+.|.+.++. +...+|..+....++|+.|.+.+|.++ .+|..| ...+|+.|+|++|++.. .+
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~-L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK-LW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc-cc
Confidence 3445555555555554332 122344444443344555555555555 344444 24555555555555542 23
Q ss_pred cccccccccccccccccc-ccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhccccccccc
Q 003855 104 NTFGNLRHLSLLSQVMNN-LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN 182 (791)
Q Consensus 104 ~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 182 (791)
..+..+++|+.|+++++. +..++ .+..+++|+.|+|++|.....+|..+..+ .+|+.|++++|...+.
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip----------~ls~l~~Le~L~L~~c~~L~~lp~si~~L-~~L~~L~L~~c~~L~~ 696 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIP----------DLSMATNLETLKLSDCSSLVELPSSIQYL-NKLEDLDMSRCENLEI 696 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCC----------ccccCCcccEEEecCCCCccccchhhhcc-CCCCEEeCCCCCCcCc
Confidence 344555555555555442 22221 24455566666665554444444444433 2355555555443334
Q ss_pred CCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccC-------CCC
Q 003855 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLS-------GHI 255 (791)
Q Consensus 183 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-------~~~ 255 (791)
+|..+ ++++|+.|+|++|......|.. ..+|++|+|++|.++ .+|..+ .+++|+.|++.++... ...
T Consensus 697 Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~ 770 (1153)
T PLN03210 697 LPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLT 770 (1153)
T ss_pred cCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccc
Confidence 45444 5666677777666544333322 346666777777665 444433 4566666666653321 111
Q ss_pred CccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccc
Q 003855 256 PPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALK 335 (791)
Q Consensus 256 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 335 (791)
+..+...++|+.|+|++|.....+|..+.++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|.. ..
T Consensus 771 ~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~ 846 (1153)
T PLN03210 771 PLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---ST 846 (1153)
T ss_pred hhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---cc
Confidence 2222234567777777776655667777777777777777664434555544 5677777777776544344432 35
Q ss_pred cccccccccccCCCCCCcccCCCCCCcEEEccCC-ccCCCCchhhhhcccCceEEccCCC
Q 003855 336 DLETLSLARNQFQGPIPESVGSLISLESLDLSGN-NLSGKIPKSLETLSQLKQFNVSHNR 394 (791)
Q Consensus 336 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~l~l~~N~ 394 (791)
+|+.|+|++|.++ .+|.++..+++|+.|+|++| ++. .+|..+..+++|+.+++++|.
T Consensus 847 nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 847 NISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 6777777777776 56677777777777777764 344 466666677777777777664
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=269.42 Aligned_cols=195 Identities=19% Similarity=0.266 Sum_probs=139.0
Q ss_pred ccC-Cccceeeeee-------ccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEe
Q 003855 554 VRH-RNLIKILSSC-------SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIH 625 (791)
Q Consensus 554 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H 625 (791)
++| +||+++++++ ...+..+.++||+ +++|.+++......+++.++..++.||++||+||| +.+|+|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~gIvH 103 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH----SQGIVV 103 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH----hCCeee
Confidence 455 5888888877 2234567788988 66999999876666999999999999999999999 789999
Q ss_pred cCCCCCCeEeCCC-------------------CcEEEeeeccccccCCCCC--------------cceeecccccccccC
Q 003855 626 CDLKPTNILLDEN-------------------MAAHVSDFGISKLLGEGED--------------SVTQTMTMATIGYMA 672 (791)
Q Consensus 626 ~dlk~~Nill~~~-------------------~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~g~~~y~a 672 (791)
|||||+|||++.. +.+|++|||+++....... .......+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999654 4455666666653211000 001112357889999
Q ss_pred CCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHH
Q 003855 673 PEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIM 752 (791)
Q Consensus 673 PE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~ 752 (791)
||++.+..++.++|||||||++|||++|..|+..... ....+... ...+.. ........
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~--------~~~~~~----------~~~~~~~~ 242 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHR--------VLPPQI----------LLNWPKEA 242 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHh--------hcChhh----------hhcCHHHH
Confidence 9999999999999999999999999999887653111 11111000 000000 01123345
Q ss_pred HHHhhccccCCCCCCCHHHHHH
Q 003855 753 DLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 753 ~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+++.+||+++|.+||+|.|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7888999999999999999975
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=265.51 Aligned_cols=338 Identities=20% Similarity=0.256 Sum_probs=272.8
Q ss_pred ccccCCCCCCeeecCCCc------ccccCCccccCCC-CCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCC
Q 003855 7 TEIGNLQNLQYLVFAENN------LSGLVPPTIFNIS-TMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIP 79 (791)
Q Consensus 7 ~~~~~l~~L~~L~Ls~n~------l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~ 79 (791)
..|.+|++|+.|.+..+. +...+|+.|..++ +|+.|.++++.++ .+|..+. ..+|++|+|++|+|. .++
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f~--~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNFR--PENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcCC--ccCCcEEECcCcccc-ccc
Confidence 458899999999997653 3445788888775 6999999999998 9998864 689999999999999 578
Q ss_pred ccCcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCC
Q 003855 80 HSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILP 159 (791)
Q Consensus 80 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 159 (791)
..+..+++|+.|+|++|......+ .++.+++|+.|++++|..-. .++..+..+++|+.|++++|..-+.+|
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~--------~lp~si~~L~~L~~L~L~~c~~L~~Lp 698 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLV--------ELPSSIQYLNKLEDLDMSRCENLEILP 698 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCcc--------ccchhhhccCCCCEEeCCCCCCcCccC
Confidence 888999999999999876443444 48889999999999875321 234568899999999999986555667
Q ss_pred hhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCc-------ccCC
Q 003855 160 PVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLE-------GSIP 232 (791)
Q Consensus 160 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-------~~~~ 232 (791)
..+ ...+|+.|.+++|......|.. ..+|+.|+|++|.++ ..|..+ .+++|++|++.++... ...+
T Consensus 699 ~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~ 771 (1153)
T PLN03210 699 TGI--NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTP 771 (1153)
T ss_pred CcC--CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccch
Confidence 655 3467999999999877666653 468999999999998 455554 6889999999875432 1222
Q ss_pred ccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCC
Q 003855 233 YDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKV 312 (791)
Q Consensus 233 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~ 312 (791)
..+...++|+.|+|++|.....+|..++++++|+.|+|++|...+.+|..+ .+++|+.|++++|.....+|.. .++
T Consensus 772 ~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~n 847 (1153)
T PLN03210 772 LMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STN 847 (1153)
T ss_pred hhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccc
Confidence 233445789999999998877899999999999999999986555677665 7899999999998765555543 368
Q ss_pred CCEEecCCcccCCCCCcchhcccccccccccc-ccCCCCCCcccCCCCCCcEEEccCCc
Q 003855 313 LTVLDLSRNQLSGDIPSTIGALKDLETLSLAR-NQFQGPIPESVGSLISLESLDLSGNN 370 (791)
Q Consensus 313 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~ 370 (791)
|+.|+|++|.++ .+|..+..+++|+.|+|++ |++. .+|..+..+++|+.|++++|.
T Consensus 848 L~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 848 ISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 999999999998 7899999999999999998 4566 688888999999999999885
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=244.38 Aligned_cols=167 Identities=30% Similarity=0.377 Sum_probs=90.3
Q ss_pred CCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEc
Q 003855 191 SGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHL 270 (791)
Q Consensus 191 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 270 (791)
++|+.|+|++|+|+++ |.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|.. .++|+.|++
T Consensus 302 ~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~L 369 (788)
T PRK15387 302 PGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWA 369 (788)
T ss_pred cccceeECCCCccccC-CCC---cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehh
Confidence 3455555555555532 221 1235555555555552 3321 1345555555555552 3322 234556666
Q ss_pred CCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCC
Q 003855 271 GSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGP 350 (791)
Q Consensus 271 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 350 (791)
++|+|.+ +|.. ..+|+.|++++|+|++ +|.. .++|+.|++++|+++ .+|.. ..+|+.|++++|+|+ .
T Consensus 370 s~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~ 436 (788)
T PRK15387 370 YNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-R 436 (788)
T ss_pred hcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-c
Confidence 6666653 3322 2346666666666653 3322 245667777777776 34542 235666777777776 5
Q ss_pred CCcccCCCCCCcEEEccCCccCCCCchhhhhc
Q 003855 351 IPESVGSLISLESLDLSGNNLSGKIPKSLETL 382 (791)
Q Consensus 351 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 382 (791)
+|..+..+++|+.|+|++|+|++..+..+..+
T Consensus 437 LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 437 LPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred cChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 66666677777777777777776666655443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-26 Score=213.07 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=188.6
Q ss_pred cccccccCCCcceEEEEEEecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 503 FNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
.....+|.+...|+.|+|+|+ |..+++|++.... ....++|..|.-.++-+.||||+.++|+|..+....++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344557889999999999995 5677778876442 3344678889888888999999999999999999999999999
Q ss_pred CCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 581 NGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 581 ~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
.|+|...++.... ..+..+..+++.++|+|++|||+.. .-|..--+.+..|++|++.+++|+= +-+++ +.
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarism-ad~kf------sf 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SF 341 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheec-cccee------ee
Confidence 9999999996643 4677889999999999999999632 2244446899999999999988741 11111 11
Q ss_pred eeecccccccccCCCccCCCC---CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 660 TQTMTMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
......-.+.||+||.++... .-.++|+|||++++||+.|+..||.+..+.|--. .+..
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm------------------kial 403 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM------------------KIAL 403 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh------------------hhhh
Confidence 111223467899999887655 3347999999999999999999998754433211 1111
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
++.+...+...+..+.++|.-|.+.||.+||.+..|+-.|++++
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 12122222345566779999999999999999999999999874
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=242.00 Aligned_cols=266 Identities=26% Similarity=0.337 Sum_probs=174.3
Q ss_pred CCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEe
Q 003855 13 QNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALD 92 (791)
Q Consensus 13 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 92 (791)
.+-..|+|++|+|+ .+|..+. .+|+.|++++|+|+ .+|.. +++|++|+|++|+|+. +|.. .++|+.|+
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l----p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~ 268 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL----PPELRTLEVSGNQLTS-LPVL---PPGLLELS 268 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC----CCCCcEEEecCCccCc-ccCc---ccccceee
Confidence 45678999999998 5677775 48999999999998 78863 5789999999999994 4543 36788999
Q ss_pred ccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhh
Q 003855 93 LGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKF 172 (791)
Q Consensus 93 L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L 172 (791)
|++|.+..+.. . ..+|+.|++++|+|+.++. ..++|+.|+|++|+|+++ |. .+.+
T Consensus 269 Ls~N~L~~Lp~-l---p~~L~~L~Ls~N~Lt~LP~------------~p~~L~~LdLS~N~L~~L-p~----lp~~---- 323 (788)
T PRK15387 269 IFSNPLTHLPA-L---PSGLCKLWIFGNQLTSLPV------------LPPGLQELSVSDNQLASL-PA----LPSE---- 323 (788)
T ss_pred ccCCchhhhhh-c---hhhcCEEECcCCccccccc------------cccccceeECCCCccccC-CC----Cccc----
Confidence 99998875432 2 2467778888888886642 236788888888888753 32 1123
Q ss_pred hcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccC
Q 003855 173 YAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLS 252 (791)
Q Consensus 173 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 252 (791)
|+.|++++|+|++ +|.. ..+|++|+|++|+|+ .+|.. ..+|+.|++++|+|+
T Consensus 324 --------------------L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~ 375 (788)
T PRK15387 324 --------------------LCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT 375 (788)
T ss_pred --------------------ccccccccCcccc-cccc---ccccceEecCCCccC-CCCCC---Ccccceehhhccccc
Confidence 4444555555542 2211 134555555555555 23322 134555556666665
Q ss_pred CCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchh
Q 003855 253 GHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIG 332 (791)
Q Consensus 253 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 332 (791)
. +|.. .++|+.|+|++|+|++ +|.. .++|+.|++++|.++. +|.. ..+|+.|++++|+|+ .+|..+.
T Consensus 376 ~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~ 442 (788)
T PRK15387 376 S-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLI 442 (788)
T ss_pred c-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHh
Confidence 2 3432 2456677777777763 3332 2467777777777764 4443 245677888888887 6777788
Q ss_pred ccccccccccccccCCCCCCcccC
Q 003855 333 ALKDLETLSLARNQFQGPIPESVG 356 (791)
Q Consensus 333 ~l~~L~~L~L~~N~l~~~~~~~~~ 356 (791)
.+++|+.|+|++|+|++..+..+.
T Consensus 443 ~L~~L~~LdLs~N~Ls~~~~~~L~ 466 (788)
T PRK15387 443 HLSSETTVNLEGNPLSERTLQALR 466 (788)
T ss_pred hccCCCeEECCCCCCCchHHHHHH
Confidence 888888888888888876666553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=217.61 Aligned_cols=169 Identities=23% Similarity=0.227 Sum_probs=130.8
Q ss_pred HHHHhhccccccccCCCcceEEEEEEec--CCcEEEEEEeehh-----hhHHHHHHHHHHHHHHhccCCccceeeeeecc
Q 003855 496 IQRATDEFNECNLLGTGSFGSVYKGTIS--DGTDVAIKIFNLQ-----LERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568 (791)
Q Consensus 496 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 568 (791)
.....++|.+.+.||+|+||+||+|... +++.||||++... .....+.+.+|++++++++|+|++..+..+
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3445678999999999999999999864 5778899986532 122356689999999999999998533322
Q ss_pred CCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCC-CCCCeEeCCCCcEEEeeec
Q 003855 569 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDL-KPTNILLDENMAAHVSDFG 647 (791)
Q Consensus 569 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dl-k~~Nill~~~~~~kl~Dfg 647 (791)
+..++||||++|++|.. +... . ...++.++++||.||| +.+|+|||| ||+||+++.++.+||+|||
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~~----~---~~~~~~~i~~aL~~lH----~~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARPH----G---DPAWFRSAHRALRDLH----RAGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCcc----c---hHHHHHHHHHHHHHHH----HCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 45799999999999973 2111 1 1467889999999999 789999999 9999999999999999999
Q ss_pred cccccCCCCCcce------eecccccccccCCCccCCC
Q 003855 648 ISKLLGEGEDSVT------QTMTMATIGYMAPEYGSEG 679 (791)
Q Consensus 648 la~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~~ 679 (791)
+|+.+........ .....+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997765432111 1234678889999986543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-21 Score=206.07 Aligned_cols=261 Identities=19% Similarity=0.192 Sum_probs=196.1
Q ss_pred ccccccccCCCcceEEEEEEecCC--cEEEEEEeehhhhHHHHHHHHHHHHHHhccC----Cccceeeeee-ccCCeeeE
Q 003855 502 EFNECNLLGTGSFGSVYKGTISDG--TDVAIKIFNLQLERAFRSFDSECEVLRNVRH----RNLIKILSSC-SNPDFKAL 574 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l 574 (791)
+|.+.+.||+|+||.||.+..... ..+|+|.-..........+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 5789888765433222267778888888862 6889999888 57778899
Q ss_pred EEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC-----CcEEEeeecc
Q 003855 575 VLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN-----MAAHVSDFGI 648 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~-----~~~kl~Dfgl 648 (791)
||+.+ |.+|.++..... ..++..+..+|+.|++.+|+++| +.+++||||||.|+.+... -.+.+.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH----~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH----SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH----hcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999886544 67999999999999999999999 7899999999999999854 4699999999
Q ss_pred ccccC--CCCCc----c-e-eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHH
Q 003855 649 SKLLG--EGEDS----V-T-QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 720 (791)
Q Consensus 649 a~~~~--~~~~~----~-~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 720 (791)
|+.+. ..... . . .....||..|+++....+...+++.|+||++.++.|+..|..||........ .......
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~ 252 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKD 252 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHH
Confidence 98332 11110 1 1 1234599999999999999999999999999999999999999965332211 1111000
Q ss_pred hcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 721 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 721 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
........ .....+.++.++...+-..+..++|....+.+.+.+....
T Consensus 253 ~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 253 PRKLLTDR--------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhhhcccc--------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 00000000 0112345566777777778999999999999998877554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-22 Score=228.16 Aligned_cols=253 Identities=21% Similarity=0.210 Sum_probs=187.5
Q ss_pred cccccCCCcceEEEEEEec-CCcEEEEEEee-----hhhh-HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 505 ECNLLGTGSFGSVYKGTIS-DGTDVAIKIFN-----LQLE-RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 505 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~-----~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
..+.+|.|++|.|+..... ....++.|.+. .... .....+..|+.+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4568999999977776532 33334444332 1111 222236677778888899999998888877766666799
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++ ||..++.... .+...++..++.|+..|+.|+| +.+|.|||+|++|++++.+|.+||+|||.+....-...
T Consensus 402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h----~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH----SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH----hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 9999998763 3788889999999999999999 78999999999999999999999999999987654433
Q ss_pred c--ceeecccccccccCCCccCCCCCCc-cccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 658 S--VTQTMTMATIGYMAPEYGSEGIVSA-KCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 658 ~--~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
. ......+|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||......+..+ ...........
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~~~~~------ 546 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSDQRNI------ 546 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhcccccccc------
Confidence 3 4455568999999999999988877 4899999999999999999987643333222 00001111111
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...........+..-..++.++++++|.+|.|+.+|++
T Consensus 547 --~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 --FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred --ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11111222345566678999999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.8e-21 Score=185.01 Aligned_cols=263 Identities=16% Similarity=0.158 Sum_probs=200.7
Q ss_pred hccccccccCCCcceEEEEEE-ecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
-.|++.++||+|.||+++.|+ +-+++.||||.=...+ ...++..|.+..+.+ ..++|..++-+..++-+-.+|+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368999999999999999998 4579999999644332 235677799999988 579999999888888888999998
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC-----CcEEEeeeccccccC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN-----MAAHVSDFGISKLLG 653 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~-----~~~kl~Dfgla~~~~ 653 (791)
+ |.||.|+..-.++.++..++..+|.|+..-++|+| ++..|+|||||+|+||... ..+.++|||+|+.+.
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH----~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH----EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH----hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8 88999998866667999999999999999999999 6789999999999999754 358999999999887
Q ss_pred CCCCc-----ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 654 EGEDS-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 654 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
+.... .......||.+||+--...+.+.+.+.|.=|+|-|+.+.+.|..||.+.... ....++-+--.......
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~-tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD-TNKEKYEKIGETKRSTP 259 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc-chHHHHHHhccccccCC
Confidence 65432 2233446999999999999999999999999999999999999999875322 11122111000000000
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
-....+..|.++..-+.-.-..+=.+-|...-+...+..+.+.
T Consensus 260 -----------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 260 -----------IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred -----------HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 0112234566666777777777778888877666666555444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=179.03 Aligned_cols=263 Identities=19% Similarity=0.208 Sum_probs=197.9
Q ss_pred hhccccccccCCCcceEEEEEE-ecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccC-CccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRH-RNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 577 (791)
..+|.++++||.|+||.+|.|. ..+|..||||+=....+ ..++..|..+.+.+++ ..|..+..+..+.+.-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999998 56899999998654433 2467778999999965 678888888888888899999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC---CCcEEEeeeccccccCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE---NMAAHVSDFGISKLLGE 654 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgla~~~~~ 654 (791)
.. |.||.+...--.+.++..+++..+-|+..-++|+| .++++||||||+|.|+.- ...+.++|||+|+.+.+
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH----~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH----LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH----hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 88 88999998855556899999999999999999999 678999999999999963 45689999999998765
Q ss_pred CCCc-----ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh
Q 003855 655 GEDS-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV 729 (791)
Q Consensus 655 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
.... .......||.+|.+--...+...+.+.|+=|+|.++...-.|..||.+...... .+++ ..+
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-~QKy---------EkI 236 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-KQKY---------EKI 236 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-HHHH---------HHH
Confidence 4322 223344689999888877777788899999999999999999999987533211 1111 001
Q ss_pred cchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 730 VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 730 ~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
....+.. .-.......|.++.-.+.-|-..-=++-|...-+-+.+..+..
T Consensus 237 ~EkK~s~--~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 237 SEKKMST--PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHhhcCC--CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 1111000 0011223455667777888888888888887777776665543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=224.18 Aligned_cols=163 Identities=28% Similarity=0.451 Sum_probs=99.6
Q ss_pred CCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEc
Q 003855 191 SGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHL 270 (791)
Q Consensus 191 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 270 (791)
++|+.|+|++|+|+. +|..+. ++|+.|+|++|+|++ +|..+. ++|+.|++++|.++. +|..+. ++|+.|++
T Consensus 262 s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~L 332 (754)
T PRK15370 262 SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEA 332 (754)
T ss_pred CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccc
Confidence 357777777777763 444443 467777777777763 443332 356677777777763 443332 56777777
Q ss_pred CCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCC
Q 003855 271 GSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGP 350 (791)
Q Consensus 271 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 350 (791)
++|.+++ +|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .
T Consensus 333 s~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~ 402 (754)
T PRK15370 333 GENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-R 402 (754)
T ss_pred cCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-c
Confidence 7777764 444442 56777777777776 3454442 46777777777777 4555443 35777777777776 4
Q ss_pred CCccc----CCCCCCcEEEccCCccC
Q 003855 351 IPESV----GSLISLESLDLSGNNLS 372 (791)
Q Consensus 351 ~~~~~----~~l~~L~~L~l~~N~l~ 372 (791)
+|..+ +.++++..|+|.+|+++
T Consensus 403 LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 403 LPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CchhHHHHhhcCCCccEEEeeCCCcc
Confidence 44433 33466677777777766
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.9e-22 Score=224.67 Aligned_cols=287 Identities=22% Similarity=0.336 Sum_probs=176.7
Q ss_pred CCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEe
Q 003855 13 QNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALD 92 (791)
Q Consensus 13 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 92 (791)
.+.+.|++++++++. +|..+. ++|+.|+|++|+|+ .+|..++ ++|++|+|++|+++. +|..+. .+|+.|+
T Consensus 178 ~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~ 247 (754)
T PRK15370 178 NNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ---GNIKTLYANSNQLTS-IPATLP--DTIQEME 247 (754)
T ss_pred cCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc---cCCCEEECCCCcccc-CChhhh--ccccEEE
Confidence 467899999999984 566553 57999999999998 8888764 589999999999984 566554 4799999
Q ss_pred ccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhh
Q 003855 93 LGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKF 172 (791)
Q Consensus 93 L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L 172 (791)
|++|.+..++ ..+. .+|+.|++++|+|+.++.. +. ++|+.|++++|+|+. +|..+ +.+|+.|
T Consensus 248 Ls~N~L~~LP-~~l~--s~L~~L~Ls~N~L~~LP~~---------l~--~sL~~L~Ls~N~Lt~-LP~~l---p~sL~~L 309 (754)
T PRK15370 248 LSINRITELP-ERLP--SALQSLDLFHNKISCLPEN---------LP--EELRYLSVYDNSIRT-LPAHL---PSGITHL 309 (754)
T ss_pred CcCCccCcCC-hhHh--CCCCEEECcCCccCccccc---------cC--CCCcEEECCCCcccc-Ccccc---hhhHHHH
Confidence 9999998543 3332 4788899999998876532 22 478999999998885 34332 2456777
Q ss_pred hcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccC
Q 003855 173 YAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLS 252 (791)
Q Consensus 173 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 252 (791)
++++|+++. +|..+. ++|+.|++++|.++. +|..+. ++|+.|+|++|+|+ .+|..
T Consensus 310 ~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~------------------ 364 (754)
T PRK15370 310 NVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPET------------------ 364 (754)
T ss_pred HhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChh------------------
Confidence 777777663 343322 456666666666653 333332 45555555555555 23332
Q ss_pred CCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcc----cccCCCCCEEecCCcccCCCCC
Q 003855 253 GHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSN----VQKLKVLTVLDLSRNQLSGDIP 328 (791)
Q Consensus 253 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~----~~~l~~L~~L~l~~N~l~~~~~ 328 (791)
+. ++|+.|+|++|+|+. +|..+. ..|+.|++++|+++ .+|.. +..++.+..|++.+|.++.
T Consensus 365 ------lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~--- 429 (754)
T PRK15370 365 ------LP--PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE--- 429 (754)
T ss_pred ------hc--CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH---
Confidence 21 345555555555552 233222 24555666666665 33332 3344677888888888762
Q ss_pred cchhccccccccccccccCCC-CCCcccCCCCCCcEEEccCCcc
Q 003855 329 STIGALKDLETLSLARNQFQG-PIPESVGSLISLESLDLSGNNL 371 (791)
Q Consensus 329 ~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l 371 (791)
..+.+|+.| ++.+.+.| .++...+.+.+++....-.+.+
T Consensus 430 ---~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~ 469 (754)
T PRK15370 430 ---RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAV 469 (754)
T ss_pred ---HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHH
Confidence 345555555 44454443 2333444444444433333333
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-20 Score=200.46 Aligned_cols=258 Identities=30% Similarity=0.396 Sum_probs=198.4
Q ss_pred cccccccCCCcceEEEEEEecCCcEEEEEEeehhhhH---HHHHHHHHHHHHHhccCC-ccceeeeeeccCCeeeEEEec
Q 003855 503 FNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLER---AFRSFDSECEVLRNVRHR-NLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 578 (791)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999986 78999988765432 467899999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC-cEEEeeeccccccCCC
Q 003855 579 MPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-AAHVSDFGISKLLGEG 655 (791)
Q Consensus 579 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~ 655 (791)
+.++++.+++.... ..+.......++.|++.++.|+| ..+++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H----~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH----SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 99999997777654 25889999999999999999999 67899999999999999988 7999999999866544
Q ss_pred CCcc----eeecccccccccCCCccCC---CCCCccccHHhHHHHHHHHHhCCCCCCccccC--cchHHHHHHHhcCCCh
Q 003855 656 EDSV----TQTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG--EMSLRRWVKESLPHGL 726 (791)
Q Consensus 656 ~~~~----~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~ 726 (791)
.... ......|+..|+|||.... ..++...|+||+|++++++++|..|+...... .......+........
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 3221 2345679999999998877 57889999999999999999999996653321 1122222221111100
Q ss_pred hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 727 ~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
......... ......+.+++..|+..+|..|.++.+....
T Consensus 236 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNP---------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCcccc---------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000 1223457789999999999999999987764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=208.17 Aligned_cols=219 Identities=26% Similarity=0.353 Sum_probs=169.1
Q ss_pred HHhccCCccceeeeeeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCC
Q 003855 551 LRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKP 630 (791)
Q Consensus 551 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~ 630 (791)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......+++.....++++|+.||.|+|+ +.--.|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence 356789999999999999999999999999999999999887789999999999999999999994 33339999999
Q ss_pred CCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCC-------CCCccccHHhHHHHHHHHHhCCCC
Q 003855 631 TNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG-------IVSAKCDVYSYGVLLMETFTRKRP 703 (791)
Q Consensus 631 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~s~G~vl~elltg~~p 703 (791)
+|+++|..+.+|++|||+.................-..-|.|||.+... ..+.++||||||++++|+++++.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999999876432222222222345679999987663 146789999999999999999999
Q ss_pred CCccccCcch--HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 704 TDEMFTGEMS--LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 704 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
|+.....+.. ....++. .....+.+.+.... +..+.+..++.+||..+|++||++.+|...++.+..
T Consensus 158 ~~~~~~~~~~~eii~~~~~----~~~~~~rP~i~~~~-------e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK----GGSNPFRPSIELLN-------ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHh----cCCCCcCcchhhhh-------hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9874443332 2222222 11222222222111 344568899999999999999999999999988765
Q ss_pred Hh
Q 003855 782 KF 783 (791)
Q Consensus 782 ~~ 783 (791)
..
T Consensus 227 ~~ 228 (484)
T KOG1023|consen 227 GG 228 (484)
T ss_pred cc
Confidence 43
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-21 Score=185.59 Aligned_cols=171 Identities=12% Similarity=0.131 Sum_probs=132.5
Q ss_pred HhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHH---------HHHHHHHHHHHhccCCccceeeeeeccC
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAF---------RSFDSECEVLRNVRHRNLIKILSSCSNP 569 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv~l~~~~~~~ 569 (791)
...+|+..+.+|.|+||.||.+.. ++..+|||++........ +.+.+|+..+.++.||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999766 577899999975432211 2268899999999999999998886532
Q ss_pred --------CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcE
Q 003855 570 --------DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAA 641 (791)
Q Consensus 570 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~ 641 (791)
...++||||++|.+|.++.. .+. ....+++.++..+| ..+++|||++|+||++++++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH----~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH----QHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH----HcCCccCCCChHHEEEeCCC-E
Confidence 35789999999999988732 222 24569999999999 78999999999999999998 9
Q ss_pred EEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHH
Q 003855 642 HVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 698 (791)
Q Consensus 642 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ell 698 (791)
+++|||........... ..+.....+..++|+||||+++.-..
T Consensus 174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988654221110 00334445667999999999877554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.8e-20 Score=178.93 Aligned_cols=140 Identities=19% Similarity=0.190 Sum_probs=108.6
Q ss_pred ccccCCCcceEEEEEEecCCcEEEEEEeehhhhH--H------------------------HHHHHHHHHHHHhccCCcc
Q 003855 506 CNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLER--A------------------------FRSFDSECEVLRNVRHRNL 559 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni 559 (791)
...||+|+||.||+|...+|+.||||+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998654210 0 1123459999999988877
Q ss_pred ceeeeeeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC
Q 003855 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM 639 (791)
Q Consensus 560 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~ 639 (791)
.....+.. ...++||||++++++....... ..++......++.|++.+|.|+|+ ..+|+||||||+||+++ ++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 54433322 2238999999988776553333 348889999999999999999942 56899999999999998 47
Q ss_pred cEEEeeecccccc
Q 003855 640 AAHVSDFGISKLL 652 (791)
Q Consensus 640 ~~kl~Dfgla~~~ 652 (791)
.++++|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-21 Score=172.44 Aligned_cols=177 Identities=30% Similarity=0.475 Sum_probs=131.7
Q ss_pred cCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEe
Q 003855 238 LKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLD 317 (791)
Q Consensus 238 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~ 317 (791)
+.+++.|.||+|+++ .+|..++.+.+|+.|++++|+|+ ..|.+++.+++|+.|+++-|++. ..|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 444455555555555 44445666666666666666665 45666666666666666666664 6677777777777777
Q ss_pred cCCcccCC-CCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCc
Q 003855 318 LSRNQLSG-DIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396 (791)
Q Consensus 318 l~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 396 (791)
|++|.+.. .+|..|..+..|+.|+|++|.+. .+|..++++.+|+.|.+.+|.+- .+|..++.+..|++|.+.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 77777653 57888889999999999999998 88999999999999999999998 88999999999999999999999
Q ss_pred ccCCCCCCCcCCc---cccccCCccc
Q 003855 397 GEIPVKGSFKNFS---VESFFGNYAL 419 (791)
Q Consensus 397 ~~~~~~~~~~~l~---~~~~~~n~~~ 419 (791)
-.+|+.+.+.-+. ......|||.
T Consensus 187 vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 187 VLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 9999876654432 2334556654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-19 Score=172.38 Aligned_cols=141 Identities=21% Similarity=0.234 Sum_probs=110.8
Q ss_pred ccccCCCcceEEEEEEecCCcEEEEEEeehhhhH--------------------------HHHHHHHHHHHHHhccCCcc
Q 003855 506 CNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLER--------------------------AFRSFDSECEVLRNVRHRNL 559 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni 559 (791)
...||+|+||.||+|+..+|+.||||++...... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998754210 01234678999999999987
Q ss_pred ceeeeeeccCCeeeEEEecCCCCCHHHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC
Q 003855 560 IKILSSCSNPDFKALVLEFMPNGSLEKW-LYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN 638 (791)
Q Consensus 560 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~ 638 (791)
.....+... ..++||||++++++... +.. ..++..+..+++.+++.++.++|+ ..+|+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ---EAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCChhhEEEE-C
Confidence 555444332 24899999998865443 332 236788899999999999999993 27999999999999999 8
Q ss_pred CcEEEeeeccccccCC
Q 003855 639 MAAHVSDFGISKLLGE 654 (791)
Q Consensus 639 ~~~kl~Dfgla~~~~~ 654 (791)
+.++|+|||+|+....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 9999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-19 Score=167.85 Aligned_cols=188 Identities=16% Similarity=0.102 Sum_probs=139.3
Q ss_pred ccccccCCCcceEEEEEEecCCcEEEEEEeehhhh---H-HHHHHHHHHHHHHhcc-CCccceeeeeeccCCeeeEEEec
Q 003855 504 NECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE---R-AFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 504 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.+...+++|+||+||.+.. .+++++.+.+..... . ....+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997665 678888777765432 1 1235789999999995 5889999886 346899999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCC-CCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDL-KPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dl-k~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
++|.+|.+.... ....++.|+++++.++| ..+|+|||| ||+||++++++.++|+|||+|....+...
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH----~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH----RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH----HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998764321 12347789999999999 789999999 79999999999999999999986544332
Q ss_pred cc---e--------eecccccccccCCCccCC-CCCC-ccccHHhHHHHHHHHHhCCCCCCccc
Q 003855 658 SV---T--------QTMTMATIGYMAPEYGSE-GIVS-AKCDVYSYGVLLMETFTRKRPTDEMF 708 (791)
Q Consensus 658 ~~---~--------~~~~~g~~~y~aPE~~~~-~~~~-~~~Dv~s~G~vl~elltg~~p~~~~~ 708 (791)
.. . ......++.|++|+-..- ...+ ...+.++-|.-+|.++||..+.....
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 0 111235677777773211 1122 46799999999999999999865533
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.79 E-value=5e-21 Score=203.90 Aligned_cols=210 Identities=28% Similarity=0.361 Sum_probs=118.3
Q ss_pred cccCCCCCCEEEccCCccccccCccccCCCC---CCEEEcccccCcc----cCCcccccc-CCCceEEecCCccCCC---
Q 003855 186 EIGNLSGLTLLSLHSNDLNGTISPTMGRLKR---LQGLSLRNNNLEG----SIPYDLCHL-KLMFGIRLTGNKLSGH--- 254 (791)
Q Consensus 186 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~L~~N~i~~~--- 254 (791)
.+..+++|+.|++++|.+....+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++.
T Consensus 76 ~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~ 155 (319)
T cd00116 76 GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE 155 (319)
T ss_pred HHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH
Confidence 3444555555555555554333333333333 5566665555542 111223334 5556666666655521
Q ss_pred -CCccccCCCCCcEEEcCCCcCCCC----CCccccCCCCCCeEEccCCcCccc----CCcccccCCCCCEEecCCcccCC
Q 003855 255 -IPPCLVSLTSLRELHLGSNKLTSS----IPSSLWSLEYILDINLSSNSLNDS----LPSNVQKLKVLTVLDLSRNQLSG 325 (791)
Q Consensus 255 -~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~i~~~----~~~~~~~l~~L~~L~l~~N~l~~ 325 (791)
++..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++
T Consensus 156 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 156 ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 233445556666667666666532 222334445677777777766533 22345566777777777777764
Q ss_pred CCCcchhc-----cccccccccccccCCC----CCCcccCCCCCCcEEEccCCccCCC----Cchhhhhc-ccCceEEcc
Q 003855 326 DIPSTIGA-----LKDLETLSLARNQFQG----PIPESVGSLISLESLDLSGNNLSGK----IPKSLETL-SQLKQFNVS 391 (791)
Q Consensus 326 ~~~~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l-~~L~~l~l~ 391 (791)
.....+.. .+.|+.|++++|.++. .+...+..+++|+.+++++|.++.. ....+... +.|+++++.
T Consensus 236 ~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (319)
T cd00116 236 AGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVK 315 (319)
T ss_pred HHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccC
Confidence 33333322 2677788888887752 2334455567888888888888754 34445455 677888887
Q ss_pred CCCC
Q 003855 392 HNRL 395 (791)
Q Consensus 392 ~N~l 395 (791)
+|++
T Consensus 316 ~~~~ 319 (319)
T cd00116 316 DDSF 319 (319)
T ss_pred CCCC
Confidence 7764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.4e-21 Score=170.83 Aligned_cols=165 Identities=30% Similarity=0.506 Sum_probs=115.5
Q ss_pred ccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCc
Q 003855 187 IGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLR 266 (791)
Q Consensus 187 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 266 (791)
+.++++++.|-|++|+++ .+|+.++.+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445667777778888877 56667777778888888888877 66777777777777777777776 6677777777777
Q ss_pred EEEcCCCcCCC-CCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccc
Q 003855 267 ELHLGSNKLTS-SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARN 345 (791)
Q Consensus 267 ~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 345 (791)
.|||++|.+.. ..|..|..++.|+.|+|+.|.+. .+|..++++++|+.|.+..|.+. .+|..++.+..|++|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 77777777753 35666666777777777777764 56666777777777777777666 56666666666666666666
Q ss_pred cCCCCCCcccCC
Q 003855 346 QFQGPIPESVGS 357 (791)
Q Consensus 346 ~l~~~~~~~~~~ 357 (791)
+++ .+|..+++
T Consensus 184 rl~-vlppel~~ 194 (264)
T KOG0617|consen 184 RLT-VLPPELAN 194 (264)
T ss_pred eee-ecChhhhh
Confidence 666 55555544
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.5e-21 Score=202.15 Aligned_cols=285 Identities=24% Similarity=0.304 Sum_probs=144.7
Q ss_pred eeecCCCccc-ccCCccccCCCCCcEEeCCCCcCcc----cCCchhhhcCCCccEEEccCCccee------cCCccCcCC
Q 003855 17 YLVFAENNLS-GLVPPTIFNISTMRILTLEGNQLSG----RLPSTVGHLLPNIESLLLAANNLTG------IIPHSITNA 85 (791)
Q Consensus 17 ~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l 85 (791)
.|+|+.+.++ ...+..|..+.+|++|+++++.+++ .++..+.. .++|++|+++++.+.+ .++..+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~-~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~ 80 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRP-QPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhh-CCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence 4666777765 3344555666777778887777742 23333333 4567777777776652 223455666
Q ss_pred CCCCEEeccCcccccccccccccccc---ccccccccccccccCCCccccccccccCCC-CCCcEEEccCCCCcccCChh
Q 003855 86 TKLVALDLGFNSFAGHILNTFGNLRH---LSLLSQVMNNLTTESSSADQWSFLSSLTNC-RNLTILSFGSNPLGGILPPV 161 (791)
Q Consensus 86 ~~L~~L~L~~N~i~~~~~~~~~~l~~---L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~ 161 (791)
++|++|+|++|.+....+..|..+.+ |+.|++++|+++..... .....+..+ ++|+.|++++|.+++.....
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~----~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 156 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR----LLAKGLKDLPPALEKLVLGRNRLEGASCEA 156 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH----HHHHHHHhCCCCceEEEcCCCcCCchHHHH
Confidence 67777777777766444444444333 55555555544421100 011123333 44555555555444211111
Q ss_pred hhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccc----cCccccCCCCCCEEEcccccCcccCCccccc
Q 003855 162 IGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGT----ISPTMGRLKRLQGLSLRNNNLEGSIPYDLCH 237 (791)
Q Consensus 162 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 237 (791)
++..+..+++|+.|++++|.+++. .+..+..+++|++|+|++|.+++....
T Consensus 157 ---------------------~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~---- 211 (319)
T cd00116 157 ---------------------LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS---- 211 (319)
T ss_pred ---------------------HHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH----
Confidence 112233344455555555554421 111223334444444444444321111
Q ss_pred cCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCcccc-----CCCCCCeEEccCCcCcc----cCCcccc
Q 003855 238 LKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLW-----SLEYILDINLSSNSLND----SLPSNVQ 308 (791)
Q Consensus 238 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~l~~N~i~~----~~~~~~~ 308 (791)
.++..+..+++|++|++++|.+++.....+. ..+.|+.|++++|.+++ .+...+.
T Consensus 212 ----------------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~ 275 (319)
T cd00116 212 ----------------ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLA 275 (319)
T ss_pred ----------------HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHh
Confidence 1223344556666666666666532222221 23567777777777652 2233455
Q ss_pred cCCCCCEEecCCcccCCC----CCcchhcc-ccccccccccccC
Q 003855 309 KLKVLTVLDLSRNQLSGD----IPSTIGAL-KDLETLSLARNQF 347 (791)
Q Consensus 309 ~l~~L~~L~l~~N~l~~~----~~~~~~~l-~~L~~L~L~~N~l 347 (791)
.+++|+.+++++|.++.. ....+... +.|+.|++.+|.+
T Consensus 276 ~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 276 EKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred cCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 567788888888888754 23333344 6778888877754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-19 Score=180.09 Aligned_cols=231 Identities=20% Similarity=0.263 Sum_probs=148.0
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccC----------Cccceeeeeec
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRH----------RNLIKILSSCS 567 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~ 567 (791)
.+...+.||.|+|+.||.+++. +++++|||++.... ....+.+++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456778999999999999975 68999999885432 3456677776655544322 11222222211
Q ss_pred ---------cC---C-----eeeEEEecCCCCCHHHHHh---hCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeE
Q 003855 568 ---------NP---D-----FKALVLEFMPNGSLEKWLY---SHN---YFLDILERLNIMIDVGSALEYLHHGHSSAPII 624 (791)
Q Consensus 568 ---------~~---~-----~~~lv~e~~~~g~L~~~l~---~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~ 624 (791)
.. . ..+++|+-+ .+||.+++. ... .......+..+..|+.+.+++|| +.+++
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh----~~GlV 167 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH----SYGLV 167 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTTEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh----hcceE
Confidence 11 1 225678877 569988865 221 12344556677789999999999 78999
Q ss_pred ecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCC--------CCCCccccHHhHHHHHHH
Q 003855 625 HCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE--------GIVSAKCDVYSYGVLLME 696 (791)
Q Consensus 625 H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~s~G~vl~e 696 (791)
|+||+|+|++++++|.+.|+||+.....+.. ......+..|.+||.... ..++.+.|.|++|+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999888764321 111334578999996533 357889999999999999
Q ss_pred HHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCC
Q 003855 697 TFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMR 766 (791)
Q Consensus 697 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 766 (791)
|++|+.||+.......... .+....+.++.+.++|..+++.+|++|
T Consensus 243 lWC~~lPf~~~~~~~~~~~------------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW------------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG------------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc------------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999986433211100 111222567788899999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.6e-20 Score=202.97 Aligned_cols=249 Identities=21% Similarity=0.233 Sum_probs=176.6
Q ss_pred ccccccccCCCcceEEEEEEecCCcEEEEEEeehhh-hH---HHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 502 EFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL-ER---AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++...+.+|.+.|=.|.+|+.+.|. |+||++-+.. .- .+.+-..|++ ...++|||.+.+.-+-......|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777889999999999999998887 9999986654 22 2233333444 555689999999888777788889999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc--CCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL--GEG 655 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~--~~~ 655 (791)
|+.+ +|.|.+..+. ++...+.+.|++|+..|+..+| ..+|+|||||.+|||+++=.=+.|+||..-+.. .++
T Consensus 102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH----~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH----KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH----HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 9966 9999997654 4777888889999999999999 789999999999999998878899999654322 111
Q ss_pred CC---cceeecccccccccCCCccCC----------CC-CCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHH
Q 003855 656 ED---SVTQTMTMATIGYMAPEYGSE----------GI-VSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKE 720 (791)
Q Consensus 656 ~~---~~~~~~~~g~~~y~aPE~~~~----------~~-~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 720 (791)
.. .........-..|+|||.+-. .. .+++=||||.|||++|+++ |++||.- .+...-
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--------SQL~aY 247 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--------SQLLAY 247 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--------HHHHhH
Confidence 11 111111112235999995322 11 5678899999999999998 6777753 111110
Q ss_pred hcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 721 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 721 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
.... -.+++...+. . ....+..++..|++.||++|.++.+.++.-+
T Consensus 248 r~~~----~~~~e~~Le~-----I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 248 RSGN----ADDPEQLLEK-----I--EDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred hccC----ccCHHHHHHh-----C--cCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 0000 1111111110 0 0124678999999999999999999998743
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4e-19 Score=177.00 Aligned_cols=195 Identities=26% Similarity=0.319 Sum_probs=138.8
Q ss_pred cCCccceeeeeecc---------------------------CCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHH
Q 003855 555 RHRNLIKILSSCSN---------------------------PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 607 (791)
Q Consensus 555 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i 607 (791)
+|||||++.++|.+ +...|+||...+. +|.+|+..+. .+.....-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999877632 3467899998855 9999998765 4555667789999
Q ss_pred HHHHHHHHccCCCCCeEecCCCCCCeEe--CCCCc--EEEeeeccccccCCC----CCcceeecccccccccCCCccCCC
Q 003855 608 GSALEYLHHGHSSAPIIHCDLKPTNILL--DENMA--AHVSDFGISKLLGEG----EDSVTQTMTMATIGYMAPEYGSEG 679 (791)
Q Consensus 608 ~~~l~~LH~~~~~~~i~H~dlk~~Nill--~~~~~--~kl~Dfgla~~~~~~----~~~~~~~~~~g~~~y~aPE~~~~~ 679 (791)
++|+.||| .++|.|||+|++|||+ |+|+. ..|+|||.+---... ......-...|...-||||+....
T Consensus 351 LEav~hL~----~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 351 LEAVTHLH----KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHH----HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999 7899999999999998 44444 678999987432111 011111223466779999975432
Q ss_pred --C----CCccccHHhHHHHHHHHHhCCCCCCccccCcchH--HHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHH
Q 003855 680 --I----VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL--RRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSI 751 (791)
Q Consensus 680 --~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l 751 (791)
+ .-.|+|.|+.|.+.||+++...||.. .+++.+ +.+-. ..-..-+..|++.+
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~L~~r~Yqe------------------~qLPalp~~vpp~~ 486 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEMLLDTRTYQE------------------SQLPALPSRVPPVA 486 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccc--cchheechhhhhh------------------hhCCCCcccCChHH
Confidence 2 23489999999999999999999976 233222 11100 00111233577888
Q ss_pred HHHHhhccccCCCCCCCHHHHHHHH
Q 003855 752 MDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 752 ~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
.+++...++.||++|++..-+...+
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHH
Confidence 9999999999999999987665554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-20 Score=198.10 Aligned_cols=225 Identities=24% Similarity=0.296 Sum_probs=174.3
Q ss_pred ccCCCcceEEEEEE----ecCCcEEEEEEeehhhh--HHHHHHHHHHHHHHhcc-CCccceeeeeeccCCeeeEEEecCC
Q 003855 508 LLGTGSFGSVYKGT----ISDGTDVAIKIFNLQLE--RAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 508 ~ig~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
.+|+|.||.|+.++ .+.|+.+|.|+.++... ........|..++...+ ||.++++..+++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999998764 23577788888765431 11125566788888886 9999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+|++...+..... ++..........++-|++++| +.+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh----~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH----KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc----hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 9999998876654 566666777788999999999 78999999999999999999999999999987543222
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHh
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 740 (791)
.+||..|||||+.. .....+|.||||++++||+||..||.. ....+ +... .
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~-----------------Il~~--~ 203 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKR-----------------ILKA--E 203 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHH-----------------Hhhh--c
Confidence 17899999999987 456789999999999999999999875 11111 1110 1
Q ss_pred hHHHHHHHHHHHHHHhhccccCCCCCCCH
Q 003855 741 FSAKMDCILSIMDLALDCCIESPDMRINV 769 (791)
Q Consensus 741 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 769 (791)
...+.+....+.+++..+...+|.+|...
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 11223445556678888888888888765
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-18 Score=195.06 Aligned_cols=201 Identities=23% Similarity=0.259 Sum_probs=161.4
Q ss_pred hHHHHHhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc---CCccceeeeeeccCC
Q 003855 494 LDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR---HRNLIKILSSCSNPD 570 (791)
Q Consensus 494 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~ 570 (791)
.+.+...+.|.+.+.||+|+||.||+|...+|+.||+|+=+...... |---.+++.+|+ -+-|..+..++.-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 34555667899999999999999999998889999999865543221 111123333443 244555666666667
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC-------CCCcEEE
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD-------ENMAAHV 643 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~-------~~~~~kl 643 (791)
.-++|+||.+.|+|.+++... ...+|.-+..+..|+++.+++|| ..+|||+||||+|.++. +...++|
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH----~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLH----AMGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred cceeeeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHH----hcceecccCCcceeEeecccCCCCcccceEE
Confidence 778999999999999999844 44899999999999999999999 77899999999999994 2345899
Q ss_pred eeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCC
Q 003855 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR 702 (791)
Q Consensus 644 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~ 702 (791)
+|||.+..+..-.+.......++|-++--+|...++.|++.+|-|.++.+++-|+.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999987765555555566778999999999999999999999999999999999974
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=162.55 Aligned_cols=136 Identities=18% Similarity=0.250 Sum_probs=105.4
Q ss_pred ccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-----cCCccceeeeeeccCC---e-eeE
Q 003855 504 NECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-----RHRNLIKILSSCSNPD---F-KAL 574 (791)
Q Consensus 504 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l 574 (791)
...+.||+|+||.||. ..+....+||++........+.+.+|+.+++++ .||||++++|++.+.. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3456899999999996 433333479988765444556789999999999 5799999999998763 3 337
Q ss_pred EEec--CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHHccCCCCCeEecCCCCCCeEeCC----CCcEEEeeec
Q 003855 575 VLEF--MPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL-EYLHHGHSSAPIIHCDLKPTNILLDE----NMAAHVSDFG 647 (791)
Q Consensus 575 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~~i~H~dlk~~Nill~~----~~~~kl~Dfg 647 (791)
|+|| +++|+|.+++.+.. +++. ..++.+++.++ +||| +.+|+||||||+||+++. ++.++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh----~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL----DNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 56799999997642 4544 35677888777 9999 678999999999999974 3479999954
Q ss_pred cc
Q 003855 648 IS 649 (791)
Q Consensus 648 la 649 (791)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=5e-17 Score=161.75 Aligned_cols=134 Identities=23% Similarity=0.364 Sum_probs=113.4
Q ss_pred cccCCCcceEEEEEEecCCcEEEEEEeehhh--------hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 507 NLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--------ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+.||+|++|.||+|.. +|..|++|+..... ......+..|+.++..+.|+++.....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 67789999765322 11234577899999999999988877777777788999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
++|++|.+++.... + .+..++.+++.++.++| ..+++|||++|.||+++ ++.++++|||.++.
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH----~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH----SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH----hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999987532 2 78899999999999999 67899999999999999 78999999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-17 Score=162.03 Aligned_cols=141 Identities=20% Similarity=0.171 Sum_probs=110.3
Q ss_pred ccccccccCCCcceEEEEEE--ecCCcEEEEEEeehhhh------------------------HHHHHHHHHHHHHHhcc
Q 003855 502 EFNECNLLGTGSFGSVYKGT--ISDGTDVAIKIFNLQLE------------------------RAFRSFDSECEVLRNVR 555 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l~ 555 (791)
-|++.+.||+|+||.||+|. ..+|+.||+|++..... .....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 56899999999864321 01134568999999997
Q ss_pred CCc--cceeeeeeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCC-eEecCCCCCC
Q 003855 556 HRN--LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP-IIHCDLKPTN 632 (791)
Q Consensus 556 h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~-i~H~dlk~~N 632 (791)
+.. +.+++++ ...++||||++++++..+..... .....+...++.|++.++.||| ..+ ++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY----KEGELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH----hcCCEEeCCCChhh
Confidence 533 3444443 23489999999988877653322 3555667889999999999999 678 9999999999
Q ss_pred eEeCCCCcEEEeeecccccc
Q 003855 633 ILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 633 ill~~~~~~kl~Dfgla~~~ 652 (791)
|+++ ++.++++|||.|...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=155.22 Aligned_cols=138 Identities=20% Similarity=0.193 Sum_probs=109.2
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhh----------------------HHHHHHHHHHHHHHhccCCc
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE----------------------RAFRSFDSECEVLRNVRHRN 558 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~n 558 (791)
..|.+.+.||+|+||.||+|...+|+.||||++..... .....+..|..++..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 34778899999999999999988899999998754210 01123667888999988774
Q ss_pred --cceeeeeeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC
Q 003855 559 --LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD 636 (791)
Q Consensus 559 --iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~ 636 (791)
+...++. ...++||||+++++|.+.... .....++.+++.++.++| ..+++||||+|+||+++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh----~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY----KHGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH----HCCCCcCCCCcccEEEc
Confidence 4444432 345899999999999775431 245678899999999999 67899999999999999
Q ss_pred CCCcEEEeeeccccccC
Q 003855 637 ENMAAHVSDFGISKLLG 653 (791)
Q Consensus 637 ~~~~~kl~Dfgla~~~~ 653 (791)
+++.++|+|||.+....
T Consensus 160 ~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcEEEEECCccccCC
Confidence 99999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.5e-16 Score=176.25 Aligned_cols=137 Identities=23% Similarity=0.308 Sum_probs=111.6
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehh--h------hHHHHHHHHHHHHHHhccCCccceeeeeeccCCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQ--L------ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 571 (791)
...|...+.||+|+||+||+|.+... .+++|+.... . ....+.+.+|++++++++|++++....++.++..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34556788999999999999987543 4444432211 0 1123568899999999999999988887777777
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++||||+++++|.+++. ....++.++++++.||| ..+++|||+||+||++ +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH----~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH----KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH----hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999886 35678999999999999 6789999999999999 678999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.3e-16 Score=153.39 Aligned_cols=130 Identities=24% Similarity=0.361 Sum_probs=106.8
Q ss_pred ccCCCcceEEEEEEecCCcEEEEEEeehhh--------hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 508 LLGTGSFGSVYKGTISDGTDVAIKIFNLQL--------ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 508 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.||+|+||.||+|.+ ++..|++|+..... ....+.+.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 67889999864321 112356778999999999887666555555666778999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
+|++|.+++..... .++.+++++|.++| ..+++|||++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH----~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH----KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH----HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998764321 78999999999999 78999999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.5e-17 Score=182.48 Aligned_cols=213 Identities=23% Similarity=0.270 Sum_probs=145.4
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.+|..++.|..|+||.||..+++ +.+.+|.|+=+.. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee-------------------
Confidence 67899999999999999999876 5677888542211 00000 22222333333
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC---
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE--- 656 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~--- 656 (791)
||-...+...+. ++. +++.+++|+| +.+|+|||+||+|.+++.-|.+|++|||+++......
T Consensus 136 --gDc~tllk~~g~-lPv--------dmvla~Eylh----~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 --GDCATLLKNIGP-LPV--------DMVLAVEYLH----SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred --chhhhhcccCCC-Ccc--------hhhHHhHhhc----cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 555555554332 222 2278899999 7899999999999999999999999999987532110
Q ss_pred -----C-----cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCCh
Q 003855 657 -----D-----SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL 726 (791)
Q Consensus 657 -----~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 726 (791)
. .......+||+.|+|||++....|...+|+|++|+|+||.+.|+.||.+.. .|..+...+...+. +
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt-peelfg~visd~i~--w 277 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVISDDIE--W 277 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC-HHHHHhhhhhhhcc--c
Confidence 0 011223479999999999999999999999999999999999999998732 22223332221110 0
Q ss_pred hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 003855 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772 (791)
Q Consensus 727 ~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev 772 (791)
. +.....+.++.+++.+.++.+|..|--....
T Consensus 278 p--------------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 278 P--------------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred c--------------ccCcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 0 0112344667899999999999999754433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.9e-17 Score=172.77 Aligned_cols=173 Identities=23% Similarity=0.387 Sum_probs=129.1
Q ss_pred eeeEEEecCCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecc
Q 003855 571 FKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGI 648 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl 648 (791)
..++.|++|...+|.+|+..+ ....++.....++.|++.|++| ++.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-------ccchhhhccccccccccchhhhhhhhhh
Confidence 578999999999999999733 3457888899999999999999 2689999999999999999999999999
Q ss_pred ccccCCCC----CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcC
Q 003855 649 SKLLGEGE----DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLP 723 (791)
Q Consensus 649 a~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 723 (791)
........ .....+..+||..||+||.+.+..|+.|+||||+|++++|++. =..+++. ...+.+. .
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~-----r 473 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDI-----R 473 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhh-----h
Confidence 98765544 2234555689999999999999999999999999999999997 2222221 1111110 0
Q ss_pred CChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 003855 724 HGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772 (791)
Q Consensus 724 ~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev 772 (791)
...+++.+.. ++ ++-..++.+++.+.|.+||++.++
T Consensus 474 ---~g~ip~~~~~---------d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 ---DGIIPPEFLQ---------DY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ---cCCCChHHhh---------cC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 0111111111 11 122478999999999999955443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-16 Score=178.38 Aligned_cols=256 Identities=22% Similarity=0.284 Sum_probs=195.3
Q ss_pred hhccccccccCCCcceEEEEEEec--CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhcc-CCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS--DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 574 (791)
...|...+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++++++...+++..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 346777888999999999887653 34456666554432 333445555777766675 9999999999999999999
Q ss_pred EEecCCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC-cEEEeeecccccc
Q 003855 575 VLEFMPNGSLEKWL-YSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-AAHVSDFGISKLL 652 (791)
Q Consensus 575 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~ 652 (791)
+.+|..+|++.+.+ .......+.........|+..++.|+|. ..++.|||+||+|.+++..+ ..+++|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~---~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP---ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc---ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999999988 5443246666777889999999999994 45799999999999999999 9999999999988
Q ss_pred CC-CCCcceeecccc-cccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh
Q 003855 653 GE-GEDSVTQTMTMA-TIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV 729 (791)
Q Consensus 653 ~~-~~~~~~~~~~~g-~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
.. ..........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++........+..|........
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 251 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT---- 251 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc----
Confidence 77 444455555678 999999998777 45667899999999999999999999876555555455544321100
Q ss_pred cchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003855 730 VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAA 773 (791)
Q Consensus 730 ~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~ 773 (791)
...+........++..+++..+|+.|.+.+++.
T Consensus 252 -----------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 -----------QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -----------cCccccCChhhhhcccccccCCchhcccccccc
Confidence 001112234456888899999999999988764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=141.93 Aligned_cols=136 Identities=22% Similarity=0.255 Sum_probs=96.9
Q ss_pred ccccCCCcceEEEEEEecCCcEEEEEEeehhhhH--HHHH----------------------HHHHHHHHHhccCCc--c
Q 003855 506 CNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLER--AFRS----------------------FDSECEVLRNVRHRN--L 559 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i 559 (791)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998653211 1111 134555555554432 3
Q ss_pred ceeeeeeccCCeeeEEEecCCCCCHHHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CCeEecCCCCCCeEeCC
Q 003855 560 IKILSSCSNPDFKALVLEFMPNGSLEKW-LYSHNYFLDILERLNIMIDVGSALEYLHHGHSS-APIIHCDLKPTNILLDE 637 (791)
Q Consensus 560 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~~i~H~dlk~~Nill~~ 637 (791)
.+.+++ ...++||||++++++... +.... .. .+...++.+++.++.++| . .+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh----~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY----REAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh----hccCcCcCCCChhhEEEE-
Confidence 333433 235899999998543211 11111 11 567789999999999999 5 7899999999999999
Q ss_pred CCcEEEeeeccccccC
Q 003855 638 NMAAHVSDFGISKLLG 653 (791)
Q Consensus 638 ~~~~kl~Dfgla~~~~ 653 (791)
++.++++|||.|....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 9999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.4e-14 Score=134.29 Aligned_cols=135 Identities=23% Similarity=0.284 Sum_probs=113.5
Q ss_pred cccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccC--CccceeeeeeccCCeeeEEEecCCCC
Q 003855 505 ECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRH--RNLIKILSSCSNPDFKALVLEFMPNG 582 (791)
Q Consensus 505 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 582 (791)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..++.++| +.+++++++...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35689999999999999854 7899998865433 4578889999999976 58999999888888899999999988
Q ss_pred CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 583 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 583 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
++..+ +......++.+++++++++|..+ ..+++|+|++|+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77653 55677788999999999999432 24799999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.5e-16 Score=164.23 Aligned_cols=178 Identities=30% Similarity=0.493 Sum_probs=138.6
Q ss_pred CCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeE
Q 003855 213 RLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDI 292 (791)
Q Consensus 213 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 292 (791)
.+..-...||+.|++. .+|..++.+-.|+.+.|++|.|. .+|..++++..|+.|+|+.|++. ..|..++.++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3445566777777777 77777777777777888888877 67777888888888888888886 5666677665 7788
Q ss_pred EccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccC
Q 003855 293 NLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS 372 (791)
Q Consensus 293 ~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 372 (791)
-+++|+++ .+|..++....|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|..++.| .|..||+|.|+++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 88888886 67777887788888888888887 67777888888888888888887 566777754 6788888888888
Q ss_pred CCCchhhhhcccCceEEccCCCCcccC
Q 003855 373 GKIPKSLETLSQLKQFNVSHNRLEGEI 399 (791)
Q Consensus 373 ~~~~~~~~~l~~L~~l~l~~N~l~~~~ 399 (791)
.+|-.|.+|+.|++|-|.+|+|...+
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCCCCh
Confidence 78888888888888888888887644
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.9e-14 Score=139.59 Aligned_cols=135 Identities=18% Similarity=0.215 Sum_probs=104.0
Q ss_pred cccC-CCcceEEEEEEecCCcEEEEEEeehhh------h-------HHHHHHHHHHHHHHhccCCcc--ceeeeeeccC-
Q 003855 507 NLLG-TGSFGSVYKGTISDGTDVAIKIFNLQL------E-------RAFRSFDSECEVLRNVRHRNL--IKILSSCSNP- 569 (791)
Q Consensus 507 ~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~------~-------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~- 569 (791)
..|| .|+.|+||.+... +..++||.+.... . .....+.+|++++.+++|+++ ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8899999998874 7789999875311 1 122457789999999998875 6667664332
Q ss_pred C---eeeEEEecCCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEee
Q 003855 570 D---FKALVLEFMPN-GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSD 645 (791)
Q Consensus 570 ~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~D 645 (791)
. ..++||||+++ .+|.+++.... ++.. .+.+++.++.+|| ..+|+||||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~lH----~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARFH----DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHHH----HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 69999886532 4433 3578999999999 78999999999999999999999999
Q ss_pred ecccccc
Q 003855 646 FGISKLL 652 (791)
Q Consensus 646 fgla~~~ 652 (791)
||.++..
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988753
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1e-13 Score=158.65 Aligned_cols=119 Identities=39% Similarity=0.671 Sum_probs=104.3
Q ss_pred CCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEcc
Q 003855 312 VLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVS 391 (791)
Q Consensus 312 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 391 (791)
.++.|+|++|.+.+.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|++++.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccCCCC--CCCcCCccccccCCccccCCCCCCCCCCCC
Q 003855 392 HNRLEGEIPVK--GSFKNFSVESFFGNYALCGPPKLRVPPCKP 432 (791)
Q Consensus 392 ~N~l~~~~~~~--~~~~~l~~~~~~~n~~~c~~~~~~~~~c~~ 432 (791)
+|+++|.+|.. ..+..+..+.+.+|+.+|+.+. .++|.+
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~~ 539 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACGP 539 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCcc
Confidence 99999999864 1223455678899999999764 356753
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.9e-15 Score=156.46 Aligned_cols=197 Identities=27% Similarity=0.433 Sum_probs=165.3
Q ss_pred cCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcE
Q 003855 188 GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRE 267 (791)
Q Consensus 188 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 267 (791)
..+.--...||+.|++. .+|..+..+..|+.|.|.+|.|. .+|..++++..|+.|+|+.|+++ ..|..++.++ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 34555667899999998 77888888888999999999998 78889999999999999999998 7777788775 899
Q ss_pred EEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccC
Q 003855 268 LHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQF 347 (791)
Q Consensus 268 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 347 (791)
|.+++|+++ .+|+.++.+..|..|+.+.|+|. .+|..++.+.+|+.|.+..|.+. .+|..++. -.|..||+|.|++
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNki 223 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKI 223 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCce
Confidence 999999998 67888888889999999999996 67888999999999999999998 67777774 4688999999999
Q ss_pred CCCCCcccCCCCCCcEEEccCCccCCCCchhhhhccc---CceEEccCCC
Q 003855 348 QGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQ---LKQFNVSHNR 394 (791)
Q Consensus 348 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~---L~~l~l~~N~ 394 (791)
. .+|-.|.+|..|++|-|.+|++. ..|..+...-. .++|+..-++
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 9 89999999999999999999998 66766644332 3677777664
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.7e-13 Score=150.22 Aligned_cols=262 Identities=26% Similarity=0.336 Sum_probs=141.8
Q ss_pred EEeccCccccccccccccccccccccccccccccccCCCccccccccccCCC-CCCcEEEccCCCCcccCChhhhhhhhh
Q 003855 90 ALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNC-RNLTILSFGSNPLGGILPPVIGNFSAS 168 (791)
Q Consensus 90 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~~~~~ 168 (791)
.|+++.|.+.. .......+..++.|++.+|+++.++.. ...+ ++|+.|++++|++...
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~~i~~~---------~~~~~~nL~~L~l~~N~i~~l----------- 155 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNITDIPPL---------IGLLKSNLKELDLSDNKIESL----------- 155 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccccCccc---------cccchhhcccccccccchhhh-----------
Confidence 45555555531 222333445566666666666655431 2223 2666666666666521
Q ss_pred hhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecC
Q 003855 169 LQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTG 248 (791)
Q Consensus 169 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 248 (791)
|..+..+++|+.|++++|+++ ..+.....+++|+.|++++|+++ .+|........|++|.+++
T Consensus 156 ---------------~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~ 218 (394)
T COG4886 156 ---------------PSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSN 218 (394)
T ss_pred ---------------hhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcC
Confidence 123445566666666666665 33333335566666666666666 4444444445566666666
Q ss_pred CccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCC
Q 003855 249 NKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP 328 (791)
Q Consensus 249 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 328 (791)
|.+. ..+..+.++.++..|.+.+|++. ..+..+..+++++.|++++|.++...+ ++.+.+|+.|++++|.+....+
T Consensus 219 N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 219 NSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred Ccce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccch
Confidence 6433 34455666666666667777665 235566666677777777777764433 6677777777777777775555
Q ss_pred cchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcc
Q 003855 329 STIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEG 397 (791)
Q Consensus 329 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 397 (791)
........... ... +.+. ..+........+...++..+... ..+..+.....+..++...+....
T Consensus 295 ~~~~~~~~~~~-~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 359 (394)
T COG4886 295 LIALLLLLLEL-LLN-LLLT-LKALELKLNSILLNNNILSNGET-SSPEALSILESLNNLWTLDNALDE 359 (394)
T ss_pred hhhccchhHHh-hhh-hhhh-ccccccccccccccccccccccc-ccchhhcccccccCceeccccccc
Confidence 43333222222 111 3333 22223333334444455555555 555566666666666666655543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=5e-13 Score=146.03 Aligned_cols=141 Identities=20% Similarity=0.268 Sum_probs=99.7
Q ss_pred cccCCCcceEEEEEEecCCcEEEEEEeehhhhHHH----------------------------------------HHHHH
Q 003855 507 NLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAF----------------------------------------RSFDS 546 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 546 (791)
+.||.|++|.||+|++++|+.||||+......+.. -+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999864321110 02444
Q ss_pred HHHHHHhcc-----CCccceeeeeeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHHccCCC
Q 003855 547 ECEVLRNVR-----HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS-ALEYLHHGHSS 620 (791)
Q Consensus 547 e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~~~~ 620 (791)
|+..+.+++ ++++.-..-+.......++||||++|+++.++........ .+.+++..++. .+..+| .
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~----~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL----R 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH----h
Confidence 555555552 3333222222222345689999999999998876432222 23456666666 467788 6
Q ss_pred CCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 621 ~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
.+++|+|++|.||++++++.++++|||++..+.+
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7899999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-13 Score=149.68 Aligned_cols=187 Identities=36% Similarity=0.544 Sum_probs=152.2
Q ss_pred cCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCC-CCCCEEEccCCccccccCccccCCCC
Q 003855 138 LTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNL-SGLTLLSLHSNDLNGTISPTMGRLKR 216 (791)
Q Consensus 138 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~ 216 (791)
+..++.++.|++.+|.++. ++.....+ .+|+.|++++|.+. .+|..+..+++
T Consensus 112 ~~~~~~l~~L~l~~n~i~~--------------------------i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~ 164 (394)
T COG4886 112 LLELTNLTSLDLDNNNITD--------------------------IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPN 164 (394)
T ss_pred hhcccceeEEecCCccccc--------------------------Cccccccchhhcccccccccchh-hhhhhhhcccc
Confidence 3444566666666666663 33444445 38999999999999 55577899999
Q ss_pred CCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccC
Q 003855 217 LQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSS 296 (791)
Q Consensus 217 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 296 (791)
|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.+++|++. ..+..+..+.++..+.+.+
T Consensus 165 L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~ 241 (394)
T COG4886 165 LKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSN 241 (394)
T ss_pred ccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCC
Confidence 999999999999 67766768999999999999999 67766667777999999999654 4667788999999999999
Q ss_pred CcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCC
Q 003855 297 NSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGS 357 (791)
Q Consensus 297 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 357 (791)
|++.. .+..++.+++|+.|++++|.++. ++. ++.+.+|+.|++++|.+...+|.....
T Consensus 242 n~~~~-~~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~ 299 (394)
T COG4886 242 NKLED-LPESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLIALL 299 (394)
T ss_pred ceeee-ccchhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhhhcc
Confidence 99974 46788999999999999999994 444 899999999999999999666654443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.6e-12 Score=127.51 Aligned_cols=197 Identities=21% Similarity=0.260 Sum_probs=136.8
Q ss_pred HHHhccCCccceeeeeeccC-----CeeeEEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCC
Q 003855 550 VLRNVRHRNLIKILSSCSNP-----DFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHHGHSSA 621 (791)
Q Consensus 550 ~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ 621 (791)
-+-++.|.|||+++.|+.+. ....++.|||+.|++.++|++. ...+......+++.||..||.|||.. .+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~--~P 197 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC--DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc--CC
Confidence 34456799999999998543 4567899999999999999843 33467777788999999999999963 56
Q ss_pred CeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC---CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHH
Q 003855 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE---DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 698 (791)
Q Consensus 622 ~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ell 698 (791)
+|+|+++.-+-|++..+|-+|++----.. ..... .........+-++|.|||+-.....+..+|||+||....||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 89999999999999999988874211111 10000 011112234678999999988888888999999999999999
Q ss_pred hCCCC-CCcccc--CcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 699 TRKRP-TDEMFT--GEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 699 tg~~p-~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+..- ...... .+...... .....+-+ -.+++..|++..|..||+|.+.+.
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~-----i~~len~l--------------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANV-----IIGLENGL--------------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhhhhhhh-----eeeccCcc--------------------ccCcCcccccCCCCCCcchhhhhc
Confidence 88753 221100 01110000 00000000 125788999999999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.6e-11 Score=132.56 Aligned_cols=167 Identities=16% Similarity=0.194 Sum_probs=129.8
Q ss_pred ecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHH
Q 003855 522 ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL 601 (791)
Q Consensus 522 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 601 (791)
..++.+|.|...+...........+-++.++.++||+|+++++.+......|+|+|.+. .|..++.+.+ ...+.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 34788888888876655555667778899999999999999999999999999999984 6777777643 55667
Q ss_pred HHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCC
Q 003855 602 NIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV 681 (791)
Q Consensus 602 ~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 681 (791)
..++||+.||.|||+ ...++|++|....|+|++.|+.||++|-++........ ......--..|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~---d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLND---DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHhc---cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 789999999999996 45799999999999999999999999998865432221 001111223467777654433
Q ss_pred CccccHHhHHHHHHHHHhCC
Q 003855 682 SAKCDVYSYGVLLMETFTRK 701 (791)
Q Consensus 682 ~~~~Dv~s~G~vl~elltg~ 701 (791)
-..|.|-|||++||++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 3459999999999999993
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.8e-14 Score=138.97 Aligned_cols=211 Identities=21% Similarity=0.296 Sum_probs=96.9
Q ss_pred cccCCCCCCeeecCCCcccc----cCCccccCCCCCcEEeCCCC---cCcccCCchhhhcCCCccEEEccCCcceecCCc
Q 003855 8 EIGNLQNLQYLVFAENNLSG----LVPPTIFNISTMRILTLEGN---QLSGRLPSTVGHLLPNIESLLLAANNLTGIIPH 80 (791)
Q Consensus 8 ~~~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~L~~n---~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~ 80 (791)
.+..+..+++|+||+|.+.. .+...+.+.++|+..++|+= ++..++|+.+-. ...
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~------------------l~~ 86 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKM------------------LSK 86 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHH------------------HHH
Confidence 34456667777777776632 23344555666666666652 222234443221 113
Q ss_pred cCcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCCh
Q 003855 81 SITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPP 160 (791)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 160 (791)
++...++|++||||.|-+....+..|..+ +.++..|++|.|.+|.+. |.
T Consensus 87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~l----------------------------l~s~~~L~eL~L~N~Glg---~~ 135 (382)
T KOG1909|consen 87 ALLGCPKLQKLDLSDNAFGPKGIRGLEEL----------------------------LSSCTDLEELYLNNCGLG---PE 135 (382)
T ss_pred HHhcCCceeEeeccccccCccchHHHHHH----------------------------HHhccCHHHHhhhcCCCC---hh
Confidence 34445566666666666553333333221 334555666666666554 22
Q ss_pred hhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCcccccc----CccccCCCCCCEEEcccccCcccC----C
Q 003855 161 VIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTI----SPTMGRLKRLQGLSLRNNNLEGSI----P 232 (791)
Q Consensus 161 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~----~ 232 (791)
.=..+...|..|. .++. ...-+.|+++...+|++.... ...|...+.|+.+.++.|.|.... .
T Consensus 136 ag~~l~~al~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~ 206 (382)
T KOG1909|consen 136 AGGRLGRALFELA--VNKK-------AASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALA 206 (382)
T ss_pred HHHHHHHHHHHHH--HHhc-------cCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHH
Confidence 2222223344443 1111 113345666666666664222 123444455666666666554211 1
Q ss_pred ccccccCCCceEEecCCccCCC----CCccccCCCCCcEEEcCCCcCC
Q 003855 233 YDLCHLKLMFGIRLTGNKLSGH----IPPCLVSLTSLRELHLGSNKLT 276 (791)
Q Consensus 233 ~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~ 276 (791)
..|..+++|+.|||.+|-++.. +...+..+++|++|++++|.+.
T Consensus 207 eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~ 254 (382)
T KOG1909|consen 207 EALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLE 254 (382)
T ss_pred HHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccc
Confidence 2234444444444444444321 1223333444444444444443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.8e-13 Score=129.83 Aligned_cols=209 Identities=22% Similarity=0.271 Sum_probs=142.2
Q ss_pred CccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecC-CccCCCCCccccCC
Q 003855 184 PQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTG-NKLSGHIPPCLVSL 262 (791)
Q Consensus 184 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l 262 (791)
|-.+.-+.+|..+.++.+.-..+ .+.-..-+.|+++.+.+..++. .| .+-..+.+..+.-+. .-.+|..-..+..-
T Consensus 207 ~f~l~~f~~l~~~~~s~~~~~~i-~~~~~~kptl~t~~v~~s~~~~-~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dTW 283 (490)
T KOG1259|consen 207 SFNLNAFRNLKTLKFSALSTENI-VDIELLKPTLQTICVHNTTIQD-VP-SLLPETILADPSGSEPSTSNGSALVSADTW 283 (490)
T ss_pred ccchHHhhhhheeeeeccchhhe-eceeecCchhheeeeecccccc-cc-cccchhhhcCccCCCCCccCCceEEecchH
Confidence 33344556677777777654422 2222334677888777766652 11 111111111111111 01112222222233
Q ss_pred CCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhcccccccccc
Q 003855 263 TSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSL 342 (791)
Q Consensus 263 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 342 (791)
..|++||||+|.|+ .+.++..-++.++.|++|+|.|..+ ..+..+++|+.||||+|.++ .+..+-..+.+.+.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 56899999999998 5667788889999999999999744 34888999999999999998 56666677899999999
Q ss_pred ccccCCCCCCcccCCCCCCcEEEccCCccCCCC-chhhhhcccCceEEccCCCCcccCCC
Q 003855 343 ARNQFQGPIPESVGSLISLESLDLSGNNLSGKI-PKSLETLSQLKQFNVSHNRLEGEIPV 401 (791)
Q Consensus 343 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~~ 401 (791)
+.|.|.. + ..+..+-+|..||+++|+|.... ...++++|.|+.+.|.+|++.+.+..
T Consensus 360 a~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 360 AQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred hhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence 9999973 2 45777889999999999997433 35788999999999999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.1e-12 Score=138.26 Aligned_cols=247 Identities=22% Similarity=0.251 Sum_probs=180.8
Q ss_pred ccccccccCC--CcceEEEEEEe---cCCcEEEEEEeehhhh--HHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeee
Q 003855 502 EFNECNLLGT--GSFGSVYKGTI---SDGTDVAIKIFNLQLE--RAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 502 ~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 573 (791)
.|.....+|. |.+|.||.+.. .++..+|+|.-+.... .....-.+|+.....+ .|++.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566778999 99999999986 3688899997443322 2222223455555555 4999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHHccCCCCCeEecCCCCCCeEeCCC-CcEEEeeecc
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS----ALEYLHHGHSSAPIIHCDLKPTNILLDEN-MAAHVSDFGI 648 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfgl 648 (791)
+-.|++ +.++.++.+.....++....+....+..+ |+.++| +..++|-|+||.||+...+ ..++++|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h----s~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH----SNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC----CCcccccccchhheecccccceeecCCcce
Confidence 999988 57999999887777888888889999988 999999 7789999999999999999 8899999999
Q ss_pred ccccCCCCCcce---eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCc-cccCcchHHHHHHHhcCC
Q 003855 649 SKLLGEGEDSVT---QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDE-MFTGEMSLRRWVKESLPH 724 (791)
Q Consensus 649 a~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~-~~~~~~~~~~~~~~~~~~ 724 (791)
...+.+...... .....|...|++||... +.++.+.|+|++|.++.|..++..+... ....-..+++++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------ 342 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------ 342 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc------
Confidence 998877653221 11225778899999764 5678899999999999999998765322 111111111110
Q ss_pred ChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 725 GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 725 ~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
-..+.++ .-..++...+..+++.+|-.|++++.+..
T Consensus 343 ip~e~~~--------------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 IPLEFCE--------------GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred Cchhhhc--------------CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0011111 11233445888999999999999887654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.7e-12 Score=121.34 Aligned_cols=114 Identities=28% Similarity=0.355 Sum_probs=40.9
Q ss_pred ccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccc
Q 003855 33 IFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHL 112 (791)
Q Consensus 33 ~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L 112 (791)
+.+..++++|+|++|+|+ .+. .+...+.+|++|+|++|.|+.+ ..+..+++|+.|++++|+|+.+.......+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNL 90 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence 445556777888888876 553 3443366778888888888754 357777888888888888876544333467888
Q ss_pred cccccccccccccCCCccccccccccCCCCCCcEEEccCCCCccc
Q 003855 113 SLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGI 157 (791)
Q Consensus 113 ~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 157 (791)
+.|++++|+|..+.. +..+..+++|+.|+|.+|+++..
T Consensus 91 ~~L~L~~N~I~~l~~-------l~~L~~l~~L~~L~L~~NPv~~~ 128 (175)
T PF14580_consen 91 QELYLSNNKISDLNE-------LEPLSSLPKLRVLSLEGNPVCEK 128 (175)
T ss_dssp -EEE-TTS---SCCC-------CGGGGG-TT--EEE-TT-GGGGS
T ss_pred CEEECcCCcCCChHH-------hHHHHcCCCcceeeccCCcccch
Confidence 888888888876543 34577889999999999998743
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.6e-11 Score=135.51 Aligned_cols=145 Identities=17% Similarity=0.227 Sum_probs=90.6
Q ss_pred hhccccccccCCCcceEEEEEEecC-CcEEEEEEeehhhhH----------------------------------HHHHH
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISD-GTDVAIKIFNLQLER----------------------------------AFRSF 544 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~~ 544 (791)
-..|+. +.||.|++|.||+|++++ |+.||||+......+ ..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 355776 789999999999999987 999999998754211 11122
Q ss_pred ------HHHHHHHHhcc----CCccceeeeeecc-CCeeeEEEecCCCCCHHHHH--hhCCCCCCHHHHHHHHHHHHHH-
Q 003855 545 ------DSECEVLRNVR----HRNLIKILSSCSN-PDFKALVLEFMPNGSLEKWL--YSHNYFLDILERLNIMIDVGSA- 610 (791)
Q Consensus 545 ------~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~i~~~i~~~- 610 (791)
..|+..+.+++ +...+.+=..+.+ ....++||||++|+++.++- ...+ .+... ++...++.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~~---la~~~v~~~ 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMKL---LAERGVEVF 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHHH---HHHHHHHHH
Confidence 23333333331 2222222111111 23457999999999998753 2222 22221 22222211
Q ss_pred HHHHHccCCCCCeEecCCCCCCeEeCCCC----cEEEeeeccccccCC
Q 003855 611 LEYLHHGHSSAPIIHCDLKPTNILLDENM----AAHVSDFGISKLLGE 654 (791)
Q Consensus 611 l~~LH~~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfgla~~~~~ 654 (791)
+..+. ..+++|+|++|.||+++.++ .+++.|||++..+.+
T Consensus 273 ~~Qif----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 273 FTQVF----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHH----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 22233 35899999999999999888 999999999987754
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.2e-13 Score=133.83 Aligned_cols=178 Identities=21% Similarity=0.276 Sum_probs=102.5
Q ss_pred cccCCCCCCcEEEccCCCCcccCChhhhhhhh---hhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCcccc
Q 003855 136 SSLTNCRNLTILSFGSNPLGGILPPVIGNFSA---SLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMG 212 (791)
Q Consensus 136 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~---~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 212 (791)
+++-++++|++||||.|-+....+..+..+.. +|++|+|.+|.+...-...++. .|..|. .| ...+
T Consensus 86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~-------kk~~ 154 (382)
T KOG1909|consen 86 KALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VN-------KKAA 154 (382)
T ss_pred HHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HH-------hccC
Confidence 45778889999999999998766666665532 3555555555554222222211 111111 11 1233
Q ss_pred CCCCCCEEEcccccCcccCC----ccccccCCCceEEecCCccCCC----CCccccCCCCCcEEEcCCCcCCCC----CC
Q 003855 213 RLKRLQGLSLRNNNLEGSIP----YDLCHLKLMFGIRLTGNKLSGH----IPPCLVSLTSLRELHLGSNKLTSS----IP 280 (791)
Q Consensus 213 ~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~ 280 (791)
.-++|+++....|++..... ..|...+.|+.+.++.|.|... ....|..+++|+.|||..|-++.. +.
T Consensus 155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La 234 (382)
T KOG1909|consen 155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA 234 (382)
T ss_pred CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence 45788999999998874332 3456667888888888887522 234566777777777777777632 22
Q ss_pred ccccCCCCCCeEEccCCcCcccCCccc-----ccCCCCCEEecCCcccC
Q 003855 281 SSLWSLEYILDINLSSNSLNDSLPSNV-----QKLKVLTVLDLSRNQLS 324 (791)
Q Consensus 281 ~~~~~l~~L~~L~l~~N~i~~~~~~~~-----~~l~~L~~L~l~~N~l~ 324 (791)
..++.+++|+.|++++|.+......+| ...++|+.|.|.+|.|+
T Consensus 235 kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 235 KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 344445555555555555543322222 12344444444444444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.1e-12 Score=117.67 Aligned_cols=128 Identities=29% Similarity=0.377 Sum_probs=45.0
Q ss_pred ccCCCCCcEEEcCCCcCCCCCCcccc-CCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcch-hcccc
Q 003855 259 LVSLTSLRELHLGSNKLTSSIPSSLW-SLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTI-GALKD 336 (791)
Q Consensus 259 ~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~ 336 (791)
+.+..++++|+|++|+|+.+ +.+. .+.+|+.|+|++|.|+.. +.+..++.|+.|++++|+|+. ++..+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 33444567777777777632 2344 456777777777777643 246667778888888888873 44334 35778
Q ss_pred ccccccccccCCCCC-CcccCCCCCCcEEEccCCccCCCCc---hhhhhcccCceEEcc
Q 003855 337 LETLSLARNQFQGPI-PESVGSLISLESLDLSGNNLSGKIP---KSLETLSQLKQFNVS 391 (791)
Q Consensus 337 L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~l~l~ 391 (791)
|++|+|++|+|...- -..++.+++|+.|+|.+|+++...- ..+..+|+|+.||-.
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 888888888876421 2456678888888888888874321 246677888877643
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.7e-13 Score=145.04 Aligned_cols=88 Identities=28% Similarity=0.323 Sum_probs=53.7
Q ss_pred CCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCC---CCCcc-cCCCCCCcEE
Q 003855 289 ILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQG---PIPES-VGSLISLESL 364 (791)
Q Consensus 289 L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---~~~~~-~~~l~~L~~L 364 (791)
|+.+++++|.+.. .+..+..+..+..|++++|++... ..+.....+..+.+..|.+.. ..... .+..+.++.+
T Consensus 234 L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (414)
T KOG0531|consen 234 LRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTL 310 (414)
T ss_pred HHHHhcccCcccc-ccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcccccccccccccc
Confidence 5555666665542 224455666777777777777632 234556667777777777652 11122 4566788888
Q ss_pred EccCCccCCCCchhh
Q 003855 365 DLSGNNLSGKIPKSL 379 (791)
Q Consensus 365 ~l~~N~l~~~~~~~~ 379 (791)
.+..|.+....+...
T Consensus 311 ~~~~~~~~~~~~~~~ 325 (414)
T KOG0531|consen 311 TLELNPIRKISSLDL 325 (414)
T ss_pred ccccCcccccccccH
Confidence 888888876655443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.1e-12 Score=126.68 Aligned_cols=129 Identities=29% Similarity=0.374 Sum_probs=73.5
Q ss_pred CCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecC
Q 003855 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLS 319 (791)
Q Consensus 240 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~ 319 (791)
.|+++|||+|.|+ .+.....=+|.++.|++|+|.|..+ +.+..+++|+.||||+|.++ .+..+-.++.+++.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 3444444444444 2333333344444444444444421 12444455555555555544 222333455666777777
Q ss_pred CcccCCCCCcchhccccccccccccccCCCCC-CcccCCCCCCcEEEccCCccCCC
Q 003855 320 RNQLSGDIPSTIGALKDLETLSLARNQFQGPI-PESVGSLISLESLDLSGNNLSGK 374 (791)
Q Consensus 320 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~ 374 (791)
.|.|.+ -+.++.+-+|..||+++|+|.... -..++++|.|+.|.|.+|++.+.
T Consensus 361 ~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 361 QNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 777652 234666777777888888776321 35688999999999999999844
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.8e-11 Score=140.25 Aligned_cols=114 Identities=38% Similarity=0.660 Sum_probs=105.6
Q ss_pred CCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEcc
Q 003855 288 YILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLS 367 (791)
Q Consensus 288 ~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 367 (791)
.++.|+|++|.+++.+|..++.+++|+.|+|++|.+.+.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccCCCCchhhhhc-ccCceEEccCCCCcccCCC
Q 003855 368 GNNLSGKIPKSLETL-SQLKQFNVSHNRLEGEIPV 401 (791)
Q Consensus 368 ~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~~ 401 (791)
+|+++|.+|..+..+ .++..+++.+|+..|..|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence 999999999998764 5778999999987665553
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.3e-12 Score=143.32 Aligned_cols=268 Identities=22% Similarity=0.251 Sum_probs=147.9
Q ss_pred CCCeeecCCCcccccCCccc-cCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEe
Q 003855 14 NLQYLVFAENNLSGLVPPTI-FNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALD 92 (791)
Q Consensus 14 ~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 92 (791)
.++.++..++.+... ..+ ..+..++.++++.|.|. .+-..+.. +++|+.|++.+|+|..+ ...+..+++|++|+
T Consensus 50 ~~~~~~~~~~~~~~~--~~~~~~l~~l~~l~l~~n~i~-~~~~~l~~-~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ 124 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSD--EDLVESLTSLKELNLRQNLIA-KILNHLSK-LKSLEALDLYDNKIEKI-ENLLSSLVNLQVLD 124 (414)
T ss_pred hhhhhcchhccccch--hhhHHHhHhHHhhccchhhhh-hhhccccc-ccceeeeeccccchhhc-ccchhhhhcchhee
Confidence 344445554443321 111 45667777778888886 42222322 67888888888888843 33367788888888
Q ss_pred ccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhh
Q 003855 93 LGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKF 172 (791)
Q Consensus 93 L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L 172 (791)
|++|+|+.+. .+..++.|+.|++++|.|+.+. .+..+++|+.+++++|++...-+... .....++.+
T Consensus 125 ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~~----------~~~~l~~L~~l~l~~n~i~~ie~~~~-~~~~~l~~l 191 (414)
T KOG0531|consen 125 LSFNKITKLE--GLSTLTLLKELNLSGNLISDIS----------GLESLKSLKLLDLSYNRIVDIENDEL-SELISLEEL 191 (414)
T ss_pred cccccccccc--chhhccchhhheeccCcchhcc----------CCccchhhhcccCCcchhhhhhhhhh-hhccchHHH
Confidence 8888887543 4566666888888888887754 35667888888888888875433101 112334555
Q ss_pred hcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccC
Q 003855 173 YAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLS 252 (791)
Q Consensus 173 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 252 (791)
++.+|.+..+ ..+..+..+..+++..|.++.+.+ +..+.. ..|+.+++++|.+.
T Consensus 192 ~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~----------------------~~L~~l~l~~n~i~ 245 (414)
T KOG0531|consen 192 DLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVM----------------------LHLRELYLSGNRIS 245 (414)
T ss_pred hccCCchhcc--cchHHHHHHHHhhcccccceeccC--cccchh----------------------HHHHHHhcccCccc
Confidence 5555555421 222333333444555555542211 111111 02444555555544
Q ss_pred CCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCccc---CCc-ccccCCCCCEEecCCcccCCCCC
Q 003855 253 GHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDS---LPS-NVQKLKVLTVLDLSRNQLSGDIP 328 (791)
Q Consensus 253 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~---~~~-~~~~l~~L~~L~l~~N~l~~~~~ 328 (791)
..+..+..++++..|++.+|++... ..+.....+..+.+..|.+... ... .....+.++.+.+..|.+....+
T Consensus 246 -~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 246 -RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred -cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 2223445555566666666666422 2234444555555555555421 111 14556778888888888875444
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.3e-11 Score=115.30 Aligned_cols=131 Identities=18% Similarity=0.196 Sum_probs=95.4
Q ss_pred ccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccc-eeeeeeccCCeeeEEEecCCCCCH
Q 003855 506 CNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI-KILSSCSNPDFKALVLEFMPNGSL 584 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L 584 (791)
++.++.|.++.||+++.. +..|++|+...... ....+..|+.+++.+.+.+++ +++++.. ...++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 357899999999999874 77899998754432 123467899999988655544 4444432 345799999999887
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 585 EKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS-SAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 585 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
.+. . .....++.+++++++.||.... ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~----~-----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE----D-----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc----c-----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 643 0 1123456789999999994221 22369999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.6e-12 Score=129.03 Aligned_cols=210 Identities=20% Similarity=0.142 Sum_probs=98.0
Q ss_pred CCccEEEccCCcceecCC-ccCcCCCCCCEEeccCccccccc--cccccccccccccccccccccccCCCcccccccccc
Q 003855 62 PNIESLLLAANNLTGIIP-HSITNATKLVALDLGFNSFAGHI--LNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSL 138 (791)
Q Consensus 62 ~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l 138 (791)
.+|+...|.+..+..... .....+++++.||||.|-+.... ......|++|+.|+++.|++.....+.. -
T Consensus 121 kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~-------~ 193 (505)
T KOG3207|consen 121 KKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNT-------T 193 (505)
T ss_pred HhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccc-------h
Confidence 344444444444441111 23444555555555555544321 2234455666666666666554332221 1
Q ss_pred CCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCcccccc-CccccCCCCC
Q 003855 139 TNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTI-SPTMGRLKRL 217 (791)
Q Consensus 139 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L 217 (791)
..+++|+.|.|+.|.++-.--..+....++|+.|+|..|...........-++.|+.|||++|++.... ....+.++.|
T Consensus 194 ~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L 273 (505)
T KOG3207|consen 194 LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGL 273 (505)
T ss_pred hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccch
Confidence 245778888888888773211122222234455555544322222222333444555555555543211 1223444455
Q ss_pred CEEEcccccCcccCCccccccCCCceEEecCCccCCCCCcc-----ccCCCCCcEEEcCCCcCCCC-CCccccCCCCCCe
Q 003855 218 QGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPC-----LVSLTSLRELHLGSNKLTSS-IPSSLWSLEYILD 291 (791)
Q Consensus 218 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~-----~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~ 291 (791)
..|+++.|.|..+- .|+. ...+++|+.|+++.|+|... .-..+..+++|+.
T Consensus 274 ~~Lnls~tgi~si~-----------------------~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~ 330 (505)
T KOG3207|consen 274 NQLNLSSTGIASIA-----------------------EPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKH 330 (505)
T ss_pred hhhhccccCcchhc-----------------------CCCccchhhhcccccceeeecccCccccccccchhhccchhhh
Confidence 55555555444211 1222 23455666677776666422 1123444566666
Q ss_pred EEccCCcCcc
Q 003855 292 INLSSNSLND 301 (791)
Q Consensus 292 L~l~~N~i~~ 301 (791)
|.+..|.++.
T Consensus 331 l~~~~n~ln~ 340 (505)
T KOG3207|consen 331 LRITLNYLNK 340 (505)
T ss_pred hhcccccccc
Confidence 6666666653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.2e-12 Score=131.30 Aligned_cols=214 Identities=21% Similarity=0.160 Sum_probs=141.0
Q ss_pred cCCCCCCEEeccCcccccccc-ccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChh
Q 003855 83 TNATKLVALDLGFNSFAGHIL-NTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPV 161 (791)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 161 (791)
.++.+|+...|.+..+..... .....+++++.|+|+.|-+..... ...-...+|+|+.|+|+.|++......
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~------v~~i~eqLp~Le~LNls~Nrl~~~~~s- 190 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFP------VLKIAEQLPSLENLNLSSNRLSNFISS- 190 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHH------HHHHHHhcccchhcccccccccCCccc-
Confidence 345566666666666653332 345556666666666665553221 112234556666666666665421110
Q ss_pred hhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCcccccc-CccccCCCCCCEEEcccccCcccCCccccccCC
Q 003855 162 IGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTI-SPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240 (791)
Q Consensus 162 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 240 (791)
. .-..+++|+.|.|+.|.++... ......+|+|+.|+|..|...........-++.
T Consensus 191 --------------------~---~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~ 247 (505)
T KOG3207|consen 191 --------------------N---TTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQT 247 (505)
T ss_pred --------------------c---chhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhH
Confidence 0 0124678899999999997332 223457899999999999644355556667888
Q ss_pred CceEEecCCccCCCC-CccccCCCCCcEEEcCCCcCCCCC-Ccc-----ccCCCCCCeEEccCCcCccc-CCcccccCCC
Q 003855 241 MFGIRLTGNKLSGHI-PPCLVSLTSLRELHLGSNKLTSSI-PSS-----LWSLEYILDINLSSNSLNDS-LPSNVQKLKV 312 (791)
Q Consensus 241 L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~-~~~-----~~~l~~L~~L~l~~N~i~~~-~~~~~~~l~~ 312 (791)
|+.|||++|.+.... -...+.++.|+.|+++.|.+.++. |+. ...+++|++|+++.|+|.+. .-..+..+++
T Consensus 248 L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~n 327 (505)
T KOG3207|consen 248 LQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLEN 327 (505)
T ss_pred HhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccch
Confidence 999999999887322 245788999999999999998653 322 34578999999999999632 1134566788
Q ss_pred CCEEecCCcccCCC
Q 003855 313 LTVLDLSRNQLSGD 326 (791)
Q Consensus 313 L~~L~l~~N~l~~~ 326 (791)
|+.|.+..|.+..+
T Consensus 328 lk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 328 LKHLRITLNYLNKE 341 (505)
T ss_pred hhhhhccccccccc
Confidence 89999999999843
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.7e-10 Score=106.66 Aligned_cols=136 Identities=21% Similarity=0.222 Sum_probs=97.4
Q ss_pred cccCCCcceEEEEEEecC-------CcEEEEEEeehhh------------h----------HHHHH----HHHHHHHHHh
Q 003855 507 NLLGTGSFGSVYKGTISD-------GTDVAIKIFNLQL------------E----------RAFRS----FDSECEVLRN 553 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~----~~~e~~~l~~ 553 (791)
..||.|.-+.||.|...+ +..+|||+.+... . ...+. .++|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999998543 4799999875321 0 01122 3479999998
Q ss_pred ccC--CccceeeeeeccCCeeeEEEecCCCCCHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHH-HccCCCCCeEecCCC
Q 003855 554 VRH--RNLIKILSSCSNPDFKALVLEFMPNGSLEK-WLYSHNYFLDILERLNIMIDVGSALEYL-HHGHSSAPIIHCDLK 629 (791)
Q Consensus 554 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~~i~H~dlk 629 (791)
+.. -++.+++++ ...++||||+.++.+.. .+... .++..+...+..+++.++..+ | ..+++|||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H----~~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK----ECNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH----hCCeecCCCC
Confidence 853 355566654 44689999997653322 22221 244556677889999999999 6 5689999999
Q ss_pred CCCeEeCCCCcEEEeeeccccccC
Q 003855 630 PTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 630 ~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+.||+++ ++.+.++|||.|....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.3e-10 Score=100.41 Aligned_cols=142 Identities=21% Similarity=0.251 Sum_probs=106.9
Q ss_pred cccccCCCcceEEEEEEecCCcEEEEEEeehhh--------hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 505 ECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--------ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 505 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
....+-||+-+.|+++.+ .|+...||.-.... .-..+...+|++.+.+++--.|....-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456788999999999998 57777777432221 122456778999999987666666666666777778999
Q ss_pred ecCCC-CCHHHHHhhCCCCCCHHH-HHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC---cEEEeeeccccc
Q 003855 577 EFMPN-GSLEKWLYSHNYFLDILE-RLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM---AAHVSDFGISKL 651 (791)
Q Consensus 577 e~~~~-g~L~~~l~~~~~~~~~~~-~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfgla~~ 651 (791)
||++| .++.+++......-.... ....+..|-+.+.-|| ...|+|+||..+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH----~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH----DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh----hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 488899886533222333 3678899999999999 67899999999999997554 458999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.9e-10 Score=101.33 Aligned_cols=131 Identities=23% Similarity=0.330 Sum_probs=102.3
Q ss_pred cccCCCcceEEEEEEecCCcEEEEEEeehhh--------hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 507 NLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--------ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
..+++|+-+.+|.+.+. |.++++|.-.++. +-..+.-..|++++.+++--.|....-+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999874 4457777532221 11234567799999998776776666677788888999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
++|..|.+++... ...++..+-.-+.-|| ..+|+|+|+.++||++..+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH----~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH----KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH----hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888765 2456777888888999 78999999999999998765 99999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.9e-11 Score=126.78 Aligned_cols=249 Identities=20% Similarity=0.151 Sum_probs=171.6
Q ss_pred HhhccccccccCCCcceEEEEEEec--CCcEEEEEEeehhhhHHHHH--HHHHHHHHHhc-cCCccceeeeeeccCCeee
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS--DGTDVAIKIFNLQLERAFRS--FDSECEVLRNV-RHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 573 (791)
-..+|..+..||.|.|+.|++...+ ++..|++|...........+ -..|+.+...+ -|.+++.....+..-+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3467888999999999999998754 67889999765433211111 12344444444 5888888877777777778
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC-CcEEEeeecccccc
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN-MAAHVSDFGISKLL 652 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfgla~~~ 652 (791)
+--||+++++....... ...++...++++..|++.++.++| ++.++|+|+||+||++..+ +..+++|||.++.+
T Consensus 343 ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~----s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIH----SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred CchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhcccccc----chhhhcccccccceeeccchhhhhcccccccccc
Confidence 88999999988876632 223677788999999999999999 7899999999999999886 88899999998642
Q ss_pred CCCCCcceeeccccccccc--CCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 653 GEGEDSVTQTMTMATIGYM--APEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
.- ........-+++ +|+......+-.++|+||||.-+.|.+++..--+. . ..|..- ..+
T Consensus 418 ~~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~------~~~~~i--~~~----- 478 (524)
T KOG0601|consen 418 AF-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-G------VQSLTI--RSG----- 478 (524)
T ss_pred ce-----ecccccccccccccchhhccccccccccccccccccccccccCcccCcc-c------ccceee--ecc-----
Confidence 11 111112233344 55666677888999999999999999998753211 0 011000 000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
..+........+..+...+...++..||.+.+.....+..+
T Consensus 479 ---------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 479 ---------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ---------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00000011245567888889999999999988876655443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.9e-10 Score=110.52 Aligned_cols=143 Identities=22% Similarity=0.250 Sum_probs=110.4
Q ss_pred cccCCCcceEEEEEEecCCcEEEEEEeehhhh-HHHHHHHHHHHHHHhccC--CccceeeeeeccCC---eeeEEEecCC
Q 003855 507 NLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRH--RNLIKILSSCSNPD---FKALVLEFMP 580 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 580 (791)
+.++.|..+.||++...+|+.+++|+...... .....+..|+++++.+++ ..+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778999998754432 134577889999999965 34567777776542 5689999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccC------------------------------------------
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH------------------------------------------ 618 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------ 618 (791)
|.++.+.+.. ..++..+...++.++++++.+||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888775532 23677788888899999999998410
Q ss_pred ----------CCCCeEecCCCCCCeEeCC--CCcEEEeeeccccc
Q 003855 619 ----------SSAPIIHCDLKPTNILLDE--NMAAHVSDFGISKL 651 (791)
Q Consensus 619 ----------~~~~i~H~dlk~~Nill~~--~~~~kl~Dfgla~~ 651 (791)
....++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1346899999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-10 Score=135.14 Aligned_cols=131 Identities=25% Similarity=0.363 Sum_probs=84.7
Q ss_pred CCCCCeeecCCCc--ccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCC
Q 003855 12 LQNLQYLVFAENN--LSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLV 89 (791)
Q Consensus 12 l~~L~~L~Ls~n~--l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 89 (791)
.++|+.|-+.+|. +..+.++.|..++.|++|||++|.=-+.+|+.++. +-+|++|+|++..|+ .+|..++++++|.
T Consensus 544 ~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~-Li~LryL~L~~t~I~-~LP~~l~~Lk~L~ 621 (889)
T KOG4658|consen 544 NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGE-LVHLRYLDLSDTGIS-HLPSGLGNLKKLI 621 (889)
T ss_pred CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhh-hhhhhcccccCCCcc-ccchHHHHHHhhh
Confidence 3467777777775 55444445666777777777766544577777776 567777777777777 6777777777777
Q ss_pred EEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEcc
Q 003855 90 ALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFG 150 (791)
Q Consensus 90 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~ 150 (791)
+||+.++.-....++....|.+|++|.+.......- ...+..+..+.+|+.+...
T Consensus 622 ~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~------~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 622 YLNLEVTGRLESIPGILLELQSLRVLRLPRSALSND------KLLLKELENLEHLENLSIT 676 (889)
T ss_pred eeccccccccccccchhhhcccccEEEeeccccccc------hhhHHhhhcccchhhheee
Confidence 777777765555566666677777777666551110 1123344555555555553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.4e-11 Score=135.41 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=169.6
Q ss_pred HHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCee
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
+...+.+.+.+-+..|.++.++.++-. .|...+.|+..... +...+....+-.+.-..+||.++...--+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 445677888888999999999887643 34334444332211 12223333333333334567777666665566778
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++|++|..++++...++..+. .+..........+.++.+||| ...+.|||++|.|.+...++..+++|||.....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~----s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH----SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred chhhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc----cchhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999999987653 444444455667888999999 556899999999999999999999999854322
Q ss_pred CCC---------------------C--------CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCC
Q 003855 653 GEG---------------------E--------DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703 (791)
Q Consensus 653 ~~~---------------------~--------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p 703 (791)
... . ........+||+.|.|||...+......+|+|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 0 00112334689999999999999999999999999999999999999
Q ss_pred CCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHH
Q 003855 704 TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVT 770 (791)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 770 (791)
|....+... +.......+. -...+...+....+++...+..+|.+|..+.
T Consensus 1035 ~na~tpq~~-----f~ni~~~~~~------------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQI-----FENILNRDIP------------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhh-----hhccccCCCC------------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 976432211 1111111000 0011123345566888888899999998765
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.9e-10 Score=85.71 Aligned_cols=58 Identities=40% Similarity=0.554 Sum_probs=25.0
Q ss_pred CcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcc
Q 003855 39 MRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNS 97 (791)
Q Consensus 39 L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 97 (791)
|++|++++|+|+ .+|...+..+++|++|++++|.|+.+.|.+|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 444444444443 4443333334444444444444444444444444444444444443
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=7e-10 Score=129.72 Aligned_cols=288 Identities=23% Similarity=0.260 Sum_probs=129.2
Q ss_pred CCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCc--ceecCCccCcCCCCCCEEeccCccccccccccccccccccc
Q 003855 37 STMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANN--LTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSL 114 (791)
Q Consensus 37 ~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 114 (791)
...+.+.+-+|.+. .++..... ++|++|-+..|. +..+....|..++.|+.|||++|.-.+..|..+++|-+|++
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~--~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSEN--PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hheeEEEEeccchh-hccCCCCC--CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 45555555555554 44443332 355566555553 44344444555666666666655554555556666666666
Q ss_pred cccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCC
Q 003855 115 LSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLT 194 (791)
Q Consensus 115 L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 194 (791)
|++++..++.+| ..+.+|++|.+|++..+.-...+| .....+++|+
T Consensus 600 L~L~~t~I~~LP---------~~l~~Lk~L~~Lnl~~~~~l~~~~-------------------------~i~~~L~~Lr 645 (889)
T KOG4658|consen 600 LDLSDTGISHLP---------SGLGNLKKLIYLNLEVTGRLESIP-------------------------GILLELQSLR 645 (889)
T ss_pred ccccCCCccccc---------hHHHHHHhhheecccccccccccc-------------------------chhhhccccc
Confidence 666666655433 335556666666666554332221 1222334444
Q ss_pred EEEccCCccc--cccCccccCCCCCCEEEcccccCcccCCccccccCCCc----eEEecCCccCCCCCccccCCCCCcEE
Q 003855 195 LLSLHSNDLN--GTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF----GIRLTGNKLSGHIPPCLVSLTSLREL 268 (791)
Q Consensus 195 ~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~i~~~~~~~~~~l~~L~~L 268 (791)
+|.+..-... ...-..+..+.+|+.|....... .+-..+..++.|. .+.+.++... ..+..+..+.+|+.|
T Consensus 646 ~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L 722 (889)
T KOG4658|consen 646 VLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEEL 722 (889)
T ss_pred EEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceE
Confidence 4444332211 11111222233333333322211 0001111111111 2222222222 233445566666666
Q ss_pred EcCCCcCCCCCCccccCC------CCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhcccccccccc
Q 003855 269 HLGSNKLTSSIPSSLWSL------EYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSL 342 (791)
Q Consensus 269 ~L~~N~l~~~~~~~~~~l------~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 342 (791)
.+.++.+.......+... +++..+...++..- ..+.+..-.++|+.|.+..+.....+......+..++.+-+
T Consensus 723 ~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~ 801 (889)
T KOG4658|consen 723 SILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELIL 801 (889)
T ss_pred EEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEe
Confidence 666666653322222111 12222222222111 12222233467788888877766566566666666666666
Q ss_pred ccccCCCC-CCcccCCCCCCcEEE
Q 003855 343 ARNQFQGP-IPESVGSLISLESLD 365 (791)
Q Consensus 343 ~~N~l~~~-~~~~~~~l~~L~~L~ 365 (791)
..+.+.+. .-...+.++++..+.
T Consensus 802 ~f~~~~~l~~~~~l~~l~~i~~~~ 825 (889)
T KOG4658|consen 802 PFNKLEGLRMLCSLGGLPQLYWLP 825 (889)
T ss_pred cccccccceeeecCCCCceeEecc
Confidence 66666644 233334444443333
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.1e-10 Score=85.28 Aligned_cols=61 Identities=43% Similarity=0.544 Sum_probs=51.8
Q ss_pred CCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccccccccccc
Q 003855 62 PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122 (791)
Q Consensus 62 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l 122 (791)
|+|++|++++|+|+.+.+..|.++++|++|++++|+++.+.++.|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5788999999999988888899999999999999999888888888888888887777764
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=7.1e-08 Score=98.64 Aligned_cols=263 Identities=13% Similarity=0.069 Sum_probs=162.9
Q ss_pred cccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeee------ecc-CCeeeEEE
Q 003855 505 ECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSS------CSN-PDFKALVL 576 (791)
Q Consensus 505 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~------~~~-~~~~~lv~ 576 (791)
..+.+|+|+-+.+|-.-- -...+.|++......... +.+..|... .||-+-.=+.| ..+ +....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 356799999999986421 122345776544322111 123344443 56644331221 112 23366788
Q ss_pred ecCCCC-CHHHHHh-----hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 577 EFMPNG-SLEKWLY-----SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 577 e~~~~g-~L~~~l~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..+.+. ....+.. .+-...+|....++++.+|.+.+.|| ..|.+-+|+.++|+|+.+++.|.+.|-..-.
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH----~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH----EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH----hcCCcccccCccceeeecCceEEEEccccee
Confidence 877654 2333332 11223789999999999999999999 6788899999999999999999999854333
Q ss_pred ccCCCCCcceeecccccccccCCCcc-----CCCCCCccccHHhHHHHHHHHHhC-CCCCCccccCc---chHHHHHHHh
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYG-----SEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGE---MSLRRWVKES 721 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~---~~~~~~~~~~ 721 (791)
.-. ........+|...|.+||.- .+...+...|-|.+||++++++.| +.||.+..... ..+..-+..
T Consensus 166 i~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~- 241 (637)
T COG4248 166 INA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH- 241 (637)
T ss_pred ecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc-
Confidence 321 12234456899999999953 344567789999999999999986 89997643211 111100000
Q ss_pred cCCChhhhcchhhhhhH----HhhHHHHHHHHHHHHHHhhccccC--CCCCCCHHHHHHHHHHHHHHhcc
Q 003855 722 LPHGLTEVVDANLVREE----QAFSAKMDCILSIMDLALDCCIES--PDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 722 ~~~~~~~~~d~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~~--P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
..+.+..-...+ ...+...-.++.+..+..+|+... |.-|||++..+..|..++++...
T Consensus 242 -----g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 242 -----GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred -----ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 000010000000 111222345566778888998764 56899999999999999887643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.1e-08 Score=94.49 Aligned_cols=125 Identities=23% Similarity=0.278 Sum_probs=82.5
Q ss_pred EEEEEEecCCcEEEEEEeehhh--------------------------hHHHHHHHHHHHHHHhccCC--ccceeeeeec
Q 003855 516 SVYKGTISDGTDVAIKIFNLQL--------------------------ERAFRSFDSECEVLRNVRHR--NLIKILSSCS 567 (791)
Q Consensus 516 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 567 (791)
.||.|...+|..+|||+..... ........+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998899999999875320 01134567899999999755 455666553
Q ss_pred cCCeeeEEEecCC--CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HccCCCCCeEecCCCCCCeEeCCCCcEEEe
Q 003855 568 NPDFKALVLEFMP--NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL-HHGHSSAPIIHCDLKPTNILLDENMAAHVS 644 (791)
Q Consensus 568 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~~i~H~dlk~~Nill~~~~~~kl~ 644 (791)
...+||||++ |..+..+.... ++......++.+++..+..+ | ..+++|+|+.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~----~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH----KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH----CTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH----hcCceecCCChhhEEeecc-eEEEE
Confidence 2479999998 55554433321 11234556777888866664 6 6799999999999999988 99999
Q ss_pred eecccccc
Q 003855 645 DFGISKLL 652 (791)
Q Consensus 645 Dfgla~~~ 652 (791)
|||.|...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.1e-07 Score=96.46 Aligned_cols=138 Identities=14% Similarity=0.091 Sum_probs=97.3
Q ss_pred cCCCcceEEEEEEecCCcEEEEEEeehhhhH-HHH----------HHHHHHHHHHhccCCccc--eeeeeecc-----CC
Q 003855 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLER-AFR----------SFDSECEVLRNVRHRNLI--KILSSCSN-----PD 570 (791)
Q Consensus 509 ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~e~~~l~~l~h~niv--~l~~~~~~-----~~ 570 (791)
+-.-....|.+..+ +|+.|.||........ ..+ .+.+|...+.++...+|. .++++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344667666 6788999977433211 111 367888888888533333 33444432 23
Q ss_pred eeeEEEecCCCC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-------CCcE
Q 003855 571 FKALVLEFMPNG-SLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-------NMAA 641 (791)
Q Consensus 571 ~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-------~~~~ 641 (791)
..++|+|++++. +|.+++... ....+...+..++.+++..+.-|| ..+|+|+|++++|||++. ++.+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH----~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH----AAGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCccCCCChhhEEEeccccCCCCCceE
Confidence 467999999876 899988632 223456677789999999999999 789999999999999975 5689
Q ss_pred EEeeeccccc
Q 003855 642 HVSDFGISKL 651 (791)
Q Consensus 642 kl~Dfgla~~ 651 (791)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998854
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.1e-10 Score=125.65 Aligned_cols=129 Identities=32% Similarity=0.333 Sum_probs=79.3
Q ss_pred CCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCc-chhcccccccccc
Q 003855 264 SLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPS-TIGALKDLETLSL 342 (791)
Q Consensus 264 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L 342 (791)
.|.+.+.+.|++. ....++.-++.|+.|+|++|+++... .+..++.|+.|||++|.+. .+|. ...++. |+.|.+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 3566666667665 44455666666777777777766442 5666677777777777776 3343 223333 777777
Q ss_pred ccccCCCCCCcccCCCCCCcEEEccCCccCCCC-chhhhhcccCceEEccCCCCcccC
Q 003855 343 ARNQFQGPIPESVGSLISLESLDLSGNNLSGKI-PKSLETLSQLKQFNVSHNRLEGEI 399 (791)
Q Consensus 343 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~ 399 (791)
++|.++. + ..+.++.+|+.||+++|-|.+-- -..+..|..|+.|+|.||++.+.+
T Consensus 240 rnN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 240 RNNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred cccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 7777662 2 34566777777777777665422 133455666777777777776644
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.7e-07 Score=96.09 Aligned_cols=165 Identities=21% Similarity=0.240 Sum_probs=124.3
Q ss_pred eEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeec----cCCeeeEEEecCCC-CCHHHHH
Q 003855 515 GSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS----NPDFKALVLEFMPN-GSLEKWL 588 (791)
Q Consensus 515 g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~~l 588 (791)
.+.|++..+ ||..|++|++.............-++.++++.|+|+|++.+++. .....++||+|.++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 577898854 89999999995543332223334578899999999999998875 34567899999875 3666544
Q ss_pred hh--------------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 589 YS--------------HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 589 ~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
.. .+...++..+|.++.|++.||.++| +.|..-+-+.+++|+++.+.+++|+..|....+..
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH----ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH----SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH----hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 31 1233678899999999999999999 67888899999999999999999998888766543
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCC
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR 702 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~ 702 (791)
+.. |.+.+ ..+-|.-.||.+++.|.||..
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 320 11111 135699999999999999964
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=9.2e-08 Score=93.34 Aligned_cols=134 Identities=22% Similarity=0.232 Sum_probs=95.7
Q ss_pred cccccccCCCcceEEEEEEecCCcEEEEEEeehhh----------------------hHHHHHHHHHHHHHHhccCC--c
Q 003855 503 FNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL----------------------ERAFRSFDSECEVLRNVRHR--N 558 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--n 558 (791)
..+.+.||-|.-+.||.|....|.++|||.-.... .-.....++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45668999999999999999999999999543210 01233567889999988544 6
Q ss_pred cceeeeeeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC
Q 003855 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN 638 (791)
Q Consensus 559 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~ 638 (791)
+.+.+++ +...+||||++|-.|...- ++......++..|+.-+.-.- ..||||+|+.+-||+++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~----~~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY----RRGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH----HcCccccCCchheEEEecC
Confidence 6666655 4567999999986665421 123333344444544444443 3579999999999999999
Q ss_pred CcEEEeeecccc
Q 003855 639 MAAHVSDFGISK 650 (791)
Q Consensus 639 ~~~kl~Dfgla~ 650 (791)
|.+.++||--+.
T Consensus 239 g~~~vIDwPQ~v 250 (304)
T COG0478 239 GDIVVIDWPQAV 250 (304)
T ss_pred CCEEEEeCcccc
Confidence 999999996554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.9e-09 Score=116.44 Aligned_cols=158 Identities=24% Similarity=0.229 Sum_probs=108.7
Q ss_pred CccccCCCCCCeeecCCCcccccCCccccC---------------------------------CCCCcEEeCCCCcCccc
Q 003855 6 PTEIGNLQNLQYLVFAENNLSGLVPPTIFN---------------------------------ISTMRILTLEGNQLSGR 52 (791)
Q Consensus 6 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~---------------------------------l~~L~~L~L~~n~l~~~ 52 (791)
|-.|..+.+|++|.|.++.|... ..+.. ...|...+.+.|++. .
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~ 178 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-L 178 (1096)
T ss_pred CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-h
Confidence 56788899999999999988521 11111 124556666777775 5
Q ss_pred CCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCcccc
Q 003855 53 LPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQW 132 (791)
Q Consensus 53 ~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 132 (791)
+.+.+ ++++.|+.|+|++|+++.. ..+..+++|++|||++|++..++--...+.. |..|.+++|.++++.
T Consensus 179 mD~SL-qll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL~------ 248 (1096)
T KOG1859|consen 179 MDESL-QLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTLR------ 248 (1096)
T ss_pred HHHHH-HHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhhh------
Confidence 54443 3478888888888888854 3778888888888888888755443334443 888888888888754
Q ss_pred ccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhccccccc
Q 003855 133 SFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180 (791)
Q Consensus 133 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~ 180 (791)
.+.+|++|+-||+++|-|.+.---.+--...+|+.|+|.+|.+-
T Consensus 249 ----gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 249 ----GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ----hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 37788888888888888775422222222356788888888765
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.2e-09 Score=92.34 Aligned_cols=133 Identities=27% Similarity=0.306 Sum_probs=80.4
Q ss_pred CcEEEcCCCcCCCCCCc---cccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccc
Q 003855 265 LRELHLGSNKLTSSIPS---SLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLS 341 (791)
Q Consensus 265 L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 341 (791)
+..++|++|++. .+++ .+.....|+..+|++|.+.+..+..-...+.++.|+|++|.|+ .+|.++..++.|+.|+
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 455566666654 2222 2333445555667777665433333334556777777777777 5676777777777777
Q ss_pred cccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCC
Q 003855 342 LARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPV 401 (791)
Q Consensus 342 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 401 (791)
++.|.+. ..|..+..+.+|-.||..+|.+. .+|..+-.-......++.+++|.+..+.
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 7777777 66777777777777777777776 4443332223333445566667666553
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.2e-08 Score=109.18 Aligned_cols=151 Identities=17% Similarity=0.253 Sum_probs=103.2
Q ss_pred HHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce-------eecccccccccCCCccC
Q 003855 605 IDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT-------QTMTMATIGYMAPEYGS 677 (791)
Q Consensus 605 ~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~ 677 (791)
.+++.|+.|+|. +.++||++|.|++|.++..+.+||+.|+.+........+.. .........|.|||++.
T Consensus 106 ~~v~dgl~flh~---sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHR---SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhcc---CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345599999994 67899999999999999999999999999876544222111 11123466799999999
Q ss_pred CCCCCccccHHhHHHHHHHHHhCCCC-CCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHh
Q 003855 678 EGIVSAKCDVYSYGVLLMETFTRKRP-TDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLAL 756 (791)
Q Consensus 678 ~~~~~~~~Dv~s~G~vl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~ 756 (791)
+...+.++|+||+||++|.+..|..+ +... .....+.. ... .+ +-..+......+.++.+=+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-~~~~~~~~-~~~---------~~-----~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAAN-GGLLSYSF-SRN---------LL-----NAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhcc-CCcchhhh-hhc---------cc-----ccccccccccCcHHHHHHHH
Confidence 98999999999999999999954443 3321 11111000 000 00 00011112356778888999
Q ss_pred hccccCCCCCCCHHHHHH
Q 003855 757 DCCIESPDMRINVTDAAA 774 (791)
Q Consensus 757 ~cl~~~P~~RPt~~ev~~ 774 (791)
+++..++..||++.++..
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 999999999997766543
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.54 E-value=9.6e-09 Score=98.58 Aligned_cols=186 Identities=19% Similarity=0.191 Sum_probs=102.7
Q ss_pred ccCCCCCCEEEcccccCcccCCcc----ccccCCCceEEecCCccCCCCCc-------------cccCCCCCcEEEcCCC
Q 003855 211 MGRLKRLQGLSLRNNNLEGSIPYD----LCHLKLMFGIRLTGNKLSGHIPP-------------CLVSLTSLRELHLGSN 273 (791)
Q Consensus 211 ~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~L~~N~i~~~~~~-------------~~~~l~~L~~L~L~~N 273 (791)
+..+++|+..+||.|.+....|.. +++-+.|.+|.|++|.+....-. -..+-|.|++.....|
T Consensus 88 Llkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrN 167 (388)
T COG5238 88 LLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRN 167 (388)
T ss_pred HhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccc
Confidence 444555555555555555443332 23345555555555554311111 1234567888888888
Q ss_pred cCCCCCCc-----cccCCCCCCeEEccCCcCcccCC-----cccccCCCCCEEecCCcccCCCCC----cchhccccccc
Q 003855 274 KLTSSIPS-----SLWSLEYILDINLSSNSLNDSLP-----SNVQKLKVLTVLDLSRNQLSGDIP----STIGALKDLET 339 (791)
Q Consensus 274 ~l~~~~~~-----~~~~l~~L~~L~l~~N~i~~~~~-----~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~l~~L~~ 339 (791)
++.. .+. .+..-.+|+.+.+..|.|....- ..+..+.+|+.|||..|-++.... ..++.++.|++
T Consensus 168 Rlen-gs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrE 246 (388)
T COG5238 168 RLEN-GSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRE 246 (388)
T ss_pred hhcc-CcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhh
Confidence 8863 222 22333577888888887753211 123445778888888888774322 34455677777
Q ss_pred cccccccCCCCCCccc------CCCCCCcEEEccCCccCCCCchh-----h--hhcccCceEEccCCCCcc
Q 003855 340 LSLARNQFQGPIPESV------GSLISLESLDLSGNNLSGKIPKS-----L--ETLSQLKQFNVSHNRLEG 397 (791)
Q Consensus 340 L~L~~N~l~~~~~~~~------~~l~~L~~L~l~~N~l~~~~~~~-----~--~~l~~L~~l~l~~N~l~~ 397 (791)
|.+..|-++.....++ ...++|..|-..+|.+.+.+-.. + ..+|-|..|.+.+|++..
T Consensus 247 L~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~E 317 (388)
T COG5238 247 LRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIKE 317 (388)
T ss_pred ccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcchh
Confidence 7777777765433322 12466777777777665432211 1 234555555666666543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3e-08 Score=96.48 Aligned_cols=40 Identities=33% Similarity=0.421 Sum_probs=18.7
Q ss_pred CCCCcEEEccCCccCCC-CchhhhhcccCceEEccCCCCcc
Q 003855 358 LISLESLDLSGNNLSGK-IPKSLETLSQLKQFNVSHNRLEG 397 (791)
Q Consensus 358 l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~ 397 (791)
++.+..|+|+.|+|... .-+.+.++++|..|.+++|+|..
T Consensus 223 ~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 223 FPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred CCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 34444445555554321 12344455555555555555543
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2e-08 Score=96.38 Aligned_cols=196 Identities=21% Similarity=0.242 Sum_probs=110.3
Q ss_pred ccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCcc----
Q 003855 135 LSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPT---- 210 (791)
Q Consensus 135 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~---- 210 (791)
++++-+||+|+..+||.|.+....|+.+..+ +++-+.|..|.|++|.+..+.-.-
T Consensus 85 l~aLlkcp~l~~v~LSDNAfg~~~~e~L~d~---------------------is~~t~l~HL~l~NnGlGp~aG~rigka 143 (388)
T COG5238 85 LKALLKCPRLQKVDLSDNAFGSEFPEELGDL---------------------ISSSTDLVHLKLNNNGLGPIAGGRIGKA 143 (388)
T ss_pred HHHHhcCCcceeeeccccccCcccchHHHHH---------------------HhcCCCceeEEeecCCCCccchhHHHHH
Confidence 4567889999999999999987777666554 456677888888888775322222
Q ss_pred ---------ccCCCCCCEEEcccccCcccCCcc-----ccccCCCceEEecCCccCCCCC-----ccccCCCCCcEEEcC
Q 003855 211 ---------MGRLKRLQGLSLRNNNLEGSIPYD-----LCHLKLMFGIRLTGNKLSGHIP-----PCLVSLTSLRELHLG 271 (791)
Q Consensus 211 ---------~~~l~~L~~L~L~~N~l~~~~~~~-----~~~l~~L~~L~L~~N~i~~~~~-----~~~~~l~~L~~L~L~ 271 (791)
.+.-|.|++.+...|++.. .+.. +..-.+|+.+.+..|.|....- ..+..+.+|+.|+|.
T Consensus 144 l~~la~nKKaa~kp~Le~vicgrNRlen-gs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlq 222 (388)
T COG5238 144 LFHLAYNKKAADKPKLEVVICGRNRLEN-GSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQ 222 (388)
T ss_pred HHHHHHHhhhccCCCceEEEeccchhcc-CcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeecc
Confidence 2344677777777777762 2221 2222466666666666652211 112234455555555
Q ss_pred CCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchh------ccccccccccccc
Q 003855 272 SNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIG------ALKDLETLSLARN 345 (791)
Q Consensus 272 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~------~l~~L~~L~L~~N 345 (791)
.|-++..... .+...++..+.|+.|.+..|-++......+- ..++|..|-..+|
T Consensus 223 DNtft~~gS~--------------------~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yn 282 (388)
T COG5238 223 DNTFTLEGSR--------------------YLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYN 282 (388)
T ss_pred ccchhhhhHH--------------------HHHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchh
Confidence 5555421110 1112333344455555555555543333221 2455666666666
Q ss_pred cCCCCCCcc-------cCCCCCCcEEEccCCccC
Q 003855 346 QFQGPIPES-------VGSLISLESLDLSGNNLS 372 (791)
Q Consensus 346 ~l~~~~~~~-------~~~l~~L~~L~l~~N~l~ 372 (791)
...+.+-.. -.+++-|..|-+.+|+|.
T Consensus 283 e~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~ 316 (388)
T COG5238 283 ERRGGIILDISLNEFEQDAVPLLVDLERNGNRIK 316 (388)
T ss_pred hhcCceeeeechhhhhhcccHHHHHHHHccCcch
Confidence 555322111 135677888888888887
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=9.2e-09 Score=88.55 Aligned_cols=59 Identities=25% Similarity=0.396 Sum_probs=28.9
Q ss_pred CCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCC
Q 003855 288 YILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQ 348 (791)
Q Consensus 288 ~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 348 (791)
.++.|+|++|+|+ .+|..+..++.|+.|++++|.+. ..|..+..+.+|..|+..+|.+.
T Consensus 78 t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 78 TATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred hhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 4444444444444 23444555555555555555554 44444444555555555555544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 791 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-38 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-38 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-35 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-35 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-33 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-25 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-23 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-15 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-11 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-06 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-06 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 5e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-05 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 398 bits (1024), Expect = e-127
Identities = 128/443 (28%), Positives = 198/443 (44%), Gaps = 21/443 (4%)
Query: 3 GQIPTE-IGNLQNLQYLVFAENNLSGLVPPTIFNIST-MRILTLEGNQLSGRLPSTVGHL 60
G++P + + ++ L+ L + N SG +P ++ N+S + L L N SG + +
Sbjct: 332 GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN 391
Query: 61 -LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVM 119
++ L L N TG IP +++N ++LV+L L FN +G I ++ G+L L L +
Sbjct: 392 PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451
Query: 120 NNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKL 179
N L L + L L N L G +P + N + +L +L
Sbjct: 452 NMLE--------GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRL 502
Query: 180 KGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
G IP+ IG L L +L L +N +G I +G + L L L N G+IP +
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 562
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSN--KLTSSIPSSLWSLEYILDINLSSN 297
+ N ++G + + +E H N + L L N++S
Sbjct: 563 GK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSR 618
Query: 298 SLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGS 357
+ LD+S N LSG IP IG++ L L+L N G IP+ VG
Sbjct: 619 VYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGD 678
Query: 358 LISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNY 417
L L LDLS N L G+IP+++ L+ L + ++S+N L G IP G F+ F F N
Sbjct: 679 LRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP 738
Query: 418 ALCGPPKLRVPPCKPDNSKSTKN 440
LCG P +P C P N+ +
Sbjct: 739 GLCGYP---LPRCDPSNADGYAH 758
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-100
Identities = 109/403 (27%), Positives = 181/403 (44%), Gaps = 19/403 (4%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
G I L+ L + N G +PP + +++ L+L N+ +G +P +
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACD 294
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHI-LNTFGNLRHLSLLSQVMNN 121
+ L L+ N+ G +P + + L +L L N+F+G + ++T +R L +L N
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354
Query: 122 LTTESSSADQWSFLSSLTNCR-NLTILSFGSNPLGGILPPVIGNFSA-SLQKFYAYECKL 179
+ SLTN +L L SN G + P + +LQ+ Y
Sbjct: 355 FSG--------ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGF 406
Query: 180 KGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
G IP + N S L L L N L+GTI ++G L +L+ L L N LEG IP +L ++K
Sbjct: 407 TGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK 466
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL 299
+ + L N L+G IP L + T+L + L +N+LT IP + LE + + LS+NS
Sbjct: 467 TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF 526
Query: 300 NDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLI 359
+ ++P+ + + L LDL+ N +G IP+ + + +A N G + +
Sbjct: 527 SGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDG 582
Query: 360 SLESLDLSGN--NLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400
+ +GN G + L LS N++ G
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = 6e-98
Identities = 123/410 (30%), Positives = 181/410 (44%), Gaps = 18/410 (4%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
IP +G+ LQ+L + N LSG I + +++L + NQ G +P L
Sbjct: 214 TGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLK 269
Query: 63 NIESLLLAANNLTGIIPHSIT-NATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNN 121
+++ L LA N TG IP ++ L LDL N F G + FG+ L L+ NN
Sbjct: 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 122 LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKG 181
+ E +L R L +L N G LP + N SASL G
Sbjct: 330 FSGELPM-------DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382
Query: 182 NIPQEIGN--LSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
I + + L L L +N G I PT+ L L L N L G+IP L L
Sbjct: 383 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL 299
+ ++L N L G IP L+ + +L L L N LT IPS L + + I+LS+N L
Sbjct: 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502
Query: 300 NDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLI 359
+P + +L+ L +L LS N SG+IP+ +G + L L L N F G IP ++
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ- 561
Query: 360 SLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
S ++ N ++GK ++ K+ + + N LE + S
Sbjct: 562 ---SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 8e-85
Identities = 99/386 (25%), Positives = 172/386 (44%), Gaps = 21/386 (5%)
Query: 23 NNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIP--H 80
N V ++ +++ + L L + ++G + ++ SL L+ N+L+G +
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF--KCSASLTSLDLSRNSLSGPVTTLT 120
Query: 81 SITNATKLVALDLGFNSFAGHI-LNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLT 139
S+ + + L L++ N+ ++ L L +L N+++ +
Sbjct: 121 SLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG-----WVLSD 175
Query: 140 NCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLH 199
C L L+ N + G + + +L+ IP +G+ S L L +
Sbjct: 176 GCGELKHLAISGNKISGDVD--VSRCV-NLEFLDVSSNNFSTGIP-FLGDCSALQHLDIS 231
Query: 200 SNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCL 259
N L+G S + L+ L++ +N G IP L + + L NK +G IP L
Sbjct: 232 GNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK-SLQY-LSLAENKFTGEIPDFL 289
Query: 260 V-SLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLD 317
+ +L L L N ++P S + + LSSN+ + LP + K++ L VLD
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLD 349
Query: 318 LSRNQLSGDIPSTIGALK-DLETLSLARNQFQGPIPESVG--SLISLESLDLSGNNLSGK 374
LS N+ SG++P ++ L L TL L+ N F GPI ++ +L+ L L N +GK
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409
Query: 375 IPKSLETLSQLKQFNVSHNRLEGEIP 400
IP +L S+L ++S N L G IP
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIP 435
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 4e-66
Identities = 91/343 (26%), Positives = 143/343 (41%), Gaps = 44/343 (12%)
Query: 66 SLLLAANNLTGI---IPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
S+ L++ L + S+ + T L +L L + G + F L+ L N+L
Sbjct: 54 SIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSL 112
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN 182
+ ++ L+SL +C L L+ SN L G SL+ + G
Sbjct: 113 SGPVTT------LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 183 IPQEI---GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
L L++ N ++G + + R L+ L + +NN IP L
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCS 223
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL 299
+ + ++GNKLSG + + T L+ L++ SN+ IP L S
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL----------PLKS--- 270
Query: 300 NDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTI-GALKDLETLSLARNQFQGPIPESVGSL 358
L L L+ N+ +G+IP + GA L L L+ N F G +P GS
Sbjct: 271 -------------LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317
Query: 359 ISLESLDLSGNNLSGKIPK-SLETLSQLKQFNVSHNRLEGEIP 400
LESL LS NN SG++P +L + LK ++S N GE+P
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 6e-91
Identities = 90/306 (29%), Positives = 136/306 (44%), Gaps = 14/306 (4%)
Query: 133 SFLSSLTNCRNL----TILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKG--NIPQE 186
L N L + G+L + + L IP
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPSS 71
Query: 187 IGNLSGLTLLSLHS-NDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIR 245
+ NL L L + N+L G I P + +L +L L + + N+ G+IP L +K + +
Sbjct: 72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131
Query: 246 LTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYIL-DINLSSNSLNDSLP 304
+ N LSG +PP + SL +L + N+++ +IP S S + + +S N L +P
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Query: 305 SNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESL 364
L L +DLSRN L GD G+ K+ + + LA+N + VG +L L
Sbjct: 192 PTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGL 249
Query: 365 DLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPPK 424
DL N + G +P+ L L L NVS N L GEIP G+ + F V ++ N LCG P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP- 308
Query: 425 LRVPPC 430
+P C
Sbjct: 309 --LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-56
Identities = 74/355 (20%), Positives = 125/355 (35%), Gaps = 89/355 (25%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSG--LVPPTIFNISTMRILTLEG-NQLSGRLPSTVGH 59
G + + L + NL +P ++ N+ + L + G N L G +P +
Sbjct: 40 GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99
Query: 60 LLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVM 119
L + L + N++G IP ++ LV LD +N+ +G +
Sbjct: 100 -LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL----------------- 141
Query: 120 NNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKL 179
S+++ NL ++F N + G +P G+FS +L
Sbjct: 142 ---------------PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 180 KGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
G IP NL+ L + L N L G S G K Q + L N+L +
Sbjct: 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK------ 239
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL 299
+ +L L L +N++ ++P L
Sbjct: 240 -------------------VGLSKNLNGLDLRNNRIYGTLPQGL---------------- 264
Query: 300 NDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQ--GPIP 352
+LK L L++S N L G+IP G L+ + + A N+ P+P
Sbjct: 265 --------TQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 4e-81
Identities = 94/283 (33%), Positives = 145/283 (51%), Gaps = 14/283 (4%)
Query: 489 RRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSEC 548
R P +D++ AT+ F+ L+G G FG VYKG + DG VA+K + + F++E
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 549 EVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLY---SHNYFLDILERLNIMI 605
E L RH +L+ ++ C + L+ ++M NG+L++ LY + +RL I I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 606 DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM 665
L YLH IIH D+K NILLDEN ++DFGISK E + + T+
Sbjct: 147 GAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 666 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMF-TGEMSLRRWVKESLPH 724
T+GY+ PEY +G ++ K DVYS+GV+L E + + ++L W ES +
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 725 G-LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMR 766
G L ++VD NL + + + + D A+ C S + R
Sbjct: 263 GQLEQIVDPNLADK-----IRPESLRKFGDTAVKCLALSSEDR 300
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 1e-79
Identities = 105/297 (35%), Positives = 150/297 (50%), Gaps = 25/297 (8%)
Query: 483 LPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAF- 541
+ L +R ++Q A+D F+ N+LG G FG VYKG ++DGT VA+K +L+
Sbjct: 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK----RLKEERT 67
Query: 542 ----RSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLY---SHNYF 594
F +E E++ HRNL+++ C P + LV +M NGS+ L
Sbjct: 68 QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127
Query: 595 LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654
LD +R I + L YLH H IIH D+K NILLDE A V DFG++KL+
Sbjct: 128 LDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE--- 711
+ VT T TIG++APEY S G S K DV+ YGV+L+E T +R D
Sbjct: 187 KDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 712 MSLRRWVKESLPHG-LTEVVDANLVREEQAFSAK-MDCILSIMDLALDCCIESPDMR 766
+ L WVK L L +VD +L + + + ++ ++ + AL C SP R
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDL---QGNYKDEEVEQLIQV---ALLCTQSSPMER 296
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-68
Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 27/288 (9%)
Query: 493 YLDIQRATDEFNE------CNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERA----FR 542
+ +++ T+ F+E N +G G FG VYKG + + T VA+K ++ +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 543 SFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF--LDILER 600
FD E +V+ +H NL+++L S+ D LV +MPNGSL L + L R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 601 LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660
I + + +LH IH D+K NILLDE A +SDFG+++ + +V
Sbjct: 136 CKIAQGAANGINFLHEN----HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 720
+ + T YMAPE G ++ K D+YS+GV+L+E T DE L +E
Sbjct: 192 TSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR-EPQLLLDIKEE 249
Query: 721 SL--PHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMR 766
+ + +D + + + ++ +A C E + R
Sbjct: 250 IEDEEKTIEDYIDKKM----NDADST--SVEAMYSVASQCLHEKKNKR 291
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-66
Identities = 66/443 (14%), Positives = 140/443 (31%), Gaps = 67/443 (15%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGL-------------------VPPTIFNISTMRILTLE 45
+ + L L+ + N+ + + +
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257
Query: 46 GNQLSGRLPSTVGHLLPNIESLLLAANNLTGI--------IPHSITNATKLVALDLGFNS 97
+LP+ + L P ++ + +A N K+ + +G+N+
Sbjct: 258 NCPNLTKLPTFLKAL-PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 98 FA-GHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGG 156
+ + ++ L +L + N L L + + L L+ N +
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLE---------GKLPAFGSEIKLASLNLAYNQITE 367
Query: 157 ILPPVIGNFSASLQKFYAYECKLKGNIPQ--EIGNLSGLTLLSLHSNDLNG-------TI 207
I P F+ ++ KLK IP + ++S ++ + N++ +
Sbjct: 368 I-PANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425
Query: 208 SPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSG-------HIPPCLV 260
PT + + ++L NN + + I L GN L+
Sbjct: 426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFK 485
Query: 261 SLTSLRELHLGSNKLTSSIPS-SLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVL--- 316
+ L + L NKLT +L Y++ I+LS NS + P+ L
Sbjct: 486 NTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIR 544
Query: 317 ---DLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSG 373
D N+ + P I L L + N + + E + ++ LD+ N
Sbjct: 545 NQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNIS 601
Query: 374 KIPKSLETLSQLKQFNVSHNRLE 396
+ + + + +++ +
Sbjct: 602 IDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-66
Identities = 61/416 (14%), Positives = 128/416 (30%), Gaps = 47/416 (11%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
I + NN++ + + ++ +R + +
Sbjct: 173 KSIKKSSRITLKDTQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICEAWENE- 230
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
N L +++ + L + L++ N
Sbjct: 231 -----NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPL-GGILPPVIGNFSASLQKFYAYECKLKG 181
+ D W L+ + I+ G N L + + L +L+G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK-KLGMLECLYNQLEG 344
Query: 182 NIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEG-SIPYDLCHLKL 240
+P G+ L L+L N + + G ++++ LS +N L+ +D + +
Sbjct: 345 KLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSV 403
Query: 241 MFGIRLTGNKLSG-------HIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDIN 293
M I + N++ + P ++ ++L +N+++ + + IN
Sbjct: 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSIN 463
Query: 294 LSSNSLND-------SLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGA--LKDLETLSLAR 344
L N L + N + +LT +DL N+L+ + A L L + L+
Sbjct: 464 LMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSY 522
Query: 345 NQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400
N F P + +L+ + + NR E P
Sbjct: 523 NSFSK-FPTQPLNSSTLKGFGIRNQ------------------RDAQGNRTLREWP 559
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 3e-65
Identities = 68/426 (15%), Positives = 135/426 (31%), Gaps = 51/426 (11%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIF--NISTMRILTLEGNQLSGRLPSTVGHLLP 62
P I + + + + S + + + + + +
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR-ITL 183
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
+ +NN+T + ++ TKL +G + F + +
Sbjct: 184 KDTQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA----QQY 238
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK-- 180
TE N ++LT + + P LP + +Q +
Sbjct: 239 KTED---------LKWDNLKDLTDVEVYNCPNLTKLPTFLKALP-EMQLINVACNRGISG 288
Query: 181 ------GNIPQEIGNLSGLTLLSLHSNDL-NGTISPTMGRLKRLQGLSLRNNNLEGSIPY 233
+ + ++ + N+L + ++ ++K+L L N LEG +P
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP- 347
Query: 234 DLCHLKLMFGIRLTGNKLSGHIPPCLVS-LTSLRELHLGSNKLTSSIPSSL--WSLEYIL 290
+ + L N+++ IP + L NKL IP+ S+ +
Sbjct: 348 AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMS 405
Query: 291 DINLSSNSLN-------DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLA 343
I+ S N + D L K ++ ++LS NQ+S L +++L
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLM 465
Query: 344 RNQFQG-------PIPESVGSLISLESLDLSGNNLSGKIPKSLE--TLSQLKQFNVSHNR 394
N E+ + L S+DL N L+ + TL L ++S+N
Sbjct: 466 GNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNS 524
Query: 395 LEGEIP 400
P
Sbjct: 525 FSK-FP 529
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 8e-62
Identities = 57/413 (13%), Positives = 128/413 (30%), Gaps = 48/413 (11%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSG----RLPSTVG 58
Q + + + L SG VP I ++ + +L L + P +
Sbjct: 71 AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGIS 130
Query: 59 HLLPNIESLLLAANNLTGIIPHSITNA--TKLVALDLGFNSFAGHILNTFGNLRHLSLLS 116
+ + E + + L+ + + I + + +
Sbjct: 131 ANMSD-EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 117 QVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYE 176
Q+ NN+T ++ L G++P S
Sbjct: 190 QLSNNIT---------FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE------Y 234
Query: 177 CKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLC 236
+ + NL LT + +++ + + L +Q +++ N
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS------- 287
Query: 237 HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS-SIPSSLWSLEYILDINLS 295
K ++ +++G N L + + +SL ++ + +
Sbjct: 288 ---------GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECL 338
Query: 296 SNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQG-PIPES 354
N L LP+ L L+L+ NQ++ + G + +E LS A N+ + P
Sbjct: 339 YNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFD 397
Query: 355 VGSLISLESLDLSGNNLSG-------KIPKSLETLSQLKQFNVSHNRLEGEIP 400
S+ + ++D S N + + + + N+S+N++
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK 450
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-51
Identities = 53/348 (15%), Positives = 121/348 (34%), Gaps = 22/348 (6%)
Query: 72 NNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQ 131
+ S+ + ++ L L +G + + G L L +L+ +
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERL--- 123
Query: 132 WSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSAS-LQKFYAYECKLKGNIPQEIGNL 190
++ + S L K + +I +
Sbjct: 124 -FGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 191 SGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNK 250
T + SN++ +S + RL +L+ + N+ + + +
Sbjct: 183 LKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN-----SEYAQ 236
Query: 251 LSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL--------NDS 302
+L L ++ + + + +P+ L +L + IN++ N +
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296
Query: 303 LPSNVQKLKVLTVLDLSRNQL-SGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISL 361
++ + + ++ + N L + + +++ +K L L NQ +G +P GS I L
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKL 355
Query: 362 ESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
SL+L+ N ++ Q++ + +HN+L+ IP K+ S
Sbjct: 356 ASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVS 402
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-42
Identities = 49/322 (15%), Positives = 95/322 (29%), Gaps = 39/322 (12%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
+ T + ++ L L N L G P + + L L NQ++ +P+
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGK-LPAFGSEIKLASLNLAYNQITE-IPANFCGFTE 377
Query: 63 NIESLLLAANNLTGI-IPHSITNATKLVALDLGFNSFAGHILNTF-------GNLRHLSL 114
+E+L A N L I + + + A+D +N F ++S
Sbjct: 378 QVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437
Query: 115 LSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGI-------LPPVIGNFSA 167
++ N ++ + L+ ++ N L I N
Sbjct: 438 INLSNNQISKFPKE--------LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY- 488
Query: 168 SLQKFYAYECKLKGNIPQEI--GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRN- 224
L KL + + L L + L N + L+G +RN
Sbjct: 489 LLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 225 -----NNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSI 279
N P + + +++ N + + + ++ L + N S
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISID 603
Query: 280 PSSLWSLEYILDINLSSNSLND 301
S + L + D
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-20
Identities = 40/263 (15%), Positives = 73/263 (27%), Gaps = 61/263 (23%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
+ N+ + + N +S S + + L GN L+ +P
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPK------- 474
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
N + N L ++DL FN L+++ ++
Sbjct: 475 ----------NSLKDENENFKNTYLLTSIDLRFNK-----------------LTKLSDDF 507
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYEC----- 177
T L + N P N S +L+ F
Sbjct: 508 --------------RATTLPYLVGIDLSYNSFSKF-PTQPLNSS-TLKGFGIRNQRDAQG 551
Query: 178 -KLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLC 236
+ P+ I LT L + SND+ ++ + + L +++N +C
Sbjct: 552 NRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVC 608
Query: 237 HLKLMFGIRLTGNKLSGHIPPCL 259
L +K I C
Sbjct: 609 PYIEAGMYMLFYDKTQ-DIRGCD 630
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-65
Identities = 79/459 (17%), Positives = 150/459 (32%), Gaps = 44/459 (9%)
Query: 3 GQIPTEIG---NLQNLQYLVFAENNLSGLVPPTIFN--ISTMRILTLEGNQLSGRLPSTV 57
+ ++ +++ L + + LS T + + +L L N L+ +
Sbjct: 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
Query: 58 GHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLG---------FNSFAGHILNTFGN 108
L P +E L NN+ + HS+ + L+L S +F
Sbjct: 269 AWL-PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQW 327
Query: 109 LRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPV---IGNF 165
L+ L L+ N++ S+ T NL LS ++ +
Sbjct: 328 LKCLEHLNMEDNDIPGIKSNM--------FTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379
Query: 166 SASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRN 224
+ L + K+ L L +L L N++ ++ L+ + + L
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 225 NNLEGSIPYDLCHLKLMFGIRLTGNKLSG--HIPPCLVSLTSLRELHLGSNKLTSSIPSS 282
N + + + L L P L +L L L +N + +
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
Query: 283 LWSLEYILDINLSSNSLND--------SLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGAL 334
L LE + ++L N+L ++ L L +L+L N L
Sbjct: 500 LEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559
Query: 335 KDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLET-LSQLKQFNVSHN 393
+L+ + L N + +SL+SL+L N ++ K L + ++ N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 394 RLEGEIPVKGSFKNFSVES-----FFGNYALCG-PPKLR 426
+ F N+ E+ ++ LC PP
Sbjct: 620 PFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYH 658
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 8e-65
Identities = 88/424 (20%), Positives = 145/424 (34%), Gaps = 29/424 (6%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
L L N +S L P + +++L L+ N+LS L N+
Sbjct: 41 PAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNL 99
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTT 124
L L +N++ I + L+ LDL N + L T L +L L N +
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 125 ESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIP 184
S SS L L SN + P L + +L ++
Sbjct: 160 LKSEELDIFANSS------LKKLELSSNQIKEFSPGCFHAIG-RLFGLFLNNVQLGPSLT 212
Query: 185 QEIG---NLSGLTLLSLHSNDLNGTISPTMGRLK--RLQGLSLRNNNLEGSIPYDLCHLK 239
+++ + + LSL ++ L+ T + T LK L L L NNL L
Sbjct: 213 EKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLP 272
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSN---------KLTSSIPSSLWSLEYIL 290
+ L N + L L ++R L+L + L S L+ +
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 291 DINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIG----ALKDLETLSLARNQ 346
+N+ N + + L L L LS + S + A L L+L +N+
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNK 392
Query: 347 FQGPIPESVGSLISLESLDLSGNNLSGKIPKS-LETLSQLKQFNVSHNRLEGEIPVKGSF 405
++ L LE LDL N + ++ L + + +S+N+ SF
Sbjct: 393 ISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR--NSF 450
Query: 406 KNFS 409
Sbjct: 451 ALVP 454
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 6e-64
Identities = 68/415 (16%), Positives = 125/415 (30%), Gaps = 29/415 (6%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
NL L N++ + + L L N LS T L
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ-LE 145
Query: 63 NIESLLLAANNLTGIIPHSITNA--TKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
N++ LLL+ N + + + + L L+L N F + L L
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSA-SLQKFYAYECKL 179
L + L ++ LS ++ L +L L
Sbjct: 206 QLGPSLTEK-----LCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL 260
Query: 180 KGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
L L L N++ S ++ L ++ L+L+ + + SI
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL------ 314
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL 299
L L L L++ N + + L + ++LS++
Sbjct: 315 ---------ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 300 NDSLPSNVQ----KLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV 355
+ +N L +L+L++N++S L LE L L N+ +
Sbjct: 366 SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE 425
Query: 356 -GSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
L ++ + LS N S + L++ + L+ F+
Sbjct: 426 WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 4e-63
Identities = 86/425 (20%), Positives = 152/425 (35%), Gaps = 31/425 (7%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
Q+P ++ N+ L N L L S + L + N +S P LP
Sbjct: 18 QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQK-LPM 74
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
++ L L N L+ + + T L L L NS N F ++L L N L+
Sbjct: 75 LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFS-ASLQKFYAYECKLKGN 182
+ L + NL L +N + + + F+ +SL+K ++K
Sbjct: 135 STK--------LGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEF 186
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMG---RLKRLQGLSLRNNNLEGSIPYDLCHLK 239
P + L L L++ L +++ + ++ LSL N+ L + LK
Sbjct: 187 SPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246
Query: 240 LMF--GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSN 297
+ L+ N L+ L L L N + SL L + +NL +
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306
Query: 298 SLNDSLPSNV---------QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQ 348
S+ Q LK L L++ N + G + L +L+ LSL+ +
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
Query: 349 GPIPESVG----SLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGS 404
+ + L L+L+ N +S + L L+ ++ N + E+
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT-GQE 425
Query: 405 FKNFS 409
++
Sbjct: 426 WRGLE 430
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 5e-56
Identities = 87/386 (22%), Positives = 142/386 (36%), Gaps = 55/386 (14%)
Query: 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFA 99
+ +L+ ++P L NI L L N L + + T ++L +LD+GFN+ +
Sbjct: 7 EVADCSHLKLT-QVPDD---LPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 100 GHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILP 159
L L +L+ N L+ S + C NLT L SN + I
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDK--------TFAFCTNLTELHLMSNSIQKI-- 112
Query: 160 PVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQG 219
L L L N L+ T T +L+ LQ
Sbjct: 113 -----------------------KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQE 149
Query: 220 LSLRNNNLEGSIPYDLCHLKLMF--GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS 277
L L NN ++ +L + L+ N++ P C ++ L L L + +L
Sbjct: 150 LLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP 209
Query: 278 SIPSSL---WSLEYILDINLSSNSLNDSLPSNVQKLKV--LTVLDLSRNQLSGDIPSTIG 332
S+ L + I +++LS++ L+ + + LK LT+LDLS N L+ +
Sbjct: 210 SLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA 269
Query: 333 ALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGN---------NLSGKIPKSLETLS 383
L LE L N Q S+ L ++ L+L + +L S + L
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329
Query: 384 QLKQFNVSHNRLEGEIPVKGSFKNFS 409
L+ N+ N + G F
Sbjct: 330 CLEHLNMEDNDIPGIKS--NMFTGLI 353
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-41
Identities = 54/274 (19%), Positives = 97/274 (35%), Gaps = 13/274 (4%)
Query: 143 NLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSND 202
+ + L + P + ++ +L+ S LT L + N
Sbjct: 5 SHEVADCSHLKLTQV-PD---DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 203 LNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSL 262
++ +L L+ L+L++N L + + L N + V
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 263 TSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQ--KLKVLTVLDLSR 320
+L L L N L+S+ + LE + ++ LS+N + + L L+LS
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 321 NQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVG---SLISLESLDLSGNNLSGKIPK 377
NQ+ P A+ L L L Q + E + + S+ +L LS + LS
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 378 SLETL--SQLKQFNVSHNRLEGEIPVKGSFKNFS 409
+ L + L ++S+N L SF
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGN--DSFAWLP 272
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 5e-64
Identities = 63/306 (20%), Positives = 119/306 (38%), Gaps = 22/306 (7%)
Query: 492 PYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVL 551
++ + + G FG V+K + VA+KIF +Q +++++ + E L
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYSL 72
Query: 552 RNVRHRNLIKILSSCSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 607
++H N+++ + + L+ F GSL +L + E +I +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETM 130
Query: 608 GSALEYLH------HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661
L YLH I H D+K N+LL N+ A ++DFG++ G+ +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 662 TMTMATIGYMAPEYGSEGI-----VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRR 716
+ T YMAPE I + D+Y+ G++L E +R D M
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 717 WVKESLP--HGLTEVVDANLVREE-QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAA 773
P + EVV R + + K + + + +C + R++
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 774 AKLKKI 779
++ ++
Sbjct: 311 ERITQM 316
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 5e-63
Identities = 79/433 (18%), Positives = 146/433 (33%), Gaps = 46/433 (10%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRI----LTLEGNQLSGRLPSTVG 58
++P NL NL++L + N + + + + M + L L N ++ P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 59 HLLPNIESLLLAANNLTG-IIPHSITNATKLVALDLGFNSFAGH------ILNTFGNLRH 111
+ + L L N + ++ I L L F + L +
Sbjct: 199 EI--RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 112 LSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQK 171
L++ L D N++ S S + + +++ Q
Sbjct: 257 LTIEE---FRLAYLDYYLDDII--DLFNCLTNVSSFSLVSVTIERVKD---FSYNFGWQH 308
Query: 172 FYAYECKL-------------------KGNIPQEIGNLSGLTLLSLHSNDLN--GTISPT 210
CK KG +L L L L N L+ G S +
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 211 MGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELH 269
L+ L L N + + + L+ + + + L +SL +L L
Sbjct: 369 DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 270 LGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIP 328
+ + L + + ++ NS ++ ++ +L+ LT LDLS+ QL P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 329 STIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETL-SQLKQ 387
+ +L L+ L+++ N F L SL+ LD S N++ + L+ S L
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 547
Query: 388 FNVSHNRLEGEIP 400
N++ N
Sbjct: 548 LNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 6e-59
Identities = 92/419 (21%), Positives = 145/419 (34%), Gaps = 30/419 (7%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
L +LQ LV E NL+ L I ++ T++ L + N + L N+
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151
Query: 65 ESLLLAANNLTGIIPHSITNATKL----VALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
E L L++N + I + ++ ++LDL N F +R L L+ N
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNN 210
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+ + + L L G G L + L E +L
Sbjct: 211 FDSLNVMK----TCIQGLAGLEVHR-LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 181 ------GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYD 234
+I L+ ++ SL S + Q L L N
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLK 323
Query: 235 LCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT--SSIPSSLWSLEYILDI 292
L LK RLT G V L SL L L N L+ S + + +
Sbjct: 324 LKSLK-----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 293 NLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP-STIGALKDLETLSLARNQFQGPI 351
+LS N + ++ SN L+ L LD + L S +L++L L ++ +
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 352 PESVGSLISLESLDLSGNNLSGKI-PKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
L SLE L ++GN+ P L L ++S +LE P +F + S
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP--TAFNSLS 494
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 7e-56
Identities = 81/421 (19%), Positives = 127/421 (30%), Gaps = 31/421 (7%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
+ LQ L + + + ++S + L L GN + L
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG-LS 100
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAG-HILNTFGNLRHLSLLSQVMNN 121
+++ L+ NL + I + L L++ N + F NL +L L N
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160
Query: 122 LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKG 181
+ + + L + L NP+ I P L K
Sbjct: 161 IQSIYCTD--LRVLHQMPL--LNLSLDLSLNPMNFIQPGAFKEI--RLHKLTLRNNFDSL 214
Query: 182 NIPQE-IGNLSGLTLLSLHSNDLNGT------ISPTMGRLKRLQGLSLRNNNLEGS---I 231
N+ + I L+GL + L + + L L R L+ I
Sbjct: 215 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDI 274
Query: 232 PYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILD 291
L + L + + L L + K L SL+
Sbjct: 275 IDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLK---- 328
Query: 292 INLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLS--GDIPSTIGALKDLETLSLARNQFQG 349
L+ S + L L LDLSRN LS G + L+ L L+ N
Sbjct: 329 -RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 350 PIPESVGSLISLESLDLSGNNLSGKIPKS-LETLSQLKQFNVSHNRLEGEIPVKGSFKNF 408
+ + L LE LD +NL S +L L ++SH G F
Sbjct: 388 -MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN--GIFNGL 444
Query: 409 S 409
S
Sbjct: 445 S 445
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 6e-42
Identities = 67/364 (18%), Positives = 119/364 (32%), Gaps = 32/364 (8%)
Query: 59 HLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQV 118
+L + ++L L+ N L + +S + +L LDL + +L HLS L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 119 MNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECK 178
N + + + A + +L L L + IG+ +L++
Sbjct: 85 GNPIQSLALGA--------FSGLSSLQKLVAVETNLASLENFPIGHLK-TLKELNVAHNL 135
Query: 179 LKG-NIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQ----GLSLRNNNLEGSIPY 233
++ +P+ NL+ L L L SN + + L ++ L L N + P
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 234 DLCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHL------GSNKLTSSIPSSLWSL 286
++L + L N S ++ C+ L L L L S+L L
Sbjct: 196 AFKEIRLHK-LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254
Query: 287 EYILDINLSSNSLNDSLPSNV---QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLA 343
+ L+ L + L ++ L + + + L L
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELV 312
Query: 344 RNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKG 403
+F + SL L G N S L L+ ++S N L +
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTSNKGGNAF-----SEVDLPSLEFLDLSRNGLSFKGCCSQ 367
Query: 404 SFKN 407
S
Sbjct: 368 SDFG 371
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-41
Identities = 65/389 (16%), Positives = 122/389 (31%), Gaps = 31/389 (7%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILT--------LEGNQLSGRLPST 56
+ T I L L+ F+ S + L L
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276
Query: 57 VGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLS 116
+ + L N+ S L + + + S L+L F +L+ L+ S
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTS 334
Query: 117 QVMNNLTTESS---------SADQWSFL----SSLTNCRNLTILSFGSNPLGGILPPVIG 163
N +E S + SF S +L L N + +
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFL 393
Query: 164 NFSASLQKFYAYECKLKGNIPQEI-GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSL 222
L+ LK + +L L L + + L L+ L +
Sbjct: 394 GLE-QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 223 RNNNLEGSIPYD-LCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPS 281
N+ + + D L+ + + L+ +L P SL+SL+ L++ N S
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512
Query: 282 SLWSLEYILDINLSSNSLNDSLPSNVQKL-KVLTVLDLSRNQLSGDIPST--IGALKDLE 338
L + ++ S N + S +Q L L+L++N + + +KD
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQR 572
Query: 339 TLSLARNQFQGPIPESVGSLISLESLDLS 367
L + + + P + + SL+++
Sbjct: 573 QLLVEVERMECATPSDKQGM-PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-35
Identities = 47/267 (17%), Positives = 89/267 (33%), Gaps = 15/267 (5%)
Query: 138 LTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLS 197
+ N+T N + N S + L+ + L +L
Sbjct: 4 VEVVPNITYQCMELN-----FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLD 58
Query: 198 LHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPP 257
L ++ L L L L N ++ L + + L+
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 258 CLVSLTSLRELHLGSNKLTS-SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTV- 315
+ L +L+EL++ N + S +P +L + ++LSSN + ++++ L + +
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 316 ---LDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNL 371
LDLS N ++ P ++ L L+L N + ++ L LE L
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
Query: 372 SGKI---PKSLETLSQLKQFNVSHNRL 395
+ L L + RL
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRL 264
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-27
Identities = 33/165 (20%), Positives = 60/165 (36%), Gaps = 6/165 (3%)
Query: 246 LTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPS 305
IP L S + L L N L S +S + ++LS +
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 306 NVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLD 365
Q L L+ L L+ N + L L+ L +G L +L+ L+
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 366 LSGNNL-SGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
++ N + S K+P+ L+ L+ ++S N+++ +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC--TDLRVLH 173
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-20
Identities = 33/199 (16%), Positives = 70/199 (35%), Gaps = 12/199 (6%)
Query: 3 GQIPTEI-GNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLL 61
+ +L+NL YL + + +S++ +L + GN + L
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469
Query: 62 PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNN 121
N+ L L+ L + P + + + L L++ N+F + L L +L +N+
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 122 LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPV-IGNFSASLQKFYAYECKLK 180
+ T L +L L+ N + ++ +++
Sbjct: 530 IMTSKKQE-----LQHF--PSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERME 582
Query: 181 GNIPQEIGNLSGLTLLSLH 199
P + G+ +LSL+
Sbjct: 583 CATP---SDKQGMPVLSLN 598
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 8e-61
Identities = 64/445 (14%), Positives = 136/445 (30%), Gaps = 54/445 (12%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
I I L LQ + FA + + + + + +L ++
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNL-KDL 493
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAG---------HILNTFGNLRHLSLL 115
+ L +P + + +L +L++ N + + + +
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 116 SQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAY 175
NNL +SA SL L +L N + + G L
Sbjct: 554 YMGYNNLEEFPASA-------SLQKMVKLGLLDCVHNKVRHL--EAFGTNV-KLTDLKLD 603
Query: 176 ECKLKGNIPQEIG-NLSGLTLLSLHSNDLNG-TISPTMGRLKRLQGLSLRNNNLEGSIPY 233
+++ IP++ + L N L + + + N +
Sbjct: 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662
Query: 234 DLCHLKLMFGIRLT-----GNKLSGHIPPCLVSLTSLRELHLGSNKLTS-------SIPS 281
C + GI + N++ + + + + L +N +TS
Sbjct: 663 ISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDG 722
Query: 282 SLWSLEYILDINLSSNSLNDSLPSN--VQKLKVLTVLDLSRNQLSGDIPSTIGALKDLET 339
+ + + I+L N L SL + L L+ +D+S N S P+ L+
Sbjct: 723 NYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKA 780
Query: 340 LSLAR------NQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHN 393
+ N+ P + + SL L + N++ K+ + L QL +++ N
Sbjct: 781 FGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADN 837
Query: 394 RL-EGEIPVKGSFKNFSVESFFGNY 417
++ + + +
Sbjct: 838 PNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 8e-57
Identities = 62/451 (13%), Positives = 137/451 (30%), Gaps = 54/451 (11%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
Q ++ N + L A G VP I ++ +++L+ + + L
Sbjct: 313 DQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELT 372
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
S + +L DL ++ ++ S +S + +
Sbjct: 373 PDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR--NPEMKPIKKDSRIS--LKDT 428
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGI-------------------LPPVIG 163
+ + ++ L I+ F ++P
Sbjct: 429 QIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWS 488
Query: 164 NFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNG---------TISPTMGRL 214
N L Y C +P + +L L L++ N ++
Sbjct: 489 NLK-DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTG 547
Query: 215 KRLQGLSLRNNNLEG-SIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSN 273
++Q + NNLE L + + + NK+ + L +L L N
Sbjct: 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYN 605
Query: 274 KLTSSIPSSLWS-LEYILDINLSSNSLNDSLPSNVQ--KLKVLTVLDLSRNQLSGDIPST 330
++ IP + + + + S N L +P+ + V+ +D S N++ + +
Sbjct: 606 QIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNI 663
Query: 331 -----IGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS-------GKIPKS 378
+ T++L+ N+ Q E + + ++ LS N ++ +
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGN 723
Query: 379 LETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
+ L ++ N+L +
Sbjct: 724 YKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 7e-43
Identities = 55/353 (15%), Positives = 113/353 (32%), Gaps = 36/353 (10%)
Query: 72 NNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQ 131
+ + N ++ L L G + + G L L +LS ++ T
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 132 WSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLS 191
++ R I + ++ L + + N E+ +
Sbjct: 369 EELTPDMSEERKHRIRM--------HYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIK 418
Query: 192 GLTLLSLHSNDLNG------TISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIR 245
+ +SL + IS + RL +LQ + N+
Sbjct: 419 KDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN----- 473
Query: 246 LTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLND---- 301
K + +L L ++ L + + +P L+ L + +N++ N
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL 533
Query: 302 -----SLPSNVQKLKVLTVLDLSRNQLSG-DIPSTIGALKDLETLSLARNQFQGPIPESV 355
L + + + + N L +++ + L L N+ + E+
Sbjct: 534 KADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAF 591
Query: 356 GSLISLESLDLSGNNLSGKIPKSL-ETLSQLKQFNVSHNRLEGEIPVKGSFKN 407
G+ + L L L N + IP+ Q++ SHN+L+ IP + K+
Sbjct: 592 GTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-33
Identities = 37/241 (15%), Positives = 77/241 (31%), Gaps = 12/241 (4%)
Query: 177 CKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLC 236
++ N +T LSL G + +G+L L+ LS ++ S
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 237 HLKLMFGIRLTGNKLSGHIPPC-LVSLTSLRELHLGSNKLTS-----SIPSSLWSLEYIL 290
+++ H L L L + + I
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
Query: 291 DINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGP 350
I +N + + +Q+L L ++ + + + D + D E + +
Sbjct: 429 QIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYEN 482
Query: 351 IPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSV 410
S +L L ++L ++P L L +L+ N++ NR +K + +
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 411 E 411
+
Sbjct: 543 D 543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-33
Identities = 40/328 (12%), Positives = 91/328 (27%), Gaps = 38/328 (11%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
+ + L L N + L + L L+ NQ+ +P +
Sbjct: 565 ASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQV 621
Query: 65 ESLLLAANNLTGI-IPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVM---- 119
E L + N L I + + + ++D +N N ++ ++
Sbjct: 622 EGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681
Query: 120 -NNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGI-------LPPVIGNFSASLQK 171
N + + ++ + +N + I N L
Sbjct: 682 YNEIQKFPTEL--------FATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY-LLTT 732
Query: 172 FYAYECKLKGNIPQEI--GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLR------ 223
KL + + L L+ + + N + + +L+ +R
Sbjct: 733 IDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAE 790
Query: 224 NNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSL 283
N + P + + +++ N + + L L L + N S +S+
Sbjct: 791 GNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSV 847
Query: 284 WSLEYILDINLSSNSLNDSLPSNVQKLK 311
L + D + ++
Sbjct: 848 CPYIEAGMYVLLYDKTQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 8e-12
Identities = 18/135 (13%), Positives = 44/135 (32%), Gaps = 2/135 (1%)
Query: 262 LTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRN 321
L + + S ++ + N + D ++ +T L L+
Sbjct: 275 KAIWEALDGKNWRYYSGTINNTIHSL-NWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGF 333
Query: 322 QLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK-SLE 380
G +P IG L +L+ LS + ++ + + + + K L+
Sbjct: 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLD 393
Query: 381 TLSQLKQFNVSHNRL 395
+L ++ + +
Sbjct: 394 YDQRLNLSDLLQDAI 408
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 14/73 (19%), Positives = 25/73 (34%), Gaps = 4/73 (5%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQL-SGRLPSTVGHLL 61
Q PT I +L L N++ + + + IL + N S + S ++
Sbjct: 796 RQWPTGITTCPSLIQLQIGSNDIRKV-DEKLT--PQLYILDIADNPNISIDVTSVCPYIE 852
Query: 62 PNIESLLLAANNL 74
+ LL
Sbjct: 853 AGMYVLLYDKTQD 865
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 4e-60
Identities = 72/301 (23%), Positives = 127/301 (42%), Gaps = 54/301 (17%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQ-------LERAFRSFDSECEVLR 552
+E +G G FG V+KG + D + VAIK L + F+ F E ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 553 NVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 612
N+ H N++K+ NP +V+EF+P G L L + + +L +M+D+ +E
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDE-----NMAAHVSDFGISKLLGEGEDSVTQTMTMA- 666
Y+ + + PI+H DL+ NI L + A V+DFG+S+ +++
Sbjct: 137 YMQ--NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVHSVSGLL 187
Query: 667 -TIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE--- 720
+MAPE E + K D YS+ ++L T + P DE G++ ++E
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247
Query: 721 --SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778
++P DC + ++ C P R + + +L +
Sbjct: 248 RPTIPE---------------------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
Query: 779 I 779
+
Sbjct: 287 L 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 7e-59
Identities = 65/211 (30%), Positives = 110/211 (52%), Gaps = 9/211 (4%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRN 558
+ N +G GSFG+V++ G+DVA+KI Q F E +++ +RH N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHH 616
++ + + + P ++V E++ GSL + L+ LD RL++ DV + YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYG 676
+ + PI+H +LK N+L+D+ V DFG+S+L + ++ T +MAPE
Sbjct: 155 -NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVL 211
Query: 677 SEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
+ + K DVYS+GV+L E T ++P +
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNL 242
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-58
Identities = 67/271 (24%), Positives = 119/271 (43%), Gaps = 26/271 (9%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRN 558
+ +G+GSFG+VYKG DVA+K+ N+ + ++F +E VLR RH N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
++ + + P A+V ++ SL L++ ++ + ++I ++YLH
Sbjct: 82 ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE---Y 675
+ IIH DLK NI L E+ + DFG++ S +I +MAPE
Sbjct: 138 -AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735
S + DVY++G++L E T + P + + + E+V +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------EMVGRGSL 243
Query: 736 REEQAFSAKMDCILSIMDLALDCCIESPDMR 766
+ + + +C + L +C + D R
Sbjct: 244 SPDLS-KVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 7e-58
Identities = 84/432 (19%), Positives = 152/432 (35%), Gaps = 31/432 (7%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
+ L LV N L + + ++ L +S + + +
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN-QKTL 131
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSL--LSQVMNNL 122
ESL L +N+++ I KL LD N+ +L+ + L+ N++
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 123 TTESSSADQWSFLSSL-----------------TNCRNLTILSFGSNPLGGILPPVIGNF 165
A + SL + ++L + +F I P V
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 166 SA-SLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRN 224
S++ + SGL L L + L+ + + L L+ L L
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 225 NNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSS--IPS 281
N E + + + + GN + CL +L +LREL L + + +S
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 282 SLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSG-DIPSTIGALKDLETL 340
L +L ++ +NLS N ++ L +LDL+ +L D S L L+ L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 341 SLARNQFQGPIPESVGSLISLESLDLSGNNLSGKI---PKSLETLSQLKQFNVSHNRLEG 397
+L+ + + L +L+ L+L GN+ SL+TL +L+ +S L
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 398 EIPVKGSFKNFS 409
+F +
Sbjct: 491 IDQ--HAFTSLK 500
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-54
Identities = 84/412 (20%), Positives = 152/412 (36%), Gaps = 19/412 (4%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL--LP 62
+ N + L+ L N++S + P F +++L + N + + L
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQAT 180
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
N+ L L N++ G I ++ +L+ G I N SL ++
Sbjct: 181 NLS-LNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN 182
E S + L + ++ ++ + I FS LQ+ L
Sbjct: 239 DDEDISPAVFEGLCEM----SVESINLQKHYFFNISSNTFHCFS-GLQELDLTATHLS-E 292
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYD-LCHLKLM 241
+P + LS L L L +N + L LS++ N + L +L+ +
Sbjct: 293 LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352
Query: 242 FGIRLTGNKL--SGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL 299
+ L+ + + S L +L+ L+ L+L N+ S + + ++L+ L
Sbjct: 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412
Query: 300 NDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGS- 357
+ Q L +L VL+LS + L L L+ L+L N F + S
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472
Query: 358 --LISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKN 407
L LE L LS +LS + +L + ++SHNRL + +
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI--EALSH 522
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-52
Identities = 72/418 (17%), Positives = 149/418 (35%), Gaps = 30/418 (7%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+IP + + + L F+ N L + T + + L L Q+ T
Sbjct: 26 EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQS-QHR 82
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
+++L+L AN L + +++ L L + N + L L N+++
Sbjct: 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN- 182
+ L L +L F +N + + + + L GN
Sbjct: 143 SIK--------LPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ-QATNLS---LNLNGND 190
Query: 183 ---IPQEIGNLSGLTLLSLHSNDLNGTISPTMG--RLKRLQGLSLRNNNLEG---SIPYD 234
I + + L+ I + ++ L + + + E ++
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 235 LCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINL 294
LC + + I L + + L+EL L + L+ +PS L L + + L
Sbjct: 251 LCEMSVES-INLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308
Query: 295 SSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPS-TIGALKDLETLSLARNQFQ--GPI 351
S+N + + LT L + N ++ + + L++L L L+ + +
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368
Query: 352 PESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
+ +L L+SL+LS N ++ + QL+ +++ RL+ + F+N
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQNLH 425
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-51
Identities = 80/404 (19%), Positives = 143/404 (35%), Gaps = 24/404 (5%)
Query: 6 PTEIGNLQNLQ--YLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL-LP 62
++ +LQ L N+++G+ P F+ + + L G Q + + + +
Sbjct: 170 KEDMSSLQQATNLSLNLNGNDIAGI-EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
Query: 63 NIESLLLAANNLTGIIPHSITN--ATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
++ + I P + +++L + F NTF L L
Sbjct: 229 SLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTAT 288
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+L+ S L L L +N + NF SL +
Sbjct: 289 HLS---------ELPSGLVGLSTLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKR 338
Query: 181 GNI-PQEIGNLSGLTLLSLHSNDLN--GTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCH 237
+ + NL L L L +D+ + + L LQ L+L N
Sbjct: 339 LELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKE 398
Query: 238 LKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSS 296
+ + L +L +L L+ L+L + L S L + +NL
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458
Query: 297 NSL---NDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPE 353
N N +++Q L L +L LS LS +LK + + L+ N+ E
Sbjct: 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518
Query: 354 SVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEG 397
++ L + L+L+ N++S +P L LSQ + N+ N L+
Sbjct: 519 ALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 6e-49
Identities = 77/374 (20%), Positives = 131/374 (35%), Gaps = 20/374 (5%)
Query: 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFA 99
+ E L+ +P L + E L + N L I + + L LDL
Sbjct: 15 KTYNCENLGLN-EIPG---TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70
Query: 100 GHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILP 159
+TF + L L N L + +A L+ + L L F + I
Sbjct: 71 WIHEDTFQSQHRLDTLVLTANPLIFMAETA--------LSGPKALKHLFFIQTGISSIDF 122
Query: 160 PVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQG 219
+ N +L+ Y + + L +L +N ++ M L++
Sbjct: 123 IPLHNQK-TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATN 181
Query: 220 LSLR-NNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLV--SLTSLRELHLGSNKLT 276
LSL N N I + + G + I L ++ SL
Sbjct: 182 LSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241
Query: 277 SSIPSSLWSLE--YILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGAL 334
P+ L + INL + + + L LDL+ LS ++PS + L
Sbjct: 242 DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGL 300
Query: 335 KDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKI-PKSLETLSQLKQFNVSHN 393
L+ L L+ N+F+ S + SL L + GN ++ LE L L++ ++SH+
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 394 RLEGEIPVKGSFKN 407
+E +N
Sbjct: 361 DIETSDCCNLQLRN 374
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-33
Identities = 68/324 (20%), Positives = 124/324 (38%), Gaps = 19/324 (5%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
++P+ + L L+ LV + N L + N ++ L+++GN L + L N
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
Query: 64 IESLLLAANNLTGI--IPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNN 121
+ L L+ +++ + N + L +L+L +N F L LL
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411
Query: 122 LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKG 181
L + + S N L +L+ + L + +LQ
Sbjct: 412 LKVKDAQ-------SPFQNLHLLKVLNLSHSLLDISSEQLFDGLP-ALQHLNLQGNHFPK 463
Query: 182 NIPQEIGNLSGLT---LLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHL 238
Q+ +L L +L L DL+ LK + + L +N L S L HL
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523
Query: 239 KLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNS 298
K ++ + L N +S +P L L+ R ++L N L + S+++ LE+ +
Sbjct: 524 KGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT-CSNIYFLEWYKENMQKLED 581
Query: 299 LND---SLPSNVQKLKVLTVLDLS 319
D P ++ +++ V LS
Sbjct: 582 TEDTLCENPPLLRGVRLSDV-TLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-26
Identities = 40/210 (19%), Positives = 67/210 (31%), Gaps = 11/210 (5%)
Query: 220 LSLRNNNLE---GSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT 276
+ N L G++P L + N L L +L L L ++
Sbjct: 17 YNCENLGLNEIPGTLPNSTECL------EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70
Query: 277 SSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKD 336
+ S + + L++N L + + K L L + +S + K
Sbjct: 71 WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130
Query: 337 LETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQ--FNVSHNR 394
LE+L L N L+ LD N + + + +L Q N++ N
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190
Query: 395 LEGEIPVKGSFKNFSVESFFGNYALCGPPK 424
+ G P F +F G L K
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFK 220
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 21/96 (21%), Positives = 42/96 (43%), Gaps = 2/96 (2%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
Q + L L+ LV + +LS + ++ M + L N+L+ + HL
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL-- 523
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSF 98
L LA+N+++ I+P + ++ ++L N
Sbjct: 524 KGIYLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-57
Identities = 74/292 (25%), Positives = 114/292 (39%), Gaps = 43/292 (14%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
E ++G G+FG V K DVAIK + ER ++F E L V H N++
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHHGH 618
K+ +C NP LV+E+ GSL L+ + ++ + + YLH
Sbjct: 65 KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS-M 121
Query: 619 SSAPIIHCDLKPTNILLDENM-AAHVSDFGISKLLGEGEDSVTQTMTMA--TIGYMAPEY 675
+IH DLKP N+LL + DFG + + MT + +MAPE
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-------IQTHMTNNKGSAAWMAPEV 174
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE----SLPHGLTEVVD 731
S KCDV+S+G++L E TR++P DE+ + V L
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK------- 227
Query: 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783
+ I L C + P R ++ + + + F
Sbjct: 228 --------------NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 5e-57
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRN 558
+ N L G ++KG G D+ +K+ ++ R R F+ EC LR H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 559 LIKILSSCSNPDFK--ALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLH 615
++ +L +C +P L+ +MP GSL L+ N+ +D + + +D+ + +LH
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE- 674
I L ++++DE+M A +S + S M ++APE
Sbjct: 129 T--LEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179
Query: 675 --YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
E D++S+ VLL E TR+ P ++
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-56
Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 24/227 (10%)
Query: 494 LDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQ----LERAFRSFDSECE 549
L+I E ++G G FG VY+ G +VA+K + + + E +
Sbjct: 2 LEIDF--AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAK 58
Query: 550 VLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 609
+ ++H N+I + C LV+EF G L + L + +N + +
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIAR 116
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAH--------VSDFGISKLLGEGEDSVTQ 661
+ YLH + PIIH DLK +NIL+ + + ++DFG+++ T
Sbjct: 117 GMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-----TT 170
Query: 662 TMTMA-TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
M+ A +MAPE + S DV+SYGVLL E T + P +
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 1e-53
Identities = 74/320 (23%), Positives = 130/320 (40%), Gaps = 37/320 (11%)
Query: 491 TPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEV 550
+ D L+G G +G+VYKG++ D VA+K+F+ + +F +E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 551 --LRNVRHRNLIKILSSCSNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNI 603
+ + H N+ + + LV+E+ PNGSL K+L H D + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116
Query: 604 MIDVGSALEYLH-----HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL------ 652
V L YLH H I H DL N+L+ + +SDFG+S L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 653 GEGEDSVTQTMTMATIGYMAPEYGSEGI-------VSAKCDVYSYGVLLMETFTRK---R 702
GE+ + TI YMAPE + + D+Y+ G++ E F R
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 703 PTDEMFTGEMSLRRWVKESLP-HGLTEVVDANLVREE--QAFSAKMDCILSIMDLALDCC 759
P + + +M+ + V + +V R + +A+ + S+ + DC
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 760 IESPDMRINVTDAAAKLKKI 779
+ + R+ A ++ ++
Sbjct: 297 DQDAEARLTAQXAEERMAEL 316
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-53
Identities = 63/279 (22%), Positives = 107/279 (38%), Gaps = 34/279 (12%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNL 559
+ +LG G FG K T G + +K E R+F E +V+R + H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
+K + + E++ G+L + S + +R++ D+ S + YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---- 125
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA------------T 667
S IIH DL N L+ EN V+DFG+++L+ + + ++
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 668 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727
+MAPE + K DV+S+G++L E R +
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-----------------LPR 228
Query: 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMR 766
+ VR +C S + + CC P+ R
Sbjct: 229 TMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-53
Identities = 57/294 (19%), Positives = 109/294 (37%), Gaps = 39/294 (13%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRN 558
++ L+G G FG VY G +VAI++ +++ E ++F E R RH N
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
++ + +C +P A++ +L + LD+ + I ++ + YLH
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--- 147
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA---TIGYMAPE- 674
+ I+H DLK N+ D ++DFG+ + G + + + ++APE
Sbjct: 148 -AKGILHKDLKSKNVFYDNGK-VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 675 --------YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL 726
+ S DV++ G + E R+ P +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII------------- 252
Query: 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780
+ + +++ I D+ L C + R T L+K+
Sbjct: 253 -WQMGTGMKPNL----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-52
Identities = 69/321 (21%), Positives = 116/321 (36%), Gaps = 40/321 (12%)
Query: 483 LPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFR 542
LPL R T IQ +G G +G V+ G G VA+K+F
Sbjct: 27 LPLLVQR-TIAKQIQ-------MVKQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEA 74
Query: 543 SFDSECEV--LRNVRHRNLIKILSSCSNPDFK----ALVLEFMPNGSLEKWLYSHNYFLD 596
S+ E E+ +RH N++ +++ L+ ++ NGSL +L + LD
Sbjct: 75 SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLD 132
Query: 597 ILERLNIMIDVGSALEYLH----HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652
L + S L +LH I H DLK NIL+ +N ++D G++
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 653 GEGEDSVTQTMTMA--TIGYMAPE--YGSEGIVSA----KCDVYSYGVLLMETFTRKRPT 704
+ V T YM PE S D+YS+G++L E R
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 705 DEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ-----AFSAKMDCILSIMDLALDCC 759
+ ++ + E + + ++ + +C+ + L +C
Sbjct: 253 GIVEEYQLP---YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECW 309
Query: 760 IESPDMRINVTDAAAKLKKIK 780
+P R+ L K+
Sbjct: 310 AHNPASRLTALRVKKTLAKMS 330
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-51
Identities = 70/313 (22%), Positives = 126/313 (40%), Gaps = 39/313 (12%)
Query: 490 RTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECE 549
RT DI EC +G G +G V++G+ G +VA+KIF+ + E+ S+ E E
Sbjct: 4 RTVARDIT-----LLEC--VGKGRYGEVWRGSW-QGENVAVKIFSSRDEK---SWFRETE 52
Query: 550 V--LRNVRHRNLIKILSSCSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNI 603
+ +RH N++ ++S + L+ + GSL +L LD + L I
Sbjct: 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRI 110
Query: 604 MIDVGSALEYLH----HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659
++ + S L +LH I H DLK NIL+ +N ++D G++ + + + +
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL 170
Query: 660 TQTMTMA--TIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
T YMAPE + D++++G++L E R + +
Sbjct: 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
Query: 712 MSLRRWVKESLPHGLTEVVDANLVREEQ-----AFSAKMDCILSIMDLALDCCIESPDMR 766
+ E + + ++Q + S+ L +C ++P R
Sbjct: 231 PP---FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287
Query: 767 INVTDAAAKLKKI 779
+ L KI
Sbjct: 288 LTALRIKKTLTKI 300
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-49
Identities = 75/420 (17%), Positives = 133/420 (31%), Gaps = 34/420 (8%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRI----LTLEGNQLSGRLPSTVGH 59
++P NL NL ++ + N + + + + L + N + +
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQ 202
Query: 60 LLPNIESLLLAANNLTG-IIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQV 118
+ + L L N + I+ + N L L F + L V
Sbjct: 203 GI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261
Query: 119 MNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECK 178
+ + + D + N++ +S + + Q C+
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED---VPKHFKWQSLSIIRCQ 318
Query: 179 L-------------------KGNIPQEIGNLSGLTLLSLHSNDLN--GTISPTMGRLKRL 217
L KG+I + L L+ L L N L+ G S + L
Sbjct: 319 LKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378
Query: 218 QGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLT 276
+ L L N + + L+ + + + L +SL L L +
Sbjct: 379 RHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 277 SSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALK 335
L + + ++ NS D+ SNV LT LDLS+ QL L
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497
Query: 336 DLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRL 395
L+ L+++ N L SL +LD S N + L FN+++N +
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-49
Identities = 84/416 (20%), Positives = 148/416 (35%), Gaps = 25/416 (6%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
P L +L+ LV E L+ L I + T++ L + N + L N+
Sbjct: 96 SPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNL 155
Query: 65 ESLLLAANNLTGIIPHSITNATKL----VALDLGFNSFAGHILNTFG--NLRHLSLLSQV 118
+ L+ N + I + + + ++LD+ N F L L+L
Sbjct: 156 VHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR--- 212
Query: 119 MNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSA-SLQKFYAYEC 177
N + + L+ L R + L P ++ ++ +F
Sbjct: 213 -GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271
Query: 178 KLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCH 237
+ + L+ ++ +SL + + + + Q LS+ L+ DL
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQFPTLDLPF 329
Query: 238 LKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEY--ILDINLS 295
LK + LT NK S I V+L SL L L N L+ S S L + ++LS
Sbjct: 330 LKS---LTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 296 SNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP-STIGALKDLETLSLARNQFQGPIPES 354
N + +N L+ L LD + L S +L+ L L ++ +
Sbjct: 385 FNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 355 VGSLISLESLDLSGNNLSGKIPKS-LETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
L SL +L ++GN+ + + L ++S +LE G F
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW--GVFDTLH 497
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-46
Identities = 76/419 (18%), Positives = 133/419 (31%), Gaps = 32/419 (7%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
N LQ+L + + + + + L L GN + L ++
Sbjct: 48 KSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSL 106
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAG-HILNTFGNLRHLSLLSQVMNNLT 123
E+L+ L + I L L++ N + F NL +L + N +
Sbjct: 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 124 TESSSADQWSFLSSLTNCR-NLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN 182
T + + L L L NP+ I L + N
Sbjct: 167 TITVND-----LQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI--KLHELTLRGNFNSSN 219
Query: 183 IPQE-IGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGL--------SLRNNNLEGSIPY 233
I + + NL+GL + L + + + ++GL L N
Sbjct: 220 IMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIV 279
Query: 234 DLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDIN 293
L + + L G + + + L + +L L L+ +
Sbjct: 280 KFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKS---LT 334
Query: 294 LSSNSLNDSLPSNVQKLKVLTVLDLSRNQLS--GDIPSTIGALKDLETLSLARNQFQGPI 351
L+ N + S L L+ LDLSRN LS G + L L L+ N +
Sbjct: 335 LTMNKGSISFKK--VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-M 391
Query: 352 PESVGSLISLESLDLSGNNLSGKIPKS-LETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
+ L L+ LD + L S +L +L ++S+ + + G F +
Sbjct: 392 SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD--GIFLGLT 448
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-44
Identities = 79/419 (18%), Positives = 136/419 (32%), Gaps = 36/419 (8%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
++P +I + + + + + N L L + N S ++ L L ++ + H L +
Sbjct: 25 KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET-IEDKAWHGLHH 81
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
+ +L+L N + P S + T L L A G L L L+ N +
Sbjct: 82 LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNF---SASLQKFYAYECKLK 180
+ A +N NL + N + I + +
Sbjct: 142 SCKLPA-------YFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGR-LKRLQGLSLRNNNLEG---------S 230
I + L L+L N + I T + L L L + S
Sbjct: 195 -FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPS 253
Query: 231 IPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYIL 290
I LC + + RLT L ++ + L + +
Sbjct: 254 IMEGLCDVTIDE-FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQ 310
Query: 291 DINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQ-- 348
+++ L + L L L L+ N+ S I AL L L L+RN
Sbjct: 311 SLSIIRCQLKQFPTLD---LPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFS 365
Query: 349 GPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKN 407
G S SL LDLS N + + L +L+ + H+ L+ + +F +
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR-VTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-41
Identities = 56/389 (14%), Positives = 109/389 (28%), Gaps = 45/389 (11%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSG-----RLPSTV 57
I + L L N S + T N++ + + L + ++
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 58 GHLLPNI--ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAG-HILNTFGNLRHLSL 114
L ++ + L N + A+ L S + + LS+
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSI 314
Query: 115 LS--------QVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFS 166
+ + L + + + ++ S +L+ L N L +
Sbjct: 315 IRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374
Query: 167 A-SLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRN 224
SL+ + L L L + L L++L L +
Sbjct: 375 TNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY 433
Query: 225 NNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPC-LVSLTSLRELHLGSNKLTSSIPSSL 283
N + L + +++ GN + + T+L L L +L
Sbjct: 434 TNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF 493
Query: 284 WSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLA 343
L L +L++S N L S L L TL +
Sbjct: 494 ------------------------DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529
Query: 344 RNQFQGPIPESVGSLISLESLDLSGNNLS 372
N+ + SL +L+ N+++
Sbjct: 530 FNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-38
Identities = 75/382 (19%), Positives = 132/382 (34%), Gaps = 37/382 (9%)
Query: 42 LTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGH 101
+LS ++P + + +++ L+ N L + +S +N ++L LDL
Sbjct: 16 YQCMDQKLS-KVPD---DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 102 ILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPV 161
+ L HLS L N + + S + + +L L L +
Sbjct: 72 EDKAWHGLHHLSNLILTGNPIQSFSPGS--------FSGLTSLENLVAVETKLASLESFP 123
Query: 162 IGNFSASLQKFYAYECKLKG-NIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQG- 219
IG +L+K + +P NL+ L + L N + + L+
Sbjct: 124 IGQLI-TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV 182
Query: 220 ---LSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHL----- 270
L + N ++ +KL + L GN S +I CL +L L L
Sbjct: 183 NLSLDMSLNPIDFIQDQAFQGIKL-HELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241
Query: 271 -GSNKLTSSIPSSLWSLE--YILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDI 327
L PS + L I + L+ + L ++ + L+ + +
Sbjct: 242 KDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YL 300
Query: 328 PSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQ 387
K ++LS+ R Q + P L L+SL L+ N S I L L
Sbjct: 301 EDVPKHFK-WQSLSIIRCQLKQ-FPTL--DLPFLKSLTLTMNKGS--ISFKKVALPSLSY 354
Query: 388 FNVSHNRLEGEIPVKGSFKNFS 409
++S N L S+ +
Sbjct: 355 LDLSRNALSFSGC--CSYSDLG 374
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-23
Identities = 35/170 (20%), Positives = 69/170 (40%), Gaps = 5/170 (2%)
Query: 229 GSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEY 288
GS+ + + + + KLS +P + +S + + L N L S +
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 289 ILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQ 348
+ ++LS + L L+ L L+ N + P + L LE L +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 349 GPIPESVGSLISLESLDLSGNNLSG-KIPKSLETLSQLKQFNVSHNRLEG 397
+G LI+L+ L+++ N + K+P L+ L ++S+N ++
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-21
Identities = 53/319 (16%), Positives = 91/319 (28%), Gaps = 65/319 (20%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTM--RILTLEGNQLSGRLPSTVGHL 60
G I + L +L YL + N LS + ++ T R L L N + S
Sbjct: 340 GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI--IMSANFMG 397
Query: 61 LPNIESLLLAANNLTGIIPHS-ITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVM 119
L ++ L + L + S + KL+ LD+ + + F L
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL---------- 447
Query: 120 NNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKL 179
+L L N +
Sbjct: 448 ----------------------TSLNTLKMAGNSFKDNTLSNV----------------- 468
Query: 180 KGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
N + LT L L L L RLQ L++ +NNL L
Sbjct: 469 -------FANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY 521
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL 299
+ + + N++ SL +L +N + I L+++ + ++
Sbjct: 522 SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLVNV 580
Query: 300 ND---SLPSNVQKLKVLTV 315
+ P + VL
Sbjct: 581 EQMTCATPVEMNTSLVLDF 599
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-47
Identities = 92/391 (23%), Positives = 167/391 (42%), Gaps = 61/391 (15%)
Query: 7 TEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIES 66
+L V + +++ + T + ++ L + G +++ + +L N+E
Sbjct: 16 FPDADLAEGIRAVLQKASVTDV--VTQEELESITKLVVAGEKVAS--IQGIEYL-TNLEY 70
Query: 67 LLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTES 126
L L N +T I P ++N KL L +G N ++ NL +L L +N++
Sbjct: 71 LNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD-- 124
Query: 127 SSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQE 186
+S L N + L+ G+N L P + N + L E K+K P
Sbjct: 125 --------ISPLANLTKMYSLNLGANHNLSDLSP-LSNMT-GLNYLTVTESKVKDVTP-- 172
Query: 187 IGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRL 246
I NL+ L LSL+ N + ISP + L L + N + P
Sbjct: 173 IANLTDLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP-------------- 216
Query: 247 TGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIP-SSLWSLEYILDINLSSNSLNDSLPS 305
+ ++T L L +G+NK+T P ++L L ++ + +N ++D +
Sbjct: 217 ------------VANMTRLNSLKIGNNKITDLSPLANLSQLTWL---EIGTNQISD--IN 259
Query: 306 NVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLD 365
V+ L L +L++ NQ+S S + L L +L L NQ E +G L +L +L
Sbjct: 260 AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317
Query: 366 LSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396
LS N+++ P L +LS++ + ++ ++
Sbjct: 318 LSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-43
Identities = 74/343 (21%), Positives = 144/343 (41%), Gaps = 32/343 (9%)
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
L +L ++T ++ + L + A + L +L L+ N
Sbjct: 21 LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGN 76
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+T +S L+N LT L G+N + I + N + +L++ Y E +
Sbjct: 77 QITD----------ISPLSNLVKLTNLYIGTNKITDI--SALQNLT-NLRELYLNEDNIS 123
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
P + NL+ + L+L +N +SP + + L L++ + ++ P + +L
Sbjct: 124 DISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTD 178
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
++ + L N++ P L SLTSL N++T P + ++ + + + +N +
Sbjct: 179 LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT 234
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
D S + L LT L++ NQ+S + + L L+ L++ NQ + +L
Sbjct: 235 DL--SPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQ 288
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKG 403
L SL L+ N L + + + L+ L +S N + P+
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLAS 331
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 57/272 (20%), Positives = 111/272 (40%), Gaps = 27/272 (9%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
+ + NL NL+ L E+N+S + + N++ M L L N S + + + +
Sbjct: 102 DISALQNLTNLRELYLNEDNISDI--SPLANLTKMYSLNLGANHNLS-DLSPLSN-MTGL 157
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTT 124
L + + + + P I N T L +L L +N ++ +L L + +N +T
Sbjct: 158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITD 213
Query: 125 ESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIP 184
++ + N L L G+N + + P + N S L ++
Sbjct: 214 ----------ITPVANMTRLNSLKIGNNKITDLSP--LANLS-QLTWLEIGTNQISD--I 258
Query: 185 QEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGI 244
+ +L+ L +L++ SN ++ IS + L +L L L NN L + L + +
Sbjct: 259 NAVKDLTKLKMLNVGSNQISD-ISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 245 RLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT 276
L+ N ++ P L SL+ + + +
Sbjct: 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 24/225 (10%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+ + N+ L YL E+ + + I N++ + L+L NQ+ S + L +
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDV--TPIANLTDLYSLSLNYNQIED--ISPLAS-LTS 200
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
+ N +T I P + N T+L +L +G N L+ NL L+ L N ++
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQIS 256
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNI 183
++++ + L +L+ GSN + I V+ N S L + +L
Sbjct: 257 D----------INAVKDLTKLKMLNVGSNQISDI--SVLNNLS-QLNSLFLNNNQLGNED 303
Query: 184 PQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLE 228
+ IG L+ LT L L N + I P + L ++ N ++
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITD-IRP-LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 28/149 (18%), Positives = 57/149 (38%), Gaps = 10/149 (6%)
Query: 259 LVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDL 318
L L +T + LE I + ++ + ++ L L L+L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVAS--IQGIEYLTNLEYLNL 73
Query: 319 SRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKS 378
+ NQ++ P + L L L + N+ ++ +L +L L L+ +N+S P
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP-- 127
Query: 379 LETLSQLKQFNVSHNRLEGEIPVKGSFKN 407
L L+++ N+ N ++ +
Sbjct: 128 LANLTKMYSLNLGANHNLSDLSPLSNMTG 156
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 20/105 (19%), Positives = 40/105 (38%), Gaps = 8/105 (7%)
Query: 292 INLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPI 351
+ +N P L L + ++ T L+ + L +A +
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVAS-- 58
Query: 352 PESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396
+ + L +LE L+L+GN ++ P L L +L + N++
Sbjct: 59 IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT 101
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-47
Identities = 60/243 (24%), Positives = 101/243 (41%), Gaps = 32/243 (13%)
Query: 483 LPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFR 542
LPL R T I +G G FG V++G G +VA+KIF+ + ER
Sbjct: 32 LPLLVQR-TIARTIVLQ-------ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--- 79
Query: 543 SFDSECEV--LRNVRHRNLIKILSSCSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLD 596
S+ E E+ +RH N++ +++ + + LV ++ +GSL +L + Y +
Sbjct: 80 SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVT 137
Query: 597 ILERLNIMIDVGSALEYLH----HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652
+ + + + S L +LH I H DLK NIL+ +N ++D G++
Sbjct: 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197
Query: 653 GEGEDSVTQTMTMA--TIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRPT 704
D++ T YMAPE + D+Y+ G++ E R
Sbjct: 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257
Query: 705 DEM 707
Sbjct: 258 GIH 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-46
Identities = 96/386 (24%), Positives = 161/386 (41%), Gaps = 39/386 (10%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+ + L NL + F+ N L+ + P + N++ + + + NQ++ + + + L N
Sbjct: 59 KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLAN-LTN 113
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
+ L L N +T I P + N T L L+L N+ + ++ L L LS N +T
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLS-FGNQVT 168
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNI 183
L L N L L SN + I V+ + +L+ A ++
Sbjct: 169 D----------LKPLANLTTLERLDISSNKVSDI--SVLAKLT-NLESLIATNNQISDIT 215
Query: 184 PQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFG 243
P +G L+ L LSL+ N L T+ L L L L NN + P L L +
Sbjct: 216 P--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 269
Query: 244 IRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSL 303
++L N++S I P L LT+L L L N+L P + +L+ + + L N+++D
Sbjct: 270 LKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDI- 324
Query: 304 PSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLES 363
S V L L L N++S S++ L ++ LS NQ P + +L +
Sbjct: 325 -SPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQ 379
Query: 364 LDLSGNNLSGKIPKSLETLSQLKQFN 389
L L+ + +S
Sbjct: 380 LGLNDQAWTNAPVNYKANVSIPNTVK 405
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-45
Identities = 99/395 (25%), Positives = 164/395 (41%), Gaps = 41/395 (10%)
Query: 9 IGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLL 68
L V + N++ V ++ + L + + V + L N+ +
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEY-LNNLTQIN 74
Query: 69 LAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSS 128
+ N LT I P + N TKLV + + N A + NL +L+ L+ N +T
Sbjct: 75 FSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD---- 126
Query: 129 ADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIG 188
+ L N NL L SN + I + + SLQ+ + +
Sbjct: 127 ------IDPLKNLTNLNRLELSSNTISDI--SALSGLT-SLQQLSFGNQVTD---LKPLA 174
Query: 189 NLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTG 248
NL+ L L + SN + + + +L L+ L NN + P L L + + L G
Sbjct: 175 NLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNG 230
Query: 249 NKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQ 308
N+L L SLT+L +L L +N++++ P L L + ++ L +N +++ S +
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLA 284
Query: 309 KLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSG 368
L LT L+L+ NQL P I LK+L L+L N P V SL L+ L
Sbjct: 285 GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340
Query: 369 NNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKG 403
N +S SL L+ + + HN++ P+
Sbjct: 341 NKVSD--VSSLANLTNINWLSAGHNQISDLTPLAN 373
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-45
Identities = 93/412 (22%), Positives = 167/412 (40%), Gaps = 43/412 (10%)
Query: 6 PTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIE 65
+L + L + + + ++ + + NQL+ + + + L +
Sbjct: 39 TVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD--ITPLKN-LTKLV 93
Query: 66 SLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTE 125
+L+ N + I P + N T L L L N ++ NL +L+ L N ++
Sbjct: 94 DILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD- 148
Query: 126 SSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQ 185
+S+L+ +L LSFG+ + N + +L++ K+
Sbjct: 149 ---------ISALSGLTSLQQLSFGNQVTD---LKPLANLT-TLERLDISSNKVSD--IS 193
Query: 186 EIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIR 245
+ L+ L L +N ++ I+P +G L L LSL N L+ L L + +
Sbjct: 194 VLAKLTNLESLIATNNQISD-ITP-LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLD 249
Query: 246 LTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPS 305
L N++S P L LT L EL LG+N++++ P L L + ++ L+ N L D S
Sbjct: 250 LANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--IS 303
Query: 306 NVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLD 365
+ LK LT L L N +S P + +L L+ L N+ S+ +L ++ L
Sbjct: 304 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLS 359
Query: 366 LSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNY 417
N +S P L L+++ Q ++ N S+ + N
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPV--NYKANVSIPNTVKNV 407
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-41
Identities = 90/395 (22%), Positives = 158/395 (40%), Gaps = 40/395 (10%)
Query: 7 TEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIES 66
T + NL NL L N ++ + + N++ + L L N +S S + L +++
Sbjct: 106 TPLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD--ISALSGL-TSLQQ 160
Query: 67 LLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTES 126
L N +T + P + N T L LD+ N + ++ L +L L N ++
Sbjct: 161 LSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-- 213
Query: 127 SSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQE 186
++ L NL LS N L I + + + +L ++ P
Sbjct: 214 --------ITPLGILTNLDELSLNGNQLKDI--GTLASLT-NLTDLDLANNQISNLAP-- 260
Query: 187 IGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRL 246
+ L+ LT L L +N ++ ISP + L L L L N LE P + +LK + + L
Sbjct: 261 LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316
Query: 247 TGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSN 306
N +S P + SLT L+ L +NK++ SSL +L I ++ N ++D +
Sbjct: 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTP 370
Query: 307 VQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPI-PESVGSLISLESLD 365
+ L +T L L+ + + ++ + +N I P ++ S D
Sbjct: 371 LANLTRITQLGLNDQAWTNAPVN---YKANVSIPNTVKNVTGALIAPATISDGGSYTEPD 427
Query: 366 LSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400
++ N S + T SQ G +
Sbjct: 428 ITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-37
Identities = 81/348 (23%), Positives = 139/348 (39%), Gaps = 34/348 (9%)
Query: 66 SLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHI-LNTFGNLRHLSLLS-------- 116
+ + + I T + + LG + + + L
Sbjct: 6 ATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG 63
Query: 117 -QVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAY 175
+ +NNLT + S +Q + ++ L N L + +N + I P + N + +L +
Sbjct: 64 VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP--LANLT-NLTGLTLF 120
Query: 176 ECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDL 235
++ P + NL+ L L L SN ++ + L LQ LS N + P L
Sbjct: 121 NNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSF-GNQVTDLKP--L 173
Query: 236 CHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLS 295
+L + + ++ NK+S L LT+L L +N+++ P L L + +++L+
Sbjct: 174 ANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLN 229
Query: 296 SNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV 355
N L D + L LT LDL+ NQ+S P + L L L L NQ P +
Sbjct: 230 GNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--L 283
Query: 356 GSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKG 403
L +L +L+L+ N L P + L L + N + PV
Sbjct: 284 AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSS 329
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 18/92 (19%), Positives = 37/92 (40%), Gaps = 5/92 (5%)
Query: 6 PTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIE 65
+ + NL N+ +L N +S L P + N++ + L L + P + +I
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNYKANV-SIP 401
Query: 66 SLLLAANNLTGIIPHSITNATKLVALDLGFNS 97
+ + I P +I++ D+ +N
Sbjct: 402 NTVKNVTGAL-IAPATISDGGSYTEPDITWNL 432
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-43
Identities = 63/341 (18%), Positives = 109/341 (31%), Gaps = 38/341 (11%)
Query: 59 HLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQV 118
H E+L + ++ + D H N + + ++
Sbjct: 9 HHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRT 64
Query: 119 MNNLTTESSSADQWSFLSSLTNCR--NLTILSFGSNPLGGILPPVIGNFSASLQKFYAYE 176
L + L + L S PL P S LQ
Sbjct: 65 GRALK---------ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDA 113
Query: 177 CKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLC 236
L +P + +GL L+L N L + ++ L RL+ LS+R +P L
Sbjct: 114 AGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 237 HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSS 296
L +L+ L L + S +P+S+ +L+ + + + +
Sbjct: 172 STDA---------------SGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRN 215
Query: 297 NSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLA-RNQFQGPIPESV 355
+ L+ +L + L L LDL + P G L+ L L + +P +
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDI 273
Query: 356 GSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396
L LE LDL G ++P + L V +
Sbjct: 274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-36
Identities = 52/324 (16%), Positives = 99/324 (30%), Gaps = 60/324 (18%)
Query: 79 PHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSL 138
H +++ L ++ + + + ++W
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADR------------NRWHSAWRQ 52
Query: 139 TNCRNLTILSFGSNPLGGILPPVIGNF-SASLQKFYAYECKLKGNIPQEIGNLSGLTLLS 197
N N I + L ++ + L P + LS L ++
Sbjct: 53 ANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMT 110
Query: 198 LHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPP 257
+ + L + TM + L+ L+L N L +P
Sbjct: 111 IDAAGLM-ELPDTMQQFAGLETLTLARNPLR-------------------------ALPA 144
Query: 258 CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLD 317
+ SL LREL + + + +P L S Q L L L
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLR 189
Query: 318 LSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK 377
L + +P++I L++L++L + + + ++ L LE LDL G P
Sbjct: 190 LEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPP 247
Query: 378 SLETLSQLKQFNVSH-NRLEGEIP 400
+ LK+ + + L +P
Sbjct: 248 IFGGRAPLKRLILKDCSNLL-TLP 270
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 53/310 (17%), Positives = 97/310 (31%), Gaps = 29/310 (9%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVGHL-LP 62
+ Q + + N + +I T G L + P
Sbjct: 28 YHDVLSQWQRHYNA-----DRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQP 81
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
+L L + L P + L + + + +T L L+ N L
Sbjct: 82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL 139
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSA--------SLQKFYA 174
+ +S+ + L LS + P LP + + A +LQ
Sbjct: 140 R---------ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRL 190
Query: 175 YECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYD 234
++ ++P I NL L L + ++ L+ + P + L +L+ L LR + P
Sbjct: 191 EWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPI 248
Query: 235 LCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINL 294
+ + L +P + LT L +L L S +PS + L I +
Sbjct: 249 FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV 308
Query: 295 SSNSLNDSLP 304
+
Sbjct: 309 PPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 48/286 (16%), Positives = 85/286 (29%), Gaps = 11/286 (3%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTM--RILTLEGNQLSGRLPSTVGHLL 61
N N Q L + + + L L L + P L
Sbjct: 47 HSAWRQANSNNPQIETRTGRALKAT-ADLLEDATQPGRVALELRSVPLP-QFPDQAFRL- 103
Query: 62 PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLS-QVMN 120
+++ + + A L +P ++ L L L N + + +L L LS +
Sbjct: 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
LT NL L + LP I N +L+ L
Sbjct: 162 ELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQ-NLKSLKIRNSPLS 219
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
+ I +L L L L P G L+ L L++ + ++P D+ L
Sbjct: 220 A-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ 278
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSL 286
+ + L G +P + L + + + + +
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 53/264 (20%), Positives = 92/264 (34%), Gaps = 10/264 (3%)
Query: 5 IPTEIGNLQ--NLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
+ + L L P F +S ++ +T++ L LP T+
Sbjct: 71 TADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF-A 127
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
+E+L LA N L +P SI + +L L + + + + NL
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG-LVNL 185
Query: 123 TTESSSADQWSFL-SSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKG 181
+ L +S+ N +NL L ++PL L P I + L++ C
Sbjct: 186 QSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLP-KLEELDLRGCTALR 243
Query: 182 NIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLM 241
N P G + L L L T+ + RL +L+ L LR +P + L
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 242 FGIRLTGNKLSGHIPPCLVSLTSL 265
I + + + V+ +
Sbjct: 304 CIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 14/120 (11%), Positives = 25/120 (20%), Gaps = 23/120 (19%)
Query: 302 SLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPES------- 354
S + L + + + R S
Sbjct: 3 SSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIET 62
Query: 355 --------------VGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400
+ +L+L L + P LS L+ + L E+P
Sbjct: 63 RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELP 120
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 5e-42
Identities = 84/439 (19%), Positives = 139/439 (31%), Gaps = 48/439 (10%)
Query: 6 PTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIE 65
+ LQ L + + + ++S + L L GN + L L +++
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQ 103
Query: 66 SLLLAANNLTGIIPHSITNATKLVALDLGFNSFA-GHILNTFGNLRHLSLLSQVMNNLTT 124
L+ NL + I + L L++ N + F NL +L L N + +
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 125 ESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIP 184
+ L + L NP+ I P L K N+
Sbjct: 164 IYCTD--LRVLHQMPL--LNLSLDLSLNPMNFIQPGAFKEIR--LHKLTLRNNFDSLNVM 217
Query: 185 QE-IGNLSGLTLLSL------HSNDLNGTISPTMGRLKRLQGLSLRNNNLEGS---IPYD 234
+ I L+GL + L + +L + L L R L+ I
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 235 LCHLKLMFGIRLTGNKLSGHIPP--------------------CLVSLTSLRELHLGSNK 274
L + L + + + L SL+ L SNK
Sbjct: 278 FNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK 336
Query: 275 LTSSIP-SSLWSLEYILDINLSSNSLN--DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTI 331
++ L SLE++ +LS N L+ + L LDLS N + + S
Sbjct: 337 GGNAFSEVDLPSLEFL---DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF 392
Query: 332 GALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNV 390
L+ LE L + + SV SL +L LD+S + LS L+ +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 391 SHNRLEGEIPVKGSFKNFS 409
+ N + F
Sbjct: 453 AGNSFQENFL-PDIFTELR 470
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-39
Identities = 79/418 (18%), Positives = 146/418 (34%), Gaps = 32/418 (7%)
Query: 6 PTEIGNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPST---VGHLL 61
IG+L+ L+ L A N + P F N++ + L L N++ + + +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 62 PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHIL-NTFGNLRHLSLLSQVMN 120
SL L+ N + I P + +L L L N + +++ L L + V+
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+ + S+L NLTI F L L +I F+ +
Sbjct: 236 EF--RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNG-------------------TISPTMGRLKRLQGLS 221
++ G L L + + + L L+ L
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLD 353
Query: 222 LRNNNLE--GSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSI 279
L N L G + + L+ N + + + L L L + L
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMS 412
Query: 280 PSSLW-SLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTI-GALKDL 337
S++ SL ++ +++S + L L VL ++ N + I L++L
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 338 ETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRL 395
L L++ Q + P + SL SL+ L+++ N L + L+ L++ + N
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-38
Identities = 85/419 (20%), Positives = 151/419 (36%), Gaps = 31/419 (7%)
Query: 4 QIPTEI-GNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQL-SGRLPSTVGHLL 61
+ L +LQ LV E NL+ L I ++ T++ L + N + S +LP +L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL- 148
Query: 62 PNIESLLLAANNLTGIIPHSITNATKL----VALDLGFNSFAGHILNTFG--NLRHLSLL 115
N+E L L++N + I + ++ ++LDL N F L L+L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 116 SQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSA-SLQKFYA 174
NN + + L+ L R + L + ++++F
Sbjct: 209 ----NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 175 YECKLKGN-IPQEIGNLSGLTLLSLHSNDLNGTIS-PTMGRLKRLQGLSLRNNNLEGSIP 232
+ I L+ ++ SL S + + L+ ++ +
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKL 324
Query: 233 YDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT--SSIPSSLWSLEYIL 290
L L T NK V L SL L L N L+ S + +
Sbjct: 325 KSLKRL------TFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 291 DINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSG-DIPSTIGALKDLETLSLARNQFQG 349
++LS N + ++ SN L+ L LD + L S +L++L L ++ +
Sbjct: 377 YLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 350 PIPESVGSLISLESLDLSGNNLSGKIPK-SLETLSQLKQFNVSHNRLEGEIPVKGSFKN 407
L SLE L ++GN+ L L ++S +LE ++ +F +
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLS-PTAFNS 492
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-35
Identities = 88/423 (20%), Positives = 145/423 (34%), Gaps = 56/423 (13%)
Query: 22 ENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHS 81
E N +P + + + L L N L L S P ++ L L+ + I +
Sbjct: 16 ELNFYK-IPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 82 ITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNC 141
+ + L L L N L F L L L V NL + + + +
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP--------IGHL 123
Query: 142 RNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTL----LS 197
+ L L+ N + P + +L+ K++ ++ L + L L
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 198 LHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCH-------LKLMFGIRLTGNK 250
L N +N I P + RL L+LRNN ++ +L+ G
Sbjct: 184 LSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 251 LSGHIPPCLVSLTSLRELHLGSNKLT---SSIPSSLWSLEYILDINLSSNSLN------- 300
L L L +L L I L + +L S ++
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302
Query: 301 --------------DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQ 346
P+ KLK L L + N+ + S + L LE L L+RN
Sbjct: 303 NFGWQHLELVNCKFGQFPTL--KLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNG 358
Query: 347 --FQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGS 404
F+G +S SL+ LDLS N + + + L QL+ + H+ L+ ++
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSV 416
Query: 405 FKN 407
F +
Sbjct: 417 FLS 419
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-35
Identities = 72/401 (17%), Positives = 140/401 (34%), Gaps = 41/401 (10%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRI----LTLEGNQLSGRLPSTVGH 59
++P NL NL++L + N + + + + M + L L N ++ +
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
Query: 60 LLPNIESLLLAANNLTG-IIPHSITNATKLVALDLGFNSFAGHI------LNTFGNLRHL 112
+ + L L N + ++ I L L F + L +L
Sbjct: 199 EI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 113 SLLS-----------------QVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLG 155
++ + N+++ S + + + L + G
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 156 GILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLN--GTISPTMGR 213
SL++ K GN E+ +L L L L N L+ G S +
Sbjct: 318 QF----PTLKLKSLKRLTFTSNKG-GNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 214 LKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPC-LVSLTSLRELHLGS 272
L+ L L N + ++ + L+ + + + L +SL +L L +
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 273 NKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTI 331
+ L + + ++ NS ++ ++ +L+ LT LDLS+ QL P+
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
Query: 332 GALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS 372
+L L+ L++A NQ + L SL+ + L N
Sbjct: 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 57/348 (16%), Positives = 109/348 (31%), Gaps = 24/348 (6%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQL--SGRLPSTVGHL 60
I L L N S V T ++ + + L + G L
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 61 LPNIESLLLAANNLTGI------IPHSITNATKLVALDLGFNSFAG-HILNTFGNLRHLS 113
L + +L + L + I T + + L + + +HL
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 114 LLSQVMNNLTTESS--------SADQWSFLSSLTNCRNLTILSFGSNPLGGI-LPPVIGN 164
L++ T ++++ S + +L L N L
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 165 FSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLR 223
+ SL+ + + L L L ++L ++ L+ L L +
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 224 NNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSS 282
+ + + L + +++ GN + P L +L L L +L P++
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
Query: 283 LWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPS 329
SL + +N++SN L S+P + +L L + L N P
Sbjct: 490 FNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-19
Identities = 34/166 (20%), Positives = 63/166 (37%), Gaps = 8/166 (4%)
Query: 246 LTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPS 305
IP L S + L L N L S +S + ++LS + ++
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIED 69
Query: 306 NV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESL 364
Q L L+ L L+ N + L L+ L +G L +L+ L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 365 DLSGNNL-SGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
+++ N + S K+P+ L+ L+ ++S N+++ I +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIY-CTDLRVLH 173
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-18
Identities = 53/290 (18%), Positives = 91/290 (31%), Gaps = 22/290 (7%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
I L N+ + + +N + L L + + P+ L +
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVTIERV-KDFSYNFG-WQHLELVNCKFG-QFPT---LKLKS 326
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFN--SFAGHILNTFGNLRHLSLLSQVMNN 121
++ L +N S + L LDL N SF G + L L N
Sbjct: 327 LKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 122 LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKG 181
+ + S+ L L F + L + + +L +
Sbjct: 385 VI---------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 182 NIPQEIGNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
LS L +L + N P + L+ L L L LE P L
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 241 MFGIRLTGNKLSGHIPPC-LVSLTSLRELHLGSNKLTSSIPSSLWSLEYI 289
+ + + N+L +P LTSL+++ L +N S P + ++
Sbjct: 496 LQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWL 544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-40
Identities = 91/417 (21%), Positives = 155/417 (37%), Gaps = 86/417 (20%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRI-------------LTLEGNQLS 50
++P E N+++ A + PP M + L L LS
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 51 GRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLR 110
LP L P++ESL+ + N+LT +P + L+ + + + L
Sbjct: 85 -SLPE----LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP----PLLE 134
Query: 111 HLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQ 170
+L + + N L L L N L I+ +N L LP + + L+
Sbjct: 135 YLGVSN---NQLEK----------LPELQNSSFLKIIDVDNNSL-KKLPDLPPS----LE 176
Query: 171 KFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNG------------------TISPTMG 212
A +L+ +P E+ NL LT + +N L P +
Sbjct: 177 FIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQ 234
Query: 213 RLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGS 272
L L + NN L+ ++P L+ + + N L+ +P SLT L
Sbjct: 235 NLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT-DLPELPQSLTFLDVSENIF 289
Query: 273 NKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIG 332
+ L+ +P +L+ L N SSN + SL L L++S N+L ++P+
Sbjct: 290 SGLS-ELPPNLYYL------NASSNEIR-SLCDL---PPSLEELNVSNNKLI-ELPALPP 337
Query: 333 ALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFN 389
LE L + N +PE +L+ L + N L + P E++ L+ +
Sbjct: 338 ---RLERLIASFNHLAE-VPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRMNS 386
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-37
Identities = 90/408 (22%), Positives = 145/408 (35%), Gaps = 69/408 (16%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLL--- 61
I + LQ + +NL+ + P N+ + ++ P G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLTEM-PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 62 ---------PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHL 112
L L L+ +P + L +L NS + +L+ L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSL 116
Query: 113 SLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKF 172
+ + NNL LS L L L +N L + P + N S L+
Sbjct: 117 LVDN---NNLKA----------LSDLPP--LLEYLGVSNNQLEKL--PELQNSS-FLKII 158
Query: 173 YAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIP 232
LK +P + L ++ +N L P + L L + NN+L+ +P
Sbjct: 159 DVDNNSLK-KLPDLPPS---LEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLP 211
Query: 233 YDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDI 292
L+ I N L P L +L L ++ +N L ++P SLE +
Sbjct: 212 DLPLSLES---IVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA---L 262
Query: 293 NLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIP 352
N+ N L LP Q L L V + + LS P+ L L+ + N+ I
Sbjct: 263 NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNE----IR 310
Query: 353 ESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400
SLE L++S N L ++P +L++ S N L E+P
Sbjct: 311 SLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVP 353
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-36
Identities = 76/406 (18%), Positives = 146/406 (35%), Gaps = 74/406 (18%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVP---------------PTIFNISTMRILTLEGNQL 49
+P +L++L LS L P P + N S ++I+ ++ N L
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSL 165
Query: 50 SGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNL 109
+LP L P++E + N L + + N L A+ NS + + +L
Sbjct: 166 K-KLPD----LPPSLEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLK-KLPDLPLSL 217
Query: 110 RHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASL 169
+ + N L L L N LT + +N L LP + + L
Sbjct: 218 ESIVAGN---NILEE----------LPELQNLPFLTTIYADNNLLK-TLPDLPPS----L 259
Query: 170 QKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEG 229
+ + L ++P+ +L+ L + + L+ L L+ +N +
Sbjct: 260 EALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELP-------PNLYYLNASSNEIR- 310
Query: 230 SIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYI 289
S+ L+ + ++ NKL +P L L N L +P +L+ +
Sbjct: 311 SLCDLPPSLE---ELNVSNNKLI-ELPA---LPPRLERLIASFNHLAE-VPELPQNLKQL 362
Query: 290 LDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQG 349
++ N L P + ++ L + + L+ ++P LK L + N +
Sbjct: 363 ---HVEYNPLR-EFPDIPESVEDLRMN----SHLA-EVPELPQNLK---QLHVETNPLRE 410
Query: 350 PIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRL 395
P+ S+ E L ++ + + ET +L+ H+
Sbjct: 411 -FPDIPESV---EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 61/264 (23%), Positives = 100/264 (37%), Gaps = 41/264 (15%)
Query: 157 ILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRL-- 214
I P + N LQ+ + L +P E N+ T ++ P G
Sbjct: 3 INPRNVSN--TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59
Query: 215 -----------KRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLT 263
++ L L N L S+P HL+ + + N L+ +P SL
Sbjct: 60 MAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLK 114
Query: 264 SLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQL 323
SL + L S +P L L +S+N L LP +Q L ++D+ N L
Sbjct: 115 SLLVDNNNLKAL-SDLPPLLEYL------GVSNNQLE-KLPE-LQNSSFLKIIDVDNNSL 165
Query: 324 SGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLS 383
+P + LE ++ NQ + +PE + +L L ++ N+L K+P
Sbjct: 166 K-KLPDLPPS---LEFIAAGNNQLEE-LPE-LQNLPFLTAIYADNNSLK-KLPDL---PL 215
Query: 384 QLKQFNVSHNRLEGEIPVKGSFKN 407
L+ +N LE E+P +
Sbjct: 216 SLESIVAGNNILE-ELPELQNLPF 238
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-23
Identities = 63/343 (18%), Positives = 110/343 (32%), Gaps = 63/343 (18%)
Query: 8 EIGNLQNLQYLVFAENNLSGL------------------VPPTIFNISTMRILTLEGNQL 49
E+ N L+ + N+L L P + N+ + + + N L
Sbjct: 148 ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSL 207
Query: 50 SGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNL 109
+LP L ++ES++ N L + N L + N + + +L
Sbjct: 208 K-KLPD----LPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSL 259
Query: 110 RHLSLLSQVMNNLTTESSSADQWSFLSSLTNC--------RNLTILSFGSNPLGGILPPV 161
L++ N LT +FL N NL L+ SN + L +
Sbjct: 260 EALNVRD---NYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRS-LCDL 315
Query: 162 IGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLS 221
+ L++ KL +P L L N L + LK+L
Sbjct: 316 PPS----LEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQNLKQL---H 363
Query: 222 LRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPS 281
+ N L P ++ L N +P +L++LH+ +N L P
Sbjct: 364 VEYNPLR-EFPDIPESVE-----DLRMNSHLAEVPE---LPQNLKQLHVETNPLRE-FPD 413
Query: 282 SLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLS 324
S+E D+ ++S + D + L +
Sbjct: 414 IPESVE---DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 55/297 (18%), Positives = 104/297 (35%), Gaps = 49/297 (16%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+ +L+ +V N L L P + N+ + + + N L LP L P+
Sbjct: 206 SLKKLPDLPLSLESIVAGNNILEEL--PELQNLPFLTTIYADNNLLK-TLPD----LPPS 258
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
+E+L + N LT + P + T L + F+ + NL +L+ S N +
Sbjct: 259 LEALNVRDNYLTDL-PELPQSLTFLDVSENIFSGLSELP----PNLYYLNASS---NEIR 310
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNI 183
+ +L L+ +N L LP + L++ A L +
Sbjct: 311 SLCDL------------PPSLEELNVSNNKLI-ELPALPPR----LERLIASFNHLA-EV 352
Query: 184 PQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFG 243
P+ NL L + N L ++ LR N+ +P +LK +
Sbjct: 353 PELPQNL---KQLHVEYNPLR-EFPDIPESVE-----DLRMNSHLAEVPELPQNLKQL-- 401
Query: 244 IRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ N L P S+ +L + S ++ + + + + D + +
Sbjct: 402 -HVETNPLR-EFPD---IPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 39/167 (23%), Positives = 65/167 (38%), Gaps = 27/167 (16%)
Query: 254 HIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKV- 312
I P VS T L+E S+ LT +P +++ + + + + P + +
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 313 ------------LTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
L+L+ LS +P LE+L + N +PE SL S
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKS 115
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKN 407
L + + LS +P LE L VS+N+LE ++P +
Sbjct: 116 LLVDNNNLKALSD-LPPLLEYL------GVSNNQLE-KLPELQNSSF 154
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-39
Identities = 66/290 (22%), Positives = 122/290 (42%), Gaps = 40/290 (13%)
Query: 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRN 558
++ +G G+FG V+ G + +D T VA+K L F E +L+ H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
+++++ C+ +V+E + G +L + L + L ++ D + +EYL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE--- 230
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE 678
S IH DL N L+ E +SDFG+S+ +G + + + + + APE +
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 679 GIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737
G S++ DV+S+G+LL ETF+ P + + +E + G
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ------TREFVEKGG----------- 332
Query: 738 EQAFSAKMDC-------ILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780
++ C + +M C P R + + +L+ I+
Sbjct: 333 ------RLPCPELCPDAVFRLM---EQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 26/281 (9%)
Query: 502 EFNECNL-----LGTGSFGSVYKGTI-----SDGTDVAIKIFNLQLERAFRSFDSECEVL 551
+F E +L LG G+FGSV + G VA+K E R F+ E E+L
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 552 RNVRHRNLIKILSSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 609
++++H N++K C + + L++E++P GSL +L H +D ++ L +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS-VTQTMTMATI 668
+EYL IH DL NIL++ + DFG++K+L + ++ + + I
Sbjct: 126 GMEYLGTKR----YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 669 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG--- 725
+ APE +E S DV+S+GV+L E FT + M + + G
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM----IGNDKQGQMI 237
Query: 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMR 766
+ +++ L++ C I + +C + + R
Sbjct: 238 VFHLIE--LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 276
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-39
Identities = 71/281 (25%), Positives = 126/281 (44%), Gaps = 26/281 (9%)
Query: 502 EFNECNL-----LGTGSFGSVYKGTI-----SDGTDVAIKIFNLQLERAFRSFDSECEVL 551
+F E +L LG G+FGSV + G VA+K E R F+ E E+L
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 552 RNVRHRNLIKILSSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 609
++++H N++K C + + L++E++P GSL +L H +D ++ L +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS-VTQTMTMATI 668
+EYL + IH DL NIL++ + DFG++K+L + ++ + + I
Sbjct: 157 GMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212
Query: 669 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG--- 725
+ APE +E S DV+S+GV+L E FT + M + + G
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM----IGNDKQGQMI 268
Query: 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMR 766
+ +++ L++ C I + +C + + R
Sbjct: 269 VFHLIE--LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 307
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-38
Identities = 74/419 (17%), Positives = 153/419 (36%), Gaps = 33/419 (7%)
Query: 9 IGNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVGHLLPNIESL 67
G L +L+YL N L ++F N++ ++ L + + + L ++ L
Sbjct: 94 FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153
Query: 68 LLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESS 127
+ A +L S+ + + L L + A + L + L NL
Sbjct: 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213
Query: 128 SADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKG------ 181
S +SS + + + L + +C L G
Sbjct: 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNEL--LKLLRYILELSEVEFDDCTLNGLGDFNP 271
Query: 182 NIPQEIGNLSGLTLLSLHSNDLNG-----TISPTMGRLKRLQGLSLRNNNLEGSIPYDLC 236
+ + L + +++ + +S L++++ +++ N+ + +P
Sbjct: 272 SESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFS 330
Query: 237 -HLKLMFGIRLTGNKLSGHIPP---CLVSLTSLRELHLGSNKLTS--SIPSSLWSLEYIL 290
HLK + + L+ N + C + SL+ L L N L S L +L+ +
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT 390
Query: 291 DINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGP 350
+++S N+ + +P + Q + + L+LS + + + + LE L ++ N
Sbjct: 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLDS- 445
Query: 351 IPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
L L+ L +S N L +P + L +S N+L+ +P G F +
Sbjct: 446 FSLF---LPRLQELYISRNKLK-TLPDAS-LFPVLLVMKISRNQLK-SVP-DGIFDRLT 497
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-38
Identities = 76/399 (19%), Positives = 154/399 (38%), Gaps = 26/399 (6%)
Query: 6 PTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIE 65
++ NLQ L+ + ++ + +++ ++ L L N LS L S+ L +++
Sbjct: 43 HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLK 101
Query: 66 SLLLAANNLTGI-IPHSITNATKLVALDLGFNSFAGHIL-NTFGNLRHLSLLSQVMNNLT 123
L L N + + N T L L +G I F L L+ L +L
Sbjct: 102 YLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNI 183
S + L + R++ L+ + + + + +S++ + L
Sbjct: 162 NYQSQS--------LKSIRDIHHLTLHLSESAFL-LEIFADILSSVRYLELRDTNLARFQ 212
Query: 184 PQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFG 243
+ + + + + + L +L L + +E +D C L +
Sbjct: 213 FSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE----FDDCTLNGLGD 268
Query: 244 IRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSL 303
+ + + + V ++R LH+ L + + LE + I + ++ + +
Sbjct: 269 FNPSESDVVSELG--KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LV 325
Query: 304 PSNV-QKLKVLTVLDLSRNQLSGDIPST---IGALKDLETLSLARNQFQ--GPIPESVGS 357
P + Q LK L LDLS N + + GA L+TL L++N + E + +
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 358 LISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396
L +L SLD+S N +P S + +++ N+S +
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-34
Identities = 65/400 (16%), Positives = 133/400 (33%), Gaps = 36/400 (9%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVGHLLP 62
+ + NL NLQ L + F ++++ L ++ L S +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIR 172
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
+I L L + ++ + + L+L + A + S + ++
Sbjct: 173 DIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232
Query: 123 TTESSSADQW--SFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSA-------SLQKFY 173
+ + + L + + N LG P S ++++ +
Sbjct: 233 SVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292
Query: 174 AYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPY 233
+ L ++ L + +++ ++ + LK L+ L L N +
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
Query: 234 DLCHLKLMFGIR---LTGNKLS--GHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEY 288
+ ++ L+ N L L++L +L L + N +P S E
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEK 411
Query: 289 ILDINLSSN---SLNDSLPSNVQKLKV--------------LTVLDLSRNQLSGDIPSTI 331
+ +NLSS + +P ++ L V L L +SRN+L +P
Sbjct: 412 MRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDA- 469
Query: 332 GALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNL 371
L + ++RNQ + L SL+ + L N
Sbjct: 470 SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-34
Identities = 63/410 (15%), Positives = 139/410 (33%), Gaps = 45/410 (10%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
IP+ + ++ L + N ++ + + + +++L L+ ++++ + + L +
Sbjct: 19 SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGS 75
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILN-TFGNLRHLSLLSQVMNNL 122
+E L L+ N+L+ + + L L+L N + + F NL +L L
Sbjct: 76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN 182
+E +L L + L
Sbjct: 136 FSEIRR-------IDFAGLTSLNELEIKALSLRNY------------------------- 163
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
Q + ++ + L+LH ++ + L ++ L LR+ NL L ++
Sbjct: 164 QSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223
Query: 243 GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDS 302
++ + S L L L +++ +L + D N S + +
Sbjct: 224 PMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD----CTLNGLGDFNPSESDVVSE 279
Query: 303 LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLE 362
L + + L + + L D+ + L+ ++ +++ ++ L SLE
Sbjct: 280 LGKV--ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLE 337
Query: 363 SLDLSGNNLSGKIPKS---LETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
LDLS N + + K+ L+ +S N L
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-19
Identities = 53/296 (17%), Positives = 90/296 (30%), Gaps = 45/296 (15%)
Query: 8 EIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESL 67
E + F + + T+R L + L STV LL ++ +
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF-YDLSTVYSLLEKVKRI 315
Query: 68 LLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNT---FGNLRHLSLLSQVMNNLTT 124
+ + + + + L LDL N L G L L N+L +
Sbjct: 316 TVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS 375
Query: 125 ESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIP 184
+ + L +NLT L N +P
Sbjct: 376 MQKTGE------ILLTLKNLTSLDISRNTFH--------------------------PMP 403
Query: 185 QEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGI 244
+ L+L S + + L+ L + NNNL+ S L L+ +
Sbjct: 404 DSCQWPEKMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNLD-SFSLFLPRLQE---L 456
Query: 245 RLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
++ NKL +P L + + N+L S L + I L +N +
Sbjct: 457 YISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-16
Identities = 55/371 (14%), Positives = 96/371 (25%), Gaps = 98/371 (26%)
Query: 41 ILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAG 100
+ + +PS L ++SL L+ N +T I + L L L +
Sbjct: 9 VCDGRSRSFT-SIPS---GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT 64
Query: 101 HILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPP 160
+ F +L +L L N L +
Sbjct: 65 IEGDAFYSLG--------------------------------SLEHLDLSDNHLSSLSSS 92
Query: 161 VIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNG-TISPTMGRLKRLQG 219
G LS L L+L N ++ L LQ
Sbjct: 93 WFGP-------------------------LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127
Query: 220 LSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSI 279
L + N I LTSL EL + + L +
Sbjct: 128 LRIGNVETFSEIR-----------------------RIDFAGLTSLNELEIKALSLRNYQ 164
Query: 280 PSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLET 339
SL S+ I + L + L L + L+L L+ S + +
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224
Query: 340 LSLARNQFQGP----------IPESVGSLISLESLDLSGNNL---SGKIPKSLETLSQLK 386
+ + + + L +E D + N L + + L +++
Sbjct: 225 MKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE 284
Query: 387 QFNVSHNRLEG 397
+ +
Sbjct: 285 TVTIRRLHIPQ 295
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 32/154 (20%), Positives = 58/154 (37%), Gaps = 11/154 (7%)
Query: 260 VSLTSLRELHLGSNKLTS---SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVL 316
+S + S TS + +++ SL +LS N + +++ L VL
Sbjct: 2 LSCDASGVCDGRSRSFTSIPSGLTAAMKSL------DLSFNKITYIGHGDLRACANLQVL 55
Query: 317 DLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSG-KI 375
L ++++ +L LE L L+ N G L SL+ L+L GN +
Sbjct: 56 ILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGV 115
Query: 376 PKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
L+ L+ + + EI + F +
Sbjct: 116 TSLFPNLTNLQTLRIGNVETFSEIR-RIDFAGLT 148
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 77/294 (26%), Positives = 124/294 (42%), Gaps = 27/294 (9%)
Query: 490 RTPYLDIQRATD--EFNECNL-----LGTGSFGSVYKGTI-----SDGTDVAIKIFNLQL 537
+ + D F E +L LG G+FGSV + G VA+K
Sbjct: 5 HHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG 64
Query: 538 ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFL 595
R F E ++L+ + ++K P ++ LV+E++P+G L +L H L
Sbjct: 65 PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL 124
Query: 596 DILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655
D L + +EYL +H DL NIL++ ++DFG++KLL
Sbjct: 125 DASRLLLYSSQICKGMEYLGSRR----CVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180
Query: 656 EDS-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMS 713
+D V + + I + APE S+ I S + DV+S+GV+L E FT + +
Sbjct: 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS----CSPSAE 236
Query: 714 LRRWVKESLP-HGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMR 766
R + L+ +++ L+ E Q A C + +L C SP R
Sbjct: 237 FLRMMGCERDVPALSRLLE--LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDR 288
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 59/303 (19%), Positives = 118/303 (38%), Gaps = 22/303 (7%)
Query: 489 RRTPYLD---IQRATDEFNECNLLGTGSFGSVYKGT-----ISDGTDVAIKIF-NLQLER 539
+ +D ++ LG G FG V + G VA+K
Sbjct: 8 KPATEVDPTHFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN 65
Query: 540 AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDI 597
E E+LRN+ H N++K C+ L++EF+P+GSL+++L + +++
Sbjct: 66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL 125
Query: 598 LERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657
++L + + ++YL +H DL N+L++ + DFG++K + ++
Sbjct: 126 KQQLKYAVQICKGMDYLGSRQ----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 658 S-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRR 716
+ + + + APE + DV+S+GV L E T + +
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
Query: 717 WVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776
+ T +V+ ++E + +C + L C P R + +
Sbjct: 242 PTHGQMTV--TRLVN--TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
Query: 777 KKI 779
+ +
Sbjct: 298 EAL 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-37
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 509 LGTGSFGSVYKGTISDG-----TDVAIKIFNL-QLERAFRSFDSECEVLRNVRHRNLIKI 562
LG+G+FG+VYKG VAIK +A + E V+ +V + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
L C + L+ + MP G L ++ H + LN + + + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL----EDRR 137
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVS 682
++H DL N+L+ ++DFG++KLLG E I +MA E I +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 683 AKCDVYSYGVLLMETFTR-KRPTDEM 707
+ DV+SYGV + E T +P D +
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 509 LGTGSFGSVYKGT---ISDGTDVAIKIF-NLQLERAFRSFDSECEVLRNVRHRNLIKILS 564
LG G+FGSV +G DVAIK+ + E +++ + + +++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPII 624
C LV+E G L K+L + + ++ V ++YL +
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL----EEKNFV 132
Query: 625 HCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS-VTQTMTMATIGYMAPEYGSEGIVSA 683
H DL N+LL A +SDFG+SK LG + ++ + + APE + S+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 684 KCDVYSYGVLLMETFTR-KRPTDEM 707
+ DV+SYGV + E + ++P +M
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKM 217
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-37
Identities = 72/399 (18%), Positives = 142/399 (35%), Gaps = 30/399 (7%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
Q+P L + L+ + N + + + + +++L L + LPN
Sbjct: 18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHIL--NTFGNLRHLSLLSQVMNN 121
+ L L ++ + + P + L L L F + +L F NL+ L+ L N
Sbjct: 75 LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134
Query: 122 LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSA-SLQKFYAYECKLK 180
+ + S +L + F SN + + + +L F L
Sbjct: 135 IRSLYLH-------PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187
Query: 181 GNIPQEIGN-LSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
+ + G ++ + L D++G + +N + S + L
Sbjct: 188 SRVSVDWGKCMNPFRNMVLEILDVSGN-------GWTVDITGNFSNAISKSQAFSLILAH 240
Query: 240 LMFGIRLTGNKLSGHIPPCL---VSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSS 296
+ G + + ++ +S+R L L + S +L+ + +NL+
Sbjct: 241 HIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAY 299
Query: 297 NSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVG 356
N +N L L VL+LS N L S L + + L +N ++
Sbjct: 300 NKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFK 359
Query: 357 SLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRL 395
L L++LDL N L+ ++ + + +S N+L
Sbjct: 360 FLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-36
Identities = 90/423 (21%), Positives = 150/423 (35%), Gaps = 39/423 (9%)
Query: 11 NLQNLQYLVFAENNLSGL-VPPTIF-NISTMRILTLEGNQLSGRLPSTVGHLLPNIESLL 68
L +L L LS + F N+ + L L NQ+ L +++S+
Sbjct: 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154
Query: 69 LAANNLTGIIPHSITN--ATKLVALDLGFNSFAGHILNTFGNL------RHLSLLSQVMN 120
++N + + H + L L NS + +G L +L N
Sbjct: 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214
Query: 121 NLTTE----SSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGN-FSASLQKFYAY 175
T + S+A S SL ++ FG + + +S++
Sbjct: 215 GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLS 274
Query: 176 ECKLKGNIPQEI-GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYD 234
+ ++ + L L +L+L N +N L LQ L+L N L +
Sbjct: 275 HGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333
Query: 235 LCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT-----SSIPS---SLWSL 286
L + I L N ++ L L+ L L N LT SIP S L
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKL 393
Query: 287 EYILDINLSSNSL--------NDSLPSNVQKLKVLTVLDLSRNQLSG-DIPSTIGALKDL 337
+ INL++N + N + + ++ L +L L++N+ S T L
Sbjct: 394 VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453
Query: 338 ETLSLARNQFQGPIPESV-----GSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSH 392
E L L N Q + L L+ L L+ N L+ P L+ L+ +++
Sbjct: 454 EQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNS 513
Query: 393 NRL 395
NRL
Sbjct: 514 NRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-32
Identities = 91/516 (17%), Positives = 170/516 (32%), Gaps = 72/516 (13%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTM--RILTLEGNQLSGRLPSTVGHLL 61
+ G L +L+ + F+ N + + + + +L N L R+ G +
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198
Query: 62 PNIESLLL-----------------AANNLTGIIPHSITNATKLVALDLGFNSFAGHILN 104
+++L +N ++ S+ A ++ GF++ N
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258
Query: 105 TFGNLRHLSL----LSQVMNNLTTESSSADQWSFLSSLT------------------NCR 142
TF L S+ LS + S ++ + L L
Sbjct: 259 TFAGLARSSVRHLDLSH--GFVF--SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLD 314
Query: 143 NLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSND 202
NL +L+ N LG + + + + Q L L L L N
Sbjct: 315 NLQVLNLSYNLLGELYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA 373
Query: 203 LNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSG-HIPPCLVS 261
L T+ + + + L N L +L + L+ N+L I L+
Sbjct: 374 LT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLI----HLSENRLENLDILYFLLR 424
Query: 262 LTSLRELHLGSNKLTS-SIPSSLWSLEYILDINLSSNSLNDSLPSNV-----QKLKVLTV 315
+ L+ L L N+ +S S + + + L N L + + + + L L V
Sbjct: 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 316 LDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKI 375
L L+ N L+ P L L LSL N+ + + +LE LD+S N L
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHND-LPANLEILDISRNQLLAPN 542
Query: 376 PKSLETLSQLKQFNVSHNRLEGEIPVKG-----SFKNFSVESFFGNYALCGPPKLRVPPC 430
P + L +++HN+ E + + N ++ + P
Sbjct: 543 P---DVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSL 599
Query: 431 KPDNSKSTKNVALTVLKYILPPIVCSVLLVITIIMY 466
+++ + IVC+V L + ++
Sbjct: 600 FSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTI 635
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 60/208 (28%), Positives = 82/208 (39%), Gaps = 14/208 (6%)
Query: 509 LGTGSFGSVYKGT----ISDGTDVAIKIFN---LQLERAFRSFDSECEVLRNVRHRNLIK 561
LG GSFG V +G VA+K L A F E + ++ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
+ P K +V E P GSL L H + + V + YL S
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL----ESK 140
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS-VTQTMTMATIGYMAPEYGSEGI 680
IH DL N+LL + DFG+ + L + +D V Q + APE
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 681 VSAKCDVYSYGVLLMETFTR-KRPTDEM 707
S D + +GV L E FT + P +
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEPWIGL 228
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-37
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 502 EFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLI 560
F ++LG G+ G++ + D DVA+K + F D E ++LR H N+I
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVI 81
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
+ + + F+ + +E +L++++ ++ LE + ++ S L +LH S
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----S 136
Query: 621 APIIHCDLKPTNILLDE-----NMAAHVSDFGISKLLGEGEDSVTQTMTMA-TIGYMAPE 674
I+H DLKP NIL+ + A +SDFG+ K L G S ++ + T G++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 675 Y---GSEGIVSAKCDVYSYGVLLMETFTRKRP 703
+ + D++S G + +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 69/363 (19%), Positives = 126/363 (34%), Gaps = 54/363 (14%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLA 70
L N + + F + + L + + + +L L Q+ + + I+ L +
Sbjct: 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG 101
Query: 71 ANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSAD 130
N + + PH N L L L N + F N L+ LS NNL
Sbjct: 102 FNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT- 160
Query: 131 QWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNL 190
+L L SN L + ++ +
Sbjct: 161 -------FQATTSLQNLQLSSNRLTHV----------------------------DLSLI 185
Query: 191 SGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLC-HLKLMFGIRLTGN 249
L ++ N L+ T+ ++ L +N++ + + L + ++L N
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELTI---LKLQHN 236
Query: 250 KLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQK 309
L+ L++ L E+ L N+L + ++ + + +S+N L +L Q
Sbjct: 237 NLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 293
Query: 310 LKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGN 369
+ L VLDLS N L + LE L L N + + +L++L LS N
Sbjct: 294 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHN 349
Query: 370 NLS 372
+
Sbjct: 350 DWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 8e-36
Identities = 74/421 (17%), Positives = 149/421 (35%), Gaps = 57/421 (13%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
I + + + ++ +I+T + + + +LP+ + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTT 124
E L L + I ++ A + L +GFN+ + F N+ L++L N+L++
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 125 ESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIP 184
N LT LS +N L I
Sbjct: 132 LPRGI--------FHNTPKLTTLSMSNNNL--------------------------ERIE 157
Query: 185 QEI-GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFG 243
+ + L L L SN L + + L ++ N L ++ ++
Sbjct: 158 DDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS-TLA-IPIAVEE--- 209
Query: 244 IRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSL 303
+ + N ++ + + L L L N LT + L + +++++LS N L + +
Sbjct: 210 LDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL-EKI 263
Query: 304 PSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLE 362
+ K++ L L +S N+L + + L+ L L+ N + + LE
Sbjct: 264 MYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLE 321
Query: 363 SLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGP 422
+L L N++ + L T LK +SHN + ++ F+N + + C
Sbjct: 322 NLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKI 377
Query: 423 P 423
Sbjct: 378 D 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 56/306 (18%), Positives = 112/306 (36%), Gaps = 25/306 (8%)
Query: 95 FNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPL 154
+N + ++ ++ F N I++F ++ +
Sbjct: 1 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDV---YFGFEDITLNNQKIVTFKNSTM 57
Query: 155 GGILPPVIGNFSASLQKFYAYECKLKGNIPQEI-GNLSGLTLLSLHSNDLNGTISP-TMG 212
+ ++ +F ++ + +++ I + L + N + + P
Sbjct: 58 RKLPAALLDSFR-QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ 114
Query: 213 RLKRLQGLSLRNNNLEGSIPYDL-CHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHL 270
+ L L L N+L S+P + + + + ++ N L I + TSL+ L L
Sbjct: 115 NVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQL 172
Query: 271 GSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPST 330
SN+LT S + SL + N+S N L S + + LD S N ++ +
Sbjct: 173 SSNRLTHVDLSLIPSLFHA---NVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG- 222
Query: 331 IGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNV 390
+L L L N + + L +DLS N L + + +L++ +
Sbjct: 223 -PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 279
Query: 391 SHNRLE 396
S+NRL
Sbjct: 280 SNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 53/282 (18%), Positives = 96/282 (34%), Gaps = 33/282 (11%)
Query: 4 QIPTEI-GNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
+P I N L L + NNL + T ++++ L L N+L+ + L+P
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL---SLIP 186
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
++ ++ N L+ ++ + LD NS L L L NNL
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQH---NNL 238
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN 182
T + L N L + N L I+ L++ Y +L
Sbjct: 239 TD----------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ-RLERLYISNNRLV-A 286
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
+ + L +L L N L + + RL+ L L +N++ ++ +
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLK 342
Query: 243 GIRLTGNKLSGHIPPCLVSL-TSLRELHLGSNKLTSSIPSSL 283
+ L+ N L +L ++ + I L
Sbjct: 343 NLTLSHNDWD---CNSLRALFRNVARPAVDDADQHCKIDYQL 381
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 19/136 (13%), Positives = 47/136 (34%), Gaps = 2/136 (1%)
Query: 272 SNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTI 331
I S+L D+++ + + L ++ + + + +
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 332 GALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVS 391
+ + +E L+L Q + + +++ L + N + P + + L +
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125
Query: 392 HNRLEGEIPVKGSFKN 407
N L +P +G F N
Sbjct: 126 RNDLS-SLP-RGIFHN 139
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-36
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 11/210 (5%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
+ LG G FG V+ GT + T VAIK +F E +V++ +RH L+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 242
Query: 561 KILSSCS-NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGH 618
++ + S P + +V E+M GSL +L +L + + +++ + S + Y+
Sbjct: 243 QLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---- 296
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE 678
+H DL+ NIL+ EN+ V+DFG+++L+ + E + Q I + APE
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALY 355
Query: 679 GIVSAKCDVYSYGVLLMETFTR-KRPTDEM 707
G + K DV+S+G+LL E T+ + P M
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 509 LGTGSFGSVYKGTI----SDGTDVAIKIFNL-QLERAFRSFDSECEVLRNVRHRNLIKIL 563
+G+G G V G + VAIK ER R F SE ++ H N+I++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPI 623
+ +V E+M NGSL+ +L +H+ I++ + ++ VG+ + YL S
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL----SDLGY 172
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV-TQTMTMATIGYMAPEYGSEGIVS 682
+H DL N+L+D N+ VSDFG+S++L + D+ T T I + APE + S
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 683 AKCDVYSYGVLLMETFTR-KRPTDEM 707
+ DV+S+GV++ E +RP M
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNM 258
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIF--NLQLERAFRSFDSECEVLRNVRHRNLIKILSSC 566
+G+G FG V+ G + VAIK E F E EV+ + H L+++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVC 72
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
LV EFM +G L +L + L + +DV + YL A +IH
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL----EEACVIHR 128
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
DL N L+ EN VSDFG+++ + + + T T + + +PE S S+K D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 687 VYSYGVLLMETFTR-KRPTDEM 707
V+S+GVL+ E F+ K P +
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENR 209
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 70/265 (26%), Positives = 120/265 (45%), Gaps = 30/265 (11%)
Query: 509 LGTGSFGSVYKGTI----SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKIL 563
+G G FG V G + VAIK + E+ R F E ++ H N+I++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPI 623
+ +V E+M NGSL+ +L H+ +++ + ++ + S ++YL S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL----SDMGY 168
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV-TQTMTMATIGYMAPEYGSEGIVS 682
+H DL NIL++ N+ VSDFG+ ++L + ++ T I + +PE + +
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 683 AKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741
+ DV+SYG++L E + +RP EM +V+ A V E
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEM-----------------SNQDVIKA--VDEGYRL 269
Query: 742 SAKMDCILSIMDLALDCCIESPDMR 766
MDC ++ L LDC + + R
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNR 294
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 34/227 (14%)
Query: 498 RATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRH 556
R +F E +LG G+FG V K D AIK E + SE +L ++ H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH 61
Query: 557 RNLIKILSSCSNPDFKA-------------LVLEFMPNGSLEKWLYSHNYFLDILERLNI 603
+ +++ ++ + +E+ NG+L ++S N E +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 604 MIDVGSALEYLH-HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT 662
+ AL Y+H G IIH DLKP NI +DE+ + DFG++K + D +
Sbjct: 122 FRQILEALSYIHSQG-----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 663 MTMAT---------IG---YMAPE-YGSEGIVSAKCDVYSYGVLLME 696
IG Y+A E G + K D+YS G++ E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 509 LGTGSFGSVYKGTI---SDGTDVAIKIF--NLQLERAFRSFDSECEVLRNVRHRNLIKIL 563
LG+G+FG+V KG VA+KI +E V++ + + +++++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPI 623
C + LV+E G L K+L + + + + ++ V ++YL +
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYL----EESNF 138
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS-VTQTMTMATIGYMAPEYGSEGIVS 682
+H DL N+LL A +SDFG+SK L E+ QT + + APE + S
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 683 AKCDVYSYGVLLMETFTR-KRPTDEM 707
+K DV+S+GVL+ E F+ ++P M
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGM 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 67/281 (23%), Positives = 113/281 (40%), Gaps = 28/281 (9%)
Query: 502 EFNECNL-----LGTGSFGSVYKGTI-----SDGTDVAIKIFNLQ---LERAFRSFDSEC 548
F++ L LG G FG V G VA+K L+ + + E
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEI 84
Query: 549 EVLRNVRHRNLIKILSSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 606
++LR + H ++IK C + + LV+E++P GSL +L H+ + + + L
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQ 142
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS-VTQTMTM 665
+ + YLH H IH DL N+LLD + + DFG++K + EG + +
Sbjct: 143 ICEGMAYLHAQH----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 666 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG 725
+ + + APE E DV+S+GV L E T + T + L + +
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV- 257
Query: 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMR 766
+ + L+ + C + L +C R
Sbjct: 258 -LRLTE--LLERGERLPRPDKCPAEVYHLMKNCWETEASFR 295
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-36
Identities = 58/228 (25%), Positives = 107/228 (46%), Gaps = 17/228 (7%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
+ LG G FG V+ T + T VA+K + +F +E V++ ++H L+
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 561 KILSSCS-NPDFKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHHGH 618
K+ + + P + ++ EFM GSL +L S + + ++ + + ++
Sbjct: 247 KLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---- 300
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE 678
IH DL+ NIL+ ++ ++DFG+++++ + E + + I + APE +
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINF 359
Query: 679 GIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHG 725
G + K DV+S+G+LLME T + P M E V +L G
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERG 401
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIF--NLQLERAFRSFDSECEVLRNVRHRNLIKILSSC 566
LG+G FG V G DVA+K+ E F E + + + H L+K C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ---EAQTMMKLSHPKLVKFYGVC 72
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
S +V E++ NG L +L SH L+ + L + DV + +L S IH
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL----ESHQFIHR 128
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
DL N L+D ++ VSDFG+++ + + V+ T + + APE S+K D
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 687 VYSYGVLLMETFTR-KRPTDEM 707
V+++G+L+ E F+ K P D
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLY 209
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 12/213 (5%)
Query: 496 IQRATDEFNECNLLGTGSFGSVYKGTISDG----TDVAIKIFN-LQLERAFRSFDSECEV 550
I + ++G G FG VY G D AIK + + + +F E +
Sbjct: 16 IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL 75
Query: 551 LRNVRHRNLIKILSSCSNPD-FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 609
+R + H N++ ++ P+ ++L +M +G L +++ S + + ++ + V
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT-- 667
+EYL + +H DL N +LDE+ V+DFG+++ + + E Q A
Sbjct: 136 GMEYL----AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 668 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTR 700
+ + A E + K DV+S+GVLL E TR
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 509 LGTGSFGSVYKGTISDG----TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKIL 563
+G G FG V++G VAIK + F E +R H +++K++
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 564 SSCS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
+ NP + +++E G L +L Y LD+ + + +AL YL S
Sbjct: 83 GVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL----ESKR 136
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVS 682
+H D+ N+L+ N + DFG+S+ + E + I +MAPE + +
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 683 AKCDVYSYGVLLMETFTR-KRPTDEM 707
+ DV+ +GV + E +P +
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQGV 221
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 509 LGTGSFGSVYKGTISDG-----TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKI 562
LG+G FG+V+KG V IK+ + ++F++ + ++ H +++++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
L C + LV +++P GSL + H L LN + + + YL
Sbjct: 81 LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL----EEHG 135
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVS 682
++H +L N+LL V+DFG++ LL + + + I +MA E G +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 683 AKCDVYSYGVLLMETFTR-KRPTDEM 707
+ DV+SYGV + E T P +
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEPYAGL 221
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-36
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 7/200 (3%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568
LGTG FG V G DVAIK+ + F E +V+ N+ H L+++ C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 569 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDL 628
++ E+M NG L +L + + L + DV A+EYL S +H DL
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL----ESKQFLHRDL 146
Query: 629 KPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVY 688
N L+++ VSDFG+S+ + ++ + + + + PE S+K D++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 689 SYGVLLMETFTR-KRPTDEM 707
++GVL+ E ++ K P +
Sbjct: 206 AFGVLMWEIYSLGKMPYERF 225
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-36
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 11/210 (5%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
+ LG G FG V+ GT + T VAIK +F E +V++ +RH L+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 325
Query: 561 KILSSCS-NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGH 618
++ + S P + +V E+M GSL +L +L + + +++ + S + Y+
Sbjct: 326 QLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---- 379
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE 678
+H DL+ NIL+ EN+ V+DFG+++L+ + E + Q I + APE
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALY 438
Query: 679 GIVSAKCDVYSYGVLLMETFTR-KRPTDEM 707
G + K DV+S+G+LL E T+ + P M
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVPYPGM 468
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 507 NLLGTGSFGSVYKGTISDG----TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 561
++G G FG VY GT+ D A+K N F +E ++++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 562 ILSSCSNPDFKAL-VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
+L C + L VL +M +G L ++ + + + + + + V ++YL +S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----AS 146
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT--IGYMAPEYGSE 678
+H DL N +LDE V+DFG+++ + + E T A + +MA E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 679 GIVSAKCDVYSYGVLLMETFTR-KRP 703
+ K DV+S+GVLL E TR P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-35
Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 509 LGTGSFGSVYKGTISDG---TDVAIKIF-NLQLERAFRSFDSECEVLRNVRHRNLIKILS 564
LG G+FGSV +G DVAIK+ + E +++ + + +++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPII 624
C LV+E G L K+L + + ++ V ++YL +
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL----EEKNFV 458
Query: 625 HCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS-VTQTMTMATIGYMAPEYGSEGIVSA 683
H +L N+LL A +SDFG+SK LG + ++ + + APE + S+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 684 KCDVYSYGVLLMETFTR-KRPTDEM 707
+ DV+SYGV + E + ++P +M
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKM 543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 509 LGTGSFGSVYKGTISDG-----TDVAIKIFNL-QLERAFRSFDSECEVLRNVRHRNLIKI 562
LG+G+FG+VYKG VAIK +A + E V+ +V + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
L C + L+ + MP G L ++ H + LN + + + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL----EDRR 137
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVS 682
++H DL N+L+ ++DFG++KLLG E I +MA E I +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 683 AKCDVYSYGVLLMETFTR-KRPTDEM 707
+ DV+SYGV + E T +P D +
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 62/266 (23%), Positives = 111/266 (41%), Gaps = 18/266 (6%)
Query: 452 PIVCSVLLVITIIMYKRCRNRSTKHLDHEDFLPLATWRRTPYLDIQRATDEFNECNL--- 508
+CS+ + T + K + + L+ +Q + +
Sbjct: 35 DGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFN 94
Query: 509 --LGTGSFGSVYKGTISDG----TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 561
+G G FG VY GT+ D A+K N F +E ++++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 562 ILSSCSNPDFKAL-VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
+L C + L VL +M +G L ++ + + + + + + V +++L +S
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----AS 210
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT--IGYMAPEYGSE 678
+H DL N +LDE V+DFG+++ + + E T A + +MA E
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 679 GIVSAKCDVYSYGVLLMETFTR-KRP 703
+ K DV+S+GVLL E TR P
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 12/207 (5%)
Query: 509 LGTGSFGSVYKG-----TISDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKI 562
+G G FG VYKG + VAIK E+ F E ++ H N+I++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
S ++ E+M NG+L+K+L + +L+ + ++ + + ++YL ++
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL----ANMN 167
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM-TMATIGYMAPEYGSEGIV 681
+H DL NIL++ N+ VSDFG+S++L + ++ T I + APE S
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 682 SAKCDVYSYGVLLMETFTR-KRPTDEM 707
++ DV+S+G+++ E T +RP E+
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERPYWEL 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 509 LGTGSFGSVYKGT----ISDGTDVAIKIFNL-QLERAFRSFDSECEVLRNVRHRNLIKIL 563
LG G FG VY+G + +VA+K F SE +++N+ H +++K++
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 564 SSCS-NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP 622
P + +++E P G L +L + L +L + + + A+ YL S
Sbjct: 80 GIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL----ESIN 133
Query: 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVS 682
+H D+ NIL+ + DFG+S+ + E ED ++T I +M+PE + +
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 683 AKCDVYSYGVLLMETFTR-KRPTDEM 707
DV+ + V + E + K+P +
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWL 218
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 53/206 (25%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
+ LG G FG V+ G + T VA+K +F +E +++ ++H+ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 561 KILSSCS-NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGH 618
++ + + P + ++ E+M NGSL +L + + L I + L++ + + ++
Sbjct: 72 RLYAVVTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---- 125
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE 678
IH DL+ NIL+ + ++ ++DFG+++L+ E + + I + APE +
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINY 184
Query: 679 GIVSAKCDVYSYGVLLMETFTR-KRP 703
G + K DV+S+G+LL E T + P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-34
Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568
+G G FG V G G VA+K ++ + ++F +E V+ +RH NL+++L
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 569 --PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIH 625
+V E+M GSL +L S L L +DV A+EYL +H
Sbjct: 258 EKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL----EGNNFVH 312
Query: 626 CDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKC 685
DL N+L+ E+ A VSDFG++K E S TQ + + APE E S K
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 686 DVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHG 725
DV+S+G+LL E ++ + P + + V + G
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKG 402
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 35/226 (15%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFN-LQLERAFRSFDSECEVLRNVRHRN 558
+ ++LG G+ +V++G G AIK+FN + R E EVL+ + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 559 LIKILS--SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGSALEYL 614
++K+ + + K L++EF P GSL L + + E L ++ DV + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 615 H-HGHSSAPIIHCDLKPTNILL----DENMAAHVSDFGISKLLGEGEDSVTQTMTMATI- 668
+G I+H ++KP NI+ D ++DFG ++ L + E ++
Sbjct: 129 RENG-----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-------QFVSLY 176
Query: 669 ---GYMAPEYGSEGIV--------SAKCDVYSYGVLLMETFTRKRP 703
Y+ P+ ++ A D++S GV T P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 57/229 (24%), Positives = 92/229 (40%), Gaps = 29/229 (12%)
Query: 497 QRATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR 555
+R +F E L+G+G FG V+K DG IK E+A R E + L +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62
Query: 556 HRNLIKILSSCSNPDFKA----------------LVLEFMPNGSLEKWLYSHN-YFLDIL 598
H N++ D+ + +EF G+LE+W+ LD +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 599 ERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658
L + + ++Y+H +I+ DLKP+NI L + + DFG+ L
Sbjct: 123 LALELFEQITKGVDYIHSKK----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
T+ YM+PE S + D+Y+ G++L E E
Sbjct: 179 TRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 15/228 (6%)
Query: 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNL 559
+ + LG G +G VY+G VA+K F E V++ ++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 278
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGH 618
+++L C+ ++ EFM G+L +L N + + L + + SA+EYL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---- 334
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE 678
IH +L N L+ EN V+DFG+S+L+ + I + APE +
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAY 393
Query: 679 GIVSAKCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHG 725
S K DV+++GVLL E T P + + V E L
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKD 435
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 24/213 (11%)
Query: 507 NLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNL--IKI 562
+G+G V++ AIK NL+ + S+ +E L ++ + I++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-HGHSSA 621
+ +V+E N L WL D ER + ++ A+ +H HG
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 147
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE------- 674
I+H DLKP N L+ + M + DFGI+ + SV + + T+ YM PE
Sbjct: 148 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 675 ----YGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
S+ +S K DV+S G +L K P
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 509 LGTGSFGSVYKGTISDG----TDVAIKIF--NLQLERAFRSFDSECEVLRNVRHRNLIKI 562
LG G FGSV + + VA+K+ ++ F E ++ H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 563 LSSCSNPDFKA------LVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGSAL 611
+ K ++L FM +G L +L + + L + + M+D+ +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYM 671
EYL SS IH DL N +L E+M V+DFG+S+ + G+ + + ++
Sbjct: 151 EYL----SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 672 APEYGSEGIVSAKCDVYSYGVLLMETFTR 700
A E ++ + + DV+++GV + E TR
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTR 235
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 16/235 (6%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNL--QLERAFRSFDSECEVLRNVRHRNLIKILS 564
+G GSF +VYKG +VA + + F E E+L+ ++H N+++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 565 SCSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
S + LV E M +G+L+ +L + R + + L++LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-SWCRQILKGLQFLHT--RT 149
Query: 621 APIIHCDLKPTNILLD-ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG 679
PIIH DLK NI + + + D G++ L S + + + T +MAPE E
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAV-IGTPEFMAPEMYEEK 205
Query: 680 IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734
DVY++G+ ++E T + P E RR P +V +
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 24/213 (11%)
Query: 507 NLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNL--IKI 562
+G+G V++ AIK NL+ + S+ +E L ++ + I++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-HGHSSA 621
+ +V+E N L WL D ER + ++ A+ +H HG
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 128
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE------- 674
I+H DLKP N L+ + M + DFGI+ + SV + + T+ YM PE
Sbjct: 129 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 675 ----YGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
S+ +S K DV+S G +L K P
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-34
Identities = 69/363 (19%), Positives = 126/363 (34%), Gaps = 54/363 (14%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLA 70
L N + + F + + L + + + +L L Q+ + + I+ L +
Sbjct: 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG 107
Query: 71 ANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSAD 130
N + + PH N L L L N + F N L+ LS NNL
Sbjct: 108 FNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT- 166
Query: 131 QWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNL 190
+L L SN L + ++ +
Sbjct: 167 -------FQATTSLQNLQLSSNRLTHV----------------------------DLSLI 191
Query: 191 SGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLC-HLKLMFGIRLTGN 249
L ++ N L+ T+ ++ L +N++ + + L + ++L N
Sbjct: 192 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELTI---LKLQHN 242
Query: 250 KLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQK 309
L+ L++ L E+ L N+L + ++ + + +S+N L +L Q
Sbjct: 243 NLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 299
Query: 310 LKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGN 369
+ L VLDLS N L + LE L L N + + +L++L LS N
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHN 355
Query: 370 NLS 372
+
Sbjct: 356 DWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-33
Identities = 77/417 (18%), Positives = 152/417 (36%), Gaps = 61/417 (14%)
Query: 14 NLQYLVFAENNLSGLVPPTIF------NISTMRILTLEGNQLSGRLPSTVGHLLPNIESL 67
NLQY + + ++ ++ +I+T + + + +LP+ + +E L
Sbjct: 22 NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELL 80
Query: 68 LLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESS 127
L + I ++ A + L +GFN+ + F N+ L++L N+L++
Sbjct: 81 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPR 140
Query: 128 SADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEI 187
N LT LS +N L I
Sbjct: 141 GI--------FHNTPKLTTLSMSNNNLERIEDDT-------------------------F 167
Query: 188 GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247
+ L L L SN L + + L ++ N L ++ ++ + +
Sbjct: 168 QATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS-TLA-IPIAVEE---LDAS 219
Query: 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV 307
N ++ + + L L L N LT + L + +++++LS N L + + +
Sbjct: 220 HNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL-EKIMYHP 273
Query: 308 -QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDL 366
K++ L L +S N+L + + L+ L L+ N + + LE+L L
Sbjct: 274 FVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYL 331
Query: 367 SGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPP 423
N++ + L T LK +SHN + ++ F+N + + C
Sbjct: 332 DHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKID 384
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 63/358 (17%), Positives = 131/358 (36%), Gaps = 33/358 (9%)
Query: 4 QIPTEI-GNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
++P + + + ++ L + + + T++ L + N + LP V +P
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVP 123
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
+ L+L N+L+ + N KL L + N+ +TF L L N L
Sbjct: 124 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 183
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN 182
T L+ +L + N L + P+ ++++ A +
Sbjct: 184 TH-----------VDLSLIPSLFHANVSYNLLSTLAIPI------AVEELDASHNSIN-V 225
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYD-LCHLKLM 241
+ + LT+L L N+L T + + L + L N LE I Y ++ +
Sbjct: 226 VRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRL 280
Query: 242 FGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLND 301
+ ++ N+L + + +L+ L L N L + + + + ++ L NS+
Sbjct: 281 ERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV- 337
Query: 302 SLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLI 359
+L + L L LS N + S +++ ++ I + +
Sbjct: 338 TLKLST--HHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEHGL 391
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 38/216 (17%), Positives = 80/216 (37%), Gaps = 12/216 (5%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
I + + + + L + ++ +N+ + L + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 243 GIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLND 301
+ L ++ I ++++L++G N + P ++ + + L N L+
Sbjct: 79 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136
Query: 302 SLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360
SLP + LT L +S N L T A L+ L L+ N+ + + S
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDL--SLIPS 193
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396
L ++S N LS +L +++ + SHN +
Sbjct: 194 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 1e-16
Identities = 26/168 (15%), Positives = 60/168 (35%), Gaps = 2/168 (1%)
Query: 230 SIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYI 289
I +L + + + + + + ++L + + + ++ + + L S +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 290 LDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQ 348
+NL+ + + + + L + N + P + L L L RN
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 349 GPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396
+ L +L +S NNL + + + L+ +S NRL
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 26/155 (16%), Positives = 57/155 (36%), Gaps = 6/155 (3%)
Query: 255 IPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVL 313
I L ++H+ +L + ++++ LP+ + + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 314 TVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLS 372
+L+L+ Q+ ++ L + N + +P V ++ L L L N+LS
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 136
Query: 373 GKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKN 407
+L ++S+N LE I +F+
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLE-RIE-DDTFQA 169
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 13/133 (9%), Positives = 35/133 (26%), Gaps = 26/133 (19%)
Query: 277 SSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKD 336
I S+L D+++ + + L ++ + +
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR------------ 64
Query: 337 LETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396
L +E L+L+ + + +++ + N +
Sbjct: 65 ----KLPAALLDS--------FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR 112
Query: 397 GEIPVKGSFKNFS 409
+P F+N
Sbjct: 113 -YLP-PHVFQNVP 123
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 509 LGTGSFGSVYKGTISDG----TDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKI 562
LG G FGSV +G + VA+K L +R F SE +++ H N+I++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 563 LSSCSNPDFKA-----LVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGSALE 612
L C + ++L FM G L +L + + L M+D+ +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
YL S+ +H DL N +L ++M V+DFG+SK + G+ + + ++A
Sbjct: 162 YL----SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 673 PEYGSEGIVSAKCDVYSYGVLLMETFTR 700
E ++ + ++K DV+++GV + E TR
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATR 245
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 5e-34
Identities = 52/241 (21%), Positives = 96/241 (39%), Gaps = 19/241 (7%)
Query: 470 RNRSTKHLDHEDFLPLATWRRTPYLDIQRATDEFNECNL-----LGTGSFGSVYKGTISD 524
R+ + + +D+ + Y E + +G G FG V++G
Sbjct: 355 RSHTVSVSETDDYAEIID-EEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMS 413
Query: 525 G----TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCS-NPDFKALVLEF 578
VAIK + F E +R H +++K++ + NP + +++E
Sbjct: 414 PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW--IIMEL 471
Query: 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN 638
G L +L + LD+ + + +AL YL S +H D+ N+L+ N
Sbjct: 472 CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL----ESKRFVHRDIAARNVLVSSN 527
Query: 639 MAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETF 698
+ DFG+S+ + E + I +MAPE + ++ DV+ +GV + E
Sbjct: 528 DCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586
Query: 699 T 699
Sbjct: 587 M 587
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-34
Identities = 73/403 (18%), Positives = 135/403 (33%), Gaps = 51/403 (12%)
Query: 14 NLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANN 73
++ Y+ + N+++ L + + ++ L +E + + L ++ L L N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 74 LTGIIPHSITNATKLVALDLGFNSFAGHIL--NTFGNLRHLSLLSQVMNNLTTESSSADQ 131
+ + L L L + G +L N F L L +L NN+
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK----KIQP 146
Query: 132 WSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLS 191
SF ++ +L N + I + NF LS
Sbjct: 147 ASFFLNMR---RFHVLDLTFNKVKSICEEDLLNFQGKHFTLL---------------RLS 188
Query: 192 GLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKL 251
+TL ++ L + + L L N + S+ I+
Sbjct: 189 SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248
Query: 252 SGHIPPCLVS---------------LTSLRELHLGSNKLTS---SIPSSLWSLEYILDIN 293
S ++ + ++ L +K+ + S+ S LE +
Sbjct: 249 SYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQ---LT 305
Query: 294 LSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTI-GALKDLETLSLARNQFQGPI 351
L+ N +N + N L L L+LS+N L I S + L LE L L+ N + +
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-L 362
Query: 352 PESV-GSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHN 393
+ L +L+ L L N L + L+ L++ + N
Sbjct: 363 GDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 73/380 (19%), Positives = 126/380 (33%), Gaps = 50/380 (13%)
Query: 50 SGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHI-LNTFGN 108
R V L ++ + L+ N++ + S + L L + + I NTF
Sbjct: 18 INRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRG 77
Query: 109 LRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPL-GGILPPVIGNFS- 166
L L +L N + A NL +L+ L G +L F
Sbjct: 78 LSSLIILKLDYNQFLQLETGA--------FNGLANLEVLTLTQCNLDGAVLSG--NFFKP 127
Query: 167 -ASLQKFYAYECKLKGNIPQEI-GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRN 224
SL+ + +K P N+ +L L N + S L QG
Sbjct: 128 LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK---SICEEDLLNFQGKHFTL 184
Query: 225 NNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLW 284
L + L + L TS+ L L N S+ +
Sbjct: 185 L--------RLSSITL---QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFF 233
Query: 285 SL-------------EYILDINLSSNSLNDSLPSNVQKLKV--LTVLDLSRNQLSGDIPS 329
Y + + + D + L+ + DLS++++ +
Sbjct: 234 DAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLK 292
Query: 330 TI-GALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLSGKIPKSLETLSQLKQ 387
++ DLE L+LA+N+ I ++ L L L+LS N L + E L +L+
Sbjct: 293 SVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEV 351
Query: 388 FNVSHNRLEGEIPVKGSFKN 407
++S+N + + SF
Sbjct: 352 LDLSYNHIR-ALG-DQSFLG 369
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 72/343 (20%), Positives = 113/343 (32%), Gaps = 64/343 (18%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQL-SGRLPSTVGHLLPNIESLL 68
L +L L N L F ++ + +LTL L L L ++E L+
Sbjct: 77 GLSSLIILKLDYNQFLQL-ETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLV 135
Query: 69 LAANNLTGIIPHSI-TNATKLVALDLGFNSFAGHILNTFGNL--RHLSLLSQVMNNLTTE 125
L NN+ I P S N + LDL FN N +H +LL L
Sbjct: 136 LRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDM 195
Query: 126 SSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGN-------FSASLQKFYAYECK 178
+ W + ++T L N + + S L Y
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 179 LKGNIPQEI-------------------------------GNLSGLTLLSLHSNDLNGTI 207
++ + + L L+L N++N I
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KI 314
Query: 208 SPTM-GRLKRLQGLSLRNNNLEGSIPYD----LCHLKLMFGIRLTGNKLSGHIPPCL-VS 261
L L L+L N L GSI L L++ + L+ N + + +
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEV---LDLSYNHIR-ALGDQSFLG 369
Query: 262 LTSLRELHLGSNKLTSSIP----SSLWSLEYILDINLSSNSLN 300
L +L+EL L +N+L S+P L SL+ I L +N +
Sbjct: 370 LPNLKELALDTNQLK-SVPDGIFDRLTSLQK---IWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 43/244 (17%), Positives = 88/244 (36%), Gaps = 21/244 (8%)
Query: 191 SGLTLLSLHSNDLNGTISPT-MGRLKRLQGLSLRNNNLEGSIPYDLC-HLKLMFGIRLTG 248
+ + + L N + ++ T RL+ LQ L + I + L + ++L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 249 NKLSGHIPP-CLVSLTSLRELHLGSNKLTSSI--PSSLWSLEYILDINLSSNSLNDSLPS 305
N+ + L +L L L L ++ + L + + L N++ P+
Sbjct: 89 NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147
Query: 306 NV-QKLKVLTVLDLSRNQLSGDIPSTIGAL--KDLETLSLARNQ--------FQGPIPES 354
+ ++ VLDL+ N++ + K L L+ +
Sbjct: 148 SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207
Query: 355 VGSLISLESLDLSGNNLSGKIPK---SLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVE 411
S+ +LDLSGN + K ++++ +S++ G +FK+
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
Query: 412 SFFG 415
+F G
Sbjct: 268 TFKG 271
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-34
Identities = 60/396 (15%), Positives = 122/396 (30%), Gaps = 52/396 (13%)
Query: 33 IFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALD 92
N + +I + + L + +++ N++ L L+ N L+ I + TKL L+
Sbjct: 6 KQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 93 LGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSN 152
L N +L L L + NN + L ++ L +N
Sbjct: 65 LSSNVLYE--TLDLESLSTLRTLD-LNNNY------------VQELLVGPSIETLHAANN 109
Query: 153 PLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTM- 211
+ + G + Y K+ + G S + L L N+++ +
Sbjct: 110 NISRV-SCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165
Query: 212 GRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLG 271
L+ L+L+ N + + + KL + L+ NKL+ + P S + + L
Sbjct: 166 ASSDTLEHLNLQYNFIY-DVKGQVVFAKLKT-LDLSSNKLA-FMGPEFQSAAGVTWISLR 222
Query: 272 SNKLTSSIPSSLWSLEYILDINLSSNSLN-DSLPSNVQKLKVLTVLDLSRNQ-LSGDI-- 327
+NKL I +L + + +L N + +L K + + + + L+G
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
Query: 328 ----------------PSTIGALKDLETLSLARNQFQ-------GPIPESVGSLISLESL 364
L L + + + +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREI 341
Query: 365 DLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400
D I + L+ ++
Sbjct: 342 DALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-33
Identities = 51/388 (13%), Positives = 118/388 (30%), Gaps = 30/388 (7%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
+ + + N++ L + N LS + + + + +L L N L L +
Sbjct: 26 LASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLES--LSTL 82
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTT 124
+L L N + + + L N+ + + +++ L + N +T
Sbjct: 83 RTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLAN---NKITM 134
Query: 125 ESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIP 184
+ L N + + + S +L+ + ++
Sbjct: 135 LRDLD--------EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185
Query: 185 QEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGI 244
++ + L L L SN L + P + +SLRNN L I L + +
Sbjct: 186 GQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 245 RLTGNKLS-GHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSL 303
L GN G + ++ + + K + ++ + + D
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH--YGAYCCEDLP 300
Query: 304 PSNVQKLKVLTVLDLSRNQLSGD----IPSTIGALKDLETLSLARNQFQGPIPESVGSLI 359
+L L + + G + + + Q++ I +
Sbjct: 301 APFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQ 360
Query: 360 SLESLDLSGNNLSGKIPKSLETLSQLKQ 387
+ +L+ L ++ ++L
Sbjct: 361 AKITLEQKKKALDEQVSNGRRAHAELDG 388
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 52/347 (14%), Positives = 103/347 (29%), Gaps = 25/347 (7%)
Query: 55 STVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSL 114
+ + + ++L + +A + LDL N + L L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 115 LSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYA 174
L+ N L L + L L +N + +L S++ +A
Sbjct: 63 LNLSSNVLYE----------TLDLESLSTLRTLDLNNNYVQELLVG------PSIETLHA 106
Query: 175 YECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEG-SIPY 233
+ + G + L +N + G R+Q L L+ N ++ +
Sbjct: 107 ANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 234 DLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDIN 293
+ + L N + + V L+ L L SNKL + S + I+
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 294 LSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPE 353
L +N L + ++ + L DL N K+ ++A+ + +
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQ 278
Query: 354 SVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400
+ + L LK+ + +G
Sbjct: 279 NEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET 325
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-30
Identities = 53/321 (16%), Positives = 112/321 (34%), Gaps = 27/321 (8%)
Query: 78 IPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSS 137
I N + + +S + + + ++ L N L+ S++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAAD-------- 53
Query: 138 LTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLS 197
L L +L+ SN L + + S +L+ L N QE+ + L
Sbjct: 54 LAPFTKLELLNLSSNVLYET--LDLESLS-TLRTLD-----LNNNYVQELLVGPSIETLH 105
Query: 198 LHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSG-HIP 256
+N+++ +S R + + + L NN + D + + L N++ +
Sbjct: 106 AANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162
Query: 257 PCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVL 316
S +L L+L N + + + + ++LSSN L + Q +T +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 317 DLSRNQLSGDIPSTIGALKDLETLSLARNQFQ-GPIPESVGSLISLESLDLSGNNLSGKI 375
L N+L I + ++LE L N F G + + ++++ +
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLT 276
Query: 376 PKSLETLSQLKQFNVSHNRLE 396
++ E + + E
Sbjct: 277 GQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 47/394 (11%), Positives = 112/394 (28%), Gaps = 36/394 (9%)
Query: 8 EIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESL 67
Q + + A N ++ L S ++ L L+ N++ + + +E L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 68 LLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESS 127
L N + + KL LDL N A + F + ++ +S N L
Sbjct: 175 NLQYNFIYDV--KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV---- 227
Query: 128 SADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEI 187
+L +NL N FS + + + +K Q
Sbjct: 228 -----LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNE 280
Query: 188 GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247
+ TL + +P RL L+ + +GS
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET--------------- 325
Query: 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV 307
+ + RE+ + + I + + + +L++ + +
Sbjct: 326 -----ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGR 380
Query: 308 QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQF-QGPIPESVGSLISLESLDL 366
+ L ++ L+ L ++ + + + ++ D+
Sbjct: 381 RAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDM 439
Query: 367 SGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400
+ + ++ + +++ +
Sbjct: 440 YQHKETQLAEENARLKKLNGEADLALASANATLQ 473
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 9e-20
Identities = 32/163 (19%), Positives = 67/163 (41%), Gaps = 11/163 (6%)
Query: 245 RLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLP 304
++T + L + S +++EL L N L+ + L + +NLSSN L +
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--T 73
Query: 305 SNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESL 364
+++ L L LDL+ N + + +ETL A N + S G +++
Sbjct: 74 LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR-VSCSRGQ--GKKNI 125
Query: 365 DLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKN 407
L+ N ++ S+++ ++ N ++ + +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 29/149 (19%), Positives = 60/149 (40%), Gaps = 12/149 (8%)
Query: 261 SLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSR 320
+ + + + L ++ S S + +++LS N L+ +++ L +L+LS
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 321 NQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLE 380
N L + +L L TL L N Q + S+E+L + NN+S ++
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS--CS 117
Query: 381 TLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
K +++N++ + S
Sbjct: 118 RGQGKKNIYLANNKIT-MLR-DLDEGCRS 144
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 9e-15
Identities = 28/133 (21%), Positives = 53/133 (39%), Gaps = 21/133 (15%)
Query: 264 SLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQL 323
++ E+ N+ ++ +SL +L S Q + LDLS N L
Sbjct: 1 AIHEIKQNGNRYKI--------------EKVTDSSLKQALASLRQSAWNVKELDLSGNPL 46
Query: 324 SGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLS 383
S + + LE L+L+ N + + SL +L +LDL+ N + L
Sbjct: 47 SQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGP 99
Query: 384 QLKQFNVSHNRLE 396
++ + ++N +
Sbjct: 100 SIETLHAANNNIS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 16/77 (20%), Positives = 31/77 (40%)
Query: 327 IPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLK 386
I + + + + + S +++ LDLSGN LS L ++L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 387 QFNVSHNRLEGEIPVKG 403
N+S N L + ++
Sbjct: 62 LLNLSSNVLYETLDLES 78
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 27/226 (11%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHR 557
+++ +GTGS+G K SDG + K + E + SE +LR ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 558 NLIKILSSCSNPDFKAL--VLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALE 612
N+++ + L V+E+ G L + +LD L +M + AL+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 613 YLHHGHSSA-PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYM 671
H ++H DLKP N+ LD + DFG++++L +T T YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFV-GTPYYM 183
Query: 672 APE------YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
+PE Y K D++S G LL E P FT
Sbjct: 184 SPEQMNRMSYNE------KSDIWSLGCLLYELCALMPP----FTAF 219
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-33
Identities = 73/332 (21%), Positives = 124/332 (37%), Gaps = 69/332 (20%)
Query: 497 QRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQ-LERAFRSFDSECEVLR-NV 554
Q + +LG GS G+V G VA+K + + A E ++L +
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESD 66
Query: 555 RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL------NIMIDVG 608
H N+I+ S + F + LE N +L+ + S N + L+ +++ +
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 609 SALEYLH-HGHSSAPIIHCDLKPTNILLD-------------ENMAAHVSDFGISKLLGE 654
S + +LH IIH DLKP NIL+ EN+ +SDFG+ K L
Sbjct: 126 SGVAHLHSLK-----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 655 GEDSVTQTMTMA--TIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRKRPTD 705
G+ S + T G+ APE ++ ++ D++S G + ++ +
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-- 238
Query: 706 EMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSA-KMDCILSIMDLALD---CCIE 761
P G ++N++R + K S++ A D I+
Sbjct: 239 -----------------PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMID 281
Query: 762 S-PDMRINVTDAAA----KLKKIKVKFLDDAS 788
P R K K++FL S
Sbjct: 282 HDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVS 313
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 9/198 (4%)
Query: 509 LGTGSFGSVYKGTISDG-TDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
LG G +G VY+G VA+K F E V++ ++H NL+++L C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
++ EFM G+L +L N + + L + + SA+EYL IH
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL----EKKNFIHR 135
Query: 627 DLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCD 686
DL N L+ EN V+DFG+S+L+ + I + APE + S K D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSD 194
Query: 687 VYSYGVLLMETFTR-KRP 703
V+++GVLL E T P
Sbjct: 195 VWAFGVLLWEIATYGMSP 212
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 508 LLGTGSFGSVYKGTISD-GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC 566
+LG G++G VY G +AIK + R + E + ++++H+N+++ L S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSALEYLHHGHSSAPII 624
S F + +E +P GSL L S L E+ + L+YLH I+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ----IV 144
Query: 625 HCDLKPTNILLD-ENMAAHVSDFGISKLLGEGEDSVTQTMTMA-TIGYMAPE--YGSEGI 680
H D+K N+L++ + +SDFG SK L T T T+ YMAPE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRL---AGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 681 VSAKCDVYSYGVLLMETFTRKRP 703
D++S G ++E T K P
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPP 224
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 59/362 (16%), Positives = 114/362 (31%), Gaps = 52/362 (14%)
Query: 33 IFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALD 92
N + +I + + L + +++ N++ L L+ N L+ I + TKL L+
Sbjct: 6 KQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 93 LGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSN 152
L N +L L L N + L ++ L +N
Sbjct: 65 LSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-------------ELLVGPSIETLHAANN 109
Query: 153 PLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTM- 211
+ + G + Y K+ + G S + L L N+++ +
Sbjct: 110 NISRV-SCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165
Query: 212 GRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLG 271
L+ L+L+ N + + V L+ L L
Sbjct: 166 ASSDTLEHLNLQYNFIY-------------------------DVKG-QVVFAKLKTLDLS 199
Query: 272 SNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTI 331
SNKL + S + I+L +N L + ++ + L DL N
Sbjct: 200 SNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRD 256
Query: 332 GALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK-SLETLSQLKQFNV 390
K+ ++A+ + + ++ +L G +P + L L +
Sbjct: 257 FFSKNQRVQTVAKQTVKK-LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHH 315
Query: 391 SH 392
H
Sbjct: 316 HH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 49/278 (17%), Positives = 98/278 (35%), Gaps = 16/278 (5%)
Query: 140 NCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLH 199
N I + L L + + ++++ L ++ + L LL+L
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAW-NVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 200 SNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCL 259
SN L + + L L+ L L NN ++ + ++ + N +S +
Sbjct: 67 SNVL--YETLDLESLSTLRTLDLNNNYVQ-ELL-VGPSIET---LHAANNNIS-RVSC-- 116
Query: 260 VSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLND-SLPSNVQKLKVLTVLDL 318
+ ++L +NK+T + ++L N ++ + L L+L
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 319 SRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKS 378
N + D+ + L+TL L+ N+ + S + + L N L I K+
Sbjct: 177 QYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 379 LETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGN 416
L L+ F++ N KN V++
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 41/215 (19%), Positives = 85/215 (39%), Gaps = 13/215 (6%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
I + N + + + + L ++ ++ L L N L DL +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 243 GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDS 302
+ L+ N L L SL++LR L L +N + L I ++ ++N+++
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 303 LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQG-PIPESVGSLISL 361
+ + + + L+ N+++ G ++ L L N+ E S +L
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 362 ESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396
E L+L N + + + ++LK ++S N+L
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 50/320 (15%), Positives = 96/320 (30%), Gaps = 55/320 (17%)
Query: 6 PTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIE 65
++ L+ L + N L + ++ST+R L L N + L P+IE
Sbjct: 51 AADLAPFTKLELLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-ELLV-----GPSIE 102
Query: 66 SLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTE 125
+L A NN++ + + L N G + L +N + T
Sbjct: 103 TLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159
Query: 126 SSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQ 185
+ + + L L+ N + ++
Sbjct: 160 NFAE-------LAASSDTLEHLNLQYNFI--------------------------YDVKG 186
Query: 186 EIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIR 245
++ + L L L SN L + P + +SLRNN L I L + +
Sbjct: 187 QV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFD 243
Query: 246 LTGNKLS-GHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLP 304
L GN G + ++ + + K + ++ + + LP
Sbjct: 244 LRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG---AYCCEDLP 300
Query: 305 SNVQKLKVLTVLDLSRNQLS 324
++ L +
Sbjct: 301 ----APFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 27/130 (20%), Positives = 52/130 (40%), Gaps = 9/130 (6%)
Query: 278 SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDL 337
+I + ++ +SL +L S Q + LDLS N LS + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 338 ETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEG 397
E L+L+ N + + SL +L +LDL+ N + L ++ + ++N +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 398 EIPVKGSFKN 407
+ +
Sbjct: 113 RVS-CSRGQG 121
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 14/195 (7%)
Query: 507 NLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC 566
+G G FG V G G VA+K ++ + ++F +E V+ +RH NL+++L
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 567 S-NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPII 624
+V E+M GSL +L S L L +DV A+EYL +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL----EGNNFV 139
Query: 625 HCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAK 684
H DL N+L+ E+ A VSDFG++K E S TQ + + APE E S K
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 685 CDVYSYGVLLMETFT 699
DV+S+G+LL E ++
Sbjct: 195 SDVWSFGILLWEIYS 209
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 29/223 (13%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFN-LQLERAFRSFDSECEVLRNVRHRN 558
+ ++LG G+ +V++G G AIK+FN + R E EVL+ + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 559 LIKILS--SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGSALEYL 614
++K+ + + K L++EF P GSL L + + E L ++ DV + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 615 H-HGHSSAPIIHCDLKPTNILL----DENMAAHVSDFGISKLLGEGEDSVTQTMTMA-TI 668
+G I+H ++KP NI+ D ++DFG ++ L + E Q +++ T
Sbjct: 129 RENG-----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTE 179
Query: 669 GYMAPEYGSEGIV--------SAKCDVYSYGVLLMETFTRKRP 703
Y+ P+ ++ A D++S GV T P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 24/213 (11%)
Query: 507 NLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNL--IKI 562
+G+G V++ AIK NL+ + S+ +E L ++ + I++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-HGHSSA 621
+ +V+E N L WL D ER + ++ A+ +H HG
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSI-DPWERKSYWKNMLEAVHTIHQHG---- 175
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE------- 674
I+H DLKP N L+ + M + DFGI+ + SV + + + YM PE
Sbjct: 176 -IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 675 ----YGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
S+ +S K DV+S G +L K P
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 64/292 (21%), Positives = 113/292 (38%), Gaps = 41/292 (14%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC 566
LG G F V + DG A+K ++ E ++ R H N++++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 567 SNPDFKA----LVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHHGHS 619
L+L F G+L + FL + L +++ + LE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---- 151
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA-------TIGYMA 672
+ H DLKPTNILL + + D G + Q +T+ TI Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 673 PE----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728
PE I + DV+S G +L + P D +F S+ V+ L
Sbjct: 212 PELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS----- 265
Query: 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780
+ + S+ + +L+ M + +D P R ++ ++L+ ++
Sbjct: 266 ------IPQSPRHSSALWQLLNSM-MTVD-----PHQRPHIPLLLSQLEALQ 305
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-32
Identities = 82/392 (20%), Positives = 134/392 (34%), Gaps = 61/392 (15%)
Query: 12 LQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAA 71
L E+ L+ L P + + L + N L+ LP+ L P + +L ++
Sbjct: 39 NNGNAVLNVGESGLTTL-PDCLPA--HITTLVIPDNNLT-SLPA----LPPELRTLEVSG 90
Query: 72 NNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQ 131
N LT +P +L H+ L L + N LT+
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLT----HLPALPSGLCKLWIFG---NQLTSLPVL--- 139
Query: 132 WSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLS 191
L LS N L LP + L K +AY +L ++P L
Sbjct: 140 ---------PPGLQELSVSDNQLAS-LPALPSE----LCKLWAYNNQLT-SLPMLPSGL- 183
Query: 192 GLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKL 251
LS+ N L ++ L +L NN L S+P LK + ++GN+L
Sbjct: 184 --QELSVSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLPALPSGLKE---LIVSGNRL 233
Query: 252 SGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLK 311
+ +P + L+EL + N+LTS +P L + ++ N L LP ++ L
Sbjct: 234 T-SLPV---LPSELKELMVSGNRLTS-LPMLPSGLLSL---SVYRNQLT-RLPESLIHLS 284
Query: 312 VLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQ---GPIPESVGSLISLESLDLSG 368
T ++L N LS + + S +F P +L + L
Sbjct: 285 SETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVP 344
Query: 369 NNLSG----KIPKSLETLSQLKQFNVSHNRLE 396
F++ +RL
Sbjct: 345 AREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-31
Identities = 76/358 (21%), Positives = 133/358 (37%), Gaps = 53/358 (14%)
Query: 43 TLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHI 102
E + + L L + + LT +P + + L + N+ +
Sbjct: 21 AEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SL 76
Query: 103 LNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVI 162
LR L + N LT S L+I S L +
Sbjct: 77 PALPPELRTLEVSG---NQLT---------SLPVLPPGLLELSIFSNPLTHLPALPS--- 121
Query: 163 GNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSL 222
L K + + +L ++P L L++ L S L L
Sbjct: 122 -----GLCKLWIFGNQLT-SLPVLPPGLQELSVSDNQLASLPALPS-------ELCKLWA 168
Query: 223 RNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSS 282
NN L S+P L+ + ++ N+L+ +P + L +L +N+LTS +P+
Sbjct: 169 YNNQLT-SLPMLPSGLQE---LSVSDNQLA-SLPT---LPSELYKLWAYNNRLTS-LPAL 219
Query: 283 LWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSL 342
L+ + +S N L SLP +L L +S N+L+ +P L +LS+
Sbjct: 220 PSGLKEL---IVSGNRLT-SLPVLPSEL---KELMVSGNRLT-SLPMLPS---GLLSLSV 268
Query: 343 ARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400
RNQ +PES+ L S +++L GN LS + ++L ++ ++ R +
Sbjct: 269 YRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGA 325
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-28
Identities = 68/351 (19%), Positives = 113/351 (32%), Gaps = 57/351 (16%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+P L+ L+ + N L+ L P + + I + L L
Sbjct: 75 SLPALPPELRTLE---VSGNQLTSL-PVLPPGLLELSIFSNPLTHLPA--------LPSG 122
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
+ L + N LT +P L L + N A + L L + N LT
Sbjct: 123 LCKLWIFGNQLTS-LPVLPPG---LQELSVSDNQLA-SLPALPSELCKLWAYN---NQLT 174
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNI 183
S + L LS N L LP + L K +AY +L ++
Sbjct: 175 ---------SLPMLPS---GLQELSVSDNQL-ASLPTLPSE----LYKLWAYNNRLT-SL 216
Query: 184 PQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFG 243
P L L + N L ++ LK L + N L S+P L +
Sbjct: 217 PALPSG---LKELIVSGNRLT-SLPVLPSELKE---LMVSGNRLT-SLPMLPSGLLSLS- 267
Query: 244 IRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS---SIPSSLWSLEYILDINLSSNSLN 300
+ N+L+ +P L+ L+S ++L N L+ + S + +
Sbjct: 268 --VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAG 324
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSG----DIPSTIGALKDLETLSLARNQF 347
S P + L + L + D G + + SL ++
Sbjct: 325 ASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRL 375
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 46/242 (19%), Positives = 85/242 (35%), Gaps = 16/242 (6%)
Query: 467 KRCRNRSTKHLDHEDFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGT-ISDG 525
+ + + D+E L + Y + + +G GSFG V++ G
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTG 83
Query: 526 TDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLE 585
A+K L+ E + ++ + + + + +E + GSL
Sbjct: 84 FQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 586 KWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN-MAAHVS 644
+ + + + LEYLH + I+H D+K N+LL + A +
Sbjct: 139 QLIKQMGCLPEDRAL-YYLGQALEGLEYLH----TRRILHGDVKADNVLLSSDGSRAALC 193
Query: 645 DFGISKLLGEGEDSVTQTMTMATIG---YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 701
DFG + L + G +MAPE AK D++S +++
Sbjct: 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
Query: 702 RP 703
P
Sbjct: 254 HP 255
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 13/210 (6%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIK---IFNLQLERAFRSFDSECEVLRNVRH 556
F +G G F VY+ + DG VA+K IF+L +A E ++L+ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEY 613
N+IK +S + +VLE G L + + + + + SALE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAP 673
+H ++H D+KP N+ + + D G+ + + + ++ T YM+P
Sbjct: 152 MHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLV-GTPYYMSP 205
Query: 674 EYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
E E + K D++S G LL E + P
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 49/213 (23%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHR 557
+++ +G GSFG DG IK N+ + E VL N++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHH 616
N+++ S +V+++ G L K + + + L+ + + AL+++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE-- 674
I+H D+K NI L ++ + DFGI+++L + + + T Y++PE
Sbjct: 144 RK----ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-LARACI-GTPYYLSPEIC 197
Query: 675 ----YGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
Y + K D+++ G +L E T K
Sbjct: 198 ENKPYNN------KSDIWALGCVLYELCTLKHA 224
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 30/225 (13%)
Query: 498 RATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNL-QLERAFRSFDSECEVLRNVR 555
R +F LG G FG V++ D + AIK L E A E + L +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 556 HRNLIKILSS----------CSNPDFKAL--VLEFMPNGSLEKWLYSHNYFLDILER--L 601
H +++ ++ + L ++ +L+ W+ + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 602 NIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661
+I + + A+E+LH ++H DLKP+NI + V DFG+ + + E+ T
Sbjct: 122 HIFLQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 662 TMTMATIG----------YMAPEYGSEGIVSAKCDVYSYGVLLME 696
M YM+PE S K D++S G++L E
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 48/215 (22%), Positives = 88/215 (40%), Gaps = 32/215 (14%)
Query: 509 LGTGSFGSVYKGT--------ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
LG G+F ++KG T+V +K+ + SF ++ + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
C D LV EF+ GSL+ +L + ++IL +L + + +A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL----EE 131
Query: 621 APIIHCDLKPTNILLD--------ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
+IH ++ NILL +SD GIS + + + I ++
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVP 185
Query: 673 PE---YGSEGIVSAKCDVYSYGVLLMETFTR-KRP 703
PE ++ D +S+G L E + +P
Sbjct: 186 PECIENP--KNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 20/211 (9%)
Query: 508 LLGTGSFGSVYKGTISD---GTDVAIKIFNLQLER--AFRS-FDSECEVLRNVRHRNLIK 561
L+G G G VY+ D VA+K+ + L FR+ E ++ +++
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
I + + + L L L + I+ +GSAL+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--- 154
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT-MTMATIGYMAPEYGSEGI 680
H D+KP NIL+ + A++ DFGI+ + +TQ T+ T+ YMAPE SE
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIASATTDE--KLTQLGNTVGTLYYMAPERFSESH 211
Query: 681 VSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
+ + D+Y+ +L E T P + G+
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-32
Identities = 74/359 (20%), Positives = 122/359 (33%), Gaps = 43/359 (11%)
Query: 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFA 99
R + + +P + L L N + + + L L+L N +
Sbjct: 14 RAVLCHRKRFV-AVPE---GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69
Query: 100 GHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILP 159
F NL +L L N L T NLT L N + +L
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLKLIPLGV--------FTGLSNLTKLDISENKIVILLD 121
Query: 160 PVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISP-TMGRLKRLQ 218
F +L L L + NDL IS L L+
Sbjct: 122 ---YMFQ----------------------DLYNLKSLEVGDNDLV-YISHRAFSGLNSLE 155
Query: 219 GLSLRNNNLEGSIPYD-LCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS 277
L+L NL SIP + L HL + +RL ++ L L+ L +
Sbjct: 156 QLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 278 SIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKD 336
++ + + ++++ +L ++P + L L L+LS N +S S + L
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLR 273
Query: 337 LETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRL 395
L+ + L Q P + L L L++SGN L+ ++ L+ + N L
Sbjct: 274 LQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 77/346 (22%), Positives = 126/346 (36%), Gaps = 40/346 (11%)
Query: 29 VPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKL 88
VP I + R+L L N++ L P++E L L N ++ + P + N L
Sbjct: 26 VPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 89 VALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILS 148
L L N L F L +L+ L N + + NL L
Sbjct: 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYM--------FQDLYNLKSLE 134
Query: 149 FGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTIS 208
G N L I FS L+ L L+L +L +I
Sbjct: 135 VGDNDLVYISH---RAFS----------------------GLNSLEQLTLEKCNLT-SIP 168
Query: 209 P-TMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRE 267
+ L L L LR+ N+ Y L + + ++ + P + +L
Sbjct: 169 TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228
Query: 268 LHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGD 326
L + LT+ ++ L Y+ +NLS N + ++ ++ +L L + L QL+
Sbjct: 229 LSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI-STIEGSMLHELLRLQEIQLVGGQLAVV 287
Query: 327 IPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS 372
P L L L+++ NQ S+ +LE+L L N L+
Sbjct: 288 EPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-30
Identities = 75/347 (21%), Positives = 128/347 (36%), Gaps = 40/347 (11%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+P I + L +N + L + + L L N +S + + L N
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN 81
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
+ +L L +N L I T + L LD+ N + F +L +L L N+L
Sbjct: 82 LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNI 183
S A + +L L+ L I S
Sbjct: 142 YISHRA--------FSGLNSLEQLTLEKCNLTSIPT---EALS----------------- 173
Query: 184 PQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFG 243
+L GL +L L ++N + RL RL+ L + + ++ + + +
Sbjct: 174 -----HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228
Query: 244 IRLTGNKLSGHIPPC-LVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDS 302
+ +T L+ +P + L LR L+L N +++ S L L + +I L L
Sbjct: 229 LSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-V 286
Query: 303 LPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQ 348
+ + L L VL++S NQL+ S ++ +LETL L N
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-25
Identities = 59/275 (21%), Positives = 104/275 (37%), Gaps = 17/275 (6%)
Query: 142 RNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEI-GNLSGLTLLSLHS 200
+L G N + + +F L++ E + + NL L L L S
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFP-HLEELELNENIVS-AVEPGAFNNLFNLRTLGLRS 89
Query: 201 NDLNGTISPTM-GRLKRLQGLSLRNNNLEGSIP----YDLCHLKLMFGIRLTGNKLSGHI 255
N L I + L L L + N + + DL +LK + + N L +I
Sbjct: 90 NRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKS---LEVGDNDLV-YI 143
Query: 256 PP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLT 314
L SL +L L LTS +L L ++ + L ++N + ++L L
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 315 VLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGK 374
VL++S + +L +LS+ +V L+ L L+LS N +S
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI 263
Query: 375 IPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
L L +L++ + +L + +F+ +
Sbjct: 264 EGSMLHELLRLQEIQLVGGQLA-VVE-PYAFRGLN 296
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-15
Identities = 33/166 (19%), Positives = 65/166 (39%), Gaps = 5/166 (3%)
Query: 244 IRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSL 303
+ + +P + T R L LG N++ + S ++ ++ L+ N ++
Sbjct: 16 VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72
Query: 304 PSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLES 363
P L L L L N+L L +L L ++ N+ + L +L+S
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKS 132
Query: 364 LDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
L++ N+L ++ L+ L+Q + L IP + +
Sbjct: 133 LEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIP-TEALSHLH 176
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKIL 563
LG G +VY VAIK + E + F+ E + H+N++ ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPI 623
D LV+E++ +L +++ SH L + +N + +++ H I
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMR----I 132
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT-MTMATIGYMAPEYGSEGIVS 682
+H D+KP NIL+D N + DFGI+K L E S+TQT + T+ Y +PE
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 683 AKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
D+YS G++L E + P F GE
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 509 LGTGSFGSVYKGTISDG------TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 561
LG GSFG VY+G T VAIK N R F +E V++ ++++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSALE 612
+L S +++E M G L+ +L S + + + + ++ +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
YL ++ +H DL N ++ E+ + DFG+++ + E + + + +M+
Sbjct: 153 YL----NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 673 PEYGSEGIVSAKCDVYSYGVLLMETFTR 700
PE +G+ + DV+S+GV+L E T
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIATL 236
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 509 LGTGSFGSVYKGTISDG------TDVAIKIFN-LQLERAFRSFDSECEVLRNVRHRNLIK 561
LG G+FG VY+G +S VA+K + E+ F E ++ H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSH------NYFLDILERLNIMIDVGSALEYLH 615
+ + +++E M G L+ +L L +L+ L++ D+ +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 616 HGHSSAPIIHCDLKPTNILLD---ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
IH D+ N LL A + DFG+++ + M + +M
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 673 PEYGSEGIVSAKCDVYSYGVLLMETFT 699
PE EGI ++K D +S+GVLL E F+
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 509 LGTGSFGSVYKGTI------SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKI 562
LG G+FG V+ D VA+K A + F E E+L N++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDV 607
C + D +V E+M +G L K+L +H L + + L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT 667
S + YL +S +H DL N L+ N+ + DFG+S+ + + TM
Sbjct: 143 ASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 668 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
I +M PE + + DV+S+GV+L E FT
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLER--AFRS-FDSECEVLRNVRHRNLIKIL 563
+LG G V+ + D DVA+K+ L R +F F E + + H ++ +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 564 SSCSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
+ +V+E++ +L +++ + + ++ D AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQNG- 136
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT-MTMATIGYMAPEYGSE 678
IIH D+KP NI++ A V DFGI++ + + +SVTQT + T Y++PE
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
V A+ DVYS G +L E T + P FTG+
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 5e-31
Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 20/220 (9%)
Query: 497 QRATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV 554
+ + LGTG FG V + G VAIK +L + + E ++++ +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 555 RHRNLIKIL------SSCSNPDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMID 606
H N++ + D L +E+ G L K+L L ++ D
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAH---VSDFGISKLLGEGEDSVTQTM 663
+ SAL YLH IIH DLKP NI+L + D G +K L +GE
Sbjct: 130 ISSALRYLHENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF-- 183
Query: 664 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
+ T+ Y+APE + + D +S+G L E T RP
Sbjct: 184 -VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-31
Identities = 44/213 (20%), Positives = 81/213 (38%), Gaps = 29/213 (13%)
Query: 508 LLGTGSFGSVYKG--TISDGTDVAIKIFNLQLERAFRS-FDSECEVLRNVRHRNLIKILS 564
+ G G +Y +G V +K + ++ +E + L V H ++++I +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 565 SCSNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
+ D +V+E++ SL++ L + E + ++++ AL YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---- 199
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT-MTMATIGYMAPEYGSE 678
S +++ DLKP NI+L E + D G + T G+ APE
Sbjct: 200 SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-------RINSFGYLYGTPGFQAPEI-VR 250
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
+ D+Y+ G L G
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 509 LGTGSFGSVYKGTISDG------TDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKI 562
LG G+FG V+ + VA+K E A + F E E+L ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 563 LSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF--------------LDILERLNIMIDVG 608
C+ +V E+M +G L ++L SH L + + L + V
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
+ + YL + +H DL N L+ + + + DFG+S+ + + TM I
Sbjct: 169 AGMVYL----AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 669 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+M PE + + DV+S+GV+L E FT
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 509 LGTGSFGSVYKGTISDG------TDVAIKIFN-LQLERAFRSFDSECEVLRNVRHRNLIK 561
LG G+FG VY+G +S VA+K + E+ F E ++ H+N+++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSH------NYFLDILERLNIMIDVGSALEYLH 615
+ + ++LE M G L+ +L L +L+ L++ D+ +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 616 HGHSSAPIIHCDLKPTNILLD---ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
IH D+ N LL A + DFG+++ + M + +M
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 673 PEYGSEGIVSAKCDVYSYGVLLMETFT 699
PE EGI ++K D +S+GVLL E F+
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-30
Identities = 71/413 (17%), Positives = 137/413 (33%), Gaps = 25/413 (6%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLA 70
Q L+YL + N L + + ++ L L N + ++ L L+
Sbjct: 67 FNQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123
Query: 71 ANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSAD 130
+L I + L + ++ L+ + S + T +
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFI 181
Query: 131 QWSFLSSLTNC--RNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIG 188
+ ++ N N+ + + + + L + N I
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241
Query: 189 NL---SGLTLLSLHSNDLNG-----TISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
L + + S+ + L G + LK L + ++ Y
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSN 301
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
M T + C ++ L +N LT ++ + L + + L N L
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 301 DSLPSNV---QKLKVLTVLDLSRNQLSGDIPSTI-GALKDLETLSLARNQFQGPIPESVG 356
L ++K L LD+S+N +S D K L +L+++ N I +
Sbjct: 362 -ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL- 419
Query: 357 SLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
++ LDL N + IPK + L L++ NV+ N+L+ +P G F +
Sbjct: 420 -PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVP-DGIFDRLT 468
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 83/440 (18%), Positives = 154/440 (35%), Gaps = 48/440 (10%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+P ++ L ++N +S L I ++S +RIL + N++ L +V
Sbjct: 14 HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQE 70
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAG-HILNTFGNLRHLSLLS------ 116
+E L L+ N L I H N L LDL FN+F I FGN+ L L
Sbjct: 71 LEYLDLSHNKLVKISCHPTVN---LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHL 127
Query: 117 --------QVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSAS 168
+N + + ++ S I + S
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVK 187
Query: 169 LQKF----------YAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRL---K 215
+C +I ++ L+ L+L++ + + +L
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT 247
Query: 216 RLQGLSLRNNNLEG-----SIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHL 270
+ S+ N L+G Y LK + ++ + +++ +
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF 307
Query: 271 GSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPST 330
+ + L ++ S+N L D++ N L L L L NQL ++
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKI 366
Query: 331 IGA---LKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLSGKIPKSLETLSQLK 386
+K L+ L +++N + SL SL++S N L+ I + L ++K
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIK 424
Query: 387 QFNVSHNRLEGEIPVKGSFK 406
++ N+++ IP K K
Sbjct: 425 VLDLHSNKIK-SIP-KQVVK 442
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 68/378 (17%), Positives = 141/378 (37%), Gaps = 15/378 (3%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLP--STVGHLLP 62
I E GN+ L++L + +L I +++ ++L + G +
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN-N 121
++ + I+ S+ L ++ L L ++ N
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLT 226
Query: 122 LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSA-SLQKFYAYECKLK 180
L ++ + + + L + S + L G L ++S SL+ ++
Sbjct: 227 LNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSD 286
Query: 181 G-NIPQEIG--NLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCH 237
PQ S + + + + ++ L NN L ++ + H
Sbjct: 287 VFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGH 346
Query: 238 LKLMFGIRLTGNKLSGHIPPCLV--SLTSLRELHLGSNKLTSSIPSSLWS-LEYILDINL 294
L + + L N+L + + SL++L + N ++ S + +L +N+
Sbjct: 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406
Query: 295 SSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPES 354
SSN L D++ + + VLDL N++ IP + L+ L+ L++A NQ + +P+
Sbjct: 407 SSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDG 462
Query: 355 V-GSLISLESLDLSGNNL 371
+ L SL+ + L N
Sbjct: 463 IFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 52/381 (13%), Positives = 116/381 (30%), Gaps = 21/381 (5%)
Query: 29 VPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKL 88
VP + IL + N +S L ++ L + L+++ N + + +L
Sbjct: 15 VPKDLS--QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 89 VALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILS 148
LDL N + NL+HL L N +++ L L
Sbjct: 72 EYLDLSHNKLVKISCHPTVNLKHLDLSF---NAFDALPICK----EFGNMSQ---LKFLG 121
Query: 149 FGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTIS 208
+ L I + + S E + ++ L SLH
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGE---KEDPEGLQDFNTESLHIVFPTNKEF 178
Query: 209 PTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLREL 268
+ + +L +N++ + + C L +L N ++ + T +
Sbjct: 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
Query: 269 HLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP 328
+ +++ I ++ L + LK L++ + +
Sbjct: 239 RILQLVWHTTVWYF-----SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQS 293
Query: 329 STIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQF 388
++ + + + + LD S N L+ + ++ L++L+
Sbjct: 294 YIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353
Query: 389 NVSHNRLEGEIPVKGSFKNFS 409
+ N+L+ +
Sbjct: 354 ILQMNQLKELSKIAEMTTQMK 374
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 68/355 (19%), Positives = 117/355 (32%), Gaps = 43/355 (12%)
Query: 8 EIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESL 67
+ LQ+ + I ++S + LE + + L +I +
Sbjct: 156 DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAK 215
Query: 68 LLAANNLTG-------IIPHSITNATKLVAL-DLGFNSFAGHILNTFGNLRHLSLLSQVM 119
L L+ +S +LV + + S + L + R +
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL 275
Query: 120 NNLTTESSSADQWSFLSSL--TNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYEC 177
L+ +D + F S N+ I +F + + S
Sbjct: 276 KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS-PFLHLDFSNN 334
Query: 178 KLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMG---RLKRLQGLSLRNNNLEGSIPYD 234
L + + G+L+ L L L N L +S ++K LQ L + N++
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
Query: 235 LCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINL 294
C SL L++ SN LT +I L +LD L
Sbjct: 394 DCS-----------------------WTKSLLSLNMSSNILTDTIFRCLPPRIKVLD--L 428
Query: 295 SSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP-STIGALKDLETLSLARNQFQ 348
SN + S+P V KL+ L L+++ NQL +P L L+ + L N +
Sbjct: 429 HSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 507 NLLGTGSFGSVYKGTISDG---TDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIK 561
+++G G+FG V K I D AIK + R F E EVL + H N+I
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF---------------LDILERLNIMID 606
+L +C + + L +E+ P+G+L +L L + L+ D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
V ++YL S IH DL NIL+ EN A ++DFG+S+ E V +TM
Sbjct: 151 VARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MA E + + + DV+SYGVLL E +
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 3e-30
Identities = 44/251 (17%), Positives = 76/251 (30%), Gaps = 25/251 (9%)
Query: 491 TPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTD------VAIKIFNLQLERAFRSF 544
P + Q + +LLG G+F VY+ T D D +K+ F
Sbjct: 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114
Query: 545 DSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSL----EKWLYSHNYFLDILER 600
E L+ +K S+ + LV E G+L + + +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 601 LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAH-----------VSDFGIS 649
++ + + +E +H IIH D+KP N +L + D G S
Sbjct: 175 ISFAMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFT 709
+ T T G+ E S + + D + + +
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 710 GEMSLRRWVKE 720
GE +
Sbjct: 291 GECKPEGLFRR 301
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 26/213 (12%)
Query: 509 LGTGSFGSVYKGTISDG------TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 561
LG FG VYKG + VAIK + F E + ++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMID 606
+L + +++ + +G L ++L L+ + ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
+ + +EYL SS ++H DL N+L+ + + +SD G+ + + + ++
Sbjct: 137 IAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
I +MAPE G S D++SYGV+L E F+
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 509 LGTGSFGSVYKGTI------SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLI 560
LG G+FG V + + VA+K+ R+ SE ++L ++ H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 561 KILSSCSNPDFKALV-LEFMPNGSLEKWLYSH---------------NYFLDILERLNIM 604
+L +C+ P +V +EF G+L +L S FL + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 605 IDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT 664
V +E+L +S IH DL NILL E + DFG+++ + + D V +
Sbjct: 155 FQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 665 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MAPE + + + + DV+S+GVLL E F+
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 51/229 (22%), Positives = 80/229 (34%), Gaps = 23/229 (10%)
Query: 484 PLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERA 540
L + P F + LG GS+G V+K DG A+K +
Sbjct: 40 TLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD 99
Query: 541 FRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE 599
+E V +H +++ + L E SL++ + L +
Sbjct: 100 RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQ 158
Query: 600 RLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659
+ D AL +LH ++H D+KP NI L + DFG+ L G
Sbjct: 159 VWGYLRDTLLALAHLHSQG----LVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGA 212
Query: 660 TQTMTMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
+ YMAPE YG+ DV+S G+ ++E
Sbjct: 213 GEVQE-GDPRYMAPELLQGSYGT------AADVFSLGLTILEVACNMEL 254
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 63/242 (26%), Positives = 96/242 (39%), Gaps = 61/242 (25%)
Query: 490 RTPYLDIQRATDEFNE----CNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSF 544
R L +T F E +LG G V + + A+KI ++ +F +
Sbjct: 2 RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 545 D---------SECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF 594
+ E ++LR V H N+I++ + F LV + M G L F
Sbjct: 62 EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL---------F 112
Query: 595 LDILER--------LNIMIDVGSALEYLH-HGHSSAPIIHCDLKPTNILLDENMAAHVSD 645
+ E+ IM + + LH I+H DLKP NILLD++M ++D
Sbjct: 113 DYLTEKVTLSEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTD 167
Query: 646 FGISKLLGEGEDSVTQTMTMA-TIGYMAPE------------YGSEGIVSAKCDVYSYGV 692
FG S L GE + + T Y+APE YG E D++S GV
Sbjct: 168 FGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGV 217
Query: 693 LL 694
++
Sbjct: 218 IM 219
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 34/221 (15%)
Query: 509 LGTGSFGSVYKGTISDG------TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIK 561
LG G FG V K T T VA+K+ R SE VL+ V H ++IK
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSH-----------------------NYFLDIL 598
+ +CS L++E+ GSL +L L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 599 ERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658
+ ++ + ++YL + ++H DL NIL+ E +SDFG+S+ + E +
Sbjct: 151 DLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
V ++ + +MA E + I + + DV+S+GVLL E T
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 509 LGTGSFGSVYKGTISD--------GTDVAIKIFN-LQLERAFRSFDSECEVLRNV-RHRN 558
LG G+FG V VA+K+ E+ SE E+++ + +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNI 603
+I +L +C+ +++E+ G+L ++L + + + ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 604 MIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM 663
+ +EYL +S IH DL N+L+ EN ++DFG+++ + + T
Sbjct: 163 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 664 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MAPE + + + + DV+S+GVL+ E FT
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 29/216 (13%)
Query: 509 LGTGSFGSVYKGTISD------GTDVAIKIFNLQ-LERAFRSFDSECEVLRNV-RHRNLI 560
LG G+FG V + T VA+K+ + SE +VL + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSH-----------------NYFLDILERLNI 603
+L +C+ ++ E+ G L +L LD+ + L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 604 MIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM 663
V + +L +S IH DL NILL + DFG+++ + + V +
Sbjct: 151 SYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 664 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MAPE + + + DV+SYG+ L E F+
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 45/215 (20%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN 558
F +LG+G+F V+ G A+K S ++E VL+ ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGSA 610
++ + + LV++ + G L F ILER ++ V SA
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL---------FDRILERGVYTEKDASLVIQQVLSA 118
Query: 611 LEYLH-HGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMTMA 666
++YLH +G I+H DLKP N+L +EN ++DFG+SK+ G T
Sbjct: 119 VKYLHENG-----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTAC 168
Query: 667 -TIGYMAPE------YGSEGIVSAKCDVYSYGVLL 694
T GY+APE Y D +S GV+
Sbjct: 169 GTPGYVAPEVLAQKPYSKA------VDCWSIGVIT 197
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 48/214 (22%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 507 NLLGTGSFGSVYKGTISD------GTDVAIKIFNLQ-LERAFRSFDSECEVLRNV-RHRN 558
LG G+FG V + T VA+K+ + SE +++ ++ +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH-------------NYFLDILERLNIMI 605
++ +L +C++ ++ E+ G L +L N + L+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 606 DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM 665
V + +L +S IH D+ N+LL A + DFG+++ + + + +
Sbjct: 172 QVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 666 ATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MAPE + + + + DV+SYG+LL E F+
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFN---LQLERAFRSFDSECEVLRNVRH 556
++F LG G FG+VY +A+K+ L+ E E+ ++RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
N++++ + L+LE+ P G++ + L + F + + ++ +AL Y H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHS 127
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM--TMATIGYMAPE 674
+IH D+KP N+LL ++DFG S S + T+ Y+ PE
Sbjct: 128 KR----VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDLCGTLD---YLPPE 177
Query: 675 YGSEGIVSAKCDVYSYGVLLME 696
+ K D++S GVL E
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYE 199
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-29
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 509 LGTGSFGSVYKGTI--------SDGTDVAIKIFN-LQLERAFRSFDSECEVLRNV-RHRN 558
LG G+FG V + T VA+K+ E+ SE E+++ + +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNI 603
+I +L +C+ +++E+ G+L ++L + L + ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 604 MIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM 663
V +EYL +S IH DL N+L+ E+ ++DFG+++ + + T
Sbjct: 197 AYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 664 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MAPE + I + + DV+S+GVLL E FT
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-29
Identities = 61/402 (15%), Positives = 126/402 (31%), Gaps = 51/402 (12%)
Query: 9 IGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLL 68
L L L ++++ + I ++ + L N ++ L + N+ L
Sbjct: 38 EEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNITT-LDLS---QNTNLTYLA 91
Query: 69 LAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSS 128
+N LT + +T TKL L+ N ++ L +L+ N LT
Sbjct: 92 CDSNKLTNL---DVTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCAR---NTLTE---- 141
Query: 129 ADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIG 188
+++ LT L N I + + L K+ + +
Sbjct: 142 -------IDVSHNTQLTELDCHLNKK--ITKLDVTPQT-QLTTLDCSFNKIT-ELD--VS 188
Query: 189 NLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTG 248
L L+ +N++ + + +L L +N L D+ L + +
Sbjct: 189 QNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSV 242
Query: 249 NKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQ 308
N L+ + +L+ L LH L + L Y + +V
Sbjct: 243 NPLT-ELDVS--TLSKLTTLHCIQTDLLEIDLTHNTQLIY-----FQAEGCRKIKELDVT 294
Query: 309 KLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSG 368
L +LD ++ ++ + L L L + + V L+SL
Sbjct: 295 HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVN 348
Query: 369 NNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSV 410
++ S+ + L + + + + ++
Sbjct: 349 AHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTI 388
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-25
Identities = 72/371 (19%), Positives = 122/371 (32%), Gaps = 53/371 (14%)
Query: 8 EIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESL 67
++ NL YL N L+ L + ++ + L + N+L+ P + L
Sbjct: 80 DLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT----KLDVSQNPLLTYL 132
Query: 68 LLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESS 127
A N LT I +++ T+L LD N L+ L N +T
Sbjct: 133 NCARNTLTEI---DVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITE--- 184
Query: 128 SADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEI 187
++ + L L+ +N + + + L KL I +
Sbjct: 185 --------LDVSQNKLLNRLNCDTNNITKL---DLNQNI-QLTFLDCSSNKLT-EID--V 229
Query: 188 GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247
L+ LT N L + L +L L +L I DL H + +
Sbjct: 230 TPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EI--DLTHNTQLIYFQAE 283
Query: 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV 307
G + + + T L L + +T S L Y+ L++ L L V
Sbjct: 284 GCRKIKELD--VTHNTQLYLLDCQAAGITELDLSQNPKLVYL---YLNNTELT-ELD--V 335
Query: 308 QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSL------ISL 361
L L + D S +G + L A Q +P+ + +S
Sbjct: 336 SHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTIT-MPKETLTNNSLTIAVSP 392
Query: 362 ESLDLSGNNLS 372
+ LD GN ++
Sbjct: 393 DLLDQFGNPMN 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 44/326 (13%), Positives = 95/326 (29%), Gaps = 42/326 (12%)
Query: 8 EIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESL 67
++ + L L N + + + + L N+++ V + L
Sbjct: 143 DVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITE---LDVSQN-KLLNRL 196
Query: 68 LLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESS 127
NN+T + + +L LD N + L + N LT
Sbjct: 197 NCDTNNITKL---DLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSV---NPLTELDV 250
Query: 128 SADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEI 187
S LT L L I + + + Q Y + ++
Sbjct: 251 S-----------TLSKLTTLHCIQTDLLEI------DLTHNTQLIYFQAEGCRKIKELDV 293
Query: 188 GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247
+ + L LL + + + + +L L L N L + D+ H + +
Sbjct: 294 THNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-EL--DVSHNTKLKSLSCV 347
Query: 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLS----SNSLNDSL 303
+ + + +L + + +L + + ++ + +
Sbjct: 348 NAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIE 405
Query: 304 PSNVQKLKVLTVLDLSRNQLSGDIPS 329
P + T ++ LS D P+
Sbjct: 406 PGDGGVYDQAT-NTITWENLSTDNPA 430
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 46/217 (21%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRH 556
+D ++ LG G+F V + + G + A KI N + R F+ + E + R ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVG 608
N++++ S F LV + + G L F DI+ R + + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQQIL 115
Query: 609 SALEYLH-HGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMT 664
++ Y H +G I+H +LKP N+LL + A ++DFG++ + + E
Sbjct: 116 ESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHG 166
Query: 665 MA-TIGYMAPE------YGSEGIVSAKCDVYSYGVLL 694
A T GY++PE Y D+++ GV+L
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 197
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 34/212 (16%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFN---LQLERAFRSFDS--------------ECEVL 551
L G F + D A+K + L+ +R F ++ E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 552 RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF-------LDILERLNIM 604
++++ + +N D ++ E+M N S+ K+ + I I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 605 IDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT 664
V ++ Y+H+ + I H D+KP+NIL+D+N +SDFG S+ + D + +
Sbjct: 158 KSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG-S 210
Query: 665 MATIGYMAPE--YGSEGIVSAKCDVYSYGVLL 694
T +M PE AK D++S G+ L
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 34/221 (15%)
Query: 509 LGTGSFGSVYKGTISDG------TDVAIKIFN-LQLERAFRSFDSECEVLRNVRHRNLIK 561
+G G+FG V++ T VA+K+ F E ++ + N++K
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSH-----------------------NYFLDIL 598
+L C+ L+ E+M G L ++L S L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 599 ERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658
E+L I V + + YL S +H DL N L+ ENM ++DFG+S+ + +
Sbjct: 175 EQLCIARQVAAGMAYL----SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
I +M PE + + DV++YGV+L E F+
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 509 LGTGSFGSVYKGTISD--------GTDVAIKIFN-LQLERAFRSFDSECEVLRNV-RHRN 558
LG G FG V VA+K+ E+ SE E+++ + +H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNI 603
+I +L +C+ +++E+ G+L ++L + + + ++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 604 MIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM 663
+ +EYL +S IH DL N+L+ EN ++DFG+++ + + T
Sbjct: 209 TYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 664 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ +MAPE + + + + DV+S+GVL+ E FT
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 50/225 (22%)
Query: 496 IQRATDEFNE----CNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSEC 548
+ A+ +F++ LG G+F V + + G + A KI N + R F+ + E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 549 EVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER-------- 600
+ R ++H N++++ S F LV + + G L F DI+ R
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADA 130
Query: 601 LNIMIDVGSALEYLH-HGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGE 656
+ + + ++ Y H +G I+H +LKP N+LL + A ++DFG++ + + E
Sbjct: 131 SHCIQQILESIAYCHSNG-----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185
Query: 657 DSVTQTMTMA-TIGYMAPE------YGSEGIVSAKCDVYSYGVLL 694
A T GY++PE Y D+++ GV+L
Sbjct: 186 ----AWHGFAGTPGYLSPEVLKKDPYSKP------VDIWACGVIL 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 67/266 (25%), Positives = 114/266 (42%), Gaps = 12/266 (4%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSF-DSECEVLRNVRHRN 558
D+F + + LG G+ G V+K + G +A K+ +L+++ A R+ E +VL
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFL-DILERLNIMIDVGSALEYLHHG 617
++ + + ++ +E M GSL++ L IL + + I V L YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--VSIAVIKGLTYLREK 150
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS 677
H I+H D+KP+NIL++ + DFG+S G+ DS+ + T YM+PE
Sbjct: 151 HK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFV-GTRSYMSPERLQ 203
Query: 678 EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737
S + D++S G+ L+E + P E+ L + T R
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 738 EQAFSAKMDCILSIMDLALDCCIESP 763
F ++I +L E P
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 42/225 (18%)
Query: 509 LGTGSFGSVYKGTISDG------TDVAIKIFNLQL-----ERAFRSFDSECEVLRNV-RH 556
LG+G+FG V T VA+K L + SE +++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVK----MLKEKADSSEREALMSELKMMTQLGSH 108
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH----------------------NYF 594
N++ +L +C+ L+ E+ G L +L S
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 595 LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654
L + L V +E+L +H DL N+L+ + DFG+++ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL----EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
+ V + + +MAPE EGI + K DV+SYG+LL E F+
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 44/211 (20%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFN--------LQLERAFRSFDSECEVLRNVRHRNL 559
LG+G+ G V VAIKI + + + ++E E+L+ + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSALEYLH-H 616
IKI + D+ +VLE M G L + + E + A++YLH +
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAVQYLHEN 133
Query: 617 GHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMTMA-TIGYMA 672
G IIH DLKP N+LL +E+ ++DFG SK+LGE T+ T Y+A
Sbjct: 134 G-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLA 184
Query: 673 PE---------YGSEGIVSAKCDVYSYGVLL 694
PE Y D +S GV+L
Sbjct: 185 PEVLVSVGTAGYNRA------VDCWSLGVIL 209
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-28
Identities = 37/261 (14%), Positives = 82/261 (31%), Gaps = 54/261 (20%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNL----------------QLERAFR-------- 542
+LG + + T G + + R R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 543 ----SFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM-PNGSLE---KWLYSH--- 591
F +++++ + + +I++ + + + +L+ + L SH
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 592 NYFLDILERLNIMIDVGSALEYLH-HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650
+ L RL + + V L LH +G ++H L+P +I+LD+ ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG-----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 651 LLGEGEDSVTQTMTMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLLMETFTRKRPTD 705
G S A A +++ D ++ G+ + + P
Sbjct: 260 RDGASAVSPI-GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP-- 316
Query: 706 EMFTGE--MSLRRWVKESLPH 724
T + + W+ S +
Sbjct: 317 --NTDDAALGGSEWIFRSCKN 335
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 50/208 (24%), Positives = 79/208 (37%), Gaps = 49/208 (23%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
+G GS+G V A K F E E+++++ H N+I++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGSALEYLH-HGH 618
+ LV+E G L F ++ + IM DV SA+ Y H
Sbjct: 77 DNTDIYLVMELCTGGEL---------FERVVHKRVFRESDAARIMKDVLSAVAYCHKLN- 126
Query: 619 SSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMTMATI----GYM 671
+ H DLKP N L + + DFG++ G+ M T Y+
Sbjct: 127 ----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-------MMRTKVGTPYYV 175
Query: 672 APE-----YGSEGIVSAKCDVYSYGVLL 694
+P+ YG E CD +S GV++
Sbjct: 176 SPQVLEGLYGPE------CDEWSAGVMM 197
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-28
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 42/210 (20%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFN--------LQLERAFRSFDSECEVLRNVRHRNL 559
LG+G+ G V VAI+I + + + ++E E+L+ + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--NIMIDVGSALEYLH-H 616
IKI + D+ +VLE M G L + + E + A++YLH +
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQMLLAVQYLHEN 258
Query: 617 GHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAP 673
G IIH DLKP N+LL +E+ ++DFG SK+LGE + +T+ T Y+AP
Sbjct: 259 G-----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTL-CGTPTYLAP 310
Query: 674 E---------YGSEGIVSAKCDVYSYGVLL 694
E Y D +S GV+L
Sbjct: 311 EVLVSVGTAGYNRA------VDCWSLGVIL 334
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 50/215 (23%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNL--------QLERAFRSFDSECEVLRNVR-HRN 558
+G G V + + G + A+KI + QLE + E +LR V H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL--------NIMIDVGSA 610
+I ++ S + F LV + M G L F + E++ +IM + A
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL---------FDYLTEKVALSEKETRSIMRSLLEA 212
Query: 611 LEYLH-HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATI- 668
+ +LH + I+H DLKP NILLD+NM +SDFG S L GE + +
Sbjct: 213 VSFLHANN-----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-------KLRELC 260
Query: 669 ---GYMAPE------YGSEGIVSAKCDVYSYGVLL 694
GY+APE + + D+++ GV+L
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 501 DEFNECNLLGTGSFGSVYKG-TISDGTDVAIKIFN---LQLERAFRSFDSECEVLRNVRH 556
D+F+ LG G FG+VY + +A+K+ L+ E E E+ ++RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
N++++ + + L+LEF P G L K L H F + M ++ AL Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHE 132
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM--TMATIGYMAPE 674
+IH D+KP N+L+ ++DFG S +TM T+ Y+ PE
Sbjct: 133 RK----VIHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRTMCGTLD---YLPPE 182
Query: 675 ------YGSEGIVSAKCDVYSYGVLLME 696
+ K D++ GVL E
Sbjct: 183 MIEGKTHD------EKVDLWCAGVLCYE 204
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 37/266 (13%), Positives = 82/266 (30%), Gaps = 63/266 (23%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNL----------------QLERAFRSFDSECEV 550
+LG + + T G + + R R ++ +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 551 LRNVR------------HRNLIKILSSCSNPDFKALVLEFM----PNGSLEKWLYSH--- 591
++R + +I++ + + + + + L SH
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 592 NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651
+ L RL + + V L LHH ++H L+P +I+LD+ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 652 LGEGEDSVTQTMTMATIGYMAPEY-----------GSEGIVSAKCDVYSYGVLLMETFTR 700
G S + G+ PE +++ D ++ G+++ +
Sbjct: 256 DGARVVSSV------SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 701 KRPTDEMFTGE--MSLRRWVKESLPH 724
P T + + W+ S +
Sbjct: 310 DLP----ITKDAALGGSEWIFRSCKN 331
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 51/210 (24%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFN--LQLERAFRSFDSECEVLRNVRHRNLIKILSS 565
LG GSFG V K + A+K+ N + + E E+L+ + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 566 CSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGSALEYLH-H 616
+ +V E G L F +I++R I+ V S + Y+H H
Sbjct: 90 LEDSSSFYIVGELYTGGEL---------FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 617 GHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMTMATI----G 669
I+H DLKP NILL +++ + DFG+S + M
Sbjct: 141 N-----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-------KMKDRIGTAY 188
Query: 670 YMAPE-----YGSEGIVSAKCDVYSYGVLL 694
Y+APE Y + CDV+S GV+L
Sbjct: 189 YIAPEVLRGTYDEK------CDVWSAGVIL 212
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 50/193 (25%), Positives = 93/193 (48%), Gaps = 14/193 (7%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFN---LQLERAFRSFDSECEVLRNVRHRNLIKIL 563
LLG GSF VY+ I G +VAIK+ + + + +E ++ ++H +++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPI 623
+ + ++ LVLE NG + ++L + E + M + + + YLH I
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG----I 133
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM--TMATIGYMAPEYGSEGIV 681
+H DL +N+LL NM ++DFG++ L + T+ T Y++PE +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQL-KMPHEKHYTLCGTPN---YISPEIATRSAH 189
Query: 682 SAKCDVYSYGVLL 694
+ DV+S G +
Sbjct: 190 GLESDVWSLGCMF 202
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 61/298 (20%), Positives = 107/298 (35%), Gaps = 50/298 (16%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSS 565
+L G F VY+ + G + A+K E R+ E ++ + H N+++ S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 566 CS-------NPDFKALVLEFMPNGSLEKWL--YSHNYFLDILERLNIMIDVGSALEYLHH 616
S + L+L + G L ++L L L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA---------- 666
PIIH DLK N+LL + DFG + + D A
Sbjct: 155 --QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 667 TIGYMAPE---YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP 723
T Y PE S + K D+++ G +L R+ P F LR
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKLR-------- 260
Query: 724 HGLTEVVDANLVR-EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780
+V+ ++ M L ++ P+ R+++ + +L++I
Sbjct: 261 -----IVNGKYSIPPHDTQYTVFHSLIRAM-LQVN-----PEERLSIAEVVHQLQEIA 307
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 45/193 (23%), Positives = 80/193 (41%), Gaps = 15/193 (7%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFN---LQLERAFRSFDSECEVLRNVRHRNLIKIL 563
LG G F ++ + A KI L E + R++ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPI 623
+ DF +VLE SL + + R + + +YLH +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR----V 136
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM--TMATIGYMAPEYGSEGIV 681
IH DLK N+ L+E++ + DFG++ + E + + + T Y+APE S+
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPN---YIAPEVLSKKGH 192
Query: 682 SAKCDVYSYGVLL 694
S + DV+S G ++
Sbjct: 193 SFEVDVWSIGCIM 205
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 49/219 (22%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFD-----SECEVLRN 553
T+E+ LG G+F V + + G + A I N + + D E + R
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIIN---TKKLSARDHQKLEREARICRL 66
Query: 554 VRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMI 605
++H N++++ S S L+ + + G L F DI+ R + +
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---------FEDIVAREYYSEADASHCIQ 117
Query: 606 DVGSALEYLH-HGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQ 661
+ A+ + H G ++H +LKP N+LL + A ++DFG++ + EGE
Sbjct: 118 QILEAVLHCHQMG-----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWF 171
Query: 662 TMTMATIGYMAPE------YGSEGIVSAKCDVYSYGVLL 694
T GY++PE YG D+++ GV+L
Sbjct: 172 GF-AGTPGYLSPEVLRKDPYGKP------VDLWACGVIL 203
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 45/193 (23%), Positives = 80/193 (41%), Gaps = 15/193 (7%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFN---LQLERAFRSFDSECEVLRNVRHRNLIKIL 563
LG G F ++ + A KI L E + R++ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPI 623
+ DF +VLE SL + + R + + +YLH +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR----V 162
Query: 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM--TMATIGYMAPEYGSEGIV 681
IH DLK N+ L+E++ + DFG++ + E + + + T Y+APE S+
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPN---YIAPEVLSKKGH 218
Query: 682 SAKCDVYSYGVLL 694
S + DV+S G ++
Sbjct: 219 SFEVDVWSIGCIM 231
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 53/236 (22%), Positives = 89/236 (37%), Gaps = 56/236 (23%)
Query: 492 PYLDIQRATDEFNE----CNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFD- 545
LD+ F + C ++G G F V + G A+KI ++ +
Sbjct: 11 GILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 546 ----SECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL 601
E + ++H +++++L + S+ +V EFM L +I++R
Sbjct: 71 EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRA 121
Query: 602 N------------IMIDVGSALEYLH-HGHSSAPIIHCDLKPTNILL---DENMAAHVSD 645
+ M + AL Y H + IIH D+KP +LL + + +
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNN-----IIHRDVKPHCVLLASKENSAPVKLGG 176
Query: 646 FGISKLLGEGEDSVTQTMTMA-TIGYMAPE------YGSEGIVSAKCDVYSYGVLL 694
FG++ LGE T +MAPE YG DV+ GV+L
Sbjct: 177 FGVAIQLGESGLVAG---GRVGTPHFMAPEVVKREPYGKP------VDVWGCGVIL 223
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-27
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 491 TPYLDIQRATDEFNEC----NLLGTGSFGSVYKGT-ISDGTDVAIKIFN---LQLERAFR 542
TP + +Q +T F++ +LG GSFG V G + A+K+ + ++ +
Sbjct: 12 TPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 71
Query: 543 SFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL- 601
S E ++L+ + H N++K+ + + LV E G L + S F E
Sbjct: 72 SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF---SEVDA 128
Query: 602 -NIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGED 657
I+ V S + Y+H I+H DLKP N+LL ++ + DFG+S +
Sbjct: 129 ARIIRQVLSGITYMH----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 658 SVTQTMTMATIGYMAPE-----YGSEGIVSAKCDVYSYGVLL 694
+ T Y+APE Y KCDV+S GV+L
Sbjct: 185 MKDKI---GTAYYIAPEVLHGTYDE------KCDVWSTGVIL 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 40/206 (19%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFN-LQLERAFRSFDSECEVLRNVRHRNLIKILSSC 566
LG+G+FG V+ S G + IK N + + ++E EVL+++ H N+IKI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 567 SNPDFKALVLEFMPNGSL-----EKWLYSHNYFLDILER--LNIMIDVGSALEYLH-HGH 618
+ +V+E G L E +M + +AL Y H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKAL----SEGYVAELMKQMMNALAYFHSQH- 144
Query: 619 SSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMTMA--TIGYMAP 673
++H DLKP NIL + + DFG+++L + T A T YMAP
Sbjct: 145 ----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-----EHSTNAAGTALYMAP 195
Query: 674 E-----YGSEGIVSAKCDVYSYGVLL 694
E + CD++S GV++
Sbjct: 196 EVFKRDVTFK------CDIWSAGVVM 215
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 26/254 (10%), Positives = 59/254 (23%), Gaps = 46/254 (18%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFN---LQLERAFRSFDSECEVLRNVRHRNLIKIL 563
L G V+ + D A+K+F + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 564 SSC----------------------SNPDFKA----LVLEFM-----PNGSLEKWLYSHN 592
D+ L++ S ++Y
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 593 YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652
IL + + L ++H P N+ + + + D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 653 GEGEDSVTQTMTMATIGYMAPEY--GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG 710
G + + Y E+ S + + + G+ + + P + G
Sbjct: 245 GT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 711 EMSLRRWVKESLPH 724
+ +P
Sbjct: 300 IKGSWKRPSLRVPG 313
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 57/299 (19%), Positives = 109/299 (36%), Gaps = 38/299 (12%)
Query: 112 LSLLSQVMNNLTTESSSADQ------WSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNF 165
+S++ + NN + +S + S+ + N +L + N
Sbjct: 1 MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN- 59
Query: 166 SASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNN 225
+ L ++P + +T+L + N L ++ L+ L +N
Sbjct: 60 --QFSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASLEYL---DACDN 110
Query: 226 NLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWS 285
L ++P LK + + N+L+ +P L ++ +N+LT +P S
Sbjct: 111 RLS-TLPELPASLKHL---DVDNNQLT-MLPE---LPALLEYINADNNQLTM-LPELPTS 161
Query: 286 LEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLET----LS 341
LE + ++ +N L LP + L LD+S N L +P+ E
Sbjct: 162 LEVL---SVRNNQLT-FLPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFR 213
Query: 342 LARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400
N+ IPE++ SL ++ L N LS +I +SL + ++
Sbjct: 214 CRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 7e-20
Identities = 56/364 (15%), Positives = 104/364 (28%), Gaps = 46/364 (12%)
Query: 12 LQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAA 71
+ L NLS L P + + +L + N L LP L E L
Sbjct: 58 INQFSELQLNRLNLSSL-PDNLP--PQITVLEITQNALI-SLPELPASL----EYLDACD 109
Query: 72 NNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQ 131
N L+ +P + L LD+ N + L +++ + N LT
Sbjct: 110 NRLS-TLPELPAS---LKHLDVDNNQLT-MLPELPALLEYINADN---NQLTMLPEL--- 158
Query: 132 WSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLS 191
+L +LS +N L LP + + L+ L+ ++P
Sbjct: 159 ---------PTSLEVLSVRNNQLTF-LPELPES----LEALDVSTNLLE-SLPAVPVRNH 203
Query: 192 GLT----LLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247
N + I + L + L +N L I L
Sbjct: 204 HSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPD--YH 260
Query: 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV 307
G ++ + + + + S + + + + +N+ + L +
Sbjct: 261 GPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL-DRL 319
Query: 308 QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLS 367
R Q++ + + L L ES ++L +L
Sbjct: 320 SDTVSARNTSGFREQVA----AWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLR 375
Query: 368 GNNL 371
L
Sbjct: 376 KTLL 379
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 1e-18
Identities = 59/366 (16%), Positives = 116/366 (31%), Gaps = 48/366 (13%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+P + + L +N L L P + + L N+LS LP L +
Sbjct: 73 SLPDNLP--PQITVLEITQNALISL-PELPAS---LEYLDACDNRLS-TLPE----LPAS 121
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
++ L + N LT ++P L ++ N + +L LS+ + N LT
Sbjct: 122 LKHLDVDNNQLT-MLPELPAL---LEYINADNNQL-TMLPELPTSLEVLSVRN---NQLT 173
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIG---NFSASLQKFYAYECKLK 180
L L +L L +N L LP V + + F E ++
Sbjct: 174 F----------LPEL--PESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT 220
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
+IP+ I +L + L N L+ I ++ + S +
Sbjct: 221 -HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRP 279
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + + + E +N ++ + ++ +
Sbjct: 280 LADAVTAW--FPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNT-----SGFR 332
Query: 301 DSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIG-----ALKDLETLSLARNQFQGPIPESV 355
+ + + ++KL L ++ D + +L L +G
Sbjct: 333 EQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDT 392
Query: 356 GSLISL 361
G+L+SL
Sbjct: 393 GALLSL 398
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 41/264 (15%)
Query: 465 MYKRCRNRSTKHLDHEDFLPLATWRRTPYLDIQRATDEFNEC----NLLGTGSFGSVYKG 520
M+ + S + E+ + TP + I +E LG+G++G V
Sbjct: 1 MHHHHHHSSGR----ENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLC 56
Query: 521 T-ISDGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577
+ AIKI + E VL+ + H N++K+ + LV+E
Sbjct: 57 RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116
Query: 578 FMPNGSLEKWLYSHNYFLDILER--LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL 635
G L + F E I+ V S + YLH I+H DLKP N+LL
Sbjct: 117 CYKGGELFDEIIHRMKF---NEVDAAVIIKQVLSGVTYLH----KHNIVHRDLKPENLLL 169
Query: 636 ---DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE-----YGSEGIVSAKCDV 687
+++ + DFG+S + + + + T Y+APE Y KCDV
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKMKER---LGTAYYIAPEVLRKKYDE------KCDV 220
Query: 688 YSYGVLLMETFTRKRPTDEMFTGE 711
+S GV+L P F G+
Sbjct: 221 WSIGVILFILLAGYPP----FGGQ 240
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 16/227 (7%)
Query: 476 HLDHEDFLPLATWRRTPYLDIQRATDEFNE----CNLLGTGSFGSVYKGT-ISDGTDVAI 530
++ D W++ ++ + LG+G+FG V++ + G
Sbjct: 22 KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81
Query: 531 KIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYS 590
K N + +E ++ + H LI + + + L+LEF+ G L + +
Sbjct: 82 KFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA 141
Query: 591 HNYFLDILERLNIMIDVGSALEYLH-HGHSSAPIIHCDLKPTNILLDENMAAHV--SDFG 647
+Y + E +N M L+++H H I+H D+KP NI+ + A+ V DFG
Sbjct: 142 EDYKMSEAEVINYMRQACEGLKHMHEHS-----IVHLDIKPENIMCETKKASSVKIIDFG 196
Query: 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 694
++ L E +T AT + APE V D+++ GVL
Sbjct: 197 LATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL-ERAFRSFDSECEV-LRNVRHR 557
++ + +G G++GSV K G +A+K + E+ + + +V +R+
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLD---ILERL--NIMIDVGSALE 612
+++ + + +E M + S +K Y + Y + I E + I + AL
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDK-FYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
+L IIH D+KP+NILLD + + DFGIS G+ DS+ +T YMA
Sbjct: 140 HLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMA 193
Query: 673 PE----YGSEGIVSAKCDVYSYGVLLME 696
PE S + DV+S G+ L E
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRH 556
+ +N +LG GSFG V K + A+K+ N + + E E+L+ + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGSALEYL 614
N++K+ + +V E G L + F E I+ V S + Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVFSGITYM 137
Query: 615 HHGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYM 671
H I+H DLKP NILL +++ + DFG+S + + + T Y+
Sbjct: 138 H----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYI 190
Query: 672 APE-----YGSEGIVSAKCDVYSYGVLL 694
APE Y KCDV+S GV+L
Sbjct: 191 APEVLRGTYDE------KCDVWSAGVIL 212
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 66/342 (19%), Positives = 116/342 (33%), Gaps = 58/342 (16%)
Query: 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFA 99
R++ L ++P L P+ L L N +T I N L L L N +
Sbjct: 34 RVVQCSDLGLE-KVPK---DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 100 GHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILP 159
F L L L N L + L L N + +
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLKELPEKM----P-------KTLQELRVHENEITKVRK 138
Query: 160 PVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDL-NGTISP-TMGRLKRL 217
F+ L+ + ++ L +N L + I +K+L
Sbjct: 139 ---SVFN----------------------GLNQMIVVELGTNPLKSSGIENGAFQGMKKL 173
Query: 218 QGLSLRNNNLEGSIPYDL-CHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKL 275
+ + + N+ +IP L L + L GNK++ + L L +L +L L N +
Sbjct: 174 SYIRIADTNIT-TIPQGLPPSLTE---LHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSI 228
Query: 276 TSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSG------DIPS 329
++ SL + ++ +++L++N L +P + K + V+ L N +S P
Sbjct: 229 SAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 287
Query: 330 TIGALKDLETLSLARNQFQ-GPIPESV-GSLISLESLDLSGN 369
+SL N Q I S + ++ L
Sbjct: 288 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 21/225 (9%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRNNNLEGSIP----YDLCH 237
+P+++ LL L +N + I LK L L L NN + I L
Sbjct: 46 VPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVK 101
Query: 238 LKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSN 297
L+ + L+ N+L +P + +L+EL + N++T S L ++ + L +N
Sbjct: 102 LER---LYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 155
Query: 298 SLNDS-LPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV 355
L S + + Q +K L+ + ++ ++ IP G L L L N+ S+
Sbjct: 156 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASL 212
Query: 356 GSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400
L +L L LS N++S SL L++ ++++N+L ++P
Sbjct: 213 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-23
Identities = 62/352 (17%), Positives = 115/352 (32%), Gaps = 79/352 (22%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
+P ++ + L N ++ + N+ + L L N++S ++ L +
Sbjct: 46 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKL 102
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTT 124
E L L+ N L + L+ L + N +T
Sbjct: 103 ERLYLSKNQLKELPE------------------------KMPKTLQELRVHE---NEITK 135
Query: 125 ESSSADQWSFLSSLTNCRNLTILSFGSNPLGGI-LPPVIGNFSASLQKFYAYECKLKGNI 183
S + ++ G+NPL + G F
Sbjct: 136 VRKSV--------FNGLNQMIVVELGTNPLKSSGIEN--GAFQ----------------- 168
Query: 184 PQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFG 243
+ L+ + + ++ TI + L L L N + L L +
Sbjct: 169 -----GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAK 220
Query: 244 IRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDS 302
+ L+ N +S + L + LRELHL +NKL +P L +YI + L +N+++ +
Sbjct: 221 LGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-A 277
Query: 303 LPSNV-------QKLKVLTVLDLSRNQLSGDI--PSTIGALKDLETLSLARN 345
+ SN K + + L N + PST + + L
Sbjct: 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 56/279 (20%), Positives = 97/279 (34%), Gaps = 37/279 (13%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLA 70
NL+NL L+ N +S + P + + L L NQL LP + ++ L +
Sbjct: 74 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE---KMPKTLQELRVH 129
Query: 71 ANNLTGIIPHSITNATKLVALDLGFNSFAGHIL--NTFGNLRHLSLLSQVMNNLTTESSS 128
N +T + +++ ++LG N + F ++ LS + N+TT
Sbjct: 130 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG 189
Query: 129 ADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIG 188
+LT L N + + + + +L K L N +
Sbjct: 190 L-----------PPSLTELHLDGNKITKVDAASLKGLN-NLAKLG-----LSFNSISAVD 232
Query: 189 -----NLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEG------SIPYDLCH 237
N L L L++N L + + K +Q + L NNN+ P
Sbjct: 233 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTK 291
Query: 238 LKLMFGIRLTGNKLSGH-IPPCL-VSLTSLRELHLGSNK 274
G+ L N + I P + + LG+ K
Sbjct: 292 KASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 24/95 (25%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 313 LTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS 372
L V+ S L +P + D L L N+ +L +L +L L N +S
Sbjct: 33 LRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 373 GKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKN 407
P + L +L++ +S N+L+ E+P + K
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELP-EKMPKT 122
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN 558
+ +G GS G V G VA+K+ +L+ ++ +E ++R+ +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGSA 610
++++ S + +++EF+ G+L DI+ RLN + V A
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAVLQA 153
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG- 669
L YLH +IH D+K +ILL + +SDFG + V + ++ +G
Sbjct: 154 LAYLHAQG----VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGT 204
Query: 670 --YMAPEYGSEGIVSAKCDVYSYGVLLME 696
+MAPE S + + + D++S G++++E
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-26
Identities = 51/236 (21%), Positives = 93/236 (39%), Gaps = 16/236 (6%)
Query: 467 KRCRNRSTKHLDHEDFLPLATWRRTPYLDIQRATDEFNE----CNLLGTGSFGSVYKGT- 521
+ + D W++ ++ D + LGTG+FG V++ T
Sbjct: 119 GKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTE 178
Query: 522 ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPN 581
+ G + A K E + E + + +RH L+ + + + + ++ EFM
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-HGHSSAPIIHCDLKPTNILLDENMA 640
G L + + + + E + M V L ++H + +H DLKP NI+ +
Sbjct: 239 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN-----YVHLDLKPENIMFTTKRS 293
Query: 641 AHV--SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 694
+ DFG++ L + +T T + APE V D++S GVL
Sbjct: 294 NELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-26
Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 44/252 (17%)
Query: 471 NRSTKHLDHEDFLPLATWRRTPYLDIQRATDEFNEC----NLLGTGSFGSVYKGT-ISDG 525
+ H + L P + +++ + E LG+G++G V +
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 526 TDVAIKI-------------FNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK 572
++ AIK+ N +E+ +E +L+++ H N+IK+ + +
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 573 ALVLEFMPNGSLEKWLYSHNYFLDILER--LNIMIDVGSALEYLHHGHSSAPIIHCDLKP 630
LV EF G L + + + + F E NIM + S + YLH I+H D+KP
Sbjct: 122 YLVTEFYEGGELFEQIINRHKF---DECDAANIMKQILSGICYLH----KHNIVHRDIKP 174
Query: 631 TNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE-----YGSEGIVS 682
NILL + + + DFG+S + + + T Y+APE Y
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTAYYIAPEVLKKKYNE----- 226
Query: 683 AKCDVYSYGVLL 694
KCDV+S GV++
Sbjct: 227 -KCDVWSCGVIM 237
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-26
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 47/216 (21%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVL-RNVRHR 557
TD + +G GS+ + + + A+KI + E E+L R +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHP 76
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--------IMIDVGS 609
N+I + + + +V E M G L IL + ++ +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGEL---------LDKILRQKFFSEREASAVLFTITK 127
Query: 610 ALEYLH-HGHSSAPIIHCDLKPTNILL---DENMAA-HVSDFGISKLLGEGEDSVTQTMT 664
+EYLH G ++H DLKP+NIL N + + DFG +K L E+ + T
Sbjct: 128 TVEYLHAQG-----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTP- 180
Query: 665 MATIGYMAPE------YGSEGIVSAKCDVYSYGVLL 694
T ++APE Y + CD++S GVLL
Sbjct: 181 CYTANFVAPEVLERQGYDAA------CDIWSLGVLL 210
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN 558
++ +G G+ G+VY ++ G +VAI+ NLQ + +E V+R ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGSA 610
++ L S D +V+E++ GSL D++ ++ + + A
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSL----------TDVVTETCMDEGQIAAVCRECLQA 128
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA-TIG 669
LE+LH +IH D+K NILL + + ++DFG + ++ TM T
Sbjct: 129 LEFLHSNQ----VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPY 181
Query: 670 YMAPEYGSEGIVSAKCDVYSYGVLLME 696
+MAPE + K D++S G++ +E
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 38/211 (18%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSS 565
+LG G+ V + + A+KI Q E E+L + HRN+++++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 566 CSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--------IMIDVGSALEYLH-H 616
D LV E M GS+ I +R + ++ DV SAL++LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSI---------LSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 617 GHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGED-SVTQTMTMATI---- 668
G I H DLKP NIL ++ + DF + + D S T + T
Sbjct: 131 G-----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 669 GYMAPE-----YGSEGIVSAKCDVYSYGVLL 694
YMAPE I +CD++S GV+L
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 61/271 (22%), Positives = 97/271 (35%), Gaps = 60/271 (22%)
Query: 476 HLDHEDFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFN 534
H H ++ L++ +++ +G GS+G V AIKI N
Sbjct: 4 HHHHSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 535 LQLERAFRSFD-----SECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSL----- 584
R D +E +++ + H N+ ++ + + LV+E G L
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 585 --------------------------------EKWLYSHNYFLDILERL--NIMIDVGSA 610
+ + E+L NIM + SA
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 611 LEYLH-HGHSSAPIIHCDLKPTNILL--DENMAAHVSDFGISKLLGEGEDSVTQTMTMA- 666
L YLH G I H D+KP N L +++ + DFG+SK + + MT
Sbjct: 181 LHYLHNQG-----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 667 -TIGYMAPE--YGSEGIVSAKCDVYSYGVLL 694
T ++APE + KCD +S GVLL
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERA-FRSFDSECEV-LRNVRHR 557
D+ LG G++G V K + G +A+K + + + ++ +R V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLD--ILERL--NIMIDVGSALEY 613
+ + + +E M + SL+K Y I E + I + + ALE+
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAP 673
LH S +IH D+KP+N+L++ + DFGIS G D V + + YMAP
Sbjct: 125 LHSKLS---VIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGCKPYMAP 178
Query: 674 E----YGSEGIVSAKCDVYSYGVLLME 696
E ++ S K D++S G+ ++E
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 82/431 (19%), Positives = 139/431 (32%), Gaps = 50/431 (11%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+P ++ + L ++N++S L P I +S +R+L L N++ L V +
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFA----GHILNTFGNLRHLSL----- 114
+E L ++ N L I S L LDL FN F L L L
Sbjct: 102 LEYLDVSHNRLQNI---SCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 115 ----------LSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGN 164
L L S S + L F N L + + N
Sbjct: 159 RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN 218
Query: 165 FSASLQ----KFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRL---KRL 217
LQ K C+ E+ L ++L + S + + + +
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278
Query: 218 QGLSLRNNNLEGSIP-----YDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGS 272
+ L++ N + I Y LK + + + L
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338
Query: 273 NKLTS---SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPS 329
+ P S S + +N + N DS+ LK L L L RN L +
Sbjct: 339 SDTPFIHMVCPPSPSSFTF---LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 330 TIGALKDLETLSLARNQFQ----GPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQL 385
K++ +L + S+ L+LS N L+G + + L ++
Sbjct: 395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKV 452
Query: 386 KQFNVSHNRLE 396
K ++ +NR+
Sbjct: 453 KVLDLHNNRIM 463
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 71/410 (17%), Positives = 136/410 (33%), Gaps = 21/410 (5%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLA 70
Q+L+YL + N L + +++R L L N L + L L+
Sbjct: 98 FNQDLEYLDVSHNRLQNI-SCCPM--ASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLS 154
Query: 71 ANNLTGIIPHSITN-ATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSA 129
A + + + + LDL G + + ++L V + + S
Sbjct: 155 AAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQV 213
Query: 130 DQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIP-QEIG 188
+ N+ + L L + + E K ++ +
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273
Query: 189 NLSGLTLLSLHSNDLNGTISPTMGR-----LKRLQGLSLRNNNLEGSIPYDLCHLKLMFG 243
+ L++++ + I LK L ++N S M
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 244 IRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSL 303
L+ + C S +S L+ N T S+ +L+ + + L N L +
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-KNF 392
Query: 304 PSNVQKLKVLTVLDLSRNQL----SGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLI 359
K ++ L+ L S T + + L+L+ N G + +
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP-- 450
Query: 360 SLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
++ LDL N + IPK + L L++ NV+ N+L+ +P G F +
Sbjct: 451 KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP-DGVFDRLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-19
Identities = 61/356 (17%), Positives = 113/356 (31%), Gaps = 41/356 (11%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLS----GRLPSTVGH 59
TE + N L + S +++ + L L +L+ RL + +
Sbjct: 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSE 244
Query: 60 LLPNIESLLLAANNLTGIIPH-----SITNATKLVALDLGFNSFAGHILNTFGNLRHLSL 114
L L + ++ + L++ + I +L
Sbjct: 245 LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL 304
Query: 115 LSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYA 174
S ++ ++ + + + S + I + I + S S
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAE---MNIKMLSISDTPFIHMVCPPSPS-SFTFLNF 360
Query: 175 YECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYD 234
+ ++ Q L L L L N L K + L + +L
Sbjct: 361 TQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSL------- 412
Query: 235 LCHLKLMFGIRLTGNKLSGHIPPCLVSL-TSLRELHLGSNKLTSSIPSSLWSLEYILDIN 293
N L+ H + S+ L+L SN LT S+ L +LD
Sbjct: 413 --------------NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLD-- 456
Query: 294 LSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP-STIGALKDLETLSLARNQFQ 348
L +N + S+P +V L+ L L+++ NQL +P L L+ + L N +
Sbjct: 457 LHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 44/245 (17%), Positives = 89/245 (36%), Gaps = 20/245 (8%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPT-MGRLKRLQGLSLRNNNLEGSIPYDLC-HLKL 240
+P+++ LSL N ++ + + L L+ L L +N + S+ + + +
Sbjct: 46 VPKDL--PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIP-----SSLWSLEYILDINLS 295
+ + ++ N+L +I C + SLR L L N +P +L L ++ LS
Sbjct: 102 LEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDV-LPVCKEFGNLTKLTFL---GLS 154
Query: 296 SNSLNDSLPSNVQKLKVLTV-LDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPES 354
+ V L + + LDL + G ++ L L + +
Sbjct: 155 AAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-TTVLHLVFHPNSLFSVQV 213
Query: 355 VGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFF 414
S+ +L L LS L+ + + L T + + + + + FF
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273
Query: 415 GNYAL 419
+
Sbjct: 274 WPRPV 278
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 49/208 (23%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSC 566
LG GSF K A+KI + ++E + E L+ H N++K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN--------IMIDVGSALEYLH-HG 617
+ LV+E + G L F I ++ + IM + SA+ ++H G
Sbjct: 76 HDQLHTFLVMELLNGGEL---------FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 618 HSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMTMA--TIGYMA 672
++H DLKP N+L ++N+ + DFG ++L Q + T+ Y A
Sbjct: 127 -----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD----NQPLKTPCFTLHYAA 177
Query: 673 PE------YGSEGIVSAKCDVYSYGVLL 694
PE Y CD++S GV+L
Sbjct: 178 PELLNQNGYDES------CDLWSLGVIL 199
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 46/207 (22%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC 566
LG G+ VY+ A+K+ +++ +E VL + H N+IK+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK--IVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGSALEYLH-HG 617
P +LVLE + G L F I+E+ + + + A+ YLH +G
Sbjct: 118 ETPTEISLVLELVTGGEL---------FDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 618 HSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMTMA-TIGYMAP 673
I+H DLKP N+L + ++DFG+SK++ T+ T GY AP
Sbjct: 169 -----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYCAP 219
Query: 674 E------YGSEGIVSAKCDVYSYGVLL 694
E YG E D++S G++
Sbjct: 220 EILRGCAYGPE------VDMWSVGIIT 240
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 38/216 (17%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN 558
+ + LG G+FG VYK G A K+ + E + E E+L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVG 608
++K+L + + +++EF P G++ I+ L+ + +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAV----------DAIMLELDRGLTEPQIQVVCRQML 127
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
AL +LH IIH DLK N+L+ ++DFG+S + ++ + + I
Sbjct: 128 EALNFLHSKR----IIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSF--I 178
Query: 669 G---YMAPE-----YGSEGIVSAKCDVYSYGVLLME 696
G +MAPE + K D++S G+ L+E
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 11/231 (4%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLE--GSIPYDLCHLKL 240
+P I S T L L SN L +L +L LSL +N L G
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSL-WSLEYILDINLSSNSL 299
+ + L+ N + + + L L L + L S+ SL ++ +++S
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 300 NDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTI-GALKDLETLSLARNQFQGPIPESVGS 357
+ + L L VL ++ N + I L++L L L++ Q + P + S
Sbjct: 139 R-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
Query: 358 LISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNF 408
L SL+ L++S NN + L+ L+ + S N + K ++F
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSK-KQELQHF 246
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 50/275 (18%), Positives = 88/275 (32%), Gaps = 44/275 (16%)
Query: 104 NTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIG 163
+ L L S N L + LT LS SN L
Sbjct: 25 GIPSSATRLELES---NKLQSLPHGV--------FDKLTQLTKLSLSSNGLSFKGCC--- 70
Query: 164 NFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLR 223
Q + L L L N + T+S L++L+ L +
Sbjct: 71 --------------------SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQ 109
Query: 224 NNNLEGSIPYDL-CHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPS 281
++NL+ + + L+ + + ++ L+SL L + N +
Sbjct: 110 HSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
Query: 282 SLWS-LEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLET 339
+++ L + ++LS L + L L L VL++S N L L+
Sbjct: 169 DIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227
Query: 340 LSLARNQFQGPIPESV--GSLISLESLDLSGNNLS 372
L + N + SL L+L+ N+ +
Sbjct: 228 LDYSLNHIMT-SKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 58/313 (18%), Positives = 94/313 (30%), Gaps = 69/313 (22%)
Query: 42 LTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFN--SFA 99
+ L+ +P+ + + L L +N L + T+L L L N SF
Sbjct: 12 IRCNSKGLT-SVPT---GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 100 GHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILP 159
G + L L N + T S S+ L L F + L +
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVITMS---------SNFLGLEQLEHLDFQHSNLKQMSE 118
Query: 160 PVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQ 218
F +L L L + + L L+
Sbjct: 119 F--SVFL----------------------SLRNLIYLDISHTHTR-VAFNGIFNGLSSLE 153
Query: 219 GLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSS 278
L + N+ + + D+ L +L L L +L
Sbjct: 154 VLKMAGNSFQENFLPDI-----------------------FTELRNLTFLDLSQCQLEQL 190
Query: 279 IPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTI--GALK 335
P++ SL + +N+S N+ SL + + L L VLD S N +
Sbjct: 191 SPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPS 248
Query: 336 DLETLSLARNQFQ 348
L L+L +N F
Sbjct: 249 SLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 57/302 (18%), Positives = 93/302 (30%), Gaps = 66/302 (21%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGR-LPSTVGHLL 61
+PT I + L N L L P +F ++ + L+L N LS + S
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSL-PHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 62 PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAG-HILNTFGNLRHLSLLSQVMN 120
+++ L L+ N + + + +L LD ++ + F +LR+L L
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+ + +L +L N P F+
Sbjct: 137 HTRVAFNGI--------FNGLSSLEVLKMAGNSFQENFLP--DIFT-------------- 172
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
L LT L L L +SP L LQ L++ +NN S+
Sbjct: 173 --------ELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFP---- 218
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYIL-DINLSSNS 298
L SL+ L N + +S L L +NL+ N
Sbjct: 219 -------------------YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 259
Query: 299 LN 300
Sbjct: 260 FA 261
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 44/227 (19%), Positives = 87/227 (38%), Gaps = 25/227 (11%)
Query: 498 RATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNV 554
R T EF+E +G+G FGSV+K DG AIK L ++ E +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 555 -RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL---ERLNIMIDVGSA 610
+H ++++ S+ + D + E+ GSL + + + E ++++ VG
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV----------T 660
L Y+H ++H D+KP+NI + + + + +
Sbjct: 128 LRYIHSMS----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 661 QTMTMATIG---YMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRP 703
+ G ++A E E K D+++ + ++ +
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 502 EFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
++ +LG G FG V+K + G +A KI + + +E V+ + H NLI
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH-HGHS 619
++ + + + LV+E++ G L + +Y L L+ + M + + ++H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY-- 207
Query: 620 SAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS 677
I+H DLKP NIL A + DFG+++ E + T ++APE +
Sbjct: 208 ---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVN 261
Query: 678 EGIVSAKCDVYSYGVLL 694
VS D++S GV+
Sbjct: 262 YDFVSFPTDMWSVGVIA 278
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 65/362 (17%), Positives = 111/362 (30%), Gaps = 73/362 (20%)
Query: 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFA 99
R++ L +P + P+ L L N+++ + L AL L N +
Sbjct: 36 RVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 100 GHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILP 159
F LR L L N+L + +L L N + +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLVEIPPNL----P-------SSLVELRIHDNRIRKVPK 140
Query: 160 PVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDL-NGTISPTMGRLKRLQ 218
G FS L + + + N L N P +L
Sbjct: 141 ---GVFS----------------------GLRNMNCIEMGGNPLENSGFEPGAFDGLKLN 175
Query: 219 GLSLRNNNLEG---SIPYDLCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNK 274
L + L G +P L L L NK+ I L+ + L L LG N+
Sbjct: 176 YLRISEAKLTGIPKDLPETLNEL------HLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQ 228
Query: 275 LTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGAL 334
+ SL L + +++L +N L +P+ + LK+L V+ L N ++
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNIT---------- 277
Query: 335 KDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKI--PKSLETLSQLKQFNVSH 392
+ N F + L N + P + ++ +
Sbjct: 278 ------KVGVNDFCPVGFGV--KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN 329
Query: 393 NR 394
+
Sbjct: 330 YK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 57/225 (25%), Positives = 89/225 (39%), Gaps = 22/225 (9%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRNNNLEGSIP----YDLCH 237
+P+EI TLL L +ND++ + L+ L L L NN + I L
Sbjct: 48 VPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRK 103
Query: 238 LKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSN 297
L+ + ++ N L IPP L +SL EL + N++ L + I + N
Sbjct: 104 LQK---LYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN 157
Query: 298 SLNDS-LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV- 355
L +S L L +S +L+ IP + L L L N+ Q I
Sbjct: 158 PLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQA-IELEDL 213
Query: 356 GSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400
L L L N + SL L L++ ++ +N+L +P
Sbjct: 214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 18/234 (7%)
Query: 189 NLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRNNNLEGSIPYDL-CHLKLMFGIRL 246
L L L L +N ++ I L++LQ L + N+L IP +L L +R+
Sbjct: 76 GLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVE---LRI 130
Query: 247 TGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSS-IPSSLWSLEYILDINLSSNSLNDSLP 304
N++ +P L ++ + +G N L +S + + + +S L +P
Sbjct: 131 HDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIP 188
Query: 305 SNVQKLKVLTVLDLSRNQLSGDIPS-TIGALKDLETLSLARNQFQGPIPESVGSLISLES 363
++ + L L L N++ I + L L L NQ + S+ L +L
Sbjct: 189 KDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE 245
Query: 364 LDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNY 417
L L N LS ++P L L L+ + N + ++ V F Y
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGV-NDFCPVGFGVKRAYY 296
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 54/279 (19%), Positives = 92/279 (32%), Gaps = 38/279 (13%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLA 70
LQ+L LV N +S + + ++ L + N L +P +L ++ L +
Sbjct: 76 GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP---NLPSSLVELRIH 131
Query: 71 ANNLTGIIPHSITNATKLVALDLGFNSFAGHIL--NTFGNLRHLSLLSQVMNNLTTESSS 128
N + + + + +++G N F L+ L+ L LT
Sbjct: 132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTGIPKD 190
Query: 129 ADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIG 188
L L N + I + +S L + L N + I
Sbjct: 191 L-----------PETLNELHLDHNKIQAIELEDLLRYS-KLYRLG-----LGHNQIRMIE 233
Query: 189 -----NLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF- 242
L L L L +N L+ + + LK LQ + L NN+ D C +
Sbjct: 234 NGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVK 292
Query: 243 -----GIRLTGNKLS-GHIPPCLVS-LTSLRELHLGSNK 274
GI L N + + P +T + G+ K
Sbjct: 293 RAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 69/355 (19%), Positives = 120/355 (33%), Gaps = 84/355 (23%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
+P EI + L N++S L + + L L N++S ++ L +
Sbjct: 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKL 104
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTT 124
+ L ++ N+L I P N +L L + N +
Sbjct: 105 QKLYISKNHLVEIPP------------------------NLPSSLVELRIHD---NRIRK 137
Query: 125 ESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIP 184
+ RN+ + G NPL N
Sbjct: 138 VPKGV--------FSGLRNMNCIEMGGNPL--------------------------ENSG 163
Query: 185 QEIGNLSGLTL--LSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIP-YDLCHLKLM 241
E G GL L L + L I + + L L L +N ++ +I DL +
Sbjct: 164 FEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKL 219
Query: 242 FGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + L N++ I L L +LRELHL +NKL+ +P+ L L+ + + L +N++
Sbjct: 220 YRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
Query: 301 DSLPSNV-------QKLKVLTVLDLSRNQLSGDI--PSTIGALKDLETLSLARNQ 346
+ N K + L N + P+T + D + +
Sbjct: 278 -KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 25/95 (26%), Positives = 36/95 (37%), Gaps = 5/95 (5%)
Query: 313 LTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS 372
L V+ S L +P I D L L N + L L +L L N +S
Sbjct: 35 LRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 373 GKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKN 407
K+ L +L++ +S N L EIP +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIP-PNLPSS 124
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 9/217 (4%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYD-LCHLKLM 241
+PQ I S L+L N++ + T L L+ L L N++ I L +
Sbjct: 69 VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASL 125
Query: 242 FGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ L N L+ IP L+ LREL L +N + S + + ++ ++L
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKL 184
Query: 301 DSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLI 359
+ + + L L L+L + D+P + L LE L ++ N F P S L
Sbjct: 185 EYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLS 242
Query: 360 SLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396
SL+ L + + +S + + L+ L + N++HN L
Sbjct: 243 SLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 54/212 (25%), Positives = 82/212 (38%), Gaps = 15/212 (7%)
Query: 189 NLSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRNNNLEGSIP----YDLCHLKLMFG 243
+L L +L L N + I L L L L +N L IP L L+
Sbjct: 97 HLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRE--- 151
Query: 244 IRLTGNKLSGHIPP-CLVSLTSLRELHLGS-NKLTSSIPSSLWSLEYILDINLSSNSLND 301
+ L N + IP + SL L LG KL + L + +NL ++
Sbjct: 152 LWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK- 209
Query: 302 SLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISL 361
+P+ + L L L++S N P + L L+ L + +Q + L SL
Sbjct: 210 DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268
Query: 362 ESLDLSGNNLSGKIPKSLETLSQLKQFNVSHN 393
L+L+ NNLS L L + ++ HN
Sbjct: 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-21
Identities = 61/293 (20%), Positives = 95/293 (32%), Gaps = 49/293 (16%)
Query: 62 PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNN 121
++ L+ + P I + T+ L+L N+ +TF +L HL +L N+
Sbjct: 54 NQFSKVVCTRRGLSEV-PQGIPSNTRY--LNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 122 LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKG 181
+ A +L L N L I G F
Sbjct: 111 IRQIEVGA--------FNGLASLNTLELFDNWLTVIPS---GAFE--------------- 144
Query: 182 NIPQEIGNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRNNNLEGSIP----YDLC 236
LS L L L +N + +I R+ L L L I L
Sbjct: 145 -------YLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLF 196
Query: 237 HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSS 296
+LK + L + +P L L L EL + N P S L + + + +
Sbjct: 197 NLKYL---NLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 297 NSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQ 348
+ + + N L L L+L+ N LS L+ L L L N +
Sbjct: 252 SQV-SLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 61/302 (20%), Positives = 97/302 (32%), Gaps = 71/302 (23%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
++P I N +YL ENN+ + T ++ + +L L N + ++ + L +
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLAS 124
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSF---AGHILNTFGNLRHLSLLSQVMN 120
+ +L L N LT I + +KL L L N + N +L L L +
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGE--LK 182
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
L S A NL L+ G + +
Sbjct: 183 KLEYISEGA--------FEGLFNLKYLNLGMCNI------------KDMPNL-------- 214
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
L GL L + N I P L L+ L + N+ +
Sbjct: 215 -------TPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS----------- 255
Query: 240 LMFGIRLTGNKLSGHIPPC-LVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNS 298
I L SL EL+L N L+S L Y+++++L N
Sbjct: 256 --------------LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNP 301
Query: 299 LN 300
N
Sbjct: 302 WN 303
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 15/204 (7%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL-ERAFRSFDSECEVL-RNVRHR 557
++ +G+G+ G V+K G +A+K + + + +V+ ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG 617
+++ + + +E M EK + + + + AL YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--- 674
H +IH D+KP+NILLDE + DFGIS G D + + YMAPE
Sbjct: 144 HG---VIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERID 197
Query: 675 --YGSEGIVSAKCDVYSYGVLLME 696
++ + DV+S G+ L+E
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVE 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN 558
+ F+ LG GS+GSVYK G VAIK + E + E +++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPH 85
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
++K S +V+E+ GS+ + N L E I+ LEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG---YMAPEY 675
IH D+K NILL+ A ++DFG++ L D++ + T+ IG +MAPE
Sbjct: 146 ----KIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAPEV 196
Query: 676 GSEGIVSAKCDVYSYGVLLME 696
E + D++S G+ +E
Sbjct: 197 IQEIGYNCVADIWSLGITAIE 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 35/214 (16%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFD------SECEVLR 552
D ++ LG+G F V K S G + A K + RA R E +LR
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 553 NVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIM 604
V H N+I + N L+LE + G L F + ++ + +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFI 121
Query: 605 IDVGSALEYLHHGHSSAPIIHCDLKPTNILL----DENMAAHVSDFGISKLLGEGEDSVT 660
+ + YLH I H DLKP NI+L + DFG++ + +G
Sbjct: 122 KQILDGVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---E 174
Query: 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 694
T ++APE + + + D++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 37/215 (17%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFD------SECEVLR 552
D ++ LG+G F V K S G + A K + RA R E +LR
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 553 NVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIM 604
V H N+I + N L+LE + G L F + ++ + +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFI 121
Query: 605 IDVGSALEYLH-HGHSSAPIIHCDLKPTNILL----DENMAAHVSDFGISKLLGEGEDSV 659
+ + YLH I H DLKP NI+L + DFG++ + +G
Sbjct: 122 KQILDGVNYLHTKK-----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--E 174
Query: 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 694
+ + T ++APE + + + D++S GV+
Sbjct: 175 FKNI-FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 45/202 (22%), Positives = 87/202 (43%), Gaps = 13/202 (6%)
Query: 497 QRATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR 555
+ +++ LG G FG V++ S K ++ E +L R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIAR 59
Query: 556 HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 615
HRN++ + S + + ++ EF+ + + + + + L+ E ++ + V AL++LH
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 616 -HGHSSAPIIHCDLKPTNILL--DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
H I H D++P NI+ + + +FG ++ L G+ + Y A
Sbjct: 120 SHN-----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYA 171
Query: 673 PEYGSEGIVSAKCDVYSYGVLL 694
PE +VS D++S G L+
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLV 193
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 50/277 (18%), Positives = 90/277 (32%), Gaps = 22/277 (7%)
Query: 138 LTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQ---EIGNLSGLT 194
R+L L + + S SL++ ++ I + +SGL
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 195 LLSLHSNDLNGTISPTMGRL--KRLQGLSLRNNNLEGSIPYDL----CHLKLMFGIRLTG 248
L+L + ++ GT P + L L+LRN + + + + +
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 249 NKLSGHIPPCLVSLTSLRELHLGSNKLTSSI-------PSSLWSLEYILDINLSSNSLND 301
+ +L L L N P +L+ + N + +
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218
Query: 302 SLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGA-LKDLETLSLARNQFQGPIPESVGSLIS 360
+ L LDLS N L + L +L+L+ + +P+ + +
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--K 275
Query: 361 LESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEG 397
L LDLS N L P E L Q+ ++ N
Sbjct: 276 LSVLDLSYNRLDR-NPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 48/263 (18%), Positives = 77/263 (29%), Gaps = 18/263 (6%)
Query: 101 HILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPP 160
+ + LS + + + L L+ + + G PP
Sbjct: 54 TEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113
Query: 161 VIGNFS-ASLQKFYAYECKLKG--NIPQEIGNLS--GLTLLSLHSNDLNGTISPTMGRLK 215
+ + L E+ GL +LS+ +
Sbjct: 114 PLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173
Query: 216 RLQGLSLRNNNLEGSI-------PYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLREL 268
L L L +N G P L+++ SG + L+ L
Sbjct: 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGL 233
Query: 269 HLGSNKLTSSIPSSLWS-LEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDI 327
L N L + + + +NLS L +P + L+VLDLS N+L
Sbjct: 234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGL--PAKLSVLDLSYNRLDR-N 289
Query: 328 PSTIGALKDLETLSLARNQFQGP 350
PS L + LSL N F
Sbjct: 290 PS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 47/235 (20%), Positives = 79/235 (33%), Gaps = 25/235 (10%)
Query: 8 EIGNLQNLQYLVFAENNLSGLVPPTIFNIS--TMRILTLEGNQLSGR---LPSTVGHLLP 62
+ + LQ L ++G PP + + + IL L + R L L P
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHI-------LNTFGNLRHLSLL 115
++ L +A + + L LDL N G F L+ L+L
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 116 SQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAY 175
+ M + S + L L N L ++ + L
Sbjct: 210 NAGMETPSGVCS--------ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261
Query: 176 ECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGS 230
LK +P+ + + L++L L N L+ P+ L ++ LSL+ N S
Sbjct: 262 FTGLKQ-VPKGL--PAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 38/226 (16%), Positives = 71/226 (31%), Gaps = 34/226 (15%)
Query: 188 GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247
G S LL + + + + L+ L++R + I +
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA------------ 88
Query: 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSL--WSLEYILDINLSSNSLNDSLPS 305
++ ++ L+EL L + ++T + P L + + +NL + S
Sbjct: 89 ---------LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAW 139
Query: 306 NVQ----KLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPES----VGS 357
+ L VL +++ + L TL L+ N G
Sbjct: 140 LAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199
Query: 358 LISLESLDLSGNN---LSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400
+L+ L L SG QL+ ++SHN L
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 53/282 (18%), Positives = 85/282 (30%), Gaps = 24/282 (8%)
Query: 10 GNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLL--PNIESL 67
G L + I +++ LT+ ++ R+ +L ++ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 68 LLAANNLTGIIPHSITNAT--KLVALDLGFNSFAGH--ILNTFGNLRHLSLLSQVMNNLT 123
L +TG P + AT L L+L S+A L L +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILP---PVIGNFSASLQKFYAYECKLK 180
+ + S +Q L+ L NP G + +LQ ++
Sbjct: 161 SLNFSCEQVRVF------PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
Query: 181 ---GNIPQEIGNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRNNNLEGSIPYDLC 236
G L L L N L +L L+L L+ +P L
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP 273
Query: 237 HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSS 278
KL + L+ N+L P L + L L N S
Sbjct: 274 A-KLSV-LDLSYNRLD-RNPSPD-ELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 19/155 (12%), Positives = 46/155 (29%), Gaps = 10/155 (6%)
Query: 261 SLTSLRELHLGSNKLTSSIP-SSLWSLEYILDINLSSNSLNDSLPSNVQKLKV---LTVL 316
SL L + + + + + + + + + ++ L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 317 DLSRNQLSGDIPSTIGAL--KDLETLSLARNQFQGPIPE----SVGSLISLESLDLSGNN 370
L +++G P + DL L+L + L+ L ++ +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 371 LSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSF 405
+ + L ++S N GE + +
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 27/156 (17%), Positives = 46/156 (29%), Gaps = 20/156 (12%)
Query: 6 PTEIGNLQNLQYLVFAENNLSGLVPPTI----FNISTMRILTLEGNQLS--GRLPSTVGH 59
++ L L ++N G T+++L L + + S +
Sbjct: 166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA 225
Query: 60 LLPNIESLLLAANNLTGIIPHSI-TNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQV 118
++ L L+ N+L ++L +L+L F L L LS
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLD-LS-- 282
Query: 119 MNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPL 154
N L S + LS NP
Sbjct: 283 YNRLDR----------NPSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 21/99 (21%), Positives = 31/99 (31%), Gaps = 7/99 (7%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNI-STMRILTLEGNQLSGRLPSTVGHLL 61
G LQ L + N+L + S + L L L ++P L
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK---GLP 273
Query: 62 PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAG 100
+ L L+ N L S ++ L L N F
Sbjct: 274 AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 52/206 (25%), Positives = 81/206 (39%), Gaps = 37/206 (17%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNL-QLERAFRSFD-----SECEVLRNVRHRNLIK 561
LG+G F V K G + A K +L + R E +LR +RH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGSALEY 613
+ N L+LE + G L F + E+ + + + Y
Sbjct: 73 LHDIFENKTDVVLILELVSGGEL---------FDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 614 LH-HGHSSAPIIHCDLKPTNILL----DENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
LH I H DLKP NI+L N + DFGI+ + G + + T
Sbjct: 124 LHSKR-----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNI-FGTP 175
Query: 669 GYMAPEYGSEGIVSAKCDVYSYGVLL 694
++APE + + + D++S GV+
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNL-QLERAFRSFDSECEVLRNVRHR 557
+ F + +G GSFG V+KG VAIKI +L + E E VL
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILE--RLN------IMIDVGS 609
+ K S +++E++ GS LD+LE L+ I+ ++
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSA----------LDLLEPGPLDETQIATILREILK 130
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG 669
L+YLH IH D+K N+LL E+ ++DFG++ L D+ + T +G
Sbjct: 131 GLDYLHSEK----KIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VG 181
Query: 670 ---YMAPEYGSEGIVSAKCDVYSYGVLLME 696
+MAPE + +K D++S G+ +E
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 7/214 (3%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
+P I + + LH N ++ + + + L L L +N L L L+
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 243 GIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLND 301
+ L+ N + P L L LHL L P L + + L N+L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ- 142
Query: 302 SLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV-GSLI 359
+LP + + L LT L L N++S L L+ L L +N+ + L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLG 201
Query: 360 SLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHN 393
L +L L NNLS ++L L L+ ++ N
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 9/213 (4%)
Query: 164 NFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSL 222
A+ Q+ + + ++ LT+L LHSN L I L L+ L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDL 87
Query: 223 RNNNLEGSIPYD-LCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIP 280
+N S+ L + + L L + P L +L+ L+L N L + +P
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LP 145
Query: 281 SSLWS-LEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLE 338
+ L + + L N + S+P + L L L L +N+++ P L L
Sbjct: 146 DDTFRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204
Query: 339 TLSLARNQFQGPIPESVGSLISLESLDLSGNNL 371
TL L N E++ L +L+ L L+ N
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 40/184 (21%), Positives = 65/184 (35%), Gaps = 7/184 (3%)
Query: 217 LQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKL 275
Q + L N + + + + L N L+ I L L +L L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 276 TSSIPSSLWS-LEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTI-G 332
S+ + + L + ++L L L + + L L L L N L +P
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150
Query: 333 ALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSH 392
L +L L L N+ + L SL+ L L N ++ P + L +L +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 393 NRLE 396
N L
Sbjct: 211 NNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 47/232 (20%), Positives = 81/232 (34%), Gaps = 17/232 (7%)
Query: 72 NNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQ 131
L + P I A++ + L N + +F R+L++L N L ++A
Sbjct: 21 QGLQAV-PVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA-- 75
Query: 132 WSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEI-GNL 190
T L L N + P + L + C L+ + + L
Sbjct: 76 ------FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGL 128
Query: 191 SGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGN 249
+ L L L N L + L L L L N + L + + L N
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 250 KLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+++ H+ P L L L+L +N L++ +L L + + L+ N
Sbjct: 188 RVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 55/273 (20%), Positives = 80/273 (29%), Gaps = 65/273 (23%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+P I Q + N +S + + + IL L N L+ R+ + L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81
Query: 64 IESLLLAANN-LTGIIPHSITNATKLVALDLGFNSFAGHI-LNTFGNLRHLSLLSQVMNN 121
+E L L+ N L + P + +L L L + F L L L N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 122 LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKG 181
L + NLT L N + + F
Sbjct: 141 LQALPDDT--------FRDLGNLTHLFLHGNRISSVPE---RAFR--------------- 174
Query: 182 NIPQEIGNLSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
L L L LH N + + P L RL L L NNL ++P +
Sbjct: 175 -------GLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEA----- 220
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSN 273
L L +L+ L L N
Sbjct: 221 ------------------LAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 17/94 (18%), Positives = 32/94 (34%), Gaps = 4/94 (4%)
Query: 314 TVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSG 373
+ L +P I + + L N+ S + +L L L N L+
Sbjct: 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70
Query: 374 KIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKN 407
+ L+ L+Q ++S N + +F
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVD-PATFHG 103
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 35/207 (16%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFN----LQLERAFRSFDSECEVLRNVRHRNLIKI 562
LLG GS+G V + A+KI ++ + E ++LR +RH+N+I++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 563 LS--SCSNPDFKALVLEFMPNGSLEKWLY----------SHNYFLDILERLNIMIDVGSA 610
+ +V+E+ G E +H YF ++
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI----------DG 121
Query: 611 LEYLH-HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG 669
LEYLH G I+H D+KP N+LL +S G+++ L T + +
Sbjct: 122 LEYLHSQG-----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 670 YMAPE--YGSEGIVSAKCDVYSYGVLL 694
+ PE G + K D++S GV L
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTL 203
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 56/281 (19%), Positives = 89/281 (31%), Gaps = 75/281 (26%)
Query: 498 RATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNL-QLERAFRSFDSECEVLRNVR 555
R +F +G G FG V++ D + AIK L E A E + L +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 556 HRNLIK---------------------------------------------ILSSCSNPD 570
H +++ + S +
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 571 FKALVLEFMPNGSL------------EKWLYSHNY--FLDILERLNIMIDVGSALEYLHH 616
+ P L + W+ + L+I I + A+E+LH
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH- 181
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA---------- 666
S ++H DLKP+NI + V DFG+ + + E+ T M
Sbjct: 182 ---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707
T YM+PE S K D++S G++L E E
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER 279
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 48/206 (23%), Positives = 79/206 (38%), Gaps = 37/206 (17%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFN-LQLERAFRSFD-----SECEVLRNVRHRNLIK 561
LG+G F V K S G A K + + + R E +L+ ++H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILER--------LNIMIDVGSALEY 613
+ N L+LE + G L F + E+ + + + + Y
Sbjct: 79 LHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 614 LH-HGHSSAPIIHCDLKPTNILL----DENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
LH I H DLKP NI+L + DFG++ + G T
Sbjct: 130 LHSLQ-----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTP 181
Query: 669 GYMAPEYGSEGIVSAKCDVYSYGVLL 694
++APE + + + D++S GV+
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 47/204 (23%), Positives = 78/204 (38%), Gaps = 35/204 (17%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFN--LQLERAFRSFDSECEVLRNVRHR-NLIKILS 564
LG G F V + S G + A K + + E VL + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERL----------NIMIDVGSALEYL 614
N L+LE+ G + F L L ++ + + YL
Sbjct: 97 VYENTSEIILILEYAAGGEI---------FSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 615 H-HGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGY 670
H + I+H DLKP NILL + DFG+S+ +G + + M T Y
Sbjct: 148 HQNN-----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREI-MGTPEY 199
Query: 671 MAPEYGSEGIVSAKCDVYSYGVLL 694
+APE + ++ D+++ G++
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIA 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 29/210 (13%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFN-------LQLERAFRSFDSECEVLR 552
++F +LG GSF +V ++ + AIKI ++ E +V+
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT----RERDVMS 85
Query: 553 NVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 612
+ H +K+ + + + L + NG L K++ F + R ++ SALE
Sbjct: 86 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALE 144
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM-ATIGYM 671
YLH IIH DLKP NILL+E+M ++DFG +K+L + T Y+
Sbjct: 145 YLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQYV 199
Query: 672 APEYGSEGIVSAK-----CDVYSYGVLLME 696
+PE +++ K D+++ G ++ +
Sbjct: 200 SPE-----LLTEKSACKSSDLWALGCIIYQ 224
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 52/214 (24%), Positives = 86/214 (40%), Gaps = 57/214 (26%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVL-RNVRHRNLIKILSS 565
+LG G G V + G A+K+ +A + E + + +++ IL
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90
Query: 566 CSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVGSAL 611
N +++E M G L F I ER + IM D+G+A+
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL---------FSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 612 EYLH-HGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMTMA- 666
++LH H I H D+KP N+L +++ ++DFG +K + T
Sbjct: 142 QFLHSHN-----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPCY 191
Query: 667 TIGYMAPE------YGSEGIVSAKCDVYSYGVLL 694
T Y+APE Y CD++S GV++
Sbjct: 192 TPYYVAPEVLGPEKYDKS------CDMWSLGVIM 219
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 51/229 (22%), Positives = 87/229 (37%), Gaps = 36/229 (15%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQ-----LERAFRSFDSECEVLRNVRHRNLIK 561
LG G++G V VA+KI +++ E + E + + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSALE 612
+ + L LE+ G L + +F ++ + +
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGVV 119
Query: 613 YLH-HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYM 671
YLH G I H D+KP N+LLDE +SDFG++ + T+ Y+
Sbjct: 120 YLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 672 APE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 719
APE + DV+S G++L + P D+ W +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 501 DEFNECNLLGTGSFGSVY----KGTISDGTDVAIKIFNLQL---ERAFRSFDSECEVLRN 553
D F +G GSFG V T A+K N Q R+ E ++++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 554 VRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 613
+ H L+ + S + + +V++ + G L L + +F + +L I ++ AL+Y
Sbjct: 72 LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDY 130
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA-TIGYMA 672
L + IIH D+KP NILLDE+ H++DF I+ +L TQ TMA T YMA
Sbjct: 131 LQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMA 182
Query: 673 PEYGSEGIVSAKC--------DVYSYGVLLMETFTRKRP 703
PE + S++ D +S GV E +RP
Sbjct: 183 PE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-22
Identities = 44/236 (18%), Positives = 85/236 (36%), Gaps = 22/236 (9%)
Query: 475 KHLDHEDFLPLATWRRTPYLDIQRATDEFNECNLLGTG--SFGSVYKGT-ISDGTDVAIK 531
H H L + +L + ++G G +V G V ++
Sbjct: 2 AHHHHHHMENLYFQGMSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58
Query: 532 IFNL--QLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLY 589
NL E V + H N++ ++ + +V FM GS + L
Sbjct: 59 RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LI 117
Query: 590 SHNYFLDILERL--NIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFG 647
++ + E I+ V AL+Y+HH +H +K ++IL+ + ++S
Sbjct: 118 CTHFMDGMNELAIAYILQGVLKALDYIHHMG----YVHRSVKASHILISVDGKVYLSGLR 173
Query: 648 ISKLLGEGED--SVTQTMTMATIG---YMAPEYGSEGIV--SAKCDVYSYGVLLME 696
+ + V ++ +++PE + + AK D+YS G+ E
Sbjct: 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 27/201 (13%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFN------------LQLERAFRSFDSECEVLRNVR 555
LG+G+FG V+ +V +K +L + E +L V
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL----EIAILSRVE 87
Query: 556 HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLY-SHNYFLDILERLNIMIDVGSALEYL 614
H N+IK+L N F LV+E +G L+ + + + LD I + SA+ YL
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146
Query: 615 HHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE 674
IIH D+K NI++ E+ + DFG + L G+ T TI Y APE
Sbjct: 147 RLKD----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCAPE 199
Query: 675 -YGSEGIVSAKCDVYSYGVLL 694
+ +++S GV L
Sbjct: 200 VLMGNPYRGPELEMWSLGVTL 220
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 51/229 (22%), Positives = 87/229 (37%), Gaps = 36/229 (15%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQ-----LERAFRSFDSECEVLRNVRHRNLIK 561
LG G++G V VA+KI +++ E + E + + + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSALE 612
+ + L LE+ G L + +F ++ + +
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGVV 119
Query: 613 YLH-HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYM 671
YLH G I H D+KP N+LLDE +SDFG++ + T+ Y+
Sbjct: 120 YLHGIG-----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 672 APE-YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 719
APE + DV+S G++L + P D+ W +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 60/229 (26%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFN---LQLERAFRSFDS----------------- 546
+G GS+G V +D T A+K+ + L + F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 547 ------ECEVLRNVRHRNLIKILSSCSNPDFKAL--VLEFMPNGSL----------EKWL 588
E +L+ + H N++K++ +P+ L V E + G + E
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED-- 137
Query: 589 YSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGI 648
+ YF D++ +EYLH+ IIH D+KP+N+L+ E+ ++DFG+
Sbjct: 138 QARFYFQDLI----------KGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 649 SKLLGEGEDSVTQTMTMATIGYMAPE--YGSEGIVS-AKCDVYSYGVLL 694
S +G D++ T+ T +MAPE + I S DV++ GV L
Sbjct: 184 SNEF-KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDS---ECEVLRNVR 555
F++ +G GSFG+VY + + VAIK + +++ + E L+ +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 556 HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 615
H N I+ LV+E+ GS L H L +E + L YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG---YMA 672
S +IH D+K NILL E + DFG + ++ + +G +MA
Sbjct: 172 ----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANSF--VGTPYWMA 218
Query: 673 PE---YGSEGIVSAKCDVYSYGVLLME 696
PE EG K DV+S G+ +E
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 39/205 (19%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQ-------LERAFRSFDSECEVLRNVRHRNL 559
LG G+FG V G G VA+KI N Q + + R E + L+ RH ++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR----EIQNLKLFRHPHI 73
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSA 610
IK+ S P +V+E++ G L ++ H F IL SA
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----------SA 123
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGY 670
++Y H ++H DLKP N+LLD +M A ++DFG+S ++ +GE T + + Y
Sbjct: 124 VDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT---SCGSPNY 176
Query: 671 MAPE-YGSEGIVSAKCDVYSYGVLL 694
APE + D++S GV+L
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVIL 201
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 49/216 (22%), Positives = 82/216 (37%), Gaps = 62/216 (28%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKIL--- 563
LG G G V + A+K+ +A R E E+ + ++++I+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124
Query: 564 -SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVGSALE 612
+ + +V+E + G L F I +R + IM +G A++
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 613 YLH-HGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
YLH I H D+KP N+L N ++DFG +K ++ T
Sbjct: 176 YLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-------SLTTP 223
Query: 669 ----GYMAPE------YGSEGIVSAKCDVYSYGVLL 694
Y+APE Y CD++S GV++
Sbjct: 224 CYTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 253
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 33/217 (15%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDS---ECEVLRNVRH 556
D++ ++G+G+ V VAIK NL E+ S D E + + H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL--EKCQTSMDELLKEIQAMSQCHH 72
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLE---KWLYSHNYFLD-ILERLNIMI---DVGS 609
N++ +S D LV++ + GS+ K + + +L+ I +V
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG 669
LEYLH IH D+K NILL E+ + ++DFG+S L G D + +G
Sbjct: 133 GLEYLHKNG----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 670 ---YMAPE-------YGSEGIVSAKCDVYSYGVLLME 696
+MAPE Y K D++S+G+ +E
Sbjct: 189 TPCWMAPEVMEQVRGYDF------KADIWSFGITAIE 219
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 7e-22
Identities = 49/265 (18%), Positives = 88/265 (33%), Gaps = 20/265 (7%)
Query: 143 NLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEI-GNLSGLTLLSLHSN 201
+ L +N + I + +LQ + I ++ +L L L L N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 202 DLNGTISPTM-GRLKRLQGLSLRNNNLEGSIPYDL-CHLKLMFGIRLTGNKLSGHIPP-C 258
L +S + L L L+L N + L HL + +R+ I
Sbjct: 111 YL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 259 LVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLD 317
LT L EL + ++ L S P SL S++ + + L L + L+
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228
Query: 318 LSRNQLSGDIPSTIGA--------LKDLETLSLARNQFQGPIPESVGSLISLESLDLSGN 369
L L S + + + + + + + L L+ S N
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRN 287
Query: 370 NLSGKIPKS-LETLSQLKQFNVSHN 393
L +P + L+ L++ + N
Sbjct: 288 QLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-21
Identities = 59/317 (18%), Positives = 104/317 (32%), Gaps = 58/317 (18%)
Query: 60 LLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFN---SFAGHILNTFGNLRHLSLLS 116
L ++SL L+ N +T I + L AL L N + ++ G+L HL L
Sbjct: 50 LTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109
Query: 117 QVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYE 176
N L+ SSS +LT L+ NP + + + LQ
Sbjct: 110 ---NYLSNLSSSW--------FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158
Query: 177 CKLKGNIPQEI-GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDL 235
I ++ L+ L L + ++DL ++ ++ + L L +
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF 217
Query: 236 CHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLS 295
+ +S+ L L L + S L
Sbjct: 218 -----------------------VDVTSSVECLELRDTDLDTFHFSEL------------ 242
Query: 296 SNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV 355
S +SL K + ++ L + + + L L +RNQ + +P+ +
Sbjct: 243 STGETNSLI----KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGI 296
Query: 356 -GSLISLESLDLSGNNL 371
L SL+ + L N
Sbjct: 297 FDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 51/309 (16%), Positives = 103/309 (33%), Gaps = 53/309 (17%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
IP+ + + ++ L + N ++ + + ++ L L N ++ + L ++
Sbjct: 46 IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAG-HILNTFGNLRHLSLLSQVMNNLT 123
E L L+ N L+ + + L L+L N + + F +L L +L +
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNI 183
T+ D L L ++ L P
Sbjct: 163 TKIQRKD-------FAGLTFLEELEIDASDLQSYEPKS---LK----------------- 195
Query: 184 PQEIGNLSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRNNNLEG----SIP----YD 234
++ ++ L LH + + ++ L LR+ +L+ +
Sbjct: 196 -----SIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNS 249
Query: 235 LCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS---SIPSSLWSLEYILD 291
L +++T L + L ++ L EL N+L S I L SL+
Sbjct: 250 LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQK--- 305
Query: 292 INLSSNSLN 300
I L +N +
Sbjct: 306 IWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 44/220 (20%), Positives = 79/220 (35%), Gaps = 9/220 (4%)
Query: 217 LQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKL 275
++ L L NN + DL + + LT N ++ I SL SL L L N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 276 TSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPS-TIGA 333
++ S L + +NL N +++ L L +L + I
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172
Query: 334 LKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHN 393
L LE L + + Q P+S+ S+ ++ L L + ++ S ++ +
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232
Query: 394 RLEG----EIPVKGSFKNFSVESFFGNYALCGPPKLRVPP 429
L+ E+ G + + F N + +V
Sbjct: 233 DLDTFHFSELS-TGETNSLIKKFTFRNVKITDESLFQVMK 271
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-22
Identities = 51/203 (25%), Positives = 77/203 (37%), Gaps = 37/203 (18%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFN---LQLERAFRSFDSECEVLRNVRHRNLIKIL 563
+G+G+FG VA+K E R E R++RH N+++
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82
Query: 564 SSCSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSALEYL 614
P A+++E+ G L + + + +F +L S + Y
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL----------SGVSYC 132
Query: 615 HHGHSSAPIIHCDLKPTNILLDENMAAH--VSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
H I H DLK N LLD + A + DFG SK + T+ T Y+A
Sbjct: 133 HSMQ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIA 185
Query: 673 PE-YGSEGIVSAKCDVYSYGVLL 694
PE + DV+S GV L
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTL 208
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 38/203 (18%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFN------LQLERAFRSFDSECEVLRNVRHRNLIK 561
+G G+F V I G +VAIKI + L++ FR E +++ + H N++K
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSALE 612
+ L++E+ G + +L +H + F I+ SA++
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----------SAVQ 128
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
Y H I+H DLK N+LLD +M ++DFG S G Y A
Sbjct: 129 YCHQKR----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAA 181
Query: 673 PE-YGSEGIVSAKCDVYSYGVLL 694
PE + + + DV+S GV+L
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVIL 204
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-22
Identities = 61/239 (25%), Positives = 98/239 (41%), Gaps = 50/239 (20%)
Query: 488 WRRTPYLDIQRATD---EFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRS 543
R +D+ D F L+G G++G VYKG + G AIK+ ++ +
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEE 66
Query: 544 FDSECEVLRNV-RHRNLIK-----ILSSCSNPDFKA-LVLEFMPNGSLEKWLYSHNYFLD 596
E +L+ HRN+ I + D + LV+EF GS+ D
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----------TD 116
Query: 597 ILERLN-----------IMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSD 645
+++ I ++ L +LH +IH D+K N+LL EN + D
Sbjct: 117 LIKNTKGNTLKEEWIAYICREILRGLSHLHQHK----VIHRDIKGQNVLLTENAEVKLVD 172
Query: 646 FGISKLLGEGEDSVTQTMTMATIG---YMAPE-----YGSEGIVSAKCDVYSYGVLLME 696
FG+S L + +V + T IG +MAPE + K D++S G+ +E
Sbjct: 173 FGVSAQL---DRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 45/208 (21%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQ-------LERAFRSFDSECEVLRNVRHRNL 559
LG G+FG V G G VA+KI N Q + + R E + L+ RH ++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR----EIQNLKLFRHPHI 78
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSA 610
IK+ S P +V+E++ G L ++ + F IL S
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----------SG 128
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG- 669
++Y H ++H DLKP N+LLD +M A ++DFG+S ++ +GE T + G
Sbjct: 129 VDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGS 178
Query: 670 --YMAPE-YGSEGIVSAKCDVYSYGVLL 694
Y APE + D++S GV+L
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVIL 206
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 7e-21
Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 9/197 (4%)
Query: 216 RLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNK 274
+ L+L N ++ HL+ + ++L+ N + I L +L L L N+
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNR 123
Query: 275 LTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSR-NQLSGDIPSTIG 332
LT+ + L + ++ L +N + S+PS ++ L LDL +LS
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182
Query: 333 ALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSH 392
L +L L+LA + IP ++ LI L+ LDLSGN+LS P S + L L++ +
Sbjct: 183 GLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240
Query: 393 NRLEGEIPVKGSFKNFS 409
++++ I + +F N
Sbjct: 241 SQIQ-VIE-RNAFDNLQ 255
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 15/212 (7%)
Query: 189 NLSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRNNNLEGSIP----YDLCHLKLMFG 243
+L L +L L N + TI L L L L +N L +IP L LK
Sbjct: 86 HLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKE--- 140
Query: 244 IRLTGNKLSGHIPP-CLVSLTSLRELHLGS-NKLTSSIPSSLWSLEYILDINLSSNSLND 301
+ L N + IP + SLR L LG +L+ + L + +NL+ +L
Sbjct: 141 LWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR- 198
Query: 302 SLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISL 361
+P+ + L L LDLS N LS P + L L+ L + ++Q Q + +L SL
Sbjct: 199 EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257
Query: 362 ESLDLSGNNLSGKIPKSLETLSQLKQFNVSHN 393
++L+ NNL+ L L++ ++ HN
Sbjct: 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 61/301 (20%), Positives = 95/301 (31%), Gaps = 69/301 (22%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
++P I N + L EN + + + ++ + IL L N + + + L N
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFN---SFAGHILNTFGNLRHLSLLSQVMN 120
+ +L L N LT I + +KL L L N S + N +LR L L +
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGE--LK 171
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
L+ S A NL L+ L I
Sbjct: 172 RLSYISEGA--------FEGLSNLRYLNLAMCNLREI----------------------- 200
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
+ L L L L N L+ + L LQ L + + ++
Sbjct: 201 ----PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ------------ 244
Query: 241 MFGIRLTGNKLSGHIPPC-LVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL 299
I +L SL E++L N LT L ++ I+L N
Sbjct: 245 -------------VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
Query: 300 N 300
N
Sbjct: 292 N 292
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 7e-21
Identities = 66/287 (22%), Positives = 109/287 (37%), Gaps = 71/287 (24%)
Query: 458 LLVITIIMYKRCRNRSTKHLDH-EDFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGS 516
LL I I +Y C N + + ++L A + ++ ++F ++G G+FG
Sbjct: 30 LLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGE 89
Query: 517 VY----KGTISDGTDVAIKIFN----LQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCS 567
V K A+KI N L+ E A F E +VL N + + + +
Sbjct: 90 VAVVKLKNA---DKVFAMKILNKWEMLKRAETAC--FREERDVLVNGDSKWITTLHYAFQ 144
Query: 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMID----------VGSALEYLHHG 617
+ + LV+++ G L + L + + + A++ +H
Sbjct: 145 DDNNLYLVMDYYVGGDL----LTL------LSKFEDRLPEEMARFYLAEMVIAIDSVH-- 192
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATIGYMAPE- 674
+H D+KP NIL+D N H+ +DFG L E + + T Y++PE
Sbjct: 193 --QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVA-VGTPDYISPEI 247
Query: 675 ----------YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
YG E CD +S GV + EM GE
Sbjct: 248 LQAMEGGKGRYGPE------CDWWSLGVCMY----------EMLYGE 278
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 96.3 bits (239), Expect = 8e-21
Identities = 60/262 (22%), Positives = 107/262 (40%), Gaps = 19/262 (7%)
Query: 135 LSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLT 194
+ + + + + S+ + A +K ++ Q I L +T
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTDAVT--QNELN-SIDQIIANNSDIK-SV-QGIQYLPNVT 68
Query: 195 LLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGH 254
L L+ N L I P + LK L L L N ++ + L LK + + L N +S
Sbjct: 69 KLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-D 123
Query: 255 IPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLT 314
I LV L L L+LG+NK+T + L L + ++L N ++D + L L
Sbjct: 124 ING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQ 178
Query: 315 VLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGK 374
L LS+N +S D+ + LK+L+ L L + +L+ ++ + +L
Sbjct: 179 NLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--V 234
Query: 375 IPKSLETLSQLKQFNVSHNRLE 396
P+ + ++ NV + E
Sbjct: 235 TPEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 7e-16
Identities = 49/299 (16%), Positives = 102/299 (34%), Gaps = 29/299 (9%)
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
L ++T + + + + +++ + + +
Sbjct: 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS-----------DIKSVQGIQY-LP 65
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
N+T + ++ + + LTN +NL L N + + + + L+ +
Sbjct: 66 NVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKDLSS--LKDLK-KLKSLSLEHNGIS 122
Query: 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
+I + +L L L L +N + I+ + RL +L LSL +N + I L L
Sbjct: 123 -DI-NGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIV-PLAGLTK 176
Query: 241 MFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ + L+ N +S + L L +L L L S + + + +L + + SL
Sbjct: 177 LQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234
Query: 301 D----SLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV 355
S + +K V L N++S + K Q +
Sbjct: 235 TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVS 293
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 36/200 (18%), Positives = 65/200 (32%), Gaps = 26/200 (13%)
Query: 7 TEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL--LPNI 64
I L N+ L N L+ + P + N+ + L L+ N++ + L L +
Sbjct: 59 QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI-----KDLSSLKDLKKL 111
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTT 124
+SL L N ++ I + + +L +L LG N + L L LS N ++
Sbjct: 112 KSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISD 167
Query: 125 ESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIP 184
+ L L L N + + + +L + +
Sbjct: 168 ----------IVPLAGLTKLQNLYLSKNHISDLRA--LAGLK-NLDVLELFSQECLNKPI 214
Query: 185 QEIGNLSGLTLLSLHSNDLN 204
NL + L
Sbjct: 215 NHQSNLVVPNTVKNTDGSLV 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 26/183 (14%), Positives = 63/183 (34%), Gaps = 9/183 (4%)
Query: 9 IGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLL 68
+ +L L+ L N ++ + + ++ + L+LE NQ+S + G L +++L
Sbjct: 127 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVPLAG--LTKLQNLY 181
Query: 69 LAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSS 128
L+ N+++ + + L L+L +N NL + + +L T
Sbjct: 182 LSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 239
Query: 129 ADQWSFLSSLTNCRNLTILSFGS--NPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQE 186
+D + + S + F + + + ++
Sbjct: 240 SDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGT 299
Query: 187 IGN 189
+
Sbjct: 300 VIK 302
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 68/296 (22%), Positives = 115/296 (38%), Gaps = 54/296 (18%)
Query: 447 KYILPPIVCSV--LLVITIIMYKRCRNRSTKHLDH-EDFLPLATWRRTPYLDIQRAT--- 500
+ +L P + LL + + +++ + DFL W + ++
Sbjct: 4 QLVLDPGFLGLEPLLDLLLGVHQELGASELAQDKYVADFL---QWAEPIVVRLKEVRLQR 60
Query: 501 DEFNECNLLGTGSFGSVY----KGTISDGTDVAIKIFNLQ--LERA-FRSFDSECEVLRN 553
D+F ++G G+F V K T G A+KI N L+R F E +VL N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 554 VRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGSALE 612
R + ++ + + ++ LV+E+ G L L + E + ++ A++
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP-AEMARFYLAEIVMAID 176
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATIGY 670
+H +H D+KP NILLD H+ +DFG L + + T Y
Sbjct: 177 SVH----RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVA-VGTPDY 229
Query: 671 MAPE-------------YGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 708
++PE YG E CD ++ GV E F + P T E +
Sbjct: 230 LSPEILQAVGGGPGTGSYGPE------CDWWALGVFAYEMFYGQTPFYADSTAETY 279
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 62/256 (24%), Positives = 95/256 (37%), Gaps = 53/256 (20%)
Query: 501 DEFNECNLLGTGSFGSVY----KGTISDGTDVAIKIFNLQLERAFRSFDSEC-----EVL 551
+ F + +LG G FG V + T G A K L+ +R + ++L
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKK--LEKKRIKKRKGEAMALNEKQIL 238
Query: 552 RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI-DVGSA 610
V R ++ + + D LVL M G L+ +Y R ++
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMA-T 667
LE LH I++ DLKP NILLD++ H+ SD G++ + EG+ T
Sbjct: 299 LEDLH----RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQ----TIKGRVGT 348
Query: 668 IGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFT---------RKRPTDEMFTGEM 712
+GYMAPE Y D ++ G LL E +K +E+
Sbjct: 349 VGYMAPEVVKNERYTFS------PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
Query: 713 SLRRWVKESLPHGLTE 728
V E +
Sbjct: 403 E----VPEEYSERFSP 414
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 69/316 (21%), Positives = 113/316 (35%), Gaps = 83/316 (26%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIK-IFNLQLE--------------RAFRSFDSECEVLRN 553
+ +GS+G+V G S+G VAIK +FN + R R E +L +
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR----EIRLLNH 85
Query: 554 VRHRNLIKIL---SSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 608
H N++ + P LV E M L + ++ + M +
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MA 666
L LH A ++H DL P NILL +N + DF +++ ED+ T +
Sbjct: 145 LGLHVLH----EAGVVHRDLHPGNILLADNNDITICDFNLAR-----EDTADANKTHYVT 195
Query: 667 TIGYMAPEY-GSEGIVSAKCDVYSYGVLLMETFTRK--------------------RPTD 705
Y APE + D++S G ++ E F RK P
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 706 E--MFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFS-----AKMDCI--LSIMDLAL 756
E + S R +++ SL + +A++ A + ++ M L
Sbjct: 256 EDVVMFSSPSARDYLRNSLSN-----------VPARAWTAVVPTADPVALDLIAKM-LEF 303
Query: 757 DCCIESPDMRINVTDA 772
+ P RI+ A
Sbjct: 304 N-----PQRRISTEQA 314
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 59/277 (21%), Positives = 115/277 (41%), Gaps = 38/277 (13%)
Query: 451 PPIVCSV--LLVITIIMYKRCRNRSTKHLDH-EDFLPLATWRRTPYLDIQRATDEFNECN 507
P + LL + + + + ++FL D++ +++
Sbjct: 16 PKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVK 75
Query: 508 LLGTGSFGSVY----KGTISDGTDVAIKIFNLQ--LERA-FRSFDSECEVLRNVRHRNLI 560
++G G+FG V K T A+K+ + ++R+ F E +++ ++
Sbjct: 76 VIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
++ + + + +V+E+MP G L + +++ + R +V AL+ +H S
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTA-EVVLALDAIH----S 186
Query: 621 APIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATIGYMAPE---- 674
IH D+KP N+LLD++ H+ +DFG + + T T Y++PE
Sbjct: 187 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKS 243
Query: 675 YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
G +G +CD +S GV L EM G+
Sbjct: 244 QGGDGYYGRECDWWSVGVFLY----------EMLVGD 270
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 59/207 (28%), Positives = 82/207 (39%), Gaps = 37/207 (17%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFN----------LQLERAFRSFDSECEVLRNVRH 556
LLG+G FGSVY G +SD VAIK R E +L+ V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLKKVSS 105
Query: 557 R--NLIKILSSCSNPDFKALVLEF-MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 613
+I++L PD L+LE P L ++ L + V A+ +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRH 164
Query: 614 LH-HGHSSAPIIHCDLKPTNILLDEN-MAAHVSDFGISKLLGEGEDSVTQTMTMATIGYM 671
H G ++H D+K NIL+D N + DFG LL +D+V T Y
Sbjct: 165 CHNCG-----VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYS 215
Query: 672 APEYGS----EGIVSAKCDVYSYGVLL 694
PE+ G V+S G+LL
Sbjct: 216 PPEWIRYHRYHG---RSAAVWSLGILL 239
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 3e-20
Identities = 63/283 (22%), Positives = 107/283 (37%), Gaps = 56/283 (19%)
Query: 475 KHLDHEDFLPLATWRRTPYLDIQRATDEFNECNLLGTGSFGSVY----KGTISDGTDVAI 530
K ++ + F W+ L+I ++F+ ++G G FG VY T G A+
Sbjct: 164 KFIESDKFTRFCQWK-NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADT---GKMYAM 219
Query: 531 KIFNLQLERAFRSFDSEC--------EVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNG 582
K L +R ++ ++ + + PD + +L+ M G
Sbjct: 220 KC--LDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 583 SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAH 642
L L H F + R ++ LE++H + +++ DLKP NILLDE+ H
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAA-EIILGLEHMH----NRFVVYRDLKPANILLDEH--GH 330
Query: 643 V--SDFGISKLLGEGEDSVTQTMTMA-TIGYMAPEYGSEGIVSAK------CDVYSYGVL 693
V SD G++ + + T GYMAPE ++ D +S G +
Sbjct: 331 VRISDLGLACDFSKK-----KPHASVGTHGYMAPE-----VLQKGVAYDSSADWFSLGCM 380
Query: 694 LMETFTRKRP--------TDEMFTGEMSLRRWVKESLPHGLTE 728
L + P E+ M+L + LP +
Sbjct: 381 LFKLLRGHSPFRQHKTKDKHEID--RMTLT--MAVELPDSFSP 419
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 491 TPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEV 550
+ ++ + C ++G GSFG V++ + + +VAIK R E ++
Sbjct: 30 SDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQI 85
Query: 551 LRNVRHRNLIKIL----SSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNI- 603
+R V+H N++ + S+ D LVLE++P ++ + + + L I
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIK 144
Query: 604 --MIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAA-HVSDFGISKLLGEGEDSVT 660
M + +L Y+H S I H D+KP N+LLD + DFG +K+L GE +V+
Sbjct: 145 LYMYQLLRSLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200
Query: 661 QTMTMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 701
+ + Y APE Y + D++S G ++ E +
Sbjct: 201 Y---ICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 46/208 (22%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQ-------LERAFRSFDSECEVLRNVRHRNL 559
LG GSFG V T VA+K + Q R R E L+ +RH ++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER----EISYLKLLRHPHI 71
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSA 610
IK+ + P +V+E+ G L ++ +F I+ A
Sbjct: 72 IKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQII----------CA 120
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIG- 669
+EY H I+H DLKP N+LLD+N+ ++DFG+S ++ +G T + G
Sbjct: 121 IEYCHRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT------SCGS 170
Query: 670 --YMAPE-YGSEGIVSAKCDVYSYGVLL 694
Y APE + + DV+S G++L
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVL 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-20
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 36/220 (16%)
Query: 500 TDEFNECNLLGTGSFGSVYKGTISD-GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN 558
+ + ++G GSFG VY+ + D G VAIK R E +++R + H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108
Query: 559 LIKIL----SSCSNPDFKAL--VLEFMPNGSLEKWLYSHNYFLDILERLNI---MIDVGS 609
++++ SS D L VL+++P ++ + ++ L + + M +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAA-HVSDFGISKLLGEGEDSVTQTMTMATI 668
+L Y+H S I H D+KP N+LLD + A + DFG +K L GE +V+ + +
Sbjct: 168 SLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 220
Query: 669 GYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 701
Y APE Y ++ DV+S G +L E +
Sbjct: 221 YYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-20
Identities = 31/183 (16%), Positives = 72/183 (39%), Gaps = 7/183 (3%)
Query: 191 SGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNK 250
S + T + T ++ L ++L N N+ + + + + +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIH 77
Query: 251 LSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKL 310
+ + P + L++L L + +TS +L L + +++S ++ +DS+ + + L
Sbjct: 78 AT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 311 KVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNN 370
+ +DLS N DI + L +L++L++ + + L L
Sbjct: 136 PKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
Query: 371 LSG 373
+ G
Sbjct: 193 IGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 25/143 (17%), Positives = 57/143 (39%), Gaps = 7/143 (4%)
Query: 262 LTSLRELHLGSNKLTSSIP-SSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSR 320
+ SL + L + +T +++ + +++ + + + L L L +
Sbjct: 43 MNSLTYITLANINVTDLTGIEYAHNIKDL---TINNIHATNY--NPISGLSNLERLRIMG 97
Query: 321 NQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLE 380
++ D + L L L ++ + I + +L + S+DLS N I L+
Sbjct: 98 KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLK 156
Query: 381 TLSQLKQFNVSHNRLEGEIPVKG 403
TL +LK N+ + + ++
Sbjct: 157 TLPELKSLNIQFDGVHDYRGIED 179
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 26/218 (11%), Positives = 62/218 (28%), Gaps = 44/218 (20%)
Query: 62 PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHI--LNTFGNLRHLSLLSQVM 119
++ L + + L + L + + + N++ L++ +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTGIEYAHNIKDLTINN--- 75
Query: 120 NNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKL 179
+ T + ++ NL L + P + + SL
Sbjct: 76 IHATN----------YNPISGLSNLERLRIMGKDVTSDKIPNLSGLT-SLTLLDISHSAH 124
Query: 180 KGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
+I +I L + + L N I P + L L+ L+++ + + D ++
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-----DYRGIE 178
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS 277
L +L+ S +
Sbjct: 179 ---------------------DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 27/153 (17%), Positives = 54/153 (35%), Gaps = 18/153 (11%)
Query: 7 TEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIES 66
T I N++ L + + P I +S + L + G ++ + L ++
Sbjct: 60 TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSG-LTSLTL 116
Query: 67 LLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHI--LNTFGNLRHLSLLSQVMNNLTT 124
L ++ + I I K+ ++DL +N I L T L+ L++ + +
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQF---DGVHD 173
Query: 125 ESSSADQWSFLSSLTNCRNLTILSFGSNPLGGI 157
+ + L L S +GG
Sbjct: 174 ----------YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 30/174 (17%), Positives = 62/174 (35%), Gaps = 21/174 (12%)
Query: 8 EIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL--LPNIE 65
+ +L Y+ A N++ L I ++ LT+ + + L N+E
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHAT-----NYNPISGLSNLE 91
Query: 66 SLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTE 125
L + ++T +++ T L LD+ ++ IL L ++ + N T+
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 126 SSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKL 179
+ L L L+ + + I +F L + YA+ +
Sbjct: 152 ---------IMPLKTLPELKSLNIQFDGVHDYRG--IEDFP-KLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 24/216 (11%), Positives = 59/216 (27%), Gaps = 45/216 (20%)
Query: 14 NLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL--LPNIESLLLAA 71
+ + S T ++++ +TL + + + + NI+ L +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV-----TDLTGIEYAHNIKDLTINN 75
Query: 72 NNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQ 131
+ T P I+ + L L + + L L+LL +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI----- 128
Query: 132 WSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLS 191
L+ + + + N I + + L
Sbjct: 129 ---LTKINTLPKVNSIDLSYNGA-------ITDIMP-------------------LKTLP 159
Query: 192 GLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNL 227
L L++ + ++ + +L L + +
Sbjct: 160 ELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 14/91 (15%), Positives = 29/91 (31%), Gaps = 4/91 (4%)
Query: 6 PTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIE 65
+ L +L L + + + I + + + L N + LP ++
Sbjct: 105 IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKT--LPELK 162
Query: 66 SLLLAANNLTGIIPHSITNATKLVALDLGFN 96
SL + + + I + KL L
Sbjct: 163 SLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 9e-20
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 40/213 (18%)
Query: 501 DEFNECNLLGTGSFGSVY----KGTISDGTDVAIKIFNLQLERAFRSFDSEC-----EVL 551
+F LGTGSFG V+ + G A+K+ L+ E R E +L
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHN---GRYYAMKV--LKKEIVVRLKQVEHTNDERLML 60
Query: 552 RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 611
V H +I++ + + ++++++ G L L F + + + +V AL
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLAL 119
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTM-ATI 668
EYLH II+ DLKP NILLD+N H+ +DFG +K + + T T+ T
Sbjct: 120 EYLHSKD----IIYRDLKPENILLDKN--GHIKITDFGFAKYVPD------VTYTLCGTP 167
Query: 669 GYMAPEYGSEGIVSAK-----CDVYSYGVLLME 696
Y+APE +VS K D +S+G+L+ E
Sbjct: 168 DYIAPE-----VVSTKPYNKSIDWWSFGILIYE 195
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 9e-20
Identities = 68/265 (25%), Positives = 103/265 (38%), Gaps = 54/265 (20%)
Query: 475 KHLDHEDFLPLATWRRTPYLDIQRAT-DEFNECNLLGTGSFGSVY----KGTISDGTDVA 529
+ LD FL W+ +L+ Q D F + +LG G FG V+ K T G A
Sbjct: 161 EFLDSLYFLRFLQWK---WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYA 214
Query: 530 IKIFNLQLERAFRSFDSEC-----EVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSL 584
K L +R + + ++L V R ++ + + LV+ M G +
Sbjct: 215 CKK--LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI 272
Query: 585 EKWLYSHNYFLDIL--ERLNIMI-DVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAA 641
+Y+ + R + S LE+LH II+ DLKP N+LLD++
Sbjct: 273 RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH----QRNIIYRDLKPENVLLDDD--G 326
Query: 642 HV--SDFGISKLLGEGEDSVTQTMTMA-TIGYMAPE------YGSEGIVSAKCDVYSYGV 692
+V SD G++ L G+ T A T G+MAPE Y D ++ GV
Sbjct: 327 NVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFS------VDYFALGV 377
Query: 693 LLMETFT---------RKRPTDEMF 708
L E K E+
Sbjct: 378 TLYEMIAARGPFRARGEKVENKELK 402
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 52/205 (25%), Positives = 79/205 (38%), Gaps = 31/205 (15%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFN----------LQLERAFRSFDSECEVLRNVR- 555
LLG G FG+V+ G ++D VAIK+ E +L V
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL----EVALLWKVGA 93
Query: 556 ---HRNLIKILSSCSNPDFKALVLEF-MPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 611
H +I++L + LVLE +P L ++ + R V +A+
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAI 152
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLD-ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGY 670
++ H ++H D+K NIL+D A + DFG LL D T Y
Sbjct: 153 QHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTD-FDGTRVY 204
Query: 671 MAPEY-GSEGIVSAKCDVYSYGVLL 694
PE+ + V+S G+LL
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILL 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 497 QRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLER------AFRSFDSECEV 550
Q +++ + +G G++G VYK S G VA+K L E A R E +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISL 72
Query: 551 LRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 610
L+ + H N++ ++ + LV EFM L+K L + L + + +
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MATI 668
+ + H I+H DLKP N+L++ + A ++DFG+++ G ++ T + T+
Sbjct: 132 VAHCHQHR----ILHRDLKPQNLLINSDGALKLADFGLARAFG----IPVRSYTHEVVTL 183
Query: 669 GYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
Y AP+ GS+ S D++S G + E T K
Sbjct: 184 WYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGK 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 2e-19
Identities = 51/222 (22%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLER------AFRSFDSECEVLRN 553
++ + +G G++G+V+K VA+K L + A R E +L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57
Query: 554 VRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 613
++H+N++++ + LV EF L+K+ S N LD + + + L +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MATIGYM 671
H + ++H DLKP N+L++ N +++FG+++ G + + + T+ Y
Sbjct: 117 CHSRN----VLHRDLKPQNLLINRNGELKLANFGLARAFG----IPVRCYSAEVVTLWYR 168
Query: 672 APE--YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
P+ +G++ + S D++S G + E RP +F G
Sbjct: 169 PPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 91.4 bits (226), Expect = 3e-19
Identities = 47/209 (22%), Positives = 74/209 (35%), Gaps = 12/209 (5%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
+ E+ + L L + TI M L L D +
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD 423
Query: 243 GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDS 302
+R +K + +R LHL LT L L + ++LS N L +
Sbjct: 424 DLR---SKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLR-A 477
Query: 303 LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQG-PIPESVGSLISL 361
LP + L+ L VL S N L ++ + L L+ L L N+ Q + + S L
Sbjct: 478 LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535
Query: 362 ESLDLSGNNLSGK---IPKSLETLSQLKQ 387
L+L GN+L + + E L +
Sbjct: 536 VLLNLQGNSLCQEEGIQERLAEMLPSVSS 564
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 3e-09
Identities = 41/205 (20%), Positives = 73/205 (35%), Gaps = 15/205 (7%)
Query: 198 LHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLC----HLKLMFGIRLTGNKLSG 253
L + LN + R+ S + L P C + +F L+ K +
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST- 362
Query: 254 HIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKL--K 311
+ L S L+EL + +I + +L+ +L + + ++ +
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS-----TLKAVDPM 417
Query: 312 VLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNL 371
LD R++ + D+ L LA + + L+ + LDLS N L
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRL 475
Query: 372 SGKIPKSLETLSQLKQFNVSHNRLE 396
+P +L L L+ S N LE
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE 499
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 40/213 (18%)
Query: 501 DEFNECNLLGTGSFGSVY----KGTISDGTDVAIKIFNL-------QLERAFRSFDSECE 549
D+F+ LGTGSFG V K + G A+KI + Q+E +E
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTL----NEKR 93
Query: 550 VLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 609
+L+ V L+K+ S + +V+E++ G + L F + R +
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVL 152
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTM-ATI 668
EYLH +I+ DLKP N+L+D+ V+DFG +K + +T T+ T
Sbjct: 153 TFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTP 202
Query: 669 GYMAPEYGSEGIVSAK-----CDVYSYGVLLME 696
+APE I+ +K D ++ GVL+ E
Sbjct: 203 EALAPE-----IILSKGYNKAVDWWALGVLIYE 230
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 501 DEFNECNLLGTGSFGSVY----KGTISDGTDVAIKIFNLQLERAFRSFDSEC-----EVL 551
+EF LLG G+FG V K T G A+KI L+ E + VL
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKI--LKKEVIVAKDEVAHTLTENRVL 202
Query: 552 RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 611
+N RH L + S D V+E+ G L L F + R ++ SAL
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSAL 261
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYM 671
+YLH + +++ DLK N++LD++ ++DFG+ K G + + +T T Y+
Sbjct: 262 DYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYL 316
Query: 672 APEYGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 708
APE + D + GV++ E + P +++F
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 49/220 (22%), Positives = 96/220 (43%), Gaps = 24/220 (10%)
Query: 497 QRATDEFNECNLLGTGSFGSVYKGTISD-GTDVAIK-IFNLQLERAFRSFDSECEVLRNV 554
++ D F + G G+FG+V G G VAIK + R + L +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNREL-QIMQDLAVL 76
Query: 555 RHRNLIKILS---SCSNPDFK----ALVLEFMPNGSLEKWLYSHNYFLDILERLNI---M 604
H N++++ S + D + +V+E++P+ +L + ++ + I +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 605 IDVGSALEYLHHGHSSAPIIHCDLKPTNILLD-ENMAAHVSDFGISKLLGEGEDSVTQTM 663
+ ++ LH S + H D+KP N+L++ + + DFG +K L E +V
Sbjct: 136 FQLIRSIGCLHL--PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA--- 190
Query: 664 TMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
+ + Y APE +G++ + D++S G + E +
Sbjct: 191 YICSRYYRAPELIFGNQH-YTTAVDIWSVGCIFAEMMLGE 229
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 52/232 (22%), Positives = 78/232 (33%), Gaps = 40/232 (17%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRNNNLEGSIP----YDLCH 237
IP + L L N L + LQ L L ++ +I L H
Sbjct: 22 IPDNL--PFSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 238 LKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTS------SIPSSLWSLEYIL 290
L + LTGN + + L+SL++L L S +L L
Sbjct: 78 LSTL---ILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL---- 129
Query: 291 DINLSSNSLNDSLPSNV--QKLKVLTVLDLSRNQLSGDIPSTIGALKDL-------ETLS 341
N++ N + S L L LDLS N++ I L+ L +L
Sbjct: 130 --NVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC--TDLRVLHQMPLLNLSLD 183
Query: 342 LARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHN 393
L+ N I I L+ L L N L + L+ L++ + N
Sbjct: 184 LSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 59/236 (25%), Positives = 90/236 (38%), Gaps = 28/236 (11%)
Query: 72 NNLTGI---IPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSS 128
N I +P S N LDL FN +F + L +L + T
Sbjct: 17 LNFYKIPDNLPFSTKN------LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 129 ADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEI- 187
A SL++ L+ L NP+ L + +SLQK A E L ++
Sbjct: 71 A-----YQSLSH---LSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLA-SLENFPI 120
Query: 188 GNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRNNNLEGSIPYD----LCHLK-LM 241
G+L L L++ N + P L L+ L L +N ++ SI L + L
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLN 179
Query: 242 FGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSN 297
+ L+ N ++ I P L+EL L +N+L S L + I L +N
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 50/248 (20%), Positives = 87/248 (35%), Gaps = 42/248 (16%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+P + + L + N L L F + +++L L ++ + L +
Sbjct: 26 LPF------STKNLDLSFNPLRHL-GSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
+ +L+L N + + + + + L L + A G+L+ L L+ N +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNI 183
S + S+LT NL L SN + I +
Sbjct: 138 ----SFKLPEYFSNLT---NLEHLDLSSNKIQSIYCTDLRVLH----------------- 173
Query: 184 PQEIGNLSGLTL-LSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYD-LCHLKLM 241
+ L L L L N +N I P + RL+ L+L N L+ S+P L +
Sbjct: 174 -----QMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSL 226
Query: 242 FGIRLTGN 249
I L N
Sbjct: 227 QKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 23/84 (27%), Positives = 36/84 (42%), Gaps = 2/84 (2%)
Query: 313 LTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNL 371
LDLS N L + + +L+ L L+R + Q I + SL L +L L+GN +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPI 88
Query: 372 SGKIPKSLETLSQLKQFNVSHNRL 395
+ LS L++ L
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNL 112
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 32/158 (20%), Positives = 55/158 (34%), Gaps = 22/158 (13%)
Query: 5 IPTEI-GNLQNLQYLVFAENNLSGLVPPTIFNI-STMRILTLEGNQLSGRLPST-VGHLL 61
+ L +LQ LV E NL+ L T++ L + N + L
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASL-ENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNL 148
Query: 62 PNIESLLLAANNLTGIIPHSITNATKL----VALDLGFNSFAGHILNTFGNLR--HLSLL 115
N+E L L++N + I + ++ ++LDL N F +R L+L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALD 208
Query: 116 SQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNP 153
+ N L + +L + +NP
Sbjct: 209 T---NQLKSVPDGI--------FDRLTSLQKIWLHTNP 235
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 10/189 (5%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
+P ++ T+L L N L T+ RL L+L L + D L ++
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDG-TLPVLG 80
Query: 243 GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDS 302
+ L+ N+L +P +L +L L + N+LTS +L L + ++ L N L +
Sbjct: 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL-KT 138
Query: 303 LPSNV-QKLKVLTVLDLSRNQLSGDIPSTI-GALKDLETLSLARNQFQGPIPESVGSLIS 360
LP + L L L+ N L+ ++P+ + L++L+TL L N IP+
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHL 196
Query: 361 LESLDLSGN 369
L L GN
Sbjct: 197 LPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 54/169 (31%), Positives = 79/169 (46%), Gaps = 13/169 (7%)
Query: 245 RLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS-SIPSSLWSLEYILDINLSSNSLNDSL 303
L+ N L L+ T L +L+L +LT + +L L ++LS N L SL
Sbjct: 37 HLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT---LDLSHNQLQ-SL 92
Query: 304 PSNVQKLKVLTVLDLSRNQLSGDIPSTI-GALKDLETLSLARNQFQGPIPESV-GSLISL 361
P Q L LTVLD+S N+L+ +P L +L+ L L N+ + +P + L
Sbjct: 93 PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKL 150
Query: 362 ESLDLSGNNLSGKIPKSL-ETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
E L L+ NNL+ ++P L L L + N L IP KG F +
Sbjct: 151 EKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IP-KGFFGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 46/201 (22%), Positives = 71/201 (35%), Gaps = 24/201 (11%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+P ++ ++ L +EN L + + L L+ +L+ +L V LP
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTF-SLATLMPYTRLTQLNLDRAELT-KLQ--VDGTLPV 78
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFN---SFAGHILNTFGNLRHLSLLSQVMN 120
+ +L L+ N L +P L LD+ FN S L G L+ L L N
Sbjct: 79 LGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG---N 134
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
L T L+ L LS +N L + ++ +L E L
Sbjct: 135 ELKTLPPGL-----LTPTP---KLEKLSLANNNLTELPAGLLNGLE-NLDTLLLQENSLY 185
Query: 181 GNIPQEIGNLSGLTLLSLHSN 201
IP+ L LH N
Sbjct: 186 -TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 40/142 (28%), Positives = 57/142 (40%), Gaps = 31/142 (21%)
Query: 256 PPCLVS-LTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLT 314
P C VS + S E++ LT+ +P L P + T
Sbjct: 2 PICEVSKVASHLEVNCDKRNLTA-LPPDL--------------------PKD------TT 34
Query: 315 VLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGK 374
+L LS N L +T+ L L+L R + + G+L L +LDLS N L
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-S 91
Query: 375 IPKSLETLSQLKQFNVSHNRLE 396
+P +TL L +VS NRL
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLT 113
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 59/340 (17%), Positives = 116/340 (34%), Gaps = 55/340 (16%)
Query: 68 LLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESS 127
+ + I P + + G ++ T +L ++ LS +TT
Sbjct: 3 ITQPTAINVIFP--DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--- 55
Query: 128 SADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEI 187
+ + NL L N + + P + N + + + LK N+ I
Sbjct: 56 -------IEGVQYLNNLIGLELKDNQITDLAP--LKNLT-KITELELSGNPLK-NVS-AI 103
Query: 188 GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247
L + L L S + ++P + L LQ L L N +
Sbjct: 104 AGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQIT------------------- 142
Query: 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV 307
+I P L LT+L+ L +G+ +++ + L +L + + N ++D S +
Sbjct: 143 ------NISP-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI--SPL 191
Query: 308 QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLS 367
L L + L NQ+S D+ + +L ++L +L+ +
Sbjct: 192 ASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVP--NVVK 247
Query: 368 GNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKN 407
G + + P ++ N++ N V +F
Sbjct: 248 GPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQ 287
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 55/316 (17%), Positives = 115/316 (36%), Gaps = 58/316 (18%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL--LPNIESLL 68
L N + ++N++ V ++ + L+ G + +T+ + L N+ L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-----TTIEGVQYLNNLIGLE 69
Query: 69 LAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSS 128
L N +T + P + N TK+ L+L N ++ L+ + L +T
Sbjct: 70 LKDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD---- 121
Query: 129 ADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIG 188
++ L NL +L N + I P +
Sbjct: 122 ------VTPLAGLSNLQVLYLDLNQITNISP---------------------------LA 148
Query: 189 NLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTG 248
L+ L LS+ + ++ ++P + L +L L +N + I L L + + L
Sbjct: 149 GLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKN 204
Query: 249 NKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQ 308
N++S P L + ++L + L + +T+ ++ ++ + S P+ +
Sbjct: 205 NQISDVSP--LANTSNLFIVTLTNQTITN--QPVFYNNNLVVPNVVKGPSGAPIAPATIS 260
Query: 309 KLKVLTVLDLSRNQLS 324
+L+ N S
Sbjct: 261 DNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 53/293 (18%), Positives = 110/293 (37%), Gaps = 33/293 (11%)
Query: 6 PTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIE 65
+L + L ++ + + ++ + L L+ NQ++ + + + L I
Sbjct: 34 TVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQITD--LAPLKN-LTKIT 88
Query: 66 SLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTE 125
L L+ N L + I + LDL + L +L +L +N +T
Sbjct: 89 ELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITN- 143
Query: 126 SSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQ 185
+S L NL LS G+ + + P + N S L A + K+ +I
Sbjct: 144 ---------ISPLAGLTNLQYLSIGNAQVSDLTP--LANLS-KLTTLKADDNKIS-DIS- 189
Query: 186 EIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIR 245
+ +L L + L +N ++ +SP + L ++L N + + +L + ++
Sbjct: 190 PLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVK 247
Query: 246 LTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNS 298
I P T S LT ++ S + ++ Y + +++ +
Sbjct: 248 GPSGAP---IAP----ATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKN 293
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 49/211 (23%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLER------AFRSFDSECEVLRNV 554
++++ +G G++G VYK + G A+K L+ E R E +L+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57
Query: 555 RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 614
+H N++K+ LV E + L+K L L+ + + ++ + + + Y
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 615 HHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MATIGYMA 672
H ++H DLKP N+L++ ++DFG+++ G + T + T+ Y A
Sbjct: 117 HDRR----VLHRDLKPQNLLINREGELKIADFGLARAFG----IPVRKYTHEIVTLWYRA 168
Query: 673 PE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
P+ GS+ S D++S G + E
Sbjct: 169 PDVLMGSK-KYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 67/323 (20%), Positives = 127/323 (39%), Gaps = 75/323 (23%)
Query: 498 RATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLER------AFRSFDSECEV 550
++ + +G G+FG V+K G VA+K ++ E+ A R E ++
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKI 69
Query: 551 LRNVRHRNLIKIL------SSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLN 602
L+ ++H N++ ++ +S N + LV +F + L L + + E
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128
Query: 603 IMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT 662
+M + + L Y+H I+H D+K N+L+ + ++DFG+++ ++S
Sbjct: 129 VMQMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 663 MT--MATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK------------ 701
T + T+ Y PE YG D++ G ++ E +TR
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPP------IDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238
Query: 702 --------RPTDEMFTGEMSLRRWVKESLPHG----LTEVVDANLVREEQAFSAKMDCIL 749
T E++ + + K L G + + + VR+ A ++
Sbjct: 239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL-KAYVRDPYALD-----LI 292
Query: 750 SIMDLALDCCIESPDMRINVTDA 772
+ L LD P RI+ DA
Sbjct: 293 DKL-LVLD-----PAQRIDSDDA 309
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 494 LDIQRATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFR-SFDS----E 547
LD++ + + + LG G F +VYK + VAIK L + + E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 548 CEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 607
++L+ + H N+I +L + + +LV +FM LE + ++ L M+
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--M 665
LEYLH I+H DLKP N+LLDEN ++DFG++K G S + T +
Sbjct: 122 LQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFG----SPNRAYTHQV 173
Query: 666 ATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
T Y APE +G+ + D+++ G +L E R
Sbjct: 174 VTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRV 210
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 42/230 (18%)
Query: 501 DEFNECNLLGTGSFGSV----YKGTISDGTDVAIKIFNLQLERAFRSFDSEC-----EVL 551
++F+ LLG G+FG V K T G A+KI L+ E + VL
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKI--LRKEVIIAKDEVAHTVTESRVL 59
Query: 552 RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 611
+N RH L + + D V+E+ G L L F + R ++ SAL
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSAL 118
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATIG 669
EYLH S +++ D+K N++LD++ H+ +DFG+ K G + + +T T
Sbjct: 119 EYLH----SRDVVYRDIKLENLMLDKD--GHIKITDFGLCK-EGISDGATMKTFC-GTPE 170
Query: 670 YMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 708
Y+APE YG D + GV++ E + P + +F
Sbjct: 171 YLAPEVLEDNDYGRA------VDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 34/255 (13%), Positives = 69/255 (27%), Gaps = 58/255 (22%)
Query: 508 LLGTGSFGSVYKGTISD---GTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIK 561
G ++ D VA+ + Q + + S L + + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 562 ILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
+L +V E++ GSL++ + + + M + +A + H A
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR----A 148
Query: 622 PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV 681
+ P+ + VS G L A M
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPD-------A 179
Query: 682 SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR-------------RWVKESLPHGLTE 728
+ + D+ G L + P E L + +P ++
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEA-GVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238
Query: 729 VVDANLVREEQAFSA 743
V ++ + SA
Sbjct: 239 VAARSVQGDGGIRSA 253
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-18
Identities = 71/411 (17%), Positives = 129/411 (31%), Gaps = 77/411 (18%)
Query: 37 STMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLT----GIIPHSITNATKLVALD 92
++ L ++ +LS + + LL + + L LT I ++ L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 93 LGFNSF--------AGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNL 144
L N + ++ LSL + LT S+L L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN---CCLTGAGCGV----LSSTLRTLPTL 115
Query: 145 TILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLN 204
L N LG + L L L L L+
Sbjct: 116 QELHLSDNLLG---DAGLQLLCEGLLD-----------------PQCRLEKLQLEYCSLS 155
Query: 205 GT----ISPTMGRLKRLQGLSLRNNNLEGSIPYDLC------HLKLMFGIRLTGNKLS-- 252
++ + + L++ NN++ + LC +L ++L ++
Sbjct: 156 AASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA-LKLESCGVTSD 214
Query: 253 --GHIPPCLVSLTSLRELHLGSNKLTSS-----IPSSLWSLEYILDINLSSNSLND---- 301
+ + S SLREL LGSNKL P L + + + +
Sbjct: 215 NCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG 274
Query: 302 SLPSNVQKLKVLTVLDLSRNQLSGDIPSTIG-ALKD----LETLSLARNQFQGPIPESVG 356
L ++ + L L L+ N+L + + L + LE+L + F
Sbjct: 275 DLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334
Query: 357 SLI----SLESLDLSGNNLSGKIPKSL-----ETLSQLKQFNVSHNRLEGE 398
S++ L L +S N L + L + S L+ ++ +
Sbjct: 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-16
Identities = 75/415 (18%), Positives = 124/415 (29%), Gaps = 84/415 (20%)
Query: 12 LQNLQYLVFAENNLSGLVPPTIFNI----STMRILTLEGNQLSGR----LPSTVGHLLPN 63
LQ Q + + L+ I + + L L N+L + +
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86
Query: 64 IESLLLAANNLT----GIIPHSITNATKLVALDLGFNSF--------AGHILNTFGNLRH 111
I+ L L LT G++ ++ L L L N +L+ L
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146
Query: 112 LSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQK 171
L L +L+ S S L + L+ +N + + L+
Sbjct: 147 LQLEY---CSLSAASCEP----LASVLRAKPDFKELTVSNNDIN---EAGVRVLCQGLKD 196
Query: 172 FYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLN----GTISPTMGRLKRLQGLSLRNNNL 227
+ L L L S + + + L+ L+L +N L
Sbjct: 197 -----------------SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
Query: 228 EGSIPYDLCHLKLMFGIRLTGNKLSG---------HIPPCLVSLTSLRELHLGSNKLTSS 278
+LC L RL + + L + SL+EL L N+L
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299
Query: 279 --------IPSSLWSLEYILDINLSSNSLND----SLPSNVQKLKVLTVLDLSRNQLSGD 326
+ LE + + S S S + + + L L +S N+L
Sbjct: 300 GARLLCETLLEPGCQLE---SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356
Query: 327 IPSTIG-ALKD----LETLSLARNQFQ----GPIPESVGSLISLESLDLSGNNLS 372
+ L L L LA + ++ + SL LDLS N L
Sbjct: 357 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 500 TDEFNECNLLGTGSFGSVYKGTISD-GTDVAIK----IFNLQLE--RAFRSFDSECEVLR 552
+ +G+G+ G V + +VAIK F Q RA+R E +++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 79
Query: 553 NVRHRNLIKIL----SSCSNPDFKA--LVLEFMPNGSLEKWLYS------HNYFLDILER 600
V H+N+I +L S +F+ +V+E M +L + + +Y L +
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC 138
Query: 601 LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660
+++LH SA IIH DLKP+NI++ + + DFG+++ G +
Sbjct: 139 ---------GIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----S 180
Query: 661 QTMT--MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK 701
MT + T Y APE D++S G ++ E
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 54/230 (23%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIK---IFNLQLE--RAFRSFDSECEVLRN 553
+ + +G G++G V + VAIK F Q R R E ++L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLR 81
Query: 554 VRHRNLIKIL---SSCSNPDFKA--LVLEFMPNGSLEKWLYS-------HNYFL-DILER 600
RH N+I I + + K +V + M L K L + YFL IL
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL-- 138
Query: 601 LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660
L+Y+H SA ++H DLKP+N+LL+ + DFG++++ + + T
Sbjct: 139 --------RGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHT 185
Query: 661 QTMT--MATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 701
+T +AT Y APE Y ++ I D++S G +L E + +
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGY-TKSI-----DIWSVGCILAEMLSNR 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 36/229 (15%)
Query: 501 DEFNECNLLGTGSFGSVY---KGTISDGTDV-AIKIFN----LQLERAFRSFDSECEVLR 552
+ F +LG G +G V+ K T ++ + A+K+ ++ + +E +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 553 NVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 612
V+H ++ ++ + L+LE++ G L L F++ + ++ AL
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALG 135
Query: 613 YLH-HGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATIG 669
+LH G II+ DLKP NI+L+ HV +DFG+ K + +VT T TI
Sbjct: 136 HLHQKG-----IIYRDLKPENIMLNHQ--GHVKLTDFGLCK-ESIHDGTVTHTFC-GTIE 186
Query: 670 YMAPEYGSEGIVSAK-----CDVYSYGVLLMETFTRKRP-----TDEMF 708
YMAPE I+ D +S G L+ + T P +
Sbjct: 187 YMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 34/232 (14%)
Query: 501 DEFNECNLLGTGSFGSVY---KGTISDGTDV-AIKIFN----LQLERAFRSFDSECEVLR 552
+ F +LGTG++G V+ K + D + A+K+ +Q + +E +VL
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 553 NVRHRNLIKILSSC-SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 611
++R + L L+L+++ G L L F + ++ + ++ AL
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIVLAL 172
Query: 612 EYLH-HGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATI 668
E+LH G II+ D+K NILLD N HV +DFG+SK E TI
Sbjct: 173 EHLHKLG-----IIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFC-GTI 224
Query: 669 GYMAPE---YGSEGIVSAKCDVYSYGVLLME---------TFTRKRPTDEMF 708
YMAP+ G G A D +S GVL+ E K E+
Sbjct: 225 EYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 71/324 (21%), Positives = 116/324 (35%), Gaps = 66/324 (20%)
Query: 489 RRTPYLDIQ------RATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLER-- 539
+ +D+ ++ +++ L+G GS+G V K G VAIK F +
Sbjct: 7 HHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM 66
Query: 540 ----AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFL 595
A R E ++L+ +RH NL+ +L C LV EF+ + ++ L L
Sbjct: 67 VKKIAMR----EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGL 121
Query: 596 DILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655
D + + + + + H + IIH D+KP NIL+ ++ + DFG ++ L
Sbjct: 122 DYQVVQKYLFQIINGIGFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177
Query: 656 EDSVTQTMTMATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK------- 701
+ +AT Y APE YG + DV++ G L+ E F +
Sbjct: 178 GEVYDD--EVATRWYRAPELLVGDVKYGK-AV-----DVWAIGCLVTEMFMGEPLFPGDS 229
Query: 702 -------------RPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCI 748
+ LP L R S +
Sbjct: 230 DIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKERE---PLERRYPKLSEVV--- 283
Query: 749 LSIMDLALDCCIESPDMRINVTDA 772
+DLA C PD R +
Sbjct: 284 ---IDLAKKCLHIDPDKRPFCAEL 304
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 59/227 (25%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIK---IFNLQLE--RAFRSFDSECEVLRNVRHRNLIKI 562
LG G++G V T G VAIK F+ L R R E ++L++ +H N+I I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74
Query: 563 L---SSCSNPDFKA--LVLEFMPNGSLEKWLYS-------HNYFL-DILERLNIMIDVGS 609
S +F ++ E M L + + + YF+ L
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTL----------R 123
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQT------M 663
A++ LH + +IH DLKP+N+L++ N V DFG+++++ E ++ M
Sbjct: 124 AVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 664 T--MATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 701
+AT Y APE Y S + DV+S G +L E F R+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKY-SRAM-----DVWSCGCILAELFLRR 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 47/224 (20%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIK----IFNLQLE--RAFRSFDSECEVLR 552
+ +G+G++GSV G VAIK F ++ RA+R E +L+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLK 78
Query: 553 NVRHRNLIKIL----SSCSNPDFKA--LVLEFMPNGSLEKWLYS------HNYFLDILER 600
+++H N+I +L + S +F LV+ FM L+K + Y + + +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK 137
Query: 601 LNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660
L+Y+H SA ++H DLKP N+ ++E+ + DFG+++
Sbjct: 138 ---------GLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HAD 177
Query: 661 QTMT--MATIGYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRK 701
MT + T Y APE S + D++S G ++ E T K
Sbjct: 178 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 45/209 (21%), Positives = 74/209 (35%), Gaps = 69/209 (33%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEV---LRNVRHRNLIKIL- 563
LG G G V + A+K+ + EV R + ++++I+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78
Query: 564 ---SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN----------IMIDVGSA 610
+ + +V+E + G L F I +R + IM +G A
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGEL---------FSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 611 LEYLH-HGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISK-LLGEGEDSVTQTMTM 665
++YLH I H D+KP N+L N ++DFG +K GE
Sbjct: 130 IQYLHSIN-----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK---------- 174
Query: 666 ATIGYMAPEYGSEGIVSAKCDVYSYGVLL 694
Y CD++S GV++
Sbjct: 175 ---------YDKS------CDMWSLGVIM 188
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLER------AFRSFDSECEVLRN 553
+++ + +G GS+G V+K G VAIK F + A R E +L+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQ 58
Query: 554 VRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 613
++H NL+ +L LV E+ + ++ L + + +I A+ +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MATIGYM 671
H IH D+KP NIL+ ++ + DFG ++LL + +AT Y
Sbjct: 118 CH----KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT----GPSDYYDDEVATRWYR 169
Query: 672 APE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 701
+PE YG + DV++ G + E +
Sbjct: 170 SPELLVGDTQYGP-PV-----DVWAIGCVFAELLSGV 200
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLE-----RAFRSFDSECEVLRNV 554
+ + + + LG G++ +VYKG VA+K L+ E A R E +L+++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 555 RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 614
+H N++ + LV E++ L+++L +++ + + L Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 615 HHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MATIGYMA 672
H ++H DLKP N+L++E ++DFG+++ T+T + T+ Y
Sbjct: 117 HRQK----VLHRDLKPQNLLINERGELKLADFGLARAKS----IPTKTYDNEVVTLWYRP 168
Query: 673 PE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
P+ GS S + D++ G + E T +
Sbjct: 169 PDILLGST-DYSTQIDMWGVGCIFYEMATGR 198
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 6e-17
Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 42/231 (18%)
Query: 501 DEFNECNLLGTGSFGSVY---KGTISDGTDV-AIKIFNLQLERAFRSFDSECE------V 550
+F +LG GSFG V+ K + SD + A+K+ L++A +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV----LKKATLKVRDRVRTKMERDI 79
Query: 551 LRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 610
L V H ++K+ + L+L+F+ G L L F + + + ++ A
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALA 138
Query: 611 LEYLH-HGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMAT 667
L++LH G II+ DLKP NILLDE H+ +DFG+SK + + T
Sbjct: 139 LDHLHSLG-----IIYRDLKPENILLDEE--GHIKLTDFGLSK-ESIDHEKKAYSFC-GT 189
Query: 668 IGYMAPEYGSEGIVSAK-----CDVYSYGVLLMETFTRKRP-----TDEMF 708
+ YMAPE +V+ + D +S+GVL+ E T P E
Sbjct: 190 VEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 51/229 (22%), Positives = 90/229 (39%), Gaps = 61/229 (26%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIK--IFNLQLE--RAFRSFDSECEVLRNVRHRNLIKIL 563
LG G G V+ VAIK + A R E +++R + H N++K+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 564 ------------SSCSNPDFKA--LVLEFMPNGSLEKWLYSHN-------YFLDILERLN 602
S + + +V E+M L L F+ L R
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLR-- 131
Query: 603 IMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD-ENMAAHVSDFGISKLLGEGEDSVTQ 661
L+Y+H SA ++H DLKP N+ ++ E++ + DFG+++++ S
Sbjct: 132 -------GLKYIH----SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP-HYSHKG 179
Query: 662 TMT--MATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLMETFTRK 701
++ + T Y +P Y ++ I D+++ G + E T K
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNY-TKAI-----DMWAAGCIFAEMLTGK 222
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 48/216 (22%)
Query: 509 LGTGSFGSVYKGTISD-GTDVAIKIFNLQLE------RAFRSFDSECEVLRNVRHRNLIK 561
+G+G++GSV + G VA+K + + R +R E +L++++H N+I
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 562 IL----SSCSNPDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDILERLNIMIDVG 608
+L + S +F LV M L + + + + R
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR-------- 143
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MA 666
L+Y+H SA IIH DLKP+N+ ++E+ + DFG+++ MT +A
Sbjct: 144 -GLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVA 191
Query: 667 TIGYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRK 701
T Y APE + + D++S G ++ E T +
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 49/222 (22%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNL-QLERAFRSFDSECEVLRNVR-HRNLIKILSS 565
LG G + V++ I++ V +KI + ++ R E ++L N+R N+I +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99
Query: 566 CSNPDFK--ALVLEFMPNGSLEKWLYSHN-----YFL-DILERLNIMIDVGSALEYLHHG 617
+P + ALV E + N ++ + +++ +IL+ AL+Y H
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK----------ALDYCH-- 147
Query: 618 HSSAPIIHCDLKPTNILLD-ENMAAHVSDFGISKLLGEGEDSVTQTMT--MATIGYMAPE 674
S I+H D+KP N+++D E+ + D+G L E Q +A+ + PE
Sbjct: 148 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWG----LAEFYHP-GQEYNVRVASRYFKGPE 200
Query: 675 YGSEGIVSAKC-----DVYSYGVLLMETFTRKRPTDEMFTGE 711
+V + D++S G +L RK P F G
Sbjct: 201 L----LVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGH 235
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 1e-16
Identities = 64/231 (27%), Positives = 95/231 (41%), Gaps = 43/231 (18%)
Query: 501 DEFNECNLLGTGSFGSV----YKGTISDGTDVAIKIFNLQLERAFRSFDSEC-----EVL 551
+FN +LG GSFG V KGT A+KI L+ + + D EC VL
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVL 395
Query: 552 -RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 610
+ L ++ S D V+E++ G L + F + ++
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIG 454
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATI 668
L +L S II+ DLK N++LD H+ +DFG+ K + T+T T
Sbjct: 455 LFFLQ----SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK-ENIWDGVTTKTFC-GTP 506
Query: 669 GYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 708
Y+APE YG D +++GVLL E + P DE+F
Sbjct: 507 DYIAPEIIAYQPYGKS------VDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 63/195 (32%), Positives = 89/195 (45%), Gaps = 20/195 (10%)
Query: 182 NIPQEIGNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRNNNLEGSIPYDLCH-LK 239
NIP + L L SN L+ ++ RL +L+ L L +N L+ ++P + LK
Sbjct: 34 NIP------ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELK 85
Query: 240 LMFGIRLTGNKLSGHIPPCL-VSLTSLRELHLGSNKLTS---SIPSSLWSLEYILDINLS 295
+ + +T NKL +P + L +L EL L N+L S + SL L Y+ +L
Sbjct: 86 NLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL---SLG 141
Query: 296 SNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPES 354
N L SLP V KL L L L NQL L +L+TL L NQ + +
Sbjct: 142 YNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200
Query: 355 VGSLISLESLDLSGN 369
SL L+ L L N
Sbjct: 201 FDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 60/183 (32%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 231 IPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS---SIPSSLWSLE 287
IP D L L NKLS LT LR L+L NKL + I L +LE
Sbjct: 35 IPADTKKLDLQ------SNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88
Query: 288 YILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTI-GALKDLETLSLARN 345
+ ++ N L +LP V +L L L L RNQL +P + +L L LSL N
Sbjct: 89 T---LWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYN 143
Query: 346 QFQGPIPESV-GSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGS 404
+ Q +P+ V L SL+ L L N L + + L++LK + +N+L+ +P +G+
Sbjct: 144 ELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVP-EGA 200
Query: 405 FKN 407
F +
Sbjct: 201 FDS 203
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 57/200 (28%), Positives = 80/200 (40%), Gaps = 18/200 (9%)
Query: 29 VPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKL 88
+P I + + L L+ N+LS LPS H L + L L N L + L
Sbjct: 31 IPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 89 VALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILS 148
L + N + F L +L+ L N L + F SLT LT LS
Sbjct: 88 ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRV----F-DSLTK---LTYLS 139
Query: 149 FGSNPLGGILPPVIGNFS--ASLQKFYAYECKLKGNIPQEI-GNLSGLTLLSLHSNDLNG 205
G N L LP G F SL++ Y +LK +P+ L+ L L L +N L
Sbjct: 140 LGYNELQ-SLPK--GVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKR 195
Query: 206 TISPTMGRLKRLQGLSLRNN 225
L++L+ L L+ N
Sbjct: 196 VPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 55/196 (28%), Positives = 84/196 (42%), Gaps = 24/196 (12%)
Query: 108 NLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFS- 166
+ + L L S N L++ S A LT L +L N L LP G F
Sbjct: 38 DTKKLDLQS---NKLSSLPSKA-----FHRLTK---LRLLYLNDNKLQT-LPA--GIFKE 83
Query: 167 -ASLQKFYAYECKLKGNIPQEI-GNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLR 223
+L+ + + KL+ +P + L L L L N L ++ P + L +L LSL
Sbjct: 84 LKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLG 141
Query: 224 NNNLEGSIPYDLC-HLKLMFGIRLTGNKLSGHIPPCL-VSLTSLRELHLGSNKLTSSIPS 281
N L+ S+P + L + +RL N+L +P LT L+ L L +N+L
Sbjct: 142 YNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEG 199
Query: 282 SLWSLEYILDINLSSN 297
+ SLE + + L N
Sbjct: 200 AFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 8e-08
Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 4/113 (3%)
Query: 5 IPTEI-GNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVGHLLP 62
+P + L NL L N L L PP +F +++ + L+L N+L LP V L
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKSL-PPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLT 157
Query: 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLL 115
+++ L L N L + + T+L L L N F +L L +L
Sbjct: 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 38/144 (26%), Positives = 49/144 (34%), Gaps = 11/144 (7%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLL 69
L+NL+ L +N L L P +F + + L L+ NQL LP V L + L L
Sbjct: 83 ELKNLETLWVTDNKLQAL-PIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSL 140
Query: 70 AANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSA 129
N L + T L L L N F L L L N L A
Sbjct: 141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200
Query: 130 DQWSFLSSLTNCRNLTILSFGSNP 153
+ L +L NP
Sbjct: 201 --------FDSLEKLKMLQLQENP 216
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 7/107 (6%)
Query: 292 INLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPI 351
++ SS L ++PSN+ LDL N+LS L L L L N+ Q +
Sbjct: 21 VDCSSKKL-TAIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-L 76
Query: 352 PESV-GSLISLESLDLSGNNLSGKIPKSL-ETLSQLKQFNVSHNRLE 396
P + L +LE+L ++ N L +P + + L L + + N+L+
Sbjct: 77 PAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK 122
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 45/191 (23%), Positives = 86/191 (45%), Gaps = 22/191 (11%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIK-IFN-----LQLERAFRSFDSECEVLR 552
D + +L+GTGS+G V + + VAIK I + +R R E +L
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILN 107
Query: 553 NVRHRNLIKILSSCSNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 607
+ H +++K+L D + +VLE + +K + Y ++ + ++ ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNL 165
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT 667
++Y+H SA I+H DLKP N L++++ + V DFG+++ + E+ +Q
Sbjct: 166 LVGVKYVH----SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 668 IGYMAPEYGSE 678
M
Sbjct: 222 EDDMNLVTFPH 232
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 64/341 (18%), Positives = 112/341 (32%), Gaps = 62/341 (18%)
Query: 62 PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNN 121
P + + I + + +L S T L + + ++
Sbjct: 2 PLGSETITVPTPIKQIFSDD--AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSD 57
Query: 122 LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKG 181
+ + + + N+T L N L I P
Sbjct: 58 IKS----------VQGIQYLPNVTKLFLNGNKLTDIKP---------------------- 85
Query: 182 NIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLM 241
+ NL L L L N + +S + LK+L+ LSL +N + I L HL +
Sbjct: 86 -----LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQL 136
Query: 242 FGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLND 301
+ L NK++ I L LT L L L N+++ L L + ++ LS N ++D
Sbjct: 137 ESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISD 192
Query: 302 SLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISL 361
+ LK L VL+L + + L T+ + GSL++
Sbjct: 193 --LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN-----------TDGSLVTP 239
Query: 362 ESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVK 402
E + G+ + L + F G+ +
Sbjct: 240 EIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 280
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 55/341 (16%), Positives = 105/341 (30%), Gaps = 81/341 (23%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLA 70
+ +++ V + L +I+ ++
Sbjct: 22 AFAETIKDNLKKKSVTDAVT------------------QNE---------LNSIDQIIAN 54
Query: 71 ANNLTGIIPHSITNATKLVALDLGFNSFAGHI--LNTFGNLRHLSLLSQVMNNLTTESSS 128
+++ + I + L L N + + NL++L L N +
Sbjct: 55 NSDIKSVQG--IQYLPNVTKLFLNGN----KLTDIKPLANLKNLGWLFLDENKVKD---- 104
Query: 129 ADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIG 188
LSSL + + L LS N + I +
Sbjct: 105 ------LSSLKDLKKLKSLSLEHNGISDI---------------------------NGLV 131
Query: 189 NLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTG 248
+L L L L +N + I+ + RL +L LSL +N + I L L + + L+
Sbjct: 132 HLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSK 187
Query: 249 NKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQ 308
N +S + L L +L L L S + + + +L + + SL P +
Sbjct: 188 NHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIIS 243
Query: 309 KLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQG 349
++ + L T+ A+ +F G
Sbjct: 244 DDGDYEKPNVKWH-LPEFTNEVSFIFYQPVTIGKAKARFHG 283
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 36/197 (18%), Positives = 65/197 (32%), Gaps = 26/197 (13%)
Query: 9 IGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL--LPNIES 66
I L N+ L N L+ + P + N+ + L L+ N++ + L L ++S
Sbjct: 64 IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKV-----KDLSSLKDLKKLKS 116
Query: 67 LLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTES 126
L L N ++ I + + +L +L LG N + L L LS N ++
Sbjct: 117 LSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISD-- 170
Query: 127 SSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQE 186
+ L L L N + + + +L + +
Sbjct: 171 --------IVPLAGLTKLQNLYLSKNHISDLRA--LAGLK-NLDVLELFSQECLNKPINH 219
Query: 187 IGNLSGLTLLSLHSNDL 203
NL + L
Sbjct: 220 QSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 39/150 (26%), Positives = 62/150 (41%), Gaps = 23/150 (15%)
Query: 7 TEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL--LPNI 64
+ NL+NL +L EN + L + ++ ++ L+LE N + S + L LP +
Sbjct: 84 KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGI-----SDINGLVHLPQL 136
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTT 124
ESL L N +T I ++ TKL L L N + L L L N+++
Sbjct: 137 ESLYLGNNKITDITV--LSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISD 192
Query: 125 ESSSADQWSFLSSLTNCRNLTILSFGSNPL 154
L +L +NL +L S
Sbjct: 193 ----------LRALAGLKNLDVLELFSQEC 212
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 57/249 (22%), Positives = 100/249 (40%), Gaps = 35/249 (14%)
Query: 473 STKHLDHEDFLPLATW----RRTPYLDIQRATDEFNECNLLGTGSFGSVYKGT-ISDGTD 527
+ H H L T + D + LG G++G VYK
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNET 61
Query: 528 VAIKIFNLQLER------AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPN 581
VAIK L+ E A R E +L+ ++HRN+I++ S + L+ E+ N
Sbjct: 62 VAIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117
Query: 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAA 641
L+K++ + + + + + + + + + H +H DLKP N+LL + A+
Sbjct: 118 -DLKKYMDKNPDVSMRVIK-SFLYQLINGVNFCHSRR----CLHRDLKPQNLLLSVSDAS 171
Query: 642 H-----VSDFGISKLLGEGEDSVTQTMT--MATIGYMAPE--YGSEGIVSAKCDVYSYGV 692
+ DFG+++ G + T + T+ Y PE GS S D++S
Sbjct: 172 ETPVLKIGDFGLARAFG----IPIRQFTHEIITLWYRPPEILLGSR-HYSTSVDIWSIAC 226
Query: 693 LLMETFTRK 701
+ E +
Sbjct: 227 IWAEMLMKT 235
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 44/200 (22%), Positives = 78/200 (39%), Gaps = 15/200 (7%)
Query: 187 IGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRL 246
L+ +L + + L +Q + N+N++ S+ + + + L
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHL 70
Query: 247 TGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSN 306
+ N++S + P L LT L EL + N+L + L + L +N L D +
Sbjct: 71 SHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELRD--TDS 123
Query: 307 VQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDL 366
+ LK L +L + N+L I +G L LE L L N+ + L + +DL
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179
Query: 367 SGNNLSGKIPKSLETLSQLK 386
+G + K L
Sbjct: 180 TGQKCVNEPVKYQPELYITN 199
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 43/241 (17%), Positives = 88/241 (36%), Gaps = 20/241 (8%)
Query: 135 LSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLT 194
+ N + G + ++ S +Q F ++ ++ + + L
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVS--QKELS-GVQNFNGDNSNIQ-SL-AGMQFFTNLK 66
Query: 195 LLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGH 254
L L N ++ +SP + L +L+ LS+ N L+ L +F L N+L
Sbjct: 67 ELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELR-D 120
Query: 255 IPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLT 314
L+ L +L L + +NKL S L L + ++L N + + + +LK +
Sbjct: 121 TDS-LIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITN--TGGLTRLKKVN 175
Query: 315 VLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPI-PESVGSLISLESLDLSGNNLSG 373
+DL+ + + P +L + ++ I P + + S +
Sbjct: 176 WIDLTGQKCV-NEPVKY--QPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVY 232
Query: 374 K 374
Sbjct: 233 T 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 35/138 (25%), Positives = 60/138 (43%), Gaps = 11/138 (7%)
Query: 259 LVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDL 318
L + + +LG +T S L + + N ++++ + +Q L L L
Sbjct: 15 DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHL 70
Query: 319 SRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKS 378
S NQ+S D+ S + L LE LS+ RN+ + + L L L N L S
Sbjct: 71 SHNQIS-DL-SPLKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD--TDS 123
Query: 379 LETLSQLKQFNVSHNRLE 396
L L L+ ++ +N+L+
Sbjct: 124 LIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 43/238 (18%), Positives = 79/238 (33%), Gaps = 57/238 (23%)
Query: 7 TEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHL--LPNI 64
L N + +++ LV +S ++ + + + ++ + N+
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI-----QSLAGMQFFTNL 65
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSL--LSQVMNNL 122
+ L L+ N ++ + P + + TKL L + N L + L L N L
Sbjct: 66 KELHLSHNQISDLSP--LKDLTKLEELSVNRNR-----LKNLNGIPSACLSRLFLDNNEL 118
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN 182
SL + +NL ILS +N L I+
Sbjct: 119 RD----------TDSLIHLKNLEILSIRNNKLKSIVM----------------------- 145
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKL 240
+G LS L +L LH N++ + RLK++ + L L +
Sbjct: 146 ----LGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYI 197
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 42/212 (19%), Positives = 77/212 (36%), Gaps = 18/212 (8%)
Query: 190 LSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRNNNLEGSIP----YDLCHLKLMFGI 244
L L L TI L + + + + + Y+L + I
Sbjct: 30 PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTH---I 85
Query: 245 RLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIP--SSLWSLEYILDINLSSNSLND 301
+ + +I P L L L+ L + + L P + ++S + + ++ N
Sbjct: 86 EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMT 144
Query: 302 SLPSNV-QKLKVLTV-LDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV--GS 357
S+P N Q L T+ L L N + + L+ + L +N++ I + G
Sbjct: 145 SIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV 203
Query: 358 LISLESLDLSGNNLSGKIPKSLETLSQLKQFN 389
LD+S +++ K LE L +L N
Sbjct: 204 YSGPSLLDVSQTSVTALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 45/274 (16%), Positives = 87/274 (31%), Gaps = 71/274 (25%)
Query: 55 STVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHI-LNTFGNLRHLS 113
+ L P+ ++L L +L I H+ +N + + + + + ++F NL ++
Sbjct: 24 QRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVT 83
Query: 114 LLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFY 173
+ + N RNLT + +
Sbjct: 84 HI---------------------EIRNTRNLTYIDPDA-------------LK------- 102
Query: 174 AYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPT--MGRLKRLQGLSLRNNNLEGSI 231
L L L + + L + L + +N SI
Sbjct: 103 ---------------ELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 232 PYD-LCHL-KLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIP----SSLWS 285
P + L ++L N + + + T L ++L NK + I ++S
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205
Query: 286 LEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDL 318
+LD +S S+ +LPS + LK L +
Sbjct: 206 GPSLLD--VSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 30/226 (13%), Positives = 60/226 (26%), Gaps = 37/226 (16%)
Query: 14 NLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANN 73
+ Q L E +L + N+ + + + + +L S + L + + +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 74 -LTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQW 132
LT I P ++ L L + L+
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNT-----------GLKMFP-----------------DL 123
Query: 133 SFLSSLTNCRNLTILSFGSNPLGGILPP-VIGNFSASLQKFYAYECKLKGNIPQEIGNLS 191
+ + S IL NP +P Y ++ N +
Sbjct: 124 TKVYSTD---IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGT 179
Query: 192 GLTLLSLHSNDLNGTISPTM--GRLKRLQGLSLRNNNLEGSIPYDL 235
L + L+ N I G L + ++ ++P
Sbjct: 180 KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 64/232 (27%), Positives = 96/232 (41%), Gaps = 45/232 (19%)
Query: 501 DEFNECNLLGTGSFGSV----YKGTISDGTDVAIKIFNLQLERAFRSFDSEC-----EVL 551
++F +LG GSFG V +K T AIK L+ + D EC VL
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKA--LKKDVVLMDDDVECTMVEKRVL 71
Query: 552 -RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 610
H L + + + V+E++ G L + S + F ++
Sbjct: 72 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILG 130
Query: 611 LEYLH-HGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMAT 667
L++LH G I++ DLK NILLD++ H+ +DFG+ K D+ T T T
Sbjct: 131 LQFLHSKG-----IVYRDLKLDNILLDKD--GHIKIADFGMCK-ENMLGDAKTNTFC-GT 181
Query: 668 IGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 708
Y+APE Y D +S+GVLL E + P +E+F
Sbjct: 182 PDYIAPEILLGQKYNHS------VDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 4/122 (3%)
Query: 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE 637
E + FL + + V +E+L +S IH DL NILL E
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSE 228
Query: 638 NMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMET 697
+ DFG+++ + + D V + + +MAPE + + + + DV+S+GVLL E
Sbjct: 229 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
Query: 698 FT 699
F+
Sbjct: 289 FS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 43/197 (21%), Positives = 71/197 (36%), Gaps = 25/197 (12%)
Query: 483 LPLATWRRTPYLDIQRATDEFNECNL-----LGTGSFGSVYKGTI------SDGTDVAIK 531
LPL L + EF L LG G+FG V + + VA+K
Sbjct: 1 LPLDE--HCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 58
Query: 532 IFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALV-LEFMPNGSLEKWL 588
+ R+ SE ++L ++ H N++ +L +C+ P +V +EF G+L +L
Sbjct: 59 MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
Query: 589 YSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGI 648
S N + + G I DLK + + ++ S F
Sbjct: 119 RSKR---------NEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169
Query: 649 SKLLGEGEDSVTQTMTM 665
K L + E+
Sbjct: 170 EKSLSDVEEEEAPEDLY 186
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 48/216 (22%)
Query: 509 LGTGSFGSVYKGTISD-GTDVAIK-IFN-----LQLERAFRSFDSECEVLRNVRHRNLIK 561
+G+G++G+V G VAIK ++ L +RA+R E +L+++RH N+I
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 562 IL----SSCSNPDFKA--LVLEFMPNGSLEKWLYS-------HNYFLDILERLNIMIDVG 608
+L + DF LV+ FM L K + + + + +
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK-------- 139
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MA 666
L Y+H +A IIH DLKP N+ ++E+ + DFG+++ MT +
Sbjct: 140 -GLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QADSEMTGYVV 187
Query: 667 TIGYMAPEY-GSEGIVSAKCDVYSYGVLLMETFTRK 701
T Y APE + + D++S G ++ E T K
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-16
Identities = 59/246 (23%), Positives = 97/246 (39%), Gaps = 69/246 (28%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIK-IFN-----LQLERAFRSFDSECEVLR 552
++ LG G++G V+K G VA+K IF+ +R FR E +L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILT 63
Query: 553 NVR-HRNLIKILSSCSNPDFKA--LVLEFMPNGSLEKWLYS-------HNYFL-DILERL 601
+ H N++ +L+ + + LV ++M L + + Y + ++
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLI--- 119
Query: 602 NIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFG-------------- 647
++YLH S ++H D+KP+NILL+ V+DFG
Sbjct: 120 -------KVIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 648 ---ISKLLGEGEDSVTQTMT--MATIGYMAPE-------YGSEGIVSAKCDVYSYGVLLM 695
E D +T +AT Y APE Y ++GI D++S G +L
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY-TKGI-----DMWSLGCILG 222
Query: 696 ETFTRK 701
E K
Sbjct: 223 EILCGK 228
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-16
Identities = 65/231 (28%), Positives = 98/231 (42%), Gaps = 43/231 (18%)
Query: 501 DEFNECNLLGTGSFGSVY----KGTISDGTDVAIKIFNLQLERAFRSFDSEC-----EVL 551
+F+ ++G GSFG V K A+K+ LQ + + + + VL
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAE---EVFYAVKV--LQKKAILKKKEEKHIMSERNVL 92
Query: 552 -RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 610
+NV+H L+ + S D VL+++ G L L FL+ R ++ SA
Sbjct: 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASA 151
Query: 611 LEYLH-HGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMAT 667
L YLH I++ DLKP NILLD H+ +DFG+ K +S T T T
Sbjct: 152 LGYLHSLN-----IVYRDLKPENILLDSQ--GHIVLTDFGLCK-ENIEHNSTTSTFC-GT 202
Query: 668 IGYMAPEYGSEGIVSAK-----CDVYSYGVLLMETFTRKRP-----TDEMF 708
Y+APE ++ + D + G +L E P T EM+
Sbjct: 203 PEYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 9e-16
Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 40/221 (18%)
Query: 500 TDEFNECNLLGTGSFGSVYKGTISD-GTDVAIK----IFNLQLE--RAFRSFDSECEVLR 552
+ +G+G+ G V + +VAIK F Q RA+R E +++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 116
Query: 553 NVRHRNLIKIL----SSCSNPDFKA--LVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 606
V H+N+I +L + +F+ LV+E M +L + + LD ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME---LDHERMSYLLYQ 172
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT-- 664
+ +++LH SA IIH DLKP+NI++ + + DFG+++ G + MT
Sbjct: 173 MLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPY 223
Query: 665 MATIGYMAPEYGSEGIVSAKC----DVYSYGVLLMETFTRK 701
+ T Y APE I+ D++S G ++ E K
Sbjct: 224 VVTRYYRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 9e-16
Identities = 34/238 (14%), Positives = 75/238 (31%), Gaps = 26/238 (10%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRNNNLEGSIPYD------- 234
IP ++ L L I L+ + + N++ I D
Sbjct: 24 IPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 235 LCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDIN 293
L +++ N L +I P +L +L+ L + + + + ++
Sbjct: 81 LHEIRI-----EKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 134
Query: 294 LSSNSLNDSLPSNV-QKLKV-LTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPI 351
+ N ++ N L +L L++N + S + E N +
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELP 194
Query: 352 PESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
+ LD+S + LE L +L+ + + + ++P + +
Sbjct: 195 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP---TLEKLV 246
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 50/321 (15%), Positives = 103/321 (32%), Gaps = 66/321 (20%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+IP+++ +N L F L + + + + N + + + V LP
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 64 IESL-LLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
+ + + ANNL I P + N L L + ++HL +
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT-----------GIKHLPDV------- 122
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN 182
+ SL +L N + +F
Sbjct: 123 ----------HKIHSL----QKVLLDIQDNINIHTIER--NSFV---------------- 150
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYD-LCHLKLM 241
G +L L+ N + I + +L L+L +NN +P D
Sbjct: 151 -----GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGP 204
Query: 242 FGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
+ ++ ++ +P L +L LR + K +P +L L +++ +L+ S
Sbjct: 205 VILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYPSHC 259
Query: 301 DSLPSNVQKLKVLTVLDLSRN 321
+ + +++ L +
Sbjct: 260 CAFANWRRQISELHPICNKSI 280
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 68/231 (29%), Positives = 93/231 (40%), Gaps = 43/231 (18%)
Query: 501 DEFNECNLLGTGSFGSVY----KGTISDGTDVAIKIFNLQLERAFRSFDSEC-----EVL 551
D F +LG GSFG V K T G A+K+ L+ + + D EC +L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKET---GDLYAVKV--LKKDVILQDDDVECTMTEKRIL 77
Query: 552 RNV-RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 610
H L ++ PD V+EF+ G L + F + R ++ SA
Sbjct: 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISA 136
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATI 668
L +LH II+ DLK N+LLD H +DFG+ K G T T T
Sbjct: 137 LMFLH----DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCK-EGICNGVTTATFC-GTP 188
Query: 669 GYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMF 708
Y+APE YG D ++ GVLL E P D++F
Sbjct: 189 DYIAPEILQEMLYGPA------VDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 41/230 (17%)
Query: 501 DEFNECNLLGTGSFGSV----YKGTISDGTDVAIKIFNLQLERAFRSFDSEC-----EVL 551
+FN +LG GSFG V KGT A+KI L+ + + D EC VL
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVL 74
Query: 552 -RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 610
+ L ++ S D V+E++ G L + F + ++
Sbjct: 75 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIG 133
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATI 668
L +L S II+ DLK N++LD H+ +DFG+ K + T+T T
Sbjct: 134 LFFLQ----SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK-ENIWDGVTTKTFC-GTP 185
Query: 669 GYMAPEYGSEGIVSAK-----CDVYSYGVLLMETFTRKRP-----TDEMF 708
Y+APE I++ + D +++GVLL E + P DE+F
Sbjct: 186 DYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 499 ATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLER-----AFRSFDSECEVLR 552
++ +F + LG G++ +VYKG + G VA+K L E A R E +++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMK 58
Query: 553 NVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF-----LDILERLNIMIDV 607
++H N++++ + LV EFM N L+K++ S L++ +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--M 665
L + H I+H DLKP N+L+++ + DFG+++ G T + +
Sbjct: 118 LQGLAFCHENK----ILHRDLKPQNLLINKRGQLKLGDFGLARAFG----IPVNTFSSEV 169
Query: 666 ATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
T+ Y AP+ GS S D++S G +L E T K
Sbjct: 170 VTLWYRAPDVLMGSR-TYSTSIDIWSCGCILAEMITGK 206
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 39/192 (20%), Positives = 72/192 (37%), Gaps = 40/192 (20%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIK-IFN-----LQLERAFRSFDSECEVLRNVRHRNLIK 561
+G GS+G VY + +VAIK + + +R R E +L ++ +I+
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89
Query: 562 IL---SSCSNPDFKA--LVLEFMPNGSLEKWLYSHN--------YFL-DILERLNIMIDV 607
+ F +VLE + L+K + L ++L
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLL--------- 139
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT 667
++H + IIH DLKP N LL+++ + V DFG+++ + +D+
Sbjct: 140 -LGENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 668 IGYMAPEYGSEG 679
+
Sbjct: 195 EEPGPHNKNLKK 206
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 37/225 (16%)
Query: 498 RATDEFNECNLLGTGSFGSVYKGTISDGTD--VAIKIFNLQLER------AFRSFDSECE 549
RA ++ +G G++G V+K VA+K +Q R E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------E 61
Query: 550 V-----LRNVRHRNLIKILSSCSNPDFKA-----LVLEFMPNGSLEKWLYSH-NYFLDIL 598
V L H N++++ C+ LV E + L +L +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 599 ERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658
++M + L++LH ++H DLKP NIL+ + ++DFG++++
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQ 173
Query: 659 VTQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
+ T + T+ Y APE S + D++S G + E F RK
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 55/227 (24%), Positives = 89/227 (39%), Gaps = 39/227 (17%)
Query: 498 RATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLER---------AFRSFDSE 547
AT + +G G++G+VYK G VA+K + R
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR----- 60
Query: 548 CEV-----LRNVRHRNLIKILSSCSNPDFKA-----LVLEFMPNGSLEKWLYSHN-YFLD 596
EV L H N+++++ C+ LV E + L +L L
Sbjct: 61 -EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 597 ILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656
++M L++LH I+H DLKP NIL+ ++DFG++++
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYS--- 171
Query: 657 DSVTQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLLMETFTRK 701
+ T + T+ Y APE S + D++S G + E F RK
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRK 216
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 48/208 (23%), Positives = 75/208 (36%), Gaps = 23/208 (11%)
Query: 231 IPYDLCHLKLMFGIRLTGNKLSGHIPP--CLVSLTSLRELHLGSNKLTSSIPSSLWSLEY 288
+P L L+ N LS + LT+L L L N L + +
Sbjct: 37 LPSYTALL------DLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89
Query: 289 ILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQF 347
+ ++LSSN L+ +L + L+ L VL L N + + + L+ L L++NQ
Sbjct: 90 LRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI 148
Query: 348 QGPIPESV----GSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVS--HNRLE---GE 398
P + L L LDLS N L L+ L + + +N LE
Sbjct: 149 SR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207
Query: 399 IPVKGSF--KNFSVESFFGNYALCGPPK 424
+ + + S F C K
Sbjct: 208 YQLFSHWQYRQLSSVMDFQEDLYCMHSK 235
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 40/165 (24%), Positives = 65/165 (39%), Gaps = 14/165 (8%)
Query: 217 LQGLSLRNNNLEGSIP--YDLCHLKLMFGIRLTGNKLSGHIPPC-LVSLTSLRELHLGSN 273
L L +NNL + + L + + L+ N L+ I V + +LR L L SN
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 274 KLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIP---- 328
L + L+ + + L +N + + N + + L L LS+NQ+S P
Sbjct: 99 HLHTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELI 156
Query: 329 STIGALKDLETLSLARNQFQGPIPESVGSLISL--ESLDLSGNNL 371
L L L L+ N+ + + L + L L N L
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 35/148 (23%), Positives = 56/148 (37%), Gaps = 12/148 (8%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLL 69
L NL L+ + N+L+ + F + +R L L N L L + L +E LLL
Sbjct: 62 RLTNLHSLLLSHNHLNFI-SSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 70 AANNLTGIIPHSITNATKLVALDLGFN---SFAGHILNTFGNLRHLSLLSQVMNNLTTES 126
N++ + ++ + +L L L N F ++ L L LL N L
Sbjct: 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLP 179
Query: 127 SSADQWSFLSSLTNCRNLTILSFGSNPL 154
+ L + L +NPL
Sbjct: 180 LTD--LQKLPAWV----KNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 56/222 (25%), Positives = 75/222 (33%), Gaps = 51/222 (22%)
Query: 29 VPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKL 88
VP ++ S +L L N LS L N+ SLLL+ N+L I + L
Sbjct: 33 VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNL 90
Query: 89 VALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILS 148
LDL N +L L S L L +L
Sbjct: 91 RYLDLSSN-----------HLHTL------------------DEFLFSDLQ---ALEVLL 118
Query: 149 FGSNPLGGILPPVIGNFS--ASLQKFYAYECKLKGNIPQEI----GNLSGLTLLSLHSND 202
+N + + F A LQK Y + ++ P E+ L L LL L SN
Sbjct: 119 LYNNHIVVVDR---NAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNK 174
Query: 203 LNGTISPTMGRLKRL--QGLSLRNNNLEGSIPYDLCHLKLMF 242
L + +L GL L NN LE C L +F
Sbjct: 175 LKKLPLTDLQKLPAWVKNGLYLHNNPLECD-----CKLYQLF 211
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 33/164 (20%), Positives = 58/164 (35%), Gaps = 9/164 (5%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+P + + L + NNLS L ++ + L L N L+ + S +PN
Sbjct: 33 VPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
+ L L++N+L + ++ L L L N N F ++ L L N ++
Sbjct: 90 LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSA 167
+ L +L SN L + + A
Sbjct: 150 RFPVEL-----IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPA 188
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 56/257 (21%), Positives = 100/257 (38%), Gaps = 62/257 (24%)
Query: 500 TDEFNECNLLGTGSFGSVYKGTISD-GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN 558
+ +++ LGTGSFG V + + G A+K R E ++++ + H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61
Query: 559 LIKIL------------------------------------SSCSNPDFKA--LVLEFMP 580
+IK++ + K +++E++P
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 581 NGSLEKWLYSHNYFLDILERLNI---MIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE 637
+ +L K L S + I + + A+ ++H S I H D+KP N+L++
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH----SLGICHRDIKPQNLLVNS 176
Query: 638 NMAA-HVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE--YGSEGIVSAKCDVYSYGVLL 694
+ DFG +K L E S + + Y APE G+ + D++S G +
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATE-YTPSIDLWSIGCVF 232
Query: 695 METFTRKRPTDEMFTGE 711
E K P +F+GE
Sbjct: 233 GELILGK-P---LFSGE 245
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 38/214 (17%)
Query: 501 DEFNECNLLGTGSFGSVY----KGTISDGTDVAIKIFNLQLERAFRSFDSEC-----EVL 551
+F+ ++G GS+ V K T A+K+ ++ E D + V
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKV--VKKELVNDDEDIDWVQTEKHVF 63
Query: 552 -RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 610
+ H L+ + S V+E++ G L + + R ++ A
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLA 122
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATI 668
L YLH II+ DLK N+LLD H+ +D+G+ K G T T T
Sbjct: 123 LNYLH----ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-EGLRPGDTTSTFC-GTP 174
Query: 669 GYMAPE------YGSEGIVSAKCDVYSYGVLLME 696
Y+APE YG D ++ GVL+ E
Sbjct: 175 NYIAPEILRGEDYGFS------VDWWALGVLMFE 202
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 54/229 (23%), Positives = 85/229 (37%), Gaps = 48/229 (20%)
Query: 501 DEFNECNLLGTGSFGSVY----KGTISDGTDVAIKIFNLQLERAFRSFDSEC-----EVL 551
+F+ ++G GS+ V K T A+++ ++ E D + V
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKT---DRIYAMRV--VKKELVNDDEDIDWVQTEKHVF 106
Query: 552 -RNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 610
+ H L+ + S V+E++ G L + + R ++ A
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLA 165
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATI 668
L YLH II+ DLK N+LLD H+ +D+G+ K G T T T
Sbjct: 166 LNYLH----ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-EGLRPGDTTSTFC-GTP 217
Query: 669 GYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
Y+APE YG D ++ GVL+ EM G
Sbjct: 218 NYIAPEILRGEDYGFS------VDWWALGVLMF----------EMMAGR 250
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-14
Identities = 32/128 (25%), Positives = 59/128 (46%), Gaps = 4/128 (3%)
Query: 244 IRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDS 302
IRL N + IPP LR + L +N+++ P + L + + L N +
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 303 LPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISL 361
LP ++ + L L +L L+ N+++ L +L LSL N+ Q + L ++
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154
Query: 362 ESLDLSGN 369
+++ L+ N
Sbjct: 155 QTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-13
Identities = 29/134 (21%), Positives = 58/134 (43%), Gaps = 6/134 (4%)
Query: 263 TSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRN 321
++ E+ L N + P + + + I+LS+N + L + Q L+ L L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGN 90
Query: 322 QLSGDIPSTI-GALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLSGKIPKSL 379
+++ ++P ++ L L+ L L N+ + L +L L L N L +
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTF 148
Query: 380 ETLSQLKQFNVSHN 393
L ++ +++ N
Sbjct: 149 SPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 42/173 (24%), Positives = 66/173 (38%), Gaps = 44/173 (25%)
Query: 182 NIPQEIGNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRNNNLEGSIP----YDLC 236
N+P+ I T + L N + I P K+L+ + L NN + + L
Sbjct: 29 NLPETI------TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 237 HLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLS 295
L + L GNK++ +P L SL+ L L +NK+
Sbjct: 81 SLNS---LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN------------------- 117
Query: 296 SNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQF 347
L + Q L L +L L N+L T L+ ++T+ LA+N F
Sbjct: 118 ------CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 32/133 (24%), Positives = 60/133 (45%), Gaps = 21/133 (15%)
Query: 272 SNKLTS---SIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDI 327
LT ++P ++ + L N++ +P K L +DLS NQ+S ++
Sbjct: 20 GKGLTEIPTNLPETITEI------RLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-EL 71
Query: 328 PSTIGA---LKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLSGKIPK-SLETL 382
A L+ L +L L N+ +P+S+ L SL+ L L+ N ++ + + + L
Sbjct: 72 AP--DAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDL 127
Query: 383 SQLKQFNVSHNRL 395
L ++ N+L
Sbjct: 128 HNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 35/151 (23%), Positives = 57/151 (37%), Gaps = 17/151 (11%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+P I + L+ N + + PP F +R + L NQ+S L L +
Sbjct: 30 LPETITEI-RLEQ-----NTIKVI-PPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
+ SL+L N +T + L L L N ++ F +L +L+LLS N L
Sbjct: 82 LNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPL 154
T + + R + + NP
Sbjct: 142 TIAKGT--------FSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 36/164 (21%), Positives = 55/164 (33%), Gaps = 33/164 (20%)
Query: 62 PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNN 121
I + L N + I P + + KL +DL N + + F LR L+ L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 122 LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKG 181
+T S L +L +L +N + + F
Sbjct: 92 ITELPKSL-----FEGLF---SLQLLLLNANKINCLRV---DAFQ--------------- 125
Query: 182 NIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNN 225
+L L LLSL+ N L T L+ +Q + L N
Sbjct: 126 -------DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 52/253 (20%), Positives = 96/253 (37%), Gaps = 50/253 (19%)
Query: 477 LDHEDFLPLATWRRTPYLDIQRATDEFNECNL-LGTGSFGSVYKG---TISDGTDVAIKI 532
+D++ + L++ R R D F +G G++G VYK D D A+K
Sbjct: 3 MDYDFKVKLSSERE-------RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK- 54
Query: 533 FNLQLERAFRSFDSECEV--LRNVRHRNLIKILSSCSNPDFKA--LVLEFMPNGSLEKWL 588
Q+E S + E+ LR ++H N+I + + + L+ ++ + L +
Sbjct: 55 ---QIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII 110
Query: 589 YSHNYFLDILERLNI--------MIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA 640
H + + + + + + YLH ++H DLKP NIL+
Sbjct: 111 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW----VLHRDLKPANILVMGEGP 166
Query: 641 AH----VSDFGISKLLGEGEDSVTQ-TMTMATIGYMAPE-------YGSEGIVSAKCDVY 688
++D G ++L + + T Y APE Y D++
Sbjct: 167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA------IDIW 220
Query: 689 SYGVLLMETFTRK 701
+ G + E T +
Sbjct: 221 AIGCIFAELLTSE 233
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 44/222 (19%)
Query: 194 TLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSG 253
+L + T + T L + + N++++
Sbjct: 22 IKANLKKKSV--TDAVTQNELNSIDQIIANNSDIKSVQGIQ------------------- 60
Query: 254 HIPPCLVSLTSLRELHLGSNKLTSSIPS--SLWSLEYILDINLSSNSLNDSLPSNV-QKL 310
L ++R L LG NKL I + L +L Y+ L+ N L SLP+ V KL
Sbjct: 61 -------YLPNVRYLALGGNKLHD-ISALKELTNLTYL---ILTGNQLQ-SLPNGVFDKL 108
Query: 311 KVLTVLDLSRNQLSGDIPSTI-GALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSG 368
L L L NQL +P + L +L L+LA NQ Q +P+ V L +L LDLS
Sbjct: 109 TNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSY 166
Query: 369 NNLSGKIPKSL-ETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
N L +P+ + + L+QLK + N+L+ +P G F +
Sbjct: 167 NQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VP-DGVFDRLT 205
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 50/224 (22%), Positives = 82/224 (36%), Gaps = 53/224 (23%)
Query: 135 LSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIG---NLS 191
+ ++ + ++ + + I + +++ L GN +I L+
Sbjct: 34 AVTQNELNSIDQIIANNSDIKSV--QGI-QYLPNVRYLA-----LGGNKLHDISALKELT 85
Query: 192 GLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRNN---NLEGSIPYDLCHLKLMFGIRLT 247
LT L L N L ++ + +L L+ L L N +L + L +L + L
Sbjct: 86 NLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL---NLA 141
Query: 248 GNKLSGHIPPCLV-SLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSN 306
N+L +P + LT+L EL L N+L SLP
Sbjct: 142 HNQLQS-LPKGVFDKLTNLTELDLSYNQLQ-------------------------SLPEG 175
Query: 307 V-QKLKVLTVLDLSRNQLSGDIPSTIGA---LKDLETLSLARNQ 346
V KL L L L +NQL +P G L L+ + L N
Sbjct: 176 VFDKLTQLKDLRLYQNQLKS-VPD--GVFDRLTSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 35/137 (25%), Positives = 58/137 (42%), Gaps = 14/137 (10%)
Query: 263 TSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQ 322
+ +L +T ++ + L I I +++ + S+ +Q L + L L N+
Sbjct: 19 AETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNK 74
Query: 323 LSGDIPSTIGA---LKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLSGKIPKS 378
L I A L +L L L NQ Q +P V L +L+ L L N L
Sbjct: 75 L-----HDISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGV 128
Query: 379 LETLSQLKQFNVSHNRL 395
+ L+ L N++HN+L
Sbjct: 129 FDKLTNLTYLNLAHNQL 145
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 21/131 (16%), Positives = 45/131 (34%), Gaps = 21/131 (16%)
Query: 272 SNKLT---SSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP 328
+ + NL S+ + +L + + + + + +
Sbjct: 7 TPIKQIFPDDAFAETIKA------NLKKKSVT-DAVTQ-NELNSIDQIIANNSDIKS-VQ 57
Query: 329 STIGALKDLETLSLARNQFQGPIPESVG---SLISLESLDLSGNNLSGKIPKSLETLSQL 385
I L ++ L+L N+ + L +L L L+GN L + L+ L
Sbjct: 58 G-IQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNL 111
Query: 386 KQFNVSHNRLE 396
K+ + N+L+
Sbjct: 112 KELVLVENQLQ 122
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 35/108 (32%), Positives = 48/108 (44%), Gaps = 6/108 (5%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIFN-ISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLL 69
L NL YL+ N L L P +F+ ++ ++ L L NQL LP V L N+ L L
Sbjct: 83 ELTNLTYLILTGNQLQSL-PNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNL 140
Query: 70 AANNLTGIIPHSITNATKLVALDLGFN---SFAGHILNTFGNLRHLSL 114
A N L + T L LDL +N S + + L+ L L
Sbjct: 141 AHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRL 188
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (167), Expect = 1e-12
Identities = 38/200 (19%), Positives = 61/200 (30%), Gaps = 55/200 (27%)
Query: 499 ATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKI--------FNLQLERAFRSFDSECEV 550
T++ C +G G FG V++ I+D T VAIKI N ++ F E +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 551 LRNV---------RHRNLIKILSSC------------------------------SNPDF 571
+ + R I + S D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 572 KALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKP 630
+VLEF G LE+ + +I+ + ++L H DL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR---FEHRDLHW 190
Query: 631 TNILLDENMAAHVSDFGISK 650
N+LL + + K
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 47/153 (30%), Positives = 63/153 (41%), Gaps = 24/153 (15%)
Query: 245 RLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS---SIPSSLWSLEYILDINLSSNSLND 301
L L+ LT L L+L N+L + + L L + L++N L
Sbjct: 41 DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGT---LGLANNQLA- 96
Query: 302 SLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGA---LKDLETLSLARNQFQGPIPESV-G 356
SLP V L L L L NQL +PS G L L+ L L NQ Q IP
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKS-LPS--GVFDRLTKLKELRLNTNQLQS-IPAGAFD 152
Query: 357 SLISLESLDLSGNNLSGKIP-------KSLETL 382
L +L++L LS N L +P L+T+
Sbjct: 153 KLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTI 184
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 218 QGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLT 276
+ L L++ L L + + L N+L + LT L L L +N+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 277 S---SIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIG 332
S + L L+ + L N L SLPS V +L L L L+ NQL IP+ G
Sbjct: 97 SLPLGVFDHLTQLDKL---YLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPA--G 149
Query: 333 A---LKDLETLSLARNQFQGPIPESVGSLISLESLDLSGN 369
A L +L+TLSL+ NQ Q + L L+++ L GN
Sbjct: 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 50/161 (31%), Positives = 75/161 (46%), Gaps = 14/161 (8%)
Query: 194 TLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDL-CHLKLMFGIRLTGNKLS 252
L L S L T L +L L+L N L+ ++ + L + + L N+L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 253 GHIPPCLV-SLTSLRELHLGSNKLTSSIPS----SLWSLEYILDINLSSNSLNDSLPSNV 307
+P + LT L +L+LG N+L S +PS L L+ + L++N L S+P+
Sbjct: 97 S-LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKEL---RLNTNQLQ-SIPAGA 150
Query: 308 -QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQF 347
KL L L LS NQL L L+T++L NQF
Sbjct: 151 FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 44/164 (26%), Positives = 61/164 (37%), Gaps = 15/164 (9%)
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTT 124
E L L + L + + TKL L+L +N F +L L L N L +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 125 ESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFS--ASLQKFYAYECKLKGN 182
LT L L G N L LP G F L++ +L+ +
Sbjct: 98 LPLGV-----FDHLTQ---LDKLYLGGNQLKS-LPS--GVFDRLTKLKELRLNTNQLQ-S 145
Query: 183 IPQEI-GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNN 225
IP L+ L LSL +N L RL +LQ ++L N
Sbjct: 146 IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 25/84 (29%), Positives = 39/84 (46%), Gaps = 4/84 (4%)
Query: 314 TVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLS 372
LDL L+ +T L L L+L NQ Q + V L L +L L+ N L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 373 GKIPKSL-ETLSQLKQFNVSHNRL 395
+P + + L+QL + + N+L
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQL 119
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 47/235 (20%), Positives = 90/235 (38%), Gaps = 53/235 (22%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR----------- 555
LG G F +V+ + + T VA+KI + + + E ++L+ V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 556 HRNLIKILSS----CSNPDFKALVLEFMPNGSLEKWLYSHNYF---LDILERLNIMIDVG 608
+++K+L N +V E + +L + + + L +++ I +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQLL 141
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAH------VSDFGISKLLGEGEDSVTQT 662
L+Y+H IIH D+KP N+L++ + ++D G + E + QT
Sbjct: 142 LGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 663 MTMATIGYMAPE------YGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711
Y +PE +G D++S L+ E T +F +
Sbjct: 199 RE-----YRSPEVLLGAPWG------CGADIWSTACLIFELITGDF----LFEPD 238
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 37/151 (24%), Positives = 66/151 (43%), Gaps = 18/151 (11%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI-KILSSC 566
+G G+FG + G + VAIK+ ++ E + + + I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 567 SNPDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIH 625
+ A+VLE + G SLE + + L I I + S +EY+H S +I+
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH----SKNLIY 128
Query: 626 CDLKPTNILL------DENMAAHVSDFGISK 650
D+KP N L+ + + H+ DF ++K
Sbjct: 129 RDVKPENFLIGRPGNKTQQV-IHIIDFALAK 158
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 54/219 (24%), Positives = 83/219 (37%), Gaps = 55/219 (25%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHR------NLI 560
++G GSFG V K VA+K+ +R R E +L ++R + N+I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 561 KILSS-------CSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLN----------- 602
+L + C + E L S N + +++++
Sbjct: 163 HMLENFTFRNHIC-------MTFE----------LLSMNLY-ELIKKNKFQGFSLPLVRK 204
Query: 603 IMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAH--VSDFGISKLLGEGEDSVT 660
+ L+ LH IIHCDLKP NILL + + V DFG S + +
Sbjct: 205 FAHSILQCLDALH----KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI 260
Query: 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
Q+ Y APE D++S G +L E T
Sbjct: 261 QSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 33/151 (21%), Positives = 61/151 (40%), Gaps = 18/151 (11%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI-KILSSC 566
+G GSFG +++GT + + VAIK + + E + + I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 567 SNPDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIH 625
LV++ + G SLE L + + + ++ +H +++
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVY 129
Query: 626 CDLKPTNILL------DENMAAHVSDFGISK 650
D+KP N L+ + NM +V DFG+ K
Sbjct: 130 RDIKPDNFLIGRPNSKNANM-IYVVDFGMVK 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI-KILSSC 566
+G+GSFG +Y GT I+ G +VAIK+ ++ + E ++ + ++ I I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 567 SNPDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIH 625
+ D+ +V+E + G SLE + + L + + S +EY+H S IH
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIH 128
Query: 626 CDLKPTNILLDENMAAH---VSDFGISK 650
D+KP N L+ + + DFG++K
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 30/142 (21%), Positives = 61/142 (42%), Gaps = 7/142 (4%)
Query: 267 ELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGD 326
ELH + + ++L +L+ + LS+N++ S++ ++ L +L L RN +
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-K 84
Query: 327 IPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSG-KIPKSLETLSQL 385
I + LE L ++ NQ + L++L L +S N ++ L L +L
Sbjct: 85 IENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL 142
Query: 386 KQFNVSHNRLEGEIPVKGSFKN 407
+ ++ N L + +
Sbjct: 143 EDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 49/213 (23%)
Query: 169 LQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNG--TISPTMGRLKRLQGLSLRNNN 226
+ K + ++ ++ + + LH + + T+ LK + L+L NN
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKVELH-GMIPPIEKMDATLSTLKACKHLALSTNN 59
Query: 227 LEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT--SSIPSSLW 284
+E K+S L + +LR L LG N + ++ +
Sbjct: 60 IE---------------------KISS-----LSGMENLRILSLGRNLIKKIENLDAVAD 93
Query: 285 SLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLS--GDIPSTIGALKDLETLSL 342
+LE + +S N + S ++KL L VL +S N+++ G+I + AL LE L L
Sbjct: 94 TLEEL---WISYNQIAS--LSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLL 147
Query: 343 ARNQFQGPIPES----------VGSLISLESLD 365
A N E+ V L +L+ LD
Sbjct: 148 AGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 30/135 (22%), Positives = 57/135 (42%), Gaps = 7/135 (5%)
Query: 263 TSLRELHLGSNKLTSSIPSSLWS-LEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSR 320
EL L +N+ T + ++ L + IN S+N + + + + + L+
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTS 90
Query: 321 NQLSGDIPSTI-GALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLSGKIPKS 378
N+L ++ + L+ L+TL L N+ + L S+ L L N ++ P +
Sbjct: 91 NRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGA 148
Query: 379 LETLSQLKQFNVSHN 393
+TL L N+ N
Sbjct: 149 FDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 24/129 (18%), Positives = 51/129 (39%), Gaps = 12/129 (9%)
Query: 272 SNKLTS---SIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDI 327
+ KL IP L L++N + + +KL L ++ S N+++
Sbjct: 20 NQKLNKIPEHIPQYTAELR------LNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIE 73
Query: 328 PSTIGALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLSGKIPKSLETLSQLK 386
+ + L N+ + + + L SL++L L N ++ S LS ++
Sbjct: 74 EGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR 132
Query: 387 QFNVSHNRL 395
++ N++
Sbjct: 133 LLSLYDNQI 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 26/118 (22%), Positives = 51/118 (43%), Gaps = 12/118 (10%)
Query: 189 NLSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRNNNLEGSIP----YDLCHLKLMFG 243
L L ++ +N + I + + L +N LE ++ L LK +
Sbjct: 55 KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLM- 111
Query: 244 IRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300
L N+++ + + L+S+R L L N++T+ P + +L + +NL +N N
Sbjct: 112 --LRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 24/110 (21%), Positives = 50/110 (45%), Gaps = 6/110 (5%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIFN-ISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLL 69
L L+ + F+ N ++ + F S + + L N+L + + L ++++L+L
Sbjct: 55 KLPQLRKINFSNNKITDI-EEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLML 112
Query: 70 AANNLTGIIPHSITNATKLVALDLGFN---SFAGHILNTFGNLRHLSLLS 116
+N +T + S + + L L N + A +T +L L+LL+
Sbjct: 113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLA 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 17/88 (19%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 12 LQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLA 70
+ ++ N L + +F + +++ L L N+++ + + L ++ L L
Sbjct: 80 ASGVNEILLTSNRLENV-QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLY 137
Query: 71 ANNLTGIIPHSITNATKLVALDLGFNSF 98
N +T + P + L L+L N F
Sbjct: 138 DNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 31/173 (17%), Positives = 56/173 (32%), Gaps = 35/173 (20%)
Query: 29 VPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKL 88
+P I L L N+ + + + LP + + + N +T I + A+ +
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 89 VALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILS 148
+ L N F L L L N +T + + L+ ++ +LS
Sbjct: 84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDS-----FIGLS---SVRLLS 135
Query: 149 FGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSN 201
N + + P G F L L+ L+L +N
Sbjct: 136 LYDNQITTVAP---GAFD----------------------TLHSLSTLNLLAN 163
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI-KILSSC 566
+G+GSFG +Y GT I +VAIK+ N++ + E ++ R ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 567 SNPDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIH 625
D+ LV++ + G SLE + L + L + + + +E++H S +H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH----SKSFLH 126
Query: 626 CDLKPTNILLDENMAAH---VSDFGISK 650
D+KP N L+ A+ + DFG++K
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 11/112 (9%)
Query: 263 TSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRN 321
+ EL+L N+ T +P L + +++ I+LS+N ++ +L + + L L LS N
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88
Query: 322 QLSGDIPSTIGA---LKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGN 369
+L IP LK L LSL N +PE L +L L + N
Sbjct: 89 RLR-CIPP--RTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 33/122 (27%), Positives = 50/122 (40%), Gaps = 20/122 (16%)
Query: 272 SNKLTS---SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP 328
+ L IP + L L N +P + K LT++DLS N++S
Sbjct: 19 NKGLKVLPKGIPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSN 71
Query: 329 STIGALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLSGKIP-------KSLE 380
+ + L TL L+ N+ + IP L SL L L GN++S +P +L
Sbjct: 72 QSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALS 129
Query: 381 TL 382
L
Sbjct: 130 HL 131
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 31/135 (22%), Positives = 48/135 (35%), Gaps = 35/135 (25%)
Query: 218 QGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLV-SLTSLRELHLGSNKLT 276
L L N +P +L + K + I L+ N++S + ++T L L L N+L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 277 SSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGA-- 333
+P LK L +L L N +S +P GA
Sbjct: 92 -------------------------CIPPRTFDGLKSLRLLSLHGNDISV-VPE--GAFN 123
Query: 334 -LKDLETLSLARNQF 347
L L L++ N
Sbjct: 124 DLSALSHLAIGANPL 138
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 47/325 (14%), Positives = 101/325 (31%), Gaps = 53/325 (16%)
Query: 64 IESLLLAANNLT--GIIPHS--ITNATKLVALDLGFNSF-------AGHILNTFGNLRHL 112
IE L + +T + + + L N+ + + +L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 113 SLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNF---SASL 169
+ E A + L +L C L + N G + +F L
Sbjct: 66 EFSDIFTGRVKDEIPEALR-LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 170 QKFYAYECKL-------------KGNIPQEIGNLSGLTLLSLHSNDLNG----TISPTMG 212
+ Y + L + + ++ N L + N L + T
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184
Query: 213 RLKRLQGLSLRNNNL-----EGSIPYDLCHLKLMFGIRLTGNKLSG----HIPPCLVSLT 263
+ L + + N + E + L + + + + L N + + L S
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244
Query: 264 SLRELHLGSNKLTS----SIPSSLWSLE--YILDINLSSNSLNDS-----LPSNVQKLKV 312
+LREL L L++ ++ + LE + + L N + +K+
Sbjct: 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 304
Query: 313 LTVLDLSRNQLSGDIPSTIGALKDL 337
L L+L+ N+ + + ++++
Sbjct: 305 LLFLELNGNRF-SEEDDVVDEIREV 328
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 5e-10
Identities = 90/703 (12%), Positives = 190/703 (27%), Gaps = 218/703 (31%)
Query: 77 IIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQ----- 131
I+ + + + + + L + ++++ +
Sbjct: 21 ILSVFEDAFVD----NFDCK----DVQDM---PKSI-LSKEEIDHIIMSKDAVSGTLRLF 68
Query: 132 WSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLS 191
W+ LS + F + +L N+ + E + P + +
Sbjct: 69 WTLLSKQEE----MVQKF----VEEVLRI---NYKFLMSP-IKTEQR----QPSMMTRMY 112
Query: 192 GLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNK 250
L+ ND N + + RL+ L LR L L+ + + G
Sbjct: 113 IEQRDRLY-ND-NQVFAKYNVSRLQPY--LKLRQA---------LLELRPAKNVLIDGVL 159
Query: 251 LSGHIPPCLVSLTSLRE-------------LHLGSNKLTSSIPSSLWSLEYILDINLSSN 297
SG + L+L + ++ L L Y +D N +S
Sbjct: 160 GSGK--TWVALDV-CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 298 SLN-DSLPSNVQKLK--------------VLTVLDLSRNQLSGDI--PSTIGALKDLE-- 338
S + ++ + ++ L VL ++ A +L
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL--------NVQNAKAWNAF-NLSCK 267
Query: 339 TLSLARNQFQGPIPESVG-SLISLESLDLSGNNLSGKIPKSLETLSQLKQF-NVSHNRLE 396
L R + V L + + +S ++ S + E S L ++ + L
Sbjct: 268 ILLTTRFK-------QVTDFLSAATTTHISLDHHSMTLTPD-EVKSLLLKYLDCRPQDLP 319
Query: 397 GEIPVKGSFKNFSVESFFGNYALCGPPKLRVPPCKPDNSKSTKNVALTVLKYILPPIVCS 456
E+ + + + ++ +R DN K LT
Sbjct: 320 REV-LTTN--PRRL-------SIIA-ESIRDGLATWDNWKHVNCDKLT------------ 356
Query: 457 VLLVITIIMYKRCRNRSTKHLDHEDF---------------LPLAT----WRRTPYLDIQ 497
TII S L+ ++ +P W D+
Sbjct: 357 -----TII------ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM 405
Query: 498 RATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHR 557
++ ++ +L+ + I I ++ LE + E + HR
Sbjct: 406 VVVNKLHKYSLV------------EKQPKESTISIPSIYLE-----LKVKLENEYAL-HR 447
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWL--YSHNYF------LDILERLNIMIDVGS 609
+++ D + F + + +L Y +++ ++ ER+ + V
Sbjct: 448 SIV---------DHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMV-- 496
Query: 610 ALEYLHHGHSSAPIIHCDLKP------TNILLD-ENMAAHVSDFGISKLLGEGEDSVTQT 662
+L I H N L + ++ D +
Sbjct: 497 ---FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICD-----------NDPKYE 542
Query: 663 MTMATIGYMAPEYGSEGIVSAKCDV------YSYGVLLMETFT 699
+ I P+ I S D+ + E
Sbjct: 543 RLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 8e-05
Identities = 64/531 (12%), Positives = 141/531 (26%), Gaps = 152/531 (28%)
Query: 291 DINLSSNSLNDSLPSNVQKLK----VLTVLDLSRNQLSG----DI---PSTIGALKDLET 339
+ D L V D+ ++ LS I + L
Sbjct: 10 ETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFW 69
Query: 340 LSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK-SLETLSQLKQFNVSHNRLEGE 398
L++ + E V + E L ++ L I + + + +RL +
Sbjct: 70 TLLSKQE------EMVQKFVE-EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 399 IPVKGSFKNFSVESFFGNYALCGPPKLRVPPCKPDNSKSTKNVALTVLK---YILPPIVC 455
V F K V + + AL L+ + ++
Sbjct: 123 NQV------------F--------AKYNVS--RLQPYLKLRQ-ALLELRPAKNV---LID 156
Query: 456 -------SVLLVITIIMYKRCRNRSTK-HLDHEDFLPLATW-----RRTPYLDIQRATDE 502
+ + + C + + +D + F W +P ++
Sbjct: 157 GVLGSGKTWVALDV------CLSYKVQCKMDFKIF-----WLNLKNCNSPETVLEMLQKL 205
Query: 503 FN--ECNLLGTGSFGSVYKGTISDGTDVAIKIF-------------NLQLERAFRSFDSE 547
+ N S K I ++ N+Q +A+ +F+
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265
Query: 548 CEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 607
C++L R + + LS+ + + L+ + + +L
Sbjct: 266 CKILLTTRFKQVTDFLSAATT---THISLDHHSMT------LTPDEVKSLL--------- 307
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFG--ISKLLGEGEDSVTQTMTM 665
L+YL P P + + +A + D D +T +
Sbjct: 308 ---LKYLDCRPQDLPREVLTTNPRRLSI---IAESIRDGLATWDNWKHVNCDKLTTIIES 361
Query: 666 ATIGYMAPE-----YGSEGIVSAKCDVY-SYGVLLMETFTRKRPTDEMFTGEM---SL-R 715
++ + P + + + +L + F + + ++ SL
Sbjct: 362 -SLNVLEPAEYRKMFDRLSVFPP--SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418
Query: 716 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMR 766
+ KES +SI + L+ ++ +
Sbjct: 419 KQPKEST--------------------------ISIPSIYLELKVKLENEY 443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 38/111 (34%), Positives = 55/111 (49%), Gaps = 5/111 (4%)
Query: 263 TSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRN 321
T+ + L+L N++T P SL + ++ L SN L +LP V L LTVLDL N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 322 QLSGDIPSTI-GALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNL 371
QL+ +PS + L L+ L + N+ +P + L L L L N L
Sbjct: 99 QLTV-LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 44/177 (24%), Positives = 62/177 (35%), Gaps = 51/177 (28%)
Query: 194 TLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSG 253
+L LH N + L L+ L L +N L ++P +
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFD---------------- 85
Query: 254 HIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKV 312
SLT L L LG+N+LT LPS V +L
Sbjct: 86 -------SLTQLTVLDLGTNQLT-------------------------VLPSAVFDRLVH 113
Query: 313 LTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGN 369
L L + N+L+ +P I L L L+L +NQ + + L SL L GN
Sbjct: 114 LKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 41/192 (21%), Positives = 56/192 (29%), Gaps = 55/192 (28%)
Query: 158 LPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRL 217
V + Q Y ++ ++ P +L L L L SN L L +L
Sbjct: 31 HASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 218 QGLSLRNNNLEGSIP---YDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNK 274
L L N L +P +D L L+EL + NK
Sbjct: 91 TVLDLGTNQLT-VLPSAVFD--------------------------RLVHLKELFMCCNK 123
Query: 275 LTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGAL 334
LT LP +++L LT L L +NQL L
Sbjct: 124 LT-------------------------ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL 158
Query: 335 KDLETLSLARNQ 346
L L N
Sbjct: 159 SSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 29/93 (31%), Positives = 41/93 (44%), Gaps = 13/93 (13%)
Query: 314 TVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLS 372
+L L NQ++ P +L +L+ L L NQ +P V SL L LDL N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQL- 100
Query: 373 GKIPKSLET-----LSQLKQFNVSHNRLEGEIP 400
L + L LK+ + N+L E+P
Sbjct: 101 ----TVLPSAVFDRLVHLKELFMCCNKLT-ELP 128
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 40/151 (26%), Positives = 53/151 (35%), Gaps = 18/151 (11%)
Query: 78 IPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSA-DQWSFLS 136
+P I + L L N F +L +L L N L D
Sbjct: 34 VPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS----- 86
Query: 137 SLTNCRNLTILSFGSNPLGGILPPVIGNFS--ASLQKFYAYECKLKGNIPQEIGNLSGLT 194
LT LT+L G+N L LP F L++ + KL +P+ I L+ LT
Sbjct: 87 -LT---QLTVLDLGTNQLTV-LPS--AVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLT 138
Query: 195 LLSLHSNDLNGTISPTMGRLKRLQGLSLRNN 225
L+L N L RL L L N
Sbjct: 139 HLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 58/318 (18%), Positives = 98/318 (30%), Gaps = 69/318 (21%)
Query: 138 LTNCRNLTILSFGSNPLGGI----LPPVIGNFSASLQKFYAYECKLKGNIPQEIG----- 188
+ +T L N L I L N AS+ L E+
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 189 NLSGLTLLSLHSNDLNGTISPTMGRL-----KRLQGLSLRNNNLEGS--------IPYDL 235
+ +T L+L N L+ S + + + L L N+
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 236 CHLKLMFGIRLTGNKLSG----HIPPCLVSL-TSLRELHLGSNKLTS-----------SI 279
+ + L GN L + L ++ ++ L+L N L S SI
Sbjct: 138 ASITS---LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASI 194
Query: 280 PSSLWSLEYILDINLSSNSLNDS--------LPSNVQKLKVLTVLDLSRNQLSGDIPSTI 331
P+S+ SL +LS+N L S + L+L N L G +
Sbjct: 195 PASVTSL------DLSANLLGLKSYAELAYIFSSIPNHV---VSLNLCLNCLHGPSLENL 245
Query: 332 GALKD----LETLSLARNQFQGPIPESVGSLIS-------LESLDLSGNNLSGKIPKSLE 380
LKD L+T+ L + + E +L + + +D +G + +
Sbjct: 246 KLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPIS 305
Query: 381 TLSQLKQFNVSHNRLEGE 398
L + L +
Sbjct: 306 NLIRELSGKADVPSLLNQ 323
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 28/128 (21%), Positives = 47/128 (36%), Gaps = 10/128 (7%)
Query: 245 RLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS--SIPSSLWSLEYILDINLSSNSLNDS 302
+LT + + REL L K+ ++ ++L + I + S N +
Sbjct: 3 KLTAELIEQ--AAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAI---DFSDNEIRKL 57
Query: 303 LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGP-IPESVGSLISL 361
L+ L L ++ N++ AL DL L L N + + SL SL
Sbjct: 58 --DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 115
Query: 362 ESLDLSGN 369
L + N
Sbjct: 116 TYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-08
Identities = 20/128 (15%), Positives = 47/128 (36%), Gaps = 11/128 (8%)
Query: 293 NLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIP 352
L++ + + + LDL ++ I + L + + + N+ I
Sbjct: 3 KLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE----IR 55
Query: 353 --ESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE--GEIPVKGSFKNF 408
+ L L++L ++ N + + L L + +++N L G++ S K+
Sbjct: 56 KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 115
Query: 409 SVESFFGN 416
+ N
Sbjct: 116 TYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 23/120 (19%), Positives = 42/120 (35%), Gaps = 11/120 (9%)
Query: 35 NISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLG 94
N R L L G ++ + +G L +++ + N + + +L L +
Sbjct: 17 NAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVN 72
Query: 95 FNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPL 154
N L L+ L N+L + L L + ++LT L NP+
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSL-------VELGDLDPLASLKSLTYLCILRNPV 125
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 53/147 (36%), Positives = 70/147 (47%), Gaps = 22/147 (14%)
Query: 231 IPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS---SIPSSLWSLE 287
IP +L L N L LTSL +L+LG NKL S + + L SL
Sbjct: 26 IPAQTTYLDLET------NSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79
Query: 288 YILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGA---LKDLETLSLA 343
Y+ NLS+N L SLP+ V KL L L L+ NQL +P G L L+ L L
Sbjct: 80 YL---NLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPD--GVFDKLTQLKDLRLY 132
Query: 344 RNQFQGPIPESV-GSLISLESLDLSGN 369
+NQ + +P+ V L SL+ + L N
Sbjct: 133 QNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 44/160 (27%), Positives = 63/160 (39%), Gaps = 36/160 (22%)
Query: 194 TLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLC-HLKLMFGIRLTGNKLS 252
T L L +N L + L L L L N L+ S+P + L + + L+ N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 253 GHIPPCLV-SLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKL 310
+P + LT L+EL L +N+L SLP V KL
Sbjct: 90 S-LPNGVFDKLTQLKELALNTNQLQ-------------------------SLPDGVFDKL 123
Query: 311 KVLTVLDLSRNQLSGDIPSTIGA---LKDLETLSLARNQF 347
L L L +NQL +P G L L+ + L N +
Sbjct: 124 TQLKDLRLYQNQLKS-VPD--GVFDRLTSLQYIWLHDNPW 160
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 30/88 (34%), Positives = 39/88 (44%), Gaps = 12/88 (13%)
Query: 314 TVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLS 372
T LDL N L L L L L N+ Q +P V L SL L+LS N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQL- 88
Query: 373 GKIPKSLET-----LSQLKQFNVSHNRL 395
+SL L+QLK+ ++ N+L
Sbjct: 89 ----QSLPNGVFDKLTQLKELALNTNQL 112
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 507 NLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHR------NL 559
+L+G GSFG V K + VAIKI + + E +L + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 560 IKILSSCSNPDFKA---LVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLH 615
+ + F+ LV E + + +L L + N+ + + + +AL +L
Sbjct: 119 VHLKRHF---MFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 616 HGHSSAPIIHCDLKPTNILL--DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAP 673
IIHCDLKP NILL + A + DFG S LG+ Q+ Y +P
Sbjct: 175 TPE--LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSP 227
Query: 674 E------YGSEGIVSAKCDVYSYGVLLMETFT 699
E Y D++S G +L+E T
Sbjct: 228 EVLLGMPYDL------AIDMWSLGCILVEMHT 253
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 46/229 (20%), Positives = 84/229 (36%), Gaps = 57/229 (24%)
Query: 508 LLGTGSFGSVYKG--TISDGTDVAIKIF-NLQLERAFRSFDSECEVLRNVRHR------N 558
LG G+FG V + + VA+KI N+ + + E VL+ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFL 83
Query: 559 LIKILSSCSNPDFKA---LVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYL 614
+ + +F + E + + ++L +N+ + ++ + AL +L
Sbjct: 84 CVLMSDWF---NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 615 HHGHSSAPIIHCDLKPTNILLDENMAAH-------------------VSDFGISKLLGEG 655
H + H DLKP NIL + V+DFG + E
Sbjct: 140 HENQ----LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195
Query: 656 EDSVTQTMTMATIGYMAPEYGSEGIV-----SAKCDVYSYGVLLMETFT 699
++ T Y PE ++ + CDV+S G +L E +
Sbjct: 196 HTTIVATRH-----YRPPE-----VILELGWAQPCDVWSIGCILFEYYR 234
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 28/168 (16%), Positives = 62/168 (36%), Gaps = 32/168 (19%)
Query: 508 LLGTGSFGSVYKGTISDGTDVAIKIFN-----------LQLERAFRSFDSECEVLRNVRH 556
+G G FG +Y ++ V L E F ++ E ++
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 557 RNLIKIL----------SSCSNPDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMI 605
+K L + ++ ++++ G L+K ++ L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 606 DVGSALEYLHHGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISK 650
+ LEY+H +H D+K +N+LL + + ++ D+G++
Sbjct: 160 RILDILEYIHEHE----YVHGDIKASNLLLNYKNPDQ-VYLVDYGLAY 202
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 52/234 (22%), Positives = 89/234 (38%), Gaps = 63/234 (26%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIF-NLQLERAFRSFDSECEVLRNVRHR-----NLI 560
+G G+FG V I + A+K+ N++ + RS E ++L+ +++ N++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 561 KILSSCSNPDFKA---LVLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLH 615
K + L+ E + SL + + +NY F + I++ AL YL
Sbjct: 100 KYHGKF---MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIK-LYCIEILKALNYLR 154
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVS-------------------------DFGISK 650
+ H DLKP NILLD+ DFG +
Sbjct: 155 KMS----LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 651 LLGEGEDSVTQTMTMATIGYMAPEYGSEGIV-----SAKCDVYSYGVLLMETFT 699
+ S+ T Y APE ++ D++S+G +L E +T
Sbjct: 211 FKSDYHGSIINTRQ-----YRAPE-----VILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 26/111 (23%), Positives = 52/111 (46%), Gaps = 4/111 (3%)
Query: 261 SLTSLRELHLGSNKLTS-SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLS 319
+ + ++EL L +++ + E + ++ + L +N+ KL L L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 320 RNQLSGDIPSTIGALKDLETLSLARNQFQGP-IPESVGSLISLESLDLSGN 369
N++SG + +L L+L+ N+ + E + L +L+SLDL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-06
Identities = 31/120 (25%), Positives = 50/120 (41%), Gaps = 9/120 (7%)
Query: 299 LNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSL 358
L + PS+V++L VLD SR+ G + ++LE LS ++ L
Sbjct: 11 LRNRTPSDVKEL----VLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT--SIANLPKL 63
Query: 359 ISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE--GEIPVKGSFKNFSVESFFGN 416
L+ L+LS N +SG + E L N+S N+++ I +N F
Sbjct: 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 22/120 (18%), Positives = 42/120 (35%), Gaps = 9/120 (7%)
Query: 35 NISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLG 94
S ++ L L+ ++ + + +E L LT I ++ KL L+L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 95 FNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPL 154
N +G + +L+ L+ N + S + L NL L + +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK-------DLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 31/157 (19%), Positives = 55/157 (35%), Gaps = 31/157 (19%)
Query: 189 NLSGLTLLSLHSNDLN-GTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247
S + L L ++ N G + + L+ LS N L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT------------------- 55
Query: 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLND-SLPSN 306
++ L L L++L L N+++ + + +NLS N + D S
Sbjct: 56 --SIAN-----LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP 108
Query: 307 VQKLKVLTVLDLSRNQLSGDI---PSTIGALKDLETL 340
++KL+ L LDL +++ + L L L
Sbjct: 109 LKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYL 145
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 48/229 (20%), Positives = 86/229 (37%), Gaps = 57/229 (24%)
Query: 508 LLGTGSFGSVYKG--TISDGTDVAIKIF-NLQLERAFRSFDSECEVLRNVRHR------N 558
LG G+FG V + + G VA+KI N+ +R + SE +VL ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 559 LIKILSSCSNPDFKA---LVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYL 614
+++L + +V E + S ++ + + + + + ++ +L
Sbjct: 79 CVQMLEWF---EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 615 HHGHSSAPIIHCDLKPTNILLDENMAAHVS-------------------DFGISKLLGEG 655
H + H DLKP NIL ++ DFG + E
Sbjct: 135 HSNK----LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190
Query: 656 EDSVTQTMTMATIGYMAPEYGSEGIV-----SAKCDVYSYGVLLMETFT 699
++ T Y APE ++ S CDV+S G +L+E +
Sbjct: 191 HSTLVSTRH-----YRAPE-----VILALGWSQPCDVWSIGCILIEYYL 229
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 30/165 (18%), Positives = 63/165 (38%), Gaps = 29/165 (17%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNL------QLERAFRSF---DSECEVLRNVRHR 557
+G+G FG +Y + A + + L + + + + + + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 558 NLIKI---------LSSCSNPDFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDV 607
L + L+ ++ +V+E + G L+K + N L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRM 160
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMA--AHVSDFGISK 650
LEY+H +H D+K N+LL +++D+G+S
Sbjct: 161 LDVLEYIHENE----YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 21/101 (20%), Positives = 43/101 (42%), Gaps = 2/101 (1%)
Query: 296 SNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPS-TIGALKDLETLSLARNQFQGPIPES 354
+ ++ + LT L + Q + + L +L L++ ++ + P++
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 355 VGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRL 395
L L+LS N L K+++ LS L++ +S N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 20/101 (19%), Positives = 36/101 (35%), Gaps = 2/101 (1%)
Query: 272 SNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPST 330
+ L E + ++ + + L + L L L + ++ L P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 331 IGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNL 371
L L+L+ N + + +SL+ L LSGN L
Sbjct: 76 FHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 182 NIPQEIGNLSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRNNNLEGSIPYD-LCHLK 239
+ + LT L + + + + L L+ L++ + L + D
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT 276
+ + L+ N L + V SL+EL L N L
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 17/95 (17%), Positives = 28/95 (29%), Gaps = 3/95 (3%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+ +NL L + + +R LT+ + L + H P
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSF 98
+ L L+ N L + L L L N
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 22/95 (23%), Positives = 36/95 (37%), Gaps = 2/95 (2%)
Query: 230 SIPYDLCHLKLMFGIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEY 288
+ L + + + + + H+ L L LR L + + L P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 289 ILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQL 323
+ +NLS N+L SL + L L LS N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 17/88 (19%), Positives = 31/88 (35%), Gaps = 2/88 (2%)
Query: 29 VPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKL 88
+ + L +E Q L L + +L + + L + P + +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 89 VALDLGFNSFAGHILNTFG--NLRHLSL 114
L+L FN+ T +L+ L L
Sbjct: 83 SRLNLSFNALESLSWKTVQGLSLQELVL 110
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 31/122 (25%), Positives = 49/122 (40%), Gaps = 17/122 (13%)
Query: 254 HIPPCLVSLTSLRELHLGSNKLTSSIPSSLW-SLEYILDINLSSNSLNDSLPSNV-QKLK 311
IP EL L N+L L+ L +++ + L N L + N +
Sbjct: 26 DIP------LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78
Query: 312 VLTVLDLSRNQLSGDIPSTIGA---LKDLETLSLARNQFQGPIPESV-GSLISLESLDLS 367
+ L L N++ +I + L L+TL+L NQ + L SL SL+L+
Sbjct: 79 HIQELQLGENKIK-EISN--KMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLA 134
Query: 368 GN 369
N
Sbjct: 135 SN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 34/137 (24%), Positives = 52/137 (37%), Gaps = 37/137 (27%)
Query: 218 QGLSLRNNNLEGSIPYD--LCHLKLMFGIRLTGNKLSGHIPPCLV-SLTSLRELHLGSNK 274
L L +N L I D L + + L N+L+G I P + ++EL LG NK
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENK 89
Query: 275 LTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRNQLSGDIPSTIGA 333
+ + + + L L L+L NQ+S + G+
Sbjct: 90 IK-------------------------EISNKMFLGLHQLKTLNLYDNQISC-VMP--GS 121
Query: 334 ---LKDLETLSLARNQF 347
L L +L+LA N F
Sbjct: 122 FEHLNSLTSLNLASNPF 138
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 38/112 (33%), Positives = 55/112 (49%), Gaps = 10/112 (8%)
Query: 263 TSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV-QKLKVLTVLDLSRN 321
+S L L SNKL S L + ++LS N + SLP V KL LT+L L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
Query: 322 QLSGDIPSTIGA---LKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGN 369
+L +P+ G L L+ L+L NQ + +P+ + L SL+ + L N
Sbjct: 87 KLQS-LPN--GVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 6/98 (6%)
Query: 314 TVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNLS 372
T L+L N+L L L LSL++NQ Q +P+ V L L L L N L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQ 89
Query: 373 GKIPKSL-ETLSQLKQFNVSHNRLEGEIPVKGSFKNFS 409
+P + + L+QLK+ + N+L+ +P G F +
Sbjct: 90 -SLPNGVFDKLTQLKELALDTNQLKS-VP-DGIFDRLT 124
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 35/132 (26%), Positives = 57/132 (43%), Gaps = 7/132 (5%)
Query: 261 SLTSLRELHLGSNKLT-SSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLS 319
+ ++REL L + K I + ++L + L SN+ KL L L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 320 RNQLSGDIPSTIGALKDLETLSLARNQFQGP-IPESVGSLISLESLDLSGN---NLSGKI 375
N++ G + L +L L+L+ N+ + E + L L+SLDL NL+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYR 139
Query: 376 PKSLETLSQLKQ 387
+ L QL
Sbjct: 140 ESVFKLLPQLTY 151
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 29/122 (23%), Positives = 47/122 (38%), Gaps = 9/122 (7%)
Query: 297 NSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVG 356
L + P+ V++L VLD ++ G I +LE LSL ++
Sbjct: 16 LELRNRTPAAVREL----VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI--SVSNLP 68
Query: 357 SLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE--GEIPVKGSFKNFSVESFF 414
L L+ L+LS N + G + E L L N+S N+L+ + + F
Sbjct: 69 KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLF 128
Query: 415 GN 416
Sbjct: 129 NC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 24/120 (20%), Positives = 41/120 (34%), Gaps = 9/120 (7%)
Query: 35 NISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLG 94
+ +R L L+ + + + N+E L L L + ++ KL L+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 95 FNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPL 154
N G + L +L+ L+ N L S L L L L + +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK-------DISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 35/152 (23%), Positives = 54/152 (35%), Gaps = 34/152 (22%)
Query: 179 LKGNIPQEIG--NLSGLTLLSLHSNDLN-GTISPTMGRLKRLQGLSLRNNNLEGSIPYDL 235
+K I E+ + + L L + N G I L+ LSL N L
Sbjct: 10 MKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI------- 62
Query: 236 CHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLS 295
+S L L L++L L N++ + L + +NLS
Sbjct: 63 --------------SVSN-----LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103
Query: 296 SNSLNDSLPSNVQKLKV---LTVLDLSRNQLS 324
N L D S ++ LK L LDL +++
Sbjct: 104 GNKLKD--ISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 26/166 (15%), Positives = 55/166 (33%), Gaps = 30/166 (18%)
Query: 509 LGTGSFGSVYKGT---------ISDGTDVAIKI--FNLQLERAFRSFDSECEV------- 550
+ G +Y+ ++K+ + +L F +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 551 -LRNVRHRNLIKILSSCSN-PDFKALVLEFMPNG-SLEK-WLYSHNYFLDILERLNIMID 606
L + + + + ++ LVL + G SL+ S + L L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV--SDFGISK 650
+ ALE+LH +H ++ NI +D + V + +G +
Sbjct: 168 LLDALEFLHENE----YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 2e-07
Identities = 25/185 (13%), Positives = 57/185 (30%), Gaps = 27/185 (14%)
Query: 204 NGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVS-- 261
+SP + + L L ++ N +LK + + L + ++
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL---EIISGGLPDSVVEDILGSD 217
Query: 262 LTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRN 321
L +L +L L + + + + L L +
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLF---------------SKDRFPNLKWLGIVDA 262
Query: 322 QLSGDIPSTIGA---LKDLETLSLARNQFQG----PIPESVGSLISLESLDLSGNNLSGK 374
+ + L LET+ ++ + + V + L+ +++ N LS +
Sbjct: 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
Query: 375 IPKSL 379
+ K L
Sbjct: 323 MKKEL 327
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.1 bits (121), Expect = 7e-07
Identities = 29/161 (18%), Positives = 60/161 (37%), Gaps = 15/161 (9%)
Query: 253 GHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEY--ILDINLSSNSLNDSLPSNVQKL 310
+ P L ++ L L + S +L+ I+ L + + D L S++ L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 311 KVLTVLDLSRNQLSGDIPSTI------GALKDLETLSLARNQFQGPIPESVGS---LISL 361
+ L + + + +L+ L + + Q + E L L
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 362 ESLDLSGNNLSGK----IPKSLETLSQLKQFNVSHNRLEGE 398
E++D+S L+ + + ++ + LK N+ +N L E
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 36/153 (23%), Positives = 64/153 (41%), Gaps = 19/153 (12%)
Query: 262 LTSLRELHLGSNKLT----SSIPSSLWSLEYILD-INLSSNSLND-SLPSNVQKLKVLTV 315
L+SLR+L+L ++T + + + L S + LD +NL+S L+ L + +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 316 LDLSRNQLSGDIPSTIG-ALKD----LETLSLARNQFQGP----IPESVGSLISLESLDL 366
L L N L + + L + TL L+ N + E + S+ L L
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSL 190
Query: 367 SGNNLSGK----IPKSLETLSQLKQFNVSHNRL 395
L + + L+ QL++ NV++N
Sbjct: 191 LHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA 223
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 50/344 (14%), Positives = 98/344 (28%), Gaps = 54/344 (15%)
Query: 62 PNIESLLLAANNLTGIIPHSIT----NATKLVALDLGF----NSFAGHILNTFGNLRHLS 113
P+ L + G + I + T L + L + I +F N + L
Sbjct: 77 PHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLV 136
Query: 114 LLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFY 173
L S +T+ + CRNL L + + + + +F +
Sbjct: 137 LSS--CEGFSTDG-------LAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY---- 183
Query: 174 AYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPY 233
+L L + L S + + R L+ L L
Sbjct: 184 --------------TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA-------- 221
Query: 234 DLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDIN 293
+ L P L L + + S + +L + + ++
Sbjct: 222 ----------VPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLS 271
Query: 294 LSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGD-IPSTIGALKDLETLSLARNQFQGPIP 352
+++ LP+ LT L+LS + + + L+ L + +
Sbjct: 272 GFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLE 331
Query: 353 ESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396
+ L L + + P T L ++ +LE
Sbjct: 332 VLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLE 375
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 63/428 (14%), Positives = 130/428 (30%), Gaps = 55/428 (12%)
Query: 11 NLQNLQYLVFAENNLS--GLVPPTIFNISTMRILTLEG-NQLSGRLPSTVGHLLPNIESL 67
NL+ L+ + F +S L + L L+ + + ++ I++L
Sbjct: 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTL 169
Query: 68 LLAANNLTGIIPHSI----TNATKLVALDLGFNSFAG-------HILNTFGNLRHLSLLS 116
L+ ++ + + + T L L+ FA I +L + +
Sbjct: 170 LMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKV-- 227
Query: 117 QVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYE 176
+ + F + N S + +P N +
Sbjct: 228 -------GDFEILELVGFFKAAANLEEFCGGSLNEDIG---MPEKYMNLVFPRKLCRLGL 277
Query: 177 CKL-KGNIPQEIGNLSGLTLLSLHSNDLNG-TISPTMGRLKRLQGLSLRNNNLEGSIPY- 233
+ +P + + L L L + + L+ L RN + +
Sbjct: 278 SYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVL 337
Query: 234 -----DLCHLKLMFGIRLTGNKLSGHI--PPCLVSL----TSLRELHLGSNKLT----SS 278
L L++ G G + + L++L L + + + +T S
Sbjct: 338 AQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLES 397
Query: 279 IPSSLWSLEYILDINLSSNS------LNDSLPSNVQKLKVLTVLDLSRN--QLSGDIPST 330
I + L +L + L L++ + S + K L L+ S
Sbjct: 398 IGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457
Query: 331 IGAL-KDLETLSLARNQFQGP-IPESVGSLISLESLDLSGNNLSGK-IPKSLETLSQLKQ 387
IG ++ + L + E +L+ L++ G S + I ++ L L+
Sbjct: 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRY 517
Query: 388 FNVSHNRL 395
V R
Sbjct: 518 LWVQGYRA 525
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 50/351 (14%), Positives = 106/351 (30%), Gaps = 42/351 (11%)
Query: 62 PNIESLLLAANNLTGIIPHSIT----NATKLVALDLGFNSFAGHILNTFG-----NLRHL 112
P L N G + +T N +L ++ + L+ +L L
Sbjct: 84 PRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL 143
Query: 113 SLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSA---SL 169
L + TT+ LS +T+CR + L + + + SL
Sbjct: 144 KLDK--CSGFTTDG-------LLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194
Query: 170 QKFYAYECKLKG----NIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNN 225
+ Y + ++ N L + + + + L+ +
Sbjct: 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKV-GDFEILELVGFFKAAANLEEFCGGSL 253
Query: 226 NLEGSIPYDLCHLKLMFGIRLTGNKLSG--HIPPCLVSLTSLRELHL-GSNKLTSSIPSS 282
N + +P +L + G G +P +R+L L + T +
Sbjct: 254 NEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTL 313
Query: 283 LWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSL 342
+ + + + + L Q K L L + R + G + ++L
Sbjct: 314 IQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373
Query: 343 ARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSL-ETLSQLKQFNVSH 392
A+ LE + + ++++ + +S+ L L F +
Sbjct: 374 AQG------------CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVL 412
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 60/375 (16%), Positives = 110/375 (29%), Gaps = 53/375 (14%)
Query: 38 TMRILTLEGN---QLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSIT----NATKLVA 90
++ L +E + + G+ + ++E L I P + N LV+
Sbjct: 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224
Query: 91 LDLGFNSFAGH--ILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILS 148
+ +G NL S + E +L R L L
Sbjct: 225 VKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEK--------YMNLVFPRKLCRLG 276
Query: 149 FGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN-IPQEIGNLSGLTLLSLHSNDLNGTI 207
+ P++ F+A ++K L+ I L +L + + +
Sbjct: 277 LSYMGPNEM--PILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGL 334
Query: 208 SPTMGRLKRLQGLSLRNNNLEGSIPYD------------------LCHLKLMFGIRLTGN 249
K+L+ L + E + + L ++ + + +T
Sbjct: 335 EVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAV-YVSDITNE 393
Query: 250 KLSGHIPPCLVSLTSLRELHL-GSNKLT--------SSIPSSLWSLEYILDINLSSNSLN 300
L I L +L R + L ++T S+ L L L
Sbjct: 394 SLE-SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRR-FAFYLRQGGLT 451
Query: 301 D-SLPSNVQKLKVLTVLDLSRNQLSGD-IPSTIGALKDLETLSLARNQFQGP-IPESVGS 357
D L Q + + L S + + +L+ L + F I +V
Sbjct: 452 DLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTK 511
Query: 358 LISLESLDLSGNNLS 372
L SL L + G S
Sbjct: 512 LPSLRYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 49/315 (15%), Positives = 94/315 (29%), Gaps = 19/315 (6%)
Query: 87 KLVALDLGFNSFAGHILNTFGNLRHLSL---LSQVMNNLTTESSSADQWSFLSSLT-NCR 142
+ V + L + + + F NLR L L M NL E+ +++ ++ N R
Sbjct: 53 EHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLR 112
Query: 143 NLTILSFGSNPLG-GILPPVIGNFSASLQKFYAYECKLKGN--IPQEIGNLSGLTLLSLH 199
L + F + L + + L+ +C + + + + L +
Sbjct: 113 QLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLME 172
Query: 200 SNDLNGTISPTMGRL----KRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHI 255
+ + + L L+ L+ P DL + L K+
Sbjct: 173 ESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETI-ARNCRSLVSVKVGDFE 231
Query: 256 PPCLVSL----TSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL--NDSLPSNVQK 309
LV +L E GS +P +L + + S + +P
Sbjct: 232 ILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPF 291
Query: 310 LKVLTVLDLSRNQLSGD-IPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSG 368
+ LDL L + + I +LE L + L+ L +
Sbjct: 292 AAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER 351
Query: 369 NNLSGKIPKSLETLS 383
+ +S
Sbjct: 352 GADEQGMEDEEGLVS 366
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 42/147 (28%), Positives = 62/147 (42%), Gaps = 31/147 (21%)
Query: 509 LGTGSFGSVYKG-TISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR--------HRNL 559
LG G F +V+ I VA+K+ E + E +L++VR +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 560 IKILSSCSNPDFK---------ALVLEFMPNG-SLEKWLYSHNYFLDILERL-NIMIDVG 608
+++L FK +V E + G L KW+ NY L + I+ V
Sbjct: 104 VQLLDD-----FKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILL 635
L+YLH + IIH D+KP NILL
Sbjct: 157 QGLDYLH---TKCRIIHTDIKPENILL 180
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 791 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.78 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.73 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.72 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.37 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.36 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.27 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.95 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.94 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.85 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.57 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.54 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.47 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.47 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.0 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.97 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.96 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.73 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.72 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.62 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.56 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.52 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.5 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.34 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.07 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.96 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.91 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.89 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.74 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.71 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.68 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.63 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.27 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.19 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.98 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.46 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.57 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.45 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.25 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=523.45 Aligned_cols=427 Identities=31% Similarity=0.532 Sum_probs=334.1
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCc
Q 003855 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSIT 83 (791)
Q Consensus 4 ~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 83 (791)
.+|..|+++++|++|+|++|++++.+|.. .+++|++|+|++|++++.+|..++..+++|++|+|++|++++..|..|+
T Consensus 238 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~ 315 (768)
T 3rgz_A 238 DFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315 (768)
T ss_dssp CHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGG
T ss_pred cccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHh
Confidence 33444444444444444444444333332 3444444444445554556666655446777777777777777777777
Q ss_pred CCCCCCEEeccCcccccccc-cccccccccccccccccccc-ccCCCcccc----------------ccccccCC--CCC
Q 003855 84 NATKLVALDLGFNSFAGHIL-NTFGNLRHLSLLSQVMNNLT-TESSSADQW----------------SFLSSLTN--CRN 143 (791)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~----------------~~~~~l~~--l~~ 143 (791)
++++|++|+|++|++.+..+ ..|.++++|+.|++++|+++ .++...... ..+..+.. +++
T Consensus 316 ~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~ 395 (768)
T 3rgz_A 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395 (768)
T ss_dssp GCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCC
T ss_pred cCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCC
Confidence 77777777777777764444 33777777777777777765 332211110 11223333 667
Q ss_pred CcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcc
Q 003855 144 LTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLR 223 (791)
Q Consensus 144 L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 223 (791)
|++|++++|++++.+|..+..+ ++|++|++++|.+++.+|..|.++++|+.|++++|.+++.+|..|..+++|++|+|+
T Consensus 396 L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 474 (768)
T 3rgz_A 396 LQELYLQNNGFTGKIPPTLSNC-SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474 (768)
T ss_dssp CCEEECCSSEEEEECCGGGGGC-TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred ccEEECCCCccccccCHHHhcC-CCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEec
Confidence 8888888888887777777665 468888888888888888888888889999999988888888888889999999999
Q ss_pred cccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccC
Q 003855 224 NNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSL 303 (791)
Q Consensus 224 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~ 303 (791)
+|++++.+|..+..+++|+.|+|++|++++.+|.+++.+++|++|+|++|++.+.+|..+..+++|+.|++++|.+++.+
T Consensus 475 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~i 554 (768)
T 3rgz_A 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBC
T ss_pred CCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcC
Confidence 99998888989999999999999999999889999999999999999999998889999999999999999999888766
Q ss_pred Cccc----------------------------------------------------------------------ccCCCC
Q 003855 304 PSNV----------------------------------------------------------------------QKLKVL 313 (791)
Q Consensus 304 ~~~~----------------------------------------------------------------------~~l~~L 313 (791)
|..+ ..+++|
T Consensus 555 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L 634 (768)
T 3rgz_A 555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634 (768)
T ss_dssp CGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC
T ss_pred ChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccc
Confidence 6543 335678
Q ss_pred CEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCC
Q 003855 314 TVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHN 393 (791)
Q Consensus 314 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 393 (791)
+.|||++|++++.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+++|++||+++|
T Consensus 635 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N 714 (768)
T 3rgz_A 635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714 (768)
T ss_dssp CEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred cEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCCcCCccccccCCccccCCCCCCCCCCCCCCCC
Q 003855 394 RLEGEIPVKGSFKNFSVESFFGNYALCGPPKLRVPPCKPDNSK 436 (791)
Q Consensus 394 ~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~~~~~~~c~~~~~~ 436 (791)
+++|.+|..+.+.++...++.||+++||+|. ++|.+....
T Consensus 715 ~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~~~~ 754 (768)
T 3rgz_A 715 NLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPSNAD 754 (768)
T ss_dssp EEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSCC--
T ss_pred cccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCCccC
Confidence 9999999999999999999999999999884 378765543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=448.69 Aligned_cols=264 Identities=27% Similarity=0.443 Sum_probs=209.2
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehh--hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++++..+.||+|+||+||+|++++ .||||+++.. ..+..+.|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 577888999999999999999753 6999998643 24556789999999999999999999999865 568999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
|++|+|.++++.....+++.++..|+.|||+||+||| +.+||||||||+|||+++++.+||+|||+|+........
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH----~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH----AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 9999999999877777999999999999999999999 678999999999999999999999999999876554444
Q ss_pred ceeecccccccccCCCccC---CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 659 VTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
......+||+.|||||++. .+.|+.++|||||||++|||+||+.||.+..... .+...+...... +.+.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~~~-------p~~~ 260 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGYAS-------PDLS 260 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTCCC-------CCST
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCC-------CCcc
Confidence 4445568999999999875 3569999999999999999999999997643221 122212111100 0000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
..+..|+.++.+++.+||+.||++||||.||++.|+.++...++
T Consensus 261 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 261 ------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp ------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred ------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 01224667889999999999999999999999999998765543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-55 Score=455.01 Aligned_cols=261 Identities=27% Similarity=0.424 Sum_probs=218.0
Q ss_pred hccccccccCCCcceEEEEEEec------CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
++|.+.+.||+|+||.||+|++. +++.||||+++.......+.|.+|+++|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888899999999999999863 478899999987766677889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEE
Q 003855 575 VLEFMPNGSLEKWLYSHN------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAH 642 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~k 642 (791)
|||||++|+|.++++..+ ..++|.++..|+.|||+||+||| +++|+||||||+|||+++++.+|
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccCHhhEEECCCCcEE
Confidence 999999999999998542 45899999999999999999999 67899999999999999999999
Q ss_pred EeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHh
Q 003855 643 VSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKES 721 (791)
Q Consensus 643 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 721 (791)
|+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.+.... .+...+...
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~~ 246 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECITQG 246 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHHT
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC
Confidence 999999987655443333344568999999999999999999999999999999999 89999764221 122211110
Q ss_pred cCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhc
Q 003855 722 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784 (791)
Q Consensus 722 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~ 784 (791)
. ..+.+..|+.++.+++.+||+.||++||||.||.+.|+++.+..+
T Consensus 247 ~-----------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 247 R-----------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp C-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred C-----------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 0 011223567788999999999999999999999999999876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=455.10 Aligned_cols=259 Identities=25% Similarity=0.408 Sum_probs=209.8
Q ss_pred hccccccccCCCcceEEEEEEec------CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
++|...++||+|+||+||+|++. +++.||||+++.......+.|.+|+++|++++|||||+++|+|.+++..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56778889999999999999864 478899999987666677889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc
Q 003855 575 VLEFMPNGSLEKWLYSHN--------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA 640 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~ 640 (791)
|||||++|+|.++++... ..++|.++..|+.|||+||+||| +++|+||||||+|||+++++.
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA----GLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHhhEEECCCCc
Confidence 999999999999998532 35899999999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHH
Q 003855 641 AHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVK 719 (791)
Q Consensus 641 ~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 719 (791)
+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.... .....+.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~ 274 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCIT 274 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHHHHH
Confidence 99999999997755544444455679999999999999999999999999999999999 89999764221 1112111
Q ss_pred HhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 720 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 720 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
.. ...+.+..|++++.+++.+||+.||++||||.||++.|+.+.+.
T Consensus 275 ~g-----------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 QG-----------------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HT-----------------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cC-----------------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 10 01112235677889999999999999999999999999998654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=451.04 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=212.3
Q ss_pred hccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
.+++..+.||+|+||+||+|++. +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45667789999999999999863 56889999997543 334578999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC
Q 003855 574 LVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN 638 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~ 638 (791)
+|||||++|||.++|.... ..++|.++.+|+.|||+||+||| +.+||||||||+|||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS----SHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCccccceEECCC
Confidence 9999999999999997432 35899999999999999999999 6789999999999999999
Q ss_pred CcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHH
Q 003855 639 MAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRW 717 (791)
Q Consensus 639 ~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 717 (791)
+.+||+|||+|+...........+..+||++|||||++.++.|+.++|||||||++|||+| |+.||.+... ..+...
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~~ 259 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVEM 259 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHHH
Confidence 9999999999987654443334445679999999999999999999999999999999999 8999976432 122222
Q ss_pred HHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 718 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 718 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
+... ...+.+.+|+..+.++|.+||+.||++||||.||++.|+.+
T Consensus 260 i~~~-----------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IRNR-----------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHTT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHcC-----------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2211 01122335778899999999999999999999999999754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=489.38 Aligned_cols=407 Identities=33% Similarity=0.491 Sum_probs=339.1
Q ss_pred CCccCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCc
Q 003855 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPH 80 (791)
Q Consensus 1 ~~g~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~ 80 (791)
++|.+|. ++++++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|.. .+++|++|+|++|.+++.+|.
T Consensus 212 l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~ 287 (768)
T 3rgz_A 212 FSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPD 287 (768)
T ss_dssp CCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC---CCTTCCEEECCSSEEEESCCC
T ss_pred CCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc---ccCCCCEEECcCCccCCccCH
Confidence 3566776 999999999999999999888999999999999999999998777775 378999999999999988998
Q ss_pred cCcCC-CCCCEEeccCcccccccccccccccccccccccccccc-ccCCCccccccccccCCCCCCcEEEccCCCCcccC
Q 003855 81 SITNA-TKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT-TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGIL 158 (791)
Q Consensus 81 ~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 158 (791)
.+..+ ++|++|+|++|++++..+..|+++++|+.|++++|++. .++.. .+..+++|++|++++|++++.+
T Consensus 288 ~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~--------~l~~l~~L~~L~Ls~n~l~~~~ 359 (768)
T 3rgz_A 288 FLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD--------TLLKMRGLKVLDLSFNEFSGEL 359 (768)
T ss_dssp CSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHH--------HHTTCTTCCEEECCSSEEEECC
T ss_pred HHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHH--------HHhcCCCCCEEeCcCCccCccc
Confidence 88775 99999999999999999999999999999999999997 44322 2677888888888888888777
Q ss_pred Chhhhhhhh--------------------------hhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCcccc
Q 003855 159 PPVIGNFSA--------------------------SLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMG 212 (791)
Q Consensus 159 ~~~~~~~~~--------------------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 212 (791)
|..+..+.. +|++|++++|.+++.+|..|.++++|+.|+|++|++++..|..|.
T Consensus 360 p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 439 (768)
T 3rgz_A 360 PESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439 (768)
T ss_dssp CTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG
T ss_pred cHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHh
Confidence 777766643 355556666666667777777788888888888888777788888
Q ss_pred CCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeE
Q 003855 213 RLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDI 292 (791)
Q Consensus 213 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 292 (791)
.+++|++|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+.++++|++|+|++|++++.+|.++..+++|++|
T Consensus 440 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 519 (768)
T 3rgz_A 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL 519 (768)
T ss_dssp GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEE
T ss_pred cCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEE
Confidence 88888888888888887888888888888888888888888888888888888888888888888888888888888888
Q ss_pred EccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchh----------------------------------------
Q 003855 293 NLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIG---------------------------------------- 332 (791)
Q Consensus 293 ~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~---------------------------------------- 332 (791)
+|++|++++.+|..++.+++|+.|++++|++++.+|..+.
T Consensus 520 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (768)
T 3rgz_A 520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGI 599 (768)
T ss_dssp ECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTC
T ss_pred ECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccc
Confidence 8888888888888888888888888888888777665432
Q ss_pred ------------------------------ccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhc
Q 003855 333 ------------------------------ALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETL 382 (791)
Q Consensus 333 ------------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 382 (791)
.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+..+
T Consensus 600 ~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L 679 (768)
T 3rgz_A 600 RSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL 679 (768)
T ss_dssp CGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred cchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCC
Confidence 24678888889999988889889999999999999999999999999999
Q ss_pred ccCceEEccCCCCcccCCCC-CCCcCCccccccCCccc
Q 003855 383 SQLKQFNVSHNRLEGEIPVK-GSFKNFSVESFFGNYAL 419 (791)
Q Consensus 383 ~~L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~ 419 (791)
++|+.|||++|+++|.+|.. ..+..++.+.+.+|...
T Consensus 680 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 717 (768)
T 3rgz_A 680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717 (768)
T ss_dssp TTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence 99999999999999888864 55677888888888754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=439.38 Aligned_cols=263 Identities=27% Similarity=0.417 Sum_probs=217.5
Q ss_pred HhhccccccccCCCcceEEEEEEecC------CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccC-CccceeeeeeccC-
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTISD------GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRH-RNLIKILSSCSNP- 569 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~- 569 (791)
-.++|++.+.||+|+||.||+|++.. ++.||||++.... ....+.|.+|+.+|++++| ||||+++|+|.++
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 35789999999999999999998642 3679999997654 3446789999999999965 9999999998664
Q ss_pred CeeeEEEecCCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeE
Q 003855 570 DFKALVLEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNIL 634 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nil 634 (791)
+..++|||||++|+|.++|++. ...+++.++..++.|||+||+||| +++||||||||+|||
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH----~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNIL 217 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh----hCCeecCccCcccee
Confidence 5689999999999999999853 234899999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcch
Q 003855 635 LDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMS 713 (791)
Q Consensus 635 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 713 (791)
+++++.+||+|||+|+.+............+||+.|||||++.++.|+.++|||||||++|||+| |+.||.+....+ .
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-~ 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-H
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-H
Confidence 99999999999999998766555555556679999999999999999999999999999999998 899998643322 2
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
+.+.+.... ..+.+..+++++.++|.+||+.||++||||.||++.|+++.+..
T Consensus 297 ~~~~i~~g~-----------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 297 FCRRLKEGT-----------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HHHHHHHTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHcCC-----------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 222222111 11112345677889999999999999999999999999987654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=434.72 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=209.6
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
+.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46899999999999999999975 79999999997665555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
+||+|.+++.... +++.++..++.||+.||+||| +++|+||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~~--l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-- 225 (346)
T 4fih_A 154 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-- 225 (346)
T ss_dssp TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred CCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--
Confidence 9999999998653 899999999999999999999 67899999999999999999999999999987754322
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. .....+.+....+...
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~------------- 290 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRL------------- 290 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSCCCC-------------
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCC-------------
Confidence 2334689999999999999999999999999999999999999997532 1122222222111110
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....+++++.+++.+||+.||++|||+.|+++
T Consensus 291 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111234567889999999999999999999976
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=428.50 Aligned_cols=270 Identities=21% Similarity=0.313 Sum_probs=205.5
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCC----eeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD----FKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 576 (791)
++|.+.+.||+|+||+||+|++ +|+.||||++...... ...++.|+..+.+++|||||+++|+|.+++ ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5678889999999999999998 6899999999755432 223445667777889999999999997653 579999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccC----CCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH----SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
|||++|+|.++++... ++|..+.+++.|+++||+|||+.+ ...+|+||||||+|||+++++++||+|||+|+..
T Consensus 81 Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999998764 899999999999999999999431 1248999999999999999999999999999876
Q ss_pred CCCCCcc--eeecccccccccCCCccCCC------CCCccccHHhHHHHHHHHHhCCCCCCccccCc----------chH
Q 003855 653 GEGEDSV--TQTMTMATIGYMAPEYGSEG------IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE----------MSL 714 (791)
Q Consensus 653 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~----------~~~ 714 (791)
....... .....+||++|||||++.+. .++.++|||||||++|||+||+.|+......+ ...
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 5443321 22345799999999988654 47789999999999999999987765432221 122
Q ss_pred HHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 715 RRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
............ ++.+. ......+++..+.+++.+||+.||++||||.||++.|+++.++
T Consensus 239 ~~~~~~~~~~~~----rp~~p----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVVCEQKL----RPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCC----CCCCC----GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcccC----CCCCC----ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 222221111111 11111 1112235677889999999999999999999999999998764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=428.60 Aligned_cols=257 Identities=21% Similarity=0.255 Sum_probs=209.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.+.|+..++||+|+||.||+|+.. +|+.||||+++.... ..+|+.++++++|||||++++++.+++..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 357888899999999999999975 799999999975432 24699999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC-cEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-AAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~ 657 (791)
|+||+|.++++..+ .+++.++..++.||+.||+||| +++|+||||||+|||++.+| .+||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH----TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999998654 4899999999999999999999 78999999999999999988 699999999998754332
Q ss_pred cc---eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 658 SV---TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 658 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
.. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+. +...... .+ ..
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~-~~---------~~ 275 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASE-PP---------PI 275 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHS-CC---------GG
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcC-CC---------Cc
Confidence 21 22335799999999999999999999999999999999999999986443322 1111111 00 00
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
...+..+++.+.+++.+||+.||++|||+.|+++.|.......
T Consensus 276 ------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 276 ------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp ------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 0112245677889999999999999999999999998876654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=426.33 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=209.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 67999999999999999999964 79999999997643 344577899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||++||+|.+++.+.+. +++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~~-l~e~~~~~~~~qi~~al~ylH----~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999999986544 899999999999999999999 6789999999999999999999999999999876544
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
........+||+.|||||++.+..|+.++||||+||++|||+||+.||.+... ..+.+-+.....
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~------------- 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--GLIFAKIIKLEY------------- 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCC-------------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCC-------------
Confidence 44444556899999999999999999999999999999999999999975321 111111111000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAA 773 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~ 773 (791)
..+..+++++.+++.+||+.||++|||+.|+.
T Consensus 252 -----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 00113446678999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=428.32 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=202.8
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999975 79999999997543 345678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 577 EFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+||+|.+++...+ ..+++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999998653 45789999999999999999999 678999999999999999999999999999876432
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.... ..+.+......+
T Consensus 179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~~~~~~------------ 243 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-NLVLKIISGSFP------------ 243 (350)
T ss_dssp H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCCC------------
T ss_pred c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHcCCCC------------
Confidence 1 1223457999999999999999999999999999999999999999763211 111111111111
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.+..++.++.+++.+||+.||++|||+.|+++
T Consensus 244 ------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 ------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011234567889999999999999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=414.51 Aligned_cols=244 Identities=24% Similarity=0.359 Sum_probs=195.9
Q ss_pred ccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc----CCeeeEEE
Q 003855 504 NECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN----PDFKALVL 576 (791)
Q Consensus 504 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 576 (791)
+..+.||+|+||+||+|++. +++.||||++.... ....+.|.+|++++++++|||||++++++.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999975 78999999987543 3445779999999999999999999999864 35679999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCC--eEecCCCCCCeEeC-CCCcEEEeeeccccccC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP--IIHCDLKPTNILLD-ENMAAHVSDFGISKLLG 653 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--i~H~dlk~~Nill~-~~~~~kl~Dfgla~~~~ 653 (791)
|||++|+|.+++.+.. .+++..+..++.||+.||+||| +++ |+||||||+|||++ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH----~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999998654 4899999999999999999999 455 99999999999998 48999999999998643
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.. .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.... ..............
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~----~~~~~~i~~~~~~~----- 249 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTSGVKPA----- 249 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTTTCCCG-----
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH----HHHHHHHHcCCCCC-----
Confidence 22 2234579999999998865 6999999999999999999999999753221 11111111100000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..+++++.+++.+||+.||++|||+.|+++
T Consensus 250 --------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 --------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011123456789999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=431.99 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=209.5
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
+.|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 79999999997665445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
+||+|.+++.... +++.++..++.||+.||+||| +++|+||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH----~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 231 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred CCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence 9999999998654 899999999999999999999 67899999999999999999999999999987754322
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. .......+....+...
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~------------- 367 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRL------------- 367 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCC-------------
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCC-------------
Confidence 2344679999999999999999999999999999999999999997532 1122222222111111
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....++.++.+++.+||+.||++|||+.|+++
T Consensus 368 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011234567889999999999999999999976
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=408.75 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=191.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 79999999986542 334567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+ +|+|.+++.+.+. +++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~~-l~e~~~~~~~~qi~~al~ylH----~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDK-MSEQEARRFFQQIISAVEYCH----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 6899999987654 899999999999999999999 6789999999999999999999999999998764432
Q ss_pred CcceeecccccccccCCCccCCCCC-CccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.....+||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.. ...+.+-+.....
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--~~~~~~~i~~~~~------------ 229 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--IPVLFKNISNGVY------------ 229 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCC------------
T ss_pred ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCC------------
Confidence 2234579999999999988776 579999999999999999999997521 1111111111100
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..+++++.+++.+||+.||++|||+.|+++
T Consensus 230 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 001134566789999999999999999999986
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=447.09 Aligned_cols=415 Identities=20% Similarity=0.189 Sum_probs=305.8
Q ss_pred CCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcC
Q 003855 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITN 84 (791)
Q Consensus 5 lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 84 (791)
.|..|+++++|++|+|++|+++++.|.+|.++++|++|+|++|++++..|..+.. +++|++|+|++|.|+++.+..|++
T Consensus 49 ~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~L~~n~i~~l~~~~~~~ 127 (606)
T 3t6q_A 49 QNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG-PKALKHLFFIQTGISSIDFIPLHN 127 (606)
T ss_dssp CTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSS-CTTCCEEECTTSCCSCGGGSCCTT
T ss_pred ChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcc-cccccEeeccccCcccCCcchhcc
Confidence 3566677777777777777777666777777777777777777776444444433 566666666666666555555666
Q ss_pred CCCCCEEeccCccccccccccccccccccccccccccccc--------------------------cCCCcccc------
Q 003855 85 ATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTT--------------------------ESSSADQW------ 132 (791)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~--------------------------~~~~~~~~------ 132 (791)
+++|++|+|++|++.++....+.++++|+.|++++|+++. ++......
T Consensus 128 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L 207 (606)
T 3t6q_A 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSL 207 (606)
T ss_dssp CTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEE
T ss_pred CCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhcccccc
Confidence 6666666666666655443333345555555555554443 32211100
Q ss_pred ------------------------------------------------------------c-cccccCCCCCCcEEEccC
Q 003855 133 ------------------------------------------------------------S-FLSSLTNCRNLTILSFGS 151 (791)
Q Consensus 133 ------------------------------------------------------------~-~~~~l~~l~~L~~L~L~~ 151 (791)
. ....|..+++|++|++++
T Consensus 208 ~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 287 (606)
T 3t6q_A 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287 (606)
T ss_dssp ECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTT
T ss_pred ccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccC
Confidence 0 011256677777777777
Q ss_pred CCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccC-ccccCCCCCCEEEcccccCccc
Q 003855 152 NPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTIS-PTMGRLKRLQGLSLRNNNLEGS 230 (791)
Q Consensus 152 N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~ 230 (791)
|+++ .+|+.+..+ ++|++|++++|.+.+..|..+.++++|+.|++++|.+.+..+ ..+..+++|++|++++|.+++.
T Consensus 288 n~l~-~lp~~l~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 365 (606)
T 3t6q_A 288 THLS-ELPSGLVGL-STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365 (606)
T ss_dssp SCCS-CCCSSCCSC-TTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEE
T ss_pred CccC-CCChhhccc-ccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccc
Confidence 7777 455555544 467778888888777777777778888888888887764443 3477888888888888888765
Q ss_pred C--CccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCc-cccCCCCCCeEEccCCcCcccCCccc
Q 003855 231 I--PYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPS-SLWSLEYILDINLSSNSLNDSLPSNV 307 (791)
Q Consensus 231 ~--~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~i~~~~~~~~ 307 (791)
. +..+..+++|+.|++++|++.+..|..|..+++|++|++++|++.+..+. .+..+++|+.|++++|.+++..|..+
T Consensus 366 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 445 (606)
T 3t6q_A 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF 445 (606)
T ss_dssp EESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTT
T ss_pred cCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHH
Confidence 5 67788888888888888888877888888888999999999988876554 48888999999999999988888888
Q ss_pred ccCCCCCEEecCCcccCC---CCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhccc
Q 003855 308 QKLKVLTVLDLSRNQLSG---DIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQ 384 (791)
Q Consensus 308 ~~l~~L~~L~l~~N~l~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 384 (791)
..+++|+.|++++|++.+ ..+..+..+++|+.|++++|++++..|..|+.+++|+.|+|++|++++..|..+..+++
T Consensus 446 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 525 (606)
T 3t6q_A 446 DGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525 (606)
T ss_dssp TTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCS
T ss_pred hCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcccc
Confidence 899999999999999875 23356888999999999999999888889999999999999999999999999999999
Q ss_pred CceEEccCCCCcccCCCC-CCCcCCccccccCCccccCCC
Q 003855 385 LKQFNVSHNRLEGEIPVK-GSFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 385 L~~l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~~ 423 (791)
| .|++++|++++.+|.. ..+.+++.+.+.+|++.|+.+
T Consensus 526 L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 526 I-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp C-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred c-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 9 9999999999877753 556788899999999998744
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=415.53 Aligned_cols=247 Identities=25% Similarity=0.281 Sum_probs=196.0
Q ss_pred hccccccccCCCcceEEEEEEec----CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 67999999999999999999852 57889999986542 2223467889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
|||||+||+|.+++.+.+. +++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM-FTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999999987553 899999999999999999999 67899999999999999999999999999986543
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+... ......+.....
T Consensus 179 ~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~----------- 243 (304)
T 3ubd_A 179 HEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--KETMTMILKAKL----------- 243 (304)
T ss_dssp --C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC-----------
T ss_pred CCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--HHHHHHHHcCCC-----------
Confidence 222 23346799999999999999999999999999999999999999976321 111111111000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINV-----TDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~-----~ev~~ 774 (791)
..+..+++++.+++.+||+.||++|||+ +|+++
T Consensus 244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0112345678899999999999999985 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=404.78 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=188.8
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCC--------
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD-------- 570 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 570 (791)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 57999999999999999999975 79999999986543 344567899999999999999999999986543
Q ss_pred ----eeeEEEecCCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEe
Q 003855 571 ----FKALVLEFMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVS 644 (791)
Q Consensus 571 ----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~ 644 (791)
..|+|||||++|+|.+++..... ..++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH----~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH----HCcCccccCcHHHeEECCCCcEEEc
Confidence 36899999999999999986543 3566778899999999999999 6789999999999999999999999
Q ss_pred eeccccccCCCCCc----------ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchH
Q 003855 645 DFGISKLLGEGEDS----------VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 714 (791)
Q Consensus 645 Dfgla~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~ 714 (791)
|||+|+.+...... ...+..+||+.|||||++.+..|+.++||||+||++|||++ ||..... .
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----~ 233 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----R 233 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----H
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----H
Confidence 99999877543221 12234579999999999999999999999999999999996 7754211 1
Q ss_pred HHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 715 RRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+........ .+......+.+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~--------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTDVRNLKF--------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHTTCC--------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcCCC--------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111000000 0111233455678999999999999999999986
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=443.93 Aligned_cols=408 Identities=19% Similarity=0.164 Sum_probs=307.7
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCc
Q 003855 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSIT 83 (791)
Q Consensus 4 ~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 83 (791)
++|..+. ++|++|+|++|+++++.+..|.++++|++|+|++|++++..|..+. .+++|++|+|++|.+++..|..|+
T Consensus 25 ~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~ 101 (606)
T 3vq2_A 25 KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWH-GLHHLSNLILTGNPIQSFSPGSFS 101 (606)
T ss_dssp SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT-TCTTCCEEECTTCCCCCCCTTSST
T ss_pred cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhh-chhhcCEeECCCCcccccChhhcC
Confidence 3555443 6777788888877777777777778888888888777733344443 367788888888877777777777
Q ss_pred CCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhh
Q 003855 84 NATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIG 163 (791)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 163 (791)
++++|++|+|++|.++++.+..|+++++|++|++++|++..+. ++..|.++++|++|++++|++++..+..+.
T Consensus 102 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-------lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 174 (606)
T 3vq2_A 102 GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCK-------LPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174 (606)
T ss_dssp TCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCC-------CCGGGGTCTTCCEEECCSSCCCEECTTTTH
T ss_pred CcccCCEEEccCCccccccccccCCCCCCCEEeCCCCccccee-------chHhHhhcCCCCEEEccCCcceecChhhhh
Confidence 7778888888888777777677777777888888777776532 234577777777777777777776666555
Q ss_pred hhhhh---hhhhhcccccccccCCc-------------------------------------------------------
Q 003855 164 NFSAS---LQKFYAYECKLKGNIPQ------------------------------------------------------- 185 (791)
Q Consensus 164 ~~~~~---L~~L~l~~n~l~~~~~~------------------------------------------------------- 185 (791)
.+..- +.+|++++|.+++..+.
T Consensus 175 ~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~ 254 (606)
T 3vq2_A 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254 (606)
T ss_dssp HHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGG
T ss_pred hhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHH
Confidence 44310 11333333333322211
Q ss_pred -----------------------------------------------cccCCCCCCEEEccCCccccccC----------
Q 003855 186 -----------------------------------------------EIGNLSGLTLLSLHSNDLNGTIS---------- 208 (791)
Q Consensus 186 -----------------------------------------------~~~~l~~L~~L~L~~N~l~~~~~---------- 208 (791)
.+..+++|+.|++++|.+. .+|
T Consensus 255 ~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~-~lp~~~l~~L~~L 333 (606)
T 3vq2_A 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK-QFPTLDLPFLKSL 333 (606)
T ss_dssp GTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCS-SCCCCCCSSCCEE
T ss_pred hhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCc-ccccCCCCcccee
Confidence 2333334444444444442 222
Q ss_pred ----------ccccCCCCCCEEEcccccCccc--CCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCC
Q 003855 209 ----------PTMGRLKRLQGLSLRNNNLEGS--IPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT 276 (791)
Q Consensus 209 ----------~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 276 (791)
..+..+++|++|++++|++++. .|..+..+++|+.|++++|.+++ +|..+.++++|+.|++++|++.
T Consensus 334 ~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~ 412 (606)
T 3vq2_A 334 TLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLK 412 (606)
T ss_dssp EEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEE
T ss_pred eccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccC
Confidence 1344566777777777777654 36777888888888888888874 5578889999999999999998
Q ss_pred CCCC-ccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCC-CCCcchhccccccccccccccCCCCCCcc
Q 003855 277 SSIP-SSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSG-DIPSTIGALKDLETLSLARNQFQGPIPES 354 (791)
Q Consensus 277 ~~~~-~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 354 (791)
+..+ ..+..+++|++|++++|.+++..|..+..+++|+.|++++|.+++ ..|..|..+++|+.|++++|++++..|..
T Consensus 413 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 492 (606)
T 3vq2_A 413 RVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492 (606)
T ss_dssp STTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred CccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhh
Confidence 8777 688899999999999999998899999999999999999999987 47888999999999999999999888999
Q ss_pred cCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCc-CCccccccCCccccCCC
Q 003855 355 VGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFK-NFSVESFFGNYALCGPP 423 (791)
Q Consensus 355 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~l~~~~~~~n~~~c~~~ 423 (791)
++.+++|+.|+|++|++++.+|..|..+++|+.|++++|+++..++....+. +++.+.+.+|++.|+.+
T Consensus 493 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred hcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 9999999999999999999999999999999999999999997666655565 58899999999999865
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=456.17 Aligned_cols=415 Identities=21% Similarity=0.193 Sum_probs=294.0
Q ss_pred cCCccccCCCCCCeeecCCCccc-ccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCcc-
Q 003855 4 QIPTEIGNLQNLQYLVFAENNLS-GLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHS- 81 (791)
Q Consensus 4 ~lp~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~- 81 (791)
-.|..|+++++|++|+|++|.+. .+.|.+|.++++|++|+|++|.+++..|..+.. +++|++|+|++|.+++..|..
T Consensus 39 i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~n~l~~~~~~~~ 117 (844)
T 3j0a_A 39 VTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQG-LFHLFELRLYFCGLSDAVLKDG 117 (844)
T ss_dssp ECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCS-CSSCCCEECTTCCCSSCCSTTC
T ss_pred cChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccC-CcccCEeeCcCCCCCcccccCc
Confidence 34556666666666666666332 233556666666666666666666333444443 566666666666666544333
Q ss_pred -CcCCCCCCEEeccCcccccccc-ccccccccccccccccccccccCCCccc------------------cccccccCCC
Q 003855 82 -ITNATKLVALDLGFNSFAGHIL-NTFGNLRHLSLLSQVMNNLTTESSSADQ------------------WSFLSSLTNC 141 (791)
Q Consensus 82 -~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~------------------~~~~~~l~~l 141 (791)
|.++++|++|+|++|.+++..+ ..|+++++|+.|++++|.++........ ...+..+..+
T Consensus 118 ~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~ 197 (844)
T 3j0a_A 118 YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197 (844)
T ss_dssp CCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSS
T ss_pred cccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhc
Confidence 6666666666666666655443 3566666666666666665543221100 0011223333
Q ss_pred C------CCcEEEccCCCCcccCChhhhhh-------------------------------------hhhhhhhhccccc
Q 003855 142 R------NLTILSFGSNPLGGILPPVIGNF-------------------------------------SASLQKFYAYECK 178 (791)
Q Consensus 142 ~------~L~~L~L~~N~l~~~~~~~~~~~-------------------------------------~~~L~~L~l~~n~ 178 (791)
+ +|+.|++++|.+++..+..+... ..+|+.|++++|.
T Consensus 198 ~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~ 277 (844)
T 3j0a_A 198 MNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGF 277 (844)
T ss_dssp SCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCC
T ss_pred CCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCc
Confidence 3 38888888888776666555432 1468888888888
Q ss_pred ccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCcc
Q 003855 179 LKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPC 258 (791)
Q Consensus 179 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~ 258 (791)
+.+..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|.+++..|..|..+++|+.|++++|.+++..+..
T Consensus 278 l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~ 357 (844)
T 3j0a_A 278 VFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQT 357 (844)
T ss_dssp CCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSC
T ss_pred ccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhh
Confidence 88888888888899999999999998888888888899999999999888777888888889999999999888777778
Q ss_pred ccCCCCCcEEEcCCCcCCCCCC------------------c----------------------cccCCCCCCeEEccCCc
Q 003855 259 LVSLTSLRELHLGSNKLTSSIP------------------S----------------------SLWSLEYILDINLSSNS 298 (791)
Q Consensus 259 ~~~l~~L~~L~L~~N~l~~~~~------------------~----------------------~~~~l~~L~~L~l~~N~ 298 (791)
|.++++|++|+|++|.+++... . .+..+++|+.|+|++|+
T Consensus 358 ~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~ 437 (844)
T 3j0a_A 358 FKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNR 437 (844)
T ss_dssp SCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCC
T ss_pred hcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCc
Confidence 8888888888888888764211 0 12255667777777777
Q ss_pred CcccCCc-ccccCCCCCEEecCCcccC-----CCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccC
Q 003855 299 LNDSLPS-NVQKLKVLTVLDLSRNQLS-----GDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS 372 (791)
Q Consensus 299 i~~~~~~-~~~~l~~L~~L~l~~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 372 (791)
+++..+. .+..+++|+.|+|++|.++ +..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+++
T Consensus 438 l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 517 (844)
T 3j0a_A 438 FSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517 (844)
T ss_dssp CCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCS
T ss_pred ccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCC
Confidence 6644332 3455677777777777775 333456788899999999999999888888999999999999999999
Q ss_pred CCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccccCCC
Q 003855 373 GKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 373 ~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~ 423 (791)
+..|..+. ++|+.|++++|++++.+|.. +.++..+.+.+|++.|+.+
T Consensus 518 ~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 518 VLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECE 564 (844)
T ss_dssp SCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred ccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccc
Confidence 87777766 88999999999999988854 6788999999999999654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=443.03 Aligned_cols=381 Identities=19% Similarity=0.270 Sum_probs=263.7
Q ss_pred CCccCCccccCCCCCCeeecCCCcc-------------------------------------------------------
Q 003855 1 MAGQIPTEIGNLQNLQYLVFAENNL------------------------------------------------------- 25 (791)
Q Consensus 1 ~~g~lp~~~~~l~~L~~L~Ls~n~l------------------------------------------------------- 25 (791)
++|.+|++|++|++|++|+|++|.+
T Consensus 93 l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~ 172 (636)
T 4eco_A 93 ASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172 (636)
T ss_dssp CEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTS
T ss_pred cCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccc
Confidence 4799999999999999999999943
Q ss_pred -----------------------cccCCccccCCCCCcEEeCCCCcCccc-----------------CCchhh--hcCCC
Q 003855 26 -----------------------SGLVPPTIFNISTMRILTLEGNQLSGR-----------------LPSTVG--HLLPN 63 (791)
Q Consensus 26 -----------------------~~~~~~~~~~l~~L~~L~L~~n~l~~~-----------------~p~~~~--~~l~~ 63 (791)
++ +|.+|+++++|++|+|++|++++. +|+.++ . +++
T Consensus 173 ~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~-l~~ 250 (636)
T 4eco_A 173 KSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDN-LKD 250 (636)
T ss_dssp CCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGG-CTT
T ss_pred cccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcc-cCC
Confidence 34 566777777777777777777753 777666 5 677
Q ss_pred ccEEEccCCcceecCCccCcCCCCCCEEeccCcc-ccc-ccccccccc------ccccccccccccccccCCCccccccc
Q 003855 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNS-FAG-HILNTFGNL------RHLSLLSQVMNNLTTESSSADQWSFL 135 (791)
Q Consensus 64 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-i~~-~~~~~~~~l------~~L~~L~l~~n~l~~~~~~~~~~~~~ 135 (791)
|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ ..|..+..+ ++|+.|++++|+++.++..
T Consensus 251 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~------- 323 (636)
T 4eco_A 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE------- 323 (636)
T ss_dssp CCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCH-------
T ss_pred CCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCch-------
Confidence 7777777777777777777777777777777776 766 566666665 7777777777777644320
Q ss_pred cccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCC-CCEEEccCCccccccCccccCC
Q 003855 136 SSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSG-LTLLSLHSNDLNGTISPTMGRL 214 (791)
Q Consensus 136 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l 214 (791)
..+.++++|++|++++|++++.+| .+..+ ++|++|++++|++. .+|..+.++++ |+.|++++|.++ .+|..+..+
T Consensus 324 ~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l-~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~ 399 (636)
T 4eco_A 324 TSLQKMKKLGMLECLYNQLEGKLP-AFGSE-IKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAK 399 (636)
T ss_dssp HHHTTCTTCCEEECCSCCCEEECC-CCEEE-EEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTT
T ss_pred hhhccCCCCCEEeCcCCcCccchh-hhCCC-CCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhc
Confidence 036677777777777777776666 44443 45777777777777 66666777777 777777777777 555666554
Q ss_pred C--CCCEEEcccccCcccCCcccc-------ccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccC
Q 003855 215 K--RLQGLSLRNNNLEGSIPYDLC-------HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWS 285 (791)
Q Consensus 215 ~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 285 (791)
+ +|++|+|++|.+++..|..+. .+++|+.|+|++|+++...+..+..+++|++|+|++|+++.+.+..+..
T Consensus 400 ~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~ 479 (636)
T 4eco_A 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479 (636)
T ss_dssp CSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEE
T ss_pred ccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhcc
Confidence 4 677777777777776676666 6667777777777777444444556777777777777777333333332
Q ss_pred CC-------CCCeEEccCCcCcccCCcccc--cCCCCCEEecCCcccCCCCCcchhcccccccccc------ccccCCCC
Q 003855 286 LE-------YILDINLSSNSLNDSLPSNVQ--KLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSL------ARNQFQGP 350 (791)
Q Consensus 286 l~-------~L~~L~l~~N~i~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L------~~N~l~~~ 350 (791)
.. +|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+.
T Consensus 480 ~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~ 557 (636)
T 4eco_A 480 ENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLRE 557 (636)
T ss_dssp TTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCC
T ss_pred ccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCccccc
Confidence 22 6777777777776 4566665 67777777777777775 6666777777777777 44666667
Q ss_pred CCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccC
Q 003855 351 IPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEI 399 (791)
Q Consensus 351 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 399 (791)
+|..++.+++|+.|+|++|++ +.+|..+. ++|+.|++++|++.+..
T Consensus 558 ~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 558 WPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISID 603 (636)
T ss_dssp CCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEEE
T ss_pred ChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcccc
Confidence 777777777777777777777 35565544 67777777777766533
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=435.39 Aligned_cols=403 Identities=20% Similarity=0.216 Sum_probs=274.7
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCc
Q 003855 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSIT 83 (791)
Q Consensus 4 ~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 83 (791)
++|..+.. ++++|+|++|+|+++.|.+|.++++|++|+|++|++++..|..+.. +++|++|+|++|.+++..|..|+
T Consensus 26 ~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~ 102 (606)
T 3t6q_A 26 EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQS-QHRLDTLVLTANPLIFMAETALS 102 (606)
T ss_dssp SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTT-CTTCCEEECTTCCCSEECTTTTS
T ss_pred cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccC-ccccCeeeCCCCcccccChhhhc
Confidence 56766654 7999999999999999999999999999999999999555666655 89999999999999999999999
Q ss_pred CCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhh
Q 003855 84 NATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIG 163 (791)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 163 (791)
++++|++|+|++|+++++.+..|.++++|++|++++|+++.++... +..+++|++|++++|.+++..+..+.
T Consensus 103 ~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~--------~~~l~~L~~L~L~~n~l~~~~~~~~~ 174 (606)
T 3t6q_A 103 GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK--------GFPTEKLKVLDFQNNAIHYLSKEDMS 174 (606)
T ss_dssp SCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCT--------TCCCTTCCEEECCSSCCCEECHHHHH
T ss_pred ccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCccc--------ccCCcccCEEEcccCcccccChhhhh
Confidence 9999999999999999988899999999999999999999864322 44466666666666666655554444
Q ss_pred hhhh----------------------------------------------------------------------------
Q 003855 164 NFSA---------------------------------------------------------------------------- 167 (791)
Q Consensus 164 ~~~~---------------------------------------------------------------------------- 167 (791)
.+..
T Consensus 175 ~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~ 254 (606)
T 3t6q_A 175 SLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM 254 (606)
T ss_dssp TTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGS
T ss_pred hhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcC
Confidence 4321
Q ss_pred hhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEec
Q 003855 168 SLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247 (791)
Q Consensus 168 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 247 (791)
+|+.|++++|.+.+..+..|.++++|++|++++|+++ .+|..+..+++|++|++++|.+++..|..+..+++|+.|+++
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 333 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECC
Confidence 2334444444444444444555666666666666666 445556666666666666666665555566666666666666
Q ss_pred CCccCCCCC-ccccCCCCCcEEEcCCCcCCCCC--CccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccC
Q 003855 248 GNKLSGHIP-PCLVSLTSLRELHLGSNKLTSSI--PSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLS 324 (791)
Q Consensus 248 ~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 324 (791)
+|.+.+.+| ..+..+++|++|++++|++.+.. +..+..+++|++|++++|.+++..|..|..+++|+.|++++|++.
T Consensus 334 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 413 (606)
T 3t6q_A 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413 (606)
T ss_dssp SCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEE
T ss_pred CCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCC
Confidence 666553332 33566666666666666665444 455666666666666666666655666666666666666666666
Q ss_pred CCCCc-chhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCC---CchhhhhcccCceEEccCCCCcccCC
Q 003855 325 GDIPS-TIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGK---IPKSLETLSQLKQFNVSHNRLEGEIP 400 (791)
Q Consensus 325 ~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~---~~~~~~~l~~L~~l~l~~N~l~~~~~ 400 (791)
+..+. .+..+++|+.|++++|.+++..|..++.+++|+.|++++|++++. .+..+..+++|+.|++++|++++.+|
T Consensus 414 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 493 (606)
T 3t6q_A 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493 (606)
T ss_dssp CCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECT
T ss_pred CcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccCh
Confidence 54433 356666666666666666655566666666666666666666542 22456666666666666666666554
Q ss_pred C-CCCCcCCccccccCCcc
Q 003855 401 V-KGSFKNFSVESFFGNYA 418 (791)
Q Consensus 401 ~-~~~~~~l~~~~~~~n~~ 418 (791)
. ...+++++.+.+.+|..
T Consensus 494 ~~~~~l~~L~~L~Ls~N~l 512 (606)
T 3t6q_A 494 HAFTSLKMMNHVDLSHNRL 512 (606)
T ss_dssp TTTTTCTTCCEEECCSSCC
T ss_pred hhhccccCCCEEECCCCcc
Confidence 3 24455566666666543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=437.57 Aligned_cols=415 Identities=23% Similarity=0.260 Sum_probs=258.9
Q ss_pred ccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCC
Q 003855 7 TEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNAT 86 (791)
Q Consensus 7 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 86 (791)
..|+++++|++|+|++|+++++.|.+|.++++|++|+|++|+++ .+|...+..+++|++|+|++|.++++.|..|++++
T Consensus 43 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 121 (680)
T 1ziw_A 43 ANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121 (680)
T ss_dssp GGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCT
T ss_pred HHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccC
Confidence 34555666666666666665555555555566666666666555 45543333355555555555555555455555555
Q ss_pred CCCEEeccCcccccccccccccccccccccccccccccc--------------------------CCCccc-c-------
Q 003855 87 KLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTE--------------------------SSSADQ-W------- 132 (791)
Q Consensus 87 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~--------------------------~~~~~~-~------- 132 (791)
+|++|+|++|.+++..+..|.++++|+.|++++|+++.. +..... .
T Consensus 122 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 201 (680)
T 1ziw_A 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLF 201 (680)
T ss_dssp TCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEE
T ss_pred CCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhh
Confidence 555555555555555555555555555555555444332 221000 0
Q ss_pred -----------------------------------ccccccCCCC--CCcEEEccCCCCcccCChhhhhhhhhhhhhhcc
Q 003855 133 -----------------------------------SFLSSLTNCR--NLTILSFGSNPLGGILPPVIGNFSASLQKFYAY 175 (791)
Q Consensus 133 -----------------------------------~~~~~l~~l~--~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~ 175 (791)
..+..|.+++ +|++|++++|++++..|..+..+ ++|++|+++
T Consensus 202 l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~L~ 280 (680)
T 1ziw_A 202 LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWL-PQLEYFFLE 280 (680)
T ss_dssp CTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTC-TTCCEEECC
T ss_pred ccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCc-ccccEeeCC
Confidence 0011222332 37777777777766655555444 346666666
Q ss_pred cccccccCCc---------------------------------cccCCCCCCEEEccCCccccccCccccCCCCCCEEEc
Q 003855 176 ECKLKGNIPQ---------------------------------EIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSL 222 (791)
Q Consensus 176 ~n~l~~~~~~---------------------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 222 (791)
+|.+.+..|. .|..+++|++|++++|.+++..+..|..+++|++|++
T Consensus 281 ~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 360 (680)
T 1ziw_A 281 YNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360 (680)
T ss_dssp SCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEEC
T ss_pred CCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEEC
Confidence 6666554443 2333445555555556666555555555554444444
Q ss_pred c----------------------------cccCcccCCccccccCCCceEEecCCccCCCCC-ccccCCCCCcEEEcCCC
Q 003855 223 R----------------------------NNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIP-PCLVSLTSLRELHLGSN 273 (791)
Q Consensus 223 ~----------------------------~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N 273 (791)
+ +|++++..|..|..+++|+.|+|++|.+++.+| ..|.++++|++|++++|
T Consensus 361 s~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n 440 (680)
T 1ziw_A 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYN 440 (680)
T ss_dssp TTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSC
T ss_pred CCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCC
Confidence 3 334444445556666666666666666654333 45555566666666555
Q ss_pred cCC--------------------------CCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCC
Q 003855 274 KLT--------------------------SSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDI 327 (791)
Q Consensus 274 ~l~--------------------------~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 327 (791)
++. +..|..|..+++|+.|++++|++++..+..|..+++|+.|++++|++++..
T Consensus 441 ~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~ 520 (680)
T 1ziw_A 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLW 520 (680)
T ss_dssp SEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGG
T ss_pred CcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccc
Confidence 543 345666777788888888888888777777888888888888888887532
Q ss_pred C--------cchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccC
Q 003855 328 P--------STIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEI 399 (791)
Q Consensus 328 ~--------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 399 (791)
+ ..|..+++|+.|+|++|+++...+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++++.+
T Consensus 521 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~ 600 (680)
T 1ziw_A 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600 (680)
T ss_dssp STTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCC
T ss_pred hhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccC
Confidence 1 23677888888888888888544556888999999999999999777777888999999999999998877
Q ss_pred CCC-C-CCcCCccccccCCccccCCC
Q 003855 400 PVK-G-SFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 400 ~~~-~-~~~~l~~~~~~~n~~~c~~~ 423 (791)
+.. . .+.+++.+.+.+|+|.|+.+
T Consensus 601 ~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 601 KKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp HHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred hhHhcccccccCEEEccCCCcccCCc
Confidence 653 2 46788899999999999865
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=432.84 Aligned_cols=395 Identities=18% Similarity=0.246 Sum_probs=336.5
Q ss_pred CCCCeeecCCCcccccCCccccCCCCCcEEeCCCCc--------------------------------------------
Q 003855 13 QNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQ-------------------------------------------- 48 (791)
Q Consensus 13 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~-------------------------------------------- 48 (791)
..++.|+|++|++.|.+|.+|++|++|++|+|++|.
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~ 160 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHH
Confidence 479999999999999999999999999999999984
Q ss_pred ----------------------------------CcccCCchhhhcCCCccEEEccCCcceec-----------------
Q 003855 49 ----------------------------------LSGRLPSTVGHLLPNIESLLLAANNLTGI----------------- 77 (791)
Q Consensus 49 ----------------------------------l~~~~p~~~~~~l~~L~~L~L~~N~l~~~----------------- 77 (791)
+++ +|+.+.. +++|++|+|++|.+++.
T Consensus 161 ~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~-l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ 238 (636)
T 4eco_A 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMR-LTKLRQFYMGNSPFVAENICEAWENENSEYAQQY 238 (636)
T ss_dssp HHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGG-CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred HHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhc-ccCCCEEECcCCccccccccccccccccchhccc
Confidence 444 7887776 89999999999999975
Q ss_pred CCccCc--CCCCCCEEeccCcccccccccccccccccccccccccc-ccc--cCCCccccccccccCCCCCCcEEEccCC
Q 003855 78 IPHSIT--NATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNN-LTT--ESSSADQWSFLSSLTNCRNLTILSFGSN 152 (791)
Q Consensus 78 ~~~~~~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~-l~~--~~~~~~~~~~~~~l~~l~~L~~L~L~~N 152 (791)
+|..++ ++++|++|+|++|.+.+..|..|.++++|+.|++++|+ ++. ++.... -+..+..+++|++|++++|
T Consensus 239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~---~L~~~~~l~~L~~L~L~~n 315 (636)
T 4eco_A 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ---ALADAPVGEKIQIIYIGYN 315 (636)
T ss_dssp TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHH---HHHHSGGGGTCCEEECCSS
T ss_pred CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHH---hhhccccCCCCCEEECCCC
Confidence 889988 99999999999999999999999999999999999998 764 332110 1112334589999999999
Q ss_pred CCcccCCh--hhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCC-CCEEEcccccCcc
Q 003855 153 PLGGILPP--VIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKR-LQGLSLRNNNLEG 229 (791)
Q Consensus 153 ~l~~~~~~--~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~ 229 (791)
+++ .+|. .+..+ ++|++|++++|++.+.+| .|.++++|+.|+|++|+++ .+|..|..+++ |++|+|++|.++
T Consensus 316 ~l~-~ip~~~~l~~l-~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~- 390 (636)
T 4eco_A 316 NLK-TFPVETSLQKM-KKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK- 390 (636)
T ss_dssp CCS-SCCCHHHHTTC-TTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-
T ss_pred cCC-ccCchhhhccC-CCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-
Confidence 999 6776 67665 579999999999998888 8999999999999999999 77788999999 999999999999
Q ss_pred cCCccccccC--CCceEEecCCccCCCCCcccc-------CCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCc
Q 003855 230 SIPYDLCHLK--LMFGIRLTGNKLSGHIPPCLV-------SLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLN 300 (791)
Q Consensus 230 ~~~~~~~~l~--~L~~L~L~~N~i~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~ 300 (791)
.+|..+..++ +|+.|++++|.+++..|..+. .+++|++|+|++|++++..+..+..+++|++|+|++|.++
T Consensus 391 ~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~ 470 (636)
T 4eco_A 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470 (636)
T ss_dssp SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS
T ss_pred ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC
Confidence 7888877755 899999999999988888888 8889999999999999655555667999999999999998
Q ss_pred ccCCcccccCC-------CCCEEecCCcccCCCCCcchh--ccccccccccccccCCCCCCcccCCCCCCcEEEc-----
Q 003855 301 DSLPSNVQKLK-------VLTVLDLSRNQLSGDIPSTIG--ALKDLETLSLARNQFQGPIPESVGSLISLESLDL----- 366 (791)
Q Consensus 301 ~~~~~~~~~l~-------~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l----- 366 (791)
...+..+.... +|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|
T Consensus 471 ~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ 548 (636)
T 4eco_A 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD 548 (636)
T ss_dssp BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBC
T ss_pred CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcc
Confidence 44444444333 8999999999999 7888886 89999999999999996 8899999999999999
Q ss_pred -cCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccccC
Q 003855 367 -SGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCG 421 (791)
Q Consensus 367 -~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~ 421 (791)
++|++.+.+|..+..+++|+.|++++|++ +.+|.. ..++++.+.+.+|++.|-
T Consensus 549 ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISI 602 (636)
T ss_dssp TTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEE
T ss_pred cccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCccc
Confidence 56888889999999999999999999999 556654 337899999999998874
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=430.78 Aligned_cols=401 Identities=19% Similarity=0.206 Sum_probs=327.5
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccC
Q 003855 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSI 82 (791)
Q Consensus 3 g~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 82 (791)
+-.|..|+++++|++|+|++|+++++.|.+|.++++|++|+|++|++++..|..+.. +++|++|+|++|.+++..+..|
T Consensus 46 ~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~L~~n~l~~~~~~~~ 124 (606)
T 3vq2_A 46 ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG-LTSLENLVAVETKLASLESFPI 124 (606)
T ss_dssp EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTT-CTTCCEEECTTSCCCCSSSSCC
T ss_pred EeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCC-cccCCEEEccCCcccccccccc
Confidence 445568999999999999999999998999999999999999999998444666655 8999999999999998887889
Q ss_pred cCCCCCCEEeccCcccccc-ccccccccccccccccccccccccCCCccc-c------------------ccccccCCCC
Q 003855 83 TNATKLVALDLGFNSFAGH-ILNTFGNLRHLSLLSQVMNNLTTESSSADQ-W------------------SFLSSLTNCR 142 (791)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~------------------~~~~~l~~l~ 142 (791)
+++++|++|+|++|++.+. .+..|+++++|+.|++++|+++.++..... . ..++......
T Consensus 125 ~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~ 204 (606)
T 3vq2_A 125 GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI 204 (606)
T ss_dssp TTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC
T ss_pred CCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc
Confidence 9999999999999999864 488899999999999999998876543200 0 0111111222
Q ss_pred CCcEEEccCCCCcc-cCCh-------------------------------------------------------------
Q 003855 143 NLTILSFGSNPLGG-ILPP------------------------------------------------------------- 160 (791)
Q Consensus 143 ~L~~L~L~~N~l~~-~~~~------------------------------------------------------------- 160 (791)
+|+.|++++|.+++ ..|.
T Consensus 205 ~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l 284 (606)
T 3vq2_A 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCL 284 (606)
T ss_dssp EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGG
T ss_pred eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccC
Confidence 55555555554431 0000
Q ss_pred -----------------hhhhhhhhhhhhhcccccccccCC--------------------ccccCCCCCCEEEccCCcc
Q 003855 161 -----------------VIGNFSASLQKFYAYECKLKGNIP--------------------QEIGNLSGLTLLSLHSNDL 203 (791)
Q Consensus 161 -----------------~~~~~~~~L~~L~l~~n~l~~~~~--------------------~~~~~l~~L~~L~L~~N~l 203 (791)
.+.. ..+|++|++++|.+ +.+| ..+..+++|++|++++|.+
T Consensus 285 ~~L~~L~l~~~~~~~l~~l~~-~~~L~~L~l~~n~l-~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l 362 (606)
T 3vq2_A 285 ANVSAMSLAGVSIKYLEDVPK-HFKWQSLSIIRCQL-KQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNAL 362 (606)
T ss_dssp TTCSEEEEESCCCCCCCCCCT-TCCCSEEEEESCCC-SSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCE
T ss_pred CCCCEEEecCccchhhhhccc-cccCCEEEcccccC-cccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCcc
Confidence 0000 01345555555555 2333 1456778888999999999
Q ss_pred cccc--CccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCC-ccccCCCCCcEEEcCCCcCCCCCC
Q 003855 204 NGTI--SPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIP-PCLVSLTSLRELHLGSNKLTSSIP 280 (791)
Q Consensus 204 ~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~ 280 (791)
++.. +..+..+++|++|+|++|.+++ +|..+..+++|+.|++++|++.+..| ..+.++++|++|++++|++.+..|
T Consensus 363 ~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 441 (606)
T 3vq2_A 363 SFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441 (606)
T ss_dssp EEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCT
T ss_pred CCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccch
Confidence 8663 7889999999999999999984 66899999999999999999998877 689999999999999999999899
Q ss_pred ccccCCCCCCeEEccCCcCcc-cCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCC
Q 003855 281 SSLWSLEYILDINLSSNSLND-SLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLI 359 (791)
Q Consensus 281 ~~~~~l~~L~~L~l~~N~i~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 359 (791)
..+..+++|++|++++|.+++ ..|..+..+++|+.|++++|++++..|..|..+++|+.|++++|++++.+|..++.++
T Consensus 442 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 521 (606)
T 3vq2_A 442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY 521 (606)
T ss_dssp TTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCT
T ss_pred hhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCC
Confidence 999999999999999999987 4788999999999999999999988899999999999999999999988899999999
Q ss_pred CCcEEEccCCccCCCCchhhhhcc-cCceEEccCCCCcccCCCCCCCcCC
Q 003855 360 SLESLDLSGNNLSGKIPKSLETLS-QLKQFNVSHNRLEGEIPVKGSFKNF 408 (791)
Q Consensus 360 ~L~~L~l~~N~l~~~~~~~~~~l~-~L~~l~l~~N~l~~~~~~~~~~~~l 408 (791)
+|+.|+|++|+++ .+|..+..++ +|+.|++++|++.|.++..+...++
T Consensus 522 ~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~l 570 (606)
T 3vq2_A 522 SLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWV 570 (606)
T ss_dssp TCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTTT
T ss_pred cCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccHHHHHHH
Confidence 9999999999999 6777799997 5999999999999988865434444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=429.02 Aligned_cols=404 Identities=22% Similarity=0.251 Sum_probs=274.0
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCc
Q 003855 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSIT 83 (791)
Q Consensus 4 ~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 83 (791)
+||..+. ++|++|+|++|+++++.+..|.++++|++|+|++|.+++..|..+.. +++|++|+|++|.++++.+..|+
T Consensus 18 ~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~l~~~~~~ 94 (680)
T 1ziw_A 18 QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQK-LPMLKVLNLQHNELSQLSDKTFA 94 (680)
T ss_dssp SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHH-CTTCCEEECCSSCCCCCCTTTTT
T ss_pred ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhc-ccCcCEEECCCCccCccChhhhc
Confidence 4777665 79999999999999988889999999999999999999555655555 89999999999999977777899
Q ss_pred CCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhh
Q 003855 84 NATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIG 163 (791)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 163 (791)
++++|++|+|++|+++++.+..|.++++|++|++++|.++...... +.++++|++|++++|.+++..+..+.
T Consensus 95 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~--------~~~l~~L~~L~L~~n~l~~~~~~~~~ 166 (680)
T 1ziw_A 95 FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGT--------QVQLENLQELLLSNNKIQALKSEELD 166 (680)
T ss_dssp TCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCS--------SSCCTTCCEEECCSSCCCCBCHHHHG
T ss_pred cCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchh--------hcccccCCEEEccCCcccccCHHHhh
Confidence 9999999999999999998899999999999999999998765432 56666667777666666655444433
Q ss_pred hh-hhhhhhhhcccccccccCC---------------------------------------------------ccccCCC
Q 003855 164 NF-SASLQKFYAYECKLKGNIP---------------------------------------------------QEIGNLS 191 (791)
Q Consensus 164 ~~-~~~L~~L~l~~n~l~~~~~---------------------------------------------------~~~~~l~ 191 (791)
.. ..+|++|++++|.+.+..| ..|.+++
T Consensus 167 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~ 246 (680)
T 1ziw_A 167 IFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246 (680)
T ss_dssp GGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGG
T ss_pred ccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccC
Confidence 21 1345555555554444433 3333332
Q ss_pred --CCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCC-----CCCc----ccc
Q 003855 192 --GLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSG-----HIPP----CLV 260 (791)
Q Consensus 192 --~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-----~~~~----~~~ 260 (791)
+|+.|+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|+.|++++|...+ .+|. .|.
T Consensus 247 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~ 326 (680)
T 1ziw_A 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ 326 (680)
T ss_dssp GSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTT
T ss_pred cCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcc
Confidence 26666666666666666666666666666666666665555444444444444443332211 0111 334
Q ss_pred CCCCCcEEEcCCCcCCCCCCccccCCCC----------------------------CCeEEccCCcCcccCCcccccCCC
Q 003855 261 SLTSLRELHLGSNKLTSSIPSSLWSLEY----------------------------ILDINLSSNSLNDSLPSNVQKLKV 312 (791)
Q Consensus 261 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~----------------------------L~~L~l~~N~i~~~~~~~~~~l~~ 312 (791)
.+++|++|++++|++.+..+..|..+++ |+.|++++|++++..|..|..+++
T Consensus 327 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~ 406 (680)
T 1ziw_A 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406 (680)
T ss_dssp TCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTT
T ss_pred cCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCC
Confidence 4444555555555555444444444433 444444555566666677777788
Q ss_pred CCEEecCCcccCCCCC-cchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccC--CCCchhhhhcccCceEE
Q 003855 313 LTVLDLSRNQLSGDIP-STIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS--GKIPKSLETLSQLKQFN 389 (791)
Q Consensus 313 L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~l~ 389 (791)
|+.|++++|.+.+.+| ..|..+++|++|++++|++.+..+..|..+++|+.|++++|.++ +.+|..|..+++|+.|+
T Consensus 407 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~ 486 (680)
T 1ziw_A 407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486 (680)
T ss_dssp CCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEE
T ss_pred CCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEE
Confidence 8888888888765444 56777778888888888777666667777777777777777665 45666677777777777
Q ss_pred ccCCCCcccCCC-CCCCcCCccccccCCcc
Q 003855 390 VSHNRLEGEIPV-KGSFKNFSVESFFGNYA 418 (791)
Q Consensus 390 l~~N~l~~~~~~-~~~~~~l~~~~~~~n~~ 418 (791)
+++|++++.++. ...+.+++.+.+.+|..
T Consensus 487 Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l 516 (680)
T 1ziw_A 487 LSNNNIANINDDMLEGLEKLEILDLQHNNL 516 (680)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCCCCcCChhhhccccccCEEeCCCCCc
Confidence 777777765554 24456666666666654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=424.27 Aligned_cols=404 Identities=21% Similarity=0.225 Sum_probs=298.1
Q ss_pred CCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcC
Q 003855 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITN 84 (791)
Q Consensus 5 lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 84 (791)
+|..+. +++++|+|++|+++++.+.+|.++++|++|+|++|+++ .++...+..+++|++|+|++|.++++.|..|.+
T Consensus 22 ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (570)
T 2z63_A 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (570)
T ss_dssp CCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred cCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCC-ccCcccccCchhCCEEeCcCCcCCccCHhhhcC
Confidence 454442 46777777777777776777777777777777777776 444443344677777777777777666677777
Q ss_pred CCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhh
Q 003855 85 ATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGN 164 (791)
Q Consensus 85 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 164 (791)
+++|++|+|++|+++.+....|+++++|++|++++|.++.+. ++..|.++++|++|++++|++++..+..+..
T Consensus 99 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~-------lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 171 (570)
T 2z63_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK-------LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171 (570)
T ss_dssp CTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCC-------CCGGGGGCTTCCEEECTTSCCCEECGGGGHH
T ss_pred ccccccccccccccccCCCccccccccccEEecCCCccceec-------ChhhhcccCCCCEEeCcCCccceecHHHccc
Confidence 777777777777777666656777777777777777776532 2344666777777777777776655555544
Q ss_pred hhhhh----hhhhccccccccc----------------------------------------------------------
Q 003855 165 FSASL----QKFYAYECKLKGN---------------------------------------------------------- 182 (791)
Q Consensus 165 ~~~~L----~~L~l~~n~l~~~---------------------------------------------------------- 182 (791)
+. +| ..|++++|.+.+.
T Consensus 172 l~-~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~ 250 (570)
T 2z63_A 172 LH-QMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250 (570)
T ss_dssp HH-TCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTT
T ss_pred hh-ccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhh
Confidence 32 23 3444444444333
Q ss_pred -----------------------CCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCcc-c---
Q 003855 183 -----------------------IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYD-L--- 235 (791)
Q Consensus 183 -----------------------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~--- 235 (791)
.|..|..+++|+.|++++|.++ .+|..+..+ +|++|++++|.+. .+|.. +
T Consensus 251 ~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~~~l~~L 327 (570)
T 2z63_A 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPTLKLKSL 327 (570)
T ss_dssp TGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCBCBCSSC
T ss_pred hccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCccccccc
Confidence 3344555667777777777776 455566655 6666666666665 23321 1
Q ss_pred ----------------cccCCCceEEecCCccCCCC--CccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCC
Q 003855 236 ----------------CHLKLMFGIRLTGNKLSGHI--PPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSN 297 (791)
Q Consensus 236 ----------------~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 297 (791)
..+++|+.|++++|.+++.. +..+.++++|++|++++|++.+..+. +..+++|+.|++++|
T Consensus 328 ~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n 406 (570)
T 2z63_A 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHS 406 (570)
T ss_dssp CEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTS
T ss_pred CEEeCcCCccccccccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCC
Confidence 45677888888888887543 66788888999999999988865444 888999999999999
Q ss_pred cCcccCC-cccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCC-CCCCcccCCCCCCcEEEccCCccCCCC
Q 003855 298 SLNDSLP-SNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQ-GPIPESVGSLISLESLDLSGNNLSGKI 375 (791)
Q Consensus 298 ~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~ 375 (791)
.+.+..+ ..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|+++ +.+|..+..+++|+.|+|++|++++..
T Consensus 407 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~ 486 (570)
T 2z63_A 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486 (570)
T ss_dssp EEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEEC
T ss_pred ccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCC
Confidence 9987665 56889999999999999999888889999999999999999997 568889999999999999999999888
Q ss_pred chhhhhcccCceEEccCCCCcccCCC-CCCCcCCccccccCCccccCCC
Q 003855 376 PKSLETLSQLKQFNVSHNRLEGEIPV-KGSFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 376 ~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~l~~~~~~~n~~~c~~~ 423 (791)
|..|..+++|+.|++++|++++.+|. ...+++++.+.+.+|++.|+.+
T Consensus 487 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 487 PTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 99999999999999999999998775 3567888999999999998755
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=400.21 Aligned_cols=267 Identities=24% Similarity=0.263 Sum_probs=201.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc------CCe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN------PDF 571 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 571 (791)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 67999999999999999999975 79999999996543 3445678899999999999999999998753 467
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.|+|||||+ |+|.+++.+.+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH----SAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 68999998654 4999999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCC--cceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC--h
Q 003855 652 LGEGED--SVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG--L 726 (791)
Q Consensus 652 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~ 726 (791)
+..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.... ..+........... .
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChHH
Confidence 644321 2223456899999999987764 5799999999999999999999999763221 11111111111100 0
Q ss_pred hhhcch-hhhhhHHh---------hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 727 TEVVDA-NLVREEQA---------FSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 727 ~~~~d~-~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+.. ........ ......++.++.+|+.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 00000000 0001123567889999999999999999999876
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=430.27 Aligned_cols=353 Identities=18% Similarity=0.237 Sum_probs=222.9
Q ss_pred CCchhhhcCCCccEEEccCCccee-----------------cCCccCc--CCCCCCEEeccCcccccccccccccccccc
Q 003855 53 LPSTVGHLLPNIESLLLAANNLTG-----------------IIPHSIT--NATKLVALDLGFNSFAGHILNTFGNLRHLS 113 (791)
Q Consensus 53 ~p~~~~~~l~~L~~L~L~~N~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 113 (791)
+|..+.. +++|++|+|++|.|++ .+|..++ ++++|++|+|++|.+.+..|..|.++++|+
T Consensus 440 IP~~l~~-L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~ 518 (876)
T 4ecn_A 440 ISKAIQR-LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ 518 (876)
T ss_dssp ECGGGGG-CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCC
T ss_pred hhHHHhc-CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCC
Confidence 6665555 6677777777777775 2666655 777777777777776666666777777777
Q ss_pred cccccccc-ccc--cCCCccccccccccCCCCCCcEEEccCCCCcccCCh--hhhhhhhhhhhhhcccccccccCCcccc
Q 003855 114 LLSQVMNN-LTT--ESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPP--VIGNFSASLQKFYAYECKLKGNIPQEIG 188 (791)
Q Consensus 114 ~L~l~~n~-l~~--~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~--~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 188 (791)
.|++++|+ ++. ++..... +...+..+++|+.|+|++|+++ .+|. .+..+ ++|++|++++|+++ .+| .|.
T Consensus 519 ~L~Ls~N~~lsg~~iP~~i~~--L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L-~~L~~L~Ls~N~l~-~lp-~~~ 592 (876)
T 4ecn_A 519 SLNIACNRGISAAQLKADWTR--LADDEDTGPKIQIFYMGYNNLE-EFPASASLQKM-VKLGLLDCVHNKVR-HLE-AFG 592 (876)
T ss_dssp EEECTTCTTSCHHHHHHHHHH--HHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTC-TTCCEEECTTSCCC-BCC-CCC
T ss_pred EEECcCCCCcccccchHHHHh--hhhcccccCCccEEEeeCCcCC-ccCChhhhhcC-CCCCEEECCCCCcc-cch-hhc
Confidence 77777776 553 3221110 0013445567777777777776 5555 55554 35777777777776 555 667
Q ss_pred CCCCCCEEEccCCccccccCccccCCCC-CCEEEcccccCcccCCccccccCC--CceEEecCCccCCCCCccc---c--
Q 003855 189 NLSGLTLLSLHSNDLNGTISPTMGRLKR-LQGLSLRNNNLEGSIPYDLCHLKL--MFGIRLTGNKLSGHIPPCL---V-- 260 (791)
Q Consensus 189 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~L~~N~i~~~~~~~~---~-- 260 (791)
++++|+.|+|++|+++ .+|..+..+++ |++|+|++|+|+ .+|..+..++. |+.|+|++|++.+.+|... .
T Consensus 593 ~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~ 670 (876)
T 4ecn_A 593 TNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDY 670 (876)
T ss_dssp TTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTC
T ss_pred CCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccc
Confidence 7777777777777776 55666666766 777777777776 56666655543 7777777777765544322 1
Q ss_pred CCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCccccc--------CCCCCEEecCCcccCCCCCcchh
Q 003855 261 SLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQK--------LKVLTVLDLSRNQLSGDIPSTIG 332 (791)
Q Consensus 261 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~--------l~~L~~L~l~~N~l~~~~~~~~~ 332 (791)
.+++|+.|+|++|+++...+..+..+++|+.|+|++|.|+ .+|..+.. +++|+.|+|++|+++ .+|..+.
T Consensus 671 ~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~ 748 (876)
T 4ecn_A 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFR 748 (876)
T ss_dssp CCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGS
T ss_pred cCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhh
Confidence 2346777777777776333333346677777777777776 33333222 226777777777776 5666665
Q ss_pred --ccccccccccccccCCCCCCcccCCCCCCcEEEccC------CccCCCCchhhhhcccCceEEccCCCCcccCCCCCC
Q 003855 333 --ALKDLETLSLARNQFQGPIPESVGSLISLESLDLSG------NNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGS 404 (791)
Q Consensus 333 --~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~------N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~ 404 (791)
.+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..|..+++|+.|+|++|++ +.+|.. .
T Consensus 749 ~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l 825 (876)
T 4ecn_A 749 ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-L 825 (876)
T ss_dssp TTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-C
T ss_pred hccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh-h
Confidence 67777777777777774 566666777777777755 666667777777777777777777777 444443 2
Q ss_pred CcCCccccccCCccc
Q 003855 405 FKNFSVESFFGNYAL 419 (791)
Q Consensus 405 ~~~l~~~~~~~n~~~ 419 (791)
.++|+.+.+.+|+..
T Consensus 826 ~~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 826 TPQLYILDIADNPNI 840 (876)
T ss_dssp CSSSCEEECCSCTTC
T ss_pred cCCCCEEECCCCCCC
Confidence 356666667777653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=393.31 Aligned_cols=266 Identities=19% Similarity=0.262 Sum_probs=199.1
Q ss_pred HhhccccccccCCCcceEEEEEEec----CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeee
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 573 (791)
..++|++.+.||+|+||+||+|+.+ +++.||||++..... ...+.+|+++++.+ +||||+++++++.+.+..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999853 467899998865432 34677899999998 6999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC-CcEEEeeecccccc
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN-MAAHVSDFGISKLL 652 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfgla~~~ 652 (791)
+||||+++|+|.+++. .+++.++..++.|++.||+||| +.+|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH----~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH----QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 9999999999999984 2889999999999999999999 6899999999999999876 89999999999865
Q ss_pred CCCCCc--------------------------ceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCC
Q 003855 653 GEGEDS--------------------------VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTD 705 (791)
Q Consensus 653 ~~~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~ 705 (791)
...... ......+||++|||||++.+. .|+.++||||+||++|||+||+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 432211 112335799999999988765 58999999999999999999999996
Q ss_pred ccccCcchHHHHHHHh-----------c----------C-CChhhhcch-------------hhhhhHHhhHHHHHHHHH
Q 003855 706 EMFTGEMSLRRWVKES-----------L----------P-HGLTEVVDA-------------NLVREEQAFSAKMDCILS 750 (791)
Q Consensus 706 ~~~~~~~~~~~~~~~~-----------~----------~-~~~~~~~d~-------------~~~~~~~~~~~~~~~~~~ 750 (791)
........+.....-. . + ......... ...............+++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 4322211111111100 0 0 000000000 000000001112234567
Q ss_pred HHHHHhhccccCCCCCCCHHHHHH
Q 003855 751 IMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 751 l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.+++.+||+.||++|||+.|+++
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHCcCChhHCcCHHHHhc
Confidence 889999999999999999999875
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=434.22 Aligned_cols=408 Identities=20% Similarity=0.205 Sum_probs=323.9
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCc
Q 003855 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSIT 83 (791)
Q Consensus 4 ~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 83 (791)
.||. -.++|++|+|++|+|+++.|..|.++++|++|+|++|.+.+.++...+..+++|++|+|++|.|++..|..|+
T Consensus 18 ~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~ 94 (844)
T 3j0a_A 18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94 (844)
T ss_dssp CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC
T ss_pred CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc
Confidence 4665 4589999999999999999999999999999999999766688555555699999999999999999999999
Q ss_pred CCCCCCEEeccCcccccccccc--ccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChh
Q 003855 84 NATKLVALDLGFNSFAGHILNT--FGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPV 161 (791)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 161 (791)
++++|++|+|++|.+++..+.. |.++++|+.|++++|.++.... .+.|.++++|++|+|++|.+++..+..
T Consensus 95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~-------~~~~~~L~~L~~L~Ls~N~i~~~~~~~ 167 (844)
T 3j0a_A 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL-------HPSFGKLNSLKSIDFSSNQIFLVCEHE 167 (844)
T ss_dssp SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCC-------CGGGGTCSSCCEEEEESSCCCCCCSGG
T ss_pred CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCccccccc-------chhHhhCCCCCEEECCCCcCCeeCHHH
Confidence 9999999999999999755544 9999999999999999987642 235899999999999999999988888
Q ss_pred hhhhh-hhhhhhhcccccccccCCccccC---------------------------------------------------
Q 003855 162 IGNFS-ASLQKFYAYECKLKGNIPQEIGN--------------------------------------------------- 189 (791)
Q Consensus 162 ~~~~~-~~L~~L~l~~n~l~~~~~~~~~~--------------------------------------------------- 189 (791)
+..+. .+|+.|++++|.+.+..|..+..
T Consensus 168 l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~ 247 (844)
T 3j0a_A 168 LEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF 247 (844)
T ss_dssp GHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSS
T ss_pred cccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccc
Confidence 87652 34444554444444333322211
Q ss_pred -----------------CCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccC
Q 003855 190 -----------------LSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLS 252 (791)
Q Consensus 190 -----------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 252 (791)
.++|+.|+|++|.+.+..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.++
T Consensus 248 ~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~ 327 (844)
T 3j0a_A 248 GFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327 (844)
T ss_dssp SCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCS
T ss_pred cccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCC
Confidence 156777888888887777778888888888888888888777888888888888888888888
Q ss_pred CCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCC----------------------------
Q 003855 253 GHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLP---------------------------- 304 (791)
Q Consensus 253 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~---------------------------- 304 (791)
+..|..|.++++|+.|++++|++.+..+..|..+++|+.|+|++|.+++...
T Consensus 328 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ 407 (844)
T 3j0a_A 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIH 407 (844)
T ss_dssp CCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEE
T ss_pred ccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceee
Confidence 7778888888888888888888887777788888888888888888764211
Q ss_pred ------------cccccCCCCCEEecCCcccCCCCCc-chhccccccccccccccCC-----CCCCcccCCCCCCcEEEc
Q 003855 305 ------------SNVQKLKVLTVLDLSRNQLSGDIPS-TIGALKDLETLSLARNQFQ-----GPIPESVGSLISLESLDL 366 (791)
Q Consensus 305 ------------~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~l 366 (791)
..+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|..+++|+.|+|
T Consensus 408 ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~L 487 (844)
T 3j0a_A 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487 (844)
T ss_dssp CCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCC
T ss_pred cccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEEC
Confidence 0123556667777777776643332 3455677777788888776 344566888999999999
Q ss_pred cCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccccCC
Q 003855 367 SGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGP 422 (791)
Q Consensus 367 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~ 422 (791)
++|++++..|..|..+++|+.|+|++|+|++.++.... .+++.+.+.+|....-.
T Consensus 488 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~ 542 (844)
T 3j0a_A 488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPN 542 (844)
T ss_dssp CHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCC
T ss_pred CCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCC
Confidence 99999999999999999999999999999987776543 78888888888765443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=421.70 Aligned_cols=354 Identities=17% Similarity=0.212 Sum_probs=224.4
Q ss_pred CCccccCCCCCcEEeCCCCcCcc-----------------cCCchhh-hcCCCccEEEccCCcceecCCccCcCCCCCCE
Q 003855 29 VPPTIFNISTMRILTLEGNQLSG-----------------RLPSTVG-HLLPNIESLLLAANNLTGIIPHSITNATKLVA 90 (791)
Q Consensus 29 ~~~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 90 (791)
+|..|.++++|++|+|++|+|++ .+|+.+. ..+++|++|+|++|.+.+.+|..|+++++|++
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 56667777777777777777764 2666653 22667777777777766667777777777777
Q ss_pred EeccCcc-ccc-cccccccccc-------cccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChh
Q 003855 91 LDLGFNS-FAG-HILNTFGNLR-------HLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPV 161 (791)
Q Consensus 91 L~L~~N~-i~~-~~~~~~~~l~-------~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 161 (791)
|+|++|+ +++ ..|..|.+++ +|+.|++++|+++.++. ...+.++++|+.|+|++|+++ .+| .
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~-------~~~l~~L~~L~~L~Ls~N~l~-~lp-~ 590 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA-------SASLQKMVKLGLLDCVHNKVR-HLE-A 590 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCC-------HHHHTTCTTCCEEECTTSCCC-BCC-C
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCC-------hhhhhcCCCCCEEECCCCCcc-cch-h
Confidence 7777776 665 5555555554 77777777777764331 003666777777777777776 455 4
Q ss_pred hhhhhhhhhhhhcccccccccCCccccCCCC-CCEEEccCCccccccCccccCCCC--CCEEEcccccCcccCCccc---
Q 003855 162 IGNFSASLQKFYAYECKLKGNIPQEIGNLSG-LTLLSLHSNDLNGTISPTMGRLKR--LQGLSLRNNNLEGSIPYDL--- 235 (791)
Q Consensus 162 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~--- 235 (791)
+..+ ++|+.|++++|++. .+|..+.++++ |+.|+|++|.++ .+|..+..++. |+.|+|++|++.+.+|...
T Consensus 591 ~~~L-~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l 667 (876)
T 4ecn_A 591 FGTN-VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667 (876)
T ss_dssp CCTT-SEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCT
T ss_pred hcCC-CcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhh
Confidence 4333 45777777777776 66666766766 777777777776 45566655543 7777777777765544322
Q ss_pred c--ccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccC-------CCCCCeEEccCCcCcccCCcc
Q 003855 236 C--HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWS-------LEYILDINLSSNSLNDSLPSN 306 (791)
Q Consensus 236 ~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-------l~~L~~L~l~~N~i~~~~~~~ 306 (791)
. .+++|+.|+|++|.++...+..+..+++|+.|+|++|+|..+.+..+.. +++|+.|+|++|+++ .+|..
T Consensus 668 ~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~ 746 (876)
T 4ecn_A 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDD 746 (876)
T ss_dssp TTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGG
T ss_pred ccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHH
Confidence 1 2346777777777777333333346677777777777776332222222 226777777777776 45666
Q ss_pred cc--cCCCCCEEecCCcccCCCCCcchhcccccccccccc------ccCCCCCCcccCCCCCCcEEEccCCccCCCCchh
Q 003855 307 VQ--KLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLAR------NQFQGPIPESVGSLISLESLDLSGNNLSGKIPKS 378 (791)
Q Consensus 307 ~~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~------N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 378 (791)
+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |++.+.+|..+..+++|+.|+|++|++ +.+|..
T Consensus 747 l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~ 824 (876)
T 4ecn_A 747 FRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK 824 (876)
T ss_dssp GSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC
T ss_pred hhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh
Confidence 65 67777777777777764 566666777777777755 566666677777777777777777777 466655
Q ss_pred hhhcccCceEEccCCCCcccC
Q 003855 379 LETLSQLKQFNVSHNRLEGEI 399 (791)
Q Consensus 379 ~~~l~~L~~l~l~~N~l~~~~ 399 (791)
+. ++|+.|+|++|++....
T Consensus 825 l~--~~L~~LdLs~N~l~~i~ 843 (876)
T 4ecn_A 825 LT--PQLYILDIADNPNISID 843 (876)
T ss_dssp CC--SSSCEEECCSCTTCEEE
T ss_pred hc--CCCCEEECCCCCCCccC
Confidence 44 46777777777765543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=403.32 Aligned_cols=248 Identities=20% Similarity=0.284 Sum_probs=200.1
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHH---HHHHHHHHhccCCccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSF---DSECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
.++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ....... ..++.+++.++|||||++++++.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999975 79999999997543 1222223 3345666777999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
|+||||++||+|.+++...+. +++..+..++.||+.||+||| +.+||||||||+|||++.+|.+||+|||+|+.+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~-l~E~~a~~y~~qIl~aL~yLH----~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 999999999999999987654 899999999999999999999 789999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcc-hHHHHHHHhcCCChhhhc
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM-SLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 730 (791)
.... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||.+...... .+.+.+.....
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~------- 411 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV------- 411 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC-------
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC-------
Confidence 5432 234589999999999864 5799999999999999999999999976432221 11111111000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRIN-----VTDAAA 774 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~ev~~ 774 (791)
..+..++.++.+++.+||+.||++|++ +.||++
T Consensus 412 -----------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 -----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 011234566789999999999999998 677754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=413.47 Aligned_cols=408 Identities=19% Similarity=0.233 Sum_probs=309.0
Q ss_pred CCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcC
Q 003855 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITN 84 (791)
Q Consensus 5 lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 84 (791)
.|..|.++++|++|+|++|+++++.|.+|.++++|++|+|++|+++ .+|...+..+++|++|+|++|.++++.+..|++
T Consensus 44 ~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~ 122 (570)
T 2z63_A 44 GSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122 (570)
T ss_dssp CTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTSCCCCSTTCSCTT
T ss_pred ChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCC-ccCHhhhcCccccccccccccccccCCCccccc
Confidence 4557888888899999888888888888888888888888888887 555444444788888888888888766667888
Q ss_pred CCCCCEEeccCcccccc-ccccccccccccccccccccccccCCCccc-c------------------------------
Q 003855 85 ATKLVALDLGFNSFAGH-ILNTFGNLRHLSLLSQVMNNLTTESSSADQ-W------------------------------ 132 (791)
Q Consensus 85 l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~------------------------------ 132 (791)
+++|++|+|++|.++++ .+..|+++++|+.|++++|+++.++..... .
T Consensus 123 l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L 202 (570)
T 2z63_A 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202 (570)
T ss_dssp CTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEE
T ss_pred cccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcc
Confidence 88888888888888764 477788888888888888887765432100 0
Q ss_pred ----------------------------------------------------------------------ccccccCCCC
Q 003855 133 ----------------------------------------------------------------------SFLSSLTNCR 142 (791)
Q Consensus 133 ----------------------------------------------------------------------~~~~~l~~l~ 142 (791)
..+..+..++
T Consensus 203 ~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~ 282 (570)
T 2z63_A 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282 (570)
T ss_dssp EEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGT
T ss_pred eeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcC
Confidence 0001122233
Q ss_pred CCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEc
Q 003855 143 NLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSL 222 (791)
Q Consensus 143 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 222 (791)
+|+.|++++|.++ .+|+.+... +|++|++.+|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++
T Consensus 283 ~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l 354 (570)
T 2z63_A 283 NVSSFSLVSVTIE-RVKDFSYNF--GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDL 354 (570)
T ss_dssp TCSEEEEESCEEC-SCCBCCSCC--CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEEC
T ss_pred cccEEEecCccch-hhhhhhccC--CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeC
Confidence 4444444444443 223333322 3444444444444 2222 2344555555555555433332 67899999999
Q ss_pred ccccCcccC--CccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCC-ccccCCCCCCeEEccCCcC
Q 003855 223 RNNNLEGSI--PYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIP-SSLWSLEYILDINLSSNSL 299 (791)
Q Consensus 223 ~~N~l~~~~--~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~i 299 (791)
++|++++.. |..+..+++|+.|++++|.+++..+. +..+++|++|++++|++.+..+ ..+..+++|++|++++|.+
T Consensus 355 ~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l 433 (570)
T 2z63_A 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433 (570)
T ss_dssp CSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCC
T ss_pred cCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcc
Confidence 999998654 67889999999999999999965444 9999999999999999987766 5788999999999999999
Q ss_pred cccCCcccccCCCCCEEecCCcccC-CCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchh
Q 003855 300 NDSLPSNVQKLKVLTVLDLSRNQLS-GDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKS 378 (791)
Q Consensus 300 ~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 378 (791)
.+..|..+..+++|+.|++++|.++ +.+|..+..+++|+.|++++|++++..|..+..+++|+.|+|++|++++..|..
T Consensus 434 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 513 (570)
T 2z63_A 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513 (570)
T ss_dssp EECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred cccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHH
Confidence 9999999999999999999999997 578899999999999999999999888999999999999999999999988899
Q ss_pred hhhcccCceEEccCCCCcccCCCCCCC-cCCcc--ccccCCccccCCC
Q 003855 379 LETLSQLKQFNVSHNRLEGEIPVKGSF-KNFSV--ESFFGNYALCGPP 423 (791)
Q Consensus 379 ~~~l~~L~~l~l~~N~l~~~~~~~~~~-~~l~~--~~~~~n~~~c~~~ 423 (791)
|..+++|+.|++++|+++|.+|....+ .+++. ..+.+.+ .|..+
T Consensus 514 ~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~ 560 (570)
T 2z63_A 514 FDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGS 560 (570)
T ss_dssp TTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTT
T ss_pred hhcccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCCC
Confidence 999999999999999999999876444 33322 2344444 66544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=408.23 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=210.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+.+|+.++|||||++++++.+....++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999975 7999999999766555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC--CcEEEeeeccccccCCCC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN--MAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfgla~~~~~~~ 656 (791)
|+||+|.+++......+++.++..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH----~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999999999876666999999999999999999999 6789999999999999854 899999999999875432
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.... .....+...... ..
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~i~~~~~~-~~--------- 376 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKSCDWN-MD--------- 376 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCCC-CC---------
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHhCCCC-CC---------
Confidence 233457999999999999999999999999999999999999999763221 111111111000 00
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......++.++.+|+.+||+.||++|||+.|+++
T Consensus 377 ----~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 377 ----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ----SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111234566789999999999999999999986
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=410.43 Aligned_cols=395 Identities=22% Similarity=0.285 Sum_probs=304.5
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCc
Q 003855 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSIT 83 (791)
Q Consensus 4 ~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 83 (791)
.||..+. ++|++|+|++|+++++.|.+|.++++|++|+|++|++++..|..+.. +++|++|+|++|+|+++ |..
T Consensus 14 ~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~l-p~~-- 87 (520)
T 2z7x_B 14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKF-NQELEYLDLSHNKLVKI-SCH-- 87 (520)
T ss_dssp SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTT-CTTCCEEECCSSCCCEE-ECC--
T ss_pred ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhc-ccCCCEEecCCCceeec-Ccc--
Confidence 4777776 89999999999999888889999999999999999998444656555 88999999999999954 444
Q ss_pred CCCCCCEEeccCcccccc-ccccccccccccccccccccccccCCCccccccccccCCCCCC--cEEEccCCCC--cccC
Q 003855 84 NATKLVALDLGFNSFAGH-ILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNL--TILSFGSNPL--GGIL 158 (791)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L--~~L~L~~N~l--~~~~ 158 (791)
.+++|++|+|++|+++++ .+..|+++++|+.|++++|+++.. .+..+++| +.|++++|.+ .+..
T Consensus 88 ~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~-----------~~~~l~~L~L~~L~l~~n~l~~~~~~ 156 (520)
T 2z7x_B 88 PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS-----------SVLPIAHLNISKVLLVLGETYGEKED 156 (520)
T ss_dssp CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG-----------GGGGGTTSCEEEEEEEECTTTTSSCC
T ss_pred ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchh-----------hccccccceeeEEEeecccccccccc
Confidence 789999999999999874 568899999999999999998752 25566666 9999999988 6677
Q ss_pred Chhhhhhh-------------------------hhhhhhhccccc-------ccccCCccccCCC---------------
Q 003855 159 PPVIGNFS-------------------------ASLQKFYAYECK-------LKGNIPQEIGNLS--------------- 191 (791)
Q Consensus 159 ~~~~~~~~-------------------------~~L~~L~l~~n~-------l~~~~~~~~~~l~--------------- 191 (791)
|..+..+. .+|+.|++++|. +.+.+| .+..++
T Consensus 157 ~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~ 235 (520)
T 2z7x_B 157 PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWN 235 (520)
T ss_dssp TTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHH
T ss_pred cccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHH
Confidence 76666532 345555555554 333332 344444
Q ss_pred ------------CCCEEEccCCccccccCccc-----cCCCCCCEEEcccccCcccCC-cccccc---CCCceEEecCCc
Q 003855 192 ------------GLTLLSLHSNDLNGTISPTM-----GRLKRLQGLSLRNNNLEGSIP-YDLCHL---KLMFGIRLTGNK 250 (791)
Q Consensus 192 ------------~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~L~~N~ 250 (791)
+|+.|++++|++++.+|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.
T Consensus 236 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~ 313 (520)
T 2z7x_B 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTR 313 (520)
T ss_dssp HHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSC
T ss_pred HHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCc
Confidence 44445555555554445444 5555555555555555 223 333333 456677777776
Q ss_pred cCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcc--cCCcccccCCCCCEEecCCcccCCCCC
Q 003855 251 LSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLND--SLPSNVQKLKVLTVLDLSRNQLSGDIP 328 (791)
Q Consensus 251 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~ 328 (791)
+.... .+..+++|++|++++|++++..|..+..+++|++|++++|++++ .+|..+..+++|+.|++++|++++.+|
T Consensus 314 l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~ 391 (520)
T 2z7x_B 314 MVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391 (520)
T ss_dssp CCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGG
T ss_pred ccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccc
Confidence 65322 12688999999999999998889999999999999999999986 456779999999999999999997466
Q ss_pred c-chhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCC-CCCCc
Q 003855 329 S-TIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPV-KGSFK 406 (791)
Q Consensus 329 ~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~ 406 (791)
. .+..+++|+.|++++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|+++..++. ...+.
T Consensus 392 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~ 468 (520)
T 2z7x_B 392 KGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLT 468 (520)
T ss_dssp GCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred cchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCC
Confidence 5 488899999999999999877777665 79999999999999 7888888999999999999999976654 56678
Q ss_pred CCccccccCCccccCCC
Q 003855 407 NFSVESFFGNYALCGPP 423 (791)
Q Consensus 407 ~l~~~~~~~n~~~c~~~ 423 (791)
+++.+.+.+|++.|+.+
T Consensus 469 ~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 469 SLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp TCCEEECCSSCBCCCHH
T ss_pred cccEEECcCCCCcccCC
Confidence 89999999999998743
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=409.37 Aligned_cols=397 Identities=18% Similarity=0.220 Sum_probs=257.5
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCc
Q 003855 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSIT 83 (791)
Q Consensus 4 ~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 83 (791)
+||+.+. ++|++|+|++|+++++.|.+|.++++|++|+|++|++++..|..+.. +++|++|+|++|.+++..|..|+
T Consensus 19 ~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~ 95 (549)
T 2z81_A 19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYS-LGSLEHLDLSDNHLSSLSSSWFG 95 (549)
T ss_dssp SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTT-CTTCCEEECTTSCCCSCCHHHHT
T ss_pred cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccc-cccCCEEECCCCccCccCHHHhc
Confidence 4566553 67888888888887777777888888888888888887433344443 77888888888888776666677
Q ss_pred CCCCCCEEeccCcccccc-cccccccccccccccccccc-ccccCCCccccccccccCCCCCCcEEEccCCCCcccCChh
Q 003855 84 NATKLVALDLGFNSFAGH-ILNTFGNLRHLSLLSQVMNN-LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPV 161 (791)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 161 (791)
++++|++|+|++|++++. .+..|.++++|+.|++++|+ +..++. ..|.++++|++|++++|++++..|..
T Consensus 96 ~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~--------~~~~~l~~L~~L~L~~n~l~~~~~~~ 167 (549)
T 2z81_A 96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR--------IDFAGLTSLNELEIKALSLRNYQSQS 167 (549)
T ss_dssp TCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT--------TTTTTCCEEEEEEEEETTCCEECTTT
T ss_pred cCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCH--------hhhhcccccCeeeccCCcccccChhh
Confidence 788888888888877754 34567777888888888777 444432 23677777777777777777766666
Q ss_pred hhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCcccccc---------------------------Cc----c
Q 003855 162 IGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTI---------------------------SP----T 210 (791)
Q Consensus 162 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---------------------------~~----~ 210 (791)
+..+ .+|++|+++.|.+.......+..+++|++|++++|++++.. +. .
T Consensus 168 l~~l-~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~ 246 (549)
T 2z81_A 168 LKSI-RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246 (549)
T ss_dssp TTTC-SEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGG
T ss_pred hhcc-ccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHH
Confidence 6554 24555555555544222222234555555555555554321 00 0
Q ss_pred ccC-----------------------------------------------------------CCCCCEEEcccccCcccC
Q 003855 211 MGR-----------------------------------------------------------LKRLQGLSLRNNNLEGSI 231 (791)
Q Consensus 211 ~~~-----------------------------------------------------------l~~L~~L~L~~N~l~~~~ 231 (791)
+.. +++|++|++++|.++ .+
T Consensus 247 ~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~i 325 (549)
T 2z81_A 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LV 325 (549)
T ss_dssp GGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CC
T ss_pred hhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cC
Confidence 011 124455555555554 34
Q ss_pred Cccc-cccCCCceEEecCCccCCCCC---ccccCCCCCcEEEcCCCcCCCCCC--ccccCCCCCCeEEccCCcCcccCCc
Q 003855 232 PYDL-CHLKLMFGIRLTGNKLSGHIP---PCLVSLTSLRELHLGSNKLTSSIP--SSLWSLEYILDINLSSNSLNDSLPS 305 (791)
Q Consensus 232 ~~~~-~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~l~~N~i~~~~~~ 305 (791)
|..+ ..+++|+.|++++|++++..| ..++.+++|++|+|++|++++..+ ..+..+++|++|++++|+++ .+|.
T Consensus 326 p~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~ 404 (549)
T 2z81_A 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPD 404 (549)
T ss_dssp CHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCS
T ss_pred CHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCCh
Confidence 4433 456666666666666665442 235566666666666666664322 34666666777777777666 4555
Q ss_pred ccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccC
Q 003855 306 NVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQL 385 (791)
Q Consensus 306 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 385 (791)
.+..+++|+.|++++|+++ .+|..+ .++|+.|++++|++++. +..+++|+.|+|++|+++ .+|. ...+++|
T Consensus 405 ~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~----~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L 475 (549)
T 2z81_A 405 SCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSF----SLFLPRLQELYISRNKLK-TLPD-ASLFPVL 475 (549)
T ss_dssp CCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCC----CCCCTTCCEEECCSSCCS-SCCC-GGGCTTC
T ss_pred hhcccccccEEECCCCCcc-cccchh--cCCceEEECCCCChhhh----cccCChhcEEECCCCccC-cCCC-cccCccC
Confidence 6666666777777777666 333322 24677777777777643 247889999999999998 5665 4678999
Q ss_pred ceEEccCCCCcccCCC-CCCCcCCccccccCCccccCCC
Q 003855 386 KQFNVSHNRLEGEIPV-KGSFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 386 ~~l~l~~N~l~~~~~~-~~~~~~l~~~~~~~n~~~c~~~ 423 (791)
+.|++++|++++.+|. ...+.+++.+.+.+|++.|+.+
T Consensus 476 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 476 LVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 9999999999988876 4667888889999999988643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=382.68 Aligned_cols=282 Identities=34% Similarity=0.576 Sum_probs=231.5
Q ss_pred CChhHHHHHhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCC
Q 003855 491 TPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD 570 (791)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 570 (791)
.++.++...+++|+..+.||+|+||.||+|+.++++.||||++........+.+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445556778999999999999999999998889999999987666566778999999999999999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeec
Q 003855 571 FKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFG 647 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 647 (791)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc----CCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999997543 34899999999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCc-chHHHHHHHhcC-CC
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE-MSLRRWVKESLP-HG 725 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~-~~~~~~~~~~~~-~~ 725 (791)
+++...............||+.|+|||.+.+..++.++|||||||++|||+||+.||....+.+ .....|...... ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 9987654333333344568999999999988899999999999999999999999997654432 234444333222 22
Q ss_pred hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 726 ~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
....+++..... ...+++..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 265 ~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 265 LEQIVDPNLADK-----IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCSSSSSSCTTC-----SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcChhhccc-----cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 333333332211 123567889999999999999999999999999998865
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=393.42 Aligned_cols=360 Identities=19% Similarity=0.200 Sum_probs=261.3
Q ss_pred CCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEe
Q 003855 13 QNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALD 92 (791)
Q Consensus 13 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 92 (791)
++|++|+|++|+++++.|..|.++++|++|+|++|.+.+.+|...+..+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 56677777777776666667777777777777777765555554444466777777777777766666777777777777
Q ss_pred ccCccccccccc--cccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhh
Q 003855 93 LGFNSFAGHILN--TFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQ 170 (791)
Q Consensus 93 L~~N~i~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~ 170 (791)
|++|++++..+. .|.++++|+.|++++|+++.+.... .+.++++|++|++++|++++..+..+..+.
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~---- 178 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS-------FFLNMRRFHVLDLTFNKVKSICEEDLLNFQ---- 178 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCG-------GGGGCTTCCEEECTTCCBSCCCTTTSGGGT----
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCccc-------ccCCCCcccEEeCCCCcccccChhhhhccc----
Confidence 777776653333 3666666666666666666542211 155666666666666666655554443321
Q ss_pred hhhcccccccccCCccccCCCCCCEEEccCCccccccCcc--------ccCCCCCCEEEcccccCcccCCcccccc---C
Q 003855 171 KFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPT--------MGRLKRLQGLSLRNNNLEGSIPYDLCHL---K 239 (791)
Q Consensus 171 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--------~~~l~~L~~L~L~~N~l~~~~~~~~~~l---~ 239 (791)
..+|+.|++++|.+.+..+.. +..+++|++|++++|++++..|..+... +
T Consensus 179 -------------------~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~ 239 (455)
T 3v47_A 179 -------------------GKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239 (455)
T ss_dssp -------------------TCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTC
T ss_pred -------------------cccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhcccccc
Confidence 145666666666665444332 2245566666666666666555555443 5
Q ss_pred CCceEEecCCccCC----------CCCccccC--CCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCccc
Q 003855 240 LMFGIRLTGNKLSG----------HIPPCLVS--LTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV 307 (791)
Q Consensus 240 ~L~~L~L~~N~i~~----------~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~ 307 (791)
+|+.|++++|.+.+ ..+..+.. .++|+.|++++|++.+..|..+..+++|++|++++|.+++..|..|
T Consensus 240 ~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 319 (455)
T 3v47_A 240 KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAF 319 (455)
T ss_dssp CEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTT
T ss_pred ceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHh
Confidence 66666666664432 22222322 3689999999999998889999999999999999999998888899
Q ss_pred ccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCce
Q 003855 308 QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQ 387 (791)
Q Consensus 308 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 387 (791)
..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+++|+.
T Consensus 320 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 399 (455)
T 3v47_A 320 WGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQK 399 (455)
T ss_dssp TTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred cCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccE
Confidence 99999999999999999888889999999999999999999888999999999999999999999877788899999999
Q ss_pred EEccCCCCcccCCCC
Q 003855 388 FNVSHNRLEGEIPVK 402 (791)
Q Consensus 388 l~l~~N~l~~~~~~~ 402 (791)
|++++|+++|.+|..
T Consensus 400 L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 400 IWLHTNPWDCSCPRI 414 (455)
T ss_dssp EECCSSCBCCCTTTT
T ss_pred EEccCCCcccCCCcc
Confidence 999999999999854
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=371.13 Aligned_cols=265 Identities=24% Similarity=0.391 Sum_probs=218.8
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|+..+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.++...++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 468999999999999999999975 6899999998766666778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999987677999999999999999999999 678999999999999999999999999999876543221
Q ss_pred c------------eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCCh
Q 003855 659 V------------TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL 726 (791)
Q Consensus 659 ~------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 726 (791)
. ......||+.|+|||.+.+..++.++||||||+++|||++|..|+........... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~--------~~~ 236 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--------LNV 236 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS--------BCH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh--------hhh
Confidence 1 11134699999999999999999999999999999999999999875332211100 000
Q ss_pred hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 727 ~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
.... ....+..++..+.+++.+||+.||++|||+.|+++.|++++.....
T Consensus 237 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 237 RGFL---------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp HHHH---------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred hccc---------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 0000 0011224556788999999999999999999999999999876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=379.69 Aligned_cols=263 Identities=24% Similarity=0.421 Sum_probs=216.7
Q ss_pred hhccccccccCCCcceEEEEEEec--------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS--------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNP 569 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 569 (791)
.++|++.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999852 35679999997653 34567899999999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeE
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNIL 634 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nil 634 (791)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVL 235 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchhhEE
Confidence 99999999999999999998643 24789999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcch
Q 003855 635 LDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMS 713 (791)
Q Consensus 635 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 713 (791)
++.++.+||+|||+|+...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... .
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~ 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999999987755443333334457889999999988999999999999999999999 99999763221 2
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
....+..... ...+..++..+.+++.+||+.||++||++.|+++.|+++.....+
T Consensus 314 ~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 314 LFKLLKEGHR-----------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp HHHHHHTTCC-----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHhcCCC-----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 2222211110 011124556788999999999999999999999999999776544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=400.95 Aligned_cols=379 Identities=20% Similarity=0.233 Sum_probs=300.5
Q ss_pred CccCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceec-CCc
Q 003855 2 AGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGI-IPH 80 (791)
Q Consensus 2 ~g~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~-~~~ 80 (791)
++..|..|+++++|++|+|++|+++++.|++|.++++|++|+|++|+++ .+|...+..+++|++|+|++|.+++. .|.
T Consensus 39 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 117 (549)
T 2z81_A 39 TYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117 (549)
T ss_dssp CEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC-SCCHHHHTTCTTCCEEECTTCCCSSSCSSC
T ss_pred CccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccC-ccCHHHhccCCCCcEEECCCCcccccchhh
Confidence 3456788999999999999999999999999999999999999999998 66665444589999999999999964 567
Q ss_pred cCcCCCCCCEEeccCcc-ccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCC
Q 003855 81 SITNATKLVALDLGFNS-FAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILP 159 (791)
Q Consensus 81 ~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 159 (791)
.|+++++|++|+|++|. +..+.+..|.++++|+.|++++|+++.... ..+..+++|+.|++++|.+. ..|
T Consensus 118 ~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--------~~l~~l~~L~~L~l~~n~~~-~~~ 188 (549)
T 2z81_A 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS--------QSLKSIRDIHHLTLHLSESA-FLL 188 (549)
T ss_dssp SCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT--------TTTTTCSEEEEEEEECSBST-THH
T ss_pred hhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccCh--------hhhhccccCceEecccCccc-ccc
Confidence 89999999999999998 666666789999999999999999987533 22444444444444444443 122
Q ss_pred hhhhhhhhhhhhhhcccccccccC---------------------------C----------------------------
Q 003855 160 PVIGNFSASLQKFYAYECKLKGNI---------------------------P---------------------------- 184 (791)
Q Consensus 160 ~~~~~~~~~L~~L~l~~n~l~~~~---------------------------~---------------------------- 184 (791)
+.+....++|++|++++|++.+.. +
T Consensus 189 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~ 268 (549)
T 2z81_A 189 EIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268 (549)
T ss_dssp HHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSC
T ss_pred hhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccccccccccccc
Confidence 222222233444444444443310 0
Q ss_pred ---------c--------------------------cccCCCCCCEEEccCCccccccCccc-cCCCCCCEEEcccccCc
Q 003855 185 ---------Q--------------------------EIGNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRNNNLE 228 (791)
Q Consensus 185 ---------~--------------------------~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~ 228 (791)
. .+....+|+.|++++|.++ .+|..+ ..+++|++|+|++|+++
T Consensus 269 ~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~ 347 (549)
T 2z81_A 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMV 347 (549)
T ss_dssp CCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCC
T ss_pred ccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccc
Confidence 0 0111246777888888887 445554 67999999999999999
Q ss_pred ccCC---ccccccCCCceEEecCCccCCCCC--ccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccC
Q 003855 229 GSIP---YDLCHLKLMFGIRLTGNKLSGHIP--PCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSL 303 (791)
Q Consensus 229 ~~~~---~~~~~l~~L~~L~L~~N~i~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~ 303 (791)
+..| ..+..+++|+.|+|++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++|++|++++|.++. +
T Consensus 348 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l 425 (549)
T 2z81_A 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-V 425 (549)
T ss_dssp HHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-C
T ss_pred cccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-c
Confidence 7664 347889999999999999985432 56899999999999999998 678889999999999999999974 4
Q ss_pred CcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcc
Q 003855 304 PSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLS 383 (791)
Q Consensus 304 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 383 (791)
|..+ .++|+.|++++|++++.. ..+++|++|+|++|+|+ .+|. ...+++|+.|+|++|++++.+|..+..++
T Consensus 426 ~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 497 (549)
T 2z81_A 426 KTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLT 497 (549)
T ss_dssp CTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCT
T ss_pred cchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCc
Confidence 4433 268999999999999643 57899999999999999 6776 56789999999999999999999999999
Q ss_pred cCceEEccCCCCcccCCC
Q 003855 384 QLKQFNVSHNRLEGEIPV 401 (791)
Q Consensus 384 ~L~~l~l~~N~l~~~~~~ 401 (791)
+|+.|++++|+++|.+|.
T Consensus 498 ~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 498 SLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp TCCEEECCSSCBCCCHHH
T ss_pred ccCEEEecCCCccCCCcc
Confidence 999999999999998874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=375.17 Aligned_cols=267 Identities=22% Similarity=0.329 Sum_probs=211.9
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCC----eeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD----FKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv 575 (791)
.++|++.+.||+|+||.||+|+.. ++.||||++...... ......|+.++++++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999885 799999999765433 345566899999999999999999997644 36999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC----------CeEecCCCCCCeEeCCCCcEEEee
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA----------PIIHCDLKPTNILLDENMAAHVSD 645 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~----------~i~H~dlk~~Nill~~~~~~kl~D 645 (791)
|||+++|+|.+++.... +++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|
T Consensus 101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH----~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH----EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT----CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH----hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999998754 899999999999999999999 56 899999999999999999999999
Q ss_pred eccccccCCCCCcceeecccccccccCCCccCC-----CCCCccccHHhHHHHHHHHHhCCCCCCccccCcc--------
Q 003855 646 FGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM-------- 712 (791)
Q Consensus 646 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~-------- 712 (791)
||+|+.+.............||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+......
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999987765444333444579999999998876 3567789999999999999999999976433211
Q ss_pred ---hHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 713 ---SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 713 ---~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
....+.............. .......++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLR--------DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCC--------GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCcc--------ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111111111111111 1112234567799999999999999999999999999999764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=375.32 Aligned_cols=286 Identities=36% Similarity=0.542 Sum_probs=233.8
Q ss_pred ccCCCCChhHHHHHhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhh-HHHHHHHHHHHHHHhccCCccceeee
Q 003855 486 ATWRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE-RAFRSFDSECEVLRNVRHRNLIKILS 564 (791)
Q Consensus 486 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~ 564 (791)
.....+++.+++...++|+..+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34456788899999999999999999999999999988899999999875532 22336889999999999999999999
Q ss_pred eeccCCeeeEEEecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcE
Q 003855 565 SCSNPDFKALVLEFMPNGSLEKWLYSHN---YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAA 641 (791)
Q Consensus 565 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~ 641 (791)
++.++...++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ..+|+||||||+||+++.++.+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC-DPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS-SSCEECCCCSGGGEEECTTCCE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeCCCchhhEEECCCCCE
Confidence 9999999999999999999999998543 34899999999999999999999432 2289999999999999999999
Q ss_pred EEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCcc---ccCcchHHHHH
Q 003855 642 HVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM---FTGEMSLRRWV 718 (791)
Q Consensus 642 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~---~~~~~~~~~~~ 718 (791)
||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+.. ........+|+
T Consensus 174 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 9999999987654332 2233456999999999998888999999999999999999999999742 22344566666
Q ss_pred HHhcCCC-hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 719 KESLPHG-LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 719 ~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
....... .....+...... ....++..+.+++.+||+.||++|||+.|+++.|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGN-----YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTS-----CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhhchhhhhhcChhhccc-----cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 6554433 334444333221 223567889999999999999999999999999975
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=399.14 Aligned_cols=409 Identities=18% Similarity=0.187 Sum_probs=318.3
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCc
Q 003855 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSIT 83 (791)
Q Consensus 4 ~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 83 (791)
+||+.+. +++++|||++|+|+++.|.+|.++++|++|+|++|+|+ .+|+..|..+++|++|+|++|+|+++.+..|.
T Consensus 45 ~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~ 121 (635)
T 4g8a_A 45 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 121 (635)
T ss_dssp SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECGGGGT
T ss_pred ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCCcCCCCCHHHhc
Confidence 4565442 47999999999999999999999999999999999998 78777666699999999999999988888999
Q ss_pred CCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhh
Q 003855 84 NATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIG 163 (791)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 163 (791)
++++|++|+|++|+++++.+..|+++++|+.|++++|+++.+.. +..+..+++|++|+|++|++++..+..+.
T Consensus 122 ~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~-------~~~~~~l~~L~~L~L~~N~l~~~~~~~l~ 194 (635)
T 4g8a_A 122 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL-------PEYFSNLTNLEHLDLSSNKIQSIYCTDLR 194 (635)
T ss_dssp TCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCC-------CGGGGGCTTCCEEECCSSCCCEECGGGGH
T ss_pred CCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCC-------chhhccchhhhhhcccCcccccccccccc
Confidence 99999999999999999988999999999999999999987542 34578899999999999999988777665
Q ss_pred hhhh---hhhhhhcccccccccCCc-------------------------------------------------------
Q 003855 164 NFSA---SLQKFYAYECKLKGNIPQ------------------------------------------------------- 185 (791)
Q Consensus 164 ~~~~---~L~~L~l~~n~l~~~~~~------------------------------------------------------- 185 (791)
.+.. .+..++++.|.+..+.+.
T Consensus 195 ~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~ 274 (635)
T 4g8a_A 195 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 274 (635)
T ss_dssp HHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTT
T ss_pred chhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccc
Confidence 5421 111223333333221111
Q ss_pred ------------------------------------------------cccCCCCCCEEEccCCccccccCc--------
Q 003855 186 ------------------------------------------------EIGNLSGLTLLSLHSNDLNGTISP-------- 209 (791)
Q Consensus 186 ------------------------------------------------~~~~l~~L~~L~L~~N~l~~~~~~-------- 209 (791)
.+....+|+.|++.+|.+....+.
T Consensus 275 ~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l 354 (635)
T 4g8a_A 275 LEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL 354 (635)
T ss_dssp TGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEE
T ss_pred cccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhc
Confidence 122233445555555544322221
Q ss_pred -----------cccCCCCCCEEEcccccCcc--cCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCC
Q 003855 210 -----------TMGRLKRLQGLSLRNNNLEG--SIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT 276 (791)
Q Consensus 210 -----------~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 276 (791)
.+..+++|+.|++++|.+.. ..+..+..+.+|+.|+++.|.+.. .+..+..+++|+.+++++|...
T Consensus 355 ~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~ 433 (635)
T 4g8a_A 355 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 433 (635)
T ss_dssp EEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEE
T ss_pred ccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccc
Confidence 11234455555555555532 233444455556666666665552 3445777888888888888776
Q ss_pred CCC-CccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccC-CCCCcchhccccccccccccccCCCCCCcc
Q 003855 277 SSI-PSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLS-GDIPSTIGALKDLETLSLARNQFQGPIPES 354 (791)
Q Consensus 277 ~~~-~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 354 (791)
... +..|..+.+++.++++.|.+.+..+..+..++.|+.|++++|.+. +..|..|..+++|+.|+|++|+|++..|..
T Consensus 434 ~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~ 513 (635)
T 4g8a_A 434 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 513 (635)
T ss_dssp STTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHH
Confidence 544 356788999999999999999999999999999999999999854 457888999999999999999999988999
Q ss_pred cCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCC-CCC-cCCccccccCCccccCCC
Q 003855 355 VGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVK-GSF-KNFSVESFFGNYALCGPP 423 (791)
Q Consensus 355 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~-~~l~~~~~~~n~~~c~~~ 423 (791)
|.++++|+.|+|++|+|++..|..|..+++|++|+|++|+|++.+|.. ..+ .+++.+.+.+|||.|+..
T Consensus 514 f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 514 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred HcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999999999999999999999999999999999999999998864 334 678999999999999854
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=386.17 Aligned_cols=260 Identities=25% Similarity=0.432 Sum_probs=215.1
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 468999999999999999999986 78999999987543 3344578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++|+|.+++...+..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+|+.......
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE----SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999999999876666899999999999999999999 67899999999999999999999999999986543221
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
........++..|+|||.+.++.++.++|||||||++|||+| |..||...... ....++....
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~-------------- 332 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKGG-------------- 332 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTTC--------------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC--------------
Confidence 111122335778999999988899999999999999999998 99999764221 1122211110
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+.+..++..+.+++.+||+.||++|||+.++++.|++++++
T Consensus 333 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 ---RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0111224567788999999999999999999999999999765
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=398.09 Aligned_cols=387 Identities=19% Similarity=0.235 Sum_probs=316.8
Q ss_pred CccCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceec-CCc
Q 003855 2 AGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGI-IPH 80 (791)
Q Consensus 2 ~g~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~-~~~ 80 (791)
++-.|..|+++++|++|+|++|+|+++.|++|.++++|++|+|++|+|+ .+|.. .+++|++|+|++|.+++. .|.
T Consensus 34 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~ 109 (520)
T 2z7x_B 34 SELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH---PTVNLKHLDLSFNAFDALPICK 109 (520)
T ss_dssp CCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC---CCCCCSEEECCSSCCSSCCCCG
T ss_pred cccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc---ccCCccEEeccCCccccccchh
Confidence 3445678999999999999999999999999999999999999999998 88887 489999999999999974 689
Q ss_pred cCcCCCCCCEEeccCccccccccccccccccc--cccccccccc--cccCCC-ccccc----------------------
Q 003855 81 SITNATKLVALDLGFNSFAGHILNTFGNLRHL--SLLSQVMNNL--TTESSS-ADQWS---------------------- 133 (791)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~l~~n~l--~~~~~~-~~~~~---------------------- 133 (791)
.|+++++|++|+|++|++++ ..|..+++| +.|++++|.+ ...... .....
T Consensus 110 ~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~ 186 (520)
T 2z7x_B 110 EFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186 (520)
T ss_dssp GGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCC
T ss_pred hhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhh
Confidence 99999999999999999986 467778888 9999999998 222111 10000
Q ss_pred -------------------------cccccCCCCCCcEEEccCCCCcccCChhhhhh--hhhhhhhhcccccccccCCcc
Q 003855 134 -------------------------FLSSLTNCRNLTILSFGSNPLGGILPPVIGNF--SASLQKFYAYECKLKGNIPQE 186 (791)
Q Consensus 134 -------------------------~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~--~~~L~~L~l~~n~l~~~~~~~ 186 (791)
.++.+..+++|+.|++++|.+++..+..+... ..+|++|++++|++.+.+|..
T Consensus 187 ~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~ 266 (520)
T 2z7x_B 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266 (520)
T ss_dssp TTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCC
T ss_pred hcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccc
Confidence 01123344445555555554443222222111 137999999999999999998
Q ss_pred c-----cCCCCCCEEEccCCccccccCccccCC---CCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCcc
Q 003855 187 I-----GNLSGLTLLSLHSNDLNGTISPTMGRL---KRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPC 258 (791)
Q Consensus 187 ~-----~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~ 258 (791)
+ .++++|+.+++++|.+ ......+..+ .+|+.|++++|.+.... .+..+++|+.|++++|++++..|..
T Consensus 267 ~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~ 343 (520)
T 2z7x_B 267 DFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFEN 343 (520)
T ss_dssp CCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTT
T ss_pred hhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhh
Confidence 8 9999999999999999 3433555544 68999999999987432 2368899999999999999889999
Q ss_pred ccCCCCCcEEEcCCCcCCC--CCCccccCCCCCCeEEccCCcCcccCCc-ccccCCCCCEEecCCcccCCCCCcchhccc
Q 003855 259 LVSLTSLRELHLGSNKLTS--SIPSSLWSLEYILDINLSSNSLNDSLPS-NVQKLKVLTVLDLSRNQLSGDIPSTIGALK 335 (791)
Q Consensus 259 ~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~l~~N~i~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 335 (791)
++.+++|++|+|++|++++ ..|..+..+++|++|++++|.+++.+|. .+..+++|+.|++++|++++..|..+. +
T Consensus 344 ~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~ 421 (520)
T 2z7x_B 344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--P 421 (520)
T ss_dssp CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--T
T ss_pred hccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--c
Confidence 9999999999999999986 4567899999999999999999984554 588999999999999999877776554 7
Q ss_pred cccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCC
Q 003855 336 DLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPV 401 (791)
Q Consensus 336 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 401 (791)
+|+.|++++|+|+ .+|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|+++|.++.
T Consensus 422 ~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred cCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 9999999999999 7888888999999999999999954444599999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=370.35 Aligned_cols=275 Identities=25% Similarity=0.410 Sum_probs=213.3
Q ss_pred hhccccccccCCCcceEEEEEEe-----cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeecc--CCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-----SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN--PDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 572 (791)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|+.++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999984 3688999999987766667889999999999999999999999854 4568
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 9999999999999999987767999999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCc-ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 653 GEGEDS-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 653 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
...... .......++..|+|||.+.+..++.++||||||+++|||+||..|+..... .+..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMIV 238 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH------HHHHHHCTTCCTHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH------HHHhhhcCccccchhH
Confidence 543322 222334577889999999888999999999999999999999999865321 1111111110000000
Q ss_pred hh---hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhc
Q 003855 732 AN---LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784 (791)
Q Consensus 732 ~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~ 784 (791)
.. ........+.+..++.++.+++.+||+.||++|||+.|+++.|++++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 00 000111112233567889999999999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=371.05 Aligned_cols=264 Identities=28% Similarity=0.447 Sum_probs=213.9
Q ss_pred hhccccccccCCCcceEEEEEEec----CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|++. .+..||||++.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 367899999999999999999974 34569999997653 4455778999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS----DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999877667999999999999999999999 67899999999999999999999999999988754
Q ss_pred CCCc-ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 655 GEDS-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 655 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+....
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~---------- 271 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSVEEGY---------- 271 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTC----------
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCC----------
Confidence 4322 22233356788999999988899999999999999999999 99999753221 1111111100
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhccc
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDD 786 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~ 786 (791)
..+.+..++..+.+++.+||+.||++||++.|+++.|+.+.+.....
T Consensus 272 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 272 -------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred -------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 01112245677889999999999999999999999999997665443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=360.94 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=208.8
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|+..+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36799999999999999999996 47899999999876655567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 99999999998764 899999999999999999999 67899999999999999999999999999987654332
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .........+.
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~-------------- 235 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPE-------------- 235 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCC--------------
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCC--------------
Confidence 23345799999999999999999999999999999999999999975322111 11111110000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+..++..+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0111234566889999999999999999999976
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=366.38 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=204.4
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46899999999999999999987 68899999986543 3445678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCC--eEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 578 FMPNGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHHGHSSAP--IIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
|+++|+|.+++..... .+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH----NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH----TSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH----cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999986542 3899999999999999999999 667 9999999999999999999999999998653
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+......
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~~~~~~--------- 257 (309)
T 3p86_A 191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKCKR--------- 257 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHHHSCCC---------
T ss_pred ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCC---------
Confidence 322 1233456899999999999999999999999999999999999999763221 111111110000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhccc
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDD 786 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~ 786 (791)
...+..++..+.+++.+||+.||++|||+.|+++.|+.+.+.....
T Consensus 258 -------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 258 -------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred -------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 0111234567889999999999999999999999999987655443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=389.17 Aligned_cols=396 Identities=20% Similarity=0.234 Sum_probs=255.6
Q ss_pred CCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcC
Q 003855 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITN 84 (791)
Q Consensus 5 lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 84 (791)
||..+. ++|++|+|++|+|+++.|.+|.++++|++|+|++|+|++..|..+.. +++|++|+|++|+|+. +|.. .
T Consensus 46 ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~-lp~~--~ 119 (562)
T 3a79_B 46 VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLF-NQDLEYLDVSHNRLQN-ISCC--P 119 (562)
T ss_dssp CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTT-CTTCCEEECTTSCCCE-ECSC--C
T ss_pred CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCC-CCCCCEEECCCCcCCc-cCcc--c
Confidence 444443 56666666666666555566666666666666666665333333333 5666666666666663 3333 5
Q ss_pred CCCCCEEeccCccccccc-cccccccccccccccccccccccCCCccccccccccCCCCCC--cEEEccCCCC--cccCC
Q 003855 85 ATKLVALDLGFNSFAGHI-LNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNL--TILSFGSNPL--GGILP 159 (791)
Q Consensus 85 l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L--~~L~L~~N~l--~~~~~ 159 (791)
+++|++|+|++|+++++. +..|+++++|+.|++++|+++... +..+++| ++|++++|++ ++..|
T Consensus 120 l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~-----------~~~l~~L~L~~L~L~~n~l~~~~~~~ 188 (562)
T 3a79_B 120 MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD-----------LLPVAHLHLSCILLDLVSYHIKGGET 188 (562)
T ss_dssp CTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTT-----------TGGGTTSCEEEEEEEESSCCCCSSSC
T ss_pred cccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCc-----------hhhhhhceeeEEEeecccccccccCc
Confidence 666666666666666543 356666666666666666665421 2333333 6666666666 55555
Q ss_pred hhhhhhhhhhhhhhcccccccccCCc-cccCCCCCCEEEccCCc----------------------------cccc----
Q 003855 160 PVIGNFSASLQKFYAYECKLKGNIPQ-EIGNLSGLTLLSLHSND----------------------------LNGT---- 206 (791)
Q Consensus 160 ~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~----------------------------l~~~---- 206 (791)
..+..+......+++++|.+.+.+++ .+..+++|+.|++++|+ +.+.
T Consensus 189 ~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~ 268 (562)
T 3a79_B 189 ESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVK 268 (562)
T ss_dssp CEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHH
T ss_pred ccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHH
Confidence 44444321111223333333322221 12233344444444442 1100
Q ss_pred cCccccCCCCCCEEEcccccCcccCCccc-----ccc--------------------------CCCceEEecCCccCCCC
Q 003855 207 ISPTMGRLKRLQGLSLRNNNLEGSIPYDL-----CHL--------------------------KLMFGIRLTGNKLSGHI 255 (791)
Q Consensus 207 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l--------------------------~~L~~L~L~~N~i~~~~ 255 (791)
.+.. ...++|++|++++|.+++.+|..+ ..+ .+|+.|++++|.+....
T Consensus 269 ~~~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~ 347 (562)
T 3a79_B 269 LFQF-FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV 347 (562)
T ss_dssp HHHH-HTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC
T ss_pred HHHh-hhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc
Confidence 0000 112356666666666665555444 222 45777888888776322
Q ss_pred CccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCccc--CCcccccCCCCCEEecCCcccCCCCC-cchh
Q 003855 256 PPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDS--LPSNVQKLKVLTVLDLSRNQLSGDIP-STIG 332 (791)
Q Consensus 256 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~--~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~ 332 (791)
....+++|++|++++|++++..|..+..+++|+.|++++|++++. .|..+..+++|+.|++++|++++.+| ..+.
T Consensus 348 --~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 425 (562)
T 3a79_B 348 --CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCA 425 (562)
T ss_dssp --CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCC
T ss_pred --CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhc
Confidence 126889999999999999988899999999999999999999863 34678899999999999999997455 4588
Q ss_pred ccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCC-CCCCcCCccc
Q 003855 333 ALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPV-KGSFKNFSVE 411 (791)
Q Consensus 333 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~l~~~ 411 (791)
.+++|+.|++++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|++++.++. ...+++++.+
T Consensus 426 ~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L 502 (562)
T 3a79_B 426 WAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYI 502 (562)
T ss_dssp CCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCE
T ss_pred CcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEE
Confidence 899999999999999876666554 68999999999998 6777777999999999999999976665 5677888899
Q ss_pred cccCCccccCCC
Q 003855 412 SFFGNYALCGPP 423 (791)
Q Consensus 412 ~~~~n~~~c~~~ 423 (791)
.+.+|++.|+.+
T Consensus 503 ~l~~N~~~c~c~ 514 (562)
T 3a79_B 503 WLHDNPWDCTCP 514 (562)
T ss_dssp ECCSCCBCCCHH
T ss_pred EecCCCcCCCcc
Confidence 999999998743
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=357.02 Aligned_cols=281 Identities=30% Similarity=0.469 Sum_probs=227.6
Q ss_pred CCCCChhHHHHHhhccccc------cccCCCcceEEEEEEecCCcEEEEEEeehhh----hHHHHHHHHHHHHHHhccCC
Q 003855 488 WRRTPYLDIQRATDEFNEC------NLLGTGSFGSVYKGTISDGTDVAIKIFNLQL----ERAFRSFDSECEVLRNVRHR 557 (791)
Q Consensus 488 ~~~~~~~~~~~~~~~~~~~------~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~ 557 (791)
...+.+.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3456788999999988877 8999999999999997 68899999986432 34467889999999999999
Q ss_pred ccceeeeeeccCCeeeEEEecCCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe
Q 003855 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH--NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL 635 (791)
Q Consensus 558 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill 635 (791)
||+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH----ENHHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecCCCCHHHEEE
Confidence 9999999999999999999999999999999743 345899999999999999999999 6789999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHH
Q 003855 636 DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 715 (791)
Q Consensus 636 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 715 (791)
++++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... ...
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~ 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHH
Confidence 9999999999999987655443333344578999999998764 58899999999999999999999998644332 122
Q ss_pred HHHHHh--cCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 716 RWVKES--LPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 716 ~~~~~~--~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
.+.... ....+.+.+++.+.. ....++..+.+++.+||+.||++||++.|+++.|+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMND------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSC------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhccccccc------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 222211 112233344433221 123566789999999999999999999999999998854
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=380.88 Aligned_cols=373 Identities=19% Similarity=0.195 Sum_probs=303.8
Q ss_pred CCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcce-ecCCccCcCCCCCCEEec
Q 003855 15 LQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLT-GIIPHSITNATKLVALDL 93 (791)
Q Consensus 15 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L 93 (791)
-+.++.++++++. +|. + .++|++|+|++|.+++..|..+.. +++|++|+|++|.+. .+.+..|.++++|++|+|
T Consensus 12 ~~~~~c~~~~l~~-lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L 86 (455)
T 3v47_A 12 GYNAICINRGLHQ-VPE-L--PAHVNYVDLSLNSIAELNETSFSR-LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86 (455)
T ss_dssp TTEEECCSSCCSS-CCC-C--CTTCCEEECCSSCCCEECTTTTSS-CTTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred ccccCcCCCCccc-CCC-C--CCccCEEEecCCccCcCChhHhcc-CccccEEECcCCcccceECcccccccccCCEEeC
Confidence 3467778888773 354 3 267888888888887444555544 788888888888876 345667888888888888
Q ss_pred cCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhh
Q 003855 94 GFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFY 173 (791)
Q Consensus 94 ~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~ 173 (791)
++|++++..+..|.++++|++|++++|+++..... ...|..+++|++|+|++|++++..
T Consensus 87 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~------~~~~~~l~~L~~L~L~~n~l~~~~--------------- 145 (455)
T 3v47_A 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLS------GNFFKPLTSLEMLVLRDNNIKKIQ--------------- 145 (455)
T ss_dssp TTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHH------SSTTTTCTTCCEEECCSSBCCSCC---------------
T ss_pred CCCccCccChhhccCcccCCEEeCCCCCCCccccC------cccccCcccCCEEECCCCccCccC---------------
Confidence 88888877777888888888888888887642100 112677778888888888777543
Q ss_pred cccccccccCCcc-ccCCCCCCEEEccCCccccccCccccCC--CCCCEEEcccccCcccCCcc--------ccccCCCc
Q 003855 174 AYECKLKGNIPQE-IGNLSGLTLLSLHSNDLNGTISPTMGRL--KRLQGLSLRNNNLEGSIPYD--------LCHLKLMF 242 (791)
Q Consensus 174 l~~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~--------~~~l~~L~ 242 (791)
|.. +.++++|++|+|++|++++..+..+..+ .+|+.|++++|.+.+..+.. +..+++|+
T Consensus 146 ----------~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~ 215 (455)
T 3v47_A 146 ----------PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215 (455)
T ss_dssp ----------CCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEE
T ss_pred ----------cccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceee
Confidence 333 6788999999999999999888888876 78999999999999765544 33668999
Q ss_pred eEEecCCccCCCCCccccCC---CCCcEEEcCCCcCCCC----------CCccccC--CCCCCeEEccCCcCcccCCccc
Q 003855 243 GIRLTGNKLSGHIPPCLVSL---TSLRELHLGSNKLTSS----------IPSSLWS--LEYILDINLSSNSLNDSLPSNV 307 (791)
Q Consensus 243 ~L~L~~N~i~~~~~~~~~~l---~~L~~L~L~~N~l~~~----------~~~~~~~--l~~L~~L~l~~N~i~~~~~~~~ 307 (791)
.|++++|++++..|..+..+ ++|+.|++++|.+.+. .+..+.. .++|+.|++++|.+++..|..+
T Consensus 216 ~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 295 (455)
T 3v47_A 216 TLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVF 295 (455)
T ss_dssp EEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTT
T ss_pred eEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhc
Confidence 99999999998777777654 8999999999976532 1222332 3689999999999999999999
Q ss_pred ccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCce
Q 003855 308 QKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQ 387 (791)
Q Consensus 308 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 387 (791)
..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++..|..|..+++|++
T Consensus 296 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 375 (455)
T 3v47_A 296 SHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKE 375 (455)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred ccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccE
Confidence 99999999999999999888999999999999999999999888899999999999999999999988999999999999
Q ss_pred EEccCCCCcccCCCC-CCCcCCccccccCCccccCCC
Q 003855 388 FNVSHNRLEGEIPVK-GSFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 388 l~l~~N~l~~~~~~~-~~~~~l~~~~~~~n~~~c~~~ 423 (791)
|++++|++++.++.. ..+++++.+.+.+|++.|+.+
T Consensus 376 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 376 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999999877754 578899999999999999866
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=390.43 Aligned_cols=388 Identities=17% Similarity=0.175 Sum_probs=303.3
Q ss_pred CccCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceec-CCc
Q 003855 2 AGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGI-IPH 80 (791)
Q Consensus 2 ~g~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~-~~~ 80 (791)
++-.|..|+++++|++|+|++|+|+++.|++|.++++|++|+|++|+|+ .+|.. .+++|++|+|++|+++++ .|.
T Consensus 65 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~ 140 (562)
T 3a79_B 65 SELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC---PMASLRHLDLSFNDFDVLPVCK 140 (562)
T ss_dssp CCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC---CCTTCSEEECCSSCCSBCCCCG
T ss_pred cccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc---ccccCCEEECCCCCccccCchH
Confidence 3445579999999999999999999999999999999999999999998 89987 489999999999999974 468
Q ss_pred cCcCCCCCCEEeccCccccccccccccccccc--cccccccccc--cccCCCcc-ccc-----------------ccccc
Q 003855 81 SITNATKLVALDLGFNSFAGHILNTFGNLRHL--SLLSQVMNNL--TTESSSAD-QWS-----------------FLSSL 138 (791)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~l~~n~l--~~~~~~~~-~~~-----------------~~~~l 138 (791)
.|+++++|++|+|++|+++.. .|.++++| +.|++++|++ +....... ... ....+
T Consensus 141 ~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~ 217 (562)
T 3a79_B 141 EFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217 (562)
T ss_dssp GGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEE
T ss_pred hhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcc
Confidence 999999999999999999864 45555665 9999999999 44332210 000 00123
Q ss_pred CCCCCCcEEEccCCCC----------------------------cccCChhhhh--hhhhhhhhhcccccccccCCccc-
Q 003855 139 TNCRNLTILSFGSNPL----------------------------GGILPPVIGN--FSASLQKFYAYECKLKGNIPQEI- 187 (791)
Q Consensus 139 ~~l~~L~~L~L~~N~l----------------------------~~~~~~~~~~--~~~~L~~L~l~~n~l~~~~~~~~- 187 (791)
..+++|+.|++++|+. .+.....+.. ...+|++|++++|.+.+.+|..+
T Consensus 218 ~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~ 297 (562)
T 3a79_B 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEF 297 (562)
T ss_dssp SSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCC
T ss_pred cccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhh
Confidence 4566777777777641 1100000000 01267778888888877777766
Q ss_pred ----cCCCCCCEEEccCCccccccCccccC---CCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCcccc
Q 003855 188 ----GNLSGLTLLSLHSNDLNGTISPTMGR---LKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLV 260 (791)
Q Consensus 188 ----~~l~~L~~L~L~~N~l~~~~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 260 (791)
.+++.|+.++++.|.+. .....+.. ..+|++|++++|.+.... ....+++|+.|++++|++++..|..+.
T Consensus 298 ~~~~~~L~~L~~~~~~~~~~~-~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~ 374 (562)
T 3a79_B 298 TYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCS 374 (562)
T ss_dssp CCCSCSCCEEEEEEEEECCCS-SCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCC
T ss_pred hcccccchheehhhcccceee-cChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhc
Confidence 56666666666666661 22122222 257999999999886322 127889999999999999988999999
Q ss_pred CCCCCcEEEcCCCcCCCCC--CccccCCCCCCeEEccCCcCcccCC-cccccCCCCCEEecCCcccCCCCCcchhccccc
Q 003855 261 SLTSLRELHLGSNKLTSSI--PSSLWSLEYILDINLSSNSLNDSLP-SNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDL 337 (791)
Q Consensus 261 ~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 337 (791)
++++|++|+|++|++++.. |..+..+++|++|++++|.+++.+| ..+..+++|+.|++++|++++..|..+. ++|
T Consensus 375 ~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L 452 (562)
T 3a79_B 375 TLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKV 452 (562)
T ss_dssp SCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTC
T ss_pred ccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcC
Confidence 9999999999999999643 5678999999999999999998444 4688999999999999999876665543 799
Q ss_pred cccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCC
Q 003855 338 ETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVK 402 (791)
Q Consensus 338 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 402 (791)
+.|+|++|+|+ .+|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|++.|.++..
T Consensus 453 ~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 516 (562)
T 3a79_B 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGI 516 (562)
T ss_dssp SEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHH
T ss_pred CEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchH
Confidence 99999999999 78887789999999999999999544444999999999999999999988753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=374.29 Aligned_cols=261 Identities=26% Similarity=0.467 Sum_probs=203.4
Q ss_pred hhccccccccCCCcceEEEEEEec----CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 368999999999999999999864 57789999987543 4455789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++......+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 99999999999999987767999999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCc-ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 655 GEDS-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 655 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
.... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ...+.+...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~~i~~~----------- 266 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEG----------- 266 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHHHHHTT-----------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC-----------
Confidence 3221 11222235778999999988899999999999999999998 99999753221 111111110
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
...+.+..++..+.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 001112245677889999999999999999999999999997653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=355.50 Aligned_cols=266 Identities=25% Similarity=0.395 Sum_probs=206.7
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHh--ccCCccceeeeeecc----CCeee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRN--VRHRNLIKILSSCSN----PDFKA 573 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~~~~ 573 (791)
.++|++.+.||+|+||.||+|+. +++.||||++..... +.+..|.+++.. ++||||+++++++.+ ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 57899999999999999999998 689999999875432 345556677666 799999999998643 35678
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccC----CCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH----SSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
+||||+++|+|.++++.. .+++..+..++.|++.||+|||... .+.+|+||||||+||+++.++.+||+|||+|
T Consensus 83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 999999999999999654 4899999999999999999999321 1458999999999999999999999999999
Q ss_pred cccCCCCCcc--eeecccccccccCCCccCCC------CCCccccHHhHHHHHHHHHhC----------CCCCCccccCc
Q 003855 650 KLLGEGEDSV--TQTMTMATIGYMAPEYGSEG------IVSAKCDVYSYGVLLMETFTR----------KRPTDEMFTGE 711 (791)
Q Consensus 650 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~G~vl~elltg----------~~p~~~~~~~~ 711 (791)
+......... ......||+.|+|||++.+. .++.++|||||||++|||+|| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 8765433221 12234799999999988776 566799999999999999999 78887655444
Q ss_pred chHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 712 MSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
..................... ......++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQRPNIPN--------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHTTSCCCCCCCG--------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhhhhHHHhccCCCCCCCh--------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 444333332221111111110 011224667899999999999999999999999999876
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=363.91 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=205.2
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999997 589999999987653 344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++...+. +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+......
T Consensus 94 e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCH----QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999986543 899999999999999999999 6789999999999999999999999999998765432
Q ss_pred CcceeecccccccccCCCccCCCCCC-ccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVS-AKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.....+||+.|+|||++.+..++ .++||||+||++|||++|+.||++.... .....+....
T Consensus 169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~------------- 230 (328)
T 3fe3_A 169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRERVLRGK------------- 230 (328)
T ss_dssp ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC-------------
T ss_pred ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC-------------
Confidence 22345799999999998877764 7999999999999999999999763211 1111111100
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+..++..+.+++.+||+.||++|||+.|+++
T Consensus 231 -----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 231 -----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001123456779999999999999999999976
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=352.77 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=213.9
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|+..+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 367999999999999999999998899999999875532 2357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 162 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH----hCCeecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence 999999999877777999999999999999999999 6789999999999999999999999999998764322 11
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .....+.......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~~------------- 227 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRLY------------- 227 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCC-------------
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCccCC-------------
Confidence 2223456788999999988899999999999999999999 99998753221 1111111110000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
.+..++..+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 228 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 228 ----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0112345678999999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=372.79 Aligned_cols=267 Identities=26% Similarity=0.407 Sum_probs=216.5
Q ss_pred hHHHHHhhccccccccCCCcceEEEEEEe------cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeee
Q 003855 494 LDIQRATDEFNECNLLGTGSFGSVYKGTI------SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSS 565 (791)
Q Consensus 494 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 565 (791)
.......++|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++++ +||||++++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 34444568999999999999999999974 246889999997643 34456789999999999 79999999999
Q ss_pred eccCCe-eeEEEecCCCCCHHHHHhhCCC---------------------------------------------------
Q 003855 566 CSNPDF-KALVLEFMPNGSLEKWLYSHNY--------------------------------------------------- 593 (791)
Q Consensus 566 ~~~~~~-~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------- 593 (791)
+.+.+. .++||||+++|+|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 877554 8999999999999999986432
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 594 --------------FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 594 --------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
.+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 2889999999999999999999 6789999999999999999999999999998775554444
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+. ....+.......
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~------------- 316 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRMR------------- 316 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHTCCCC-------------
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcCCCCC-------------
Confidence 4555678999999999988999999999999999999998 9999976433221 222121111111
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
.+..++.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 317 ----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 317 ----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1112446688999999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.78 Aligned_cols=260 Identities=21% Similarity=0.303 Sum_probs=212.9
Q ss_pred CCChhHHHHHhhc----------cccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCc
Q 003855 490 RTPYLDIQRATDE----------FNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN 558 (791)
Q Consensus 490 ~~~~~~~~~~~~~----------~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n 558 (791)
.+++.++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3556666666643 677789999999999999976 79999999998766556678899999999999999
Q ss_pred cceeeeeeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC
Q 003855 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN 638 (791)
Q Consensus 559 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~ 638 (791)
|+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH----AQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCC
Confidence 999999999999999999999999999998754 3899999999999999999999 6789999999999999999
Q ss_pred CcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHH
Q 003855 639 MAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV 718 (791)
Q Consensus 639 ~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 718 (791)
+.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~ 253 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRL 253 (321)
T ss_dssp CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHH
T ss_pred CcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence 9999999999987654322 22345799999999999999999999999999999999999999975321 1111111
Q ss_pred HHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 719 KESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 719 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
........ .....++..+.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 254 RDSPPPKL---------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHSSCCCC---------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCCCCc---------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111110 011134566889999999999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=377.50 Aligned_cols=347 Identities=20% Similarity=0.211 Sum_probs=268.4
Q ss_pred cEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccccccccccccccccccccc
Q 003855 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVM 119 (791)
Q Consensus 40 ~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~ 119 (791)
+.+++++++++ .+|..+. +++++|+|++|+|+++.+..|.++++|++|+|++|.++++.+..|.++++|+.|++++
T Consensus 14 ~~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 56777777776 7776543 4677777777777777777777777777777777777777777777777777777777
Q ss_pred ccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEcc
Q 003855 120 NNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLH 199 (791)
Q Consensus 120 n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 199 (791)
|+++.++... |.++++|++|+|++|++++. .+..|.++++|+.|+|+
T Consensus 90 n~l~~~~~~~--------~~~l~~L~~L~Ls~n~i~~~-------------------------~~~~~~~l~~L~~L~l~ 136 (477)
T 2id5_A 90 NRLKLIPLGV--------FTGLSNLTKLDISENKIVIL-------------------------LDYMFQDLYNLKSLEVG 136 (477)
T ss_dssp SCCCSCCTTS--------STTCTTCCEEECTTSCCCEE-------------------------CTTTTTTCTTCCEEEEC
T ss_pred CcCCccCccc--------ccCCCCCCEEECCCCccccC-------------------------ChhHccccccCCEEECC
Confidence 7777665433 67788888888888887743 33456677788888888
Q ss_pred CCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCC
Q 003855 200 SNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSI 279 (791)
Q Consensus 200 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 279 (791)
+|.+++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+
T Consensus 137 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~ 216 (477)
T 2id5_A 137 DNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTM 216 (477)
T ss_dssp CTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEE
T ss_pred CCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcccccc
Confidence 88888777778888888888888888888666667788888888888888887777777888888888888888777666
Q ss_pred CccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCC
Q 003855 280 PSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLI 359 (791)
Q Consensus 280 ~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 359 (791)
+.......+|+.|++++|.++...+..+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..++
T Consensus 217 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 296 (477)
T 2id5_A 217 TPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLN 296 (477)
T ss_dssp CTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCT
T ss_pred CcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcc
Confidence 66666666888888888888865556788888888888888888877777788888888888888888887788888888
Q ss_pred CCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccccCCC
Q 003855 360 SLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 360 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~ 423 (791)
+|+.|+|++|++++..+..|..+++|+.|++++|++.|.++..+.+.......+.++...|..|
T Consensus 297 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 297 YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp TCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred cCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 8888888888888777778888888888888888888877654444444455667777777655
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=366.17 Aligned_cols=264 Identities=25% Similarity=0.403 Sum_probs=217.6
Q ss_pred hhccccccccCCCcceEEEEEEec--------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS--------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNP 569 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 569 (791)
.++|++.+.||+|+||.||+|+.. .+..||||++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468999999999999999999852 34579999987653 34557889999999999 999999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeE
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNIL 634 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nil 634 (791)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVL 223 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCcceEE
Confidence 99999999999999999998653 34899999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcch
Q 003855 635 LDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMS 713 (791)
Q Consensus 635 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 713 (791)
+++++.+||+|||+|+...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--~~ 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HH
Confidence 99999999999999987765443333444567889999999999999999999999999999999 9999875321 11
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhccc
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDD 786 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~ 786 (791)
..+.+...... ..+..++.++.+++.+||+.||++|||+.|+++.|+++.......
T Consensus 302 ~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 302 LFKLLKEGHRM-----------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHHHHTTCCC-----------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHHHHHcCCCC-----------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 22222111100 011234567889999999999999999999999999998765443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=355.58 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=212.9
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|++.+.||+|+||.||+|+.+++..||||++..... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 468999999999999999999998888999999875532 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE----SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-V 160 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-E
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-h
Confidence 999999999876666999999999999999999999 67899999999999999999999999999987654332 2
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||+.....+ ....+......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~-------------- 224 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--VVLKVSQGHRL-------------- 224 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTCCC--------------
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--HHHHHHcCCCC--------------
Confidence 2233456778999999988889999999999999999999 999997532211 11111110000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
..+..++..+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 ---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 0011234567899999999999999999999999998854
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=356.81 Aligned_cols=251 Identities=20% Similarity=0.314 Sum_probs=208.3
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999975 68899999987543 3345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC--CCcEEEeeeccccccCCCC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE--NMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~ 656 (791)
+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+++.+....
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999999999877666999999999999999999999 678999999999999997 8899999999998875433
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
......||+.|+|||++.+..++.++||||+||++|||++|..||...... ............. +
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~------~----- 223 (321)
T 1tki_A 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYTF------D----- 223 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCC------C-----
T ss_pred ---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHcCCCCC------C-----
Confidence 233456899999999999888999999999999999999999999753211 1111111110000 0
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......++.++.+++.+||+.||++|||+.|+++
T Consensus 224 ----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 224 ----EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111245677889999999999999999999987
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=362.32 Aligned_cols=253 Identities=21% Similarity=0.329 Sum_probs=206.1
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999976 78999999986543 2334568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999987654 3899999999999999999999 67899999999999999999999999999987643333
Q ss_pred cceeecccccccccCCCccCCCCC-CccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
........||+.|+|||++.+..+ +.++||||+||++|||++|+.||............|.......
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 228 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------ 228 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS------------
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC------------
Confidence 233344579999999999877665 7899999999999999999999986544333333332211100
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....++..+.+++.+||+.||++|||+.|+++
T Consensus 229 -----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111234566789999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=365.93 Aligned_cols=258 Identities=25% Similarity=0.432 Sum_probs=205.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCc----EEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGT----DVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
.++|+..+.||+|+||.||+|++. +++ +||+|.+.... ....+.+.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 367999999999999999999964 444 36888775433 344578899999999999999999999998755 77
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+|+||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999999987777999999999999999999999 6789999999999999999999999999998876
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
............+|..|+|||++.+..++.++|||||||++|||+| |+.||...... .....+......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~~-------- 238 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERL-------- 238 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCC--------
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHcCCCC--------
Confidence 5544444444567889999999999999999999999999999999 99999764322 222222211110
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
+.+..++..+.+++.+||+.||++||++.|+++.|+++..
T Consensus 239 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 239 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1112345678899999999999999999999999998864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=355.24 Aligned_cols=278 Identities=24% Similarity=0.383 Sum_probs=211.1
Q ss_pred CChhHHHHHhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHh--ccCCccceeeeeecc
Q 003855 491 TPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRN--VRHRNLIKILSSCSN 568 (791)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~ 568 (791)
.+........++|++.+.||+|+||.||+|+.. ++.||||++..... ..+..|.+++.. ++||||+++++++.+
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 344555566789999999999999999999985 89999999865432 233445555554 489999999999877
Q ss_pred C----CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccC----CCCCeEecCCCCCCeEeCCCCc
Q 003855 569 P----DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH----SSAPIIHCDLKPTNILLDENMA 640 (791)
Q Consensus 569 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~~i~H~dlk~~Nill~~~~~ 640 (791)
. ...++||||+++|+|.+++.... +++..+..++.|++.||+|||..+ ...+|+||||||+||+++.++.
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 6 77899999999999999998754 899999999999999999999310 0118999999999999999999
Q ss_pred EEEeeeccccccCCCCCcc--eeecccccccccCCCccCCCCCCcc------ccHHhHHHHHHHHHhC----------CC
Q 003855 641 AHVSDFGISKLLGEGEDSV--TQTMTMATIGYMAPEYGSEGIVSAK------CDVYSYGVLLMETFTR----------KR 702 (791)
Q Consensus 641 ~kl~Dfgla~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~------~Dv~s~G~vl~elltg----------~~ 702 (791)
+||+|||+|+.+....... ......||+.|+|||++.+..++.+ +|||||||++|||+|| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999998765433221 1224579999999999887766665 9999999999999999 66
Q ss_pred CCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 703 PTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 703 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
||............+............... ......++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPN--------RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCG--------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cHhhhcCCCCchhhhHHHHhhhccCccccc--------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 666544444333333222211111111111 111236778899999999999999999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=371.93 Aligned_cols=261 Identities=24% Similarity=0.371 Sum_probs=211.6
Q ss_pred hhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
.++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367999999999999999999853 46789999986542 44456788999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC---cEEE
Q 003855 573 ALVLEFMPNGSLEKWLYSHN------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM---AAHV 643 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~---~~kl 643 (791)
++||||+++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999998532 34899999999999999999999 67899999999999999555 5999
Q ss_pred eeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhc
Q 003855 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL 722 (791)
Q Consensus 644 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 722 (791)
+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++ |..||..... ......+....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~i~~~~ 303 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGG 303 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC
Confidence 99999986533332333344568899999999988899999999999999999998 9999976321 11222211111
Q ss_pred CCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 723 PHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 723 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
. ...+..++..+.+++.+||+.||++||++.|+++.|+.+.+..
T Consensus 304 ~-----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 304 R-----------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp C-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred C-----------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 0 0111234566889999999999999999999999999986643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=352.96 Aligned_cols=268 Identities=24% Similarity=0.300 Sum_probs=207.7
Q ss_pred HhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
..++|++.+.||+|+||.||+|+..+|+.||+|++.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 457899999999999999999999889999999986543 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||++ |+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+......
T Consensus 99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH----QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9997 5899999877777999999999999999999999 6789999999999999999999999999998765332
Q ss_pred CcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC---CChhhhcch
Q 003855 657 DSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP---HGLTEVVDA 732 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~ 732 (791)
. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+......... .......+.
T Consensus 174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTTS
T ss_pred c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhcc
Confidence 2 2333568999999998765 568999999999999999999999998643332 22222221111 111111000
Q ss_pred hhh--------hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 733 NLV--------REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 733 ~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
... ...........++.++.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 000000111234567889999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=359.06 Aligned_cols=264 Identities=23% Similarity=0.354 Sum_probs=218.1
Q ss_pred hhccccccccCCCcceEEEEEEe------cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI------SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 571 (791)
.++|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999985 356889999997553 23457789999999999 99999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeE
Q 003855 572 KALVLEFMPNGSLEKWLYSHNY-----------------FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNIL 634 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nil 634 (791)
.++||||+++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNIL 177 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEE
Confidence 9999999999999999986542 3899999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcch
Q 003855 635 LDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMS 713 (791)
Q Consensus 635 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 713 (791)
++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... ..
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~ 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SK 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-hH
Confidence 99999999999999988765544333444567889999999888899999999999999999999 99999764322 12
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
....+....... .+..++..+.+++.+||+.||++|||+.|+++.|+++.....+
T Consensus 257 ~~~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 257 FYKMIKEGFRML-----------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp HHHHHHHTCCCC-----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred HHHHhccCCCCC-----------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 222222111110 0113456788999999999999999999999999998876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=367.71 Aligned_cols=264 Identities=24% Similarity=0.380 Sum_probs=213.6
Q ss_pred HhhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF 571 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 571 (791)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999974 34889999997653 3446788999999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCC
Q 003855 572 KALVLEFMPNGSLEKWLYSHN-----------------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDL 628 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dl 628 (791)
.++||||+++|+|.+++.... ..+++.+++.++.||++||.||| +.+|+||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dl 200 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRDL 200 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCC
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCC
Confidence 999999999999999998642 45899999999999999999999 678999999
Q ss_pred CCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCcc
Q 003855 629 KPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEM 707 (791)
Q Consensus 629 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~ 707 (791)
||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |..||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999987654333333344568899999999888889999999999999999999 99999753
Q ss_pred ccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 708 FTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
... .....+...... ..+..++..+.+++.+||+.||++||++.|+++.|+++..+...
T Consensus 281 ~~~--~~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 281 AHE--EVIYYVRDGNIL-----------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG 339 (343)
T ss_dssp CHH--HHHHHHHTTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred ChH--HHHHHHhCCCcC-----------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence 211 111111110000 01123456788999999999999999999999999998766543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=357.75 Aligned_cols=248 Identities=23% Similarity=0.269 Sum_probs=205.3
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|+..+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999975 78999999997653 33456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus 84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999998654 3899999999999999999999 678999999999999999999999999999864332
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.....
T Consensus 159 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~------------ 222 (337)
T 1o6l_A 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILMEEI------------ 222 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC------------
T ss_pred CC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHHHHHHcCCC------------
Confidence 21 23345799999999999999999999999999999999999999975321 111111111000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
..+..++.++.+++.+||+.||++|| ++.|+++
T Consensus 223 ------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 00113456678999999999999999 8998875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=365.72 Aligned_cols=272 Identities=14% Similarity=0.141 Sum_probs=210.4
Q ss_pred HhhccccccccCCCcceEEEEEEecC------CcEEEEEEeehhhhHH-----------HHHHHHHHHHHHhccCCccce
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTISD------GTDVAIKIFNLQLERA-----------FRSFDSECEVLRNVRHRNLIK 561 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~ 561 (791)
..++|++.+.||+|+||.||+|.+.. ++.||||++....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998754 4789999986543211 122345666777788999999
Q ss_pred eeeeeccC----CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC-
Q 003855 562 ILSSCSNP----DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD- 636 (791)
Q Consensus 562 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~- 636 (791)
+++++... ...++||||+ +|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH----~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH----EHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeEEecCCHHHEEEec
Confidence 99998654 4579999999 99999999987667999999999999999999999 67899999999999999
Q ss_pred -CCCcEEEeeeccccccCCCCCcc-----eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccC
Q 003855 637 -ENMAAHVSDFGISKLLGEGEDSV-----TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG 710 (791)
Q Consensus 637 -~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~ 710 (791)
.++.+||+|||+|+.+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 89999999999998765432111 112345999999999999999999999999999999999999999864322
Q ss_pred cchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhc
Q 003855 711 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784 (791)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~ 784 (791)
. ....+..........+.+++.+. ...++.++.+++..||+.+|++||++.++++.|+++.....
T Consensus 268 ~-~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 268 P-KYVRDSKIRYRENIASLMDKCFP--------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp H-HHHHHHHHHHHHCHHHHHHHHSC--------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred H-HHHHHHHHHhhhhHHHHHHHhcc--------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 2 22222221111112222221110 12346788999999999999999999999999999877643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=375.43 Aligned_cols=259 Identities=22% Similarity=0.276 Sum_probs=208.0
Q ss_pred HHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh---HHHHHHHHHHHHHHhccCCccceeeeeeccCC
Q 003855 495 DIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSCSNPD 570 (791)
Q Consensus 495 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 570 (791)
+++...++|++.+.||+|+||.||+|+.+ +++.||+|++..... ...+.+.+|+.++..++||||+++++++.+.+
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 44455689999999999999999999976 588999999975431 22334788999999999999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..++||||+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 999999999999999999876566999999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccC-----CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG 725 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (791)
....... ......+||++|+|||++. .+.++.++|||||||++|||++|+.||......+ .+...+....
T Consensus 224 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~--- 298 (437)
T 4aw2_A 224 KLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKE--- 298 (437)
T ss_dssp ECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHH---
T ss_pred hcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhhccc---
Confidence 7654332 2233457999999999876 5679999999999999999999999997532111 1111110000
Q ss_pred hhhhcchhhhhhHHhhHH-HHHHHHHHHHHHhhccccCCCC--CCCHHHHHH
Q 003855 726 LTEVVDANLVREEQAFSA-KMDCILSIMDLALDCCIESPDM--RINVTDAAA 774 (791)
Q Consensus 726 ~~~~~d~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~--RPt~~ev~~ 774 (791)
....+. ...++.++.+++.+|+..+|++ ||++.|+++
T Consensus 299 ------------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 299 ------------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ------------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ------------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000000 0124566789999999988888 999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=354.02 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=197.8
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+|+.. ..||||++.... ....+.+.+|+.++++++||||+++++++. ....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence 468999999999999999999874 359999986543 445678899999999999999999999764 456889999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++++|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999999877777999999999999999999999 67899999999999999999999999999987654333
Q ss_pred cceeecccccccccCCCccC---CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHh-cCCChhhhcchh
Q 003855 658 SVTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES-LPHGLTEVVDAN 733 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~ 733 (791)
........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+ .....+... .......
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~----- 249 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMVGRGSLSPDLSK----- 249 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHHHHTSCCCCTTS-----
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHhcccccCcchhh-----
Confidence 33334456899999999876 6678899999999999999999999997643322 122222211 1111110
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
....++..+.+++.+||+.||++||++.|+++.|+++.
T Consensus 250 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 250 ---------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ---------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 01135577889999999999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.52 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=215.4
Q ss_pred hhccccccccCCCcceEEEEEEe------cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI------SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 47899999999999999999985 245789999987543 44567889999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCC
Q 003855 573 ALVLEFMPNGSLEKWLYSHN-----------------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLK 629 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk 629 (791)
++||||+++|+|.+++.... ..+++.++..++.|+++||.||| +.+|+|||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dik 177 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA----EMKLVHRDLA 177 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH----HTTEECCCCS
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH----HCCCcccccc
Confidence 99999999999999998643 23789999999999999999999 6789999999
Q ss_pred CCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccc
Q 003855 630 PTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMF 708 (791)
Q Consensus 630 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~ 708 (791)
|+||++++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987755443333344467889999999988889999999999999999999 999997643
Q ss_pred cCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 709 TGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
.. .....+...... ..+..++..+.+++.+||+.||++||++.|+++.|+++..+
T Consensus 258 ~~--~~~~~~~~~~~~-----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PE--RLFNLLKTGHRM-----------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GG--GHHHHHHTTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH--HHHHHhhcCCcC-----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 22 222222211110 01123456788999999999999999999999999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.94 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=210.3
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|++.+.||+|+||.||+|.+.++..||||++..... ..+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 468999999999999999999998888999999975532 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT 176 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HH
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCccceEEEcCCCCEEEccccccccccccc-cc
Confidence 999999999875556999999999999999999999 6789999999999999999999999999998764322 11
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||...... .....+.......
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~~------------- 241 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLY------------- 241 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCCC-------------
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhcccCCC-------------
Confidence 2223346788999999988889999999999999999998 99999763221 1111111111000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
.+..++..+.+++.+||+.||++|||+.|+++.|.++...
T Consensus 242 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 242 ----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 0112345678999999999999999999999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=358.85 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=206.5
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhH------HHHHHHHHHHHHHhccCCccceeeeeeccCCe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLER------AFRSFDSECEVLRNVRHRNLIKILSSCSNPDF 571 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 571 (791)
..+.|++.+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467999999999999999999975 7899999998754321 34678899999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC----cEEEeeec
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM----AAHVSDFG 647 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 647 (791)
.++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999997654 4899999999999999999999 67899999999999998877 79999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
+++....... ....+||+.|+|||++.+..++.++||||+||++|||++|..||.+.... .....+......
T Consensus 165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~~~~i~~~~~~--- 236 (361)
T 2yab_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITAVSYD--- 236 (361)
T ss_dssp SCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCCC---
T ss_pred CceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCC---
Confidence 9987754322 23356999999999999889999999999999999999999999753211 111111110000
Q ss_pred hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+. .....++..+.+++.+||..||++|||+.|+++
T Consensus 237 --~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 --FDE---------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --CCH---------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CCc---------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 111234567889999999999999999999984
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.14 Aligned_cols=266 Identities=15% Similarity=0.137 Sum_probs=214.8
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++++ +|++++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999996 5799999999864432 24577899999999 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc-----EEEeeecccccc
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA-----AHVSDFGISKLL 652 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfgla~~~ 652 (791)
|+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+|+..
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 99999999977667999999999999999999999 779999999999999987776 999999999876
Q ss_pred CCCCCc-----ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh
Q 003855 653 GEGEDS-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727 (791)
Q Consensus 653 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~------- 232 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QKYER------- 232 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HHHHH-------
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH--HHHHH-------
Confidence 543321 1233456999999999999999999999999999999999999999864322111 00000
Q ss_pred hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhc
Q 003855 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784 (791)
Q Consensus 728 ~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~ 784 (791)
+....... ........++..+.+++.+||+.||++||++.++++.|+++..+..
T Consensus 233 -~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 233 -IGEKKQST--PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp -HHHHHHHS--CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -HHhhccCc--cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 00000000 0001112456788999999999999999999999999999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=352.70 Aligned_cols=260 Identities=22% Similarity=0.382 Sum_probs=206.9
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehh---hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999964 7899999998543 234567889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH----DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999998654 4899999999999999999999 678999999999999999999999999999876443
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.. .......||+.|+|||.+.+..++.++||||+|+++|||+||+.||.+..... .... ........ .
T Consensus 165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~----~~~~-~~~~~~~~-----~- 232 (294)
T 4eqm_A 165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS----IAIK-HIQDSVPN-----V- 232 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH----HHHH-HHSSCCCC-----H-
T ss_pred cc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH----HHHH-HhhccCCC-----c-
Confidence 22 12233468999999999999999999999999999999999999997632211 1111 11111000 0
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRI-NVTDAAAKLKKIK 780 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~ev~~~L~~~~ 780 (791)
.......++..+.+++.+|++.||++|| ++.++.+.|..+.
T Consensus 233 ----~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 233 ----TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp ----HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred ----chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0011123567788999999999999999 8999999988764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=359.88 Aligned_cols=265 Identities=22% Similarity=0.360 Sum_probs=212.4
Q ss_pred HhhccccccccCCCcceEEEEEEe------cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCC
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTI------SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPD 570 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 570 (791)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 357899999999999999999986 246689999987543 33456789999999999 8999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCC
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNY----------------------FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDL 628 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dl 628 (791)
..++||||+++|+|.+++..... .+++..+..++.|++.||+||| +.+|+||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Di 198 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDL 198 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTC
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCC
Confidence 99999999999999999986532 3789999999999999999999 678999999
Q ss_pred CCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCcc
Q 003855 629 KPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEM 707 (791)
Q Consensus 629 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~ 707 (791)
||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987655444334444567889999999988899999999999999999998 99999764
Q ss_pred ccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 708 FTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
... ......+...... ..+..++..+.+++.+||+.||++||++.|+++.|+.+.....+
T Consensus 279 ~~~-~~~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 279 PVD-ANFYKLIQNGFKM-----------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp CCS-HHHHHHHHTTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred CcH-HHHHHHHhcCCCC-----------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 322 2222222221111 01113456788999999999999999999999999998665443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=374.46 Aligned_cols=252 Identities=28% Similarity=0.431 Sum_probs=208.8
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCC-eeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD-FKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 578 (791)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.++++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467899999999999999999985 7899999997553 3467899999999999999999999986654 78999999
Q ss_pred CCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.+++..... .+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 999999999986543 4799999999999999999999 6789999999999999999999999999998643221
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
....++..|+|||.+.+..++.++|||||||++|||+| |+.||......+ ....+....
T Consensus 344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~-------------- 403 (450)
T 1k9a_A 344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGY-------------- 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTTC--------------
T ss_pred ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC--------------
Confidence 12356889999999999999999999999999999998 999997643222 111111100
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+.+..++..+.++|.+||+.||++|||+.++++.|+.+...
T Consensus 404 ---~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 ---KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 0111234667889999999999999999999999999998765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=365.44 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=206.4
Q ss_pred HHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
...++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 45678999999999999999999864 78999999987543 3445678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC---CCCcEEEeeeccccc
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD---ENMAAHVSDFGISKL 651 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfgla~~ 651 (791)
||||+++|+|.+++..... +++..+..++.||+.||.||| +.+|+||||||+||+++ .++.+||+|||+|+.
T Consensus 88 v~E~~~gg~L~~~i~~~~~-~~e~~~~~i~~qil~aL~~lH----~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCH----QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EECCCBCCBHHHHHHHCSC-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999999987654 899999999999999999999 67899999999999998 568899999999987
Q ss_pred cCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
...... ......||+.|+|||++.+..++.++||||+||++|||++|..||.+... ......+........
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~~~~~~----- 233 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQIKAGAYDFP----- 233 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCCCC-----
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhCCCCCC-----
Confidence 654322 22345799999999999998999999999999999999999999965321 111111111100000
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+....++.++.+++.+||+.||++|||+.|+++
T Consensus 234 ---------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 ---------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ---------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0011234567889999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.29 Aligned_cols=262 Identities=23% Similarity=0.437 Sum_probs=196.3
Q ss_pred HhhccccccccCCCcceEEEEEEecC-C---cEEEEEEeehh--hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCee
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTISD-G---TDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
..++|++.+.||+|+||.||+|+... + ..||||++... .....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34689999999999999999998653 3 27999998754 344567899999999999999999999999776655
Q ss_pred ------eEEEecCCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcE
Q 003855 573 ------ALVLEFMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAA 641 (791)
Q Consensus 573 ------~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~ 641 (791)
++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.+
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS----SRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH----cCCcccCCCCcceEEEcCCCCE
Confidence 8999999999999999742 224899999999999999999999 6789999999999999999999
Q ss_pred EEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHH
Q 003855 642 HVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKE 720 (791)
Q Consensus 642 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 720 (791)
||+|||+|+...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+..
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~ 254 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNYLIG 254 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHHHHhc
Confidence 9999999987655443333344557889999999988899999999999999999999 89999764322 11111111
Q ss_pred hcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 721 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 721 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
... ...+..++..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 255 ~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 255 GNR-----------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp TCC-----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCC-----------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 100 0111234567889999999999999999999999999986543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=360.88 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=208.4
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999975 7899999999766555556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC--CCcEEEeeeccccccCCCC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE--NMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~ 656 (791)
+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||+|+......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999999999877666999999999999999999999 678999999999999974 5789999999998875432
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... .+.
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~~-----~~~---- 271 (387)
T 1kob_A 206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWE-----FDE---- 271 (387)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHCCCC-----CCS----
T ss_pred c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCC-----CCc----
Confidence 2 2334689999999999999999999999999999999999999975321 1111111111000 000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....++.++.+++.+||+.||++|||+.|+++
T Consensus 272 -----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 -----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 001134567889999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=358.03 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=206.8
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999975 78999999997543 34456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC---CcEEEeeecccccc
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN---MAAHVSDFGISKLL 652 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfgla~~~ 652 (791)
|||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.+ +.+||+|||+++..
T Consensus 107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999998654 4899999999999999999999 6789999999999999865 45999999999876
Q ss_pred CCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+........
T Consensus 182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~~~------ 250 (362)
T 2bdw_A 182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYP------ 250 (362)
T ss_dssp TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCCC------
T ss_pred cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCCCCCC------
Confidence 54322 2335799999999999998999999999999999999999999975321 111111111110000
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.+....++.++.+++.+||+.||++||++.|+++.
T Consensus 251 --------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 --------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01112345678899999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=356.51 Aligned_cols=264 Identities=18% Similarity=0.177 Sum_probs=212.3
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+..|+.+++++ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36799999999999999999996 4789999999875432 24578899999999 99999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc-----EEEeeecccccc
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA-----AHVSDFGISKLL 652 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfgla~~~ 652 (791)
|+ +|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+|+.+
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH----SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999976667999999999999999999999 678999999999999998887 999999999876
Q ss_pred CCCCCcc-----eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh
Q 003855 653 GEGEDSV-----TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727 (791)
Q Consensus 653 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~~~------- 231 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERYQK------- 231 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHHHH-------
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHHHH-------
Confidence 5433211 1234579999999999999999999999999999999999999998643221 1111110
Q ss_pred hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 728 ~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
+........ .......++ ++.+++..||+.||.+||++.++.+.|+++..+.
T Consensus 232 -i~~~~~~~~--~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 232 -IGDTKRATP--IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -HHHHHHHSC--HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -HHhhhccCC--HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 000000000 000011244 7899999999999999999999999999987664
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.02 Aligned_cols=253 Identities=28% Similarity=0.454 Sum_probs=206.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh-------HHHHHHHHHHHHHHhccCCccceeeeeeccCCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE-------RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 571 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 368999999999999999999974 789999999854321 11267889999999999999999999997665
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCC--eEecCCCCCCeEeCCCCc-----EEEe
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP--IIHCDLKPTNILLDENMA-----AHVS 644 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--i~H~dlk~~Nill~~~~~-----~kl~ 644 (791)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.+ |+||||||+||+++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ----NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH----hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 6999999999999999877777999999999999999999999 667 999999999999988776 9999
Q ss_pred eeccccccCCCCCcceeecccccccccCCCcc--CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc
Q 003855 645 DFGISKLLGEGEDSVTQTMTMATIGYMAPEYG--SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL 722 (791)
Q Consensus 645 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (791)
|||+++.... ......||+.|+|||.+ ....++.++||||+||++|||++|+.||.............+....
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 9999975432 23345689999999988 4566889999999999999999999999764433322222222111
Q ss_pred CCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 723 PHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 723 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
... ..+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 247 ~~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 LRP----------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCC----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCC----------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 000 01123456788999999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.84 Aligned_cols=263 Identities=24% Similarity=0.417 Sum_probs=214.8
Q ss_pred hhccccccccCCCcceEEEEEEec--------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS--------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNP 569 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 569 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999863 56789999997553 34567789999999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeE
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNIL 634 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nil 634 (791)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVL 189 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCccceEE
Confidence 99999999999999999998643 23889999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcch
Q 003855 635 LDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMS 713 (791)
Q Consensus 635 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 713 (791)
++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~ 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EE 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--HH
Confidence 99999999999999987765443333334457889999999988889999999999999999999 9999875321 11
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
....+...... ..+..++..+.+++.+||+.||++||++.|+++.|+++......
T Consensus 268 ~~~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 268 LFKLLKEGHRM-----------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHHHTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHhcCCCC-----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 11211111100 01123456788999999999999999999999999999776543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=352.32 Aligned_cols=252 Identities=22% Similarity=0.289 Sum_probs=206.2
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh------HHHHHHHHHHHHHHhccCCccceeeeeeccCCe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE------RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF 571 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 571 (791)
..+.|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3467999999999999999999975 689999999875432 135678899999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC----cEEEeeec
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM----AAHVSDFG 647 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 647 (791)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH----HCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999997654 4899999999999999999999 67899999999999999887 89999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+......
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~--- 235 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSAVNYE--- 235 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHTCCC---
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHhcCCC---
Confidence 9987754322 23356899999999999899999999999999999999999999653211 111111110000
Q ss_pred hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. ......++..+.+++.+||+.||++|||+.|+++
T Consensus 236 ------~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 ------FE-----DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ------CC-----HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------cC-----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0111234567889999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=348.98 Aligned_cols=259 Identities=27% Similarity=0.405 Sum_probs=203.3
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
++|++.+.||+|+||.||+|++. ++.||||++... ...+.+.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 67899999999999999999984 788999998644 334678899999999999999999999874 4789999999
Q ss_pred CCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc-EEEeeeccccccCCCCC
Q 003855 581 NGSLEKWLYSHNY--FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA-AHVSDFGISKLLGEGED 657 (791)
Q Consensus 581 ~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~-~kl~Dfgla~~~~~~~~ 657 (791)
+|+|.+++..... .+++..+..++.|+++||+|||+.+ ..+|+||||||+||+++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ-PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCS-SSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCC-CCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 9999999986543 4788999999999999999999422 268999999999999998886 799999999765332
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||+............+......
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 223 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP------------- 223 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-------------
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-------------
Confidence 2234589999999999999999999999999999999999999975432211111111110000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcccc
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDDA 787 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~ 787 (791)
+....++..+.+++.+||+.||++|||+.|+++.|+.+.+......
T Consensus 224 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 224 ----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp ----CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred ----CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 0111345667899999999999999999999999999987765443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=385.90 Aligned_cols=392 Identities=20% Similarity=0.226 Sum_probs=317.1
Q ss_pred CccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCC
Q 003855 6 PTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNA 85 (791)
Q Consensus 6 p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 85 (791)
|.+|+++++|++|+|++|+|+++.|++|.++++|++|+|++|+|+ .+|...+..+++|++|+|++|+|+++.+..|+++
T Consensus 69 ~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L 147 (635)
T 4g8a_A 69 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 147 (635)
T ss_dssp TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTC
T ss_pred HHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcC
Confidence 457999999999999999999999999999999999999999998 8888777779999999999999998888899999
Q ss_pred CCCCEEeccCcccccc-ccccccccccccccccccccccccCCCcccc------------------c-cccccCCCCCCc
Q 003855 86 TKLVALDLGFNSFAGH-ILNTFGNLRHLSLLSQVMNNLTTESSSADQW------------------S-FLSSLTNCRNLT 145 (791)
Q Consensus 86 ~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------------------~-~~~~l~~l~~L~ 145 (791)
++|++|+|++|++++. .+..+.++++|+.|++++|+|+.+....... . ..........+.
T Consensus 148 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~ 227 (635)
T 4g8a_A 148 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH 227 (635)
T ss_dssp TTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEE
T ss_pred cccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhh
Confidence 9999999999999875 4678899999999999999998765432000 0 000000011111
Q ss_pred EEEccCC-------------------------------------------------------------------------
Q 003855 146 ILSFGSN------------------------------------------------------------------------- 152 (791)
Q Consensus 146 ~L~L~~N------------------------------------------------------------------------- 152 (791)
.|++.+|
T Consensus 228 ~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~ 307 (635)
T 4g8a_A 228 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTN 307 (635)
T ss_dssp EEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTT
T ss_pred hhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcc
Confidence 2222222
Q ss_pred ---------CCcccCChhhhhhhhhhhhhhcccccccccCC-------------------ccccCCCCCCEEEccCCccc
Q 003855 153 ---------PLGGILPPVIGNFSASLQKFYAYECKLKGNIP-------------------QEIGNLSGLTLLSLHSNDLN 204 (791)
Q Consensus 153 ---------~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-------------------~~~~~l~~L~~L~L~~N~l~ 204 (791)
.+.... .+ .....|+.|.+.+|.+....+ .....+++|+.|++++|.+.
T Consensus 308 l~~l~~~~~~~~~~~--~~-~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~ 384 (635)
T 4g8a_A 308 VSSFSLVSVTIERVK--DF-SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 384 (635)
T ss_dssp CSEEEEESCEEEECG--GG-GSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCB
T ss_pred ccccccccccccccc--cc-ccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccc
Confidence 111000 00 001134445555554443222 22345789999999999986
Q ss_pred c--ccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCC-CccccCCCCCcEEEcCCCcCCCCCCc
Q 003855 205 G--TISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHI-PPCLVSLTSLRELHLGSNKLTSSIPS 281 (791)
Q Consensus 205 ~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~ 281 (791)
. ..+..+..+.+|++|+++.|.+. ..+..+..+++|+.+++++|...... +..+..+++++.+++++|.+.+..+.
T Consensus 385 ~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~ 463 (635)
T 4g8a_A 385 FKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 463 (635)
T ss_dssp EEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTT
T ss_pred cccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhcccccccccccccccccccccccccccccccccc
Confidence 3 45566778899999999999988 45667889999999999999876554 45688999999999999999999999
Q ss_pred cccCCCCCCeEEccCCcC-cccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCC
Q 003855 282 SLWSLEYILDINLSSNSL-NDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLIS 360 (791)
Q Consensus 282 ~~~~l~~L~~L~l~~N~i-~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 360 (791)
.+..++.|+.|++++|.+ ....|..|..+++|+.|+|++|++++..|..|.++++|++|+|++|+|++..|..|..+++
T Consensus 464 ~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~ 543 (635)
T 4g8a_A 464 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 543 (635)
T ss_dssp TTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTT
T ss_pred ccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCC
Confidence 999999999999999985 4467889999999999999999999888999999999999999999999888899999999
Q ss_pred CcEEEccCCccCCCCchhhhhc-ccCceEEccCCCCcccCCCC
Q 003855 361 LESLDLSGNNLSGKIPKSLETL-SQLKQFNVSHNRLEGEIPVK 402 (791)
Q Consensus 361 L~~L~l~~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~~~ 402 (791)
|+.|||++|+|++..|..|..+ ++|+.|+|++|+|.|.+...
T Consensus 544 L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~ 586 (635)
T 4g8a_A 544 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 586 (635)
T ss_dssp CCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGH
T ss_pred CCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcH
Confidence 9999999999999999999998 68999999999999988643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=379.56 Aligned_cols=259 Identities=23% Similarity=0.409 Sum_probs=212.3
Q ss_pred HhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
..++|++.+.||+|+||.||+|.++++..||||++.... ...+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 346899999999999999999999888999999997643 34578999999999999999999999986 5678999999
Q ss_pred CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.++++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~- 338 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE- 338 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-
Confidence 99999999998542 34789999999999999999999 6789999999999999999999999999998764321
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
........++..|+|||++..+.++.++|||||||++|||+| |+.||.+.... ...+.+....
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~-------------- 402 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGY-------------- 402 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHTC--------------
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC--------------
Confidence 111223346788999999988899999999999999999999 99999763221 1111111110
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
..+.+..++..+.++|.+||+.||++|||+.++++.|+.+....
T Consensus 403 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 403 ---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 11112346678899999999999999999999999999875443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=357.05 Aligned_cols=267 Identities=21% Similarity=0.341 Sum_probs=216.2
Q ss_pred HHHhhccccccccCCCcceEEEEEEec-C-----CcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeecc
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTIS-D-----GTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSN 568 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 568 (791)
+...++|+..+.||+|+||.||+|... + +..||+|++.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 334578999999999999999999864 2 2479999987653 34456789999999999 89999999999999
Q ss_pred CCeeeEEEecCCCCCHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe
Q 003855 569 PDFKALVLEFMPNGSLEKWLYSH-------------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL 635 (791)
Q Consensus 569 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill 635 (791)
.+..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA----SKNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGCEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCcccceEEE
Confidence 99999999999999999999743 234789999999999999999999 6789999999999999
Q ss_pred CCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchH
Q 003855 636 DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSL 714 (791)
Q Consensus 636 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 714 (791)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||+| |..||...... ...
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~ 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKF 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-HHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-HHH
Confidence 9999999999999987654443333344557889999999888889999999999999999999 89998764322 122
Q ss_pred HHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 715 RRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
...+....... .+..++..+.+++.+||+.||++|||+.|+++.|+++......
T Consensus 277 ~~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 330 (333)
T 2i1m_A 277 YKLVKDGYQMA-----------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330 (333)
T ss_dssp HHHHHHTCCCC-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCC-----------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence 22222211110 1112346678999999999999999999999999998766543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=350.46 Aligned_cols=258 Identities=22% Similarity=0.354 Sum_probs=200.8
Q ss_pred hhccccccccCCCcceEEEEEEec----CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|+.. .+..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 468999999999999999999864 24579999986543 344567899999999999999999999985 456889
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999999977767999999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+......
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~~~~~--------- 236 (281)
T 1mp8_A 169 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERL--------- 236 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCC---------
T ss_pred cccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHcCCCC---------
Confidence 3221 2223356789999999988889999999999999999997 99999764322 122221111000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
+.+..++..+.+++.+||+.||++||++.|+++.|+++..+
T Consensus 237 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 237 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01123556788999999999999999999999999998664
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=358.10 Aligned_cols=274 Identities=25% Similarity=0.418 Sum_probs=216.1
Q ss_pred hhccccccccCCCcceEEEEEEe-----cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCC--ee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-----SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD--FK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~ 572 (791)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36789999999999999999984 368999999998766666778999999999999999999999986543 78
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 9999999999999999987667999999999999999999999 678999999999999999999999999999887
Q ss_pred CCCCCcce-eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 653 GEGEDSVT-QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 653 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
........ .....++..|+|||.+.+..++.++||||||+++|||+||..|+..... .+..............
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~------~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMIGNDKQGQMIV 269 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH------HHHHHHCTTCCTHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH------HHHHhhccccchhhhH
Confidence 55433221 2233567789999999888899999999999999999999998764211 1111100000000000
Q ss_pred hhh---hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 732 ANL---VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 732 ~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
..+ .......+.+..++.++.+++.+||+.||++||++.|+++.|++++++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 000 0000011122346678999999999999999999999999999998875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=354.26 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=205.1
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh-----HHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE-----RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999875 789999999875431 13567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc---EEEeeec
Q 003855 574 LVLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA---AHVSDFG 647 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg 647 (791)
+||||+++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH----DNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999888642 345899999999999999999999 678999999999999986654 9999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
+++....... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.... +.............
T Consensus 179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~i~~~~~~~--- 251 (351)
T 3c0i_A 179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKM--- 251 (351)
T ss_dssp TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHHHHHTCCCC---
T ss_pred ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHHHHcCCCCC---
Confidence 9987754322 2334579999999999999999999999999999999999999997631 11111111111000
Q ss_pred hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. ......++..+.+++.+||+.||++|||+.|+++
T Consensus 252 ---~---------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 ---N---------PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ---C---------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---C---------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0111234567889999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.08 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=213.4
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|+..+.||+|+||.||+|+..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 367999999999999999999998889999999976543 2367889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++|+|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++...... ..
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 160 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence 999999999987667899999999999999999999 6789999999999999999999999999998764321 11
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
......++..|+|||...+..++.++||||+|+++|||++ |+.||...... .....+.......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~~~~~------------- 225 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRLY------------- 225 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCC-------------
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcCCcCC-------------
Confidence 2223456788999999988889999999999999999999 89998753211 1111111110000
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
.+..++..+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 226 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 226 ----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0112345678999999999999999999999999999764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=351.35 Aligned_cols=280 Identities=22% Similarity=0.359 Sum_probs=221.4
Q ss_pred CCChhHHHHHhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHh--ccCCccceeeeeec
Q 003855 490 RTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRN--VRHRNLIKILSSCS 567 (791)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~ 567 (791)
..+....+...++|++.+.||+|+||.||+|+. +++.||||++.... .+.+..|++++.. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 456666677789999999999999999999998 58999999987543 3466778888887 78999999999998
Q ss_pred cCC----eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccC----CCCCeEecCCCCCCeEeCCCC
Q 003855 568 NPD----FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH----SSAPIIHCDLKPTNILLDENM 639 (791)
Q Consensus 568 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~~i~H~dlk~~Nill~~~~ 639 (791)
... ..++||||+++|+|.+++.... +++..++.++.|++.||+|||... .+.+|+||||||+||+++.++
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 765 7899999999999999998754 899999999999999999999311 135799999999999999999
Q ss_pred cEEEeeeccccccCCCCCcc--eeecccccccccCCCccCCC------CCCccccHHhHHHHHHHHHhC----------C
Q 003855 640 AAHVSDFGISKLLGEGEDSV--TQTMTMATIGYMAPEYGSEG------IVSAKCDVYSYGVLLMETFTR----------K 701 (791)
Q Consensus 640 ~~kl~Dfgla~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~s~G~vl~elltg----------~ 701 (791)
.+||+|||+++......... ......||+.|+|||.+.+. .++.++|||||||++|||+|| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999998765443221 22344689999999988765 344789999999999999999 6
Q ss_pred CCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 702 RPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 702 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
.||............+............+... ....+++..+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR--------WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG--------GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCccc--------ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 78876544444444444333222211111111 1123567789999999999999999999999999999977
Q ss_pred Hh
Q 003855 782 KF 783 (791)
Q Consensus 782 ~~ 783 (791)
+.
T Consensus 337 ~~ 338 (342)
T 1b6c_B 337 QE 338 (342)
T ss_dssp TT
T ss_pred Hh
Confidence 54
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=360.16 Aligned_cols=281 Identities=25% Similarity=0.363 Sum_probs=200.9
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeee-----ccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC-----SNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-----~~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|+. +++.||||++....... .....|+..+..++||||+++++++ ......++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 46899999999999999999987 68999999997554322 1223344445568999999999754 23446789
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC---------CeEecCCCCCCeEeCCCCcEEEee
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA---------PIIHCDLKPTNILLDENMAAHVSD 645 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~---------~i~H~dlk~~Nill~~~~~~kl~D 645 (791)
||||+++|+|.+++.... .++..+..++.|+++||+||| +. +|+||||||+|||++.++.+||+|
T Consensus 90 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH----~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH----TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH----CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH----hhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 999999999999998765 588999999999999999999 55 899999999999999999999999
Q ss_pred eccccccCCCCC------cceeecccccccccCCCccCC-------CCCCccccHHhHHHHHHHHHhCCCCCCccccCcc
Q 003855 646 FGISKLLGEGED------SVTQTMTMATIGYMAPEYGSE-------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM 712 (791)
Q Consensus 646 fgla~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~ 712 (791)
||+|+.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987654321 122234469999999998876 4567799999999999999999776533211110
Q ss_pred hHHHHHHHhcCCChhhhcchhhhhh------HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhccc
Q 003855 713 SLRRWVKESLPHGLTEVVDANLVRE------EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDD 786 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~d~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~ 786 (791)
....+..........+......... .........++..+.+++.+||+.||++|||+.|+++.|+++...|...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 0000000000000000000000000 0001112246678999999999999999999999999999999888766
Q ss_pred cc
Q 003855 787 AS 788 (791)
Q Consensus 787 ~~ 788 (791)
.+
T Consensus 324 ~~ 325 (336)
T 3g2f_A 324 KS 325 (336)
T ss_dssp --
T ss_pred cc
Confidence 54
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=353.95 Aligned_cols=250 Identities=26% Similarity=0.324 Sum_probs=203.5
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 368999999999999999999975 68899999997543 33456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+|+.+...
T Consensus 94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ----NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999998654 4899999999999999999999 678999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCCCccCC---CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
. .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ....+......
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~~-------- 235 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFETT-------- 235 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHHHC--------
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhhc--------
Confidence 2 2334579999999998863 458999999999999999999999997532221 11111110000
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC-HHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRIN-VTDAAA 774 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~ev~~ 774 (791)
....+..++..+.+++.+||+.||++||+ +.++.+
T Consensus 236 -------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 -------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00011234567889999999999999998 666553
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=356.54 Aligned_cols=258 Identities=22% Similarity=0.403 Sum_probs=206.6
Q ss_pred hccccccccCCCcceEEEEEEec-CCcE----EEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTD----VAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
++|+..+.||+|+||.||+|++. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57899999999999999999964 4444 7888775432 233356778999999999999999999986 456889
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+.+..
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE----EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH----HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH----hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999877666899999999999999999999 67899999999999999999999999999998766
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
...........++..|+|||.+.++.++.++|||||||++|||+| |+.||...... .....+......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~--------- 236 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKGERL--------- 236 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTTCBC---------
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCC---------
Confidence 554444455568889999999988899999999999999999999 99999764322 222222211100
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+..++..+.+++.+||+.||++||++.|+++.|+++...
T Consensus 237 --------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 --------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp --------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred --------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01112344567899999999999999999999999988543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=353.95 Aligned_cols=269 Identities=22% Similarity=0.378 Sum_probs=209.8
Q ss_pred hccccccccCCCcceEEEEEEe-----cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccC--Cee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-----SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP--DFK 572 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 572 (791)
+.|+..+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5689999999999999999984 368999999987543 33457789999999999999999999999776 668
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh----cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 9999999999999999766666999999999999999999999 678999999999999999999999999999887
Q ss_pred CCCCCc-ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC---hhh
Q 003855 653 GEGEDS-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---LTE 728 (791)
Q Consensus 653 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 728 (791)
...... .......||..|+|||.+.+..++.++||||+|+++|||+||+.|+.... ..+.....+.. ...
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHHHHCSCCGGGHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhhccCCcccccCHH
Confidence 654332 22333467888999999988899999999999999999999999864321 11111111100 000
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
.+...+. .....+.+..++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 251 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHh-ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000000 00011122345678899999999999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=360.64 Aligned_cols=249 Identities=24% Similarity=0.292 Sum_probs=199.9
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeee
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 573 (791)
..++|++.+.||+|+||.||+|+.+ +++.||||++.... ....+.+..|..+++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999975 68999999997653 33456778899999988 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+||||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 101 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999986543 899999999999999999999 6789999999999999999999999999998643
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.....
T Consensus 176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~~~---------- 241 (353)
T 3txo_A 176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--DDLFEAILNDEV---------- 241 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC----------
T ss_pred cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCC----------
Confidence 222 223345799999999999888899999999999999999999999975322 111111111000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCH------HHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINV------TDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~------~ev~~ 774 (791)
..+..++..+.+++.+|++.||++||++ .|+++
T Consensus 242 --------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 --------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0011234567899999999999999998 66654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=357.84 Aligned_cols=275 Identities=26% Similarity=0.355 Sum_probs=214.0
Q ss_pred hccccccccCCCcceEEEEEEe-----cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeec--cCCeee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-----SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS--NPDFKA 573 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~ 573 (791)
++|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6899999999999999999984 368899999998776666778999999999999999999999885 456789
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG----SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 999999999999999875556899999999999999999999 6789999999999999999999999999998875
Q ss_pred CCCCcc-eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC----hhh
Q 003855 654 EGEDSV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG----LTE 728 (791)
Q Consensus 654 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~ 728 (791)
...... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||...... +........ ...
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~------~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE------FLRMMGCERDVPALSR 252 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH------HHHHCC----CCHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch------hhhhcccccccccHHH
Confidence 443322 223345788899999998888999999999999999999999998652211 111100000 001
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcccc
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDDA 787 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~ 787 (791)
..+. .......+.+..++..+.+++.+||+.||++|||+.|+++.|+.+.....+..
T Consensus 253 ~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 253 LLEL--LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp HHHH--HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred HHHH--hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 0000 00001111223466788999999999999999999999999999876655443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=350.00 Aligned_cols=245 Identities=25% Similarity=0.321 Sum_probs=204.2
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 468999999999999999999975 79999999997653 23456788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999987543 899999999999999999999 789999999999999999999999999999875432
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+........
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~------------- 220 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNAEL------------- 220 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHCCC-------------
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC-------------
Confidence 22356999999999999999999999999999999999999999753211 11111111000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
..+..++.++.+++.+|++.||++|| ++.|+++
T Consensus 221 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 00112345678999999999999999 8888874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=356.70 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=196.9
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccC--CccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRH--RNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv 575 (791)
.++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++| |||+++++++.+....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 36799999999999999999999889999999987543 3445778999999999976 9999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
||+ .+|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+|||++ ++.+||+|||+|+.....
T Consensus 88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 995 5889999998764 4899999999999999999999 67899999999999997 678999999999877554
Q ss_pred CCcceeecccccccccCCCccCC-----------CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSE-----------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH 724 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (791)
.........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+...+......
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 43333445679999999998754 6789999999999999999999999975332211111111111110
Q ss_pred ChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 725 GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 725 ~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.. +..++..+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~-----------------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 241 EF-----------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CC-----------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC-----------------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 00 01123457799999999999999999999763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.38 Aligned_cols=274 Identities=25% Similarity=0.405 Sum_probs=213.1
Q ss_pred cccccccCCCcceEEEEEEec-----CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeecc--CCeeeE
Q 003855 503 FNECNLLGTGSFGSVYKGTIS-----DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSN--PDFKAL 574 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 574 (791)
|++.+.||+|+||.||++++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 489999999999999998753 68899999997654 3446778999999999999999999999976 467899
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH----~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH----AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999998765 899999999999999999999 67899999999999999999999999999998765
Q ss_pred CCCcc-eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC-hhhhcch
Q 003855 655 GEDSV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG-LTEVVDA 732 (791)
Q Consensus 655 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~ 732 (791)
..... ......+|..|+|||.+.+..++.++||||||+++|||+||+.||........... ..... .......
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI-----GIAQGQMTVLRLT 261 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH-----CSCCHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhh-----cccccchhHHHHH
Confidence 43322 22334578889999999888899999999999999999999999865321100000 00000 0000000
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcccc
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDDA 787 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~ 787 (791)
.........+.+..++..+.+++.+||+.||++|||+.|+++.|+++..++...+
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 0000001111223466789999999999999999999999999999988876543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=363.72 Aligned_cols=263 Identities=24% Similarity=0.407 Sum_probs=202.3
Q ss_pred hccccccccCCCcceEEEEEEec--CC--cEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeecc-CCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS--DG--TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSN-PDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l 574 (791)
..|+..+.||+|+||.||+|++. ++ ..||||.+.... ....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35777889999999999999864 22 468999886433 3456789999999999999999999998754 567899
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++......+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999999999977777899999999999999999999 67899999999999999999999999999987644
Q ss_pred CCCc--ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 655 GEDS--VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 655 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
.... .......+|+.|+|||.+.+..++.++|||||||++|||+| |.+||......+ ....+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~~~~-------- 314 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGRR-------- 314 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHTTCC--------
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHcCCC--------
Confidence 3221 12233457889999999988999999999999999999999 677776533222 2222111100
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhccc
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDD 786 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~ 786 (791)
...+..++..+.+++.+||+.||++||++.|+++.|+++...+.++
T Consensus 315 ---------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 315 ---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 0111235567889999999999999999999999999998877654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.19 Aligned_cols=267 Identities=21% Similarity=0.269 Sum_probs=204.7
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 68999999987543 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++ ++.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9965 777777766666999999999999999999999 6789999999999999999999999999998764332
Q ss_pred cceeecccccccccCCCccCCCC-CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC---hhhhcc--
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---LTEVVD-- 731 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~d-- 731 (791)
.......||+.|+|||++.+.. ++.++||||+||++|||++|..|+.........+........... ......
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 2233456899999999887655 899999999999999999998886433222222333222211110 000000
Q ss_pred -hh----hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 -AN----LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 -~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. .............++..+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00000000011134567789999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=378.09 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=212.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|++.+.||+|+||.||+|++. ++..||||++..... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 467889999999999999999986 488999999875532 356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence 9999999999864 345899999999999999999999 6789999999999999999999999999998764332
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
........++..|+|||++.+..++.++|||||||++|||+| |+.||...... ...+.+.....
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~------------- 437 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYR------------- 437 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCC-------------
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-------------
Confidence 222233446789999999988899999999999999999999 99999764322 12222211110
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
...+..++..+.++|.+||+.||++|||+.++++.|+.+.
T Consensus 438 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 438 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1112245677889999999999999999999999998763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.78 Aligned_cols=252 Identities=19% Similarity=0.256 Sum_probs=198.8
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 478999999999999999999975 68899999997653 23344578899999887 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999998654 3899999999999999999999 67899999999999999999999999999986332
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+.... ...+.+...+
T Consensus 206 ~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~---------~~~~~~~~~i 274 (396)
T 4dc2_A 206 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------NTEDYLFQVI 274 (396)
T ss_dssp TT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------CCHHHHHHHH
T ss_pred CC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch---------hhHHHHHHHH
Confidence 22 223345799999999999999999999999999999999999999965322111000 0000000000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINV 769 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 769 (791)
.... ...+..++.++.+++.+||+.||++||++
T Consensus 275 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 275 LEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred hccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0000 00111345667899999999999999995
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.19 Aligned_cols=265 Identities=24% Similarity=0.421 Sum_probs=202.1
Q ss_pred HHhhccccccccCCCcceEEEEEEec----CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCC-
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD- 570 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~- 570 (791)
...++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34578999999999999999999864 34589999987542 344577899999999999999999999997654
Q ss_pred ----eeeEEEecCCCCCHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcE
Q 003855 571 ----FKALVLEFMPNGSLEKWLYS-----HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAA 641 (791)
Q Consensus 571 ----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~ 641 (791)
..++||||+++|+|.+++.. ....+++..++.++.|+++||.||| +.+|+||||||+||+++.++.+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS----NRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCSGGGEEECTTSCE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCcE
Confidence 34899999999999999953 2345899999999999999999999 7789999999999999999999
Q ss_pred EEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHH
Q 003855 642 HVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKE 720 (791)
Q Consensus 642 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 720 (791)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+..
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~ 264 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYLLH 264 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHT
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHHc
Confidence 9999999987655433333344567889999999988999999999999999999999 88898763322 12221111
Q ss_pred hcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 721 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 721 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
.... ..+..++..+.+++.+||+.||++||++.++++.|+++..+.++
T Consensus 265 ~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 265 GHRL-----------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp TCCC-----------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred CCCC-----------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 1000 01123456788999999999999999999999999999877653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=354.74 Aligned_cols=267 Identities=26% Similarity=0.407 Sum_probs=216.6
Q ss_pred HHHHHhhccccccccCCCcceEEEEEEe------cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeee
Q 003855 495 DIQRATDEFNECNLLGTGSFGSVYKGTI------SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSC 566 (791)
Q Consensus 495 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 566 (791)
......++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3344468899999999999999999984 356889999987653 34456789999999999 799999999998
Q ss_pred ccCC-eeeEEEecCCCCCHHHHHhhCCC---------------CCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCC
Q 003855 567 SNPD-FKALVLEFMPNGSLEKWLYSHNY---------------FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKP 630 (791)
Q Consensus 567 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~ 630 (791)
...+ ..++||||+++|+|.+++..... .+++..+..++.|++.||.||| +.+|+||||||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp 176 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAA 176 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSG
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH----hCCcccccCcc
Confidence 7654 58999999999999999986543 2789999999999999999999 67899999999
Q ss_pred CCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCcccc
Q 003855 631 TNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFT 709 (791)
Q Consensus 631 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~ 709 (791)
+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999987765544444445568899999999988899999999999999999998 9999976432
Q ss_pred CcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 710 GEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
.+. ....+....... .+..++..+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 257 ~~~-~~~~~~~~~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 257 DEE-FCRRLKEGTRMR-----------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp SHH-HHHHHHHTCCCC-----------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHH-HHHHhccCccCC-----------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 221 212111111100 11123466889999999999999999999999999987654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=347.68 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=194.2
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhh----hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL----ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|+..+.||+|+||.||+|++. ++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 367899999999999999999984 8899999986543 23356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCC---eEecCCCCCCeEeCC--------CCcEEEe
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP---IIHCDLKPTNILLDE--------NMAAHVS 644 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~---i~H~dlk~~Nill~~--------~~~~kl~ 644 (791)
|||+++|+|.+++... .+++..+..++.|++.||+||| +.+ |+||||||+||+++. ++.+||+
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH----~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH----DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH----HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999999644 4899999999999999999999 445 999999999999986 7789999
Q ss_pred eeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC
Q 003855 645 DFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH 724 (791)
Q Consensus 645 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (791)
|||+++....... ....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ...+. ..
T Consensus 159 Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~---~~ 229 (271)
T 3dtc_A 159 DFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--AYGVA---MN 229 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHH---TS
T ss_pred cCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHhhh---cC
Confidence 9999986643322 234689999999999888899999999999999999999999976322111 11000 00
Q ss_pred ChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 725 GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 725 ~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
.. ..+.+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 230 ~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 KL-------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CC-------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00 0011123456788999999999999999999999999754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=358.26 Aligned_cols=258 Identities=25% Similarity=0.433 Sum_probs=202.6
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcE----EEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTD----VAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
.++|++.+.||+|+||.||+|++. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367999999999999999999964 4544 5777664332 344578889999999999999999999998765 78
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+|+||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999999987777999999999999999999999 6789999999999999999999999999998875
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+.....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~~--------- 237 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGER--------- 237 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC---------
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC---------
Confidence 5444333444557889999999988999999999999999999999 99999764322 22222221110
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
.+.+..++..+.+++.+||+.||++||++.|+++.|+++..
T Consensus 238 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 --------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 01112345668899999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=348.89 Aligned_cols=245 Identities=21% Similarity=0.231 Sum_probs=195.6
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|+..++||+|+||+||+|+.. +++.||||++.... .........|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 478999999999999999999976 79999999876432 23334455566665555 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+ +|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH----SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 77999999877667999999999999999999999 678999999999999999999999999999876433
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
. ......||++|+|||++.+ .++.++|||||||++|||++|..|+... ...... .... ..+
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~----~~~~----~~~--- 271 (311)
T 3p1a_A 211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQL----RQGY----LPP--- 271 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHH----TTTC----CCH---
T ss_pred C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHH----hccC----CCc---
Confidence 2 2233468999999998875 7899999999999999999997765431 111111 0000 000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....++.++.+++.+||+.||++|||+.|+++
T Consensus 272 ------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 ------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111235677889999999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=356.80 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=200.1
Q ss_pred cccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCCCC
Q 003855 505 ECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGS 583 (791)
Q Consensus 505 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 583 (791)
..+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3568999999999999864 789999999987655566789999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe--CCCCcEEEeeeccccccCCCCCccee
Q 003855 584 LEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL--DENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 584 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill--~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
|.+++......+++..+..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||+++.+..... .
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMH----QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 99999877667999999999999999999999 6789999999999999 6778999999999988754332 2
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhh
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAF 741 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 741 (791)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..+........... .
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~-----~---------- 309 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWDLE-----D---------- 309 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCSC-----S----------
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCC-----h----------
Confidence 2346899999999999899999999999999999999999999753221 11122211111000 0
Q ss_pred HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 742 SAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 742 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....++.++.+++.+||+.||++|||+.|+++
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011234567889999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=348.95 Aligned_cols=272 Identities=22% Similarity=0.291 Sum_probs=210.5
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCC--eeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD--FKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 575 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367999999999999999999976 58999999997543 334567789999999999999999999987654 77999
Q ss_pred EecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe----CCCCcEEEeeeccc
Q 003855 576 LEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL----DENMAAHVSDFGIS 649 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfgla 649 (791)
|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+|
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999998543 23899999999999999999999 6789999999999999 78888999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccC--------CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcc---hHHHHH
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGS--------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM---SLRRWV 718 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~---~~~~~~ 718 (791)
+....... .....||+.|+|||++. +..++.++|||||||++|||+||+.||........ .+.+..
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 87754432 22346899999999865 57899999999999999999999999975332221 222222
Q ss_pred HHhcCCChhhhcch---hhhh---hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 719 KESLPHGLTEVVDA---NLVR---EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 719 ~~~~~~~~~~~~d~---~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
..........+... .... ..........++..+.+++.+||+.||++|||+.|+++....
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 22222111110000 0000 000001123566788999999999999999999999988764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=356.52 Aligned_cols=246 Identities=25% Similarity=0.407 Sum_probs=202.1
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999996 578999999997543 22245788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+ +|+|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCH----RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 7899999876543 899999999999999999999 678999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCCCccCCCCC-CccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
.. ....+||+.|+|||.+.+..+ +.++||||+||++|||++|+.||++...... ...+....
T Consensus 162 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------~~~i~~~~- 224 (336)
T 3h4j_B 162 NF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------FKKVNSCV- 224 (336)
T ss_dssp BT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------BCCCCSSC-
T ss_pred cc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------HHHHHcCC-
Confidence 22 233469999999999988776 7899999999999999999999976322111 00000000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+..++..+.+++.+||+.||++|||+.|+++
T Consensus 225 ------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 ------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0001124466789999999999999999999976
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=357.20 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=203.6
Q ss_pred HHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCe
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDF 571 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 571 (791)
....++|++.+.||+|+||.||+|+.+ +|+.||||++.... ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445689999999999999999999975 68999999997653 33456678899999887 99999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999998654 3899999999999999999999 67899999999999999999999999999986
Q ss_pred cCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
...... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+......
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~~------- 236 (345)
T 1xjd_A 168 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDNPF------- 236 (345)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCC-------
T ss_pred cccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHhCCCC-------
Confidence 433221 23345799999999999999999999999999999999999999975321 1111111111000
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVT-DAA 773 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~-ev~ 773 (791)
.+..++.++.+++.+||+.||++||++. |++
T Consensus 237 -----------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 -----------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0112346678999999999999999997 554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=364.26 Aligned_cols=257 Identities=20% Similarity=0.277 Sum_probs=206.5
Q ss_pred HHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCC
Q 003855 495 DIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD 570 (791)
Q Consensus 495 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 570 (791)
+++...++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445689999999999999999999976 68999999997543 122345788999999999999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..++||||+++|+|.++++... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~~--~~e~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999999998654 899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCCCC----CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCCh
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSEGI----VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL 726 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 726 (791)
...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... ..+.......
T Consensus 217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~----- 289 (410)
T 3v8s_A 217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHK----- 289 (410)
T ss_dssp ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHH-----
T ss_pred eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHHHHHhcc-----
Confidence 765432 12233467999999999886654 889999999999999999999999753211 1111111000
Q ss_pred hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCC--CCCHHHHHH
Q 003855 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDM--RINVTDAAA 774 (791)
Q Consensus 727 ~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~ev~~ 774 (791)
.....+....++.++.+++.+|++.+|++ ||++.||++
T Consensus 290 ----------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 290 ----------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ----------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ----------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 00001111234567889999999999998 999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=375.18 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=206.9
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|++.+.||+|+||.||+|.++++..||||++..... ..+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 467899999999999999999998888899999975432 34678999999999999999999999976 6789999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 335 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 335 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence 999999999853 345899999999999999999999 67899999999999999999999999999987654322
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
.......++..|+|||.+.++.++.++|||||||++|||+| |+.||.+....+ ....+....
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~--------------- 398 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGY--------------- 398 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC---------------
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC---------------
Confidence 12223456789999999988899999999999999999999 999997642211 111111100
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhc
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~ 784 (791)
..+.+..++..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 399 --~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 399 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 011122466778899999999999999999999999998765443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=363.29 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=206.4
Q ss_pred HHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCC
Q 003855 495 DIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD 570 (791)
Q Consensus 495 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 570 (791)
+.+...++|++.+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 33445689999999999999999999975 79999999997543 223345788999999999999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..++||||+++|+|.+++...+..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH----RLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 999999999999999999876556999999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccC-------CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGS-------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP 723 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (791)
....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .+...+...
T Consensus 211 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~-- 286 (412)
T 2vd5_A 211 KLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-TYGKIVHYK-- 286 (412)
T ss_dssp ECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHH--
T ss_pred eccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhcc--
Confidence 7654322 2233457999999999876 4678999999999999999999999997532111 111111000
Q ss_pred CChhhhcchhhhhhHHhhH-HHHHHHHHHHHHHhhccccCCCCC---CCHHHHHH
Q 003855 724 HGLTEVVDANLVREEQAFS-AKMDCILSIMDLALDCCIESPDMR---INVTDAAA 774 (791)
Q Consensus 724 ~~~~~~~d~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~R---Pt~~ev~~ 774 (791)
.....+ ....++.++.+++.+||. +|++| |++.|+++
T Consensus 287 -------------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 287 -------------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -------------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -------------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000000 012355778899999999 99998 58888864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=358.78 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=197.1
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhcc--CCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVR--HRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 5699999999999999999998889999999986543 445678899999999996 599999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
| +.+|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+|+.+....
T Consensus 136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56889999998765 4889999999999999999999 77899999999999996 5899999999998775443
Q ss_pred CcceeecccccccccCCCccCC-----------CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC
Q 003855 657 DSVTQTMTMATIGYMAPEYGSE-----------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG 725 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (791)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+...+.......
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 3333345579999999998754 46899999999999999999999999753222111111111100000
Q ss_pred hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 726 ~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. +..++..+.+++.+||+.||++||++.|+++
T Consensus 289 ~-----------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 289 F-----------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp C-----------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-----------------CccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 0 0112356779999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=346.34 Aligned_cols=252 Identities=24% Similarity=0.383 Sum_probs=205.4
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC--CeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP--DFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 575 (791)
.++|+..+.||+|+||.||+|+++ ++.||||++.... ....+.+.+|+.++++++||||+++++++.++ ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 367999999999999999999984 8899999987543 34456799999999999999999999999876 778999
Q ss_pred EecCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCC--eEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 576 LEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHHGHSSAP--IIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
|||+++|+|.+++..... .+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.++++|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH----TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT----TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh----cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999987543 5899999999999999999999 566 999999999999999999999999987643
Q ss_pred CCCCCcceeecccccccccCCCccCCCCCCc---cccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSEGIVSA---KCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV 729 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
.. ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||......+. ...........
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~----- 230 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVALEGLRP----- 230 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHHHSCCCC-----
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHHhcCCCC-----
Confidence 22 2245799999999887665544 79999999999999999999975322111 11111110000
Q ss_pred cchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 730 VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 730 ~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
..+..++..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 231 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 ------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0112345678899999999999999999999999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=351.01 Aligned_cols=249 Identities=25% Similarity=0.328 Sum_probs=195.8
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh--------------------------HHHHHHHHHHHHHH
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE--------------------------RAFRSFDSECEVLR 552 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 552 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999864 789999999864421 12356889999999
Q ss_pred hccCCccceeeeeecc--CCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCC
Q 003855 553 NVRHRNLIKILSSCSN--PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKP 630 (791)
Q Consensus 553 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~ 630 (791)
+++||||+++++++.+ ....++||||+++|+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH----YQKIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCH
Confidence 9999999999999976 5678999999999999886543 34899999999999999999999 67899999999
Q ss_pred CCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCC---CCccccHHhHHHHHHHHHhCCCCCCcc
Q 003855 631 TNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKRPTDEM 707 (791)
Q Consensus 631 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~ 707 (791)
+||+++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999987654322 233457999999999987654 478899999999999999999999753
Q ss_pred ccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 708 FTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. ......+...... .+....++..+.+++.+||+.||++||++.|+++
T Consensus 244 ~~--~~~~~~~~~~~~~----------------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RI--MCLHSKIKSQALE----------------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SH--HHHHHHHHHCCCC----------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cH--HHHHHHHhcccCC----------------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 11 1111111110000 0011134566889999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=341.68 Aligned_cols=263 Identities=23% Similarity=0.402 Sum_probs=214.1
Q ss_pred hcccccc-ccCCCcceEEEEEEec---CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 501 DEFNECN-LLGTGSFGSVYKGTIS---DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 501 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
++|.+.+ .||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5666666 9999999999999853 67889999997643 34567889999999999999999999999 45568999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999877667999999999999999999999 678999999999999999999999999999887543
Q ss_pred CCcc-eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 656 EDSV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 656 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+......
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~~~~~~--------- 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRM--------- 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTCCC---------
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHhcCCcC---------
Confidence 3221 1223356889999999988889999999999999999998 9999976322 1222222111100
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcccc
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDDA 787 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~ 787 (791)
..+..++..+.+++.+||+.||++||++.|+++.|.++........
T Consensus 233 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 233 --------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp --------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred --------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 0112455778899999999999999999999999999976654433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=359.74 Aligned_cols=271 Identities=18% Similarity=0.239 Sum_probs=206.2
Q ss_pred hhccccccccCCC--cceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTG--SFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.++|++.+.||+| +||.||+|+.. +++.||||++.... .+..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999976 79999999997654 4456778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 575 VLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
||||+++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999865 345899999999999999999999 6789999999999999999999999999986543
Q ss_pred CCCC-----cceeecccccccccCCCccCC--CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC-
Q 003855 654 EGED-----SVTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG- 725 (791)
Q Consensus 654 ~~~~-----~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 725 (791)
.... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+........ ..+....+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~ 258 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTVPCLL 258 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH-HC---------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHhcCCCCccc
Confidence 2211 111222468999999999877 679999999999999999999999997643332211 1111110000
Q ss_pred ----------------------hhhhcchh----hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 726 ----------------------LTEVVDAN----LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 726 ----------------------~~~~~d~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..+..... ........+....++..+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000000 000000111223456779999999999999999999999853
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=347.40 Aligned_cols=263 Identities=23% Similarity=0.365 Sum_probs=210.5
Q ss_pred ccccccccCCCcceEEEEEEec-C---CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCee-eEE
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-D---GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK-ALV 575 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv 575 (791)
.|...+.||+|+||.||+|++. + +..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4666789999999999999853 2 2379999987543 34567889999999999999999999999776655 899
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+.+|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA----EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999987677899999999999999999999 678999999999999999999999999999866443
Q ss_pred CC--cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 656 ED--SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 656 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.. ........+++.|+|||...+..++.++||||||+++|||++|..|+..... .......+......
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~--------- 247 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGRRL--------- 247 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTTCCC---------
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcCCCC---------
Confidence 21 1122334578899999999999999999999999999999996665433222 22222222221111
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhccc
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDD 786 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~ 786 (791)
+.+..++..+.+++.+||+.||++|||+.|+++.|+++..+...+
T Consensus 248 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 248 --------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred --------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 111234566889999999999999999999999999998877654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.03 Aligned_cols=263 Identities=24% Similarity=0.395 Sum_probs=208.5
Q ss_pred hccccccccCCCcceEEEEEEecC----CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeee-ccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISD----GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSC-SNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~l 574 (791)
.+|++.+.||+|+||.||+|+..+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++ ...+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 568889999999999999998642 2358999886533 34557789999999999999999999986 45567899
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999999877777899999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCc--ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 655 GEDS--VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 655 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
.... .......+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||...... .....+......
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~------- 251 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRRL------- 251 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHHHTTCCC-------
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhcCCCC-------
Confidence 3221 22333457889999999988899999999999999999999 55566543221 111111111100
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhccc
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDD 786 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~ 786 (791)
..+..++..+.+++.+||+.||++||++.|+++.|+++...+..+
T Consensus 252 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 252 ----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred ----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 001124466889999999999999999999999999998876543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=360.47 Aligned_cols=348 Identities=26% Similarity=0.394 Sum_probs=283.0
Q ss_pred CCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCE
Q 003855 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVA 90 (791)
Q Consensus 11 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 90 (791)
.+++|+.|++++|.++.+ | .+..+++|++|+|++|.++ .+|. +. .+++|++|+|++|.+++..+ |.++++|++
T Consensus 44 ~l~~l~~L~l~~~~i~~l-~-~~~~l~~L~~L~Ls~n~l~-~~~~-~~-~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKSI-D-GVEYLNNLTQINFSNNQLT-DITP-LK-NLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHTCCEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCC-CCGG-GT-TCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred HhccccEEecCCCCCccC-c-chhhhcCCCEEECCCCccC-Cchh-hh-ccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 467899999999999854 4 4889999999999999998 6666 44 48999999999999997655 999999999
Q ss_pred EeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhh
Q 003855 91 LDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQ 170 (791)
Q Consensus 91 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~ 170 (791)
|+|++|.++++.+ |.++++|+.|++++|++..++ .+..+++|++|+++ |.+.+..+ +..+ ++|+
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~----------~~~~l~~L~~L~l~-~~~~~~~~--~~~l-~~L~ 180 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS----------ALSGLTSLQQLSFG-NQVTDLKP--LANL-TTLE 180 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG----------GGTTCTTCSEEEEE-ESCCCCGG--GTTC-TTCC
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh----------hhccCCcccEeecC-CcccCchh--hccC-CCCC
Confidence 9999999987654 999999999999999998753 37889999999997 55554322 4433 5688
Q ss_pred hhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCc
Q 003855 171 KFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNK 250 (791)
Q Consensus 171 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 250 (791)
+|++++|.+.+. ..+..+++|+.|++++|.+++..+ ++.+++|++|++++|++++. ..+..+++|+.|++++|.
T Consensus 181 ~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~ 254 (466)
T 1o6v_A 181 RLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQ 254 (466)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred EEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCc
Confidence 888888888754 347888888888888888886554 67788888888888888743 467788888888888888
Q ss_pred cCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcc
Q 003855 251 LSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPST 330 (791)
Q Consensus 251 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 330 (791)
+++..+ +..+++|+.|++++|++.+..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..|
T Consensus 255 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-- 326 (466)
T 1o6v_A 255 ISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-- 326 (466)
T ss_dssp CCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--
T ss_pred cccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--
Confidence 886544 7888888888888888886544 7788888888888888876543 7788888888888888886554
Q ss_pred hhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccC
Q 003855 331 IGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEI 399 (791)
Q Consensus 331 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 399 (791)
+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++.+
T Consensus 327 ~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p 391 (466)
T 1o6v_A 327 VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAP 391 (466)
T ss_dssp GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECCC
T ss_pred hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCCc
Confidence 77888888888888888854 467888888888888888887776 788888888888888888754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=350.86 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=205.4
Q ss_pred hhccccccccCCCcceEEEEEEec-CC-------cEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DG-------TDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 571 (791)
.++|++.+.||+|+||.||+|+.. ++ ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 468999999999999999999865 33 5799999987766677889999999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc--------EEE
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA--------AHV 643 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~--------~kl 643 (791)
.++||||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE----ENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh----hCCeECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999987766999999999999999999999 678999999999999998887 999
Q ss_pred eeeccccccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc
Q 003855 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL 722 (791)
Q Consensus 644 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (791)
+|||+++..... ....|++.|+|||.+.+ ..++.++|||||||++|||++|..|+........ ........
T Consensus 163 ~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~- 234 (289)
T 4fvq_A 163 SDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDR- 234 (289)
T ss_dssp CCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTT-
T ss_pred ccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhcc-
Confidence 999999754321 22357889999998877 7799999999999999999996554432111111 11111110
Q ss_pred CCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 723 PHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 723 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
... +..++.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 235 -~~~-----------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 235 -HQL-----------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp -CCC-----------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred -CCC-----------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 000 011234567999999999999999999999999988543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=352.59 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=200.4
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|..+++++ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 367999999999999999999975 68999999997653 34456788899999988 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus 88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999998654 3899999999999999999999 67899999999999999999999999999986432
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcch---HHHHHHHhcCCChhhhcc
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS---LRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~d 731 (791)
... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||......... ....+..
T Consensus 163 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----------- 229 (345)
T 3a8x_A 163 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ----------- 229 (345)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH-----------
T ss_pred CCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH-----------
Confidence 221 233457999999999999999999999999999999999999999753221100 0000000
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINV 769 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 769 (791)
.+.... ...+..++..+.+++.+||+.||++||++
T Consensus 230 -~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 230 -VILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -HHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -HHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 000000 00111345678899999999999999996
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=352.68 Aligned_cols=261 Identities=26% Similarity=0.452 Sum_probs=206.0
Q ss_pred hccccccccCCCcceEEEEEEecC-----CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISD-----GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
++|...+.||+|+||.||+|.... +..||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 567788999999999999998642 2459999987543 3445678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999987667999999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCc-ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 655 GEDS-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 655 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
.... .......+|..|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~~~---------- 267 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAINDGF---------- 267 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTC----------
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHCCC----------
Confidence 3221 12222346788999999988899999999999999999999 99999653221 1111111100
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhc
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~ 784 (791)
..+.+..++..+.+++.+||+.||++||++.|+++.|+++.+...
T Consensus 268 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 268 -------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp -------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 001112355678899999999999999999999999999876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=348.85 Aligned_cols=266 Identities=23% Similarity=0.301 Sum_probs=202.7
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|++.+.||+|+||.||+|+..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999999889999999986543 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++ +|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 975 999999876666999999999999999999999 67899999999999999999999999999987643221
Q ss_pred ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC---Chhhh-----
Q 003855 659 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH---GLTEV----- 729 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~----- 729 (791)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+.+........ .....
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHCCCChhhchhhhcccc
Confidence 2233468999999998865 45899999999999999999999999764221 1122222211110 00000
Q ss_pred cchhhhhhH--HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 VDANLVREE--QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 ~d~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.++.+.... ........++.++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 000001134567889999999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=353.86 Aligned_cols=245 Identities=24% Similarity=0.253 Sum_probs=204.4
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999975 78999999997653 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EcCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999986543 899999999999999999999 678999999999999999999999999999876432
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~------------- 255 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGKV------------- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC-------------
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHHHHcCCC-------------
Confidence 22346899999999999999999999999999999999999999753211 11111111100
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRIN-----VTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~ev~~ 774 (791)
..+..++..+.+++.+||+.||++||+ +.|+++
T Consensus 256 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 001134566889999999999999998 777764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.03 Aligned_cols=267 Identities=22% Similarity=0.314 Sum_probs=203.8
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehh---hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 46799999999999999999996 47899999998753 244567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 576 LEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
|||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999974 3456899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.............+.. ......
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~--- 258 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ---CDYPPL--- 258 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT---TCSCCC---
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc---ccCCCC---
Confidence 43321 1223468999999999999999999999999999999999999987532221112111111 000000
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhccccc
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDDAS 788 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~~ 788 (791)
....++..+.+++.+||+.||++||++.++++.|++++....++-+
T Consensus 259 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 259 ----------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp ----------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred ----------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 0113456788999999999999999999999999999988776543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=349.81 Aligned_cols=266 Identities=22% Similarity=0.263 Sum_probs=210.5
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeec----cCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS----NPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 36899999999999999999997 578999999987666666778899999999999999999999986 3457889
Q ss_pred EEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 575 VLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
||||+++|+|.+++.. ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH----AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999985 3556899999999999999999999 67899999999999999999999999999876
Q ss_pred cCCCCCcc-------eeecccccccccCCCccCCCC---CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHh
Q 003855 652 LGEGEDSV-------TQTMTMATIGYMAPEYGSEGI---VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES 721 (791)
Q Consensus 652 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 721 (791)
........ ......||+.|+|||.+.... ++.++||||||+++|||++|+.||+............+...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 53211110 012235799999999887543 78899999999999999999999975333222222211110
Q ss_pred cCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhccc
Q 003855 722 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDD 786 (791)
Q Consensus 722 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~ 786 (791)
. ..+....++..+.+++.+||+.||++||++.|+++.|+.+....+..
T Consensus 264 ~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 264 L-----------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred C-----------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 0 00111234567889999999999999999999999999886554443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.79 Aligned_cols=259 Identities=21% Similarity=0.333 Sum_probs=208.4
Q ss_pred hhccccccccCCCcceEEEEEEecC----CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISD----GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|++.+ +..||||++.... ....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4789999999999999999998642 3469999987653 34567889999999999999999999998754 5689
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE----SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999999876666899999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
... .......+++.|+|||...+..++.++||||||+++|||+| |+.||...... .....+......
T Consensus 166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~~~~~--------- 233 (281)
T 3cc6_A 166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEKGDRL--------- 233 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHHTCCC---------
T ss_pred ccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhcCCCC---------
Confidence 322 12233457889999999988889999999999999999998 99999753222 122222111100
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
+.+..++..+.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 234 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 234 --------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 111134566889999999999999999999999999987654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=351.11 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=198.3
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCC------
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD------ 570 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 570 (791)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3578999999999999999999986 89999999987543 345578899999999999999999999885433
Q ss_pred ---------------------------------------------------eeeEEEecCCCCCHHHHHhhCCC--CCCH
Q 003855 571 ---------------------------------------------------FKALVLEFMPNGSLEKWLYSHNY--FLDI 597 (791)
Q Consensus 571 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~ 597 (791)
..++||||+++|+|.+++..... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37899999999999999986532 3566
Q ss_pred HHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc----------ceeeccccc
Q 003855 598 LERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS----------VTQTMTMAT 667 (791)
Q Consensus 598 ~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~g~ 667 (791)
..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++........ .......||
T Consensus 164 ~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred HHHHHHHHHHHHHHHHHH----hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 778999999999999999 678999999999999999999999999999887654221 122335699
Q ss_pred ccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHH
Q 003855 668 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDC 747 (791)
Q Consensus 668 ~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 747 (791)
+.|+|||.+.+..++.++|||||||++|||++|..|+.... .......... ........
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------~~~~~~~~~~--------------~~~~~~~~ 298 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------RIITDVRNLK--------------FPLLFTQK 298 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------HHHHHHHTTC--------------CCHHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------HHHHHhhccC--------------CCcccccC
Confidence 99999999998899999999999999999999877643210 1111000000 00111234
Q ss_pred HHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 748 ILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 748 ~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+..+.+++.+||+.||++|||+.|+++
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 466789999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=353.00 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=190.4
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3567999999999999999999976 68899999987553 23567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC---CCcEEEeeeccccccCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE---NMAAHVSDFGISKLLGE 654 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgla~~~~~ 654 (791)
|+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH----ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999998654 4899999999999999999999 678999999999999975 89999999999987643
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+......... .. .
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-~~----~--- 272 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-FI----S--- 272 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-CC----T---
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-cC----C---
Confidence 22 1233568999999999999899999999999999999999999997532222111111111000 00 0
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+....++.++.+++.+||+.||++|||+.|+++
T Consensus 273 -------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 -------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011134567889999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=340.15 Aligned_cols=254 Identities=21% Similarity=0.330 Sum_probs=208.7
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3478999999999999999999975 78999999987543 344577889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||.+..+....
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp ECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999999987543 4899999999999999999999 6789999999999999999999999999998764332
Q ss_pred CcceeecccccccccCCCccCCCCC-CccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||............|......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 227 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------ 227 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT------------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc------------
Confidence 2222334568999999999877665 789999999999999999999998754433333333221100
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......++..+.+++.+||+.||++|||+.|+++
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 -----LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0011134566789999999999999999999976
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=357.22 Aligned_cols=270 Identities=24% Similarity=0.292 Sum_probs=194.7
Q ss_pred HHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehh--hhHHHHHHHHHHHHHHhcc-CCccceeeeeeccC--Ce
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVR-HRNLIKILSSCSNP--DF 571 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~ 571 (791)
...++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++++. ||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45678999999999999999999864 7899999998543 2344567788999999997 99999999998654 46
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++||||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999997 6999999874 3899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCC-------------------CcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCc
Q 003855 652 LGEGE-------------------DSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711 (791)
Q Consensus 652 ~~~~~-------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 711 (791)
+.... .....+..+||++|+|||++.+ ..++.++||||+||++|||++|+.||.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~- 237 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM- 237 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 64311 1112233579999999998876 67999999999999999999999999763221
Q ss_pred chHHHHHHHhcCCCh-----------hhhcch-----------------hhhhhHHhhHHHHHHHHHHHHHHhhccccCC
Q 003855 712 MSLRRWVKESLPHGL-----------TEVVDA-----------------NLVREEQAFSAKMDCILSIMDLALDCCIESP 763 (791)
Q Consensus 712 ~~~~~~~~~~~~~~~-----------~~~~d~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P 763 (791)
..+...+........ ...+.. ..............++.++.+++.+||+.||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 111221111100000 000000 0000000000111346778999999999999
Q ss_pred CCCCCHHHHHHH
Q 003855 764 DMRINVTDAAAK 775 (791)
Q Consensus 764 ~~RPt~~ev~~~ 775 (791)
++|||+.|+++.
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=356.38 Aligned_cols=265 Identities=24% Similarity=0.416 Sum_probs=213.4
Q ss_pred HHHHHhhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeec
Q 003855 495 DIQRATDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCS 567 (791)
Q Consensus 495 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 567 (791)
+.+...++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445688999999999999999999864 36789999987543 334567889999999999999999999999
Q ss_pred cCCeeeEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC
Q 003855 568 NPDFKALVLEFMPNGSLEKWLYSHN---------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN 638 (791)
Q Consensus 568 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~ 638 (791)
+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTT
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCCccCCCccceEEEcCC
Confidence 9999999999999999999997421 34689999999999999999999 6789999999999999999
Q ss_pred CcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHH
Q 003855 639 MAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRW 717 (791)
Q Consensus 639 ~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 717 (791)
+.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ....+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~ 252 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVLRF 252 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--HHHHHH
Confidence 9999999999986644332222333457889999999988889999999999999999999 8889875321 111111
Q ss_pred HHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 718 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 718 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
+... .. ...+..++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 253 ~~~~---~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 253 VMEG---GL--------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHTT---CC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHcC---Cc--------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 1110 00 001123456788999999999999999999999999876443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.76 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=215.6
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
..++|++.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578999999999999999999976 58899999987543 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 578 FMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 578 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
|+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH----HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH----HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999864 345899999999999999999999 6789999999999999999999999999998765433
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
. .......+++.|+|||.+.+..++.++||||+|+++|||++ |..||...... .....+......
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~~~----------- 231 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYRM----------- 231 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCCC-----------
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccCCC-----------
Confidence 2 23333457889999999988899999999999999999999 99998763222 222222211110
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
..+..++..+.+++.+|++.||++||++.|+++.|+++....
T Consensus 232 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 232 ------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111234567889999999999999999999999999886654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=355.75 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=194.5
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999976 789999999875432 235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc--EEEeeeccccccCCCC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA--AHVSDFGISKLLGEGE 656 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfgla~~~~~~~ 656 (791)
+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+|+......
T Consensus 98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH----~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999997654 3899999999999999999999 678999999999999987765 9999999997533221
Q ss_pred CcceeecccccccccCCCccCCCCCCcc-ccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAK-CDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.....+||+.|+|||++.+..++.+ +||||+||++|||++|+.||....... .....+........
T Consensus 173 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~~--------- 239 (361)
T 3uc3_A 173 ---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVKY--------- 239 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTCC---------
T ss_pred ---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCCC---------
Confidence 2233569999999999877777655 899999999999999999997643322 22222221111100
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..+....++..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 ----SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 001111234667899999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.82 Aligned_cols=265 Identities=19% Similarity=0.225 Sum_probs=211.9
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeee-ccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC-SNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++.++|++++..++++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999996 5899999999865432 24578899999999998877766665 56777899999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC---CCCcEEEeeeccccccCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD---ENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfgla~~~~~ 654 (791)
|+ +++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 99999999866667999999999999999999999 67899999999999994 889999999999987654
Q ss_pred CCCcc-----eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCc--chHHHHHHHhcCCChh
Q 003855 655 GEDSV-----TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE--MSLRRWVKESLPHGLT 727 (791)
Q Consensus 655 ~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~ 727 (791)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 234 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------ 234 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH------
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc------
Confidence 43211 1234568999999999999999999999999999999999999998643221 1111111110
Q ss_pred hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 728 ~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
.... .......++..+.+++.+||+.||++||++.++++.|+++......
T Consensus 235 ------~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 235 ------MSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ------HHSC--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ------cCCc--hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0000 0001124567789999999999999999999999999999776543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.42 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=206.2
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
..++|++.+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3578999999999999999999975 578999999987665566789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe---CCCCcEEEeeeccccccCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfgla~~~~~ 654 (791)
|+++++|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 87 LCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCH----KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred ccCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999986543 899999999999999999999 6789999999999999 7889999999999987654
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
... .....||+.|+|||.+.+. ++.++||||+|+++|||++|+.||...... .....+........
T Consensus 162 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~-------- 227 (277)
T 3f3z_A 162 GKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVMLKIREGTFTFP-------- 227 (277)
T ss_dssp TSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCCC--------
T ss_pred ccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCCCCCC--------
Confidence 332 2334689999999987654 899999999999999999999999763221 11111111000000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......++..+.+++.+|++.||++||++.|+++
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 ------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011134567889999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.65 Aligned_cols=265 Identities=19% Similarity=0.231 Sum_probs=208.4
Q ss_pred HhhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeee-ccCCeeeEEE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC-SNPDFKALVL 576 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 576 (791)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+..|+.+++.++|++++..++++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 5789999998754432 23577899999999988877777665 6677889999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe---CCCCcEEEeeeccccccC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLG 653 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfgla~~~~ 653 (791)
||+ +|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 99999999876666999999999999999999999 6789999999999999 789999999999998765
Q ss_pred CCCCc-----ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCc--chHHHHHHHhcCCCh
Q 003855 654 EGEDS-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE--MSLRRWVKESLPHGL 726 (791)
Q Consensus 654 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~ 726 (791)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------ 233 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK------ 233 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH------
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc------
Confidence 44321 12234568999999999999999999999999999999999999997643321 111111111
Q ss_pred hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhc
Q 003855 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784 (791)
Q Consensus 727 ~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~ 784 (791)
..... .......++..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 234 ------~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 234 ------KMSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ------HHHSC--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ------cccch--hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 00000 000112346788999999999999999999999999999977654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=346.74 Aligned_cols=267 Identities=24% Similarity=0.343 Sum_probs=190.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999865 68999999987543 2234577889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 578 FMPNGSLEKWLYSH-----NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 578 ~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
|++ |+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH----ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 997 5999998743 234899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC--CC-hhh
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP--HG-LTE 728 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~-~~~ 728 (791)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..+......... .. ...
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 159 GIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp TSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTCGG
T ss_pred CCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHhhh
Confidence 43322 2233468999999998866 46899999999999999999999999763321 112222111110 00 000
Q ss_pred hc-----chhhh-------hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 VV-----DANLV-------REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 ~~-----d~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. .+.+. ...........++.++.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 00000 000000011134567889999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=340.87 Aligned_cols=248 Identities=24% Similarity=0.333 Sum_probs=202.1
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
+.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3578999999999999999999875 67899999986543 2235678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~qi~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999999986543 899999999999999999999 77999999999999999999999999999865433
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
. ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... .....+....
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~------------ 223 (279)
T 3fdn_A 162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISRVE------------ 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTC------------
T ss_pred c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHHHHHHhCC------------
Confidence 2 223346899999999999999999999999999999999999999753211 1111111100
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
...+..++..+.+++.+||+.||++||++.|+++.
T Consensus 224 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00111244667899999999999999999999874
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=358.59 Aligned_cols=334 Identities=28% Similarity=0.320 Sum_probs=253.0
Q ss_pred ccCCccccCCCCCCeeecCCCcccccCCccccCCCCC-------------cEEeCCCCcCcccCCchhhhcCCCccEEEc
Q 003855 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTM-------------RILTLEGNQLSGRLPSTVGHLLPNIESLLL 69 (791)
Q Consensus 3 g~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-------------~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L 69 (791)
|+||++|+++++|++|++++|++++.+|..++++.+| ++|++++|+++ .+|.. .++|++|+|
T Consensus 24 ~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp~~----~~~L~~L~l 98 (454)
T 1jl5_A 24 TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL----PPHLESLVA 98 (454)
T ss_dssp ----------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCCSC----CTTCSEEEC
T ss_pred hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCCCC----cCCCCEEEc
Confidence 7899999999999999999999999999999998875 99999999998 77762 479999999
Q ss_pred cCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEc
Q 003855 70 AANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSF 149 (791)
Q Consensus 70 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L 149 (791)
++|.+++ +|.. .++|++|++++|+++++... .++|+.|++++|+++.++ +|.++++|++|++
T Consensus 99 ~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~----~~~L~~L~L~~n~l~~lp----------~~~~l~~L~~L~l 160 (454)
T 1jl5_A 99 SCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDL----PPLLEYLGVSNNQLEKLP----------ELQNSSFLKIIDV 160 (454)
T ss_dssp CSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSC----CTTCCEEECCSSCCSSCC----------CCTTCTTCCEEEC
T ss_pred cCCcCCc-cccc---cCCCcEEECCCCccCcccCC----CCCCCEEECcCCCCCCCc----------ccCCCCCCCEEEC
Confidence 9999996 5644 37899999999999864321 268999999999998654 3889999999999
Q ss_pred cCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcc
Q 003855 150 GSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEG 229 (791)
Q Consensus 150 ~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 229 (791)
++|++++ +|..+ .+|++|++++|++++ +| .+.++++|+.|++++|++++ +|.. .++|++|++++|.++
T Consensus 161 ~~N~l~~-lp~~~----~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~- 228 (454)
T 1jl5_A 161 DNNSLKK-LPDLP----PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE- 228 (454)
T ss_dssp CSSCCSC-CCCCC----TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-
T ss_pred CCCcCcc-cCCCc----ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC---cCcccEEECcCCcCC-
Confidence 9999996 45433 479999999999997 55 69999999999999999986 3433 258999999999998
Q ss_pred cCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCccccc
Q 003855 230 SIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQK 309 (791)
Q Consensus 230 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~ 309 (791)
.+| .+..+++|+.|++++|++++ +|.. +++|+.|++++|++++ +|.. +++|+.|++++|.+++. |..
T Consensus 229 ~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~--- 295 (454)
T 1jl5_A 229 ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL--- 295 (454)
T ss_dssp SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---
T ss_pred ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---
Confidence 667 48899999999999999985 4442 4789999999999986 4443 37888999999988762 211
Q ss_pred CCCCCEEecCCcccCCCCCcchhcc-ccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceE
Q 003855 310 LKVLTVLDLSRNQLSGDIPSTIGAL-KDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQF 388 (791)
Q Consensus 310 l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l 388 (791)
.++|+.|++++|++++ ++ .+ ++|+.|++++|++++ +|.. +++|+.|++++|+++ .+|. .+++|+.|
T Consensus 296 ~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L 362 (454)
T 1jl5_A 296 PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQL 362 (454)
T ss_dssp CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEE
T ss_pred CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEE
Confidence 1567777777777763 22 22 467777777777774 4443 466777777777776 3444 35677777
Q ss_pred EccCCCCcc
Q 003855 389 NVSHNRLEG 397 (791)
Q Consensus 389 ~l~~N~l~~ 397 (791)
++++|++++
T Consensus 363 ~L~~N~l~~ 371 (454)
T 1jl5_A 363 HVEYNPLRE 371 (454)
T ss_dssp ECCSSCCSS
T ss_pred ECCCCCCCc
Confidence 777777776
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=337.58 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=205.5
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999975 68999999987553 344577889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc---EEEeeeccccccC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA---AHVSDFGISKLLG 653 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfgla~~~~ 653 (791)
||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999988654 3899999999999999999999 678999999999999986655 9999999998765
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.... .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||..... ......+........
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~------- 227 (284)
T 3kk8_A 160 DSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYP------- 227 (284)
T ss_dssp SSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCCC-------
T ss_pred cCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--hHHHHHHHhccccCC-------
Confidence 4322 2335689999999999999999999999999999999999999965321 111111111110000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+....++..+.+++.+|++.||++|||+.|+++
T Consensus 228 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 -------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0011134566889999999999999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=380.16 Aligned_cols=260 Identities=22% Similarity=0.400 Sum_probs=207.3
Q ss_pred cccccc-ccCCCcceEEEEEEec---CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 502 EFNECN-LLGTGSFGSVYKGTIS---DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 502 ~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++.+.+ .||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++.+ +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 444444 7999999999999864 56679999997643 3356789999999999999999999999976 5689999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999999877677999999999999999999999 6789999999999999999999999999998765433
Q ss_pred Ccc-eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 657 DSV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 657 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
... ......+++.|+|||++.++.++.++|||||||++|||++ |+.||...... .....+....
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~------------ 556 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGK------------ 556 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTTC------------
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC------------
Confidence 221 1222345689999999988899999999999999999998 99999764322 1222221110
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
....+..++.++.++|.+||+.||++||++.++++.|+.+......
T Consensus 557 -----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 557 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 0111224667889999999999999999999999999998666543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=355.93 Aligned_cols=266 Identities=15% Similarity=0.171 Sum_probs=201.7
Q ss_pred hhccccccccCCCcceEEEEEEec----CCcEEEEEEeehhhhH-----------HHHHHHHHHHHHHhccCCccceeee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQLER-----------AFRSFDSECEVLRNVRHRNLIKILS 564 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~ 564 (791)
.++|++.+.||+|+||.||+|+.. ++..||||+....... ..+.+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 368999999999999999999975 5788999998654211 1234667888999999999999999
Q ss_pred eecc----CCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC-
Q 003855 565 SCSN----PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM- 639 (791)
Q Consensus 565 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~- 639 (791)
++.. ....++||||+ +++|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH----ENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCcCHHHEEEccCCC
Confidence 9877 77889999999 999999998655 5899999999999999999999 67899999999999999887
Q ss_pred -cEEEeeeccccccCCCCCc-----ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcch
Q 003855 640 -AAHVSDFGISKLLGEGEDS-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS 713 (791)
Q Consensus 640 -~~kl~Dfgla~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 713 (791)
.+||+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999876432211 1113446899999999999889999999999999999999999999653322222
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
.......... . +...+. .......++.++.+++.+||+.||++||++.++++.|+++.
T Consensus 270 ~~~~~~~~~~-~----~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAKTNLLD-E----LPQSVL----KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHH-T----TTHHHH----HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHhhcc-c----ccHHHH----hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 2111111000 0 000000 00001145678899999999999999999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=352.18 Aligned_cols=249 Identities=22% Similarity=0.241 Sum_probs=203.0
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeee
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 573 (791)
..++|++.+.||+|+||.||+|+.+ +++.||||++.... ....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999976 57899999997653 23456788899999988 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+||||+++|+|.+++...+. +++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|+...
T Consensus 98 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999986543 899999999999999999999 6789999999999999999999999999998643
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.....
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~~~---------- 238 (353)
T 2i0e_A 173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEHNV---------- 238 (353)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC----------
T ss_pred cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHHHHHhCCC----------
Confidence 222 123345799999999999999999999999999999999999999975321 111111111000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRIN-----VTDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~ev~~ 774 (791)
..+..++.++.+++.+||+.||++||+ +.|+++
T Consensus 239 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 001134566789999999999999995 466654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.34 Aligned_cols=262 Identities=23% Similarity=0.396 Sum_probs=210.9
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|++.+.||+|+||.||+|+..+++.||||++..... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 468999999999999999999998888999999875432 34678899999999999999999999864 4588999999
Q ss_pred CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence 9999999997542 24899999999999999999999 67899999999999999999999999999987654321
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
.......++..|+|||.+.++.++.++||||||+++|||++ |+.||...... .....+......
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~~------------- 229 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRM------------- 229 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCCC-------------
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcccCC-------------
Confidence 12223356788999999988889999999999999999999 89998753221 111111111000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcccc
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDDA 787 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~ 787 (791)
..+..++..+.+++.+|++.||++|||+.++++.|+++........
T Consensus 230 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 230 ----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred ----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 0112345678899999999999999999999999999987665444
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=354.93 Aligned_cols=257 Identities=17% Similarity=0.135 Sum_probs=209.0
Q ss_pred HHhhccccccccCCCcceEEEEEE------ecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc---CCccceeeeeecc
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGT------ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR---HRNLIKILSSCSN 568 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 568 (791)
...++|.+.+.||+|+||.||+|. ..+++.||||++..... ..+..|+.++++++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 34788999999875533 45667778887776 9999999999999
Q ss_pred CCeeeEEEecCCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-------
Q 003855 569 PDFKALVLEFMPNGSLEKWLYS----HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE------- 637 (791)
Q Consensus 569 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~------- 637 (791)
.+..++||||+++|+|.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECGGGTCC--
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEecccccCccc
Confidence 9999999999999999999974 3456999999999999999999999 778999999999999998
Q ss_pred ----CCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcch
Q 003855 638 ----NMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS 713 (791)
Q Consensus 638 ----~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 713 (791)
++.+||+|||+|+.+............+||++|+|||++.+..++.++|||||||++|||+||+.||.....+...
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 294 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence 8999999999998665433344455567999999999999999999999999999999999999998654332110
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCC-CCHHHHHHHHHHHHHHhcc
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMR-INVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-Pt~~ev~~~L~~~~~~~~~ 785 (791)
+...+... .....+.+++..|++.+|.+| |++.++.+.|+++..+...
T Consensus 295 ----------------~~~~~~~~--------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 295 ----------------PEGLFRRL--------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp ----------------ECSCCTTC--------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred ----------------echhcccc--------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 00000000 012446689999999999998 6888999999888766543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=349.49 Aligned_cols=246 Identities=27% Similarity=0.340 Sum_probs=201.5
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehh---hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQ---LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
+.|+..+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5689999999999999999996 57899999998643 2344567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+. |++.+++......+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9996 6899988766666999999999999999999999 678999999999999999999999999999875432
Q ss_pred CcceeecccccccccCCCcc---CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 657 DSVTQTMTMATIGYMAPEYG---SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
....||+.|+|||++ ..+.++.++|||||||++|||++|+.||....... ..........+.
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~--------- 272 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA--------- 272 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC---------
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCC---------
Confidence 234689999999987 35779999999999999999999999986532111 111111110000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
. ....++..+.+++.+||+.||++|||+.|+++.
T Consensus 273 ~--------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 L--------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp C--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C--------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 011234667899999999999999999999753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.53 Aligned_cols=264 Identities=24% Similarity=0.372 Sum_probs=211.2
Q ss_pred hhcccccc-ccCCCcceEEEEEEec---CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 500 TDEFNECN-LLGTGSFGSVYKGTIS---DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 500 ~~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
.++|++.+ .||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 36788887 9999999999999642 46889999987543 23457789999999999999999999999 556789
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH----hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999998754 3899999999999999999999 6789999999999999999999999999998775
Q ss_pred CCCCcc-eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 654 EGEDSV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 654 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+......
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~------- 239 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERM------- 239 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCC-------
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCC-------
Confidence 543322 1222346788999999988889999999999999999999 9999976322 1122222111100
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhccccc
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDDAS 788 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~~ 788 (791)
..+..++..+.+++.+||+.||++||++.|+++.|+++-.+...+..
T Consensus 240 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~ 286 (291)
T 1xbb_A 240 ----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286 (291)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhccc
Confidence 01123556788999999999999999999999999999877665543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=352.01 Aligned_cols=260 Identities=23% Similarity=0.299 Sum_probs=203.4
Q ss_pred HHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-----hHHHHHHHHHHHHHHhccCCccceeeeeecc
Q 003855 495 DIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-----ERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568 (791)
Q Consensus 495 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 568 (791)
++....++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45667789999999999999999999974 78899999987542 3445788999999999999999999999999
Q ss_pred CCeeeEEEecCCCCCHHHHHhhC---------------------------------------CCCCCHHHHHHHHHHHHH
Q 003855 569 PDFKALVLEFMPNGSLEKWLYSH---------------------------------------NYFLDILERLNIMIDVGS 609 (791)
Q Consensus 569 ~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~ 609 (791)
.+..++||||+++|+|.+++... ...+++..+..++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 112356778899999999
Q ss_pred HHHHHHccCCCCCeEecCCCCCCeEeCCCC--cEEEeeeccccccCCCCC--cceeecccccccccCCCccCC--CCCCc
Q 003855 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENM--AAHVSDFGISKLLGEGED--SVTQTMTMATIGYMAPEYGSE--GIVSA 683 (791)
Q Consensus 610 ~l~~LH~~~~~~~i~H~dlk~~Nill~~~~--~~kl~Dfgla~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~--~~~~~ 683 (791)
||+||| +.+|+||||||+||+++.++ .+||+|||+++.+..... ........||+.|+|||.+.+ ..++.
T Consensus 180 ~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 180 ALHYLH----NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHH----HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHH----HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 999999 67899999999999998776 899999999987643221 222344579999999998865 67899
Q ss_pred cccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCC
Q 003855 684 KCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESP 763 (791)
Q Consensus 684 ~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P 763 (791)
++|||||||++|||++|+.||......+ ...+......... .+....++..+.+++.+||+.||
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKKLCFE---------------NPNYNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCTT---------------SGGGGGSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcccccC---------------CcccccCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999997632211 1111111110000 01112345678899999999999
Q ss_pred CCCCCHHHHHH
Q 003855 764 DMRINVTDAAA 774 (791)
Q Consensus 764 ~~RPt~~ev~~ 774 (791)
++||++.|+++
T Consensus 320 ~~Rps~~~~l~ 330 (345)
T 3hko_A 320 DERFDAMRALQ 330 (345)
T ss_dssp TTSCCHHHHHH
T ss_pred hHCCCHHHHhc
Confidence 99999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=348.99 Aligned_cols=248 Identities=22% Similarity=0.295 Sum_probs=193.5
Q ss_pred hhccccccccCCCcceEEEEEEe----cCCcEEEEEEeehhh----hHHHHHHHHHHHHHHhccCCccceeeeeeccCCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI----SDGTDVAIKIFNLQL----ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 571 (791)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999986 478999999987542 2334567889999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH----QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH----hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999998654 3889999999999999999999 67899999999999999999999999999976
Q ss_pred cCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 171 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~--------- 238 (327)
T 3a62_A 171 SIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-KTIDKILKCKL--------- 238 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCC---------
T ss_pred cccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCC---------
Confidence 432221 223356899999999998889999999999999999999999999753211 11111111000
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
..+..++..+.+++.+||+.||++|| ++.|+++
T Consensus 239 ----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 00112346678999999999999999 6777765
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=343.49 Aligned_cols=252 Identities=22% Similarity=0.290 Sum_probs=206.3
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh------HHHHHHHHHHHHHHhccCCccceeeeeeccCCe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE------RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF 571 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 571 (791)
..++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3578999999999999999999975 689999999875432 135678999999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC----cEEEeeec
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM----AAHVSDFG 647 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 647 (791)
.++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999998654 4899999999999999999999 67899999999999999888 79999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+......
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~--- 236 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANITSVSYD--- 236 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHTTCCC---
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhcccc---
Confidence 9987654322 23346899999999999899999999999999999999999999753211 111111110000
Q ss_pred hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+. .....++..+.+++.+||+.||++|||+.|+++
T Consensus 237 --~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 237 --FDE---------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCH---------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --cCh---------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 011234567889999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=340.69 Aligned_cols=249 Identities=23% Similarity=0.390 Sum_probs=186.1
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhh---HHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLE---RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|++.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999997 4789999999975432 2346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++++|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH----SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999999987667999999999999999999999 678999999999999999999999999999876432
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ........ .
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~--------~- 229 (278)
T 3cok_A 166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNKVVLAD--------Y- 229 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCSSC--------C-
T ss_pred CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHHHhhcc--------c-
Confidence 21 12234689999999999988999999999999999999999999975322111 00000000 0
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..++.++.+++.+||+.||++||++.|+++
T Consensus 230 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 ------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 001124466789999999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=361.94 Aligned_cols=247 Identities=27% Similarity=0.411 Sum_probs=205.2
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999975 79999999997653 23356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999998654 4899999999999999999999 789999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCCCccCCCCC-CccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
.. ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||++... ......+.....
T Consensus 170 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~----------- 233 (476)
T 2y94_A 170 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--PTLFKKICDGIF----------- 233 (476)
T ss_dssp CC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--HHHHHHHHTTCC-----------
T ss_pred cc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--HHHHHHHhcCCc-----------
Confidence 22 233569999999999887765 7899999999999999999999975321 111111111000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..++..+.+++.+||+.||++|||+.|+++
T Consensus 234 -------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 -------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 001123456789999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.43 Aligned_cols=261 Identities=23% Similarity=0.369 Sum_probs=207.1
Q ss_pred hhccccccccCCCcceEEEEEEe------cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI------SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
.++|++.+.||+|+||.||+|++ .+++.||||++.... ......+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999984 257789999986442 34456788999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC---CCcEEE
Q 003855 573 ALVLEFMPNGSLEKWLYSHN------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE---NMAAHV 643 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~---~~~~kl 643 (791)
++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++. +..+||
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999998653 34889999999999999999999 678999999999999994 456999
Q ss_pred eeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhc
Q 003855 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESL 722 (791)
Q Consensus 644 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 722 (791)
+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~ 262 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGG 262 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHTTC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHHhcCC
Confidence 99999986544333333344568899999999988889999999999999999998 9999875321 11222221111
Q ss_pred CCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 723 PHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 723 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
.. ..+..++..+.+++.+||+.||++||++.|+++.|..+....
T Consensus 263 ~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 263 RM-----------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CC-----------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 00 011234567889999999999999999999999999886543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.69 Aligned_cols=248 Identities=22% Similarity=0.300 Sum_probs=180.3
Q ss_pred ccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CCccceeeeeeccCCeeeEEEecCCCCC
Q 003855 506 CNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKALVLEFMPNGS 583 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~ 583 (791)
.+.||+|+||.||+|+.. +++.||||++.... ...+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999975 78999999987543 356678999999997 9999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC---cEEEeeeccccccCCCCCcce
Q 003855 584 LEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM---AAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 584 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfgla~~~~~~~~~~~ 660 (791)
|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+++....... .
T Consensus 93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~ 165 (325)
T 3kn6_A 93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH----DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P 165 (325)
T ss_dssp HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence 999998764 4899999999999999999999 67899999999999998765 899999999987644322 2
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCc--chHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE--MSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ............... . .
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-~-----~---- 235 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-S-----F---- 235 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-C-----C----
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-C-----C----
Confidence 234568999999999999999999999999999999999999997643211 111111111111100 0 0
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.......++.++.+++.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 -EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00112245677889999999999999999998863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.76 Aligned_cols=270 Identities=20% Similarity=0.223 Sum_probs=206.8
Q ss_pred ChhHHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-----CCccceeeee
Q 003855 492 PYLDIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-----HRNLIKILSS 565 (791)
Q Consensus 492 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~ 565 (791)
.+.+.....++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+..|+.+++.+. ||||++++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 34444555689999999999999999999974 7899999998743 233456778999999986 9999999999
Q ss_pred eccCCeeeEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-------
Q 003855 566 CSNPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE------- 637 (791)
Q Consensus 566 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~------- 637 (791)
+...+..++||||+ +++|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR----KMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCTTCCEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCcccEEEccccccccc
Confidence 99999999999999 999999998654 35899999999999999999999 678999999999999975
Q ss_pred ------------------CCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh
Q 003855 638 ------------------NMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699 (791)
Q Consensus 638 ------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt 699 (791)
++.+||+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 8899999999998754322 23468999999999999999999999999999999999
Q ss_pred CCCCCCccccCcchHHHHHHHhcCCChhhh------------cchhh-h----hhH---H--------hhHHHHHHHHHH
Q 003855 700 RKRPTDEMFTGEMSLRRWVKESLPHGLTEV------------VDANL-V----REE---Q--------AFSAKMDCILSI 751 (791)
Q Consensus 700 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------~d~~~-~----~~~---~--------~~~~~~~~~~~l 751 (791)
|+.||...... .....+........... ++... . ... . ...........+
T Consensus 255 g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 255 GSLLFRTHEHM--EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp SSCSCCCSSHH--HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred CCCCCCCCcHH--HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 99999753221 11111111111110000 00000 0 000 0 000011122567
Q ss_pred HHHHhhccccCCCCCCCHHHHHH
Q 003855 752 MDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 752 ~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+++.+||+.||++|||+.|+++
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhcCChhhCCCHHHHhc
Confidence 89999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=354.47 Aligned_cols=267 Identities=11% Similarity=0.110 Sum_probs=209.0
Q ss_pred hhccccccccCCCcceEEEEEEecC---------CcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccce---------
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISD---------GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIK--------- 561 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 561 (791)
.++|++.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999753 789999998754 35778999999999999998
Q ss_pred ------eeeeecc-CCeeeEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCe
Q 003855 562 ------ILSSCSN-PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNI 633 (791)
Q Consensus 562 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Ni 633 (791)
+++++.. ....++||||+ +|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH----ENEYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHE
Confidence 4556554 67889999999 99999999865 345999999999999999999999 67899999999999
Q ss_pred EeCCCC--cEEEeeeccccccCCCCCc-----ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCc
Q 003855 634 LLDENM--AAHVSDFGISKLLGEGEDS-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDE 706 (791)
Q Consensus 634 ll~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~ 706 (791)
+++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876543211 112334789999999999998999999999999999999999999987
Q ss_pred cccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 707 MFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
.................. .....+.. .....++..+.+++.+||+.||++||++.++++.|+++......
T Consensus 271 ~~~~~~~~~~~~~~~~~~-~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDK-PGPFVGPC--------GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp GTTCHHHHHHHHHHHHHS-CCCEECTT--------SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCcCHHHHHHHHHhccCC-hhhhhhhc--------cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 543332222222111000 00000000 00012356788999999999999999999999999999877543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=344.32 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=198.2
Q ss_pred hccccc-cccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNEC-NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 577 (791)
+.|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567774 78999999999999964 7899999999766555567888999999985 79999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc---EEEeeeccccccCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA---AHVSDFGISKLLGE 654 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfgla~~~~~ 654 (791)
|+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH----NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999998654 4899999999999999999999 678999999999999998776 99999999986543
Q ss_pred CCC-----cceeecccccccccCCCccCC-----CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC
Q 003855 655 GED-----SVTQTMTMATIGYMAPEYGSE-----GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH 724 (791)
Q Consensus 655 ~~~-----~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (791)
... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||............ .....
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~ 243 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---GEACP 243 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc---cccch
Confidence 221 111223468999999998764 56889999999999999999999999764332210000 00000
Q ss_pred ChhhhcchhhhhhHHhh--HHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 725 GLTEVVDANLVREEQAF--SAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 725 ~~~~~~d~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....+...+....... .....++..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00000000000000000 011235677889999999999999999999987
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=358.94 Aligned_cols=349 Identities=22% Similarity=0.227 Sum_probs=282.0
Q ss_pred CCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEecc
Q 003855 15 LQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLG 94 (791)
Q Consensus 15 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 94 (791)
-+.++.++++++ .+|..+. +++++|+|++|+|+ .++...+..+++|++|+|++|.|+++.|..|.++++|++|+|+
T Consensus 13 ~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 88 (477)
T 2id5_A 13 DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR 88 (477)
T ss_dssp TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccc-eECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECC
Confidence 467889999987 4566553 58999999999998 5544444448999999999999998889999999999999999
Q ss_pred CccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhc
Q 003855 95 FNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYA 174 (791)
Q Consensus 95 ~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l 174 (791)
+|+++.+.+..|.++++|+.|++++|++..+... .|..+++|++|+|++|.+++.
T Consensus 89 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~--------~~~~l~~L~~L~l~~n~l~~~----------------- 143 (477)
T 2id5_A 89 SNRLKLIPLGVFTGLSNLTKLDISENKIVILLDY--------MFQDLYNLKSLEVGDNDLVYI----------------- 143 (477)
T ss_dssp SSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTT--------TTTTCTTCCEEEECCTTCCEE-----------------
T ss_pred CCcCCccCcccccCCCCCCEEECCCCccccCChh--------HccccccCCEEECCCCcccee-----------------
Confidence 9999988888899999999999999999876543 388899999999999988754
Q ss_pred ccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCC
Q 003855 175 YECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGH 254 (791)
Q Consensus 175 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~ 254 (791)
.+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.
T Consensus 144 --------~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~ 215 (477)
T 2id5_A 144 --------SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215 (477)
T ss_dssp --------CTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCE
T ss_pred --------ChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccc
Confidence 344567778888888888888877666788888888888888888877777888888888888888877666
Q ss_pred CCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhcc
Q 003855 255 IPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGAL 334 (791)
Q Consensus 255 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 334 (791)
+|..+....+|++|+|++|++++..+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..+
T Consensus 216 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 295 (477)
T 2id5_A 216 MTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGL 295 (477)
T ss_dssp ECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTC
T ss_pred cCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCc
Confidence 66666666788888888888886655678888888888888888888777788888899999999999988888888899
Q ss_pred ccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCC
Q 003855 335 KDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPV 401 (791)
Q Consensus 335 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 401 (791)
++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..+. ..-...+..+++.++...|..|.
T Consensus 296 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~-~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 296 NYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL-LWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp TTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG-HHHHTTTTSSCCTTCCCBEEESG
T ss_pred ccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch-HhHHhhhhccccCccCceeCCch
Confidence 9999999999999977777788899999999999999854332 22223344566677777766554
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=349.31 Aligned_cols=266 Identities=20% Similarity=0.270 Sum_probs=199.1
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhH-HHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLER-AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999975 7899999998654322 122455799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++ |+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH----RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 154 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--
Confidence 97 5999999987777999999999999999999999 6789999999999999999999999999998654322
Q ss_pred ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc---CCChhhhcchhh
Q 003855 659 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL---PHGLTEVVDANL 734 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~~~ 734 (791)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ........... ...+........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHhchhhhcchh
Confidence 22333468999999998766 66899999999999999999999999763222 11222111111 111111111100
Q ss_pred hhh--------HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VRE--------EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~--------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
... .........++..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000 0001112235567889999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=347.13 Aligned_cols=262 Identities=22% Similarity=0.368 Sum_probs=198.7
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCe----
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF---- 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 571 (791)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999996 578999999997643 3445678899999999999999999999865443
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 489999999999999998654 3899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCc-ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 652 LGEGEDS-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 652 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. ....... ...
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~---~~~---- 237 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVRE---DPI---- 237 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHC---CCC----
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcC---CCC----
Confidence 6543322 222334689999999999988999999999999999999999999976322111 1111110 000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHH-HHHHHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA-AAKLKKIKVK 782 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev-~~~L~~~~~~ 782 (791)
. .......++..+.+++.+||+.||++||++.++ ...+.+....
T Consensus 238 ~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 238 P--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp C--------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred C--------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 0 001112356778899999999999999966655 4556555433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=350.45 Aligned_cols=243 Identities=25% Similarity=0.339 Sum_probs=202.6
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh--------HHHHHHHHHHHHHHhccCCccceeeeeeccC
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE--------RAFRSFDSECEVLRNVRHRNLIKILSSCSNP 569 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 569 (791)
..++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999864 789999999875431 1234567799999999999999999999999
Q ss_pred CeeeEEEecCCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecc
Q 003855 570 DFKALVLEFMPNG-SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGI 648 (791)
Q Consensus 570 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl 648 (791)
+..++||||+.+| +|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLR----LKDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 99999986644 899999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCCCccCCCCC-CccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh
Q 003855 649 SKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727 (791)
Q Consensus 649 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......
T Consensus 177 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------- 237 (335)
T 3dls_A 177 AAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------- 237 (335)
T ss_dssp CEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------------
T ss_pred ceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------------
Confidence 987754432 223468999999999887776 889999999999999999999997522110
Q ss_pred hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 728 ~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
.... ..+..++.++.+++.+||+.||++|||+.|+++.
T Consensus 238 ---~~~~-------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ---EAAI-------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TTCC-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---hhcc-------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0011234668899999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=365.63 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=207.2
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 79999999997643 23456688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 576 LEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
|||+++|+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH----~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH----RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999998653 34899999999999999999999 67899999999999999999999999999987754
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcc--hHHHHHHHhcCCChhhhcch
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM--SLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~ 732 (791)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+.+.+... +...
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~~~------ 408 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEY------ 408 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CCCC------
T ss_pred Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-cccC------
Confidence 332 2335799999999999998999999999999999999999999976432211 111111111 0000
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
+..++.++.+++.+||+.||++|| ++.|+++
T Consensus 409 -----------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 409 -----------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -----------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -----------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 113456678999999999999999 7888875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=359.63 Aligned_cols=195 Identities=27% Similarity=0.388 Sum_probs=155.3
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeec-----cCCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCS-----NPDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----~~~~ 571 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++. ....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999865 78999999986532 344567889999999999999999999984 3357
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++||||+ +|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH----SAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH----hCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 579999997654 4899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCc-------------------------ceeecccccccccCCCcc-CCCCCCccccHHhHHHHHHHHHhC
Q 003855 652 LGEGEDS-------------------------VTQTMTMATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTR 700 (791)
Q Consensus 652 ~~~~~~~-------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg 700 (791)
....... ......+||++|+|||++ ....++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 6432211 123345789999999975 567799999999999999999993
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=358.08 Aligned_cols=276 Identities=22% Similarity=0.288 Sum_probs=212.5
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCC--eeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD--FKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 575 (791)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 367999999999999999999976 58999999997543 334567789999999999999999999987654 77999
Q ss_pred EecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe----CCCCcEEEeeeccc
Q 003855 576 LEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL----DENMAAHVSDFGIS 649 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfgla 649 (791)
|||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+|
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999998543 23899999999999999999999 6789999999999999 78888999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCC--------CCCCccccHHhHHHHHHHHHhCCCCCCccccCcch---HHHHH
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSE--------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS---LRRWV 718 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~---~~~~~ 718 (791)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... +.+..
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 8765432 2233568999999998754 56788999999999999999999999754332222 22222
Q ss_pred HHhcCCChhhhcc---hhhhh---hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 719 KESLPHGLTEVVD---ANLVR---EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 719 ~~~~~~~~~~~~d---~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
....+.....+.. ..+.. ..........++..+.+++.+||+.||++||++.|+++.+..+..+
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 2221111110000 00000 0000011235677889999999999999999999999999887654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=333.95 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=208.5
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh------HHHHHHHHHHHHHHhccCCccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE------RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
.++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999976 789999999865421 1356789999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC----cEEEeeecc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM----AAHVSDFGI 648 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfgl 648 (791)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH----SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999997643 4899999999999999999999 67899999999999999877 899999999
Q ss_pred ccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 649 SKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 649 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
++....... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+...... .
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-~-- 230 (283)
T 3bhy_A 159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLTNISAVNYD-F-- 230 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTTCCC-C--
T ss_pred ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHHHhHhcccC-C--
Confidence 987644322 22346899999999999899999999999999999999999999753211 111111100000 0
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HHHHHHHHhc
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA--KLKKIKVKFL 784 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~--~L~~~~~~~~ 784 (791)
. ......++..+.+++.+||+.||++||++.|+++ .++.++.+..
T Consensus 231 --~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 231 --D---------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp --C---------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred --c---------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence 0 0111234567889999999999999999999997 5666655543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=377.24 Aligned_cols=258 Identities=28% Similarity=0.449 Sum_probs=210.6
Q ss_pred HhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
..++|++.+.||+|+||.||+|+++++..||||++..... ..+.+.+|+++|++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 3467899999999999999999998888899999975432 34678999999999999999999999976 678999999
Q ss_pred CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.+++... ...+++.++..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 417 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence 9999999999853 345899999999999999999999 6789999999999999999999999999998764321
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
........++..|+|||++..+.++.++|||||||++|||+| |+.||.+....+ ....+....
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~~-------------- 481 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGY-------------- 481 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTTC--------------
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC--------------
Confidence 111223346788999999988899999999999999999999 899997642211 111111100
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+.+..++..+.++|.+||+.||++|||+.++++.|+.+...
T Consensus 482 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 482 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 0111224567788999999999999999999999999887543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=342.02 Aligned_cols=266 Identities=21% Similarity=0.241 Sum_probs=199.9
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999975 68999999885443 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 82 e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH----KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999999887554 4899999999999999999999 6789999999999999999999999999998765332
Q ss_pred CcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh---hhcch
Q 003855 657 DSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT---EVVDA 732 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~d~ 732 (791)
. ......||..|+|||.+.+ ..++.++||||+|+++|||++|+.||.+....+ ....+......... .....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHT
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhccccccccccccc
Confidence 2 2233468999999998765 678999999999999999999999997643221 11111111111000 00000
Q ss_pred h----------hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 733 N----------LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 733 ~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. .............++..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000000011235667889999999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.23 Aligned_cols=267 Identities=24% Similarity=0.295 Sum_probs=199.1
Q ss_pred HhhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh-----hHHHHHHHHHHHHHHhc---cCCccceeeeeeccC
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL-----ERAFRSFDSECEVLRNV---RHRNLIKILSSCSNP 569 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~ 569 (791)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 478999999986432 11123556677777666 499999999999765
Q ss_pred C-----eeeEEEecCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003855 570 D-----FKALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV 643 (791)
Q Consensus 570 ~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl 643 (791)
. ..++||||+. |+|.+++..... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEE
Confidence 4 5789999996 699999986543 4899999999999999999999 678999999999999999999999
Q ss_pred eeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC
Q 003855 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP 723 (791)
Q Consensus 644 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (791)
+|||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+.........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~ 237 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGL 237 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHHHHHCC
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence 9999998764332 223456899999999998889999999999999999999999999763222 112222221110
Q ss_pred ---CChhhhc---chhhhhh--HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 724 ---HGLTEVV---DANLVRE--EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 724 ---~~~~~~~---d~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+.... ...+... ........+++..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000 0000000 0000111235577889999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=346.46 Aligned_cols=258 Identities=21% Similarity=0.255 Sum_probs=192.1
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CCccceeeeee--------ccC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSC--------SNP 569 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~--------~~~ 569 (791)
..+|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.+++++. ||||+++++++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 358999999999999999999965 78999999987666666778899999999996 99999999998 344
Q ss_pred CeeeEEEecCCCCCHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCC--eEecCCCCCCeEeCCCCcEEEee
Q 003855 570 DFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIMIDVGSALEYLHHGHSSAP--IIHCDLKPTNILLDENMAAHVSD 645 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--i~H~dlk~~Nill~~~~~~kl~D 645 (791)
...++||||+. |+|.+++.. ....+++..+..++.||+.||+||| +.+ |+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH----RQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCEEEccCCcccEEECCCCCEEEec
Confidence 55789999995 799999874 3445999999999999999999999 567 99999999999999999999999
Q ss_pred eccccccCCCCCcc----------eeecccccccccCCCcc---CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcc
Q 003855 646 FGISKLLGEGEDSV----------TQTMTMATIGYMAPEYG---SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM 712 (791)
Q Consensus 646 fgla~~~~~~~~~~----------~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~ 712 (791)
||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-- 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence 99998765433211 11134589999999987 5677899999999999999999999999653211
Q ss_pred hHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhc
Q 003855 713 SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784 (791)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~ 784 (791)
.......... ....++..+.+++.+||+.||++||++.|+++.|..+.....
T Consensus 260 ---~~~~~~~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 260 ---RIVNGKYSIP-----------------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ---------CCCC-----------------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ---HhhcCcccCC-----------------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 1111111000 011122346789999999999999999999999999976543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=365.09 Aligned_cols=249 Identities=24% Similarity=0.261 Sum_probs=196.1
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3478999999999999999999965 78999999997653 3344567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS-APIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
||||+++|+|.+++.... .+++..+..++.||+.||+||| + .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 226 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH----SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh----hcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999998654 4899999999999999999999 5 689999999999999999999999999998643
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
... ......+||++|+|||++.+..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~---------- 366 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILMEEI---------- 366 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC----------
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHHhCCC----------
Confidence 322 223345799999999999999999999999999999999999999965321 111111111000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
..+..++.++.+++.+||+.||++|| ++.|+++
T Consensus 367 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 --------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 00112446678999999999999999 9999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=341.25 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=205.5
Q ss_pred HHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeecc--------
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN-------- 568 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 568 (791)
....+|++.+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34578999999999999999999986 79999999987553 245679999999999999999998754
Q ss_pred --------CCeeeEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC
Q 003855 569 --------PDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM 639 (791)
Q Consensus 569 --------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~ 639 (791)
....++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH----SKKLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHEEEcCCC
Confidence 44578999999999999999854 345899999999999999999999 67899999999999999999
Q ss_pred cEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHH
Q 003855 640 AAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVK 719 (791)
Q Consensus 640 ~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 719 (791)
.+||+|||+++....... .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... ..+..
T Consensus 160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~ 229 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFT 229 (284)
T ss_dssp EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHH
T ss_pred CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHH
Confidence 999999999987654322 22346899999999998888999999999999999999999886431 11111
Q ss_pred HhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcccc
Q 003855 720 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDDA 787 (791)
Q Consensus 720 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~~ 787 (791)
....... ...++..+.+++.+||+.||++||++.|+++.|..+......+.
T Consensus 230 ~~~~~~~-----------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 230 DLRDGII-----------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp HHHTTCC-----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred Hhhcccc-----------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 1000000 01234567799999999999999999999999999876655443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=336.43 Aligned_cols=250 Identities=27% Similarity=0.334 Sum_probs=198.1
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 468999999999999999999975 78999999987654 2345778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe---CCCCcEEEeeeccccc
Q 003855 578 FMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKL 651 (791)
Q Consensus 578 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfgla~~ 651 (791)
|+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++.
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH----SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999998632 355899999999999999999999 6789999999999999 4568899999999987
Q ss_pred cCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
..... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||...... ...............
T Consensus 177 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~---- 246 (285)
T 3is5_A 177 FKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKATYKEPNYAV---- 246 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCCCC----
T ss_pred cCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhhccCCccccc----
Confidence 64432 223356899999999875 56899999999999999999999999763211 111111111100000
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
....+++.+.+++.+||+.||++|||+.|+++
T Consensus 247 -----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 -----------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -----------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00013456779999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=353.70 Aligned_cols=250 Identities=26% Similarity=0.295 Sum_probs=193.8
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHH-HHhccCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEV-LRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|+.+ +++.||||++.... ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999976 68899999997653 2334455666666 567899999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999998654 3789999999999999999999 67899999999999999999999999999986432
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+........
T Consensus 192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~~~------------ 256 (373)
T 2r5t_A 192 HN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILNKPL------------ 256 (373)
T ss_dssp CC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-HHHHHHHHSCC------------
T ss_pred CC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccc------------
Confidence 22 1233457999999999999999999999999999999999999999753211 11111111000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
..+..++..+.+++.+||+.||++||++.+..+.+
T Consensus 257 -------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 257 -------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp -------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 00112345678999999999999999986444333
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=354.49 Aligned_cols=347 Identities=18% Similarity=0.165 Sum_probs=250.8
Q ss_pred CccCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCcc
Q 003855 2 AGQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHS 81 (791)
Q Consensus 2 ~g~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~ 81 (791)
.+.-+..++++++|++|++++|++++. | .|..+++|++|+|++|+++ .+| +.. +++|++|+|++|.|+++ +
T Consensus 31 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~-~~~--~~~-l~~L~~L~Ls~N~l~~~-~-- 101 (457)
T 3bz5_A 31 QATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNIT-TLD--LSQ-NTNLTYLACDSNKLTNL-D-- 101 (457)
T ss_dssp CTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCS-CCC--CTT-CTTCSEEECCSSCCSCC-C--
T ss_pred CcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCC-eEc--ccc-CCCCCEEECcCCCCcee-e--
Confidence 355667889999999999999999976 5 7999999999999999998 666 444 89999999999999975 3
Q ss_pred CcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChh
Q 003855 82 ITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPV 161 (791)
Q Consensus 82 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 161 (791)
|+++++|++|+|++|+++++. ++.+++|+.|++++|+++.++ +..+++|++|++++|+..+.++
T Consensus 102 ~~~l~~L~~L~L~~N~l~~l~---~~~l~~L~~L~l~~N~l~~l~-----------l~~l~~L~~L~l~~n~~~~~~~-- 165 (457)
T 3bz5_A 102 VTPLTKLTYLNCDTNKLTKLD---VSQNPLLTYLNCARNTLTEID-----------VSHNTQLTELDCHLNKKITKLD-- 165 (457)
T ss_dssp CTTCTTCCEEECCSSCCSCCC---CTTCTTCCEEECTTSCCSCCC-----------CTTCTTCCEEECTTCSCCCCCC--
T ss_pred cCCCCcCCEEECCCCcCCeec---CCCCCcCCEEECCCCccceec-----------cccCCcCCEEECCCCCcccccc--
Confidence 899999999999999999752 899999999999999998753 7789999999999996544432
Q ss_pred hhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCC
Q 003855 162 IGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLM 241 (791)
Q Consensus 162 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 241 (791)
+.. .++|++|++++|++++. | +..+++|+.|++++|++++. .+..+++|++|+|++|++++ +| +..+++|
T Consensus 166 ~~~-l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L 235 (457)
T 3bz5_A 166 VTP-QTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQL 235 (457)
T ss_dssp CTT-CTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTC
T ss_pred ccc-CCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCC
Confidence 333 35688888888888863 3 77888888888888888865 37788888888888888886 45 7788888
Q ss_pred ceEEecCCccCCCCCccccCCC-------CCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCc--------c
Q 003855 242 FGIRLTGNKLSGHIPPCLVSLT-------SLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPS--------N 306 (791)
Q Consensus 242 ~~L~L~~N~i~~~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~--------~ 306 (791)
+.|++++|++++..+..+.+++ +|+.|++++|++.+.+| +..+++|+.|++++|...+.+|. .
T Consensus 236 ~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~ 313 (457)
T 3bz5_A 236 TYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELD 313 (457)
T ss_dssp SEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCC
T ss_pred CEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEec
Confidence 8888888888866544433333 33444444444443333 34566777777777765444432 1
Q ss_pred cccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCc
Q 003855 307 VQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLK 386 (791)
Q Consensus 307 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 386 (791)
+..+++|+.|++++|++++. + ++.+++|+.|++++|+|++ ++.|..|++++|.++|. ..+..|+
T Consensus 314 l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~ 377 (457)
T 3bz5_A 314 LSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMP 377 (457)
T ss_dssp CTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECC
T ss_pred hhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecC
Confidence 33445555555555555542 2 5555555555555555553 13344445555555543 2445677
Q ss_pred eEEccCCCCcccCCC
Q 003855 387 QFNVSHNRLEGEIPV 401 (791)
Q Consensus 387 ~l~l~~N~l~~~~~~ 401 (791)
.+++++|+++|.+|.
T Consensus 378 ~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 378 KETLTNNSLTIAVSP 392 (457)
T ss_dssp CBCCBTTBEEEECCT
T ss_pred ccccccCcEEEEcCh
Confidence 777888888877764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.50 Aligned_cols=261 Identities=21% Similarity=0.258 Sum_probs=201.4
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999975 78999999987543 23357788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH----AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999998654 4899999999999999999999 678999999999999999999999999999876443
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+....+. .
T Consensus 188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~-~--------- 254 (309)
T 2h34_A 188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR-P--------- 254 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC-G---------
T ss_pred cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC-c---------
Confidence 21 1223356899999999999999999999999999999999999999753211 111111111100 0
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHHHHh
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRI-NVTDAAAKLKKIKVKF 783 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~ev~~~L~~~~~~~ 783 (791)
......++..+.+++.+||+.||++|| ++.++++.|+++....
T Consensus 255 -----~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 -----STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -----GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -----cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 001123456788999999999999999 9999999998875443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=350.27 Aligned_cols=250 Identities=21% Similarity=0.281 Sum_probs=191.9
Q ss_pred hhccccc-cccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHh-ccCCccceeeeeecc----CCee
Q 003855 500 TDEFNEC-NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRN-VRHRNLIKILSSCSN----PDFK 572 (791)
Q Consensus 500 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~ 572 (791)
.++|.+. +.||+|+||.||+|... +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567666 68999999999999975 7899999998643 345667887754 489999999998864 5678
Q ss_pred eEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC---CCcEEEeeecc
Q 003855 573 ALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE---NMAAHVSDFGI 648 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgl 648 (791)
++||||+++|+|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999998653 35899999999999999999999 678999999999999997 78999999999
Q ss_pred ccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcc--hHHHHHHHhcCCCh
Q 003855 649 SKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM--SLRRWVKESLPHGL 726 (791)
Q Consensus 649 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~ 726 (791)
++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+.......
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~- 286 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF- 286 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC-
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC-
Confidence 98764322 22345789999999999999999999999999999999999999976432211 1111111100000
Q ss_pred hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 727 ~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..+....++.++.+++.+||+.||++|||+.|+++.
T Consensus 287 -------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 287 -------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000112355678899999999999999999999873
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=376.51 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=202.7
Q ss_pred cccCCCcceEEEEEEec---CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS---DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
+.||+|+||.||+|.+. .++.||||+++... ....+.+.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 46789999997653 2346789999999999999999999999965 457899999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc-ce
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS-VT 660 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~ 660 (791)
|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+...... ..
T Consensus 454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH----~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH----HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999998654 4899999999999999999999 678999999999999999999999999999877544322 22
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.... .....+....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~----------------- 589 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGE----------------- 589 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC-----------------
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-----------------
Confidence 333456789999999998899999999999999999998 99999764321 1111111110
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhc
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~ 784 (791)
....+..++.++.++|.+||+.||++||++.++++.|+.+..+..
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 001122456778999999999999999999999999999876653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=343.56 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=200.4
Q ss_pred hhccccccccCCCcceEEEEEEec--CCc--EEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS--DGT--DVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
.++|++.+.||+|+||.||+|++. +++ .||||++.... ....+.+.+|+.++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 368999999999999999999863 333 68999886542 345678899999999999999999999998765 7
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 8999999999999999876566899999999999999999999 678999999999999999999999999999887
Q ss_pred CCCCCcc-eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 653 GEGEDSV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 653 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+. ....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~---~~~~---- 242 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKID---KEGE---- 242 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH---TSCC----
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHH---ccCC----
Confidence 5543322 2233457889999999988889999999999999999999 99999753211 1111111 1000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+....++..+.+++.+||+.||++||++.++++.|+++...
T Consensus 243 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 243 ---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0011123556788999999999999999999999999988654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=341.22 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=201.0
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccC-CeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNP-DFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 578 (791)
.++|++.+.||+|+||.||+|+. +|+.||||++.... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46899999999999999999988 48899999987543 346788999999999999999999987544 578999999
Q ss_pred CCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.+++..... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH----hCCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 999999999985432 3788999999999999999999 6789999999999999999999999999998654321
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
....++..|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+.....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~~~------------- 232 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYK------------- 232 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTCC-------------
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCC-------------
Confidence 22357889999999988889999999999999999998 99998753221 11111111000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
...+..++..+.+++.+||+.||++||++.|+++.|++++...
T Consensus 233 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 233 ----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 0111235567889999999999999999999999999997654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=357.75 Aligned_cols=261 Identities=22% Similarity=0.228 Sum_probs=195.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehh--hhHHHHHHHHHHHHHHhccCCccceeeeeeccC------C
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSNP------D 570 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 570 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999865 7899999999754 234456788999999999999999999998654 4
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 57999999975 57777754 2889999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC-----
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG----- 725 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 725 (791)
...... .....+||++|+|||++.+..|+.++||||+||++|||++|+.||.+.... ..+...+.......
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 213 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp ----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHT
T ss_pred ecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence 764322 233457999999999999999999999999999999999999999763211 11111111110000
Q ss_pred --------------------hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 726 --------------------LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 726 --------------------~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
........+... ........+.++.+++.+||+.||++|||+.|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA--DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCC--SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HcchhhhhHhhcccccCCCChHHhCccccccc--ccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 00111223567899999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.17 Aligned_cols=257 Identities=30% Similarity=0.478 Sum_probs=205.6
Q ss_pred hccccccccCCCcceEEEEEEec-CCcE--EEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTD--VAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 575 (791)
++|++.+.||+|+||.||+|+.. ++.. ||||.+.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999865 5664 4999886532 33456788999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc
Q 003855 576 LEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA 640 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~ 640 (791)
|||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCccceEEEcCCCe
Confidence 99999999999998653 35899999999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHH
Q 003855 641 AHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVK 719 (791)
Q Consensus 641 ~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 719 (791)
+||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... ....
T Consensus 181 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~~ 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYE 252 (327)
T ss_dssp EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHH
T ss_pred EEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----HHHH
Confidence 999999999753221 12223356889999999988889999999999999999998 99999753211 1111
Q ss_pred HhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 720 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 720 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
.. .... ....+..++..+.+++.+||+.||++||++.|+++.|.++....
T Consensus 253 ~~-~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 253 KL-PQGY-------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HG-GGTC-------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred Hh-hcCC-------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 0000 00111234567889999999999999999999999999987654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=345.28 Aligned_cols=262 Identities=23% Similarity=0.279 Sum_probs=195.3
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC------C
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP------D 570 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 570 (791)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999974 79999999985432 34456788999999999999999999998765 3
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..++||||+ +++|.+++... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 88999999874 3899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC--Chh
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH--GLT 727 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 727 (791)
..... ....++|++|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+...+...... ...
T Consensus 177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence 75432 233568999999998766 77999999999999999999999999753221 1111111111100 000
Q ss_pred hhcchhhhhhH-H--------h-hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVREE-Q--------A-FSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~~-~--------~-~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+........ . . ......++..+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000000000 0 0 0001234567889999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=337.71 Aligned_cols=251 Identities=25% Similarity=0.317 Sum_probs=202.8
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
..++|++.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3478999999999999999999975 789999999976554445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe---CCCCcEEEeeeccccccCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfgla~~~~~ 654 (791)
|+++|+|.+++...+ .+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||+++....
T Consensus 87 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 87 LVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH----ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred cCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999997654 3899999999999999999999 6789999999999999 7889999999999976433
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
. ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... ......+........
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~-------- 227 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIKEGYYEFE-------- 227 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHCCCCCC--------
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCCCCC--------
Confidence 2 12234689999999999999999999999999999999999999975321 111111111100000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+....++..+.+++.+|++.||++||++.|+++
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 ------SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011234567889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=354.33 Aligned_cols=253 Identities=26% Similarity=0.324 Sum_probs=194.7
Q ss_pred HHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--------hHHHHHHHHHHHHHHhccCCccceeeeeecc
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--------ERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 568 (791)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45688999999999999999999865 68999999987542 1122357889999999999999999999854
Q ss_pred CCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC---CcEEEee
Q 003855 569 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN---MAAHVSD 645 (791)
Q Consensus 569 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~---~~~kl~D 645 (791)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.+ +.+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCCCcceEEEee
Confidence 45789999999999999887654 4899999999999999999999 6789999999999999754 4599999
Q ss_pred eccccccCCCCCcceeecccccccccCCCccC---CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc
Q 003855 646 FGISKLLGEGEDSVTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL 722 (791)
Q Consensus 646 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (791)
||+|+...... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+...+....
T Consensus 286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~~~~ 361 (419)
T 3i6u_A 286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGK 361 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHHTTC
T ss_pred cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHhcCC
Confidence 99998765322 223356899999999875 3678899999999999999999999997643222 2222222111
Q ss_pred CCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 723 PHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 723 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.... ......++..+.+++.+||+.||++||++.|+++
T Consensus 362 ~~~~--------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 362 YNFI--------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCCC--------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC--------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1100 0111235567889999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.42 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=197.9
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc----CCeee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN----PDFKA 573 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 573 (791)
..|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 35788889999999999999875 78899999987543 4456778999999999999999999998754 45689
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCC--eEecCCCCCCeEeC-CCCcEEEeeecccc
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP--IIHCDLKPTNILLD-ENMAAHVSDFGISK 650 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--i~H~dlk~~Nill~-~~~~~kl~Dfgla~ 650 (791)
+||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+ |+||||||+||+++ +++.+||+|||+++
T Consensus 106 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH----cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999998653 3899999999999999999999 566 99999999999998 88999999999997
Q ss_pred ccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
...... .....||+.|+|||.+. +.++.++||||+|+++|||++|+.||....... .............
T Consensus 181 ~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~-- 249 (290)
T 1t4h_A 181 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIYRRVTSGVKPA-- 249 (290)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHHHHHTTTCCCG--
T ss_pred cccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH----HHHHHHhccCCcc--
Confidence 654322 22346899999999876 458999999999999999999999997532221 1111111110000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....++..+.+++.+||+.||++|||+.|+++
T Consensus 250 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 -----------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 011123356889999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.79 Aligned_cols=257 Identities=27% Similarity=0.376 Sum_probs=207.2
Q ss_pred hHHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--------hHHHHHHHHHHHHHHhc-cCCccceee
Q 003855 494 LDIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--------ERAFRSFDSECEVLRNV-RHRNLIKIL 563 (791)
Q Consensus 494 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~ 563 (791)
.......++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334555678999999999999999999985 79999999986542 22356788999999999 799999999
Q ss_pred eeeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003855 564 SSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV 643 (791)
Q Consensus 564 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl 643 (791)
+++......++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH----~~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH----ANNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999998643 4899999999999999999999 678999999999999999999999
Q ss_pred eeeccccccCCCCCcceeecccccccccCCCccC------CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHH
Q 003855 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRW 717 (791)
Q Consensus 644 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 717 (791)
+|||++..+..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......
T Consensus 242 ~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~ 316 (365)
T 2y7j_A 242 SDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRM 316 (365)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH
T ss_pred EecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHH
Confidence 99999987754332 23357899999999864 34688999999999999999999999965221 111111
Q ss_pred HHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 718 VKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 718 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+....... ..+....++..+.+++.+||+.||++|||+.|+++
T Consensus 317 i~~~~~~~--------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 IMEGQYQF--------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHTCCCC--------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCCCC--------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11100000 00111234567889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=358.42 Aligned_cols=248 Identities=15% Similarity=0.199 Sum_probs=193.7
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehh---hhHHHHHHHHHH---HHHHhccCCccceee-------ee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQ---LERAFRSFDSEC---EVLRNVRHRNLIKIL-------SS 565 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 565 (791)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999996 47999999998743 334567888999 455556899999998 55
Q ss_pred eccCC-----------------eeeEEEecCCCCCHHHHHhhCCC------CCCHHHHHHHHHHHHHHHHHHHccCCCCC
Q 003855 566 CSNPD-----------------FKALVLEFMPNGSLEKWLYSHNY------FLDILERLNIMIDVGSALEYLHHGHSSAP 622 (791)
Q Consensus 566 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~~~~~ 622 (791)
+.+++ ..++||||+ +|+|.+++..... .+++..+..++.||+.||+||| +.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ 226 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYG 226 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH----HTT
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH----hCC
Confidence 54443 278999999 6899999985422 2336888899999999999999 678
Q ss_pred eEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCC-----------CCCccccHHhHH
Q 003855 623 IIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG-----------IVSAKCDVYSYG 691 (791)
Q Consensus 623 i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~s~G 691 (791)
|+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+. .++.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999986422 2334567 999999998877 899999999999
Q ss_pred HHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHH
Q 003855 692 VLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTD 771 (791)
Q Consensus 692 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e 771 (791)
|++|||++|+.||........ ...+.. ....++..+.+++.+||+.||++||++.|
T Consensus 301 ~il~elltg~~Pf~~~~~~~~-------------~~~~~~-----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGG-------------SEWIFR-----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHHHHHHSSCCC------CC-------------SGGGGS-----------SCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred HHHHHHHHCCCCCcccccccc-------------hhhhhh-----------hccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 999999999999965322110 000000 00134567889999999999999999999
Q ss_pred HHH--HHHHHHHH
Q 003855 772 AAA--KLKKIKVK 782 (791)
Q Consensus 772 v~~--~L~~~~~~ 782 (791)
+++ .+.+++..
T Consensus 357 ~l~hp~f~~~~~~ 369 (377)
T 3byv_A 357 AMETPEYEQLRTE 369 (377)
T ss_dssp HHTSHHHHHHHHH
T ss_pred HhhChHHHHHHHH
Confidence 986 56665544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=352.62 Aligned_cols=200 Identities=26% Similarity=0.358 Sum_probs=167.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC-----Ce
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP-----DF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 571 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999975 68899999996532 34456788999999999999999999998765 57
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++||||++ |+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH----~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999996 69999998654 4899999999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCc--------------------ceeecccccccccCCCcc-CCCCCCccccHHhHHHHHHHHHhCCCCCC
Q 003855 652 LGEGEDS--------------------VTQTMTMATIGYMAPEYG-SEGIVSAKCDVYSYGVLLMETFTRKRPTD 705 (791)
Q Consensus 652 ~~~~~~~--------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg~~p~~ 705 (791)
....... ......+||++|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 6543221 123456799999999975 56679999999999999999998665553
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=345.70 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=199.5
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 576 (791)
..++|++.+.||+|+||.||+|+.+ +++.||||++..... ...+|++++.++ +||||+++++++.++...++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4578999999999999999999975 789999999976543 234578888887 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC----CcEEEeeecccccc
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN----MAAHVSDFGISKLL 652 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfgla~~~ 652 (791)
||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||++.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH----~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH----AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999998654 4899999999999999999999 6789999999999998543 35999999999876
Q ss_pred CCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccC-cchHHHHHHHhcCCChhhhcc
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG-EMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~d 731 (791)
..... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+...+...... ..
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-~~---- 243 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS-LS---- 243 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC-CC----
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc-cC----
Confidence 44322 223457899999999988878999999999999999999999999753211 11111111110000 00
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+..++.++.+++.+||+.||++||++.|+++
T Consensus 244 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 244 ---------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001234567889999999999999999999876
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=338.20 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=205.6
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 468999999999999999999976 68899999987543 34556788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999987654 4899999999999999999999 678999999999999999999999999999876433
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ..... . ...
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~-~---~~~---------- 231 (294)
T 2rku_A 169 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRI-K---KNE---------- 231 (294)
T ss_dssp TC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHH-H---TTC----------
T ss_pred cc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-h---hcc----------
Confidence 22 2233568999999999988889999999999999999999999997532211 11110 0 000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
...+..++..+.+++.+||+.||++|||+.|+++.
T Consensus 232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00011234567899999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=334.98 Aligned_cols=246 Identities=25% Similarity=0.330 Sum_probs=204.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 368999999999999999999975 67899999987543 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH----ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999998654 3899999999999999999999 779999999999999999999999999999765432
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+.. ...
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~---~~~--------- 229 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ETHRRIVN---VDL--------- 229 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHT---TCC---------
T ss_pred c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HHHHHHhc---ccc---------
Confidence 1 22346899999999999999999999999999999999999999753211 11111110 000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..++..+.+++.+|++.||++||++.|+++
T Consensus 230 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 ------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 001123466789999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=358.30 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=203.1
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+..|+.++++++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 368999999999999999999975 79999999997653 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 576 LEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
|||++||+|.+++... ...+++..+..++.||+.||.||| +.+|+||||||+||+++.+|.+||+|||+++.+
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH----QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH----HcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999854 335899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .............
T Consensus 340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~~~------- 409 (543)
T 3c4z_A 340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLEQA------- 409 (543)
T ss_dssp CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHHCC-------
T ss_pred cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhhcc-------
Confidence 54332 1233479999999999999999999999999999999999999997643211 1111111100000
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINV 769 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 769 (791)
...+..++..+.+++.+||+.||++||++
T Consensus 410 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 --------VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred --------cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 00112345677899999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=354.39 Aligned_cols=262 Identities=19% Similarity=0.245 Sum_probs=209.6
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccC-CccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRH-RNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+|+. .+++.||||++...... +.+..|+++++.++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999996 47899999987654322 357789999999977 555566666677888899999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe---CCCCcEEEeeeccccccCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfgla~~~~~ 654 (791)
|+ +++|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||+ +.++.+||+|||+|+.+..
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 99999999876667999999999999999999999 6789999999999999 6889999999999987755
Q ss_pred CCCc-----ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcch--HHHHHHHhcCCChh
Q 003855 655 GEDS-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS--LRRWVKESLPHGLT 727 (791)
Q Consensus 655 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~ 727 (791)
.... .......||..|+|||++.+..++.++|||||||++|||++|+.||......... +......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~------- 231 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------- 231 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-------
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-------
Confidence 4322 1122457999999999999999999999999999999999999999874332211 1111110
Q ss_pred hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 728 ~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..... .......++.++.+++..||+.+|++||++.++++.|+.+...
T Consensus 232 -----~~~~~--~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 232 -----KVATS--IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp -----HHHSC--HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----ccccc--HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 00000 0011124567899999999999999999999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.63 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=204.8
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 368999999999999999999976 78999999987653 3445778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++|+|.+++..... +++..+..++.|++.||+|||+ ..+|+||||||+||+++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999999986543 8999999999999999999993 137999999999999999999999999999755321
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHh----------------
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES---------------- 721 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~---------------- 721 (791)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+...
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH--HHHHC------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccccCCCCCCCcccCC
Confidence 12234689999999999999999999999999999999999999975322111 1000000
Q ss_pred -----------cCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 722 -----------LPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 722 -----------~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......+..+....... .......++.++.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCC-CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCC-CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000111111000000 00011124567899999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.85 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=200.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999976 6899999998776656677889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++|+|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...... .
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH----SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L 171 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence 9999999999876566999999999999999999999 678999999999999999999999999998543211 1
Q ss_pred ceeecccccccccCCCcc-----CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 659 VTQTMTMATIGYMAPEYG-----SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.......|++.|+|||++ .+..++.++||||||+++|||++|+.||....... ..........+..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~-------- 242 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPPTL-------- 242 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCCC--------
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCccc--------
Confidence 112234689999999987 46778999999999999999999999997632211 1111111111000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..++..+.+++.+||+.||++|||+.|+++
T Consensus 243 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 --------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011234567889999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=344.28 Aligned_cols=248 Identities=22% Similarity=0.283 Sum_probs=205.2
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999975 68899999987553 34556788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++++|.+++.... .+++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999987654 4899999999999999999999 678999999999999999999999999999876433
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.||......+ ..........
T Consensus 195 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~------------- 258 (335)
T 2owb_A 195 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNEY------------- 258 (335)
T ss_dssp TC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCC-------------
T ss_pred cc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcCCC-------------
Confidence 22 2233568999999999988889999999999999999999999997532111 1111111000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..++..+.+++.+||+.||++||++.|+++
T Consensus 259 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001123456789999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=335.39 Aligned_cols=250 Identities=24% Similarity=0.281 Sum_probs=189.2
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 47899999999999999999997 478999999987543 233344555666688889999999999999999999999
Q ss_pred ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-CeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 577 EFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGHSSA-PIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 577 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
||++ |+|.+++.. ....+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH----SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9997 598888763 4556999999999999999999999 55 8999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCCCcc----CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYG----SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
.... ......||+.|+|||.+ .+..++.++||||+|+++|||++|+.||+............+....+...
T Consensus 161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 235 (290)
T 3fme_A 161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP-- 235 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC--
T ss_pred cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc--
Confidence 4432 22234689999999985 56778999999999999999999999997533222222222221111110
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...++..+.+++.+||+.||++|||+.|+++
T Consensus 236 ---------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 236 ---------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1124466889999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=356.47 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=203.8
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
..++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999975 78999999987543 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC---CCCcEEEeeecccccc
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD---ENMAAHVSDFGISKLL 652 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfgla~~~ 652 (791)
|||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++ .++.+||+|||+|+.+
T Consensus 100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999999987654 3899999999999999999999 67899999999999995 5668999999999876
Q ss_pred CCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHH-hcCCChhhhcc
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHGLTEVVD 731 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~d 731 (791)
.... .....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+... ......+.. .....
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~------ 242 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFD------ 242 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCSC------
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCCC------
Confidence 5432 2234579999999999875 599999999999999999999999975322 111111111 11000
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+....++..+.+++.+||+.||++|||+.|+++
T Consensus 243 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 243 ---------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp ---------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1112235567889999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=344.24 Aligned_cols=267 Identities=25% Similarity=0.282 Sum_probs=200.8
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 468999999999999999999975 68999999986443 334566889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH----SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH----HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999998888766444 4899999999999999999999 6789999999999999999999999999998764332
Q ss_pred CcceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC--h-------
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG--L------- 726 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~------- 726 (791)
. ......|++.|+|||++.+. .++.++||||+||++|||++|+.||......+ ............. .
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHC
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhc
Confidence 2 22335689999999988765 78999999999999999999999997632221 1111111110000 0
Q ss_pred ---hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 727 ---TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 727 ---~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....+..............++..+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000000001111245678899999999999999999999876
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.08 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=206.3
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.+.|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356899999999999999999864 78999999987553 3446788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999999754 4899999999999999999999 67899999999999999999999999999987644321
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+.......
T Consensus 175 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~------------ 238 (303)
T 3a7i_A 175 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPPT------------ 238 (303)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCCC------------
T ss_pred --ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCCC------------
Confidence 223456899999999999999999999999999999999999999753221 1111111111100
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
....++..+.+++.+||+.||++|||+.|+++.
T Consensus 239 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 -----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -----CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -----CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 011344668899999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=341.02 Aligned_cols=261 Identities=21% Similarity=0.307 Sum_probs=201.0
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CCccceeeeeecc--CCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSCSN--PDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 575 (791)
.++|++.+.||+|+||.||+|+. .+++.||||++.... .+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36899999999999999999986 478999999987443 356788999999997 9999999999987 6678999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC-cEEEeeeccccccCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-AAHVSDFGISKLLGE 654 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~~ 654 (791)
|||+++++|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+||+|||+|+....
T Consensus 112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999999864 788999999999999999999 67899999999999999776 899999999987654
Q ss_pred CCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc--
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD-- 731 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d-- 731 (791)
... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.........+.............+.++
T Consensus 184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 332 233468999999998876 67999999999999999999999998543222222222111111000000000
Q ss_pred -----hhhhh-----------hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 -----ANLVR-----------EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 -----~~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.... ..........++.++.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00000011225677899999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=344.40 Aligned_cols=269 Identities=22% Similarity=0.263 Sum_probs=195.9
Q ss_pred HHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
....++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 344578999999999999999999864 78999999986543 233456788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe-----CCCCcEEEeeecc
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL-----DENMAAHVSDFGI 648 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill-----~~~~~~kl~Dfgl 648 (791)
+||||++ |+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+||++ +.++.+||+|||+
T Consensus 110 lv~e~~~-~~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCH----SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEEecCC-CCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999997 599999987654 899999999999999999999 6789999999999999 4556699999999
Q ss_pred ccccCCCCCcceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc-CCC-
Q 003855 649 SKLLGEGEDSVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL-PHG- 725 (791)
Q Consensus 649 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~- 725 (791)
|+....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...+.... +..
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTT
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHHhCCCchh
Confidence 987643322 22334689999999988764 5899999999999999999999999763221 11222221110 000
Q ss_pred -hhhhc--------chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 726 -LTEVV--------DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 726 -~~~~~--------d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..... .+..............++.++.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 00000000000111224567889999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.35 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=197.9
Q ss_pred ccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 502 EFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
+|.....||+|+||.||+|+. .+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 445556899999999999996 4788999999976655566788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-CCcEEEeeeccccccCCCCC
Q 003855 581 NGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-NMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 581 ~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|.+++.... ...++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH----DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH----hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999998653 34678899999999999999999 678999999999999987 89999999999987643221
Q ss_pred cceeecccccccccCCCccCCCC--CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
......|++.|+|||++.+.. ++.++||||||+++|||++|+.||....................
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 245 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP----------- 245 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC-----------
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc-----------
Confidence 123346899999999876543 78999999999999999999999975322211111100000000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..++.++.+++.+||+.||++||++.|+++
T Consensus 246 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 ------EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011234567789999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=331.91 Aligned_cols=247 Identities=27% Similarity=0.423 Sum_probs=196.4
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367999999999999999999976 79999999997653 23356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++++|.+++..... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCH----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 999999999999986543 899999999999999999999 678999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCCCccCCCCC-CccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
.. .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ....+.+.....
T Consensus 165 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~----------- 228 (276)
T 2h6d_A 165 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLFKKIRGGVF----------- 228 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC-----------
T ss_pred cc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhcCcc-----------
Confidence 21 223468999999999887665 6899999999999999999999975321 111111111000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..++..+.+++.+||+.||++|||+.|+++
T Consensus 229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 001123456789999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=345.55 Aligned_cols=270 Identities=26% Similarity=0.309 Sum_probs=200.3
Q ss_pred HHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh-----HHHHHHHHHHHHHHhccCCccceeeeeeccCC
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE-----RAFRSFDSECEVLRNVRHRNLIKILSSCSNPD 570 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 570 (791)
....++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344578999999999999999999975 689999999865321 11246788999999999999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..++||||+++ +|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999975 999999877767899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC---Ch
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH---GL 726 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~ 726 (791)
.+..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|..||.+.... ..+.+.+...... .+
T Consensus 161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTS
T ss_pred eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhh
Confidence 7643322 2334568999999998865 45899999999999999999999998763221 1222222211110 00
Q ss_pred hhh------cchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 727 TEV------VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 727 ~~~------~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+. +................++.++.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 000000000000011234577889999999999999999999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=349.40 Aligned_cols=349 Identities=28% Similarity=0.384 Sum_probs=304.1
Q ss_pred cCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccccccccccccccc
Q 003855 34 FNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLS 113 (791)
Q Consensus 34 ~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 113 (791)
..+++|+.|++++|.++ .+|. +.. +++|++|+|++|.+++..+ |.++++|++|+|++|.+.+..+ |.++++|+
T Consensus 43 ~~l~~l~~L~l~~~~i~-~l~~-~~~-l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~ 115 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIK-SIDG-VEY-LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLT 115 (466)
T ss_dssp HHHHTCCEEECCSSCCC-CCTT-GGG-CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCC
T ss_pred hHhccccEEecCCCCCc-cCcc-hhh-hcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCC
Confidence 34678999999999998 7885 443 8999999999999997654 9999999999999999997766 99999999
Q ss_pred ccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCC
Q 003855 114 LLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGL 193 (791)
Q Consensus 114 ~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 193 (791)
.|++++|+++.++ .+..+++|++|++++|.+++. + .+..+ .+|++|++. |.+.+.. .+.++++|
T Consensus 116 ~L~L~~n~l~~~~----------~~~~l~~L~~L~l~~n~l~~~-~-~~~~l-~~L~~L~l~-~~~~~~~--~~~~l~~L 179 (466)
T 1o6v_A 116 GLTLFNNQITDID----------PLKNLTNLNRLELSSNTISDI-S-ALSGL-TSLQQLSFG-NQVTDLK--PLANLTTL 179 (466)
T ss_dssp EEECCSSCCCCCG----------GGTTCTTCSEEEEEEEEECCC-G-GGTTC-TTCSEEEEE-ESCCCCG--GGTTCTTC
T ss_pred EEECCCCCCCCCh----------HHcCCCCCCEEECCCCccCCC-h-hhccC-CcccEeecC-CcccCch--hhccCCCC
Confidence 9999999998754 288999999999999999864 2 34444 679999996 5555433 38999999
Q ss_pred CEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCC
Q 003855 194 TLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSN 273 (791)
Q Consensus 194 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 273 (791)
+.|++++|.+++. ..+..+++|++|++++|.+++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|
T Consensus 180 ~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n 253 (466)
T 1o6v_A 180 ERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANN 253 (466)
T ss_dssp CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSS
T ss_pred CEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCC
Confidence 9999999999854 458899999999999999996655 78899999999999999854 46889999999999999
Q ss_pred cCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCc
Q 003855 274 KLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPE 353 (791)
Q Consensus 274 ~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 353 (791)
++.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..|
T Consensus 254 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~- 326 (466)
T 1o6v_A 254 QISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP- 326 (466)
T ss_dssp CCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-
T ss_pred ccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-
Confidence 9987655 8899999999999999987544 8899999999999999996544 8899999999999999997655
Q ss_pred ccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccccCC
Q 003855 354 SVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGP 422 (791)
Q Consensus 354 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~ 422 (791)
+..+++|+.|++++|++++. ..+..+++|+.|++++|++++.+| ...++.++.+.+.+|++..-|
T Consensus 327 -~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~~p 391 (466)
T 1o6v_A 327 -VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTNAP 391 (466)
T ss_dssp -GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEECCC
T ss_pred -hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccCCc
Confidence 78999999999999999975 578999999999999999999988 677889999999999887643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.40 Aligned_cols=268 Identities=21% Similarity=0.289 Sum_probs=203.1
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc--------
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN-------- 568 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 568 (791)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999997 478999999886443 2234567789999999999999999999876
Q ss_pred CCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecc
Q 003855 569 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGI 648 (791)
Q Consensus 569 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl 648 (791)
.+..++||||+++ ++.+.+......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4468999999974 888888876666999999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCC--cceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHh---c
Q 003855 649 SKLLGEGED--SVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES---L 722 (791)
Q Consensus 649 a~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~---~ 722 (791)
|+.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... .....+... .
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSI 248 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCC
Confidence 987653322 122344578999999998765 56899999999999999999999999763221 111212111 1
Q ss_pred CCC-hhhhcchhhh----------hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 723 PHG-LTEVVDANLV----------REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 723 ~~~-~~~~~d~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.. ....-..... ............++.+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111 1110000000 000000011122456889999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=347.11 Aligned_cols=263 Identities=22% Similarity=0.292 Sum_probs=206.0
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHH-----------------HHHHHHHHHHHHhccCCcccee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERA-----------------FRSFDSECEVLRNVRHRNLIKI 562 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l 562 (791)
.++|++.+.||+|+||.||+|+. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999997653221 1788999999999999999999
Q ss_pred eeeeccCCeeeEEEecCCCCCHHHH------HhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCC-CCeEecCCCCCCeE
Q 003855 563 LSSCSNPDFKALVLEFMPNGSLEKW------LYSH-NYFLDILERLNIMIDVGSALEYLHHGHSS-APIIHCDLKPTNIL 634 (791)
Q Consensus 563 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~~i~H~dlk~~Nil 634 (791)
++++.+.+..++||||+++|+|.++ +... ...+++..+..++.|++.||.||| + .+|+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH----NEKNICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH----HTSCEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh----ccCCEeecCCChHhEE
Confidence 9999999999999999999999998 5542 456899999999999999999999 5 78999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCC-CCCc-cccHHhHHHHHHHHHhCCCCCCccccCcc
Q 003855 635 LDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG-IVSA-KCDVYSYGVLLMETFTRKRPTDEMFTGEM 712 (791)
Q Consensus 635 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dv~s~G~vl~elltg~~p~~~~~~~~~ 712 (791)
++.++.+||+|||.++..... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 259 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV- 259 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 999999999999999876432 33445689999999998877 6666 9999999999999999999997643322
Q ss_pred hHHHHHHHhcCC---ChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 713 SLRRWVKESLPH---GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 713 ~~~~~~~~~~~~---~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....+...... .......+.... ........++..+.+++.+||+.||++||++.|+++
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNK--KSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHhccCcCCccchhhhhcccccc--ccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222222111000 000000000000 000111245677889999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.89 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=201.0
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
..++|++.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3568999999999999999999975 68999999987543 23578889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++|+|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH----FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999999865556899999999999999999999 67899999999999999999999999999987643321
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+........
T Consensus 181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~----------- 245 (314)
T 3com_A 181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPPPTF----------- 245 (314)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCCC-----------
T ss_pred --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCCccc-----------
Confidence 2233468999999999998899999999999999999999999997532211 1111111110000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..++..+.+++.+||+.||++|||+.|+++
T Consensus 246 ----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011234567889999999999999999999976
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=356.80 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=199.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999975 78999999987543 233567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC---CCcEEEeeeccccccC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE---NMAAHVSDFGISKLLG 653 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgla~~~~ 653 (791)
||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++. ++.+||+|||+|+.+.
T Consensus 116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH----KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999987654 3899999999999999999999 678999999999999976 4559999999998765
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
... .....+||+.|+|||++. +.++.++||||+||++|||++|+.||.+.... .....+.......
T Consensus 191 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~-------- 256 (494)
T 3lij_A 191 NQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEKGKYTF-------- 256 (494)
T ss_dssp TTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCC--------
T ss_pred CCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCC--------
Confidence 432 223456999999999876 56999999999999999999999999763221 1111111110000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+....++..+.+++.+||+.||++|||+.|+++
T Consensus 257 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 ------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp ------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00111234567889999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.82 Aligned_cols=256 Identities=22% Similarity=0.302 Sum_probs=201.6
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeee--ccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSC--SNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++ ......++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999975 78999999987543 34456789999999999999999999987 44678899
Q ss_pred EEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccC-CCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 575 VLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHHGH-SSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+.. ...+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999743 345899999999999999999999421 01129999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.......
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~~~~----- 235 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFRR----- 235 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCC-----
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhccccc-----
Confidence 7643321 12234689999999999888899999999999999999999999976321 11111111111000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L 776 (791)
.+..++.++.+++.+||+.||++||++.|+++.+
T Consensus 236 ------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 236 ------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 0113456788999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=341.61 Aligned_cols=267 Identities=23% Similarity=0.259 Sum_probs=202.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccC-----Cee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP-----DFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 572 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999865 78899999987543 34456788999999999999999999998654 468
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||++ |+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999996 59999998754 899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCcc-eeecccccccccCCCccC-CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC---hh
Q 003855 653 GEGEDSV-TQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---LT 727 (791)
Q Consensus 653 ~~~~~~~-~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 727 (791)
....... .....+||+.|+|||++. ...++.++||||+||++|||++|+.||.+....+ .+........... ..
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH
Confidence 5432211 123347899999999754 4568999999999999999999999997643221 2222211111110 00
Q ss_pred hhcchhhhhhHH---------hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVREEQ---------AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+........ .......++.++.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 00011234567889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.07 Aligned_cols=273 Identities=21% Similarity=0.237 Sum_probs=202.2
Q ss_pred hhHHHHHhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhh-----------hHHHHHHHHHHHHHHhccCCccce
Q 003855 493 YLDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL-----------ERAFRSFDSECEVLRNVRHRNLIK 561 (791)
Q Consensus 493 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~niv~ 561 (791)
..++....++|++.+.||+|+||.||+|...+|+.||||++.... ....+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456777889999999999999999999998889999999885421 223477899999999999999999
Q ss_pred eeeeec-----cCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC
Q 003855 562 ILSSCS-----NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD 636 (791)
Q Consensus 562 l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~ 636 (791)
+++++. .....++||||++ |+|.+++......+++..+..++.|++.||.||| +.+|+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH----EAGVVHRDLHPGNILLA 168 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCEecCCChHHEEEc
Confidence 999983 3446899999997 6999999877767999999999999999999999 67899999999999999
Q ss_pred CCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHH
Q 003855 637 ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 715 (791)
Q Consensus 637 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 715 (791)
.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~ 244 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQLN 244 (362)
T ss_dssp TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHH
T ss_pred CCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence 99999999999997543322 2233568999999998776 67999999999999999999999999763211 1111
Q ss_pred HHHHHhcCCChhhh-----------cchhhhhhH--HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 716 RWVKESLPHGLTEV-----------VDANLVREE--QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 716 ~~~~~~~~~~~~~~-----------~d~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+.........+. +........ ........++..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 21111111111000 000000000 000111234567889999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.04 Aligned_cols=261 Identities=19% Similarity=0.240 Sum_probs=206.7
Q ss_pred CChhHHHHHhhccccc-cccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhc-cCCccceeeee
Q 003855 491 TPYLDIQRATDEFNEC-NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNV-RHRNLIKILSS 565 (791)
Q Consensus 491 ~~~~~~~~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 565 (791)
..+...+...+.|.+. +.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++++ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3455566777888887 89999999999999975 68999999987543 23356788999999999 56999999999
Q ss_pred eccCCeeeEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC---CCcE
Q 003855 566 CSNPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE---NMAA 641 (791)
Q Consensus 566 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~---~~~~ 641 (791)
+.+....++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH----~~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH----QNNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999998643 345899999999999999999999 678999999999999997 7899
Q ss_pred EEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHh
Q 003855 642 HVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES 721 (791)
Q Consensus 642 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 721 (791)
||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+...
T Consensus 174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~ 248 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLNISQV 248 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHT
T ss_pred EEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHHHhc
Confidence 9999999987654322 223468999999999999999999999999999999999999997532211 11111111
Q ss_pred cCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 722 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 722 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...... .....++..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~--------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 249 NVDYSE--------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CCCCCT--------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccCc--------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 100000 011134566889999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.81 Aligned_cols=255 Identities=23% Similarity=0.335 Sum_probs=197.6
Q ss_pred HHHhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhcc--CCccceeeeeeccCCee
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVR--HRNLIKILSSCSNPDFK 572 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~ 572 (791)
....++|++.+.||+|+||.||+|+..+++.||||++.... ....+.+.+|+.++++++ ||||+++++++.+....
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 33457899999999999999999998889999999986442 445678899999999997 59999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||| +.+++|.+++.... .+++..+..++.|+++||.||| +.+|+||||||+||++++ +.+||+|||+++..
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 99999 55889999998765 4899999999999999999999 678999999999999964 89999999999876
Q ss_pred CCCCCcceeecccccccccCCCccCC-----------CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHh
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSE-----------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES 721 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 721 (791)
.............|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.............+...
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 54433333334568999999998765 4788899999999999999999999975432211111111110
Q ss_pred cCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 722 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 722 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
..... +..++..+.+++.+||+.||++||++.|+++.
T Consensus 257 ~~~~~-----------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 257 HEIEF-----------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SCCCC-----------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCC-----------------cccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 00000 01123567899999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.65 Aligned_cols=263 Identities=11% Similarity=0.105 Sum_probs=187.9
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc--cCCccceee-------eee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV--RHRNLIKIL-------SSC 566 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~ 566 (791)
..+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346899999999999999999975 78999999997643 34456677886555555 599988755 333
Q ss_pred ccC-----------------CeeeEEEecCCCCCHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHHccCCCCCe
Q 003855 567 SNP-----------------DFKALVLEFMPNGSLEKWLYSHNYFLDILER------LNIMIDVGSALEYLHHGHSSAPI 623 (791)
Q Consensus 567 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~~i 623 (791)
..+ ...++||||++ |+|.+++...+..+++..+ ..++.||+.||+||| +.+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH----~~~i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ----SKGL 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH----HTTE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH----HCCC
Confidence 222 33799999998 8999999865444566666 788899999999999 6789
Q ss_pred EecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCC--CCCCccccHHhHHHHHHHHHhCC
Q 003855 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRK 701 (791)
Q Consensus 624 ~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~ 701 (791)
+||||||+|||++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987532 1213457799999999987 67999999999999999999999
Q ss_pred CCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HHHHH
Q 003855 702 RPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA--KLKKI 779 (791)
Q Consensus 702 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~--~L~~~ 779 (791)
.||.......... |... ......... ...+....++..+.+++.+||+.||++|||+.|+++ .+.++
T Consensus 291 ~Pf~~~~~~~~~~--~~~~----~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 291 LPFGLVTPGIKGS--WKRP----SLRVPGTDS-----LAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CSTTBCCTTCTTC--CCBC----CTTSCCCCS-----CCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCCCCcCcccccc--hhhh----hhhhccccc-----cchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 9998753321110 0000 000000000 001111245577889999999999999999999975 44555
Q ss_pred HHHh
Q 003855 780 KVKF 783 (791)
Q Consensus 780 ~~~~ 783 (791)
....
T Consensus 360 ~~~~ 363 (371)
T 3q60_A 360 QNEI 363 (371)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=342.23 Aligned_cols=336 Identities=22% Similarity=0.249 Sum_probs=264.9
Q ss_pred CCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccc
Q 003855 35 NISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSL 114 (791)
Q Consensus 35 ~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 114 (791)
.++++++|++++|.++ .+|..++..+++|++|+|++|.|+++.+..|..+++|++|+|++|.++++.+..|.++++|+.
T Consensus 43 ~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 4688899999999987 888887777889999999999998888888999999999999999998888888888888888
Q ss_pred cccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCC
Q 003855 115 LSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLT 194 (791)
Q Consensus 115 L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 194 (791)
|++++|+++.++... |.++++|++|++++|++++. .+..|.++++|+
T Consensus 122 L~L~~n~l~~l~~~~--------~~~l~~L~~L~L~~n~l~~~-------------------------~~~~~~~l~~L~ 168 (390)
T 3o6n_A 122 LVLERNDLSSLPRGI--------FHNTPKLTTLSMSNNNLERI-------------------------EDDTFQATTSLQ 168 (390)
T ss_dssp EECCSSCCCCCCTTT--------TTTCTTCCEEECCSSCCCBC-------------------------CTTTTSSCTTCC
T ss_pred EECCCCccCcCCHHH--------hcCCCCCcEEECCCCccCcc-------------------------ChhhccCCCCCC
Confidence 888888888766543 67888888888888888753 344567778888
Q ss_pred EEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCc
Q 003855 195 LLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNK 274 (791)
Q Consensus 195 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 274 (791)
.|++++|++++. .+..+++|++|++++|.+++ +...++|+.|++++|.+... |. ...++|+.|++++|+
T Consensus 169 ~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~--~~~~~L~~L~l~~n~ 237 (390)
T 3o6n_A 169 NLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RG--PVNVELTILKLQHNN 237 (390)
T ss_dssp EEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-EC--CCCSSCCEEECCSSC
T ss_pred EEECCCCcCCcc---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeec-cc--cccccccEEECCCCC
Confidence 888888888754 35667888888888888773 33446788888888888743 32 234788888888888
Q ss_pred CCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcc
Q 003855 275 LTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPES 354 (791)
Q Consensus 275 l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 354 (791)
+++. ..+..+++|++|++++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|++++|+++ .+|..
T Consensus 238 l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~ 313 (390)
T 3o6n_A 238 LTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERN 313 (390)
T ss_dssp CCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGG
T ss_pred Cccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCcc
Confidence 8753 567888888888888888888888888888889999999988884 5666677888999999999888 57777
Q ss_pred cCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccccCCC
Q 003855 355 VGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 355 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~ 423 (791)
+..+++|+.|+|++|+++.. + +..+++|+.|++++|++++.... ..+..+....+.++...|..+
T Consensus 314 ~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 314 QPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp HHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred ccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence 88888999999999998854 3 66788899999999998875432 234445555566777777643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=341.58 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=187.1
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4578999999999999999999864 78999999886543 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 577 EFMPNGSLEKWLYS-------HNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 577 e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
||+++|+|.+++.. ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH----KNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 99999999999974 2345899999999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCCc---ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC
Q 003855 650 KLLGEGEDS---VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG 725 (791)
Q Consensus 650 ~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (791)
+........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ... ........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~-~~~~~~~~ 246 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LML-TLQNDPPS 246 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHH-HHTSSCCC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-HHH-HhccCCCc
Confidence 876543211 11233468999999998765 5689999999999999999999999976433221 111 11111111
Q ss_pred hh-hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 726 LT-EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 726 ~~-~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. ...+.. ....++..+.+++.+||+.||++||++.|+++
T Consensus 247 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKE---------MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----C---------CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccch---------hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 000000 01134467889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.62 Aligned_cols=253 Identities=27% Similarity=0.340 Sum_probs=199.1
Q ss_pred HHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--------hHHHHHHHHHHHHHHhccCCccceeeeeecc
Q 003855 498 RATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--------ERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568 (791)
Q Consensus 498 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 568 (791)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34578999999999999999999975 68899999986432 1223457889999999999999999999876
Q ss_pred CCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc---EEEee
Q 003855 569 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA---AHVSD 645 (791)
Q Consensus 569 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~---~kl~D 645 (791)
.. .++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++. +||+|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred Cc-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 55 899999999999999997654 4899999999999999999999 678999999999999987654 99999
Q ss_pred eccccccCCCCCcceeecccccccccCCCcc---CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc
Q 003855 646 FGISKLLGEGEDSVTQTMTMATIGYMAPEYG---SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL 722 (791)
Q Consensus 646 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 722 (791)
||+++...... ......||+.|+|||++ ....++.++|||||||++|||++|+.||....... .+...+....
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~ 236 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGK 236 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHTC
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhCc
Confidence 99998764321 12234689999999985 35678999999999999999999999997643322 2222222111
Q ss_pred CCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 723 PHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 723 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..... .....++..+.+++.+||+.||++||++.|+++
T Consensus 237 ~~~~~--------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 237 YNFIP--------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCCCH--------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCc--------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 10000 011234567889999999999999999999984
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=355.10 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=201.8
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh-------------HHHHHHHHHHHHHHhccCCccceeee
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE-------------RAFRSFDSECEVLRNVRHRNLIKILS 564 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~ 564 (791)
..++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999975 688999999865421 23567889999999999999999999
Q ss_pred eeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC---cE
Q 003855 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM---AA 641 (791)
Q Consensus 565 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~---~~ 641 (791)
++.++...++||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH----KHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999997654 3899999999999999999999 67899999999999999776 69
Q ss_pred EEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHh
Q 003855 642 HVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES 721 (791)
Q Consensus 642 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 721 (791)
||+|||+|+.+.... ......||+.|+|||++. +.++.++||||+||++|+|++|..||.+.... .....+...
T Consensus 189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~ 262 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVEKG 262 (504)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC
T ss_pred EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC
Confidence 999999998775432 223356999999999886 46999999999999999999999999763221 111111110
Q ss_pred cCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 722 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 722 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
... ...+....++.++.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~--------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 263 KYY--------------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCC--------------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC--------------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 001112245677889999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=343.36 Aligned_cols=262 Identities=23% Similarity=0.285 Sum_probs=183.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC------C
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP------D 570 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 570 (791)
.++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999864 78999999986532 34456788999999999999999999998654 5
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..++|+||+ +++|.+++... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+|+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 78999998763 4899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC---h
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---L 726 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 726 (791)
..... ....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+........... .
T Consensus 181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 65432 233568999999998876 67999999999999999999999999763221 11111111111100 0
Q ss_pred hhhcchhhhhh--------HHh-hHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 727 TEVVDANLVRE--------EQA-FSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 727 ~~~~d~~~~~~--------~~~-~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+........ ... ......++..+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000000 000 0001134567889999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=328.49 Aligned_cols=244 Identities=20% Similarity=0.296 Sum_probs=198.2
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeE
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 574 (791)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+..+.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999976 79999999987532 33456788899999999 99999999999999999999
Q ss_pred EEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC-------------
Q 003855 575 VLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN------------- 638 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~------------- 638 (791)
||||+++|+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH----SMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999853 245899999999999999999999 6789999999999999844
Q ss_pred ------CcEEEeeeccccccCCCCCcceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCc
Q 003855 639 ------MAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711 (791)
Q Consensus 639 ------~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 711 (791)
..+||+|||.++...... ...||+.|+|||.+.+. .++.++|||||||++|||++|.+|+...
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---- 234 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---- 234 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----
T ss_pred cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----
Confidence 479999999998765432 23589999999988765 6778999999999999999998876431
Q ss_pred chHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 712 MSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...........+. .+..++..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 DQWHEIRQGRLPR------------------IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHHHHTTCCCC------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHHHHHcCCCCC------------------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1111111110000 01124466889999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=333.14 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=200.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh----hHHHHHHHHHHHHHHhccCCccceeeeee--ccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL----ERAFRSFDSECEVLRNVRHRNLIKILSSC--SNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~~~ 572 (791)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999974 78999999997653 23457789999999999999999999998 445678
Q ss_pred eEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
++||||+++| +.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH----SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 77777643 445899999999999999999999 67899999999999999999999999999988
Q ss_pred cCCCCCcceeecccccccccCCCccCCCC--CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSEGI--VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV 729 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
..............|++.|+|||+..+.. ++.++||||||+++|||++|+.||..... ......+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~------- 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKLFENIGKGS------- 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHCC-------
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHHhcCC-------
Confidence 75544333444557899999999887543 47899999999999999999999975221 11111111100
Q ss_pred cchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 003855 730 VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775 (791)
Q Consensus 730 ~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~ 775 (791)
...+..++..+.+++.+||+.||++||++.|+++.
T Consensus 230 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 -----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00111345678899999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=368.29 Aligned_cols=259 Identities=21% Similarity=0.358 Sum_probs=208.4
Q ss_pred HhhccccccccCCCcceEEEEEEec----CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS----DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
..++|++.+.||+|+||.||+|.+. .+..||||++.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 3478999999999999999999874 25679999986543 3445778999999999999999999999854 5689
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+||||+++|+|.+++......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 999999999999999977667999999999999999999999 6789999999999999999999999999998765
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.... .....+.....
T Consensus 543 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~i~~~~~--------- 610 (656)
T 2j0j_A 543 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER--------- 610 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHHTCC---------
T ss_pred CCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCC---------
Confidence 4322 22233456789999999988899999999999999999997 99999763221 11111111100
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
.+.+..++..+.+++.+||+.||++||++.|+++.|+++...
T Consensus 611 --------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 611 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 011124557788999999999999999999999999998654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=329.73 Aligned_cols=252 Identities=26% Similarity=0.321 Sum_probs=204.2
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---------hHHHHHHHHHHHHHHhcc-CCccceeeeeec
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---------ERAFRSFDSECEVLRNVR-HRNLIKILSSCS 567 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 567 (791)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999975 78999999986432 233567889999999995 999999999999
Q ss_pred cCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeec
Q 003855 568 NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFG 647 (791)
Q Consensus 568 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 647 (791)
+....++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999998653 4899999999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccC------CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHh
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGS------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES 721 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 721 (791)
++........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||..... ......+...
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~ 244 (298)
T 1phk_A 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSG 244 (298)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHT
T ss_pred chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHHHHHhcC
Confidence 9987654332 23346899999999764 56688999999999999999999999965321 1111111111
Q ss_pred cCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 722 LPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 722 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..... .+....++..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQFG--------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCCCC--------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CcccC--------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00000 0111234567889999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=338.77 Aligned_cols=262 Identities=21% Similarity=0.230 Sum_probs=192.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCC------
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD------ 570 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 570 (791)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999865 78999999987532 344567889999999999999999999987654
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..++||||++ |+|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+|+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999996 588888863 3889999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh-
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV- 729 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 729 (791)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+...+ ........+.
T Consensus 176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~-~~~~~~~~~~~ 250 (371)
T 2xrw_A 176 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVI-EQLGTPCPEFM 250 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-C-CCCCCHHHH
T ss_pred cccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HHhCCCCHHHH
Confidence 754321 2233568999999999999899999999999999999999999997632211 111111 0000000000
Q ss_pred --cchhhhhh---------------------HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 --VDANLVRE---------------------EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 --~d~~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+.+..... ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000 0000112234677899999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=357.17 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=205.5
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 468999999999999999999975 78999999986542 33457789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe---CCCCcEEEeeecccccc
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLL 652 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfgla~~~ 652 (791)
|||+.+|+|.+++..... +++..+..++.||+.||.||| +.+|+||||||+||++ +.++.+||+|||+|+.+
T Consensus 105 ~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMH----KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCSC-CBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999986544 899999999999999999999 6789999999999999 56789999999999877
Q ss_pred CCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcch
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 732 (791)
..... ....+||+.|+|||++.+ .++.++||||+||++|||++|+.||..... ......+.......
T Consensus 180 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~------- 246 (484)
T 3nyv_A 180 EASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKYTF------- 246 (484)
T ss_dssp CCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCC-------
T ss_pred ccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCCCCC-------
Confidence 54332 233569999999998865 689999999999999999999999976322 11111111110000
Q ss_pred hhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+....++..+.+++.+||+.||++|||+.|+++
T Consensus 247 -------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 -------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 01112245567889999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=345.70 Aligned_cols=254 Identities=24% Similarity=0.280 Sum_probs=200.8
Q ss_pred hhccccccccCCCcceEEEEEEe----cCCcEEEEEEeehhh----hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI----SDGTDVAIKIFNLQL----ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPD 570 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 570 (791)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 378999999986432 12334567799999999 6999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999998654 3899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCC--CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
.+..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~---- 281 (355)
T 1vzo_A 208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKS---- 281 (355)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHC----
T ss_pred ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhcc----
Confidence 7643222 12233569999999999875 457899999999999999999999997532221 111111110000
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAAK 775 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~~ 775 (791)
..+.+..++..+.+++.+||+.||++|| ++.|+++.
T Consensus 282 -----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 -----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 0001123446678999999999999999 99998764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=345.51 Aligned_cols=197 Identities=25% Similarity=0.310 Sum_probs=171.8
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc------cCCccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNV------RHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~ 572 (791)
..+|++.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++.+ .|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999865 68999999997543 3345677888888887 577999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc--EEEeeeccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA--AHVSDFGIS 649 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfgla 649 (791)
++||||+. |+|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++. +||+|||+|
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH----KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999995 69999998654 35899999999999999999999 668999999999999999887 999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCcc
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~ 707 (791)
+..... ....+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 765432 22346899999999999889999999999999999999999999764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=367.40 Aligned_cols=249 Identities=22% Similarity=0.247 Sum_probs=204.0
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeee
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 573 (791)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999975 68899999997642 33456778899999987 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+||||+++|+|.+++...+. +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 419 lV~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH----~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999986543 899999999999999999999 6789999999999999999999999999998643
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ..+.+.+. ....
T Consensus 494 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~~~~i~---~~~~------- 559 (674)
T 3pfq_A 494 WDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIM---EHNV------- 559 (674)
T ss_dssp CTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH---SSCC-------
T ss_pred cCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHHHHHHH---hCCC-------
Confidence 3222 23345799999999999999999999999999999999999999976321 11111111 1100
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINV-----TDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~-----~ev~~ 774 (791)
..+..++.++.+++.+||+.||++||++ .||++
T Consensus 560 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0011345668899999999999999997 66653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.98 Aligned_cols=272 Identities=21% Similarity=0.259 Sum_probs=199.6
Q ss_pred HHHhhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeecc-------
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN------- 568 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------- 568 (791)
....++|++.+.||+|+||.||+|+. .+|+.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999986 4799999999865432 22369999999999999999999843
Q ss_pred -------------------------------CCeeeEEEecCCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHH
Q 003855 569 -------------------------------PDFKALVLEFMPNGSLEKWLY---SHNYFLDILERLNIMIDVGSALEYL 614 (791)
Q Consensus 569 -------------------------------~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~L 614 (791)
....++||||++ |+|.+.+. .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334789999997 58888776 3445699999999999999999999
Q ss_pred HccCCCCCeEecCCCCCCeEeC-CCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCC-CCCccccHHhHHH
Q 003855 615 HHGHSSAPIIHCDLKPTNILLD-ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGV 692 (791)
Q Consensus 615 H~~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~ 692 (791)
| +.+|+||||||+||+++ .++.+||+|||+|+.+..... .....+|+.|+|||.+.+. .++.++||||+||
T Consensus 158 H----~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 158 H----SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp H----TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred H----HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 9 78999999999999998 689999999999987654332 2234689999999987664 5899999999999
Q ss_pred HHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc----------hhhhhhHHhhHHHHHHHHHHHHHHhhccccC
Q 003855 693 LLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD----------ANLVREEQAFSAKMDCILSIMDLALDCCIES 762 (791)
Q Consensus 693 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 762 (791)
++|||++|+.||.+.... ..+...+..........+.. +......-....+..++..+.+++.+||+.|
T Consensus 231 il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999999763221 12222222111111000000 0000000000111235567889999999999
Q ss_pred CCCCCCHHHHHH--HHHHHHH
Q 003855 763 PDMRINVTDAAA--KLKKIKV 781 (791)
Q Consensus 763 P~~RPt~~ev~~--~L~~~~~ 781 (791)
|++|||+.|+++ .+..++.
T Consensus 310 P~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 310 PDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GGGSCCHHHHHTSGGGHHHHH
T ss_pred hhhCCCHHHHhcCHHHHHHHh
Confidence 999999999984 3444443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=333.56 Aligned_cols=266 Identities=20% Similarity=0.267 Sum_probs=196.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeec-----------
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCS----------- 567 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----------- 567 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 368999999999999999999976 58999999988766666788999999999999999999998873
Q ss_pred ---cCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC-CCCcEEE
Q 003855 568 ---NPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD-ENMAAHV 643 (791)
Q Consensus 568 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~-~~~~~kl 643 (791)
+....++||||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999997 6999999754 3889999999999999999999 67899999999999997 6779999
Q ss_pred eeeccccccCCCCCc-ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHh
Q 003855 644 SDFGISKLLGEGEDS-VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKES 721 (791)
Q Consensus 644 ~Dfgla~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 721 (791)
+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..... +...
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~-~~~~ 240 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQMQL-ILES 240 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH-HHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHHh
Confidence 999999876433211 12233457899999997654 77899999999999999999999999764321 11111 1111
Q ss_pred cCCChh----hh---cchhhhhhH-----HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 722 LPHGLT----EV---VDANLVREE-----QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 722 ~~~~~~----~~---~d~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+.... +. +........ ........++.++.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111100 00 000000000 000011235678899999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.39 Aligned_cols=261 Identities=23% Similarity=0.372 Sum_probs=199.8
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||.||+|+.++ .||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4789999999999999999999753 59999986542 2233457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++++|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++ ++.+||+|||+++.......
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH----AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH----HTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 99999999999877667899999999999999999999 67899999999999998 67999999999876532211
Q ss_pred ---cceeecccccccccCCCccCC---------CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC
Q 003855 658 ---SVTQTMTMATIGYMAPEYGSE---------GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG 725 (791)
Q Consensus 658 ---~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (791)
........|++.|+|||.+.. ..++.++||||||+++|||++|+.||...... .....+.......
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--AIIWQMGTGMKPN 262 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--HHHHHHHTTCCCC
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhccCCCCC
Confidence 112233458999999998764 45789999999999999999999999753221 1111111100000
Q ss_pred hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 726 ~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
. ....++.++.+++.+||+.||++|||+.++++.|+++..+...
T Consensus 263 ~----------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 263 L----------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp C----------------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred C----------------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 0012345577999999999999999999999999998766543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=344.81 Aligned_cols=264 Identities=21% Similarity=0.243 Sum_probs=201.4
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc--------CCccceeeeeec---
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVR--------HRNLIKILSSCS--- 567 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~--- 567 (791)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 7889999998754 334567888999999985 788999999987
Q ss_pred -cCCeeeEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCC-CeEecCCCCCCeEeCCCC-----
Q 003855 568 -NPDFKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSA-PIIHCDLKPTNILLDENM----- 639 (791)
Q Consensus 568 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-~i~H~dlk~~Nill~~~~----- 639 (791)
+....++||||+ +|++.+++... ...+++..+..++.||+.||+||| +. +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH----TKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HhCCEecCCCCHHHeeEeccchhhhh
Confidence 567889999999 66777776644 356899999999999999999999 55 899999999999999775
Q ss_pred --------------------------------------------cEEEeeeccccccCCCCCcceeecccccccccCCCc
Q 003855 640 --------------------------------------------AAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675 (791)
Q Consensus 640 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~ 675 (791)
.+||+|||+|+..... ....+||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999876432 233468999999999
Q ss_pred cCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcch----HHHHHHHhcCCChhh----------hcch---------
Q 003855 676 GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS----LRRWVKESLPHGLTE----------VVDA--------- 732 (791)
Q Consensus 676 ~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~----------~~d~--------- 732 (791)
+.+..++.++|||||||++|||+||+.||......+.. ....+.......... ....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 98888999999999999999999999999764332211 111111111100000 0000
Q ss_pred ----hhhh-hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 733 ----NLVR-EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 733 ----~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+.. ..........++..+.+++.+||+.||++|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000 00011122456778999999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=329.29 Aligned_cols=253 Identities=24% Similarity=0.320 Sum_probs=193.9
Q ss_pred HhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeecc---------
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN--------- 568 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 568 (791)
..++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3578999999999999999999974 7899999998654 3445778899999999999999999998754
Q ss_pred ----CCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEe
Q 003855 569 ----PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVS 644 (791)
Q Consensus 569 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~ 644 (791)
....++||||+++|+|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH----SQGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH----hCCeecccCCHHhEEEcCCCCEEEe
Confidence 45678999999999999999977767889999999999999999999 6789999999999999999999999
Q ss_pred eeccccccCCCCC------------cceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCc
Q 003855 645 DFGISKLLGEGED------------SVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711 (791)
Q Consensus 645 Dfgla~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 711 (791)
|||+++....... ........|++.|+|||.+.+. .++.++|||||||++|||++ ||.......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 9999987643211 1122334689999999988754 78999999999999999998 554211111
Q ss_pred chHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 712 MSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. ....+.... ..... . ....++..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~-~~~~~~~~~-~~~~~----~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 N-ILKKLRSVS-IEFPP----D---------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp H-HHHHHHSTT-CCCCT----T---------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H-HHHhccccc-cccCc----c---------ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1 111111100 00000 0 01133456789999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.63 Aligned_cols=267 Identities=24% Similarity=0.248 Sum_probs=200.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccC-----Cee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP-----DFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 572 (791)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 478999999999999999999975 78999999986433 34456788999999999999999999987653 678
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||++ |+|.+++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 6999999874 3899999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCcc--------eeecccccccccCCCccC-CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC
Q 003855 653 GEGEDSV--------TQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP 723 (791)
Q Consensus 653 ~~~~~~~--------~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (791)
....... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.+....+ .+.........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~ 241 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGT 241 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCC
Confidence 5432111 122346899999999764 4779999999999999999999999997632211 11111111000
Q ss_pred C----ChhhhcchhhhhhHH---------hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 724 H----GLTEVVDANLVREEQ---------AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 724 ~----~~~~~~d~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. ............... .......++.++.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 000000000000000 00111245677889999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=335.62 Aligned_cols=255 Identities=23% Similarity=0.322 Sum_probs=197.2
Q ss_pred HHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeecc----
Q 003855 495 DIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSN---- 568 (791)
Q Consensus 495 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---- 568 (791)
++....++|++.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34445688999999999999999999974 789999999865432 346788899999999 89999999999866
Q ss_pred --CCeeeEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEee
Q 003855 569 --PDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSD 645 (791)
Q Consensus 569 --~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~D 645 (791)
....++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCcHHHEEEcCCCCEEEee
Confidence 467899999999999999998643 45899999999999999999999 67899999999999999999999999
Q ss_pred eccccccCCCCCcceeecccccccccCCCccC-----CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHH
Q 003855 646 FGISKLLGEGEDSVTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 720 (791)
Q Consensus 646 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 720 (791)
||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|+.||....... ....+..
T Consensus 173 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~ 248 (326)
T 2x7f_A 173 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--ALFLIPR 248 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH
T ss_pred CcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHhhc
Confidence 999987643221 223346899999999876 5678999999999999999999999996532211 1111111
Q ss_pred hcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 721 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 721 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...... ....++..+.+++.+||+.||++||++.|+++
T Consensus 249 ~~~~~~----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 249 NPAPRL----------------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SCCCCC----------------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CccccC----------------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000 01123466889999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=342.69 Aligned_cols=268 Identities=21% Similarity=0.229 Sum_probs=184.1
Q ss_pred hhcccc-ccccCCCcceEEEEEEec---CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeee--ccCCeee
Q 003855 500 TDEFNE-CNLLGTGSFGSVYKGTIS---DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC--SNPDFKA 573 (791)
Q Consensus 500 ~~~~~~-~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~--~~~~~~~ 573 (791)
.+.|++ .++||+|+||.||+|+.. +++.||||++..... ...+.+|+.++++++||||+++++++ ......+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 355766 458999999999999965 578899999875432 24677899999999999999999999 4577899
Q ss_pred EEEecCCCCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe----CCCCcE
Q 003855 574 LVLEFMPNGSLEKWLYSH--------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL----DENMAA 641 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill----~~~~~~ 641 (791)
+||||++ |+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+|||+ +.++.+
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 9999996 5888888622 224899999999999999999999 6789999999999999 778999
Q ss_pred EEeeeccccccCCCCCc-ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccC--------c
Q 003855 642 HVSDFGISKLLGEGEDS-VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG--------E 711 (791)
Q Consensus 642 kl~Dfgla~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~--------~ 711 (791)
||+|||+|+.+...... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999999876543221 22334578999999998876 45999999999999999999999999753221 0
Q ss_pred chHHHHHHHhcCC---Chhhhcc---h-----hhhhhHHh--------hHHHHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 003855 712 MSLRRWVKESLPH---GLTEVVD---A-----NLVREEQA--------FSAKMDCILSIMDLALDCCIESPDMRINVTDA 772 (791)
Q Consensus 712 ~~~~~~~~~~~~~---~~~~~~d---~-----~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev 772 (791)
..+...+...... .+..+.. . .+...... .......+..+.+++.+||+.||++|||+.|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 1122222111100 0110000 0 00000000 00000114567899999999999999999999
Q ss_pred HH
Q 003855 773 AA 774 (791)
Q Consensus 773 ~~ 774 (791)
++
T Consensus 332 L~ 333 (405)
T 3rgf_A 332 MQ 333 (405)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=354.37 Aligned_cols=336 Identities=22% Similarity=0.253 Sum_probs=275.0
Q ss_pred CCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccc
Q 003855 35 NISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSL 114 (791)
Q Consensus 35 ~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 114 (791)
.+.+++.|++++|.+. .+|..++..+++|++|+|++|.|+++.|..|+.+++|++|+|++|.++++.+..|+++++|+.
T Consensus 49 ~l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 127 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 127 (597)
T ss_dssp GGCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cCCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCE
Confidence 4678999999999997 888887777899999999999999888889999999999999999999988888999999999
Q ss_pred cccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCC
Q 003855 115 LSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLT 194 (791)
Q Consensus 115 L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 194 (791)
|++++|.++.++... |.++++|++|+|++|.+++. .|..|.++++|+
T Consensus 128 L~L~~n~l~~l~~~~--------~~~l~~L~~L~Ls~N~l~~~-------------------------~~~~~~~l~~L~ 174 (597)
T 3oja_B 128 LVLERNDLSSLPRGI--------FHNTPKLTTLSMSNNNLERI-------------------------EDDTFQATTSLQ 174 (597)
T ss_dssp EECCSSCCCCCCTTT--------TTTCTTCCEEECCSSCCCBC-------------------------CTTTTTTCTTCC
T ss_pred EEeeCCCCCCCCHHH--------hccCCCCCEEEeeCCcCCCC-------------------------ChhhhhcCCcCc
Confidence 999999988776544 78888999999999888754 344577788888
Q ss_pred EEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCc
Q 003855 195 LLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNK 274 (791)
Q Consensus 195 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 274 (791)
.|+|++|.+++.. +..+++|+.|++++|.+++ +...++|+.|++++|.+....+. + .++|+.|+|++|.
T Consensus 175 ~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~ 243 (597)
T 3oja_B 175 NLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNN 243 (597)
T ss_dssp EEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSC
T ss_pred EEECcCCCCCCcC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccccccc-c--CCCCCEEECCCCC
Confidence 8888888888652 5567888888888888874 34456788888988888743322 2 3689999999999
Q ss_pred CCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcc
Q 003855 275 LTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPES 354 (791)
Q Consensus 275 l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 354 (791)
+++ +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..
T Consensus 244 l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~ 319 (597)
T 3oja_B 244 LTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERN 319 (597)
T ss_dssp CCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGG
T ss_pred CCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcc
Confidence 985 4678888999999999999988888889999999999999999984 5666777899999999999998 67888
Q ss_pred cCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccccCCC
Q 003855 355 VGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 355 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~ 423 (791)
+..+++|+.|+|++|++++.. +..+++|+.|++++|+++|.... ..+..+....+.++...|+.+
T Consensus 320 ~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 320 QPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp HHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred cccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence 888999999999999998553 66778999999999999886532 234455556677888888754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=336.23 Aligned_cols=261 Identities=22% Similarity=0.256 Sum_probs=197.4
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCee----
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK---- 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 572 (791)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999865 78999999987542 34456788999999999999999999999876654
Q ss_pred --eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 573 --ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 573 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
++||||+. |+|.+++.. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999996 689888743 3899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC--hh
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG--LT 727 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 727 (791)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.... ..+........... ..
T Consensus 193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCcHHHH
Confidence 65332 233568999999998876 77999999999999999999999999763221 11222211111110 00
Q ss_pred hhcchhhhhhH----------HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVREE----------QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+........ ........++..+.+++.+||+.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000000000 000011234677899999999999999999999976
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.75 Aligned_cols=262 Identities=22% Similarity=0.268 Sum_probs=202.7
Q ss_pred hhccccccccCCCcceEEEEEEe--cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCc------cceeeeeeccCCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI--SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN------LIKILSSCSNPDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~ 571 (791)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 368899999987543 34567888999999987665 9999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-------------
Q 003855 572 KALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE------------- 637 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~------------- 637 (791)
.++||||+ +++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH----SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 889999998654 35889999999999999999999 678999999999999987
Q ss_pred ------CCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCc
Q 003855 638 ------NMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711 (791)
Q Consensus 638 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 711 (791)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999875432 223468999999999999899999999999999999999999997632211
Q ss_pred chHHHHHHHhcCCChhhhcc--------------------------hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCC
Q 003855 712 MSLRRWVKESLPHGLTEVVD--------------------------ANLVREEQAFSAKMDCILSIMDLALDCCIESPDM 765 (791)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~d--------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~ 765 (791)
....+............. ...............++..+.+++.+||+.||++
T Consensus 242 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 242 --HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp --HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred --HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 111111111100000000 0000000000112245678999999999999999
Q ss_pred CCCHHHHHH
Q 003855 766 RINVTDAAA 774 (791)
Q Consensus 766 RPt~~ev~~ 774 (791)
|||+.|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.10 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=203.9
Q ss_pred HHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
....++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344578999999999999999999975 78999999987543 234567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC---CcEEEeeecccc
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN---MAAHVSDFGISK 650 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfgla~ 650 (791)
+||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.+ +.+||+|||+++
T Consensus 98 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999987654 3899999999999999999999 6789999999999999754 479999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHH-hcCCChhhh
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE-SLPHGLTEV 729 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 729 (791)
....... .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||..... ......+.. .....
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~---- 242 (287)
T 2wei_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFD---- 242 (287)
T ss_dssp TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCCCCC----
T ss_pred eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCCCC----
Confidence 7654322 222357899999998765 489999999999999999999999976321 111111111 00000
Q ss_pred cchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 ~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+....++.++.+++.+|++.||++|||+.|+++
T Consensus 243 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 -----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -----------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0111234567889999999999999999999987
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=331.32 Aligned_cols=335 Identities=21% Similarity=0.240 Sum_probs=280.3
Q ss_pred CCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCE
Q 003855 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVA 90 (791)
Q Consensus 11 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 90 (791)
.++++++|++++|.++.+.+..|.++++|++|+|++|+++ .+|...+..+++|++|+|++|.++++.|..|+++++|++
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc-ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 4689999999999999887777899999999999999998 666544455899999999999999988999999999999
Q ss_pred EeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhh
Q 003855 91 LDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQ 170 (791)
Q Consensus 91 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~ 170 (791)
|+|++|+++.++...|.++++|+.|++++|+++.++.. .|..+++|++|++++|++++.
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~--------~~~~l~~L~~L~l~~n~l~~~------------- 180 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD--------TFQATTSLQNLQLSSNRLTHV------------- 180 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTT--------TTSSCTTCCEEECCSSCCSBC-------------
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChh--------hccCCCCCCEEECCCCcCCcc-------------
Confidence 99999999988888899999999999999999887643 388999999999999999853
Q ss_pred hhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCc
Q 003855 171 KFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNK 250 (791)
Q Consensus 171 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 250 (791)
.+..+++|+.|++++|.+++. ...++|++|++++|.++.. |.. ..++|+.|++++|.
T Consensus 181 ---------------~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~ 237 (390)
T 3o6n_A 181 ---------------DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNN 237 (390)
T ss_dssp ---------------CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSC
T ss_pred ---------------ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCC
Confidence 134567889999999988743 3446899999999999854 332 24789999999999
Q ss_pred cCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcc
Q 003855 251 LSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPST 330 (791)
Q Consensus 251 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 330 (791)
+++. ..+..+++|++|+|++|++.+..|..|..+++|+.|+|++|++++ +|..+..+++|+.|++++|+++ .+|..
T Consensus 238 l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~ 313 (390)
T 3o6n_A 238 LTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERN 313 (390)
T ss_dssp CCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGG
T ss_pred Cccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCcc
Confidence 9854 578999999999999999998889999999999999999999985 5666788999999999999998 67778
Q ss_pred hhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccC
Q 003855 331 IGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEI 399 (791)
Q Consensus 331 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 399 (791)
+..+++|+.|++++|+++. ++ +..+++|+.|++++|++.+..... -+..+....+..+...+..
T Consensus 314 ~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~~~~~--~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 314 QPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLRA--LFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp HHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHHHH--HTTTCCTTTBCCCCSCCCT
T ss_pred ccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccchhHHH--HHHHHHhhcccccCceecc
Confidence 8999999999999999984 43 778899999999999998643322 2334444445555544443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=342.52 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=193.2
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCC------eee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD------FKA 573 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~ 573 (791)
..+|+..+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++.... ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357999999999999999999987777799998764422 2235899999999999999999984432 378
Q ss_pred EEEecCCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC-CCCcEEEeeeccc
Q 003855 574 LVLEFMPNGSLEKWLY---SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD-ENMAAHVSDFGIS 649 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfgla 649 (791)
+||||++++ +.+.+. .....+++..+..++.||++||+||| +.+|+||||||+||+++ .++.+||+|||+|
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 999999764 444333 23456899999999999999999999 67899999999999999 7999999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
+.+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+... ...+...++.........
T Consensus 190 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 190 KILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp EECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHH
T ss_pred ccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHH
Confidence 87654332 2234689999999987654 599999999999999999999999976322 112222222111110000
Q ss_pred --hcchhh--------hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 --VVDANL--------VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 --~~d~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..++.. ............++.++.+++.+||+.||++|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000000 0000000011124567899999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=343.29 Aligned_cols=261 Identities=23% Similarity=0.272 Sum_probs=193.4
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeecc------CCeee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN------PDFKA 573 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~ 573 (791)
.+|+..+.||+|+||.||+|+.. +|+.||||++..... ...+|++++++++||||+++++++.. ....+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999975 689999999865422 23469999999999999999998843 22356
Q ss_pred EEEecCCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC-CcEEEeeeccc
Q 003855 574 LVLEFMPNGSLEKWLY---SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN-MAAHVSDFGIS 649 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfgla 649 (791)
+||||+++ ++.+.+. .....+++..+..++.||++||+||| +.+|+||||||+|||++.+ +.+||+|||+|
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 89999975 7776665 34456899999999999999999999 7899999999999999965 67899999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
+.+..... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... ...+.+.+..........
T Consensus 205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHH
T ss_pred hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHH
Confidence 87654332 2234689999999988664 799999999999999999999999976322 122222222111110000
Q ss_pred ----------hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 ----------VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 ----------~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+.+....-.......++.++.+++.+||+.||++||++.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000000000000001134567889999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=333.22 Aligned_cols=202 Identities=27% Similarity=0.319 Sum_probs=172.5
Q ss_pred HHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CC-----ccceeeeeeccC
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HR-----NLIKILSSCSNP 569 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~ 569 (791)
....++|++.+.||+|+||.||+|+.. +++.||||++.... .....+..|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344679999999999999999999875 78899999987542 33466778888888884 54 499999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC--CCCcEEEeee
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD--ENMAAHVSDF 646 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~--~~~~~kl~Df 646 (791)
+..++||||++ |+|.+++.... ..+++..+..++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999995 59999998654 4589999999999999999999931 35899999999999995 5788999999
Q ss_pred ccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCcc
Q 003855 647 GISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEM 707 (791)
Q Consensus 647 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~ 707 (791)
|+|+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.
T Consensus 206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999876432 22356899999999999999999999999999999999999999763
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.15 Aligned_cols=267 Identities=24% Similarity=0.319 Sum_probs=200.3
Q ss_pred HhhccccccccCCCcceEEEEEEe--cCCcEEEEEEeehhhh--HHHHHHHHHHHHHHhc---cCCccceeeeeec----
Q 003855 499 ATDEFNECNLLGTGSFGSVYKGTI--SDGTDVAIKIFNLQLE--RAFRSFDSECEVLRNV---RHRNLIKILSSCS---- 567 (791)
Q Consensus 499 ~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 567 (791)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 4688999999864431 1123455677777666 8999999999986
Q ss_pred -cCCeeeEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEee
Q 003855 568 -NPDFKALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSD 645 (791)
Q Consensus 568 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~D 645 (791)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHHHeEEcCCCCEEEec
Confidence 5667899999997 69999998653 34899999999999999999999 67899999999999999999999999
Q ss_pred eccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC
Q 003855 646 FGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG 725 (791)
Q Consensus 646 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 725 (791)
||+++..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+...+.......
T Consensus 164 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 164 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPG 239 (326)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred CcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCC
Confidence 9999865432 1223456899999999999889999999999999999999999999763221 11222221111000
Q ss_pred hhhh---cc-h--hhhhh--HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 726 LTEV---VD-A--NLVRE--EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 726 ~~~~---~d-~--~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.... .. + .+... .........++..+.+++.+||+.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00 0 00000 0000011235567889999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=333.37 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=177.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHH-HHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECE-VLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.++|+..+.||+|+||.||+|... +|+.||||++.... ......+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368899999999999999999975 78999999987543 233344555555 677789999999999999999999999
Q ss_pred ecCCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-CeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 577 EFMPNGSLEKWLYS----HNYFLDILERLNIMIDVGSALEYLHHGHSSA-PIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 577 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
||+++ +|.+++.. ....+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||+++.
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK----ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH----HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh----ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99975 88888763 2455899999999999999999999 55 899999999999999999999999999987
Q ss_pred cCCCCCcceeecccccccccCCCcc----CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYG----SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
..... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ .+.........
T Consensus 176 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~ 248 (327)
T 3aln_A 176 LVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----QLTQVVKGDPP 248 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSCCC
T ss_pred ccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----HHHHHhcCCCC
Confidence 64332 22234689999999998 466789999999999999999999999975321110 01000000000
Q ss_pred hhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. +.. .....++..+.+++.+||+.||++||++.|+++
T Consensus 249 ~-----~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 249 Q-----LSN-----SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C-----CCC-----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-----CCC-----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 000 001124567889999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.01 Aligned_cols=251 Identities=23% Similarity=0.279 Sum_probs=182.8
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999975 78999999987543 223344555566788889999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-CeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA-PIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
||+ ++.+..+.......+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK----EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 56676666554556899999999999999999999 43 8999999999999999999999999999766432
Q ss_pred CCcceeecccccccccCCCccC-----CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 656 EDSVTQTMTMATIGYMAPEYGS-----EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
. ......|++.|+|||.+. ...++.++|||||||++|||++|+.||..................+ .
T Consensus 179 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~----- 249 (318)
T 2dyl_A 179 K---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP-L----- 249 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC-C-----
T ss_pred c---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC-C-----
Confidence 2 122346899999999884 5678899999999999999999999997532221111111111100 0
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+....++..+.+++.+||+.||++||++.|+++
T Consensus 250 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 ----------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0011124566889999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=330.83 Aligned_cols=261 Identities=22% Similarity=0.247 Sum_probs=195.9
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCe-----
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF----- 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 571 (791)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367999999999999999999975 78999999986542 3345678899999999999999999999977654
Q ss_pred -eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 572 -KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 572 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
.++||||++ |+|.+++.. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 688887643 3899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC--Chh
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH--GLT 727 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 727 (791)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.... ..+.......... ...
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCBCCHHHH
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 65322 223468999999998776 67899999999999999999999999763221 1111111111000 000
Q ss_pred hhcchhhhhhH-H---------hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVREE-Q---------AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~~-~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+........ . .......++..+.+++.+|++.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000000 0 00011234677899999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=329.00 Aligned_cols=262 Identities=23% Similarity=0.287 Sum_probs=200.2
Q ss_pred hhccccccccCCCcceEEEEEEec-CC-cEEEEEEeehhhhHHHHHHHHHHHHHHhccCCc------cceeeeeeccCCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DG-TDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN------LIKILSSCSNPDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~ 571 (791)
.++|++.+.||+|+||.||+|... ++ +.||||++.... ...+.+..|+.++++++|++ ++.+.+++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999974 44 789999987542 34567788999999998766 8999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEe---------------
Q 003855 572 KALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILL--------------- 635 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill--------------- 635 (791)
.++||||+ ++++.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH----ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecccccccccccccc
Confidence 99999999 667888777553 45899999999999999999999 7799999999999999
Q ss_pred ----CCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCc
Q 003855 636 ----DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE 711 (791)
Q Consensus 636 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 711 (791)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999999875432 223468999999999999999999999999999999999999997632211
Q ss_pred chHHHHHHHhcCCChhhhc----------------chh-----hhh-----hHHhhHHHHHHHHHHHHHHhhccccCCCC
Q 003855 712 MSLRRWVKESLPHGLTEVV----------------DAN-----LVR-----EEQAFSAKMDCILSIMDLALDCCIESPDM 765 (791)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~----------------d~~-----~~~-----~~~~~~~~~~~~~~l~~li~~cl~~~P~~ 765 (791)
....+............ +.. ... ..........++..+.+++.+||+.||++
T Consensus 247 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 247 --HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp --HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred --HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 11111111110000000 000 000 00000111234567899999999999999
Q ss_pred CCCHHHHHH
Q 003855 766 RINVTDAAA 774 (791)
Q Consensus 766 RPt~~ev~~ 774 (791)
|||+.|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=332.74 Aligned_cols=243 Identities=23% Similarity=0.270 Sum_probs=198.7
Q ss_pred HHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhH------HHHHHHHHHHHHHhcc--CCccceeeeeec
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLER------AFRSFDSECEVLRNVR--HRNLIKILSSCS 567 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~ 567 (791)
....++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+..|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344578999999999999999999864 7899999998765321 2245667999999996 599999999999
Q ss_pred cCCeeeEEEecCCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC-CCCcEEEee
Q 003855 568 NPDFKALVLEFMPN-GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD-ENMAAHVSD 645 (791)
Q Consensus 568 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~-~~~~~kl~D 645 (791)
+++..++||||+.+ ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999999976 89999998654 4899999999999999999999 67899999999999999 789999999
Q ss_pred eccccccCCCCCcceeecccccccccCCCccCCCCC-CccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC
Q 003855 646 FGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH 724 (791)
Q Consensus 646 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 724 (791)
||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ........
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~~~- 261 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQVF- 261 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCCC-
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhccccc-
Confidence 99998765432 223468999999998876655 788999999999999999999996521 11110000
Q ss_pred ChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 725 GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 725 ~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
....++.++.+++.+||+.||++|||+.|+++
T Consensus 262 ------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 262 ------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01123466789999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=328.99 Aligned_cols=252 Identities=22% Similarity=0.278 Sum_probs=173.8
Q ss_pred Hhhcccccc-ccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeecc----CCee
Q 003855 499 ATDEFNECN-LLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN----PDFK 572 (791)
Q Consensus 499 ~~~~~~~~~-~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 572 (791)
..++|++.+ .||+|+||.||+|+.. +++.||||++..... ...+....++.+.||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 357888855 6999999999999976 799999999865422 11222334566799999999999865 4558
Q ss_pred eEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC---CCcEEEeeecc
Q 003855 573 ALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE---NMAAHVSDFGI 648 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgl 648 (791)
++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH----~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999998654 35899999999999999999999 678999999999999986 45699999999
Q ss_pred ccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 649 SKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 649 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . ...........
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~-~~~~~~~~~~~ 251 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-G-MKRRIRLGQYG 251 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------C
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-h-HHHhhhccccc
Confidence 98754322 223468999999999988899999999999999999999999997533221100 0 00000000000
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. ..+....++..+.+++.+||+.||++|||+.|+++
T Consensus 252 ~----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 252 F----------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp C----------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c----------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00111235567889999999999999999999987
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=334.06 Aligned_cols=346 Identities=20% Similarity=0.207 Sum_probs=252.8
Q ss_pred cCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccc
Q 003855 20 FAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFA 99 (791)
Q Consensus 20 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 99 (791)
...+......+..+.++++|++|+|++|.++ .+| .+.. +++|++|+|++|+|+++ | ++.+++|++|+|++|+++
T Consensus 25 ~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~-~l~~-l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~ 98 (457)
T 3bz5_A 25 AAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEK-LTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLT 98 (457)
T ss_dssp HHHTTCCTTSEEEHHHHTTCCEEECCSSCCC-CCT-TGGG-CTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCS
T ss_pred HHhcCcCcccccChhHcCCCCEEEccCCCcc-cCh-hhcc-cCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCc
Confidence 3344555566778899999999999999998 677 4554 89999999999999975 4 899999999999999999
Q ss_pred ccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccc
Q 003855 100 GHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKL 179 (791)
Q Consensus 100 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l 179 (791)
++. |+++++|+.|++++|+++.++ +..+++|++|++++|++++. + +..+ ++|++|++++|..
T Consensus 99 ~~~---~~~l~~L~~L~L~~N~l~~l~-----------~~~l~~L~~L~l~~N~l~~l-~--l~~l-~~L~~L~l~~n~~ 160 (457)
T 3bz5_A 99 NLD---VTPLTKLTYLNCDTNKLTKLD-----------VSQNPLLTYLNCARNTLTEI-D--VSHN-TQLTELDCHLNKK 160 (457)
T ss_dssp CCC---CTTCTTCCEEECCSSCCSCCC-----------CTTCTTCCEEECTTSCCSCC-C--CTTC-TTCCEEECTTCSC
T ss_pred eee---cCCCCcCCEEECCCCcCCeec-----------CCCCCcCCEEECCCCcccee-c--cccC-CcCCEEECCCCCc
Confidence 863 899999999999999998753 78899999999999999975 2 3333 5689999999965
Q ss_pred cccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccc
Q 003855 180 KGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCL 259 (791)
Q Consensus 180 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~ 259 (791)
.+.+ .+..+++|+.|++++|+++++ | +..+++|++|++++|++++. .+..+++|+.|++++|++++ +| +
T Consensus 161 ~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~ 229 (457)
T 3bz5_A 161 ITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--V 229 (457)
T ss_dssp CCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--C
T ss_pred cccc--ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--c
Confidence 5555 478889999999999999864 3 78889999999999999864 38888999999999999986 45 7
Q ss_pred cCCCCCcEEEcCCCcCCCCCCccccCCC-------CCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCc---
Q 003855 260 VSLTSLRELHLGSNKLTSSIPSSLWSLE-------YILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPS--- 329 (791)
Q Consensus 260 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~-------~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~--- 329 (791)
+.+++|+.|++++|++++..+..+..+. +|+.|++++|.+.+.+| ++.+++|+.|++++|...+.+|.
T Consensus 230 ~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~ 307 (457)
T 3bz5_A 230 TPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAA 307 (457)
T ss_dssp TTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTC
T ss_pred cccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCC
Confidence 8889999999999999876554444443 44555555555544444 45667777777777765544432
Q ss_pred -----chhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCC
Q 003855 330 -----TIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGS 404 (791)
Q Consensus 330 -----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~ 404 (791)
.+..+++|+.|++++|++++. + ++.+++|+.|++++|++++ ++.|..|++++|.++|.. .
T Consensus 308 ~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~~----~ 372 (457)
T 3bz5_A 308 GITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAEG----Q 372 (457)
T ss_dssp CCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEEE----E
T ss_pred cceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEecc----e
Confidence 134445556666666666542 2 5555666666666666653 134444555666665541 2
Q ss_pred CcCCccccccCCc
Q 003855 405 FKNFSVESFFGNY 417 (791)
Q Consensus 405 ~~~l~~~~~~~n~ 417 (791)
+..++.+.+..|.
T Consensus 373 ~~~l~~l~l~~N~ 385 (457)
T 3bz5_A 373 TITMPKETLTNNS 385 (457)
T ss_dssp EEECCCBCCBTTB
T ss_pred eeecCccccccCc
Confidence 3334444444444
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.06 Aligned_cols=273 Identities=19% Similarity=0.209 Sum_probs=190.4
Q ss_pred hHHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCe-
Q 003855 494 LDIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF- 571 (791)
Q Consensus 494 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~- 571 (791)
.......++|++.+.||+|+||.||+|+.. +|+.||||++..... ....+.+++..++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455677889999999999999999999975 789999998865432 22345667888889999999999999854332
Q ss_pred ------eeEEEecCCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-CCcE
Q 003855 572 ------KALVLEFMPNGSLEKWLY---SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-NMAA 641 (791)
Q Consensus 572 ------~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-~~~~ 641 (791)
.++||||+++ ++.+.+. .....+++..+..++.|++.||.|||.. +.+|+||||||+||+++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP--SVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST--TTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC--CCCeecCcCCHHHEEEeCCCCcE
Confidence 7899999976 6655544 2445589999999999999999999931 468999999999999996 8999
Q ss_pred EEeeeccccccCCCCCcceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHH
Q 003855 642 HVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 720 (791)
Q Consensus 642 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 720 (791)
||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...+..
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~ 247 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQLHEIVRV 247 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHHHHHHHHH
Confidence 9999999987654332 2334689999999987654 489999999999999999999999976322 1222222221
Q ss_pred hcCCC--hhhhcchh-----------hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 721 SLPHG--LTEVVDAN-----------LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 721 ~~~~~--~~~~~d~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..... ....+++. .............++.++.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11110 00000000 00000000011124677899999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=340.78 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=187.2
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
+.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.+++++ +||||+++++++.+....++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 3455678899999999987666689999999987543 34567899999887 8999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCC------CCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC-------------Cc
Q 003855 580 PNGSLEKWLYSHNYF------LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN-------------MA 640 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~-------------~~ 640 (791)
. |+|.+++...... .++..+..++.||+.||+||| +.+|+||||||+||+++.+ +.
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 5 6999999865321 123345789999999999999 6789999999999999754 48
Q ss_pred EEEeeeccccccCCCCCcc--eeecccccccccCCCccCC-------CCCCccccHHhHHHHHHHHHh-CCCCCCccccC
Q 003855 641 AHVSDFGISKLLGEGEDSV--TQTMTMATIGYMAPEYGSE-------GIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTG 710 (791)
Q Consensus 641 ~kl~Dfgla~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~ 710 (791)
+||+|||+|+.+....... ......||++|+|||++.+ ..++.++|||||||++|||+| |+.||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999999876543221 1234579999999998865 678999999999999999999 99999753322
Q ss_pred cchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 711 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+ .............. ......++.++.+++.+||+.||++|||+.|+++
T Consensus 247 ~---~~i~~~~~~~~~~~------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 E---SNIIRGIFSLDEMK------------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H---HHHHHTCCCCCCCT------------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H---HHHhcCCCCccccc------------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 12222111110000 0011245677889999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=331.85 Aligned_cols=264 Identities=19% Similarity=0.217 Sum_probs=198.3
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-----------CCccceeeeeec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-----------HRNLIKILSSCS 567 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~ 567 (791)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999999996 478999999987543 33466788999999886 899999999987
Q ss_pred cCC----eeeEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCC-CeEecCCCCCCeEeC-----
Q 003855 568 NPD----FKALVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSA-PIIHCDLKPTNILLD----- 636 (791)
Q Consensus 568 ~~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-~i~H~dlk~~Nill~----- 636 (791)
..+ ..++||||+ +++|.+++... ...+++..+..++.||+.||+||| +. +|+||||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH----RRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH----hcCCEEecCCChHHeEEeccCCC
Confidence 543 789999999 89999999864 345899999999999999999999 55 899999999999994
Q ss_pred -CCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCc----
Q 003855 637 -ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE---- 711 (791)
Q Consensus 637 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~---- 711 (791)
..+.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999876432 223468999999999998899999999999999999999999997533211
Q ss_pred -chHHHHHHHhcCCCh---------hhhcch-------------hhh-hhHHhhHHHHHHHHHHHHHHhhccccCCCCCC
Q 003855 712 -MSLRRWVKESLPHGL---------TEVVDA-------------NLV-REEQAFSAKMDCILSIMDLALDCCIESPDMRI 767 (791)
Q Consensus 712 -~~~~~~~~~~~~~~~---------~~~~d~-------------~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 767 (791)
..+...+........ ...+.. .+. ........+..++.++.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 111111111000000 000000 000 00001112245678899999999999999999
Q ss_pred CHHHHHH
Q 003855 768 NVTDAAA 774 (791)
Q Consensus 768 t~~ev~~ 774 (791)
|+.|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=319.74 Aligned_cols=307 Identities=27% Similarity=0.404 Sum_probs=212.7
Q ss_pred ccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccc
Q 003855 33 IFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHL 112 (791)
Q Consensus 33 ~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L 112 (791)
+..+++|++|++++|.+. .+|. +.. +++|++|+|++|.++++.+ |..+++|++|+|++|.++.+ ..|.++++|
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~~-~~~-~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L 112 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQG-IEY-LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNL 112 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCTT-GGG-CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred chhcccccEEEEeCCccc-cchh-hhh-cCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcC
Confidence 445666777777777665 5553 333 6667777777776664433 66667777777777766643 246666666
Q ss_pred cccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCC
Q 003855 113 SLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSG 192 (791)
Q Consensus 113 ~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 192 (791)
++|++++|+++.++ .+..+++|+.|++++|..... +..+..+++
T Consensus 113 ~~L~l~~n~i~~~~----------~~~~l~~L~~L~l~~n~~~~~--------------------------~~~~~~l~~ 156 (347)
T 4fmz_A 113 RELYLNEDNISDIS----------PLANLTKMYSLNLGANHNLSD--------------------------LSPLSNMTG 156 (347)
T ss_dssp SEEECTTSCCCCCG----------GGTTCTTCCEEECTTCTTCCC--------------------------CGGGTTCTT
T ss_pred CEEECcCCcccCch----------hhccCCceeEEECCCCCCccc--------------------------ccchhhCCC
Confidence 66666666666543 156677777777777754322 122566777
Q ss_pred CCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCC
Q 003855 193 LTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGS 272 (791)
Q Consensus 193 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 272 (791)
|++|++++|.+.+..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|++|++++
T Consensus 157 L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~ 230 (347)
T 4fmz_A 157 LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGN 230 (347)
T ss_dssp CCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCS
T ss_pred CcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccC
Confidence 7777887777774433 6777778888888887774333 7777778888888887775433 77777888888888
Q ss_pred CcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCC
Q 003855 273 NKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIP 352 (791)
Q Consensus 273 N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 352 (791)
|++++..+ +..+++|++|++++|.+++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..+
T Consensus 231 n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~ 304 (347)
T 4fmz_A 231 NKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDM 304 (347)
T ss_dssp SCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGH
T ss_pred CccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcCh
Confidence 88875443 77778888888888887653 4577788888888888888743 457778888888888888887777
Q ss_pred cccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCc
Q 003855 353 ESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396 (791)
Q Consensus 353 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 396 (791)
..++.+++|+.|++++|++++..| +..+++|+.|++++|+++
T Consensus 305 ~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 305 EVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 778888888888888888886655 777888888888888775
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=335.02 Aligned_cols=352 Identities=24% Similarity=0.237 Sum_probs=267.0
Q ss_pred cccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCC-------------ccEEEccCCcc
Q 003855 8 EIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN-------------IESLLLAANNL 74 (791)
Q Consensus 8 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~-------------L~~L~L~~N~l 74 (791)
.--..+.|++|++++|++ +.+|.+|+++++|++|++++|++.|.+|..++. +++ +++|++++|.+
T Consensus 6 ~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~-l~~L~~l~l~~c~~~~l~~L~l~~~~l 83 (454)
T 1jl5_A 6 RNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGE-QREMAVSRLRDCLDRQAHELELNNLGL 83 (454)
T ss_dssp -----------------------------CCHHHHHHHHHHHHHTSCTTSCC-CHHHHHHHHHHHHHHTCSEEECTTSCC
T ss_pred cccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCccccc-chhcchhhhhhhhccCCCEEEecCCcc
Confidence 334568999999999999 688999999999999999999999999998876 454 59999999999
Q ss_pred eecCCccCcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCC
Q 003855 75 TGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPL 154 (791)
Q Consensus 75 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 154 (791)
++ +|.. .++|++|++++|.++++. . .+++|+.|++++|+++.++. + .++|++|++++|++
T Consensus 84 ~~-lp~~---~~~L~~L~l~~n~l~~lp-~---~~~~L~~L~l~~n~l~~l~~----------~--~~~L~~L~L~~n~l 143 (454)
T 1jl5_A 84 SS-LPEL---PPHLESLVASCNSLTELP-E---LPQSLKSLLVDNNNLKALSD----------L--PPLLEYLGVSNNQL 143 (454)
T ss_dssp SC-CCSC---CTTCSEEECCSSCCSSCC-C---CCTTCCEEECCSSCCSCCCS----------C--CTTCCEEECCSSCC
T ss_pred cc-CCCC---cCCCCEEEccCCcCCccc-c---ccCCCcEEECCCCccCcccC----------C--CCCCCEEECcCCCC
Confidence 96 4442 378999999999999743 3 24889999999999987542 1 16999999999999
Q ss_pred cccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCcc
Q 003855 155 GGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYD 234 (791)
Q Consensus 155 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 234 (791)
++ +| .+..+ .+|++|++++|++++ +|..+ .+|++|++++|++++ +| .|+.+++|++|++++|++++ +|..
T Consensus 144 ~~-lp-~~~~l-~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~ 213 (454)
T 1jl5_A 144 EK-LP-ELQNS-SFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL 213 (454)
T ss_dssp SS-CC-CCTTC-TTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC
T ss_pred CC-Cc-ccCCC-CCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC
Confidence 97 56 45554 679999999999996 55543 589999999999996 45 69999999999999999995 4543
Q ss_pred ccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCC
Q 003855 235 LCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLT 314 (791)
Q Consensus 235 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~ 314 (791)
. ++|+.|++++|.++ .+|. ++.+++|++|++++|++++ +|.. +++|+.|++++|.+++ +|.. .++|+
T Consensus 214 ~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~ 280 (454)
T 1jl5_A 214 P---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLT 280 (454)
T ss_dssp C---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCC
T ss_pred c---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCC
Confidence 3 58999999999999 5664 9999999999999999985 4432 4899999999999986 4543 47899
Q ss_pred EEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCC-CCCcEEEccCCccCCCCchhhhhcccCceEEccCC
Q 003855 315 VLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSL-ISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHN 393 (791)
Q Consensus 315 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 393 (791)
.|++++|++++ +|.. .++|+.|++++|++++ ++ .+ ++|+.|++++|++++ +|.. +++|+.|++++|
T Consensus 281 ~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N 347 (454)
T 1jl5_A 281 FLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFN 347 (454)
T ss_dssp EEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSS
T ss_pred EEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCC
Confidence 99999999985 2221 2689999999999985 33 23 589999999999996 5654 589999999999
Q ss_pred CCcccCCCCCCCcCCccccccCCcccc
Q 003855 394 RLEGEIPVKGSFKNFSVESFFGNYALC 420 (791)
Q Consensus 394 ~l~~~~~~~~~~~~l~~~~~~~n~~~c 420 (791)
++++. |. .+.+++.+.+.+|...+
T Consensus 348 ~l~~l-p~--~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 348 HLAEV-PE--LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp CCSCC-CC--CCTTCCEEECCSSCCSS
T ss_pred ccccc-cc--hhhhccEEECCCCCCCc
Confidence 99964 44 57889999999998765
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.76 Aligned_cols=245 Identities=25% Similarity=0.302 Sum_probs=190.4
Q ss_pred HHHHHhhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh------HHHHHHHHHHHHHHhc----cCCccceee
Q 003855 495 DIQRATDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE------RAFRSFDSECEVLRNV----RHRNLIKIL 563 (791)
Q Consensus 495 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~ 563 (791)
+.....++|++.+.||+|+||.||+|+.. +++.||||++..... .....+..|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455678999999999999999999864 789999999865432 1223456789999998 899999999
Q ss_pred eeeccCCeeeEEEec-CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC-CCCcE
Q 003855 564 SSCSNPDFKALVLEF-MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD-ENMAA 641 (791)
Q Consensus 564 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~-~~~~~ 641 (791)
+++.+.+..++|||| +.+++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH----SRGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HHTEECCCCSGGGEEEETTTTEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChhhEEEeCCCCeE
Confidence 999999999999999 78999999998654 3899999999999999999999 67899999999999999 89999
Q ss_pred EEeeeccccccCCCCCcceeecccccccccCCCccCCCCC-CccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHH
Q 003855 642 HVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE 720 (791)
Q Consensus 642 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 720 (791)
||+|||+++...... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||.... .....
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~ 248 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEA 248 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHT
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhhh
Confidence 999999998765432 223468999999998876655 458999999999999999999996521 11110
Q ss_pred hcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 721 SLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 721 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. .....++..+.+++.+||+.||++||++.|+++
T Consensus 249 ~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 249 EL-------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CC-------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cc-------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 001124456789999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=336.75 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=187.4
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
..+|+..+.||+|+||+||.....+++.||||++...... .+.+|+.+++++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3568889999999999866555558999999998654322 345799999999 799999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-----CCcEEEeeeccccccC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-----NMAAHVSDFGISKLLG 653 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfgla~~~~ 653 (791)
+. |+|.+++........+..+..++.||+.||+||| +.+|+||||||+||+++. ...+||+|||+|+...
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH----HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH----HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 96 6999999876655566667889999999999999 678999999999999953 3358899999998765
Q ss_pred CCCCc-ceeecccccccccCCCccC---CCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 654 EGEDS-VTQTMTMATIGYMAPEYGS---EGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 654 ~~~~~-~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
..... .......||++|+|||++. ...++.++|||||||++|||+| |..||....... ... ........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---~~~---~~~~~~~~ 248 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---ANI---LLGACSLD 248 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---HHH---HTTCCCCT
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---HHH---HhccCCcc
Confidence 43221 2234457999999999987 4667889999999999999999 899986422111 111 11110000
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
... .....+..+.+++.+||+.||++|||+.||++
T Consensus 249 ~~~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 CLH-----------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TSC-----------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccC-----------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 01123455779999999999999999999984
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.81 Aligned_cols=308 Identities=25% Similarity=0.384 Sum_probs=261.6
Q ss_pred cccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCC
Q 003855 8 EIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATK 87 (791)
Q Consensus 8 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 87 (791)
.+.++++|++|++++|++..+ | .+..+++|++|++++|+++ .+|. + ..+++|++|+|++|.++++ ..|.++++
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~-~~~~-~-~~l~~L~~L~L~~n~i~~~--~~~~~l~~ 111 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQIT-DISP-L-SNLVKLTNLYIGTNKITDI--SALQNLTN 111 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCC-CCGG-G-TTCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred cchhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccc-cchh-h-hcCCcCCEEEccCCcccCc--hHHcCCCc
Confidence 345789999999999999854 4 4899999999999999998 7776 4 4489999999999999964 46999999
Q ss_pred CCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhh
Q 003855 88 LVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSA 167 (791)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 167 (791)
|++|+|++|.+....+ +.++++|+.|++++|..... ++.+..+++|++|++++|.+.+..
T Consensus 112 L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~---------~~~~~~l~~L~~L~l~~~~~~~~~--------- 171 (347)
T 4fmz_A 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD---------LSPLSNMTGLNYLTVTESKVKDVT--------- 171 (347)
T ss_dssp CSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC---------CGGGTTCTTCCEEECCSSCCCCCG---------
T ss_pred CCEEECcCCcccCchh--hccCCceeEEECCCCCCccc---------ccchhhCCCCcEEEecCCCcCCch---------
Confidence 9999999999987655 99999999999999964432 234889999999999999987431
Q ss_pred hhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEec
Q 003855 168 SLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247 (791)
Q Consensus 168 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 247 (791)
.+..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|+.|+++
T Consensus 172 ------------------~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~ 229 (347)
T 4fmz_A 172 ------------------PIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIG 229 (347)
T ss_dssp ------------------GGGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECC
T ss_pred ------------------hhccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEcc
Confidence 15678889999999999985543 8889999999999999985544 8889999999999
Q ss_pred CCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCC
Q 003855 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDI 327 (791)
Q Consensus 248 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 327 (791)
+|.+++..+ +..+++|++|++++|++++. ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..
T Consensus 230 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~ 303 (347)
T 4fmz_A 230 NNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNED 303 (347)
T ss_dssp SSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGG
T ss_pred CCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcC
Confidence 999985443 88999999999999999864 5688899999999999999865 46889999999999999999888
Q ss_pred CcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccC
Q 003855 328 PSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS 372 (791)
Q Consensus 328 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 372 (791)
+..+..+++|+.|++++|++++..| +..+++|+.|++++|+|+
T Consensus 304 ~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 8889999999999999999996555 888999999999999986
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=342.02 Aligned_cols=313 Identities=21% Similarity=0.234 Sum_probs=270.9
Q ss_pred CCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCE
Q 003855 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVA 90 (791)
Q Consensus 11 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 90 (791)
.+.+++.|++++|.+..+++..|.++++|++|+|++|.|+ .+|...+..+++|++|+|++|.|+++.|..|+++++|++
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 127 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 127 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCC-CCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCE
Confidence 4688999999999999888888999999999999999999 555434445899999999999999999999999999999
Q ss_pred EeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhh
Q 003855 91 LDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQ 170 (791)
Q Consensus 91 L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~ 170 (791)
|+|++|.++.+++..|.++++|+.|++++|.++.++.. .|.++++|++|+|++|.+++..
T Consensus 128 L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~--------~~~~l~~L~~L~L~~N~l~~~~------------ 187 (597)
T 3oja_B 128 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD--------TFQATTSLQNLQLSSNRLTHVD------------ 187 (597)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTT--------TTTTCTTCCEEECTTSCCSBCC------------
T ss_pred EEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChh--------hhhcCCcCcEEECcCCCCCCcC------------
Confidence 99999999998888899999999999999999987643 4899999999999999998531
Q ss_pred hhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCc
Q 003855 171 KFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNK 250 (791)
Q Consensus 171 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 250 (791)
+..+++|+.|++++|.+++. ...++|+.|++++|.++...+.. .++|+.|+|++|.
T Consensus 188 ----------------~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~ 243 (597)
T 3oja_B 188 ----------------LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNN 243 (597)
T ss_dssp ----------------GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSC
T ss_pred ----------------hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCC
Confidence 33467888999999988743 34568999999999988543332 2689999999999
Q ss_pred cCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcc
Q 003855 251 LSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPST 330 (791)
Q Consensus 251 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 330 (791)
+++ +..+..+++|+.|+|++|.+.+..|..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..
T Consensus 244 l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~ 319 (597)
T 3oja_B 244 LTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERN 319 (597)
T ss_dssp CCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGG
T ss_pred CCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcc
Confidence 985 3678999999999999999998889999999999999999999986 5667788999999999999999 67888
Q ss_pred hhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCC
Q 003855 331 IGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKI 375 (791)
Q Consensus 331 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 375 (791)
+..+++|+.|+|++|+|++. + +..+++|+.|+|++|++.+..
T Consensus 320 ~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 320 QPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp HHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHH
T ss_pred cccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChh
Confidence 99999999999999999854 3 777899999999999998653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=346.07 Aligned_cols=270 Identities=24% Similarity=0.294 Sum_probs=201.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehh-hhHHHHHHHHHHHHHHhccCCccceeeeeecc------CCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSCSN------PDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 571 (791)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999874 7899999998654 24445678999999999999999999998765 677
Q ss_pred eeEEEecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc---EEEeee
Q 003855 572 KALVLEFMPNGSLEKWLYSHN--YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA---AHVSDF 646 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~---~kl~Df 646 (791)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH----s~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH----ENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH----HTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999998643 25888999999999999999999 678999999999999997665 999999
Q ss_pred ccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC-
Q 003855 647 GISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG- 725 (791)
Q Consensus 647 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 725 (791)
|+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...|........
T Consensus 169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC----
T ss_pred ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccc
Confidence 99987654332 2335689999999999999999999999999999999999999965311 111111110000
Q ss_pred ----hhhhcchhhhhhH---HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHH-----HHHHHHHHH
Q 003855 726 ----LTEVVDANLVREE---QAFSAKMDCILSIMDLALDCCIESPDMRINVTD-----AAAKLKKIK 780 (791)
Q Consensus 726 ----~~~~~d~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e-----v~~~L~~~~ 780 (791)
..+.......... ........++..+.+++.+||+.||++|||+.| ..+.+..+.
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 0000000000000 000011235678899999999999999999988 445555554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=317.69 Aligned_cols=241 Identities=34% Similarity=0.592 Sum_probs=227.2
Q ss_pred cCCccccCCCCCCEEEccC-CccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCcccc
Q 003855 182 NIPQEIGNLSGLTLLSLHS-NDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLV 260 (791)
Q Consensus 182 ~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 260 (791)
.+|..|.++++|++|+|++ |.+.+.+|..|..+++|++|+|++|++++.+|..|..+++|++|+|++|.+++.+|..+.
T Consensus 67 ~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 146 (313)
T 1ogq_A 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146 (313)
T ss_dssp ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG
T ss_pred ccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHh
Confidence 4566788899999999995 999989999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcCCCCCCccccCCC-CCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccc
Q 003855 261 SLTSLRELHLGSNKLTSSIPSSLWSLE-YILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLET 339 (791)
Q Consensus 261 ~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 339 (791)
.+++|++|+|++|++++.+|..+..++ +|++|++++|.+++..|..+..++ |+.|++++|.+++..|..|..+++|+.
T Consensus 147 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 225 (313)
T 1ogq_A 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQK 225 (313)
T ss_dssp GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSE
T ss_pred cCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCE
Confidence 999999999999999988999999998 999999999999999999999997 999999999999999999999999999
Q ss_pred cccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccc
Q 003855 340 LSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYAL 419 (791)
Q Consensus 340 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~ 419 (791)
|+|++|++++.+|. +..+++|+.|+|++|++++.+|..+..+++|+.|++++|++++.+|..+.+++++.+.+.+|+++
T Consensus 226 L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~l 304 (313)
T 1ogq_A 226 IHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304 (313)
T ss_dssp EECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEE
T ss_pred EECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCc
Confidence 99999999966555 88899999999999999999999999999999999999999999999888999999999999999
Q ss_pred cCCCC
Q 003855 420 CGPPK 424 (791)
Q Consensus 420 c~~~~ 424 (791)
||.|.
T Consensus 305 c~~p~ 309 (313)
T 1ogq_A 305 CGSPL 309 (313)
T ss_dssp ESTTS
T ss_pred cCCCC
Confidence 99874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=310.15 Aligned_cols=233 Identities=12% Similarity=0.087 Sum_probs=185.5
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+..+++++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999975 58999999997553 344578899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++++|.+++... ....++.+++.|++.||+||| +.+|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH----~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH----RAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH----HCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999643 355678899999999999999 6789999999999999999999997443
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
|++| ++.++|||||||++|||+||+.||.+........ ........ ....
T Consensus 175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------~~~~~~~~----~~~~ 224 (286)
T 3uqc_A 175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------PAERDTAG----QPIE 224 (286)
T ss_dssp -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------ECCBCTTS----CBCC
T ss_pred -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------HHHHHhcc----CCCC
Confidence 3333 6789999999999999999999998643221000 00000000 0000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
.......++..+.+++.+||+.||++| |+.|+++.|+++....
T Consensus 225 ---~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 225 ---PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp ---HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ---hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 001112456778899999999999999 9999999999986543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=347.71 Aligned_cols=241 Identities=22% Similarity=0.298 Sum_probs=194.7
Q ss_pred hhccccccccCCCcceEEEEEEec--CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCe-----
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS--DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDF----- 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 571 (791)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999975 68999999986432 3445678899999999999999999999976554
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++||||+++++|.+++.. .+++.++..++.||+.||.||| +.+|+||||||+||+++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH----~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH----SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH----HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999998765 4899999999999999999999 6789999999999999986 999999999987
Q ss_pred cCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
.... ....||++|+|||++.++ ++.++|||||||++|||++|..|+........ ..
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------~~--- 286 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------PE--- 286 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------CT---
T ss_pred cccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc--------------cc---
Confidence 6432 334689999999988665 48899999999999999999988765322110 00
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRI-NVTDAAAKLKKIKV 781 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~ev~~~L~~~~~ 781 (791)
. .....++..+.+++.+||+.||++|| ++.++.+.+..+..
T Consensus 287 -~--------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 287 -D--------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp -T--------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred -c--------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0 00112345678999999999999999 46667777776644
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=304.17 Aligned_cols=289 Identities=21% Similarity=0.273 Sum_probs=191.4
Q ss_pred CCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccccc
Q 003855 37 STMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLS 116 (791)
Q Consensus 37 ~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 116 (791)
.+|+.+++++|.++ .+|..++ ++|++|+|++|.|+++.|..|.++++|++|+|++|+++++.+..|.++++|+.|+
T Consensus 33 c~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 33 CHLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp EETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred ccCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 36899999999998 8888764 5899999999999988888899999999999999999887777777776666666
Q ss_pred cccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEE
Q 003855 117 QVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLL 196 (791)
Q Consensus 117 l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 196 (791)
+++|+++.++... . ++|++|++++|++++. .+..|.++++|+.|
T Consensus 109 L~~n~l~~l~~~~---------~--~~L~~L~l~~n~i~~~-------------------------~~~~~~~l~~L~~L 152 (332)
T 2ft3_A 109 ISKNHLVEIPPNL---------P--SSLVELRIHDNRIRKV-------------------------PKGVFSGLRNMNCI 152 (332)
T ss_dssp CCSSCCCSCCSSC---------C--TTCCEEECCSSCCCCC-------------------------CSGGGSSCSSCCEE
T ss_pred CCCCcCCccCccc---------c--ccCCEEECCCCccCcc-------------------------CHhHhCCCccCCEE
Confidence 6666666544321 1 4555555555555421 22234455556666
Q ss_pred EccCCccc--cccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCc
Q 003855 197 SLHSNDLN--GTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNK 274 (791)
Q Consensus 197 ~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 274 (791)
++++|.++ +..+..|..+ +|++|++++|+++ + +|..+. ++|++|++++|+
T Consensus 153 ~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~------------------------~-l~~~~~--~~L~~L~l~~n~ 204 (332)
T 2ft3_A 153 EMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT------------------------G-IPKDLP--ETLNELHLDHNK 204 (332)
T ss_dssp ECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS------------------------S-CCSSSC--SSCSCCBCCSSC
T ss_pred ECCCCccccCCCCcccccCC-ccCEEECcCCCCC------------------------c-cCcccc--CCCCEEECCCCc
Confidence 66666553 2344444444 5555555555554 2 222222 456666666666
Q ss_pred CCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcc
Q 003855 275 LTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPES 354 (791)
Q Consensus 275 l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 354 (791)
+++..+..|..+++|+.|++++|.+++..+..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|+|++..+..
T Consensus 205 i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~ 283 (332)
T 2ft3_A 205 IQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVND 283 (332)
T ss_dssp CCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTS
T ss_pred CCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhH
Confidence 66555556666666666666666666655556666667777777777776 56666667777777777777777555555
Q ss_pred cCC------CCCCcEEEccCCccC--CCCchhhhhcccCceEEccCCC
Q 003855 355 VGS------LISLESLDLSGNNLS--GKIPKSLETLSQLKQFNVSHNR 394 (791)
Q Consensus 355 ~~~------l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~l~l~~N~ 394 (791)
|.. ..+|+.|++++|++. +..|..|..+++|+.+++++|+
T Consensus 284 ~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 544 357888999999887 6777888888999999988875
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=303.99 Aligned_cols=299 Identities=22% Similarity=0.304 Sum_probs=223.5
Q ss_pred cCCccccCC------CCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceec
Q 003855 4 QIPTEIGNL------QNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGI 77 (791)
Q Consensus 4 ~lp~~~~~l------~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~ 77 (791)
++|..+... .+++.++++++.++ .+|..+. ++|++|+|++|.++ .++...+..+++|++|+|++|.|+++
T Consensus 18 ~lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~ 93 (332)
T 2ft3_A 18 SLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKI 93 (332)
T ss_dssp -------CCCCSSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred cCCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCC-ccCHhHhhCCCCCcEEECCCCccCcc
Confidence 466655443 37999999999998 5576664 69999999999998 55544444489999999999999999
Q ss_pred CCccCcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCccc
Q 003855 78 IPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGI 157 (791)
Q Consensus 78 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 157 (791)
.|..|.++++|++|+|++|+++.+....+ ++|+.|++++|+++.++... |.++++|+.|++++|.++..
T Consensus 94 ~~~~~~~l~~L~~L~L~~n~l~~l~~~~~---~~L~~L~l~~n~i~~~~~~~--------~~~l~~L~~L~l~~n~l~~~ 162 (332)
T 2ft3_A 94 HEKAFSPLRKLQKLYISKNHLVEIPPNLP---SSLVELRIHDNRIRKVPKGV--------FSGLRNMNCIEMGGNPLENS 162 (332)
T ss_dssp CGGGSTTCTTCCEEECCSSCCCSCCSSCC---TTCCEEECCSSCCCCCCSGG--------GSSCSSCCEEECCSCCCBGG
T ss_pred CHhHhhCcCCCCEEECCCCcCCccCcccc---ccCCEEECCCCccCccCHhH--------hCCCccCCEEECCCCccccC
Confidence 89999999999999999999996665554 79999999999999876543 88999999999999999731
Q ss_pred CChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccc
Q 003855 158 LPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCH 237 (791)
Q Consensus 158 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 237 (791)
+..+..+..+ +|+.|++++|++++ +|..+. ++|++|+|++|.+++..+..|..
T Consensus 163 -----------------------~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~ 215 (332)
T 2ft3_A 163 -----------------------GFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLR 215 (332)
T ss_dssp -----------------------GSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTT
T ss_pred -----------------------CCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcC
Confidence 1345567777 99999999999996 444443 78999999999998777778888
Q ss_pred cCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccC------C
Q 003855 238 LKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKL------K 311 (791)
Q Consensus 238 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l------~ 311 (791)
+++|+.|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|+.|++++|.|++..+..|... .
T Consensus 216 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~ 294 (332)
T 2ft3_A 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRA 294 (332)
T ss_dssp CTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSC
T ss_pred CCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccc
Confidence 888888888888888777777888888888888888887 566667777777777777777776655555432 3
Q ss_pred CCCEEecCCcccC--CCCCcchhccccccccccccc
Q 003855 312 VLTVLDLSRNQLS--GDIPSTIGALKDLETLSLARN 345 (791)
Q Consensus 312 ~L~~L~l~~N~l~--~~~~~~~~~l~~L~~L~L~~N 345 (791)
.|+.|++++|.+. +..|..|..+++|+.|++++|
T Consensus 295 ~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 295 YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp CBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred cccceEeecCcccccccCcccccccchhhhhhcccc
Confidence 4555555555554 333444444444444444444
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=328.83 Aligned_cols=239 Identities=15% Similarity=0.153 Sum_probs=180.5
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccC-Cccceeeee----------
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRH-RNLIKILSS---------- 565 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~~~---------- 565 (791)
..|...+.||+|+||.||+|++ .+|+.||||++.... ....+.+.+|+.+++.++| +|......+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577889999999999999995 479999999987332 2335678899999999976 322211111
Q ss_pred -----------ecc-----CCeeeEEEecCCCCCHHHHHh------hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCe
Q 003855 566 -----------CSN-----PDFKALVLEFMPNGSLEKWLY------SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPI 623 (791)
Q Consensus 566 -----------~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i 623 (791)
+.. ....+++|+++ +++|.+++. .....+++..+..++.|+++||+||| +.+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~i 232 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYGL 232 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTTE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH----hCCc
Confidence 111 22356777766 689999985 22445788899999999999999999 6789
Q ss_pred EecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCcc----------CCCCCCccccHHhHHHH
Q 003855 624 IHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYG----------SEGIVSAKCDVYSYGVL 693 (791)
Q Consensus 624 ~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dv~s~G~v 693 (791)
+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999865322 334567 999999988 66678999999999999
Q ss_pred HHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 003855 694 LMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAA 773 (791)
Q Consensus 694 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~ 773 (791)
+|||+||+.||......+. ...+ +. ....++..+.+++.+||+.||++||++.|++
T Consensus 307 l~elltg~~Pf~~~~~~~~-------------~~~~----~~-------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG-------------SEWI----FR-------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC-------------SGGG----GS-------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhh-------------HHHH----Hh-------hcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999976322111 0000 00 0012446688999999999999999987775
Q ss_pred H
Q 003855 774 A 774 (791)
Q Consensus 774 ~ 774 (791)
+
T Consensus 363 ~ 363 (413)
T 3dzo_A 363 E 363 (413)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=306.28 Aligned_cols=230 Identities=21% Similarity=0.292 Sum_probs=178.9
Q ss_pred hhccccc-cccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHH-HhccCCccceeeeeecc----CCee
Q 003855 500 TDEFNEC-NLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVL-RNVRHRNLIKILSSCSN----PDFK 572 (791)
Q Consensus 500 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 572 (791)
.++|.+. +.||+|+||.||+|... +++.||+|++... ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 78999999999999974 7899999998643 3456788887 55599999999999876 6778
Q ss_pred eEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC---CCcEEEeeecc
Q 003855 573 ALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE---NMAAHVSDFGI 648 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgl 648 (791)
++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999998654 35899999999999999999999 678999999999999998 78999999999
Q ss_pred ccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 649 SKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 649 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
|+... +..++.++||||+||++|||++|+.||........ .........
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------~~~~~~~~~- 215 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------SPGMKTRIR- 215 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------CCSCCSSC-
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------hHHHHHHHh-
Confidence 86532 23467899999999999999999999965322110 000000000
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..... ...+....++.++.+++.+||+.||++|||+.|+++
T Consensus 216 --~~~~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 216 --MGQYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp --TTCCS---SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --hcccc---CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 000111245677899999999999999999999987
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.15 Aligned_cols=290 Identities=21% Similarity=0.262 Sum_probs=185.0
Q ss_pred CCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccccc
Q 003855 37 STMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLS 116 (791)
Q Consensus 37 ~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 116 (791)
.+|+.++++++.++ .+|..+. ++|++|+|++|.|+++.+..|.++++|++|+|++|+++++.+..|.++++|+.|+
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCCeEEEecCCCcc-ccCccCC---CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 46888888888887 8887653 5888889999988877777888888899999988888877777777766666666
Q ss_pred cccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEE
Q 003855 117 QVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLL 196 (791)
Q Consensus 117 l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 196 (791)
+++|+++.++... .++|++|++++|++++. .+..|.++++|+.|
T Consensus 107 Ls~n~l~~l~~~~-----------~~~L~~L~l~~n~l~~~-------------------------~~~~~~~l~~L~~L 150 (330)
T 1xku_A 107 LSKNQLKELPEKM-----------PKTLQELRVHENEITKV-------------------------RKSVFNGLNQMIVV 150 (330)
T ss_dssp CCSSCCSBCCSSC-----------CTTCCEEECCSSCCCBB-------------------------CHHHHTTCTTCCEE
T ss_pred CCCCcCCccChhh-----------cccccEEECCCCccccc-------------------------CHhHhcCCccccEE
Confidence 6666666544221 14555555555555432 22334555666666
Q ss_pred EccCCcccc--ccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCc
Q 003855 197 SLHSNDLNG--TISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNK 274 (791)
Q Consensus 197 ~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 274 (791)
++++|.++. ..+..|..+++|++|++++|.++. +|.. +. ++|++|++++|+
T Consensus 151 ~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~------------------------~~--~~L~~L~l~~n~ 203 (330)
T 1xku_A 151 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQG------------------------LP--PSLTELHLDGNK 203 (330)
T ss_dssp ECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSS------------------------CC--TTCSEEECTTSC
T ss_pred ECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcc------------------------cc--ccCCEEECCCCc
Confidence 666666642 444555555555555555555552 2222 21 455555555555
Q ss_pred CCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcc
Q 003855 275 LTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPES 354 (791)
Q Consensus 275 l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 354 (791)
+++..+..|..+++|+.|++++|.+++..+..+..+++|+.|+|++|+++ .+|..+..+++|++|++++|+|++..+..
T Consensus 204 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~ 282 (330)
T 1xku_A 204 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282 (330)
T ss_dssp CCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTS
T ss_pred CCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhh
Confidence 55555555555555666666666555555555666666666666666666 55555666666666666666666554444
Q ss_pred cCC------CCCCcEEEccCCccCC--CCchhhhhcccCceEEccCCC
Q 003855 355 VGS------LISLESLDLSGNNLSG--KIPKSLETLSQLKQFNVSHNR 394 (791)
Q Consensus 355 ~~~------l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~l~l~~N~ 394 (791)
|.. ...|+.|++++|++.. ..|..|..+++++.+++++|+
T Consensus 283 f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred cCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 432 3678888888888863 567788888888888888885
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=297.06 Aligned_cols=292 Identities=21% Similarity=0.257 Sum_probs=224.8
Q ss_pred CCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEE
Q 003855 12 LQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVAL 91 (791)
Q Consensus 12 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 91 (791)
..++++++++++.++ .+|..+. ++|++|+|++|+++ .+|...+..+++|++|+|++|.++++.|..|.++++|++|
T Consensus 30 ~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (330)
T 1xku_A 30 QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL 105 (330)
T ss_dssp EEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred cCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCC-EeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEE
Confidence 348999999999998 4566664 68999999999998 6666444558999999999999998889999999999999
Q ss_pred eccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhh
Q 003855 92 DLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQK 171 (791)
Q Consensus 92 ~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~ 171 (791)
+|++|+++.+....+ ++|+.|++++|+++.++.. .|.++++|+.|++++|.++..
T Consensus 106 ~Ls~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~--------~~~~l~~L~~L~l~~n~l~~~-------------- 160 (330)
T 1xku_A 106 YLSKNQLKELPEKMP---KTLQELRVHENEITKVRKS--------VFNGLNQMIVVELGTNPLKSS-------------- 160 (330)
T ss_dssp ECCSSCCSBCCSSCC---TTCCEEECCSSCCCBBCHH--------HHTTCTTCCEEECCSSCCCGG--------------
T ss_pred ECCCCcCCccChhhc---ccccEEECCCCcccccCHh--------HhcCCccccEEECCCCcCCcc--------------
Confidence 999999996655544 7899999999999976643 388999999999999998731
Q ss_pred hhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCcc
Q 003855 172 FYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKL 251 (791)
Q Consensus 172 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i 251 (791)
+..+..|.++++|+.|++++|.++. +|..+. ++|++|+|++|++++..|..|..+++|+.|+|++|.+
T Consensus 161 ---------~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 228 (330)
T 1xku_A 161 ---------GIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228 (330)
T ss_dssp ---------GBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCC
T ss_pred ---------CcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcC
Confidence 1345667888999999999999985 444433 7899999999999877788888888888888888888
Q ss_pred CCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccC------CCCCEEecCCcccCC
Q 003855 252 SGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKL------KVLTVLDLSRNQLSG 325 (791)
Q Consensus 252 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l------~~L~~L~l~~N~l~~ 325 (791)
++..+..+..+++|++|+|++|+++ .+|..+..+++|++|++++|+|++..+..|+.. ..|+.|++++|.+..
T Consensus 229 ~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 229 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp CEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred ceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccc
Confidence 8777777888888888888888887 566677777888888888888776665555432 455556666665542
Q ss_pred --CCCcchhccccccccccccc
Q 003855 326 --DIPSTIGALKDLETLSLARN 345 (791)
Q Consensus 326 --~~~~~~~~l~~L~~L~L~~N 345 (791)
..|..|..+.+++.++|++|
T Consensus 308 ~~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 308 WEIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp GGSCGGGGTTCCCGGGEEC---
T ss_pred cccCccccccccceeEEEeccc
Confidence 23344444444444444444
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=312.93 Aligned_cols=243 Identities=19% Similarity=0.217 Sum_probs=183.9
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhh--------hHHHHHHHHHHHHHHhcc----------------
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--------ERAFRSFDSECEVLRNVR---------------- 555 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------------- 555 (791)
.++|++.+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.++++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 47899999999999999999998 78999999997542 223467888999999886
Q ss_pred ----------CCccceeeeeecc-------------CCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q 003855 556 ----------HRNLIKILSSCSN-------------PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 612 (791)
Q Consensus 556 ----------h~niv~l~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~ 612 (791)
||||+++++++.+ ....++||||+++|++.+.+.+ ..+++..+..++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 5666666666654 7889999999999977766654 34899999999999999999
Q ss_pred HHHccCCCCCeEecCCCCCCeEeCCCC--------------------cEEEeeeccccccCCCCCcceeecccccccccC
Q 003855 613 YLHHGHSSAPIIHCDLKPTNILLDENM--------------------AAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672 (791)
Q Consensus 613 ~LH~~~~~~~i~H~dlk~~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~a 672 (791)
|||+ +.+|+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+|
T Consensus 176 ~lH~---~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~a 245 (336)
T 2vuw_A 176 VAEA---SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMD 245 (336)
T ss_dssp HHHH---HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTC
T ss_pred HHHH---hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccC
Confidence 9992 24799999999999999887 8999999999876432 2468999999
Q ss_pred CCccCCCCCCccccHHhHHHH-HHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHH
Q 003855 673 PEYGSEGIVSAKCDVYSYGVL-LMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSI 751 (791)
Q Consensus 673 PE~~~~~~~~~~~Dv~s~G~v-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l 751 (791)
||++.+.. +.++||||+|++ .+++++|..||..................... .........++.++
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT------------KCNTPAMKQIKRKI 312 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS------------CCCSHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc------------ccchhhhhhcCHHH
Confidence 99988665 899999998777 77888899997531000000000000000000 00011233577889
Q ss_pred HHHHhhccccCCCCCCCHHHHH
Q 003855 752 MDLALDCCIESPDMRINVTDAA 773 (791)
Q Consensus 752 ~~li~~cl~~~P~~RPt~~ev~ 773 (791)
.+++.+||+.| |+.|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999966 888887
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=303.23 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=229.9
Q ss_pred CCCcEEEccCCCCcc--cCChhhhhhhhhhhhhhccc-ccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCC
Q 003855 142 RNLTILSFGSNPLGG--ILPPVIGNFSASLQKFYAYE-CKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQ 218 (791)
Q Consensus 142 ~~L~~L~L~~N~l~~--~~~~~~~~~~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 218 (791)
.+++.|+|++|.+++ .+|+.+..+ +.|++|++++ |.+.+.+|..|.++++|++|+|++|++++..|..|..+++|+
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l-~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 128 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANL-PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGC-TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred ceEEEEECCCCCccCCcccChhHhCC-CCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence 467777777777777 677776665 4577777774 777778888899999999999999999989999999999999
Q ss_pred EEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCC-CCcEEEcCCCcCCCCCCccccCCCCCCeEEccCC
Q 003855 219 GLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLT-SLRELHLGSNKLTSSIPSSLWSLEYILDINLSSN 297 (791)
Q Consensus 219 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 297 (791)
+|+|++|.+++.+|..+..+++|++|+|++|++++.+|..+..++ +|++|++++|++++..|..+..++ |+.|++++|
T Consensus 129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N 207 (313)
T 1ogq_A 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence 999999999999999999999999999999999988999999998 999999999999989999999987 999999999
Q ss_pred cCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCch
Q 003855 298 SLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK 377 (791)
Q Consensus 298 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 377 (791)
.+++..|..|..+++|+.|+|++|.+++..|. +..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++.+|.
T Consensus 208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~ 286 (313)
T 1ogq_A 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred cccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence 99999999999999999999999999966655 88899999999999999999999999999999999999999999998
Q ss_pred hhhhcccCceEEccCCC-Cccc
Q 003855 378 SLETLSQLKQFNVSHNR-LEGE 398 (791)
Q Consensus 378 ~~~~l~~L~~l~l~~N~-l~~~ 398 (791)
. ..+++|+.+++++|+ ++|.
T Consensus 287 ~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 287 G-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp S-TTGGGSCGGGTCSSSEEEST
T ss_pred C-ccccccChHHhcCCCCccCC
Confidence 7 889999999999999 5553
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=339.90 Aligned_cols=360 Identities=18% Similarity=0.172 Sum_probs=245.4
Q ss_pred CCCCeeecCCCcccccCCcc-ccCCCCCcEEeCCCCcCcc----cCCchhhhcCCCccEEEccCCcceecCCccC-cCCC
Q 003855 13 QNLQYLVFAENNLSGLVPPT-IFNISTMRILTLEGNQLSG----RLPSTVGHLLPNIESLLLAANNLTGIIPHSI-TNAT 86 (791)
Q Consensus 13 ~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~----~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~ 86 (791)
++|++|+|++|+++...... +..+++|++|+|++|++++ .++..+.. +++|++|+|++|.+++..+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~-~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRV-NPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHT-CTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHh-CCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 56788888888887554443 6778888888888888873 23444444 6888888888888875443333 2344
Q ss_pred ----CCCEEeccCccccc----cccccccccccccccccccccccccCCCccccccccc-cCCCCCCcEEEccCCCCccc
Q 003855 87 ----KLVALDLGFNSFAG----HILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSS-LTNCRNLTILSFGSNPLGGI 157 (791)
Q Consensus 87 ----~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~-l~~l~~L~~L~L~~N~l~~~ 157 (791)
+|++|+|++|+++. ..+..|..+++|+.|++++|.++...... +... ...+++|++|++++|++++.
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~----l~~~l~~~~~~L~~L~L~~n~l~~~ 157 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL----LCEGLLDPQCRLEKLQLEYCSLSAA 157 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH----HHHHHTSTTCCCCEEECTTSCCBGG
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHH----HHHHHhcCCCcceEEECCCCCCCHH
Confidence 68888888888874 33666777777777777777776432111 1111 22355677777777777653
Q ss_pred CChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCcccc-----CCCCCCEEEcccccCccc--
Q 003855 158 LPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMG-----RLKRLQGLSLRNNNLEGS-- 230 (791)
Q Consensus 158 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~-- 230 (791)
....+ +..+..+++|+.|+|++|.++...+..+. .+++|++|+|++|.+++.
T Consensus 158 ~~~~l---------------------~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~ 216 (461)
T 1z7x_W 158 SCEPL---------------------ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC 216 (461)
T ss_dssp GHHHH---------------------HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHH
T ss_pred HHHHH---------------------HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHH
Confidence 32222 33455667788888888887654444443 256788888888887753
Q ss_pred --CCccccccCCCceEEecCCccCCCC-----CccccCCCCCcEEEcCCCcCCCC----CCccccCCCCCCeEEccCCcC
Q 003855 231 --IPYDLCHLKLMFGIRLTGNKLSGHI-----PPCLVSLTSLRELHLGSNKLTSS----IPSSLWSLEYILDINLSSNSL 299 (791)
Q Consensus 231 --~~~~~~~l~~L~~L~L~~N~i~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~i 299 (791)
++..+..+++|+.|++++|.+++.. +..+..+++|++|++++|+++.. ++..+..+++|++|++++|.+
T Consensus 217 ~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i 296 (461)
T 1z7x_W 217 RDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296 (461)
T ss_dssp HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCC
T ss_pred HHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCC
Confidence 3566677788888888888776432 22233577888888888888753 455666678888888888888
Q ss_pred cccCCccccc-----CCCCCEEecCCcccCCC----CCcchhccccccccccccccCCCCCCcccCC-----CCCCcEEE
Q 003855 300 NDSLPSNVQK-----LKVLTVLDLSRNQLSGD----IPSTIGALKDLETLSLARNQFQGPIPESVGS-----LISLESLD 365 (791)
Q Consensus 300 ~~~~~~~~~~-----l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~ 365 (791)
++..+..+.. .++|+.|++++|.+++. ++..+..+++|++|++++|++++..+..+.. .++|+.|+
T Consensus 297 ~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~ 376 (461)
T 1z7x_W 297 GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376 (461)
T ss_dssp HHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred chHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEE
Confidence 6554444433 25788888888888754 3455666788888888888887544444432 56888888
Q ss_pred ccCCccCC----CCchhhhhcccCceEEccCCCCccc
Q 003855 366 LSGNNLSG----KIPKSLETLSQLKQFNVSHNRLEGE 398 (791)
Q Consensus 366 l~~N~l~~----~~~~~~~~l~~L~~l~l~~N~l~~~ 398 (791)
|++|++++ .+|..+..+++|++|++++|++++.
T Consensus 377 L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp CTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred CCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 88888875 6777888888888888888888764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=337.43 Aligned_cols=365 Identities=20% Similarity=0.150 Sum_probs=231.9
Q ss_pred ccCCCCCCeeecCCCcccc----cCCccccCCCCCcEEeCCCCcCcccCCchhhhcCC----CccEEEccCCccee----
Q 003855 9 IGNLQNLQYLVFAENNLSG----LVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP----NIESLLLAANNLTG---- 76 (791)
Q Consensus 9 ~~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~----~L~~L~L~~N~l~~---- 76 (791)
+..+++|++|+|++|+++. .++..+..+++|++|+|++|.+++..+..++..++ +|++|+|++|.|+.
T Consensus 24 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~ 103 (461)
T 1z7x_W 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 103 (461)
T ss_dssp HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred HhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHH
Confidence 6788999999999999974 35778888999999999999998655666666666 79999999999994
Q ss_pred cCCccCcCCCCCCEEeccCccccccccccccc-----cccccccccccccccccCCCccccccccccCCCCCCcEEEccC
Q 003855 77 IIPHSITNATKLVALDLGFNSFAGHILNTFGN-----LRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGS 151 (791)
Q Consensus 77 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~-----l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~ 151 (791)
.++..|..+++|++|+|++|.++...+..+.. .++|+.|++++|+++..... .++..+..+++|++|++++
T Consensus 104 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~----~l~~~l~~~~~L~~L~L~~ 179 (461)
T 1z7x_W 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE----PLASVLRAKPDFKELTVSN 179 (461)
T ss_dssp HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH----HHHHHHHHCTTCCEEECCS
T ss_pred HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH----HHHHHHhhCCCCCEEECcC
Confidence 45889999999999999999998665554433 56899999999999864321 1344577789999999999
Q ss_pred CCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccc----cCccccCCCCCCEEEcccccC
Q 003855 152 NPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGT----ISPTMGRLKRLQGLSLRNNNL 227 (791)
Q Consensus 152 N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l 227 (791)
|.+++..+..+..... ...++|+.|+|++|.++.. ++..+..+++|++|+|++|.+
T Consensus 180 n~i~~~~~~~l~~~l~--------------------~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l 239 (461)
T 1z7x_W 180 NDINEAGVRVLCQGLK--------------------DSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239 (461)
T ss_dssp SBCHHHHHHHHHHHHH--------------------HSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred CCcchHHHHHHHHHHh--------------------cCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcC
Confidence 9998654444433211 1233555555555555532 234444555555555555555
Q ss_pred cccC-----CccccccCCCceEEecCCccCCC----CCccccCCCCCcEEEcCCCcCCCCCCccccC-----CCCCCeEE
Q 003855 228 EGSI-----PYDLCHLKLMFGIRLTGNKLSGH----IPPCLVSLTSLRELHLGSNKLTSSIPSSLWS-----LEYILDIN 293 (791)
Q Consensus 228 ~~~~-----~~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~ 293 (791)
++.. +..+..+++|+.|++++|.++.. ++..+..+++|++|++++|.+++..+..+.. .++|++|+
T Consensus 240 ~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~ 319 (461)
T 1z7x_W 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW 319 (461)
T ss_dssp HHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred ChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeE
Confidence 4322 11122355555666666555532 3444555566666666666654332222221 24566666
Q ss_pred ccCCcCccc----CCcccccCCCCCEEecCCcccCCCCCcchhc-----cccccccccccccCCC----CCCcccCCCCC
Q 003855 294 LSSNSLNDS----LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGA-----LKDLETLSLARNQFQG----PIPESVGSLIS 360 (791)
Q Consensus 294 l~~N~i~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~ 360 (791)
+++|.+++. ++..+..+++|+.|++++|.+++..+..+.. .++|+.|++++|++++ .+|..+..+++
T Consensus 320 L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~ 399 (461)
T 1z7x_W 320 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399 (461)
T ss_dssp CTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCC
T ss_pred cCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCC
Confidence 666666543 3344555566666666666665444443332 4566666666666664 45555566666
Q ss_pred CcEEEccCCccCCCCchhhhh-----cccCceEEccCCCCcc
Q 003855 361 LESLDLSGNNLSGKIPKSLET-----LSQLKQFNVSHNRLEG 397 (791)
Q Consensus 361 L~~L~l~~N~l~~~~~~~~~~-----l~~L~~l~l~~N~l~~ 397 (791)
|+.|+|++|++++.....+.. ..+|+.|++.++.+..
T Consensus 400 L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 400 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp CCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred ccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence 666666666665432222221 2246666666665543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=272.55 Aligned_cols=279 Identities=19% Similarity=0.215 Sum_probs=144.1
Q ss_pred EEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccc--cccccccccccccccc
Q 003855 41 ILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHI--LNTFGNLRHLSLLSQV 118 (791)
Q Consensus 41 ~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~l~ 118 (791)
.++++++.++ .+|..+. ++|++|+|++|.++.+.+..|.++++|++|+|++|+++... +..+.++++|+.|+++
T Consensus 11 ~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp EEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred EEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 4455555554 4444332 34555555555555433334455555555555555544221 2333344444444444
Q ss_pred cccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEc
Q 003855 119 MNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSL 198 (791)
Q Consensus 119 ~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 198 (791)
+|.++.++ ..+..+++|++|++++|++++..+ ...+..+++|++|++
T Consensus 87 ~n~i~~l~---------~~~~~l~~L~~L~l~~n~l~~~~~------------------------~~~~~~l~~L~~L~l 133 (306)
T 2z66_A 87 FNGVITMS---------SNFLGLEQLEHLDFQHSNLKQMSE------------------------FSVFLSLRNLIYLDI 133 (306)
T ss_dssp SCSEEEEE---------EEEETCTTCCEEECTTSEEESSTT------------------------TTTTTTCTTCCEEEC
T ss_pred CCccccCh---------hhcCCCCCCCEEECCCCccccccc------------------------chhhhhccCCCEEEC
Confidence 44444321 224445555555555555543211 123445555666666
Q ss_pred cCCccccccCccccCCCCCCEEEcccccCcc-cCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCC
Q 003855 199 HSNDLNGTISPTMGRLKRLQGLSLRNNNLEG-SIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS 277 (791)
Q Consensus 199 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 277 (791)
++|.+++..+..|..+++|++|+|++|.+++ ..|..+..+++|+.|+|++|++++..|..+..+++|++|+|++|++++
T Consensus 134 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 213 (306)
T 2z66_A 134 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213 (306)
T ss_dssp TTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSB
T ss_pred CCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCc
Confidence 6666655555555666666666666666554 345555566666666666666655555556666666666666666665
Q ss_pred CCCccccCCCCCCeEEccCCcCcccCCcccccCC-CCCEEecCCcccCCCCC--cchhccccccccccccccCCCCCCcc
Q 003855 278 SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLK-VLTVLDLSRNQLSGDIP--STIGALKDLETLSLARNQFQGPIPES 354 (791)
Q Consensus 278 ~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~ 354 (791)
..+..+..+++|+.|++++|.+++..|..+..++ +|+.|+|++|.+++..+ .....+...+.+....+.+....|..
T Consensus 214 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~ 293 (306)
T 2z66_A 214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 293 (306)
T ss_dssp CCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGG
T ss_pred cChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchh
Confidence 5555556666666666666666665666666553 66666666666654321 11222333444444444444444443
Q ss_pred cC
Q 003855 355 VG 356 (791)
Q Consensus 355 ~~ 356 (791)
+.
T Consensus 294 ~~ 295 (306)
T 2z66_A 294 KQ 295 (306)
T ss_dssp GT
T ss_pred hC
Confidence 33
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=273.83 Aligned_cols=278 Identities=21% Similarity=0.242 Sum_probs=177.7
Q ss_pred cEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCC
Q 003855 65 ESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNL 144 (791)
Q Consensus 65 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L 144 (791)
+.++.+++.++ .+|..+. ++|++|+|++|+++.+....|. ++++|
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~--------------------------------~l~~L 54 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFD--------------------------------KLTQL 54 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTT--------------------------------TCTTC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhh--------------------------------ccccC
Confidence 46677777777 3444433 4677777777776654444444 44555
Q ss_pred cEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEccc
Q 003855 145 TILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRN 224 (791)
Q Consensus 145 ~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 224 (791)
++|+|++|+++... ..+..+..+++|++|+|++|.++. .+..+..+++|++|++++
T Consensus 55 ~~L~L~~n~l~~~~-----------------------~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~ 110 (306)
T 2z66_A 55 TKLSLSSNGLSFKG-----------------------CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH 110 (306)
T ss_dssp SEEECCSSCCCEEE-----------------------EEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTT
T ss_pred CEEECCCCccCccc-----------------------CcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEEECCC
Confidence 55555555554210 112233345666666666666663 344466666666666666
Q ss_pred ccCcccCC-ccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCC-CCCccccCCCCCCeEEccCCcCccc
Q 003855 225 NNLEGSIP-YDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS-SIPSSLWSLEYILDINLSSNSLNDS 302 (791)
Q Consensus 225 N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~i~~~ 302 (791)
|++++..+ ..+..+++|+.|++++|.+.+..+..+.++++|++|++++|++.+ ..|..+..+++|++|++++|.+++.
T Consensus 111 n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 190 (306)
T 2z66_A 111 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 190 (306)
T ss_dssp SEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEE
T ss_pred CcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCc
Confidence 66664433 456666666666666666666666666777777777777777765 4566677777777777777777766
Q ss_pred CCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCC-CCcEEEccCCccCCCCc--hhh
Q 003855 303 LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLI-SLESLDLSGNNLSGKIP--KSL 379 (791)
Q Consensus 303 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~--~~~ 379 (791)
.|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|++++..|..+..++ +|+.|+|++|++++..+ ...
T Consensus 191 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~ 270 (306)
T 2z66_A 191 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 270 (306)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHH
T ss_pred CHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHH
Confidence 677777777777777777777766666677777888888888888777777777774 78888888888875432 223
Q ss_pred hhcccCceEEccCCCCcccCCC
Q 003855 380 ETLSQLKQFNVSHNRLEGEIPV 401 (791)
Q Consensus 380 ~~l~~L~~l~l~~N~l~~~~~~ 401 (791)
..+...+.+.+..+.+.|..|.
T Consensus 271 ~~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 271 QWIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp HHHHHTGGGBSCGGGCBEEESG
T ss_pred HHHHhhhhhhccccccccCCch
Confidence 3344555556666666666554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=281.99 Aligned_cols=283 Identities=20% Similarity=0.223 Sum_probs=184.8
Q ss_pred CCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccccccccccccccccc
Q 003855 36 ISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLL 115 (791)
Q Consensus 36 l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 115 (791)
.+.....++++|+++ .+|..+. ++|++|+|++|.|+++.+..|.++++|++|+|++|+++++.+..|.++++|+.|
T Consensus 30 C~~~~~c~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 30 CDRNGICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp ECTTSEEECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCeEeeCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 345556777777777 7777554 477888888888877666677778888888888887777666666666666666
Q ss_pred ccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCE
Q 003855 116 SQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTL 195 (791)
Q Consensus 116 ~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 195 (791)
++++|+++.++... |.++++|++|++++|++++..+ ...|.++++|++
T Consensus 106 ~Ls~n~l~~~~~~~--------~~~l~~L~~L~L~~n~l~~l~~------------------------~~~~~~l~~L~~ 153 (353)
T 2z80_A 106 DLSYNYLSNLSSSW--------FKPLSSLTFLNLLGNPYKTLGE------------------------TSLFSHLTKLQI 153 (353)
T ss_dssp ECCSSCCSSCCHHH--------HTTCTTCSEEECTTCCCSSSCS------------------------SCSCTTCTTCCE
T ss_pred ECCCCcCCcCCHhH--------hCCCccCCEEECCCCCCcccCc------------------------hhhhccCCCCcE
Confidence 66666666544222 5566666666666666653210 024556667777
Q ss_pred EEccCC-ccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCc
Q 003855 196 LSLHSN-DLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNK 274 (791)
Q Consensus 196 L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 274 (791)
|++++| .++...+..|..+++|++|++++|++++..|..+..+++|+.|++++|+++...+..+..+++|+.|++++|+
T Consensus 154 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~ 233 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTD 233 (353)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCB
T ss_pred EECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCc
Confidence 777776 3555556666677777777777777766666666666667777777766653333333446666666666666
Q ss_pred CCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCC----CCCcchhccccccccccccccCCCC
Q 003855 275 LTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSG----DIPSTIGALKDLETLSLARNQFQGP 350 (791)
Q Consensus 275 l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~ 350 (791)
+++..+..+.. ......++.+++++|.+.+ .+|..+..+++|+.|++++|+++ .
T Consensus 234 l~~~~~~~l~~---------------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~ 291 (353)
T 2z80_A 234 LDTFHFSELST---------------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-S 291 (353)
T ss_dssp CTTCCCC---------------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-C
T ss_pred ccccccccccc---------------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-c
Confidence 66443322211 1123345555555555543 35667888889999999999998 4
Q ss_pred CCcc-cCCCCCCcEEEccCCccCCCCc
Q 003855 351 IPES-VGSLISLESLDLSGNNLSGKIP 376 (791)
Q Consensus 351 ~~~~-~~~l~~L~~L~l~~N~l~~~~~ 376 (791)
+|.. |..+++|+.|+|++|++.+..|
T Consensus 292 i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 292 VPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 5554 6889999999999999997654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=281.15 Aligned_cols=282 Identities=17% Similarity=0.200 Sum_probs=207.4
Q ss_pred ccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCC
Q 003855 7 TEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNAT 86 (791)
Q Consensus 7 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 86 (791)
+.-..++.....++++++++ .+|..+. ++|++|+|++|+++ .+|...+..+++|++|+|++|.|+++.|..|.+++
T Consensus 25 ~~~~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 100 (353)
T 2z80_A 25 QASLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG 100 (353)
T ss_dssp --CCEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred ccCCCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCc-ccCHHHhccCCCCCEEECCCCccCccCHhhcCCCC
Confidence 34445667778999999998 4566665 48999999999998 67765455589999999999999998899999999
Q ss_pred CCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCC-CcccCChhhhhh
Q 003855 87 KLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNP-LGGILPPVIGNF 165 (791)
Q Consensus 87 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~~ 165 (791)
+|++|+|++|+++++.+..|.++++|++|++++|+++.++.. ..+..+++|++|++++|+ ++..
T Consensus 101 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~-------~~~~~l~~L~~L~l~~n~~~~~~-------- 165 (353)
T 2z80_A 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGET-------SLFSHLTKLQILRVGNMDTFTKI-------- 165 (353)
T ss_dssp TCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSS-------CSCTTCTTCCEEEEEESSSCCEE--------
T ss_pred CCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCch-------hhhccCCCCcEEECCCCcccccc--------
Confidence 999999999999988888899999999999999999977641 238899999999999994 5532
Q ss_pred hhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEE
Q 003855 166 SASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIR 245 (791)
Q Consensus 166 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 245 (791)
.+..|.++++|+.|++++|++++..|..|..+++|++|++++|+++...+..+..+++|+.|+
T Consensus 166 -----------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~ 228 (353)
T 2z80_A 166 -----------------QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLE 228 (353)
T ss_dssp -----------------CTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEE
T ss_pred -----------------CHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEE
Confidence 345577888999999999999988888999999999999999998754444556688999999
Q ss_pred ecCCccCCCCCcccc---CCCCCcEEEcCCCcCCC----CCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEec
Q 003855 246 LTGNKLSGHIPPCLV---SLTSLRELHLGSNKLTS----SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDL 318 (791)
Q Consensus 246 L~~N~i~~~~~~~~~---~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l 318 (791)
+++|.+++..+..+. ..+.++.++|++|.+.+ .+|..+..+++|+.|++++|+++...+..|..+++|+.|++
T Consensus 229 L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L 308 (353)
T 2z80_A 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWL 308 (353)
T ss_dssp EESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEe
Confidence 999999866554333 24455666666655543 12333444444444444444444222222344444444444
Q ss_pred CCcccC
Q 003855 319 SRNQLS 324 (791)
Q Consensus 319 ~~N~l~ 324 (791)
++|++.
T Consensus 309 ~~N~~~ 314 (353)
T 2z80_A 309 HTNPWD 314 (353)
T ss_dssp CSSCBC
T ss_pred eCCCcc
Confidence 444444
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-30 Score=266.78 Aligned_cols=233 Identities=22% Similarity=0.218 Sum_probs=164.9
Q ss_pred CCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCc-cCCCCCccccCCCCCcEEE
Q 003855 191 SGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNK-LSGHIPPCLVSLTSLRELH 269 (791)
Q Consensus 191 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~ 269 (791)
++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|..+++|+.|++++|. ++...|..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 466777777777776666667777777777777777776666667777777777777775 6655566677777777777
Q ss_pred cCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCC
Q 003855 270 LGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQG 349 (791)
Q Consensus 270 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 349 (791)
+++|++++..+..|..+++|++|++++|.+++..+..|..+++|+.|++++|++++..+..|..+++|+.|++++|++++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 77777776666667777777777777777776666667777777777777777775555567777777777777777776
Q ss_pred CCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccccCCC
Q 003855 350 PIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 350 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~ 423 (791)
..|..+..+++|+.|++++|++++..+..+..+++|+.|++++|++.+..+....+.+++......+...|..|
T Consensus 192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p 265 (285)
T 1ozn_A 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCc
Confidence 66777777777777888777777766667777777788888888777766654444555555555666666544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=281.52 Aligned_cols=252 Identities=21% Similarity=0.220 Sum_probs=204.2
Q ss_pred CcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcc
Q 003855 144 LTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLR 223 (791)
Q Consensus 144 L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 223 (791)
...++.+++.++. +|..+ +..++.|+|++|++++..+..|.++++|+.|+|++|+|+++.+..|.++++|++|+|+
T Consensus 56 ~~~v~c~~~~l~~-iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 56 FSKVVCTRRGLSE-VPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SCEEECCSSCCSS-CCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CcEEEECCCCcCc-cCCCC---CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 3455555555553 23322 2455666666666666677778888899999999999988888888889999999999
Q ss_pred cccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCC-CcCCCCCCccccCCCCCCeEEccCCcCccc
Q 003855 224 NNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGS-NKLTSSIPSSLWSLEYILDINLSSNSLNDS 302 (791)
Q Consensus 224 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~ 302 (791)
+|+|++..+..|..+++|+.|+|++|+|+...+..|.++++|+.|++++ |.+....+..|..+++|++|+|++|.+++.
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 9999877777788889999999999998877777888899999999988 556555556788889999999999998754
Q ss_pred CCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhc
Q 003855 303 LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETL 382 (791)
Q Consensus 303 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 382 (791)
| .+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+
T Consensus 212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 3 47888899999999999988888888999999999999999988888888889999999999999987777888889
Q ss_pred ccCceEEccCCCCcccCCC
Q 003855 383 SQLKQFNVSHNRLEGEIPV 401 (791)
Q Consensus 383 ~~L~~l~l~~N~l~~~~~~ 401 (791)
++|+.|+|++|++.|.+..
T Consensus 290 ~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 290 RYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TTCCEEECCSSCEECSTTT
T ss_pred cCCCEEEccCCCcCCCCCc
Confidence 9999999999998887653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-29 Score=275.44 Aligned_cols=248 Identities=24% Similarity=0.275 Sum_probs=179.0
Q ss_pred CCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccccccccccccccccccc
Q 003855 38 TMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQ 117 (791)
Q Consensus 38 ~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l 117 (791)
..+.++++++.++ .+|..+. ++++.|+|++|+|+.+.+..|.++++|++|+|++|+|+.+.+..|.++++|+.|++
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 5678999999998 8998764 58999999999999888899999999999999999999888888888888888888
Q ss_pred ccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEE
Q 003855 118 VMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLS 197 (791)
Q Consensus 118 ~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 197 (791)
++|+|+.++... |..+++|++|+|++|+++.. .+..|.++++|+.|+
T Consensus 120 ~~n~l~~~~~~~--------~~~l~~L~~L~L~~N~i~~~-------------------------~~~~~~~l~~L~~L~ 166 (440)
T 3zyj_A 120 FDNRLTTIPNGA--------FVYLSKLKELWLRNNPIESI-------------------------PSYAFNRIPSLRRLD 166 (440)
T ss_dssp CSSCCSSCCTTT--------SCSCSSCCEEECCSCCCCEE-------------------------CTTTTTTCTTCCEEE
T ss_pred CCCcCCeeCHhH--------hhccccCceeeCCCCccccc-------------------------CHHHhhhCcccCEeC
Confidence 888887765433 67777777777777777642 223456677777777
Q ss_pred ccC-CccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCC
Q 003855 198 LHS-NDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT 276 (791)
Q Consensus 198 L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 276 (791)
|++ |.+..+.+..|.++++|++|+|++|+|+ .+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+++
T Consensus 167 l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 244 (440)
T 3zyj_A 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244 (440)
T ss_dssp CCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCcee
Confidence 777 4455455556777777777777777776 333 3566666666666666666655666666666666666666666
Q ss_pred CCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccC
Q 003855 277 SSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLS 324 (791)
Q Consensus 277 ~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 324 (791)
+..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 245 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 245 VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp EECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred EEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 666666666666666666666666555555666666666666666654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=279.32 Aligned_cols=252 Identities=23% Similarity=0.259 Sum_probs=205.3
Q ss_pred CcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcc
Q 003855 144 LTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLR 223 (791)
Q Consensus 144 L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 223 (791)
.+.++.+++.++. +|..+ +..++.|+|++|++.+..+..|.++++|++|+|++|.|+.+.+..|.++++|++|+|+
T Consensus 45 ~~~v~c~~~~l~~-iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 45 FSKVICVRKNLRE-VPDGI---STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp SCEEECCSCCCSS-CCSCC---CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCEEEeCCCCcCc-CCCCC---CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3455555555552 33322 2345556666666666667778888999999999999988888889999999999999
Q ss_pred cccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCC-CcCCCCCCccccCCCCCCeEEccCCcCccc
Q 003855 224 NNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGS-NKLTSSIPSSLWSLEYILDINLSSNSLNDS 302 (791)
Q Consensus 224 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~ 302 (791)
+|+|++..+..|..+++|+.|+|++|+|+...+..|.++++|++|+|++ |.+....+..|.++++|++|+|++|.++.
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~- 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE- 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-
Confidence 9999877777888999999999999999877777888999999999998 45555555678889999999999999874
Q ss_pred CCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhc
Q 003855 303 LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETL 382 (791)
Q Consensus 303 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 382 (791)
+| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+
T Consensus 200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 44 47888899999999999998888889999999999999999998888889999999999999999998888888889
Q ss_pred ccCceEEccCCCCcccCCC
Q 003855 383 SQLKQFNVSHNRLEGEIPV 401 (791)
Q Consensus 383 ~~L~~l~l~~N~l~~~~~~ 401 (791)
++|+.|+|++|++.|.+..
T Consensus 279 ~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 279 HHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp TTCCEEECCSSCEECSSTT
T ss_pred cCCCEEEcCCCCccCCCCc
Confidence 9999999999999887653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=274.27 Aligned_cols=250 Identities=20% Similarity=0.219 Sum_probs=210.2
Q ss_pred cCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhccccccc-ccCCcccc-------CCCCCCEEEccCCccccccCc
Q 003855 138 LTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK-GNIPQEIG-------NLSGLTLLSLHSNDLNGTISP 209 (791)
Q Consensus 138 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~ 209 (791)
++..++|+.|++++|.+ .+|..+... |+.|++++|.+. ..+|..+. ++++|++|+|++|++++..|.
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 44556677777777777 456655443 888888888884 45666555 799999999999999988888
Q ss_pred cc--cCCCCCCEEEcccccCcccCCcccccc-----CCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCC--CC
Q 003855 210 TM--GRLKRLQGLSLRNNNLEGSIPYDLCHL-----KLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSS--IP 280 (791)
Q Consensus 210 ~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~ 280 (791)
.+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+++++|++|+|++|++.+. .+
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 76 8999999999999999976 8888887 9999999999999988889999999999999999998754 23
Q ss_pred ccc--cCCCCCCeEEccCCcCcc---cCCcccccCCCCCEEecCCcccCCCCC-cchhccccccccccccccCCCCCCcc
Q 003855 281 SSL--WSLEYILDINLSSNSLND---SLPSNVQKLKVLTVLDLSRNQLSGDIP-STIGALKDLETLSLARNQFQGPIPES 354 (791)
Q Consensus 281 ~~~--~~l~~L~~L~l~~N~i~~---~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~ 354 (791)
..+ ..+++|++|++++|++++ .....+..+++|+.|++++|++++..| ..+..+++|+.|+|++|+|+ .+|..
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~ 271 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence 334 889999999999999983 222445688999999999999997765 45677899999999999999 77877
Q ss_pred cCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCccc
Q 003855 355 VGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGE 398 (791)
Q Consensus 355 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 398 (791)
+. ++|+.|||++|+|++. |. +..+++|+.|++++|++++.
T Consensus 272 ~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 272 LP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp CC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred cc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 76 8999999999999976 65 89999999999999999863
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=262.27 Aligned_cols=255 Identities=20% Similarity=0.205 Sum_probs=128.9
Q ss_pred cEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccccccccccccccccccccc
Q 003855 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVM 119 (791)
Q Consensus 40 ~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~ 119 (791)
++++++++.++ .+|..+ .++|++|+|++|.|+++.+..|.++++|++|+|++|.++++.+..|.++++|+.|++++
T Consensus 14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 56677777776 666543 34677777777777766666677777777777777777665555554444444444444
Q ss_pred cc-ccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEc
Q 003855 120 NN-LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSL 198 (791)
Q Consensus 120 n~-l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 198 (791)
|. ++.++. ..|..+++|++|++++|++
T Consensus 90 n~~l~~~~~--------~~~~~l~~L~~L~l~~n~l-------------------------------------------- 117 (285)
T 1ozn_A 90 NAQLRSVDP--------ATFHGLGRLHTLHLDRCGL-------------------------------------------- 117 (285)
T ss_dssp CTTCCCCCT--------TTTTTCTTCCEEECTTSCC--------------------------------------------
T ss_pred CCCccccCH--------HHhcCCcCCCEEECCCCcC--------------------------------------------
Confidence 43 333221 1133444444444444444
Q ss_pred cCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCC
Q 003855 199 HSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSS 278 (791)
Q Consensus 199 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 278 (791)
++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..|.++++|++|++++|++++.
T Consensus 118 -----~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 118 -----QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp -----CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred -----CEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 333333333444444444444444433333344444444444444444433333444455555555555555544
Q ss_pred CCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccC
Q 003855 279 IPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVG 356 (791)
Q Consensus 279 ~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 356 (791)
.|..|..+++|+.|++++|.+++..+..+..+++|+.|++++|.+....+. ...+..++.+..+.+.+....|..+.
T Consensus 193 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred CHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHhC
Confidence 455555555555555555555544444455555555555555555532221 11223344455555555555555443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-29 Score=275.54 Aligned_cols=248 Identities=23% Similarity=0.282 Sum_probs=172.6
Q ss_pred CCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccccccccccccccccccc
Q 003855 38 TMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQ 117 (791)
Q Consensus 38 ~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l 117 (791)
+.+.++++++.++ .+|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+..|.++++|+.|++
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 4567888888887 8887653 58889999999998888888889999999999999888887788888777777777
Q ss_pred ccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEE
Q 003855 118 VMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLS 197 (791)
Q Consensus 118 ~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 197 (791)
++|+|+.++... |..+++|++|+|++|+++.. .+..|.++++|+.|+
T Consensus 131 ~~n~l~~~~~~~--------~~~l~~L~~L~L~~N~l~~~-------------------------~~~~~~~l~~L~~L~ 177 (452)
T 3zyi_A 131 FDNWLTVIPSGA--------FEYLSKLRELWLRNNPIESI-------------------------PSYAFNRVPSLMRLD 177 (452)
T ss_dssp CSSCCSBCCTTT--------SSSCTTCCEEECCSCCCCEE-------------------------CTTTTTTCTTCCEEE
T ss_pred CCCcCCccChhh--------hcccCCCCEEECCCCCccee-------------------------CHhHHhcCCcccEEe
Confidence 777777665433 66777777777777776632 223456667777777
Q ss_pred ccC-CccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCC
Q 003855 198 LHS-NDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT 276 (791)
Q Consensus 198 L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 276 (791)
|++ |.+..+.+..|..+++|++|+|++|+|++ +| .+..+++|+.|+|++|.|++..|..|.++++|+.|+|++|+++
T Consensus 178 l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 255 (452)
T 3zyi_A 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS 255 (452)
T ss_dssp CCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCC
T ss_pred CCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCc
Confidence 776 45554555566777777777777777763 23 3556666666666666666656666666666666666666666
Q ss_pred CCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccC
Q 003855 277 SSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLS 324 (791)
Q Consensus 277 ~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 324 (791)
+..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 256 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 256 LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred eECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 655666666666666666666666555555566666666666666654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-30 Score=288.49 Aligned_cols=149 Identities=21% Similarity=0.187 Sum_probs=80.4
Q ss_pred CCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCcccc-CCCCCCeEEccCCcCcccCCcccccCCCCCEEe
Q 003855 239 KLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLW-SLEYILDINLSSNSLNDSLPSNVQKLKVLTVLD 317 (791)
Q Consensus 239 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~ 317 (791)
++|+.|+|++|.+++..|..++++++|+.|+|++|.+++..|..+. .+++|+.|+|++|.|++.. .+..+++|+.|+
T Consensus 120 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~--~~~~l~~L~~L~ 197 (487)
T 3oja_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLD 197 (487)
T ss_dssp SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEE
T ss_pred CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccccc--ccccCCCCCEEE
Confidence 3444444444444444444444444555555555555444444443 3455555555555554331 122355666666
Q ss_pred cCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccC-CCCchhhhhcccCceEEcc
Q 003855 318 LSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS-GKIPKSLETLSQLKQFNVS 391 (791)
Q Consensus 318 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~l~l~ 391 (791)
|++|.+++ +|..+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|++. +.+|..+..++.|+.++++
T Consensus 198 Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 198 LSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 66666663 33336666666666666666663 5555666666677777776666 4555666666666665554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-28 Score=277.35 Aligned_cols=268 Identities=28% Similarity=0.351 Sum_probs=148.8
Q ss_pred CCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEec
Q 003855 14 NLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDL 93 (791)
Q Consensus 14 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 93 (791)
++++|++++|+|+ .+|..+. ++|++|+|++|.|+ .+|. .+++|++|+|++|+|++ +|. .+++|++|+|
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 4556666666665 3344443 45666666666665 5554 14555555555555553 222 3455555555
Q ss_pred cCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhh
Q 003855 94 GFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFY 173 (791)
Q Consensus 94 ~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~ 173 (791)
++|+++++.. .+++|+.|++++|++++.
T Consensus 109 s~N~l~~l~~------------------------------------~l~~L~~L~L~~N~l~~l---------------- 136 (622)
T 3g06_A 109 FSNPLTHLPA------------------------------------LPSGLCKLWIFGNQLTSL---------------- 136 (622)
T ss_dssp CSCCCCCCCC------------------------------------CCTTCCEEECCSSCCSCC----------------
T ss_pred cCCcCCCCCC------------------------------------CCCCcCEEECCCCCCCcC----------------
Confidence 5555543221 234455555555555421
Q ss_pred cccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCC
Q 003855 174 AYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSG 253 (791)
Q Consensus 174 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 253 (791)
|. .+++|++|+|++|+++++ |. .+++|+.|++++|.|++ +| ..+++|+.|++++|.|++
T Consensus 137 ----------p~---~l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~ 195 (622)
T 3g06_A 137 ----------PV---LPPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS 195 (622)
T ss_dssp ----------CC---CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC
T ss_pred ----------CC---CCCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC
Confidence 11 124555555555555532 21 23455556666665553 33 234555556666665553
Q ss_pred CCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhc
Q 003855 254 HIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGA 333 (791)
Q Consensus 254 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 333 (791)
+|. .+++|+.|++++|.++. +|. .+++|+.|++++|.|++ +| ..+++|+.|+|++|+|+ .+|. .
T Consensus 196 -l~~---~~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~ 259 (622)
T 3g06_A 196 -LPT---LPSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---L 259 (622)
T ss_dssp -CCC---CCTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---C
T ss_pred -CCC---ccchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---c
Confidence 232 13566666666666663 332 23566666666666664 33 34466777777777776 3444 4
Q ss_pred cccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcc
Q 003855 334 LKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLS 383 (791)
Q Consensus 334 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 383 (791)
+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++..|..+..++
T Consensus 260 ~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 260 PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred cccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 566777777777777 5666677777777777777777776666666655
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-29 Score=262.52 Aligned_cols=227 Identities=22% Similarity=0.307 Sum_probs=179.1
Q ss_pred CCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEE
Q 003855 141 CRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGL 220 (791)
Q Consensus 141 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 220 (791)
.++++.|+|++|.++ .+|..+.++++|++|+|++|.++ .+|..|+.+++|++|
T Consensus 80 ~~~l~~L~L~~n~l~--------------------------~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L 132 (328)
T 4fcg_A 80 QPGRVALELRSVPLP--------------------------QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETL 132 (328)
T ss_dssp STTCCEEEEESSCCS--------------------------SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEE
T ss_pred ccceeEEEccCCCch--------------------------hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEE
Confidence 356777777777776 23444555677777777777777 566677777777777
Q ss_pred EcccccCcccCCccccccCCCceEEecCCccCCCCCcccc---------CCCCCcEEEcCCCcCCCCCCccccCCCCCCe
Q 003855 221 SLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLV---------SLTSLRELHLGSNKLTSSIPSSLWSLEYILD 291 (791)
Q Consensus 221 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~---------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 291 (791)
+|++|.++ .+|..+..+++|+.|+|++|.+.+.+|..+. ++++|++|+|++|+++ .+|..+..+++|++
T Consensus 133 ~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~ 210 (328)
T 4fcg_A 133 TLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS 210 (328)
T ss_dssp EEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCE
T ss_pred ECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCE
Confidence 77777777 5677777777777777777766666666554 4888888888888888 67778888888888
Q ss_pred EEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCcc
Q 003855 292 INLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNL 371 (791)
Q Consensus 292 L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 371 (791)
|+|++|.+++ +|..+..+++|+.|+|++|.+.+.+|..++.+++|+.|+|++|++.+.+|..+..+++|+.|+|++|++
T Consensus 211 L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~ 289 (328)
T 4fcg_A 211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289 (328)
T ss_dssp EEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTT
T ss_pred EEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCc
Confidence 8888888874 566788888899999999888888888888889999999999888888888888889999999999888
Q ss_pred CCCCchhhhhcccCceEEccCCCCcc
Q 003855 372 SGKIPKSLETLSQLKQFNVSHNRLEG 397 (791)
Q Consensus 372 ~~~~~~~~~~l~~L~~l~l~~N~l~~ 397 (791)
.+.+|..+..+++|+.+++..|.+..
T Consensus 290 ~~~iP~~l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 290 LSRLPSLIAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp CCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred hhhccHHHhhccCceEEeCCHHHHHH
Confidence 88899999999999998888776543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=272.73 Aligned_cols=266 Identities=20% Similarity=0.175 Sum_probs=168.6
Q ss_pred CcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccccccc
Q 003855 39 MRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQV 118 (791)
Q Consensus 39 L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~ 118 (791)
++.++++++.+. ..+..++..+++|++|+|++|.|+++.|..|.++++|++|+|++|++++..+ |..+++|+.|+++
T Consensus 12 l~i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 12 YKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred eeEeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 344555566554 4444444445566666666666665555566666666666666666654433 5555556666655
Q ss_pred cccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEc
Q 003855 119 MNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSL 198 (791)
Q Consensus 119 ~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 198 (791)
+|+++.++ ..++|++|++++|++++..+ ..+++|+.|++
T Consensus 89 ~n~l~~l~-------------~~~~L~~L~l~~n~l~~~~~----------------------------~~~~~L~~L~l 127 (317)
T 3o53_A 89 NNYVQELL-------------VGPSIETLHAANNNISRVSC----------------------------SRGQGKKNIYL 127 (317)
T ss_dssp SSEEEEEE-------------ECTTCCEEECCSSCCSEEEE----------------------------CCCSSCEEEEC
T ss_pred CCcccccc-------------CCCCcCEEECCCCccCCcCc----------------------------cccCCCCEEEC
Confidence 55555422 23567777777777664311 12456777777
Q ss_pred cCCccccccCccccCCCCCCEEEcccccCcccCCcccc-ccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCC
Q 003855 199 HSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLC-HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS 277 (791)
Q Consensus 199 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 277 (791)
++|++++..+..|..+++|++|+|++|.+++..+..+. .+++|+.|+|++|.|++. + ....+++|++|+|++|++++
T Consensus 128 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~ 205 (317)
T 3o53_A 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF 205 (317)
T ss_dssp CSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE
T ss_pred CCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc
Confidence 77777766666777777777777777777765555553 567777777777777643 2 23347777777777777774
Q ss_pred CCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccC-CCCCcchhcccccccccccc-ccCCCCCC
Q 003855 278 SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLS-GDIPSTIGALKDLETLSLAR-NQFQGPIP 352 (791)
Q Consensus 278 ~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~-N~l~~~~~ 352 (791)
. |..+..+++|+.|++++|.++ .+|..+..+++|+.|++++|.+. +..|..+..+++|+.|++++ +.+++..|
T Consensus 206 l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 206 M-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp E-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred c-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 3 344777777777777777776 35666777777777777777777 55666777777777777773 34554443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-28 Score=276.71 Aligned_cols=253 Identities=29% Similarity=0.333 Sum_probs=150.9
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCc
Q 003855 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSIT 83 (791)
Q Consensus 4 ~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 83 (791)
+||..+. ++|++|+|++|+|+.+ |. .+++|++|+|++|+|+ .+|. .+++|++|+|++|.|+++ |.
T Consensus 54 ~lp~~l~--~~L~~L~L~~N~l~~l-p~---~l~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~l~~l-~~--- 118 (622)
T 3g06_A 54 TLPDCLP--AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLT-SLPV----LPPGLLELSIFSNPLTHL-PA--- 118 (622)
T ss_dssp CCCSCCC--TTCSEEEECSCCCSCC-CC---CCTTCCEEEECSCCCS-CCCC----CCTTCCEEEECSCCCCCC-CC---
T ss_pred ccChhhC--CCCcEEEecCCCCCCC-CC---cCCCCCEEEcCCCcCC-cCCC----CCCCCCEEECcCCcCCCC-CC---
Confidence 6777776 8999999999999854 54 5789999999999998 8887 378999999999999964 44
Q ss_pred CCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhh
Q 003855 84 NATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIG 163 (791)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 163 (791)
.+++|+.|+|++|+++.++. .+++|+.|++++|+++.++. .+++|+.|++++|.+++
T Consensus 119 ~l~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~l~~------------~~~~L~~L~L~~N~l~~------- 175 (622)
T 3g06_A 119 LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPA------------LPSELCKLWAYNNQLTS------- 175 (622)
T ss_dssp CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCC------------CCTTCCEEECCSSCCSC-------
T ss_pred CCCCcCEEECCCCCCCcCCC----CCCCCCEEECcCCcCCCcCC------------ccCCCCEEECCCCCCCC-------
Confidence 56889999999999886433 13555555555555544321 12344444555444442
Q ss_pred hhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCce
Q 003855 164 NFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFG 243 (791)
Q Consensus 164 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 243 (791)
+| ..+++|+.|+|++|.|+++ |. .+++|+.|++++|.|+ .+|..
T Consensus 176 -------------------l~---~~~~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~-~l~~~--------- 219 (622)
T 3g06_A 176 -------------------LP---MLPSGLQELSVSDNQLASL-PT---LPSELYKLWAYNNRLT-SLPAL--------- 219 (622)
T ss_dssp -------------------CC---CCCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS-SCCCC---------
T ss_pred -------------------Cc---ccCCCCcEEECCCCCCCCC-CC---ccchhhEEECcCCccc-ccCCC---------
Confidence 11 1234555555555555532 21 1245555555555555 22221
Q ss_pred EEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCccc
Q 003855 244 IRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQL 323 (791)
Q Consensus 244 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l 323 (791)
+++|+.|+|++|+|++ +| ..+++|+.|+|++|.|+. +|. .+++|+.|+|++|+|
T Consensus 220 ------------------~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L 273 (622)
T 3g06_A 220 ------------------PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQL 273 (622)
T ss_dssp ------------------CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred ------------------CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCC
Confidence 2444555555555443 22 233445555555555542 222 344555555555555
Q ss_pred CCCCCcchhccccccccccccccCCCCCCcccCC
Q 003855 324 SGDIPSTIGALKDLETLSLARNQFQGPIPESVGS 357 (791)
Q Consensus 324 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 357 (791)
+ .+|..+..+++|+.|+|++|++++..|..+..
T Consensus 274 ~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~ 306 (622)
T 3g06_A 274 T-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 306 (622)
T ss_dssp C-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHH
T ss_pred C-cCCHHHhhccccCEEEecCCCCCCcCHHHHHh
Confidence 5 44555555555555555555555544444443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=260.60 Aligned_cols=134 Identities=19% Similarity=0.288 Sum_probs=62.8
Q ss_pred ccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCc
Q 003855 187 IGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLR 266 (791)
Q Consensus 187 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 266 (791)
|.++++|++|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|.+.+.+|..++++++|+
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~ 256 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence 444555555555555555 34444555555555555555555 2333444444444444444444444444444444444
Q ss_pred EEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcc
Q 003855 267 ELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQ 322 (791)
Q Consensus 267 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~ 322 (791)
+|+|++|.+.+.+|..+..+++|+.|+|++|.+.+.+|..+..+++|+.+++..|.
T Consensus 257 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~ 312 (328)
T 4fcg_A 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312 (328)
T ss_dssp EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHH
Confidence 44444444444444444444444444444444444444444444444444444333
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-30 Score=268.88 Aligned_cols=267 Identities=20% Similarity=0.177 Sum_probs=164.2
Q ss_pred ccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCC
Q 003855 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRN 143 (791)
Q Consensus 64 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~ 143 (791)
++.++++.+.+.......+..+++|++|+|++|+++++.+..|.++++|+.|++++|+++... .+..+
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~----------~~~~l-- 79 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL----------DLESL-- 79 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEE----------EETTC--
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcch----------hhhhc--
Confidence 444555556555444444555556666666666666555555555555555555555444321 13444
Q ss_pred CcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcc
Q 003855 144 LTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLR 223 (791)
Q Consensus 144 L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 223 (791)
++|++|+|++|++++.. ..++|++|+++
T Consensus 80 -----------------------------------------------~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~ 107 (317)
T 3o53_A 80 -----------------------------------------------STLRTLDLNNNYVQELL-----VGPSIETLHAA 107 (317)
T ss_dssp -----------------------------------------------TTCCEEECCSSEEEEEE-----ECTTCCEEECC
T ss_pred -----------------------------------------------CCCCEEECcCCcccccc-----CCCCcCEEECC
Confidence 44444444444444222 12445555555
Q ss_pred cccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCcccc-CCCCCCeEEccCCcCccc
Q 003855 224 NNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLW-SLEYILDINLSSNSLNDS 302 (791)
Q Consensus 224 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~i~~~ 302 (791)
+|+|++..+.. +++|+.|++++|++++..+..+..+++|++|+|++|++++..+..+. .+++|++|++++|.+++.
T Consensus 108 ~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 184 (317)
T 3o53_A 108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (317)
T ss_dssp SSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc
Confidence 55554332222 34455555555555544445555556666666666666555444443 456666666666666544
Q ss_pred CCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccC-CCCchhhhh
Q 003855 303 LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS-GKIPKSLET 381 (791)
Q Consensus 303 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~ 381 (791)
+ ....+++|+.|+|++|++++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++ +.+|..+..
T Consensus 185 -~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~ 260 (317)
T 3o53_A 185 -K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (317)
T ss_dssp -E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHT
T ss_pred -c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhc
Confidence 2 22347788888888888884 5555888888999999999888 57778888999999999999998 778888999
Q ss_pred cccCceEEccC-CCCcccCCC
Q 003855 382 LSQLKQFNVSH-NRLEGEIPV 401 (791)
Q Consensus 382 l~~L~~l~l~~-N~l~~~~~~ 401 (791)
+++|+.+++++ +.++|..|.
T Consensus 261 ~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 261 NQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp CHHHHHHHHHHHHHHHSSSSC
T ss_pred cccceEEECCCchhccCCchh
Confidence 99999999984 456655543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=267.03 Aligned_cols=252 Identities=22% Similarity=0.258 Sum_probs=131.8
Q ss_pred CCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCc-ccCCchhh-------hcCCCccEEEccCCcceecCCccC
Q 003855 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLS-GRLPSTVG-------HLLPNIESLLLAANNLTGIIPHSI 82 (791)
Q Consensus 11 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~p~~~~-------~~l~~L~~L~L~~N~l~~~~~~~~ 82 (791)
..++|++|++++|++ .+|..+... |+.|+|++|+++ ..+|..++ . +++|++|+|++|.+++..|..+
T Consensus 41 ~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 41 GGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLG-ISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHT-TSCCCEEEEEEEBCBSCCCCCS
T ss_pred cCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcC-cCCccEEEccCCcccchhHHHH
Confidence 344455555555555 334444332 555555555552 23444332 2 4455555555555554444443
Q ss_pred --cCCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCCh
Q 003855 83 --TNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPP 160 (791)
Q Consensus 83 --~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 160 (791)
..+++|++|+|++|++++. +..|.++. ...+++|++|+|++|++++.
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~---------------------------~~~~~~L~~L~L~~N~l~~~--- 164 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQ---------------------------QWLKPGLKVLSIAQAHSLNF--- 164 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHH---------------------------TTCCTTCCEEEEESCSCCCC---
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHH---------------------------HhhcCCCcEEEeeCCCCccc---
Confidence 4555555555555555544 34444430 00115555555555555432
Q ss_pred hhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccc--cCccc--cCCCCCCEEEcccccCcc---cCCc
Q 003855 161 VIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGT--ISPTM--GRLKRLQGLSLRNNNLEG---SIPY 233 (791)
Q Consensus 161 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~--~~l~~L~~L~L~~N~l~~---~~~~ 233 (791)
.|..|.++++|++|+|++|++.+. .+..+ ..+++|++|+|++|+|++ ....
T Consensus 165 ----------------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 222 (312)
T 1wwl_A 165 ----------------------SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222 (312)
T ss_dssp ----------------------CTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHH
T ss_pred ----------------------hHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHH
Confidence 223344555555555555554432 11222 555566666666665552 1112
Q ss_pred cccccCCCceEEecCCccCCCCC-ccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCC
Q 003855 234 DLCHLKLMFGIRLTGNKLSGHIP-PCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKV 312 (791)
Q Consensus 234 ~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~ 312 (791)
.+..+++|+.|+|++|++++..| ..+..+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++
T Consensus 223 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~ 297 (312)
T 1wwl_A 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQ 297 (312)
T ss_dssp HHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCE
T ss_pred HHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCC
Confidence 33455566666666666665443 34455667777777777776 4455444 6677777777777654 44 677777
Q ss_pred CCEEecCCcccCC
Q 003855 313 LTVLDLSRNQLSG 325 (791)
Q Consensus 313 L~~L~l~~N~l~~ 325 (791)
|+.|++++|++++
T Consensus 298 L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 298 VGNLSLKGNPFLD 310 (312)
T ss_dssp EEEEECTTCTTTC
T ss_pred CCEEeccCCCCCC
Confidence 7777777777763
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-31 Score=306.78 Aligned_cols=404 Identities=13% Similarity=0.075 Sum_probs=217.0
Q ss_pred CccccCCCCCCeeecCCCcc---cccCCcccc------------CCCCCcEEeCCCCcCcccCCchhhhcCCC-ccEEEc
Q 003855 6 PTEIGNLQNLQYLVFAENNL---SGLVPPTIF------------NISTMRILTLEGNQLSGRLPSTVGHLLPN-IESLLL 69 (791)
Q Consensus 6 p~~~~~l~~L~~L~Ls~n~l---~~~~~~~~~------------~l~~L~~L~L~~n~l~~~~p~~~~~~l~~-L~~L~L 69 (791)
+..+..+++|++|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..+...+++ |++|+|
T Consensus 66 ~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L 145 (592)
T 3ogk_B 66 DRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKL 145 (592)
T ss_dssp HHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEE
T ss_pred HHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEEC
Confidence 34456788888888887533 133443333 67888889998888876666666553444 888888
Q ss_pred cCCc-cee-cCCccCcCCCCCCEEeccCcccccc----ccccccccccccccccccccccccCCCccccccccccCCCCC
Q 003855 70 AANN-LTG-IIPHSITNATKLVALDLGFNSFAGH----ILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRN 143 (791)
Q Consensus 70 ~~N~-l~~-~~~~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~ 143 (791)
++|. ++. .++....++++|++|+|++|.+++. ....+.++++|+.|++++|.++.+... .+...+.++++
T Consensus 146 ~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~----~l~~~~~~~~~ 221 (592)
T 3ogk_B 146 DKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPK----DLETIARNCRS 221 (592)
T ss_dssp ESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHH----HHHHHHHHCTT
T ss_pred cCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHH----HHHHHHhhCCC
Confidence 8886 221 1222334778888888888887655 233456778888888888888643321 12333567788
Q ss_pred CcEEEccCCCCcccCChhhhhhhhhhhhhhccccccc---ccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEE
Q 003855 144 LTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK---GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGL 220 (791)
Q Consensus 144 L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 220 (791)
|+.|++++|.+.+ ++..+... ++|++|.+..+... ...+..+..+++|+.|+++++... ..+..+..+++|++|
T Consensus 222 L~~L~L~~~~~~~-l~~~~~~~-~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L 298 (592)
T 3ogk_B 222 LVSVKVGDFEILE-LVGFFKAA-ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKL 298 (592)
T ss_dssp CCEEECSSCBGGG-GHHHHHHC-TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEE
T ss_pred CcEEeccCccHHH-HHHHHhhh-hHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEE
Confidence 8888888888875 44444444 56777777643322 223334555566666666654333 344455555666666
Q ss_pred EcccccCcccCC-ccccccCCCceEEecCCccC-CCCCccccCCCCCcEEEcCC-----------CcCCCCCC-ccccCC
Q 003855 221 SLRNNNLEGSIP-YDLCHLKLMFGIRLTGNKLS-GHIPPCLVSLTSLRELHLGS-----------NKLTSSIP-SSLWSL 286 (791)
Q Consensus 221 ~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~-----------N~l~~~~~-~~~~~l 286 (791)
+|++|.+++... ..+..+++|+.|+++ +.+. ..++..+..+++|++|++++ |.++.... ..+..+
T Consensus 299 ~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~ 377 (592)
T 3ogk_B 299 DLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGC 377 (592)
T ss_dssp EETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHC
T ss_pred ecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhC
Confidence 666666543222 224455556666655 2222 12222234455555555552 34432211 112234
Q ss_pred CCCCeEEccCCcCcccCCccccc-CCCCCEEecC----CcccCCC-----CCcchhcccccccccccccc--CCCCCCcc
Q 003855 287 EYILDINLSSNSLNDSLPSNVQK-LKVLTVLDLS----RNQLSGD-----IPSTIGALKDLETLSLARNQ--FQGPIPES 354 (791)
Q Consensus 287 ~~L~~L~l~~N~i~~~~~~~~~~-l~~L~~L~l~----~N~l~~~-----~~~~~~~l~~L~~L~L~~N~--l~~~~~~~ 354 (791)
++|++|+++.|.+++..+..+.. +++|+.|+++ .|.+++. ++..+..+++|+.|++++|. +++..+..
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 55555555555555444444433 5555555553 4444432 11223445555555554322 33322222
Q ss_pred cC-CCCCCcEEEccCCccCC-CCchhhhhcccCceEEccCCCCcccC-CC-CCCCcCCccccccCCc
Q 003855 355 VG-SLISLESLDLSGNNLSG-KIPKSLETLSQLKQFNVSHNRLEGEI-PV-KGSFKNFSVESFFGNY 417 (791)
Q Consensus 355 ~~-~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~l~l~~N~l~~~~-~~-~~~~~~l~~~~~~~n~ 417 (791)
++ .+++|+.|+|++|++++ .++..+..+++|+.|++++|++++.. +. ...+++++.+.+.+|.
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 22 24455555555555543 22333344555555555555544321 11 1223444555555544
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-31 Score=302.78 Aligned_cols=375 Identities=17% Similarity=0.097 Sum_probs=284.5
Q ss_pred CCCCCCeeecCCCcccccCCccccCC--CCCcEEeCCCCc-Ccc-cCCchhhhcCCCccEEEccCCcceec----CCccC
Q 003855 11 NLQNLQYLVFAENNLSGLVPPTIFNI--STMRILTLEGNQ-LSG-RLPSTVGHLLPNIESLLLAANNLTGI----IPHSI 82 (791)
Q Consensus 11 ~l~~L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~L~~n~-l~~-~~p~~~~~~l~~L~~L~L~~N~l~~~----~~~~~ 82 (791)
.+++|++|+|++|.+++..+..+..+ .+|++|+|++|. ++. .++ .+...+++|++|+|++|.+++. ++..+
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~-~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~ 188 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLL-SIVTHCRKIKTLLMEESSFSEKDGKWLHELA 188 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHH-HHHHHCTTCSEEECTTCEEECCCSHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHH-HHHhhCCCCCEEECccccccCcchhHHHHHH
Confidence 78999999999999987777777664 459999999987 321 122 2233479999999999998865 33355
Q ss_pred cCCCCCCEEeccCcccccc----ccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCc---
Q 003855 83 TNATKLVALDLGFNSFAGH----ILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLG--- 155 (791)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~--- 155 (791)
..+++|++|+|++|.+++. .+..+.++++|+.|++++|.+..++ ..+..+++|+.|+++.+...
T Consensus 189 ~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~---------~~~~~~~~L~~L~l~~~~~~~~~ 259 (592)
T 3ogk_B 189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV---------GFFKAAANLEEFCGGSLNEDIGM 259 (592)
T ss_dssp HHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH---------HHHHHCTTCCEEEECBCCCCTTC
T ss_pred hcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH---------HHHhhhhHHHhhcccccccccch
Confidence 7789999999999999733 3445678899999999999887643 34788899999999864332
Q ss_pred ccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccC-ccccCCCCCCEEEcccccCc-ccCCc
Q 003855 156 GILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTIS-PTMGRLKRLQGLSLRNNNLE-GSIPY 233 (791)
Q Consensus 156 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~-~~~~~ 233 (791)
...+..+... .+|+.|.+.++.. ..+|..+..+++|++|+|++|.+++... ..+..+++|++|+++ |.+. ..++.
T Consensus 260 ~~~~~~l~~~-~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~ 336 (592)
T 3ogk_B 260 PEKYMNLVFP-RKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEV 336 (592)
T ss_dssp TTSSSCCCCC-TTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHH
T ss_pred HHHHHHhhcc-ccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHH
Confidence 1112222222 4688888887543 3667788889999999999999875443 346889999999999 4444 33444
Q ss_pred cccccCCCceEEecC-----------CccCCCC-CccccCCCCCcEEEcCCCcCCCCCCccccC-CCCCCeEEcc----C
Q 003855 234 DLCHLKLMFGIRLTG-----------NKLSGHI-PPCLVSLTSLRELHLGSNKLTSSIPSSLWS-LEYILDINLS----S 296 (791)
Q Consensus 234 ~~~~l~~L~~L~L~~-----------N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~l~----~ 296 (791)
.+..+++|+.|+|++ |.+++.. +..+..+++|++|+++.|.+++..+..+.. +++|+.|+++ .
T Consensus 337 ~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~ 416 (592)
T 3ogk_B 337 LAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDRE 416 (592)
T ss_dssp HHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCC
T ss_pred HHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCC
Confidence 557789999999993 5666432 233456899999999999998766666665 8899999996 7
Q ss_pred CcCccc-----CCcccccCCCCCEEecCCcc--cCCCCCcchhc-cccccccccccccCCC-CCCcccCCCCCCcEEEcc
Q 003855 297 NSLNDS-----LPSNVQKLKVLTVLDLSRNQ--LSGDIPSTIGA-LKDLETLSLARNQFQG-PIPESVGSLISLESLDLS 367 (791)
Q Consensus 297 N~i~~~-----~~~~~~~l~~L~~L~l~~N~--l~~~~~~~~~~-l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~ 367 (791)
|.+++. ++..+.++++|+.|++++|. +++..+..+.. +++|+.|++++|++++ .++..+..+++|+.|+|+
T Consensus 417 n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~ 496 (592)
T 3ogk_B 417 ERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMR 496 (592)
T ss_dssp SCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEE
T ss_pred ccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeecc
Confidence 788763 33447789999999998544 66555555544 8999999999999985 345556788999999999
Q ss_pred CCccCCC-CchhhhhcccCceEEccCCCCccc
Q 003855 368 GNNLSGK-IPKSLETLSQLKQFNVSHNRLEGE 398 (791)
Q Consensus 368 ~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~ 398 (791)
+|++++. ++..+..+++|+.|++++|+++..
T Consensus 497 ~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 497 GCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp SCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred CCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 9998755 445567899999999999998765
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=278.88 Aligned_cols=185 Identities=19% Similarity=0.092 Sum_probs=131.4
Q ss_pred ccCCCcceEEEEEE-ecCCcEEEEEEeehh----------hhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEE
Q 003855 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQ----------LERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 508 ~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 575 (791)
..+.|++|.+..++ .-.|+.||||++... .+...++|.+|+++|+++ .|+||+++++++++....|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45677777666654 336899999998653 133456799999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||++||+|.++|...+. ++.. +|+.||+.||+|+| +.+||||||||+|||++++|.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~ylH----~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAALE----KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHHH----HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHHH----HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999987654 5543 58899999999999 789999999999999999999999999999876543
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCC
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p 703 (791)
.. .....+||++|||||.+.+ .+..++|+||+|++++++.++..|
T Consensus 393 ~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 22 2334679999999998865 467789999999998887766543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8e-27 Score=241.51 Aligned_cols=211 Identities=22% Similarity=0.217 Sum_probs=183.2
Q ss_pred CCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEc
Q 003855 191 SGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHL 270 (791)
Q Consensus 191 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 270 (791)
++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+++..+..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 47889999999998777778888999999999999998777778888999999999999998777788899999999999
Q ss_pred CCCcCCCCCCccccCCCCCCeEEccCCcCccc-CCcccccCCCCCEEecCCcccCCCCCcchhcccccc----ccccccc
Q 003855 271 GSNKLTSSIPSSLWSLEYILDINLSSNSLNDS-LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLE----TLSLARN 345 (791)
Q Consensus 271 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~----~L~L~~N 345 (791)
++|++.+..+..+..+++|++|++++|.+++. +|..+..+++|+.|++++|++++..+..+..+++|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99999877777888999999999999999864 588899999999999999999977777888888887 8899999
Q ss_pred cCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCC
Q 003855 346 QFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVK 402 (791)
Q Consensus 346 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 402 (791)
++++..+..+. ..+|+.|+|++|++++..+..|..+++|+.|++++|+++|.++..
T Consensus 188 ~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 188 PMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred cccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 99965555554 458999999999999887778899999999999999999988754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=267.55 Aligned_cols=234 Identities=21% Similarity=0.185 Sum_probs=146.0
Q ss_pred CccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCC
Q 003855 63 NIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCR 142 (791)
Q Consensus 63 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~ 142 (791)
+|++|+|++|.|++..|..|..+++|++|+|++|.+++..+ |.++++|+.|++++|.|+.++ ..+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-------------~~~ 99 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-------------VGP 99 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-------------ECT
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-------------CCC
Confidence 56666666666666666666666666666666666665443 555555555555555555432 125
Q ss_pred CCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEc
Q 003855 143 NLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSL 222 (791)
Q Consensus 143 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 222 (791)
+|+.|++++|.+++..+ ..+++|+.|+|++|.+++..|..|+.+++|++|+|
T Consensus 100 ~L~~L~L~~N~l~~~~~----------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 151 (487)
T 3oja_A 100 SIETLHAANNNISRVSC----------------------------SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151 (487)
T ss_dssp TCCEEECCSSCCCCEEE----------------------------CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEEC
T ss_pred CcCEEECcCCcCCCCCc----------------------------cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEEC
Confidence 66666666666664311 12356667777777776666666666777777777
Q ss_pred ccccCcccCCcccc-ccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcc
Q 003855 223 RNNNLEGSIPYDLC-HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLND 301 (791)
Q Consensus 223 ~~N~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~ 301 (791)
++|.|++..|..+. .+++|+.|+|++|.|++. + .+..+++|+.|+|++|+|++..| .+..+++|+.|+|++|.+++
T Consensus 152 s~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~ 228 (487)
T 3oja_A 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL 228 (487)
T ss_dssp TTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE
T ss_pred CCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc
Confidence 77777665665554 566666677776666644 2 23346677777777777765333 36666777777777777764
Q ss_pred cCCcccccCCCCCEEecCCcccC-CCCCcchhccccccccccc
Q 003855 302 SLPSNVQKLKVLTVLDLSRNQLS-GDIPSTIGALKDLETLSLA 343 (791)
Q Consensus 302 ~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~ 343 (791)
+|..+..+++|+.|++++|.+. +.+|..+..++.|+.|+++
T Consensus 229 -lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 229 -IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp -ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred -cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 4555666677777777777766 4455556666666666665
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-25 Score=230.97 Aligned_cols=206 Identities=22% Similarity=0.254 Sum_probs=172.2
Q ss_pred CCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcC
Q 003855 192 GLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLG 271 (791)
Q Consensus 192 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 271 (791)
+.+.+++++|+++. +|..+. ++|++|+|++|+|++..+..|..+++|+.|+|++|.++...+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 56788888888884 454443 578888888888887777788888888888888888886666677888888999998
Q ss_pred CCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCC
Q 003855 272 SNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPI 351 (791)
Q Consensus 272 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 351 (791)
+|++.+..+..|..+++|++|++++|.+++..+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 88888777777888888999999999888877778888899999999999998766667888999999999999998776
Q ss_pred CcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCC
Q 003855 352 PESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400 (791)
Q Consensus 352 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 400 (791)
+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++.+.++
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 7778889999999999999987777778889999999999999888765
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.9e-26 Score=234.01 Aligned_cols=207 Identities=20% Similarity=0.191 Sum_probs=176.7
Q ss_pred hhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecC
Q 003855 169 LQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTG 248 (791)
Q Consensus 169 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 248 (791)
|++|++++|++++..+..|.++++|++|+|++|+++++.+..|..+++|++|+|++|++++..+..|..+++|+.|++++
T Consensus 30 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 109 (276)
T 2z62_A 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109 (276)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCC
Confidence 33344444444444455688899999999999999988888899999999999999999988888999999999999999
Q ss_pred CccCCCCCccccCCCCCcEEEcCCCcCCCC-CCccccCCCCCCeEEccCCcCcccCCcccccCCCCC----EEecCCccc
Q 003855 249 NKLSGHIPPCLVSLTSLRELHLGSNKLTSS-IPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLT----VLDLSRNQL 323 (791)
Q Consensus 249 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~----~L~l~~N~l 323 (791)
|.+++..+..+.++++|++|++++|++++. +|..+..+++|++|++++|++++..+..+..+++|+ .|++++|.+
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l 189 (276)
T 2z62_A 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189 (276)
T ss_dssp SCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCC
T ss_pred CCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcc
Confidence 999987777899999999999999999874 588999999999999999999988888888887777 899999999
Q ss_pred CCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCc
Q 003855 324 SGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 376 (791)
Q Consensus 324 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 376 (791)
++..+..+. ..+|+.|++++|++++..+..+..+++|+.|+|++|++++..|
T Consensus 190 ~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 190 NFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 965555444 4589999999999997777778999999999999999997554
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-25 Score=230.07 Aligned_cols=207 Identities=23% Similarity=0.189 Sum_probs=175.5
Q ss_pred ccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCc
Q 003855 187 IGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLR 266 (791)
Q Consensus 187 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 266 (791)
+.++++++.+++++|+++. +|..+. +++++|+|++|.|++..+..|..+++|+.|+|++|.|++..+ .+.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence 6678889999999999984 444443 688999999999988888889999999999999999985433 37888999
Q ss_pred EEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhcccccccccccccc
Q 003855 267 ELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQ 346 (791)
Q Consensus 267 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 346 (791)
+|+|++|+++ .+|..+..+++|++|++++|+|++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 9999999998 567788889999999999999988777889999999999999999997777778889999999999999
Q ss_pred CCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCC
Q 003855 347 FQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400 (791)
Q Consensus 347 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 400 (791)
|++..+..|..+++|+.|+|++|+++ .+|..+..+++|+.+++++|++.|.+.
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence 99666667788999999999999998 677777788899999999999887653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-24 Score=224.67 Aligned_cols=205 Identities=29% Similarity=0.285 Sum_probs=172.6
Q ss_pred CCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEc
Q 003855 143 NLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSL 222 (791)
Q Consensus 143 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 222 (791)
+++.+++++|+++.+ | ..+. ++|+.|+|++|+++++.+..|..+++|++|+|
T Consensus 17 ~~~~l~~~~~~l~~i-p-------------------------~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 68 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAI-P-------------------------SNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYL 68 (270)
T ss_dssp TTTEEECTTSCCSSC-C-------------------------SCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEEC
T ss_pred CCCEEEccCCCCCcc-C-------------------------CCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEEC
Confidence 567888888888742 2 2222 46888888888888777778888888888888
Q ss_pred ccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCccc
Q 003855 223 RNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDS 302 (791)
Q Consensus 223 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~ 302 (791)
++|.|+...+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++.
T Consensus 69 ~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 148 (270)
T 2o6q_A 69 NDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSL 148 (270)
T ss_dssp CSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCcc
Confidence 88888866666778888888999998888877777788899999999999999888888888999999999999999877
Q ss_pred CCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCC
Q 003855 303 LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKI 375 (791)
Q Consensus 303 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 375 (791)
.+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++...-
T Consensus 149 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred CHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 7777889999999999999999777777899999999999999999777777899999999999999997543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=231.45 Aligned_cols=185 Identities=24% Similarity=0.230 Sum_probs=89.2
Q ss_pred CCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEE
Q 003855 190 LSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELH 269 (791)
Q Consensus 190 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 269 (791)
+++|++|+|++|.+++. +.+..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..+..|.++++|++|+
T Consensus 62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 34444444444444421 2344444444444444444433333444444444444444444444444444444555555
Q ss_pred cCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCC
Q 003855 270 LGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQG 349 (791)
Q Consensus 270 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 349 (791)
+++|++++..+..|..+++|+.|++++|++++..+..+..+++|+.|++++|++++..+..+..+++|+.|++++|.+.+
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 55555444444444445555555555555544444444555555555555555554444445555555555555555442
Q ss_pred CCCcccCCCCCCcEEEccCCccCCCCchhhhhcc
Q 003855 350 PIPESVGSLISLESLDLSGNNLSGKIPKSLETLS 383 (791)
Q Consensus 350 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 383 (791)
. +++|+.|+++.|.++|.+|..++.++
T Consensus 220 ~-------~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 220 T-------CPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp C-------TTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred c-------CcHHHHHHHHHHhCCCcccCcccccC
Confidence 2 33455555666666666665555443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=229.55 Aligned_cols=222 Identities=24% Similarity=0.227 Sum_probs=197.5
Q ss_pred hhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEec
Q 003855 168 SLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247 (791)
Q Consensus 168 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 247 (791)
.+..+.+..+.+.... .+..+++|+.|++++|.++.. ..+..+++|++|+|++|.+++. ..+..+++|+.|+|+
T Consensus 20 ~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCccccccc--ccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC
Confidence 4667778887776543 356789999999999999843 4688999999999999999853 478999999999999
Q ss_pred CCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCC
Q 003855 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDI 327 (791)
Q Consensus 248 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 327 (791)
+|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|.+++..+..+..+++|+.|++++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP 173 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence 99999888888999999999999999999888888999999999999999999888888899999999999999999887
Q ss_pred CcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCC
Q 003855 328 PSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVK 402 (791)
Q Consensus 328 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 402 (791)
+..|..+++|+.|++++|++++..+..+..+++|+.|+|++|++.+. +++|+.++++.|.++|.+|..
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence 77889999999999999999988888899999999999999999865 457889999999999998864
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-25 Score=228.10 Aligned_cols=207 Identities=27% Similarity=0.260 Sum_probs=186.9
Q ss_pred cccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCC
Q 003855 210 TMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYI 289 (791)
Q Consensus 210 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 289 (791)
.+..+++++++++++|.++ .+|..+. ++++.|+|++|.|++..+..|.++++|++|+|++|+|++..+. ..+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 4678899999999999999 5665554 6899999999999988889999999999999999999865443 789999
Q ss_pred CeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCC
Q 003855 290 LDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGN 369 (791)
Q Consensus 290 ~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 369 (791)
++|++++|.++ .+|..+..+++|+.|++++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 99999999998 67888999999999999999999877788999999999999999999877888899999999999999
Q ss_pred ccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccccCC
Q 003855 370 NLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGP 422 (791)
Q Consensus 370 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~ 422 (791)
+|++..+..|..+++|+.|+|++|+++..++.......++.+.+.+|+|.|+.
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 99977778889999999999999999987777667778899999999999974
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.7e-28 Score=278.07 Aligned_cols=399 Identities=14% Similarity=0.111 Sum_probs=206.4
Q ss_pred ccCCCCCCeeecCCCcccc---cCCc------------cccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCC-
Q 003855 9 IGNLQNLQYLVFAENNLSG---LVPP------------TIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAAN- 72 (791)
Q Consensus 9 ~~~l~~L~~L~Ls~n~l~~---~~~~------------~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N- 72 (791)
+..+++|++|+|++|.... ..|. .+..+++|++|+|++|.+++..+..+...+++|++|+|++|
T Consensus 62 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~ 141 (594)
T 2p1m_B 62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE 141 (594)
T ss_dssp HHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCE
T ss_pred HhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcC
Confidence 4567889999998875321 1221 12457889999999998886666666544789999999988
Q ss_pred cceec-CCccCcCCCCCCEEeccCcccccccccccc----ccccccccccccccccccCCCccccccccccCCCCCCcEE
Q 003855 73 NLTGI-IPHSITNATKLVALDLGFNSFAGHILNTFG----NLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTIL 147 (791)
Q Consensus 73 ~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~----~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L 147 (791)
.++.. ++..+.++++|++|+|++|.+++..+..+. .+++|+.|++++|. ..+.... +..-+..+++|+.|
T Consensus 142 ~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~----l~~l~~~~~~L~~L 216 (594)
T 2p1m_B 142 GFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSA----LERLVTRCPNLKSL 216 (594)
T ss_dssp EEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHH----HHHHHHHCTTCCEE
T ss_pred CCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHH----HHHHHHhCCCCcEE
Confidence 55532 344455788899999999988765554444 55688999888886 2221111 11112456888999
Q ss_pred EccCCCCcccCChhhhhhhhhhhhhhcccc-------cccccCCccccCCCCCCEE-EccCCccccccCccccCCCCCCE
Q 003855 148 SFGSNPLGGILPPVIGNFSASLQKFYAYEC-------KLKGNIPQEIGNLSGLTLL-SLHSNDLNGTISPTMGRLKRLQG 219 (791)
Q Consensus 148 ~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n-------~l~~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~ 219 (791)
++++|.-.+.++..+... ++|++|.+..+ .+.+ ++..+.++++|+.| .+.+.... ..+..+..+++|++
T Consensus 217 ~L~~~~~~~~l~~~~~~~-~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~-~l~~~~~~~~~L~~ 293 (594)
T 2p1m_B 217 KLNRAVPLEKLATLLQRA-PQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVPA-YLPAVYSVCSRLTT 293 (594)
T ss_dssp ECCTTSCHHHHHHHHHHC-TTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG-GGGGGHHHHTTCCE
T ss_pred ecCCCCcHHHHHHHHhcC-CcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccchh-hHHHHHHhhCCCCE
Confidence 998883222244444333 45777764433 2222 22244555555555 23322221 22333334555555
Q ss_pred EEcccccCcccCC-ccccccCCCceEEecCCccCCC-CCccccCCCCCcEEEcC---------CCcCCCCCCcccc-CCC
Q 003855 220 LSLRNNNLEGSIP-YDLCHLKLMFGIRLTGNKLSGH-IPPCLVSLTSLRELHLG---------SNKLTSSIPSSLW-SLE 287 (791)
Q Consensus 220 L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~---------~N~l~~~~~~~~~-~l~ 287 (791)
|+|++|.+++... ..+..+++|+.|++++| +... ++.....+++|++|+++ .+.+++.....+. .++
T Consensus 294 L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~ 372 (594)
T 2p1m_B 294 LNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCP 372 (594)
T ss_dssp EECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCT
T ss_pred EEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhch
Confidence 6665555442211 12334555555555555 2211 11112235555555552 2333322111121 245
Q ss_pred CCCeEEccCCcCcccCCcccc-cCCCCCEEecC--C----cccCCCCC-----cchhccccccccccccccCCCCCCccc
Q 003855 288 YILDINLSSNSLNDSLPSNVQ-KLKVLTVLDLS--R----NQLSGDIP-----STIGALKDLETLSLARNQFQGPIPESV 355 (791)
Q Consensus 288 ~L~~L~l~~N~i~~~~~~~~~-~l~~L~~L~l~--~----N~l~~~~~-----~~~~~l~~L~~L~L~~N~l~~~~~~~~ 355 (791)
+|+.|.++.|.+++.....+. .+++|+.|+++ + |.+++... ..+..+++|+.|++++ .+++..+..+
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l 451 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYI 451 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHH
Confidence 555555555555543333333 35555555555 2 33331111 1134455555555544 3433333333
Q ss_pred CC-CCCCcEEEccCCccCCCCchhh-hhcccCceEEccCCCCcccCC--CCCCCcCCccccccCCc
Q 003855 356 GS-LISLESLDLSGNNLSGKIPKSL-ETLSQLKQFNVSHNRLEGEIP--VKGSFKNFSVESFFGNY 417 (791)
Q Consensus 356 ~~-l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~l~l~~N~l~~~~~--~~~~~~~l~~~~~~~n~ 417 (791)
+. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|++++... ....+++|+.+.+.+|+
T Consensus 452 ~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp HHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred HHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 33 4555555555555544333333 445555555555555533221 11224445555554443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-27 Score=277.04 Aligned_cols=374 Identities=16% Similarity=0.134 Sum_probs=260.6
Q ss_pred ccCCCCCCeeecCCCcccccCCcccc-CCCCCcEEeCCCC-cCcccCCchhhhcCCCccEEEccCCcceecCCccC----
Q 003855 9 IGNLQNLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGN-QLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSI---- 82 (791)
Q Consensus 9 ~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L~~n-~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~---- 82 (791)
...+++|++|+|++|.+++..+..+. .+++|++|+|++| .+++.....+...+++|++|+|++|.+++..+..+
T Consensus 101 ~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~ 180 (594)
T 2p1m_B 101 SSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFP 180 (594)
T ss_dssp HHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSC
T ss_pred HHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHh
Confidence 35788999999999999887777776 7899999999999 66533223344348999999999999886554444
Q ss_pred cCCCCCCEEeccCcccccccccc----ccccccccccccccc-cccccCCCccccccccccCCCCCCcEEEccCCCC---
Q 003855 83 TNATKLVALDLGFNSFAGHILNT----FGNLRHLSLLSQVMN-NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPL--- 154 (791)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~~~~----~~~l~~L~~L~l~~n-~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l--- 154 (791)
..+++|++|+|++|. ..+.... +.++++|+.|++++| .+.. ++..+..+++|+.|+++.+..
T Consensus 181 ~~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~---------l~~~~~~~~~L~~L~l~~~~~~~~ 250 (594)
T 2p1m_B 181 DTYTSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEK---------LATLLQRAPQLEELGTGGYTAEVR 250 (594)
T ss_dssp TTCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH---------HHHHHHHCTTCSEEECSBCCCCCC
T ss_pred hcCCcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH---------HHHHHhcCCcceEcccccccCccc
Confidence 367799999999997 2222233 345699999999988 3332 234467889999999776643
Q ss_pred ----cccCChhhhhhhhhhhhh-hcccccccccCCccccCCCCCCEEEccCCccccccCc-cccCCCCCCEEEcccccCc
Q 003855 155 ----GGILPPVIGNFSASLQKF-YAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISP-TMGRLKRLQGLSLRNNNLE 228 (791)
Q Consensus 155 ----~~~~~~~~~~~~~~L~~L-~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~ 228 (791)
.+ ++..+.++ ++|+.| .+.+... +.++..+..+++|+.|+|++|.++..... .+..+++|++|++++| +.
T Consensus 251 ~~~~~~-l~~~l~~~-~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~ 326 (594)
T 2p1m_B 251 PDVYSG-LSVALSGC-KELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IE 326 (594)
T ss_dssp HHHHHH-HHHHHHTC-TTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GH
T ss_pred hhhHHH-HHHHHhcC-CCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cC
Confidence 21 11122221 234444 2222221 23444455778999999999997643322 3568899999999988 54
Q ss_pred cc-CCccccccCCCceEEecC---------CccCCCCCcccc-CCCCCcEEEcCCCcCCCCCCcccc-CCCCCCeEEcc-
Q 003855 229 GS-IPYDLCHLKLMFGIRLTG---------NKLSGHIPPCLV-SLTSLRELHLGSNKLTSSIPSSLW-SLEYILDINLS- 295 (791)
Q Consensus 229 ~~-~~~~~~~l~~L~~L~L~~---------N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~- 295 (791)
.. ++.....+++|+.|++++ +.+++.....+. ++++|+.|.++.|.+++.....+. .+++|+.|+++
T Consensus 327 ~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~ 406 (594)
T 2p1m_B 327 DAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCI 406 (594)
T ss_dssp HHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEE
T ss_pred HHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeec
Confidence 22 222334588999999943 455533233333 478999999999998865555554 57899999999
Q ss_pred -C----CcCccc-----CCcccccCCCCCEEecCCcccCCCCCcchhc-cccccccccccccCCCCCCccc-CCCCCCcE
Q 003855 296 -S----NSLNDS-----LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGA-LKDLETLSLARNQFQGPIPESV-GSLISLES 363 (791)
Q Consensus 296 -~----N~i~~~-----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~ 363 (791)
+ |.+++. ++..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.
T Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~ 485 (594)
T 2p1m_B 407 IEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRK 485 (594)
T ss_dssp SSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCE
T ss_pred ccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCE
Confidence 4 566532 122367788999999987 666555555555 8899999999999876544444 56889999
Q ss_pred EEccCCccCCCCch-hhhhcccCceEEccCCCCcc
Q 003855 364 LDLSGNNLSGKIPK-SLETLSQLKQFNVSHNRLEG 397 (791)
Q Consensus 364 L~l~~N~l~~~~~~-~~~~l~~L~~l~l~~N~l~~ 397 (791)
|+|++|++++..+. ....+++|+.|++++|+++.
T Consensus 486 L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 486 LEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp EEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred EECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 99999999654443 44568999999999998843
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.3e-26 Score=254.99 Aligned_cols=186 Identities=19% Similarity=0.191 Sum_probs=146.3
Q ss_pred ccccccCCCcceEEEEEEecCCcEEEEEEeehhh--------hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 504 NECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--------ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 504 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
...+.||+|+||.||+|.. .++.+++|+..... ....+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4456899999999999965 57889999764321 12245689999999999999999766666677778999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++.. +..++.|+++||.||| +.+|+||||||+|||+++ .+||+|||+|+.....
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH----~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH----KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH----HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH----HCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999876 4579999999999999 678999999999999999 9999999999987543
Q ss_pred CCcc-----eeecccccccccCCCccCC--CCCCccccHHhHHHHHHHHHhCCCCCC
Q 003855 656 EDSV-----TQTMTMATIGYMAPEYGSE--GIVSAKCDVYSYGVLLMETFTRKRPTD 705 (791)
Q Consensus 656 ~~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~ 705 (791)
.... ......||+.|||||++.. ..|+.++|+|+..+-..+-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2211 1234579999999998876 568888999999999999988887764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-26 Score=244.98 Aligned_cols=265 Identities=19% Similarity=0.177 Sum_probs=138.1
Q ss_pred eeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCc----hhhhcCC-CccEEEccCCcceecCCccCcCC-----C
Q 003855 17 YLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPS----TVGHLLP-NIESLLLAANNLTGIIPHSITNA-----T 86 (791)
Q Consensus 17 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~ 86 (791)
+++|++|++++.+|..+...++|++|+|++|.++ ..+. ..+..++ +|++|+|++|.|++..+..|..+ +
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~-~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLY-SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGG-GSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCC-hHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 4567777777777776666666777777777776 4442 2223355 67777777777776656666554 6
Q ss_pred CCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCC-CCCcEEEccCCCCcccCChhhhhh
Q 003855 87 KLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNC-RNLTILSFGSNPLGGILPPVIGNF 165 (791)
Q Consensus 87 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~~ 165 (791)
+|++|+|++|++++..+..+... +..+ ++|++|+|++|++++..+..+...
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~----------------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 132 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKT----------------------------LAAIPFTITVLDLGWNDFSSKSSSEFKQA 132 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHH----------------------------HHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred CccEEECcCCcCChHHHHHHHHH----------------------------HHhCCCCccEEECcCCcCCcHHHHHHHHH
Confidence 77777777777766555443332 2222 344444444444443322222211
Q ss_pred hhhhhhhhcccccccccCCccccCC-CCCCEEEccCCccccccC----ccccCCC-CCCEEEcccccCcccCCccccc--
Q 003855 166 SASLQKFYAYECKLKGNIPQEIGNL-SGLTLLSLHSNDLNGTIS----PTMGRLK-RLQGLSLRNNNLEGSIPYDLCH-- 237 (791)
Q Consensus 166 ~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~-- 237 (791)
+..+ ++|++|+|++|+++...+ ..+..++ +|++|+|++|+|++..+..+..
T Consensus 133 ---------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l 191 (362)
T 3goz_A 133 ---------------------FSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFL 191 (362)
T ss_dssp ---------------------HTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred ---------------------HHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHH
Confidence 1121 244444444444442211 1122222 4444555544444333332222
Q ss_pred --c-CCCceEEecCCccCCC----CCccccC-CCCCcEEEcCCCcCCCCCC----ccccCCCCCCeEEccCCcCccc---
Q 003855 238 --L-KLMFGIRLTGNKLSGH----IPPCLVS-LTSLRELHLGSNKLTSSIP----SSLWSLEYILDINLSSNSLNDS--- 302 (791)
Q Consensus 238 --l-~~L~~L~L~~N~i~~~----~~~~~~~-l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~l~~N~i~~~--- 302 (791)
+ ++|+.|+|++|.|++. ++..+.. .++|++|+|++|++++..+ ..+..+++|+.|+|++|.+.+.
T Consensus 192 ~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~ 271 (362)
T 3goz_A 192 ASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKE 271 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHH
T ss_pred HhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHH
Confidence 2 3455555555554432 2233333 2356666666666654332 2334556666666666664322
Q ss_pred ----CCcccccCCCCCEEecCCcccCCCCCcch
Q 003855 303 ----LPSNVQKLKVLTVLDLSRNQLSGDIPSTI 331 (791)
Q Consensus 303 ----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 331 (791)
++..+..+++|+.||+++|.+.+..+..+
T Consensus 272 ~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~ 304 (362)
T 3goz_A 272 QCKALGAAFPNIQKIILVDKNGKEIHPSHSIPI 304 (362)
T ss_dssp HHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHH
T ss_pred HHHHHHHHhccCCceEEEecCCCcCCCcchHHH
Confidence 22345666777777777777775544433
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-26 Score=251.52 Aligned_cols=189 Identities=20% Similarity=0.229 Sum_probs=99.2
Q ss_pred ccCCCCCCEEEccCCcccc----ccCccccCCCCCCEEEcccccCcccCCcccc----cc---------CCCceEEecCC
Q 003855 187 IGNLSGLTLLSLHSNDLNG----TISPTMGRLKRLQGLSLRNNNLEGSIPYDLC----HL---------KLMFGIRLTGN 249 (791)
Q Consensus 187 ~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l---------~~L~~L~L~~N 249 (791)
|..+++|++|+|++|.++. .++..+..+++|++|+|++|.|+...+..+. .+ ++|+.|+|++|
T Consensus 90 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n 169 (386)
T 2ca6_A 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 169 (386)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCC
Confidence 3445555555555555553 2334445555555555555555433222222 22 55555555555
Q ss_pred ccC-CCCC---ccccCCCCCcEEEcCCCcCCC-----CCCccccCCCCCCeEEccCCcCc----ccCCcccccCCCCCEE
Q 003855 250 KLS-GHIP---PCLVSLTSLRELHLGSNKLTS-----SIPSSLWSLEYILDINLSSNSLN----DSLPSNVQKLKVLTVL 316 (791)
Q Consensus 250 ~i~-~~~~---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~l~~N~i~----~~~~~~~~~l~~L~~L 316 (791)
+++ ...+ ..+..+++|++|+|++|+++. ..+..+..+++|+.|+|++|.++ ..+|..+..+++|+.|
T Consensus 170 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L 249 (386)
T 2ca6_A 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 249 (386)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred CCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEE
Confidence 554 2222 345556666666666666652 22335555666666666666664 3455556666666666
Q ss_pred ecCCcccCCC----CCcchhc--cccccccccccccCCC----CCCccc-CCCCCCcEEEccCCccCCCC
Q 003855 317 DLSRNQLSGD----IPSTIGA--LKDLETLSLARNQFQG----PIPESV-GSLISLESLDLSGNNLSGKI 375 (791)
Q Consensus 317 ~l~~N~l~~~----~~~~~~~--l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~l~~N~l~~~~ 375 (791)
+|++|.+++. ++..+.. +++|+.|+|++|.+++ .+|..+ .++++|+.|+|++|++++..
T Consensus 250 ~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 250 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred ECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 6666666543 2333322 5555555555555553 244444 34556666666666665544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=226.79 Aligned_cols=202 Identities=19% Similarity=0.217 Sum_probs=166.3
Q ss_pred CCCCCEEEccCCccccccCccc--cCCCCCCEEEcccccCcccCC----ccccccCCCceEEecCCccCCCCCccccCCC
Q 003855 190 LSGLTLLSLHSNDLNGTISPTM--GRLKRLQGLSLRNNNLEGSIP----YDLCHLKLMFGIRLTGNKLSGHIPPCLVSLT 263 (791)
Q Consensus 190 l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~ 263 (791)
+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|+.|+|++|++++..+..|++++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 4569999999999988888887 889999999999999986555 3455788999999999999888888899999
Q ss_pred CCcEEEcCCCcCCCC---C-CccccCCCCCCeEEccCCcCcccCCc----ccccCCCCCEEecCCcccCCCCCcchhcc-
Q 003855 264 SLRELHLGSNKLTSS---I-PSSLWSLEYILDINLSSNSLNDSLPS----NVQKLKVLTVLDLSRNQLSGDIPSTIGAL- 334 (791)
Q Consensus 264 ~L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~l~~N~i~~~~~~----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l- 334 (791)
+|++|+|++|++.+. . +..+..+++|++|+|++|+++. ++. .+..+++|++|+|++|++++..|..+..+
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 999999999998642 1 2334678899999999999963 233 35788999999999999997778777766
Q ss_pred --ccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcc
Q 003855 335 --KDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEG 397 (791)
Q Consensus 335 --~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 397 (791)
++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|++++|+|+.
T Consensus 249 ~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 249 WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 69999999999999 6777664 7999999999999964 43 6788999999999999874
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-24 Score=215.24 Aligned_cols=196 Identities=18% Similarity=0.174 Sum_probs=140.2
Q ss_pred CCCEEEccCCccccccCccccCCCCCCEEEccccc-CcccCCccccccCCCceEEecC-CccCCCCCccccCCCCCcEEE
Q 003855 192 GLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNN-LEGSIPYDLCHLKLMFGIRLTG-NKLSGHIPPCLVSLTSLRELH 269 (791)
Q Consensus 192 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~ 269 (791)
+|+.|++++|+++++.+..|..+++|++|++++|+ +++..+..|.++++|+.|++++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 67777788777777766677777778888887776 7766666777777777777777 777766666777777788888
Q ss_pred cCCCcCCCCCCccccCCCCCC---eEEccCC-cCcccCCcccccCCCCC-EEecCCcccCCCCCcchhcccccccccccc
Q 003855 270 LGSNKLTSSIPSSLWSLEYIL---DINLSSN-SLNDSLPSNVQKLKVLT-VLDLSRNQLSGDIPSTIGALKDLETLSLAR 344 (791)
Q Consensus 270 L~~N~l~~~~~~~~~~l~~L~---~L~l~~N-~i~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 344 (791)
+++|++++ +|. |..+++|+ +|++++| .+++..+..|..+++|+ .|++++|+++...+..|.. ++|+.|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 88777775 444 67777777 7777777 77766666677777777 7888887777333333444 6777777777
Q ss_pred cc-CCCCCCcccCCC-CCCcEEEccCCccCCCCchhhhhcccCceEEccCC
Q 003855 345 NQ-FQGPIPESVGSL-ISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHN 393 (791)
Q Consensus 345 N~-l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 393 (791)
|+ +++..+..|..+ ++|+.|++++|++++..+. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 74 775556667777 7777777777777744333 4566777777665
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-25 Score=238.96 Aligned_cols=123 Identities=21% Similarity=0.255 Sum_probs=97.1
Q ss_pred CCccCCccccCCCCCCeeecCCCcccccCC----ccccCCC-CCcEEeCCCCcCcccCCchhhhc----CCCccEEEccC
Q 003855 1 MAGQIPTEIGNLQNLQYLVFAENNLSGLVP----PTIFNIS-TMRILTLEGNQLSGRLPSTVGHL----LPNIESLLLAA 71 (791)
Q Consensus 1 ~~g~lp~~~~~l~~L~~L~Ls~n~l~~~~~----~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~~----l~~L~~L~L~~ 71 (791)
++|.+|..+...++|++|+|++|+|++..+ +.|.+++ +|++|+|++|++++..+..+... .++|++|+|++
T Consensus 10 ~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~ 89 (362)
T 3goz_A 10 GSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSG 89 (362)
T ss_dssp TCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCS
T ss_pred chHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcC
Confidence 478888888888889999999999998877 8888999 99999999999986656666552 28999999999
Q ss_pred CcceecCCccCc----CC-CCCCEEeccCcccccccccccccc-----cccccccccccccc
Q 003855 72 NNLTGIIPHSIT----NA-TKLVALDLGFNSFAGHILNTFGNL-----RHLSLLSQVMNNLT 123 (791)
Q Consensus 72 N~l~~~~~~~~~----~l-~~L~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~l~~n~l~ 123 (791)
|.+++..+..+. .+ ++|++|+|++|+++......+... ++|+.|++++|+++
T Consensus 90 n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 90 NFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp SCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred CcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 999977666444 44 899999999999987776655432 35555555555554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-26 Score=249.09 Aligned_cols=245 Identities=17% Similarity=0.240 Sum_probs=195.5
Q ss_pred ccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCcc---ccccCccc
Q 003855 135 LSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDL---NGTISPTM 211 (791)
Q Consensus 135 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l---~~~~~~~~ 211 (791)
+..+..+++|+.|+|++|.++...+..+ +..|..+++|+.|+|++|.+ ++.+|..+
T Consensus 25 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l---------------------~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~ 83 (386)
T 2ca6_A 25 FAVLLEDDSVKEIVLSGNTIGTEAARWL---------------------SENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83 (386)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHH---------------------HHTTTTCTTCCEEECCSCCTTSCGGGSHHHH
T ss_pred HHHHhcCCCccEEECCCCCCCHHHHHHH---------------------HHHHHhCCCccEEeCcccccCccccchhHHH
Confidence 4456777888888888888875433222 23466788899999988644 44444444
Q ss_pred -------cCCCCCCEEEcccccCcc----cCCccccccCCCceEEecCCccCCCCCcccc----CC---------CCCcE
Q 003855 212 -------GRLKRLQGLSLRNNNLEG----SIPYDLCHLKLMFGIRLTGNKLSGHIPPCLV----SL---------TSLRE 267 (791)
Q Consensus 212 -------~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~----~l---------~~L~~ 267 (791)
..+++|++|+|++|.+++ .+|..+..+++|+.|+|++|.++...+..+. .+ ++|++
T Consensus 84 ~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~ 163 (386)
T 2ca6_A 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRS 163 (386)
T ss_dssp HHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCE
T ss_pred HHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcE
Confidence 789999999999999997 4677889999999999999999754444443 33 89999
Q ss_pred EEcCCCcCC-CCCC---ccccCCCCCCeEEccCCcCcc-----cCCcccccCCCCCEEecCCcccC----CCCCcchhcc
Q 003855 268 LHLGSNKLT-SSIP---SSLWSLEYILDINLSSNSLND-----SLPSNVQKLKVLTVLDLSRNQLS----GDIPSTIGAL 334 (791)
Q Consensus 268 L~L~~N~l~-~~~~---~~~~~l~~L~~L~l~~N~i~~-----~~~~~~~~l~~L~~L~l~~N~l~----~~~~~~~~~l 334 (791)
|+|++|+++ ...+ ..+..+++|++|++++|.++. ..+..+..+++|+.|+|++|.++ ..+|..+..+
T Consensus 164 L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~ 243 (386)
T 2ca6_A 164 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243 (386)
T ss_dssp EECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred EECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccC
Confidence 999999997 3334 467788999999999999973 34447889999999999999995 4677888999
Q ss_pred ccccccccccccCCCC----CCccc--CCCCCCcEEEccCCccCC----CCchhh-hhcccCceEEccCCCCcccCC
Q 003855 335 KDLETLSLARNQFQGP----IPESV--GSLISLESLDLSGNNLSG----KIPKSL-ETLSQLKQFNVSHNRLEGEIP 400 (791)
Q Consensus 335 ~~L~~L~L~~N~l~~~----~~~~~--~~l~~L~~L~l~~N~l~~----~~~~~~-~~l~~L~~l~l~~N~l~~~~~ 400 (791)
++|+.|+|++|+|++. ++..+ +.+++|+.|+|++|++++ .+|..+ .++++|+.|++++|++++..+
T Consensus 244 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 9999999999999865 45666 448999999999999997 478777 668999999999999987664
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-24 Score=216.37 Aligned_cols=197 Identities=19% Similarity=0.195 Sum_probs=166.0
Q ss_pred hhhhhhcccccccccCCccccCCCCCCEEEccCCc-cccccCccccCCCCCCEEEccc-ccCcccCCccccccCCCceEE
Q 003855 168 SLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSND-LNGTISPTMGRLKRLQGLSLRN-NNLEGSIPYDLCHLKLMFGIR 245 (791)
Q Consensus 168 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ 245 (791)
+|++|++++|+++++.+..|.++++|++|++++|+ ++.+.+..|..+++|++|+|++ |+|++..+..|.++++|+.|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45555555555555556678889999999999997 8888888999999999999998 999987788899999999999
Q ss_pred ecCCccCCCCCccccCCCCCc---EEEcCCC-cCCCCCCccccCCCCCC-eEEccCCcCcccCCcccccCCCCCEEecCC
Q 003855 246 LTGNKLSGHIPPCLVSLTSLR---ELHLGSN-KLTSSIPSSLWSLEYIL-DINLSSNSLNDSLPSNVQKLKVLTVLDLSR 320 (791)
Q Consensus 246 L~~N~i~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~ 320 (791)
+++|++++ +|. +..+++|+ +|++++| ++++..+..|..+++|+ .|++++|+++...+..|.. ++|+.|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 99999996 565 88899998 9999999 99987778899999999 9999999998555555555 8999999999
Q ss_pred cc-cCCCCCcchhcc-ccccccccccccCCCCCCcccCCCCCCcEEEccCCc
Q 003855 321 NQ-LSGDIPSTIGAL-KDLETLSLARNQFQGPIPESVGSLISLESLDLSGNN 370 (791)
Q Consensus 321 N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 370 (791)
|+ +++..+..|..+ ++|+.|++++|++++ +|.. .+++|+.|+++++.
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNTW 237 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC-
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCcc
Confidence 95 987777889999 999999999999994 5543 67899999998764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=220.70 Aligned_cols=213 Identities=24% Similarity=0.352 Sum_probs=176.6
Q ss_pred hhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecC
Q 003855 169 LQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTG 248 (791)
Q Consensus 169 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 248 (791)
+..+.+..+.+..... +..+++|+.|++++|.++.. + .+..+++|++|+|++|.+++..+ +..+++|+.|+|++
T Consensus 21 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~ 94 (308)
T 1h6u_A 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (308)
T ss_dssp HHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCceec--HHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccC
Confidence 4455666666665433 45678899999999999854 3 68889999999999999985444 89999999999999
Q ss_pred CccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCC
Q 003855 249 NKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP 328 (791)
Q Consensus 249 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 328 (791)
|++++. + .+..+++|++|++++|++++.. .+..+++|++|++++|.+++..+ +..+++|+.|++++|++++. +
T Consensus 95 n~l~~~-~-~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~ 167 (308)
T 1h6u_A 95 NPLKNV-S-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-T 167 (308)
T ss_dssp CCCSCC-G-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-G
T ss_pred CcCCCc-h-hhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-h
Confidence 999853 3 6889999999999999998643 38899999999999999986543 88999999999999999854 3
Q ss_pred cchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccC
Q 003855 329 STIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEI 399 (791)
Q Consensus 329 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 399 (791)
. +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|++++|++++.+
T Consensus 168 ~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 168 P-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp G-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCC
T ss_pred h-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCC
Confidence 3 8899999999999999985433 8889999999999999996553 889999999999999998744
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-23 Score=210.55 Aligned_cols=179 Identities=23% Similarity=0.252 Sum_probs=103.6
Q ss_pred CCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcC
Q 003855 192 GLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLG 271 (791)
Q Consensus 192 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 271 (791)
+.+.++++++.++ .+|..+. ++|+.|+|++|.+++..+..|..+++|+.|+|++|.|++..+..|.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4566777777777 3344433 467777777777776666666666666666666666666556566666666666666
Q ss_pred CCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCC
Q 003855 272 SNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPI 351 (791)
Q Consensus 272 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 351 (791)
+|++++..+..|..+++|++|+|++|.|++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 66666555555555556666666666555444444555555555555555555444434555555555555555555444
Q ss_pred CcccCCCCCCcEEEccCCccCC
Q 003855 352 PESVGSLISLESLDLSGNNLSG 373 (791)
Q Consensus 352 ~~~~~~l~~L~~L~l~~N~l~~ 373 (791)
+..+..+++|+.|+|++|++++
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCT
T ss_pred HHHHhCCCCCCEEEeeCCceeC
Confidence 4444445555555555555443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.1e-23 Score=210.20 Aligned_cols=183 Identities=22% Similarity=0.232 Sum_probs=158.1
Q ss_pred CCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEc
Q 003855 215 KRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINL 294 (791)
Q Consensus 215 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 294 (791)
.+.++++++++.++ .+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 35678999999988 5665554 58899999999999888888999999999999999999888888899999999999
Q ss_pred cCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCC
Q 003855 295 SSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGK 374 (791)
Q Consensus 295 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 374 (791)
++|.+++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99999887778888999999999999999877777788899999999999999976677888899999999999999988
Q ss_pred CchhhhhcccCceEEccCCCCcccCC
Q 003855 375 IPKSLETLSQLKQFNVSHNRLEGEIP 400 (791)
Q Consensus 375 ~~~~~~~l~~L~~l~l~~N~l~~~~~ 400 (791)
.+..|..+++|+.|++++|+++|...
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred CHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 88888899999999999999988743
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=218.72 Aligned_cols=196 Identities=22% Similarity=0.329 Sum_probs=147.5
Q ss_pred cCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCC
Q 003855 138 LTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRL 217 (791)
Q Consensus 138 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 217 (791)
+..+++|++|++++|.++.. + .+..+++|+.|+|++|.+++..+ +..+++|
T Consensus 37 ~~~l~~L~~L~l~~~~i~~l--------------------------~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L 87 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTTI--------------------------E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKI 87 (308)
T ss_dssp HHHHHTCCEEECTTSCCCCC--------------------------T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSC
T ss_pred HHHcCCcCEEEeeCCCccCc--------------------------h-hhhccCCCCEEEccCCcCCCChh--HccCCCC
Confidence 34456677777777766531 1 35567778888888887775443 7777888
Q ss_pred CEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCC
Q 003855 218 QGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSN 297 (791)
Q Consensus 218 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 297 (791)
++|+|++|++++. ..+..+++|+.|++++|++++. +. +..+++|++|++++|++++..+ +..+++|+.|++++|
T Consensus 88 ~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n 161 (308)
T 1h6u_A 88 TELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNA 161 (308)
T ss_dssp CEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred CEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCC
Confidence 8888888887743 3577788888888888888753 33 7888888888888888875543 778888888888888
Q ss_pred cCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCC
Q 003855 298 SLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGK 374 (791)
Q Consensus 298 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 374 (791)
.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++.. .+..+++|+.|+|++|++++.
T Consensus 162 ~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 162 QVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp CCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECC
T ss_pred cCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecC
Confidence 8876433 8888889999999998885433 788899999999999998544 378899999999999999853
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.7e-23 Score=218.22 Aligned_cols=242 Identities=18% Similarity=0.174 Sum_probs=129.6
Q ss_pred cEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccc-ccccccccccccccccc
Q 003855 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGH-ILNTFGNLRHLSLLSQV 118 (791)
Q Consensus 40 ~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~l~ 118 (791)
++++.++++++ ++|..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+. ..+.|
T Consensus 12 ~~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f------------ 75 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF------------ 75 (350)
T ss_dssp TEEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSB------------
T ss_pred CEEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHh------------
Confidence 56778888887 888765 35788888888888876667788888888888888876432 22233
Q ss_pred cccccccCCCccccccccccCCCCCCcE-EEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEE
Q 003855 119 MNNLTTESSSADQWSFLSSLTNCRNLTI-LSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLS 197 (791)
Q Consensus 119 ~n~l~~~~~~~~~~~~~~~l~~l~~L~~-L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 197 (791)
.++++|++ +.+++|+++. +.|..|.++++|++|+
T Consensus 76 --------------------~~L~~l~~~l~~~~N~l~~-------------------------l~~~~f~~l~~L~~L~ 110 (350)
T 4ay9_X 76 --------------------SNLPKLHEIRIEKANNLLY-------------------------INPEAFQNLPNLQYLL 110 (350)
T ss_dssp --------------------CSCTTCCEEEEEEETTCCE-------------------------ECTTSBCCCTTCCEEE
T ss_pred --------------------hcchhhhhhhcccCCcccc-------------------------cCchhhhhcccccccc
Confidence 33333332 3333444442 2334456666666666
Q ss_pred ccCCccccccCccccCCCCCCEEEccc-ccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCC
Q 003855 198 LHSNDLNGTISPTMGRLKRLQGLSLRN-NNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT 276 (791)
Q Consensus 198 L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 276 (791)
+++|+|+...+..+....++..|++.+ |++....+..|..+. ..++.|+|++|+|+
T Consensus 111 l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~-----------------------~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS-----------------------FESVILWLNKNGIQ 167 (350)
T ss_dssp EEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB-----------------------SSCEEEECCSSCCC
T ss_pred ccccccccCCchhhcccchhhhhhhccccccccccccchhhcc-----------------------hhhhhhcccccccc
Confidence 666666655555555555666666644 345533333444332 13444555555554
Q ss_pred CCCCccccCCCCCCeEEccC-CcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCccc
Q 003855 277 SSIPSSLWSLEYILDINLSS-NSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV 355 (791)
Q Consensus 277 ~~~~~~~~~l~~L~~L~l~~-N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 355 (791)
.+.+. .....+|+.|++++ |.++.+.+..|..+++|+.|||++|+|+...+..|.++++|+.+++ +.++ .+| .+
T Consensus 168 ~i~~~-~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l 242 (350)
T 4ay9_X 168 EIHNS-AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TL 242 (350)
T ss_dssp EECTT-SSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CT
T ss_pred CCChh-hccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-Cc
Confidence 32222 22233444555442 3443333334555555555555555555333333444444444333 2233 344 25
Q ss_pred CCCCCCcEEEccCCc
Q 003855 356 GSLISLESLDLSGNN 370 (791)
Q Consensus 356 ~~l~~L~~L~l~~N~ 370 (791)
..+++|+.++++++.
T Consensus 243 ~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 243 EKLVALMEASLTYPS 257 (350)
T ss_dssp TTCCSCCEEECSCHH
T ss_pred hhCcChhhCcCCCCc
Confidence 556666666665443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-23 Score=218.29 Aligned_cols=224 Identities=18% Similarity=0.206 Sum_probs=187.3
Q ss_pred CCCCEEEccCCccccccCc---cccCCCCCCEEEcccccCcccCCccc--cccCCCceEEecCCccCCCCC----ccccC
Q 003855 191 SGLTLLSLHSNDLNGTISP---TMGRLKRLQGLSLRNNNLEGSIPYDL--CHLKLMFGIRLTGNKLSGHIP----PCLVS 261 (791)
Q Consensus 191 ~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~i~~~~~----~~~~~ 261 (791)
..++.|.+.++.++..... .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 4578889988887632111 12245779999999999999999888 999999999999999997655 44567
Q ss_pred CCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCccc--C--CcccccCCCCCEEecCCcccCCCCCc----chhc
Q 003855 262 LTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDS--L--PSNVQKLKVLTVLDLSRNQLSGDIPS----TIGA 333 (791)
Q Consensus 262 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~--~--~~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~ 333 (791)
+++|++|+|++|++.+..+..|..+++|++|+|++|++.+. . +..+..+++|++|+|++|+++ .++. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 99999999999999988889999999999999999998652 1 233478999999999999997 3444 3578
Q ss_pred cccccccccccccCCCCCCcccCCC---CCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCcc
Q 003855 334 LKDLETLSLARNQFQGPIPESVGSL---ISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSV 410 (791)
Q Consensus 334 l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~ 410 (791)
+++|++|+|++|++++..|..+..+ ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|++++. |....+++++.
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~ 298 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDN 298 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccE
Confidence 8999999999999998878888776 69999999999999 6677664 8999999999999985 33567889999
Q ss_pred ccccCCccc
Q 003855 411 ESFFGNYAL 419 (791)
Q Consensus 411 ~~~~~n~~~ 419 (791)
+.+.+|++.
T Consensus 299 L~L~~N~l~ 307 (310)
T 4glp_A 299 LTLDGNPFL 307 (310)
T ss_dssp EECSSTTTS
T ss_pred EECcCCCCC
Confidence 999999864
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=224.03 Aligned_cols=247 Identities=16% Similarity=0.133 Sum_probs=179.0
Q ss_pred ccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCccee-cCCccCcCCCC
Q 003855 9 IGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTG-IIPHSITNATK 87 (791)
Q Consensus 9 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~ 87 (791)
+..+.. +.++.++++++ .+|..+ .+++++|+|++|+|+ .+|...|..+++|++|+|++|++.+ +.+.+|.++++
T Consensus 6 ~C~C~~-~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~ 80 (350)
T 4ay9_X 6 ICHCSN-RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80 (350)
T ss_dssp SSEEET-TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTT
T ss_pred ccEeeC-CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchh
Confidence 344433 67889999998 557666 368999999999998 8998777779999999999999865 44568899998
Q ss_pred CCE-EeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccC-CCCcccCChhhhhh
Q 003855 88 LVA-LDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGS-NPLGGILPPVIGNF 165 (791)
Q Consensus 88 L~~-L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~~ 165 (791)
|.+ +.+++|+++.+.++.|.++++|+.|++++|+|..++... +....++..|++.+ |+++...+
T Consensus 81 l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~--------~~~~~~l~~l~l~~~~~i~~l~~------ 146 (350)
T 4ay9_X 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH--------KIHSLQKVLLDIQDNINIHTIER------ 146 (350)
T ss_dssp CCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCT--------TCCBSSCEEEEEESCTTCCEECT------
T ss_pred hhhhhcccCCcccccCchhhhhccccccccccccccccCCchh--------hcccchhhhhhhccccccccccc------
Confidence 875 667789999999999999999999999999998876543 56667788888865 45654322
Q ss_pred hhhhhhhhcccccccccCCccccCC-CCCCEEEccCCccccccCccccCCCCCCEEEccc-ccCcccCCccccccCCCce
Q 003855 166 SASLQKFYAYECKLKGNIPQEIGNL-SGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRN-NNLEGSIPYDLCHLKLMFG 243 (791)
Q Consensus 166 ~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~ 243 (791)
..|..+ ..++.|+|++|+|+.+.+..| ...+|++|++++ |.++.+.++.|..+++|+.
T Consensus 147 -------------------~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~ 206 (350)
T 4ay9_X 147 -------------------NSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206 (350)
T ss_dssp -------------------TSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSE
T ss_pred -------------------cchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccch
Confidence 234444 357778888888875555444 456788888864 6676555567788888888
Q ss_pred EEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCc
Q 003855 244 IRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNS 298 (791)
Q Consensus 244 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 298 (791)
|+|++|+|+...+..+. +|+.|.+.++.-...+| .+..+++|+.++++++.
T Consensus 207 LdLs~N~l~~lp~~~~~---~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 207 LDISRTRIHSLPSYGLE---NLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp EECTTSCCCCCCSSSCT---TCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHH
T ss_pred hhcCCCCcCccChhhhc---cchHhhhccCCCcCcCC-CchhCcChhhCcCCCCc
Confidence 88888888855444444 45555544433323455 47778888888887654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-24 Score=230.46 Aligned_cols=254 Identities=16% Similarity=0.206 Sum_probs=148.0
Q ss_pred CcEEeCCCCcCcccCCchhhhcC--CCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccc-cccccccccccccc
Q 003855 39 MRILTLEGNQLSGRLPSTVGHLL--PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGH-ILNTFGNLRHLSLL 115 (791)
Q Consensus 39 L~~L~L~~n~l~~~~p~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L 115 (791)
++.|++++|.+. |..+.. + ++++.|++++|.+.+..+. +..+++|++|+|++|.++.. .+..+..+++|+.|
T Consensus 49 ~~~l~l~~~~~~---~~~~~~-~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGR-LLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp SSEEECTTCBCC---HHHHHH-HHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred heeeccccccCC---HHHHHh-hhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 556666666654 222222 3 5666666666666654443 34566666666666666544 45556666666666
Q ss_pred ccccccccccCCCccccccccccCCCCCCcEEEccCC-CCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCC
Q 003855 116 SQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSN-PLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLT 194 (791)
Q Consensus 116 ~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 194 (791)
++++|.++.. .+..+..+++|++|++++| .+++.. ++..+.++++|+
T Consensus 124 ~L~~~~l~~~--------~~~~l~~~~~L~~L~L~~~~~l~~~~------------------------l~~~~~~~~~L~ 171 (336)
T 2ast_B 124 SLEGLRLSDP--------IVNTLAKNSNLVRLNLSGCSGFSEFA------------------------LQTLLSSCSRLD 171 (336)
T ss_dssp ECTTCBCCHH--------HHHHHTTCTTCSEEECTTCBSCCHHH------------------------HHHHHHHCTTCC
T ss_pred eCcCcccCHH--------HHHHHhcCCCCCEEECCCCCCCCHHH------------------------HHHHHhcCCCCC
Confidence 6666665432 2334566777777777777 455310 112234456666
Q ss_pred EEEccCC-ccccc-cCccccCCC-CCCEEEcccc--cCc-ccCCccccccCCCceEEecCCc-cCCCCCccccCCCCCcE
Q 003855 195 LLSLHSN-DLNGT-ISPTMGRLK-RLQGLSLRNN--NLE-GSIPYDLCHLKLMFGIRLTGNK-LSGHIPPCLVSLTSLRE 267 (791)
Q Consensus 195 ~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~L~~N--~l~-~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~ 267 (791)
+|++++| .+++. .+..+..++ +|++|+|++| .++ +.+|..+..+++|+.|++++|. +++..+..+..+++|++
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~ 251 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 251 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCE
Confidence 6666666 66543 344556666 6777777666 343 2345556666777777777776 55555566677777777
Q ss_pred EEcCCCc-CCCCCCccccCCCCCCeEEccCCcCcccCCcccccC-CCCCEEecCCcccCCCCCcchhc
Q 003855 268 LHLGSNK-LTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKL-KVLTVLDLSRNQLSGDIPSTIGA 333 (791)
Q Consensus 268 L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~ 333 (791)
|++++|. +.......+..+++|+.|++++| ++. ..+..+ ..|+.|++++|++++..|..++.
T Consensus 252 L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 252 LSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred eeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence 7777774 22222224666777777777777 432 223333 23666667778877777766554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-24 Score=229.09 Aligned_cols=252 Identities=21% Similarity=0.255 Sum_probs=199.1
Q ss_pred CCcEEEccCCCCcccCChhhhhh-hhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccc-cCccccCCCCCCEE
Q 003855 143 NLTILSFGSNPLGGILPPVIGNF-SASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGT-ISPTMGRLKRLQGL 220 (791)
Q Consensus 143 ~L~~L~L~~N~l~~~~~~~~~~~-~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L 220 (791)
.++.|++++|.+. +..+..+ ...++.|++.+|.+.+..+. +..+++|++|+|++|.+++. .+..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4778888888876 3444443 25678888888888876665 55789999999999998865 67788899999999
Q ss_pred EcccccCcccCCccccccCCCceEEecCC-ccCCC-CCccccCCCCCcEEEcCCC-cCCCC-CCccccCCC-CCCeEEcc
Q 003855 221 SLRNNNLEGSIPYDLCHLKLMFGIRLTGN-KLSGH-IPPCLVSLTSLRELHLGSN-KLTSS-IPSSLWSLE-YILDINLS 295 (791)
Q Consensus 221 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~l~ 295 (791)
+|++|.+++..+..+..+++|+.|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|++|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999998888888899999999999999 67742 5666888999999999999 88754 466678888 99999999
Q ss_pred CC--cCc-ccCCcccccCCCCCEEecCCcc-cCCCCCcchhcccccccccccccc-CCCCCCcccCCCCCCcEEEccCCc
Q 003855 296 SN--SLN-DSLPSNVQKLKVLTVLDLSRNQ-LSGDIPSTIGALKDLETLSLARNQ-FQGPIPESVGSLISLESLDLSGNN 370 (791)
Q Consensus 296 ~N--~i~-~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~ 370 (791)
+| .++ +.++..+..+++|+.|++++|. +++..+..+..+++|+.|++++|. +.......++.+++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 99 555 4566777889999999999999 776777888999999999999996 32222225788999999999999
Q ss_pred cCCCCchhhhhc-ccCceEEccCCCCcccCCCC
Q 003855 371 LSGKIPKSLETL-SQLKQFNVSHNRLEGEIPVK 402 (791)
Q Consensus 371 l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~~~ 402 (791)
++. ..+..+ ..++.|++++|++++..|..
T Consensus 283 i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 283 VPD---GTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp SCT---TCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred cCH---HHHHHHHhhCcceEEecccCccccCCc
Confidence 442 344444 34777789999999887753
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-22 Score=210.09 Aligned_cols=149 Identities=16% Similarity=0.140 Sum_probs=119.2
Q ss_pred HHHhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhh------------------HHHHHHHHHHHHHHhccCCc
Q 003855 497 QRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLE------------------RAFRSFDSECEVLRNVRHRN 558 (791)
Q Consensus 497 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~n 558 (791)
......|.+.+.||+|+||.||+|+..+|+.||||++..... .....+.+|+.++++++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 333455677799999999999999997899999999864321 23467889999999998 4
Q ss_pred cceeeeeeccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC
Q 003855 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN 638 (791)
Q Consensus 559 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~ 638 (791)
+++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.||| +.+|+||||||+|||++ +
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH----~~giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEE-T
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH----HCCCEeCCCCHHHEEEE-C
Confidence 666665543 55699999999999988 422 124569999999999999 67899999999999999 9
Q ss_pred CcEEEeeeccccccCCCCCcceeecccccccccCCCccC
Q 003855 639 MAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS 677 (791)
Q Consensus 639 ~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 677 (791)
+.+||+|||+|+. +..|+|||++.
T Consensus 229 ~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 229 EGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp TEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9999999999863 33478888753
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-21 Score=191.46 Aligned_cols=163 Identities=25% Similarity=0.244 Sum_probs=121.4
Q ss_pred CCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEc
Q 003855 191 SGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHL 270 (791)
Q Consensus 191 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 270 (791)
++|++|++++|+++++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 46788888888887766667777888888888888887666666777778888888888777666666777788888888
Q ss_pred CCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCC
Q 003855 271 GSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGP 350 (791)
Q Consensus 271 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 350 (791)
++|++++..+..|..+++|+.|++++|.+++..+..+..+++|+.|++++|.+.+ .+++|+.|+++.|+++|.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ 180 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGV 180 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTT
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCce
Confidence 8888876666667777777788887777776666667777778888887776653 345677777777777777
Q ss_pred CCcccCCCCC
Q 003855 351 IPESVGSLIS 360 (791)
Q Consensus 351 ~~~~~~~l~~ 360 (791)
+|..++.++.
T Consensus 181 ip~~~~~l~~ 190 (208)
T 2o6s_A 181 VRNSAGSVAP 190 (208)
T ss_dssp BBCTTSSBCT
T ss_pred eeccCccccC
Confidence 7777766654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.6e-21 Score=190.86 Aligned_cols=179 Identities=23% Similarity=0.201 Sum_probs=102.6
Q ss_pred CEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCC
Q 003855 194 TLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSN 273 (791)
Q Consensus 194 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 273 (791)
+.++.+++.++.+ |..+ .++|++|+|++|++++..+..|..+++|+.|++++|++++..+..|.++++|++|+|++|
T Consensus 10 ~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 4566777777633 3332 346777777777777555555666666666666666666555555666666666666666
Q ss_pred cCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCc
Q 003855 274 KLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPE 353 (791)
Q Consensus 274 ~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 353 (791)
++++..+..|..+++|++|++++|.+++..+..|..+++|+.|++++|++++..+..|..+++|+.|++++|.+.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence 6665555555566666666666666655444445555555555555555554444445555555555555554432
Q ss_pred ccCCCCCCcEEEccCCccCCCCchhhhhc
Q 003855 354 SVGSLISLESLDLSGNNLSGKIPKSLETL 382 (791)
Q Consensus 354 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 382 (791)
.+++|+.|+++.|+++|.+|..++.+
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred ---CCCCHHHHHHHHHhCCceeeccCccc
Confidence 22344555555555555555444433
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.7e-21 Score=216.35 Aligned_cols=169 Identities=25% Similarity=0.325 Sum_probs=107.5
Q ss_pred CCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEc
Q 003855 191 SGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHL 270 (791)
Q Consensus 191 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 270 (791)
++|+.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.. +|+.|+|++|+|++ +|. .+++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 45667777777766 333 345667777777777764 444 444 67777777777764 443 4667777777
Q ss_pred CCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccc-------cccccc
Q 003855 271 GSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDL-------ETLSLA 343 (791)
Q Consensus 271 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-------~~L~L~ 343 (791)
++|+|++ +|. .+++|+.|+|++|.|++ +|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|+
T Consensus 148 s~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls 215 (571)
T 3cvr_A 148 DNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCR 215 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECC
T ss_pred CCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecC
Confidence 7777764 333 45667777777777765 444 44 66777777777776 4454 433 55 777777
Q ss_pred cccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhccc
Q 003855 344 RNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQ 384 (791)
Q Consensus 344 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 384 (791)
+|+|+ .+|..+..+++|+.|+|++|++++.+|..+..++.
T Consensus 216 ~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp SSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred CCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 77777 56666666777777777777777777777666544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.7e-21 Score=192.02 Aligned_cols=156 Identities=23% Similarity=0.267 Sum_probs=101.5
Q ss_pred eEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCC-ccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCc
Q 003855 243 GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIP-SSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRN 321 (791)
Q Consensus 243 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N 321 (791)
.+++++|.++ .+|..+. ..+++|+|++|+|++..+ ..|..+++|+.|+|++|.|++..+..|..+++|+.|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4555555554 2333332 234566666666665433 34566666666666666666655556666677777777777
Q ss_pred ccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCC
Q 003855 322 QLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPV 401 (791)
Q Consensus 322 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 401 (791)
++++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|++++|+|+|.++.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 77665556667777777777777777766667777777777777777777776677777777777777777777776653
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=211.30 Aligned_cols=182 Identities=25% Similarity=0.358 Sum_probs=157.0
Q ss_pred CCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcC
Q 003855 192 GLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLG 271 (791)
Q Consensus 192 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 271 (791)
+|+.|+|++|+|++ +|..+ +++|++|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 89999999999997 55544 379999999999999 566 457999999999999996 666 665 99999999
Q ss_pred CCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCC
Q 003855 272 SNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPI 351 (791)
Q Consensus 272 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 351 (791)
+|+|++ +|. .+++|+.|+|++|.|++ +|. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 999997 555 68999999999999986 554 57899999999999996 666 65 99999999999999 67
Q ss_pred CcccCCCCCC-------cEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCC
Q 003855 352 PESVGSLISL-------ESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPV 401 (791)
Q Consensus 352 ~~~~~~l~~L-------~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 401 (791)
|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 76 655 77 99999999999 6788888899999999999999997764
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.84 E-value=6.9e-21 Score=197.91 Aligned_cols=188 Identities=23% Similarity=0.334 Sum_probs=115.9
Q ss_pred hhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecC
Q 003855 169 LQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTG 248 (791)
Q Consensus 169 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 248 (791)
+..+.+..+.+.+..+ +..+++|+.|++++|.++.. +.+..+++|++|+|++|++++..+ +..+++|+.|++++
T Consensus 26 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 4555666666654332 34677888888888888744 247778888888888888875433 77777777777777
Q ss_pred CccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCC
Q 003855 249 NKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP 328 (791)
Q Consensus 249 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 328 (791)
|.+++ ++ .+..+++|++|++++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..+
T Consensus 100 n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 100 NKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp SCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 77764 23 366777777777777777643 3455566666666666666543 345555566666666665553322
Q ss_pred cchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccC
Q 003855 329 STIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS 372 (791)
Q Consensus 329 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 372 (791)
+..+++|+.|++++|++++ ++ .+..+++|+.|++++|+++
T Consensus 174 --l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 174 --LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp --GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred --hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCccc
Confidence 5555555555555555553 22 2555555555555555554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=4e-21 Score=190.86 Aligned_cols=155 Identities=22% Similarity=0.294 Sum_probs=92.8
Q ss_pred eEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcc
Q 003855 243 GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQ 322 (791)
Q Consensus 243 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~ 322 (791)
.+++++|.++ .+|..+. ++|+.|+|++|+|+++.+..|..+++|+.|+|++|.|++..|..|.++++|+.|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3444444444 2333222 455555666665555555555556666666666666655555666666666666666666
Q ss_pred cCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCC
Q 003855 323 LSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400 (791)
Q Consensus 323 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 400 (791)
|+...+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.|...
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 664444455666666666666666665556666666666666666666666666666666667777777776666543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-20 Score=202.46 Aligned_cols=176 Identities=23% Similarity=0.185 Sum_probs=107.0
Q ss_pred CEEEccCCccccccCccccCCCCCCEEEcccccCcccCCcccc-ccCCCceEEecCCccCCCCCccccCCCCCcEEEcCC
Q 003855 194 TLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLC-HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGS 272 (791)
Q Consensus 194 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 272 (791)
+.+++++|+++. +|..+. ..++.|+|++|+|++..+..|. .+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 577888888874 444433 4577788888888766666666 677777777777777766666677777777777777
Q ss_pred CcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcch---hccccccccccccccCCC
Q 003855 273 NKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTI---GALKDLETLSLARNQFQG 349 (791)
Q Consensus 273 N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~ 349 (791)
|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 77766555566666666666666666666556666666666666666666663322223 334445555555555543
Q ss_pred CCCcccCCCCC--CcEEEccCCccC
Q 003855 350 PIPESVGSLIS--LESLDLSGNNLS 372 (791)
Q Consensus 350 ~~~~~~~~l~~--L~~L~l~~N~l~ 372 (791)
..+..+..++. |+.|+|++|++.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 33333444433 244444444444
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.8e-20 Score=210.63 Aligned_cols=199 Identities=23% Similarity=0.323 Sum_probs=153.6
Q ss_pred hhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEec
Q 003855 168 SLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247 (791)
Q Consensus 168 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 247 (791)
.+..+.+..+.+....+ +..+++|+.|++++|.|... + .|..+++|+.|+|++|+|++..| +..+++|+.|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 35666777777765544 56778899999999998854 3 58889999999999999986554 8888899999999
Q ss_pred CCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCC
Q 003855 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDI 327 (791)
Q Consensus 248 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 327 (791)
+|.|++ ++ .+..+++|+.|+|++|+|.+. ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+++..
T Consensus 96 ~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~ 169 (605)
T 1m9s_A 96 ENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 169 (605)
T ss_dssp SSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCG
T ss_pred CCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCch
Confidence 998884 33 688888899999999988753 4577888888888888888765 56788888888888888888655
Q ss_pred CcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhc
Q 003855 328 PSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETL 382 (791)
Q Consensus 328 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 382 (791)
| +..+++|+.|+|++|+|++ + ..+..+++|+.|+|++|++++.....+..+
T Consensus 170 ~--l~~l~~L~~L~Ls~N~i~~-l-~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l 220 (605)
T 1m9s_A 170 P--LAGLTKLQNLYLSKNHISD-L-RALAGLKNLDVLELFSQECLNKPINHQSNL 220 (605)
T ss_dssp G--GTTCTTCCEEECCSSCCCB-C-GGGTTCTTCSEEECCSEEEECCCCCCCSSC
T ss_pred h--hccCCCCCEEECcCCCCCC-C-hHHccCCCCCEEEccCCcCcCCcccccccE
Confidence 5 7788888888888888875 3 357788888888888888875544443333
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=4.4e-20 Score=191.83 Aligned_cols=192 Identities=26% Similarity=0.354 Sum_probs=165.1
Q ss_pred CCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcC
Q 003855 192 GLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLG 271 (791)
Q Consensus 192 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 271 (791)
.+..+.+..+.++... .+..+++|++|++++|.++.. + .+..+++|+.|+|++|++++..+ +.++++|++|+++
T Consensus 25 ~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~ 98 (291)
T 1h6t_A 25 ETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD 98 (291)
T ss_dssp HHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECC
Confidence 3445567777777443 456789999999999999854 4 48899999999999999996544 9999999999999
Q ss_pred CCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCC
Q 003855 272 SNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPI 351 (791)
Q Consensus 272 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 351 (791)
+|++++. ..+..+++|++|++++|.+++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..
T Consensus 99 ~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~ 172 (291)
T 1h6t_A 99 ENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 172 (291)
T ss_dssp SSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG
T ss_pred CCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccch
Confidence 9999853 3489999999999999999864 5789999999999999999964 67999999999999999999654
Q ss_pred CcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccC
Q 003855 352 PESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEI 399 (791)
Q Consensus 352 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 399 (791)
+ +..+++|+.|+|++|++++ ++ .+..+++|+.|++++|+++..+
T Consensus 173 ~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 173 P--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp G--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECCC
T ss_pred h--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCCc
Confidence 4 9999999999999999995 44 4899999999999999998744
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.82 E-value=5.9e-20 Score=209.09 Aligned_cols=130 Identities=30% Similarity=0.430 Sum_probs=80.6
Q ss_pred ccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCc
Q 003855 187 IGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLR 266 (791)
Q Consensus 187 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 266 (791)
+..+++|+.|+|++|.|++. +.+..+++|++|+|++|+|++. ..+..+++|+.|+|++|.|++. ..+..+++|+
T Consensus 83 l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~ 156 (605)
T 1m9s_A 83 LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLD 156 (605)
T ss_dssp GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCS
T ss_pred hccCCCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCC
Confidence 44555666666666666532 2456666666666666666532 3466666666666666666643 4566666677
Q ss_pred EEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCC
Q 003855 267 ELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGD 326 (791)
Q Consensus 267 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 326 (791)
.|+|++|+|.+..| +..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.+.+.
T Consensus 157 ~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 157 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred EEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 77777776665544 66666667777777666643 3466667777777777776643
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-19 Score=180.66 Aligned_cols=134 Identities=22% Similarity=0.280 Sum_probs=85.2
Q ss_pred CCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecC
Q 003855 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLS 319 (791)
Q Consensus 240 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~ 319 (791)
+|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|.|+...+..|..+++|+.|+|+
T Consensus 33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 112 (220)
T 2v9t_B 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112 (220)
T ss_dssp TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence 34444444444443444445555555555555555555555555555666666666666655444556666667777777
Q ss_pred CcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCC
Q 003855 320 RNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSG 373 (791)
Q Consensus 320 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 373 (791)
+|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 777766666677777777777777777776666677778888888888888864
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-19 Score=180.40 Aligned_cols=137 Identities=28% Similarity=0.298 Sum_probs=76.3
Q ss_pred CCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhcccccccccc
Q 003855 263 TSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSL 342 (791)
Q Consensus 263 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 342 (791)
++|++|+|++|+|.+..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 44555555555555444444555555555555555554444444555555555555555555444444555555666666
Q ss_pred ccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCC
Q 003855 343 ARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400 (791)
Q Consensus 343 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 400 (791)
++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|+++|.++
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 666655 455555566666666666666665555556666666666666666665554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.7e-20 Score=197.50 Aligned_cols=179 Identities=26% Similarity=0.229 Sum_probs=111.2
Q ss_pred CEEEcccccCcccCCccccccCCCceEEecCCccCCCCCcccc-CCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccC
Q 003855 218 QGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLV-SLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSS 296 (791)
Q Consensus 218 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 296 (791)
+.+++++|.|+ .+|..+. +.++.|+|++|+|++..+..+. ++++|+.|+|++|+|+++.+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 45666666666 3444332 2456666666666655555555 666666666666666665556666666666666666
Q ss_pred CcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCccc---CCCCCCcEEEccCCccCC
Q 003855 297 NSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV---GSLISLESLDLSGNNLSG 373 (791)
Q Consensus 297 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~~ 373 (791)
|+|+...+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 66665555566666666666666666665556666666666666666666664333333 446666666666666665
Q ss_pred CCchhhhhccc--CceEEccCCCCcccC
Q 003855 374 KIPKSLETLSQ--LKQFNVSHNRLEGEI 399 (791)
Q Consensus 374 ~~~~~~~~l~~--L~~l~l~~N~l~~~~ 399 (791)
..+..+..++. |+.|+|++|++.|.+
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred cCHHHhhhccHhhcceEEecCCCccCCc
Confidence 55556666665 366666666666544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.6e-19 Score=179.32 Aligned_cols=134 Identities=24% Similarity=0.269 Sum_probs=89.6
Q ss_pred eEEecCCccCCCCC-ccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCc
Q 003855 243 GIRLTGNKLSGHIP-PCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRN 321 (791)
Q Consensus 243 ~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N 321 (791)
.|+|++|+|++..+ ..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|
T Consensus 36 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 115 (220)
T 2v70_A 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSN 115 (220)
T ss_dssp EEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTS
T ss_pred EEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCC
Confidence 34444444433322 23455556666666666665555555666666666666666666666666777777777777777
Q ss_pred ccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCc
Q 003855 322 QLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 376 (791)
Q Consensus 322 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 376 (791)
++++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++.+..+
T Consensus 116 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 116 RITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred cCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 7776667777777788888888888877677888888888888888888876544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-20 Score=199.91 Aligned_cols=296 Identities=11% Similarity=0.083 Sum_probs=145.7
Q ss_pred CccCCccccC--CCCCCeeecCCCcccccCCccccC-CCCCcEEeCCCCcCcc-cCCchhhhcCCCccEEEccCCcceec
Q 003855 2 AGQIPTEIGN--LQNLQYLVFAENNLSGLVPPTIFN-ISTMRILTLEGNQLSG-RLPSTVGHLLPNIESLLLAANNLTGI 77 (791)
Q Consensus 2 ~g~lp~~~~~--l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~-~~p~~~~~~l~~L~~L~L~~N~l~~~ 77 (791)
+|+++..+.. +.+|++|.++++ +....-..+.. +++|++|||++|+|.. ..+... ++.+..+.+..|. +
T Consensus 12 ~g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~---I 84 (329)
T 3sb4_A 12 PGTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANF---V 84 (329)
T ss_dssp TTCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTE---E
T ss_pred CCcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccc---ccccccccccccc---c
Confidence 4667776664 778888888864 22221223334 7788888998888861 011111 1223344444442 3
Q ss_pred CCccCcC--------CCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEc
Q 003855 78 IPHSITN--------ATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSF 149 (791)
Q Consensus 78 ~~~~~~~--------l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L 149 (791)
.+.+|.+ +++|+.|+|.+ .++.+...+|.++++|+.+++..|.+..++..+ |.++.++..+.+
T Consensus 85 ~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~a--------F~~~~~l~~l~~ 155 (329)
T 3sb4_A 85 PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEA--------LADSVTAIFIPL 155 (329)
T ss_dssp CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTS--------SCTTTCEEEECT
T ss_pred CHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhh--------hcCCCceEEecC
Confidence 3445555 66666666665 555555566666666666666666655555433 555555555544
Q ss_pred cCCCC----cccCChhhhhhhhhhh-hhhccccc-ccccCCccccCCCCCCEEEccCCccccccCccc-cCCCCCCEEEc
Q 003855 150 GSNPL----GGILPPVIGNFSASLQ-KFYAYECK-LKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSL 222 (791)
Q Consensus 150 ~~N~l----~~~~~~~~~~~~~~L~-~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L 222 (791)
+.+.. .......+.... .|+ .+.+.... +.......-....+++.+.+.++-.. .....+ ..+++|+.|+|
T Consensus 156 ~~~~~~~~~~~i~~~~f~~~~-~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L 233 (329)
T 3sb4_A 156 GSSDAYRFKNRWEHFAFIEGE-PLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDI 233 (329)
T ss_dssp TCTHHHHTSTTTTTSCEEESC-CCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEEC
T ss_pred cchhhhhcccccccccccccc-ccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEEC
Confidence 43211 000000000000 000 00000000 00000000012234444444443221 111111 12455666666
Q ss_pred ccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCc-EEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcc
Q 003855 223 RNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLR-ELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLND 301 (791)
Q Consensus 223 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~ 301 (791)
++|+++.+.+..|.++++|+.|+|.+| ++...+.+|.++++|+ .|++.+ .++.+.+..|.++++|+.|+++.|.++.
T Consensus 234 ~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~ 311 (329)
T 3sb4_A 234 SKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITT 311 (329)
T ss_dssp TTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCE
T ss_pred CCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCc
Confidence 665555555555666666666666555 4445555666666666 666665 5555555666666666666666666665
Q ss_pred cCCcccccCCCCCEEe
Q 003855 302 SLPSNVQKLKVLTVLD 317 (791)
Q Consensus 302 ~~~~~~~~l~~L~~L~ 317 (791)
+.+.+|.++++|+.++
T Consensus 312 I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 312 LGDELFGNGVPSKLIY 327 (329)
T ss_dssp ECTTTTCTTCCCCEEE
T ss_pred cchhhhcCCcchhhhc
Confidence 5566666666666665
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=6.8e-19 Score=175.97 Aligned_cols=155 Identities=26% Similarity=0.279 Sum_probs=104.9
Q ss_pred CEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCC
Q 003855 218 QGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSN 297 (791)
Q Consensus 218 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 297 (791)
+.++++++.++ .+|..+. ++|+.|+|++|.|++..|..|.++++|++|+|++|+|....+..|..+++|+.|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 33444444444 2332222 44555555555555555555666666666666666666555555666666777777777
Q ss_pred cCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCc
Q 003855 298 SLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 376 (791)
Q Consensus 298 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 376 (791)
+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|+|++|++.+..+
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 776666666777778888888888887 667777888888888888888886666778888999999999999886544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=5.1e-21 Score=216.57 Aligned_cols=211 Identities=18% Similarity=0.203 Sum_probs=100.1
Q ss_pred cCCCCCCEEeccCccccccccccccccccccccccccccc-cccCCCc----cccccccccCCCCCCcEEE-ccCCCCcc
Q 003855 83 TNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL-TTESSSA----DQWSFLSSLTNCRNLTILS-FGSNPLGG 156 (791)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l-~~~~~~~----~~~~~~~~l~~l~~L~~L~-L~~N~l~~ 156 (791)
..+++|+.|+|++|+++ ..|..++++++|+.|++++|.. ...+... .....+..+..+++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 45677777777777776 4566777777777777755541 1000000 0000112233333444443 333221
Q ss_pred cCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCcccc
Q 003855 157 ILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLC 236 (791)
Q Consensus 157 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 236 (791)
..|..+.+.+|.+....+ ..|+.|+|++|+|++ +|. |+.+++|++|+|++|+|+ .
T Consensus 423 ----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~------ 477 (567)
T 1dce_A 423 ----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-A------ 477 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-C------
T ss_pred ----------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-c------
Confidence 123444444444442211 124455555555543 222 444555555555555554 3
Q ss_pred ccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccC-CcccccCCCCCE
Q 003855 237 HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSL-PSNVQKLKVLTV 315 (791)
Q Consensus 237 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~-~~~~~~l~~L~~ 315 (791)
+|..|+++++|+.|+|++|+|++ +| .+..+++|+.|+|++|+|++.. |..+..+++|+.
T Consensus 478 ------------------lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~ 537 (567)
T 1dce_A 478 ------------------LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 537 (567)
T ss_dssp ------------------CCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCE
T ss_pred ------------------cchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCE
Confidence 44445555555555555555543 23 4455555555555555555443 555555555555
Q ss_pred EecCCcccCCCCCc---chhccccccccc
Q 003855 316 LDLSRNQLSGDIPS---TIGALKDLETLS 341 (791)
Q Consensus 316 L~l~~N~l~~~~~~---~~~~l~~L~~L~ 341 (791)
|+|++|++++..|. .+..+++|+.|+
T Consensus 538 L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 538 LNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp EECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred EEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 55555555543322 122355555554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.6e-21 Score=220.63 Aligned_cols=202 Identities=18% Similarity=0.114 Sum_probs=121.8
Q ss_pred CCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccc
Q 003855 35 NISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSL 114 (791)
Q Consensus 35 ~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 114 (791)
..++|+.|+|++|+|+ .+|+.+.. +++|++|++++|......|.. +..+.+.+..+..++++++|+.
T Consensus 347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~-l~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 347 TDEQLFRCELSVEKST-VLQSELES-CKELQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp TTTTSSSCCCCHHHHH-HHHHHHHH-HHHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHHH
T ss_pred cCccceeccCChhhHH-hhHHHHHH-HHHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhccc
Confidence 4556666666666665 66666555 456666666554311000000 0001133345555666666666
Q ss_pred cc-cccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCC
Q 003855 115 LS-QVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGL 193 (791)
Q Consensus 115 L~-l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 193 (791)
|+ ++.|.+..+........-+..+. ...|+.|+|++|+|++ +|. |.++++|
T Consensus 414 L~~l~~n~~~~L~~l~l~~n~i~~l~-~~~L~~L~Ls~n~l~~--------------------------lp~-~~~l~~L 465 (567)
T 1dce_A 414 VDPMRAAYLDDLRSKFLLENSVLKME-YADVRVLHLAHKDLTV--------------------------LCH-LEQLLLV 465 (567)
T ss_dssp HCGGGHHHHHHHHHHHHHHHHHHHHH-HTTCSEEECTTSCCSS--------------------------CCC-GGGGTTC
T ss_pred CcchhhcccchhhhhhhhcccccccC-ccCceEEEecCCCCCC--------------------------CcC-ccccccC
Confidence 65 45444332211000000000000 0135566666666553 344 7778899
Q ss_pred CEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCC-CccccCCCCCcEEEcCC
Q 003855 194 TLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHI-PPCLVSLTSLRELHLGS 272 (791)
Q Consensus 194 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~ 272 (791)
+.|+|++|+|+ .+|..|+.+++|++|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..++.+++|+.|+|++
T Consensus 466 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~ 542 (567)
T 1dce_A 466 THLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 542 (567)
T ss_dssp CEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTT
T ss_pred cEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecC
Confidence 99999999999 678889999999999999999985 55 7788888888888888887665 77788888888888888
Q ss_pred CcCCCCCC
Q 003855 273 NKLTSSIP 280 (791)
Q Consensus 273 N~l~~~~~ 280 (791)
|++++.+|
T Consensus 543 N~l~~~~~ 550 (567)
T 1dce_A 543 NSLCQEEG 550 (567)
T ss_dssp SGGGGSSS
T ss_pred CcCCCCcc
Confidence 88775543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-19 Score=184.44 Aligned_cols=168 Identities=23% Similarity=0.321 Sum_probs=91.1
Q ss_pred hhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEec
Q 003855 168 SLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247 (791)
Q Consensus 168 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 247 (791)
.+..+++.+|.+++.. .+..+++|+.|++++|+++.. + .+..+++|++|+|++|+|++..+ +..+++
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~------- 86 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTK------- 86 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSS-------
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCC-------
Confidence 4566666666666433 355566666666666666532 2 45555666666666666553222 444444
Q ss_pred CCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCC
Q 003855 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDI 327 (791)
Q Consensus 248 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 327 (791)
|++|+|++|++++. +. +.. ++|+.|++++|++++. ..+..+++|+.|++++|++++.
T Consensus 87 -----------------L~~L~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~- 143 (263)
T 1xeu_A 87 -----------------LEELSVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI- 143 (263)
T ss_dssp -----------------CCEEECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-
T ss_pred -----------------CCEEECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-
Confidence 44444444444432 11 111 4455555555555432 2355556666666666666532
Q ss_pred CcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCC
Q 003855 328 PSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGK 374 (791)
Q Consensus 328 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 374 (791)
+ .+..+++|+.|++++|++++. ..+..+++|+.|++++|++++.
T Consensus 144 ~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 144 V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 2 455566666666666666643 4566666666666666666644
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.9e-19 Score=180.89 Aligned_cols=170 Identities=19% Similarity=0.289 Sum_probs=128.0
Q ss_pred CCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCE
Q 003855 140 NCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQG 219 (791)
Q Consensus 140 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 219 (791)
.+.++..+++++|.+++.. .+..+ .+|+.|++++|.++. ++ .+..+++|+.|+|++|+|++..+ +..+++|++
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l-~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~ 89 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKEL-SGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEE 89 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHH-TTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCE
T ss_pred HHHHHHHHHhcCCCccccc--chhhc-CcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCE
Confidence 5677888999999998654 34443 679999999999985 44 78999999999999999997655 999999999
Q ss_pred EEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcC
Q 003855 220 LSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL 299 (791)
Q Consensus 220 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i 299 (791)
|+|++|+|++ +|.. .. ++|+.|+|++|++++. + .+..+++|+.|+|++|++++. + .+..+++|+.|++++|.+
T Consensus 90 L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 90 LSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp EECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCC
T ss_pred EECCCCccCC-cCcc-cc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcC
Confidence 9999999995 3332 22 7788888888888753 3 477777777777777777754 2 466666777777777776
Q ss_pred cccCCcccccCCCCCEEecCCcccCC
Q 003855 300 NDSLPSNVQKLKVLTVLDLSRNQLSG 325 (791)
Q Consensus 300 ~~~~~~~~~~l~~L~~L~l~~N~l~~ 325 (791)
++. ..+..+++|+.|++++|++.+
T Consensus 163 ~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 163 TNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp CBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred cch--HHhccCCCCCEEeCCCCcccC
Confidence 654 456666666666666666653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.4e-19 Score=171.85 Aligned_cols=153 Identities=18% Similarity=0.305 Sum_probs=74.4
Q ss_pred cCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcE
Q 003855 188 GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRE 267 (791)
Q Consensus 188 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 267 (791)
..+++|+.|++++|.++ .++ .+..+++|++|++++|.++. + ..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~------------------------~~l~~l~~L~~ 92 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--Y------------------------NPISGLSNLER 92 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--C------------------------GGGTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--c------------------------hhhhcCCCCCE
Confidence 34455555566555555 222 35555555555555554431 1 23444555555
Q ss_pred EEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcc-cCCCCCcchhcccccccccccccc
Q 003855 268 LHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQ-LSGDIPSTIGALKDLETLSLARNQ 346 (791)
Q Consensus 268 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~L~~N~ 346 (791)
|++++|++++..+..+..+++|++|++++|.+++..+..+..+++|+.|++++|. ++ .+| .+..+++|+.|++++|+
T Consensus 93 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp EEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBC
T ss_pred EEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCC
Confidence 5555555544444445555555555555555544444455555555555555554 33 222 34455555555555555
Q ss_pred CCCCCCcccCCCCCCcEEEccCCccC
Q 003855 347 FQGPIPESVGSLISLESLDLSGNNLS 372 (791)
Q Consensus 347 l~~~~~~~~~~l~~L~~L~l~~N~l~ 372 (791)
+++ ++ .+..+++|+.|++++|++.
T Consensus 171 i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 171 VHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CcC-hH-HhccCCCCCEEEeeCcccC
Confidence 542 22 3444555555555555543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.2e-19 Score=171.48 Aligned_cols=154 Identities=17% Similarity=0.289 Sum_probs=131.3
Q ss_pred cccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCE
Q 003855 236 CHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTV 315 (791)
Q Consensus 236 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~ 315 (791)
..+++|+.|++++|.++ .+| .+..+++|++|++++|.+.. +..+..+++|++|++++|.+++..+..++.+++|+.
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 55666777777777777 445 58888999999999998763 357899999999999999999888899999999999
Q ss_pred EecCCcccCCCCCcchhcccccccccccccc-CCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCC
Q 003855 316 LDLSRNQLSGDIPSTIGALKDLETLSLARNQ-FQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNR 394 (791)
Q Consensus 316 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~ 394 (791)
|++++|++++..+..+..+++|++|++++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 9999999998788899999999999999998 76 565 68999999999999999996 44 78999999999999999
Q ss_pred Ccc
Q 003855 395 LEG 397 (791)
Q Consensus 395 l~~ 397 (791)
+.+
T Consensus 193 i~~ 195 (197)
T 4ezg_A 193 IGG 195 (197)
T ss_dssp ---
T ss_pred cCC
Confidence 864
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.4e-19 Score=209.41 Aligned_cols=224 Identities=19% Similarity=0.168 Sum_probs=121.7
Q ss_pred CCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEE
Q 003855 142 RNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLS 221 (791)
Q Consensus 142 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 221 (791)
+.++.|+|.+|.+... +.. .|+.+.|+.|.+. .+++..|++. ..++.|..+++|+.|+
T Consensus 173 ~~~~~l~L~~n~~~~~-~~~------~l~~l~Ls~~~i~--------------~~~~~~n~~~-~~~~~~~~l~~L~~L~ 230 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-NQA------LLQHKKLSQYSID--------------EDDDIENRMV-MPKDSKYDDQLWHALD 230 (727)
T ss_dssp -----------------------------------------------------------------------CCCCCCEEE
T ss_pred CccceEEeeCCCCCcc-hhh------HhhcCccCccccc--------------Ccccccccee-cChhhhccCCCCcEEE
Confidence 5567777777776642 211 2344444444333 3455666666 6778888999999999
Q ss_pred cccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcc
Q 003855 222 LRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLND 301 (791)
Q Consensus 222 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~ 301 (791)
|++|.|. .+|..+..+++|+.|+|++|.|+ .+|..|+++++|++|+|++|+|+ .+|..|..+++|++|+|++|.|+
T Consensus 231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~- 306 (727)
T 4b8c_D 231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT- 306 (727)
T ss_dssp CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-
T ss_pred CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-
Confidence 9999998 67777778999999999999998 78888999999999999999998 66888999999999999999997
Q ss_pred cCCcccccCCCCCEEecCCcccCCCCCcchhcccc-ccccccccccCCCCCCcccCCCCCCcEEEccCC--------ccC
Q 003855 302 SLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKD-LETLSLARNQFQGPIPESVGSLISLESLDLSGN--------NLS 372 (791)
Q Consensus 302 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N--------~l~ 372 (791)
.+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.. |+.|++++| .+.
T Consensus 307 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~ 380 (727)
T 4b8c_D 307 TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQ 380 (727)
T ss_dssp CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--------------------------
T ss_pred ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCcc
Confidence 67778999999999999999999888888766533 345889999999887764 556677777 333
Q ss_pred CCCchhhhhcccCceEEccCCCCcc
Q 003855 373 GKIPKSLETLSQLKQFNVSHNRLEG 397 (791)
Q Consensus 373 ~~~~~~~~~l~~L~~l~l~~N~l~~ 397 (791)
+..+..+..+..+....+++|-+.+
T Consensus 381 ~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 381 QSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp ---------------------CCCG
T ss_pred ccccchhhcccccceeeeecccccc
Confidence 3334444555555556666665543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=7.1e-19 Score=170.61 Aligned_cols=175 Identities=21% Similarity=0.262 Sum_probs=108.7
Q ss_pred ceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCc-cccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCC
Q 003855 242 FGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPS-SLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSR 320 (791)
Q Consensus 242 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~ 320 (791)
+.+++++|.++ .+|..+.. +|++|++++|+|++..+. .|..+++|++|+|++|.|++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56778888776 45554432 777777777777765553 366777777777777777776677777777777777777
Q ss_pred cccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchh-hhhcccCceEEccCCCCcccC
Q 003855 321 NQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKS-LETLSQLKQFNVSHNRLEGEI 399 (791)
Q Consensus 321 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~l~l~~N~l~~~~ 399 (791)
|+|++..+..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|++++..+.. +. ..++...+..+...+..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~--~~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHH--HHHHHcCCCCCCCCCCC
Confidence 7777666666777777777777777777666667777777777777777776554421 11 11222233344444433
Q ss_pred CCCCCCcCCccccccCCccccCCC
Q 003855 400 PVKGSFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 400 ~~~~~~~~l~~~~~~~n~~~c~~~ 423 (791)
|. .+.......+..+...|.++
T Consensus 166 P~--~l~~~~l~~l~~~~~~C~~~ 187 (192)
T 1w8a_A 166 PS--KVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp ST--TTTTSBGGGSCTTTCCCCCC
T ss_pred Ch--HHcCCChhhCcHhhcCcCCC
Confidence 32 23444444455555555543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.1e-19 Score=189.30 Aligned_cols=102 Identities=13% Similarity=0.055 Sum_probs=53.9
Q ss_pred CCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhcccccc-ccccccccCCCCCCcccCCCCCCcEE
Q 003855 286 LEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLE-TLSLARNQFQGPIPESVGSLISLESL 364 (791)
Q Consensus 286 l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L 364 (791)
+++|+.|+|++|+++.+.+..|.++++|+.|+|++| ++.+.+..|.++++|+ .+++.+ .++...+.+|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 344555555555554444445555555555555554 4434444555555555 555555 4443444555555555555
Q ss_pred EccCCccCCCCchhhhhcccCceEE
Q 003855 365 DLSGNNLSGKIPKSLETLSQLKQFN 389 (791)
Q Consensus 365 ~l~~N~l~~~~~~~~~~l~~L~~l~ 389 (791)
++++|+++...+.+|.++++|+.++
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EeCCCccCccchhhhcCCcchhhhc
Confidence 5555555555555555555555554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=6.8e-18 Score=163.63 Aligned_cols=155 Identities=25% Similarity=0.331 Sum_probs=120.8
Q ss_pred cEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCc-ccccCCCCCEEecCCcccCCCCCcchhcccccccccccc
Q 003855 266 RELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPS-NVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLAR 344 (791)
Q Consensus 266 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 344 (791)
+.+++++|+++ .+|..+.. +|++|++++|.|++..+. .|..+++|+.|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67888888886 45554433 788888888888766654 478888888888888888877788888888888888888
Q ss_pred ccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccccCCC
Q 003855 345 NQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 345 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~ 423 (791)
|+|++..+..|..+++|+.|+|++|++++..|..|..+++|+.|++++|+++|.++.......++...+.++...|+.|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 8888777777888888888888888888888888888888888888888888877654333344444566666777755
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.3e-18 Score=175.32 Aligned_cols=137 Identities=22% Similarity=0.289 Sum_probs=106.8
Q ss_pred cccccccCCCcceEEEEEEe-cCCcE--EEEEEeehhhh------------------------HHHHHHHHHHHHHHhcc
Q 003855 503 FNECNLLGTGSFGSVYKGTI-SDGTD--VAIKIFNLQLE------------------------RAFRSFDSECEVLRNVR 555 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l~ 555 (791)
|++.+.||+|+||.||+|.. .+|+. ||||++..... .....+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66788999999999999998 68989 99998753311 11236788999999998
Q ss_pred CCcc--ceeeeeeccCCeeeEEEecCCC-C----CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCC
Q 003855 556 HRNL--IKILSSCSNPDFKALVLEFMPN-G----SLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDL 628 (791)
Q Consensus 556 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dl 628 (791)
|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.|+.|||. +.+|+||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ---EAELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH---TSCEECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH---HCCEEeCCC
Confidence 8864 333332 356899999942 3 77776543 2234567899999999999993 357999999
Q ss_pred CCCCeEeCCCCcEEEeeecccccc
Q 003855 629 KPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 629 k~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
||+|||+++ .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.74 E-value=8.1e-17 Score=174.19 Aligned_cols=264 Identities=10% Similarity=0.105 Sum_probs=128.0
Q ss_pred CCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEe
Q 003855 13 QNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALD 92 (791)
Q Consensus 13 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 92 (791)
..++.+.+. +.++.+...+|.+. +|+.+.|.+| ++ .++...|.. .+|+.+.|.+ .++.+.+.+|.++++|+.++
T Consensus 113 ~~l~~i~ip-~~i~~I~~~aF~~~-~L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 113 KGYNEIILP-NSVKSIPKDAFRNS-QIAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp SSCSEEECC-TTCCEECTTTTTTC-CCSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred CCccEEEEC-CccCEehHhhcccC-CccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 445555554 23444555555552 4555555544 44 444444443 3455555553 44445555555555555555
Q ss_pred ccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhh
Q 003855 93 LGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKF 172 (791)
Q Consensus 93 L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L 172 (791)
|++|+++.+....|.. .+|+.+.+. +.++.++..+ |.++++|+.+++
T Consensus 187 l~~n~l~~I~~~aF~~-~~L~~l~lp-~~l~~I~~~a--------F~~~~~L~~l~l----------------------- 233 (401)
T 4fdw_A 187 LSKTKITKLPASTFVY-AGIEEVLLP-VTLKEIGSQA--------FLKTSQLKTIEI----------------------- 233 (401)
T ss_dssp CTTSCCSEECTTTTTT-CCCSEEECC-TTCCEECTTT--------TTTCTTCCCEEC-----------------------
T ss_pred cCCCcceEechhhEee-cccCEEEeC-CchheehhhH--------hhCCCCCCEEec-----------------------
Confidence 5555555555555542 444444444 2244433332 444444444444
Q ss_pred hcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccC
Q 003855 173 YAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLS 252 (791)
Q Consensus 173 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 252 (791)
..| ++.+...+|.+ .+|+.+.| .+.++.+....|.++++|+.+++.+|.+.
T Consensus 234 --------------------------~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 234 --------------------------PEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp --------------------------CTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred --------------------------CCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 432 33333344443 34444444 23333333444444444444444444332
Q ss_pred -----CCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCC
Q 003855 253 -----GHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDI 327 (791)
Q Consensus 253 -----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 327 (791)
...+.+|.++++|+.+.|. +.++.+....|.++.+|+.+.|..| ++.+...+|.++ +|+.|++++|.+....
T Consensus 285 ~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~ 361 (401)
T 4fdw_A 285 DDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVF 361 (401)
T ss_dssp CCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCC
T ss_pred CCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccc
Confidence 2334455555555555555 2354444555555555555555433 444445555555 5666666666555444
Q ss_pred Ccchhccc-cccccccccccC
Q 003855 328 PSTIGALK-DLETLSLARNQF 347 (791)
Q Consensus 328 ~~~~~~l~-~L~~L~L~~N~l 347 (791)
+..|.+++ .++.|++..+.+
T Consensus 362 ~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 362 EKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp CSSCCCSCTTCCEEEECGGGH
T ss_pred cccccCCCCCccEEEeCHHHH
Confidence 44555553 455555555543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.2e-18 Score=199.92 Aligned_cols=155 Identities=21% Similarity=0.286 Sum_probs=126.2
Q ss_pred cCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccccccccc
Q 003855 28 LVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFG 107 (791)
Q Consensus 28 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 107 (791)
..|+.|..+.+|+.|+|++|.+. .+|..++. +++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+ .+|..|.
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~-l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~ 290 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFK-YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELG 290 (727)
T ss_dssp -------CCCCCCEEECTTSCCS-CCCGGGGG-CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGG
T ss_pred cChhhhccCCCCcEEECCCCCCC-CCChhhcC-CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhc
Confidence 55888999999999999999998 99999886 899999999999999 78899999999999999999999 5588899
Q ss_pred ccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccc
Q 003855 108 NLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEI 187 (791)
Q Consensus 108 ~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 187 (791)
+|++|+.|+|++|.|+.++ ..|..+++|+.|+|++|.|++.+|..+......+..++|.+|.+++.+|..
T Consensus 291 ~l~~L~~L~L~~N~l~~lp---------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~- 360 (727)
T 4b8c_D 291 SCFQLKYFYFFDNMVTTLP---------WEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE- 360 (727)
T ss_dssp GGTTCSEEECCSSCCCCCC---------SSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred CCCCCCEEECCCCCCCccC---------hhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc-
Confidence 9999999999999998654 458999999999999999999999988877666677889999999877754
Q ss_pred cCCCCCCEEEccCC
Q 003855 188 GNLSGLTLLSLHSN 201 (791)
Q Consensus 188 ~~l~~L~~L~L~~N 201 (791)
|..|+++.|
T Consensus 361 -----l~~l~l~~n 369 (727)
T 4b8c_D 361 -----RRFIEINTD 369 (727)
T ss_dssp --------------
T ss_pred -----cceeEeecc
Confidence 556677776
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.72 E-value=9.9e-17 Score=173.51 Aligned_cols=267 Identities=10% Similarity=0.096 Sum_probs=218.7
Q ss_pred cCCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccC
Q 003855 60 LLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLT 139 (791)
Q Consensus 60 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~ 139 (791)
....++.+.+.+ .++.+...+|.+. +|+.++|..| ++.+...+|.+ .+|+.+.+.. .++.++..+ |.
T Consensus 111 ~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~a--------F~ 177 (401)
T 4fdw_A 111 ILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDI--------FY 177 (401)
T ss_dssp ECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSST--------TT
T ss_pred ecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHH--------hh
Confidence 346777777765 4666777888875 7888888776 77788888888 4688888875 677766555 88
Q ss_pred CCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCE
Q 003855 140 NCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQG 219 (791)
Q Consensus 140 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 219 (791)
+|++|+.++++.|+++.+ ...+|. ..+|+.+.|.++ ++.+...+|.++++|+.
T Consensus 178 ~c~~L~~l~l~~n~l~~I-------------------------~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~ 230 (401)
T 4fdw_A 178 YCYNLKKADLSKTKITKL-------------------------PASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKT 230 (401)
T ss_dssp TCTTCCEEECTTSCCSEE-------------------------CTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCC
T ss_pred CcccCCeeecCCCcceEe-------------------------chhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCE
Confidence 888999999888887743 233454 578999999855 88789999999999999
Q ss_pred EEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCC-----CCCCccccCCCCCCeEEc
Q 003855 220 LSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT-----SSIPSSLWSLEYILDINL 294 (791)
Q Consensus 220 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~l 294 (791)
+++..| ++.+....|.+ .+|+.+.|. +.++.....+|.++++|+.+++.+|.+. .+.+..|.++++|+.+.|
T Consensus 231 l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l 307 (401)
T 4fdw_A 231 IEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEI 307 (401)
T ss_dssp EECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECC
T ss_pred EecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEe
Confidence 999975 66677788888 899999994 5576677899999999999999998875 467789999999999999
Q ss_pred cCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCC-CCcEEEccCCccC
Q 003855 295 SSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLI-SLESLDLSGNNLS 372 (791)
Q Consensus 295 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~ 372 (791)
. +.++.+...+|.++++|+.++|..| ++...+..|.++ +|+.+++++|.+....+..|.+++ +++.|++..+.+.
T Consensus 308 ~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 308 P-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp C-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred C-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 9 5588788889999999999999766 666778899999 999999999999877778888884 7899999887764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.2e-17 Score=160.02 Aligned_cols=131 Identities=24% Similarity=0.349 Sum_probs=86.1
Q ss_pred cEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccc
Q 003855 266 RELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARN 345 (791)
Q Consensus 266 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 345 (791)
+.+++++|.++ .+|..+. ++|++|++++|.|+ .+|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 34555555554 2333222 35666666666665 44566666667777777777776665666777777777777777
Q ss_pred cCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCC
Q 003855 346 QFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400 (791)
Q Consensus 346 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 400 (791)
+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.|...
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 7776666677777777777777777776666667777777777777777776554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-16 Score=151.50 Aligned_cols=135 Identities=24% Similarity=0.249 Sum_probs=102.7
Q ss_pred CCCcEEEcCCCcCC-CCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccc
Q 003855 263 TSLRELHLGSNKLT-SSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLS 341 (791)
Q Consensus 263 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 341 (791)
++|++|++++|+++ +.+|..+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56777777777776 45666677777777777777777654 6677778888888888888766777777788888888
Q ss_pred cccccCCCCC-CcccCCCCCCcEEEccCCccCCCCc---hhhhhcccCceEEccCCCCcccC
Q 003855 342 LARNQFQGPI-PESVGSLISLESLDLSGNNLSGKIP---KSLETLSQLKQFNVSHNRLEGEI 399 (791)
Q Consensus 342 L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~l~l~~N~l~~~~ 399 (791)
+++|++++.. +..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+...+
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 163 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP 163 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence 8888887432 2678888888888888888886655 57888888888888888876544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-15 Score=165.91 Aligned_cols=335 Identities=9% Similarity=0.064 Sum_probs=195.3
Q ss_pred cccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccccc
Q 003855 24 NLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHIL 103 (791)
Q Consensus 24 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 103 (791)
+++.+...+|.++.+|+.+.|.. .++ .|++..|...++|+.++|.++ ++.+...+|.++++|+.+.+..+ +..+..
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~ 133 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGV 133 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECT
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-Ccc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecc
Confidence 35556667788888888888864 366 777777776778888888654 66566777888888887776644 455666
Q ss_pred ccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccC
Q 003855 104 NTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNI 183 (791)
Q Consensus 104 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 183 (791)
.+|.+...+..... +.+..+.. .+|.++++|+.+.+..+. ..+ ++..+....+|+.+.+..+ +..+.
T Consensus 134 ~aF~~~~~~~~~~~--~~~~~i~~--------~aF~~c~~L~~i~l~~~~-~~I-~~~~F~~c~~L~~i~l~~~-~~~I~ 200 (394)
T 4fs7_A 134 EAFKGCDFKEITIP--EGVTVIGD--------EAFATCESLEYVSLPDSM-ETL-HNGLFSGCGKLKSIKLPRN-LKIIR 200 (394)
T ss_dssp TTTTTCCCSEEECC--TTCCEECT--------TTTTTCTTCCEEECCTTC-CEE-CTTTTTTCTTCCBCCCCTT-CCEEC
T ss_pred eeeecccccccccC--ccccccch--------hhhcccCCCcEEecCCcc-cee-ccccccCCCCceEEEcCCC-ceEeC
Confidence 67776654433322 22222322 237888888888887553 322 2222222234555555544 34344
Q ss_pred CccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCC
Q 003855 184 PQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLT 263 (791)
Q Consensus 184 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~ 263 (791)
..+|.++..|+.+.+..+... + .+.+....+|+.+.+..+ ++.+....|..+..|+.+.+..+... .....|..+.
T Consensus 201 ~~~F~~~~~L~~i~~~~~~~~-i-~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~ 276 (394)
T 4fs7_A 201 DYCFAECILLENMEFPNSLYY-L-GDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCS 276 (394)
T ss_dssp TTTTTTCTTCCBCCCCTTCCE-E-CTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCT
T ss_pred chhhccccccceeecCCCceE-e-ehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eecccccccc
Confidence 555666666666666655443 2 223333456666666533 23244555666666666666665443 4455566666
Q ss_pred CCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccc
Q 003855 264 SLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLA 343 (791)
Q Consensus 264 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~ 343 (791)
.|+.+....+.+. ...|..+.+|+.+.+..+ ++.+...+|.++.+|+.++|..+ ++.....+|.++.+|+.+++.
T Consensus 277 ~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp 351 (394)
T 4fs7_A 277 GLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFP 351 (394)
T ss_dssp TCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCC
T ss_pred ccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEEC
Confidence 6666666555432 235566666666666544 44455556666666666666543 444445566666666666666
Q ss_pred cccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCce
Q 003855 344 RNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQ 387 (791)
Q Consensus 344 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 387 (791)
.| ++.....+|.++.+|+.+++..+ ++ .+...|.++++|+.
T Consensus 352 ~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 352 LS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp TT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred cc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 55 54344556666666666666543 22 23345555655554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-16 Score=150.83 Aligned_cols=84 Identities=27% Similarity=0.301 Sum_probs=45.0
Q ss_pred CCCCEEEccCCccc-cccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEE
Q 003855 191 SGLTLLSLHSNDLN-GTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELH 269 (791)
Q Consensus 191 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 269 (791)
++|+.|++++|+++ +.+|..+..+++|++|+|++|.|++. ..+..+++|+.|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 55666666666665 34455555556666666666665533 4445555555555555555544444444455555555
Q ss_pred cCCCcCC
Q 003855 270 LGSNKLT 276 (791)
Q Consensus 270 L~~N~l~ 276 (791)
|++|+++
T Consensus 102 Ls~N~l~ 108 (168)
T 2ell_A 102 LSGNKLK 108 (168)
T ss_dssp CBSSSCC
T ss_pred ccCCccC
Confidence 5555544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.5e-15 Score=165.05 Aligned_cols=328 Identities=11% Similarity=0.058 Sum_probs=246.0
Q ss_pred cccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCC
Q 003855 8 EIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATK 87 (791)
Q Consensus 8 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 87 (791)
+|.++++|+.+.|.. .++.+...+|.++++|+.++|.++ ++ .++...|...++|+.+.+..+ +..+...+|.+...
T Consensus 66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~ 141 (394)
T 4fs7_A 66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF 141 (394)
T ss_dssp TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence 467899999999984 588888899999999999999865 76 788888888889999888765 55477778877765
Q ss_pred CCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhh
Q 003855 88 LVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSA 167 (791)
Q Consensus 88 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 167 (791)
+...... .+..+...+|.++.+|+.+.+..+ +..++..+ |.++.+|+.+.+..| ++.+....+.. ..
T Consensus 142 ~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~--------F~~c~~L~~i~l~~~-~~~I~~~~F~~-~~ 208 (394)
T 4fs7_A 142 KEITIPE--GVTVIGDEAFATCESLEYVSLPDS-METLHNGL--------FSGCGKLKSIKLPRN-LKIIRDYCFAE-CI 208 (394)
T ss_dssp SEEECCT--TCCEECTTTTTTCTTCCEEECCTT-CCEECTTT--------TTTCTTCCBCCCCTT-CCEECTTTTTT-CT
T ss_pred cccccCc--cccccchhhhcccCCCcEEecCCc-cceecccc--------ccCCCCceEEEcCCC-ceEeCchhhcc-cc
Confidence 4443333 233456677888888888887644 34454443 788888888888766 44343333333 34
Q ss_pred hhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEec
Q 003855 168 SLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT 247 (791)
Q Consensus 168 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 247 (791)
.|+.+.+..+... +.+.+....+|+.+.+..+ ++.+....|..+.+|+.+.+..+... .....|..+..++.+...
T Consensus 209 ~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~ 284 (394)
T 4fs7_A 209 LLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYG 284 (394)
T ss_dssp TCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEEC
T ss_pred ccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccC
Confidence 5666666555433 2334445678999988755 44477788899999999999887655 777888999999999888
Q ss_pred CCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCC
Q 003855 248 GNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDI 327 (791)
Q Consensus 248 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 327 (791)
.+.+. ...|.++.+|+.+.+..+ ++.+....|.++.+|+.++|..+ ++.+...+|.++.+|+.+++..| ++...
T Consensus 285 ~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~ 358 (394)
T 4fs7_A 285 SVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIG 358 (394)
T ss_dssp SSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEEC
T ss_pred ceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEeh
Confidence 77654 356888999999999765 66677788999999999999755 77677789999999999999887 76677
Q ss_pred CcchhccccccccccccccCCCCCCcccCCCCCCcEE
Q 003855 328 PSTIGALKDLETLSLARNQFQGPIPESVGSLISLESL 364 (791)
Q Consensus 328 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 364 (791)
..+|.++.+|+.+++..+ ++ .+...|.++.+|+.+
T Consensus 359 ~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 359 ANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp TTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred HHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 788999999999999766 44 345678888888764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.4e-16 Score=146.01 Aligned_cols=128 Identities=23% Similarity=0.274 Sum_probs=86.1
Q ss_pred CCCcEEEcCCCcCC-CCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccc
Q 003855 263 TSLRELHLGSNKLT-SSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLS 341 (791)
Q Consensus 263 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 341 (791)
++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45566666666665 44555555666666666666666544 5566667777777777777755666666677777777
Q ss_pred cccccCCCC-CCcccCCCCCCcEEEccCCccCCCCc---hhhhhcccCceEEccC
Q 003855 342 LARNQFQGP-IPESVGSLISLESLDLSGNNLSGKIP---KSLETLSQLKQFNVSH 392 (791)
Q Consensus 342 L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~l~l~~ 392 (791)
+++|++++. .+..++.+++|+.|++++|++++..+ ..+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 777777742 23667778888888888888876655 5677888888887763
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=6.6e-16 Score=147.62 Aligned_cols=113 Identities=26% Similarity=0.280 Sum_probs=57.4
Q ss_pred CCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEcc
Q 003855 288 YILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLS 367 (791)
Q Consensus 288 ~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 367 (791)
+|+.|++++|++++..+..|..+++|+.|++++|++++..+..|..+++|+.|++++|+|++..+..+..+++|+.|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 108 (177)
T 2o6r_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD 108 (177)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence 34444444444443333344444455555555555543333444555555555555555554444445555555555555
Q ss_pred CCccCCCCchhhhhcccCceEEccCCCCcccCC
Q 003855 368 GNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400 (791)
Q Consensus 368 ~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 400 (791)
+|++++..+..+..+++|+.|++++|+++|.+|
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 555554444445555556666666665555444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.5e-15 Score=147.00 Aligned_cols=127 Identities=21% Similarity=0.287 Sum_probs=89.1
Q ss_pred CEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCC
Q 003855 194 TLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSN 273 (791)
Q Consensus 194 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 273 (791)
+.+++++|+++. +|..+. ++|++|+|++|+|+ .+|..|..+++|+.|+|++|.|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 567777777773 444332 57777777777777 55667777777777777777777666667777777777777777
Q ss_pred cCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccC
Q 003855 274 KLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLS 324 (791)
Q Consensus 274 ~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 324 (791)
+|++..+..|..+++|+.|+|++|.|+...+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 777666666777777777777777776555556666777777777777665
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.3e-16 Score=145.07 Aligned_cols=126 Identities=24% Similarity=0.251 Sum_probs=71.7
Q ss_pred CCCCEEEccCCccc-cccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEE
Q 003855 191 SGLTLLSLHSNDLN-GTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELH 269 (791)
Q Consensus 191 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 269 (791)
++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|+.|++++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56777777777776 55566666777777777777777643 4555666666666666666654555555566666666
Q ss_pred cCCCcCCCC-CCccccCCCCCCeEEccCCcCcccCC---cccccCCCCCEEec
Q 003855 270 LGSNKLTSS-IPSSLWSLEYILDINLSSNSLNDSLP---SNVQKLKVLTVLDL 318 (791)
Q Consensus 270 L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~i~~~~~---~~~~~l~~L~~L~l 318 (791)
+++|++++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l 147 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG 147 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence 666665532 12344444445555555444443332 23444444444444
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.5e-16 Score=167.58 Aligned_cols=139 Identities=14% Similarity=0.140 Sum_probs=97.6
Q ss_pred cccccccCCCcceEEEEEEecCCcEEEEEEeehhh--------------hHHHHHHHHHHHHHHhccCCccceeeeeecc
Q 003855 503 FNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--------------ERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568 (791)
Q Consensus 503 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 568 (791)
|++.+.||+|+||.||+|...+|+.||||+++... .........+.++.....|+|+.+++.....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 88999999999999999999899999999875321 0011122222333333334444444322211
Q ss_pred ------CCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC---
Q 003855 569 ------PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM--- 639 (791)
Q Consensus 569 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~--- 639 (791)
....++||||++|++|.++... .....++.|++.+|.||| ..+||||||||.|||+++++
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH----~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA----KHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEEEEECSS
T ss_pred CCeeeeccCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEeCCCCcc
Confidence 1123699999999888654321 124568899999999999 57899999999999998876
Q ss_pred -------cEEEeeecccccc
Q 003855 640 -------AAHVSDFGISKLL 652 (791)
Q Consensus 640 -------~~kl~Dfgla~~~ 652 (791)
.+.|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 3899999987654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-15 Score=144.31 Aligned_cols=132 Identities=27% Similarity=0.296 Sum_probs=100.0
Q ss_pred ceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCc
Q 003855 242 FGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRN 321 (791)
Q Consensus 242 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N 321 (791)
+.+++++|+++ .+|..+ .++|++|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|+.|++++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 45566666665 333322 256777777777777666666777777888888888877666666788888888888888
Q ss_pred ccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCc
Q 003855 322 QLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIP 376 (791)
Q Consensus 322 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 376 (791)
++++..+..|..+++|+.|++++|++++..+..+..+++|+.|+|++|++.+..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 8887666677888899999999999986666667889999999999999987655
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.59 E-value=1.7e-15 Score=144.61 Aligned_cols=133 Identities=21% Similarity=0.223 Sum_probs=91.9
Q ss_pred ccCCCCCcEEEcCCCcCCCCCCccccCCC-CCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccc
Q 003855 259 LVSLTSLRELHLGSNKLTSSIPSSLWSLE-YILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDL 337 (791)
Q Consensus 259 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 337 (791)
+.++++|++|++++|+++.. +. +..+. +|++|++++|.|++. ..+..+++|+.|++++|++++..+..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 45556666666666666633 33 33333 677777777777654 456777777777777777775444555777788
Q ss_pred cccccccccCCCCCCc--ccCCCCCCcEEEccCCccCCCCch----hhhhcccCceEEccCCCCcc
Q 003855 338 ETLSLARNQFQGPIPE--SVGSLISLESLDLSGNNLSGKIPK----SLETLSQLKQFNVSHNRLEG 397 (791)
Q Consensus 338 ~~L~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~l~l~~N~l~~ 397 (791)
+.|++++|+|+ .+|. .+..+++|+.|++++|+++ .+|. .+..+++|+.||+++|.+..
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 88888888776 4554 6777888888888888887 4454 37888888888888887654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.2e-17 Score=159.91 Aligned_cols=134 Identities=24% Similarity=0.313 Sum_probs=99.7
Q ss_pred ccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhcccc
Q 003855 257 PCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKD 336 (791)
Q Consensus 257 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 336 (791)
..+..+++|++|+|++|++++ +| .+..+++|+.|++++|.++ .+|..+..+++|+.|++++|++++ +| .+..+++
T Consensus 42 ~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~ 116 (198)
T 1ds9_A 42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVN 116 (198)
T ss_dssp HHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHH
T ss_pred HHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCC
Confidence 367777777777777777775 44 6777777888888888776 456667777888888888888874 44 5778888
Q ss_pred ccccccccccCCCCCC-cccCCCCCCcEEEccCCccCCCCch----------hhhhcccCceEEccCCCCcc
Q 003855 337 LETLSLARNQFQGPIP-ESVGSLISLESLDLSGNNLSGKIPK----------SLETLSQLKQFNVSHNRLEG 397 (791)
Q Consensus 337 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~----------~~~~l~~L~~l~l~~N~l~~ 397 (791)
|+.|++++|++++..+ ..+..+++|+.|++++|++++..|. .+..+++|+.|| +|+++.
T Consensus 117 L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred CCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 8888888888874222 3678888889999998888766554 377888888876 666553
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=3.4e-15 Score=142.42 Aligned_cols=105 Identities=19% Similarity=0.219 Sum_probs=53.7
Q ss_pred CCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCc--chhccccccccc
Q 003855 264 SLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPS--TIGALKDLETLS 341 (791)
Q Consensus 264 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~--~~~~l~~L~~L~ 341 (791)
+|+.|++++|+|++. ..+..+++|++|++++|.|++..+..+..+++|+.|++++|+++ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 444444444444432 34444445555555555554433333455555555555555554 3333 455555555555
Q ss_pred cccccCCCCCCcc----cCCCCCCcEEEccCCccC
Q 003855 342 LARNQFQGPIPES----VGSLISLESLDLSGNNLS 372 (791)
Q Consensus 342 L~~N~l~~~~~~~----~~~l~~L~~L~l~~N~l~ 372 (791)
+++|+++ .+|.. +..+++|+.||+++|.+.
T Consensus 120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 5555555 33432 555666666666666554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=7.1e-17 Score=157.42 Aligned_cols=129 Identities=24% Similarity=0.297 Sum_probs=60.0
Q ss_pred CCCCEEEccCCccccccCc------cccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCC
Q 003855 191 SGLTLLSLHSNDLNGTISP------TMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTS 264 (791)
Q Consensus 191 ~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 264 (791)
..++.++++.|.+.+..|. .|..+++|++|+|++|+|++ +| .+..+++|+.|++++|.++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3444444454444444333 45555555555555555553 33 4455555555555555554 33444444445
Q ss_pred CcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCC-cccccCCCCCEEecCCcccC
Q 003855 265 LRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLP-SNVQKLKVLTVLDLSRNQLS 324 (791)
Q Consensus 265 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~ 324 (791)
|++|++++|++++ +| .+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~ 153 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccc
Confidence 5555555555543 12 34444444444444444442211 23444444444444444444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.50 E-value=8.8e-13 Score=143.17 Aligned_cols=322 Identities=10% Similarity=0.134 Sum_probs=184.6
Q ss_pred ccccCCccccCCC-CCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCc---ceecCCccCcCCCCCCEEeccCccccc
Q 003855 25 LSGLVPPTIFNIS-TMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANN---LTGIIPHSITNATKLVALDLGFNSFAG 100 (791)
Q Consensus 25 l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~L~~L~L~~N~i~~ 100 (791)
++.+...+|.+.. .|+.+.+-.+ ++ .|.+..|....+|+.+.++.|. ++.+...+|.++.+|+.+.+..+ ++.
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~ 127 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE 127 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce
Confidence 4455556666653 4666666543 55 5666666556677777766553 55555666777777776666544 444
Q ss_pred cccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhccccccc
Q 003855 101 HILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180 (791)
Q Consensus 101 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~ 180 (791)
+....|.+..+|+.+.+.. .+..+...+ |..+.+|+.+.+..+ ++.+..
T Consensus 128 I~~~aF~~c~~L~~i~lp~-~~~~I~~~~--------F~~c~~L~~i~~~~~-~~~I~~--------------------- 176 (394)
T 4gt6_A 128 IDSEAFHHCEELDTVTIPE-GVTSVADGM--------FSYCYSLHTVTLPDS-VTAIEE--------------------- 176 (394)
T ss_dssp ECTTTTTTCTTCCEEECCT-TCCEECTTT--------TTTCTTCCEEECCTT-CCEECT---------------------
T ss_pred ehhhhhhhhcccccccccc-eeeeecccc--------eecccccccccccce-eeEecc---------------------
Confidence 6666677777777766643 334443333 667777777777544 332211
Q ss_pred ccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCcc--------------ccccCCCceEEe
Q 003855 181 GNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYD--------------LCHLKLMFGIRL 246 (791)
Q Consensus 181 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--------------~~~l~~L~~L~L 246 (791)
.+|.+ .+|+.+.+..+-.. +...+|..+.++.......+.... .... +.....+..+.+
T Consensus 177 ----~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 249 (394)
T 4gt6_A 177 ----RAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPA-IDNVLYEKSANGDYALIRYPSQREDPAFKI 249 (394)
T ss_dssp ----TTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCB-SSSCEEEECTTSCEEEEECCTTCCCSEEEC
T ss_pred ----ccccc-cceeEEEECCcccc-cccchhhhccccceeccccccccc-ccceeecccccccccccccccccccceEEc
Confidence 22222 33444444433322 344444455555544444333221 1111 111223333333
Q ss_pred cCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCC
Q 003855 247 TGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGD 326 (791)
Q Consensus 247 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~ 326 (791)
.. .++.....+|.++++|+.+.+.++... +....|.++..|+.+.+. +.++.+....|.++.+|+.++|..+ ++.+
T Consensus 250 p~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I 325 (394)
T 4gt6_A 250 PN-GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQI 325 (394)
T ss_dssp CT-TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEE
T ss_pred CC-cceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEe
Confidence 32 233344566777788888888665543 566677788888888885 4455566677888888888888765 5545
Q ss_pred CCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCC
Q 003855 327 IPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRL 395 (791)
Q Consensus 327 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 395 (791)
...+|.++.+|+.+.+..+ ++.....+|.++.+|+.+++.+|.... ..+....+|+.+.+..|.+
T Consensus 326 ~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 326 LDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp CTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred hHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 6677888888888888655 664556788888888888888876542 4566677788887776654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=5.4e-14 Score=133.03 Aligned_cols=90 Identities=23% Similarity=0.257 Sum_probs=46.7
Q ss_pred CCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEc
Q 003855 311 KVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNV 390 (791)
Q Consensus 311 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 390 (791)
++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 34444555555554444444555555555555555555444444455555555555555555444445555555555555
Q ss_pred cCCCCcccCC
Q 003855 391 SHNRLEGEIP 400 (791)
Q Consensus 391 ~~N~l~~~~~ 400 (791)
++|++++.++
T Consensus 110 ~~N~~~c~c~ 119 (170)
T 3g39_A 110 LNNPWDCACS 119 (170)
T ss_dssp CSSCBCTTBG
T ss_pred CCCCCCCCch
Confidence 5555555443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.4e-12 Score=141.53 Aligned_cols=303 Identities=11% Similarity=0.097 Sum_probs=222.7
Q ss_pred CcccCCchhhhcC-CCccEEEccCCcceecCCccCcCCCCCCEEeccCcc---ccccccccccccccccccccccccccc
Q 003855 49 LSGRLPSTVGHLL-PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNS---FAGHILNTFGNLRHLSLLSQVMNNLTT 124 (791)
Q Consensus 49 l~~~~p~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~---i~~~~~~~~~~l~~L~~L~l~~n~l~~ 124 (791)
++ .|++..|... ..|+.+.+..+ ++.+...+|.++++|+.+.++.|. ++.+...+|.+..+|+.+.+..+ ++.
T Consensus 51 Vt-~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~ 127 (394)
T 4gt6_A 51 VS-KIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE 127 (394)
T ss_dssp EE-EECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE
T ss_pred ee-EcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce
Confidence 44 6667666544 35899999754 777888999999999999998874 77778889999999998877654 555
Q ss_pred cCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccc
Q 003855 125 ESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLN 204 (791)
Q Consensus 125 ~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 204 (791)
++..+ |.++.+|+.+.+..+-.. +...+|.++.+|+.+.+.++ ++
T Consensus 128 I~~~a--------F~~c~~L~~i~lp~~~~~--------------------------I~~~~F~~c~~L~~i~~~~~-~~ 172 (394)
T 4gt6_A 128 IDSEA--------FHHCEELDTVTIPEGVTS--------------------------VADGMFSYCYSLHTVTLPDS-VT 172 (394)
T ss_dssp ECTTT--------TTTCTTCCEEECCTTCCE--------------------------ECTTTTTTCTTCCEEECCTT-CC
T ss_pred ehhhh--------hhhhcccccccccceeee--------------------------ecccceecccccccccccce-ee
Confidence 55444 888999999988644221 23456788899999999866 55
Q ss_pred cccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCcc-------------ccCCCCCcEEEcC
Q 003855 205 GTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPC-------------LVSLTSLRELHLG 271 (791)
Q Consensus 205 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~-------------~~~l~~L~~L~L~ 271 (791)
.+...+|.. .+|+.+.+..+-.. .....|..+.++.......+......... +.....+..+.+.
T Consensus 173 ~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip 250 (394)
T 4gt6_A 173 AIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP 250 (394)
T ss_dssp EECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC
T ss_pred Eeccccccc-cceeEEEECCcccc-cccchhhhccccceecccccccccccceeecccccccccccccccccccceEEcC
Confidence 577777764 67999999766544 66778888888888887766554221111 1122334455543
Q ss_pred CCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCC
Q 003855 272 SNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPI 351 (791)
Q Consensus 272 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 351 (791)
+.++.+....|.++..|+.+.+..+..+ +....|.++++|+.+.+. +.++......|.++.+|+.+++..+ ++...
T Consensus 251 -~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~ 326 (394)
T 4gt6_A 251 -NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQIL 326 (394)
T ss_dssp -TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEEC
T ss_pred -CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEeh
Confidence 2344455678888999999999776553 667788999999999996 4565566778999999999999865 66456
Q ss_pred CcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCc
Q 003855 352 PESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396 (791)
Q Consensus 352 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 396 (791)
..+|.++.+|+.+.+..+ ++.....+|.++++|+.+++.+|...
T Consensus 327 ~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 327 DDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp TTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred HhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 678999999999999654 77666788999999999999988643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.2e-13 Score=130.97 Aligned_cols=104 Identities=20% Similarity=0.226 Sum_probs=48.1
Q ss_pred cEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccc
Q 003855 266 RELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARN 345 (791)
Q Consensus 266 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 345 (791)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45566666664 3333332 44555555555555444444445555555555555554333333444444444444444
Q ss_pred cCCCCCCcccCCCCCCcEEEccCCccC
Q 003855 346 QFQGPIPESVGSLISLESLDLSGNNLS 372 (791)
Q Consensus 346 ~l~~~~~~~~~~l~~L~~L~l~~N~l~ 372 (791)
+|++..+..|..+++|+.|+|++|++.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 444333333444444444444444444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=2.4e-13 Score=128.46 Aligned_cols=108 Identities=25% Similarity=0.255 Sum_probs=82.3
Q ss_pred CcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhcccccccccccc
Q 003855 265 LRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLAR 344 (791)
Q Consensus 265 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 344 (791)
.+.|++++|+++. +|..+ .++|+.|+|++|.|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4566677776663 44433 26677777777777777777788888888888888888866666778888888888888
Q ss_pred ccCCCCCCcccCCCCCCcEEEccCCccCCCC
Q 003855 345 NQFQGPIPESVGSLISLESLDLSGNNLSGKI 375 (791)
Q Consensus 345 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 375 (791)
|+|++..+..|..+++|+.|+|++|++++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 8888666667888999999999999998654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.3e-15 Score=163.19 Aligned_cols=177 Identities=19% Similarity=0.171 Sum_probs=93.2
Q ss_pred CCCcEEeCCCCcCcccCCchhhhc----CCCccEEEccCCcceecCCccC-cCCCCCCEEeccCcccccccccccc----
Q 003855 37 STMRILTLEGNQLSGRLPSTVGHL----LPNIESLLLAANNLTGIIPHSI-TNATKLVALDLGFNSFAGHILNTFG---- 107 (791)
Q Consensus 37 ~~L~~L~L~~n~l~~~~p~~~~~~----l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~i~~~~~~~~~---- 107 (791)
++|+.|+|++|.|+..-...+... .++|++|+|++|.|+......+ ..+++|++|+|++|.++......+.
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 455566666666542222222221 1356666666665543222222 2344566666666666544433332
Q ss_pred -ccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCcc
Q 003855 108 -NLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQE 186 (791)
Q Consensus 108 -~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 186 (791)
..++|+.|++++|.|+..... .+...+..+++|++|+|++|.|++..... ++..
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~----~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~---------------------L~~~ 206 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVA----VLMEGLAGNTSVTHLSLLHTGLGDEGLEL---------------------LAAQ 206 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHH----HHHHHHHTCSSCCEEECTTSSCHHHHHHH---------------------HHHH
T ss_pred hcCCccceeeCCCCCCChHHHH----HHHHHHhcCCCcCEEeCCCCCCCcHHHHH---------------------HHHH
Confidence 235566666666666543211 12334566777888888888776432111 1233
Q ss_pred ccCCCCCCEEEccCCcccccc----CccccCCCCCCEEEcccccCcccCCcccccc
Q 003855 187 IGNLSGLTLLSLHSNDLNGTI----SPTMGRLKRLQGLSLRNNNLEGSIPYDLCHL 238 (791)
Q Consensus 187 ~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 238 (791)
+...++|+.|+|++|.|+... +..+...++|++|+|++|.|++.....+..+
T Consensus 207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 262 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDL 262 (372)
T ss_dssp GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHC
T ss_pred HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHH
Confidence 445567777777777776432 2334455777777777777775544444433
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=3.6e-13 Score=127.71 Aligned_cols=85 Identities=25% Similarity=0.270 Sum_probs=38.2
Q ss_pred CCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecC
Q 003855 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLS 319 (791)
Q Consensus 240 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~ 319 (791)
+|+.|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|+
T Consensus 34 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~ 113 (174)
T 2r9u_A 34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLY 113 (174)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred CCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeC
Confidence 33334444444433334444444444444444444443333334444444444444444443333334455555555555
Q ss_pred CcccC
Q 003855 320 RNQLS 324 (791)
Q Consensus 320 ~N~l~ 324 (791)
+|.+.
T Consensus 114 ~N~~~ 118 (174)
T 2r9u_A 114 NNPWD 118 (174)
T ss_dssp SSCBC
T ss_pred CCCcc
Confidence 55554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=7.7e-15 Score=157.10 Aligned_cols=171 Identities=20% Similarity=0.151 Sum_probs=85.1
Q ss_pred CCCCEEEccCCccccccCccccC-----CCCCCEEEcccccCcccCCccc-cccCCCceEEecCCccCCCCCccc-----
Q 003855 191 SGLTLLSLHSNDLNGTISPTMGR-----LKRLQGLSLRNNNLEGSIPYDL-CHLKLMFGIRLTGNKLSGHIPPCL----- 259 (791)
Q Consensus 191 ~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~i~~~~~~~~----- 259 (791)
++|+.|+|++|.|+......+.. .++|++|+|++|.|+......+ ..+++|+.|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 56888888888887544444332 2678888888887764333222 234556666666666653322222
Q ss_pred cCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCC----Ccchhccc
Q 003855 260 VSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDI----PSTIGALK 335 (791)
Q Consensus 260 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~ 335 (791)
...++|++|+|++|.|+..... .++..+..+++|++|+|++|.|++.. +..+...+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~--------------------~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~ 211 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVA--------------------VLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR 211 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHH--------------------HHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCS
T ss_pred hcCCccceeeCCCCCCChHHHH--------------------HHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCC
Confidence 1234455555555555321111 11222334445555555555544221 22233344
Q ss_pred cccccccccccCCCC----CCcccCCCCCCcEEEccCCccCCCCchhhhh
Q 003855 336 DLETLSLARNQFQGP----IPESVGSLISLESLDLSGNNLSGKIPKSLET 381 (791)
Q Consensus 336 ~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 381 (791)
+|+.|+|++|.|++. +...+...++|+.|||++|+|+......+..
T Consensus 212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 455555555544421 1222334456666666666666444444443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.36 E-value=4.4e-11 Score=129.08 Aligned_cols=314 Identities=11% Similarity=0.015 Sum_probs=191.2
Q ss_pred ccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCC
Q 003855 9 IGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKL 88 (791)
Q Consensus 9 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 88 (791)
+....+|+.+.+. ..++.+...+|.++.+|+.++|..+ ++ .|+...|... +|+.+.+..+ ++.+...+|... +|
T Consensus 42 ~~~~~~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~-~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L 115 (379)
T 4h09_A 42 YKDRDRISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VT-SIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DL 115 (379)
T ss_dssp GGGGGGCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CC
T ss_pred cccccCCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ce-EechhhhcCC-CCceEECCce-eeEeccceeccC-Cc
Confidence 4456778888887 4577788889999999999999754 76 7777777754 7888887654 665777778764 79
Q ss_pred CEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhh
Q 003855 89 VALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSAS 168 (791)
Q Consensus 89 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~ 168 (791)
+.+++..+ +..+....|.+. +|+...+. +.++.+... .|..+.+|+.+.+..+.........
T Consensus 116 ~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~-~~v~~i~~~--------~f~~~~~l~~~~~~~~~~~~~~~~~------- 177 (379)
T 4h09_A 116 DDFEFPGA-TTEIGNYIFYNS-SVKRIVIP-KSVTTIKDG--------IGYKAENLEKIEVSSNNKNYVAENY------- 177 (379)
T ss_dssp SEEECCTT-CCEECTTTTTTC-CCCEEEEC-TTCCEECSC--------TTTTCTTCCEEEECTTCSSEEEETT-------
T ss_pred ccccCCCc-cccccccccccc-eeeeeecc-ceeeccccc--------hhcccccccccccccccceeecccc-------
Confidence 99988765 444566666654 44444333 234444333 3777888888887766544221110
Q ss_pred hhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecC
Q 003855 169 LQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTG 248 (791)
Q Consensus 169 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 248 (791)
...+.. ......+.....+..+.+..+.-. .....+....+|+.+.+..+ +..+....|.++..|+.+.+..
T Consensus 178 -----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~ 249 (379)
T 4h09_A 178 -----VLYNKN-KTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPK 249 (379)
T ss_dssp -----EEEETT-SSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECT
T ss_pred -----eecccc-cceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCC
Confidence 000111 122234455566666666554433 55566667777777777554 3435556667777777777765
Q ss_pred CccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCC
Q 003855 249 NKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP 328 (791)
Q Consensus 249 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 328 (791)
+ ++.....+|.++.+|+.+.+..+ +..+....|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+..
T Consensus 250 ~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~ 326 (379)
T 4h09_A 250 N-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQV 326 (379)
T ss_dssp T-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECT
T ss_pred C-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHH
Confidence 5 44345566666777777776543 44445556666677777777666666555666666666777666544 443445
Q ss_pred cchhccccccccccccccCCCCCCcccCCC
Q 003855 329 STIGALKDLETLSLARNQFQGPIPESVGSL 358 (791)
Q Consensus 329 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 358 (791)
.+|.++.+|+.+.+..+ ++.....+|.++
T Consensus 327 ~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 327 YAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp TTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred HHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 55666666666666543 432333444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=4e-12 Score=135.51 Aligned_cols=131 Identities=21% Similarity=0.190 Sum_probs=70.6
Q ss_pred EEcCCC-cCCCCCCccccCCCCCCeEEccC-CcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccc
Q 003855 268 LHLGSN-KLTSSIPSSLWSLEYILDINLSS-NSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARN 345 (791)
Q Consensus 268 L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~-N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 345 (791)
++++++ +|++ +|. +..+++|+.|+|++ |.|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 344444 4442 333 44455555555553 5555444455555555666666666655555555566666666666666
Q ss_pred cCCCCCCcccCCCCCCcEEEccCCccCCCCc-hhhhhcccCceEEccCCCCcccCCC
Q 003855 346 QFQGPIPESVGSLISLESLDLSGNNLSGKIP-KSLETLSQLKQFNVSHNRLEGEIPV 401 (791)
Q Consensus 346 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~~ 401 (791)
+|++..+..|..++ |+.|+|++|++...-. .+|..+.......+..++++|.-|.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 66644444454444 7777777777764322 3344433333444555666666554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.27 E-value=3.8e-10 Score=121.72 Aligned_cols=291 Identities=9% Similarity=0.046 Sum_probs=205.7
Q ss_pred ccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCC
Q 003855 7 TEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNAT 86 (791)
Q Consensus 7 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 86 (791)
.+|.++.+|+.++|.. .++.+...+|.+. +|+.+.+-.+ ++ .++...|.. .+|+.+.+..+- +.+...+|.+.
T Consensus 63 ~aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~~-~~L~~i~lp~~~-~~i~~~~F~~~- 135 (379)
T 4h09_A 63 ANFNSCYNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQG-TDLDDFEFPGAT-TEIGNYIFYNS- 135 (379)
T ss_dssp TTTTTCTTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTTT-CCCSEEECCTTC-CEECTTTTTTC-
T ss_pred HHhhCCCCCCEEEeCC-cceEechhhhcCC-CCceEECCce-ee-Eeccceecc-CCcccccCCCcc-ccccccccccc-
Confidence 3578999999999975 4887888899887 6888887654 66 777877774 589999998764 44667778775
Q ss_pred CCCEEeccCccccccccccccccccccccccccccccccCCCccc----cccccccCCCCCCcEEEccCCCCcccCChhh
Q 003855 87 KLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQ----WSFLSSLTNCRNLTILSFGSNPLGGILPPVI 162 (791)
Q Consensus 87 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 162 (791)
+|+...+-.+ ++.+....|.+..+++...+..+........... ......+.....+..+.+..+.
T Consensus 136 ~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 205 (379)
T 4h09_A 136 SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTV--------- 205 (379)
T ss_dssp CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTC---------
T ss_pred eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccce---------
Confidence 5777776544 5557778888888888877766554332211100 0011123333444444333221
Q ss_pred hhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCc
Q 003855 163 GNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242 (791)
Q Consensus 163 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 242 (791)
.......+....+|+.+.+..+ ++.+....|.++.+|+.+.+..+ ++.+....|.++.+|+
T Consensus 206 -----------------~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~ 266 (379)
T 4h09_A 206 -----------------KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK 266 (379)
T ss_dssp -----------------CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred -----------------eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence 1233456677788888888765 44477778888888998888766 6656777888888888
Q ss_pred eEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcc
Q 003855 243 GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQ 322 (791)
Q Consensus 243 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~ 322 (791)
.+.+..+ +......+|.++++|+.+.+.++.++.+....|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+
T Consensus 267 ~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~- 343 (379)
T 4h09_A 267 TLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS- 343 (379)
T ss_dssp EEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-
T ss_pred ccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-
Confidence 8888755 54456677888899999999888888777788889999999999755 66667778999999999988765
Q ss_pred cCCCCCcchhcccc
Q 003855 323 LSGDIPSTIGALKD 336 (791)
Q Consensus 323 l~~~~~~~~~~l~~ 336 (791)
++.+...+|.+++.
T Consensus 344 v~~I~~~aF~~c~~ 357 (379)
T 4h09_A 344 ITLIESGAFEGSSI 357 (379)
T ss_dssp CCEECTTTTTTSSC
T ss_pred cCEEchhHhhCCCC
Confidence 55455667776643
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=2.2e-11 Score=129.81 Aligned_cols=102 Identities=22% Similarity=0.204 Sum_probs=49.6
Q ss_pred EEEccCC-ccccccCccccCCCCCCEEEccc-ccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCC
Q 003855 195 LLSLHSN-DLNGTISPTMGRLKRLQGLSLRN-NNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGS 272 (791)
Q Consensus 195 ~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 272 (791)
.++++++ +|+. +|. +..+++|++|+|++ |.|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3455555 5553 333 55555555555554 555544444555555555555555555544444455555555555555
Q ss_pred CcCCCCCCccccCCCCCCeEEccCCcC
Q 003855 273 NKLTSSIPSSLWSLEYILDINLSSNSL 299 (791)
Q Consensus 273 N~l~~~~~~~~~~l~~L~~L~l~~N~i 299 (791)
|+|++..+..|..++ |+.|+|.+|.+
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~ 115 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPL 115 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCc
Confidence 555433333333332 44444444333
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3.3e-11 Score=122.89 Aligned_cols=148 Identities=13% Similarity=0.115 Sum_probs=115.0
Q ss_pred HHHHhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CCccceeeeeeccCCeeeE
Q 003855 496 IQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 496 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 574 (791)
+....+.|+....++.|+++.||++... ++.+++|+...........+.+|+.+++.+. +..+.++++++.+.+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3455577888888999999999999864 6889999987532222345788999999884 6778899999988889999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccC------------------------------------
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH------------------------------------ 618 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 618 (791)
||||++|.++.+.+.. ......++.++++++..||...
T Consensus 88 v~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999999876321 1223468889999999999610
Q ss_pred -------------------CCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 619 -------------------SSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 619 -------------------~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
....++|+|+++.||+++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876667799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.05 E-value=2.1e-10 Score=116.73 Aligned_cols=138 Identities=15% Similarity=0.089 Sum_probs=100.7
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCc--cceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN--LIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~ 578 (791)
..+.+....+.|..+.||++...+|+.+++|+.... ....+..|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345543333456669999998777888999997643 2245678999999886544 55688888877788999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccC----------------------------------------
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH---------------------------------------- 618 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 618 (791)
++|.++. ... .+ ...++.++++.+..||...
T Consensus 97 i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 97 VPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 9998884 211 11 2357778888888888421
Q ss_pred --------------CCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 619 --------------SSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 619 --------------~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
....++|+|++|.||++++++.+.|+|||.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 01129999999999999887667799999874
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.95 E-value=2.8e-10 Score=120.49 Aligned_cols=207 Identities=14% Similarity=0.170 Sum_probs=128.2
Q ss_pred CCCCeeecCCCcccc-c-------CCccccCCCCCcEEeCCCCcCc---------ccCCchhhhcCCCccEEEccCCc-c
Q 003855 13 QNLQYLVFAENNLSG-L-------VPPTIFNISTMRILTLEGNQLS---------GRLPSTVGHLLPNIESLLLAANN-L 74 (791)
Q Consensus 13 ~~L~~L~Ls~n~l~~-~-------~~~~~~~l~~L~~L~L~~n~l~---------~~~p~~~~~~l~~L~~L~L~~N~-l 74 (791)
..++.|.+......+ . +..++..+++|+.|.+..+... +.++. +...+|+|+.|.|++|. +
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~-ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSP-VLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHH-HHHTCTTCCEEEEECCBTC
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHH-HHhcCCCCcEEEEeCCCCc
Confidence 356677777655431 1 1334556788999988765331 12333 33347899999998884 3
Q ss_pred eecCCccCcCCCCCCEEeccCcccccccccccc--cccccccccccc--ccccccCCCcccccccccc--CCCCCCcEEE
Q 003855 75 TGIIPHSITNATKLVALDLGFNSFAGHILNTFG--NLRHLSLLSQVM--NNLTTESSSADQWSFLSSL--TNCRNLTILS 148 (791)
Q Consensus 75 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~l~~--n~l~~~~~~~~~~~~~~~l--~~l~~L~~L~ 148 (791)
. . +. +. +++|++|+|..|.+.......+. .+++|+.|+|+. |..... ..... +.+.+ ..+++|+.|+
T Consensus 186 ~-l-~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~-~~~~~--l~~~l~~~~~p~Lr~L~ 258 (362)
T 2ra8_A 186 S-I-GK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFD-GDMNV--FRPLFSKDRFPNLKWLG 258 (362)
T ss_dssp B-C-CS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCC-SCGGG--TGGGSCTTTCTTCCEEE
T ss_pred e-e-cc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccc-hhHHH--HHHHHhcCCCCCcCEEe
Confidence 2 2 22 43 78999999999988765555554 789999998864 221110 00000 01112 3579999999
Q ss_pred ccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCcccccc----CccccCCCCCCEEEccc
Q 003855 149 FGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTI----SPTMGRLKRLQGLSLRN 224 (791)
Q Consensus 149 L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~ 224 (791)
|++|.+++..+..+.. ...+++|++|+|+.|.|+... +..+..+++|+.|+|++
T Consensus 259 L~~~~i~~~~~~~la~----------------------a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~ 316 (362)
T 2ra8_A 259 IVDAEEQNVVVEMFLE----------------------SDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKY 316 (362)
T ss_dssp EESCTTHHHHHHHHHH----------------------CSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCS
T ss_pred CCCCCCchHHHHHHHh----------------------CccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCC
Confidence 9999987532222211 013578999999999987543 23334578999999999
Q ss_pred ccCcccCCccccccCCCceEEecCCc
Q 003855 225 NNLEGSIPYDLCHLKLMFGIRLTGNK 250 (791)
Q Consensus 225 N~l~~~~~~~~~~l~~L~~L~L~~N~ 250 (791)
|.|+...-..+...- ...+++++++
T Consensus 317 n~i~d~~~~~l~~al-g~~~~~~~~~ 341 (362)
T 2ra8_A 317 NYLSDEMKKELQKSL-PMKIDVSDSQ 341 (362)
T ss_dssp BBCCHHHHHHHHHHC-CSEEECCSBC
T ss_pred CcCCHHHHHHHHHHc-CCEEEecCCc
Confidence 988754443444311 3568888887
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.5e-10 Score=122.59 Aligned_cols=84 Identities=18% Similarity=0.241 Sum_probs=39.1
Q ss_pred CCCCCEEecCCcccCCCCCcchh---ccccccccccccccCCCC----CCcccCCCCCCcEEEccCCccCCCCchhhhhc
Q 003855 310 LKVLTVLDLSRNQLSGDIPSTIG---ALKDLETLSLARNQFQGP----IPESVGSLISLESLDLSGNNLSGKIPKSLETL 382 (791)
Q Consensus 310 l~~L~~L~l~~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 382 (791)
+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.+++. ++..+..+++|+.|+|++|.|+...-..+...
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 45566666665555432222222 245555556655555532 12222344566666666665553333333321
Q ss_pred ccCceEEccCCC
Q 003855 383 SQLKQFNVSHNR 394 (791)
Q Consensus 383 ~~L~~l~l~~N~ 394 (791)
- ...+++++|+
T Consensus 331 l-g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L-PMKIDVSDSQ 341 (362)
T ss_dssp C-CSEEECCSBC
T ss_pred c-CCEEEecCCc
Confidence 0 2345555554
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.85 E-value=4.8e-09 Score=112.12 Aligned_cols=143 Identities=15% Similarity=0.213 Sum_probs=105.9
Q ss_pred cccccCCCcceEEEEEEecCCcEEEEEEee--hhh-hHHHHHHHHHHHHHHhcc--CCccceeeeeeccC---CeeeEEE
Q 003855 505 ECNLLGTGSFGSVYKGTISDGTDVAIKIFN--LQL-ERAFRSFDSECEVLRNVR--HRNLIKILSSCSNP---DFKALVL 576 (791)
Q Consensus 505 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 576 (791)
.++.++.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999999875 4678888775 322 122356788999999996 45678888888766 4578999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccC--------------------------------------
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH-------------------------------------- 618 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------- 618 (791)
||++|.++.+.. -..++..++..++.+++++|+.||...
T Consensus 121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999997774311 122677888899999999999999520
Q ss_pred ----------------CCCCeEecCCCCCCeEeCCCCc--EEEeeeccccc
Q 003855 619 ----------------SSAPIIHCDLKPTNILLDENMA--AHVSDFGISKL 651 (791)
Q Consensus 619 ----------------~~~~i~H~dlk~~Nill~~~~~--~kl~Dfgla~~ 651 (791)
....++|+|+++.||+++.++. +.|.||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 0246999999999999997753 68999999865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=2e-09 Score=112.06 Aligned_cols=188 Identities=15% Similarity=0.150 Sum_probs=122.5
Q ss_pred ccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CCc--cceeeeeeccCC---eeeEEEecC
Q 003855 506 CNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRN--LIKILSSCSNPD---FKALVLEFM 579 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 579 (791)
++.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568899999999863 56899986533 33467888999998883 332 344555443333 347899999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc------------------------------------------
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG------------------------------------------ 617 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------ 617 (791)
+|.++.+.... .++..++..++.++++.++.||..
T Consensus 99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99888754332 256777888888888888888841
Q ss_pred ------------CCCCCeEecCCCCCCeEeCC--CCcEEEeeeccccccCCCCCcceeecc------------ccccccc
Q 003855 618 ------------HSSAPIIHCDLKPTNILLDE--NMAAHVSDFGISKLLGEGEDSVTQTMT------------MATIGYM 671 (791)
Q Consensus 618 ------------~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~------------~g~~~y~ 671 (791)
.....++|+|++|.||++++ +..+.++||+.+..-.+..+....... ....++.
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 01235899999999999998 556889999998754321110000000 0001111
Q ss_pred C-CCccCCCCCCccccHHhHHHHHHHHHhCCCCC
Q 003855 672 A-PEYGSEGIVSAKCDVYSYGVLLMETFTRKRPT 704 (791)
Q Consensus 672 a-PE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~ 704 (791)
. |+... ......+.|++|.++|++.+|..+|
T Consensus 256 ~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 22111 1112368999999999999998765
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.57 E-value=9.3e-09 Score=98.17 Aligned_cols=120 Identities=10% Similarity=0.081 Sum_probs=61.5
Q ss_pred cccCCCCCcEEeCCCC-cCccc----CCchhhhcCCCccEEEccCCcceec----CCccCcCCCCCCEEeccCccccccc
Q 003855 32 TIFNISTMRILTLEGN-QLSGR----LPSTVGHLLPNIESLLLAANNLTGI----IPHSITNATKLVALDLGFNSFAGHI 102 (791)
Q Consensus 32 ~~~~l~~L~~L~L~~n-~l~~~----~p~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~ 102 (791)
.+...++|++|+|++| .|... +...+.. .++|++|+|++|.|... +...+...++|++|+|++|.|+...
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~-~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKT-NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTT-CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHh-CCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 3444455555555555 44321 1111111 34555555555555421 2233344455666666666555432
Q ss_pred ----ccccccccccccccc--ccccccccCCCccccccccccCCCCCCcEEEccCCCCcc
Q 003855 103 ----LNTFGNLRHLSLLSQ--VMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGG 156 (791)
Q Consensus 103 ----~~~~~~l~~L~~L~l--~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 156 (791)
...+...++|+.|++ ++|.|+..... .+...+...++|++|+|++|.+..
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~----~l~~~L~~n~~L~~L~L~~n~i~~ 165 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEM----EIANMLEKNTTLLKFGYHFTQQGP 165 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH----HHHHHHHHCSSCCEEECCCSSHHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHH----HHHHHHHhCCCcCEEeccCCCCCh
Confidence 333444455666666 55665543211 123446677889999999998864
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.54 E-value=1.3e-08 Score=97.09 Aligned_cols=71 Identities=11% Similarity=0.120 Sum_probs=37.0
Q ss_pred cCCCCCCcEEEccCC-CCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCcccccc----Ccccc
Q 003855 138 LTNCRNLTILSFGSN-PLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTI----SPTMG 212 (791)
Q Consensus 138 l~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~ 212 (791)
+...++|++|+|++| .+.......+ ...+...++|++|+|++|.|.... ...+.
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l---------------------~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~ 90 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKAC---------------------AEALKTNTYVKKFSIVGTRSNDPVAFALAEMLK 90 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHH---------------------HHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHH---------------------HHHHHhCCCcCEEECcCCCCChHHHHHHHHHHH
Confidence 555666677777766 6653221111 122344556666666666665322 22333
Q ss_pred CCCCCCEEEcccccCcc
Q 003855 213 RLKRLQGLSLRNNNLEG 229 (791)
Q Consensus 213 ~l~~L~~L~L~~N~l~~ 229 (791)
..++|++|+|++|.|+.
T Consensus 91 ~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 91 VNNTLKSLNVESNFISG 107 (185)
T ss_dssp HCSSCCEEECCSSCCCH
T ss_pred hCCCcCEEECcCCcCCH
Confidence 44556666666666553
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.47 E-value=2.5e-08 Score=99.91 Aligned_cols=80 Identities=26% Similarity=0.410 Sum_probs=52.5
Q ss_pred ccCCCCCEEecCCcccCC--CCCcchhccccccccccccccCCCCCCcccCCCC--CCcEEEccCCccCCCCc-------
Q 003855 308 QKLKVLTVLDLSRNQLSG--DIPSTIGALKDLETLSLARNQFQGPIPESVGSLI--SLESLDLSGNNLSGKIP------- 376 (791)
Q Consensus 308 ~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~------- 376 (791)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|++++..|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 456677777777777765 3345566777777777777777743 2333333 78888888888876554
Q ss_pred hhhhhcccCceEE
Q 003855 377 KSLETLSQLKQFN 389 (791)
Q Consensus 377 ~~~~~l~~L~~l~ 389 (791)
..+..+|+|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 2466778887764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.40 E-value=5.9e-08 Score=97.22 Aligned_cols=113 Identities=19% Similarity=0.171 Sum_probs=55.8
Q ss_pred ccCCCCCcE--EeCCCCcCcccCCc---hhhhcCCCccEEEccCCcceec--CCccCcCCCCCCEEeccCcccccc-ccc
Q 003855 33 IFNISTMRI--LTLEGNQLSGRLPS---TVGHLLPNIESLLLAANNLTGI--IPHSITNATKLVALDLGFNSFAGH-ILN 104 (791)
Q Consensus 33 ~~~l~~L~~--L~L~~n~l~~~~p~---~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~i~~~-~~~ 104 (791)
|...+.|+. ++++.|+.. .++. .+...+++|++|+|++|+|+++ +|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~ 215 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELD 215 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGG
T ss_pred cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhh
Confidence 333444444 555666443 3322 1122356666666666666652 334555666666666666666654 122
Q ss_pred cccccccccccccccccccccCCCccccccccccCCCCCCcEEE
Q 003855 105 TFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILS 148 (791)
Q Consensus 105 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~ 148 (791)
.+.++ +|+.|++++|.+..-...... -....+..+++|+.||
T Consensus 216 ~l~~l-~L~~L~L~~Npl~~~~~~~~~-y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 216 KIKGL-KLEELWLDGNSLCDTFRDQST-YISAIRERFPKLLRLD 257 (267)
T ss_dssp GGTTS-CCSEEECTTSTTGGGCSSHHH-HHHHHHHHCTTCCEES
T ss_pred hcccC-CcceEEccCCcCccccCcchh-HHHHHHHHCcccCeEC
Confidence 22223 666666666666531100000 0011255667777765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=4.2e-06 Score=86.78 Aligned_cols=137 Identities=14% Similarity=0.111 Sum_probs=94.8
Q ss_pred ccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCC---ccceeeeeec-cCCeeeEEEecCCC
Q 003855 506 CNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHR---NLIKILSSCS-NPDFKALVLEFMPN 581 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 581 (791)
++.++.|....||+. |..+++|+... ......+..|.++++.+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899987 57788998532 23446788999999999642 3556666663 44567899999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccC-------------------------------------------
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH------------------------------------------- 618 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------- 618 (791)
.++.+.... .++..+...++.++++.|..||...
T Consensus 98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 888763221 1344555556666666666665311
Q ss_pred -------------CCCCeEecCCCCCCeEeCC---CCc-EEEeeeccccc
Q 003855 619 -------------SSAPIIHCDLKPTNILLDE---NMA-AHVSDFGISKL 651 (791)
Q Consensus 619 -------------~~~~i~H~dlk~~Nill~~---~~~-~kl~Dfgla~~ 651 (791)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999997 455 58999997753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=4.2e-06 Score=85.15 Aligned_cols=135 Identities=19% Similarity=0.129 Sum_probs=97.1
Q ss_pred ccCCCcce-EEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CCccceeeeeeccCCeeeEEEecCCCCCH
Q 003855 508 LLGTGSFG-SVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKALVLEFMPNGSL 584 (791)
Q Consensus 508 ~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 584 (791)
.+..|..| .||+.... ++..+++|+-... ....+..|...++.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445554 68987754 5678999986543 2346778999998884 33467788888888999999999999888
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-----------------------------------------------
Q 003855 585 EKWLYSHNYFLDILERLNIMIDVGSALEYLHHG----------------------------------------------- 617 (791)
Q Consensus 585 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------------------------------------------- 617 (791)
.+...... .....++.+++..+..||..
T Consensus 108 ~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 77654321 22345666777777777730
Q ss_pred -------CCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 618 -------HSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 618 -------~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
.....++|+|+.+.||++++++.+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 012237899999999999988777899998774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=5.3e-06 Score=88.23 Aligned_cols=80 Identities=10% Similarity=-0.010 Sum_probs=55.4
Q ss_pred cccc-CCCcceEEEEEEec-------CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhcc-C--CccceeeeeeccC--
Q 003855 506 CNLL-GTGSFGSVYKGTIS-------DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVR-H--RNLIKILSSCSNP-- 569 (791)
Q Consensus 506 ~~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~-- 569 (791)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88889999998764 26789999865432 001235677888888884 3 3466778777655
Q ss_pred -CeeeEEEecCCCCCHH
Q 003855 570 -DFKALVLEFMPNGSLE 585 (791)
Q Consensus 570 -~~~~lv~e~~~~g~L~ 585 (791)
+..++||||++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999886653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.97 E-value=1.6e-06 Score=80.27 Aligned_cols=82 Identities=15% Similarity=0.140 Sum_probs=38.1
Q ss_pred CCCEEEccCCccccccCccccCCCCCCEEEccccc-CcccCCcccccc----CCCceEEecCCc-cCCCCCccccCCCCC
Q 003855 192 GLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNN-LEGSIPYDLCHL----KLMFGIRLTGNK-LSGHIPPCLVSLTSL 265 (791)
Q Consensus 192 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-i~~~~~~~~~~l~~L 265 (791)
+|+.||++++.|+......+..+++|++|+|++|. |++..-..++.+ ++|+.|+|++|. |+...-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45566666665554444455555566666665553 443322333332 234455554442 433222333344444
Q ss_pred cEEEcCCC
Q 003855 266 RELHLGSN 273 (791)
Q Consensus 266 ~~L~L~~N 273 (791)
++|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 44444443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.96 E-value=1.5e-06 Score=80.49 Aligned_cols=84 Identities=8% Similarity=0.000 Sum_probs=38.6
Q ss_pred CCCCeeecCCCcccccCCccccCCCCCcEEeCCCCc-CcccCCchhhhc---CCCccEEEccCCc-ceecCCccCcCCCC
Q 003855 13 QNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQ-LSGRLPSTVGHL---LPNIESLLLAANN-LTGIIPHSITNATK 87 (791)
Q Consensus 13 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~~---l~~L~~L~L~~N~-l~~~~~~~~~~l~~ 87 (791)
.+|++|||++|.|+..--..+.++++|++|+|++|. |++.--..+... .++|++|+|++|. |++.--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 345556666555554444445555555555555553 442111112110 1235555555542 44332233444555
Q ss_pred CCEEeccCc
Q 003855 88 LVALDLGFN 96 (791)
Q Consensus 88 L~~L~L~~N 96 (791)
|++|+|+++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 555555554
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=9.5e-05 Score=79.69 Aligned_cols=75 Identities=15% Similarity=0.179 Sum_probs=48.9
Q ss_pred ccccCCCcceEEEEEEec-CCcEEEEEEeehhhh-------HHHHHHHHHHHHHHhccC--Cc-cceeeeeeccCCeeeE
Q 003855 506 CNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE-------RAFRSFDSECEVLRNVRH--RN-LIKILSSCSNPDFKAL 574 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 574 (791)
.+.+|.|.++.||++... +++.|+||......+ .....+..|.++++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999754 568899997643221 112345678888888742 43 3355544 3445689
Q ss_pred EEecCCCC
Q 003855 575 VLEFMPNG 582 (791)
Q Consensus 575 v~e~~~~g 582 (791)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00019 Score=75.58 Aligned_cols=139 Identities=15% Similarity=0.135 Sum_probs=78.5
Q ss_pred cccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-----CCccceee-e--eeccCCeeeEEEec
Q 003855 507 NLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-----HRNLIKIL-S--SCSNPDFKALVLEF 578 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~ 578 (791)
+.|+.|..+.||+....+| .+++|+..... ..+..|..+++.+. .|.++... | +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987554 58999887532 22334555555553 23333311 1 11245677899999
Q ss_pred CCCCCHH--------------HHHhh--CCC-----------CCCHHHHH------------------------------
Q 003855 579 MPNGSLE--------------KWLYS--HNY-----------FLDILERL------------------------------ 601 (791)
Q Consensus 579 ~~~g~L~--------------~~l~~--~~~-----------~~~~~~~~------------------------------ 601 (791)
++|.++. ..++. ... ...|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986431 11221 100 01232110
Q ss_pred -HHHHHHHHHHHHHHc--------c-CCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 602 -NIMIDVGSALEYLHH--------G-HSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 602 -~i~~~i~~~l~~LH~--------~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
.+...+..++.+|+. . .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123345666652 0 014679999999999999888899999998764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.62 E-value=1.2e-05 Score=75.87 Aligned_cols=68 Identities=15% Similarity=0.133 Sum_probs=33.6
Q ss_pred cCcCCCCCCEEeccCcccccccc----ccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCC
Q 003855 81 SITNATKLVALDLGFNSFAGHIL----NTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSN 152 (791)
Q Consensus 81 ~~~~l~~L~~L~L~~N~i~~~~~----~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N 152 (791)
++...+.|+.|+|++|+|..... .++..-+.|+.|+|++|.|+..... .+.+.+...+.|++|+|++|
T Consensus 65 aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~----ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 65 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA----RLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH----HHHHHTTTTCCCSEEECCCC
T ss_pred HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH----HHHHHHhhCCceeEEECCCC
Confidence 33444455555555555543222 2222334455555555555433221 23445666667777777755
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.56 E-value=1.4e-05 Score=75.55 Aligned_cols=18 Identities=11% Similarity=0.340 Sum_probs=8.8
Q ss_pred cCCCCCCcEEEccCCCCc
Q 003855 138 LTNCRNLTILSFGSNPLG 155 (791)
Q Consensus 138 l~~l~~L~~L~L~~N~l~ 155 (791)
+...+.|+.|+|++|+|.
T Consensus 66 L~~N~~L~~L~L~~n~ig 83 (197)
T 1pgv_A 66 ACNSKHIEKFSLANTAIS 83 (197)
T ss_dssp HTTCSCCCEEECTTSCCB
T ss_pred HhhCCCcCEEEccCCCCC
Confidence 344444555555555554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00021 Score=73.09 Aligned_cols=78 Identities=15% Similarity=0.135 Sum_probs=56.9
Q ss_pred ccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-C--CccceeeeeeccCCeeeEEEec
Q 003855 502 EFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-H--RNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e~ 578 (791)
+...++.+|.|..+.||+.+..||+.|+||+...........+..|+..|+.+. . --+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 455567899999999999999999999999876443333346788999999884 2 1244555542 23789999
Q ss_pred CCCCC
Q 003855 579 MPNGS 583 (791)
Q Consensus 579 ~~~g~ 583 (791)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00058 Score=70.27 Aligned_cols=138 Identities=14% Similarity=0.094 Sum_probs=92.0
Q ss_pred cccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc---CCccceeeeeeccCCeeeEEEecCCC
Q 003855 505 ECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR---HRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 505 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
..+.|+.|....+|+... ++..+++|+.... ....+..|.+.++.+. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999886 5678899987643 2456788999998884 35688888888877889999999998
Q ss_pred CCHH--------H---HHhhCCC---------------------CCCHHHHH---HHHHH----------------HHHH
Q 003855 582 GSLE--------K---WLYSHNY---------------------FLDILERL---NIMID----------------VGSA 610 (791)
Q Consensus 582 g~L~--------~---~l~~~~~---------------------~~~~~~~~---~i~~~----------------i~~~ 610 (791)
.++. + .|+.... .-+|.... ++..+ +...
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7541 1 2222111 12454332 11111 1111
Q ss_pred -HHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeec
Q 003855 611 -LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFG 647 (791)
Q Consensus 611 -l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 647 (791)
...|........++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 12332112345799999999999999887 8888873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00084 Score=72.77 Aligned_cols=80 Identities=15% Similarity=0.119 Sum_probs=48.9
Q ss_pred CCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCC---CCCCccccHHhHHHHHHH
Q 003855 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLME 696 (791)
Q Consensus 620 ~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~e 696 (791)
...++|+|+++.||+++.++ ++++||+.+..-.+..+-. .....-...|.+|+.... .......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 45799999999999999876 9999999887532211100 000001134666664431 112233556678888888
Q ss_pred HHhCC
Q 003855 697 TFTRK 701 (791)
Q Consensus 697 lltg~ 701 (791)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00069 Score=59.70 Aligned_cols=60 Identities=22% Similarity=0.365 Sum_probs=38.8
Q ss_pred ccccccccCC-CCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCC
Q 003855 339 TLSLARNQFQ-GPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400 (791)
Q Consensus 339 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 400 (791)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|++.+...
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~ 72 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR 72 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence 4555666654 23443332 357777777777776666777777777777777777766543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00093 Score=58.86 Aligned_cols=56 Identities=25% Similarity=0.393 Sum_probs=36.3
Q ss_pred EEeCCCCcCc-ccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccc
Q 003855 41 ILTLEGNQLS-GRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFA 99 (791)
Q Consensus 41 ~L~L~~n~l~-~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 99 (791)
.++.+++.++ ..+|..+ .++|++|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~l---p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF---PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCC---CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCC---CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666666663 3566543 236777777777777666666777777777777777654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0034 Score=65.12 Aligned_cols=156 Identities=12% Similarity=0.126 Sum_probs=85.5
Q ss_pred ChhHHHHHhhcccc-----ccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCc--cceeee
Q 003855 492 PYLDIQRATDEFNE-----CNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN--LIKILS 564 (791)
Q Consensus 492 ~~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~ 564 (791)
+..++......|.. .+.|+.|....+|+....+| .+++|+..... ..+.+..|+.+++.+.... +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 34445555555543 34567788889999987655 68899876521 1234456777777764222 233332
Q ss_pred ee------ccCCeeeEEEecCCCCCHH-----------H---HHhhC--C--CC----C---CHHHHHH-----------
Q 003855 565 SC------SNPDFKALVLEFMPNGSLE-----------K---WLYSH--N--YF----L---DILERLN----------- 602 (791)
Q Consensus 565 ~~------~~~~~~~lv~e~~~~g~L~-----------~---~l~~~--~--~~----~---~~~~~~~----------- 602 (791)
.. ...+..+++++|++|..+. + .++.. . .. . .|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 21 1235678999999886431 0 11210 0 00 1 1222110
Q ss_pred -HHHHHHHHHHHHHcc---CCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 603 -IMIDVGSALEYLHHG---HSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 603 -i~~~i~~~l~~LH~~---~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
+...+.+.+++++.. .....++|+|+.+.||+++++..+.++||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455555532 113469999999999999987666899998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0026 Score=65.31 Aligned_cols=137 Identities=16% Similarity=0.165 Sum_probs=74.7
Q ss_pred ccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCcc-ceeeeeeccCCeeeEEEecC-CCCC
Q 003855 506 CNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNL-IKILSSCSNPDFKALVLEFM-PNGS 583 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~ 583 (791)
.+.|+.|....+|+. ..+++|+....... ......|+.+++.+....+ .+++++. ++.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 567888999999998 56888987643211 1123457777777743222 4555554 33457899999 5543
Q ss_pred HHH------------------HHhhCCCC----CCH-HHHHHHHH--------------HHHHHH----HHHHccCCCCC
Q 003855 584 LEK------------------WLYSHNYF----LDI-LERLNIMI--------------DVGSAL----EYLHHGHSSAP 622 (791)
Q Consensus 584 L~~------------------~l~~~~~~----~~~-~~~~~i~~--------------~i~~~l----~~LH~~~~~~~ 622 (791)
+.. .++..... .+. ..+..+.. .+.+.+ ..+........
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 321 01111110 111 11111100 011111 11111122345
Q ss_pred eEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 623 IIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 623 i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
++|+|+.+.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667789999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0057 Score=63.78 Aligned_cols=140 Identities=12% Similarity=0.080 Sum_probs=73.0
Q ss_pred cccCCCcceE-EEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccC--CccceeeeeeccCCeeeEEEecCCCCC
Q 003855 507 NLLGTGSFGS-VYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRH--RNLIKILSSCSNPDFKALVLEFMPNGS 583 (791)
Q Consensus 507 ~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~ 583 (791)
+.++.|.... +|+....++..+++|....... +.+..|+.+++.+.. -.+.+++.+..+.+ ++|||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3565554444 6677654467788886543321 233446677766632 23455666543333 78999997767
Q ss_pred HHHHHhhCC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHHHc--
Q 003855 584 LEKWLYSHN-------------------------YFLDILERL-------N-I------------MIDVGSALEYLHH-- 616 (791)
Q Consensus 584 L~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~~i~~~l~~LH~-- 616 (791)
+.+++.... ..++..... . + ...+...+..+..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 665443210 011111100 0 0 0011112222211
Q ss_pred cCCCCCeEecCCCCCCeEeCCC----CcEEEeeeccccc
Q 003855 617 GHSSAPIIHCDLKPTNILLDEN----MAAHVSDFGISKL 651 (791)
Q Consensus 617 ~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfgla~~ 651 (791)
......++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1114569999999999999875 6899999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0069 Score=57.34 Aligned_cols=103 Identities=14% Similarity=0.063 Sum_probs=68.8
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCccee
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 661 (791)
-+|.+.|+..+.+++++++|.++.|.+.+|.-.-... .. ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR--QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 3899999998889999999999999999987762100 01 1222456889999999998763 1110
Q ss_pred ecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCC
Q 003855 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703 (791)
Q Consensus 662 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p 703 (791)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122466888763 3556788999999999998875444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.017 Score=60.03 Aligned_cols=155 Identities=12% Similarity=0.077 Sum_probs=85.9
Q ss_pred hhHHHHHhhcccc-----ccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCc--cceeeee
Q 003855 493 YLDIQRATDEFNE-----CNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN--LIKILSS 565 (791)
Q Consensus 493 ~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~ 565 (791)
...+....+.|.. ...++ |....||+....+|+.+++|+...... ....+..|..+++.+.... +.+++..
T Consensus 13 ~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~ 90 (328)
T 1zyl_A 13 PDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAF 90 (328)
T ss_dssp HHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCB
T ss_pred HHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeec
Confidence 3444444444432 23466 778899998877777899999863321 2345666888887774222 3444443
Q ss_pred -----eccCCeeeEEEecCCCCCHH-----H------H---Hhh--C------CCCCCHHHH----HHH-----------
Q 003855 566 -----CSNPDFKALVLEFMPNGSLE-----K------W---LYS--H------NYFLDILER----LNI----------- 603 (791)
Q Consensus 566 -----~~~~~~~~lv~e~~~~g~L~-----~------~---l~~--~------~~~~~~~~~----~~i----------- 603 (791)
....+..++||||++|.++. . . ++. . ....++... ..+
T Consensus 91 ~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 170 (328)
T 1zyl_A 91 NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGL 170 (328)
T ss_dssp TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTT
T ss_pred CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHH
Confidence 11234567899999875321 1 1 111 0 011222211 001
Q ss_pred ----HHHHHHHHHHHHcc---CCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 604 ----MIDVGSALEYLHHG---HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 604 ----~~~i~~~l~~LH~~---~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
...+...++.+... .....++|+|+++.||+++ + .+.++||+.+..
T Consensus 171 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 171 KAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 01111223333211 1244689999999999999 4 899999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0026 Score=68.85 Aligned_cols=71 Identities=13% Similarity=0.185 Sum_probs=48.3
Q ss_pred ccccCCCcceEEEEEEecC--------CcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCc-cceeeeeeccCCeeeEEE
Q 003855 506 CNLLGTGSFGSVYKGTISD--------GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN-LIKILSSCSNPDFKALVL 576 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 576 (791)
++.|+.|....+|+....+ ++.+++|+...... .+.+..|..+++.+...+ ..++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888889999998753 57899998843211 134457888888884333 3566766543 3899
Q ss_pred ecCCCC
Q 003855 577 EFMPNG 582 (791)
Q Consensus 577 e~~~~g 582 (791)
||++|-
T Consensus 152 e~l~G~ 157 (429)
T 1nw1_A 152 EYIPSR 157 (429)
T ss_dssp CCCCEE
T ss_pred EEeCCc
Confidence 999863
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0073 Score=63.79 Aligned_cols=139 Identities=12% Similarity=0.154 Sum_probs=81.7
Q ss_pred cccCCCcceEEEEEEec--------CCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CCccceeeeeeccCCeeeEEEe
Q 003855 507 NLLGTGSFGSVYKGTIS--------DGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 577 (791)
+.+..|-...+|+.... +++.|++|+.... ........+|..+++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46767778889998864 2478999986332 223345668999998884 3333566776654 28999
Q ss_pred cCCCCCHH--------------HH---HhhCC----CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 003855 578 FMPNGSLE--------------KW---LYSHN----YFLD--ILERLNIMIDVGS-------------------ALEYLH 615 (791)
Q Consensus 578 ~~~~g~L~--------------~~---l~~~~----~~~~--~~~~~~i~~~i~~-------------------~l~~LH 615 (791)
|++|.++. +. ++... .... +.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99875432 11 11111 1122 3444444443321 233332
Q ss_pred ----ccCCCCCeEecCCCCCCeEeCCC----CcEEEeeecccc
Q 003855 616 ----HGHSSAPIIHCDLKPTNILLDEN----MAAHVSDFGISK 650 (791)
Q Consensus 616 ----~~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfgla~ 650 (791)
.......++|+|+.+.||+++.+ +.+.++||..|.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22224468999999999999876 789999998775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.27 E-value=0.006 Score=66.29 Aligned_cols=73 Identities=14% Similarity=0.167 Sum_probs=46.6
Q ss_pred ccccCCCcceEEEEEEecC-CcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCcc-ceeeeeeccCCeeeEEEecCCCCC
Q 003855 506 CNLLGTGSFGSVYKGTISD-GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNL-IKILSSCSNPDFKALVLEFMPNGS 583 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~ 583 (791)
++.|+.|-...+|+....+ +..+++|+........ -....|..+++.+...++ .++++++. + ..||||++|-+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888889999998764 4788999874332111 112468888888864444 46677663 2 35999998743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0057 Score=64.88 Aligned_cols=73 Identities=14% Similarity=0.255 Sum_probs=43.8
Q ss_pred ccccCCCcceEEEEEEecC---------CcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCc-cceeeeeeccCCeeeEE
Q 003855 506 CNLLGTGSFGSVYKGTISD---------GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN-LIKILSSCSNPDFKALV 575 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 575 (791)
.+.++.|....+|+....+ ++.+++|+....... ......|..+++.+...+ ..++++... -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence 3467778888999988653 268899987543222 112356888888774333 345665442 2689
Q ss_pred EecCCCCC
Q 003855 576 LEFMPNGS 583 (791)
Q Consensus 576 ~e~~~~g~ 583 (791)
|||++|.+
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.98 E-value=0.024 Score=59.19 Aligned_cols=32 Identities=19% Similarity=0.334 Sum_probs=28.0
Q ss_pred CCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 620 ~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
...++|+|+.+.||++++++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.57 E-value=0.23 Score=53.15 Aligned_cols=73 Identities=14% Similarity=0.243 Sum_probs=46.8
Q ss_pred ccccCCCcceEEEEEEecC--------CcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CCccceeeeeeccCCeeeEEE
Q 003855 506 CNLLGTGSFGSVYKGTISD--------GTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 576 (791)
++.+..|-...+|+....+ ++.|++|+..... +..-...+|..+++.+. +.-..++++.+. -+.||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567777788999988753 5789999864332 11112356888888774 333345555432 26899
Q ss_pred ecCCCCC
Q 003855 577 EFMPNGS 583 (791)
Q Consensus 577 e~~~~g~ 583 (791)
||++|.+
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 9998865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.45 E-value=0.091 Score=56.12 Aligned_cols=30 Identities=33% Similarity=0.387 Sum_probs=24.9
Q ss_pred CeEecCCCCCCeEe------CCCCcEEEeeeccccc
Q 003855 622 PIIHCDLKPTNILL------DENMAAHVSDFGISKL 651 (791)
Q Consensus 622 ~i~H~dlk~~Nill------~~~~~~kl~Dfgla~~ 651 (791)
.++|+|+.+.||++ +++..++++||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999988753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.25 E-value=0.2 Score=54.35 Aligned_cols=59 Identities=12% Similarity=0.045 Sum_probs=16.8
Q ss_pred cccccCCCcceEEEEEEecC-CcEEEE------EEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeee
Q 003855 505 ECNLLGTGSFGSVYKGTISD-GTDVAI------KIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSC 566 (791)
Q Consensus 505 ~~~~ig~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 566 (791)
+.+.+| ||+||+|.+.. ..+||| |...... ++....+.+|..+++..+|||+++.+++.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 445676 99999999864 467888 6654322 23345678889999999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 791 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 1e-64
Identities = 69/285 (24%), Positives = 125/285 (43%), Gaps = 26/285 (9%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRN 558
+ +G+GSFG+VYKG DVA+K+ N+ + ++F +E VLR RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
++ + + P A+V ++ SL L+ ++++ ++I ++YLH
Sbjct: 66 ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY--- 675
IIH DLK NI L E++ + DFG++ + S +I +MAPE
Sbjct: 123 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735
+ S + DVY++G++L E T + P + + + + L L++V
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS---- 236
Query: 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780
+C ++ L +C + D R A ++ +
Sbjct: 237 ----------NCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 6e-56
Identities = 64/270 (23%), Positives = 115/270 (42%), Gaps = 10/270 (3%)
Query: 496 IQRATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRS-FDSECEVLRN 553
++ D+F + + LG G+ G V+K + G +A K+ +L+++ A R+ E +VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 554 VRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 613
++ + + ++ +E M GSL++ L + + I V L Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAP 673
L H I+H D+KP+NIL++ + DFG+S L DS+ + + T YM+P
Sbjct: 120 LREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSF-VGTRSYMSP 172
Query: 674 EYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733
E S + D++S G+ L+E + P E+ L + T
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 734 LVREEQAFSAKMDCILSIMDLALDCCIESP 763
R ++ ++I +L E P
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 8e-56
Identities = 70/304 (23%), Positives = 121/304 (39%), Gaps = 39/304 (12%)
Query: 493 YLDIQRATDEFNEC---------NLLGTGSFGSVYKG----TISDGTDVAIKIFNLQL-E 538
+ D A EF + ++G G FG V G VAIK E
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 539 RAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL 598
+ R F SE ++ H N+I + + ++ EFM NGSL+ +L ++ ++
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 128
Query: 599 ERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658
+ + ++ + + ++YL + +H DL NIL++ N+ VSDFG+S+ L +
Sbjct: 129 QLVGMLRGIAAGMKYLADMN----YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 659 VTQTMT---MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 715
T T I + APE ++ DV+SYG+++ E +
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW--------- 235
Query: 716 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775
+T N + ++ MDC ++ L LDC + + R
Sbjct: 236 ---------DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 776 LKKI 779
L K+
Sbjct: 287 LDKM 290
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-55
Identities = 62/280 (22%), Positives = 122/280 (43%), Gaps = 26/280 (9%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
+ LG G FG V+ G + T VA+K + +F +E +++ ++H+ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHHGHS 619
++ + + ++ E+M NGSL +L + + L I + L++ + + ++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---- 126
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG 679
IH DL+ NIL+ + ++ ++DFG+++L+ + E + I + APE + G
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYG 185
Query: 680 IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739
+ K DV+S+G+LL E T R T ++ + +VR +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-----------GYRMVRPD- 233
Query: 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
+C + L C E P+ R + L+
Sbjct: 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-54
Identities = 64/279 (22%), Positives = 109/279 (39%), Gaps = 24/279 (8%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
E +G+G FG V+ G + VAIK F E EV+ + H L+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
++ C LV EFM +G L +L + L + +DV + YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 121
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGI 680
+IH DL N L+ EN VSDFG+++ + + + + + + + +PE S
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSR 178
Query: 681 VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740
S+K DV+S+GVL+ E F+ + E + + + + ++
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVY----- 232
Query: 741 FSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
+ C E P+ R + +L +I
Sbjct: 233 ------------QIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-54
Identities = 60/290 (20%), Positives = 118/290 (40%), Gaps = 22/290 (7%)
Query: 509 LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN 568
+G G FG V++G G +VA+KIF+ + ER++ ++E +RH N++ +++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 569 PDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG----HSS 620
+ LV ++ +GSL +L + Y + + + + + S L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT--MATIGYMAPEYGSE 678
I H DLK NIL+ +N ++D G++ D++ + T YMAPE +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 679 GI------VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKE--SLPHGLTEVV 730
I + D+Y+ G++ E R ++ V S+ V
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780
+ L + + + + +C + R+ L ++
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-54
Identities = 62/279 (22%), Positives = 110/279 (39%), Gaps = 24/279 (8%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
+ LGTG FG V G DVAIK+ + F E +V+ N+ H L+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
++ C+ ++ E+M NG L +L + + L + DV A+EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---- 118
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGI 680
+H DL N L+++ VSDFG+S+ + + E + + + + + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLMYSK 177
Query: 681 VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740
S+K D++++GVL+ E ++ + E FT + + L + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLRLYRPHLASEKVY----- 231
Query: 741 FSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
+ C E D R + + +
Sbjct: 232 ------------TIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 3e-54
Identities = 75/282 (26%), Positives = 117/282 (41%), Gaps = 32/282 (11%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
E +G G FG V G G VA+K ++ + ++F +E V+ +RH NL+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63
Query: 561 KILSSCSNPDFK-ALVLEFMPNGSLEKWLYSHNY-FLDILERLNIMIDVGSALEYLHHGH 618
++L +V E+M GSL +L S L L +DV A+EYL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE 678
+H DL N+L+ E+ A VSDFG++K S TQ + + APE E
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALRE 174
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738
S K DV+S+G+LL E ++ R + + R V +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------------------VEKG 216
Query: 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780
A C ++ ++ +C MR + +L+ IK
Sbjct: 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 4e-54
Identities = 63/283 (22%), Positives = 112/283 (39%), Gaps = 30/283 (10%)
Query: 509 LGTGSFGSVYKGTI---SDGTDVAIKIFNLQLERAFR-SFDSECEVLRNVRHRNLIKILS 564
LG G+FGSV +G DVAIK+ E+A E +++ + + +++++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 565 SCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPII 624
C LV+E G L K+L + + ++ V ++YL +
Sbjct: 77 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE----KNFV 131
Query: 625 HCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA-TIGYMAPEYGSEGIVSA 683
H DL N+LL A +SDFG+SK LG + T + + APE + S+
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 684 KCDVYSYGVLLMETFTR-KRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFS 742
+ DV+SYGV + E + ++P +M E+ + + +
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------------------MAFIEQGKRME 232
Query: 743 AKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785
+C + L DC I + R + +++
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-52
Identities = 59/281 (20%), Positives = 103/281 (36%), Gaps = 30/281 (10%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHR 557
+++ +GTGS+G K SDG + K + E + SE +LR ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 558 NLIKILSSCSNPDFKAL--VLEFMPNGSLEKWLYSH---NYFLDILERLNIMIDVGSALE 612
N+++ + L V+E+ G L + +LD L +M + AL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 613 YLH-HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYM 671
H ++H DLKP N+ LD + DFG++++L + T YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYM 181
Query: 672 APEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731
+PE + + K D++S G LL E P + L ++E +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFRRIPYRYS 239
Query: 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772
L ++ R +V +
Sbjct: 240 DELN-----------------EIITRMLNLKDYHRPSVEEI 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-52
Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 26/280 (9%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLI 560
+ LG G FG V+ GT + T VAIK + +F E +V++ +RH L+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 75
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDIL-ERLNIMIDVGSALEYLHHGHS 619
++ + S +V E+M GSL +L L + +++ + S + Y+ +
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 620 SAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEG 679
+H DL+ NIL+ EN+ V+DFG+++L+ + E + Q I + APE G
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYG 189
Query: 680 IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739
+ K DV+S+G+LL E T+ R L + V
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ------------------VERGY 231
Query: 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
+C S+ DL C + P+ R A L+
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 9e-52
Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 29/286 (10%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTD-----VAIKIFNLQL-ERAFRSFDSECEVLRNV 554
++G G FG VYKG + + VAIK E+ F E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 555 RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYL 614
H N+I++ S ++ E+M NG+L+K+L + +L+ + ++ + + ++YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 615 HHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV-TQTMTMATIGYMAP 673
+ +H DL NIL++ N+ VSDFG+S++L + ++ T + I + AP
Sbjct: 127 A----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 674 EYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733
E S ++ DV+S+G+++ E T E+S +K
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGER----PYWELSNHEVMK-------------- 224
Query: 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
+ + MDC +I L + C + R D + L K+
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-51
Identities = 62/302 (20%), Positives = 126/302 (41%), Gaps = 30/302 (9%)
Query: 493 YLDIQRATDEFNECNLLGTGSFGSVYKGTISD----GTDVAIKIFNLQLERAFRS-FDSE 547
++ I ++ + ++G G FG VY GT+ D A+K N + S F +E
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 548 CEVLRNVRHRNLIKILSSCSNPDFKA-LVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 606
++++ H N++ +L C + +VL +M +G L ++ + + + + + +
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT-- 664
V +++L +H DL N +LDE V+DFG+++ + + E T
Sbjct: 139 VAKGMKFLAS----KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 665 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH 724
+ +MA E + K DV+S+GVLL E TR P +++
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVY---- 246
Query: 725 GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784
+ + + C + ++ L C +MR + ++ +++ I F+
Sbjct: 247 ----------LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296
Query: 785 DD 786
+
Sbjct: 297 GE 298
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (450), Expect = 1e-50
Identities = 63/320 (19%), Positives = 117/320 (36%), Gaps = 53/320 (16%)
Query: 491 TPYL-DIQRATDEFNECNLLGTGSFGSVYKGT------ISDGTDVAIKIFNLQLERAFRS 543
P L ++ + +G G+FG V++ T VA+K+ + ++
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 544 -FDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF-------- 594
F E ++ + N++K+L C+ L+ E+M G L ++L S +
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 595 ---------------LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM 639
L E+L I V + + YL +H DL N L+ ENM
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLVGENM 177
Query: 640 AAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT 699
++DFG+S+ + + I +M PE + + DV++YGV+L E F+
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 700 RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCC 759
E + ++ + +C L + +L C
Sbjct: 238 YGLQPYYGMAHEEVIYYVRDGNIL------------------ACPENCPLELYNLMRLCW 279
Query: 760 IESPDMRINVTDAAAKLKKI 779
+ P R + L+++
Sbjct: 280 SKLPADRPSFCSIHRILQRM 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (446), Expect = 2e-50
Identities = 67/281 (23%), Positives = 111/281 (39%), Gaps = 26/281 (9%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISD-GTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNL 559
+ + LG G +G VY+G VA+K F E V++ ++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF-LDILERLNIMIDVGSALEYLHHGH 618
+++L C+ ++ EFM G+L +L N + + L + + SA+EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE 678
IH DL N L+ EN V+DFG+S+L+ G+ I + APE +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738
S K DV+++GVLL E T G+ L+ ++
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYP------------------GIDLSQVYELLEKD 232
Query: 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
C + +L C +P R + + + +
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 3e-50
Identities = 62/289 (21%), Positives = 105/289 (36%), Gaps = 32/289 (11%)
Query: 493 YLDIQR---ATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSEC 548
Y + R D + LG G+FG VYK A K+ + + E + E
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 549 EVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVG 608
++L + H N++K+L + + +++EF G+++ + L + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 609 SALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATI 668
AL YLH IIH DLK NIL + ++DFG+S +
Sbjct: 121 DALNYLH----DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT--P 174
Query: 669 GYMAPEY-----GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP 723
+MAPE + K DV+S G+ L+E + P E+ + L + K P
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPP 233
Query: 724 HGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772
+ + D C ++ D R +
Sbjct: 234 T----------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (448), Expect = 3e-50
Identities = 64/280 (22%), Positives = 97/280 (34%), Gaps = 36/280 (12%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNL---QLERAFRSFDSECEVLRNVR 555
F++ +G GSFG+VY + + VAIK + Q ++ E L+ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 556 HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 615
H N I+ LV+E+ + + H L +E + L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675
S +IH D+K NILL E + DFG + ++ + T +MAPE
Sbjct: 133 ----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEV 182
Query: 676 ---GSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732
EG K DV+S G+ +E RK P M L + P +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSE 241
Query: 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772
+ C + P R
Sbjct: 242 YFR-----------------NFVDSCLQKIPQDRPTSEVL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-50
Identities = 67/294 (22%), Positives = 118/294 (40%), Gaps = 35/294 (11%)
Query: 493 YLDIQRATDEFNECNLLGTGSFGSVYKGTISD---GTDVAIKIFNLQL--ERAFRSFDSE 547
YLD + T E E LG+G+FG+V KG VA+KI + +E
Sbjct: 2 YLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 58
Query: 548 CEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 607
V++ + + +++++ C + LV+E G L K+L + + + + ++ V
Sbjct: 59 ANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQV 116
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA- 666
++YL + +H DL N+LL A +SDFG+SK L E+
Sbjct: 117 SMGMKYLEESN----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP-HG 725
+ + APE + S+K DV+S+GVL+ E F+ + P G
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK-------------------PYRG 213
Query: 726 LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
+ ++ + + C + DL C + R +L+
Sbjct: 214 MKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 9e-50
Identities = 66/293 (22%), Positives = 122/293 (41%), Gaps = 30/293 (10%)
Query: 494 LDIQRATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL-----ERAFRSFDSE 547
L I + T+ F + +LG+G+FG+VYKG I +G V I + +L +A + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 548 CEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDV 607
V+ +V + ++ ++L C + L+ + MP G L ++ H + LN + +
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 608 GSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMAT 667
+ YL ++H DL N+L+ ++DFG++KLLG E
Sbjct: 121 AKGMNYLED----RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 668 IGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727
I +MA E I + + DV+SYGV + E T G+
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIP 218
Query: 728 EVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780
++++ + + C + + + + C + D R + + K+
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-49
Identities = 69/288 (23%), Positives = 99/288 (34%), Gaps = 30/288 (10%)
Query: 501 DEFNECNLLGTGSFGSVYKGTI----SDGTDVAIKIFNLQL---ERAFRSFDSECEVLRN 553
+ LG GSFG V +G VA+K + A F E + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 554 VRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 613
+ HRNLI++ P K +V E P GSL L H + + V + Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS-VTQTMTMATIGYMA 672
L S IH DL N+LL + DFG+ + L + +D V Q + A
Sbjct: 127 LE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 673 PEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732
PE S D + +GV L E FT + G L + KE
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--------- 233
Query: 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780
DC I ++ + C P+ R L + +
Sbjct: 234 --------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-49
Identities = 58/307 (18%), Positives = 108/307 (35%), Gaps = 51/307 (16%)
Query: 501 DEFNECNLLGTGSFGSVYKGT------ISDGTDVAIKIFNLQLERAFR-SFDSECEVLRN 553
+ +LG+G+FG V T VA+K+ + + + R + SE +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 554 V-RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHN-------------------- 592
+ H N++ +L +C+ L+ E+ G L +L S
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 593 --YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650
L + L V +E+L +H DL N+L+ + DFG+++
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 651 LLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTG 710
+ + V + + +MAPE EGI + K DV+SYG+LL E F+
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 711 EMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVT 770
+ + + ++ I + C R +
Sbjct: 273 DANFYKLIQNGFK-----------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 771 DAAAKLK 777
+ + L
Sbjct: 316 NLTSFLG 322
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 59/304 (19%), Positives = 106/304 (34%), Gaps = 46/304 (15%)
Query: 501 DEFNECNLLGTGSFGSVYKGTI------SDGTDVAIKIFNLQLERAFR-SFDSECEVLRN 553
+ + LG G+FG V + T VA+K+ R + SE +VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 554 V-RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSH-----------------NYFL 595
+ H N++ +L +C+ ++ E+ G L +L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 596 DILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655
D+ + L+ V + +L + IH DL NILL + DFG+++ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN----CIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 715
+ V + + +MAPE + + + DV+SYG+ L E F+ +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 716 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775
+ +KE + + D+ C P R
Sbjct: 259 KMIKEGFR-----------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 776 LKKI 779
++K
Sbjct: 302 IEKQ 305
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 3e-49
Identities = 55/275 (20%), Positives = 102/275 (37%), Gaps = 25/275 (9%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNL-QLERAFRSFDSECEVLRNVRHRN 558
++++ LG G++G V VA+KI ++ + + E + + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
++K + + L LE+ G L + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM-PEPDAQRFFHQLMAGVVYLHGIG 123
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY-GS 677
I H D+KP N+LLDE +SDFG++ + T+ Y+APE
Sbjct: 124 ----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 678 EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737
+ DV+S G++L + P D+ W ++ + +D+ +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL-- 237
Query: 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772
L +E+P RI + D
Sbjct: 238 ---------------ALLHKILVENPSARITIPDI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 1e-48
Identities = 63/272 (23%), Positives = 108/272 (39%), Gaps = 33/272 (12%)
Query: 509 LGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSS 565
+G GSF +VYKG +VA + + + F E E+L+ ++H N+++ S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 566 C----SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSA 621
LV E M +G+L+ +L + I + + L++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTP-- 133
Query: 622 PIIHCDLKPTNILL-DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGI 680
PIIH DLK NI + + + D G++ L S + + + T +MAPE E
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAV-IGTPEFMAPEMYEEK- 188
Query: 681 VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQA 740
DVY++G+ ++E T + P E RR P +V +
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK----- 243
Query: 741 FSAKMDCILSIMDLALDCCIESPDMRINVTDA 772
++ C ++ D R ++ D
Sbjct: 244 ------------EIIEGCIRQNKDERYSIKDL 263
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-48
Identities = 76/310 (24%), Positives = 121/310 (39%), Gaps = 49/310 (15%)
Query: 490 RTPYLDIQRATDEFNECNLLGTGSFGSVYKGTISDG---TDVAIKIFNLQLER-AFRSFD 545
P LD ++ +++G G+FG V K I D AIK + R F
Sbjct: 3 IYPVLDW----NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58
Query: 546 SECEVLRNV-RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF---------- 594
E EVL + H N+I +L +C + + L +E+ P+G+L +L
Sbjct: 59 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118
Query: 595 -----LDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649
L + L+ DV ++YL IH DL NIL+ EN A ++DFG+S
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIADFGLS 174
Query: 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFT 709
+ E V +TM + +MA E + + + DV+SYGVLL E +
Sbjct: 175 RG---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--- 228
Query: 710 GEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINV 769
M+ + + + ++C + DL C E P R +
Sbjct: 229 -GMTCAELYE--------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF 273
Query: 770 TDAAAKLKKI 779
L ++
Sbjct: 274 AQILVSLNRM 283
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 9e-48
Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 35/277 (12%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFN---LQLERAFRSFDSECEVLRNVRH 556
++F LG G FG+VY +A+K+ L+ E E+ ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
N++++ + L+LE+ P G++ + L + F D + ++ +AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCH- 123
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYG 676
S +IH D+KP N+LL ++DFG S +T T+ Y+ PE
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMI 176
Query: 677 SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR-RWVKESLPHGLTEVVDANLV 735
+ K D++S GVL E K P + E R V+ + P +TE
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE------- 229
Query: 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772
DL +P R + +
Sbjct: 230 --------------GARDLISRLLKHNPSQRPMLREV 252
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 57/274 (20%), Positives = 105/274 (38%), Gaps = 26/274 (9%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN 558
++ +G G+ G+VY ++ G +VAI+ NLQ + +E V+R ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
++ L S D +V+E++ GSL + + + + ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLH--- 133
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE 678
S +IH D+K NILL + + ++DFG + + ++ + T +MAPE +
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTR 190
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738
K D++S G++ +E + P +L P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPE-------------- 235
Query: 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772
D C + R + +
Sbjct: 236 --LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 169 bits (430), Expect = 2e-47
Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 26/275 (9%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNL 559
D ++ LGTG+FG V++ T + G + A K E + E + + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
+ + + + + ++ EFM G L + + + + E + M V L ++H +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 620 SAPIIHCDLKPTNILL--DENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS 677
+H DLKP NI+ + + DFG++ L + T T + APE
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAE 198
Query: 678 EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737
V D++S GVL + P + E+ L V + +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSP-------------FGGENDDETLRNVKSCDWNMD 245
Query: 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772
+ AFS D + P+ R+ + A
Sbjct: 246 DSAFS---GISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 7e-47
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 9/211 (4%)
Query: 497 QRATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL---ERAFRSFDSECEVLR 552
++ ++F +LG GSF +V ++ + AIKI + E E +V+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 553 NVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 612
+ H +K+ + + + L + NG L K++ F D ++ SALE
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALE 122
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
YLH IIH DLKP NILL+E+M ++DFG +K+L + T Y++
Sbjct: 123 YLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 673 PEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
PE +E D+++ G ++ + P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-46
Identities = 60/289 (20%), Positives = 108/289 (37%), Gaps = 31/289 (10%)
Query: 496 IQRATDEFNECNLLGTGSFGSVYKG----TISDGTDVAIKIFNLQLERAFRS-FDSECEV 550
IQR + +G G FG V++G + VAIK + R F E
Sbjct: 4 IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 551 LRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSA 610
+R H +++K++ + + +++E G L +L Y LD+ + + +A
Sbjct: 62 MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 611 LEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGY 670
L YL S +H D+ N+L+ N + DFG+S+ + + + I +
Sbjct: 121 LAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKW 175
Query: 671 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730
MAPE + ++ DV+ +GV + E + + R
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------------- 221
Query: 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
+ + +C ++ L C P R T+ A+L I
Sbjct: 222 ----IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (423), Expect = 2e-46
Identities = 65/275 (23%), Positives = 109/275 (39%), Gaps = 26/275 (9%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNL 559
D ++ LG+G+FG V++ + G K N + +E ++ + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
I + + + L+LEF+ G L + + +Y + E +N M L+++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---- 144
Query: 620 SAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS 677
I+H D+KP NI+ + A+ V DFG++ L E +T AT + APE
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVD 201
Query: 678 EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737
V D+++ GVL + P + E L V + +
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSP-------------FAGEDDLETLQNVKRCDWEFD 248
Query: 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772
E AFS D + + P R+ V DA
Sbjct: 249 EDAFS---SVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-46
Identities = 62/304 (20%), Positives = 121/304 (39%), Gaps = 38/304 (12%)
Query: 501 DEFNECNLLGTGSFGSVYKGT------ISDGTDVAIKIFNL-QLERAFRSFDSECEVLRN 553
++ LG GSFG VY+G T VAIK N R F +E V++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 554 VRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF---------LDILERLNIM 604
+++++L S +++E M G L+ +L S + + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 605 IDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT 664
++ + YL+ + +H DL N ++ E+ + DFG+++ + E +
Sbjct: 140 GEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 665 MATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH 724
+ + +M+PE +G+ + DV+S+GV+L E T + + E LR ++ L
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL- 254
Query: 725 GLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784
+C + +L C +P MR + + + +K+
Sbjct: 255 -----------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
Query: 785 DDAS 788
+ S
Sbjct: 298 REVS 301
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 66/304 (21%), Positives = 117/304 (38%), Gaps = 47/304 (15%)
Query: 501 DEFNECNLLGTGSFGSVYKGT--------ISDGTDVAIKIFNLQL-ERAFRSFDSECEVL 551
D LG G+FG V + T VA+K+ E+ SE E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 552 RNV-RHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYF---------------L 595
+ + +H+N+I +L +C+ +++E+ G+L ++L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 596 DILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655
+ ++ V +EYL S IH DL N+L+ E+ ++DFG+++ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR 715
+ T + +MAPE + I + + DV+S+GVLL E FT
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP--------- 239
Query: 716 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775
G+ L++E +C + + DC P R
Sbjct: 240 ---------GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 776 LKKI 779
L +I
Sbjct: 291 LDRI 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (391), Expect = 6e-43
Identities = 63/290 (21%), Positives = 119/290 (41%), Gaps = 31/290 (10%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVR 555
+D + +LG G V+ + DVA+K+ L + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 556 HRNLIKILSSCSNPDFKA----LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 611
H ++ + + +V+E++ +L +++ + + ++ D AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMA-TIGY 670
+ H IIH D+KP NI++ A V DFGI++ + + +SVTQT + T Y
Sbjct: 125 NFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 671 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730
++PE V A+ DVYS G +L E T + P ++ + ++ +P
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP------- 233
Query: 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRI-NVTDAAAKLKKI 779
+ SA +D + L ++P+ R + A L ++
Sbjct: 234 ---PSARHEGLSADLD------AVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-42
Identities = 55/275 (20%), Positives = 114/275 (41%), Gaps = 27/275 (9%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNL 559
+++ LG G FG V++ S K ++ E +L RHRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNI 63
Query: 560 IKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHS 619
+ + S + + ++ EF+ + + + + + L+ E ++ + V AL++LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---- 119
Query: 620 SAPIIHCDLKPTNILLDENMAAHV--SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGS 677
S I H D++P NI+ ++ + +FG ++ L G+ + Y APE
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176
Query: 678 EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737
+VS D++S G L+ + P ++ E+ + +++A +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINP-------------FLAETNQQIIENIMNAEYTFD 223
Query: 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772
E+AF + + MD ++ R+ ++A
Sbjct: 224 EEAFK---EISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 6e-42
Identities = 65/303 (21%), Positives = 108/303 (35%), Gaps = 45/303 (14%)
Query: 501 DEFNECNLLGTGSFGSVYKGT------ISDGTDVAIKIFNL-QLERAFRSFDSECEVLRN 553
D LG G+FG V + + VA+K+ R+ SE ++L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 554 VRHRNLIKIL--SSCSNPDFKALVLEFMPNGSLEKWLYSHNY---------------FLD 596
+ H + L + +++EF G+L +L S FL
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 597 ILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656
+ + V +E+L S IH DL NILL E + DFG+++ + +
Sbjct: 133 LEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRR 716
D V + + +MAPE + + + + DV+S+GVLL E F+ + R
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 717 WVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKL 776
+KE A + LDC P R ++ L
Sbjct: 249 RLKEGTR-----------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 777 KKI 779
+
Sbjct: 292 GNL 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (386), Expect = 3e-41
Identities = 56/283 (19%), Positives = 106/283 (37%), Gaps = 34/283 (12%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNL------QLERAFRSFDSECEVLRN 553
++F+ ++G G FG VY G A+K + Q E + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 554 VRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 613
++ + + PD + +L+ M G L L H F + + ++ LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-ADMRFYAAEIILGLEH 122
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAP 673
+H+ +++ DLKP NILLDE+ +SD G++ + + ++ T GYMAP
Sbjct: 123 MHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAP 174
Query: 674 EYGSEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDA 732
E +G+ + D +S G +L + P + T + + ++ L +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 733 NLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAK 775
L L + R+ A+
Sbjct: 235 ELR-----------------SLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (379), Expect = 7e-41
Identities = 69/292 (23%), Positives = 118/292 (40%), Gaps = 38/292 (13%)
Query: 488 WRRTPYLDIQRATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQ-LERAFRSFD 545
W++ DI+ D ++ ++LGTG+F V VAIK + LE S +
Sbjct: 1 WKQAE--DIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME 55
Query: 546 SECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMI 605
+E VL ++H N++ + + L+++ + G L + F + ++
Sbjct: 56 NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIF 114
Query: 606 DVGSALEYLHHGHSSAPIIHCDLKPTNILL---DENMAAHVSDFGISKLLGEGEDSVTQT 662
V A++YLH I+H DLKP N+L DE+ +SDFG+SK+ G +
Sbjct: 115 QVLDAVKYLHDLG----IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLS 167
Query: 663 MTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL 722
T GY+APE ++ S D +S GV+ P F E + + +
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDENDAKLFEQ--- 220
Query: 723 PHGLTEVVDANLVREEQAFSAKMDCILS--IMDLALDCCIESPDMRINVTDA 772
+++ E F + +S D + P+ R A
Sbjct: 221 -----------ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (373), Expect = 5e-40
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 15/227 (6%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRH 556
+F LGTGSFG V+ +G A+K+ ++ + + E +L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
+I++ + + ++++++ G L + +V ALEYLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYLH- 121
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYG 676
S II+ DLKP NILLD+N ++DFG +K + + T Y+APE
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVV 173
Query: 677 SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP 723
S + D +S+G+L+ E P + T + + + L
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILNAELR 219
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 61/258 (23%), Positives = 102/258 (39%), Gaps = 18/258 (6%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFN---LQLERAFRSFDSECEVL-RNVR 555
++F +LG GSFG V+ AIK + ++ E VL
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 556 HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLH 615
H L + + + V+E++ G L + S + F D+ ++ L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLH 120
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675
I++ DLK NILLD++ ++DFG+ K G+ T Y+APE
Sbjct: 121 SKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEI 174
Query: 676 GSEGIVSAKCDVYSYGVLLMETFTRKRP-----TDEMFTGEMSLRRWVKESLPHGLTEVV 730
+ D +S+GVLL E + P +E+F + L +++
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 234
Query: 731 DANLVRE-EQAFSAKMDC 747
VRE E+ + D
Sbjct: 235 VKLFVREPEKRLGVRGDI 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (364), Expect = 3e-39
Identities = 64/286 (22%), Positives = 106/286 (37%), Gaps = 35/286 (12%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNL---------QLERAFRSFDSECEV 550
+ + +LG G V + + A+KI ++ +++ + E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 551 LRNVR-HRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGS 609
LR V H N+I++ + F LV + M G L +L L E IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLE 121
Query: 610 ALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT---MA 666
+ LH I+H DLKP NILLD++M ++DFG S L GE T +A
Sbjct: 122 VICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 177
Query: 667 TIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGL 726
+ + D++S GV++ P + LR + + G
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQFGS 236
Query: 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772
E D +S ++ DL + P R +A
Sbjct: 237 PEWDD---------YSD------TVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 7e-39
Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 26/296 (8%)
Query: 496 IQRATDEFNECNLLGTGSFGSVYKGT--ISDGTDVAIKIFNLQL--ERAFRSFDSECEVL 551
+ RA ++ +G G++G V+K + G VA+K +Q E S E VL
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 552 R---NVRHRNLIKILSSCSNPDFKA-----LVLEFMPNGSLEKWLYSHNYFLDILERLNI 603
R H N++++ C+ LV E + + ++
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 604 MIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTM 663
M + L++LH S ++H DLKP NIL+ + ++DFG++++ + T
Sbjct: 122 MFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTS 174
Query: 664 TMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP------TDEMFTGEMSLRRW 717
+ T+ Y APE + + D++S G + E F RK D++ +
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234
Query: 718 VKESLPHGLTEVVDANLVREEQAFSAKMDCI-LSIMDLALDCCIESPDMRINVTDA 772
+E P + A + Q + I DL L C +P RI+ A
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-38
Identities = 58/290 (20%), Positives = 101/290 (34%), Gaps = 21/290 (7%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFN-LQLERAFRSFDSECEVLRNVRHR 557
+ + +G G++G V + VAIK + + + + E ++L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYS--HNYFLDILERLNIMIDVGSALEYLH 615
N+I I P + + ++ + LY L + + L+Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT-MATIGYMAPE 674
SA ++H DLKP+N+LL+ + DFG++++ D +AT Y APE
Sbjct: 127 ----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 675 YGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733
+ D++S G +L E + + + P N
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 734 LVREEQAFSAKMDCILSI-----------MDLALDCCIESPDMRINVTDA 772
L S + +DL +P RI V A
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (353), Expect = 1e-37
Identities = 57/284 (20%), Positives = 112/284 (39%), Gaps = 19/284 (6%)
Query: 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRN 558
++++ +G G++G VYK + G A+K L+ E + E +L+ ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
++K+ LV E + + L+K L L+ + + ++ + + + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 619 SSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE-YGS 677
++H DLKP N+L++ ++DFG+++ G T + T+ Y AP+
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 678 EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737
S D++S G + E + + +R + P+ L +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 738 EQAFSAKMDCIL---------SIMDLALDCCIESPDMRINVTDA 772
+ F+ S +DL P+ RI A
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 69/281 (24%), Positives = 110/281 (39%), Gaps = 22/281 (7%)
Query: 507 NLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL-----ERAFRSFDSECEVLRNVRHRNLI 560
+ LG G F +VYK + VAIK L + R+ E ++L+ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 561 KILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSS 620
+L + + +LV +FM + ++ L M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 621 APIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE-YGSEG 679
I+H DLKP N+LLDEN ++DFG++K G T + T Y APE
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGAR 176
Query: 680 IVSAKCDVYSYGVLLMETFTRKRP------TDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733
+ D+++ G +L E R D++ +L +E P +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 734 LVREEQAFSAKMDCILS--IMDLALDCCIESPDMRINVTDA 772
+ ++DL + +P RI T A
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 19/285 (6%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHR 557
+ F + +G G++G VYK G VA+K L E + E +L+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG 617
N++K+L + LV EF+ + S + + + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE-YG 676
S ++H DLKP N+L++ A ++DFG+++ G + T + + Y APE
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT--LWYRAPEILL 175
Query: 677 SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736
S D++S G + E TR+ + R + P + ++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 737 EEQAFSAKMDCILS---------IMDLALDCCIESPDMRINVTDA 772
+ +F S L P+ RI+ A
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 58/229 (25%), Positives = 87/229 (37%), Gaps = 22/229 (9%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRS------FDSECEVLRNVR--HRN 558
LLG+G FGSVY G +SD VAIK + E +L+ V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 559 LIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGH 618
+I++L PD L+LE + L + V A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 619 SSAPIIHCDLKPTNILLDEN-MAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY-G 676
+ ++H D+K NIL+D N + DFG LL + T T Y PE+
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIR 182
Query: 677 SEGIVSAKCDVYSYGVLLMETFTRKRP---TDEMFTGEMSLRRWVKESL 722
V+S G+LL + P +E+ G++ R+ V
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (342), Expect = 4e-36
Identities = 50/293 (17%), Positives = 99/293 (33%), Gaps = 31/293 (10%)
Query: 498 RATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRH 556
R + + +G+GSFG +Y GT I+ G +VAIK+ ++ + E ++ + ++
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQG 61
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
I + C +++ + SLE + + L + + S +EY+H
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH- 120
Query: 617 GHSSAPIIHCDLKPTNIL---LDENMAAHVSDFGISKLLGEGEDSVTQTMTMA-----TI 668
S IH D+KP N L + ++ DFG++K + T
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 669 GYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE--MSLRRWVKESLPHGL 726
Y + S + D+ S G +LM P + R ++ + +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779
+ C D + + + + +
Sbjct: 238 EVLCK--------------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 5e-36
Identities = 60/283 (21%), Positives = 108/283 (38%), Gaps = 35/283 (12%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL------ERAFRSFDSECEVLRN 553
D ++ LG+G F V K S G A K + + + E +L+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 554 VRHRNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEY 613
++H N+I + N L+LE + G L +L + E + + + + Y
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 128
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAA----HVSDFGISKLLGEGEDSVTQTMTMATIG 669
LH S I H DLKP NI+L + + DFG++ + G + T
Sbjct: 129 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 181
Query: 670 YMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV 729
++APE + + + D++S GV+ + P ++ ++ L V
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-------------FLGDTKQETLANV 228
Query: 730 VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDA 772
N E++ FS + D ++ P R+ + D+
Sbjct: 229 SAVNYEFEDEYFS---NTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 6e-36
Identities = 53/286 (18%), Positives = 112/286 (39%), Gaps = 21/286 (7%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHR 557
++ + +G G++G+V+K VA+K L E S E +L+ ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 558 NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG 617
N++++ + LV EF + + + + + + L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-IVKSFLFQLLKGLGFCHSR 120
Query: 618 HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPE-YG 676
+ ++H DLKP N+L++ N +++FG+++ G + + T+ Y P+
Sbjct: 121 N----VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLF 174
Query: 677 SEGIVSAKCDVYSYGVLLMETFTRKRP------TDEMFTGEMSLRRWVKESLPHGLTEVV 730
+ S D++S G + E RP D+ L E +T++
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 731 DANLVREEQAFSAKMDCILSIMDLALD----CCIESPDMRINVTDA 772
D A ++ ++ + + D +P RI+ +A
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 1e-35
Identities = 57/276 (20%), Positives = 99/276 (35%), Gaps = 36/276 (13%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC 566
+LG G G V + A+K+ +A R + R + ++++I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELH---WRASQCPHIVRIVDVY 74
Query: 567 SNPDFKA----LVLEFMPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSA 621
N +V+E + G L + + E IM +G A++YLH S
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SI 130
Query: 622 PIIHCDLKPTNILLD---ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSE 678
I H D+KP N+L N ++DFG +K + T T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGP 187
Query: 679 GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738
CD++S GV++ P F L ++ + + +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLA----------ISPGMKTRIRMGQ 233
Query: 739 QAFSAKMDCILS--IMDLALDCCIESPDMRINVTDA 772
F +S + L + P R+ +T+
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-35
Identities = 56/289 (19%), Positives = 106/289 (36%), Gaps = 29/289 (10%)
Query: 503 FNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIK 561
+ + ++G GSFG VY+ G VAIK + E +++R + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77
Query: 562 ILSSCSNPD------FKALVLEFMPNGSLEKWLY--SHNYFLDILERLNIMIDVGSALEY 613
+ + + LVL+++P + L ++ M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 614 LHHGHSSAPIIHCDLKPTNILLDENMAAH-VSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
+H S I H D+KP N+LLD + A + DFG +K L GE + +
Sbjct: 138 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAP 191
Query: 673 PEYGSEGIVSAKCDVYSYGVLLMETFTRKRP------TDEMFTGEMSLRRWVKESLPHGL 726
++ DV+S G +L E + D++ L +E +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 727 TEVVDANLVR-EEQAFSAKMDCILS--IMDLALDCCIESPDMRINVTDA 772
+ + + ++ + L +P R+ +A
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 132 bits (332), Expect = 1e-34
Identities = 40/292 (13%), Positives = 87/292 (29%), Gaps = 31/292 (10%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC 566
+G GSFG +++GT + + VAIK + + E + + I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 567 SNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHC 626
+++ + SLE L + + + ++ +H +++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS----LVYR 125
Query: 627 DLKPTNILLDENMAAH-----VSDFGISKLLGEGEDSVTQTMTMA-----TIGYMAPEYG 676
D+KP N L+ + + V DFG+ K + T YM+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 677 SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736
S + D+ + G + M G + + + + +
Sbjct: 186 LGREQSRRDDLEALGHVFM----------YFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI--KVKFLDD 786
+ A + D + K+ ++ +D
Sbjct: 236 PLRELCA--GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 6e-34
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 11/207 (5%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRH 556
++F+ LLG G+FG V + G A+KI ++ + +E VL+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
L + + D V+E+ G L L F + ++ SALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLH- 122
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYG 676
S +++ D+K N++LD++ ++DFG+ K D T T Y+APE
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVL 177
Query: 677 SEGIVSAKCDVYSYGVLLMETFTRKRP 703
+ D + GV++ E + P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 7e-34
Identities = 58/301 (19%), Positives = 115/301 (38%), Gaps = 31/301 (10%)
Query: 498 RATDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNV 554
++ + +G G+FG V+K G VA+K ++ E + E ++L+ +
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 555 RHRNLIKILSSCSNPDFKA--------LVLEFMPNGSLEKWLYSHNYFLDILERLNIMID 606
+H N++ ++ C LV +F + F + E +M
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF-TLSEIKRVMQM 125
Query: 607 VGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMT-- 664
+ + L Y+H I+H D+K N+L+ + ++DFG+++ ++S T
Sbjct: 126 LLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 665 MATIGYMAPE-YGSEGIVSAKCDVYSYGVLLMETFTRKRP-TDEMFTGEMSLRRWVKESL 722
+ T+ Y PE E D++ G ++ E +TR +++L + S+
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 723 PHGLTEVVDANLVREEQAFSAKMDCILS-----------IMDLALDCCIESPDMRINVTD 771
+ VD + E+ + +DL + P RI+ D
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 772 A 772
A
Sbjct: 302 A 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 1e-33
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 14/207 (6%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRH 556
D+F+ LGTGSFG V G A+KI + Q + +E +L+ V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
L+K+ S + +V+E++ G + L F + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLH- 158
Query: 617 GHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYG 676
S +I+ DLKP N+L+D+ V+DFG +K T +APE
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEII 210
Query: 677 SEGIVSAKCDVYSYGVLLMETFTRKRP 703
+ D ++ GVL+ E P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 2e-31
Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRN 558
D++ LG G + V++ I++ V +KI ++ + E ++L N+R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK---REIKILENLRGGPN 91
Query: 559 LIKILSSCSNPDFK--ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHH 616
+I + +P + ALV E + N ++ + L + M ++ AL+Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS 147
Query: 617 GHSSAPIIHCDLKPTNILLD-ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEY 675
I+H D+KP N+++D E+ + D+G+++ G+ + +A+ + PE
Sbjct: 148 MG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL 200
Query: 676 GSE-GIVSAKCDVYSYGVLLMETFTRKRP 703
+ + D++S G +L RK P
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 17/214 (7%)
Query: 501 DEFNECNLLGTGSFGSVYKG----TISDGTDVAIKIFN----LQLERAFRSFDSECEVLR 552
+ F +LGTG++G V+ G A+K+ +Q + +E +VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 553 NVRHR-NLIKILSSCSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 611
++R L+ + + L+L+++ G L L F + + I VG +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIV 139
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYM 671
L H H II+ D+K NILLD N ++DFG+SK E TI YM
Sbjct: 140 LALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYM 197
Query: 672 APE--YGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
AP+ G + D +S GVL+ E T P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-30
Identities = 58/302 (19%), Positives = 108/302 (35%), Gaps = 35/302 (11%)
Query: 495 DIQRATDEFNE----CNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSE 547
++ + E +G+G++G+V G VAIK E + E
Sbjct: 8 EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67
Query: 548 CEVLRNVRHRNLIKILSSCSNPDFKA------LVLEFMPNGSLEKWLYSHNYFLDILERL 601
+L+++RH N+I +L + + LV+ FM G+ L H L
Sbjct: 68 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGEDRIQ 124
Query: 602 NIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQ 661
++ + L Y+H IIH DLKP N+ ++E+ + DFG+++ DS
Sbjct: 125 FLVYQMLKGLRYIHAAG----IIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMT 176
Query: 662 TMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP---------TDEMFTGEM 712
+ + + D++S G ++ E T K E+
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 713 SLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILS--IMDLALDCCIESPDMRINVT 770
+ + L + L E+ A + S ++L + + R+
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 771 DA 772
+A
Sbjct: 297 EA 298
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-28
Identities = 53/291 (18%), Positives = 107/291 (36%), Gaps = 27/291 (9%)
Query: 500 TDEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRH 556
+ + + +G+G++GSV G VA+K + + E +L++++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 557 RNLIKILSSCSNP----DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALE 612
N+I +L + +F + L G+ + D ++ + L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQFLIYQILRGLK 135
Query: 613 YLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMA 672
Y+H IIH DLKP+N+ ++E+ + DFG+++ D
Sbjct: 136 YIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAP 187
Query: 673 PEYGSEGIVSAKCDVYSYGVLLMETFTRKRP---TDEMFTGEMSLRRWVK--ESLPHGLT 727
+ + D++S G ++ E T + TD + ++ LR L ++
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 728 EVVDANLVREEQAFSAK--MDCILSIMDLALD----CCIESPDMRINVTDA 772
N ++ + + LA+D + D RI A
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-27
Identities = 57/303 (18%), Positives = 102/303 (33%), Gaps = 42/303 (13%)
Query: 501 DEFNECNLLGTGSFGSVYKGT-ISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHR 557
+ +G+G+ G V +VAIK + + + E +++ V H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 558 NLIKILSSCSNPDFK------ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 611
N+I +L+ + LV+E M + D ++ + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGI 132
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYM 671
++LH IIH DLKP+NI++ + + DFG+++ G T + T Y
Sbjct: 133 KHLHSAG----IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYR 185
Query: 672 APEYGSEGIVSAKCDVYSYGVLLMETFTRKRP--------------------TDEMFTGE 711
APE D++S G ++ E K E
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 712 MSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILS--IMDLALDCCIESPDMRINV 769
R E+ P ++ + + + DL + P RI+V
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 770 TDA 772
DA
Sbjct: 306 DDA 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 110 bits (275), Expect = 1e-26
Identities = 82/387 (21%), Positives = 145/387 (37%), Gaps = 27/387 (6%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLA 70
L V + N++ V T ++ + L + + V +L N+ + +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYL-NNLTQINFS 74
Query: 71 ANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSAD 130
N LT I P + N TKLV + + N A L +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 131 QWSF----LSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQE 186
+ +++++ L+ L+ G + + K +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 187 IGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRL 246
+ L+ L L +N ++ + L LSL N L+ L L + + L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 247 TGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSN 306
N++S P L LT L EL LG+N++++ P L L + ++ L+ N L D S
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISP 302
Query: 307 VQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDL 366
+ LK LT L L N +S P + +L L+ L A N+ S+ +L ++ L
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSA 358
Query: 367 SGNNLSGKIPKSLETLSQLKQFNVSHN 393
N +S P L L+++ Q ++
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 92.4 bits (228), Expect = 1e-20
Identities = 69/347 (19%), Positives = 131/347 (37%), Gaps = 22/347 (6%)
Query: 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMN 120
L + +L + I + L ++ N + NL L + N
Sbjct: 43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNN 98
Query: 121 NLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLK 180
+ + A+ + +T + N + N + + +
Sbjct: 99 QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQ 158
Query: 181 GNIPQEIGNLSGLTLLSLHS----NDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLC 236
+ ++ +L L L+ + + + +L L+ L NN + P +
Sbjct: 159 LSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL 218
Query: 237 HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSS 296
+ + L GN+L L SLT+L +L L +N++++ P L L + ++ L +
Sbjct: 219 TN--LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272
Query: 297 NSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVG 356
N +++ P + L LT L+L+ NQ + S I LK+L L+L N P V
Sbjct: 273 NQISNISP--LAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDISP--VS 326
Query: 357 SLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKG 403
SL L+ L + N +S SL L+ + + HN++ P+
Sbjct: 327 SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLAN 371
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 3e-04
Identities = 18/65 (27%), Positives = 28/65 (43%), Gaps = 5/65 (7%)
Query: 8 EIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESL 67
+ +L LQ L FA N +S ++ N++ + L+ NQ+S P L I L
Sbjct: 324 PVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL---ANLTRITQL 378
Query: 68 LLAAN 72
L
Sbjct: 379 GLNDQ 383
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (273), Expect = 2e-26
Identities = 44/213 (20%), Positives = 80/213 (37%), Gaps = 21/213 (9%)
Query: 508 LLGTGSFGSVYKGT-ISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSC 566
LG G F +V+ + + T VA+KI + + + E ++L+ V + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 567 SNPDFK---------------ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSAL 611
+N K +V E + L + + ++ I + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 612 EYLHHGHSSAPIIHCDLKPTNILLD-ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGY 670
+Y+H IIH D+KP N+L++ + ++ I+ L T ++ T Y
Sbjct: 139 DYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 671 MAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRP 703
+PE D++S L+ E T
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.8 bits (229), Expect = 4e-21
Identities = 45/271 (16%), Positives = 88/271 (32%), Gaps = 12/271 (4%)
Query: 142 RNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSN 201
+ +L +N + I N +L K+ P L L L L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 202 DLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVS 261
L L+ L+ + S+ L + ++ + K SG
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQG 148
Query: 262 LTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRN 321
+ L + + +T+ SL + +L N + ++++ L L L LS N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 322 QLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSG------KI 375
+S ++ L L L N+ +P + ++ + L NN+S
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 376 PKSLETLSQLKQFNVSHNRLEGEIPVKGSFK 406
P + ++ N ++ +F+
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.2 bits (217), Expect = 1e-19
Identities = 60/302 (19%), Positives = 96/302 (31%), Gaps = 24/302 (7%)
Query: 50 SGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNL 109
L L P+ L L N +T I N L L L N + F L
Sbjct: 19 DLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPL 78
Query: 110 RHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFS-AS 168
L L N L + L N + + V +
Sbjct: 79 VKLERLYLSKNQLKELPEKMPKTL-----------QELRVHENEITKVRKSVFNGLNQMI 127
Query: 169 LQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLE 228
+ + K G + L+ + + ++ + G L L L N +
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKIT 184
Query: 229 GSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEY 288
L L + + L+ N +S L + LRELHL +NKL +P L +Y
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243
Query: 289 ILDINLSSNSLND------SLPSNVQKLKVLTVLDLSRNQLS-GDI-PSTIGALKDLETL 340
I + L +N+++ P K + + L N + +I PST + +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303
Query: 341 SL 342
L
Sbjct: 304 QL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.5 bits (192), Expect = 2e-16
Identities = 54/262 (20%), Positives = 95/262 (36%), Gaps = 6/262 (2%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
+P+++ LL L +N + LK L L L NN + P L +
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 243 GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDS 302
+ L+ N+L +L LR K+ S+ + L ++++ + +
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNPLKSSGI 141
Query: 303 LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLE 362
Q +K L+ + ++ ++ IP G L L L N+ S+ L +L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 363 SLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGP 422
L LS N++S SL L++ ++++N+L K V N
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIG 258
Query: 423 PKLRVPPCKPDNSKSTKNVALT 444
PP S V+L
Sbjct: 259 SNDFCPPGYNTKKASYSGVSLF 280
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.4 bits (189), Expect = 4e-16
Identities = 47/294 (15%), Positives = 94/294 (31%), Gaps = 24/294 (8%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
++P ++ + L N ++ + N+ + L L N++S P L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP-LVK 80
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
+E L L+ N L + +L + + N + + L + + +
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNI 183
E+ + + L+ + + I SL + + K+
Sbjct: 141 IEN---------GAFQGMKKLSYIRIADTNITTIPQ----GLPPSLTELHLDGNKITKVD 187
Query: 184 PQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFG 243
+ L+ L L L N ++ + ++ L+ L L NN L H +
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQV- 246
Query: 244 IRLTGNKLSG------HIPPCLVSLTSLRELHLGSNKLT-SSIPSSLWSLEYIL 290
+ L N +S P S + L SN + I S + Y+
Sbjct: 247 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 300
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.0 bits (162), Expect = 2e-12
Identities = 51/276 (18%), Positives = 92/276 (33%), Gaps = 27/276 (9%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
+ NL+NL L+ N +S + P + + L L NQL LP + +
Sbjct: 47 KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPE---KMPKTL 102
Query: 65 ESLLLAANNLTGIIPHSITNATKLVALDLGF--NSFAGHILNTFGNLRHLSLLSQVMNNL 122
+ L + N +T + +++ ++LG +G F ++ LS + N+
Sbjct: 103 QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 162
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN 182
TT +LT L N + + + + +L K +
Sbjct: 163 TTIPQG-----------LPPSLTELHLDGNKITKVDAASLKGLN-NLAKLGLSFNSISAV 210
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEG------SIPYDLC 236
+ N L L L++N L + K +Q + L NNN+ P
Sbjct: 211 DNGSLANTPHLRELHLNNNKLVKVP-GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 269
Query: 237 HLKLMFGIRLTGNKLSGH--IPPCLVSLTSLRELHL 270
G+ L N + P + + L
Sbjct: 270 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.2 bits (134), Expect = 5e-09
Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 3/108 (2%)
Query: 292 INLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPI 351
+ S L + +P ++ +LDL N+++ LK+L TL L N+
Sbjct: 15 VQCSDLGL-EKVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 352 PESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEI 399
P + L+ LE L LS N L K +TL +L+ ++ +
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 119
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 39/233 (16%), Positives = 77/233 (33%), Gaps = 23/233 (9%)
Query: 3 GQIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLP 62
P L L+ L ++N L L ++ L + N+++ S L
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKT---LQELRVHENEITKVRKSVFNGLNQ 125
Query: 63 NIE-SLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNN 121
I L +GI + KL + + + +L L L
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHL------- 178
Query: 122 LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKG 181
+ +SL NL L N + + + N L++ + KL
Sbjct: 179 ----DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP-HLRELHLNNNKLV- 232
Query: 182 NIPQEIGNLSGLTLLSLHSNDLNGTISPTM------GRLKRLQGLSLRNNNLE 228
+P + + + ++ LH+N+++ S + G+SL +N ++
Sbjct: 233 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.3 bits (124), Expect = 9e-08
Identities = 30/165 (18%), Positives = 51/165 (30%), Gaps = 9/165 (5%)
Query: 264 SLRELHLGSNKLTS---SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSR 320
LR + L +P L +L +N + + + + LK L L L
Sbjct: 11 HLRVVQCSDLGLEKVPKDLPPDTALL------DLQNNKITEIKDGDFKNLKNLHTLILIN 64
Query: 321 NQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLE 380
N++S P L LE L L++NQ + + +L L + + + L
Sbjct: 65 NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN 124
Query: 381 TLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPPKL 425
+ ++ E K S P L
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL 169
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.5 bits (203), Expect = 1e-18
Identities = 26/159 (16%), Positives = 48/159 (30%), Gaps = 21/159 (13%)
Query: 507 NLLGTGSFGSVYKGTISDGTDVAIKIFNLQL----------ERAFRSFDSECEVLRNVRH 556
L+G G +V+ + +K + + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 557 RNLIKILSSCSNPDFKALVLEFMPNGSL-EKWLYSHNYFLDILERLNIMIDVGSALEYLH 615
R L K+ + + N L E Y + + ++ + + +
Sbjct: 66 RALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 616 HGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654
H I+H DL N+L+ E + DF S +GE
Sbjct: 121 HRG----IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGE 154
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 85.2 bits (209), Expect = 2e-18
Identities = 71/298 (23%), Positives = 114/298 (38%), Gaps = 32/298 (10%)
Query: 136 SSLTNCRNLTILSFGSNPLGGI--LPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGL 193
+ T + L L +P + N + L G IP I L+ L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 194 TLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSG 253
L + +++G I + ++K L L N L G++P + L + GI GN++SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 254 HIPPCLVSLTSLRE-LHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKV 312
IP S + L + + N+LT IP + L S ++ + S +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA--NLNLAFVDLSRNMLEGDASVLFGSDK 221
Query: 313 LTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLS 372
T +G K+L L L N+ G +P+ + L L SL++S NNL
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 373 GKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPPKLRVPPC 430
G+IP+ G+ + F V ++ N LCG P +P C
Sbjct: 282 GEIPQG------------------------GNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.5 bits (189), Expect = 5e-16
Identities = 47/284 (16%), Positives = 97/284 (34%), Gaps = 18/284 (6%)
Query: 75 TGIIPHSITNATKLVALDLGFNSFAG--HILNTFGNLRHLS--LLSQVMNNLTTESSSAD 130
G++ + T ++ LDL + I ++ NL +L+ + + N + +
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 131 QWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNL 190
+ + L L + + +L L G +P I +L
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFL----------SQIKTLVTLDFSYNALSGTLPPSISSL 148
Query: 191 SGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNK 250
L ++ N ++G I + G +L + N L
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-NLNLAFVDLSRN 207
Query: 251 LSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKL 310
+ L + + + + + + ++L +N + +LP + +L
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267
Query: 311 KVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQ--GPIP 352
K L L++S N L G+IP G L+ + + A N+ P+P
Sbjct: 268 KFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 56/260 (21%), Positives = 97/260 (37%), Gaps = 13/260 (5%)
Query: 42 LTLEGNQLSGR--LPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFA 99
L L G L +PS++ +L + NNL G IP +I T+L L + + +
Sbjct: 55 LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114
Query: 100 GHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILP 159
G I + ++ L L N + S+++ NL ++F N + G +P
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNA--------LSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 160 PVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQG 219
G+FS +L G IP NL+ S ++ + + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAF--VDLSRNMLEGDASVLFGSDKNTQ 224
Query: 220 LSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSI 279
N + K + G+ L N++ G +P L L L L++ N L I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 280 PSSLWSLEYILDINLSSNSL 299
P +L+ ++N
Sbjct: 285 P-QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.6 bits (166), Expect = 5e-13
Identities = 51/249 (20%), Positives = 88/249 (35%), Gaps = 17/249 (6%)
Query: 3 GQIPTEIGNLQNLQYLVFAEN-NLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLL 61
IP+ + NL L +L NL G +PP I ++ + L + +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN-VSGAIPDFLSQI 124
Query: 62 PNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNN 121
+ +L + N L+G +P SI++ LV + N +G I +++G+ L + N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 122 --------------LTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSA 167
L S + +S+ + S
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSK 244
Query: 168 SLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNL 227
+L ++ G +PQ + L L L++ N+L G I P G L+R + NN
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKC 303
Query: 228 EGSIPYDLC 236
P C
Sbjct: 304 LCGSPLPAC 312
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (204), Expect = 3e-18
Identities = 56/266 (21%), Positives = 84/266 (31%), Gaps = 12/266 (4%)
Query: 60 LLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVM 119
+ + + L N ++ + S L L L N A F L L L
Sbjct: 30 IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89
Query: 120 NNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKL 179
N ++ L L L P + A+LQ Y + L
Sbjct: 90 NAQLR-------SVDPATFHGLGRLHTLHL-DRCGLQELGPGLFRGLAALQYLYLQDNAL 141
Query: 180 KGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
+ +L LT L LH N ++ L L L L N + P+ L
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 240 LMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL 299
+ + L N LS L L +L+ L L N + ++ SS+ +
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEV 260
Query: 300 NDSLPSNVQKLKVLTVLDLSRNQLSG 325
SLP L + L+ N L G
Sbjct: 261 PCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (202), Expect = 7e-18
Identities = 58/266 (21%), Positives = 97/266 (36%), Gaps = 15/266 (5%)
Query: 108 NLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSA 167
+ + L N ++ ++ S CRNLTIL SN L I +
Sbjct: 33 ASQRIFLHG---NRISHVPAA--------SFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 168 SLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNL 227
Q + +L+ P L L L L L L LQ L L++N L
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141
Query: 228 EGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLE 287
+ L + + L GN++S L SL L L N++ P + L
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 288 YILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQF 347
++ + L +N+L+ + L+ L L L+ N D + L+ + ++
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEV 260
Query: 348 QGPIPESVGSLISLESLDLSGNNLSG 373
+P+ L + L+ N+L G
Sbjct: 261 PCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.8 bits (169), Expect = 1e-13
Identities = 54/246 (21%), Positives = 88/246 (35%), Gaps = 4/246 (1%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
+P I + + LH N ++ + + + L L L +N L L L+
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 243 GIRLTGNKLSGHIPP-CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLND 301
+ L+ N + P L L LHL L P L + + L N+L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 302 SLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISL 361
+ L LT L L N++S L L+ L L +N+ P + L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 362 ESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC- 420
+L L NNLS ++L L L+ ++ N + + + + C
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263
Query: 421 GPPKLR 426
P +L
Sbjct: 264 LPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.7 bits (140), Expect = 6e-10
Identities = 42/199 (21%), Positives = 60/199 (30%), Gaps = 22/199 (11%)
Query: 23 NNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSI 82
L + P T + + L L L + L ++ L L N L + +
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHL-DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149
Query: 83 TNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSA------------- 129
+ L L L N + F L L L N + A
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 130 ---DQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQE 186
+L R L L NP A LQKF ++ ++PQ
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVPCSLPQ- 266
Query: 187 IGNLSGLTLLSLHSNDLNG 205
L+G L L +NDL G
Sbjct: 267 --RLAGRDLKRLAANDLQG 283
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 27/102 (26%), Positives = 39/102 (38%), Gaps = 9/102 (8%)
Query: 236 CHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLS 295
L + N S I SL EL++ +NKL +P+ LE + S
Sbjct: 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIAS 312
Query: 296 SNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDL 337
N L +P Q LK L + N L P +++DL
Sbjct: 313 FNHLA-EVPELPQNLK---QLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 4e-07
Identities = 22/96 (22%), Positives = 39/96 (40%), Gaps = 10/96 (10%)
Query: 198 LHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPP 257
+ N + I L+ L++ NN L +P L+ + + N L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPE 321
Query: 258 CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDIN 293
+L++LH+ N L P S+E L +N
Sbjct: 322 ---LPQNLKQLHVEYNPLR-EFPDIPESVED-LRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 1e-06
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 8/95 (8%)
Query: 318 LSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPK 377
N S +I S LE L+++ N+ +P L E L S N+L+ ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFNHLA-EVP- 320
Query: 378 SLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVES 412
E LKQ +V +N L + S ++ + S
Sbjct: 321 --ELPQNLKQLHVEYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 6e-06
Identities = 53/324 (16%), Positives = 99/324 (30%), Gaps = 17/324 (5%)
Query: 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFA 99
L L LS LP L P++ESL+ + N+LT +P + L+ + + +
Sbjct: 41 HELELNNLGLS-SLPE----LPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALS 94
Query: 100 GHI--LNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGI 157
L G + + N + + L L + N
Sbjct: 95 DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154
Query: 158 LPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRL 217
LP + + K ++P + ++ + +L T
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214
Query: 218 QGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS 277
+L + + L+ L N ++
Sbjct: 215 LLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274
Query: 278 SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDL 337
I S + ++N+S+N L LP+ +L+ L S N L+ ++P LK
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELPQNLK-- 327
Query: 338 ETLSLARNQFQGPIPESVGSLISL 361
L + N + P+ S+ L
Sbjct: 328 -QLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 7e-04
Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 10/92 (10%)
Query: 23 NNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSI 82
N S + ++ L + N+L LP+ L P +E L+ + N+L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA----LPPRLERLIASFNHLAE-VPELP 323
Query: 83 TNATKLVALDLGFNSFAGHILNTFGNLRHLSL 114
N L L + +N + ++ L +
Sbjct: 324 QN---LKQLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 18/76 (23%), Positives = 28/76 (36%), Gaps = 11/76 (14%)
Query: 11 NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLA 70
+L+ L + N L L P + L N L + V L N++ L +
Sbjct: 282 LPPSLEELNVSNNKLIEL-PALPPR---LERLIASFNHL-----AEVPELPQNLKQLHVE 332
Query: 71 ANNLTGI--IPHSITN 84
N L IP S+ +
Sbjct: 333 YNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.004
Identities = 22/67 (32%), Positives = 28/67 (41%), Gaps = 5/67 (7%)
Query: 263 TSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQ 322
EL L + L+ S+P LE + S NSL LP Q LK L V + +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 323 LSGDIPS 329
LS P
Sbjct: 93 LSDLPPL 99
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (134), Expect = 8e-09
Identities = 14/90 (15%), Positives = 28/90 (31%), Gaps = 5/90 (5%)
Query: 313 LTVLDLSRNQLS-GDIPSTIGALKDLETLSLARNQFQG----PIPESVGSLISLESLDLS 367
+ LD+ +LS + L+ + + L I ++ +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 368 GNNLSGKIPKSLETLSQLKQFNVSHNRLEG 397
N L + Q + L+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 3e-08
Identities = 19/83 (22%), Positives = 31/83 (37%), Gaps = 9/83 (10%)
Query: 313 LTVLDLSRNQLSGD----IPSTIGALKDLETLSLARNQFQGPIPESVGSLI-----SLES 363
L VL L+ +S + +T+ A L L L+ N + + LE
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 364 LDLSGNNLSGKIPKSLETLSQLK 386
L L S ++ L+ L + K
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 3e-07
Identities = 15/89 (16%), Positives = 30/89 (33%), Gaps = 10/89 (11%)
Query: 292 INLSSNSLNDS-LPSNVQKLKVLTVLDLSRNQLSGD----IPSTIGALKDLETLSLARNQ 346
+++ L+D+ + L+ V+ L L+ I S + L L+L N+
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 347 FQGPIPESVGSLI-----SLESLDLSGNN 370
V + ++ L L
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 16/95 (16%), Positives = 35/95 (36%), Gaps = 10/95 (10%)
Query: 264 SLRELHLGSNKLTSSIPSSLWS-LEYILDINLSSNSLND----SLPSNVQKLKVLTVLDL 318
++ L + +L+ + + L L+ + L L + + S ++ L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 319 SRNQLSGDIPSTIG-ALKD----LETLSLARNQFQ 348
N+L + L+ ++ LSL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 3e-05
Identities = 16/73 (21%), Positives = 24/73 (32%), Gaps = 9/73 (12%)
Query: 337 LETLSLARNQFQG----PIPESVGSLISLESLDLSGNNLSGKIPKSL-----ETLSQLKQ 387
L L LA + ++ + SL LDLS N L L + L+Q
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 388 FNVSHNRLEGEIP 400
+ E+
Sbjct: 431 LVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 6e-05
Identities = 17/110 (15%), Positives = 33/110 (30%), Gaps = 21/110 (19%)
Query: 193 LTLLSLHSNDLNGT-ISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKL 251
+ L + +L+ + + L++ Q + L + L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL--------------------TEAR 43
Query: 252 SGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLND 301
I L +L EL+L SN+L + + SL +
Sbjct: 44 CKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 2e-04
Identities = 21/106 (19%), Positives = 36/106 (33%), Gaps = 27/106 (25%)
Query: 244 IRLTGNKLSG----HIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSL 299
+ L +S + L++ SLREL L +N L + L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV--------------- 418
Query: 300 NDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALK----DLETLS 341
+S+ L+ L L S ++ + AL+ L +S
Sbjct: 419 -ESVRQPGCLLE---QLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 16/85 (18%), Positives = 30/85 (35%), Gaps = 12/85 (14%)
Query: 42 LTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGI----IPHSITNATKLVALDLGFNS 97
L ++ +LS + + LL + + L LT I ++ L L+L N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 98 FAGHILNTFG--------NLRHLSL 114
++ ++ LSL
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 16/89 (17%), Positives = 31/89 (34%), Gaps = 9/89 (10%)
Query: 14 NLQYLVFAENNLSGLVPPTIF-NISTMRILTLEGNQLSGRLPSTVGHLL---PNIESLLL 69
++Q L LS + + +++ L+ L+ + L P + L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 70 AANNLTGIIPHSITNA-----TKLVALDL 93
+N L + H + K+ L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 40/185 (21%), Positives = 67/185 (36%), Gaps = 4/185 (2%)
Query: 164 NFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLR 223
+ + E L + + LT L+L T G L L L L
Sbjct: 28 DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA--ELTKLQVDGTLPVLGTLDLS 85
Query: 224 NNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSL 283
+N L+ + + ++ N+L+ L L L+EL+L N+L + P L
Sbjct: 86 HNQLQSLPLLGQTLPA-LTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL 144
Query: 284 WSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLA 343
+ ++L++N+L + + L+ L L L N L IP L L
Sbjct: 145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH 203
Query: 344 RNQFQ 348
N +
Sbjct: 204 GNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 32/208 (15%), Positives = 57/208 (27%), Gaps = 17/208 (8%)
Query: 32 TIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVAL 91
+ +++ + + L+ LP L + L L+ N L ++ T+L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 92 DLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGS 151
+L ++ + LS + ++ R ++
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 152 NP------------LGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLH 199
LPP + + L+K L + L L L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 200 SNDLNGTISPTMGRLKRLQGLSLRNNNL 227
N L TI L L N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 2e-07
Identities = 48/212 (22%), Positives = 74/212 (34%), Gaps = 11/212 (5%)
Query: 186 EIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIR 245
E+ ++ ++ +L + P + K L L N L L R
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYT-----R 56
Query: 246 LTGNKLSGHIPPCLVSLTSLRELHL--GSNKLTSSIPSSLWSLEYILDINLSSNSLNDSL 303
LT L L +L L S+ S+P +L + +++S N L
Sbjct: 57 LTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 304 PSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLES 363
++ L L L L N+L P + LE LSLA N + L +L++
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 364 LDLSGNNLSGKIPKSLETLSQLKQFNVSHNRL 395
L L N+L IPK L + N
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 8e-06
Identities = 40/187 (21%), Positives = 61/187 (32%), Gaps = 9/187 (4%)
Query: 142 RNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSN 201
++ TIL N L + ++ L + L ++ L +L
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYT-RLTQLN-----LDRAELTKLQVDGTLPVLGTLDL 84
Query: 202 DLNGTIS--PTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCL 259
N S L L L + N L L L + + L GN+L P L
Sbjct: 85 SHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL 144
Query: 260 VSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLS 319
L +L L +N LT L LE + + L NS ++P +L L
Sbjct: 145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS-LYTIPKGFFGSHLLPFAFLH 203
Query: 320 RNQLSGD 326
N +
Sbjct: 204 GNPWLCN 210
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 0.001
Identities = 52/214 (24%), Positives = 78/214 (36%), Gaps = 12/214 (5%)
Query: 210 TMGRLKRLQGLSLRNNNLE---GSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLR 266
+ ++ ++ NL +P D L L+ N L L+ T L
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPKDTTIL------HLSENLLYTFSLATLMPYTRLT 58
Query: 267 ELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGD 326
+L+L +LT + L S++ SLP Q L LTVLD+S N+L+
Sbjct: 59 QLNLDRAELTKLQVDGTLPV---LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL 115
Query: 327 IPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLK 386
+ L +L+ L L N+ + P + LE L L+ NNL+ L L L
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 387 QFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
+ N L GN LC
Sbjct: 176 TLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.001
Identities = 35/201 (17%), Positives = 61/201 (30%), Gaps = 16/201 (7%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPN 63
+P ++ ++ L +EN L T+ + + L L+ + V LP
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE---LTKLQVDGTLPV 78
Query: 64 IESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLT 123
+ +L L+ N L + T + N +L +L
Sbjct: 79 LGTLDLSHNQLQSLPLLGQTL---------PALTVLDVSFNRLTSLPLGALRGLGELQEL 129
Query: 124 TESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNI 183
+ + LT L LS +N L + ++ +L E L I
Sbjct: 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLE-NLDTLLLQENSLY-TI 187
Query: 184 PQEIGNLSGLTLLSLHSNDLN 204
P+ L LH N
Sbjct: 188 PKGFFGSHLLPFAFLHGNPWL 208
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 2e-07
Identities = 34/126 (26%), Positives = 51/126 (40%), Gaps = 9/126 (7%)
Query: 266 RELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSG 325
R LHL LT L L + ++LS N L P+ + L+ L VL S N
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--L 55
Query: 326 DIPSTIGALKDLETLSLARNQFQG-PIPESVGSLISLESLDLSGNNLSGK---IPKSLET 381
+ + L L+ L L N+ Q + + S L L+L GN+L + + E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 382 LSQLKQ 387
L +
Sbjct: 116 LPSVSS 121
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 6e-06
Identities = 21/116 (18%), Positives = 39/116 (33%), Gaps = 26/116 (22%)
Query: 315 VLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISL------------- 361
VL L+ L+ + + L + L L+ N+ + P ++ +L L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 362 ---------ESLDLSGNNL-SGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKN 407
+ L L N L + L + +L N+ N L E ++
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 28/115 (24%), Positives = 40/115 (34%), Gaps = 10/115 (8%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
+ + L +T L L N L P + L+ L+ L +N LE
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALP-PALAALRCLEVLQASDNALENVDGVANLPRLQE- 69
Query: 243 GIRLTGNKL-SGHIPPCLVSLTSLRELHLGSNKLT------SSIPSSLWSLEYIL 290
+ L N+L LVS L L+L N L + L S+ IL
Sbjct: 70 -LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.003
Identities = 21/115 (18%), Positives = 41/115 (35%), Gaps = 11/115 (9%)
Query: 5 IPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNI 64
+ + L + +L + N L L P ++ +R L + + LP +
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALENVDGVANLPRL 67
Query: 65 ESLLLAANNLTGI-IPHSITNATKLVALDLGFNSFAG------HILNTFGNLRHL 112
+ LLL N L + + +LV L+L NS + ++ +
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 3e-06
Identities = 43/226 (19%), Positives = 72/226 (31%), Gaps = 18/226 (7%)
Query: 167 ASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNN 226
A+ K A + + + Q +L G+T LS + TI + L L GL L++N
Sbjct: 19 ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 227 LEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSL 286
+ P + K I T ++ + S+L L
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 287 EYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQ 346
L+ + + L S + + L L TL N+
Sbjct: 135 YLDLNQITNISPLAGLTNLQYL----------SIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 347 FQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSH 392
P + SL +L + L N +S P L S L +++
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 34/225 (15%), Positives = 73/225 (32%), Gaps = 29/225 (12%)
Query: 84 NATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRN 143
+ + G ++ + T +L ++ LS +TT + + N
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT----------IEGVQYLNN 64
Query: 144 LTILSFGSNPL------GGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLS 197
L L N + + S + K + L+ ++ + +
Sbjct: 65 LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 198 LHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFG-------IRLTGNK 250
L + + ++ + L+ N SI ++ NK
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 251 LSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLS 295
+S P L SL +L E+HL +N+++ P L + + + L+
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.0 bits (107), Expect = 1e-05
Identities = 44/335 (13%), Positives = 95/335 (28%), Gaps = 34/335 (10%)
Query: 112 LSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQK 171
+ S ++ +TTE D+ S + L ++ + N +G + AS +
Sbjct: 5 IEGKSLKLDAITTE----DEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 172 F------YAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNN 225
+ ++K IP+ + L L + + + + + L +
Sbjct: 61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120
Query: 226 NLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWS 285
+ L G ++ + + LR + G N+L +
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180
Query: 286 LEYIL-------------DINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIG 332
+ L + L + + + + S + +
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240
Query: 333 ALKDLETLSLARNQFQGPIPESVG------SLISLESLDLSGNNLSGKIPKSL-----ET 381
+ +L L L +V I L++L L N + ++L E
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 382 LSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGN 416
+ L ++ NR E V + G
Sbjct: 301 MPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 7e-04
Identities = 43/356 (12%), Positives = 90/356 (25%), Gaps = 44/356 (12%)
Query: 63 NIESLLLAANNLTG----IIPHSITNATKLVALDLGFNSFA-------GHILNTFGNLRH 111
+IE L + +T + + + + L N+ + + +L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 112 LSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQK 171
+ E A + L +L C L + N G + +F +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRL-LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122
Query: 172 FYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSI 231
G PQ + + L + + N +
Sbjct: 123 LEHLYLHNNGLGPQAG---------AKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 173
Query: 232 PYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILD 291
L K+ + L E +L
Sbjct: 174 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS 233
Query: 292 INLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIG------ALKDLETLSLARN 345
++ L L L+ LS + + L+TL L N
Sbjct: 234 AL----------AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN 283
Query: 346 QFQGPIPESVGSLI-----SLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396
+ + ++ ++I L L+L+GN + ++ + ++ L+
Sbjct: 284 EIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFS-TRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 38/344 (11%), Positives = 89/344 (25%), Gaps = 48/344 (13%)
Query: 4 QIPTEIGNLQNLQYLVFAENNLSG----LVPPTIFNISTMRILTLEGNQLSGRLPSTVGH 59
+ + +++ +V + N + + I + + I R+ +
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG-RVKDEIPE 80
Query: 60 LLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVM 119
L + LL L + +T +L
Sbjct: 81 ALRLLLQALLKCPKLHTVRLSDNAFGP-----TAQEPLIDFLSKHTPLEHLYLHNNGLGP 135
Query: 120 NNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKL 179
+ + + + N L + G N L S + + +
Sbjct: 136 QAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQ 195
Query: 180 KGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLK 239
G P+ I +L L + T + ++ L
Sbjct: 196 NGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF------------THLGSSALAIALKSWP 243
Query: 240 LMFGIRLTGNKLSGHIPPCLV------SLTSLRELHLGSNKLTSSIPSSLWSLEYILDIN 293
+ + L LS +V L+ L L N++ +L
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL---------- 293
Query: 294 LSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDL 337
+++ +P L L+L+ N+ + + ++++
Sbjct: 294 --KTVIDEKMPD-------LLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 5e-05
Identities = 37/283 (13%), Positives = 76/283 (26%), Gaps = 23/283 (8%)
Query: 66 SLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTE 125
+L L NL + + + ++A + + F R + + + +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 126 SSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQ 185
+ L+ C L LS L + + S +L + C
Sbjct: 62 T-------LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS-NLVRLNLSGCSGFSEFAL 113
Query: 186 EIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEG---------SIPYDLC 236
+ S L L+ + + ++ NL G
Sbjct: 114 QTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRR 173
Query: 237 HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHL-GSNKLTSSIPSSLWSLEYILDINLS 295
L+ L L L+ L L + L + + + +
Sbjct: 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233
Query: 296 SNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLE 338
+ +L + L L ++ + + TIG K+ E
Sbjct: 234 GIVPDGTLQLLKEALP---HLQINCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 39/239 (16%), Positives = 74/239 (30%), Gaps = 36/239 (15%)
Query: 184 PQEIGNLSGLTLLSLH-SNDLNGTISPTMGRLKRLQGLSLRNNNLEG-SIPYDLCHLKLM 241
P G L +++ R+Q + L N+ +E ++ L +
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73
Query: 242 FGIRLTGNKLSGHIPPCLVSLTSLREL--------HLGSNKLTSSIPSSLWSLEYILDIN 293
+ L G +LS I L ++L L + + S S L L +
Sbjct: 74 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133
Query: 294 LSSNSLNDSLPSNVQKLKVLTVLDLSRN-------------------------QLSGDIP 328
+ + ++ + + L + +N L D
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193
Query: 329 STIGALKDLETLSLAR-NQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLK 386
L L+ LSL+R +G + +L++L + G G + E L L+
Sbjct: 194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 252
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 6e-05
Identities = 27/121 (22%), Positives = 43/121 (35%), Gaps = 10/121 (8%)
Query: 254 HIPPCLVSLTSLRELHLGSNKLTS--SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLK 311
P LV+ L+ S+ + I ++ L L+++ + D + S VQK
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLS-LNLSNNRLYRLDDMSSIVQKAP 91
Query: 312 VLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVG-------SLISLESL 364
L +L+LS N+L + LE L L N + L L
Sbjct: 92 NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151
Query: 365 D 365
D
Sbjct: 152 D 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 4e-04
Identities = 27/169 (15%), Positives = 55/169 (32%), Gaps = 26/169 (15%)
Query: 245 RLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLP 304
L ++ + + + L L S L + + +N S+ + +L
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSS-MAATLR 58
Query: 305 SNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESL 364
+ + L L+LS N+L + V +L+ L
Sbjct: 59 IIEENIPELLSLNLSNNRLYR----------------------LDDMSSIVQKAPNLKIL 96
Query: 365 DLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESF 413
+LSGN L + +L++ + N L + ++ + E F
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 2e-04
Identities = 30/150 (20%), Positives = 53/150 (35%), Gaps = 9/150 (6%)
Query: 244 IRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSL 303
++LT + + REL L K+ I + +L+ I+ S N +
Sbjct: 1 VKLTAELIEQ--AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-- 55
Query: 304 PSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQG-PIPESVGSLISLE 362
L+ L L ++ N++ AL DL L L N + + SL SL
Sbjct: 56 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 115
Query: 363 SLDLSGNN---LSGKIPKSLETLSQLKQFN 389
L + N + + Q++ +
Sbjct: 116 YLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 24/150 (16%), Positives = 50/150 (33%), Gaps = 10/150 (6%)
Query: 178 KLKGNIPQEIG---NLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYD 234
KL + ++ N L L + I L + + +N + +
Sbjct: 2 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF- 59
Query: 235 LCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS-SIPSSLWSLEYILDIN 293
L+ + + + N++ +L L EL L +N L L SL+ + +
Sbjct: 60 -PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 118
Query: 294 LSS---NSLNDSLPSNVQKLKVLTVLDLSR 320
+ + + K+ + VLD +
Sbjct: 119 ILRNPVTNKKHYRLYVIYKVPQVRVLDFQK 148
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.6 bits (93), Expect = 3e-04
Identities = 38/174 (21%), Positives = 68/174 (39%), Gaps = 29/174 (16%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTM-GRLKRLQGLSLRNNNLEGSIPYDLCHLKLM 241
IP++I T L L+ N+L S + GRL L L L+ N L G P +
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 242 FGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSL------------------ 283
++L NK+ + L L+ L+L N+++ +P S
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 284 -----WSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIG 332
W E++ +L+ + PS V+ +++ DL ++ ++ G
Sbjct: 141 NCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIK---DLPHSEFKCSSENSEG 191
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 3e-04
Identities = 20/109 (18%), Positives = 36/109 (33%), Gaps = 2/109 (1%)
Query: 313 LTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESV-GSLISLESLDLSGNNL 371
+ L +R+ D + ++L L + Q + L L +L + + L
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 372 SGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALC 420
P + +L + N+S N LE + GN C
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 4e-04
Identities = 24/234 (10%), Positives = 56/234 (23%), Gaps = 11/234 (4%)
Query: 72 NNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQ 131
+ +T I P + + L F ++
Sbjct: 18 SKVTEI-PSDLP--RNAIELRFVLTKLRVIQKGAFSGFGD-----LEKIEISQNDVLEVI 69
Query: 132 WSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLS 191
+ + S + + +N L + K ++ +
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 192 GLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKL 251
L + + N + +G L L N ++ +L N L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 252 SGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPS 305
+ L + ++ S L +L+ + + + LP+
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 5e-04
Identities = 29/242 (11%), Positives = 69/242 (28%), Gaps = 12/242 (4%)
Query: 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFA 99
R+ + ++++ +PS L N L L I + + L +++ N
Sbjct: 11 RVFLCQESKVT-EIPSD---LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 66
Query: 100 GHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILP 159
I + ++ ++++ + + +L +
Sbjct: 67 EVIEADVFSNLP-----KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV 121
Query: 160 PVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQG 219
I + L +G +L L+ N + + + +
Sbjct: 122 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDEL 181
Query: 220 LSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSI 279
NNNLE + ++ ++ L +L LR + K +
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KL 238
Query: 280 PS 281
P+
Sbjct: 239 PT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 24/216 (11%), Positives = 54/216 (25%), Gaps = 6/216 (2%)
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
IP ++ L L L+ + + N++ I D+
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 243 GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNK--LTSSIPSSLWSLEYILDINLSS--NS 298
+ +L + + + +++ N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 299 LNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSL 358
S V +L L++N + + E N + +
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 359 ISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNR 394
LD+S + LE L +L+ + + +
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 30/207 (14%), Positives = 62/207 (29%), Gaps = 28/207 (13%)
Query: 183 IPQEIG------NLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLC 236
+P I + +L + + T L + + N++++ +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS--VQGIQ 65
Query: 237 HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLT---------------SSIPS 281
+L + + L GNKL+ P + L K + S
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
Query: 282 SLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLS 341
+ L ++ + N V + DI + L L+ L
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLY 184
Query: 342 LARNQFQGPIPESVGSLISLESLDLSG 368
L++N ++ L +L+ L+L
Sbjct: 185 LSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 33/214 (15%), Positives = 64/214 (29%), Gaps = 18/214 (8%)
Query: 133 SFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSG 192
+ S + + + N S+ + A +K I L
Sbjct: 15 KQIFSDDAFAETIKDNLKKKSVTDAVTQ---NELNSIDQIIANNSDIKSVQG--IQYLPN 69
Query: 193 LTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLS 252
+T L L+ N L + L L+ L + +
Sbjct: 70 VTKLFLNGNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 253 GHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKV 312
I + + ++ S L L+ + + + + + L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAGLTK 179
Query: 313 LTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQ 346
L L LS+N +S D+ + + LK+L+ L L +Q
Sbjct: 180 LQNLYLSKNHIS-DLRA-LAGLKNLDVLEL-FSQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 34/227 (14%), Positives = 66/227 (29%), Gaps = 32/227 (14%)
Query: 4 QIPTEIG------NLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTV 57
+PT I + +++ V ++++ + + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGI-- 64
Query: 58 GHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQ 117
LPN+ L L N LT I P + L L F +
Sbjct: 65 -QYLPNVTKLFLNGNKLTDIKPLA-----NLKNLGWLFLDENKVKDLSSLKDLKKLKSLS 118
Query: 118 VMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYEC 177
+ +N ++ + L SL N + L + +
Sbjct: 119 LEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKL------------DTLSLEDN 166
Query: 178 KLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRN 224
++ +P + L+ L L L N ++ + LK L L L +
Sbjct: 167 QISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 31/234 (13%), Positives = 68/234 (29%), Gaps = 33/234 (14%)
Query: 69 LAANNLTGIIPHSI------TNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122
L + +T +P I + + +L S + T L + + +++
Sbjct: 3 LGSETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDI 58
Query: 123 TTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGN 182
+ + + N+T L N L I A+L+
Sbjct: 59 KS----------VQGIQYLPNVTKLFLNGNKLTDI------KPLANLKNLGWLFLDENKV 102
Query: 183 IPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMF 242
++ I+ + + N + ++ L L +
Sbjct: 103 KDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLS 162
Query: 243 GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSS 296
+ + L LT L+ L+L N ++ +L L+ + + L S
Sbjct: 163 LEDNQISDI-----VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 33/209 (15%), Positives = 69/209 (33%), Gaps = 26/209 (12%)
Query: 83 TNATKLVALDLGFNSFAGHI-LNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNC 141
T + + LG + + + L + + + +
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADR---LGIKS----------IDGVEYL 61
Query: 142 RNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSN 201
NLT ++F +N L + N + + + NL+GLT ++
Sbjct: 62 NNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLT--LFNNQ 117
Query: 202 DLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVS 261
+ + L RL+ S +++ ++T L +
Sbjct: 118 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD-------LKPLAN 170
Query: 262 LTSLRELHLGSNKLTS-SIPSSLWSLEYI 289
LT+L L + SNK++ S+ + L +LE +
Sbjct: 171 LTTLERLDISSNKVSDISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 791 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.98 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.81 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.8 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.61 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.59 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.59 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.59 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.57 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.56 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.56 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.33 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.62 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.53 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.42 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.85 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.79 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.71 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.32 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.31 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.17 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.88 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.2 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.68 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=428.34 Aligned_cols=263 Identities=25% Similarity=0.426 Sum_probs=209.5
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehh--hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQ--LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+.++++++|||||+++|++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 367899999999999999999874 36999998644 24556789999999999999999999999865 45799999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++|+|.+++......+++..+..++.|||+||+||| +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh----cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999999999877777999999999999999999999 67899999999999999999999999999987765444
Q ss_pred cceeecccccccccCCCccCC---CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc-CCChhhhcchh
Q 003855 658 SVTQTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL-PHGLTEVVDAN 733 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~ 733 (791)
........||+.|||||++.+ +.|+.++|||||||++|||+||+.||.+..... .....+.... .....
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~p~~~------ 232 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRGYLSPDLS------ 232 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHHTSCCCCGG------
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCCCcch------
Confidence 444455679999999998754 458999999999999999999999997643222 1222221111 11110
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhc
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFL 784 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~ 784 (791)
.....+++++.+++.+||+.||++||||.|+++.|+.+++..+
T Consensus 233 --------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 233 --------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp --------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 1122466788999999999999999999999999999987654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=420.15 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=204.5
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
++|+..+.||+|+||.||+|++.+++.||||++.... ...+.+.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788999999999999999999888999999987543 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+|+|.+++......+++..+..++.|||+||+||| +.+|+||||||+|||+++++.+||+|||+|+........ .
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-S 158 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh----ccceeecccchhheeecCCCCeEecccchheeccCCCce-e
Confidence 99999999887777999999999999999999999 678999999999999999999999999999876543322 2
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCC-CCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK-RPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....||+.|+|||++.+..++.++|||||||++|||+|+. +||... ....+.+.+......
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~--------------- 221 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRL--------------- 221 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHHHHHTCCC---------------
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHHHHhcCCC---------------
Confidence 23356899999999999999999999999999999999954 444431 111222222221111
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+..++.++.+++.+||+.||++||||+||++.|+++...
T Consensus 222 --~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 222 --YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11123456788999999999999999999999999998653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=416.71 Aligned_cols=252 Identities=21% Similarity=0.335 Sum_probs=206.5
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|++.+.||+|+||+||+|+.. +|+.||||++.... .+..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 68999999999999999999975 79999999987543 33446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+++|+|.+++.... .+++.++..++.||++||+||| +.+|+||||||+|||+++++.+||+|||+|+........
T Consensus 85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH----~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999997654 4899999999999999999999 678999999999999999999999999999987544433
Q ss_pred ceeecccccccccCCCccCCCCC-CccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||............+......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------------- 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence 33455689999999999877765 678999999999999999999997644333322222111000
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......++.++.+++.+||+.||++|||+.|+++
T Consensus 226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111234566789999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=414.27 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=209.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
++|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999964 79999999998766555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++|+|.+++.... +++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~~~--l~~~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-- 171 (293)
T d1yhwa1 100 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (293)
T ss_dssp TTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH----HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--
Confidence 9999999887653 899999999999999999999 67899999999999999999999999999998754332
Q ss_pred eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 660 TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....+||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+ .+........+.
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~--------------- 235 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE--------------- 235 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC---------------
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCC---------------
Confidence 2344579999999999999999999999999999999999999997532211 111111111110
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+..++.++.+++.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111234567889999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-50 Score=420.33 Aligned_cols=259 Identities=25% Similarity=0.444 Sum_probs=203.1
Q ss_pred hccccccccCCCcceEEEEEEec-CC---cEEEEEEeehh-hhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DG---TDVAIKIFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
++|+..+.||+|+||+||+|+++ ++ ..||||++... .....+.|.+|++++++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45677889999999999999975 23 35899988654 344567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++......+++.++..++.|||+||+||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA----DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh----hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999999987777999999999999999999999 678999999999999999999999999999877543
Q ss_pred CCcc---eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 656 EDSV---TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 656 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
.... ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.+... ..+...+....
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i~~~~--------- 250 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAIEQDY--------- 250 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTC---------
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC---------
Confidence 3221 1222457899999999999999999999999999999998 8999976322 12222222111
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+.+.+++.++.+++.+||+.||++||||.||++.|+++.+.
T Consensus 251 --------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 251 --------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1112234667788999999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=414.18 Aligned_cols=259 Identities=23% Similarity=0.418 Sum_probs=212.9
Q ss_pred hccccccc-cCCCcceEEEEEEec---CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 501 DEFNECNL-LGTGSFGSVYKGTIS---DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 501 ~~~~~~~~-ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
++|.+.+. ||+|+||+||+|.++ ++..||||+++... ....+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 56667774 999999999999864 45679999987543 4456789999999999999999999999965 457899
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++......+++..+.+++.||++||+||| +++|+||||||+||+++.++.+||+|||+|+.+...
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH----~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 9999999999999877677999999999999999999999 678999999999999999999999999999987654
Q ss_pred CCcc-eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 656 EDSV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 656 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+... ..+...+....
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~~~----------- 229 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGK----------- 229 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTC-----------
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC-----------
Confidence 3322 2333468999999999998999999999999999999998 8999986432 12222222110
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
..+.+..++.++.+++.+||+.||++||||.+|.+.|+.+....
T Consensus 230 ------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 230 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 01112346678889999999999999999999999998875544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=408.74 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=213.9
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMP 580 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 580 (791)
++|+..++||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57899999999999999999998889999999876533 34679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcce
Q 003855 581 NGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSVT 660 (791)
Q Consensus 581 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 660 (791)
+|++.+++......+++..+.+++.|+++||+||| +.+|+||||||+||++++++.+||+|||+|+....... ..
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH----~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS 157 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh----hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-ee
Confidence 99999998877777999999999999999999999 67899999999999999999999999999987655432 23
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....+.....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~~~~---------------- 219 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLR---------------- 219 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTCC----------------
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHhCCC----------------
Confidence 344578999999999999999999999999999999998 79999764322 12221211111
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKK 778 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~ 778 (791)
.+.+..+++++.+++.+||+.||++||||.|+++.|..
T Consensus 220 -~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 -LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11122355678899999999999999999999998753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=407.29 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=206.2
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||+||+|+.+ +++.||+|++.... ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 78999999987543 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~~~-l~e~~~~~i~~qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred eecCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH----HCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 99999999999986543 899999999999999999999 6789999999999999999999999999998764322
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.+... ....+.+.. ...
T Consensus 161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~---~~~---------- 221 (263)
T d2j4za1 161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETYKRISR---VEF---------- 221 (263)
T ss_dssp ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHT---TCC----------
T ss_pred ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HHHHHHHHc---CCC----------
Confidence 2345799999999999999999999999999999999999999975321 111111111 000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..+++++.+++.+||+.||++|||+.|+++
T Consensus 222 -----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 -----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 011134567889999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=412.55 Aligned_cols=256 Identities=23% Similarity=0.408 Sum_probs=208.4
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|++.+.||+|+||.||+|++++++.||||++.... ...+.|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 36789999999999999999999888999999997543 234679999999999999999999998865 5578999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++|+|.+++... ...+++..+.+|+.||++||.||| +.+|+||||||+|||+++++.+||+|||+|+...... .
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH----~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y 164 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccchhheeeecccceeeccccceEEccCCc-c
Confidence 999999988643 234899999999999999999999 6789999999999999999999999999999875432 2
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
.......||+.|+|||++.++.++.++|||||||++|||+||..|+...... ....+.+.....
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~i~~~~~--------------- 228 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERGYR--------------- 228 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCC---------------
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCC---------------
Confidence 2233456899999999999899999999999999999999976654432211 112222211110
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
...+..+++++.+++.+||+.||++||||.||++.|+.+-
T Consensus 229 --~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 229 --MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 0111245667889999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=415.72 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=208.4
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
+.|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999975 78999999998766666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV 659 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 659 (791)
++|+|.+++.+....+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH----~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH----DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ 165 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--cc
Confidence 999999998876666999999999999999999999 678999999999999999999999999999764321 11
Q ss_pred eeecccccccccCCCcc-----CCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 660 TQTMTMATIGYMAPEYG-----SEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 660 ~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
......||+.|+|||++ .+..|+.++|||||||++|||+||+.||.+....+ .+.+......+.
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~~~---------- 234 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEPPT---------- 234 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCCCC----------
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCCC----------
Confidence 22345799999999987 34668999999999999999999999997643222 222221111110
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
...+..++.++.+++.+||+.||++|||+.|+++
T Consensus 235 ------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 ------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112245567889999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-50 Score=415.44 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=212.9
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|++.+.||+|+||+||+|++. +++.||||+++.... ..+.+.+|++++++++|||||+++|+|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 468999999999999999999975 688999999875533 356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.+++... ...+++..+..++.||++||+||| +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~- 169 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 169 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH----HCCcccCccccCeEEECCCCcEEEccccceeecCCCC-
Confidence 9999999999854 456899999999999999999999 6789999999999999999999999999998765433
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
........|++.|+|||++.++.++.++|||||||++|||++|..|+..... .....+.+.....
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i~~~~~-------------- 234 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYR-------------- 234 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCC--------------
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHHhcCCC--------------
Confidence 2233445688999999999999999999999999999999997776543211 1112222221111
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
.+.+..++.++.+++.+||+.||++||||.|+++.|+.+.
T Consensus 235 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 ---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1112245677889999999999999999999999998874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=410.39 Aligned_cols=260 Identities=25% Similarity=0.442 Sum_probs=205.9
Q ss_pred hccccccccCCCcceEEEEEEecCC-----cEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDG-----TDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
+.|+..+.||+|+||.||+|.++++ ..||||++.... ......|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688899999999999999987532 469999986543 3445678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+.+|++.+++......+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH----~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc----ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999999887777999999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCc-ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDS-VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.... .......||+.|+|||++.++.++.++|||||||++|||++|..|+...... ....+.+....
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~----------- 230 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGF----------- 230 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTC-----------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhccC-----------
Confidence 3322 2233346899999999999999999999999999999999976665432211 12222222111
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+.+.+++.++.+++.+||+.||++||||.||++.|+++.+.
T Consensus 231 ------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 ------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 0111224567788999999999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=417.40 Aligned_cols=255 Identities=23% Similarity=0.391 Sum_probs=209.2
Q ss_pred hccccccccCCCcceEEEEEEecC-C-----cEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISD-G-----TDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 572 (791)
++|++.+.||+|+||+||+|++.. + ..||||++.... ......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 679999999999999999998642 2 369999886543 33456788999999998 899999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCC
Q 003855 573 ALVLEFMPNGSLEKWLYSHN----------------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKP 630 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~ 630 (791)
++||||+++|+|.++++... ..+++..+..++.||++||+||| +++|+||||||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH----~~~IiHRDlKp 192 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAA 192 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTCSG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCch
Confidence 99999999999999998543 24789999999999999999999 67899999999
Q ss_pred CCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCcccc
Q 003855 631 TNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFT 709 (791)
Q Consensus 631 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~ 709 (791)
+||+++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987765554444455678999999999999999999999999999999998 8999976432
Q ss_pred CcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 003855 710 GEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLK 777 (791)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~ 777 (791)
. ..+.+.+....+ .+.+..+++++.++|.+||+.||++||||+||++.|.
T Consensus 273 ~-~~~~~~~~~~~~-----------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D-ANFYKLIQNGFK-----------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S-HHHHHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H-HHHHHHHhcCCC-----------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2 222332222111 1112345677889999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=406.95 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=202.7
Q ss_pred cccCCCcceEEEEEEec---CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecCCC
Q 003855 507 NLLGTGSFGSVYKGTIS---DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFMPN 581 (791)
Q Consensus 507 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 581 (791)
++||+|+||+||+|.++ .++.||||+++... ....+.+.+|++++++++|||||+++|+|.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 47999999999999864 35689999986543 33456899999999999999999999999654 57899999999
Q ss_pred CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCcc-e
Q 003855 582 GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDSV-T 660 (791)
Q Consensus 582 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~ 660 (791)
|+|.++++.... +++..+..++.||++||+||| +.+|+||||||+|||++.++.+||+|||+|+.+....... .
T Consensus 92 g~L~~~l~~~~~-l~~~~~~~i~~qi~~gl~ylH----~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhccC-CCHHHHHHHHHHHHHHHhhHH----hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999987654 899999999999999999999 6789999999999999999999999999999876544332 2
Q ss_pred eecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhHH
Q 003855 661 QTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREEQ 739 (791)
Q Consensus 661 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 739 (791)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.... .+...+....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~----------------- 227 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGE----------------- 227 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC-----------------
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCC-----------------
Confidence 334568999999999999999999999999999999998 89999763221 2222222110
Q ss_pred hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 740 AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 740 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+.+..++.++.+++.+||+.||++||||+||.+.|+..-.+
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 1111234667888999999999999999999999998876443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=402.30 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=194.4
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc--CCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN--PDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 574 (791)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... +...+.+.+|++++++++|||||++++++.+ ....++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999975 78999999986543 3445678999999999999999999999864 456799
Q ss_pred EEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHccC-CCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 575 VLEFMPNGSLEKWLYS---HNYFLDILERLNIMIDVGSALEYLHHGH-SSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
||||+++|+|.+++.+ ....+++..++.++.|++.||.|||+.. ...+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999874 2456999999999999999999999532 12359999999999999999999999999999
Q ss_pred ccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
.+..... .....+||+.|||||++.+..++.++|||||||++|||+||+.||.+... ..+...+.......
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i~~~~~~~----- 233 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFRR----- 233 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCCC-----
T ss_pred ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCCC-----
Confidence 8754322 22345799999999999999999999999999999999999999975321 11111111110000
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+..+++++.+++.+||+.||++|||+.|+++
T Consensus 234 ------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11234567889999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=408.76 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=204.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999974 79999999997543 334567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|+|.+++...+. +++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~~~-l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccCC-CCHHHHHHHHHHHHHHHHhhc----cccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999999886543 899999999999999999999 6789999999999999999999999999999876544
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
........+||+.|+|||++.+..++.++||||+||++|||+||+.||.+... ....+-+.. ...
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~~---~~~---------- 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQKIIK---LEY---------- 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHT---TCC----------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHHHHHHc---CCC----------
Confidence 44444456799999999999999999999999999999999999999975321 111111111 000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..+++++.+++.+||+.||++|||+.|+.+
T Consensus 228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 001134566789999999999999999999754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=395.39 Aligned_cols=244 Identities=25% Similarity=0.370 Sum_probs=195.4
Q ss_pred ccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc----CCeeeEEE
Q 003855 504 NECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN----PDFKALVL 576 (791)
Q Consensus 504 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 576 (791)
+..++||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55668999999999999975 78899999987543 3445678999999999999999999999854 45678999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCC--eEecCCCCCCeEeC-CCCcEEEeeeccccccC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAP--IIHCDLKPTNILLD-ENMAAHVSDFGISKLLG 653 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~--i~H~dlk~~Nill~-~~~~~kl~Dfgla~~~~ 653 (791)
||+++|+|.+++.+.. .+++..+..++.||++||+||| +.+ |+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH----~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH----HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999998654 3899999999999999999999 455 99999999999996 58999999999998643
Q ss_pred CCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 654 EGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 654 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
.. .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+...... +.+.+.. .....
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~~~~i~~---~~~~~----- 232 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVTS---GVKPA----- 232 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHTT---TCCCG-----
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-HHHHHHc---CCCCc-----
Confidence 32 2234579999999998865 599999999999999999999999975322211 1111111 00000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..+..+++++.+++.+||+.||++|||+.|+++
T Consensus 233 --------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 --------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 011123456789999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=413.43 Aligned_cols=272 Identities=23% Similarity=0.303 Sum_probs=208.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.++++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999975 78999999987543 3345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
|+++|+|.+++.+.+. +++..+..++.|++.||.|||+ ..+|+||||||+|||+++++.+||+|||+|+.+.+.
T Consensus 85 y~~gg~L~~~l~~~~~-l~~~~~~~~~~qil~aL~yLH~---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp CCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred cCCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHH---hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 9999999999986544 8999999999999999999994 237999999999999999999999999999875322
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHH--HHhcC------------
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWV--KESLP------------ 723 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~--~~~~~------------ 723 (791)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+....... .....
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 12345799999999999999999999999999999999999999976332211110000 00000
Q ss_pred -----------CChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HHHHHH
Q 003855 724 -----------HGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA--KLKKIK 780 (791)
Q Consensus 724 -----------~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~--~L~~~~ 780 (791)
....+..+......... ......+.++.+++.+||+.||++|||+.|+++ .+.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPK-LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCC-CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCcc-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 00000000000000000 000123467889999999999999999999988 455443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=409.08 Aligned_cols=258 Identities=25% Similarity=0.435 Sum_probs=208.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCc----EEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGT----DVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
++|++.+.||+|+||+||+|++. +|+ +||||++.... .+..+.+.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 444 58999886443 34567899999999999999999999999875 4678
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
++||+.+|+|.+++......+++..+.+++.|||.||+||| +++|+||||||+||+++.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH----HcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999999999988778999999999999999999999 67899999999999999999999999999998766
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
...........||+.|+|||++.++.++.++|||||||++|||+| |+.||++.... .+...+....
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~~~~----------- 230 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE----------- 230 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHHHTC-----------
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC-----------
Confidence 554444445578999999999999999999999999999999999 78888764322 2222222111
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+.+..++.++.+++.+||+.||++||||.|+++.|.++.+.
T Consensus 231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 1112234567788999999999999999999999999988653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.7e-48 Score=406.84 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=210.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999974 7999999999766655667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC--CCCcEEEeeeccccccCCCC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD--ENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfgla~~~~~~~ 656 (791)
+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999766666999999999999999999999 67899999999999996 46889999999998875433
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
. .....||+.|||||++.+..++.++||||+||++|||+||+.||.+.... ..+...........
T Consensus 181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~----------- 245 (350)
T d1koaa2 181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWNMD----------- 245 (350)
T ss_dssp C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCSC-----------
T ss_pred c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCC-----------
Confidence 2 33457999999999999999999999999999999999999999753211 11111111110000
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......+++++.+++.+||+.||++|||++|+++
T Consensus 246 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 246 ----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ----CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011234567889999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-48 Score=401.72 Aligned_cols=251 Identities=25% Similarity=0.302 Sum_probs=191.3
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
.+.|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999975 78999999987554 3334567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC---CCCcEEEeeeccccccCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD---ENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfgla~~~~~ 654 (791)
|++||+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||+++ +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh----hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999998654 4899999999999999999999 67899999999999995 578999999999987644
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANL 734 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 734 (791)
... ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+... ......+........
T Consensus 163 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~~~~~~~~-------- 229 (307)
T d1a06a_ 163 GSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLFEQILKAEYEFD-------- 229 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHTTCCCCC--------
T ss_pred CCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCCCC--------
Confidence 322 2335799999999999999999999999999999999999999975322 111111111110000
Q ss_pred hhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 735 VREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 735 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+....+++++.+++.+||+.||++|||+.|+++
T Consensus 230 ------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 ------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0111234567889999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=403.18 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=206.0
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEecC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEFM 579 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 579 (791)
.++|++.+.||+|+||.||+|++++++.||||++.... ...+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 36899999999999999999999888899999987543 234679999999999999999999999965 5578999999
Q ss_pred CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 580 PNGSLEKWLYSH-NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 580 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
++|+|..++... ...+++.++..++.||++||+||| +.+|+||||||+|||+++++++||+|||+|+.+.....
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH----~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh----hhheecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 999999998743 345899999999999999999999 67899999999999999999999999999987654332
Q ss_pred ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhhH
Q 003855 659 VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVREE 738 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 738 (791)
.......||+.|+|||++.++.++.++|||||||++|||+||..|+...... ......+.....
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~--------------- 232 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYR--------------- 232 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCC---------------
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCC---------------
Confidence 2334456899999999999999999999999999999999977665442221 122222221111
Q ss_pred HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhcc
Q 003855 739 QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLD 785 (791)
Q Consensus 739 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~ 785 (791)
.+.+..+++++.+++.+||+.||++||+|.+|+++|+........
T Consensus 233 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 233 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred --CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 111224567788999999999999999999999998876544433
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-47 Score=405.56 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=210.5
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 367999999999999999999974 7999999999766555567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC--CCCcEEEeeeccccccCCCC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD--ENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfgla~~~~~~~ 656 (791)
+++|+|.+++......+++.++..++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999999998877767999999999999999999999 67899999999999998 67899999999999876543
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
. .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... .....+....... .
T Consensus 184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~~~~~~-~--------- 248 (352)
T d1koba_ 184 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNVKRCDWEF-D--------- 248 (352)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHCCCCC-C---------
T ss_pred c---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCCC-C---------
Confidence 2 33456899999999999999999999999999999999999999753221 1111111110000 0
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......++.++.+++.+||+.||++|||+.|+++
T Consensus 249 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 249 ----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011134567889999999999999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-48 Score=404.02 Aligned_cols=245 Identities=25% Similarity=0.299 Sum_probs=201.1
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
+.|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999964 78999999986542 344567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+++|++..++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp ECCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 9999999987666543 4899999999999999999999 678999999999999999999999999999865432
Q ss_pred CcceeecccccccccCCCccCC---CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSE---GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
....||+.|||||++.+ +.|+.++|||||||++|||++|+.||.+....+ .+........+.
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~~~--------- 233 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA--------- 233 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC---------
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCC---------
Confidence 23469999999998753 568999999999999999999999997532211 111111110000
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.....+++++.+++.+||+.||++|||+.|+++
T Consensus 234 --------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 001134567889999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=397.60 Aligned_cols=258 Identities=22% Similarity=0.363 Sum_probs=202.3
Q ss_pred hhccccccccCCCcceEEEEEEecC----CcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISD----GTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 574 (791)
.++|++.+.||+|+||.||+|++.. +..||||++.... ....+.+.+|+.++++++||||++++|++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 3689999999999999999998642 4568999886543 3445679999999999999999999999964 66899
Q ss_pred EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCC
Q 003855 575 VLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGE 654 (791)
Q Consensus 575 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 654 (791)
||||+++|++.+++......+++..+..++.||++||.||| +.+|+||||||+||++++++.+||+|||+|+....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc----ccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999999999887777999999999999999999999 67899999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchh
Q 003855 655 GEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDAN 733 (791)
Q Consensus 655 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 733 (791)
... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||...... .+...+.....
T Consensus 161 ~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~~~~---------- 227 (273)
T d1mp8a_ 161 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGER---------- 227 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCC----------
T ss_pred Ccc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC----------
Confidence 322 23334568999999999999999999999999999999998 88898764332 22222221110
Q ss_pred hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 734 LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 734 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
.+.+..++.++.+++.+||+.||++|||+.||++.|+++.++
T Consensus 228 -------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 228 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 011224567788999999999999999999999999988654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-48 Score=404.49 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=211.7
Q ss_pred hhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
.++|++.+.||+|+||+||+|+++ +++.||||++.... .+..+.+.+|++++++++||||++++++|.+....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 468999999999999999999864 45789999987544 34456799999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCC
Q 003855 573 ALVLEFMPNGSLEKWLYSHN-----------------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLK 629 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk 629 (791)
++||||+++|+|.++++... ..+++..+..++.|++.||+||| +.+|+|||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH----~~~ivHrDlK 167 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRDLA 167 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCS
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc----cCCeEeeEEc
Confidence 99999999999999997432 23789999999999999999999 6789999999
Q ss_pred CCCeEeCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCC-CCCCccc
Q 003855 630 PTNILLDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK-RPTDEMF 708 (791)
Q Consensus 630 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~-~p~~~~~ 708 (791)
|+|||++.++.+||+|||+|+...........+...|++.|+|||++.+..++.++|||||||++|||++|. +||.+..
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998775544444444567899999999999999999999999999999999986 5676532
Q ss_pred cCcchHHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 003855 709 TGEMSLRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIK 780 (791)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~ 780 (791)
.. .....+..... .+.+..++.++.+++.+||+.||++||||.||+++|+++.
T Consensus 248 ~~--e~~~~v~~~~~-----------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HE--EVIYYVRDGNI-----------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HH--HHHHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HH--HHHHHHHcCCC-----------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 21 12222221110 0112245567889999999999999999999999999873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=397.77 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=200.8
Q ss_pred hccccccccCCCcceEEEEEEec--C--CcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeee
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS--D--GTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKA 573 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~--~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 573 (791)
++|++.+.||+|+||.||+|++. + +..||||++.... .+..+.|.+|+.++++++||||++++|++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 67999999999999999999864 2 2468999886542 34467899999999999999999999999764 578
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
+||||+++|++.+++..+...+++..+..++.|||+||.||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh----hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 999999999999999877667999999999999999999999 6789999999999999999999999999999876
Q ss_pred CCCCcc-eeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 654 EGEDSV-TQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 654 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
...... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.+.... ....++.. ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~---~~------ 231 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDK---EG------ 231 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHT---SC------
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHHh---CC------
Confidence 554332 2233457889999999999999999999999999999998 89999753221 12122211 11
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKI 779 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~ 779 (791)
...+.+..++.++.+++.+||+.||++||||.||.+.|++.
T Consensus 232 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 00111224556788999999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=400.64 Aligned_cols=272 Identities=21% Similarity=0.323 Sum_probs=205.2
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCC----eeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD----FKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv 575 (791)
.++|...+.||+|+||.||+|++ +|+.||||++...... ....+.|+..+.+++||||+++++++.+.+ ..++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35678889999999999999997 6899999998754322 222344556666789999999999997543 57899
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc----CCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG----HSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
|||+++|+|.+++++.. ++|..+.+++.|+|.||+|+|+. ...++|+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999998764 89999999999999999999942 1136899999999999999999999999999987
Q ss_pred cCCCCCcc--eeecccccccccCCCccCCCC------CCccccHHhHHHHHHHHHhCCCCCCccccCcc----------h
Q 003855 652 LGEGEDSV--TQTMTMATIGYMAPEYGSEGI------VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEM----------S 713 (791)
Q Consensus 652 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~----------~ 713 (791)
........ .....+||++|+|||++.+.. ++.++|||||||++|||+||..|+........ .
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 75543322 233467999999999876543 67799999999999999999887754222211 1
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
............ .++.+. ......+++..+.+++.+||+.||++||||.||++.|+++.++-
T Consensus 238 ~~~~~~~~~~~~----~~p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 238 VEEMRKVVCEQK----LRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHTTSC----CCCCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccc----cCCCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 111111111111 111111 11122346677899999999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=393.05 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=206.5
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh------hHHHHHHHHHHHHHHhccCCccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL------ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
.+.|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999974 79999999986432 12357889999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC----cEEEeeecc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM----AAHVSDFGI 648 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfgl 648 (791)
++||||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+|++|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH----~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh----hcceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999998654 4899999999999999999999 67899999999999999776 499999999
Q ss_pred ccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 649 SKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 649 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
|+....... .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.... .....+...... .
T Consensus 164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i~~~~~~-~-- 235 (293)
T d1jksa_ 164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSAVNYE-F-- 235 (293)
T ss_dssp CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHTTCCC-C--
T ss_pred hhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHHHHHHhcCCC-C--
Confidence 988754332 23356899999999999999999999999999999999999999753211 111111110000 0
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.......++..+.+++.+||+.||++|||+.|+++
T Consensus 236 -----------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 236 -----------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111235567889999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=388.66 Aligned_cols=252 Identities=29% Similarity=0.427 Sum_probs=201.0
Q ss_pred hhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeecc-CCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN-PDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 578 (791)
.++|+..+.||+|+||.||+|++ .|+.||||+++... ..+.+.+|++++++++||||++++|+|.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 46788999999999999999998 47899999996543 34678999999999999999999999854 4568999999
Q ss_pred CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 579 MPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 579 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
+++|+|.+++.... ..+++..+.+++.||+.||.||| +.+|+||||||+||+++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH----~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc----cCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 99999999997543 34899999999999999999999 678999999999999999999999999999865432
Q ss_pred cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
.....++..|+|||++.++.++.++|||||||++|||+| |+.||.... ......++......
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--~~~~~~~i~~~~~~------------ 219 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGYKM------------ 219 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHHTTTCCC------------
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCC------------
Confidence 222357889999999999999999999999999999998 677776532 22333333211111
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
+.+..++.++.+++.+||+.||++||||.|++++|++++..
T Consensus 220 -----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 220 -----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 11123456788999999999999999999999999999764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=394.46 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=202.1
Q ss_pred hccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccC-Ce
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNP-DF 571 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~ 571 (791)
++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+..|...+.++ +||||+.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 68999999999999999999863 34689999987543 34456778888888877 689999999987654 56
Q ss_pred eeEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeC
Q 003855 572 KALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLD 636 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~ 636 (791)
.++||||+++|+|.++++... ..+++.++..++.||++||+||| +++|+||||||+|||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLS 168 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEC
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH----hCCCcCCcCCccceeEC
Confidence 899999999999999997532 34889999999999999999999 67899999999999999
Q ss_pred CCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCC-CCCCccccCcchHH
Q 003855 637 ENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK-RPTDEMFTGEMSLR 715 (791)
Q Consensus 637 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~-~p~~~~~~~~~~~~ 715 (791)
+++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. .||...... ..+.
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFC 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-HHHH
Confidence 99999999999998776555444445567999999999999999999999999999999999975 567653222 2222
Q ss_pred HHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 716 RWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 716 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+...... ..+..+++++.+++.+||+.||++||||.|+++.|+++.+.
T Consensus 248 ~~~~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 248 RRLKEGTRM-----------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHTCCC-----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCC-----------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 222221111 11123456788999999999999999999999999998643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=396.01 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=209.8
Q ss_pred ccccCCCcceEEEEEEecC----CcEEEEEEeehh-hhHHHHHHHHHHHHHHhccCCccceeeeeecc-CCeeeEEEecC
Q 003855 506 CNLLGTGSFGSVYKGTISD----GTDVAIKIFNLQ-LERAFRSFDSECEVLRNVRHRNLIKILSSCSN-PDFKALVLEFM 579 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 579 (791)
.++||+|+||+||+|++.+ ...||||+++.. .....+.|.+|++++++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999999743 236899998643 34556789999999999999999999999865 56789999999
Q ss_pred CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc-
Q 003855 580 PNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS- 658 (791)
Q Consensus 580 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 658 (791)
++|+|.+++.......++..+.+++.|+++||.|+| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH----~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc----ccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999987777889999999999999999999 678999999999999999999999999999877544322
Q ss_pred -ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhhh
Q 003855 659 -VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVRE 737 (791)
Q Consensus 659 -~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 737 (791)
.......||+.|+|||++.++.++.++||||||+++|||+||+.||....... ....++....+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~-------------- 252 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRR-------------- 252 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC--------------
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCC--------------
Confidence 22333468999999999999999999999999999999999888875432221 12222211110
Q ss_pred HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHhccc
Q 003855 738 EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKFLDD 786 (791)
Q Consensus 738 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~~~~ 786 (791)
...+..++.++.++|.+||+.||++||+|.||++.|+++...+..+
T Consensus 253 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 253 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ---CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 0111235567889999999999999999999999999998876654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-47 Score=396.18 Aligned_cols=248 Identities=23% Similarity=0.265 Sum_probs=207.3
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|++.+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 478999999999999999999974 79999999997653 33457788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++...+. +++..+..++.||+.||+||| +++|+||||||+|||++++|.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhcccC-CcHHHHHHHHHHHhhhhhhhh----hcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999999987654 889999999999999999999 679999999999999999999999999999876433
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+... ..+.+.+.....
T Consensus 159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~~~~i~~~~~------------ 222 (337)
T d1o6la_ 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILMEEI------------ 222 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC------------
T ss_pred Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--HHHHHHHhcCCC------------
Confidence 22 23346799999999999999999999999999999999999999976322 111111111000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRIN-----VTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~ev~~ 774 (791)
..+..++.++.+++.+||+.||++||+ +.|+++
T Consensus 223 ------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 011234566789999999999999995 788775
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=391.86 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=216.7
Q ss_pred hhccccccccCCCcceEEEEEEe------cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI------SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 571 (791)
.++|+..+.||+|+||.||+|++ .+++.||||+++... ......+.+|+.+++++ +|||||+++|+|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 36889999999999999999985 246789999997544 34456788999999999 69999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeE
Q 003855 572 KALVLEFMPNGSLEKWLYSHN-----------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNIL 634 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nil 634 (791)
.++||||+++|+|.++++... ..+++..+..++.||++||+||| +.+++||||||+||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH----~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNIL 177 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccccccccc
Confidence 999999999999999998542 24889999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchH
Q 003855 635 LDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL 714 (791)
Q Consensus 635 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~ 714 (791)
++.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+|+..|+.........+
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999998776555555566789999999999999999999999999999999999555543333333333
Q ss_pred HHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 715 RRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 715 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
.+.+....+.. .+..++..+.++|.+||+.||++||||.||+++|+++...
T Consensus 258 ~~~i~~~~~~~-----------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKEGFRML-----------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTCCCC-----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCC-----------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 44433322111 1123456788999999999999999999999999987654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-46 Score=392.25 Aligned_cols=245 Identities=25% Similarity=0.320 Sum_probs=205.2
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEE
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 575 (791)
.++|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 368999999999999999999974 79999999997543 33457789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||++||++.+++..... +++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eeecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhc----cCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999999886654 788889999999999999999 789999999999999999999999999999886532
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
. ...+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.... ....+......
T Consensus 158 ~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~~------------- 218 (316)
T d1fota_ 158 T-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNAEL------------- 218 (316)
T ss_dssp B-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHCCC-------------
T ss_pred c-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-HHHHHHHcCCC-------------
Confidence 2 2357999999999999999999999999999999999999999753211 11111111000
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
..+..+++++.+++.+||+.||++|| |++|+++
T Consensus 219 ------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 01113446678999999999999996 8898875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=394.37 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=210.0
Q ss_pred hhccccccccCCCcceEEEEEEecC--------CcEEEEEEeehhh-hHHHHHHHHHHHHHHhc-cCCccceeeeeeccC
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTISD--------GTDVAIKIFNLQL-ERAFRSFDSECEVLRNV-RHRNLIKILSSCSNP 569 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 569 (791)
.++|++.+.||+|+||.||+|+... +..||||++.... ......+.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3689999999999999999998532 3479999997654 34457788899999888 899999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeE
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHN---------------YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNIL 634 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nil 634 (791)
+..++||||+++|+|.+++.... ..+++.++.+++.||+.||+||| +.+|+||||||+|||
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH----~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVL 167 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh----hCCEEeeeeccccee
Confidence 99999999999999999997543 34899999999999999999999 678999999999999
Q ss_pred eCCCCcEEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHh-CCCCCCccccCcch
Q 003855 635 LDENMAAHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFT-RKRPTDEMFTGEMS 713 (791)
Q Consensus 635 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 713 (791)
++.++.+||+|||+++...............|++.|+|||++.++.|+.++|||||||++|||++ |..||.+... ..
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--~~ 245 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 245 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--HH
Confidence 99999999999999998765554444455678999999999999999999999999999999998 6888865322 12
Q ss_pred HHHHHHHhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHH
Q 003855 714 LRRWVKESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVK 782 (791)
Q Consensus 714 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~ 782 (791)
..+.+..... .+.+..++..+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 246 ~~~~i~~~~~-----------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 LFKLLKEGHR-----------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHTTCC-----------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCC-----------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 2222221111 111123456788999999999999999999999999998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.5e-46 Score=382.92 Aligned_cols=260 Identities=22% Similarity=0.358 Sum_probs=203.3
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCC----e
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD----F 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 571 (791)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 479999999997543 344567899999999999999999999986543 4
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++||||++||+|.+++...+. +++.++..++.||++||+||| +.+|+||||||+||+++.++.++++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~-l~~~~~~~i~~qi~~al~~lH----~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccCC-CCHHHHHHHHHHHHHHHHHHH----hCCccCccccCcccccCccccceeehhhhhhh
Confidence 7899999999999999876553 899999999999999999999 67899999999999999999999999999976
Q ss_pred cCCCCC-cceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhc
Q 003855 652 LGEGED-SVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVV 730 (791)
Q Consensus 652 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (791)
...... .......+||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+ ...+.+..... ..
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~~~~~~~~--~~--- 234 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQHVREDPI--PP--- 234 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHCCCC--CG---
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HHHHHHhcCCC--CC---
Confidence 543322 223344579999999999999999999999999999999999999997532211 11111111000 00
Q ss_pred chhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHH
Q 003855 731 DANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRI-NVTDAAAKLKKIK 780 (791)
Q Consensus 731 d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~ev~~~L~~~~ 780 (791)
......++.++.+++.+|++.||++|| |+.++++.|.+++
T Consensus 235 ----------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 ----------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 011123556788999999999999999 8999999998875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-46 Score=387.64 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=207.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.++|++.+.||+|+||+||+|+.. +|+.||||+++....+ ...+.+|++++++++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999975 7889999999765433 35678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCC--CcEEEeeeccccccCCCC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDEN--MAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfgla~~~~~~~ 656 (791)
++||+|.+++...+..+++.++..++.||+.||+||| +.+|+||||||+|||++.+ ..+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH----~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 9999999999877666999999999999999999999 6789999999999999854 589999999998764432
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
......+|+.|+|||...+..++.++||||+||++|||++|+.||...... ....-+...... . +
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~i~~~~~~-~----~----- 223 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNAEYT-F----D----- 223 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCCC-C----C-----
T ss_pred ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCCC-C----C-----
Confidence 233456899999999999999999999999999999999999999763211 111111110000 0 0
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......++.++.+++.+|++.||++|||+.|+++
T Consensus 224 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 ----EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111234567889999999999999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-45 Score=377.50 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=204.5
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh---------hHHHHHHHHHHHHHHhcc-CCccceeeeeeccC
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL---------ERAFRSFDSECEVLRNVR-HRNLIKILSSCSNP 569 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 569 (791)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999996 478999999986532 223456889999999996 99999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccc
Q 003855 570 DFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGIS 649 (791)
Q Consensus 570 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla 649 (791)
+..++||||+++|+|.+++..++ .+++.++..++.||++||+||| ..+|+||||||+||+++.++.+||+|||+|
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HcCCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999998655 4899999999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccC------CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGS------EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP 723 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 723 (791)
+....... ....+||+.|+|||++. ...++.++||||+||++|||+||+.||.+... ....+.+.....
T Consensus 158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--~~~~~~i~~~~~ 232 (277)
T d1phka_ 158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSGNY 232 (277)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCC
T ss_pred eEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--HHHHHHHHhCCC
Confidence 98755332 23457999999999764 34578899999999999999999999976322 111111111100
Q ss_pred CChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 724 HGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 724 ~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. ..+....+++++.+++.+||+.||++|||+.||++
T Consensus 233 ~~--------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 233 QF--------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CC--------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CC--------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 00111245577889999999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=393.18 Aligned_cols=257 Identities=30% Similarity=0.460 Sum_probs=205.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCc--EEEEEEeehh-hhHHHHHHHHHHHHHHhc-cCCccceeeeeeccCCeeeEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGT--DVAIKIFNLQ-LERAFRSFDSECEVLRNV-RHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 575 (791)
++|+..+.||+|+||+||+|+++ +|. .||||++... ..+..+.+.+|+++++++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 68899999999999999999975 444 4778877543 334556899999999998 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc
Q 003855 576 LEFMPNGSLEKWLYSH---------------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA 640 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~ 640 (791)
|||+++|+|.++++.. ...+++..+..++.|||.||.|+| +.+|+||||||+|||++.++.
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH----~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh----cCCccccccccceEEEcCCCc
Confidence 9999999999999753 345899999999999999999999 678999999999999999999
Q ss_pred EEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCC-CCCccccCcchHHHHHH
Q 003855 641 AHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKR-PTDEMFTGEMSLRRWVK 719 (791)
Q Consensus 641 ~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~-p~~~~~~~~~~~~~~~~ 719 (791)
+||+|||+|+....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||.+.. ...+.+.+.
T Consensus 166 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~~~i~ 240 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLP 240 (309)
T ss_dssp EEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHGG
T ss_pred eEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHHHHHHH
Confidence 99999999986543222 223458999999999999999999999999999999999765 565421 111111111
Q ss_pred HhcCCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 720 ESLPHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 720 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
. + ...+.+..+++++.++|.+||+.||++||||.||++.|+++.++.
T Consensus 241 ~----~-------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 241 Q----G-------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp G----T-------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred h----c-------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1 0 001112245677889999999999999999999999999987543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-45 Score=392.03 Aligned_cols=249 Identities=20% Similarity=0.282 Sum_probs=199.7
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHH---HHHHHHHhccCCccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFD---SECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+. .|+.+++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999975 79999999986542 11222333 446677777899999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccccc
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLL 652 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~ 652 (791)
++||||+++|+|.+++..... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~ylH----~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHhccc-ccHHHHHHHHHHHHHHHHHHH----HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999986543 789999999999999999999 678999999999999999999999999999876
Q ss_pred CCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcc
Q 003855 653 GEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVD 731 (791)
Q Consensus 653 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d 731 (791)
.... ....+||+.|+|||++.. ..|+.++||||+||++|||+||+.||....... .............
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~~~~~~----- 226 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAV----- 226 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHHHSSSCCC-----
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcccCCC-----
Confidence 5432 233579999999998864 568999999999999999999999997643222 1111111111100
Q ss_pred hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 003855 732 ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRIN-----VTDAAA 774 (791)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~ev~~ 774 (791)
..+..+++++.+++.+||+.||++||| +.|+++
T Consensus 227 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 001134566889999999999999999 677764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-46 Score=393.60 Aligned_cols=244 Identities=24% Similarity=0.256 Sum_probs=205.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 576 (791)
++|++++.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 68999999999999999999975 79999999987543 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
||+.+|+|.+++...+. +++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH----~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcCC-CCHHHHHHHHHHHHHHHHHHH----hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 99999999999986653 899999999999999999999 678999999999999999999999999999876432
Q ss_pred CcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhhh
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLVR 736 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 736 (791)
.....||+.|||||++.+..++.++||||+||++|||+||+.||.+.. .......+.....
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~~~------------- 255 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSGKV------------- 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCC-------------
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHHHHHhcCCC-------------
Confidence 223569999999999999999999999999999999999999997532 1111111111100
Q ss_pred hHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 737 EEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 737 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
..+..++.++.+++.+||+.||++|+ |+.|+++
T Consensus 256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 01113456788999999999999994 8999876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=392.09 Aligned_cols=259 Identities=23% Similarity=0.392 Sum_probs=211.5
Q ss_pred hhccccccccCCCcceEEEEEEec------CCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCCee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS------DGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFK 572 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 572 (791)
.++|+..+.||+|+||+||+|.++ +++.||||+++... .+....+.+|+.++++++||||++++|++......
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 378899999999999999999863 35789999997543 34456789999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003855 573 ALVLEFMPNGSLEKWLYSH---------NYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHV 643 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl 643 (791)
++||||+++|+|.+++... ...+++..+.+++.|+|+||.||| +.+|+||||||+|||+++++++||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH----~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTTCCEEE
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeeceEcCCceeecCCceEEE
Confidence 9999999999999998732 134789999999999999999999 678999999999999999999999
Q ss_pred eeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCC-CCCCccccCcchHHHHHHHhc
Q 003855 644 SDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRK-RPTDEMFTGEMSLRRWVKESL 722 (791)
Q Consensus 644 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~ 722 (791)
+|||+|+...............||+.|+|||.+.++.++.++|||||||++|||+||. .||.+... .++.....
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-----~~~~~~i~ 249 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLRFVM 249 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHHHHHHH
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH
Confidence 9999998775544433344456899999999999999999999999999999999985 66654211 11111111
Q ss_pred CCChhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 723 PHGLTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 723 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
... ..+.+..++..+.+++.+||+.+|++||||.||+++|++..+
T Consensus 250 ~~~--------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGG--------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCC--------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 100 011122455778999999999999999999999999987643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=389.16 Aligned_cols=247 Identities=25% Similarity=0.319 Sum_probs=202.8
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh---hHHHHHHHHHHHHHH-hccCCccceeeeeeccCCeeeEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL---ERAFRSFDSECEVLR-NVRHRNLIKILSSCSNPDFKALV 575 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 575 (791)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999975 79999999997543 233455666777665 68999999999999999999999
Q ss_pred EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCC
Q 003855 576 LEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 576 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 655 (791)
|||+++|+|.+++..... +++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH----~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHH----hCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999986544 889999999999999999999 678999999999999999999999999999876443
Q ss_pred CCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhhcchhhh
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEVVDANLV 735 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 735 (791)
.. ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+... ..+.+-+....+
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~------------ 220 (320)
T d1xjda_ 157 DA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDNP------------ 220 (320)
T ss_dssp TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCCC------------
T ss_pred cc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCC------------
Confidence 22 23445799999999999999999999999999999999999999976321 111111111100
Q ss_pred hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 003855 736 REEQAFSAKMDCILSIMDLALDCCIESPDMRINVT-DAAA 774 (791)
Q Consensus 736 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~-ev~~ 774 (791)
..+..++.++.+++.+||+.||++||++. |+++
T Consensus 221 ------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 01113456788999999999999999995 6653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=386.47 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=198.7
Q ss_pred hhcccccc-ccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhc-cCCccceeeeeecc----CCee
Q 003855 500 TDEFNECN-LLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNV-RHRNLIKILSSCSN----PDFK 572 (791)
Q Consensus 500 ~~~~~~~~-~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~ 572 (791)
.++|++.+ .||+|+||.||+|+. .+++.||||++... ..+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898875 599999999999996 47899999998643 3456788887655 89999999999865 4668
Q ss_pred eEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC---CCcEEEeeecc
Q 003855 573 ALVLEFMPNGSLEKWLYSHN-YFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE---NMAAHVSDFGI 648 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgl 648 (791)
|+|||||+||+|.+++...+ ..+++.++..++.||+.||+||| +.+|+||||||+|||+++ ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH----~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH----HcCCccccccccccccccccccccccccccce
Confidence 99999999999999998653 46899999999999999999999 678999999999999985 56799999999
Q ss_pred ccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 649 SKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 649 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
|+....... ....+||+.|+|||++.+..|+.++||||+||++|||+||+.||.+..... ....+..........
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKTRIRMGQYE 235 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSSS
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHHHHHHHhcCCCC
Confidence 987654332 234579999999999999999999999999999999999999997632221 111111111111000
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
. ..+....+++++.+++.+||+.||++|||+.|+++
T Consensus 236 ~----------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 F----------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp C----------CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C----------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 00122346678899999999999999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=380.10 Aligned_cols=266 Identities=24% Similarity=0.300 Sum_probs=201.0
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++|++++.||+|+||+||+|+. .+|+.||||++.... +...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999997 479999999986543 2335678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCC
Q 003855 578 FMPNGSLEKWLY-SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGE 656 (791)
Q Consensus 578 ~~~~g~L~~~l~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 656 (791)
|+.+ ++.+++. .....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH----~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh----cCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9965 5555554 44556999999999999999999999 6789999999999999999999999999998765432
Q ss_pred CcceeecccccccccCCCccCCCC-CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC-C-C-hhhhcc-
Q 003855 657 DSVTQTMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP-H-G-LTEVVD- 731 (791)
Q Consensus 657 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~-~-~~~~~d- 731 (791)
. ......||+.|+|||...... ++.++||||+||++|||++|+.||.+....+ .+......... . . ......
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhccccccc
Confidence 2 233357999999999866654 5889999999999999999999997642221 12221211111 0 0 000000
Q ss_pred hhhhhh------HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 ANLVRE------EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 ~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+..... .........++.++.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000 0000111134567889999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=377.04 Aligned_cols=262 Identities=26% Similarity=0.297 Sum_probs=194.2
Q ss_pred cccccCCCcceEEEEEEec-CCcEEEEEEeehhhhH-----HHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 505 ECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLER-----AFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 505 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
.+++||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 7999999998654321 234688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+.++++..+. .....+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh----ccceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 9887666554 44455888999999999999999999 67899999999999999999999999999987654332
Q ss_pred ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC---CChhhhcch--
Q 003855 659 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP---HGLTEVVDA-- 732 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~-- 732 (791)
.....+||+.|+|||++.. ..++.++||||+||++|||+||+.||.+....+ .+......... .........
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccch
Confidence 2233579999999998765 468999999999999999999999997532211 11111111100 000000000
Q ss_pred --hhhh--hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 733 --NLVR--EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 733 --~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.... ...........++++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000 00000011134567889999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=374.29 Aligned_cols=239 Identities=24% Similarity=0.270 Sum_probs=195.5
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhh------HHHHHHHHHHHHHHhcc--CCccceeeeeeccCCe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE------RAFRSFDSECEVLRNVR--HRNLIKILSSCSNPDF 571 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 571 (791)
++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999964 799999999875421 11234667999999996 8999999999999999
Q ss_pred eeEEEecCCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-CCcEEEeeeccc
Q 003855 572 KALVLEFMPN-GSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-NMAAHVSDFGIS 649 (791)
Q Consensus 572 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfgla 649 (791)
.++||||+.+ +++.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++. ++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 68888887654 3899999999999999999999 678999999999999985 579999999999
Q ss_pred cccCCCCCcceeecccccccccCCCccCCCCC-CccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhh
Q 003855 650 KLLGEGEDSVTQTMTMATIGYMAPEYGSEGIV-SAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTE 728 (791)
Q Consensus 650 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (791)
+..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... +..+... .
T Consensus 159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~~--~--- 222 (273)
T d1xwsa_ 159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV--F--- 222 (273)
T ss_dssp EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC--C---
T ss_pred eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhccc--C---
Confidence 875432 2234579999999998876654 677999999999999999999997521 1111100 0
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.+..++.++.+++.+||+.||++|||+.|+++
T Consensus 223 --------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 --------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01123466789999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.8e-44 Score=370.74 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=200.6
Q ss_pred hccccccccCCCcceEEEEEEecCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 578 (791)
++|++.+.||+|+||+||+|+.++|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999999999999986543 33356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCCc
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGEDS 658 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 658 (791)
+.++.+..+.. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|++|||.|........
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH----~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhc----cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 97765555544 4455999999999999999999999 67899999999999999999999999999987654322
Q ss_pred ceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC---hhhhcc---
Q 003855 659 VTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---LTEVVD--- 731 (791)
Q Consensus 659 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~d--- 731 (791)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+ .+.+......... ......
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhhhh
Confidence 2333468999999998765 557999999999999999999999997643221 1222121111100 000000
Q ss_pred --hhhhh-hH-HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 732 --ANLVR-EE-QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 732 --~~~~~-~~-~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
..... .. .........++.+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00 000111234567889999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-44 Score=372.47 Aligned_cols=267 Identities=24% Similarity=0.293 Sum_probs=198.8
Q ss_pred hhccccccccCCCcceEEEEEEec-C-CcEEEEEEeehhh--hHHHHHHHHHHHHHHhc---cCCccceeeeeecc----
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-D-GTDVAIKIFNLQL--ERAFRSFDSECEVLRNV---RHRNLIKILSSCSN---- 568 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 568 (791)
.++|++++.||+|+||+||+|+.. + ++.||||++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999973 4 6779999986542 22223455677777665 79999999999842
Q ss_pred -CCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeec
Q 003855 569 -PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFG 647 (791)
Q Consensus 569 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 647 (791)
....+++|||+++|++..........+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH----~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecCCCccEEEEcCCCCeeecchh
Confidence 35678999999988777666666667999999999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh
Q 003855 648 ISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT 727 (791)
Q Consensus 648 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 727 (791)
+++..... .......||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.... ..+.............
T Consensus 162 ~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGG
T ss_pred hhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCchh
Confidence 99865322 2334467999999999999999999999999999999999999999763221 1222222111110000
Q ss_pred hh---c---chhhhhh--HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EV---V---DANLVRE--EQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~---~---d~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. . ....... ..........++.+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0 0000000 0000011234567889999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=368.30 Aligned_cols=268 Identities=22% Similarity=0.240 Sum_probs=197.2
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh-hHHHHHHHHHHHHHHhccCCccceeeeeeccCC----eee
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL-ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD----FKA 573 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 573 (791)
.++|++++.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999986 489999999986543 444567889999999999999999999986543 234
Q ss_pred EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccC
Q 003855 574 LVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLG 653 (791)
Q Consensus 574 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~ 653 (791)
++++|+.+|+|.+++.... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH----~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcCC--CCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 4556677999999998654 899999999999999999999 6789999999999999999999999999998765
Q ss_pred CCCCc-ceeecccccccccCCCccC-CCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChh---h
Q 003855 654 EGEDS-VTQTMTMATIGYMAPEYGS-EGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLT---E 728 (791)
Q Consensus 654 ~~~~~-~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 728 (791)
..... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||........ .............. .
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhccCCChhhhhh
Confidence 43222 1233457999999999874 45678999999999999999999999976332111 11111111111000 0
Q ss_pred hcchhhhhhHH---------hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 729 VVDANLVREEQ---------AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 729 ~~d~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
........... ........+.++.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 00011123456889999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-42 Score=361.07 Aligned_cols=260 Identities=19% Similarity=0.210 Sum_probs=203.0
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCcccee-eeeeccCCeeeEEEec
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKI-LSSCSNPDFKALVLEF 578 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e~ 578 (791)
++|++.+.||+|+||+||+|+.. +|+.||||++..... .+.+..|++++++++|++++.. .+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999964 789999998875432 2357789999999987765555 5555778888999999
Q ss_pred CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC---CCcEEEeeeccccccCCC
Q 003855 579 MPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE---NMAAHVSDFGISKLLGEG 655 (791)
Q Consensus 579 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfgla~~~~~~ 655 (791)
+ +|++.+.+......+++..+..++.|++.||+||| +.+|+||||||+||+++. +..+|++|||+|+.+...
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 66888888776667999999999999999999999 678999999999999864 557999999999987543
Q ss_pred CCc-----ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcch--HHHHHHHhcCCChhh
Q 003855 656 EDS-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMS--LRRWVKESLPHGLTE 728 (791)
Q Consensus 656 ~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 728 (791)
... ......+||+.|+|||...+..++.++|||||||++|||+||+.||......... ...+...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-------- 231 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-------- 231 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH--------
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc--------
Confidence 322 1233457999999999999999999999999999999999999999764322211 1111000
Q ss_pred hcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHH
Q 003855 729 VVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKV 781 (791)
Q Consensus 729 ~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~ 781 (791)
.... ........++.++.+++..||+.+|++||++.++.+.|+.+..
T Consensus 232 ----~~~~--~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 232 ----KMST--PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----HHHS--CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----cCCC--ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0000 0001122466789999999999999999999999999988743
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.1e-42 Score=355.56 Aligned_cols=264 Identities=15% Similarity=0.140 Sum_probs=211.0
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccC-CccceeeeeeccCCeeeEEEe
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRH-RNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 577 (791)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... .+.+.+|++.++.+.| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367999999999999999999965 789999998865432 2356778899999965 899999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCC-----CCcEEEeeecccccc
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDE-----NMAAHVSDFGISKLL 652 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfgla~~~ 652 (791)
|+ +|+|.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++. ++.+||+|||+|+.+
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH----~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH----HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 78999999887777999999999999999999999 789999999999999974 678999999999887
Q ss_pred CCCCCc-----ceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchH-HHHHHHhcCCCh
Q 003855 653 GEGEDS-----VTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSL-RRWVKESLPHGL 726 (791)
Q Consensus 653 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~ 726 (791)
...... ......+||+.|||||.+.+..++.++|||||||++|||+||+.||.+........ ...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~------ 230 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE------ 230 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH------
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh------
Confidence 543221 12334579999999999999999999999999999999999999997643322111 000100
Q ss_pred hhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHHHh
Q 003855 727 TEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAAKLKKIKVKF 783 (791)
Q Consensus 727 ~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~~L~~~~~~~ 783 (791)
...... .......+++++.+++..|++.+|++||+++.+.+.|+++..+.
T Consensus 231 -----~~~~~~--~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 231 -----KKQSTP--LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp -----HHHHSC--HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----ccCCCC--hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 000000 00111246678999999999999999999999999998876544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=363.25 Aligned_cols=268 Identities=20% Similarity=0.269 Sum_probs=196.2
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeecc--------
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSN-------- 568 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 568 (791)
.++|++++.||+|+||+||+|+.. +|+.||||++.... +...+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999974 89999999986542 3345678899999999999999999998754
Q ss_pred CCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecc
Q 003855 569 PDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGI 648 (791)
Q Consensus 569 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgl 648 (791)
.+..++||||++++.+.. .......++...+..++.|++.||.||| +.+|+||||||+|||++.++.+|++|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH----~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhc----cCCEEecCcCchheeecCCCcEEeeecce
Confidence 346789999998766554 4444455899999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCCc--ceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhc---
Q 003855 649 SKLLGEGEDS--VTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESL--- 722 (791)
Q Consensus 649 a~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--- 722 (791)
|+.+...... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... .....+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--~~~~~i~~~~~~~ 241 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSI 241 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--HHHHHHHHhcCCC
Confidence 9876543322 122334699999999987654 6899999999999999999999999753221 1111111111
Q ss_pred CCC-hhhhcchhhhh----------hHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 723 PHG-LTEVVDANLVR----------EEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 723 ~~~-~~~~~d~~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
... ........... ............+.+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 100 00000000000 00001111233456789999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=364.27 Aligned_cols=262 Identities=23% Similarity=0.284 Sum_probs=195.1
Q ss_pred hhccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCC------
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPD------ 570 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 570 (791)
.++|++++.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999964 79999999987542 344567889999999999999999999987654
Q ss_pred eeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 571 FKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 571 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
..++||||+ +++|..+++... +++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH----~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHH----hCCCcccccCcchhhccccccccccccccee
Confidence 569999999 668888876544 899999999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCC--Chh
Q 003855 651 LLGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPH--GLT 727 (791)
Q Consensus 651 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 727 (791)
..... .+..+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+... ...+.......... ...
T Consensus 170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHH
T ss_pred ccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHHHHHHHhccCCCcHHHH
Confidence 76432 234578999999998765 5678999999999999999999999976321 11122221111110 000
Q ss_pred hhcchhhhhhHH----------hhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EVVDANLVREEQ----------AFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~~d~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
............ .......+++.+.+++.+||..||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000 00001134567789999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-42 Score=355.32 Aligned_cols=267 Identities=20% Similarity=0.250 Sum_probs=204.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccCCeeeEEEe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNPDFKALVLE 577 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 577 (791)
++|++++.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999974 78999999986543 3456788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccccCCCCC
Q 003855 578 FMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKLLGEGED 657 (791)
Q Consensus 578 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 657 (791)
++.++++..++...+ .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH----~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh----cCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999998888776544 4889999999999999999999 67899999999999999999999999999988754432
Q ss_pred cceeecccccccccCCCccCCCC-CCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC---hh---hhc
Q 003855 658 SVTQTMTMATIGYMAPEYGSEGI-VSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---LT---EVV 730 (791)
Q Consensus 658 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~---~~~ 730 (791)
......++..|+|||.+.... ++.++||||+||++|||++|+.||..................... .. ...
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 223345788999999876654 689999999999999999999997442222222222211111110 00 000
Q ss_pred ch---h-hhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 731 DA---N-LVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 731 d~---~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
+. . ..............+..+.+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 00000000111234466789999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=364.92 Aligned_cols=261 Identities=23% Similarity=0.282 Sum_probs=192.0
Q ss_pred ccccccccCCCcceEEEEEEec-CCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCccceeeeeecc------CCeeeE
Q 003855 502 EFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNLIKILSSCSN------PDFKAL 574 (791)
Q Consensus 502 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~l 574 (791)
+|+..++||+|+||+||+|+.. +|+.||||++..... ...+|++++++++||||+++++++.. ....++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999975 799999999875432 23469999999999999999999843 345789
Q ss_pred EEecCCCCCHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC-cEEEeeeccccc
Q 003855 575 VLEFMPNGSLEKWLY--SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-AAHVSDFGISKL 651 (791)
Q Consensus 575 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~ 651 (791)
||||+++|.+....+ .....+++.++..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+|+.
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH----~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH----hcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999997654333332 34556999999999999999999999 78999999999999999775 899999999987
Q ss_pred cCCCCCcceeecccccccccCCCccCC-CCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCC---hh
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSE-GIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHG---LT 727 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 727 (791)
...... ....+||..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+...++...... ..
T Consensus 173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhhh
Confidence 654332 233578999999997654 57899999999999999999999999753221 11112111110000 00
Q ss_pred hh----cc---hhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 728 EV----VD---ANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 728 ~~----~d---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. .+ +...............++++.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00 0000000000001134567889999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=359.05 Aligned_cols=252 Identities=25% Similarity=0.298 Sum_probs=200.8
Q ss_pred hccccccccCCCcceEEEEEEe----cCCcEEEEEEeehhh----hHHHHHHHHHHHHHHhccC-CccceeeeeeccCCe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI----SDGTDVAIKIFNLQL----ERAFRSFDSECEVLRNVRH-RNLIKILSSCSNPDF 571 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 571 (791)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 7799999999999999999985 258899999986432 2234567889999999976 899999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++||||+.+|+|.+++..... ++...+..++.|++.|++|+| +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh----cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999986654 678889999999999999999 67899999999999999999999999999987
Q ss_pred cCCCCCcceeecccccccccCCCccCCC--CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSEG--IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV 729 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (791)
+...... ......|++.|+|||.+.+. .++.++||||+||++|||+||+.||......... ..........
T Consensus 179 ~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-~~i~~~~~~~----- 251 (322)
T d1vzoa_ 179 FVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRILKS----- 251 (322)
T ss_dssp CCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHHHHC-----
T ss_pred hcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcccC-----
Confidence 6543322 23345689999999987654 4788999999999999999999999764333221 1111110000
Q ss_pred cchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 003855 730 VDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRI-----NVTDAAA 774 (791)
Q Consensus 730 ~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~ev~~ 774 (791)
..+.+..++.++.+++.+||++||++|| |+.|+++
T Consensus 252 ----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0011124567788999999999999999 4788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-41 Score=357.95 Aligned_cols=260 Identities=19% Similarity=0.292 Sum_probs=196.4
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CCccceeeeeecc--CCeeeEEE
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSCSN--PDFKALVL 576 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 576 (791)
++|+++++||+|+||+||+|+. .+|+.||||+++... .+.+.+|+.+++++. ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6899999999999999999997 479999999987543 356788999999995 9999999999864 45689999
Q ss_pred ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCC-cEEEeeeccccccCCC
Q 003855 577 EFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENM-AAHVSDFGISKLLGEG 655 (791)
Q Consensus 577 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfgla~~~~~~ 655 (791)
||+++|+|.++. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH----~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh----hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999987653 24899999999999999999999 78899999999999998655 6999999999877544
Q ss_pred CCcceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHH------------HHHHHhc
Q 003855 656 EDSVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLR------------RWVKESL 722 (791)
Q Consensus 656 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~------------~~~~~~~ 722 (791)
.. ....++|+.|+|||.+.+. .++.++||||+||++|||++|+.||........... .|.....
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 32 2345689999999987654 579999999999999999999999865332111111 1111100
Q ss_pred CCC---hhhhcchhhh---hhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 723 PHG---LTEVVDANLV---REEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 723 ~~~---~~~~~d~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
... .......... ...........+++++.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000000 000000111234567889999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=353.99 Aligned_cols=260 Identities=22% Similarity=0.236 Sum_probs=190.3
Q ss_pred hccccccccCCCcceEEEEEEec-CCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeec------cCCe
Q 003855 501 DEFNECNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCS------NPDF 571 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~------~~~~ 571 (791)
++|++.++||+|+||+||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++. +..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999975 79999999997543 344567889999999999999999999985 3468
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.|+||||+.+ ++.+.+.. .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~-~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH----~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccch-HHHHhhhc---CCCHHHHHHHHHHHHHHHHHhh----hcccccccCCccccccccccceeeechhhhhc
Confidence 8999999966 45555532 3899999999999999999999 67899999999999999999999999999886
Q ss_pred cCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcC--------
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLP-------- 723 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 723 (791)
..... .....++|+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ......+.....
T Consensus 169 ~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 169 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHTT
T ss_pred ccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhccCCCHHHHHH
Confidence 54322 233456899999999999999999999999999999999999999653211 111111111100
Q ss_pred --------------CC---hhhhcchhhhhhHHhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 724 --------------HG---LTEVVDANLVREEQAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 724 --------------~~---~~~~~d~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
.. ........... .........+.++.+++.+|++.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFP--ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSC--CSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCcccccccccccccccccc--ccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00000000000 011123345678899999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-41 Score=355.62 Aligned_cols=262 Identities=21% Similarity=0.277 Sum_probs=194.8
Q ss_pred hhccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhh--hHHHHHHHHHHHHHHhccCCccceeeeeeccC-----Ce
Q 003855 500 TDEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQL--ERAFRSFDSECEVLRNVRHRNLIKILSSCSNP-----DF 571 (791)
Q Consensus 500 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 571 (791)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999996 479999999987543 33456788999999999999999999998532 34
Q ss_pred eeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeeccccc
Q 003855 572 KALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISKL 651 (791)
Q Consensus 572 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~~ 651 (791)
.++|++|+.+|+|.+++..+ .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+|++|||+|..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH----~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH----hCCCcccccCCccccccccccccccccchhcc
Confidence 46677788899999999754 3899999999999999999999 67899999999999999999999999999976
Q ss_pred cCCCCCcceeecccccccccCCCccCCC-CCCccccHHhHHHHHHHHHhCCCCCCccccCcchHHHHHHHhcCCChhhh-
Q 003855 652 LGEGEDSVTQTMTMATIGYMAPEYGSEG-IVSAKCDVYSYGVLLMETFTRKRPTDEMFTGEMSLRRWVKESLPHGLTEV- 729 (791)
Q Consensus 652 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 729 (791)
... ......|++.|+|||...+. .++.++||||+||++|||++|+.||.+... ......+.........+.
T Consensus 171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCHHHH
T ss_pred cCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChHHh
Confidence 432 22335689999999976554 568999999999999999999999975321 111111111111100000
Q ss_pred --cchhhhhhH----------HhhHHHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 003855 730 --VDANLVREE----------QAFSAKMDCILSIMDLALDCCIESPDMRINVTDAAA 774 (791)
Q Consensus 730 --~d~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev~~ 774 (791)
......... ........++..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000000 000011134567889999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-35 Score=318.04 Aligned_cols=265 Identities=19% Similarity=0.211 Sum_probs=187.7
Q ss_pred hccccccccCCCcceEEEEEEe-cCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-----------CCccceeeeeecc
Q 003855 501 DEFNECNLLGTGSFGSVYKGTI-SDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-----------HRNLIKILSSCSN 568 (791)
Q Consensus 501 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 568 (791)
.+|+++++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+.++++++ ||||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999997 4799999999975532 3456778888888775 5789999988754
Q ss_pred --CCeeeEEEecCCCCC-HHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCc----
Q 003855 569 --PDFKALVLEFMPNGS-LEKWLY-SHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMA---- 640 (791)
Q Consensus 569 --~~~~~lv~e~~~~g~-L~~~l~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~---- 640 (791)
....+++++++..+. ...... .....+++..+..++.||+.|++|||+ ..+|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~---~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh---hcCcccccCChhHeeeeccCccccc
Confidence 455566666655443 333332 344568899999999999999999994 368999999999999986653
Q ss_pred --EEEeeeccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHHHHHHhCCCCCCccccCc-----ch
Q 003855 641 --AHVSDFGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLLMETFTRKRPTDEMFTGE-----MS 713 (791)
Q Consensus 641 --~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~-----~~ 713 (791)
++++|||.|...... ....+||+.|+|||.+....++.++||||+||+++||++|+.||....... ..
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 999999999865322 234579999999999999999999999999999999999999987532110 01
Q ss_pred HHHHHHHhcC--CC-------hhhhcc-------------hhhhhh-HHhhHHHHHHHHHHHHHHhhccccCCCCCCCHH
Q 003855 714 LRRWVKESLP--HG-------LTEVVD-------------ANLVRE-EQAFSAKMDCILSIMDLALDCCIESPDMRINVT 770 (791)
Q Consensus 714 ~~~~~~~~~~--~~-------~~~~~d-------------~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 770 (791)
....+..... .. .....+ ...... ..........+.++.+++.+|++.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111111000 00 000000 000000 001111235677899999999999999999999
Q ss_pred HHHH
Q 003855 771 DAAA 774 (791)
Q Consensus 771 ev~~ 774 (791)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.98 E-value=1.7e-32 Score=287.31 Aligned_cols=261 Identities=33% Similarity=0.571 Sum_probs=239.0
Q ss_pred CCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccC-CccccccCccccCCCCCCEE
Q 003855 142 RNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHS-NDLNGTISPTMGRLKRLQGL 220 (791)
Q Consensus 142 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L 220 (791)
.+++.|+|++|.+++.. .+|++++++++|++|+|++ |++++.+|..|+++++|++|
T Consensus 50 ~~v~~L~L~~~~l~g~~-----------------------~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L 106 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPY-----------------------PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106 (313)
T ss_dssp CCEEEEEEECCCCSSCE-----------------------ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEE
T ss_pred EEEEEEECCCCCCCCCC-----------------------CCChHHhcCccccccccccccccccccccccccccccchh
Confidence 36778888888777531 4678899999999999997 89999999999999999999
Q ss_pred EcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCC-CeEEccCCcC
Q 003855 221 SLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYI-LDINLSSNSL 299 (791)
Q Consensus 221 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~l~~N~i 299 (791)
+|++|++.+..+..+..+..|+.+++++|.+.+.+|..+.++++|+.+++++|.+.+.+|..+..+..+ +.+++++|++
T Consensus 107 ~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l 186 (313)
T d1ogqa_ 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp EEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred hhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999888876 8899999999
Q ss_pred cccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhh
Q 003855 300 NDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSL 379 (791)
Q Consensus 300 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 379 (791)
++..|..+..+..+ .+++++|...+.+|..+..+++|+.+++++|.+.+.+ ..++.+++|+.|+|++|+++|.+|..|
T Consensus 187 ~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l 264 (313)
T d1ogqa_ 187 TGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp EEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGG
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHH
Confidence 99999988887654 7999999999999999999999999999999999655 468889999999999999999999999
Q ss_pred hhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccccCCCCCCCCCC
Q 003855 380 ETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGPPKLRVPPC 430 (791)
Q Consensus 380 ~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~~~~~~~~c 430 (791)
.++++|++|+|++|+|+|.+|..+.+.++..+++.||+.+||.| .|+|
T Consensus 265 ~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p---lp~c 312 (313)
T d1ogqa_ 265 TQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT---SSCC
T ss_pred hCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC---CCCC
Confidence 99999999999999999999988889999999999999999987 3567
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=5.9e-30 Score=276.24 Aligned_cols=343 Identities=23% Similarity=0.324 Sum_probs=226.2
Q ss_pred cCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCC
Q 003855 10 GNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLV 89 (791)
Q Consensus 10 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 89 (791)
..+.+|++|++++|+|+.+ +.+..+++|++|+|++|+|+ .+|. +.. +++|++|+|++|.|+++. .++++++|+
T Consensus 41 ~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~-~l~~-l~~-L~~L~~L~L~~n~i~~i~--~l~~l~~L~ 113 (384)
T d2omza2 41 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT-DITP-LKN-LTKLVDILMNNNQIADIT--PLANLTNLT 113 (384)
T ss_dssp HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCC-CCGG-GTT-CTTCCEEECCSSCCCCCG--GGTTCTTCC
T ss_pred HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCC-CCcc-ccC-Cccccccccccccccccc--ccccccccc
Confidence 3566777777777777643 45667777777777777776 5653 333 677777777777777543 366777777
Q ss_pred EEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhh
Q 003855 90 ALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASL 169 (791)
Q Consensus 90 ~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L 169 (791)
.|++++|.+++... ......+..+....|.+....... ................+.. +... ...
T Consensus 114 ~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~~~~-----~~~~-~~~ 177 (384)
T d2omza2 114 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS--------GLTSLQQLSFGNQVTDLKP-----LANL-TTL 177 (384)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGT--------TCTTCSEEEEEESCCCCGG-----GTTC-TTC
T ss_pred cccccccccccccc--cccccccccccccccccccccccc--------ccccccccccccccchhhh-----hccc-ccc
Confidence 77777777765433 334445555556666555433211 1111122222222222111 1000 111
Q ss_pred hhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCC
Q 003855 170 QKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGN 249 (791)
Q Consensus 170 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 249 (791)
.......|.. .....+..+++++.|++++|.+++..+ +..+++|++|++++|+++. ...+..+++|+.|++++|
T Consensus 178 ~~~~~~~~~~--~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n 251 (384)
T d2omza2 178 ERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251 (384)
T ss_dssp CEEECCSSCC--CCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSS
T ss_pred cccccccccc--ccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--cchhhcccccchhccccC
Confidence 1112222222 234556777888888888888886543 4567788888888888874 236778888888888888
Q ss_pred ccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCc
Q 003855 250 KLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPS 329 (791)
Q Consensus 250 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 329 (791)
.+++.. .+..+++|++|++++|++.+.. .+..++.++.+.++.|.+++. ..+..+++++.|++++|++++..
T Consensus 252 ~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~-- 323 (384)
T d2omza2 252 QISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS-- 323 (384)
T ss_dssp CCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--
T ss_pred ccCCCC--cccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--
Confidence 887543 3777888888888888887543 367788888888888888653 45777888888888888887543
Q ss_pred chhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCC
Q 003855 330 TIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHN 393 (791)
Q Consensus 330 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 393 (791)
.+..+++|+.|++++|+|++ ++ .++++++|++|++++|++++..| +.++++|+.|+|++|
T Consensus 324 ~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 324 PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 37788888888888888873 44 57888888888888888886554 778888888888887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=3e-29 Score=270.66 Aligned_cols=357 Identities=26% Similarity=0.337 Sum_probs=275.0
Q ss_pred eecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcc
Q 003855 18 LVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNS 97 (791)
Q Consensus 18 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 97 (791)
..++.+++++.+. ...+.+|++|++++|.|+ .++ ++.. +++|++|+|++|+|+++. .|+++++|++|++++|+
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l~-gl~~-L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~ 99 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEY-LNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQ 99 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CCT-TGGG-CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Ccc-cccc-CCCCCEEeCcCCcCCCCc--cccCCcccccccccccc
Confidence 3566666665543 346778899999999987 663 4544 789999999999998653 38889999999999999
Q ss_pred ccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccc
Q 003855 98 FAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYEC 177 (791)
Q Consensus 98 i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n 177 (791)
+.++. .++++++|+.|++++|.++.... ......+..+....|.+....+..... ... ....
T Consensus 100 i~~i~--~l~~l~~L~~L~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~~~~~~~~----~~~--~~~~ 161 (384)
T d2omza2 100 IADIT--PLANLTNLTGLTLFNNQITDIDP----------LKNLTNLNRLELSSNTISDISALSGLT----SLQ--QLSF 161 (384)
T ss_dssp CCCCG--GGTTCTTCCEEECCSSCCCCCGG----------GTTCTTCSEEEEEEEEECCCGGGTTCT----TCS--EEEE
T ss_pred ccccc--ccccccccccccccccccccccc----------ccccccccccccccccccccccccccc----ccc--cccc
Confidence 87654 37888889999888888876542 445567777777777765432211111 001 1111
Q ss_pred cccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCc
Q 003855 178 KLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPP 257 (791)
Q Consensus 178 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~ 257 (791)
.........+...+.........|... ....+..+++++.|++++|.+++..| +...++|+.|++++|+++. + .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~ 235 (384)
T d2omza2 162 GNQVTDLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-G 235 (384)
T ss_dssp EESCCCCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-G
T ss_pred ccccchhhhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-c
Confidence 111123345666677777777777765 34667889999999999999996554 5677899999999999984 3 3
Q ss_pred cccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccc
Q 003855 258 CLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDL 337 (791)
Q Consensus 258 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 337 (791)
.+..+++|+.|++++|++++.. .+..+++|+.|++++|.+++.. .+..++.++.++++.|.+++ ...+..++++
T Consensus 236 ~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l 309 (384)
T d2omza2 236 TLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNL 309 (384)
T ss_dssp GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTC
T ss_pred hhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhccc
Confidence 6889999999999999998654 3888999999999999998653 47889999999999999984 3458899999
Q ss_pred cccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCC
Q 003855 338 ETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGN 416 (791)
Q Consensus 338 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n 416 (791)
+.|++++|++++.. .+..+++|+.|++++|+|++ ++ .+..+++|++|++++|++++.+| ...+++|+.+.+.+|
T Consensus 310 ~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 310 TYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp SEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 99999999999643 38899999999999999985 44 68999999999999999998776 556788888888776
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=2e-30 Score=271.31 Aligned_cols=257 Identities=30% Similarity=0.442 Sum_probs=226.4
Q ss_pred ccccccccccccccccccCCCccccccccccCCCCCCcEEEccC-CCCcccCChhhhhhhhhhhhhhcccccccccCCcc
Q 003855 108 NLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGS-NPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQE 186 (791)
Q Consensus 108 ~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 186 (791)
.-.+++.|+|++|.+.... ..++++.++++|++|+|++ |++++. +|..
T Consensus 48 ~~~~v~~L~L~~~~l~g~~------~lp~~l~~L~~L~~L~Ls~~N~l~g~-------------------------iP~~ 96 (313)
T d1ogqa_ 48 QTYRVNNLDLSGLNLPKPY------PIPSSLANLPYLNFLYIGGINNLVGP-------------------------IPPA 96 (313)
T ss_dssp SCCCEEEEEEECCCCSSCE------ECCGGGGGCTTCSEEEEEEETTEESC-------------------------CCGG
T ss_pred CcEEEEEEECCCCCCCCCC------CCChHHhcCccccccccccccccccc-------------------------cccc
Confidence 3457999999999987531 3466799999999999986 777654 5566
Q ss_pred ccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCC-
Q 003855 187 IGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSL- 265 (791)
Q Consensus 187 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L- 265 (791)
|+++++|++|+|++|++.+..+..+..+.+|+++++++|.+.+.+|..+.+++.|+.+++++|.+.+.+|..+..+.++
T Consensus 97 i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~ 176 (313)
T d1ogqa_ 97 IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176 (313)
T ss_dssp GGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTC
T ss_pred cccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccc
Confidence 7788999999999999998888889999999999999999998999999999999999999999998899999888886
Q ss_pred cEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccc
Q 003855 266 RELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARN 345 (791)
Q Consensus 266 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 345 (791)
+.+++++|++++..|..+..+..+ .+++++|...+..|..+..+++|+.+++++|.+.+.+| .++.+++|+.|+|++|
T Consensus 177 ~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N 254 (313)
T d1ogqa_ 177 TSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNN 254 (313)
T ss_dssp CEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSS
T ss_pred cccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccC
Confidence 889999999998888888877654 79999999999999999999999999999999986554 6888999999999999
Q ss_pred cCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCC-Cccc
Q 003855 346 QFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNR-LEGE 398 (791)
Q Consensus 346 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~-l~~~ 398 (791)
+++|.+|..++++++|++|||++|+|+|.+|. +.++++|+.+++++|+ ++|.
T Consensus 255 ~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp CCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred eecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 99999999999999999999999999999984 6889999999999998 5664
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=1.7e-27 Score=247.90 Aligned_cols=283 Identities=22% Similarity=0.267 Sum_probs=155.9
Q ss_pred CCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccccccccccccccccccc
Q 003855 38 TMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQ 117 (791)
Q Consensus 38 ~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l 117 (791)
.++.++.++++++ ++|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.++.|.++++|+.|++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence 4566777777777 7777653 47788888888887666667888888888888888887776777777666666666
Q ss_pred ccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEE
Q 003855 118 VMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLS 197 (791)
Q Consensus 118 ~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 197 (791)
++|+|+.++.. ..+.|..|++..|.+.+.. +..+.....+..++
T Consensus 87 ~~n~l~~l~~~-----------~~~~l~~L~~~~n~l~~l~-------------------------~~~~~~~~~~~~l~ 130 (305)
T d1xkua_ 87 SKNQLKELPEK-----------MPKTLQELRVHENEITKVR-------------------------KSVFNGLNQMIVVE 130 (305)
T ss_dssp CSSCCSBCCSS-----------CCTTCCEEECCSSCCCBBC-------------------------HHHHTTCTTCCEEE
T ss_pred cCCccCcCccc-----------hhhhhhhhhccccchhhhh-------------------------hhhhhccccccccc
Confidence 66666655421 1245666666666665321 12233444555666
Q ss_pred ccCCccc--cccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcC
Q 003855 198 LHSNDLN--GTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKL 275 (791)
Q Consensus 198 L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 275 (791)
...|... ...+..|..+++|+++++++|.+. .+|..+ . ++|+.|++++|.+
T Consensus 131 ~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~------------------------~~L~~L~l~~n~~ 183 (305)
T d1xkua_ 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--P------------------------PSLTELHLDGNKI 183 (305)
T ss_dssp CCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--C------------------------TTCSEEECTTSCC
T ss_pred cccccccccCCCccccccccccCccccccCCcc-ccCccc--C------------------------CccCEEECCCCcC
Confidence 6665432 223344555556666666666555 222221 2 3444444444444
Q ss_pred CCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCC---
Q 003855 276 TSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIP--- 352 (791)
Q Consensus 276 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--- 352 (791)
....+..|..++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|+....
T Consensus 184 ~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f 262 (305)
T d1xkua_ 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 262 (305)
T ss_dssp CEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred CCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhc
Confidence 4444444444444444444444444444444444445555555555444 334444445555555555555442211
Q ss_pred ---cccCCCCCCcEEEccCCccC--CCCchhhhhcccCceE
Q 003855 353 ---ESVGSLISLESLDLSGNNLS--GKIPKSLETLSQLKQF 388 (791)
Q Consensus 353 ---~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~l 388 (791)
.....+.+|+.|+|++|++. ...|..|..+.....+
T Consensus 263 ~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~~ 303 (305)
T d1xkua_ 263 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303 (305)
T ss_dssp SCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGE
T ss_pred cCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCccc
Confidence 22334566777777777664 2445555544444333
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=7.7e-27 Score=242.90 Aligned_cols=269 Identities=22% Similarity=0.275 Sum_probs=207.3
Q ss_pred CCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEec
Q 003855 14 NLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDL 93 (791)
Q Consensus 14 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 93 (791)
.++.++-++++++ .+|..+. +++++|+|++|+|+ .+|+..+..+++|++|++++|.++.+.|..|.++++|++|++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence 5678899999998 4466664 68999999999998 888766666899999999999999888889999999999999
Q ss_pred cCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhh
Q 003855 94 GFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFY 173 (791)
Q Consensus 94 ~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~ 173 (791)
++|+++.+....+ ..|..|.+..|.+..++... +.....+..++...|.....
T Consensus 87 ~~n~l~~l~~~~~---~~l~~L~~~~n~l~~l~~~~--------~~~~~~~~~l~~~~n~~~~~---------------- 139 (305)
T d1xkua_ 87 SKNQLKELPEKMP---KTLQELRVHENEITKVRKSV--------FNGLNQMIVVELGTNPLKSS---------------- 139 (305)
T ss_dssp CSSCCSBCCSSCC---TTCCEEECCSSCCCBBCHHH--------HTTCTTCCEEECCSSCCCGG----------------
T ss_pred cCCccCcCccchh---hhhhhhhccccchhhhhhhh--------hhcccccccccccccccccc----------------
Confidence 9999987665443 46777888888888765433 66777888888888866521
Q ss_pred cccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCC
Q 003855 174 AYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSG 253 (791)
Q Consensus 174 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 253 (791)
...+..+..+++|+.+++++|.++.. +.. .+++|++|++++|.+....+..|..++.++.|++++|.+++
T Consensus 140 -------~~~~~~~~~l~~L~~l~l~~n~l~~l-~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~ 209 (305)
T d1xkua_ 140 -------GIENGAFQGMKKLSYIRIADTNITTI-PQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 209 (305)
T ss_dssp -------GBCTTGGGGCTTCCEEECCSSCCCSC-CSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred -------CCCccccccccccCccccccCCcccc-Ccc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccc
Confidence 12345577788889999999988743 333 35788999999998888888888888888888888888887
Q ss_pred CCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCccc------ccCCCCCEEecCCcccC
Q 003855 254 HIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNV------QKLKVLTVLDLSRNQLS 324 (791)
Q Consensus 254 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~------~~l~~L~~L~l~~N~l~ 324 (791)
..+..+.++++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+.+....| ..+.+|+.|+|++|.++
T Consensus 210 ~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 210 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp ECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 77788888888888888888887 446677888888888888888875443333 33455666666666654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.1e-27 Score=240.82 Aligned_cols=231 Identities=22% Similarity=0.210 Sum_probs=171.9
Q ss_pred CCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEec-CCccCCCCCccccCCCCCcEEE
Q 003855 191 SGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLT-GNKLSGHIPPCLVSLTSLRELH 269 (791)
Q Consensus 191 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-~N~i~~~~~~~~~~l~~L~~L~ 269 (791)
+++++|+|++|+|+.+.+.+|.++++|++|++++|+|..+.+..+..+..+..+... .|.++...+..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 456777777777776666677777777777777777777777777777777777654 5566666677777888888888
Q ss_pred cCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCC
Q 003855 270 LGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQG 349 (791)
Q Consensus 270 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 349 (791)
+++|.+....+..+....+|+.+++++|.|+++.+..|..+++|+.|++++|++++..+..|.++++|+.+++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 88888776666677777788888888888877666777777888888888888877667777888888888888888887
Q ss_pred CCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccccC
Q 003855 350 PIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCG 421 (791)
Q Consensus 350 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~ 421 (791)
..|..|..+++|++||+++|++.+..+..|..+++|+.|++++|++.|.++......+++......+...|.
T Consensus 192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~ 263 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeC
Confidence 777888888888888888888887777788888888888888888887765433333444444444555554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.5e-26 Score=237.76 Aligned_cols=255 Identities=19% Similarity=0.200 Sum_probs=134.2
Q ss_pred cEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCcccccccccccccccccccccc-c
Q 003855 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQ-V 118 (791)
Q Consensus 40 ~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l-~ 118 (791)
..+++++++++ ++|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|++..+....+.++..+..+.. .
T Consensus 14 ~~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~ 89 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccc
Confidence 34567777777 7777553 46788888888888777777888888888888888887776666665555555433 2
Q ss_pred cccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEc
Q 003855 119 MNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSL 198 (791)
Q Consensus 119 ~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 198 (791)
.|.++.++.. .|.++++|++|++++|.
T Consensus 90 ~~~~~~l~~~--------~~~~l~~L~~L~l~~n~--------------------------------------------- 116 (284)
T d1ozna_ 90 NAQLRSVDPA--------TFHGLGRLHTLHLDRCG--------------------------------------------- 116 (284)
T ss_dssp CTTCCCCCTT--------TTTTCTTCCEEECTTSC---------------------------------------------
T ss_pred ccccccccch--------hhcccccCCEEecCCcc---------------------------------------------
Confidence 3333333221 14444444444444444
Q ss_pred cCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCC
Q 003855 199 HSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSS 278 (791)
Q Consensus 199 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 278 (791)
+....+..+..+++|+.+++++|+|+++.+..|..+++|+.|++++|++++..+.+|.++++|+.+++++|++++.
T Consensus 117 ----~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 117 ----LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp ----CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred ----cccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 4333333344444444444444444433334444444444444444444444444444555555555555555544
Q ss_pred CCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccC
Q 003855 279 IPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVG 356 (791)
Q Consensus 279 ~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 356 (791)
.|..|..+++|++|++++|.+.+..+..|..+++|++|+|++|.+...-+. -.-...++.+....+++....|..+.
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~ 269 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHc
Confidence 455555555555555555555544445555555555555555555432211 11122344444455555444444443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.4e-24 Score=218.72 Aligned_cols=206 Identities=23% Similarity=0.198 Sum_probs=158.5
Q ss_pred cCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcE
Q 003855 188 GNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRE 267 (791)
Q Consensus 188 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 267 (791)
.+...+.+.+.++++++. +|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+. ++ .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccc
Confidence 345566677888888874 454443 467888888888876666777788888888888888773 33 3567888888
Q ss_pred EEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccC
Q 003855 268 LHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQF 347 (791)
Q Consensus 268 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 347 (791)
|+|++|+++ ..+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|
T Consensus 82 L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred ccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 888888887 3466777888888888888888777777778888888888888888876677777888888888888888
Q ss_pred CCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCC
Q 003855 348 QGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400 (791)
Q Consensus 348 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 400 (791)
++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++.|.+.
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 8777777888888888888888888 677777788888888888888877553
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=5.7e-24 Score=215.85 Aligned_cols=205 Identities=27% Similarity=0.254 Sum_probs=183.5
Q ss_pred cCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCe
Q 003855 212 GRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILD 291 (791)
Q Consensus 212 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 291 (791)
.....+.+++.+++.|+ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|+|+.. + .+..+++|+.
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccc
Confidence 45667788899999999 5676654 5799999999999977778899999999999999999854 3 4678999999
Q ss_pred EEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCcc
Q 003855 292 INLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNL 371 (791)
Q Consensus 292 L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 371 (791)
|+|++|+++. .+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.++...+..+..+++|+.|++++|++
T Consensus 82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred cccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 9999999984 567899999999999999999988888899999999999999999977788889999999999999999
Q ss_pred CCCCchhhhhcccCceEEccCCCCcccCCCCCCCcCCccccccCCccccCC
Q 003855 372 SGKIPKSLETLSQLKQFNVSHNRLEGEIPVKGSFKNFSVESFFGNYALCGP 422 (791)
Q Consensus 372 ~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~l~~~~~~~n~~~c~~ 422 (791)
++..+..|..+++|+.|+|++|+|+..++....+..++.+.+.||||.|+.
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCc
Confidence 988889999999999999999999966666677888999999999999974
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.89 E-value=5.6e-21 Score=202.41 Aligned_cols=303 Identities=25% Similarity=0.275 Sum_probs=189.8
Q ss_pred CCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEe
Q 003855 13 QNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALD 92 (791)
Q Consensus 13 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 92 (791)
.++++|||++|+++. +|+. .++|++|+|++|+|+ .+|+. +.+|+.|++++|.++. ++.. .+.|++|+
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~~-l~~l---p~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLKA-LSDL---PPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSC-CCSC---CTTCCEEE
T ss_pred cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccch-hhhh---cccccccc
Confidence 367788888888874 4543 457788888888887 77754 3577888888887773 2321 13577788
Q ss_pred ccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhh
Q 003855 93 LGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKF 172 (791)
Q Consensus 93 L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L 172 (791)
|++|.+..+. .++.+++|+.|++++|.+...+. ....+..+.+..+...
T Consensus 105 L~~n~l~~lp--~~~~l~~L~~L~l~~~~~~~~~~------------~~~~l~~l~~~~~~~~----------------- 153 (353)
T d1jl5a_ 105 VSNNQLEKLP--ELQNSSFLKIIDVDNNSLKKLPD------------LPPSLEFIAAGNNQLE----------------- 153 (353)
T ss_dssp CCSSCCSSCC--CCTTCTTCCEEECCSSCCSCCCC------------CCTTCCEEECCSSCCS-----------------
T ss_pred cccccccccc--chhhhccceeecccccccccccc------------ccccccchhhcccccc-----------------
Confidence 8877776543 24566667777766666654321 2244555555544433
Q ss_pred hcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccC
Q 003855 173 YAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLS 252 (791)
Q Consensus 173 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 252 (791)
.+..+..++.++.|++++|.+.... . .....+.+..+++.+. ..+ .+..++.|+.+++++|...
T Consensus 154 ----------~~~~l~~l~~l~~L~l~~n~~~~~~-~---~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~ 217 (353)
T d1jl5a_ 154 ----------ELPELQNLPFLTAIYADNNSLKKLP-D---LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK 217 (353)
T ss_dssp ----------SCCCCTTCTTCCEEECCSSCCSSCC-C---CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS
T ss_pred ----------ccccccccccceecccccccccccc-c---cccccccccccccccc-ccc-ccccccccccccccccccc
Confidence 2234566777888888888776322 1 2234556666666665 333 3566778888888888766
Q ss_pred CCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccC-CCCCEEecCCcccCCCCCcch
Q 003855 253 GHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKL-KVLTVLDLSRNQLSGDIPSTI 331 (791)
Q Consensus 253 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~ 331 (791)
. .+. ...++..+.+.+|++... + .....+...++..+.+.+. ..+ ......++..|.+.+. .
T Consensus 218 ~-~~~---~~~~l~~~~~~~~~~~~~-~---~~~~~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~~----~ 280 (353)
T d1jl5a_ 218 T-LPD---LPPSLEALNVRDNYLTDL-P---ELPQSLTFLDVSENIFSGL-----SELPPNLYYLNASSNEIRSL----C 280 (353)
T ss_dssp S-CCS---CCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSEE-----SCCCTTCCEEECCSSCCSEE----C
T ss_pred c-ccc---cccccccccccccccccc-c---ccccccccccccccccccc-----ccccchhcccccccCccccc----c
Confidence 3 332 345677788888877632 2 2234566666666655432 111 3445666777766522 2
Q ss_pred hccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCC
Q 003855 332 GALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIP 400 (791)
Q Consensus 332 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 400 (791)
..+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|++++|+|+..+.
T Consensus 281 ~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~lp~ 341 (353)
T d1jl5a_ 281 DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREFPD 341 (353)
T ss_dssp CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSSCCC
T ss_pred ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCCCCc
Confidence 34577888888888887 56643 567888888888887 45543 4578888888888876443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=6.5e-23 Score=196.56 Aligned_cols=169 Identities=18% Similarity=0.181 Sum_probs=120.8
Q ss_pred ccccccCCCcceEEEEEEecCCcEEEEEEeehhh------------------hHHHHHHHHHHHHHHhccCCccceeeee
Q 003855 504 NECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQL------------------ERAFRSFDSECEVLRNVRHRNLIKILSS 565 (791)
Q Consensus 504 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~niv~l~~~ 565 (791)
.+.++||+|+||+||+|+..+|+.||||+++... .........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4578999999999999998899999999875321 1122345678889999999999988766
Q ss_pred eccCCeeeEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEee
Q 003855 566 CSNPDFKALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSD 645 (791)
Q Consensus 566 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~D 645 (791)
.. .++||||++++.+.+ ++......++.|+++|++||| ..+|+||||||+|||++++ .++++|
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH----~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh----hCCEEEccCChhheeeeCC-CEEEEE
Confidence 42 379999998865533 344456789999999999999 6789999999999999965 488999
Q ss_pred eccccccCCCCCcceeecccccccccCCCccCCCCCCccccHHhHHHHH
Q 003855 646 FGISKLLGEGEDSVTQTMTMATIGYMAPEYGSEGIVSAKCDVYSYGVLL 694 (791)
Q Consensus 646 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~vl 694 (791)
||.|+..............+... .|.+ .+.|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~~~l~rd~~~~----~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWREILERDVRNI----ITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHHHHHHHHHHH----HHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHHHHHHHH----HHHH-cCCCCCcccHHHHHHHH
Confidence 99997654321110000000000 0111 25678899999976443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=3.2e-19 Score=188.66 Aligned_cols=299 Identities=24% Similarity=0.285 Sum_probs=195.3
Q ss_pred cCCccccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCc
Q 003855 4 QIPTEIGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSIT 83 (791)
Q Consensus 4 ~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 83 (791)
+||+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++. ..+.|++|+|++|.|+. +|. ++
T Consensus 52 ~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~----lp~~L~~L~L~~n~l~~-lp~-~~ 117 (353)
T d1jl5a_ 52 SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD----LPPLLEYLGVSNNQLEK-LPE-LQ 117 (353)
T ss_dssp CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS----CCTTCCEEECCSSCCSS-CCC-CT
T ss_pred CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh----hcccccccccccccccc-ccc-hh
Confidence 57753 478999999999998 557654 57999999999998 7764 23579999999999995 453 67
Q ss_pred CCCCCCEEeccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhh
Q 003855 84 NATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIG 163 (791)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 163 (791)
.+++|++|++++|.+..... ....+..+.+..+..... ..+..++.++.|++++|.+.....
T Consensus 118 ~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~~----------~~l~~l~~l~~L~l~~n~~~~~~~---- 179 (353)
T d1jl5a_ 118 NSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEEL----------PELQNLPFLTAIYADNNSLKKLPD---- 179 (353)
T ss_dssp TCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSC----------CCCTTCTTCCEEECCSSCCSSCCC----
T ss_pred hhccceeecccccccccccc----ccccccchhhcccccccc----------ccccccccceeccccccccccccc----
Confidence 89999999999999874332 234555666666555432 237788999999999998874211
Q ss_pred hhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCce
Q 003855 164 NFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFG 243 (791)
Q Consensus 164 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 243 (791)
.....+.+...++.+. .. ..+..++.|+.+++++|.... .+. ...++..
T Consensus 180 -------------------------~~~~~~~l~~~~~~~~-~~-~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~ 228 (353)
T d1jl5a_ 180 -------------------------LPLSLESIVAGNNILE-EL-PELQNLPFLTTIYADNNLLKT-LPD---LPPSLEA 228 (353)
T ss_dssp -------------------------CCTTCCEEECCSSCCS-SC-CCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCE
T ss_pred -------------------------cccccccccccccccc-cc-ccccccccccccccccccccc-ccc---ccccccc
Confidence 1122344555555554 22 234556677777777766552 222 2345566
Q ss_pred EEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCC-CCCCeEEccCCcCcccCCcccccCCCCCEEecCCcc
Q 003855 244 IRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSL-EYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQ 322 (791)
Q Consensus 244 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~ 322 (791)
+.+.+|.+.. .+. ...++...++..|.+.+. ..+ ......++..|.+.+. ...+++|++|+|++|+
T Consensus 229 ~~~~~~~~~~-~~~---~~~~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~ 295 (353)
T d1jl5a_ 229 LNVRDNYLTD-LPE---LPQSLTFLDVSENIFSGL-----SELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNK 295 (353)
T ss_dssp EECCSSCCSC-CCC---CCTTCCEEECCSSCCSEE-----SCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSC
T ss_pred cccccccccc-ccc---cccccccccccccccccc-----ccccchhcccccccCccccc----cccCCCCCEEECCCCc
Confidence 6666666652 222 234566666666655422 111 2345566666666532 2345678888888888
Q ss_pred cCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEc
Q 003855 323 LSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNV 390 (791)
Q Consensus 323 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 390 (791)
|+ .+|.. +++|+.|+|++|+|+ .+|.. +.+|+.|+|++|+|+ .+|... .+|+.|.+
T Consensus 296 l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~ 351 (353)
T d1jl5a_ 296 LI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDLRM 351 (353)
T ss_dssp CS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEEEC
T ss_pred cC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc---cccCeeEC
Confidence 87 55543 567888888888887 56643 457888888888887 556533 24555544
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=3.5e-20 Score=185.00 Aligned_cols=218 Identities=15% Similarity=0.114 Sum_probs=113.5
Q ss_pred cEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccc-cccccccccccccccccc
Q 003855 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAG-HILNTFGNLRHLSLLSQV 118 (791)
Q Consensus 40 ~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~l~ 118 (791)
+.++++++.++ .+|+.++ +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+.. +.+..|.++++++.+.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 45666666665 6665443 356666666666665555566666666666666666543 334455555555555543
Q ss_pred -cccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEE
Q 003855 119 -MNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLS 197 (791)
Q Consensus 119 -~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 197 (791)
.|++...+.. .|.++++|+.|++++|.++...+ ...+..+..+..+.
T Consensus 87 ~~n~l~~~~~~--------~~~~l~~L~~l~l~~~~l~~~~~------------------------~~~~~~l~~l~~~~ 134 (242)
T d1xwdc1 87 KANNLLYINPE--------AFQNLPNLQYLLISNTGIKHLPD------------------------VHKIHSLQKVLLDI 134 (242)
T ss_dssp CCTTCCEECTT--------SEECCTTCCEEEEESCCCCSCCC------------------------CTTTCBSSCEEEEE
T ss_pred ccccccccccc--------cccccccccccccchhhhccccc------------------------cccccccccccccc
Confidence 2444443322 25566666666666666553211 01122334444455
Q ss_pred ccCCccccccCccccCCC-CCCEEEcccccCcccCCccccccCCCce-EEecCCccCCCCCccccCCCCCcEEEcCCCcC
Q 003855 198 LHSNDLNGTISPTMGRLK-RLQGLSLRNNNLEGSIPYDLCHLKLMFG-IRLTGNKLSGHIPPCLVSLTSLRELHLGSNKL 275 (791)
Q Consensus 198 L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 275 (791)
..++.+..+.+..|.+++ .++.|++++|+++...+..|. .+++.. +.+++|+++...+..|.++++|++|+|++|+|
T Consensus 135 ~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l 213 (242)
T d1xwdc1 135 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 213 (242)
T ss_dssp ESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCC
T ss_pred ccccccccccccccccccccceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcC
Confidence 555555555555555443 556666666666633333332 233322 23455555544444455566666666666666
Q ss_pred CCCCCccccCCCCCCeEEc
Q 003855 276 TSSIPSSLWSLEYILDINL 294 (791)
Q Consensus 276 ~~~~~~~~~~l~~L~~L~l 294 (791)
+...+..|.++++|+.+++
T Consensus 214 ~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 214 HSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CCCCSSSCTTCCEEESSSE
T ss_pred CccCHHHHcCCcccccCcC
Confidence 5444444555554544444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=1.6e-19 Score=178.03 Aligned_cols=206 Identities=25% Similarity=0.355 Sum_probs=165.6
Q ss_pred hhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecC
Q 003855 169 LQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTG 248 (791)
Q Consensus 169 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 248 (791)
+..+++..+++++.. .+..+.+|+.|++.+|+|+.+ ..+..+++|++|++++|+|++..| +..+++|+.+++++
T Consensus 21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (227)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence 445667777776543 356678899999999999854 358899999999999999985443 88899999999999
Q ss_pred CccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCC
Q 003855 249 NKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP 328 (791)
Q Consensus 249 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 328 (791)
|.++. ++ .+.++++|+.+++++|...+. ..+...+.+..+.++++.+... ..+..+++|+.|++++|.+.+.
T Consensus 95 n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~-- 166 (227)
T d1h6ua2 95 NPLKN-VS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL-- 166 (227)
T ss_dssp CCCSC-CG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--
T ss_pred ccccc-cc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--
Confidence 99884 43 588899999999999988743 3467788899999999988643 3477888999999999998743
Q ss_pred cchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccC
Q 003855 329 STIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSH 392 (791)
Q Consensus 329 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 392 (791)
..++.+++|+.|+|++|++++ ++ .++.+++|++|+|++|++++.. .+.++++|+.|++++
T Consensus 167 ~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 167 TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 348889999999999999984 44 3888999999999999998543 388999999999874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=2.3e-22 Score=221.42 Aligned_cols=363 Identities=20% Similarity=0.159 Sum_probs=176.7
Q ss_pred CCCeeecCCCcccccC-CccccCCCCCcEEeCCCCcCcc----cCCchhhhcCCCccEEEccCCcceec----CCccCc-
Q 003855 14 NLQYLVFAENNLSGLV-PPTIFNISTMRILTLEGNQLSG----RLPSTVGHLLPNIESLLLAANNLTGI----IPHSIT- 83 (791)
Q Consensus 14 ~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~- 83 (791)
+|++||++.|++++.. .+.+..++++++|+|++|+|+. .+...+.. .++|++|+|++|.|+.. +...+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~-~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRV-NPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHT-CTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhc-CCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 5788888888886432 3345567888888888888762 22333333 67888888888887632 222332
Q ss_pred CCCCCCEEeccCccccccc----cccccccccccccccccccccccCCCcc-------------------------cccc
Q 003855 84 NATKLVALDLGFNSFAGHI----LNTFGNLRHLSLLSQVMNNLTTESSSAD-------------------------QWSF 134 (791)
Q Consensus 84 ~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~~-------------------------~~~~ 134 (791)
...+|++|+|++|+++... +..+..+++|+.|++++|.|+....... ....
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 2346888888888876543 3456667788888888887764321110 0001
Q ss_pred ccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEEccCCccccc----cCcc
Q 003855 135 LSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGT----ISPT 210 (791)
Q Consensus 135 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~ 210 (791)
...+...+.++.++++++.+....-..+.. .+. ........+++.++.+... ....
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~---~l~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~~~ 221 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQ---GLK-----------------DSPCQLEALKLESCGVTSDNCRDLCGI 221 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHH---HHH-----------------HSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccc---ccc-----------------cccccccccccccccccchhhhccccc
Confidence 112233445555555555543211001100 000 1112334455554444311 1112
Q ss_pred ccCCCCCCEEEcccccCccc-----CCccccccCCCceEEecCCccCCC----CCccccCCCCCcEEEcCCCcCCCCCCc
Q 003855 211 MGRLKRLQGLSLRNNNLEGS-----IPYDLCHLKLMFGIRLTGNKLSGH----IPPCLVSLTSLRELHLGSNKLTSSIPS 281 (791)
Q Consensus 211 ~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~ 281 (791)
+...+.++.+++++|.+... .+........++.+++++|.+... ....+...+.++.+++++|.+......
T Consensus 222 l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~ 301 (460)
T d1z7xw1 222 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 301 (460)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred ccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 23344555555555544311 112222334555555555554321 112233445555555555555421111
Q ss_pred cc-----cCCCCCCeEEccCCcCcccCCc----ccccCCCCCEEecCCcccCCCCCcc----hh-ccccccccccccccC
Q 003855 282 SL-----WSLEYILDINLSSNSLNDSLPS----NVQKLKVLTVLDLSRNQLSGDIPST----IG-ALKDLETLSLARNQF 347 (791)
Q Consensus 282 ~~-----~~l~~L~~L~l~~N~i~~~~~~----~~~~l~~L~~L~l~~N~l~~~~~~~----~~-~l~~L~~L~L~~N~l 347 (791)
.+ .....|+.+++++|.++..... .+...++|++|+|++|++++..... +. ..+.|++|+|++|+|
T Consensus 302 ~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i 381 (460)
T d1z7xw1 302 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 381 (460)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred hhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCC
Confidence 11 1223455666666555433222 2233445666666666654321111 11 234466666666666
Q ss_pred CCC----CCcccCCCCCCcEEEccCCccCCCCchhhh-----hcccCceEEccCCCCcc
Q 003855 348 QGP----IPESVGSLISLESLDLSGNNLSGKIPKSLE-----TLSQLKQFNVSHNRLEG 397 (791)
Q Consensus 348 ~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-----~l~~L~~l~l~~N~l~~ 397 (791)
+.. ++..+..+++|++|||++|+|+......+. ....|+.|++++|.+..
T Consensus 382 ~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 382 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred ChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 531 222334455666666666666543222221 12246666666666554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.7e-22 Score=222.40 Aligned_cols=375 Identities=18% Similarity=0.152 Sum_probs=254.6
Q ss_pred CCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCccee----cCCccCcCCCCCCEEeccCccccccccccc----c-c
Q 003855 38 TMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTG----IIPHSITNATKLVALDLGFNSFAGHILNTF----G-N 108 (791)
Q Consensus 38 ~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~----~-~ 108 (791)
+|+.||+++|++++.-=..+...++++++|+|++|.|+. .++..+..+++|++|||++|+|+......+ . .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 689999999999843212334447999999999999984 235567889999999999999975432222 2 2
Q ss_pred cccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhh-------cccccccc
Q 003855 109 LRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFY-------AYECKLKG 181 (791)
Q Consensus 109 l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~-------l~~n~l~~ 181 (791)
..+|+.|++++|++++.... .+...+..+++|++|+|++|.++......+.. .+.... .....+..
T Consensus 83 ~~~L~~L~L~~n~it~~~~~----~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~---~l~~~~~~~~~~~~~~~~~~~ 155 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCG----VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE---GLLDPQCRLEKLQLEYCSLSA 155 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHH----HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH---HHTSTTCCCCEEECTTSCCBG
T ss_pred CCCCCEEECCCCCccccccc----cccchhhccccccccccccccchhhhhhhhhh---cccccccccccccccccccch
Confidence 35799999999999865422 23456889999999999999998543322222 222111 11111111
Q ss_pred ----cCCccccCCCCCCEEEccCCccccccCc----cc-cCCCCCCEEEcccccCcccC----CccccccCCCceEEecC
Q 003855 182 ----NIPQEIGNLSGLTLLSLHSNDLNGTISP----TM-GRLKRLQGLSLRNNNLEGSI----PYDLCHLKLMFGIRLTG 248 (791)
Q Consensus 182 ----~~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~-~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~ 248 (791)
.....+.....++.++++++.+...... .+ ........+++..+.+.... ...+...+.++.+++++
T Consensus 156 ~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~ 235 (460)
T d1z7xw1 156 ASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS 235 (460)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCS
T ss_pred hhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhh
Confidence 1112244567899999999887522111 11 23346778899888776321 12345678899999999
Q ss_pred CccCC-----CCCccccCCCCCcEEEcCCCcCCCCC----CccccCCCCCCeEEccCCcCcccCCccc-----ccCCCCC
Q 003855 249 NKLSG-----HIPPCLVSLTSLRELHLGSNKLTSSI----PSSLWSLEYILDINLSSNSLNDSLPSNV-----QKLKVLT 314 (791)
Q Consensus 249 N~i~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~N~i~~~~~~~~-----~~l~~L~ 314 (791)
|.+.. ..+........|+.|++++|.+.... ...+...+.++.+++++|.+++.....+ .....|+
T Consensus 236 n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~ 315 (460)
T d1z7xw1 236 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLE 315 (460)
T ss_dssp SBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCC
T ss_pred ccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccc
Confidence 98742 22344556778999999999987432 2345567899999999999975333222 2346899
Q ss_pred EEecCCcccCCCCCcch----hccccccccccccccCCCC----CCcccC-CCCCCcEEEccCCccCCC----Cchhhhh
Q 003855 315 VLDLSRNQLSGDIPSTI----GALKDLETLSLARNQFQGP----IPESVG-SLISLESLDLSGNNLSGK----IPKSLET 381 (791)
Q Consensus 315 ~L~l~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~----~~~~~~-~l~~L~~L~l~~N~l~~~----~~~~~~~ 381 (791)
.+++++|.++......+ ...++|++|+|++|+|++. ++..+. ..+.|+.|+|++|+|+.. ++..+..
T Consensus 316 ~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~ 395 (460)
T d1z7xw1 316 SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA 395 (460)
T ss_dssp EEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHH
T ss_pred cccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhc
Confidence 99999999986543433 4567899999999999743 233333 456799999999999853 4556778
Q ss_pred cccCceEEccCCCCcccCCC------CCCCcCCccccccCCccc
Q 003855 382 LSQLKQFNVSHNRLEGEIPV------KGSFKNFSVESFFGNYAL 419 (791)
Q Consensus 382 l~~L~~l~l~~N~l~~~~~~------~~~~~~l~~~~~~~n~~~ 419 (791)
+++|++|+|++|+++..... ...-..++.+.+.+|.+.
T Consensus 396 ~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 396 NHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp CCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred CCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 89999999999999753211 011224677777777664
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=4.4e-20 Score=184.28 Aligned_cols=221 Identities=14% Similarity=0.092 Sum_probs=151.8
Q ss_pred CCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCccee-cCCccCcCCCCCCEEec
Q 003855 15 LQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTG-IIPHSITNATKLVALDL 93 (791)
Q Consensus 15 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L 93 (791)
.+.++.++++++ .+|+.+. +++++|+|++|+|+ .+|...|..+++|++|+|++|.+.. +.+.+|.+++++++|++
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 367888888888 5565553 57899999999998 8888777778999999999998875 45667889999999987
Q ss_pred c-CccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhh
Q 003855 94 G-FNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKF 172 (791)
Q Consensus 94 ~-~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L 172 (791)
. .|.+....++.|.++++|+.+++++|++...+.. ..+..++.|..+..+++.+....+..+....
T Consensus 86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~-------~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~------ 152 (242)
T d1xwdc1 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV-------HKIHSLQKVLLDIQDNINIHTIERNSFVGLS------ 152 (242)
T ss_dssp ECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCC-------TTTCBSSCEEEEEESCTTCCEECTTSSTTSB------
T ss_pred cccccccccccccccccccccccccchhhhcccccc-------ccccccccccccccccccccccccccccccc------
Confidence 5 4678888888899999999999999998765432 2355667777777778777754333322222
Q ss_pred hcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEE-EcccccCcccCCccccccCCCceEEecCCcc
Q 003855 173 YAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGL-SLRNNNLEGSIPYDLCHLKLMFGIRLTGNKL 251 (791)
Q Consensus 173 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i 251 (791)
..++.|++++|+++.+.+..|. .+++..+ ++++|+|+...+..|.++++|+.|+|++|+|
T Consensus 153 ------------------~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l 213 (242)
T d1xwdc1 153 ------------------FESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 213 (242)
T ss_dssp ------------------SSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCC
T ss_pred ------------------ccceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcC
Confidence 2566666666666654444433 3343333 4566666644445566667777777777777
Q ss_pred CCCCCccccCCCCCcEEEcC
Q 003855 252 SGHIPPCLVSLTSLRELHLG 271 (791)
Q Consensus 252 ~~~~~~~~~~l~~L~~L~L~ 271 (791)
+...+..|.++++|+.|++.
T Consensus 214 ~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 214 HSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp CCCCSSSCTTCCEEESSSEE
T ss_pred CccCHHHHcCCcccccCcCC
Confidence 65545556666666555543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=1.1e-19 Score=179.16 Aligned_cols=58 Identities=24% Similarity=0.276 Sum_probs=27.3
Q ss_pred CCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccccccccccccccccccccccc
Q 003855 61 LPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHILNTFGNLRHLSLLSQVMNNL 122 (791)
Q Consensus 61 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l 122 (791)
+.+|++|++++|.|+.+ ..+..+++|++|++++|+++++.+ |.++++|+.+++++|.+
T Consensus 40 l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 40 LDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred cCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence 34555555555555532 235555555555555555543221 33344444444443333
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=4e-19 Score=169.95 Aligned_cols=175 Identities=22% Similarity=0.254 Sum_probs=116.9
Q ss_pred eEEecCCccCCCCCccccCCCCCcEEEcCCCcCCC-CCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCc
Q 003855 243 GIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTS-SIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRN 321 (791)
Q Consensus 243 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N 321 (791)
.++.++++++ .+|..+. +++++|+|++|+|++ ..+..|..+++|+.|+|++|.+....+..|..+++|+.|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4555555555 3343332 456667777776654 33455666777777777777777666677777777777777777
Q ss_pred ccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcccCCC
Q 003855 322 QLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEGEIPV 401 (791)
Q Consensus 322 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 401 (791)
+|+...+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++.+..... .-...++.+.+..|.+++..|.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSST
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCCh
Confidence 777666667777777777777777777666777788888888888888887443321 1223456667777888776664
Q ss_pred CCCCcCCccccccCCccccCCC
Q 003855 402 KGSFKNFSVESFFGNYALCGPP 423 (791)
Q Consensus 402 ~~~~~~l~~~~~~~n~~~c~~~ 423 (791)
.+..++...+..|...|.++
T Consensus 168 --~l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 168 --KVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp --TTTTSBGGGSCTTTCCCCCC
T ss_pred --hhcCCEeeecCHhhCcCCCC
Confidence 35666677777888778655
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=8.2e-19 Score=167.76 Aligned_cols=173 Identities=22% Similarity=0.261 Sum_probs=115.9
Q ss_pred CCEEEccCCccccccCccccCCCCCCEEEcccccCcc-cCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcC
Q 003855 193 LTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEG-SIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLG 271 (791)
Q Consensus 193 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 271 (791)
.+.++.++|+++. +|..+. +++++|+|++|+|+. ..+..|.++++|+.|+|++|.+....+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 3567888888874 444442 578888888888864 345667778888888888888877777788888888888888
Q ss_pred CCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhccccccccccccccCCCCC
Q 003855 272 SNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPI 351 (791)
Q Consensus 272 ~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 351 (791)
+|+|.++.+..|.++++|++|+|++|+|+.+.+..|..+++|++|+|++|.+..... ...-...++.+.+..|.++...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCC
Confidence 888887777778888888888888888877777777788888888888887764322 1111233455555555554333
Q ss_pred CcccCCCCCCcEEEccCCccC
Q 003855 352 PESVGSLISLESLDLSGNNLS 372 (791)
Q Consensus 352 ~~~~~~l~~L~~L~l~~N~l~ 372 (791)
|..+ ..++.++|+.|.+.
T Consensus 166 p~~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 166 PSKV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp STTT---TTSBGGGSCTTTCC
T ss_pred Chhh---cCCEeeecCHhhCc
Confidence 3322 23333444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=2.4e-18 Score=166.93 Aligned_cols=183 Identities=25% Similarity=0.323 Sum_probs=97.3
Q ss_pred hhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecC
Q 003855 169 LQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTG 248 (791)
Q Consensus 169 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 248 (791)
.....+..+.+.+.++. ..+.+|+.|++++|.++... .+..+++|++|+|++|+|++.. .++.+++|+.|++++
T Consensus 26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~ 99 (210)
T d1h6ta2 26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDE 99 (210)
T ss_dssp HHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCS
T ss_pred HHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccc
Confidence 33445666666554443 23556777777777776432 3566777777777777776422 245556666666666
Q ss_pred CccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCC
Q 003855 249 NKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP 328 (791)
Q Consensus 249 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 328 (791)
|+|++ ++ .+.++++|+.|++++|.+.. ...+ ..++.|+.+++++|.+++ +
T Consensus 100 n~i~~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l------------------------~~l~~l~~l~~~~n~l~~--~ 149 (210)
T d1h6ta2 100 NKVKD-LS-SLKDLKKLKSLSLEHNGISD--INGL------------------------VHLPQLESLYLGNNKITD--I 149 (210)
T ss_dssp SCCCC-GG-GGTTCTTCCEEECTTSCCCC--CGGG------------------------GGCTTCCEEECCSSCCCC--C
T ss_pred ccccc-cc-cccccccccccccccccccc--cccc------------------------cccccccccccccccccc--c
Confidence 66552 22 35555555555555555542 1234 444444455555444442 2
Q ss_pred cchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEcc
Q 003855 329 STIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVS 391 (791)
Q Consensus 329 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 391 (791)
..+..+++|+.+++++|++++ ++ .++++++|+.|+|++|+|+. +| .+..+++|++|+|+
T Consensus 150 ~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 150 TVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp GGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred ccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 234445555555555555542 22 24555555555555555552 33 35555555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=5e-18 Score=164.67 Aligned_cols=164 Identities=27% Similarity=0.369 Sum_probs=123.1
Q ss_pred cCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEe
Q 003855 238 LKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLD 317 (791)
Q Consensus 238 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~ 317 (791)
+.+|+.|++++|.++.. + .+..+++|++|+|++|+|++.. .++.+++|+.|++++|+|++ ++ .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccc
Confidence 44555555555555532 2 2566777777777777776533 35667777788887777764 33 578889999999
Q ss_pred cCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCcc
Q 003855 318 LSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLEG 397 (791)
Q Consensus 318 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 397 (791)
+++|.+.. + ..+..++.++.+++++|.+++ +..+..+++|+.+++++|++++.. .+.++++|+.|++++|+++.
T Consensus 119 l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 119 LEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD 192 (210)
T ss_dssp CTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB
T ss_pred cccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC
Confidence 99999873 3 468899999999999999984 346788999999999999998643 38899999999999999986
Q ss_pred cCCCCCCCcCCcccccc
Q 003855 398 EIPVKGSFKNFSVESFF 414 (791)
Q Consensus 398 ~~~~~~~~~~l~~~~~~ 414 (791)
. |....+++|+.+.+.
T Consensus 193 l-~~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 193 L-RALAGLKNLDVLELF 208 (210)
T ss_dssp C-GGGTTCTTCSEEEEE
T ss_pred C-hhhcCCCCCCEEEcc
Confidence 4 445667777777654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=7.9e-18 Score=161.82 Aligned_cols=180 Identities=28% Similarity=0.397 Sum_probs=98.1
Q ss_pred hhhhhcccccccccCCccccCCCCCCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecC
Q 003855 169 LQKFYAYECKLKGNIPQEIGNLSGLTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTG 248 (791)
Q Consensus 169 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 248 (791)
...+.+..+.+++..+ ...+.+++.|++++|.|+.. +.+..+++|++|+|++|+|++..| ++++++|+.|++++
T Consensus 20 ~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~ 93 (199)
T d2omxa2 20 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 93 (199)
T ss_dssp HHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccc
Confidence 3445666666665433 23566777778877777743 346667777777777777764322 55666666666666
Q ss_pred CccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCC
Q 003855 249 NKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIP 328 (791)
Q Consensus 249 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 328 (791)
|.+.. ++ .+.++++|+.|++++|.+... ..+. .+++|+.|++++|++.. +
T Consensus 94 n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~------------------------~l~~L~~L~l~~n~l~~-~- 143 (199)
T d2omxa2 94 NQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLK------------------------NLTNLNRLELSSNTISD-I- 143 (199)
T ss_dssp SCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGT------------------------TCTTCSEEECCSSCCCC-C-
T ss_pred ccccc-cc-ccccccccccccccccccccc--cccc------------------------hhhhhHHhhhhhhhhcc-c-
Confidence 66552 22 255555566665555555422 2234 44445555555554441 2
Q ss_pred cchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceE
Q 003855 329 STIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQF 388 (791)
Q Consensus 329 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l 388 (791)
..+..+++|+.|++++|++++ ++ .++++++|+.|++++|++++ ++ .+..+++|++|
T Consensus 144 ~~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 144 SALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ccccccccccccccccccccC-Cc-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 234445555555555555552 22 25555666666666666653 22 35555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=8.4e-18 Score=161.63 Aligned_cols=160 Identities=25% Similarity=0.393 Sum_probs=118.0
Q ss_pred ccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEE
Q 003855 237 HLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVL 316 (791)
Q Consensus 237 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L 316 (791)
.+.+++.|++++|.|+. + +.+..+++|++|++++|++++..+ +..+++|++|++++|.+... + .+.+++.|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccc-c-ccccccccccc
Confidence 34455555555555542 2 235666777777777777765432 67777777777777777543 2 47888999999
Q ss_pred ecCCcccCCCCCcchhccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCCCchhhhhcccCceEEccCCCCc
Q 003855 317 DLSRNQLSGDIPSTIGALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGKIPKSLETLSQLKQFNVSHNRLE 396 (791)
Q Consensus 317 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 396 (791)
++++|.+... ..+..+++|+.|++++|++. .++ .+..+++|+.|++++|++++.. .+.++++|+.|++++|+++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred cccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence 9999988743 45788999999999999998 444 5889999999999999998643 4889999999999999998
Q ss_pred ccCCCCCCCcCCc
Q 003855 397 GEIPVKGSFKNFS 409 (791)
Q Consensus 397 ~~~~~~~~~~~l~ 409 (791)
.. +....+++|+
T Consensus 186 ~i-~~l~~L~~L~ 197 (199)
T d2omxa2 186 DI-SVLAKLTNLE 197 (199)
T ss_dssp CC-GGGGGCTTCS
T ss_pred CC-ccccCCCCCC
Confidence 74 3344455544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.61 E-value=2e-17 Score=174.02 Aligned_cols=262 Identities=17% Similarity=0.225 Sum_probs=129.4
Q ss_pred ccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccC---Chhhhhhhhhhhhhhccccccc
Q 003855 104 NTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGIL---PPVIGNFSASLQKFYAYECKLK 180 (791)
Q Consensus 104 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~---~~~~~~~~~~L~~L~l~~n~l~ 180 (791)
..+.....|+.|++++|.|...... .+...+..+++|+.|+++++...... +..+..
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~----~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~---------------- 84 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAAR----WLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRL---------------- 84 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHH----HHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHH----------------
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHH----HHHHHHHhCCCCCEEECCCCcccccccccchHHHH----------------
Confidence 3455566777777777776543221 12334666677777777766544211 111111
Q ss_pred ccCCccccCCCCCCEEEccCCcccccc----CccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCC
Q 003855 181 GNIPQEIGNLSGLTLLSLHSNDLNGTI----SPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIP 256 (791)
Q Consensus 181 ~~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 256 (791)
+...+..+++|+.|+|++|.+.... ...+...++|++|++++|.+.......+... +..+ ...
T Consensus 85 --l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~--l~~~---------~~~ 151 (344)
T d2ca6a1 85 --LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQEL---------AVN 151 (344)
T ss_dssp --HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HHHH---------HHH
T ss_pred --HHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccccccccc--cccc---------ccc
Confidence 1233555667777777777775432 2233456677777777776642211111000 0000 000
Q ss_pred ccccCCCCCcEEEcCCCcCCCC----CCccccCCCCCCeEEccCCcCccc-----CCcccccCCCCCEEecCCcccCCC-
Q 003855 257 PCLVSLTSLRELHLGSNKLTSS----IPSSLWSLEYILDINLSSNSLNDS-----LPSNVQKLKVLTVLDLSRNQLSGD- 326 (791)
Q Consensus 257 ~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~i~~~-----~~~~~~~l~~L~~L~l~~N~l~~~- 326 (791)
......+.|+.|++++|++... +...+...+.|+.|+|++|.|+.. +...+..+++|+.|+|++|.++..
T Consensus 152 ~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g 231 (344)
T d2ca6a1 152 KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG 231 (344)
T ss_dssp HHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH
T ss_pred cccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccc
Confidence 0012233445555555544321 111223344555555555554421 122344555566666666655422
Q ss_pred ---CCcchhccccccccccccccCCCCCCcc----cC--CCCCCcEEEccCCccCCC----Cchhhh-hcccCceEEccC
Q 003855 327 ---IPSTIGALKDLETLSLARNQFQGPIPES----VG--SLISLESLDLSGNNLSGK----IPKSLE-TLSQLKQFNVSH 392 (791)
Q Consensus 327 ---~~~~~~~l~~L~~L~L~~N~l~~~~~~~----~~--~l~~L~~L~l~~N~l~~~----~~~~~~-~l~~L~~l~l~~ 392 (791)
+...+..+++|++|+|++|.|++..... +. ..+.|+.|++++|+|+.. +...+. ++++|+.|++++
T Consensus 232 ~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~ 311 (344)
T d2ca6a1 232 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311 (344)
T ss_dssp HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTT
T ss_pred cccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCC
Confidence 2233445566666666666665321111 21 235678888888877643 223332 466788888888
Q ss_pred CCCccc
Q 003855 393 NRLEGE 398 (791)
Q Consensus 393 N~l~~~ 398 (791)
|++...
T Consensus 312 N~~~~~ 317 (344)
T d2ca6a1 312 NRFSEE 317 (344)
T ss_dssp SBSCTT
T ss_pred CcCCCc
Confidence 887643
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.59 E-value=6.1e-17 Score=170.22 Aligned_cols=201 Identities=18% Similarity=0.185 Sum_probs=116.5
Q ss_pred ccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCChhhhhhhhhhhhhhcccccccccCCccc
Q 003855 108 NLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEI 187 (791)
Q Consensus 108 ~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 187 (791)
..++|+.|++++|.++..... .+...+..+++|+.|++++|.++...... +...+..+.... ..
T Consensus 91 ~~~~L~~L~L~~n~i~~~~~~----~l~~~l~~~~~L~~L~l~~n~l~~~~~~~---l~~~l~~~~~~~---------~~ 154 (344)
T d2ca6a1 91 KCPKLHTVRLSDNAFGPTAQE----PLIDFLSKHTPLEHLYLHNNGLGPQAGAK---IARALQELAVNK---------KA 154 (344)
T ss_dssp TCTTCCEEECCSCCCCTTTHH----HHHHHHHHCTTCCEEECCSSCCHHHHHHH---HHHHHHHHHHHH---------HH
T ss_pred hCCCccccccccccccccccc----chhhhhcccccchheeccccccccccccc---cccccccccccc---------cc
Confidence 344555555555555432211 12334556778888888888876332222 222233332211 12
Q ss_pred cCCCCCCEEEccCCcccccc----CccccCCCCCCEEEcccccCccc-----CCccccccCCCceEEecCCccCCC----
Q 003855 188 GNLSGLTLLSLHSNDLNGTI----SPTMGRLKRLQGLSLRNNNLEGS-----IPYDLCHLKLMFGIRLTGNKLSGH---- 254 (791)
Q Consensus 188 ~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~L~~N~i~~~---- 254 (791)
...+.|+.|++++|.++... ...+...+.|++|+|++|+|+.. +...+...++|+.|+|++|.++..
T Consensus 155 ~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~ 234 (344)
T d2ca6a1 155 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 234 (344)
T ss_dssp HTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHH
T ss_pred ccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccc
Confidence 34567888888888876322 23345677888888888888642 233456677788888888877532
Q ss_pred CCccccCCCCCcEEEcCCCcCCCCCCccc----c--CCCCCCeEEccCCcCcccC----Cccc-ccCCCCCEEecCCccc
Q 003855 255 IPPCLVSLTSLRELHLGSNKLTSSIPSSL----W--SLEYILDINLSSNSLNDSL----PSNV-QKLKVLTVLDLSRNQL 323 (791)
Q Consensus 255 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~--~l~~L~~L~l~~N~i~~~~----~~~~-~~l~~L~~L~l~~N~l 323 (791)
+...+..+++|++|+|++|.|++.....+ . ....|++|++++|+|+... ...+ .++++|+.|+|++|++
T Consensus 235 L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 235 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp HHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred ccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 33455677778888888887764322222 2 2345777777777765422 2222 2456677777777776
Q ss_pred C
Q 003855 324 S 324 (791)
Q Consensus 324 ~ 324 (791)
.
T Consensus 315 ~ 315 (344)
T d2ca6a1 315 S 315 (344)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=1.8e-16 Score=161.26 Aligned_cols=254 Identities=15% Similarity=0.150 Sum_probs=146.1
Q ss_pred CeeecCCCcccccCCccccCC--CCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceec-CCccCcCCCCCCEEe
Q 003855 16 QYLVFAENNLSGLVPPTIFNI--STMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGI-IPHSITNATKLVALD 92 (791)
Q Consensus 16 ~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~ 92 (791)
+.|||+++.+. |+.+..+ ..+..+.++++.+. ......+. ..+|++|+|++|.++.. +...+..+++|++|+
T Consensus 3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~-~~~~~~~~-~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~ 77 (284)
T d2astb2 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMD-QPLAEHFS-PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 77 (284)
T ss_dssp SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEEC-SCCCSCCC-CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred CEEECCCCCCC---chHHHHHHhccceEeeccccccc-cchhhhcc-CCCCCEEECCCCccCHHHHHHHHHhCCCccccc
Confidence 46788887764 2333222 23556667666654 22222222 45788888888877633 344567788888888
Q ss_pred ccCccccccccccccccccccccccccc-cccccCCCccccccccccCCCCCCcEEEccCC-CCcccC-Chhhhhhhhhh
Q 003855 93 LGFNSFAGHILNTFGNLRHLSLLSQVMN-NLTTESSSADQWSFLSSLTNCRNLTILSFGSN-PLGGIL-PPVIGNFSASL 169 (791)
Q Consensus 93 L~~N~i~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N-~l~~~~-~~~~~~~~~~L 169 (791)
|++|.+.......+..+++|+.|+++++ .+++.. +..-+.++++|++|+++++ .+++.. ...+.
T Consensus 78 L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~-------l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~------ 144 (284)
T d2astb2 78 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA-------LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA------ 144 (284)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH-------HHHHHHHCTTCCEEECCCCTTCCHHHHHHHHH------
T ss_pred ccccCCCcHHHHHHhcCCCCcCccccccccccccc-------cchhhHHHHhccccccccccccccccchhhhc------
Confidence 8888877766777777888888888774 454321 1111346788888888886 344211 01111
Q ss_pred hhhhcccccccccCCccccCCCCCCEEEccCC--ccccc-cCccccCCCCCCEEEcccc-cCcccCCccccccCCCceEE
Q 003855 170 QKFYAYECKLKGNIPQEIGNLSGLTLLSLHSN--DLNGT-ISPTMGRLKRLQGLSLRNN-NLEGSIPYDLCHLKLMFGIR 245 (791)
Q Consensus 170 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N--~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~ 245 (791)
...++|+.|+++++ .++.. +...+..+++|++|++++| .+++.....+..+++|++|+
T Consensus 145 ------------------~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~ 206 (284)
T d2astb2 145 ------------------HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS 206 (284)
T ss_dssp ------------------HSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred ------------------ccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEE
Confidence 12346667777654 23321 1122345667777777765 45555566666777777777
Q ss_pred ecCC-ccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCC-CCCCeEEccCCcCcccCCccccc
Q 003855 246 LTGN-KLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSL-EYILDINLSSNSLNDSLPSNVQK 309 (791)
Q Consensus 246 L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~i~~~~~~~~~~ 309 (791)
|++| .+++.....++++++|+.|+++++ +.. ..+..+ ..+..|.+..+.++...++.++.
T Consensus 207 L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d---~~l~~l~~~lp~L~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 207 LSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 268 (284)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCH---HHHHHHHHhCccccccCccCCCCCCCccCc
Confidence 7774 455555556677777777777776 321 111111 22333445666666555555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=5.8e-16 Score=142.42 Aligned_cols=113 Identities=18% Similarity=0.178 Sum_probs=64.2
Q ss_pred ccCCCCCCeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCC
Q 003855 9 IGNLQNLQYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKL 88 (791)
Q Consensus 9 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 88 (791)
+.++.+|++|+|++|+|+.+ +..+..+++|+.|+|++|+|+ .++. + ..+++|++|+|++|+|+.+.+..+..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-~l~~-~-~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KLDG-F-PLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EECC-C-CCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-ccCC-c-ccCcchhhhhcccccccCCCcccccccccc
Confidence 44555666666666666533 444555666666666666665 4432 2 225566666666666665544455556666
Q ss_pred CEEeccCcccccccc-cccccccccccccccccccccc
Q 003855 89 VALDLGFNSFAGHIL-NTFGNLRHLSLLSQVMNNLTTE 125 (791)
Q Consensus 89 ~~L~L~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~ 125 (791)
++|+|++|+|+.... ..+..+++|+.|++++|.++..
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~ 127 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccc
Confidence 666666666654322 3455555555555555555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=2e-15 Score=138.83 Aligned_cols=127 Identities=23% Similarity=0.231 Sum_probs=78.9
Q ss_pred ccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhcccccc
Q 003855 259 LVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGALKDLE 338 (791)
Q Consensus 259 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 338 (791)
+.+..+|++|+|++|+|+. ++..+..+++|+.|+|++|+|+.. +.|..+++|+.|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 4455556666666666653 244445566666666666666533 2356666677777777776644444456677777
Q ss_pred ccccccccCCCCCC--cccCCCCCCcEEEccCCccCCCC---chhhhhcccCceEE
Q 003855 339 TLSLARNQFQGPIP--ESVGSLISLESLDLSGNNLSGKI---PKSLETLSQLKQFN 389 (791)
Q Consensus 339 ~L~L~~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~---~~~~~~l~~L~~l~ 389 (791)
.|++++|+|+. ++ ..+..+++|+.|++++|+++... +..+..+|+|+.||
T Consensus 91 ~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccc-cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 77777777763 32 35667778888888888776332 23567778887776
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=8e-16 Score=156.36 Aligned_cols=255 Identities=15% Similarity=0.157 Sum_probs=178.1
Q ss_pred cEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccCccccccc-cccccccccccccccc
Q 003855 40 RILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGFNSFAGHI-LNTFGNLRHLSLLSQV 118 (791)
Q Consensus 40 ~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~l~ 118 (791)
+.|||+++.+.......+.. ..+..+.++...+.... .......+|++|||++|.+.... ...+.++++|++|+++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred CEEECCCCCCCchHHHHHHh--ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence 57999998886444444433 35678888888777433 33445678999999999987543 4567889999999999
Q ss_pred cccccccCCCccccccccccCCCCCCcEEEccCC-CCcccCChhhhhhhhhhhhhhcccccccccCCccccCCCCCCEEE
Q 003855 119 MNNLTTESSSADQWSFLSSLTNCRNLTILSFGSN-PLGGILPPVIGNFSASLQKFYAYECKLKGNIPQEIGNLSGLTLLS 197 (791)
Q Consensus 119 ~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 197 (791)
++.++.. .+..+..+++|++|++++| .+++. .+.. -+.++++|++|+
T Consensus 80 ~~~l~~~--------~~~~l~~~~~L~~L~Ls~c~~itd~---~l~~---------------------l~~~~~~L~~L~ 127 (284)
T d2astb2 80 GLRLSDP--------IVNTLAKNSNLVRLNLSGCSGFSEF---ALQT---------------------LLSSCSRLDELN 127 (284)
T ss_dssp TCBCCHH--------HHHHHTTCTTCSEEECTTCBSCCHH---HHHH---------------------HHHHCTTCCEEE
T ss_pred ccCCCcH--------HHHHHhcCCCCcCcccccccccccc---ccch---------------------hhHHHHhccccc
Confidence 9987643 2445788899999999986 45521 1111 124578999999
Q ss_pred ccCC-ccccc-cCcccc-CCCCCCEEEcccc--cCccc-CCccccccCCCceEEecCC-ccCCCCCccccCCCCCcEEEc
Q 003855 198 LHSN-DLNGT-ISPTMG-RLKRLQGLSLRNN--NLEGS-IPYDLCHLKLMFGIRLTGN-KLSGHIPPCLVSLTSLRELHL 270 (791)
Q Consensus 198 L~~N-~l~~~-~~~~~~-~l~~L~~L~L~~N--~l~~~-~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L 270 (791)
++++ .++.. ....+. ..++|+.|+++++ .++.. +...+.++++|+.|++++| .+++.....+..+++|++|+|
T Consensus 128 ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L 207 (284)
T d2astb2 128 LSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSL 207 (284)
T ss_dssp CCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEEC
T ss_pred cccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEEC
Confidence 9996 45422 112233 3578999999975 34432 2334467899999999997 577677788999999999999
Q ss_pred CCC-cCCCCCCccccCCCCCCeEEccCCcCccc-CCcccccCCCCCEEecCCcccCCCCCcchhc
Q 003855 271 GSN-KLTSSIPSSLWSLEYILDINLSSNSLNDS-LPSNVQKLKVLTVLDLSRNQLSGDIPSTIGA 333 (791)
Q Consensus 271 ~~N-~l~~~~~~~~~~l~~L~~L~l~~N~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 333 (791)
++| .+++.....+..+++|+.|+++++ +++. +......+++| .+..+.++...+..++.
T Consensus 208 ~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L---~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 208 SRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHL---QINCSHFTTIARPTIGN 268 (284)
T ss_dssp TTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTS---EESCCCSCCTTCSSCSS
T ss_pred CCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccc---cccCccCCCCCCCccCc
Confidence 995 677666677888999999999988 4332 22222345554 46777887665555544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.56 E-value=5.3e-15 Score=129.11 Aligned_cols=105 Identities=25% Similarity=0.295 Sum_probs=81.2
Q ss_pred CeeecCCCcccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEeccC
Q 003855 16 QYLVFAENNLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALDLGF 95 (791)
Q Consensus 16 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 95 (791)
|+|+|++|+|+.. + .+.++++|++|++++|+|+ .+|+.+.. +++|++|++++|.|+++ | .|+.+++|++|++++
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~-l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAA-LRCLEVLQASDNALENV-D-GVANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGG-CTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCS
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhh-hhccccccccccccccc-C-ccccccccCeEECCC
Confidence 5789999999844 4 4888899999999999998 88877665 78899999999998854 3 588888888888888
Q ss_pred ccccccc-cccccccccccccccccccccccC
Q 003855 96 NSFAGHI-LNTFGNLRHLSLLSQVMNNLTTES 126 (791)
Q Consensus 96 N~i~~~~-~~~~~~l~~L~~L~l~~n~l~~~~ 126 (791)
|+|+... ...+..+++|+.|++++|.++..+
T Consensus 75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred CccCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence 8887654 355666777777777777766543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=2.6e-14 Score=124.63 Aligned_cols=77 Identities=27% Similarity=0.401 Sum_probs=33.6
Q ss_pred EEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcCCCc
Q 003855 195 LLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLGSNK 274 (791)
Q Consensus 195 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 274 (791)
.|+|++|+|+.. + .+..+++|++|++++|+|+ .+|..++.+++|+.|++++|+|+. +| .++.+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 345555555422 2 2444445555555555544 233344444444444444444442 22 24444444444444444
Q ss_pred CC
Q 003855 275 LT 276 (791)
Q Consensus 275 l~ 276 (791)
|.
T Consensus 77 i~ 78 (124)
T d1dcea3 77 LQ 78 (124)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=1.6e-15 Score=144.70 Aligned_cols=131 Identities=20% Similarity=0.235 Sum_probs=80.5
Q ss_pred CCeeecCCC--cccccCCccccCCCCCcEEeCCCCcCcccCCchhhhcCCCccEEEccCCcceecCCccCcCCCCCCEEe
Q 003855 15 LQYLVFAEN--NLSGLVPPTIFNISTMRILTLEGNQLSGRLPSTVGHLLPNIESLLLAANNLTGIIPHSITNATKLVALD 92 (791)
Q Consensus 15 L~~L~Ls~n--~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 92 (791)
++.++++++ .++ .+|.+|..+++|++|+|++|+|+ .++. +.. +++|++|+|++|.|+. +|..+..+++|++|+
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~~-l~~-l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~ 99 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS-LSG-MENLRILSLGRNLIKK-IENLDAVADTLEELW 99 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCCC-HHH-HTTCCEEECCEEEECS-CSSHHHHHHHCCEEE
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Cccc-ccC-CccccChhhccccccc-ccccccccccccccc
Confidence 445555543 233 34556667777777777777776 5642 333 6677777777777763 444445555677777
Q ss_pred ccCccccccccccccccccccccccccccccccCCCccccccccccCCCCCCcEEEccCCCCcccCC
Q 003855 93 LGFNSFAGHILNTFGNLRHLSLLSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLGGILP 159 (791)
Q Consensus 93 L~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 159 (791)
+++|+|+.+ ..+.++++|+.|++++|+|+.++. +..|..+++|+.|+|++|++....+
T Consensus 100 l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~-------~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 100 ISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGE-------IDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp CSEEECCCH--HHHHHHHHSSEEEESEEECCCHHH-------HHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccccc--ccccccccccccccccchhccccc-------cccccCCCccceeecCCCccccCcc
Confidence 777777643 346667777777777777765421 2236677777777777777664433
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=5.9e-15 Score=140.60 Aligned_cols=129 Identities=25% Similarity=0.345 Sum_probs=79.0
Q ss_pred CCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCCCcchhcc
Q 003855 255 IPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDIPSTIGAL 334 (791)
Q Consensus 255 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 334 (791)
++..+..+++|++|+|++|+|+.+ + .+..+++|+.|+|++|.|+ .++..+..+++|+.|++++|+++. + ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 344455556666666666666532 2 3555666666666666665 234444445567777777777763 2 346667
Q ss_pred ccccccccccccCCCCCC--cccCCCCCCcEEEccCCccCCCCch----------hhhhcccCceEE
Q 003855 335 KDLETLSLARNQFQGPIP--ESVGSLISLESLDLSGNNLSGKIPK----------SLETLSQLKQFN 389 (791)
Q Consensus 335 ~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~~~----------~~~~l~~L~~l~ 389 (791)
++|+.|++++|+|+. ++ ..+..+++|+.|+|++|++....+. .+..+|+|+.||
T Consensus 115 ~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 115 VNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccccchhcc-ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 777777777777763 33 3567777888888888877643332 256677777765
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=2.4e-12 Score=116.97 Aligned_cols=83 Identities=18% Similarity=0.108 Sum_probs=35.8
Q ss_pred CCEEEccCCccccccCccccCCCCCCEEEcccc-cCcccCCccccccCCCceEEecCCccCCCCCccccCCCCCcEEEcC
Q 003855 193 LTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNN-NLEGSIPYDLCHLKLMFGIRLTGNKLSGHIPPCLVSLTSLRELHLG 271 (791)
Q Consensus 193 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 271 (791)
.+.++.+++++. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+...+.+|.++++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344555555544 23344444445555555433 2443333344444444444444444443333444444444444444
Q ss_pred CCcCC
Q 003855 272 SNKLT 276 (791)
Q Consensus 272 ~N~l~ 276 (791)
+|+|+
T Consensus 89 ~N~l~ 93 (156)
T d2ifga3 89 FNALE 93 (156)
T ss_dssp SSCCS
T ss_pred CCCCc
Confidence 44443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=1.6e-12 Score=118.19 Aligned_cols=108 Identities=23% Similarity=0.158 Sum_probs=68.3
Q ss_pred CCCCEEEcccccCcccCCccccccCCCceEEecCC-ccCCCCCccccCCCCCcEEEcCCCcCCCCCCccccCCCCCCeEE
Q 003855 215 KRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGN-KLSGHIPPCLVSLTSLRELHLGSNKLTSSIPSSLWSLEYILDIN 293 (791)
Q Consensus 215 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 293 (791)
...+.++++++.+. ..|..+..+++|++|++++| .|+...+.+|.++++|+.|+|++|+|+.+.+..|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34455666666665 45566666667777777554 36655556666677777777777777666666666777777777
Q ss_pred ccCCcCcccCCcccccCCCCCEEecCCcccC
Q 003855 294 LSSNSLNDSLPSNVQKLKVLTVLDLSRNQLS 324 (791)
Q Consensus 294 l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~ 324 (791)
|++|+|+...+..|..+ +|+.|+|++|.+.
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhccc-cccccccCCCccc
Confidence 77777764444444433 5667777777664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=1.8e-09 Score=98.35 Aligned_cols=104 Identities=23% Similarity=0.217 Sum_probs=64.1
Q ss_pred CCCCCCeEEccCCcCcccCCcccccCCCCCEEecCCcccCCCC--CcchhccccccccccccccCCCCCCcccCCCCCCc
Q 003855 285 SLEYILDINLSSNSLNDSLPSNVQKLKVLTVLDLSRNQLSGDI--PSTIGALKDLETLSLARNQFQGPIPESVGSLISLE 362 (791)
Q Consensus 285 ~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 362 (791)
.+..+..++..+|.+. .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+....+|+
T Consensus 40 ~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~ 118 (162)
T d1koha1 40 AQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118 (162)
T ss_dssp TTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCS
T ss_pred hccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccc
Confidence 3333444444444332 33444556778888888888887432 34466778888888888888743332333445678
Q ss_pred EEEccCCccCCCCch-------hhhhcccCceEE
Q 003855 363 SLDLSGNNLSGKIPK-------SLETLSQLKQFN 389 (791)
Q Consensus 363 ~L~l~~N~l~~~~~~-------~~~~l~~L~~l~ 389 (791)
.|++++|++++.... .+..+|+|+.||
T Consensus 119 ~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp SCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred eeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 888888888755432 355678887764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=3.4e-09 Score=96.40 Aligned_cols=104 Identities=18% Similarity=0.142 Sum_probs=51.2
Q ss_pred CCEEEccCCccccccCccccCCCCCCEEEcccccCcccCCccccccCCCceEEecCCccCCCC--CccccCCCCCcEEEc
Q 003855 193 LTLLSLHSNDLNGTISPTMGRLKRLQGLSLRNNNLEGSIPYDLCHLKLMFGIRLTGNKLSGHI--PPCLVSLTSLRELHL 270 (791)
Q Consensus 193 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~L 270 (791)
.+.|+++++... ..+..+..+..++..+|.+. .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 445555554432 12334444444455444443 33334445666666666666665332 233445566666666
Q ss_pred CCCcCCCCCCccccCCCCCCeEEccCCcCcc
Q 003855 271 GSNKLTSSIPSSLWSLEYILDINLSSNSLND 301 (791)
Q Consensus 271 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~i~~ 301 (791)
++|+|+...+-.+....+|+.|++++|.+..
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCc
Confidence 6666654332222233345555555555543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.42 E-value=5.8e-07 Score=88.70 Aligned_cols=150 Identities=13% Similarity=0.131 Sum_probs=104.6
Q ss_pred hHHHHHhhccccccccCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CCccceeeeeeccCCee
Q 003855 494 LDIQRATDEFNECNLLGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFK 572 (791)
Q Consensus 494 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 572 (791)
.++....+.|+..+..+-++.+.||+... +++.+++|+...........+.+|..+++.+. +--+.+++++..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 35666667888777655555678998865 56678889876655444455677888888773 33356778888888889
Q ss_pred eEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHcc-----------------------------------
Q 003855 573 ALVLEFMPNGSLEKWLYSHNYFLDILERLNIMIDVGSALEYLHHG----------------------------------- 617 (791)
Q Consensus 573 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------------------------------- 617 (791)
++||++++|.++.+...... ....++.++++.+..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999999988866543211 1233455666666666630
Q ss_pred --------------------CCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 618 --------------------HSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 618 --------------------~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
.....++|+|+.|.||++++++.+-|.||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 012237899999999999987777799998774
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.85 E-value=2.1e-06 Score=77.88 Aligned_cols=38 Identities=5% Similarity=0.170 Sum_probs=16.8
Q ss_pred CCccEEEccCC-cceec----CCccCcCCCCCCEEeccCcccc
Q 003855 62 PNIESLLLAAN-NLTGI----IPHSITNATKLVALDLGFNSFA 99 (791)
Q Consensus 62 ~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~i~ 99 (791)
++|++|+|+++ .++.. +..++...++|++|+|++|.+.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence 45555555542 34311 1223344444555555555444
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.79 E-value=4.8e-06 Score=75.38 Aligned_cols=114 Identities=16% Similarity=0.194 Sum_probs=55.3
Q ss_pred CCCCCcEEEcCCC-cCCCC----CCccccCCCCCCeEEccCCcCcccC----CcccccCCCCCEEecCCcccCCCCCcch
Q 003855 261 SLTSLRELHLGSN-KLTSS----IPSSLWSLEYILDINLSSNSLNDSL----PSNVQKLKVLTVLDLSRNQLSGDIPSTI 331 (791)
Q Consensus 261 ~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~l~~N~i~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 331 (791)
+.++|++|+|+++ .+... +...+...++|+.|+|++|.+.... ...+...+.|+.|+|++|.+.+.....
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~- 91 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR- 91 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH-
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH-
Confidence 4566777777763 35421 1223444455666666666554321 122333444555555555544221111
Q ss_pred hccccccccccccccCCCCCCcccCCCCCCcEEEccCCccCCC-------CchhhhhcccCceEEccCCC
Q 003855 332 GALKDLETLSLARNQFQGPIPESVGSLISLESLDLSGNNLSGK-------IPKSLETLSQLKQFNVSHNR 394 (791)
Q Consensus 332 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-------~~~~~~~l~~L~~l~l~~N~ 394 (791)
+-..+...++|+.|+|++|++... +...+...+.|+.|+++.+.
T Consensus 92 -------------------l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 -------------------LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp -------------------HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred -------------------HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 112334445666666666654422 23344555667777666553
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.71 E-value=3.1e-05 Score=75.39 Aligned_cols=131 Identities=15% Similarity=0.094 Sum_probs=84.4
Q ss_pred ccCCCcc-eEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccC--CccceeeeeeccCCeeeEEEecCCCCCH
Q 003855 508 LLGTGSF-GSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRH--RNLIKILSSCSNPDFKALVLEFMPNGSL 584 (791)
Q Consensus 508 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L 584 (791)
.+..|.. +.||+...+++..+++|....... ..+..|...++.+.. -.+.+++++..+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445553 678999888888899998654432 345668888877743 2356678888888888999999987654
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q 003855 585 EKWLYSHNYFLDILERLNIMIDVGSALEYLH------------------------------------------------- 615 (791)
Q Consensus 585 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH------------------------------------------------- 615 (791)
.+.- ... ...+.++++.+.-||
T Consensus 94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 2200 010 111222223333333
Q ss_pred --cc---CCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 616 --HG---HSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 616 --~~---~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
.. .....++|+|+.|.||+++++..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 112247999999999999987777899998764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.32 E-value=9.7e-06 Score=73.26 Aligned_cols=20 Identities=10% Similarity=0.042 Sum_probs=11.9
Q ss_pred ccCCCCCCcEEEccCCCCcc
Q 003855 137 SLTNCRNLTILSFGSNPLGG 156 (791)
Q Consensus 137 ~l~~l~~L~~L~L~~N~l~~ 156 (791)
.+..+++|++|+|++|.++.
T Consensus 41 al~~n~~L~~L~Ls~n~l~~ 60 (166)
T d1io0a_ 41 ALKTNTYVKKFSIVGTRSND 60 (166)
T ss_dssp HHTTCCSCCEEECTTSCCCH
T ss_pred HHhcCCccCeeeccCCcccH
Confidence 34555666666666666653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.31 E-value=1.2e-05 Score=72.76 Aligned_cols=69 Identities=13% Similarity=0.133 Sum_probs=33.8
Q ss_pred cCCCCCCEEeccCccccccc----cccccccccccc--cccccccccccCCCccccccccccCCCCCCcEEEccCCCCc
Q 003855 83 TNATKLVALDLGFNSFAGHI----LNTFGNLRHLSL--LSQVMNNLTTESSSADQWSFLSSLTNCRNLTILSFGSNPLG 155 (791)
Q Consensus 83 ~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~--L~l~~n~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 155 (791)
...+.|+.|++++|.+.... ...+...++|+. |+++.|.+...... .+...+...++|+.|+++.+...
T Consensus 71 ~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~----~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 71 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM----EIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH----HHHHHHHHCSSCCEEECCCSSHH
T ss_pred hhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH----HHHHHHHhCCCcCEEeCcCCCCc
Confidence 33445555555555544321 233344444543 23334444332111 12344667788888888877543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.17 E-value=0.00052 Score=70.93 Aligned_cols=76 Identities=16% Similarity=0.190 Sum_probs=47.8
Q ss_pred ccccCCCcceEEEEEEec-CCcEEEEEEeehhhh-------HHHHHHHHHHHHHHhcc-C--CccceeeeeeccCCeeeE
Q 003855 506 CNLLGTGSFGSVYKGTIS-DGTDVAIKIFNLQLE-------RAFRSFDSECEVLRNVR-H--RNLIKILSSCSNPDFKAL 574 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l 574 (791)
.+.||.|....||+.... +++.|+||.-....+ ........|.+.++.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999865 467899997543211 01223445777787662 2 345555554 4455679
Q ss_pred EEecCCCCC
Q 003855 575 VLEFMPNGS 583 (791)
Q Consensus 575 v~e~~~~g~ 583 (791)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.88 E-value=0.0022 Score=64.17 Aligned_cols=67 Identities=10% Similarity=0.084 Sum_probs=44.8
Q ss_pred eEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCcc--ceeee-----eeccCCeeeEEEecCCCC
Q 003855 515 GSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRNL--IKILS-----SCSNPDFKALVLEFMPNG 582 (791)
Q Consensus 515 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~g 582 (791)
-.||++...+|+.|++|+..... ...+++..|...+..+....+ +..+. ........+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 47999999999999999976542 234567778888888753222 11111 123345678899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.20 E-value=0.0083 Score=59.49 Aligned_cols=156 Identities=11% Similarity=0.078 Sum_probs=83.0
Q ss_pred ChhHHHHHhhccccccc-----cCCCcceEEEEEEecCCcEEEEEEeehhhhHHHHHHHHHHHHHHhccCCc-----cce
Q 003855 492 PYLDIQRATDEFNECNL-----LGTGSFGSVYKGTISDGTDVAIKIFNLQLERAFRSFDSECEVLRNVRHRN-----LIK 561 (791)
Q Consensus 492 ~~~~~~~~~~~~~~~~~-----ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-----iv~ 561 (791)
+..+++....+|...+. |..|.--+.|+.+.++| .+++|++..... .+.+..|++++..+...+ .+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccce
Confidence 34567777777876443 44566677899887665 589999864321 234455677777764322 221
Q ss_pred ee-e--eeccCCeeeEEEecCCCCCHH--------------HHHhh--C------CCCCCH------------------H
Q 003855 562 IL-S--SCSNPDFKALVLEFMPNGSLE--------------KWLYS--H------NYFLDI------------------L 598 (791)
Q Consensus 562 l~-~--~~~~~~~~~lv~e~~~~g~L~--------------~~l~~--~------~~~~~~------------------~ 598 (791)
.. | +.........++.++.+.... ..++. . ...... .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 1 112234455677776654221 01110 0 000000 0
Q ss_pred HHHHHHHHHHHHHHHHHccCCCCCeEecCCCCCCeEeCCCCcEEEeeecccc
Q 003855 599 ERLNIMIDVGSALEYLHHGHSSAPIIHCDLKPTNILLDENMAAHVSDFGISK 650 (791)
Q Consensus 599 ~~~~i~~~i~~~l~~LH~~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfgla~ 650 (791)
.....+..+...+...+...-..+++|+|+.+.||+++.+...-|.||+.|.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1112222333333333322235689999999999999988878899999774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.68 E-value=0.0096 Score=61.12 Aligned_cols=72 Identities=11% Similarity=0.146 Sum_probs=48.2
Q ss_pred ccccCCCcceEEEEEEecC--------CcEEEEEEeehhhhHHHHHHHHHHHHHHhcc-CCccceeeeeeccCCeeeEEE
Q 003855 506 CNLLGTGSFGSVYKGTISD--------GTDVAIKIFNLQLERAFRSFDSECEVLRNVR-HRNLIKILSSCSNPDFKALVL 576 (791)
Q Consensus 506 ~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 576 (791)
++.|+.|---.+|+....+ .+.|.+++.-... . .....+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3568878888999998653 3567777765322 2 234557888888884 4334577777653 5899
Q ss_pred ecCCCCC
Q 003855 577 EFMPNGS 583 (791)
Q Consensus 577 e~~~~g~ 583 (791)
||++|.+
T Consensus 121 efi~g~~ 127 (395)
T d1nw1a_ 121 EYIPSRP 127 (395)
T ss_dssp CCCCEEE
T ss_pred EEecccc
Confidence 9998753
|